"","annot_w_GO_top.qseqid","annot_w_GO_top.sseqid","annot_w_GO_top.evalue","annot_w_GO_top.bitscore","annot_w_GO_top.SPID","annot_w_GO_top.Entry.Name","annot_w_GO_top.Protein.names","annot_w_GO_top.Gene.Names","annot_w_GO_top.Organism","annot_w_GO_top.Length","annot_w_GO_top.Gene.Ontology.IDs","annot_w_GO_top.Gene.Ontology..biological.process.","annot_w_GO_top.Gene.Ontology..GO.","annot_w_GO_top.Developmental.stage","annot_w_GO_top.Induction","annot_w_GO_top.Induction.1","annot_w_GO_top.Tissue.specificity"
"1","sp|Q9UMX2|OAZ3_HUMAN","lcl|NC_088853.1_cds_XP_011416078.3_991",2.11e-19,84.3,"Q9UMX2","OAZ3_HUMAN","Ornithine decarboxylase antizyme 3 (AZ3) (ODC-Az 3)","OAZ3","Homo sapiens (Human)",235,"GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006596; GO:0007283; GO:0008073; GO:0036126; GO:0045732; GO:0051497; GO:0071532; GO:0072562; GO:0075523; GO:0090316; GO:1902268","negative regulation of polyamine transmembrane transport [GO:1902268]; negative regulation of stress fiber assembly [GO:0051497]; polyamine biosynthetic process [GO:0006596]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of protein catabolic process [GO:0045732]; spermatogenesis [GO:0007283]; viral translational frameshifting [GO:0075523]","blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; ankyrin repeat binding [GO:0071532]; ornithine decarboxylase inhibitor activity [GO:0008073]; negative regulation of polyamine transmembrane transport [GO:1902268]; negative regulation of stress fiber assembly [GO:0051497]; polyamine biosynthetic process [GO:0006596]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of protein catabolic process [GO:0045732]; spermatogenesis [GO:0007283]; viral translational frameshifting [GO:0075523]","DEVELOPMENTAL STAGE: Expression starts early in spermiogenesis and finishes in the late spermatid phase.","","","TISSUE SPECIFICITY: Testis specific."
"2","sp|Q5XHX6|TXND2_RAT","lcl|NC_088853.1_cds_XP_011425198.2_3169",1.08e-24,105,"Q5XHX6","TXND2_RAT","Thioredoxin domain-containing protein 2 (Spermatid-specific thioredoxin-1) (Sptrx-1)","Txndc2 Sptrx Sptrx1","Rattus norvegicus (Rat)",550,"GO:0001520; GO:0003756; GO:0004791; GO:0005737; GO:0007283; GO:0030154; GO:0030317; GO:0034614; GO:0036126","cell differentiation [GO:0030154]; cellular response to reactive oxygen species [GO:0034614]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; outer dense fiber [GO:0001520]; sperm flagellum [GO:0036126]; protein disulfide isomerase activity [GO:0003756]; thioredoxin-disulfide reductase (NADPH) activity [GO:0004791]; cell differentiation [GO:0030154]; cellular response to reactive oxygen species [GO:0034614]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Transiently expressed in spermiogenesis, being mostly concentrated in the periaxonemal compartment of the tail of the elongating spermatid, where it transiently associates with the longitudinal column of the FS. In the very last steps (steps 17-19), when periaxonemal expression disappears, it is still weakly present in the shrinking cytoplasmic lobe (at protein level). {ECO:0000269|PubMed:12390887}.","","","TISSUE SPECIFICITY: Testis-specific. Strongly expressed in the testicular seminiferous tubules, mostly in the round spermatids. {ECO:0000269|PubMed:12390887}."
"3","sp|P07154|CATL1_RAT","lcl|NC_088853.1_cds_XP_011430873.2_3212",3.22e-125,363,"P07154","CATL1_RAT","Procathepsin L (EC 3.4.22.15) (Cathepsin L1) (Cyclic protein 2) (CP-2) (Major excreted protein) (MEP) [Cleaved into: Cathepsin L; Cathepsin L heavy chain; Cathepsin L light chain]","Ctsl Ctsl1","Rattus norvegicus (Rat)",334,"GO:0001968; GO:0002250; GO:0004175; GO:0004177; GO:0004197; GO:0005518; GO:0005615; GO:0005634; GO:0005730; GO:0005764; GO:0005771; GO:0005886; GO:0005902; GO:0006508; GO:0006590; GO:0007283; GO:0008234; GO:0008584; GO:0009267; GO:0009749; GO:0009897; GO:0010839; GO:0016324; GO:0016540; GO:0016807; GO:0019064; GO:0019065; GO:0021675; GO:0030141; GO:0030163; GO:0030574; GO:0030984; GO:0031069; GO:0031410; GO:0031638; GO:0034230; GO:0034698; GO:0039654; GO:0042277; GO:0042393; GO:0042583; GO:0043204; GO:0043373; GO:0043394; GO:0043616; GO:0044877; GO:0045177; GO:0046697; GO:0046718; GO:0046872; GO:0048002; GO:0048102; GO:0051384; GO:0051603; GO:0060008; GO:0060309; GO:0097067; GO:0097655; GO:1904612; GO:1990834","adaptive immune response [GO:0002250]; antigen processing and presentation of peptide antigen [GO:0048002]; autophagic cell death [GO:0048102]; CD4-positive, alpha-beta T cell lineage commitment [GO:0043373]; cellular response to starvation [GO:0009267]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; elastin catabolic process [GO:0060309]; enkephalin processing [GO:0034230]; fusion of virus membrane with host endosome membrane [GO:0039654]; fusion of virus membrane with host plasma membrane [GO:0019064]; hair follicle morphogenesis [GO:0031069]; keratinocyte proliferation [GO:0043616]; male gonad development [GO:0008584]; negative regulation of keratinocyte proliferation [GO:0010839]; nerve development [GO:0021675]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904612]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to odorant [GO:1990834]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590]; zymogen activation [GO:0031638]","apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; chromaffin granule [GO:0042583]; cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; microvillus [GO:0005902]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; aminopeptidase activity [GO:0004177]; collagen binding [GO:0005518]; cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; histone binding [GO:0042393]; kininogen binding [GO:0030984]; metal ion binding [GO:0046872]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; proteoglycan binding [GO:0043394]; serpin family protein binding [GO:0097655]; adaptive immune response [GO:0002250]; antigen processing and presentation of peptide antigen [GO:0048002]; autophagic cell death [GO:0048102]; CD4-positive, alpha-beta T cell lineage commitment [GO:0043373]; cellular response to starvation [GO:0009267]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; elastin catabolic process [GO:0060309]; enkephalin processing [GO:0034230]; fusion of virus membrane with host endosome membrane [GO:0039654]; fusion of virus membrane with host plasma membrane [GO:0019064]; hair follicle morphogenesis [GO:0031069]; keratinocyte proliferation [GO:0043616]; male gonad development [GO:0008584]; negative regulation of keratinocyte proliferation [GO:0010839]; nerve development [GO:0021675]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904612]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to odorant [GO:1990834]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590]; zymogen activation [GO:0031638]","","INDUCTION: Expression in Sertoli cells is repressed by germ cells. {ECO:0000269|PubMed:11356678}.","INDUCTION: Expression in Sertoli cells is repressed by germ cells. {ECO:0000269|PubMed:11356678}.","TISSUE SPECIFICITY: Both mature cathepsin L1 and procathepsin L are found in the upper epidermis. The lower epidermis predominantly contains procathepsin L. In seminiferous tubules expression is greater at stages VI-VII than at stages IX-XII. {ECO:0000269|PubMed:10699763, ECO:0000269|PubMed:11356678}."
"4","sp|Q9Y2W6|TDRKH_HUMAN","lcl|NC_088853.1_cds_XP_034318708.2_464",5.87e-64,217,"Q9Y2W6","TDRKH_HUMAN","Tudor and KH domain-containing protein (Tudor domain-containing protein 2)","TDRKH TDRD2","Homo sapiens (Human)",561,"GO:0003723; GO:0005739; GO:0007140; GO:0007283; GO:0009566; GO:0030719; GO:0034587; GO:0043186; GO:0071546; GO:0071547","fertilization [GO:0009566]; male meiotic nuclear division [GO:0007140]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]","mitochondrion [GO:0005739]; P granule [GO:0043186]; pi-body [GO:0071546]; piP-body [GO:0071547]; RNA binding [GO:0003723]; fertilization [GO:0009566]; male meiotic nuclear division [GO:0007140]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]","","","",""
"5","sp|A2A6C4|SPP2C_MOUSE","lcl|NC_088853.1_cds_XP_034320813.2_363",3.96e-70,239,"A2A6C4","SPP2C_MOUSE","Signal peptide peptidase-like 2C (SPP-like 2C) (SPPL2c) (EC 3.4.23.-) (Intramembrane protease 5) (IMP-5)","Sppl2c Imp5","Mus musculus (Mouse)",690,"GO:0001675; GO:0004190; GO:0005789; GO:0006874; GO:0007283; GO:0007342; GO:0031293; GO:0042500; GO:0042803; GO:0050821; GO:0060090; GO:0098553; GO:0098554","acrosome assembly [GO:0001675]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; intracellular calcium ion homeostasis [GO:0006874]; membrane protein intracellular domain proteolysis [GO:0031293]; protein stabilization [GO:0050821]; spermatogenesis [GO:0007283]","cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; aspartic-type endopeptidase activity [GO:0004190]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803]; acrosome assembly [GO:0001675]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; intracellular calcium ion homeostasis [GO:0006874]; membrane protein intracellular domain proteolysis [GO:0031293]; protein stabilization [GO:0050821]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: [Isoform 1]: Highly expressed in testis where it is primarily localised in spermatids (at protein level). {ECO:0000269|PubMed:30733281, ECO:0000269|PubMed:35960805}.; TISSUE SPECIFICITY: [Isoform 2]: Highly expressed in testis where it is primarily localised in spermatids (at protein level). {ECO:0000269|PubMed:30733281, ECO:0000269|PubMed:35960805}."
"6","sp|Q9JHJ7|TEST_MOUSE","lcl|NC_088853.1_cds_XP_034321130.2_2252",1.4e-53,179,"Q9JHJ7","TEST_MOUSE","Testisin (EC 3.4.21.-) (Serine protease 21) (Tryptase 4)","Prss21","Mus musculus (Mouse)",324,"GO:0004252; GO:0005886; GO:0006508; GO:0007283; GO:0008236; GO:0016020; GO:0098552","proteolysis [GO:0006508]; spermatogenesis [GO:0007283]","membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed in post-meiotic testicular germ cells.","","","TISSUE SPECIFICITY: Testis."
"7","sp|Q9Y6M0|TEST_HUMAN","lcl|NC_088853.1_cds_XP_034321132.2_2254",9.89e-50,169,"Q9Y6M0","TEST_HUMAN","Testisin (EC 3.4.21.-) (Eosinophil serine protease 1) (ESP-1) (Serine protease 21)","PRSS21 ESP1 TEST1 UNQ266/PRO303","Homo sapiens (Human)",314,"GO:0004252; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0007283; GO:0008236; GO:0016020; GO:0098552","proteolysis [GO:0006508]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed predominantly in premeiotic testicular germ cells, mostly late pachytene and diplotene spermatocytes."
"8","sp|O70437|SMAD4_RAT","lcl|NC_088853.1_cds_XP_034321159.1_869",0,640,"O70437","SMAD4_RAT","Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (SMAD family member 4) (SMAD 4) (Smad4)","Smad4 Madh4","Rattus norvegicus (Rat)",552,"GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001222; GO:0001223; GO:0001228; GO:0001541; GO:0001649; GO:0001658; GO:0001666; GO:0001701; GO:0001702; GO:0001822; GO:0001837; GO:0003148; GO:0003190; GO:0003198; GO:0003220; GO:0003251; GO:0003279; GO:0003360; GO:0003677; GO:0003682; GO:0003700; GO:0005518; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0005829; GO:0006351; GO:0006357; GO:0006366; GO:0006879; GO:0007179; GO:0007283; GO:0007338; GO:0007369; GO:0007411; GO:0007492; GO:0007498; GO:0008283; GO:0008285; GO:0008584; GO:0008585; GO:0009653; GO:0009952; GO:0010614; GO:0010628; GO:0010631; GO:0010666; GO:0010718; GO:0014033; GO:0014898; GO:0030154; GO:0030308; GO:0030325; GO:0030509; GO:0030511; GO:0031005; GO:0032444; GO:0032525; GO:0032909; GO:0032991; GO:0033686; GO:0035556; GO:0036064; GO:0036302; GO:0042118; GO:0042127; GO:0042177; GO:0042733; GO:0042802; GO:0042803; GO:0043199; GO:0043565; GO:0044877; GO:0045892; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0046881; GO:0048382; GO:0048589; GO:0048663; GO:0048665; GO:0048729; GO:0048733; GO:0048859; GO:0051797; GO:0060065; GO:0060391; GO:0060395; GO:0060412; GO:0060956; GO:0061040; GO:0061629; GO:0062009; GO:0070102; GO:0070371; GO:0070373; GO:0070411; GO:0070412; GO:0071141; GO:0071144; GO:0071333; GO:0071559; GO:0071560; GO:0072133; GO:0072134; GO:0072520; GO:0090090; GO:0090575; GO:0097191; GO:1901203; GO:1902895; GO:1905305","adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cardiac septum development [GO:0003279]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to glucose stimulus [GO:0071333]; cellular response to transforming growth factor beta stimulus [GO:0071560]; developmental growth [GO:0048589]; DNA-templated transcription [GO:0006351]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endoderm development [GO:0007492]; endothelial cell activation [GO:0042118]; epithelial cell migration [GO:0010631]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; ERK1 and ERK2 cascade [GO:0070371]; extrinsic apoptotic signaling pathway [GO:0097191]; female gonad development [GO:0008585]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation [GO:0007369]; gastrulation with mouth forming second [GO:0001702]; in utero embryonic development [GO:0001701]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular iron ion homeostasis [GO:0006879]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; male gonad development [GO:0008584]; mesendoderm development [GO:0048382]; mesoderm development [GO:0007498]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of gene expression [GO:0010628]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cell population proliferation [GO:0042127]; regulation of hair follicle development [GO:0051797]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to transforming growth factor beta [GO:0071559]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; tissue morphogenesis [GO:0048729]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]","activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; chromatin [GO:0000785]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; collagen binding [GO:0005518]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; filamin binding [GO:0031005]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; sulfate binding [GO:0043199]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cardiac septum development [GO:0003279]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to glucose stimulus [GO:0071333]; cellular response to transforming growth factor beta stimulus [GO:0071560]; developmental growth [GO:0048589]; DNA-templated transcription [GO:0006351]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endoderm development [GO:0007492]; endothelial cell activation [GO:0042118]; epithelial cell migration [GO:0010631]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; ERK1 and ERK2 cascade [GO:0070371]; extrinsic apoptotic signaling pathway [GO:0097191]; female gonad development [GO:0008585]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation [GO:0007369]; gastrulation with mouth forming second [GO:0001702]; in utero embryonic development [GO:0001701]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular iron ion homeostasis [GO:0006879]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; male gonad development [GO:0008584]; mesendoderm development [GO:0048382]; mesoderm development [GO:0007498]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of gene expression [GO:0010628]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cell population proliferation [GO:0042127]; regulation of hair follicle development [GO:0051797]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to transforming growth factor beta [GO:0071559]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; tissue morphogenesis [GO:0048729]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]","","","",""
"9","sp|P41828|NHR23_CAEEL","lcl|NC_088853.1_cds_XP_034321284.1_2560",3.86e-80,262,"P41828","NHR23_CAEEL","Nuclear hormone receptor family member nhr-23 (Steroid hormone receptor family member chr-3)","nhr-23 chr-3 cnr-3 let-527 C01H6.5","Caenorhabditis elegans",588,"GO:0000785; GO:0000977; GO:0000978; GO:0004879; GO:0005634; GO:0006357; GO:0007283; GO:0008270; GO:0018996; GO:0045944; GO:0050829","defense response to Gram-negative bacterium [GO:0050829]; molting cycle, collagen and cuticulin-based cuticle [GO:0018996]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","chromatin [GO:0000785]; nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; defense response to Gram-negative bacterium [GO:0050829]; molting cycle, collagen and cuticulin-based cuticle [GO:0018996]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed in all blastomeres of the embryo from at least the 2-cell stage until approximately the 200-cell stage (at protein level) (PubMed:9521900). Expression becomes restricted mainly to epidermal cells and their precursors after 200 cell stage and during subsequent embryogenesis (at protein level) (PubMed:9521900). Expressed at high levels in newly hatched larvae, then decreases to a minimum at 4-6 hr after L1 stage larvae start feeding; expression increases for about 2 hr and decreases before each successive molt (PubMed:11416209). In L4 larvae, expressed in hypodermal cells of the head, vulval precursor cells of hermaphrodites, and hypodermal and tail cells of males (PubMed:33060131). Also expressed in the sperm-producing germlines of males and L4 hermaphrodites, but not in hermaphrodites producing only oocytes (PubMed:33060131). {ECO:0000269|PubMed:11416209, ECO:0000269|PubMed:33060131, ECO:0000269|PubMed:9521900}.","INDUCTION: Post-transcriptionally repressed by let-7 microRNAs. {ECO:0000269|PubMed:35968765}.","INDUCTION: Post-transcriptionally repressed by let-7 microRNAs. {ECO:0000269|PubMed:35968765}.","TISSUE SPECIFICITY: Expressed in the germline and oocytes and is a maternal gene product (PubMed:9521900). In males and sperm-producing hermaphrodites, expressed in early pachytene spermatocytes, increasing in level throughout late pachytene (PubMed:33060131). Expression is undetectable in meiotically dividing spermatocytes or mature spermatids (PubMed:33060131). {ECO:0000269|PubMed:33060131, ECO:0000269|PubMed:9521900}."
"10","sp|O01803|RB11A_CAEEL","lcl|NC_088853.1_cds_XP_034321379.1_1520",2.91e-122,346,"O01803","RB11A_CAEEL","Ras-related protein rab-11.1 (Rab GTPase rab-11.1)","rab-11.1 F53G12.1","Caenorhabditis elegans",211,"GO:0000139; GO:0000281; GO:0003924; GO:0005525; GO:0005794; GO:0005813; GO:0005819; GO:0005829; GO:0006887; GO:0006898; GO:0009792; GO:0015031; GO:0016324; GO:0030133; GO:0030703; GO:0055037; GO:0055038; GO:0060471; GO:0060473; GO:0061796; GO:1990676","cortical granule exocytosis [GO:0060471]; eggshell formation [GO:0030703]; embryo development ending in birth or egg hatching [GO:0009792]; exocytosis [GO:0006887]; membrane addition at site of mitotic cytokinesis [GO:0061796]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]","apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cortical granule [GO:0060473]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi trans cisterna membrane [GO:1990676]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; spindle [GO:0005819]; transport vesicle [GO:0030133]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cortical granule exocytosis [GO:0060471]; eggshell formation [GO:0030703]; embryo development ending in birth or egg hatching [GO:0009792]; exocytosis [GO:0006887]; membrane addition at site of mitotic cytokinesis [GO:0061796]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]","DEVELOPMENTAL STAGE: Expressed during embryogenesis (PubMed:18385514, PubMed:20116245, PubMed:26506309). Transiently expressed during cytokinesis in embryos on the ingressing furrow and at the midbody during early abscission (PubMed:20116245). Expressed during the L4 stage and young adult stage of development (PubMed:22634595). {ECO:0000269|PubMed:18385514, ECO:0000269|PubMed:20116245, ECO:0000269|PubMed:22634595, ECO:0000269|PubMed:26506309}.","","","TISSUE SPECIFICITY: Expressed weakly in sperm, but more predominantly in oocytes (PubMed:18472420). Expressed in the intestine (PubMed:24843160). {ECO:0000269|PubMed:18472420, ECO:0000269|PubMed:24843160}."
"11","sp|G5EEV2|TRR1_CAEEL","lcl|NC_088853.1_cds_XP_034321941.2_2005",5.71e-157,553,"G5EEV2","TRR1_CAEEL","Transcription-associated protein 1 (Cel-trr-1) (TRRAP-like protein 1)","trr-1 C47D12.1","Caenorhabditis elegans",4062,"GO:0000123; GO:0000124; GO:0000793; GO:0005634; GO:0006355; GO:0007283; GO:0022414; GO:0030154; GO:0035267; GO:0040010; GO:0040027; GO:0140861","cell differentiation [GO:0030154]; DNA repair-dependent chromatin remodeling [GO:0140861]; negative regulation of vulval development [GO:0040027]; positive regulation of growth rate [GO:0040010]; regulation of DNA-templated transcription [GO:0006355]; reproductive process [GO:0022414]; spermatogenesis [GO:0007283]","condensed chromosome [GO:0000793]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; cell differentiation [GO:0030154]; DNA repair-dependent chromatin remodeling [GO:0140861]; negative regulation of vulval development [GO:0040027]; positive regulation of growth rate [GO:0040010]; regulation of DNA-templated transcription [GO:0006355]; reproductive process [GO:0022414]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed throughout development from one-cell stage embryos onwards. {ECO:0000269|PubMed:15068795}.","","","TISSUE SPECIFICITY: Expressed in germ cells and somatic cells. {ECO:0000269|PubMed:15068795}."
"12","sp|Q9QXM0|ABHD2_MOUSE","lcl|NC_088853.1_cds_XP_065921569.1_1521",5.3e-120,356,"Q9QXM0","ABHD2_MOUSE","Monoacylglycerol lipase ABHD2 (EC 3.1.1.23) (2-arachidonoylglycerol hydrolase) (Abhydrolase domain-containing protein 2) (Acetylesterase) (EC 3.1.1.6) (Lung alpha/beta hydrolase 2) (MmLABH2) (Triacylglycerol lipase) (EC 3.1.1.79)","Abhd2 Labh-2 Labh2","Mus musculus (Mouse)",425,"GO:0001669; GO:0002080; GO:0003707; GO:0004806; GO:0007340; GO:0008126; GO:0009611; GO:0014909; GO:0014912; GO:0032570; GO:0036126; GO:0042562; GO:0043401; GO:0046464; GO:0047372; GO:0048240; GO:0097524; GO:0120516","acrosome reaction [GO:0007340]; acylglycerol catabolic process [GO:0046464]; negative regulation of smooth muscle cell migration [GO:0014912]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; smooth muscle cell migration [GO:0014909]; sperm capacitation [GO:0048240]; steroid hormone receptor signaling pathway [GO:0043401]","acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; sperm flagellum [GO:0036126]; sperm plasma membrane [GO:0097524]; acetylesterase activity [GO:0008126]; diacylglycerol lipase activity [GO:0120516]; hormone binding [GO:0042562]; monoacylglycerol lipase activity [GO:0047372]; nuclear steroid receptor activity [GO:0003707]; triacylglycerol lipase activity [GO:0004806]; acrosome reaction [GO:0007340]; acylglycerol catabolic process [GO:0046464]; negative regulation of smooth muscle cell migration [GO:0014912]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; smooth muscle cell migration [GO:0014909]; sperm capacitation [GO:0048240]; steroid hormone receptor signaling pathway [GO:0043401]","DEVELOPMENTAL STAGE: Detected in embryos from 7 dpc to 17 dpc. Weakly expressed in heart at 9.5 dpc. Expression is detected in endothelial cells of the dorsal aorta at 10.5 dpc and disappear at 12.5 dpc. Expression in smooth muscle cells is first detected at 11.5 dpc. Strongly expressed in vitelline vessels at 12.5 dpc. Expressed in all smooth muscle cells at 16.5 dpc. {ECO:0000269|PubMed:11922611, ECO:0000269|PubMed:15721306}.","","","TISSUE SPECIFICITY: Widely expressed with higher expression in testis. Expressed by vascular smooth muscle cells, non vascular smooth muscle cells and heart. {ECO:0000269|PubMed:11922611, ECO:0000269|PubMed:15721306}."
"13","sp|A8WTE8|TRR1_CAEBR","lcl|NC_088853.1_cds_XP_065923510.1_2006",3.58e-161,566,"A8WTE8","TRR1_CAEBR","Transcription-associated protein 1 (Cbr-trr-1) (TRRAP-like protein 1)","trr-1 CBG02835","Caenorhabditis briggsae",4115,"GO:0000124; GO:0005634; GO:0006355; GO:0007283; GO:0030154; GO:0035267; GO:0140861","cell differentiation [GO:0030154]; DNA repair-dependent chromatin remodeling [GO:0140861]; regulation of DNA-templated transcription [GO:0006355]; spermatogenesis [GO:0007283]","NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; cell differentiation [GO:0030154]; DNA repair-dependent chromatin remodeling [GO:0140861]; regulation of DNA-templated transcription [GO:0006355]; spermatogenesis [GO:0007283]","","","",""
"14","sp|Q99828|CIB1_HUMAN","lcl|NC_088853.1_cds_XP_065924237.1_2156",2.91e-42,141,"Q99828","CIB1_HUMAN","Calcium and integrin-binding protein 1 (CIB) (Calcium- and integrin-binding protein) (CIBP) (Calmyrin) (DNA-PKcs-interacting protein) (Kinase-interacting protein) (KIP) (SNK-interacting protein 2-28) (SIP2-28)","CIB1 CIB KIP PRKDCIP","Homo sapiens (Human)",191,"GO:0000287; GO:0001525; GO:0001933; GO:0001934; GO:0001954; GO:0002931; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005813; GO:0005886; GO:0006302; GO:0006915; GO:0006974; GO:0007026; GO:0007113; GO:0007155; GO:0007286; GO:0008284; GO:0008285; GO:0008427; GO:0010977; GO:0016020; GO:0016324; GO:0016604; GO:0030027; GO:0030220; GO:0030291; GO:0030307; GO:0030335; GO:0030424; GO:0030426; GO:0031122; GO:0031267; GO:0031982; GO:0032433; GO:0032587; GO:0033630; GO:0038163; GO:0042127; GO:0042383; GO:0043005; GO:0043025; GO:0043066; GO:0043085; GO:0043204; GO:0043495; GO:0044325; GO:0045653; GO:0048471; GO:0051092; GO:0051301; GO:0051302; GO:0051898; GO:0070062; GO:0070374; GO:0070886; GO:0071356; GO:0071363; GO:0071902; GO:0071944; GO:0090050; GO:0090314; GO:0097191; GO:1900026; GO:1903078; GO:1990090; GO:2000256","angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; DNA damage response [GO:0006974]; double-strand break repair [GO:0006302]; endomitotic cell cycle [GO:0007113]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; platelet formation [GO:0030220]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell division [GO:0051302]; regulation of cell population proliferation [GO:0042127]; response to ischemia [GO:0002931]; spermatid development [GO:0007286]; thrombopoietin-mediated signaling pathway [GO:0038163]","apical plasma membrane [GO:0016324]; axon [GO:0030424]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; calcium-dependent protein kinase inhibitor activity [GO:0008427]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-membrane adaptor activity [GO:0043495]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; DNA damage response [GO:0006974]; double-strand break repair [GO:0006302]; endomitotic cell cycle [GO:0007113]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; platelet formation [GO:0030220]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell division [GO:0051302]; regulation of cell population proliferation [GO:0042127]; response to ischemia [GO:0002931]; spermatid development [GO:0007286]; thrombopoietin-mediated signaling pathway [GO:0038163]","","INDUCTION: Up-regulated during breast cancer progression.","INDUCTION: Up-regulated during breast cancer progression.","TISSUE SPECIFICITY: Ubiquitously expressed. Expressed in the epidermis, hair follicles and keratinocytes (PubMed:30068544). Detected in platelets and in cell lines of megakaryocytic and erythrocytic lineages. Both isoform 1 and isoform 2 are detected in various cancer cell lines, with isoform 2 being the predominant form (at protein level). {ECO:0000269|PubMed:10477286, ECO:0000269|PubMed:11856312, ECO:0000269|PubMed:23503467, ECO:0000269|PubMed:30068544, ECO:0000269|PubMed:9030514, ECO:0000269|PubMed:9372844}."
"15","sp|Q5SZQ8|CELF3_HUMAN","lcl|NC_088853.1_cds_XP_065924346.1_2181",1.6e-169,488,"Q5SZQ8","CELF3_HUMAN","CUGBP Elav-like family member 3 (CELF-3) (Bruno-like protein 1) (CAG repeat protein 4) (CUG-BP- and ETR-3-like factor 3) (ELAV-type RNA-binding protein 1) (ETR-1) (Expanded repeat domain protein CAG/CTG 4) (RNA-binding protein BRUNOL-1) (Trinucleotide repeat-containing gene 4 protein)","CELF3 BRUNOL1 CAGH4 ERDA4 TNRC4","Homo sapiens (Human)",465,"GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:0007283; GO:0008380; GO:0016604; GO:0030317; GO:0030575; GO:0036002; GO:0048026; GO:0097322; GO:0140742; GO:1990904","flagellated sperm motility [GO:0030317]; lncRNA transcription [GO:0140742]; mRNA splice site recognition [GO:0006376]; nuclear body organization [GO:0030575]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; 7SK snRNA binding [GO:0097322]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; flagellated sperm motility [GO:0030317]; lncRNA transcription [GO:0140742]; mRNA splice site recognition [GO:0006376]; nuclear body organization [GO:0030575]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in brain. {ECO:0000269|PubMed:11158314}."
"16","sp|P16067|ANPRB_RAT","lcl|NC_088853.1_cds_XP_065924366.1_2196",0,908,"P16067","ANPRB_RAT","Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B)","Npr2","Rattus norvegicus (Rat)",1047,"GO:0000165; GO:0001541; GO:0001549; GO:0001568; GO:0001570; GO:0001945; GO:0001958; GO:0001964; GO:0001974; GO:0002062; GO:0003417; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0005929; GO:0006182; GO:0007033; GO:0007168; GO:0007173; GO:0007268; GO:0007281; GO:0007283; GO:0007338; GO:0007409; GO:0007605; GO:0008015; GO:0009611; GO:0009725; GO:0010641; GO:0010753; GO:0016941; GO:0017046; GO:0019228; GO:0019934; GO:0021562; GO:0021647; GO:0021675; GO:0030540; GO:0034699; GO:0035108; GO:0035112; GO:0035264; GO:0035483; GO:0035988; GO:0036342; GO:0042060; GO:0042562; GO:0042802; GO:0043005; GO:0045202; GO:0046068; GO:0048546; GO:0048565; GO:0048599; GO:0048668; GO:0048745; GO:0050872; GO:0051216; GO:0051276; GO:0051321; GO:0051402; GO:0051447; GO:0060173; GO:0060348; GO:0060385; GO:0060466; GO:0061042; GO:0061939; GO:0071321; GO:0071774; GO:0097011; GO:0097194; GO:0098868; GO:1900194; GO:1901653; GO:1902074; GO:1903537","activation of meiosis involved in egg activation [GO:0060466]; axonogenesis [GO:0007409]; axonogenesis involved in innervation [GO:0060385]; blood circulation [GO:0008015]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; bone development [GO:0060348]; bone growth [GO:0098868]; c-di-GMP signaling [GO:0061939]; cartilage development [GO:0051216]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cGMP biosynthetic process [GO:0006182]; cGMP metabolic process [GO:0046068]; cGMP-mediated signaling [GO:0019934]; chemical synaptic transmission [GO:0007268]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; chromosome organization [GO:0051276]; collateral sprouting [GO:0048668]; cumulus cell differentiation [GO:0001549]; digestive tract development [GO:0048565]; digestive tract morphogenesis [GO:0048546]; endochondral ossification [GO:0001958]; epidermal growth factor receptor signaling pathway [GO:0007173]; execution phase of apoptosis [GO:0097194]; female genitalia development [GO:0030540]; gastric emptying [GO:0035483]; genitalia morphogenesis [GO:0035112]; germ cell development [GO:0007281]; growth plate cartilage development [GO:0003417]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; lymph vessel development [GO:0001945]; MAPK cascade [GO:0000165]; meiotic cell cycle [GO:0051321]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; multicellular organism growth [GO:0035264]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; nerve development [GO:0021675]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of platelet-derived growth factor receptor signaling pathway [GO:0010641]; post-anal tail morphogenesis [GO:0036342]; receptor guanylyl cyclase signaling pathway [GO:0007168]; response to fibroblast growth factor [GO:0071774]; response to hormone [GO:0009725]; response to luteinizing hormone [GO:0034699]; response to salt [GO:1902074]; response to wounding [GO:0009611]; sensory perception of sound [GO:0007605]; single fertilization [GO:0007338]; smooth muscle tissue development [GO:0048745]; spermatogenesis [GO:0007283]; startle response [GO:0001964]; vacuole organization [GO:0007033]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; vestibulocochlear nerve development [GO:0021562]; vestibulocochlear nerve maturation [GO:0021647]; white fat cell differentiation [GO:0050872]; wound healing [GO:0042060]","cilium [GO:0005929]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; protein kinase activity [GO:0004672]; activation of meiosis involved in egg activation [GO:0060466]; axonogenesis [GO:0007409]; axonogenesis involved in innervation [GO:0060385]; blood circulation [GO:0008015]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; bone development [GO:0060348]; bone growth [GO:0098868]; c-di-GMP signaling [GO:0061939]; cartilage development [GO:0051216]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cGMP biosynthetic process [GO:0006182]; cGMP metabolic process [GO:0046068]; cGMP-mediated signaling [GO:0019934]; chemical synaptic transmission [GO:0007268]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; chromosome organization [GO:0051276]; collateral sprouting [GO:0048668]; cumulus cell differentiation [GO:0001549]; digestive tract development [GO:0048565]; digestive tract morphogenesis [GO:0048546]; endochondral ossification [GO:0001958]; epidermal growth factor receptor signaling pathway [GO:0007173]; execution phase of apoptosis [GO:0097194]; female genitalia development [GO:0030540]; gastric emptying [GO:0035483]; genitalia morphogenesis [GO:0035112]; germ cell development [GO:0007281]; growth plate cartilage development [GO:0003417]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; lymph vessel development [GO:0001945]; MAPK cascade [GO:0000165]; meiotic cell cycle [GO:0051321]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; multicellular organism growth [GO:0035264]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; nerve development [GO:0021675]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of platelet-derived growth factor receptor signaling pathway [GO:0010641]; post-anal tail morphogenesis [GO:0036342]; receptor guanylyl cyclase signaling pathway [GO:0007168]; response to fibroblast growth factor [GO:0071774]; response to hormone [GO:0009725]; response to luteinizing hormone [GO:0034699]; response to salt [GO:1902074]; response to wounding [GO:0009611]; sensory perception of sound [GO:0007605]; single fertilization [GO:0007338]; smooth muscle tissue development [GO:0048745]; spermatogenesis [GO:0007283]; startle response [GO:0001964]; vacuole organization [GO:0007033]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; vestibulocochlear nerve development [GO:0021562]; vestibulocochlear nerve maturation [GO:0021647]; white fat cell differentiation [GO:0050872]; wound healing [GO:0042060]","","","",""
"17","sp|P31689|DNJA1_HUMAN","lcl|NC_088853.1_cds_XP_065924946.1_2302",1.72e-156,447,"P31689","DNJA1_HUMAN","DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)","DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4","Homo sapiens (Human)",397,"GO:0001664; GO:0001671; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0008270; GO:0009408; GO:0015630; GO:0016020; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042026; GO:0043065; GO:0043066; GO:0043508; GO:0048471; GO:0050750; GO:0051082; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1903748; GO:1905259","negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; protein refolding [GO:0042026]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]","cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; C3HC4-type RING finger domain binding [GO:0055131]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; low-density lipoprotein particle receptor binding [GO:0050750]; protein-folding chaperone binding [GO:0051087]; Tat protein binding [GO:0030957]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; protein refolding [GO:0042026]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]","","INDUCTION: Up-regulated by heat shock. {ECO:0000269|PubMed:9192730}.","INDUCTION: Up-regulated by heat shock. {ECO:0000269|PubMed:9192730}.","TISSUE SPECIFICITY: Ubiquitous. Isoform 2 is highly expressed in testis and lung, but detected at low levels in thymus, prostate, colon and liver. {ECO:0000269|PubMed:10816573, ECO:0000269|PubMed:15595953}."
"18","sp|A0JPK3|ZFP57_RAT","lcl|NC_088853.1_cds_XP_065925029.1_2323",1.88e-13,73.6,"A0JPK3","ZFP57_RAT","Zinc finger protein 57 (Zfp-57)","Zfp57","Rattus norvegicus (Rat)",406,"GO:0000122; GO:0000792; GO:0003677; GO:0003682; GO:0005634; GO:0008270; GO:0010385; GO:0044027; GO:0044725; GO:0044726; GO:0071514; GO:0141068","autosome genomic imprinting [GO:0141068]; epigenetic programing of female pronucleus [GO:0044726]; epigenetic programming in the zygotic pronuclei [GO:0044725]; genomic imprinting [GO:0071514]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]","heterochromatin [GO:0000792]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; zinc ion binding [GO:0008270]; autosome genomic imprinting [GO:0141068]; epigenetic programing of female pronucleus [GO:0044726]; epigenetic programming in the zygotic pronuclei [GO:0044725]; genomic imprinting [GO:0071514]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]","","","","TISSUE SPECIFICITY: Expressed in oligodendrocytes and at lower levels in astrocytes. {ECO:0000269|PubMed:15070898}."
"19","sp|Q9W2R3|PI5K1_DROME","lcl|NC_088853.1_cds_XP_065925129.1_2358",0,545,"Q9W2R3","PI5K1_DROME","Phosphatidylinositol 4-phosphate 5-kinase type-1 sktl (EC 2.7.1.68) (Protein Skittles)","sktl fam l(2)05475 PIP5-kinase PIP5K CG9985","Drosophila melanogaster (Fruit fly)",792,"GO:0001837; GO:0003383; GO:0005634; GO:0005694; GO:0005886; GO:0005938; GO:0007032; GO:0007283; GO:0007286; GO:0007310; GO:0007444; GO:0008103; GO:0008104; GO:0016308; GO:0016324; GO:0030707; GO:0030866; GO:0031514; GO:0035323; GO:0046843; GO:0046854; GO:0048477; GO:0071711; GO:0071963; GO:1903689","apical constriction [GO:0003383]; basement membrane organization [GO:0071711]; cortical actin cytoskeleton organization [GO:0030866]; dorsal appendage formation [GO:0046843]; endosome organization [GO:0007032]; epithelial to mesenchymal transition [GO:0001837]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; follicle cell of egg chamber development [GO:0030707]; imaginal disc development [GO:0007444]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oogenesis [GO:0048477]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization [GO:0008104]; regulation of wound healing, spreading of epidermal cells [GO:1903689]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; chromosome [GO:0005694]; male germline ring canal [GO:0035323]; motile cilium [GO:0031514]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; apical constriction [GO:0003383]; basement membrane organization [GO:0071711]; cortical actin cytoskeleton organization [GO:0030866]; dorsal appendage formation [GO:0046843]; endosome organization [GO:0007032]; epithelial to mesenchymal transition [GO:0001837]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; follicle cell of egg chamber development [GO:0030707]; imaginal disc development [GO:0007444]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oogenesis [GO:0048477]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization [GO:0008104]; regulation of wound healing, spreading of epidermal cells [GO:1903689]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed in larval epithelium (at protein level) (PubMed:31704968). Expressed during oogenesis (PubMed:27747405). First detected in a subset of cells in region 2 of the germarium (PubMed:27747405). Strongly expressed in the oocyte of stage S1 to S14 egg chambers (PubMed:27747405). Weak expression in nurse cells until stage S8, after which expression increases throughout the latter stages of oogenesis (PubMed:18948416, PubMed:27747405). Expressed during spermatogenesis in primary spermatocytes and during meiotic prophase (PubMed:27747405). Basal level expression in all cells during all stages of embryogenesis (PubMed:9832529). Highly expressed in the procephalic neuroectoderm at stage 5 of embryogenesis (PubMed:9832529). During gastrulation expressed in the brain with elevated expression in the invaginating cells of the ventral and cephalic furrows (PubMed:9832529). Highly expressed in migrating germ cells and all precursor cells of the central and peripheral nervous systems at stage 11 of embryogenesis (PubMed:9832529). At embryogenesis stage 13 expressed strongly in most developing tissues, including central and peripheral nervous systems, heart, gut and muscle (PubMed:9832529). At stage 17 of embryogenesis expressed strongly in gut, pharynx and a subset of cells of the central nervous system (PubMed:9832529). Expressed in all imaginal disks of third instar larvae (PubMed:9832529). Elevated expression in the precursor of the anterior wing margin sensory organs and along the anterior-posterior axis in the wing disks, but is absent along the dorso-ventral axis (PubMed:9832529). In eye disks expression is elevated in precursors of R8 photoreceptors (PubMed:9832529). Expressed in the outer proliferation center of the optic lobes, patches of the midbrain and a subset of cells in the ventral ganglion of the third instar larval brain (PubMed:9832529). {ECO:0000269|PubMed:18948416, ECO:0000269|PubMed:27747405, ECO:0000269|PubMed:31704968, ECO:0000269|PubMed:9832529}.","","",""
"20","sp|P13569|CFTR_HUMAN","lcl|NC_088853.1_cds_XP_065931353.1_3676",3.07e-146,488,"P13569","CFTR_HUMAN","Cystic fibrosis transmembrane conductance regulator (CFTR) (ATP-binding cassette sub-family C member 7) (Channel conductance-controlling ATPase) (EC 5.6.1.6) (cAMP-dependent chloride channel)","CFTR ABCC7","Homo sapiens (Human)",1480,"GO:0005254; GO:0005260; GO:0005524; GO:0005634; GO:0005737; GO:0005765; GO:0005769; GO:0005789; GO:0005829; GO:0005886; GO:0006695; GO:0006904; GO:0009986; GO:0010008; GO:0015106; GO:0015108; GO:0015701; GO:0016020; GO:0016324; GO:0016887; GO:0017081; GO:0019869; GO:0019899; GO:0030165; GO:0030301; GO:0030660; GO:0030669; GO:0031901; GO:0032991; GO:0034707; GO:0034976; GO:0035377; GO:0035774; GO:0042626; GO:0043225; GO:0045921; GO:0048240; GO:0050891; GO:0051087; GO:0051454; GO:0051649; GO:0055037; GO:0055038; GO:0055085; GO:0060081; GO:0070175; GO:0071320; GO:0071889; GO:0097186; GO:0106138; GO:0140359; GO:1902161; GO:1902476; GO:1902943; GO:1904322","amelogenesis [GO:0097186]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; chloride transmembrane transport [GO:1902476]; cholesterol biosynthetic process [GO:0006695]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; intracellular pH elevation [GO:0051454]; membrane hyperpolarization [GO:0060081]; multicellular organismal-level water homeostasis [GO:0050891]; positive regulation of cyclic nucleotide-gated ion channel activity [GO:1902161]; positive regulation of enamel mineralization [GO:0070175]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of voltage-gated chloride channel activity [GO:1902943]; response to endoplasmic reticulum stress [GO:0034976]; sperm capacitation [GO:0048240]; transepithelial water transport [GO:0035377]; transmembrane transport [GO:0055085]; vesicle docking involved in exocytosis [GO:0006904]","apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; chloride channel complex [GO:0034707]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi-associated vesicle membrane [GO:0030660]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; 14-3-3 protein binding [GO:0071889]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride channel inhibitor activity [GO:0019869]; chloride channel regulator activity [GO:0017081]; chloride transmembrane transporter activity [GO:0015108]; enzyme binding [GO:0019899]; intracellularly ATP-gated chloride channel activity [GO:0005260]; PDZ domain binding [GO:0030165]; protein-folding chaperone binding [GO:0051087]; Sec61 translocon complex binding [GO:0106138]; amelogenesis [GO:0097186]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; chloride transmembrane transport [GO:1902476]; cholesterol biosynthetic process [GO:0006695]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; intracellular pH elevation [GO:0051454]; membrane hyperpolarization [GO:0060081]; multicellular organismal-level water homeostasis [GO:0050891]; positive regulation of cyclic nucleotide-gated ion channel activity [GO:1902161]; positive regulation of enamel mineralization [GO:0070175]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of voltage-gated chloride channel activity [GO:1902943]; response to endoplasmic reticulum stress [GO:0034976]; sperm capacitation [GO:0048240]; transepithelial water transport [GO:0035377]; transmembrane transport [GO:0055085]; vesicle docking involved in exocytosis [GO:0006904]","","","","TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level) (PubMed:15716351, PubMed:22207244). Detected in pancreatic intercalated ducts in the exocrine tissue, on epithelial cells in intralobular striated ducts in sublingual salivary glands, on apical membranes of crypt cells throughout the small and large intestine, and on the reabsorptive duct in eccrine sweat glands (PubMed:1284548, PubMed:28130590). Detected on the equatorial segment of the sperm head (at protein level) (PubMed:19923167). Detected in nasal and bronchial superficial epithelium (PubMed:15716351). Expressed by the central cells on the sebaceous glands, dermal adipocytes and, at lower levels, by epithelial cells (PubMed:28130590). {ECO:0000269|PubMed:1284548, ECO:0000269|PubMed:15716351, ECO:0000269|PubMed:19923167, ECO:0000269|PubMed:22207244, ECO:0000269|PubMed:28130590}."
"21","sp|Q10743|ADA10_RAT","lcl|NC_088853.1_cds_XP_065932282.1_154",5.74e-169,509,"Q10743","ADA10_RAT","Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c)","Adam10 Madm","Rattus norvegicus (Rat)",749,"GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0005802; GO:0005886; GO:0005912; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0007283; GO:0008021; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010629; GO:0010820; GO:0010976; GO:0014069; GO:0016485; GO:0017124; GO:0019901; GO:0030136; GO:0030307; GO:0030335; GO:0030424; GO:0030425; GO:0034205; GO:0034332; GO:0034612; GO:0038004; GO:0042117; GO:0042803; GO:0042987; GO:0043025; GO:0043065; GO:0043197; GO:0045211; GO:0045670; GO:0046872; GO:0046930; GO:0046931; GO:0051089; GO:0061001; GO:0070573; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0097327; GO:0098696; GO:0098794; GO:0098978; GO:0099173; GO:0099175; GO:0140249; GO:0140448; GO:1901342; GO:1902945","adherens junction organization [GO:0034332]; amyloid precursor protein catabolic process [GO:0042987]; amyloid-beta formation [GO:0034205]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; epidermal growth factor receptor ligand maturation [GO:0038004]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; negative regulation of gene expression [GO:0010629]; Notch signaling pathway [GO:0007219]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein catabolic process at postsynapse [GO:0140249]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of osteoclast differentiation [GO:0045670]; regulation of postsynapse organization [GO:0099175]; regulation of vasculature development [GO:1901342]; response to antineoplastic agent [GO:0097327]; response to tumor necrosis factor [GO:0034612]; signaling receptor ligand precursor processing [GO:0140448]; spermatogenesis [GO:0007283]","adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; tetraspanin-enriched microdomain [GO:0097197]; trans-Golgi network [GO:0005802]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; adherens junction organization [GO:0034332]; amyloid precursor protein catabolic process [GO:0042987]; amyloid-beta formation [GO:0034205]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; epidermal growth factor receptor ligand maturation [GO:0038004]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; negative regulation of gene expression [GO:0010629]; Notch signaling pathway [GO:0007219]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein catabolic process at postsynapse [GO:0140249]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of osteoclast differentiation [GO:0045670]; regulation of postsynapse organization [GO:0099175]; regulation of vasculature development [GO:1901342]; response to antineoplastic agent [GO:0097327]; response to tumor necrosis factor [GO:0034612]; signaling receptor ligand precursor processing [GO:0140448]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in brain, kidney, lung, spleen, ovary and testis."
"22","sp|Q61884|MNS1_MOUSE","lcl|NC_088853.1_cds_XP_065937530.1_337",3.14e-95,298,"Q61884","MNS1_MOUSE","Meiosis-specific nuclear structural protein 1","Mns1","Mus musculus (Mouse)",491,"GO:0005635; GO:0005829; GO:0005879; GO:0005882; GO:0005930; GO:0007283; GO:0007288; GO:0016607; GO:0030317; GO:0036064; GO:0036126; GO:0042802; GO:0044782; GO:0045724; GO:0051321; GO:0070986; GO:0160111","cilium organization [GO:0044782]; flagellated sperm motility [GO:0030317]; left/right axis specification [GO:0070986]; meiotic cell cycle [GO:0051321]; positive regulation of cilium assembly [GO:0045724]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]","axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; nuclear envelope [GO:0005635]; nuclear speck [GO:0016607]; sperm flagellum [GO:0036126]; identical protein binding [GO:0042802]; cilium organization [GO:0044782]; flagellated sperm motility [GO:0030317]; left/right axis specification [GO:0070986]; meiotic cell cycle [GO:0051321]; positive regulation of cilium assembly [GO:0045724]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed in the ventral embryonic node at developmental stage 8 dpc. {ECO:0000269|PubMed:30148830}.","","","TISSUE SPECIFICITY: High expression in testis (PubMed:22396656). Expressed in pachytene spermatocytes and post-meiotic spermatids (PubMed:22396656, PubMed:8032679). {ECO:0000269|PubMed:22396656, ECO:0000269|PubMed:8032679}."
"23","sp|O01798|SPE8_CAEEL","lcl|NC_088853.1_cds_XP_065942186.1_3103",4.09e-54,197,"O01798","SPE8_CAEEL","Spermatocyte protein spe-8 (EC 2.7.10.2) (Defective spermatogenesis protein spe-8)","spe-8 F53G12.6","Caenorhabditis elegans",512,"GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005886; GO:0007169; GO:0007286; GO:0030154","cell differentiation [GO:0030154]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; spermatid development [GO:0007286]","cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Expression is restricted to male germline. {ECO:0000269|PubMed:25022984}."
"24","sp|P16591|FER_HUMAN","lcl|NC_088853.1_cds_XP_065942220.1_3101",0,580,"P16591","FER_HUMAN","Tyrosine-protein kinase Fer (EC 2.7.10.2) (Feline encephalitis virus-related kinase FER) (Fujinami poultry sarcoma/Feline sarcoma-related protein Fer) (Proto-oncogene c-Fer) (Tyrosine kinase 3) (p94-Fer)","FER TYK3","Homo sapiens (Human)",822,"GO:0000226; GO:0000785; GO:0001932; GO:0004713; GO:0004715; GO:0005154; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005938; GO:0006468; GO:0006935; GO:0007155; GO:0007260; GO:0007281; GO:0008157; GO:0008284; GO:0008286; GO:0008289; GO:0009898; GO:0010591; GO:0010762; GO:0018108; GO:0019221; GO:0030036; GO:0030335; GO:0030838; GO:0032496; GO:0032991; GO:0033007; GO:0034333; GO:0034446; GO:0034614; GO:0035426; GO:0035556; GO:0036006; GO:0036119; GO:0038095; GO:0038109; GO:0042058; GO:0042995; GO:0044331; GO:0046777; GO:0048008; GO:0050904; GO:0051092; GO:0051897; GO:0060009; GO:0070102; GO:0072520; GO:0120179","actin cytoskeleton organization [GO:0030036]; adherens junction assembly [GO:0034333]; adherens junction disassembly [GO:0120179]; cell adhesion [GO:0007155]; cell-cell adhesion mediated by cadherin [GO:0044331]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to reactive oxygen species [GO:0034614]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; diapedesis [GO:0050904]; extracellular matrix-cell signaling [GO:0035426]; Fc-epsilon receptor signaling pathway [GO:0038095]; germ cell development [GO:0007281]; insulin receptor signaling pathway [GO:0008286]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; Kit signaling pathway [GO:0038109]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of mast cell activation involved in immune response [GO:0033007]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of fibroblast migration [GO:0010762]; regulation of lamellipodium assembly [GO:0010591]; regulation of protein phosphorylation [GO:0001932]; response to lipopolysaccharide [GO:0032496]; response to platelet-derived growth factor [GO:0036119]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; substrate adhesion-dependent cell spreading [GO:0034446]; tyrosine phosphorylation of STAT protein [GO:0007260]","adherens junction [GO:0005912]; cell cortex [GO:0005938]; cell projection [GO:0042995]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase 1 binding [GO:0008157]; protein tyrosine kinase activity [GO:0004713]; actin cytoskeleton organization [GO:0030036]; adherens junction assembly [GO:0034333]; adherens junction disassembly [GO:0120179]; cell adhesion [GO:0007155]; cell-cell adhesion mediated by cadherin [GO:0044331]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to reactive oxygen species [GO:0034614]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; diapedesis [GO:0050904]; extracellular matrix-cell signaling [GO:0035426]; Fc-epsilon receptor signaling pathway [GO:0038095]; germ cell development [GO:0007281]; insulin receptor signaling pathway [GO:0008286]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; Kit signaling pathway [GO:0038109]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of mast cell activation involved in immune response [GO:0033007]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of fibroblast migration [GO:0010762]; regulation of lamellipodium assembly [GO:0010591]; regulation of protein phosphorylation [GO:0001932]; response to lipopolysaccharide [GO:0032496]; response to platelet-derived growth factor [GO:0036119]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; substrate adhesion-dependent cell spreading [GO:0034446]; tyrosine phosphorylation of STAT protein [GO:0007260]","","","","TISSUE SPECIFICITY: Isoform 1 is detected in normal colon and in fibroblasts (at protein level). Isoform 3 is detected in normal testis, in colon carcinoma-derived metastases in lung, liver and ovary, and in colon carcinoma and hepato carcinoma cell lines (at protein level). Isoform 3 is not detected in normal colon or in normal fibroblasts (at protein level). Widely expressed. {ECO:0000269|PubMed:18985748, ECO:0000269|PubMed:2156206, ECO:0000269|PubMed:22223638}."
"25","sp|Q5SUV2|MYBPP_MOUSE","lcl|NC_088853.1_cds_XP_065944707.1_1244",1.27e-106,353,"Q5SUV2","MYBPP_MOUSE","MYCBP-associated protein (AMAM-1) (AMY-1-binding protein 1) (AMAP-1)","Mycbpap Amap1","Mus musculus (Mouse)",932,"GO:0005737; GO:0007268; GO:0007283; GO:0016020; GO:0030154; GO:0045202","cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; membrane [GO:0016020]; synapse [GO:0045202]; cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: In testis, weakly expressed in 3-week old mice and strongly expressed after expression of spermatids, especially after 10 weeks of age, during which time MYCBP/AMY-1 is also expressed. {ECO:0000269|PubMed:12151104}.","","",""
"26","sp|P11420|DA_DROME","lcl|NC_088853.1_cds_XP_065944729.1_1251",7.45e-25,112,"P11420","DA_DROME","Protein daughterless","da CG5102","Drosophila melanogaster (Fruit fly)",710,"GO:0000785; GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0005667; GO:0006357; GO:0007400; GO:0007423; GO:0008407; GO:0030237; GO:0030707; GO:0035019; GO:0043565; GO:0045893; GO:0045944; GO:0046982; GO:0048477; GO:0048663; GO:0050821; GO:0061101; GO:0061382; GO:0061525; GO:0140297","chaeta morphogenesis [GO:0008407]; female sex determination [GO:0030237]; follicle cell of egg chamber development [GO:0030707]; hindgut development [GO:0061525]; Malpighian tubule tip cell differentiation [GO:0061382]; neuroblast fate determination [GO:0007400]; neuroendocrine cell differentiation [GO:0061101]; neuron fate commitment [GO:0048663]; oogenesis [GO:0048477]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; somatic stem cell population maintenance [GO:0035019]","chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; chaeta morphogenesis [GO:0008407]; female sex determination [GO:0030237]; follicle cell of egg chamber development [GO:0030707]; hindgut development [GO:0061525]; Malpighian tubule tip cell differentiation [GO:0061382]; neuroblast fate determination [GO:0007400]; neuroendocrine cell differentiation [GO:0061101]; neuron fate commitment [GO:0048663]; oogenesis [GO:0048477]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; somatic stem cell population maintenance [GO:0035019]","","","","TISSUE SPECIFICITY: Ubiquitous."
"27","sp|P18824|ARM_DROME","lcl|NC_088854.1_cds_NP_001292224.1_4392",0,1138,"P18824","ARM_DROME","Armadillo segment polarity protein","arm CG11579","Drosophila melanogaster (Fruit fly)",843,"GO:0000122; GO:0000902; GO:0001709; GO:0001745; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005915; GO:0007155; GO:0007301; GO:0007367; GO:0007370; GO:0007391; GO:0007472; GO:0007507; GO:0007616; GO:0008587; GO:0014017; GO:0014019; GO:0016028; GO:0016324; GO:0016342; GO:0016922; GO:0019900; GO:0019903; GO:0030139; GO:0030424; GO:0035017; GO:0035019; GO:0035147; GO:0035153; GO:0035293; GO:0045172; GO:0045186; GO:0045294; GO:0045296; GO:0045893; GO:0045944; GO:0046530; GO:0046667; GO:0048477; GO:0048526; GO:0048754; GO:0060070; GO:0060232; GO:0060250; GO:0060914; GO:0071896; GO:0072659; GO:0090254; GO:0098609; GO:0140297; GO:1990907","branch fusion, open tracheal system [GO:0035147]; branching morphogenesis of an epithelial tube [GO:0048754]; canonical Wnt signaling pathway [GO:0060070]; cell adhesion [GO:0007155]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell fate determination [GO:0001709]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; chitin-based larval cuticle pattern formation [GO:0035293]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; cuticle pattern formation [GO:0035017]; delamination [GO:0060232]; dorsal closure [GO:0007391]; epithelial cell type specification, open tracheal system [GO:0035153]; female germline ring canal formation [GO:0007301]; germ-line stem-cell niche homeostasis [GO:0060250]; heart development [GO:0007507]; heart formation [GO:0060914]; imaginal disc-derived wing expansion [GO:0048526]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; long-term memory [GO:0007616]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast development [GO:0014019]; neuroblast fate commitment [GO:0014017]; oogenesis [GO:0048477]; photoreceptor cell differentiation [GO:0046530]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to adherens junction [GO:0071896]; protein localization to plasma membrane [GO:0072659]; segment polarity determination [GO:0007367]; somatic stem cell population maintenance [GO:0035019]; ventral furrow formation [GO:0007370]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186]","adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; beta-catenin-TCF complex [GO:1990907]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; germline ring canal [GO:0045172]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; zonula adherens [GO:0005915]; alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; kinase binding [GO:0019900]; nuclear receptor binding [GO:0016922]; protein phosphatase binding [GO:0019903]; transcription coactivator activity [GO:0003713]; branch fusion, open tracheal system [GO:0035147]; branching morphogenesis of an epithelial tube [GO:0048754]; canonical Wnt signaling pathway [GO:0060070]; cell adhesion [GO:0007155]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell fate determination [GO:0001709]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; chitin-based larval cuticle pattern formation [GO:0035293]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; cuticle pattern formation [GO:0035017]; delamination [GO:0060232]; dorsal closure [GO:0007391]; epithelial cell type specification, open tracheal system [GO:0035153]; female germline ring canal formation [GO:0007301]; germ-line stem-cell niche homeostasis [GO:0060250]; heart development [GO:0007507]; heart formation [GO:0060914]; imaginal disc-derived wing expansion [GO:0048526]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; long-term memory [GO:0007616]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast development [GO:0014019]; neuroblast fate commitment [GO:0014017]; oogenesis [GO:0048477]; photoreceptor cell differentiation [GO:0046530]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to adherens junction [GO:0071896]; protein localization to plasma membrane [GO:0072659]; segment polarity determination [GO:0007367]; somatic stem cell population maintenance [GO:0035019]; ventral furrow formation [GO:0007370]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186]","DEVELOPMENTAL STAGE: Present at all stages, but reaches the highest levels during early to mid-embryogenesis. Isoform cytoplasmic is the predominant one from the cellular blastoderm stage until germ-band retraction. Isoform neural is first seen after germ band retraction.","","","TISSUE SPECIFICITY: Isoform cytoplasmic accumulates at low levels in axons, at high levels in specific cells along the CNS midline and in leg and eye imaginal disks. Isoform neural accumulates in the axon tracts of the CNS. Both isoforms accumulate in the peripheral nervous system. {ECO:0000269|PubMed:9635189}."
"28","sp|Q64729|TGFR1_MOUSE","lcl|NC_088854.1_cds_NP_001292288.1_10593",0,580,"Q64729","TGFR1_MOUSE","TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (ESK2) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I)","Tgfbr1","Mus musculus (Mouse)",503,"GO:0001501; GO:0001525; GO:0001701; GO:0001822; GO:0001824; GO:0001935; GO:0001937; GO:0001938; GO:0002088; GO:0003222; GO:0003223; GO:0005024; GO:0005025; GO:0005102; GO:0005114; GO:0005524; GO:0005634; GO:0005654; GO:0005768; GO:0005886; GO:0005901; GO:0005923; GO:0005929; GO:0006915; GO:0007179; GO:0007507; GO:0008354; GO:0008584; GO:0009791; GO:0009952; GO:0009986; GO:0010468; GO:0010628; GO:0010717; GO:0010718; GO:0016020; GO:0030199; GO:0030307; GO:0030335; GO:0030336; GO:0031396; GO:0031625; GO:0032331; GO:0032924; GO:0035556; GO:0036446; GO:0042118; GO:0043065; GO:0043066; GO:0043542; GO:0045121; GO:0045893; GO:0046332; GO:0046847; GO:0046872; GO:0048538; GO:0048663; GO:0048701; GO:0048705; GO:0048762; GO:0048844; GO:0050431; GO:0051491; GO:0051496; GO:0051897; GO:0060017; GO:0060021; GO:0060037; GO:0060043; GO:0060317; GO:0060391; GO:0060395; GO:0060412; GO:0060978; GO:0060982; GO:0061450; GO:0070021; GO:0070411; GO:0070723; GO:0071560; GO:1901203; GO:1902462; GO:1904018; GO:1905007; GO:1905075; GO:1905223; GO:2001235; GO:2001237","activin receptor signaling pathway [GO:0032924]; angiogenesis [GO:0001525]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epicardium morphogenesis [GO:1905223]; filopodium assembly [GO:0046847]; germ cell migration [GO:0008354]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; myofibroblast differentiation [GO:0036446]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of vasculature development [GO:1904018]; post-embryonic development [GO:0009791]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein ubiquitination [GO:0031396]; response to cholesterol [GO:0070723]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; SMAD protein signal transduction [GO:0060395]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; trophoblast cell migration [GO:0061450]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]","bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell surface [GO:0009986]; cilium [GO:0005929]; endosome [GO:0005768]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transforming growth factor beta ligand-receptor complex [GO:0070021]; ATP binding [GO:0005524]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type I [GO:0005025]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625]; activin receptor signaling pathway [GO:0032924]; angiogenesis [GO:0001525]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epicardium morphogenesis [GO:1905223]; filopodium assembly [GO:0046847]; germ cell migration [GO:0008354]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; myofibroblast differentiation [GO:0036446]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of vasculature development [GO:1904018]; post-embryonic development [GO:0009791]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein ubiquitination [GO:0031396]; response to cholesterol [GO:0070723]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; SMAD protein signal transduction [GO:0060395]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; trophoblast cell migration [GO:0061450]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]","","","",""
"29","sp|P06605|TBA3_DROME","lcl|NC_088854.1_cds_NP_001292302.1_10218",0,874,"P06605","TBA3_DROME","Tubulin alpha-3 chain (EC 3.6.5.-)","alphaTub84D TubA84D CG2512","Drosophila melanogaster (Fruit fly)",450,"GO:0000226; GO:0000278; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007283; GO:0007288; GO:0016787; GO:0017022; GO:0046872; GO:0048471","microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]","","","",""
"30","sp|P02572|ACT2_DROME","lcl|NC_088854.1_cds_NP_001295818.1_9741",0,775,"P02572","ACT2_DROME","Actin-42A (EC 3.6.4.-)","Act42A CG12051","Drosophila melanogaster (Fruit fly)",376,"GO:0000281; GO:0005524; GO:0005737; GO:0015629; GO:0016787; GO:0030723; GO:0035060","mitotic cytokinesis [GO:0000281]; ovarian fusome organization [GO:0030723]","actin cytoskeleton [GO:0015629]; brahma complex [GO:0035060]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; mitotic cytokinesis [GO:0000281]; ovarian fusome organization [GO:0030723]","","INDUCTION: By 20-hydroxyecdysone.","INDUCTION: By 20-hydroxyecdysone.","TISSUE SPECIFICITY: All cells and tissues of the developing embryo. Later in development, expression is higher in midgut, brain, nerve cord, and gonads. {ECO:0000269|PubMed:1694472}."
"31","sp|Q24306|DIAP1_DROME","lcl|NC_088854.1_cds_XP_011412926.3_6944",3.82e-41,153,"Q24306","DIAP1_DROME","Death-associated inhibitor of apoptosis 1 (EC 2.3.2.27) (Apoptosis 1 inhibitor) (E3 ubiquitin-protein ligase th) (Inhibitor of apoptosis 1) (Protein thread) (RING-type E3 ubiquitin transferase Diap1)","Diap1 Iap1 th CG12284","Drosophila melanogaster (Fruit fly)",438,"GO:0000209; GO:0004842; GO:0004869; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0007283; GO:0007289; GO:0007298; GO:0008270; GO:0016055; GO:0022416; GO:0031398; GO:0031624; GO:0031625; GO:0043027; GO:0043066; GO:0044390; GO:0045035; GO:0045116; GO:0045752; GO:0046329; GO:0046673; GO:0048471; GO:0048800; GO:0051726; GO:0051865; GO:0061630; GO:0061663; GO:0070936; GO:0089720; GO:0090263; GO:1903688; GO:1990381","antennal morphogenesis [GO:0048800]; apoptotic process [GO:0006915]; border follicle cell migration [GO:0007298]; chaeta development [GO:0022416]; negative regulation of apoptotic process [GO:0043066]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; negative regulation of JNK cascade [GO:0046329]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of Toll signaling pathway [GO:0045752]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]; regulation of cell cycle [GO:0051726]; sensory organ precursor cell division [GO:0045035]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]; Wnt signaling pathway [GO:0016055]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; NEDD8 ligase activity [GO:0061663]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270]; antennal morphogenesis [GO:0048800]; apoptotic process [GO:0006915]; border follicle cell migration [GO:0007298]; chaeta development [GO:0022416]; negative regulation of apoptotic process [GO:0043066]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; negative regulation of JNK cascade [GO:0046329]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of Toll signaling pathway [GO:0045752]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]; regulation of cell cycle [GO:0051726]; sensory organ precursor cell division [GO:0045035]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]; Wnt signaling pathway [GO:0016055]","DEVELOPMENTAL STAGE: Detected in wing disks (at protein level). {ECO:0000269|PubMed:27462444}.","","",""
"32","sp|Q4V7C7|ARP3_RAT","lcl|NC_088854.1_cds_XP_011412991.2_7544",0,728,"Q4V7C7","ARP3_RAT","Actin-related protein 3 (Actin-like protein 3)","Actr3 Arp3","Rattus norvegicus (Rat)",418,"GO:0000139; GO:0001726; GO:0002102; GO:0003779; GO:0005200; GO:0005524; GO:0005634; GO:0005737; GO:0005884; GO:0005885; GO:0005903; GO:0005911; GO:0007163; GO:0007283; GO:0008356; GO:0010592; GO:0010763; GO:0016344; GO:0030027; GO:0030056; GO:0030517; GO:0030838; GO:0031252; GO:0032355; GO:0032956; GO:0033206; GO:0034314; GO:0035861; GO:0035984; GO:0043519; GO:0045666; GO:0045944; GO:0048471; GO:0048708; GO:0048711; GO:0050775; GO:0051117; GO:0051321; GO:0051491; GO:0051653; GO:0051965; GO:0060076; GO:0060271; GO:0061003; GO:0061825; GO:0061828; GO:0061830; GO:0061831; GO:0061832; GO:0061843; GO:0061851; GO:0071346; GO:0071347; GO:0071356; GO:0071364; GO:0071503; GO:0071560; GO:0090314; GO:0098794; GO:0098974; GO:0098978; GO:0099173; GO:1903078; GO:1904171; GO:1905835; GO:1905837","Arp2/3 complex-mediated actin nucleation [GO:0034314]; astrocyte differentiation [GO:0048708]; asymmetric cell division [GO:0008356]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to interleukin-1 [GO:0071347]; cellular response to pyrimidine ribonucleotide [GO:1905835]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to trichostatin A [GO:0035984]; cellular response to triterpenoid [GO:1905837]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to type II interferon [GO:0071346]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; meiotic cell cycle [GO:0051321]; meiotic chromosome movement towards spindle pole [GO:0016344]; meiotic cytokinesis [GO:0033206]; negative regulation of axon extension [GO:0030517]; negative regulation of bleb assembly [GO:1904171]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of synapse assembly [GO:0051965]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynapse organization [GO:0099173]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of myosin II filament organization [GO:0043519]; response to estradiol [GO:0032355]; response to heparin [GO:0071503]; Sertoli cell barrier remodeling [GO:0061843]; spermatogenesis [GO:0007283]; spindle localization [GO:0051653]","actin filament [GO:0005884]; apical ectoplasmic specialization [GO:0061831]; apical tubulobulbar complex [GO:0061828]; Arp2/3 protein complex [GO:0005885]; basal ectoplasmic specialization [GO:0061832]; brush border [GO:0005903]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; concave side of sperm head [GO:0061830]; cytoplasm [GO:0005737]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; hemidesmosome [GO:0030056]; lamellipodium [GO:0030027]; leading edge of lamellipodium [GO:0061851]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; podosome [GO:0002102]; podosome core [GO:0061825]; postsynapse [GO:0098794]; ruffle [GO:0001726]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; structural constituent of cytoskeleton [GO:0005200]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; astrocyte differentiation [GO:0048708]; asymmetric cell division [GO:0008356]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to interleukin-1 [GO:0071347]; cellular response to pyrimidine ribonucleotide [GO:1905835]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to trichostatin A [GO:0035984]; cellular response to triterpenoid [GO:1905837]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to type II interferon [GO:0071346]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; meiotic cell cycle [GO:0051321]; meiotic chromosome movement towards spindle pole [GO:0016344]; meiotic cytokinesis [GO:0033206]; negative regulation of axon extension [GO:0030517]; negative regulation of bleb assembly [GO:1904171]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of synapse assembly [GO:0051965]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynapse organization [GO:0099173]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of myosin II filament organization [GO:0043519]; response to estradiol [GO:0032355]; response to heparin [GO:0071503]; Sertoli cell barrier remodeling [GO:0061843]; spermatogenesis [GO:0007283]; spindle localization [GO:0051653]","","","","TISSUE SPECIFICITY: Detected in brain and kidney glomeruli (at protein level) (PubMed:18064521). Detected in kidney, lung and spleen (PubMed:18064521). {ECO:0000269|PubMed:18064521}."
"33","sp|Q9Z1L3|DEDD_MOUSE","lcl|NC_088854.1_cds_XP_011413782.1_3852",2.67e-98,293,"Q9Z1L3","DEDD_MOUSE","Death effector domain-containing protein (DEDPro1)","Dedd","Mus musculus (Mouse)",318,"GO:0003677; GO:0005730; GO:0005737; GO:0007283; GO:0008625; GO:0042177; GO:0042981; GO:0046697; GO:1901837","decidualization [GO:0046697]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; regulation of apoptotic process [GO:0042981]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; decidualization [GO:0046697]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; regulation of apoptotic process [GO:0042981]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:9774341}."
"34","sp|P50536|MSL3_DROME","lcl|NC_088854.1_cds_XP_011416485.3_5038",4.85e-25,110,"P50536","MSL3_DROME","Protein male-specific lethal-3","msl-3 CG8631","Drosophila melanogaster (Fruit fly)",512,"GO:0000228; GO:0000805; GO:0003682; GO:0003723; GO:0005700; GO:0006325; GO:0006355; GO:0007281; GO:0007549; GO:0009047; GO:0010369; GO:0016456; GO:0035064; GO:0035206; GO:0035267; GO:0048599; GO:0072487; GO:0106222; GO:0140003; GO:0140046; GO:0140566","chromatin organization [GO:0006325]; dosage compensation by hyperactivation of X chromosome [GO:0009047]; germ cell development [GO:0007281]; oocyte development [GO:0048599]; regulation of DNA-templated transcription [GO:0006355]; regulation of hemocyte proliferation [GO:0035206]; sex-chromosome dosage compensation [GO:0007549]","chromocenter [GO:0010369]; MSL complex [GO:0072487]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear chromosome [GO:0000228]; polytene chromosome [GO:0005700]; X chromosome [GO:0000805]; X chromosome located dosage compensation complex, transcription activating [GO:0016456]; chromatin binding [GO:0003682]; histone H3K36me3 reader activity [GO:0140003]; histone H4K16ac reader activity [GO:0140046]; histone reader activity [GO:0140566]; lncRNA binding [GO:0106222]; methylated histone binding [GO:0035064]; RNA binding [GO:0003723]; chromatin organization [GO:0006325]; dosage compensation by hyperactivation of X chromosome [GO:0009047]; germ cell development [GO:0007281]; oocyte development [GO:0048599]; regulation of DNA-templated transcription [GO:0006355]; regulation of hemocyte proliferation [GO:0035206]; sex-chromosome dosage compensation [GO:0007549]","","","",""
"35","sp|Q24368|ISWI_DROME","lcl|NC_088854.1_cds_XP_011417373.2_8059",0,1472,"Q24368","ISWI_DROME","Chromatin-remodeling complex ATPase chain Iswi (EC 3.6.4.-) (CHRAC 140 kDa subunit) (Nucleosome-remodeling factor 140 kDa subunit) (NURF-140) (Protein imitation swi)","Iswi CG8625","Drosophila melanogaster (Fruit fly)",1027,"GO:0000166; GO:0000785; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005667; GO:0005700; GO:0006325; GO:0006335; GO:0006338; GO:0006355; GO:0006357; GO:0007283; GO:0008094; GO:0008623; GO:0016589; GO:0016590; GO:0016887; GO:0031010; GO:0031213; GO:0031491; GO:0031507; GO:0034728; GO:0035041; GO:0035063; GO:0035092; GO:0042752; GO:0045892; GO:0045893; GO:0045944; GO:0140297; GO:0140658; GO:0140750; GO:0140751","chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; DNA replication-dependent chromatin assembly [GO:0006335]; heterochromatin formation [GO:0031507]; negative regulation of DNA-templated transcription [GO:0045892]; nuclear speck organization [GO:0035063]; nucleosome organization [GO:0034728]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sperm DNA condensation [GO:0035092]; sperm DNA decondensation [GO:0035041]; spermatogenesis [GO:0007283]","ACF complex [GO:0016590]; CHRAC [GO:0008623]; chromatin [GO:0000785]; ISWI-type complex [GO:0031010]; nucleus [GO:0005634]; NURF complex [GO:0016589]; polytene chromosome [GO:0005700]; RSF complex [GO:0031213]; transcription regulator complex [GO:0005667]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; helicase activity [GO:0004386]; histone octamer slider activity [GO:0140751]; nucleosome array spacer activity [GO:0140750]; nucleosome binding [GO:0031491]; nucleotide binding [GO:0000166]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; DNA replication-dependent chromatin assembly [GO:0006335]; heterochromatin formation [GO:0031507]; negative regulation of DNA-templated transcription [GO:0045892]; nuclear speck organization [GO:0035063]; nucleosome organization [GO:0034728]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sperm DNA condensation [GO:0035092]; sperm DNA decondensation [GO:0035041]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Present throughout embryonic, larval and pupal development and in female adults. Present at low levels in adult males (at protein level). {ECO:0000269|PubMed:8521502}.","","",""
"36","sp|P11536|E74EB_DROME","lcl|NC_088854.1_cds_XP_011417411.3_9446",7.41e-57,202,"P11536","E74EB_DROME","Ecdysone-induced protein 74EF isoform B (ETS-related protein E74B)","Eip74EF E74 CG32180","Drosophila melanogaster (Fruit fly)",883,"GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006914; GO:0007283; GO:0030154; GO:0040034; GO:0043565; GO:0045944; GO:0048477","autophagy [GO:0006914]; cell differentiation [GO:0030154]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; autophagy [GO:0006914]; cell differentiation [GO:0030154]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: In mid instar larvae salivary glands levels increase during 86-94 hours of development and represent the predominant isoform during puff stage 1. Levels remain relatively constant in late larvae until the premetamorphic pulse of ecdysone. Transcripts are detected again from puff stages 12-14 and 17-21. {ECO:0000269|PubMed:8223281}.","INDUCTION: The expression of this protein is developmentally regulated and is correlated with the 20-OH-ecdysone induced activity of puff 74EF.","INDUCTION: The expression of this protein is developmentally regulated and is correlated with the 20-OH-ecdysone induced activity of puff 74EF.",""
"37","sp|P00522|ABL_DROME","lcl|NC_088854.1_cds_XP_011417779.3_6744",0,795,"P00522","ABL_DROME","Tyrosine-protein kinase Abl (EC 2.7.10.2) (D-ash) (Protein abelson)","Abl ABL-1 Dash CG4032","Drosophila melanogaster (Fruit fly)",1620,"GO:0001764; GO:0003382; GO:0003401; GO:0004713; GO:0004715; GO:0005524; GO:0005829; GO:0005886; GO:0005938; GO:0007268; GO:0007300; GO:0007370; GO:0007391; GO:0007409; GO:0007411; GO:0007417; GO:0007419; GO:0007611; GO:0008045; GO:0008064; GO:0008360; GO:0010592; GO:0010977; GO:0016199; GO:0016318; GO:0021785; GO:0030424; GO:0031234; GO:0031647; GO:0032880; GO:0045179; GO:0045202; GO:0045886; GO:0046827; GO:0048749; GO:0048813; GO:0072499; GO:1903391","axis elongation [GO:0003401]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; compound eye development [GO:0048749]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; epithelial cell morphogenesis [GO:0003382]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; neuron migration [GO:0001764]; ommatidial rotation [GO:0016318]; ovarian nurse cell to oocyte transport [GO:0007300]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein export from nucleus [GO:0046827]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of adherens junction organization [GO:1903391]; regulation of cell shape [GO:0008360]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ventral cord development [GO:0007419]; ventral furrow formation [GO:0007370]","apical cortex [GO:0045179]; axon [GO:0030424]; cell cortex [GO:0005938]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; axis elongation [GO:0003401]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; compound eye development [GO:0048749]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; epithelial cell morphogenesis [GO:0003382]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; neuron migration [GO:0001764]; ommatidial rotation [GO:0016318]; ovarian nurse cell to oocyte transport [GO:0007300]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein export from nucleus [GO:0046827]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of adherens junction organization [GO:1903391]; regulation of cell shape [GO:0008360]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ventral cord development [GO:0007419]; ventral furrow formation [GO:0007370]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. {ECO:0000269|PubMed:2832740}.","","","TISSUE SPECIFICITY: Arm and ena colocalize with Abl at adherens junctions throughout development. {ECO:0000269|PubMed:11756472, ECO:0000269|PubMed:9635189}."
"38","sp|Q17336|CWC22_CAEEL","lcl|NC_088854.1_cds_XP_011417796.3_6728",1.6e-173,545,"Q17336","CWC22_CAEEL","Pre-mRNA-splicing factor CWC22 homolog (Lethal protein 858) (Nucampholin)","let-858 F33A8.1","Caenorhabditis elegans",897,"GO:0000398; GO:0000785; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0007369; GO:0016607; GO:0030154; GO:0042078; GO:0043073; GO:0071013","cell differentiation [GO:0030154]; gastrulation [GO:0007369]; germ-line stem cell division [GO:0042078]; mRNA splicing, via spliceosome [GO:0000398]","catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; germ cell nucleus [GO:0043073]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; gastrulation [GO:0007369]; germ-line stem cell division [GO:0042078]; mRNA splicing, via spliceosome [GO:0000398]","DEVELOPMENTAL STAGE: Expressed ubiquitously throughout development. {ECO:0000269|PubMed:9136012}.","","","TISSUE SPECIFICITY: Expressed in germ cells, oocytes, and sperm cells. {ECO:0000269|PubMed:12724425}."
"39","sp|Q96M20|CNBD2_HUMAN","lcl|NC_088854.1_cds_XP_011418195.3_9282",1.73e-24,108,"Q96M20","CNBD2_HUMAN","Cyclic nucleotide-binding domain-containing protein 2","CNBD2 C20orf152","Homo sapiens (Human)",576,"GO:0005829; GO:0007283; GO:0030552","spermatogenesis [GO:0007283]","cytosol [GO:0005829]; cAMP binding [GO:0030552]; spermatogenesis [GO:0007283]","","","",""
"40","sp|Q21898|VATL1_CAEEL","lcl|NC_088854.1_cds_XP_011418206.1_9269",2.58e-33,116,"Q21898","VATL1_CAEEL","V-type proton ATPase 16 kDa proteolipid subunit c 1 (V-ATPase 16 kDa proteolipid subunit c 1) (Vacuolar proton pump 16 kDa proteolipid subunit c 1)","vha-1 R10E11.8","Caenorhabditis elegans",169,"GO:0007042; GO:0009792; GO:0016020; GO:0030728; GO:0033179; GO:0045121; GO:0046961; GO:0060142; GO:1902600","embryo development ending in birth or egg hatching [GO:0009792]; lysosomal lumen acidification [GO:0007042]; ovulation [GO:0030728]; proton transmembrane transport [GO:1902600]; regulation of syncytium formation by plasma membrane fusion [GO:0060142]","membrane [GO:0016020]; membrane raft [GO:0045121]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; embryo development ending in birth or egg hatching [GO:0009792]; lysosomal lumen acidification [GO:0007042]; ovulation [GO:0030728]; proton transmembrane transport [GO:1902600]; regulation of syncytium formation by plasma membrane fusion [GO:0060142]","DEVELOPMENTAL STAGE: High levels during embryogenesis, moderate levels during L1 and adult stages and very low levels during L2-L4 stages. {ECO:0000269|PubMed:9712884}.","","","TISSUE SPECIFICITY: Adult H-shaped excretory cell and rectum. {ECO:0000269|PubMed:9305897, ECO:0000269|PubMed:9712884}."
"41","sp|Q7JXV9|VPS25_DROME","lcl|NC_088854.1_cds_XP_011418343.2_4164",2.14e-51,163,"Q7JXV9","VPS25_DROME","Vacuolar protein-sorting-associated protein 25 (ESCRT-II complex subunit VPS25) (Vacuolar protein sorting 25)","Vps25 l(2)44Db CG14750","Drosophila melanogaster (Fruit fly)",174,"GO:0000814; GO:0005198; GO:0008104; GO:0010669; GO:0016197; GO:0032509; GO:0042803; GO:0042981; GO:0043162; GO:0043328; GO:0045199; GO:0045450; GO:0048803; GO:0050680; GO:0070086; GO:0097352","autophagosome maturation [GO:0097352]; bicoid mRNA localization [GO:0045450]; endosomal transport [GO:0016197]; endosome transport via multivesicular body sorting pathway [GO:0032509]; epithelial structure maintenance [GO:0010669]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; negative regulation of epithelial cell proliferation [GO:0050680]; protein localization [GO:0008104]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent endocytosis [GO:0070086]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]","ESCRT II complex [GO:0000814]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; autophagosome maturation [GO:0097352]; bicoid mRNA localization [GO:0045450]; endosomal transport [GO:0016197]; endosome transport via multivesicular body sorting pathway [GO:0032509]; epithelial structure maintenance [GO:0010669]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; negative regulation of epithelial cell proliferation [GO:0050680]; protein localization [GO:0008104]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent endocytosis [GO:0070086]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]","","","",""
"42","sp|Q9NX45|SOLH2_HUMAN","lcl|NC_088854.1_cds_XP_011419197.3_5953",1.44e-14,77,"Q9NX45","SOLH2_HUMAN","Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2","SOHLH2 TEB1","Homo sapiens (Human)",425,"GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0007283; GO:0009994; GO:0030154; GO:0042803; GO:0046982; GO:1990837","cell differentiation [GO:0030154]; oocyte differentiation [GO:0009994]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; oocyte differentiation [GO:0009994]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","","","",""
"43","sp|Q9D489|SOLH2_MOUSE","lcl|NC_088854.1_cds_XP_011419198.3_5952",3.14e-16,82.4,"Q9D489","SOLH2_MOUSE","Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2","Sohlh2 Tohlh2","Mus musculus (Mouse)",467,"GO:0000977; GO:0001228; GO:0001545; GO:0005634; GO:0005737; GO:0007283; GO:0009994; GO:0010468; GO:0030154; GO:0042802; GO:0042803; GO:0045944; GO:0046982","cell differentiation [GO:0030154]; oocyte differentiation [GO:0009994]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primary ovarian follicle growth [GO:0001545]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell differentiation [GO:0030154]; oocyte differentiation [GO:0009994]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primary ovarian follicle growth [GO:0001545]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: In the embryonic gonads it is expressed as early as 13.5 dpc and later. In 3-day-old postnatal ovaries, it is expressed within oocytes in germ cell clusters and primordial follicles. In the adult, it is expressed only in small follicles, primary primordial and primary follicles. In testis, it is exclusively present in spermatogonia. Present at postnatal day 5, when spermatogonia stem cells differentiate into type A spermatogonia. Absent in Sertoli cells or spermatocytes (at protein level). Expressed in the germline as early as 12.5 dpc and precedes SOHLH1 protein expression, which occurred circa 15.5 dpc. SOHLH1 appearance at 15.5 dpc correlates with SOHLH2 translocation from the cytoplasm into the nucleus (PubMed:28504655). {ECO:0000269|PubMed:16765102, ECO:0000269|PubMed:28504655}.","INDUCTION: Up-regulated in mice lacking Sohlh1.","INDUCTION: Up-regulated in mice lacking Sohlh1.","TISSUE SPECIFICITY: Preferentially expressed in the adult ovary and testis. Expressed in the majority of spermatogonia in adult animals, but not in the most undifferentiated spermatogonial population (PubMed:22056784). {ECO:0000269|PubMed:22056784}."
"44","sp|Q23593|INX8_CAEEL","lcl|NC_088854.1_cds_XP_011419561.2_4809",5.15e-41,150,"Q23593","INX8_CAEEL","Innexin-8 (Protein opu-8)","inx-8 opu-8 ZK792.2","Caenorhabditis elegans",382,"GO:0005243; GO:0005886; GO:0005921; GO:0034220; GO:0036093; GO:0055077","germ cell proliferation [GO:0036093]; monoatomic ion transmembrane transport [GO:0034220]","gap junction [GO:0005921]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; germ cell proliferation [GO:0036093]; monoatomic ion transmembrane transport [GO:0034220]","","","",""
"45","sp|Q8N7R7|CCYL1_HUMAN","lcl|NC_088854.1_cds_XP_011420254.1_6619",2.59e-127,370,"Q8N7R7","CCYL1_HUMAN","Cyclin-Y-like protein 1","CCNYL1","Homo sapiens (Human)",359,"GO:0001932; GO:0005886; GO:0007283; GO:0007399; GO:0019901; GO:0030154; GO:0030317; GO:0060828","cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; nervous system development [GO:0007399]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of protein phosphorylation [GO:0001932]; spermatogenesis [GO:0007283]","plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; nervous system development [GO:0007399]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of protein phosphorylation [GO:0001932]; spermatogenesis [GO:0007283]","","","",""
"46","sp|O35264|PA1B2_RAT","lcl|NC_088854.1_cds_XP_011420361.2_4640",2.78e-84,252,"O35264","PA1B2_RAT","Platelet-activating factor acetylhydrolase IB subunit alpha2 (EC 3.1.1.47) (PAF acetylhydrolase 30 kDa subunit) (PAF-AH 30 kDa subunit) (PAF-AH subunit beta) (PAFAH subunit beta) (Platelet-activating factor acetylhydrolase alpha 2 subunit) (PAF-AH alpha 2)","Pafah1b2 Pafahb","Rattus norvegicus (Rat)",229,"GO:0001650; GO:0003847; GO:0005737; GO:0005829; GO:0005886; GO:0007283; GO:0008247; GO:0016042; GO:0016239; GO:0042802; GO:0042803; GO:0044877; GO:0046982; GO:0047179","lipid catabolic process [GO:0016042]; positive regulation of macroautophagy [GO:0016239]; spermatogenesis [GO:0007283]","1-alkyl-2-acetylglycerophosphocholine esterase complex [GO:0008247]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; plasma membrane [GO:0005886]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; identical protein binding [GO:0042802]; platelet-activating factor acetyltransferase activity [GO:0047179]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; lipid catabolic process [GO:0016042]; positive regulation of macroautophagy [GO:0016239]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: During the embryonic stages, high expressed in the brain, spinal cord, sensory ganglia (dorsal root and trigeminal ganglia), and thymus. In brain found throughout the ventricular and marginal zones. {ECO:0000269|PubMed:9660828}.","","","TISSUE SPECIFICITY: Expressed in heart, brain, spleen, lung, liver, kidney and testis. Not expressed in skeletal muscle. Expressed in fetal as heterodimer and adult brain as homodimer. In neural cells, expressed in granule cells, astroglial cells, and oligodendrocytes (PubMed:9660828). {ECO:0000269|PubMed:9660828}."
"47","sp|B4H9N7|RS3A_DROPE","lcl|NC_088854.1_cds_XP_011421723.2_6702",2.23e-125,359,"B4H9N7","RS3A_DROPE","Small ribosomal subunit protein eS1 (40S ribosomal protein S3a)","RpS3A GL18386","Drosophila persimilis (Fruit fly)",268,"GO:0003735; GO:0006412; GO:0022627; GO:0048477","oogenesis [GO:0048477]; translation [GO:0006412]","cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; oogenesis [GO:0048477]; translation [GO:0006412]","","","",""
"48","sp|Q62927|CNGA1_RAT","lcl|NC_088854.1_cds_XP_011422424.1_8959",0,650,"Q62927","CNGA1_RAT","Cyclic nucleotide-gated channel alpha-1 (CNG channel alpha-1) (CNG-1) (CNG1) (Cyclic nucleotide-gated cation channel 1) (Cyclic nucleotide-gated channel, photoreceptor) (Rod photoreceptor cGMP-gated cation channel subunit alpha) (cGMP-gated cation channel alpha-1)","Cnga1 Cncg Cncg1","Rattus norvegicus (Rat)",683,"GO:0001750; GO:0005221; GO:0005222; GO:0005223; GO:0005262; GO:0005272; GO:0005886; GO:0006814; GO:0006816; GO:0007283; GO:0007601; GO:0016020; GO:0017071; GO:0030552; GO:0030553; GO:0042622; GO:0043195; GO:0044877; GO:0051480; GO:0051899; GO:0098655; GO:0120200","calcium ion transport [GO:0006816]; membrane depolarization [GO:0051899]; monoatomic cation transmembrane transport [GO:0098655]; regulation of cytosolic calcium ion concentration [GO:0051480]; sodium ion transport [GO:0006814]; spermatogenesis [GO:0007283]; visual perception [GO:0007601]","intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; membrane [GO:0016020]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200]; terminal bouton [GO:0043195]; calcium channel activity [GO:0005262]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellularly cAMP-activated cation channel activity [GO:0005222]; intracellularly cGMP-activated cation channel activity [GO:0005223]; intracellularly cyclic nucleotide-activated monoatomic cation channel activity [GO:0005221]; protein-containing complex binding [GO:0044877]; sodium channel activity [GO:0005272]; calcium ion transport [GO:0006816]; membrane depolarization [GO:0051899]; monoatomic cation transmembrane transport [GO:0098655]; regulation of cytosolic calcium ion concentration [GO:0051480]; sodium ion transport [GO:0006814]; spermatogenesis [GO:0007283]; visual perception [GO:0007601]","","","","TISSUE SPECIFICITY: Rod cells in the retina."
"49","sp|P18537|FRIZ_DROME","lcl|NC_088854.1_cds_XP_011422642.2_10313",4.61e-173,503,"P18537","FRIZ_DROME","Frizzled (Frizzled-1) (dFz1)","fz CG17697","Drosophila melanogaster (Fruit fly)",581,"GO:0001736; GO:0001737; GO:0001738; GO:0001745; GO:0004930; GO:0005886; GO:0007156; GO:0007163; GO:0007186; GO:0007298; GO:0007367; GO:0007435; GO:0007464; GO:0007494; GO:0008356; GO:0008587; GO:0016020; GO:0016318; GO:0016360; GO:0017147; GO:0030010; GO:0035159; GO:0035206; GO:0035293; GO:0035317; GO:0035320; GO:0035567; GO:0042067; GO:0042685; GO:0042813; GO:0045773; GO:0048056; GO:0048665; GO:0048675; GO:0060070; GO:0060250; GO:1902669","asymmetric cell division [GO:0008356]; axon extension [GO:0048675]; border follicle cell migration [GO:0007298]; canonical Wnt signaling pathway [GO:0060070]; cardioblast cell fate specification [GO:0042685]; chitin-based larval cuticle pattern formation [GO:0035293]; compound eye morphogenesis [GO:0001745]; establishment of cell polarity [GO:0030010]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; G protein-coupled receptor signaling pathway [GO:0007186]; germ-line stem-cell niche homeostasis [GO:0060250]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing hair site selection [GO:0035320]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; midgut development [GO:0007494]; morphogenesis of a polarized epithelium [GO:0001738]; neuron fate specification [GO:0048665]; non-canonical Wnt signaling pathway [GO:0035567]; ommatidial rotation [GO:0016318]; positive regulation of axon extension [GO:0045773]; positive regulation of axon guidance [GO:1902669]; R3/R4 cell differentiation [GO:0048056]; R3/R4 cell fate commitment [GO:0007464]; regulation of hemocyte proliferation [GO:0035206]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; segment polarity determination [GO:0007367]; sensory organ precursor cell fate determination [GO:0016360]","membrane [GO:0016020]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; asymmetric cell division [GO:0008356]; axon extension [GO:0048675]; border follicle cell migration [GO:0007298]; canonical Wnt signaling pathway [GO:0060070]; cardioblast cell fate specification [GO:0042685]; chitin-based larval cuticle pattern formation [GO:0035293]; compound eye morphogenesis [GO:0001745]; establishment of cell polarity [GO:0030010]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; G protein-coupled receptor signaling pathway [GO:0007186]; germ-line stem-cell niche homeostasis [GO:0060250]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing hair site selection [GO:0035320]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; midgut development [GO:0007494]; morphogenesis of a polarized epithelium [GO:0001738]; neuron fate specification [GO:0048665]; non-canonical Wnt signaling pathway [GO:0035567]; ommatidial rotation [GO:0016318]; positive regulation of axon extension [GO:0045773]; positive regulation of axon guidance [GO:1902669]; R3/R4 cell differentiation [GO:0048056]; R3/R4 cell fate commitment [GO:0007464]; regulation of hemocyte proliferation [GO:0035206]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; segment polarity determination [GO:0007367]; sensory organ precursor cell fate determination [GO:0016360]","","","",""
"50","sp|Q9ESK4|ING2_MOUSE","lcl|NC_088854.1_cds_XP_011423006.1_5151",9.56e-33,122,"Q9ESK4","ING2_MOUSE","Inhibitor of growth protein 2 (Inhibitor of growth 1-like protein) (p33ING2)","Ing2 Ing1l","Mus musculus (Mouse)",281,"GO:0000122; GO:0003677; GO:0005634; GO:0005886; GO:0007141; GO:0007283; GO:0007286; GO:0008270; GO:0016602; GO:0030317; GO:0030336; GO:0030511; GO:0030512; GO:0035033; GO:0035091; GO:0044877; GO:0045814; GO:0045893; GO:0048133; GO:0070822; GO:0072520; GO:0140002; GO:0140566; GO:1902455; GO:1902459; GO:2001234","flagellated sperm motility [GO:0030317]; male germ-line stem cell asymmetric division [GO:0048133]; male meiosis I [GO:0007141]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell migration [GO:0030336]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","CCAAT-binding factor complex [GO:0016602]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Sin3-type complex [GO:0070822]; DNA binding [GO:0003677]; histone deacetylase regulator activity [GO:0035033]; histone H3K4me3 reader activity [GO:0140002]; histone reader activity [GO:0140566]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270]; flagellated sperm motility [GO:0030317]; male germ-line stem cell asymmetric division [GO:0048133]; male meiosis I [GO:0007141]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell migration [GO:0030336]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","","","",""
"51","sp|Q9P2B7|CFA97_HUMAN","lcl|NC_088854.1_cds_XP_011423007.3_5152",7.08e-15,78.2,"Q9P2B7","CFA97_HUMAN","Cilia- and flagella-associated protein 97","CFAP97 KIAA1430","Homo sapiens (Human)",532,"","","","","","",""
"52","sp|O44783|SPY_DROME","lcl|NC_088854.1_cds_XP_011423018.1_5166",1.16e-25,107,"O44783","SPY_DROME","Protein sprouty (Spry)","sty CG1921","Drosophila melanogaster (Fruit fly)",589,"GO:0001666; GO:0001745; GO:0005829; GO:0005886; GO:0007424; GO:0008069; GO:0009898; GO:0016318; GO:0021782; GO:0035171; GO:0040037; GO:0042059; GO:0045177; GO:0045314; GO:0046533; GO:0046580; GO:0048513; GO:0055001; GO:0060446; GO:0070373; GO:0110109; GO:0120177","animal organ development [GO:0048513]; branching involved in open tracheal system development [GO:0060446]; compound eye morphogenesis [GO:0001745]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; glial cell development [GO:0021782]; lamellocyte differentiation [GO:0035171]; muscle cell development [GO:0055001]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of imaginal disc-derived wing vein specification [GO:0110109]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of torso signaling pathway [GO:0120177]; ommatidial rotation [GO:0016318]; open tracheal system development [GO:0007424]; regulation of compound eye photoreceptor development [GO:0045314]; response to hypoxia [GO:0001666]","apical part of cell [GO:0045177]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; animal organ development [GO:0048513]; branching involved in open tracheal system development [GO:0060446]; compound eye morphogenesis [GO:0001745]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; glial cell development [GO:0021782]; lamellocyte differentiation [GO:0035171]; muscle cell development [GO:0055001]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of imaginal disc-derived wing vein specification [GO:0110109]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of torso signaling pathway [GO:0120177]; ommatidial rotation [GO:0016318]; open tracheal system development [GO:0007424]; regulation of compound eye photoreceptor development [GO:0045314]; response to hypoxia [GO:0001666]","","INDUCTION: By the BNL-FGF pathway in the tracheal system and by the egf receptor pathway in the wing imaginal disk and the follicle cells of the ovary. {ECO:0000269|PubMed:10457022, ECO:0000269|PubMed:9458049}.","INDUCTION: By the BNL-FGF pathway in the tracheal system and by the egf receptor pathway in the wing imaginal disk and the follicle cells of the ovary. {ECO:0000269|PubMed:10457022, ECO:0000269|PubMed:9458049}.","TISSUE SPECIFICITY: In ovary, expressed from stage 7 of oogenesis in the posterior follicle cells and during stage 9 when the follicle cells migrate posteriorly over the oocyte nucleus, expression is seen in the dorsal and lateral cells and is excluded from the ventral cells. Once the migration of follicle cells is complete expressed in the dorsal-anterior corner of the egg chamber. Expressed in the embryonic tracheal system, developing eye imaginal disk, embryonic chordotonal organ precursors, midline glia and wing imaginal disk. {ECO:0000269|PubMed:10226010, ECO:0000269|PubMed:10457022, ECO:0000269|PubMed:9458049}."
"53","sp|Q9V3I2|RAB5_DROME","lcl|NC_088854.1_cds_XP_011426046.1_10722",3.1e-117,333,"Q9V3I2","RAB5_DROME","Ras-related protein Rab5 (Drab5) (EC 3.6.5.2) (Small monomeric GTPase Rab5)","Rab5 Rab RAB5a CG3664","Drosophila melanogaster (Fruit fly)",219,"GO:0003924; GO:0005525; GO:0005769; GO:0005829; GO:0005886; GO:0005938; GO:0006836; GO:0006886; GO:0006887; GO:0006897; GO:0006898; GO:0006909; GO:0007032; GO:0007220; GO:0007298; GO:0007349; GO:0007399; GO:0007409; GO:0008021; GO:0012505; GO:0016050; GO:0016189; GO:0016192; GO:0016197; GO:0030139; GO:0030234; GO:0031982; GO:0032482; GO:0032509; GO:0032585; GO:0032956; GO:0034058; GO:0035088; GO:0035220; GO:0036258; GO:0043025; GO:0043195; GO:0043204; GO:0043679; GO:0045202; GO:0046664; GO:0046718; GO:0048015; GO:0048227; GO:0048477; GO:0048488; GO:0048675; GO:0048803; GO:0048813; GO:0050803; GO:0061645; GO:0061883; GO:0098830; GO:1903186","axon extension [GO:0048675]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; clathrin-dependent endocytosis involved in vitellogenesis [GO:0061883]; dendrite morphogenesis [GO:0048813]; dorsal closure, amnioserosa morphology change [GO:0046664]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome transport via multivesicular body sorting pathway [GO:0032509]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; exocytosis [GO:0006887]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; intracellular protein transport [GO:0006886]; multivesicular body assembly [GO:0036258]; nervous system development [GO:0007399]; neurotransmitter transport [GO:0006836]; Notch receptor processing [GO:0007220]; oogenesis [GO:0048477]; phagocytosis [GO:0006909]; phosphatidylinositol-mediated signaling [GO:0048015]; plasma membrane to endosome transport [GO:0048227]; Rab protein signal transduction [GO:0032482]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of synapse structure or activity [GO:0050803]; regulation of vitellogenesis [GO:1903186]; symbiont entry into host cell [GO:0046718]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle organization [GO:0016050]; vesicle-mediated transport [GO:0016192]; wing disc development [GO:0035220]","axon terminus [GO:0043679]; cell cortex [GO:0005938]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic patch [GO:0061645]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic endosome [GO:0098830]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; vesicle [GO:0031982]; enzyme regulator activity [GO:0030234]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; clathrin-dependent endocytosis involved in vitellogenesis [GO:0061883]; dendrite morphogenesis [GO:0048813]; dorsal closure, amnioserosa morphology change [GO:0046664]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome transport via multivesicular body sorting pathway [GO:0032509]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; exocytosis [GO:0006887]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; intracellular protein transport [GO:0006886]; multivesicular body assembly [GO:0036258]; nervous system development [GO:0007399]; neurotransmitter transport [GO:0006836]; Notch receptor processing [GO:0007220]; oogenesis [GO:0048477]; phagocytosis [GO:0006909]; phosphatidylinositol-mediated signaling [GO:0048015]; plasma membrane to endosome transport [GO:0048227]; Rab protein signal transduction [GO:0032482]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of synapse structure or activity [GO:0050803]; regulation of vitellogenesis [GO:1903186]; symbiont entry into host cell [GO:0046718]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle organization [GO:0016050]; vesicle-mediated transport [GO:0016192]; wing disc development [GO:0035220]","DEVELOPMENTAL STAGE: In third instar larvae expressed in the neuromuscular junctions of abdominal muscles 6/7 (at protein level) (PubMed:12743108). During early oogenesis, from germarium to stage 10, expressed in germline cells and oocyte (PubMed:19050045). A portion of early embryonic expression is derived from maternal mRNAs (PubMed:12743108). Expressed throughout development (PubMed:9197407). {ECO:0000269|PubMed:12743108, ECO:0000269|PubMed:19050045, ECO:0000269|PubMed:9197407}.","","",""
"54","sp|Q8CDR2|RSH6A_MOUSE","lcl|NC_088854.1_cds_XP_011426256.3_4711",4.06e-99,317,"Q8CDR2","RSH6A_MOUSE","Radial spoke head protein 6 homolog A (Radial spoke head-like protein 1)","Rsph6a Rshl1","Mus musculus (Mouse)",708,"GO:0001534; GO:0001535; GO:0005930; GO:0007618; GO:0030317; GO:0036126; GO:0120316; GO:1905199","flagellated sperm motility [GO:0030317]; manchette disassembly [GO:1905199]; mating [GO:0007618]; sperm flagellum assembly [GO:0120316]","axoneme [GO:0005930]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; sperm flagellum [GO:0036126]; flagellated sperm motility [GO:0030317]; manchette disassembly [GO:1905199]; mating [GO:0007618]; sperm flagellum assembly [GO:0120316]","DEVELOPMENTAL STAGE: First detected during the haploid phase of spermatogenesis when secondary spermatocytes begin to appear at about postnatal day 18 (PubMed:30185526). Expression is maintained in mature sperm (PubMed:30239614). {ECO:0000269|PubMed:30185526, ECO:0000269|PubMed:30239614}.","","","TISSUE SPECIFICITY: Expressed in sperm and testis (at protein level). {ECO:0000269|PubMed:11237735, ECO:0000269|PubMed:30185526, ECO:0000269|PubMed:30239614, ECO:0000269|PubMed:34871179}."
"55","sp|Q920G9|GMCL1_MOUSE","lcl|NC_088854.1_cds_XP_011426964.3_8895",2.02e-149,443,"Q920G9","GMCL1_MOUSE","Germ cell-less protein-like 1 (mGcl-1) (DP-interacting protein) (DIP)","Gmcl1 Gcl Gcl1","Mus musculus (Mouse)",524,"GO:0005635; GO:0006355; GO:0007281; GO:0007283; GO:0016363","germ cell development [GO:0007281]; regulation of DNA-templated transcription [GO:0006355]; spermatogenesis [GO:0007283]","nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; germ cell development [GO:0007281]; regulation of DNA-templated transcription [GO:0006355]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Highest levels in pachytene and diplotene stage spermatocytes and primordial germ cells of the male and the female.","","","TISSUE SPECIFICITY: Ubiquitously expressed at low levels throughout development and in adult tissues."
"56","sp|P34545|CBP1_CAEEL","lcl|NC_088854.1_cds_XP_011427369.3_9530",2.14e-175,592,"P34545","CBP1_CAEEL","Protein cbp-1 (EC 2.3.1.48)","cbp-1 R10E11.1","Caenorhabditis elegans",2017,"GO:0000123; GO:0003713; GO:0004402; GO:0004468; GO:0005634; GO:0005667; GO:0005737; GO:0006355; GO:0007283; GO:0008270; GO:0008630; GO:0009792; GO:0010975; GO:0017053; GO:0031490; GO:0043065; GO:0045944; GO:0061629; GO:0061733; GO:1903354","embryo development ending in birth or egg hatching [GO:0009792]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of distal tip cell migration [GO:1903354]; regulation of DNA-templated transcription [GO:0006355]; regulation of neuron projection development [GO:0010975]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]; chromatin DNA binding [GO:0031490]; histone acetyltransferase activity [GO:0004402]; L-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; protein-lysine-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; embryo development ending in birth or egg hatching [GO:0009792]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of distal tip cell migration [GO:1903354]; regulation of DNA-templated transcription [GO:0006355]; regulation of neuron projection development [GO:0010975]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed in the gonadal distal tip cells (DTC) during larval stages L2, L3 and L4. {ECO:0000269|PubMed:24811939}.","","",""
"57","sp|Q9VFG8|KIBRA_DROME","lcl|NC_088854.1_cds_XP_011427377.3_9538",4.53e-90,319,"Q9VFG8","KIBRA_DROME","Protein kibra","kibra CG33967","Drosophila melanogaster (Fruit fly)",1288,"GO:0001745; GO:0005737; GO:0006355; GO:0007298; GO:0016477; GO:0019900; GO:0035330; GO:0035332; GO:0036375; GO:0043065; GO:0045179; GO:0045463; GO:0045464; GO:0046621; GO:0060090; GO:0060253; GO:0098592; GO:0106037","border follicle cell migration [GO:0007298]; cell migration [GO:0016477]; compound eye morphogenesis [GO:0001745]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; R8 cell development [GO:0045463]; R8 cell fate specification [GO:0045464]; regulation of DNA-templated transcription [GO:0006355]; regulation of hippo signaling [GO:0035330]","apical cortex [GO:0045179]; apicomedial cortex [GO:0106037]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; Kibra-Ex-Mer complex [GO:0036375]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; border follicle cell migration [GO:0007298]; cell migration [GO:0016477]; compound eye morphogenesis [GO:0001745]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; R8 cell development [GO:0045463]; R8 cell fate specification [GO:0045464]; regulation of DNA-templated transcription [GO:0006355]; regulation of hippo signaling [GO:0035330]","","","","TISSUE SPECIFICITY: Expressed in ovarian posterior follicle cells and wing disks (at protein level). {ECO:0000269|PubMed:20159599}."
"58","sp|B4NAD3|KIBRA_DROWI","lcl|NC_088854.1_cds_XP_011427378.3_9537",3.22e-95,334,"B4NAD3","KIBRA_DROWI","Protein kibra","Kibra GK11691","Drosophila willistoni (Fruit fly)",1288,"GO:0005911; GO:0006355; GO:0007298; GO:0019900; GO:0035332; GO:0036375; GO:0043065; GO:0045463; GO:0045464; GO:0046621; GO:0060090; GO:0060253; GO:0098592; GO:0106037","border follicle cell migration [GO:0007298]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; R8 cell development [GO:0045463]; R8 cell fate specification [GO:0045464]; regulation of DNA-templated transcription [GO:0006355]","apicomedial cortex [GO:0106037]; cell-cell junction [GO:0005911]; cytoplasmic side of apical plasma membrane [GO:0098592]; Kibra-Ex-Mer complex [GO:0036375]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; border follicle cell migration [GO:0007298]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; R8 cell development [GO:0045463]; R8 cell fate specification [GO:0045464]; regulation of DNA-templated transcription [GO:0006355]","","","",""
"59","sp|Q7Z4T9|CFA91_HUMAN","lcl|NC_088854.1_cds_XP_011427467.1_6938",0,731,"Q7Z4T9","CFA91_HUMAN","Cilia- and flagella-associated protein 91 (CFAP91) (AMY-1-associating protein expressed in testis 1) (AAT-1) (MYCBP/AMY-1-associated testis-expressed protein 1) (Protein MAATS1)","CFAP91 AAT1 C3orf15 MAATS1","Homo sapiens (Human)",767,"GO:0003341; GO:0005739; GO:0005930; GO:0007283; GO:0030154; GO:0031514; GO:1904158","axonemal central apparatus assembly [GO:1904158]; cell differentiation [GO:0030154]; cilium movement [GO:0003341]; spermatogenesis [GO:0007283]","axoneme [GO:0005930]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; axonemal central apparatus assembly [GO:1904158]; cell differentiation [GO:0030154]; cilium movement [GO:0003341]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: [Isoform 1]: Strongly expressed in the liver.; TISSUE SPECIFICITY: [Isoform 7]: Widely expressed, but strongly expressed in all spermatogenesis-related tissues, including the testis, the epithelium of cauda and the corpus epididymis, as well as the spermatid and mature sperm. Also expressed in Leydig cells. {ECO:0000269|PubMed:15863901, ECO:0000269|PubMed:32161152}."
"60","sp|Q9R064|GORS2_RAT","lcl|NC_088854.1_cds_XP_011428434.2_5402",4.11e-109,330,"Q9R064","GORS2_RAT","Golgi reassembly-stacking protein 2 (GRS2) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55)","Gorasp2","Rattus norvegicus (Rat)",454,"GO:0000139; GO:0005789; GO:0005794; GO:0005797; GO:0006996; GO:0007030; GO:0007283; GO:0030154; GO:0034976; GO:0061951; GO:0070925","cell differentiation [GO:0030154]; establishment of protein localization to plasma membrane [GO:0061951]; Golgi organization [GO:0007030]; organelle assembly [GO:0070925]; organelle organization [GO:0006996]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283]","endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; cell differentiation [GO:0030154]; establishment of protein localization to plasma membrane [GO:0061951]; Golgi organization [GO:0007030]; organelle assembly [GO:0070925]; organelle organization [GO:0006996]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Detected in lung, brain, heart, liver and testis. {ECO:0000269|PubMed:10487747}."
"61","sp|P26583|HMGB2_HUMAN","lcl|NC_088854.1_cds_XP_011428545.1_4665",4.58e-51,165,"P26583","HMGB2_HUMAN","High mobility group protein B2 (High mobility group protein 2) (HMG-2)","HMGB2 HMG2","Homo sapiens (Human)",209,"GO:0000122; GO:0000400; GO:0000785; GO:0000793; GO:0000976; GO:0000987; GO:0001938; GO:0002437; GO:0003677; GO:0003684; GO:0003690; GO:0003697; GO:0003713; GO:0003723; GO:0005615; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006265; GO:0006303; GO:0006325; GO:0006334; GO:0006357; GO:0007289; GO:0008134; GO:0008301; GO:0008584; GO:0008625; GO:0010629; GO:0019904; GO:0032392; GO:0032496; GO:0032728; GO:0032991; GO:0033151; GO:0042056; GO:0044378; GO:0045087; GO:0045089; GO:0045648; GO:0045654; GO:0045892; GO:0045893; GO:0045944; GO:0048471; GO:0048545; GO:0050767; GO:0050786; GO:0050829; GO:0050830; GO:0060326; GO:0071222; GO:0072091; GO:0097100; GO:0140297; GO:1902042","cell chemotaxis [GO:0060326]; cellular response to lipopolysaccharide [GO:0071222]; chromatin organization [GO:0006325]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; DNA geometric change [GO:0032392]; DNA topological change [GO:0006265]; double-strand break repair via nonhomologous end joining [GO:0006303]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; male gonad development [GO:0008584]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to steroid hormone [GO:0048545]; spermatid nucleus differentiation [GO:0007289]; V(D)J recombination [GO:0033151]","chromatin [GO:0000785]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; chemoattractant activity [GO:0042056]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; non-sequence-specific DNA binding, bending [GO:0044378]; protein domain specific binding [GO:0019904]; RAGE receptor binding [GO:0050786]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; cell chemotaxis [GO:0060326]; cellular response to lipopolysaccharide [GO:0071222]; chromatin organization [GO:0006325]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; DNA geometric change [GO:0032392]; DNA topological change [GO:0006265]; double-strand break repair via nonhomologous end joining [GO:0006303]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; male gonad development [GO:0008584]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to steroid hormone [GO:0048545]; spermatid nucleus differentiation [GO:0007289]; V(D)J recombination [GO:0033151]","","","","TISSUE SPECIFICITY: Expressed in gastric and intestinal tissues (at protein level). {ECO:0000269|PubMed:23877675}."
"62","sp|P08182|CSK2B_DROME","lcl|NC_088854.1_cds_XP_011428559.1_4657",6.95e-132,371,"P08182","CSK2B_DROME","Casein kinase II subunit beta (CK II beta)","CkIIbeta Cask-II-b CG15224","Drosophila melanogaster (Fruit fly)",235,"GO:0005634; GO:0005737; GO:0005829; GO:0005956; GO:0007310; GO:0007622; GO:0007623; GO:0008062; GO:0016055; GO:0016319; GO:0019887; GO:0031594; GO:0045475; GO:0050807; GO:0060810; GO:0099523","circadian rhythm [GO:0007623]; eclosion rhythm [GO:0008062]; intracellular mRNA localization involved in pattern specification process [GO:0060810]; locomotor rhythm [GO:0045475]; mushroom body development [GO:0016319]; oocyte dorsal/ventral axis specification [GO:0007310]; regulation of synapse organization [GO:0050807]; rhythmic behavior [GO:0007622]; Wnt signaling pathway [GO:0016055]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; presynaptic cytosol [GO:0099523]; protein kinase CK2 complex [GO:0005956]; protein kinase regulator activity [GO:0019887]; circadian rhythm [GO:0007623]; eclosion rhythm [GO:0008062]; intracellular mRNA localization involved in pattern specification process [GO:0060810]; locomotor rhythm [GO:0045475]; mushroom body development [GO:0016319]; oocyte dorsal/ventral axis specification [GO:0007310]; regulation of synapse organization [GO:0050807]; rhythmic behavior [GO:0007622]; Wnt signaling pathway [GO:0016055]","","","",""
"63","sp|Q22592|BECN_CAEEL","lcl|NC_088854.1_cds_XP_011429584.3_9626",1.52e-33,130,"Q22592","BECN_CAEEL","Beclin homolog","bec-1 atg-6 T19E7.3","Caenorhabditis elegans",375,"GO:0000045; GO:0000407; GO:0000423; GO:0005634; GO:0005737; GO:0005768; GO:0006914; GO:0006995; GO:0008340; GO:0009267; GO:0012501; GO:0030163; GO:0030424; GO:0030425; GO:0030674; GO:0031410; GO:0034271; GO:0034272; GO:0036093; GO:0040014; GO:0040024; GO:0042078; GO:0043204; GO:0043277; GO:0043548; GO:0045138; GO:0045324; GO:0048284; GO:0051036; GO:2000643","apoptotic cell clearance [GO:0043277]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; dauer larval development [GO:0040024]; determination of adult lifespan [GO:0008340]; germ cell proliferation [GO:0036093]; germ-line stem cell division [GO:0042078]; late endosome to vacuole transport [GO:0045324]; mitophagy [GO:0000423]; nematode male tail tip morphogenesis [GO:0045138]; organelle fusion [GO:0048284]; positive regulation of early endosome to late endosome transport [GO:2000643]; programmed cell death [GO:0012501]; protein catabolic process [GO:0030163]; regulation of endosome size [GO:0051036]; regulation of multicellular organism growth [GO:0040014]","axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; endosome [GO:0005768]; nucleus [GO:0005634]; perikaryon [GO:0043204]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein-macromolecule adaptor activity [GO:0030674]; apoptotic cell clearance [GO:0043277]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; dauer larval development [GO:0040024]; determination of adult lifespan [GO:0008340]; germ cell proliferation [GO:0036093]; germ-line stem cell division [GO:0042078]; late endosome to vacuole transport [GO:0045324]; mitophagy [GO:0000423]; nematode male tail tip morphogenesis [GO:0045138]; organelle fusion [GO:0048284]; positive regulation of early endosome to late endosome transport [GO:2000643]; programmed cell death [GO:0012501]; protein catabolic process [GO:0030163]; regulation of endosome size [GO:0051036]; regulation of multicellular organism growth [GO:0040014]","DEVELOPMENTAL STAGE: Highly expressed in embryos and to a lesser extent in larvae (PubMed:16111945). Expressed in pharynx, seam cells and ventral nerve cord neurons at the L1 and L4 larval stages (PubMed:12958363, PubMed:16111945). Expressed in vulva cell precursors and somatic gonad at the L2 larval stage and in vulva at the L4 larval stage (PubMed:12958363). {ECO:0000269|PubMed:12958363, ECO:0000269|PubMed:16111945}.","","","TISSUE SPECIFICITY: Expressed in PVM touch receptor neurons, the ventral nerve cord and in the nerve ring. {ECO:0000269|PubMed:17327275}."
"64","sp|Q86B61|TBH1_DROME","lcl|NC_088854.1_cds_XP_011429599.4_9642",1.39e-129,395,"Q86B61","TBH1_DROME","Tyramine beta-hydroxylase (EC 1.14.17.-) (Tyramine beta-monooxygenase) (TbetaM)","Tbh CG1543","Drosophila melanogaster (Fruit fly)",670,"GO:0002118; GO:0002121; GO:0004500; GO:0005507; GO:0005615; GO:0006589; GO:0007612; GO:0007613; GO:0007629; GO:0008049; GO:0008345; GO:0016715; GO:0030667; GO:0030728; GO:0040011; GO:0042420; GO:0042421; GO:0043059; GO:0048047; GO:0048149; GO:0048266; GO:0050795; GO:0071927","aggressive behavior [GO:0002118]; behavioral response to ethanol [GO:0048149]; behavioral response to pain [GO:0048266]; dopamine catabolic process [GO:0042420]; flight behavior [GO:0007629]; inter-male aggressive behavior [GO:0002121]; larval locomotory behavior [GO:0008345]; learning [GO:0007612]; locomotion [GO:0040011]; male courtship behavior [GO:0008049]; mating behavior, sex discrimination [GO:0048047]; memory [GO:0007613]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]; octopamine signaling pathway [GO:0071927]; ovulation [GO:0030728]; regulation of behavior [GO:0050795]; regulation of forward locomotion [GO:0043059]","extracellular space [GO:0005615]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; aggressive behavior [GO:0002118]; behavioral response to ethanol [GO:0048149]; behavioral response to pain [GO:0048266]; dopamine catabolic process [GO:0042420]; flight behavior [GO:0007629]; inter-male aggressive behavior [GO:0002121]; larval locomotory behavior [GO:0008345]; learning [GO:0007612]; locomotion [GO:0040011]; male courtship behavior [GO:0008049]; mating behavior, sex discrimination [GO:0048047]; memory [GO:0007613]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]; octopamine signaling pathway [GO:0071927]; ovulation [GO:0030728]; regulation of behavior [GO:0050795]; regulation of forward locomotion [GO:0043059]","DEVELOPMENTAL STAGE: At larval stage, present in cell bodies of the ventral ganglion and in neuropil (at protein level). {ECO:0000269|PubMed:8656284}.","INDUCTION: Slightly down-regulated in adults fed a high calorie diet. {ECO:0000269|PubMed:25187989}.","INDUCTION: Slightly down-regulated in adults fed a high calorie diet. {ECO:0000269|PubMed:25187989}.","TISSUE SPECIFICITY: Present in head and in neurons innervating the oviduct (at protein level). {ECO:0000269|PubMed:8656284}."
"65","sp|O08785|CLOCK_MOUSE","lcl|NC_088854.1_cds_XP_011429631.3_9480",1.3e-136,423,"O08785","CLOCK_MOUSE","Circadian locomoter output cycles protein kaput (mCLOCK) (EC 2.3.1.48)","Clock","Mus musculus (Mouse)",855,"GO:0000077; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005694; GO:0005737; GO:0005829; GO:0006355; GO:0006473; GO:0007283; GO:0007623; GO:0031490; GO:0032922; GO:0033391; GO:0042634; GO:0042752; GO:0042753; GO:0043161; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046983; GO:0050729; GO:0050796; GO:0051092; GO:0051775; GO:0070888; GO:0071479; GO:1990513; GO:2000074; GO:2000323","cellular response to ionizing radiation [GO:0071479]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage checkpoint signaling [GO:0000077]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of nuclear receptor-mediated glucocorticoid signaling pathway [GO:2000323]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of inflammatory response [GO:0050729]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein acetylation [GO:0006473]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription [GO:0006355]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283]","chromatoid body [GO:0033391]; chromosome [GO:0005694]; CLOCK-BMAL transcription complex [GO:1990513]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; histone acetyltransferase activity [GO:0004402]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cellular response to ionizing radiation [GO:0071479]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage checkpoint signaling [GO:0000077]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of nuclear receptor-mediated glucocorticoid signaling pathway [GO:2000323]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of inflammatory response [GO:0050729]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein acetylation [GO:0006473]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription [GO:0006355]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283]","","INDUCTION: In the SCN, nuclear expression is lowest between CT7 and CT13. Cytoplasmic expression is highest at these times. In liver, peak levels from CT21 to CT3. Expression of both phosphorylated and unphosphorylated forms of BMAL1 with other circadian clock proteins occurs between CT15 and CT18. Expression in the heart oscillates in a circadian manner. {ECO:0000269|PubMed:11779462, ECO:0000269|PubMed:12897057, ECO:0000269|PubMed:14645221}.","INDUCTION: In the SCN, nuclear expression is lowest between CT7 and CT13. Cytoplasmic expression is highest at these times. In liver, peak levels from CT21 to CT3. Expression of both phosphorylated and unphosphorylated forms of BMAL1 with other circadian clock proteins occurs between CT15 and CT18. Expression in the heart oscillates in a circadian manner. {ECO:0000269|PubMed:11779462, ECO:0000269|PubMed:12897057, ECO:0000269|PubMed:14645221}.","TISSUE SPECIFICITY: Expressed equally in brain, eye, testes, ovaries, liver, heart, lung, kidney. In the brain, expression is abundant in the suprachiasmatic nuclei (SCN), in the pyriform cortex, and in the hippocampus. Low expression throughout the rest of the brain. Expression does not appear to undergo circadian oscillations. {ECO:0000269|PubMed:22900038, ECO:0000269|PubMed:24154698, ECO:0000269|PubMed:28903391, ECO:0000269|PubMed:9160755}."
"66","sp|P25992|YEMA_DROME","lcl|NC_088854.1_cds_XP_011429640.3_9475",2.18e-17,89.4,"P25992","YEMA_DROME","yemanuclein (Yemanuclein-alpha)","yem yema yemalpha yG4.5 CG14513","Drosophila melanogaster (Fruit fly)",1002,"GO:0000776; GO:0001940; GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0007143; GO:0042585","chromatin organization [GO:0006325]; female meiotic nuclear division [GO:0007143]","germinal vesicle [GO:0042585]; kinetochore [GO:0000776]; male pronucleus [GO:0001940]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; chromatin organization [GO:0006325]; female meiotic nuclear division [GO:0007143]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. Expressed at all oogenic stages. {ECO:0000269|PubMed:1606021}.","","","TISSUE SPECIFICITY: Oocyte specific. {ECO:0000269|PubMed:1606021, ECO:0000269|PubMed:21080953}."
"67","sp|Q8BSN3|ODAD3_MOUSE","lcl|NC_088854.1_cds_XP_011429872.1_10895",4.32e-88,284,"Q8BSN3","ODAD3_MOUSE","Outer dynein arm-docking complex subunit 3 (Coiled-coil domain-containing protein 151)","ODAD3 Ccdc151","Mus musculus (Mouse)",593,"GO:0000902; GO:0003341; GO:0005576; GO:0005814; GO:0005929; GO:0005930; GO:0007283; GO:0007338; GO:0007368; GO:0007420; GO:0007507; GO:0030317; GO:0035264; GO:0036064; GO:0036126; GO:0036158; GO:0044782; GO:0048872; GO:0060287; GO:0061371; GO:0072520; GO:0090660; GO:0120228; GO:1902017","brain development [GO:0007420]; cell morphogenesis [GO:0000902]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; outer dynein arm assembly [GO:0036158]; regulation of cilium assembly [GO:1902017]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]","axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; extracellular region [GO:0005576]; outer dynein arm docking complex [GO:0120228]; sperm flagellum [GO:0036126]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; outer dynein arm assembly [GO:0036158]; regulation of cilium assembly [GO:1902017]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: At 7.5 dpc specifically expressed in the ventral node. {ECO:0000269|PubMed:25192045}.","","",""
"68","sp|P23128|DDX6_DROME","lcl|NC_088854.1_cds_XP_011429888.1_10916",0,704,"P23128","DDX6_DROME","ATP-dependent RNA helicase me31b (EC 3.6.4.13) (Maternal expression at 31B)","me31B CG4916","Drosophila melanogaster (Fruit fly)",459,"GO:0000290; GO:0000900; GO:0000932; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005737; GO:0005783; GO:0007279; GO:0010494; GO:0016887; GO:0017148; GO:0030707; GO:0031087; GO:0033962; GO:0034063; GO:0035195; GO:0035278; GO:0036464; GO:0043025; GO:0043186; GO:0046959; GO:0050688; GO:0060148; GO:0061014; GO:0071598; GO:0071683; GO:0090328; GO:0098794; GO:0150011; GO:2000766","deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; follicle cell of egg chamber development [GO:0030707]; habituation [GO:0046959]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; pole cell formation [GO:0007279]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of post-transcriptional gene silencing [GO:0060148]; regulation of defense response to virus [GO:0050688]; regulation of neuron projection arborization [GO:0150011]; regulation of olfactory learning [GO:0090328]; stress granule assembly [GO:0034063]","cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; endoplasmic reticulum [GO:0005783]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; P granule [GO:0043186]; P-body [GO:0000932]; postsynapse [GO:0098794]; sensory dendrite [GO:0071683]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; mRNA regulatory element binding translation repressor activity [GO:0000900]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; follicle cell of egg chamber development [GO:0030707]; habituation [GO:0046959]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; pole cell formation [GO:0007279]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of post-transcriptional gene silencing [GO:0060148]; regulation of defense response to virus [GO:0050688]; regulation of neuron projection arborization [GO:0150011]; regulation of olfactory learning [GO:0090328]; stress granule assembly [GO:0034063]","DEVELOPMENTAL STAGE: First detected at low levels in the germarium region 2B where it is concentrated in the pro-oocytes (at protein level) (PubMed:11546740). Remains concentrated in the oocyte until mid-oogenesis (at protein level) (PubMed:11546740). In early egg chambers detected in nurse cells and oocytes, and later accumulates at the posterior pole of stage 10 oocytes (at protein level) (PubMed:11546740, PubMed:20452345). Expression levels increas during oogenesis (at protein level) (PubMed:20452345). Expression decreases during the first 5 hours of embryogenesis; expression levels are high during the first 2 hours of embryogenesis then sharply decrease at 2-3 hours and remains low (at protein level) (PubMed:28875934). Ubiquitously expressed in cleavage embryos but is not detected at the cellular blastoderm stage (at protein level) (PubMed:11546740). Expressed both maternally and zygotically (PubMed:1900936). {ECO:0000269|PubMed:11546740, ECO:0000269|PubMed:1900936, ECO:0000269|PubMed:20452345, ECO:0000269|PubMed:28875934}.","","","TISSUE SPECIFICITY: Ubiquitously expressed throughout the brain (at protein level) (PubMed:17178403, PubMed:21267420). Expressed in the olfactory system including the antennal lobes, projection neurons, local interneurons, mushroom-body Kenyon cells and glial cells (at protein level) (PubMed:21267420). {ECO:0000269|PubMed:17178403, ECO:0000269|PubMed:21267420}."
"69","sp|Q8NAT2|TDRD5_HUMAN","lcl|NC_088854.1_cds_XP_011431063.3_4256",7.66e-29,126,"Q8NAT2","TDRD5_HUMAN","Tudor domain-containing protein 5","TDRD5 TUDOR3","Homo sapiens (Human)",981,"GO:0007286; GO:0030719; GO:0033391; GO:0045202; GO:0071546; GO:0141196","P granule organization [GO:0030719]; spermatid development [GO:0007286]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]","chromatoid body [GO:0033391]; pi-body [GO:0071546]; synapse [GO:0045202]; P granule organization [GO:0030719]; spermatid development [GO:0007286]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]","","","",""
"70","sp|Q6ZTW0|TPGS1_HUMAN","lcl|NC_088854.1_cds_XP_011431153.1_9333",1.24e-35,129,"Q6ZTW0","TPGS1_HUMAN","Tubulin polyglutamylase complex subunit 1 (PGs1)","TPGS1 C19orf20","Homo sapiens (Human)",290,"GO:0005737; GO:0005813; GO:0005815; GO:0005874; GO:0007268; GO:0007288; GO:0008017; GO:0030424; GO:0030425; GO:0030534; GO:0031514; GO:0034451; GO:0045202; GO:0051648; GO:0070740","adult behavior [GO:0030534]; chemical synaptic transmission [GO:0007268]; sperm axoneme assembly [GO:0007288]; vesicle localization [GO:0051648]","axon [GO:0030424]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; motile cilium [GO:0031514]; synapse [GO:0045202]; microtubule binding [GO:0008017]; tubulin-glutamic acid ligase activity [GO:0070740]; adult behavior [GO:0030534]; chemical synaptic transmission [GO:0007268]; sperm axoneme assembly [GO:0007288]; vesicle localization [GO:0051648]","","","",""
"71","sp|Q9TVL3|CDK9_CAEEL","lcl|NC_088854.1_cds_XP_011431695.2_4103",3.05e-124,369,"Q9TVL3","CDK9_CAEEL","Probable cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9)","cdk-9 H25P06.2","Caenorhabditis elegans",478,"GO:0000791; GO:0002119; GO:0004693; GO:0005524; GO:0005634; GO:0007281; GO:0008353; GO:0009792; GO:0032968; GO:0106310","embryo development ending in birth or egg hatching [GO:0009792]; germ cell development [GO:0007281]; nematode larval development [GO:0002119]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]","euchromatin [GO:0000791]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; embryo development ending in birth or egg hatching [GO:0009792]; germ cell development [GO:0007281]; nematode larval development [GO:0002119]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]","","","",""
"72","sp|O60879|DIAP2_HUMAN","lcl|NC_088854.1_cds_XP_011432005.3_8406",1.43e-119,397,"O60879","DIAP2_HUMAN","Protein diaphanous homolog 2 (Diaphanous-related formin-2) (DRF2)","DIAPH2 DIA","Homo sapiens (Human)",1101,"GO:0003779; GO:0005102; GO:0005730; GO:0005769; GO:0005783; GO:0005829; GO:0005884; GO:0007292; GO:0030041; GO:0031267; GO:0043231; GO:0048477","actin filament polymerization [GO:0030041]; female gamete generation [GO:0007292]; oogenesis [GO:0048477]","actin filament [GO:0005884]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; actin binding [GO:0003779]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; actin filament polymerization [GO:0030041]; female gamete generation [GO:0007292]; oogenesis [GO:0048477]","DEVELOPMENTAL STAGE: Expressed from 16 dpc in ovary and testis and during P6-P16 during differentiation of ovarian follicles.","","","TISSUE SPECIFICITY: Expressed in testis, ovary, small intestine, prostate, lung, liver, kidney and leukocytes."
"73","sp|P48608|DIA_DROME","lcl|NC_088854.1_cds_XP_011432008.3_8409",1.37e-108,365,"P48608","DIA_DROME","Protein diaphanous","dia CG1768","Drosophila melanogaster (Fruit fly)",1091,"GO:0000281; GO:0000915; GO:0003383; GO:0003779; GO:0005546; GO:0005737; GO:0005856; GO:0005938; GO:0007015; GO:0007110; GO:0007111; GO:0007279; GO:0007349; GO:0007424; GO:0007435; GO:0007605; GO:0008104; GO:0009306; GO:0012506; GO:0016324; GO:0016476; GO:0030018; GO:0030036; GO:0030041; GO:0030589; GO:0030838; GO:0031267; GO:0031430; GO:0032154; GO:0032507; GO:0032991; GO:0035011; GO:0045010; GO:0045177; GO:0045214; GO:0045448; GO:0051225; GO:0051489; GO:0090303; GO:0097320; GO:0106036; GO:0110020","actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; actomyosin contractile ring assembly [GO:0000915]; apical constriction [GO:0003383]; assembly of apicomedial cortex actomyosin [GO:0106036]; cellularization [GO:0007349]; maintenance of protein location in cell [GO:0032507]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; melanotic encapsulation of foreign target [GO:0035011]; mitotic cell cycle, embryonic [GO:0045448]; mitotic cytokinesis [GO:0000281]; open tracheal system development [GO:0007424]; plasma membrane tubulation [GO:0097320]; pole cell formation [GO:0007279]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of wound healing [GO:0090303]; protein localization [GO:0008104]; protein secretion [GO:0009306]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actomyosin structure organization [GO:0110020]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; sensory perception of sound [GO:0007605]; spindle assembly [GO:0051225]","apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; M band [GO:0031430]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506]; Z disc [GO:0030018]; actin binding [GO:0003779]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; actomyosin contractile ring assembly [GO:0000915]; apical constriction [GO:0003383]; assembly of apicomedial cortex actomyosin [GO:0106036]; cellularization [GO:0007349]; maintenance of protein location in cell [GO:0032507]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; melanotic encapsulation of foreign target [GO:0035011]; mitotic cell cycle, embryonic [GO:0045448]; mitotic cytokinesis [GO:0000281]; open tracheal system development [GO:0007424]; plasma membrane tubulation [GO:0097320]; pole cell formation [GO:0007279]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of wound healing [GO:0090303]; protein localization [GO:0008104]; protein secretion [GO:0009306]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actomyosin structure organization [GO:0110020]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; sensory perception of sound [GO:0007605]; spindle assembly [GO:0051225]","DEVELOPMENTAL STAGE: In stage 15 embryos expressed in epithelial cells of various tubular tissues including trachea, hindgut and salivary gland (at protein level). {ECO:0000269|PubMed:23853710}.","","",""
"74","sp|Q24152|CKS1_DROME","lcl|NC_088854.1_cds_XP_011432896.1_10272",1.27e-30,103,"Q24152","CKS1_DROME","Cyclin-dependent kinases regulatory subunit","Cks30A CDI2 Cks Cks1 CG3738","Drosophila melanogaster (Fruit fly)",74,"GO:0000307; GO:0007057; GO:0007143; GO:0007144; GO:0007346; GO:0007488; GO:0019005; GO:0019901; GO:0031145; GO:0035186; GO:0042393; GO:0043130; GO:0051225; GO:0051301; GO:0061575","anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; female meiosis I [GO:0007144]; female meiotic nuclear division [GO:0007143]; histoblast morphogenesis [GO:0007488]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225]; spindle assembly involved in female meiosis I [GO:0007057]; syncytial blastoderm mitotic cell cycle [GO:0035186]","cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; SCF ubiquitin ligase complex [GO:0019005]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; histone binding [GO:0042393]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; female meiosis I [GO:0007144]; female meiotic nuclear division [GO:0007143]; histoblast morphogenesis [GO:0007488]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225]; spindle assembly involved in female meiosis I [GO:0007057]; syncytial blastoderm mitotic cell cycle [GO:0035186]","","","",""
"75","sp|P20153|USP_DROME","lcl|NC_088854.1_cds_XP_011434498.1_6218",1.15e-64,217,"P20153","USP_DROME","Protein ultraspiracle (Chorion factor 1) (Nuclear receptor subfamily 2 group B member 4) (XR2C)","usp Cf1 NR2B4 CG4380","Drosophila melanogaster (Fruit fly)",508,"GO:0000976; GO:0000978; GO:0001046; GO:0003677; GO:0003707; GO:0004879; GO:0005102; GO:0005634; GO:0005700; GO:0006697; GO:0007281; GO:0007298; GO:0007399; GO:0007552; GO:0008230; GO:0008232; GO:0008270; GO:0008289; GO:0016319; GO:0016322; GO:0030154; GO:0030425; GO:0035073; GO:0035075; GO:0035076; GO:0040034; GO:0042562; GO:0042594; GO:0045596; GO:0045892; GO:0045893; GO:0045944; GO:0046620; GO:0046982; GO:0048384; GO:0048813; GO:0071390","border follicle cell migration [GO:0007298]; cell differentiation [GO:0030154]; cellular response to ecdysone [GO:0071390]; dendrite morphogenesis [GO:0048813]; ecdysone biosynthetic process [GO:0006697]; ecdysone receptor signaling pathway [GO:0035076]; germ cell development [GO:0007281]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of cell differentiation [GO:0045596]; negative regulation of DNA-templated transcription [GO:0045892]; nervous system development [GO:0007399]; neuron remodeling [GO:0016322]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pupariation [GO:0035073]; regulation of development, heterochronic [GO:0040034]; regulation of organ growth [GO:0046620]; response to ecdysone [GO:0035075]; response to starvation [GO:0042594]; retinoic acid receptor signaling pathway [GO:0048384]","activator ecdysone receptor complex [GO:0008232]; dendrite [GO:0030425]; ecdysone receptor holocomplex [GO:0008230]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; hormone binding [GO:0042562]; lipid binding [GO:0008289]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; signaling receptor binding [GO:0005102]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; border follicle cell migration [GO:0007298]; cell differentiation [GO:0030154]; cellular response to ecdysone [GO:0071390]; dendrite morphogenesis [GO:0048813]; ecdysone biosynthetic process [GO:0006697]; ecdysone receptor signaling pathway [GO:0035076]; germ cell development [GO:0007281]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of cell differentiation [GO:0045596]; negative regulation of DNA-templated transcription [GO:0045892]; nervous system development [GO:0007399]; neuron remodeling [GO:0016322]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pupariation [GO:0035073]; regulation of development, heterochronic [GO:0040034]; regulation of organ growth [GO:0046620]; response to ecdysone [GO:0035075]; response to starvation [GO:0042594]; retinoic acid receptor signaling pathway [GO:0048384]","","","",""
"76","sp|Q9VK33|SMBT_DROME","lcl|NC_088854.1_cds_XP_011434915.3_8833",3.96e-151,478,"Q9VK33","SMBT_DROME","Polycomb protein Sfmbt (Scm-like with four MBT domain-containing protein 1) (dSfmbt)","Sfmbt CG16975","Drosophila melanogaster (Fruit fly)",1220,"GO:0003677; GO:0003682; GO:0005634; GO:0007446; GO:0008270; GO:0010629; GO:0031507; GO:0031519; GO:0035064; GO:0045892; GO:0048477","heterochromatin formation [GO:0031507]; imaginal disc growth [GO:0007446]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]","nucleus [GO:0005634]; PcG protein complex [GO:0031519]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; heterochromatin formation [GO:0031507]; imaginal disc growth [GO:0007446]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]","","","",""
"77","sp|Q4R4D5|GLPK2_MACFA","lcl|NC_088854.1_cds_XP_011436344.3_9839",0,687,"Q4R4D5","GLPK2_MACFA","Glycerol kinase 2 (GK 2) (Glycerokinase 2) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase 2) (Glycerol kinase, testis specific 2)","GK2 QtsA-10839","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)",553,"GO:0004370; GO:0005524; GO:0005741; GO:0006641; GO:0007283; GO:0019563; GO:0030317; GO:0046167; GO:0097225; GO:0097226; GO:0120317","flagellated sperm motility [GO:0030317]; glycerol catabolic process [GO:0019563]; glycerol-3-phosphate biosynthetic process [GO:0046167]; sperm mitochondrial sheath assembly [GO:0120317]; spermatogenesis [GO:0007283]; triglyceride metabolic process [GO:0006641]","mitochondrial outer membrane [GO:0005741]; sperm midpiece [GO:0097225]; sperm mitochondrial sheath [GO:0097226]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; flagellated sperm motility [GO:0030317]; glycerol catabolic process [GO:0019563]; glycerol-3-phosphate biosynthetic process [GO:0046167]; sperm mitochondrial sheath assembly [GO:0120317]; spermatogenesis [GO:0007283]; triglyceride metabolic process [GO:0006641]","","","",""
"78","sp|O14777|NDC80_HUMAN","lcl|NC_088854.1_cds_XP_011436875.3_4079",1.46e-74,252,"O14777","NDC80_HUMAN","Kinetochore protein NDC80 homolog (Highly expressed in cancer protein) (Kinetochore protein Hec1) (HsHec1) (Kinetochore-associated protein 2) (Retinoblastoma-associated protein HEC)","NDC80 HEC HEC1 KNTC2","Homo sapiens (Human)",642,"GO:0000070; GO:0000132; GO:0000278; GO:0000775; GO:0000776; GO:0000940; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0007052; GO:0007057; GO:0007059; GO:0007094; GO:0008017; GO:0008315; GO:0008608; GO:0014841; GO:0016020; GO:0016607; GO:0030332; GO:0031262; GO:0031647; GO:0042802; GO:0051298; GO:0051301; GO:0051310; GO:0051315; GO:0051383; GO:0090267; GO:0140483","attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; G2/MI transition of meiotic cell cycle [GO:0008315]; kinetochore organization [GO:0051383]; metaphase chromosome alignment [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of protein stability [GO:0031647]; skeletal muscle satellite cell proliferation [GO:0014841]; spindle assembly involved in female meiosis I [GO:0007057]","centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; Ndc80 complex [GO:0031262]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; kinetochore adaptor activity [GO:0140483]; microtubule binding [GO:0008017]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; G2/MI transition of meiotic cell cycle [GO:0008315]; kinetochore organization [GO:0051383]; metaphase chromosome alignment [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of protein stability [GO:0031647]; skeletal muscle satellite cell proliferation [GO:0014841]; spindle assembly involved in female meiosis I [GO:0007057]","DEVELOPMENTAL STAGE: Expression peaks in mitosis. {ECO:0000269|PubMed:16732327, ECO:0000269|PubMed:9295362, ECO:0000269|PubMed:9315664}.","","",""
"79","sp|O01346|EGH_DROME","lcl|NC_088854.1_cds_XP_011438823.3_8576",3.42e-147,427,"O01346","EGH_DROME","Beta-1,4-mannosyltransferase egh (EC 2.4.1.-) (Protein egghead) (Protein zeste-white 4)","egh l(1)3Ae zw4 CG9659","Drosophila melanogaster (Fruit fly)",457,"GO:0001744; GO:0005737; GO:0006688; GO:0007281; GO:0007293; GO:0007298; GO:0007299; GO:0007411; GO:0008049; GO:0016020; GO:0016325; GO:0016333; GO:0019187; GO:0030707; GO:0030720; GO:0042248; GO:0045165; GO:0045434; GO:0046662; GO:0048935","axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell fate commitment [GO:0045165]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber-cell adhesion [GO:0007299]; germ cell development [GO:0007281]; germarium-derived egg chamber formation [GO:0007293]; glycosphingolipid biosynthetic process [GO:0006688]; insect visual primordium formation [GO:0001744]; maintenance of polarity of follicular epithelium [GO:0042248]; male courtship behavior [GO:0008049]; morphogenesis of follicular epithelium [GO:0016333]; negative regulation of female receptivity, post-mating [GO:0045434]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; peripheral nervous system neuron development [GO:0048935]; regulation of egg-laying behavior [GO:0046662]","cytoplasm [GO:0005737]; membrane [GO:0016020]; beta-1,4-mannosyltransferase activity [GO:0019187]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell fate commitment [GO:0045165]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber-cell adhesion [GO:0007299]; germ cell development [GO:0007281]; germarium-derived egg chamber formation [GO:0007293]; glycosphingolipid biosynthetic process [GO:0006688]; insect visual primordium formation [GO:0001744]; maintenance of polarity of follicular epithelium [GO:0042248]; male courtship behavior [GO:0008049]; morphogenesis of follicular epithelium [GO:0016333]; negative regulation of female receptivity, post-mating [GO:0045434]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; peripheral nervous system neuron development [GO:0048935]; regulation of egg-laying behavior [GO:0046662]","","","",""
"80","sp|Q9D3R9|TAF7L_MOUSE","lcl|NC_088854.1_cds_XP_011438872.3_5083",9.62e-38,142,"Q9D3R9","TAF7L_MOUSE","Transcription initiation factor TFIID subunit 7-like (TATA box binding protein-associated factor RNA polymerase II subunit Q) (TATA box-binding protein-associated factor 50 kDa) (Transcription initiation factor TFIID 50 kDa subunit)","Taf7l Taf2q","Mus musculus (Mouse)",471,"GO:0001673; GO:0005634; GO:0005669; GO:0005737; GO:0006367; GO:0007286; GO:0030317","flagellated sperm motility [GO:0030317]; spermatid development [GO:0007286]; transcription initiation at RNA polymerase II promoter [GO:0006367]","cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; flagellated sperm motility [GO:0030317]; spermatid development [GO:0007286]; transcription initiation at RNA polymerase II promoter [GO:0006367]","","","","TISSUE SPECIFICITY: Testis-specific (at protein level). Expressed during spermatogenesis from spermatogonia stage up to the stage of round spermatids. {ECO:0000269|PubMed:11279525, ECO:0000269|PubMed:17242199}."
"81","sp|P54359|SEPT2_DROME","lcl|NC_088854.1_cds_XP_011439178.1_10065",0,543,"P54359","SEPT2_DROME","Septin-2","Septin2 Sep2 CG4173","Drosophila melanogaster (Fruit fly)",419,"GO:0003924; GO:0005525; GO:0005819; GO:0005940; GO:0007295; GO:0007298; GO:0007349; GO:0007444; GO:0008104; GO:0015630; GO:0031105; GO:0032153; GO:0042060; GO:0042803; GO:0044837; GO:0051015; GO:0051726; GO:0060090; GO:0061640","actomyosin contractile ring organization [GO:0044837]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; cytoskeleton-dependent cytokinesis [GO:0061640]; growth of a germarium-derived egg chamber [GO:0007295]; imaginal disc development [GO:0007444]; protein localization [GO:0008104]; regulation of cell cycle [GO:0051726]; wound healing [GO:0042060]","cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]; actin filament binding [GO:0051015]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803]; actomyosin contractile ring organization [GO:0044837]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; cytoskeleton-dependent cytokinesis [GO:0061640]; growth of a germarium-derived egg chamber [GO:0007295]; imaginal disc development [GO:0007444]; protein localization [GO:0008104]; regulation of cell cycle [GO:0051726]; wound healing [GO:0042060]","","","",""
"82","sp|Q6ZU15|SEP14_HUMAN","lcl|NC_088854.1_cds_XP_011439180.1_10067",1.65e-162,465,"Q6ZU15","SEP14_HUMAN","Septin-14","SEPTIN14 SEPT14","Homo sapiens (Human)",432,"GO:0001669; GO:0001764; GO:0003924; GO:0005525; GO:0005737; GO:0005856; GO:0005940; GO:0007286; GO:0008104; GO:0015630; GO:0030424; GO:0030425; GO:0031105; GO:0032153; GO:0043204; GO:0048471; GO:0060090; GO:0061640; GO:1905719","cytoskeleton-dependent cytokinesis [GO:0061640]; neuron migration [GO:0001764]; protein localization [GO:0008104]; protein localization to perinuclear region of cytoplasm [GO:1905719]; spermatid development [GO:0007286]","acrosomal vesicle [GO:0001669]; axon [GO:0030424]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; microtubule cytoskeleton [GO:0015630]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; septin complex [GO:0031105]; septin ring [GO:0005940]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; cytoskeleton-dependent cytokinesis [GO:0061640]; neuron migration [GO:0001764]; protein localization [GO:0008104]; protein localization to perinuclear region of cytoplasm [GO:1905719]; spermatid development [GO:0007286]","DEVELOPMENTAL STAGE: Expressed in all cell stages of spermatogenesis. {ECO:0000269|PubMed:32249155}.","","","TISSUE SPECIFICITY: Testis-specific (at protein level). {ECO:0000269|PubMed:17922164, ECO:0000269|PubMed:32249155}."
"83","sp|O14686|KMT2D_HUMAN","lcl|NC_088854.1_cds_XP_011439184.3_10071",0,683,"O14686","KMT2D_HUMAN","Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.364) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2)","KMT2D ALR MLL2 MLL4","Homo sapiens (Human)",5537,"GO:0000976; GO:0001555; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0006355; GO:0008270; GO:0008284; GO:0031507; GO:0032259; GO:0033148; GO:0042800; GO:0043627; GO:0044666; GO:0045944; GO:0048477; GO:0140945; GO:0140999; GO:1904837","beta-catenin-TCF complex assembly [GO:1904837]; heterochromatin formation [GO:0031507]; methylation [GO:0032259]; oocyte growth [GO:0001555]; oogenesis [GO:0048477]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; response to estrogen [GO:0043627]","MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone H3K4 trimethyltransferase activity [GO:0140999]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; beta-catenin-TCF complex assembly [GO:1904837]; heterochromatin formation [GO:0031507]; methylation [GO:0032259]; oocyte growth [GO:0001555]; oogenesis [GO:0048477]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; response to estrogen [GO:0043627]","","","","TISSUE SPECIFICITY: Expressed in most adult tissues, including a variety of hematoipoietic cells, with the exception of the liver."
"84","sp|Q5SQI0|ATAT_HUMAN","lcl|NC_088854.1_cds_XP_011439251.2_5848",2.18e-52,181,"Q5SQI0","ATAT_HUMAN","Alpha-tubulin N-acetyltransferase 1 (Alpha-TAT) (Alpha-TAT1) (TAT) (EC 2.3.1.108) (Acetyltransferase mec-17 homolog)","ATAT1 C6orf134 MEC17 Nbla00487","Homo sapiens (Human)",421,"GO:0000226; GO:0004468; GO:0005794; GO:0005829; GO:0005874; GO:0005905; GO:0005925; GO:0007283; GO:0009612; GO:0019799; GO:0021542; GO:0030424; GO:0044546; GO:0045598; GO:0048265; GO:0048666; GO:0060271; GO:0070507; GO:0071929; GO:0072686; GO:0097427; GO:1900227","alpha-tubulin acetylation [GO:0071929]; cilium assembly [GO:0060271]; dentate gyrus development [GO:0021542]; microtubule cytoskeleton organization [GO:0000226]; neuron development [GO:0048666]; NLRP3 inflammasome complex assembly [GO:0044546]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; regulation of fat cell differentiation [GO:0045598]; regulation of microtubule cytoskeleton organization [GO:0070507]; response to mechanical stimulus [GO:0009612]; response to pain [GO:0048265]; spermatogenesis [GO:0007283]","axon [GO:0030424]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule bundle [GO:0097427]; mitotic spindle [GO:0072686]; L-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; tubulin N-acetyltransferase activity [GO:0019799]; alpha-tubulin acetylation [GO:0071929]; cilium assembly [GO:0060271]; dentate gyrus development [GO:0021542]; microtubule cytoskeleton organization [GO:0000226]; neuron development [GO:0048666]; NLRP3 inflammasome complex assembly [GO:0044546]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; regulation of fat cell differentiation [GO:0045598]; regulation of microtubule cytoskeleton organization [GO:0070507]; response to mechanical stimulus [GO:0009612]; response to pain [GO:0048265]; spermatogenesis [GO:0007283]","","","",""
"85","sp|Q07327|ROP_DROME","lcl|NC_088854.1_cds_XP_011440602.1_10532",0,778,"Q07327","ROP_DROME","Protein ROP","Rop cs1 CG15811","Drosophila melanogaster (Fruit fly)",597,"GO:0000149; GO:0005737; GO:0005829; GO:0005886; GO:0006886; GO:0006887; GO:0006904; GO:0007268; GO:0007269; GO:0007317; GO:0009416; GO:0016020; GO:0016082; GO:0016192; GO:0019905; GO:0030141; GO:0030707; GO:0031234; GO:0032940; GO:0035002; GO:0043195; GO:0048489; GO:0099525; GO:1900006; GO:1990182","chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; follicle cell of egg chamber development [GO:0030707]; intracellular protein transport [GO:0006886]; liquid clearance, open tracheal system [GO:0035002]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite development [GO:1900006]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of pole plasm oskar mRNA localization [GO:0007317]; response to light stimulus [GO:0009416]; secretion by cell [GO:0032940]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; terminal bouton [GO:0043195]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; follicle cell of egg chamber development [GO:0030707]; intracellular protein transport [GO:0006886]; liquid clearance, open tracheal system [GO:0035002]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite development [GO:1900006]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of pole plasm oskar mRNA localization [GO:0007317]; response to light stimulus [GO:0009416]; secretion by cell [GO:0032940]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]","DEVELOPMENTAL STAGE: Expression is low in unfertilized eggs and early embryos, increases in older embryos and young larvae, is low in mature larvae and increases strongly in pupae and adult flies. Expression during embryogenesis is restricted to the central nervous system (CNS) and the Garland cells, a small group of nephrocytes that takes up waste materials from the hemolymph by endocytosis. In post embryonic stages, expression is seen in the larval salivary glands and the CNS, and in the adult CNS and reproductive systems.","","",""
"86","sp|Q60809|CNOT7_MOUSE","lcl|NC_088854.1_cds_XP_011441179.1_9780",3.9e-152,428,"Q60809","CNOT7_MOUSE","CCR4-NOT transcription complex subunit 7 (EC 3.1.13.4) (CCR4-associated factor 1) (CAF-1)","Cnot7 Caf1","Mus musculus (Mouse)",285,"GO:0000175; GO:0000289; GO:0000290; GO:0000932; GO:0003714; GO:0004532; GO:0004535; GO:0005634; GO:0005737; GO:0005829; GO:0006417; GO:0007283; GO:0008284; GO:0008285; GO:0016607; GO:0030014; GO:0031047; GO:0033962; GO:0034584; GO:0035279; GO:0045070; GO:0045944; GO:0046872; GO:0051607; GO:0060213; GO:0060339; GO:0140297; GO:0140991; GO:1900153","deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; P-body assembly [GO:0033962]; piRNA-mediated gene silencing by mRNA destabilization [GO:0140991]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; spermatogenesis [GO:0007283]","CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; P-body [GO:0000932]; 3'-5'-RNA exonuclease activity [GO:0000175]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; piRNA binding [GO:0034584]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA exonuclease activity [GO:0004532]; transcription corepressor activity [GO:0003714]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; P-body assembly [GO:0033962]; piRNA-mediated gene silencing by mRNA destabilization [GO:0140991]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed in embryonic stem (ES) cells. {ECO:0000269|PubMed:22367759}.","","",""
"87","sp|Q64541|AT1A4_RAT","lcl|NC_088854.1_cds_XP_011441273.4_5530",0,1376,"Q64541","AT1A4_RAT","Sodium/potassium-transporting ATPase subunit alpha-4 (Na(+)/K(+) ATPase alpha-4 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-4)","Atp1a4 Atp1al2","Rattus norvegicus (Rat)",1028,"GO:0005391; GO:0005524; GO:0005886; GO:0005890; GO:0006813; GO:0006814; GO:0006883; GO:0007283; GO:0009566; GO:0016887; GO:0019829; GO:0030007; GO:0030317; GO:0030641; GO:0035725; GO:0036376; GO:0042391; GO:0042995; GO:0046872; GO:0051649; GO:0071805; GO:0097225; GO:0097733; GO:0120200; GO:1902600; GO:1990573","establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; intracellular potassium ion homeostasis [GO:0030007]; intracellular sodium ion homeostasis [GO:0006883]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]; regulation of membrane potential [GO:0042391]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; spermatogenesis [GO:0007283]","cell projection [GO:0042995]; photoreceptor cell cilium [GO:0097733]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm midpiece [GO:0097225]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; intracellular potassium ion homeostasis [GO:0030007]; intracellular sodium ion homeostasis [GO:0006883]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]; regulation of membrane potential [GO:0042391]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; spermatogenesis [GO:0007283]","","","",""
"88","sp|Q9Z1K9|ADA17_RAT","lcl|NC_088854.1_cds_XP_011441696.3_5833",3.23e-116,372,"Q9Z1K9","ADA17_RAT","Disintegrin and metalloproteinase domain-containing protein 17 (ADAM 17) (EC 3.4.24.86) (TNF-alpha convertase) (TNF-alpha-converting enzyme) (CD antigen CD156b)","Adam17 Tace","Rattus norvegicus (Rat)",827,"GO:0001666; GO:0002467; GO:0002532; GO:0004175; GO:0004222; GO:0005112; GO:0005138; GO:0005178; GO:0005737; GO:0005886; GO:0005911; GO:0005925; GO:0006508; GO:0006509; GO:0007155; GO:0007173; GO:0007219; GO:0007220; GO:0007283; GO:0008237; GO:0008284; GO:0009410; GO:0009986; GO:0010820; GO:0010976; GO:0010977; GO:0014850; GO:0015629; GO:0016020; GO:0016324; GO:0016485; GO:0017124; GO:0019955; GO:0023061; GO:0030165; GO:0030183; GO:0030307; GO:0030335; GO:0030512; GO:0031667; GO:0032496; GO:0032587; GO:0032722; GO:0032760; GO:0033025; GO:0033077; GO:0033209; GO:0033627; GO:0035313; GO:0042987; GO:0043065; GO:0043066; GO:0043120; GO:0043491; GO:0043536; GO:0045121; GO:0045177; GO:0045742; GO:0046872; GO:0048536; GO:0048679; GO:0048870; GO:0050830; GO:0070374; GO:0070573; GO:0071260; GO:0071403; GO:0071679; GO:0097327; GO:0120163; GO:0140448; GO:1900087; GO:1902945; GO:1903265; GO:1905564; GO:1990910; GO:2001222","amyloid precursor protein catabolic process [GO:0042987]; B cell differentiation [GO:0030183]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell motility [GO:0048870]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; cellular response to mechanical stimulus [GO:0071260]; commissural neuron axon guidance [GO:0071679]; defense response to Gram-positive bacterium [GO:0050830]; epidermal growth factor receptor signaling pathway [GO:0007173]; germinal center formation [GO:0002467]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; production of molecular mediator involved in inflammatory response [GO:0002532]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of axon regeneration [GO:0048679]; regulation of mast cell apoptotic process [GO:0033025]; regulation of neuron migration [GO:2001222]; response to antineoplastic agent [GO:0097327]; response to hypobaric hypoxia [GO:1990910]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to muscle activity [GO:0014850]; response to nutrient levels [GO:0031667]; response to xenobiotic stimulus [GO:0009410]; signal release [GO:0023061]; signaling receptor ligand precursor processing [GO:0140448]; spermatogenesis [GO:0007283]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; wound healing, spreading of epidermal cells [GO:0035313]","actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; cytokine binding [GO:0019955]; endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; interleukin-6 receptor binding [GO:0005138]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; Notch binding [GO:0005112]; PDZ domain binding [GO:0030165]; SH3 domain binding [GO:0017124]; tumor necrosis factor binding [GO:0043120]; amyloid precursor protein catabolic process [GO:0042987]; B cell differentiation [GO:0030183]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell motility [GO:0048870]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; cellular response to mechanical stimulus [GO:0071260]; commissural neuron axon guidance [GO:0071679]; defense response to Gram-positive bacterium [GO:0050830]; epidermal growth factor receptor signaling pathway [GO:0007173]; germinal center formation [GO:0002467]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; production of molecular mediator involved in inflammatory response [GO:0002532]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of axon regeneration [GO:0048679]; regulation of mast cell apoptotic process [GO:0033025]; regulation of neuron migration [GO:2001222]; response to antineoplastic agent [GO:0097327]; response to hypobaric hypoxia [GO:1990910]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to muscle activity [GO:0014850]; response to nutrient levels [GO:0031667]; response to xenobiotic stimulus [GO:0009410]; signal release [GO:0023061]; signaling receptor ligand precursor processing [GO:0140448]; spermatogenesis [GO:0007283]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; wound healing, spreading of epidermal cells [GO:0035313]","","","",""
"89","sp|Q9V427|INX2_DROME","lcl|NC_088854.1_cds_XP_011441807.3_6504",7.62e-30,120,"Q9V427","INX2_DROME","Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33)","Inx2 prp33 CG4590","Drosophila melanogaster (Fruit fly)",367,"GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0007602; GO:0010496; GO:0016020; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0034220; GO:0036098","cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; male germ-line stem cell population maintenance [GO:0036098]; monoatomic ion transmembrane transport [GO:0034220]; morphogenesis of embryonic epithelium [GO:0016331]; phototransduction [GO:0007602]; spermatogenesis [GO:0007283]","apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; male germ-line stem cell population maintenance [GO:0036098]; monoatomic ion transmembrane transport [GO:0034220]; morphogenesis of embryonic epithelium [GO:0016331]; phototransduction [GO:0007602]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed maternally and zygotically. Expressed during oogenesis and embryogenesis. Expressed in larvae and pupae. {ECO:0000269|PubMed:11956317, ECO:0000269|PubMed:11960713, ECO:0000269|PubMed:16436513}.","INDUCTION: Expression in embryos at ectoderm/endoderm boundaries during gut organogenesis is induced by activation of the wg signaling cascade. {ECO:0000269|PubMed:11956317}.","INDUCTION: Expression in embryos at ectoderm/endoderm boundaries during gut organogenesis is induced by activation of the wg signaling cascade. {ECO:0000269|PubMed:11956317}.","TISSUE SPECIFICITY: In ovary, expressed in inner germarial sheath cells, prefollicular cells, follicle cells, nurse cells and oocytes. Expressed in embryonic epithelial cells. Expressed in foregut and hindgut from stage 11-17, segmentally repeated tracheal placodes at stage 14, salivary gland at stage 16 and proventriculus at stage 16-17 (at protein level). During germband extension stage (stage 7), expressed in epidermal epithelial cells. Expressed in cephalic furrow. Repeating epidermal pattern emerges at stage 11, refines to one or two cells at each side of the segment borders by stage 13. Expressed in the imaginal wing disk. In pupae, expressed in the CNS and in primary, secondary and tertiary pigment cells of the retina. Expressed in optic lamina of the adult CNS. {ECO:0000269|PubMed:10352230, ECO:0000269|PubMed:10888681, ECO:0000269|PubMed:11956317, ECO:0000269|PubMed:11960713, ECO:0000269|PubMed:15047872, ECO:0000269|PubMed:16436513, ECO:0000269|PubMed:19038051, ECO:0000269|PubMed:22001874}."
"90","sp|Q8WP13|TBB8_PAPHA","lcl|NC_088854.1_cds_XP_011442070.1_4548",0,790,"Q8WP13","TBB8_PAPHA","Tubulin beta-8 chain","TUBB8","Papio hamadryas (Hamadryas baboon)",444,"GO:0001556; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007056; GO:0045171; GO:0046872; GO:0072686; GO:0072687","oocyte maturation [GO:0001556]; spindle assembly involved in female meiosis [GO:0007056]","cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; structural constituent of cytoskeleton [GO:0005200]; oocyte maturation [GO:0001556]; spindle assembly involved in female meiosis [GO:0007056]","","","",""
"91","sp|O14753|OVOL1_HUMAN","lcl|NC_088854.1_cds_XP_011442664.3_9229",9.6e-60,194,"O14753","OVOL1_HUMAN","Putative transcription factor Ovo-like 1 (hOvo1)","OVOL1","Homo sapiens (Human)",267,"GO:0000978; GO:0000981; GO:0001227; GO:0001822; GO:0005634; GO:0006357; GO:0007283; GO:0007498; GO:0008270; GO:0009913; GO:0010839; GO:0043588; GO:0043616; GO:0044771; GO:0051729; GO:0072089; GO:1901994; GO:1990837; GO:2000647","epidermal cell differentiation [GO:0009913]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; keratinocyte proliferation [GO:0043616]; kidney development [GO:0001822]; meiotic cell cycle phase transition [GO:0044771]; mesoderm development [GO:0007498]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of meiotic cell cycle phase transition [GO:1901994]; negative regulation of stem cell proliferation [GO:2000647]; regulation of transcription by RNA polymerase II [GO:0006357]; skin development [GO:0043588]; spermatogenesis [GO:0007283]; stem cell proliferation [GO:0072089]","nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; epidermal cell differentiation [GO:0009913]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; keratinocyte proliferation [GO:0043616]; kidney development [GO:0001822]; meiotic cell cycle phase transition [GO:0044771]; mesoderm development [GO:0007498]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of meiotic cell cycle phase transition [GO:1901994]; negative regulation of stem cell proliferation [GO:2000647]; regulation of transcription by RNA polymerase II [GO:0006357]; skin development [GO:0043588]; spermatogenesis [GO:0007283]; stem cell proliferation [GO:0072089]","","","","TISSUE SPECIFICITY: Expressed in fetal kidney, and also in adult pancreas and placenta. Not expressed in intestine, peripheral blood lymphocytes and ovary."
"92","sp|P51521|OVO_DROME","lcl|NC_088854.1_cds_XP_011442665.3_9230",3.05e-67,233,"P51521","OVO_DROME","Transcriptional regulator ovo (Transcriptional repressor shavenbaby) (Transcriptional repressor svb) [Cleaved into: Transcriptional activator shavenbaby (Transcriptional activator svb)]","ovo svb CG6824","Drosophila melanogaster (Fruit fly)",1351,"GO:0000122; GO:0000978; GO:0000981; GO:0001223; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007010; GO:0008270; GO:0008343; GO:0008360; GO:0009913; GO:0016348; GO:0018992; GO:0032196; GO:0035017; GO:0035316; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0048067; GO:0048477; GO:1990837","adult feeding behavior [GO:0008343]; cuticle pattern formation [GO:0035017]; cuticle pigmentation [GO:0048067]; cytoskeleton organization [GO:0007010]; epidermal cell differentiation [GO:0009913]; germ-line sex determination [GO:0018992]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; non-sensory hair organization [GO:0035316]; oogenesis [GO:0048477]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357]; transposition [GO:0032196]","cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]; adult feeding behavior [GO:0008343]; cuticle pattern formation [GO:0035017]; cuticle pigmentation [GO:0048067]; cytoskeleton organization [GO:0007010]; epidermal cell differentiation [GO:0009913]; germ-line sex determination [GO:0018992]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; non-sensory hair organization [GO:0035316]; oogenesis [GO:0048477]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357]; transposition [GO:0032196]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically (PubMed:1712294, PubMed:17246162, PubMed:28059165, PubMed:7935398, PubMed:9012532). Isoform B: Expressed in the notum from early pupation to 36 hours after puparium formation, disappearing once epidermal cells develop apical extensions (at protein level) (PubMed:25344753). Isoform B: Expressed in the trichomes of stages 11 and 12 embryos and disappears by stage 15 but the cleaved transcriptional activator form svb is still present (at protein level) (PubMed:20647469). Isoform B: Not detected until the blastoderm stage when it is expressed in the head (PubMed:7748792). Isoform B: No expression in the primordial germ cells (PGCs) (PubMed:28059165). Isoform B: In stage 12 embryos, expressed in the trunk, and in stage 14 embryos expressed in the region of denticle belt setae and dorsal hairs (PubMed:7748792). Isoform B: Not detected in the pole cells throughout embryogenesis (PubMed:7748792). Isoform B: Expressed in the pupal tarsal segments in several segmentally separated stripes (PubMed:21527259). Isoform D: Expressed in the germinal stem cells of the germarium and later in the nurse cells (at protein level) (PubMed:7748792). Isoform D: Uniformly expressed in early cleavage and blastoderm stage embryos (at protein level) (PubMed:7748792). Isoform D: At germ band extension (stage 8), expression levels decrease rapidly and becomes localized to the pole cells in the posterior midgut pocket (at protein level) (PubMed:7748792). Isoform D: In stage 14 embryos, expressed in the forming gonads and some dispersed cells presumed to be pole cells lost during cell migration (at protein level) (PubMed:7748792). Isoform D: Expressed in male and female embryos, and in the germ cell in the gonads of male and female larvae (at protein level) (PubMed:7748792). Isoform D: Detected in adults, and in males is expressed in the apical part of each testis (at protein level) (PubMed:7748792). Isoform D: Expressed during early oogenesis in all female germline cells with slightly lower expression in early egg chambers (stages 2-4) (PubMed:10648246, PubMed:15371353). Isoform D: Weakly expressed in the apex of the testis (PubMed:12051822, PubMed:15371353). Isoform D: Expression levels in PGCs remain constant from stage 4 to stage 11, but decrease from stage 12 to stage 17 (PubMed:28059165). Isoform C: Weakly expressed in female germline stem cells and dividing cystocytes, and is very weak in early to middle stages of egg chamber differentiation (PubMed:10648246, PubMed:15371353). Isoform C: Expression levels are highest from middle to late stages of egg maturity but this is still relatively weak compared to isoform D (PubMed:10648246). Isoform C: Expressed in PGCs throughout embryogenesis but at a much lower level than isoform D (PubMed:28059165). Isoform C: Weakly expressed in the apex of the testis (PubMed:12051822, PubMed:15371353). {ECO:0000269|PubMed:10648246, ECO:0000269|PubMed:12051822, ECO:0000269|PubMed:15371353, ECO:0000269|PubMed:1712294, ECO:0000269|PubMed:17246162, ECO:0000269|PubMed:20647469, ECO:0000269|PubMed:21527259, ECO:0000269|PubMed:25344753, ECO:0000269|PubMed:28059165, ECO:0000269|PubMed:7748792, ECO:0000269|PubMed:7935398, ECO:0000269|PubMed:9012532}.","","",""
"93","sp|Q7YQM4|ATRX_PANTR","lcl|NC_088854.1_cds_XP_011442855.3_5548",1.14e-148,515,"Q7YQM4","ATRX_PANTR","Transcriptional regulator ATRX (EC 3.6.4.12) (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein) (XNP)","ATRX","Pan troglodytes (Chimpanzee)",2492,"GO:0000212; GO:0000228; GO:0000779; GO:0000781; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005721; GO:0006281; GO:0006325; GO:0006334; GO:0006338; GO:0006366; GO:0007283; GO:0008270; GO:0010571; GO:0015616; GO:0016605; GO:0016887; GO:0030330; GO:0030900; GO:0031297; GO:0031490; GO:0031509; GO:0032206; GO:0035064; GO:0035128; GO:0035264; GO:0042393; GO:0045944; GO:0060009; GO:0062072; GO:0070087; GO:0070192; GO:0070198; GO:0072520; GO:0072711; GO:0099115; GO:1904908","cellular response to hydroxyurea [GO:0072711]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; forebrain development [GO:0030900]; meiotic spindle organization [GO:0000212]; multicellular organism growth [GO:0035264]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; nucleosome assembly [GO:0006334]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic forelimb morphogenesis [GO:0035128]; protein localization to chromosome, telomeric region [GO:0070198]; replication fork processing [GO:0031297]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; spermatogenesis [GO:0007283]; subtelomeric heterochromatin formation [GO:0031509]; transcription by RNA polymerase II [GO:0006366]","chromosome, subtelomeric region [GO:0099115]; chromosome, telomeric region [GO:0000781]; condensed chromosome, centromeric region [GO:0000779]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; PML body [GO:0016605]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; chromo shadow domain binding [GO:0070087]; DNA translocase activity [GO:0015616]; helicase activity [GO:0004386]; histone binding [GO:0042393]; histone H3K9me2/3 reader activity [GO:0062072]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; cellular response to hydroxyurea [GO:0072711]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; forebrain development [GO:0030900]; meiotic spindle organization [GO:0000212]; multicellular organism growth [GO:0035264]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; nucleosome assembly [GO:0006334]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic forelimb morphogenesis [GO:0035128]; protein localization to chromosome, telomeric region [GO:0070198]; replication fork processing [GO:0031297]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; spermatogenesis [GO:0007283]; subtelomeric heterochromatin formation [GO:0031509]; transcription by RNA polymerase II [GO:0006366]","","","",""
"94","sp|Q23977|HEP_DROME","lcl|NC_088854.1_cds_XP_011442999.3_9643",8.69e-130,404,"Q23977","HEP_DROME","Dual specificity mitogen-activated protein kinase kinase hemipterous (MAPKK) (EC 2.7.12.2)","hep hem MKK7 CG4353","Drosophila melanogaster (Fruit fly)",1178,"GO:0004672; GO:0004674; GO:0004708; GO:0004712; GO:0004713; GO:0005078; GO:0005524; GO:0005829; GO:0007254; GO:0007391; GO:0007395; GO:0007411; GO:0007561; GO:0008340; GO:0008545; GO:0009408; GO:0010508; GO:0010592; GO:0010628; GO:0019731; GO:0019901; GO:0030381; GO:0030424; GO:0030707; GO:0032233; GO:0033209; GO:0033500; GO:0034769; GO:0035006; GO:0036335; GO:0042060; GO:0043068; GO:0043652; GO:0045893; GO:0046528; GO:0046529; GO:0046843; GO:0046844; GO:0048010; GO:0048666; GO:0048675; GO:0048803; GO:0051491; GO:0061057; GO:0070328; GO:0071243; GO:0071276; GO:0106310; GO:1903688","antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; basement membrane disassembly [GO:0034769]; carbohydrate homeostasis [GO:0033500]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; chorion micropyle formation [GO:0046844]; chorion-containing eggshell pattern formation [GO:0030381]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; engulfment of apoptotic cell [GO:0043652]; follicle cell of egg chamber development [GO:0030707]; imaginal disc eversion [GO:0007561]; imaginal disc fusion [GO:0046528]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; intestinal stem cell homeostasis [GO:0036335]; JNK cascade [GO:0007254]; melanization defense response [GO:0035006]; neuron development [GO:0048666]; peptidoglycan recognition protein signaling pathway [GO:0061057]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of programmed cell death [GO:0043068]; response to heat [GO:0009408]; triglyceride homeostasis [GO:0070328]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing [GO:0042060]","axon [GO:0030424]; cytosol [GO:0005829]; ATP binding [GO:0005524]; JUN kinase kinase activity [GO:0008545]; MAP kinase kinase activity [GO:0004708]; MAP-kinase scaffold activity [GO:0005078]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; basement membrane disassembly [GO:0034769]; carbohydrate homeostasis [GO:0033500]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; chorion micropyle formation [GO:0046844]; chorion-containing eggshell pattern formation [GO:0030381]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; engulfment of apoptotic cell [GO:0043652]; follicle cell of egg chamber development [GO:0030707]; imaginal disc eversion [GO:0007561]; imaginal disc fusion [GO:0046528]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; intestinal stem cell homeostasis [GO:0036335]; JNK cascade [GO:0007254]; melanization defense response [GO:0035006]; neuron development [GO:0048666]; peptidoglycan recognition protein signaling pathway [GO:0061057]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of programmed cell death [GO:0043068]; response to heat [GO:0009408]; triglyceride homeostasis [GO:0070328]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing [GO:0042060]","","","",""
"95","sp|O45244|DHX16_CAEEL","lcl|NC_088854.1_cds_XP_011443346.3_6798",0,1141,"O45244","DHX16_CAEEL","Probable pre-mRNA-splicing factor ATP-dependent RNA helicase mog-4 (EC 3.6.4.13) (Masculinization of germline protein 4) (Sex determination protein mog-4)","mog-4 C04H5.6","Caenorhabditis elegans",1008,"GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0006397; GO:0007281; GO:0008380; GO:0010172; GO:0016887; GO:0040022; GO:0048589","developmental growth [GO:0048589]; embryonic body morphogenesis [GO:0010172]; feminization of hermaphroditic germ-line [GO:0040022]; germ cell development [GO:0007281]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]","nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; developmental growth [GO:0048589]; embryonic body morphogenesis [GO:0010172]; feminization of hermaphroditic germ-line [GO:0040022]; germ cell development [GO:0007281]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]","DEVELOPMENTAL STAGE: Expressed throughout development but most strongly in embryos and the L4 larvae stage. {ECO:0000269|PubMed:10737793, ECO:0000269|PubMed:12088146}.","","",""
"96","sp|Q01534|TSPY1_HUMAN","lcl|NC_088854.1_cds_XP_011443579.1_10478",2.98e-40,142,"Q01534","TSPY1_HUMAN","Testis-specific Y-encoded protein 1 (Cancer/testis antigen 78) (CT78)","TSPY1 TSPY","Homo sapiens (Human)",308,"GO:0000785; GO:0003682; GO:0005634; GO:0005737; GO:0006334; GO:0007283; GO:0007506; GO:0007548; GO:0030154; GO:0042393","cell differentiation [GO:0030154]; gonadal mesoderm development [GO:0007506]; nucleosome assembly [GO:0006334]; sex differentiation [GO:0007548]; spermatogenesis [GO:0007283]","chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; cell differentiation [GO:0030154]; gonadal mesoderm development [GO:0007506]; nucleosome assembly [GO:0006334]; sex differentiation [GO:0007548]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Detected in 22-week old testis. {ECO:0000269|PubMed:8923009}.","INDUCTION: Up-regulated by androgen in a prostate cancer cell line. {ECO:0000269|PubMed:10747295}.","INDUCTION: Up-regulated by androgen in a prostate cancer cell line. {ECO:0000269|PubMed:10747295}.","TISSUE SPECIFICITY: Specifically expressed in testicular tissues. Isoform 1 and isoform 2 are expressed in spermatogonia and spermatocytes. Found in early testicular carcinoma in situ, spermatogonial cells in testicular tissues of 46,X,Y female and in prostate cancer cell lines. {ECO:0000269|PubMed:10747295, ECO:0000269|PubMed:8923009}."
"97","sp|Q8IZX4|TAF1L_HUMAN","lcl|NC_088854.1_cds_XP_011443588.3_10485",0,1508,"Q8IZX4","TAF1L_HUMAN","Transcription initiation factor TFIID subunit 1-like (TAF(II)210) (TBP-associated factor 1-like) (TBP-associated factor 210 kDa) (Transcription initiation factor TFIID 210 kDa subunit)","TAF1L","Homo sapiens (Human)",1826,"GO:0003677; GO:0004402; GO:0004674; GO:0005654; GO:0005669; GO:0006357; GO:0007140; GO:0016251; GO:0017025; GO:0045893; GO:0051123; GO:0070577","male meiotic nuclear division [GO:0007140]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]","nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; lysine-acetylated histone binding [GO:0070577]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; male meiotic nuclear division [GO:0007140]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]","","","","TISSUE SPECIFICITY: Testis specific, expressed apparently in germ cells."
"98","sp|P08630|BTKL_DROME","lcl|NC_088854.1_cds_XP_011444713.3_8001",7.22e-176,520,"P08630","BTKL_DROME","Tyrosine-protein kinase Btk (EC 2.7.10.2) (Dsrc28C) (Dsrc29a)","Btk Btk29A Src2 Src29A Tec29 CG8049","Drosophila melanogaster (Fruit fly)",786,"GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005886; GO:0007254; GO:0007300; GO:0007301; GO:0007349; GO:0007391; GO:0007424; GO:0007435; GO:0007485; GO:0007619; GO:0008258; GO:0008270; GO:0008340; GO:0030036; GO:0030717; GO:0030723; GO:0030833; GO:0035277; GO:0042023; GO:0045172; GO:0045177; GO:0046960; GO:0048477; GO:0071944","actin cytoskeleton organization [GO:0030036]; cellularization [GO:0007349]; courtship behavior [GO:0007619]; determination of adult lifespan [GO:0008340]; DNA endoreduplication [GO:0042023]; dorsal closure [GO:0007391]; female germline ring canal formation [GO:0007301]; head involution [GO:0008258]; imaginal disc-derived male genitalia development [GO:0007485]; JNK cascade [GO:0007254]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian fusome organization [GO:0030723]; ovarian nurse cell to oocyte transport [GO:0007300]; regulation of actin filament polymerization [GO:0030833]; salivary gland morphogenesis [GO:0007435]; sensitization [GO:0046960]; spiracle morphogenesis, open tracheal system [GO:0035277]","apical part of cell [GO:0045177]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; germline ring canal [GO:0045172]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; zinc ion binding [GO:0008270]; actin cytoskeleton organization [GO:0030036]; cellularization [GO:0007349]; courtship behavior [GO:0007619]; determination of adult lifespan [GO:0008340]; DNA endoreduplication [GO:0042023]; dorsal closure [GO:0007391]; female germline ring canal formation [GO:0007301]; head involution [GO:0008258]; imaginal disc-derived male genitalia development [GO:0007485]; JNK cascade [GO:0007254]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian fusome organization [GO:0030723]; ovarian nurse cell to oocyte transport [GO:0007300]; regulation of actin filament polymerization [GO:0030833]; salivary gland morphogenesis [GO:0007435]; sensitization [GO:0046960]; spiracle morphogenesis, open tracheal system [GO:0035277]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. Predominantly in early to middle embryogenesis, in larvae and adult females. {ECO:0000269|PubMed:10330180, ECO:0000269|PubMed:3110602}.","","","TISSUE SPECIFICITY: Ring canals in the egg chambers and imaginal disks of third-instar larvae. {ECO:0000269|PubMed:10330180, ECO:0000269|PubMed:3110602, ECO:0000269|PubMed:9655810}."
"99","sp|O54800|CADH8_RAT","lcl|NC_088854.1_cds_XP_011445615.3_9374",1.57e-52,200,"O54800","CADH8_RAT","Cadherin-8","Cdh8","Rattus norvegicus (Rat)",799,"GO:0000902; GO:0005509; GO:0005912; GO:0007043; GO:0007156; GO:0007268; GO:0007283; GO:0008013; GO:0009409; GO:0016339; GO:0016342; GO:0016477; GO:0034332; GO:0035249; GO:0042802; GO:0043083; GO:0043679; GO:0044331; GO:0045296; GO:0050807; GO:0097060; GO:0098609; GO:0098978","adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of synapse organization [GO:0050807]; response to cold [GO:0009409]; spermatogenesis [GO:0007283]; synaptic transmission, glutamatergic [GO:0035249]","adherens junction [GO:0005912]; axon terminus [GO:0043679]; catenin complex [GO:0016342]; glutamatergic synapse [GO:0098978]; synaptic cleft [GO:0043083]; synaptic membrane [GO:0097060]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of synapse organization [GO:0050807]; response to cold [GO:0009409]; spermatogenesis [GO:0007283]; synaptic transmission, glutamatergic [GO:0035249]","","","",""
"100","sp|Q17QC0|PGRC1_BOVIN","lcl|NC_088854.1_cds_XP_011446467.3_8341",8.11e-46,150,"Q17QC0","PGRC1_BOVIN","Membrane-associated progesterone receptor component 1 (mPR)","PGRMC1","Bos taurus (Bovine)",194,"GO:0000775; GO:0005496; GO:0005741; GO:0005783; GO:0006783; GO:0012505; GO:0016020; GO:0020037; GO:0030496; GO:0030868; GO:0042585; GO:0042803; GO:0046872; GO:0070062; GO:0140077; GO:1903537; GO:1990385","heme biosynthetic process [GO:0006783]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; positive regulation of lipoprotein transport [GO:0140077]","chromosome, centromeric region [GO:0000775]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; germinal vesicle [GO:0042585]; meiotic spindle midzone [GO:1990385]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; smooth endoplasmic reticulum membrane [GO:0030868]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; steroid binding [GO:0005496]; heme biosynthetic process [GO:0006783]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; positive regulation of lipoprotein transport [GO:0140077]","","","",""
"101","sp|P42003|MAD_DROME","lcl|NC_088854.1_cds_XP_011448163.2_8105",0,659,"P42003","MAD_DROME","Protein mothers against dpp","Mad CG12399","Drosophila melanogaster (Fruit fly)",455,"GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001745; GO:0003713; GO:0005634; GO:0005667; GO:0005737; GO:0005829; GO:0006357; GO:0007419; GO:0007476; GO:0007480; GO:0007488; GO:0007507; GO:0007560; GO:0008586; GO:0009653; GO:0030154; GO:0030509; GO:0030707; GO:0030718; GO:0035019; GO:0035290; GO:0036335; GO:0042078; GO:0043565; GO:0045464; GO:0045595; GO:0045705; GO:0045887; GO:0045944; GO:0046872; GO:0048100; GO:0060395; GO:0061629; GO:0070410; GO:0070411; GO:0071144; GO:0090571; GO:1904398; GO:2000134","anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; compound eye morphogenesis [GO:0001745]; follicle cell of egg chamber development [GO:0030707]; germ-line stem cell division [GO:0042078]; germ-line stem cell population maintenance [GO:0030718]; heart development [GO:0007507]; histoblast morphogenesis [GO:0007488]; imaginal disc morphogenesis [GO:0007560]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of salivary gland boundary specification [GO:0045705]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of neuromuscular junction development [GO:1904398]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R8 cell fate specification [GO:0045464]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]; somatic stem cell population maintenance [GO:0035019]; trunk segmentation [GO:0035290]; ventral cord development [GO:0007419]; wing disc anterior/posterior pattern formation [GO:0048100]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleus [GO:0005634]; RNA polymerase II transcription repressor complex [GO:0090571]; transcription regulator complex [GO:0005667]; co-SMAD binding [GO:0070410]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; compound eye morphogenesis [GO:0001745]; follicle cell of egg chamber development [GO:0030707]; germ-line stem cell division [GO:0042078]; germ-line stem cell population maintenance [GO:0030718]; heart development [GO:0007507]; histoblast morphogenesis [GO:0007488]; imaginal disc morphogenesis [GO:0007560]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of salivary gland boundary specification [GO:0045705]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of neuromuscular junction development [GO:1904398]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R8 cell fate specification [GO:0045464]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]; somatic stem cell population maintenance [GO:0035019]; trunk segmentation [GO:0035290]; ventral cord development [GO:0007419]; wing disc anterior/posterior pattern formation [GO:0048100]","DEVELOPMENTAL STAGE: Is detected in all developmental stages, though it appears most abundant in pupae, adult stages and early embryos. Its abundance decreases throughout embryonic and larval development and then returns to high levels in pupae and adult females. {ECO:0000269|PubMed:7768443}.","","","TISSUE SPECIFICITY: Stage 13 embryos display expression in the dorsal epidermis (at protein level). {ECO:0000269|PubMed:11997505}."
"102","sp|O22212|PRP4L_ARATH","lcl|NC_088854.1_cds_XP_011449094.2_8991",5.06e-119,362,"O22212","PRP4L_ARATH","U4/U6 small nuclear ribonucleoprotein PRP4-like protein (Protein EMBRYO DEFECTIVE 2776) (Protein LACHESIS)","LIS EMB2776 At2g41500 T26J13.9 T32G6.2","Arabidopsis thaliana (Mouse-ear cress)",554,"GO:0000398; GO:0001709; GO:0005681; GO:0007267; GO:0009553; GO:0009560; GO:0016607","cell fate determination [GO:0001709]; cell-cell signaling [GO:0007267]; embryo sac development [GO:0009553]; embryo sac egg cell differentiation [GO:0009560]; mRNA splicing, via spliceosome [GO:0000398]","nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; cell fate determination [GO:0001709]; cell-cell signaling [GO:0007267]; embryo sac development [GO:0009553]; embryo sac egg cell differentiation [GO:0009560]; mRNA splicing, via spliceosome [GO:0000398]","DEVELOPMENTAL STAGE: During female gametophyte development, preferentially expressed in the gametic cells. {ECO:0000269|PubMed:17326723, ECO:0000269|PubMed:22190635}.","","",""
"103","sp|P46379|BAG6_HUMAN","lcl|NC_088854.1_cds_XP_011449098.3_8987",4.99e-31,134,"P46379","BAG6_HUMAN","Large proline-rich protein BAG6 (BAG family molecular chaperone regulator 6) (BCL2-associated athanogene 6) (BAG-6) (HLA-B-associated transcript 3) (Protein G3) (Protein Scythe)","BAG6 BAT3 G3","Homo sapiens (Human)",1132,"GO:0001822; GO:0002429; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006511; GO:0006620; GO:0006915; GO:0007130; GO:0007283; GO:0007420; GO:0010498; GO:0016020; GO:0018393; GO:0030101; GO:0030154; GO:0030324; GO:0030544; GO:0031593; GO:0031625; GO:0031647; GO:0032435; GO:0036503; GO:0036506; GO:0042771; GO:0042802; GO:0043022; GO:0043066; GO:0043161; GO:0043231; GO:0045861; GO:0045995; GO:0048018; GO:0050821; GO:0051132; GO:0051787; GO:0060090; GO:0061857; GO:0070059; GO:0070062; GO:0070628; GO:0071816; GO:0071818; GO:0140597; GO:0140677; GO:1904294; GO:1990381","apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ERAD pathway [GO:0036503]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; maintenance of unfolded protein [GO:0036506]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; NK T cell activation [GO:0051132]; positive regulation of ERAD pathway [GO:1904294]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511]","BAT3 complex [GO:0071818]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; misfolded protein binding [GO:0051787]; molecular adaptor activity [GO:0060090]; molecular function activator activity [GO:0140677]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; protein carrier chaperone [GO:0140597]; receptor ligand activity [GO:0048018]; ribosome binding [GO:0043022]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381]; apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ERAD pathway [GO:0036503]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; maintenance of unfolded protein [GO:0036506]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; NK T cell activation [GO:0051132]; positive regulation of ERAD pathway [GO:1904294]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511]","","","","TISSUE SPECIFICITY: Expressed by immature dendritic cells (at protein level). {ECO:0000269|PubMed:18852879}."
"104","sp|A3KPW9|BAG6_DANRE","lcl|NC_088854.1_cds_XP_011449099.3_8986",4.24e-55,211,"A3KPW9","BAG6_DANRE","Large proline-rich protein BAG6 (BCL2-associated athanogene 6) (HLA-B-associated transcript 3)","Bag6 Bat3 si:ch211-215a10.6","Danio rerio (Zebrafish) (Brachydanio rerio)",1160,"GO:0001822; GO:0005576; GO:0005634; GO:0005829; GO:0006325; GO:0006511; GO:0007130; GO:0007283; GO:0007420; GO:0010498; GO:0018393; GO:0030324; GO:0031593; GO:0032435; GO:0036503; GO:0042771; GO:0042981; GO:0043022; GO:0045861; GO:0045995; GO:0050821; GO:0051787; GO:0061857; GO:0070059; GO:0070628; GO:0071816; GO:0071818","brain development [GO:0007420]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ERAD pathway [GO:0036503]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; proteasomal protein catabolic process [GO:0010498]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of embryonic development [GO:0045995]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511]","BAT3 complex [GO:0071818]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]; misfolded protein binding [GO:0051787]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ribosome binding [GO:0043022]; brain development [GO:0007420]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ERAD pathway [GO:0036503]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; proteasomal protein catabolic process [GO:0010498]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of embryonic development [GO:0045995]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511]","","","",""
"105","sp|P11388|TOP2A_HUMAN","lcl|NC_088854.1_cds_XP_011449277.3_9055",0,1707,"P11388","TOP2A_HUMAN","DNA topoisomerase 2-alpha (EC 5.6.2.2) (DNA topoisomerase II, alpha isozyme)","TOP2A TOP2","Homo sapiens (Human)",1531,"GO:0000287; GO:0000712; GO:0000775; GO:0000793; GO:0000819; GO:0001673; GO:0002244; GO:0003677; GO:0003682; GO:0003723; GO:0003918; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006265; GO:0006325; GO:0006974; GO:0007059; GO:0007143; GO:0008094; GO:0008301; GO:0009330; GO:0030263; GO:0032991; GO:0040016; GO:0042752; GO:0042803; GO:0043065; GO:0043130; GO:0045870; GO:0045944; GO:0046982; GO:0048511; GO:1990904","apoptotic chromosome condensation [GO:0030263]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819]","chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; male germ cell nucleus [GO:0001673]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; apoptotic chromosome condensation [GO:0030263]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819]","","","","TISSUE SPECIFICITY: Expressed in the tonsil, spleen, lymph node, thymus, skin, pancreas, testis, colon, kidney, liver, brain and lung (PubMed:9155056). Also found in high-grade lymphomas, squamous cell lung tumors and seminomas (PubMed:9155056). {ECO:0000269|PubMed:9155056}."
"106","sp|Q95TJ9|CYCG_DROME","lcl|NC_088854.1_cds_XP_011449746.2_6423",3.21e-12,69.7,"Q95TJ9","CYCG_DROME","Cyclin G","CycG CG11525","Drosophila melanogaster (Fruit fly)",566,"GO:0000082; GO:0000307; GO:0000711; GO:0003677; GO:0004864; GO:0005634; GO:0005700; GO:0005737; GO:0006302; GO:0007143; GO:0016538; GO:0045746; GO:0045927; GO:0046628; GO:0051301; GO:0051897; GO:0060429; GO:2000134","cell division [GO:0051301]; double-strand break repair [GO:0006302]; epithelium development [GO:0060429]; female meiotic nuclear division [GO:0007143]; G1/S transition of mitotic cell cycle [GO:0000082]; meiotic DNA repair synthesis [GO:0000711]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of growth [GO:0045927]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]","cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; DNA binding [GO:0003677]; protein phosphatase inhibitor activity [GO:0004864]; cell division [GO:0051301]; double-strand break repair [GO:0006302]; epithelium development [GO:0060429]; female meiotic nuclear division [GO:0007143]; G1/S transition of mitotic cell cycle [GO:0000082]; meiotic DNA repair synthesis [GO:0000711]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of growth [GO:0045927]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]","DEVELOPMENTAL STAGE: Expressed throughout all stages of the cell cycle (at protein level) (PubMed:21311225). Expressed throughout development with notably less expression in third instar larva than in embryo or adult (PubMed:18286205). {ECO:0000269|PubMed:18286205, ECO:0000269|PubMed:21311225}.","","",""
"107","sp|Q14094|CCNI_HUMAN","lcl|NC_088854.1_cds_XP_011449748.3_6424",9.59e-67,215,"Q14094","CCNI_HUMAN","Cyclin-I","CCNI","Homo sapiens (Human)",377,"GO:0000082; GO:0000307; GO:0005634; GO:0005737; GO:0007283; GO:0016538; GO:0031965","G1/S transition of mitotic cell cycle [GO:0000082]; spermatogenesis [GO:0007283]","cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; G1/S transition of mitotic cell cycle [GO:0000082]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expression is independent of the cell cycle in lung fibroblasts. {ECO:0000269|PubMed:7493655}.","","","TISSUE SPECIFICITY: Highest levels in adult heart, brain and skeletal muscle. Lower levels in adult placenta, lung, kidney and pancreas. Also high levels in fetal brain and lower levels in fetal lung, liver and kidney. Also abundant in testis and thyroid. {ECO:0000269|PubMed:7493655}."
"108","sp|P07207|NOTCH_DROME","lcl|NC_088854.1_cds_XP_011450274.3_10114",0,1910,"P07207","NOTCH_DROME","Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]","N CG3936","Drosophila melanogaster (Fruit fly)",2703,"GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048","actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]","adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699]; actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]","DEVELOPMENTAL STAGE: Expressed in follicle epithelial cells and, to a lesser extent, germline cells of the developing oocyte (at protein level). Expressed in larval developing ommatidia (at protein level) (PubMed:24554766). {ECO:0000269|PubMed:24554766, ECO:0000269|PubMed:25804739}.","","",""
"109","sp|P13508|GLP1_CAEEL","lcl|NC_088854.1_cds_XP_011450291.3_10116",1.3e-84,306,"P13508","GLP1_CAEEL","Protein glp-1 [Cleaved into: glp-1/Notch intracellular domain]","glp-1 emb-33 F02A9.6","Caenorhabditis elegans",1295,"GO:0001555; GO:0001708; GO:0002119; GO:0003713; GO:0004888; GO:0005509; GO:0005737; GO:0005886; GO:0006357; GO:0007219; GO:0007349; GO:0009880; GO:0010468; GO:0010608; GO:0010628; GO:0012505; GO:0016328; GO:0030424; GO:0043055; GO:0045944; GO:0061629; GO:0090575; GO:0099636; GO:0160096; GO:1905936; GO:1905938; GO:2000648; GO:2000737","cell fate specification [GO:0001708]; cellularization [GO:0007349]; cytoplasmic streaming [GO:0099636]; embryonic pattern specification [GO:0009880]; maintenance of dauer [GO:0043055]; negative regulation of stem cell differentiation [GO:2000737]; nematode larval development [GO:0002119]; nematode pharyngeal muscle development [GO:0160096]; Notch signaling pathway [GO:0007219]; oocyte growth [GO:0001555]; positive regulation of gene expression [GO:0010628]; positive regulation of germ cell proliferation [GO:1905938]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of gene expression [GO:0010468]; regulation of germ cell proliferation [GO:1905936]; regulation of transcription by RNA polymerase II [GO:0006357]","axon [GO:0030424]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575]; calcium ion binding [GO:0005509]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; cell fate specification [GO:0001708]; cellularization [GO:0007349]; cytoplasmic streaming [GO:0099636]; embryonic pattern specification [GO:0009880]; maintenance of dauer [GO:0043055]; negative regulation of stem cell differentiation [GO:2000737]; nematode larval development [GO:0002119]; nematode pharyngeal muscle development [GO:0160096]; Notch signaling pathway [GO:0007219]; oocyte growth [GO:0001555]; positive regulation of gene expression [GO:0010628]; positive regulation of germ cell proliferation [GO:1905938]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of gene expression [GO:0010468]; regulation of germ cell proliferation [GO:1905936]; regulation of transcription by RNA polymerase II [GO:0006357]","DEVELOPMENTAL STAGE: Acts on ABp development during 4-cell and 12-cell stages, and on ABa development during 12-cell and 28-cell stages (PubMed:8156602). Expressed in various neurons, including AWC, during the dauer larval stage (PubMed:18599512). {ECO:0000269|PubMed:18599512, ECO:0000269|PubMed:8156602}.","","","TISSUE SPECIFICITY: Expressed in the distal mitotic region of the germ line (PubMed:7607081). May be absent from the gonadal distal tip cell (DTC) (PubMed:7607081). {ECO:0000269|PubMed:7607081}."
"110","sp|O62698|PGH2_BOVIN","lcl|NC_088854.1_cds_XP_011450293.3_6086",0,625,"O62698","PGH2_BOVIN","Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2)","PTGS2 COX2","Bos taurus (Bovine)",604,"GO:0000212; GO:0001516; GO:0001550; GO:0001934; GO:0004601; GO:0004666; GO:0005637; GO:0005640; GO:0005737; GO:0005789; GO:0006979; GO:0016702; GO:0019371; GO:0020037; GO:0040019; GO:0043005; GO:0046872; GO:0071347; GO:0150077; GO:1900195; GO:1904146","cellular response to interleukin-1 [GO:0071347]; cyclooxygenase pathway [GO:0019371]; meiotic spindle organization [GO:0000212]; ovarian cumulus expansion [GO:0001550]; positive regulation of embryonic development [GO:0040019]; positive regulation of meiotic cell cycle process involved in oocyte maturation [GO:1904146]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of protein phosphorylation [GO:0001934]; prostaglandin biosynthetic process [GO:0001516]; regulation of neuroinflammatory response [GO:0150077]; response to oxidative stress [GO:0006979]","cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; neuron projection [GO:0043005]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; cellular response to interleukin-1 [GO:0071347]; cyclooxygenase pathway [GO:0019371]; meiotic spindle organization [GO:0000212]; ovarian cumulus expansion [GO:0001550]; positive regulation of embryonic development [GO:0040019]; positive regulation of meiotic cell cycle process involved in oocyte maturation [GO:1904146]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of protein phosphorylation [GO:0001934]; prostaglandin biosynthetic process [GO:0001516]; regulation of neuroinflammatory response [GO:0150077]; response to oxidative stress [GO:0006979]","","","",""
"111","sp|Q9BTM1|H2AJ_HUMAN","lcl|NC_088854.1_cds_XP_011450417.1_9982",1.67e-76,223,"Q9BTM1","H2AJ_HUMAN","Histone H2A.J (H2a/j)","H2AJ H2AFJ","Homo sapiens (Human)",129,"GO:0000786; GO:0003677; GO:0005634; GO:0030527; GO:0031507; GO:0046982; GO:0070062","heterochromatin formation [GO:0031507]","extracellular exosome [GO:0070062]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; heterochromatin formation [GO:0031507]","","","",""
"112","sp|Q7KTH8|CSN8_DROME","lcl|NC_088854.1_cds_XP_011450442.3_10007",4.86e-12,62.8,"Q7KTH8","CSN8_DROME","COP9 signalosome complex subunit 8 (Dch8) (Signalosome subunit 8)","CSN8 CG13383","Drosophila melanogaster (Fruit fly)",182,"GO:0000338; GO:0001745; GO:0005737; GO:0007476; GO:0008180; GO:0010387; GO:0042461; GO:0042742; GO:0048477; GO:0050821; GO:0060625","compound eye morphogenesis [GO:0001745]; COP9 signalosome assembly [GO:0010387]; defense response to bacterium [GO:0042742]; imaginal disc-derived wing morphogenesis [GO:0007476]; oogenesis [GO:0048477]; photoreceptor cell development [GO:0042461]; protein deneddylation [GO:0000338]; protein stabilization [GO:0050821]; regulation of protein deneddylation [GO:0060625]","COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; compound eye morphogenesis [GO:0001745]; COP9 signalosome assembly [GO:0010387]; defense response to bacterium [GO:0042742]; imaginal disc-derived wing morphogenesis [GO:0007476]; oogenesis [GO:0048477]; photoreceptor cell development [GO:0042461]; protein deneddylation [GO:0000338]; protein stabilization [GO:0050821]; regulation of protein deneddylation [GO:0060625]","DEVELOPMENTAL STAGE: Expressed maternally and zygotically throughout development. {ECO:0000269|PubMed:18298797}.","","",""
"113","sp|Q09309|RBBP5_CAEEL","lcl|NC_088854.1_cds_XP_011451298.3_10759",2.51e-87,276,"Q09309","RBBP5_CAEEL","Retinoblastoma-binding protein homolog 5","rbbp-5 lsy-15 F21H12.1","Caenorhabditis elegans",454,"GO:0005634; GO:0007281; GO:0012501; GO:0018991; GO:0044666; GO:0048188; GO:0060290; GO:0070828","egg-laying behavior [GO:0018991]; germ cell development [GO:0007281]; heterochromatin organization [GO:0070828]; programmed cell death [GO:0012501]; transdifferentiation [GO:0060290]","MLL3/4 complex [GO:0044666]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; egg-laying behavior [GO:0018991]; germ cell development [GO:0007281]; heterochromatin organization [GO:0070828]; programmed cell death [GO:0012501]; transdifferentiation [GO:0060290]","DEVELOPMENTAL STAGE: Expressed widely during early embryogenesis (PubMed:21698137). Expression is significantly reduced throughout the embryo after formation of the ASE neurons (PubMed:21698137). Expressed in the maternal germline (PubMed:21698137). {ECO:0000269|PubMed:21698137}.","","",""
"114","sp|Q9VM21|GUDU_DROME","lcl|NC_088854.1_cds_XP_011451643.3_7767",0,580,"Q9VM21","GUDU_DROME","Armadillo repeat-containing protein gudu","gudu CG5155","Drosophila melanogaster (Fruit fly)",669,"GO:0007291","sperm individualization [GO:0007291]","sperm individualization [GO:0007291]","","","","TISSUE SPECIFICITY: Highly expressed in testis. {ECO:0000269|PubMed:24055424}."
"115","sp|Q3T1I5|SRBP2_RAT","lcl|NC_088854.1_cds_XP_011452106.3_6900",1.87e-160,506,"Q3T1I5","SRBP2_RAT","Sterol regulatory element-binding protein 2 (SREBP-2) (Sterol regulatory element-binding transcription factor 2) [Cleaved into: Processed sterol regulatory element-binding protein 2 (Transcription factor SREBF2)]","Srebf2","Rattus norvegicus (Rat)",1133,"GO:0000122; GO:0000139; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005783; GO:0006355; GO:0007283; GO:0008203; GO:0008593; GO:0008610; GO:0009267; GO:0009410; GO:0009725; GO:0010288; GO:0010886; GO:0012507; GO:0016020; GO:0030425; GO:0032933; GO:0032937; GO:0033993; GO:0042632; GO:0043565; GO:0045542; GO:0045893; GO:0045944; GO:0046983; GO:0070888; GO:0071404; GO:0090370; GO:1902895; GO:1990837","cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to starvation [GO:0009267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; lipid biosynthetic process [GO:0008610]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of Notch signaling pathway [GO:0008593]; response to hormone [GO:0009725]; response to lead ion [GO:0010288]; response to lipid [GO:0033993]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]; SREBP signaling pathway [GO:0032933]","cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleus [GO:0005634]; SREBP-SCAP-Insig complex [GO:0032937]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to starvation [GO:0009267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; lipid biosynthetic process [GO:0008610]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of Notch signaling pathway [GO:0008593]; response to hormone [GO:0009725]; response to lead ion [GO:0010288]; response to lipid [GO:0033993]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]; SREBP signaling pathway [GO:0032933]","","","",""
"116","sp|Q9WV60|GSK3B_MOUSE","lcl|NC_088854.1_cds_XP_011452760.1_5534",0,658,"Q9WV60","GSK3B_MOUSE","Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)","Gsk3b","Mus musculus (Mouse)",420,"GO:0000320; GO:0001558; GO:0001837; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005977; GO:0006366; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007127; GO:0007409; GO:0007520; GO:0007623; GO:0008013; GO:0008286; GO:0009887; GO:0010508; GO:0010614; GO:0010628; GO:0010719; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0019901; GO:0030426; GO:0030877; GO:0031175; GO:0031663; GO:0032007; GO:0032436; GO:0032886; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0042752; GO:0042981; GO:0043025; GO:0043066; GO:0043161; GO:0043198; GO:0043491; GO:0045444; GO:0045719; GO:0045724; GO:0045773; GO:0045944; GO:0046825; GO:0046827; GO:0048471; GO:0048675; GO:0048863; GO:0050321; GO:0060070; GO:0070059; GO:0070840; GO:0070885; GO:0071385; GO:0072687; GO:0090090; GO:0097191; GO:0097192; GO:0098978; GO:0106310; GO:0141068; GO:1900026; GO:1900271; GO:1901030; GO:1902042; GO:1903566; GO:1903940; GO:1904780; GO:1990904; GO:1990909; GO:2000727; GO:2000738","animal organ morphogenesis [GO:0009887]; autosome genomic imprinting [GO:0141068]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell migration [GO:0016477]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to interleukin-3 [GO:0036016]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; meiosis I [GO:0007127]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein localization to centrosome [GO:1904780]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC2 signaling [GO:1903940]; neuron projection development [GO:0031175]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of autophagy [GO:0010508]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cilium assembly [GO:0045724]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of apoptotic process [GO:0042981]; regulation of cell growth [GO:0001558]; regulation of circadian rhythm [GO:0042752]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection development [GO:0010975]; regulation of protein export from nucleus [GO:0046825]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366]; Wnt signaling pathway [GO:0016055]","beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; meiotic spindle [GO:0072687]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; Wnt signalosome [GO:1990909]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynein complex binding [GO:0070840]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; animal organ morphogenesis [GO:0009887]; autosome genomic imprinting [GO:0141068]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell migration [GO:0016477]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to interleukin-3 [GO:0036016]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; meiosis I [GO:0007127]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein localization to centrosome [GO:1904780]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC2 signaling [GO:1903940]; neuron projection development [GO:0031175]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of autophagy [GO:0010508]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cilium assembly [GO:0045724]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of apoptotic process [GO:0042981]; regulation of cell growth [GO:0001558]; regulation of circadian rhythm [GO:0042752]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection development [GO:0010975]; regulation of protein export from nucleus [GO:0046825]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366]; Wnt signaling pathway [GO:0016055]","","","","TISSUE SPECIFICITY: Expressed in the liver (at protein level). {ECO:0000269|PubMed:27827363}."
"117","sp|P07174|TNR16_RAT","lcl|NC_088854.1_cds_XP_011452846.3_7750",2.59e-35,135,"P07174","TNR16_RAT","Tumor necrosis factor receptor superfamily member 16 (Gp80-LNGFR) (Low affinity neurotrophin receptor p75NTR) (Low-affinity nerve growth factor receptor) (NGF receptor) (Low-affinity nerve growth factor receptor p75NGFR) (Low-affinity nerve growth factor receptor p75NGR) (p75 ICD) (CD antigen CD271)","Ngfr Tnfrsf16","Rattus norvegicus (Rat)",425,"GO:0001540; GO:0001678; GO:0001942; GO:0005035; GO:0005168; GO:0005516; GO:0005635; GO:0005737; GO:0005739; GO:0005886; GO:0005911; GO:0006886; GO:0007266; GO:0007283; GO:0007411; GO:0007417; GO:0007623; GO:0008543; GO:0009897; GO:0009986; GO:0010468; GO:0010976; GO:0010977; GO:0014069; GO:0015026; GO:0016048; GO:0016525; GO:0021675; GO:0030336; GO:0030426; GO:0031069; GO:0031267; GO:0031594; GO:0031625; GO:0031643; GO:0032224; GO:0032496; GO:0032590; GO:0032809; GO:0032922; GO:0034599; GO:0035025; GO:0035907; GO:0035914; GO:0040037; GO:0042475; GO:0042488; GO:0042593; GO:0042734; GO:0042802; GO:0043065; GO:0043066; GO:0043121; GO:0043197; GO:0043204; GO:0043410; GO:0043524; GO:0043588; GO:0044877; GO:0045334; GO:0045471; GO:0045666; GO:0048144; GO:0048146; GO:0048406; GO:0051402; GO:0051799; GO:0051897; GO:0051902; GO:0051968; GO:0061000; GO:0070678; GO:0097191; GO:0099171; GO:1900182; GO:1902895; GO:1903588; GO:1904646; GO:2000179; GO:2000353; GO:2000377; GO:2000463; GO:2001235","axon guidance [GO:0007411]; cellular response to amyloid-beta [GO:1904646]; cellular response to oxidative stress [GO:0034599]; central nervous system development [GO:0007417]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; detection of temperature stimulus [GO:0016048]; dorsal aorta development [GO:0035907]; extrinsic apoptotic signaling pathway [GO:0097191]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast proliferation [GO:0048144]; glucose homeostasis [GO:0042593]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; intracellular glucose homeostasis [GO:0001678]; intracellular protein transport [GO:0006886]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration [GO:0030336]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of hair follicle development [GO:0051799]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; nerve development [GO:0021675]; neuron apoptotic process [GO:0051402]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of myelination [GO:0031643]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of odontogenesis of dentin-containing tooth [GO:0042488]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; Rho protein signal transduction [GO:0007266]; skeletal muscle cell differentiation [GO:0035914]; skin development [GO:0043588]; spermatogenesis [GO:0007283]","cell surface [GO:0009986]; cell-cell junction [GO:0005911]; clathrin-coated endocytic vesicle [GO:0045334]; cytoplasm [GO:0005737]; dendrite membrane [GO:0032590]; dendritic spine [GO:0043197]; external side of plasma membrane [GO:0009897]; growth cone [GO:0030426]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuronal cell body membrane [GO:0032809]; nuclear envelope [GO:0005635]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; amyloid-beta binding [GO:0001540]; calmodulin binding [GO:0005516]; coreceptor activity [GO:0015026]; death receptor activity [GO:0005035]; identical protein binding [GO:0042802]; nerve growth factor binding [GO:0048406]; neurotrophin binding [GO:0043121]; neurotrophin TRKA receptor binding [GO:0005168]; preprotein binding [GO:0070678]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625]; axon guidance [GO:0007411]; cellular response to amyloid-beta [GO:1904646]; cellular response to oxidative stress [GO:0034599]; central nervous system development [GO:0007417]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; detection of temperature stimulus [GO:0016048]; dorsal aorta development [GO:0035907]; extrinsic apoptotic signaling pathway [GO:0097191]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast proliferation [GO:0048144]; glucose homeostasis [GO:0042593]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; intracellular glucose homeostasis [GO:0001678]; intracellular protein transport [GO:0006886]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration [GO:0030336]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of hair follicle development [GO:0051799]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; nerve development [GO:0021675]; neuron apoptotic process [GO:0051402]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of myelination [GO:0031643]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of odontogenesis of dentin-containing tooth [GO:0042488]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; Rho protein signal transduction [GO:0007266]; skeletal muscle cell differentiation [GO:0035914]; skin development [GO:0043588]; spermatogenesis [GO:0007283]","","","",""
"118","sp|Q9VUZ1|TPPC2_DROME","lcl|NC_088854.1_cds_XP_011453899.1_3981",8.94e-63,189,"Q9VUZ1","TPPC2_DROME","Probable trafficking protein particle complex subunit 2 (TRAPP subunit 20 ortholog)","Trs20 l(3)72Dh CG5161","Drosophila melanogaster (Fruit fly)",139,"GO:0005634; GO:0005737; GO:0005783; GO:0006888; GO:0007283; GO:0030008; GO:0048193; GO:0048471; GO:1990071; GO:1990072","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi vesicle transport [GO:0048193]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi vesicle transport [GO:0048193]; spermatogenesis [GO:0007283]","","","",""
"119","sp|Q7KTX7|PRKN_DROME","lcl|NC_088854.1_cds_XP_011455733.3_7102",3.59e-15,80.1,"Q7KTX7","PRKN_DROME","E3 ubiquitin-protein ligase parkin (EC 2.3.2.31)","park parkin CG10523","Drosophila melanogaster (Fruit fly)",482,"GO:0000151; GO:0000209; GO:0000266; GO:0000423; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006511; GO:0006513; GO:0006979; GO:0007005; GO:0007283; GO:0008270; GO:0008344; GO:0008345; GO:0010637; GO:0010821; GO:0016567; GO:0030382; GO:0031624; GO:0042981; GO:0046329; GO:0048078; GO:0048477; GO:0051865; GO:0061630; GO:0061734; GO:0070050; GO:0090141; GO:1900407; GO:1901526; GO:1903599; GO:1904061; GO:1904457","adult locomotory behavior [GO:0008344]; larval locomotory behavior [GO:0008345]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; negative regulation of JNK cascade [GO:0046329]; negative regulation of mitochondrial fusion [GO:0010637]; neuron cellular homeostasis [GO:0070050]; oogenesis [GO:0048477]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of compound eye pigmentation [GO:0048078]; positive regulation of locomotor rhythm [GO:1904061]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitophagy [GO:1901526]; positive regulation of neuronal action potential [GO:1904457]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of mitochondrion organization [GO:0010821]; response to oxidative stress [GO:0006979]; sperm mitochondrion organization [GO:0030382]; spermatogenesis [GO:0007283]; type 2 mitophagy [GO:0061734]; ubiquitin-dependent protein catabolic process [GO:0006511]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; adult locomotory behavior [GO:0008344]; larval locomotory behavior [GO:0008345]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; negative regulation of JNK cascade [GO:0046329]; negative regulation of mitochondrial fusion [GO:0010637]; neuron cellular homeostasis [GO:0070050]; oogenesis [GO:0048477]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of compound eye pigmentation [GO:0048078]; positive regulation of locomotor rhythm [GO:1904061]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitophagy [GO:1901526]; positive regulation of neuronal action potential [GO:1904457]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of mitochondrion organization [GO:0010821]; response to oxidative stress [GO:0006979]; sperm mitochondrion organization [GO:0030382]; spermatogenesis [GO:0007283]; type 2 mitophagy [GO:0061734]; ubiquitin-dependent protein catabolic process [GO:0006511]","DEVELOPMENTAL STAGE: Expressed throughout development (PubMed:12642658, PubMed:14646593, PubMed:15073152, PubMed:16002472). Highest levels of expression in adults and early embryos (PubMed:14646593, PubMed:15073152). First detected in 0-2 hour embryos, likely due to a maternal contribution as it is not detected during the rest of embryogenesis (PubMed:15073152). Expressed in third instar larvae, throughout pupal development and in adults (PubMed:15073152). {ECO:0000269|PubMed:12642658, ECO:0000269|PubMed:14646593, ECO:0000269|PubMed:15073152, ECO:0000269|PubMed:16002472}.","","","TISSUE SPECIFICITY: In oocytes, accumulates in early egg chambers where it is enriched until stages 9-10, localizing mainly to the posterior pole and anterior margin (at protein level) (PubMed:20869429). After stage 10 it is no longer detected in the oocyte (at protein level) (PubMed:20869429). In embryos, ubiquitously expressed in the early stages (stages 2 to 5) (at protein level) (PubMed:14646593). Expression levels decrease at later stages and becomes restricted to the brain and nerve cord from stage 9 (at protein level) (PubMed:14646593). Relatively higher levels of expression in the head compared to the body (PubMed:16002472). Enriched in the dorsomedial (DM) dopaminergic neurons (PubMed:16002472). {ECO:0000269|PubMed:14646593, ECO:0000269|PubMed:16002472, ECO:0000269|PubMed:20869429}."
"120","sp|P09615|WNTG_DROME","lcl|NC_088854.1_cds_XP_011455886.1_4847",3.03e-93,288,"P09615","WNTG_DROME","Protein wingless (Protein Wnt-1) (Protein int-1) (dInt-1) (dWnt-1)","wg CG4889","Drosophila melanogaster (Fruit fly)",468,"GO:0001745; GO:0005109; GO:0005125; GO:0005539; GO:0005576; GO:0005615; GO:0005771; GO:0005783; GO:0005886; GO:0007367; GO:0007391; GO:0007398; GO:0007418; GO:0007442; GO:0007444; GO:0007448; GO:0007450; GO:0007476; GO:0007488; GO:0007498; GO:0007507; GO:0007523; GO:0007616; GO:0008284; GO:0008544; GO:0008587; GO:0009986; GO:0009996; GO:0010002; GO:0014019; GO:0016015; GO:0030182; GO:0030707; GO:0032876; GO:0035147; GO:0035153; GO:0035167; GO:0035170; GO:0035217; GO:0035220; GO:0035224; GO:0035225; GO:0035263; GO:0035277; GO:0035293; GO:0035311; GO:0042246; GO:0042691; GO:0043068; GO:0043195; GO:0043395; GO:0045121; GO:0045165; GO:0045572; GO:0045611; GO:0046672; GO:0048018; GO:0048076; GO:0048332; GO:0048542; GO:0048546; GO:0048728; GO:0048754; GO:0050808; GO:0050840; GO:0051124; GO:0060070; GO:0060914; GO:0061320; GO:0061328; GO:0061331; GO:0061332; GO:0061382; GO:0072091; GO:0090254; GO:2000648","anterior/posterior pattern specification, imaginal disc [GO:0007448]; branch fusion, open tracheal system [GO:0035147]; branching morphogenesis of an epithelial tube [GO:0048754]; canonical Wnt signaling pathway [GO:0060070]; cardioblast differentiation [GO:0010002]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell fate commitment [GO:0045165]; chitin-based larval cuticle pattern formation [GO:0035293]; compound eye morphogenesis [GO:0001745]; determination of genital disc primordium [GO:0035225]; digestive tract morphogenesis [GO:0048546]; dorsal closure [GO:0007391]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; epidermis development [GO:0008544]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; follicle cell of egg chamber development [GO:0030707]; genital disc anterior/posterior pattern formation [GO:0035224]; genital disc sexually dimorphic development [GO:0035263]; heart development [GO:0007507]; heart formation [GO:0060914]; hindgut morphogenesis [GO:0007442]; histoblast morphogenesis [GO:0007488]; imaginal disc development [GO:0007444]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; labial disc development [GO:0035217]; larval lymph gland hemopoiesis [GO:0035167]; larval visceral muscle development [GO:0007523]; long-term memory [GO:0007616]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; mesoderm morphogenesis [GO:0048332]; negative regulation of cell fate specification [GO:0009996]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of hemocyte differentiation [GO:0045611]; neuroblast development [GO:0014019]; neuron differentiation [GO:0030182]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of programmed cell death [GO:0043068]; positive regulation of stem cell proliferation [GO:2000648]; posterior Malpighian tubule development [GO:0061328]; proboscis development [GO:0048728]; regulation of compound eye pigmentation [GO:0048076]; regulation of stem cell proliferation [GO:0072091]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; tissue regeneration [GO:0042246]; ventral midline development [GO:0007418]; wing cell fate specification [GO:0035311]; wing disc development [GO:0035220]","cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]; cytokine activity [GO:0005125]; extracellular matrix binding [GO:0050840]; frizzled binding [GO:0005109]; glycosaminoglycan binding [GO:0005539]; heparan sulfate proteoglycan binding [GO:0043395]; morphogen activity [GO:0016015]; receptor ligand activity [GO:0048018]; anterior/posterior pattern specification, imaginal disc [GO:0007448]; branch fusion, open tracheal system [GO:0035147]; branching morphogenesis of an epithelial tube [GO:0048754]; canonical Wnt signaling pathway [GO:0060070]; cardioblast differentiation [GO:0010002]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell fate commitment [GO:0045165]; chitin-based larval cuticle pattern formation [GO:0035293]; compound eye morphogenesis [GO:0001745]; determination of genital disc primordium [GO:0035225]; digestive tract morphogenesis [GO:0048546]; dorsal closure [GO:0007391]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; epidermis development [GO:0008544]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; follicle cell of egg chamber development [GO:0030707]; genital disc anterior/posterior pattern formation [GO:0035224]; genital disc sexually dimorphic development [GO:0035263]; heart development [GO:0007507]; heart formation [GO:0060914]; hindgut morphogenesis [GO:0007442]; histoblast morphogenesis [GO:0007488]; imaginal disc development [GO:0007444]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; labial disc development [GO:0035217]; larval lymph gland hemopoiesis [GO:0035167]; larval visceral muscle development [GO:0007523]; long-term memory [GO:0007616]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; mesoderm morphogenesis [GO:0048332]; negative regulation of cell fate specification [GO:0009996]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of hemocyte differentiation [GO:0045611]; neuroblast development [GO:0014019]; neuron differentiation [GO:0030182]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of programmed cell death [GO:0043068]; positive regulation of stem cell proliferation [GO:2000648]; posterior Malpighian tubule development [GO:0061328]; proboscis development [GO:0048728]; regulation of compound eye pigmentation [GO:0048076]; regulation of stem cell proliferation [GO:0072091]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; tissue regeneration [GO:0042246]; ventral midline development [GO:0007418]; wing cell fate specification [GO:0035311]; wing disc development [GO:0035220]","DEVELOPMENTAL STAGE: Expressed throughout development, but barely detectable in adults. {ECO:0000269|PubMed:3111720, ECO:0000269|PubMed:3129722}.","","","TISSUE SPECIFICITY: Segmented expression in embryos. In embryonic tracheal cells, expression is in stripes flanking the tracheal placode. {ECO:0000269|PubMed:11717401, ECO:0000269|PubMed:3111720}."
"121","sp|Q28889|KIT_FELCA","lcl|NC_088854.1_cds_XP_011456194.3_10860",1.02e-79,285,"Q28889","KIT_FELCA","Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (CD antigen CD117)","KIT","Felis catus (Cat) (Felis silvestris catus)",978,"GO:0001541; GO:0002244; GO:0002327; GO:0002732; GO:0004714; GO:0005524; GO:0005886; GO:0006954; GO:0007283; GO:0008284; GO:0008360; GO:0016477; GO:0019221; GO:0019838; GO:0019955; GO:0030032; GO:0030036; GO:0030183; GO:0030217; GO:0030218; GO:0030318; GO:0030335; GO:0032765; GO:0035162; GO:0035855; GO:0038093; GO:0038109; GO:0038162; GO:0043235; GO:0043303; GO:0043473; GO:0046427; GO:0046872; GO:0048565; GO:0048863; GO:0050910; GO:0060326; GO:0060374; GO:0097324; GO:0097326","actin cytoskeleton organization [GO:0030036]; B cell differentiation [GO:0030183]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cytokine-mediated signaling pathway [GO:0019221]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; digestive tract development [GO:0048565]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; erythropoietin-mediated signaling pathway [GO:0038162]; Fc receptor signaling pathway [GO:0038093]; hematopoietic progenitor cell differentiation [GO:0002244]; immature B cell differentiation [GO:0002327]; inflammatory response [GO:0006954]; Kit signaling pathway [GO:0038109]; lamellipodium assembly [GO:0030032]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; megakaryocyte development [GO:0035855]; melanocyte adhesion [GO:0097326]; melanocyte differentiation [GO:0030318]; melanocyte migration [GO:0097324]; ovarian follicle development [GO:0001541]; pigmentation [GO:0043473]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of cell shape [GO:0008360]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]; T cell differentiation [GO:0030217]","plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; cytokine binding [GO:0019955]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; actin cytoskeleton organization [GO:0030036]; B cell differentiation [GO:0030183]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cytokine-mediated signaling pathway [GO:0019221]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; digestive tract development [GO:0048565]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; erythropoietin-mediated signaling pathway [GO:0038162]; Fc receptor signaling pathway [GO:0038093]; hematopoietic progenitor cell differentiation [GO:0002244]; immature B cell differentiation [GO:0002327]; inflammatory response [GO:0006954]; Kit signaling pathway [GO:0038109]; lamellipodium assembly [GO:0030032]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; megakaryocyte development [GO:0035855]; melanocyte adhesion [GO:0097326]; melanocyte differentiation [GO:0030318]; melanocyte migration [GO:0097324]; ovarian follicle development [GO:0001541]; pigmentation [GO:0043473]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of cell shape [GO:0008360]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]; T cell differentiation [GO:0030217]","","","",""
"122","sp|P05532|KIT_MOUSE","lcl|NC_088854.1_cds_XP_011456195.3_10861",2.44e-79,284,"P05532","KIT_MOUSE","Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (CD antigen CD117)","Kit Sl","Mus musculus (Mouse)",979,"GO:0001541; GO:0001650; GO:0001669; GO:0002020; GO:0002318; GO:0002320; GO:0002327; GO:0002551; GO:0002732; GO:0004714; GO:0005020; GO:0005524; GO:0005615; GO:0005886; GO:0005911; GO:0006687; GO:0006935; GO:0006954; GO:0007281; GO:0007283; GO:0007286; GO:0008283; GO:0008354; GO:0008360; GO:0008542; GO:0008584; GO:0009314; GO:0009897; GO:0009898; GO:0009986; GO:0010628; GO:0012501; GO:0019221; GO:0019955; GO:0030032; GO:0030036; GO:0030097; GO:0030154; GO:0030217; GO:0030218; GO:0030318; GO:0030335; GO:0031274; GO:0032765; GO:0035019; GO:0035162; GO:0035234; GO:0035556; GO:0035701; GO:0035855; GO:0038093; GO:0038162; GO:0042169; GO:0042803; GO:0043069; GO:0043303; GO:0043410; GO:0043473; GO:0043586; GO:0045747; GO:0046427; GO:0046686; GO:0046872; GO:0048066; GO:0048170; GO:0048565; GO:0048863; GO:0050673; GO:0050910; GO:0051093; GO:0060326; GO:0060374; GO:0070662; GO:0070668; GO:0097324; GO:0097326; GO:0120072; GO:1904251; GO:1904343; GO:1904349; GO:1905065; GO:2000242","actin cytoskeleton organization [GO:0030036]; cell chemotaxis [GO:0060326]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; developmental pigmentation [GO:0048066]; digestive tract development [GO:0048565]; ectopic germ cell programmed cell death [GO:0035234]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation [GO:0050673]; erythrocyte differentiation [GO:0030218]; erythropoietin-mediated signaling pathway [GO:0038162]; Fc receptor signaling pathway [GO:0038093]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; glycosphingolipid metabolic process [GO:0006687]; hematopoietic stem cell migration [GO:0035701]; hemopoiesis [GO:0030097]; immature B cell differentiation [GO:0002327]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; lymphoid progenitor cell differentiation [GO:0002320]; male gonad development [GO:0008584]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; mast cell proliferation [GO:0070662]; megakaryocyte development [GO:0035855]; melanocyte adhesion [GO:0097326]; melanocyte differentiation [GO:0030318]; melanocyte migration [GO:0097324]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of developmental process [GO:0051093]; negative regulation of programmed cell death [GO:0043069]; negative regulation of reproductive process [GO:2000242]; ovarian follicle development [GO:0001541]; pigmentation [GO:0043473]; positive regulation of cell migration [GO:0030335]; positive regulation of colon smooth muscle contraction [GO:1904343]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of gene expression [GO:0010628]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of pyloric antrum smooth muscle contraction [GO:0120072]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of vascular associated smooth muscle cell differentiation [GO:1905065]; programmed cell death [GO:0012501]; regulation of bile acid metabolic process [GO:1904251]; regulation of cell shape [GO:0008360]; response to cadmium ion [GO:0046686]; response to radiation [GO:0009314]; somatic stem cell population maintenance [GO:0035019]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]; T cell differentiation [GO:0030217]; tongue development [GO:0043586]; visual learning [GO:0008542]","acrosomal vesicle [GO:0001669]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; fibrillar center [GO:0001650]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cytokine binding [GO:0019955]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; SH2 domain binding [GO:0042169]; stem cell factor receptor activity [GO:0005020]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; actin cytoskeleton organization [GO:0030036]; cell chemotaxis [GO:0060326]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; developmental pigmentation [GO:0048066]; digestive tract development [GO:0048565]; ectopic germ cell programmed cell death [GO:0035234]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation [GO:0050673]; erythrocyte differentiation [GO:0030218]; erythropoietin-mediated signaling pathway [GO:0038162]; Fc receptor signaling pathway [GO:0038093]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; glycosphingolipid metabolic process [GO:0006687]; hematopoietic stem cell migration [GO:0035701]; hemopoiesis [GO:0030097]; immature B cell differentiation [GO:0002327]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; lymphoid progenitor cell differentiation [GO:0002320]; male gonad development [GO:0008584]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; mast cell proliferation [GO:0070662]; megakaryocyte development [GO:0035855]; melanocyte adhesion [GO:0097326]; melanocyte differentiation [GO:0030318]; melanocyte migration [GO:0097324]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of developmental process [GO:0051093]; negative regulation of programmed cell death [GO:0043069]; negative regulation of reproductive process [GO:2000242]; ovarian follicle development [GO:0001541]; pigmentation [GO:0043473]; positive regulation of cell migration [GO:0030335]; positive regulation of colon smooth muscle contraction [GO:1904343]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of gene expression [GO:0010628]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of pyloric antrum smooth muscle contraction [GO:0120072]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of vascular associated smooth muscle cell differentiation [GO:1905065]; programmed cell death [GO:0012501]; regulation of bile acid metabolic process [GO:1904251]; regulation of cell shape [GO:0008360]; response to cadmium ion [GO:0046686]; response to radiation [GO:0009314]; somatic stem cell population maintenance [GO:0035019]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]; T cell differentiation [GO:0030217]; tongue development [GO:0043586]; visual learning [GO:0008542]","","","","TISSUE SPECIFICITY: Isoform 1 and isoform 2 are detected in bone marrow cells, spermatogonia and spermatocytes, but not in round spermatids, elongating spermatids and spermatozoa. Isoform 3 is detected in round spermatids, elongating spermatids and spermatozoa, but not in spermatogonia and spermatocytes (at protein level). Isoform 1 is widely expressed and detected in fetal liver and bone marrow. Isoform 3 is detected in bone marrow cells enriched in hematopoietic stem cells. {ECO:0000269|PubMed:1378413, ECO:0000269|PubMed:18447649, ECO:0000269|PubMed:7527401}."
"123","sp|Q76II0|KIT_CALJA","lcl|NC_088854.1_cds_XP_011456196.3_10862",6.1e-82,292,"Q76II0","KIT_CALJA","Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (CD antigen CD117)","KIT","Callithrix jacchus (White-tufted-ear marmoset)",972,"GO:0001541; GO:0002244; GO:0002327; GO:0002732; GO:0004714; GO:0005524; GO:0005886; GO:0006954; GO:0007283; GO:0008360; GO:0019221; GO:0019838; GO:0019955; GO:0030032; GO:0030036; GO:0030217; GO:0030218; GO:0030318; GO:0030335; GO:0032765; GO:0035162; GO:0035855; GO:0038093; GO:0038109; GO:0038162; GO:0042127; GO:0043235; GO:0043303; GO:0043473; GO:0046427; GO:0046872; GO:0048565; GO:0048863; GO:0050910; GO:0060326; GO:0060374; GO:0097324; GO:0097326","actin cytoskeleton organization [GO:0030036]; cell chemotaxis [GO:0060326]; cytokine-mediated signaling pathway [GO:0019221]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; digestive tract development [GO:0048565]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; erythropoietin-mediated signaling pathway [GO:0038162]; Fc receptor signaling pathway [GO:0038093]; hematopoietic progenitor cell differentiation [GO:0002244]; immature B cell differentiation [GO:0002327]; inflammatory response [GO:0006954]; Kit signaling pathway [GO:0038109]; lamellipodium assembly [GO:0030032]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; megakaryocyte development [GO:0035855]; melanocyte adhesion [GO:0097326]; melanocyte differentiation [GO:0030318]; melanocyte migration [GO:0097324]; ovarian follicle development [GO:0001541]; pigmentation [GO:0043473]; positive regulation of cell migration [GO:0030335]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]; T cell differentiation [GO:0030217]","plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; cytokine binding [GO:0019955]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; actin cytoskeleton organization [GO:0030036]; cell chemotaxis [GO:0060326]; cytokine-mediated signaling pathway [GO:0019221]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; digestive tract development [GO:0048565]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; erythropoietin-mediated signaling pathway [GO:0038162]; Fc receptor signaling pathway [GO:0038093]; hematopoietic progenitor cell differentiation [GO:0002244]; immature B cell differentiation [GO:0002327]; inflammatory response [GO:0006954]; Kit signaling pathway [GO:0038109]; lamellipodium assembly [GO:0030032]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; megakaryocyte development [GO:0035855]; melanocyte adhesion [GO:0097326]; melanocyte differentiation [GO:0030318]; melanocyte migration [GO:0097324]; ovarian follicle development [GO:0001541]; pigmentation [GO:0043473]; positive regulation of cell migration [GO:0030335]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]; T cell differentiation [GO:0030217]","","","",""
"124","sp|P34183|SYH_CAEEL","lcl|NC_088854.1_cds_XP_011456431.1_7431",2.82e-177,509,"P34183","SYH_CAEEL","Histidine--tRNA ligase (EC 6.1.1.21) (Histidyl-tRNA synthetase) (HisRS)","hars-1 hrs-1 syh-1 T11G6.1","Caenorhabditis elegans",521,"GO:0002119; GO:0003723; GO:0004821; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006412; GO:0006427; GO:0007281; GO:0032543; GO:0042802","germ cell development [GO:0007281]; histidyl-tRNA aminoacylation [GO:0006427]; mitochondrial translation [GO:0032543]; nematode larval development [GO:0002119]; translation [GO:0006412]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; germ cell development [GO:0007281]; histidyl-tRNA aminoacylation [GO:0006427]; mitochondrial translation [GO:0032543]; nematode larval development [GO:0002119]; translation [GO:0006412]","","","",""
"125","sp|Q8NB90|AFG2A_HUMAN","lcl|NC_088854.1_cds_XP_011456601.3_4690",0,684,"Q8NB90","AFG2A_HUMAN","ATPase family gene 2 protein homolog A (EC 3.6.4.10) (AFG2 AAA ATPase homolog A) (Ribosome biogenesis protein SPATA5) (Spermatogenesis-associated factor protein) (Spermatogenesis-associated protein 5)","AFG2A SPAF SPATA5","Homo sapiens (Human)",893,"GO:0005524; GO:0005737; GO:0005819; GO:0005829; GO:0007283; GO:0007420; GO:0016887; GO:0030154; GO:0042273; GO:1990275","brain development [GO:0007420]; cell differentiation [GO:0030154]; ribosomal large subunit biogenesis [GO:0042273]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; preribosome binding [GO:1990275]; brain development [GO:0007420]; cell differentiation [GO:0030154]; ribosomal large subunit biogenesis [GO:0042273]; spermatogenesis [GO:0007283]","","","",""
"126","sp|Q9VU87|VPS36_DROME","lcl|NC_088854.1_cds_XP_011456694.3_8109",1.67e-106,320,"Q9VU87","VPS36_DROME","Vacuolar protein-sorting-associated protein 36 (ESCRT-II complex subunit VPS36)","Vps36 CG10711","Drosophila melanogaster (Fruit fly)",399,"GO:0000814; GO:0003730; GO:0005737; GO:0005768; GO:0008104; GO:0031902; GO:0032266; GO:0042981; GO:0043025; GO:0043130; GO:0043162; GO:0043328; GO:0045450; GO:0051028","bicoid mRNA localization [GO:0045450]; mRNA transport [GO:0051028]; protein localization [GO:0008104]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]","cytoplasm [GO:0005737]; endosome [GO:0005768]; ESCRT II complex [GO:0000814]; late endosome membrane [GO:0031902]; neuronal cell body [GO:0043025]; mRNA 3'-UTR binding [GO:0003730]; phosphatidylinositol-3-phosphate binding [GO:0032266]; ubiquitin binding [GO:0043130]; bicoid mRNA localization [GO:0045450]; mRNA transport [GO:0051028]; protein localization [GO:0008104]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]","DEVELOPMENTAL STAGE: Localizes to the anterior cortex of the oocyte in the same region as bicoid mRNA from stage 10B/11 of oogenesis. {ECO:0000269|PubMed:17268469}.","","","TISSUE SPECIFICITY: Ubiquitously expressed in the ovary. {ECO:0000269|PubMed:17268469}."
"127","sp|Q8MQJ9|BRAT_DROME","lcl|NC_088854.1_cds_XP_019919680.2_5016",0,568,"Q8MQJ9","BRAT_DROME","Protein brain tumor","brat CG10719","Drosophila melanogaster (Fruit fly)",1037,"GO:0003730; GO:0005737; GO:0005829; GO:0006417; GO:0007400; GO:0007402; GO:0007405; GO:0007406; GO:0007419; GO:0007420; GO:0008270; GO:0008285; GO:0008356; GO:0008582; GO:0009303; GO:0010629; GO:0014016; GO:0014019; GO:0017148; GO:0030182; GO:0030371; GO:0035282; GO:0043025; GO:0045179; GO:0045180; GO:0045182; GO:0048477; GO:0050767; GO:0055060; GO:0061351; GO:1900242; GO:1902692","asymmetric cell division [GO:0008356]; asymmetric neuroblast division resulting in ganglion mother cell formation [GO:0055060]; brain development [GO:0007420]; ganglion mother cell fate determination [GO:0007402]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of translation [GO:0017148]; neural precursor cell proliferation [GO:0061351]; neuroblast development [GO:0014019]; neuroblast differentiation [GO:0014016]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron differentiation [GO:0030182]; oogenesis [GO:0048477]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of translation [GO:0006417]; rRNA transcription [GO:0009303]; segmentation [GO:0035282]; ventral cord development [GO:0007419]","apical cortex [GO:0045179]; basal cortex [GO:0045180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; mRNA 3'-UTR binding [GO:0003730]; translation regulator activity [GO:0045182]; translation repressor activity [GO:0030371]; zinc ion binding [GO:0008270]; asymmetric cell division [GO:0008356]; asymmetric neuroblast division resulting in ganglion mother cell formation [GO:0055060]; brain development [GO:0007420]; ganglion mother cell fate determination [GO:0007402]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of translation [GO:0017148]; neural precursor cell proliferation [GO:0061351]; neuroblast development [GO:0014019]; neuroblast differentiation [GO:0014016]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron differentiation [GO:0030182]; oogenesis [GO:0048477]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of translation [GO:0006417]; rRNA transcription [GO:0009303]; segmentation [GO:0035282]; ventral cord development [GO:0007419]","","","","TISSUE SPECIFICITY: Expressed during embryogenesis, mainly in nervous tissues. Expressed in the embryonic central and peripheral nervous systems including the embryonic brain. In third instar larva it is expressed in the larval central nervous system including the brain and the ventral ganglion, in two glands (the ring gland and the salivary gland, and in parts of the foregut) the gastric caeca and the proventriculus. {ECO:0000269|PubMed:10949924}."
"128","sp|Q568P9|HENMT_DANRE","lcl|NC_088854.1_cds_XP_019919969.3_7734",3.88e-43,156,"Q568P9","HENMT_DANRE","Small RNA 2'-O-methyltransferase (EC 2.1.1.386) (HEN1 methyltransferase homolog 1)","henmt1 si:ch211-199m3.6 zgc:110175","Danio rerio (Zebrafish) (Brachydanio rerio)",402,"GO:0001510; GO:0003723; GO:0005634; GO:0005737; GO:0008171; GO:0008173; GO:0030422; GO:0034587; GO:0043186; GO:0043487; GO:0046872; GO:0048599; GO:0090486; GO:0140990","oocyte development [GO:0048599]; piRNA processing [GO:0034587]; primary piRNA processing [GO:0140990]; regulation of RNA stability [GO:0043487]; RNA methylation [GO:0001510]; siRNA processing [GO:0030422]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; metal ion binding [GO:0046872]; O-methyltransferase activity [GO:0008171]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; small RNA 2'-O-methyltransferase activity [GO:0090486]; oocyte development [GO:0048599]; piRNA processing [GO:0034587]; primary piRNA processing [GO:0140990]; regulation of RNA stability [GO:0043487]; RNA methylation [GO:0001510]; siRNA processing [GO:0030422]","DEVELOPMENTAL STAGE: Expression in gonads starts around 3 weeks of age, which corresponds to the start of sex determination. Expression remains present in the adult gonads, both in males and females, although expression is weaker in testis. {ECO:0000269|PubMed:20859253}.","","","TISSUE SPECIFICITY: Gonad-specific. {ECO:0000269|PubMed:20859253}."
"129","sp|Q9V7P1|UTP18_DROME","lcl|NC_088854.1_cds_XP_019922434.3_9896",3.81e-70,233,"Q9V7P1","UTP18_DROME","U3 small nucleolar RNA-associated protein 18 homolog (Protein wicked) (WD repeat protein l(2)k07824)","wcd l(2)k07824 CG7989","Drosophila melanogaster (Fruit fly)",506,"GO:0005634; GO:0005730; GO:0006364; GO:0007405; GO:0030532; GO:0032040; GO:0034388; GO:0042585; GO:0048132","female germ-line stem cell asymmetric division [GO:0048132]; neuroblast proliferation [GO:0007405]; rRNA processing [GO:0006364]","germinal vesicle [GO:0042585]; nucleolus [GO:0005730]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small nuclear ribonucleoprotein complex [GO:0030532]; small-subunit processome [GO:0032040]; female germ-line stem cell asymmetric division [GO:0048132]; neuroblast proliferation [GO:0007405]; rRNA processing [GO:0006364]","","","",""
"130","sp|Q5VCS6|TDRD5_MOUSE","lcl|NC_088854.1_cds_XP_019923909.3_4257",3.59e-54,207,"Q5VCS6","TDRD5_MOUSE","Tudor domain-containing protein 5","Tdrd5 Gm103","Mus musculus (Mouse)",1040,"GO:0007286; GO:0030719; GO:0033391; GO:0045202; GO:0071546; GO:0141196","P granule organization [GO:0030719]; spermatid development [GO:0007286]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]","chromatoid body [GO:0033391]; pi-body [GO:0071546]; synapse [GO:0045202]; P granule organization [GO:0030719]; spermatid development [GO:0007286]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]","DEVELOPMENTAL STAGE: Specifically expressed in germ cells of the developing testis, starting from 12.5 dpc. The protein is detected as early as 13.5 dpc in embryonic testes, but expression declines around the perinatal period and then is restored at around 2 weeks after birth. Also detected in the embryonic ovary at a low level. In adult testis, mainly present in the spermatocytes from the pachytene stage onward (at protein level). {ECO:0000269|PubMed:15465492, ECO:0000269|PubMed:21383078}.","","","TISSUE SPECIFICITY: Gonad-specific. Mainly expressed in testis. Present at low level in ovary (at protein level). {ECO:0000269|PubMed:15465492, ECO:0000269|PubMed:21383078}."
"131","sp|A6QNW6|S26A8_BOVIN","lcl|NC_088854.1_cds_XP_019926170.3_8574",2.34e-61,225,"A6QNW6","S26A8_BOVIN","Testis anion transporter 1 (Anion exchange transporter) (Solute carrier family 26 member 8)","SLC26A8","Bos taurus (Bovine)",960,"GO:0005886; GO:0006821; GO:0007283; GO:0015106; GO:0015108; GO:0015116; GO:0019531; GO:0030154; GO:0051321; GO:0097227; GO:0160044; GO:1902358; GO:1902476","cell differentiation [GO:0030154]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; meiotic cell cycle [GO:0051321]; spermatogenesis [GO:0007283]; sulfate transmembrane transport [GO:1902358]","plasma membrane [GO:0005886]; sperm annulus [GO:0097227]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; sulfate transmembrane transporter activity [GO:0015116]; sulfate:chloride antiporter activity [GO:0160044]; cell differentiation [GO:0030154]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; meiotic cell cycle [GO:0051321]; spermatogenesis [GO:0007283]; sulfate transmembrane transport [GO:1902358]","","","",""
"132","sp|Q3TY65|ICA1L_MOUSE","lcl|NC_088854.1_cds_XP_019927049.3_7463",7.99e-104,319,"Q3TY65","ICA1L_MOUSE","Islet cell autoantigen 1-like protein (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 15 protein homolog) (Ica69-related protein)","Ica1l Als2cr15","Mus musculus (Mouse)",431,"GO:0001669; GO:0007286; GO:0019904","spermatid development [GO:0007286]","acrosomal vesicle [GO:0001669]; protein domain specific binding [GO:0019904]; spermatid development [GO:0007286]","","","",""
"133","sp|Q99999|G3ST1_HUMAN","lcl|NC_088854.1_cds_XP_019927116.3_4558",7.11e-37,140,"Q99999","G3ST1_HUMAN","Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase)","GAL3ST1 CST","Homo sapiens (Human)",423,"GO:0000139; GO:0001733; GO:0005886; GO:0006487; GO:0006665; GO:0006681; GO:0006682; GO:0006688; GO:0007283; GO:0008146; GO:0016020; GO:0042552; GO:0046486","galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycosphingolipid biosynthetic process [GO:0006688]; myelination [GO:0042552]; protein N-linked glycosylation [GO:0006487]; spermatogenesis [GO:0007283]; sphingolipid metabolic process [GO:0006665]","Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146]; galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycosphingolipid biosynthetic process [GO:0006688]; myelination [GO:0042552]; protein N-linked glycosylation [GO:0006487]; spermatogenesis [GO:0007283]; sphingolipid metabolic process [GO:0006665]","","","","TISSUE SPECIFICITY: Expressed in kidney proximal tubule, gastric mucosa and adenocarcinoma (PubMed:10785389, PubMed:9030544). Highly expressed in renal cell carcinoma cell lines (PubMed:8830034, PubMed:9030544). {ECO:0000269|PubMed:10785389, ECO:0000269|PubMed:8830034, ECO:0000269|PubMed:9030544}."
"134","sp|A0A0A6YY25|BTBDI_MOUSE","lcl|NC_088854.1_cds_XP_019927175.1_6989",3.95e-12,70.9,"A0A0A6YY25","BTBDI_MOUSE","BTB/POZ domain-containing protein 18","Btbd18","Mus musculus (Mouse)",723,"GO:0005634; GO:0007141; GO:0007283; GO:0010526; GO:0030154; GO:0032968; GO:0140541","cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; piRNA transcription [GO:0140541]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; spermatogenesis [GO:0007283]; transposable element silencing [GO:0010526]","nucleus [GO:0005634]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; piRNA transcription [GO:0140541]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; spermatogenesis [GO:0007283]; transposable element silencing [GO:0010526]","DEVELOPMENTAL STAGE: Expressed during pachytene in testis: accumulates in early pachytene cells (stages I-VII), declines in late pachytene cells (stages VIII-X) and disappears in diplotene cells (stage XI) (at protein level). Expressed from spermatogonia to spermatids, with trace expression in mature spermatozoa and somatic Sertoli cells. {ECO:0000269|PubMed:28292424}.","","","TISSUE SPECIFICITY: Expressed in testis. {ECO:0000269|PubMed:28292424}."
"135","sp|P27619|DYN_DROME","lcl|NC_088854.1_cds_XP_034299687.2_9793",0,1062,"P27619","DYN_DROME","Dynamin (EC 3.6.5.5) (Protein shibire) (dDyn)","shi CG18102","Drosophila melanogaster (Fruit fly)",877,"GO:0001661; GO:0001738; GO:0001933; GO:0003779; GO:0003924; GO:0005525; GO:0005737; GO:0005874; GO:0005886; GO:0006897; GO:0007268; GO:0007291; GO:0007298; GO:0007349; GO:0007424; GO:0007427; GO:0007435; GO:0007612; GO:0007613; GO:0007614; GO:0007637; GO:0008017; GO:0008355; GO:0010508; GO:0016185; GO:0030198; GO:0030536; GO:0030707; GO:0030838; GO:0030866; GO:0031594; GO:0031623; GO:0032956; GO:0032970; GO:0034334; GO:0035152; GO:0035186; GO:0036465; GO:0040008; GO:0045202; GO:0046667; GO:0046718; GO:0046843; GO:0048172; GO:0048488; GO:0048489; GO:0048499; GO:0050803; GO:0061883; GO:0070864; GO:0072583; GO:0072659; GO:0072686; GO:0090148; GO:0098793; GO:0099525; GO:0150007; GO:0150008; GO:1903475","adherens junction maintenance [GO:0034334]; border follicle cell migration [GO:0007298]; bulk synaptic vesicle endocytosis [GO:0150008]; cellularization [GO:0007349]; chemical synaptic transmission [GO:0007268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent endocytosis involved in vitellogenesis [GO:0061883]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; compound eye retinal cell programmed cell death [GO:0046667]; conditioned taste aversion [GO:0001661]; cortical actin cytoskeleton organization [GO:0030866]; dorsal appendage formation [GO:0046843]; endocytosis [GO:0006897]; epithelial cell migration, open tracheal system [GO:0007427]; extracellular matrix organization [GO:0030198]; follicle cell of egg chamber development [GO:0030707]; larval feeding behavior [GO:0030536]; learning [GO:0007612]; membrane fission [GO:0090148]; memory [GO:0007613]; mitotic actomyosin contractile ring assembly [GO:1903475]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of protein phosphorylation [GO:0001933]; olfactory learning [GO:0008355]; open tracheal system development [GO:0007424]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of autophagy [GO:0010508]; presynaptic dense core vesicle exocytosis [GO:0099525]; proboscis extension reflex [GO:0007637]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of growth [GO:0040008]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synapse structure or activity [GO:0050803]; regulation of tube architecture, open tracheal system [GO:0035152]; salivary gland morphogenesis [GO:0007435]; short-term memory [GO:0007614]; sperm individualization [GO:0007291]; symbiont entry into host cell [GO:0046718]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; synaptic vesicle transport [GO:0048489]; syncytial blastoderm mitotic cell cycle [GO:0035186]","cytoplasm [GO:0005737]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; sperm individualization complex [GO:0070864]; synapse [GO:0045202]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; adherens junction maintenance [GO:0034334]; border follicle cell migration [GO:0007298]; bulk synaptic vesicle endocytosis [GO:0150008]; cellularization [GO:0007349]; chemical synaptic transmission [GO:0007268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent endocytosis involved in vitellogenesis [GO:0061883]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; compound eye retinal cell programmed cell death [GO:0046667]; conditioned taste aversion [GO:0001661]; cortical actin cytoskeleton organization [GO:0030866]; dorsal appendage formation [GO:0046843]; endocytosis [GO:0006897]; epithelial cell migration, open tracheal system [GO:0007427]; extracellular matrix organization [GO:0030198]; follicle cell of egg chamber development [GO:0030707]; larval feeding behavior [GO:0030536]; learning [GO:0007612]; membrane fission [GO:0090148]; memory [GO:0007613]; mitotic actomyosin contractile ring assembly [GO:1903475]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of protein phosphorylation [GO:0001933]; olfactory learning [GO:0008355]; open tracheal system development [GO:0007424]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of autophagy [GO:0010508]; presynaptic dense core vesicle exocytosis [GO:0099525]; proboscis extension reflex [GO:0007637]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of growth [GO:0040008]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synapse structure or activity [GO:0050803]; regulation of tube architecture, open tracheal system [GO:0035152]; salivary gland morphogenesis [GO:0007435]; short-term memory [GO:0007614]; sperm individualization [GO:0007291]; symbiont entry into host cell [GO:0046718]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; synaptic vesicle transport [GO:0048489]; syncytial blastoderm mitotic cell cycle [GO:0035186]","","","",""
"136","sp|P39052|DYN2_RAT","lcl|NC_088854.1_cds_XP_034299694.2_9794",0,1066,"P39052","DYN2_RAT","Dynamin-2 (EC 3.6.5.5)","Dnm2 Dyn2","Rattus norvegicus (Rat)",870,"GO:0000139; GO:0001891; GO:0001917; GO:0001931; GO:0002031; GO:0002102; GO:0003281; GO:0003924; GO:0005525; GO:0005546; GO:0005737; GO:0005768; GO:0005802; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0005886; GO:0005905; GO:0005938; GO:0006893; GO:0006897; GO:0006898; GO:0006909; GO:0006914; GO:0007098; GO:0007283; GO:0008017; GO:0009416; GO:0010592; GO:0014069; GO:0016185; GO:0017124; GO:0019901; GO:0030027; GO:0030054; GO:0030136; GO:0030496; GO:0030512; GO:0030516; GO:0030670; GO:0031623; GO:0031749; GO:0032587; GO:0032991; GO:0033572; GO:0035020; GO:0035904; GO:0036312; GO:0042220; GO:0043005; GO:0043149; GO:0044351; GO:0044877; GO:0045202; GO:0045211; GO:0045334; GO:0045429; GO:0045807; GO:0048471; GO:0048488; GO:0048812; GO:0050699; GO:0050766; GO:0050998; GO:0051258; GO:0055037; GO:0060976; GO:0061572; GO:0070161; GO:0071245; GO:0071481; GO:0071732; GO:0072687; GO:0097749; GO:0098793; GO:0098843; GO:0098978; GO:0099050; GO:0099092; GO:0120283; GO:0140239; GO:1900026; GO:1902856; GO:1903351; GO:1903358; GO:1903526; GO:2000370","actin filament bundle organization [GO:0061572]; aorta development [GO:0035904]; autophagy [GO:0006914]; cellular response to carbon monoxide [GO:0071245]; cellular response to dopamine [GO:1903351]; cellular response to nitric oxide [GO:0071732]; cellular response to X-ray [GO:0071481]; centrosome cycle [GO:0007098]; coronary vasculature development [GO:0060976]; endocytosis [GO:0006897]; G protein-coupled receptor internalization [GO:0002031]; Golgi to plasma membrane transport [GO:0006893]; macropinocytosis [GO:0044351]; membrane tubulation [GO:0097749]; negative regulation of membrane tubulation [GO:1903526]; negative regulation of non-motile cilium assembly [GO:1902856]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron projection morphogenesis [GO:0048812]; phagocytosis [GO:0006909]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of endocytosis [GO:0045807]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic endocytosis [GO:0140239]; protein polymerization [GO:0051258]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of axon extension [GO:0030516]; regulation of Golgi organization [GO:1903358]; regulation of Rac protein signal transduction [GO:0035020]; response to cocaine [GO:0042220]; response to light stimulus [GO:0009416]; spermatogenesis [GO:0007283]; stress fiber assembly [GO:0043149]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; transferrin transport [GO:0033572]; ventricular septum development [GO:0003281]; vesicle scission [GO:0099050]","anchoring junction [GO:0070161]; cell cortex [GO:0005938]; cell junction [GO:0030054]; centriole [GO:0005814]; centrosome [GO:0005813]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic endocytic zone [GO:0098843]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; uropod [GO:0001931]; D2 dopamine receptor binding [GO:0031749]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; protein serine/threonine kinase binding [GO:0120283]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699]; actin filament bundle organization [GO:0061572]; aorta development [GO:0035904]; autophagy [GO:0006914]; cellular response to carbon monoxide [GO:0071245]; cellular response to dopamine [GO:1903351]; cellular response to nitric oxide [GO:0071732]; cellular response to X-ray [GO:0071481]; centrosome cycle [GO:0007098]; coronary vasculature development [GO:0060976]; endocytosis [GO:0006897]; G protein-coupled receptor internalization [GO:0002031]; Golgi to plasma membrane transport [GO:0006893]; macropinocytosis [GO:0044351]; membrane tubulation [GO:0097749]; negative regulation of membrane tubulation [GO:1903526]; negative regulation of non-motile cilium assembly [GO:1902856]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron projection morphogenesis [GO:0048812]; phagocytosis [GO:0006909]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of endocytosis [GO:0045807]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic endocytosis [GO:0140239]; protein polymerization [GO:0051258]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of axon extension [GO:0030516]; regulation of Golgi organization [GO:1903358]; regulation of Rac protein signal transduction [GO:0035020]; response to cocaine [GO:0042220]; response to light stimulus [GO:0009416]; spermatogenesis [GO:0007283]; stress fiber assembly [GO:0043149]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; transferrin transport [GO:0033572]; ventricular septum development [GO:0003281]; vesicle scission [GO:0099050]","","","","TISSUE SPECIFICITY: Ubiquitously expressed. Brain expression is restricted to glial cells and fibroblasts. Highest levels in the testis. {ECO:0000269|PubMed:9725914}."
"137","sp|Q9BYT3|STK33_HUMAN","lcl|NC_088854.1_cds_XP_034299803.1_4520",5.75e-56,199,"Q9BYT3","STK33_HUMAN","Serine/threonine-protein kinase 33 (EC 2.7.11.1)","STK33","Homo sapiens (Human)",514,"GO:0002177; GO:0004674; GO:0005524; GO:0005634; GO:0007283; GO:0044773; GO:0046777; GO:0048471; GO:0106310; GO:1905198","manchette assembly [GO:1905198]; mitotic DNA damage checkpoint signaling [GO:0044773]; protein autophosphorylation [GO:0046777]; spermatogenesis [GO:0007283]","manchette [GO:0002177]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; manchette assembly [GO:1905198]; mitotic DNA damage checkpoint signaling [GO:0044773]; protein autophosphorylation [GO:0046777]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Highly expressed in testis, fetal lung and heart, followed by pituitary gland, kidney, interventricular septum, pancreas, heart, trachea, thyroid gland and uterus. Weak hybridization signals were observed in the following tissues: amygdala, aorta, esophagus, colon ascending, colon transverse, skeletal muscle, spleen, peripheral blood leukocyte, lymph node, bone marrow, placenta, prostate, liver, salivary gland, mammary gland, some tumor cell lines, fetal brain, fetal liver, fetal spleen and fetal thymus. No signal at all was detectable in RNA from tissues of the nervous system. {ECO:0000269|PubMed:11738831, ECO:0000269|PubMed:16176263}."
"138","sp|Q61456|CCNA1_MOUSE","lcl|NC_088854.1_cds_XP_034299932.1_4678",3e-104,317,"Q61456","CCNA1_MOUSE","Cyclin-A1","Ccna1","Mus musculus (Mouse)",421,"GO:0005634; GO:0005737; GO:0005819; GO:0007283; GO:0030154; GO:0051301; GO:0051321; GO:0097123","cell differentiation [GO:0030154]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; spermatogenesis [GO:0007283]","cyclin A1-CDK2 complex [GO:0097123]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; cell differentiation [GO:0030154]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: In male germ cells just prior to or during the first, but not the second meiotic division. {ECO:0000269|PubMed:9843212}.","","","TISSUE SPECIFICITY: Testis and ovaries. {ECO:0000269|PubMed:8565853}."
"139","sp|G3V7L5|PO4F2_RAT","lcl|NC_088854.1_cds_XP_034299937.1_4685",2.49e-93,282,"G3V7L5","PO4F2_RAT","POU domain, class 4, transcription factor 2 (Brain-specific homeobox/POU domain protein 3B) (Brain-3B) (Brn-3B) (Brn-3.2)","Pou4f2 Brn3b","Rattus norvegicus (Rat)",412,"GO:0000122; GO:0000165; GO:0000791; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0002039; GO:0003682; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0007283; GO:0007409; GO:0007411; GO:0007507; GO:0007605; GO:0010468; GO:0010666; GO:0016607; GO:0030182; GO:0030520; GO:0031290; GO:0032869; GO:0043068; GO:0043433; GO:0043565; GO:0045596; GO:0045597; GO:0045672; GO:0045773; GO:0045944; GO:0046326; GO:0048675; GO:0050885; GO:0051090; GO:0060041; GO:0071345; GO:0071392; GO:0071453; GO:0072332; GO:0090259; GO:1902870; GO:1904178; GO:1990791; GO:1990841; GO:2000679","axon extension [GO:0048675]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to cytokine stimulus [GO:0071345]; cellular response to estradiol stimulus [GO:0071392]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxygen levels [GO:0071453]; dorsal root ganglion development [GO:1990791]; estrogen receptor signaling pathway [GO:0030520]; heart development [GO:0007507]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; MAPK cascade [GO:0000165]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of cell differentiation [GO:0045596]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell differentiation [GO:0045597]; positive regulation of D-glucose import [GO:0046326]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gene expression [GO:0010468]; regulation of retinal ganglion cell axon guidance [GO:0090259]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to cytokine stimulus [GO:0071345]; cellular response to estradiol stimulus [GO:0071392]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxygen levels [GO:0071453]; dorsal root ganglion development [GO:1990791]; estrogen receptor signaling pathway [GO:0030520]; heart development [GO:0007507]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; MAPK cascade [GO:0000165]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of cell differentiation [GO:0045596]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell differentiation [GO:0045597]; positive regulation of D-glucose import [GO:0046326]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gene expression [GO:0010468]; regulation of retinal ganglion cell axon guidance [GO:0090259]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in the heart, brain and spinal cord (PubMed:18368538, PubMed:8835784). Expressed in cardiomyocytes (at protein level) (PubMed:18368538). Expressed in brain and spinal cord (PubMed:18368538, PubMed:8835784). Expressed in dorsal root ganglion (RGD) neurons (PubMed:8835784). {ECO:0000269|PubMed:18368538, ECO:0000269|PubMed:8835784}."
"140","sp|P17210|KINH_DROME","lcl|NC_088854.1_cds_XP_034299955.1_4707",2.72e-85,291,"P17210","KINH_DROME","Kinesin heavy chain","Khc kin CG7765","Drosophila melanogaster (Fruit fly)",975,"GO:0001754; GO:0003774; GO:0003777; GO:0005523; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0007097; GO:0007300; GO:0007310; GO:0007315; GO:0007317; GO:0007409; GO:0007411; GO:0007526; GO:0008017; GO:0008088; GO:0008103; GO:0008345; GO:0008574; GO:0010970; GO:0016887; GO:0030478; GO:0032839; GO:0035371; GO:0035617; GO:0045451; GO:0046785; GO:0046843; GO:0048311; GO:0048312; GO:0048489; GO:0048813; GO:0051012; GO:0051299; GO:0061572; GO:0098937; GO:0098957; GO:0098971; GO:1904115","actin filament bundle organization [GO:0061572]; anterograde axonal transport of mitochondrion [GO:0098957]; anterograde dendritic transport [GO:0098937]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axo-dendritic transport [GO:0008088]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; centrosome separation [GO:0051299]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; eye photoreceptor cell differentiation [GO:0001754]; intracellular distribution of mitochondria [GO:0048312]; larval locomotory behavior [GO:0008345]; larval somatic muscle development [GO:0007526]; microtubule polymerization [GO:0046785]; microtubule sliding [GO:0051012]; microtubule-based movement [GO:0007018]; mitochondrion distribution [GO:0048311]; nuclear migration [GO:0007097]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; regulation of pole plasm oskar mRNA localization [GO:0007317]; stress granule disassembly [GO:0035617]; synaptic vesicle transport [GO:0048489]; transport along microtubule [GO:0010970]","actin cap [GO:0030478]; axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; tropomyosin binding [GO:0005523]; actin filament bundle organization [GO:0061572]; anterograde axonal transport of mitochondrion [GO:0098957]; anterograde dendritic transport [GO:0098937]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axo-dendritic transport [GO:0008088]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; centrosome separation [GO:0051299]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; eye photoreceptor cell differentiation [GO:0001754]; intracellular distribution of mitochondria [GO:0048312]; larval locomotory behavior [GO:0008345]; larval somatic muscle development [GO:0007526]; microtubule polymerization [GO:0046785]; microtubule sliding [GO:0051012]; microtubule-based movement [GO:0007018]; mitochondrion distribution [GO:0048311]; nuclear migration [GO:0007097]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; regulation of pole plasm oskar mRNA localization [GO:0007317]; stress granule disassembly [GO:0035617]; synaptic vesicle transport [GO:0048489]; transport along microtubule [GO:0010970]","","","",""
"141","sp|Q8LNZ2|KN7B_ARATH","lcl|NC_088854.1_cds_XP_034299956.1_4706",3.29e-66,237,"Q8LNZ2","KN7B_ARATH","Kinesin-like protein KIN-7B (NPK1-activating kinesin-2) (AtNACK2) (Protein STUD) (Protein TETRASPORE)","KIN7B NACK2 STD TES At3g43210 F7K15.60","Arabidopsis thaliana (Mouse-ear cress)",938,"GO:0000911; GO:0003777; GO:0005524; GO:0005874; GO:0007018; GO:0007112; GO:0008017; GO:0009506; GO:0009524; GO:0009555; GO:0009558; GO:0010245; GO:0048229","cytokinesis by cell plate formation [GO:0000911]; embryo sac cellularization [GO:0009558]; gametophyte development [GO:0048229]; male meiosis cytokinesis [GO:0007112]; microtubule-based movement [GO:0007018]; pollen development [GO:0009555]; radial microtubular system formation [GO:0010245]","microtubule [GO:0005874]; phragmoplast [GO:0009524]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytokinesis by cell plate formation [GO:0000911]; embryo sac cellularization [GO:0009558]; gametophyte development [GO:0048229]; male meiosis cytokinesis [GO:0007112]; microtubule-based movement [GO:0007018]; pollen development [GO:0009555]; radial microtubular system formation [GO:0010245]","","","","TISSUE SPECIFICITY: Expressed in roots, stems, flowers, pollen mother cells and embryos. {ECO:0000269|PubMed:15569152}."
"142","sp|O17514|MES2_CAEEL","lcl|NC_088854.1_cds_XP_034300062.1_8168",1.71e-56,207,"O17514","MES2_CAEEL","Histone-lysine N-methyltransferase mes-2 (EC 2.1.1.356) (E(z) homolog) (Maternal-effect sterile protein 2)","mes-2 R06A4.7","Caenorhabditis elegans",773,"GO:0000786; GO:0003682; GO:0005634; GO:0006357; GO:0007276; GO:0007281; GO:0009888; GO:0010468; GO:0010629; GO:0031507; GO:0031519; GO:0032259; GO:0035098; GO:0040029; GO:0042054; GO:0042078; GO:0046976; GO:0140951","epigenetic regulation of gene expression [GO:0040029]; gamete generation [GO:0007276]; germ cell development [GO:0007281]; germ-line stem cell division [GO:0042078]; heterochromatin formation [GO:0031507]; methylation [GO:0032259]; negative regulation of gene expression [GO:0010629]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue development [GO:0009888]","ESC/E(Z) complex [GO:0035098]; nucleosome [GO:0000786]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; chromatin binding [GO:0003682]; histone H3K27 methyltransferase activity [GO:0046976]; histone H3K27 trimethyltransferase activity [GO:0140951]; histone methyltransferase activity [GO:0042054]; epigenetic regulation of gene expression [GO:0040029]; gamete generation [GO:0007276]; germ cell development [GO:0007281]; germ-line stem cell division [GO:0042078]; heterochromatin formation [GO:0031507]; methylation [GO:0032259]; negative regulation of gene expression [GO:0010629]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue development [GO:0009888]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. Expressed in all cells of early embryos. In late embryos and L1 larva, it is weakly expressed, while it is expressed at intermediate levels in the germline of L4 larvae. {ECO:0000269|PubMed:9609829}.","","","TISSUE SPECIFICITY: In adults, it is predominantly expressed in the germline, and weakly expressed in intestinal cells (PubMed:29702639, PubMed:9609829). Expressed in the hypoderm (PubMed:29702639). {ECO:0000269|PubMed:29702639, ECO:0000269|PubMed:9609829}."
"143","sp|Q64249|NR6A1_MOUSE","lcl|NC_088854.1_cds_XP_034300419.1_3951",1.05e-28,120,"Q64249","NR6A1_MOUSE","Nuclear receptor subfamily 6 group A member 1 (Germ cell nuclear factor) (GCNF) (mGCNF) (Retinoid receptor-related testis-specific receptor) (RTR)","Nr6a1 Gcnf","Mus musculus (Mouse)",495,"GO:0000122; GO:0000978; GO:0001217; GO:0001228; GO:0005634; GO:0005667; GO:0007276; GO:0007283; GO:0008270; GO:0030154; GO:0042803; GO:0043565; GO:0045944; GO:2000741","cell differentiation [GO:0030154]; gamete generation [GO:0007276]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]","nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity [GO:0001217]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; gamete generation [GO:0007276]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in the germ cells of both the adult testis and ovary, being most abundant in spermatids. {ECO:0000269|PubMed:7835709, ECO:0000269|PubMed:7854358}."
"144","sp|A0P8Z4|NR6A1_PIG","lcl|NC_088854.1_cds_XP_034300421.1_3953",1.12e-45,167,"A0P8Z4","NR6A1_PIG","Nuclear receptor subfamily 6 group A member 1 (Germ cell nuclear factor) (GCNF)","NR6A1 GCNF","Sus scrofa (Pig)",479,"GO:0000785; GO:0004879; GO:0005634; GO:0006357; GO:0007283; GO:0008270; GO:0030154; GO:0034056","cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","chromatin [GO:0000785]; nucleus [GO:0005634]; estrogen response element binding [GO:0034056]; nuclear receptor activity [GO:0004879]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","","","",""
"145","sp|Q5H9L4|TAF7L_HUMAN","lcl|NC_088854.1_cds_XP_034300766.2_5084",4.18e-47,166,"Q5H9L4","TAF7L_HUMAN","Transcription initiation factor TFIID subunit 7-like (Cancer/testis antigen 40) (CT40) (RNA polymerase II TBP-associated factor subunit Q) (TATA box-binding protein-associated factor 50 kDa) (Transcription initiation factor TFIID 50 kDa subunit)","TAF7L TAF2Q","Homo sapiens (Human)",462,"GO:0005669; GO:0005737; GO:0007283; GO:0030154; GO:0051123","cell differentiation [GO:0030154]; RNA polymerase II preinitiation complex assembly [GO:0051123]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; transcription factor TFIID complex [GO:0005669]; cell differentiation [GO:0030154]; RNA polymerase II preinitiation complex assembly [GO:0051123]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Testis-specific. {ECO:0000269|PubMed:11279525}."
"146","sp|Q0P557|MIEAP_MOUSE","lcl|NC_088854.1_cds_XP_034300877.1_9440",4.15e-89,284,"Q0P557","MIEAP_MOUSE","Mitochondria-eating protein (Spermatogenesis-associated protein 18)","Spata18 Mieap","Mus musculus (Mouse)",537,"GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005759; GO:0005829; GO:0035694; GO:0035695; GO:0042802; GO:0043231; GO:0043232; GO:0140693; GO:1900210; GO:1901612","mitochondrial protein catabolic process [GO:0035694]; mitophagy by internal vacuole formation [GO:0035695]; positive regulation of cardiolipin metabolic process [GO:1900210]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; intracellular membraneless organelle [GO:0043232]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; cardiolipin binding [GO:1901612]; identical protein binding [GO:0042802]; molecular condensate scaffold activity [GO:0140693]; mitochondrial protein catabolic process [GO:0035694]; mitophagy by internal vacuole formation [GO:0035695]; positive regulation of cardiolipin metabolic process [GO:1900210]","","INDUCTION: By p53/TP53 and p63/TP63. Directly activated by p53/TP53. {ECO:0000269|PubMed:21300779}.","INDUCTION: By p53/TP53 and p63/TP63. Directly activated by p53/TP53. {ECO:0000269|PubMed:21300779}.","TISSUE SPECIFICITY: In testis, expressed primarily in spermatids. {ECO:0000269|PubMed:21300779}."
"147","sp|Q6AYL6|MIEAP_RAT","lcl|NC_088854.1_cds_XP_034300879.1_9441",2.92e-60,208,"Q6AYL6","MIEAP_RAT","Mitochondria-eating protein (Spermatid-expressing gene 1 protein) (Spetex-1) (Spermatogenesis-associated protein 18)","Spata18 Mieap Spetex1","Rattus norvegicus (Rat)",556,"GO:0005737; GO:0005739; GO:0005741; GO:0005759; GO:0005829; GO:0007283; GO:0035694; GO:0035695; GO:0036126; GO:0042802; GO:0043231; GO:0043232; GO:0140693; GO:1900210; GO:1901612","mitochondrial protein catabolic process [GO:0035694]; mitophagy by internal vacuole formation [GO:0035695]; positive regulation of cardiolipin metabolic process [GO:1900210]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; intracellular membraneless organelle [GO:0043232]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; sperm flagellum [GO:0036126]; cardiolipin binding [GO:1901612]; identical protein binding [GO:0042802]; molecular condensate scaffold activity [GO:0140693]; mitochondrial protein catabolic process [GO:0035694]; mitophagy by internal vacuole formation [GO:0035695]; positive regulation of cardiolipin metabolic process [GO:1900210]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed at late stages of spermatogenesis, from late to maturing spermatids. {ECO:0000269|PubMed:15236321}.","","","TISSUE SPECIFICITY: High expressed in testis and weakly expressed in lung, intestine, and spleen. Not expressed in spermatogonia, spermatocytes, and round spematids in adult testis but specifically detected in elongated spermatids. {ECO:0000269|PubMed:15236321}."
"148","sp|Q04671|P_HUMAN","lcl|NC_088854.1_cds_XP_034301113.2_8837",4.19e-154,470,"Q04671","P_HUMAN","P protein (Melanocyte-specific transporter protein) (Pink-eyed dilution protein homolog)","OCA2 D15S12 P","Homo sapiens (Human)",838,"GO:0005254; GO:0005765; GO:0005789; GO:0006583; GO:0007286; GO:0008283; GO:0010008; GO:0030318; GO:0033162; GO:0035752; GO:0042438","cell population proliferation [GO:0008283]; lysosomal lumen pH elevation [GO:0035752]; melanin biosynthetic process [GO:0042438]; melanin biosynthetic process from tyrosine [GO:0006583]; melanocyte differentiation [GO:0030318]; spermatid development [GO:0007286]","endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; melanosome membrane [GO:0033162]; chloride channel activity [GO:0005254]; cell population proliferation [GO:0008283]; lysosomal lumen pH elevation [GO:0035752]; melanin biosynthetic process [GO:0042438]; melanin biosynthetic process from tyrosine [GO:0006583]; melanocyte differentiation [GO:0030318]; spermatid development [GO:0007286]","DEVELOPMENTAL STAGE: Expressed at early stages of melanosome differentiation. {ECO:0000269|PubMed:32966160}.","INDUCTION: Expression is under the control of an enhancer element that is encoded in an intron of the close-by HERC2 gene. The enhancer element containing the T-allele of the polymorphism rs12913832 mediates binding of the transcription factors HLTF, LEF1 and MITF and increases OCA2 expression. In contrast, transcription factor binding and OCA2 expression are reduced in carriers of the C-allele of polymorphism rs12913832. Thus, people homozygous for the C-allele have light-colored eyes, while people homozygous for the T-allele of polymorphism rs12913832 most often have brown eyes. {ECO:0000269|PubMed:18172690, ECO:0000269|PubMed:18252222, ECO:0000269|PubMed:22234890}.","INDUCTION: Expression is under the control of an enhancer element that is encoded in an intron of the close-by HERC2 gene. The enhancer element containing the T-allele of the polymorphism rs12913832 mediates binding of the transcription factors HLTF, LEF1 and MITF and increases OCA2 expression. In contrast, transcription factor binding and OCA2 expression are reduced in carriers of the C-allele of polymorphism rs12913832. Thus, people homozygous for the C-allele have light-colored eyes, while people homozygous for the T-allele of polymorphism rs12913832 most often have brown eyes. {ECO:0000269|PubMed:18172690, ECO:0000269|PubMed:18252222, ECO:0000269|PubMed:22234890}.","TISSUE SPECIFICITY: Expressed in melanocytes and retinal pigment epithelium. {ECO:0000269|PubMed:25513726, ECO:0000269|PubMed:32966160}."
"149","sp|Q01320|TOP2A_MOUSE","lcl|NC_088854.1_cds_XP_034301282.2_9054",0,1739,"Q01320","TOP2A_MOUSE","DNA topoisomerase 2-alpha (EC 5.6.2.2) (DNA topoisomerase II, alpha isozyme)","Top2a Top-2 Top2","Mus musculus (Mouse)",1528,"GO:0000228; GO:0000287; GO:0000775; GO:0000793; GO:0001673; GO:0002244; GO:0003682; GO:0003918; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005814; GO:0006265; GO:0006325; GO:0006974; GO:0007059; GO:0007143; GO:0008301; GO:0009330; GO:0030261; GO:0030263; GO:0040016; GO:0042752; GO:0042803; GO:0043065; GO:0043130; GO:0045870; GO:0045944; GO:0046982; GO:0048511; GO:0051309; GO:1990904","apoptotic chromosome condensation [GO:0030263]; chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiosis chromosome separation [GO:0051309]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]","centriole [GO:0005814]; chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; male germ cell nucleus [GO:0001673]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding, bending [GO:0008301]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; ubiquitin binding [GO:0043130]; apoptotic chromosome condensation [GO:0030263]; chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiosis chromosome separation [GO:0051309]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]","","","",""
"150","sp|P17955|NUP62_RAT","lcl|NC_088854.1_cds_XP_034301287.2_9063",1.16e-72,239,"P17955","NUP62_RAT","Nuclear pore glycoprotein p62 (62 kDa nucleoporin) (Nucleoporin Nup62)","Nup62","Rattus norvegicus (Rat)",525,"GO:0000922; GO:0005543; GO:0005635; GO:0005642; GO:0005643; GO:0005737; GO:0005813; GO:0006405; GO:0006606; GO:0007080; GO:0007098; GO:0007100; GO:0007166; GO:0007283; GO:0008285; GO:0017056; GO:0019894; GO:0030159; GO:0030544; GO:0031965; GO:0032991; GO:0042059; GO:0042169; GO:0042306; GO:0043066; GO:0043069; GO:0043123; GO:0043130; GO:0044613; GO:0044877; GO:0045840; GO:0045893; GO:0046580; GO:0046601; GO:0046966; GO:0051028; GO:0051425; GO:0051879; GO:0060236; GO:0072686; GO:0090398; GO:0090543; GO:0098534; GO:1903438; GO:1904781; GO:1990904","cell surface receptor signaling pathway [GO:0007166]; cellular senescence [GO:0090398]; centriole assembly [GO:0098534]; centrosome cycle [GO:0007098]; mitotic centrosome separation [GO:0007100]; mitotic metaphase chromosome alignment [GO:0007080]; mRNA transport [GO:0051028]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of programmed cell death [GO:0043069]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of centriole replication [GO:0046601]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of protein localization to centrosome [GO:1904781]; protein import into nucleus [GO:0006606]; regulation of mitotic spindle organization [GO:0060236]; regulation of protein import into nucleus [GO:0042306]; RNA export from nucleus [GO:0006405]; spermatogenesis [GO:0007283]","annulate lamellae [GO:0005642]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; spindle pole [GO:0000922]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinesin binding [GO:0019894]; nuclear thyroid hormone receptor binding [GO:0046966]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; PTB domain binding [GO:0051425]; SH2 domain binding [GO:0042169]; signaling receptor complex adaptor activity [GO:0030159]; structural constituent of nuclear pore [GO:0017056]; ubiquitin binding [GO:0043130]; cell surface receptor signaling pathway [GO:0007166]; cellular senescence [GO:0090398]; centriole assembly [GO:0098534]; centrosome cycle [GO:0007098]; mitotic centrosome separation [GO:0007100]; mitotic metaphase chromosome alignment [GO:0007080]; mRNA transport [GO:0051028]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of programmed cell death [GO:0043069]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of centriole replication [GO:0046601]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of protein localization to centrosome [GO:1904781]; protein import into nucleus [GO:0006606]; regulation of mitotic spindle organization [GO:0060236]; regulation of protein import into nucleus [GO:0042306]; RNA export from nucleus [GO:0006405]; spermatogenesis [GO:0007283]","","","",""
"151","sp|G5ECD6|CHS1_CAEEL","lcl|NC_088854.1_cds_XP_034301296.2_9075",7.79e-180,578,"G5ECD6","CHS1_CAEEL","Chitin synthase chs-1 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-1)","chs-1 T25G3.2","Caenorhabditis elegans",1322,"GO:0004100; GO:0005886; GO:0005938; GO:0006031; GO:0030703; GO:1904778","chitin biosynthetic process [GO:0006031]; eggshell formation [GO:0030703]; positive regulation of protein localization to cell cortex [GO:1904778]","cell cortex [GO:0005938]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; eggshell formation [GO:0030703]; positive regulation of protein localization to cell cortex [GO:1904778]","DEVELOPMENTAL STAGE: Expressed at L3-L4 larval stages and in adults. {ECO:0000269|PubMed:11589574}.","","",""
"152","sp|Q9VF87|CYFIP_DROME","lcl|NC_088854.1_cds_XP_034301365.2_9170",0,1839,"Q9VF87","CYFIP_DROME","Cytoplasmic FMR1-interacting protein (Specifically Rac1-associated protein 1)","Cyfip Sra-1 CG4931","Drosophila melanogaster (Fruit fly)",1291,"GO:0000340; GO:0000902; GO:0001745; GO:0005737; GO:0006417; GO:0007411; GO:0008360; GO:0022416; GO:0030031; GO:0030833; GO:0030866; GO:0031209; GO:0031267; GO:0033627; GO:0034315; GO:0043005; GO:0045177; GO:0045202; GO:0050807; GO:0051491; GO:0060269","axon guidance [GO:0007411]; cell adhesion mediated by integrin [GO:0033627]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; centripetally migrating follicle cell migration [GO:0060269]; chaeta development [GO:0022416]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin filament polymerization [GO:0030833]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]; regulation of translation [GO:0006417]","apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; SCAR complex [GO:0031209]; synapse [GO:0045202]; RNA 7-methylguanosine cap binding [GO:0000340]; small GTPase binding [GO:0031267]; axon guidance [GO:0007411]; cell adhesion mediated by integrin [GO:0033627]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; centripetally migrating follicle cell migration [GO:0060269]; chaeta development [GO:0022416]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin filament polymerization [GO:0030833]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]; regulation of translation [GO:0006417]","DEVELOPMENTAL STAGE: Expressed throughout the life cycle with no major peaks of expression. In the embryo, uniquitously and highly expressed at precellular and cellular blastoderm stages. {ECO:0000269|PubMed:12818175}.","","","TISSUE SPECIFICITY: In the embryo, expressed mainly in the gut and in the developing central nervous system where high levels of expression are found in the CNS neuropile. Expression in the gut diminishes as development proceeds (at protein level). In the adult, expressed specifically in the nervous system. {ECO:0000269|PubMed:12818175, ECO:0000269|PubMed:15269173}."
"153","sp|Q58F21|BRDT_HUMAN","lcl|NC_088854.1_cds_XP_034301489.2_10223",1.88e-104,354,"Q58F21","BRDT_HUMAN","Bromodomain testis-specific protein (Cancer/testis antigen 9) (CT9) (RING3-like protein)","BRDT","Homo sapiens (Human)",947,"GO:0000785; GO:0003682; GO:0003713; GO:0004674; GO:0005634; GO:0006338; GO:0006355; GO:0006357; GO:0006397; GO:0007140; GO:0007141; GO:0008380; GO:0010628; GO:0035092; GO:0042393; GO:0043484; GO:0070577; GO:0140008","chromatin remodeling [GO:0006338]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; mRNA processing [GO:0006397]; positive regulation of gene expression [GO:0010628]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]; sperm DNA condensation [GO:0035092]","chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone H4 reader activity [GO:0140008]; lysine-acetylated histone binding [GO:0070577]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; mRNA processing [GO:0006397]; positive regulation of gene expression [GO:0010628]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]; sperm DNA condensation [GO:0035092]","DEVELOPMENTAL STAGE: Expressed in embryo testis.","","","TISSUE SPECIFICITY: Testis-specific. A 3-fold higher expression is seen in adult testis than in embryo testis. Expression seems to be correlated with histone H4 hyperacetylation during the haploid phase of spermatogenesis (spermiogenesis). No expression, or very low expression is seen in patients' testes with abnormal spermatogenesis. Expressed in cancers such as non-small cell lung cancer and squamous cell carcinomas of the head and neck as well as of esophagus, but not in melanoma or in cancers of the colon, breast, kidney and bladder. {ECO:0000269|PubMed:10704737, ECO:0000269|PubMed:15647849, ECO:0000269|PubMed:9367677}."
"154","sp|P25440|BRD2_HUMAN","lcl|NC_088854.1_cds_XP_034301490.2_10222",2.15e-118,388,"P25440","BRD2_HUMAN","Bromodomain-containing protein 2 (O27.1.1)","BRD2 KIAA9001 RING3","Homo sapiens (Human)",801,"GO:0000785; GO:0001843; GO:0003682; GO:0004674; GO:0005634; GO:0005654; GO:0005737; GO:0006334; GO:0006338; GO:0006357; GO:0007283; GO:0016607; GO:0042393; GO:0071168; GO:0140011; GO:0140012; GO:0140015; GO:0140033; GO:0140588; GO:2000330","chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; neural tube closure [GO:0001843]; nucleosome assembly [GO:0006334]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; protein localization to chromatin [GO:0071168]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acetylation-dependent protein binding [GO:0140033]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone H3K14ac reader activity [GO:0140015]; histone H4K12ac reader activity [GO:0140011]; histone H4K5ac reader activity [GO:0140012]; protein serine/threonine kinase activity [GO:0004674]; chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; neural tube closure [GO:0001843]; nucleosome assembly [GO:0006334]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; protein localization to chromatin [GO:0071168]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","","","",""
"155","sp|Q93847|WDR52_CAEEL","lcl|NC_088854.1_cds_XP_034301501.2_10231",3.19e-138,399,"Q93847","WDR52_CAEEL","WD repeat-containing protein wdr-5.2","wdr-5.2 swd-3.2 K04G11.4","Caenorhabditis elegans",395,"GO:0000132; GO:0000776; GO:0005635; GO:0005875; GO:0005881; GO:0007097; GO:0007281; GO:0008090; GO:0031023; GO:0043005; GO:0043025; GO:0047496; GO:0048854; GO:0051010; GO:0070840; GO:1904115; GO:1990234","brain morphogenesis [GO:0048854]; establishment of mitotic spindle orientation [GO:0000132]; germ cell development [GO:0007281]; microtubule organizing center organization [GO:0031023]; nuclear migration [GO:0007097]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496]","axon cytoplasm [GO:1904115]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; transferase complex [GO:1990234]; dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010]; brain morphogenesis [GO:0048854]; establishment of mitotic spindle orientation [GO:0000132]; germ cell development [GO:0007281]; microtubule organizing center organization [GO:0031023]; nuclear migration [GO:0007097]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496]","","","",""
"156","sp|Q8CJ27|ASPM_MOUSE","lcl|NC_088854.1_cds_XP_034301567.2_6789",0,1168,"Q8CJ27","ASPM_MOUSE","Abnormal spindle-like microcephaly-associated protein homolog (Calmodulin-binding protein Sha1) (Calmodulin-binding protein 1) (Spindle and hydroxyurea checkpoint abnormal protein)","Aspm Calmbp1 Sha1","Mus musculus (Mouse)",3122,"GO:0000922; GO:0001764; GO:0002052; GO:0005516; GO:0005634; GO:0005737; GO:0005813; GO:0005874; GO:0007283; GO:0007405; GO:0007420; GO:0008356; GO:0008584; GO:0016324; GO:0021873; GO:0021987; GO:0030496; GO:0036449; GO:0045665; GO:0045769; GO:0048477; GO:0048589; GO:0051445; GO:0051653; GO:0051661; GO:0072687; GO:0090263; GO:0090306; GO:0097150; GO:0097431","asymmetric cell division [GO:0008356]; brain development [GO:0007420]; cerebral cortex development [GO:0021987]; developmental growth [GO:0048589]; forebrain neuroblast division [GO:0021873]; maintenance of centrosome location [GO:0051661]; male gonad development [GO:0008584]; meiotic spindle assembly [GO:0090306]; negative regulation of asymmetric cell division [GO:0045769]; negative regulation of neuron differentiation [GO:0045665]; neuroblast proliferation [GO:0007405]; neuron migration [GO:0001764]; neuronal stem cell population maintenance [GO:0097150]; oogenesis [GO:0048477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of meiotic cell cycle [GO:0051445]; spermatogenesis [GO:0007283]; spindle localization [GO:0051653]","apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; spindle pole [GO:0000922]; calmodulin binding [GO:0005516]; asymmetric cell division [GO:0008356]; brain development [GO:0007420]; cerebral cortex development [GO:0021987]; developmental growth [GO:0048589]; forebrain neuroblast division [GO:0021873]; maintenance of centrosome location [GO:0051661]; male gonad development [GO:0008584]; meiotic spindle assembly [GO:0090306]; negative regulation of asymmetric cell division [GO:0045769]; negative regulation of neuron differentiation [GO:0045665]; neuroblast proliferation [GO:0007405]; neuron migration [GO:0001764]; neuronal stem cell population maintenance [GO:0097150]; oogenesis [GO:0048477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of meiotic cell cycle [GO:0051445]; spermatogenesis [GO:0007283]; spindle localization [GO:0051653]","DEVELOPMENTAL STAGE: Expressed during cerebral cortical neurogenesis, specifically in the cerebral cortical ventricular zone at 14.5 dpc and 16.5 dpc. Expression is greatly reduced by the day of birth (P0), when neurogenesis in the cortical ventricular zone is completed and gliogenesis is increased. Expression is limited to rare scattered cells in the neocortex by postnatal day 9 (P9). {ECO:0000269|PubMed:12355089}.","","","TISSUE SPECIFICITY: Expressed in fetal brain, peripheral nervous system, liver and spleen. In the adult, expressed exclusively in testis, ovary and spleen. {ECO:0000269|PubMed:12351193, ECO:0000269|PubMed:12355089}."
"157","sp|Q8VIG3|RSPH1_MOUSE","lcl|NC_088854.1_cds_XP_034301768.2_7884",6.75e-88,266,"Q8VIG3","RSPH1_MOUSE","Radial spoke head 1 homolog (Male meiotic metaphase chromosome-associated acidic protein) (Meichroacidin) (Testis-specific gene A2 protein)","Rsph1 Tsga2","Mus musculus (Mouse)",301,"GO:0000794; GO:0001520; GO:0001534; GO:0001535; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007286; GO:0007618; GO:0030317; GO:0031514; GO:0035082; GO:0036126; GO:0051321; GO:0072687; GO:0097729; GO:0120336; GO:0120338","axoneme assembly [GO:0035082]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286]","9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 3 [GO:0120338]; sperm flagellum [GO:0036126]; axoneme assembly [GO:0035082]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286]","DEVELOPMENTAL STAGE: During male germ cell development it is not detected until 12 days. Significant expression is detected from 14-day-old through to adult testis. Expression is first detected in the pachytene spermatocytes at stage V, becomes stronger from the late pachytene spermatocytes to round spermatid stage, and then gradually decreases as the morphogenesis proceeds further. Not expressed in germ cells located in the first layer of the seminiferous epithelium (spermatogonia, leptotene and zygotene spermatocytes). {ECO:0000269|PubMed:9578619}.","","","TISSUE SPECIFICITY: Expressed in the trachea, ependymal cells, oviduct and ependymal cells (at protein level) (PubMed:32203505, PubMed:34871179). Germ cell specific. Specifically expressed in testis, and to a lower extent in ovary. Not expressed in somatic tissues (PubMed:9578619). {ECO:0000269|PubMed:32203505, ECO:0000269|PubMed:34871179, ECO:0000269|PubMed:9578619}."
"158","sp|Q9BXU7|UBP26_HUMAN","lcl|NC_088854.1_cds_XP_034302215.2_7493",3.83e-47,184,"Q9BXU7","UBP26_HUMAN","Ubiquitin carboxyl-terminal hydrolase 26 (EC 3.4.19.12) (Deubiquitinating enzyme 26) (Ubiquitin thioesterase 26) (Ubiquitin-specific-processing protease 26)","USP26","Homo sapiens (Human)",913,"GO:0000082; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0006508; GO:0007283; GO:0016579; GO:0031647; GO:0032435; GO:0036126; GO:0060765; GO:0101005; GO:1990380","G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of protein stability [GO:0031647]; spermatogenesis [GO:0007283]","cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; cysteine-type deubiquitinase activity [GO:0004843]; deubiquitinase activity [GO:0101005]; K48-linked deubiquitinase activity [GO:1990380]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of protein stability [GO:0031647]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in testis. {ECO:0000269|PubMed:34202084}."
"159","sp|Q99MX1|UBP26_MOUSE","lcl|NC_088854.1_cds_XP_034302216.2_7490",1.8e-35,146,"Q99MX1","UBP26_MOUSE","Ubiquitin carboxyl-terminal hydrolase 26 (EC 3.4.19.12) (Deubiquitinating enzyme 26) (Ubiquitin thioesterase 26) (Ubiquitin-specific-processing protease 26)","Usp26","Mus musculus (Mouse)",835,"GO:0004843; GO:0005634; GO:0005737; GO:0005856; GO:0006508; GO:0007283; GO:0016579; GO:0031514; GO:0032435; GO:0060765; GO:1990380","negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of androgen receptor signaling pathway [GO:0060765]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; K48-linked deubiquitinase activity [GO:1990380]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of androgen receptor signaling pathway [GO:0060765]; spermatogenesis [GO:0007283]","","","",""
"160","sp|O18388|IMB_DROME","lcl|NC_088854.1_cds_XP_034302242.1_7548",0,1116,"O18388","IMB_DROME","Importin subunit beta (Karyopherin subunit beta) (Protein ketel)","Fs(2)Ket CG2637","Drosophila melanogaster (Fruit fly)",884,"GO:0000278; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0006606; GO:0006607; GO:0007304; GO:0008139; GO:0031267; GO:0043186; GO:0046822; GO:0061608","chorion-containing eggshell formation [GO:0007304]; mitotic cell cycle [GO:0000278]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; regulation of nucleocytoplasmic transport [GO:0046822]","cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; small GTPase binding [GO:0031267]; chorion-containing eggshell formation [GO:0007304]; mitotic cell cycle [GO:0000278]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; regulation of nucleocytoplasmic transport [GO:0046822]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. {ECO:0000269|PubMed:11102382}.","","","TISSUE SPECIFICITY: Ubiquitously expressed in embryos. {ECO:0000269|PubMed:11102382}."
"161","sp|Q9Z148|EHMT2_MOUSE","lcl|NC_088854.1_cds_XP_034302578.2_5927",0,755,"Q9Z148","EHMT2_MOUSE","Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.367) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a)","Ehmt2 Bat8 G9a Ng36","Mus musculus (Mouse)",1263,"GO:0000122; GO:0000785; GO:0000977; GO:0001222; GO:0002039; GO:0005634; GO:0005654; GO:0006275; GO:0006346; GO:0006357; GO:0007130; GO:0007286; GO:0008270; GO:0009267; GO:0009566; GO:0016279; GO:0016607; GO:0018027; GO:0035265; GO:0036166; GO:0044027; GO:0046974; GO:0046976; GO:0048148; GO:0048599; GO:0048665; GO:0070742; GO:0071314; GO:0140759; GO:0140947; GO:1902902; GO:1990841","behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; cellular response to starvation [GO:0009267]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; fertilization [GO:0009566]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; oocyte development [GO:0048599]; organ growth [GO:0035265]; peptidyl-lysine dimethylation [GO:0018027]; phenotypic switching [GO:0036166]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130]","chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; histone H3K27 methyltransferase activity [GO:0046976]; histone H3K56 methyltransferase activity [GO:0140759]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9me2 methyltransferase activity [GO:0140947]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270]; behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; cellular response to starvation [GO:0009267]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; fertilization [GO:0009566]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; oocyte development [GO:0048599]; organ growth [GO:0035265]; peptidyl-lysine dimethylation [GO:0018027]; phenotypic switching [GO:0036166]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130]","","","","TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:15774718}."
"162","sp|P41220|RGS2_HUMAN","lcl|NC_088854.1_cds_XP_034302596.2_5982",1.1e-41,145,"P41220","RGS2_HUMAN","Regulator of G-protein signaling 2 (RGS2) (Cell growth-inhibiting gene 31 protein) (G0/G1 switch regulatory protein 8)","RGS2 G0S8 GIG31","Homo sapiens (Human)",211,"GO:0001965; GO:0001975; GO:0003924; GO:0005096; GO:0005516; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0007186; GO:0007283; GO:0008277; GO:0009898; GO:0010614; GO:0010855; GO:0010976; GO:0017148; GO:0045471; GO:0045744; GO:0046329; GO:0048487; GO:0050873; GO:0055119; GO:0060087; GO:0060135; GO:0060452; GO:0061052; GO:0071877; GO:1900738; GO:1900924","brown fat cell differentiation [GO:0050873]; G protein-coupled receptor signaling pathway [GO:0007186]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glycine import across plasma membrane [GO:1900924]; negative regulation of JNK cascade [GO:0046329]; negative regulation of translation [GO:0017148]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071877]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; relaxation of cardiac muscle [GO:0055119]; relaxation of vascular associated smooth muscle [GO:0060087]; response to amphetamine [GO:0001975]; response to ethanol [GO:0045471]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenylate cyclase inhibitor activity [GO:0010855]; beta-tubulin binding [GO:0048487]; calmodulin binding [GO:0005516]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; brown fat cell differentiation [GO:0050873]; G protein-coupled receptor signaling pathway [GO:0007186]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glycine import across plasma membrane [GO:1900924]; negative regulation of JNK cascade [GO:0046329]; negative regulation of translation [GO:0017148]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071877]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; relaxation of cardiac muscle [GO:0055119]; relaxation of vascular associated smooth muscle [GO:0060087]; response to amphetamine [GO:0001975]; response to ethanol [GO:0045471]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in acute myelogenous leukemia (AML) and in acute lymphoblastic leukemia (ALL). {ECO:0000269|PubMed:7643615}."
"163","sp|Q8TB22|SPT20_HUMAN","lcl|NC_088854.1_cds_XP_034302609.2_5994",0,746,"Q8TB22","SPT20_HUMAN","Spermatogenesis-associated protein 20 (Sperm-specific protein 411) (Ssp411)","SPATA20","Homo sapiens (Human)",786,"GO:0005576; GO:0005739; GO:0005975; GO:0007283; GO:0030154","carbohydrate metabolic process [GO:0005975]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","extracellular region [GO:0005576]; mitochondrion [GO:0005739]; carbohydrate metabolic process [GO:0005975]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","","","",""
"164","sp|Q0VFN8|CF157_XENTR","lcl|NC_088854.1_cds_XP_034302654.1_6061",8.82e-88,281,"Q0VFN8","CF157_XENTR","Cilia- and flagella-associated protein 157","cfap157","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)",519,"GO:0005737; GO:0007288; GO:0008017; GO:0036064","sperm axoneme assembly [GO:0007288]","ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule binding [GO:0008017]; sperm axoneme assembly [GO:0007288]","","","",""
"165","sp|Q32KU2|PRS37_BOVIN","lcl|NC_088854.1_cds_XP_034302754.2_10857",5.44e-14,70.9,"Q32KU2","PRS37_BOVIN","Probable inactive serine protease 37 (Probable inactive trypsin-X2)","PRSS37 TRYX2","Bos taurus (Bovine)",235,"GO:0001669; GO:0005615; GO:0006508; GO:0007339; GO:0008354; GO:0016477; GO:0051604; GO:0070613; GO:1905516; GO:2000344","binding of sperm to zona pellucida [GO:0007339]; cell migration [GO:0016477]; germ cell migration [GO:0008354]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of fertilization [GO:1905516]; protein maturation [GO:0051604]; proteolysis [GO:0006508]; regulation of protein processing [GO:0070613]","acrosomal vesicle [GO:0001669]; extracellular space [GO:0005615]; binding of sperm to zona pellucida [GO:0007339]; cell migration [GO:0016477]; germ cell migration [GO:0008354]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of fertilization [GO:1905516]; protein maturation [GO:0051604]; proteolysis [GO:0006508]; regulation of protein processing [GO:0070613]","","","",""
"166","sp|P27731|TTHY_CHICK","lcl|NC_088854.1_cds_XP_034302776.1_6995",6.26e-14,65.5,"P27731","TTHY_CHICK","Transthyretin (Prealbumin) (TBPA)","TTR","Gallus gallus (Chicken)",150,"GO:0001555; GO:0005179; GO:0005615; GO:0009615; GO:0019904; GO:0030136; GO:0032991; GO:0036094; GO:0042562; GO:0042572; GO:0046982; GO:0051262; GO:0060417; GO:0065003; GO:0070324; GO:0070327","oocyte growth [GO:0001555]; protein tetramerization [GO:0051262]; protein-containing complex assembly [GO:0065003]; response to virus [GO:0009615]; retinol metabolic process [GO:0042572]; thyroid hormone transport [GO:0070327]","clathrin-coated vesicle [GO:0030136]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; yolk [GO:0060417]; hormone activity [GO:0005179]; hormone binding [GO:0042562]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; small molecule binding [GO:0036094]; thyroid hormone binding [GO:0070324]; oocyte growth [GO:0001555]; protein tetramerization [GO:0051262]; protein-containing complex assembly [GO:0065003]; response to virus [GO:0009615]; retinol metabolic process [GO:0042572]; thyroid hormone transport [GO:0070327]","","","","TISSUE SPECIFICITY: Detected in serum (at protein level). Detected in liver and choroid plexus. {ECO:0000269|PubMed:1799976, ECO:0000269|PubMed:1833190, ECO:0000269|PubMed:8612621}."
"167","sp|Q9BKU4|PHB1_CAEEL","lcl|NC_088854.1_cds_XP_034302792.2_7583",3.39e-118,340,"Q9BKU4","PHB1_CAEEL","Mitochondrial prohibitin complex protein 1 (Prohibitin-1)","phb-1 Y37E3.9","Caenorhabditis elegans",275,"GO:0002082; GO:0005739; GO:0005743; GO:0006979; GO:0007005; GO:0007283; GO:0008406; GO:0009792; GO:0030421; GO:0031966; GO:0035632; GO:0040018; GO:0043051; GO:0048477; GO:0050821","defecation [GO:0030421]; embryo development ending in birth or egg hatching [GO:0009792]; gonad development [GO:0008406]; mitochondrion organization [GO:0007005]; oogenesis [GO:0048477]; positive regulation of multicellular organism growth [GO:0040018]; protein stabilization [GO:0050821]; regulation of nematode pharyngeal pumping [GO:0043051]; regulation of oxidative phosphorylation [GO:0002082]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]","mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial prohibitin complex [GO:0035632]; mitochondrion [GO:0005739]; defecation [GO:0030421]; embryo development ending in birth or egg hatching [GO:0009792]; gonad development [GO:0008406]; mitochondrion organization [GO:0007005]; oogenesis [GO:0048477]; positive regulation of multicellular organism growth [GO:0040018]; protein stabilization [GO:0050821]; regulation of nematode pharyngeal pumping [GO:0043051]; regulation of oxidative phosphorylation [GO:0002082]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]","","","",""
"168","sp|Q9V3A4|CSUP_DROME","lcl|NC_088854.1_cds_XP_034302986.2_4254",8.66e-51,181,"Q9V3A4","CSUP_DROME","Protein catecholamines up","Catsup CG10449","Drosophila melanogaster (Fruit fly)",449,"GO:0005385; GO:0005783; GO:0005789; GO:0006882; GO:0007300; GO:0008021; GO:0010312; GO:0030234; GO:0030424; GO:0042069; GO:0043025; GO:0045202; GO:0071577; GO:0097038; GO:1903688; GO:2000274","detoxification of zinc ion [GO:0010312]; intracellular zinc ion homeostasis [GO:0006882]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of border follicle cell migration [GO:1903688]; regulation of catecholamine metabolic process [GO:0042069]; regulation of epithelial cell migration, open tracheal system [GO:2000274]; zinc ion transmembrane transport [GO:0071577]","axon [GO:0030424]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025]; perinuclear endoplasmic reticulum [GO:0097038]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; enzyme regulator activity [GO:0030234]; zinc ion transmembrane transporter activity [GO:0005385]; detoxification of zinc ion [GO:0010312]; intracellular zinc ion homeostasis [GO:0006882]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of border follicle cell migration [GO:1903688]; regulation of catecholamine metabolic process [GO:0042069]; regulation of epithelial cell migration, open tracheal system [GO:2000274]; zinc ion transmembrane transport [GO:0071577]","","","",""
"169","sp|P51954|NEK1_MOUSE","lcl|NC_088854.1_cds_XP_034303189.2_9926",1.55e-171,546,"P51954","NEK1_MOUSE","Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1)","Nek1","Mus musculus (Mouse)",1203,"GO:0001822; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0006974; GO:0007283; GO:0010212; GO:0030030; GO:0035264; GO:0046872; GO:0051301; GO:0071889; GO:0106310; GO:2000001","cell division [GO:0051301]; cell projection organization [GO:0030030]; DNA damage response [GO:0006974]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; regulation of DNA damage checkpoint [GO:2000001]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283]","centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; cell division [GO:0051301]; cell projection organization [GO:0030030]; DNA damage response [GO:0006974]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; regulation of DNA damage checkpoint [GO:2000001]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: In female, expressed as follicles enter the secondary stage until ovulation occurs. In the male reproductive system, the expression is limited to spermatocytes and spermatids.","","","TISSUE SPECIFICITY: Predominantly in testes (germ cells and Sertoli cells). Lower levels in ovary (oocytes and granulosa cells), thymus and lung. {ECO:0000269|PubMed:1382974}."
"170","sp|P63146|UBE2B_HUMAN","lcl|NC_088854.1_cds_XP_034303345.1_8008",1.16e-98,281,"P63146","UBE2B_HUMAN","Ubiquitin-conjugating enzyme E2 B (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme B) (RAD6 homolog B) (HR6B) (hHR6B) (Ubiquitin carrier protein B) (Ubiquitin-conjugating enzyme E2-17 kDa) (Ubiquitin-protein ligase B)","UBE2B RAD6B UBCH1","Homo sapiens (Human)",152,"GO:0000209; GO:0000785; GO:0001701; GO:0001741; GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005886; GO:0006281; GO:0006301; GO:0006325; GO:0006511; GO:0006915; GO:0006974; GO:0007283; GO:0007288; GO:0009410; GO:0009411; GO:0010845; GO:0016567; GO:0031625; GO:0033503; GO:0035234; GO:0043066; GO:0043161; GO:0045141; GO:0050821; GO:0051026; GO:0051093; GO:0051865; GO:0061631; GO:0070193; GO:0070534; GO:0070936; GO:0070979; GO:0090263; GO:1901874; GO:2000242","apoptotic process [GO:0006915]; chiasma assembly [GO:0051026]; chromatin organization [GO:0006325]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; ectopic germ cell programmed cell death [GO:0035234]; in utero embryonic development [GO:0001701]; meiotic telomere clustering [GO:0045141]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of post-translational protein modification [GO:1901874]; negative regulation of reproductive process [GO:2000242]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of reciprocal meiotic recombination [GO:0010845]; postreplication repair [GO:0006301]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411]; response to xenobiotic stimulus [GO:0009410]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]; synaptonemal complex organization [GO:0070193]; ubiquitin-dependent protein catabolic process [GO:0006511]","chromatin [GO:0000785]; cytoplasm [GO:0005737]; HULC complex [GO:0033503]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; replication fork [GO:0005657]; XY body [GO:0001741]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; chiasma assembly [GO:0051026]; chromatin organization [GO:0006325]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; ectopic germ cell programmed cell death [GO:0035234]; in utero embryonic development [GO:0001701]; meiotic telomere clustering [GO:0045141]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of post-translational protein modification [GO:1901874]; negative regulation of reproductive process [GO:2000242]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of reciprocal meiotic recombination [GO:0010845]; postreplication repair [GO:0006301]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411]; response to xenobiotic stimulus [GO:0009410]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]; synaptonemal complex organization [GO:0070193]; ubiquitin-dependent protein catabolic process [GO:0006511]","","","",""
"171","sp|B1Q3J6|DNM1B_ORYSJ","lcl|NC_088854.1_cds_XP_034303442.2_10958",2.61e-162,532,"B1Q3J6","DNM1B_ORYSJ","DNA (cytosine-5)-methyltransferase 1B (OsMET1b) (EC 2.1.1.37) (DNA methyltransferase 1-2) (OsMET1-2)","MET1B MET1-2 Os07g0182900 LOC_Os07g08500 OJ1506_G02.17","Oryza sativa subsp. japonica (Rice)",1529,"GO:0003677; GO:0003682; GO:0003886; GO:0005634; GO:0006346; GO:0009793; GO:0032259; GO:0044027; GO:0071514","DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; embryo development ending in seed dormancy [GO:0009793]; genomic imprinting [GO:0071514]; methylation [GO:0032259]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]","nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; embryo development ending in seed dormancy [GO:0009793]; genomic imprinting [GO:0071514]; methylation [GO:0032259]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]","","INDUCTION: Induced by salt stress, cold stress and drought stress. {ECO:0000269|PubMed:19788421}.","INDUCTION: Induced by salt stress, cold stress and drought stress. {ECO:0000269|PubMed:19788421}.","TISSUE SPECIFICITY: Expressed in roots and inflorescences (PubMed:14513380). Expressed in roots, panicles, anthers, pistils, endosperm and imbibed embryos (PubMed:18281124). Expressed in tissues containing actively replicating and dividing cells, such as shoot and root meristems (PubMed:24535433). {ECO:0000269|PubMed:14513380, ECO:0000269|PubMed:18281124, ECO:0000269|PubMed:24535433}."
"172","sp|Q76MZ3|2AAA_MOUSE","lcl|NC_088854.1_cds_XP_034303479.1_10994",0,991,"Q76MZ3","2AAA_MOUSE","Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (PP2Aa) (PP2A subunit A isoform PR65-alpha) (PP2A subunit A isoform R1-alpha)","Ppp2r1a","Mus musculus (Mouse)",589,"GO:0000159; GO:0000775; GO:0000785; GO:0004722; GO:0005634; GO:0005829; GO:0007059; GO:0007143; GO:0016328; GO:0019888; GO:0030425; GO:0035331; GO:0043025; GO:0043029; GO:0045202; GO:0046982; GO:0051232; GO:0051306; GO:0051754; GO:0051898; GO:0090443; GO:0098978; GO:0160232; GO:0160240; GO:1903538; GO:1990405; GO:2001241","chromosome segregation [GO:0007059]; female meiotic nuclear division [GO:0007143]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; meiotic spindle elongation [GO:0051232]; mitotic sister chromatid separation [GO:0051306]; negative regulation of hippo signaling [GO:0035331]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; RNA polymerase II transcription initiation surveillance [GO:0160240]; T cell homeostasis [GO:0043029]","chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; glutamatergic synapse [GO:0098978]; INTAC complex [GO:0160232]; lateral plasma membrane [GO:0016328]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; synapse [GO:0045202]; protein antigen binding [GO:1990405]; protein heterodimerization activity [GO:0046982]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]; chromosome segregation [GO:0007059]; female meiotic nuclear division [GO:0007143]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; meiotic spindle elongation [GO:0051232]; mitotic sister chromatid separation [GO:0051306]; negative regulation of hippo signaling [GO:0035331]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; RNA polymerase II transcription initiation surveillance [GO:0160240]; T cell homeostasis [GO:0043029]","","","",""
"173","sp|Q8R5M8|CADM1_MOUSE","lcl|NC_088854.1_cds_XP_034303511.1_10369",1.47e-14,77.4,"Q8R5M8","CADM1_MOUSE","Cell adhesion molecule 1 (Immunoglobulin superfamily member 4) (IgSF4) (Nectin-like protein 2) (NECL-2) (Spermatogenic immunoglobulin superfamily) (SgIgSF) (Synaptic cell adhesion molecule) (SynCAM) (Tumor suppressor in lung cancer 1) (TSLC-1)","Cadm1 Igsf4 Necl2 Ra175 Syncam SynCam1 Tslc1","Mus musculus (Mouse)",456,"GO:0005102; GO:0005886; GO:0005911; GO:0006915; GO:0007155; GO:0007156; GO:0007157; GO:0007283; GO:0007416; GO:0008021; GO:0008037; GO:0009826; GO:0016323; GO:0016338; GO:0030154; GO:0030165; GO:0030424; GO:0030425; GO:0042271; GO:0042734; GO:0042803; GO:0043196; GO:0045202; GO:0045211; GO:0045954; GO:0051606; GO:0060348; GO:0070852; GO:0097021; GO:0098685; GO:0098880; GO:0098942; GO:0098978; GO:0099054; GO:0099560","apoptotic process [GO:0006915]; bone development [GO:0060348]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell recognition [GO:0008037]; detection of stimulus [GO:0051606]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lymphocyte migration into lymphoid organs [GO:0097021]; maintenance of postsynaptic specialization structure [GO:0098880]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; presynapse assembly [GO:0099054]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; spermatogenesis [GO:0007283]; susceptibility to natural killer cell mediated cytotoxicity [GO:0042271]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]; unidimensional cell growth [GO:0009826]","axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cell body fiber [GO:0070852]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; varicosity [GO:0043196]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; apoptotic process [GO:0006915]; bone development [GO:0060348]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell recognition [GO:0008037]; detection of stimulus [GO:0051606]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lymphocyte migration into lymphoid organs [GO:0097021]; maintenance of postsynaptic specialization structure [GO:0098880]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; presynapse assembly [GO:0099054]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; spermatogenesis [GO:0007283]; susceptibility to natural killer cell mediated cytotoxicity [GO:0042271]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]; unidimensional cell growth [GO:0009826]","DEVELOPMENTAL STAGE: Expressed in spermatogenic cells during early spermatogenesis. Expression increases in intermediate spermatogonia through to zygotene spermatocytes but becomes diminished in the steps from early pachytene spermatocytes through to round spermatids. After meiosis, expression reappears in spermatids and is present in elongating spermatids until spermiation. Not detected in Sertoli cells. {ECO:0000269|PubMed:12606335}.","","","TISSUE SPECIFICITY: Expressed dominantly in epithelial cells but not expressed in fibroblast cells (at protein level) (PubMed:12826663). Expressed in the T-cell area of lymph nodes, specifically in CD8+ and CD4- CD8- dendritic cells (at protein level) (PubMed:19752223). Expressed in CD8+ dendritic cells in the spleen (at protein level) (PubMed:19752223). Expressed in CD103+ dendritic cells in the small intestine lamina propria and mesenteric lymph nodes (at protein level) (PubMed:24687959). Expressed in brain, lung, kidney, testis, heart, spleen and liver, but not expressed in skeletal muscle (PubMed:12202822, PubMed:12242005, PubMed:12606335). {ECO:0000269|PubMed:12202822, ECO:0000269|PubMed:12242005, ECO:0000269|PubMed:12606335, ECO:0000269|PubMed:12826663, ECO:0000269|PubMed:19752223, ECO:0000269|PubMed:24687959}."
"174","sp|P12613|TCPA_DROME","lcl|NC_088854.1_cds_XP_034303596.2_9534",0,875,"P12613","TCPA_DROME","T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha) (Chaperonin containing TCP1 subunit 1)","CCT1 CCT-1 T-cp1 Tcp-1 CG5374","Drosophila melanogaster (Fruit fly)",557,"GO:0005524; GO:0005829; GO:0005832; GO:0006457; GO:0016887; GO:0030707; GO:0051082; GO:0140662","follicle cell of egg chamber development [GO:0030707]; protein folding [GO:0006457]","chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; unfolded protein binding [GO:0051082]; follicle cell of egg chamber development [GO:0030707]; protein folding [GO:0006457]","","","",""
"175","sp|Q99MT2|MSH4_MOUSE","lcl|NC_088854.1_cds_XP_034303791.2_7290",0,882,"Q99MT2","MSH4_MOUSE","MutS protein homolog 4 (mMsh4)","Msh4","Mus musculus (Mouse)",958,"GO:0000793; GO:0000794; GO:0000795; GO:0001541; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005713; GO:0006298; GO:0007129; GO:0007283; GO:0007292; GO:0030983; GO:0051321; GO:0140664","female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; ovarian follicle development [GO:0001541]; spermatogenesis [GO:0007283]","chromosome [GO:0005694]; condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; recombination nodule [GO:0005713]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; mismatched DNA binding [GO:0030983]; female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; ovarian follicle development [GO:0001541]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Predominantly expressed in testis."
"176","sp|D3Z3K2|CIP1_MOUSE","lcl|NC_088854.1_cds_XP_034303795.2_7292",1.05e-69,218,"D3Z3K2","CIP1_MOUSE","E3 ubiquitin-protein ligase CCNB1IP1 (EC 2.3.2.27) (Cyclin-B1-interacting protein 1) (RING-type E3 ubiquitin transferase CCNB1IP1)","Ccnb1ip1 Gm288 Hei10 Mei4","Mus musculus (Mouse)",276,"GO:0000794; GO:0000795; GO:0001825; GO:0004842; GO:0007131; GO:0007286; GO:0008270; GO:0016567; GO:0042802; GO:0051026; GO:0061630","blastocyst formation [GO:0001825]; chiasma assembly [GO:0051026]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]","condensed nuclear chromosome [GO:0000794]; synaptonemal complex [GO:0000795]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; blastocyst formation [GO:0001825]; chiasma assembly [GO:0051026]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]","DEVELOPMENTAL STAGE: In spermatocytes, synaptonemal complex-associated Ccnb1ip1 foci are detected by early pachynema and their number peaks during midpachynema. In late-pachytene nuclei, Ccnb1ip1 foci number descrease. At the onset of diplonema, foci are no longer detected (at protein level). {ECO:0000269|PubMed:21779533, ECO:0000269|PubMed:24390283}.","","","TISSUE SPECIFICITY: Expressed predominantly in the testes and 17 day embryos (corresponding to prophase I in females). Weakly or not expressed in other tissues. {ECO:0000269|PubMed:17784788}."
"177","sp|Q9NPC3|CIP1_HUMAN","lcl|NC_088854.1_cds_XP_034303796.2_7291",9.03e-71,220,"Q9NPC3","CIP1_HUMAN","E3 ubiquitin-protein ligase CCNB1IP1 (EC 2.3.2.27) (Cyclin-B1-interacting protein 1) (Human enhancer of invasion 10) (RING-type E3 ubiquitin transferase CCNB1IP1)","CCNB1IP1 C14orf18 HEI10","Homo sapiens (Human)",277,"GO:0000795; GO:0001825; GO:0007131; GO:0007286; GO:0008270; GO:0016567; GO:0042802; GO:0051026; GO:0061630","blastocyst formation [GO:0001825]; chiasma assembly [GO:0051026]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]","synaptonemal complex [GO:0000795]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; blastocyst formation [GO:0001825]; chiasma assembly [GO:0051026]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Highly expressed in heart. Detected at intermediate levels in liver and kidney, and at low levels in placenta, brain and lung. {ECO:0000269|PubMed:12612082}."
"178","sp|Q5W041|ARMC3_HUMAN","lcl|NC_088854.1_cds_XP_034303809.2_7303",1.54e-167,511,"Q5W041","ARMC3_HUMAN","Armadillo repeat-containing protein 3 (Beta-catenin-like protein) (Cancer/testis antigen 81) (CT81) (KU-CT-1)","ARMC3","Homo sapiens (Human)",872,"GO:0007286; GO:0030317; GO:0034517; GO:0070062","flagellated sperm motility [GO:0030317]; ribophagy [GO:0034517]; spermatid development [GO:0007286]","extracellular exosome [GO:0070062]; flagellated sperm motility [GO:0030317]; ribophagy [GO:0034517]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: [Isoform 1]: Expressed in skeletal muscle, brain, lung, kidney, prostate and testis. {ECO:0000269|PubMed:16915934}.; TISSUE SPECIFICITY: [Isoform 3]: Mainly expressed in skeletal muscle, liver, spleen and thymus. {ECO:0000269|PubMed:16915934}.; TISSUE SPECIFICITY: [Isoform 5]: Expressed only in the testis among normal tissues but is expressed frequently in various cancer tissues and, particularly, in pancreatic, lung and endometrial cancers. {ECO:0000269|PubMed:16397042}."
"179","sp|P13055|E75BB_DROME","lcl|NC_088854.1_cds_XP_034303848.2_4903",1.79e-118,399,"P13055","E75BB_DROME","Ecdysone-induced protein 75B, isoform B (E75-C) (Nuclear receptor subfamily 1 group D member 3, isoform B)","Eip75B NR1D3 CG8127","Drosophila melanogaster (Fruit fly)",1412,"GO:0000122; GO:0000978; GO:0003677; GO:0004879; GO:0005634; GO:0007553; GO:0007591; GO:0008270; GO:0009755; GO:0010468; GO:0018990; GO:0020037; GO:0030154; GO:0030522; GO:0035075; GO:0045944; GO:0048477; GO:0061060","cell differentiation [GO:0030154]; ecdysis, chitin-based cuticle [GO:0018990]; hormone-mediated signaling pathway [GO:0009755]; intracellular receptor signaling pathway [GO:0030522]; molting cycle, chitin-based cuticle [GO:0007591]; negative regulation of peptidoglycan recognition protein signaling pathway [GO:0061060]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of ecdysteroid metabolic process [GO:0007553]; regulation of gene expression [GO:0010468]; response to ecdysone [GO:0035075]","nucleus [GO:0005634]; DNA binding [GO:0003677]; heme binding [GO:0020037]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; ecdysis, chitin-based cuticle [GO:0018990]; hormone-mediated signaling pathway [GO:0009755]; intracellular receptor signaling pathway [GO:0030522]; molting cycle, chitin-based cuticle [GO:0007591]; negative regulation of peptidoglycan recognition protein signaling pathway [GO:0061060]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of ecdysteroid metabolic process [GO:0007553]; regulation of gene expression [GO:0010468]; response to ecdysone [GO:0035075]","DEVELOPMENTAL STAGE: In mid instar larvae salivary glands, levels increase during puff stage 1, then remain relatively constant until the premetamorphic pulse of ecdysone at puff stage 5. Levels increase again in late larvae at puff stages 9-10. At puff stage 1 expression is also seen in the gut. Levels are low in the gut, Malpighian tubules, fat body and wing disks between stages 1 and 11. {ECO:0000269|PubMed:8223281}.","INDUCTION: The expression of this protein is developmentally regulated and is correlated with the 20-OH-ecdysone induced activity of puff 75B. {ECO:0000269|PubMed:8223281}.","INDUCTION: The expression of this protein is developmentally regulated and is correlated with the 20-OH-ecdysone induced activity of puff 75B. {ECO:0000269|PubMed:8223281}.",""
"180","sp|Q9BZA8|PC11Y_HUMAN","lcl|NC_088854.1_cds_XP_034303886.2_5294",8.16e-117,392,"Q9BZA8","PC11Y_HUMAN","Protocadherin-11 Y-linked (Protocadherin-11) (Protocadherin on the Y chromosome) (PCDH-Y) (Protocadherin prostate cancer) (Protocadherin-PC) (Protocadherin-22)","PCDH11Y PCDH11 PCDH22 PCDHY","Homo sapiens (Human)",1340,"GO:0005509; GO:0005886; GO:0007155; GO:0007156; GO:0007283; GO:0030177; GO:0061827; GO:0097225","cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of Wnt signaling pathway [GO:0030177]; spermatogenesis [GO:0007283]","plasma membrane [GO:0005886]; sperm head [GO:0061827]; sperm midpiece [GO:0097225]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of Wnt signaling pathway [GO:0030177]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed strongly in fetal brain and brain (cortex, amygdala, thalamus, substantia nigra, hippocampus, caudate nucleus and corpus callosum). Expressed at low level in testis. Expressed in apoptosis-resistant cells. {ECO:0000269|PubMed:11003707, ECO:0000269|PubMed:12420223, ECO:0000269|PubMed:14727141, ECO:0000269|PubMed:16331680}."
"181","sp|Q9R1K9|CETN2_MOUSE","lcl|NC_088854.1_cds_XP_034303889.1_5300",3.81e-80,236,"Q9R1K9","CETN2_MOUSE","Centrin-2 (Caltractin isoform 1)","Cetn2 Calt","Mus musculus (Mouse)",172,"GO:0005509; GO:0005737; GO:0005813; GO:0005814; GO:0005929; GO:0006289; GO:0007099; GO:0007283; GO:0008017; GO:0015031; GO:0031683; GO:0032391; GO:0032465; GO:0032795; GO:0036064; GO:0044615; GO:0045177; GO:0051028; GO:0051301; GO:0070390; GO:0071942; GO:0097386; GO:0097729","cell division [GO:0051301]; centriole replication [GO:0007099]; mRNA transport [GO:0051028]; nucleotide-excision repair [GO:0006289]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; spermatogenesis [GO:0007283]","9+2 motile cilium [GO:0097729]; apical part of cell [GO:0045177]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; glial cell projection [GO:0097386]; nuclear pore nuclear basket [GO:0044615]; photoreceptor connecting cilium [GO:0032391]; transcription export complex 2 [GO:0070390]; XPC complex [GO:0071942]; calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; heterotrimeric G-protein binding [GO:0032795]; microtubule binding [GO:0008017]; cell division [GO:0051301]; centriole replication [GO:0007099]; mRNA transport [GO:0051028]; nucleotide-excision repair [GO:0006289]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Ubiquitously expressed in all adult tissues tested, with strongest expression in brain, spleen, kidney, small intestine and ovary. Also expressed in the NIH 3T3 fibroblast cell line and peripheral blood lymphocytes. {ECO:0000269|PubMed:11250075}."
"182","sp|P62877|RBX1_HUMAN","lcl|NC_088854.1_cds_XP_034317514.1_5675",5.85e-71,208,"P62877","RBX1_HUMAN","E3 ubiquitin-protein ligase RBX1 (EC 2.3.2.27) (EC 2.3.2.32) (E3 ubiquitin-protein transferase RBX1) (Protein ZYP) (RING finger protein 75) (RING-box protein 1) (Rbx1) (Regulator of cullins 1) (ROC1) [Cleaved into: E3 ubiquitin-protein ligase RBX1, N-terminally processed (E3 ubiquitin-protein transferase RBX1, N-terminally processed)]","RBX1 RNF75 ROC1","Homo sapiens (Human)",108,"GO:0000165; GO:0000209; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006283; GO:0006511; GO:0006513; GO:0006974; GO:0007283; GO:0008270; GO:0016567; GO:0019005; GO:0019788; GO:0030891; GO:0031146; GO:0031461; GO:0031462; GO:0031463; GO:0031464; GO:0031465; GO:0031466; GO:0031467; GO:0031625; GO:0032436; GO:0032480; GO:0034450; GO:0034599; GO:0034644; GO:0042110; GO:0043123; GO:0043161; GO:0043687; GO:0044877; GO:0045116; GO:0045732; GO:0046627; GO:0060090; GO:0061629; GO:0061630; GO:0061663; GO:0062197; GO:0070936; GO:0071230; GO:0080008; GO:0090090; GO:0097602; GO:0140627; GO:0160240; GO:1900076; GO:1901525; GO:1902499; GO:1902883; GO:1904263","cellular response to amino acid stimulus [GO:0071230]; cellular response to chemical stress [GO:0062197]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of mitophagy [GO:1901525]; negative regulation of response to oxidative stress [GO:1902883]; negative regulation of type I interferon production [GO:0032480]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of TORC1 signaling [GO:1904263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cellular response to insulin stimulus [GO:1900076]; RNA polymerase II transcription initiation surveillance [GO:0160240]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; spermatogenesis [GO:0007283]; T cell activation [GO:0042110]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul5-RING ubiquitin ligase complex [GO:0031466]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891]; cullin family protein binding [GO:0097602]; molecular adaptor activity [GO:0060090]; NEDD8 ligase activity [GO:0061663]; NEDD8 transferase activity [GO:0019788]; protein-containing complex binding [GO:0044877]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; cellular response to amino acid stimulus [GO:0071230]; cellular response to chemical stress [GO:0062197]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of mitophagy [GO:1901525]; negative regulation of response to oxidative stress [GO:1902883]; negative regulation of type I interferon production [GO:0032480]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of TORC1 signaling [GO:1904263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cellular response to insulin stimulus [GO:1900076]; RNA polymerase II transcription initiation surveillance [GO:0160240]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; spermatogenesis [GO:0007283]; T cell activation [GO:0042110]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","","","","TISSUE SPECIFICITY: Widely expressed."
"183","sp|P24348|LET23_CAEEL","lcl|NC_088854.1_cds_XP_065927243.1_5412",2.81e-180,575,"P24348","LET23_CAEEL","Receptor tyrosine-protein kinase let-23 (EC 2.7.10.1) (Lethal protein 23)","let-23 kin-7 ZK1067.1","Caenorhabditis elegans",1323,"GO:0002119; GO:0004714; GO:0005006; GO:0005524; GO:0005886; GO:0005911; GO:0006355; GO:0007173; GO:0008289; GO:0009925; GO:0016323; GO:0016324; GO:0016328; GO:0030182; GO:0030431; GO:0030539; GO:0030728; GO:0032436; GO:0040026; GO:0043066; GO:0043235; GO:0043410; GO:0050679; GO:0060065; GO:0072327; GO:0140677","epidermal growth factor receptor signaling pathway [GO:0007173]; male genitalia development [GO:0030539]; negative regulation of apoptotic process [GO:0043066]; nematode larval development [GO:0002119]; neuron differentiation [GO:0030182]; ovulation [GO:0030728]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of vulval development [GO:0040026]; regulation of DNA-templated transcription [GO:0006355]; sleep [GO:0030431]; uterus development [GO:0060065]; vulval cell fate specification [GO:0072327]","apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; epidermal growth factor receptor activity [GO:0005006]; lipid binding [GO:0008289]; molecular function activator activity [GO:0140677]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; epidermal growth factor receptor signaling pathway [GO:0007173]; male genitalia development [GO:0030539]; negative regulation of apoptotic process [GO:0043066]; nematode larval development [GO:0002119]; neuron differentiation [GO:0030182]; ovulation [GO:0030728]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of vulval development [GO:0040026]; regulation of DNA-templated transcription [GO:0006355]; sleep [GO:0030431]; uterus development [GO:0060065]; vulval cell fate specification [GO:0072327]","DEVELOPMENTAL STAGE: Expressed during L2 and L3 larval stages (PubMed:10359617). Highly expressed in vulval precursor cells P6.p in late L2 and early L3 stage larvae (PubMed:32053105). {ECO:0000269|PubMed:10359617, ECO:0000269|PubMed:32053105}.","","","TISSUE SPECIFICITY: Expressed in vulval precursor cells (at protein level) (PubMed:10359617). Expressed in ALA neurons, 2 ventral head neurons, a single neuron in the tail, pharyngeal-intestinal valve and posterior arcade epithelial cells (PubMed:17891142). {ECO:0000269|PubMed:10359617, ECO:0000269|PubMed:17891142}."
"184","sp|P04412|EGFR_DROME","lcl|NC_088854.1_cds_XP_065927245.1_5414",0,937,"P04412","EGFR_DROME","Epidermal growth factor receptor (Egfr) (EC 2.7.10.1) (Drosophila relative of ERBB) (Gurken receptor) (Protein torpedo)","Egfr c-erbB DER top CG10079","Drosophila melanogaster (Fruit fly)",1426,"GO:0001654; GO:0001742; GO:0001751; GO:0002009; GO:0003015; GO:0004714; GO:0005006; GO:0005524; GO:0005886; GO:0007173; GO:0007298; GO:0007309; GO:0007367; GO:0007390; GO:0007391; GO:0007395; GO:0007422; GO:0007426; GO:0007431; GO:0007443; GO:0007444; GO:0007455; GO:0007472; GO:0007474; GO:0007476; GO:0007477; GO:0007479; GO:0007482; GO:0008071; GO:0008284; GO:0008340; GO:0008355; GO:0008406; GO:0008586; GO:0009792; GO:0009880; GO:0009925; GO:0010628; GO:0010629; GO:0016318; GO:0016324; GO:0016330; GO:0016333; GO:0022008; GO:0030031; GO:0030182; GO:0030381; GO:0030718; GO:0035088; GO:0035149; GO:0035159; GO:0035160; GO:0035225; GO:0035277; GO:0035309; GO:0035310; GO:0042327; GO:0042675; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043703; GO:0045198; GO:0045199; GO:0045465; GO:0045572; GO:0046530; GO:0046673; GO:0046843; GO:0048149; GO:0048546; GO:0048749; GO:0048865; GO:0050679; GO:0051781; GO:0061331; GO:0070374; GO:0090303; GO:1903688; GO:2000134; GO:2001234","behavioral response to ethanol [GO:0048149]; border follicle cell migration [GO:0007298]; cell projection assembly [GO:0030031]; chorion-containing eggshell pattern formation [GO:0030381]; compound eye cone cell differentiation [GO:0042675]; compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; determination of genital disc primordium [GO:0035225]; digestive tract morphogenesis [GO:0048546]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic pattern specification [GO:0009880]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; eye development [GO:0001654]; eye-antennal disc morphogenesis [GO:0007455]; germ-band shortening [GO:0007390]; germ-line stem cell population maintenance [GO:0030718]; gonad development [GO:0008406]; haltere development [GO:0007482]; heart process [GO:0003015]; imaginal disc development [GO:0007444]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; leg disc proximal/distal pattern formation [GO:0007479]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; Malpighian tubule morphogenesis [GO:0007443]; maternal determination of dorsal/ventral axis, ovarian follicular epithelium, soma encoded [GO:0008071]; morphogenesis of an epithelium [GO:0002009]; morphogenesis of follicular epithelium [GO:0016333]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; notum cell fate specification [GO:0035310]; notum development [GO:0007477]; oenocyte differentiation [GO:0001742]; olfactory learning [GO:0008355]; ommatidial rotation [GO:0016318]; oocyte axis specification [GO:0007309]; peripheral nervous system development [GO:0007422]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell fate determination [GO:0043703]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphorylation [GO:0042327]; positive regulation of wound healing [GO:0090303]; R8 cell differentiation [GO:0045465]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland development [GO:0007431]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; stem cell fate commitment [GO:0048865]; tracheal outgrowth, open tracheal system [GO:0007426]; wing and notum subfield formation [GO:0035309]; wing disc morphogenesis [GO:0007472]","apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; epidermal growth factor receptor activity [GO:0005006]; identical protein binding [GO:0042802]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; behavioral response to ethanol [GO:0048149]; border follicle cell migration [GO:0007298]; cell projection assembly [GO:0030031]; chorion-containing eggshell pattern formation [GO:0030381]; compound eye cone cell differentiation [GO:0042675]; compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; determination of genital disc primordium [GO:0035225]; digestive tract morphogenesis [GO:0048546]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic pattern specification [GO:0009880]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; eye development [GO:0001654]; eye-antennal disc morphogenesis [GO:0007455]; germ-band shortening [GO:0007390]; germ-line stem cell population maintenance [GO:0030718]; gonad development [GO:0008406]; haltere development [GO:0007482]; heart process [GO:0003015]; imaginal disc development [GO:0007444]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; leg disc proximal/distal pattern formation [GO:0007479]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; Malpighian tubule morphogenesis [GO:0007443]; maternal determination of dorsal/ventral axis, ovarian follicular epithelium, soma encoded [GO:0008071]; morphogenesis of an epithelium [GO:0002009]; morphogenesis of follicular epithelium [GO:0016333]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; notum cell fate specification [GO:0035310]; notum development [GO:0007477]; oenocyte differentiation [GO:0001742]; olfactory learning [GO:0008355]; ommatidial rotation [GO:0016318]; oocyte axis specification [GO:0007309]; peripheral nervous system development [GO:0007422]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell fate determination [GO:0043703]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphorylation [GO:0042327]; positive regulation of wound healing [GO:0090303]; R8 cell differentiation [GO:0045465]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland development [GO:0007431]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; stem cell fate commitment [GO:0048865]; tracheal outgrowth, open tracheal system [GO:0007426]; wing and notum subfield formation [GO:0035309]; wing disc morphogenesis [GO:0007472]","","","","TISSUE SPECIFICITY: Ubiquitously expressed in embryos. In larvae, uniform expression is seen in wing disks, genital disk, anlagen of testis and ovary, and brain cortex. In eye-antenna disk, highest expression is anterior to morphogenetic furrow, levels remain high in photoreceptor precursor cells. This pattern is reversed in posterior eye disk. In adults expression is high in brain cortex and thoracic and abdominal ganglia. {ECO:0000269|PubMed:9882502}."
"185","sp|P52194|CLGN_MOUSE","lcl|NC_088854.1_cds_XP_065927328.1_8918",0,528,"P52194","CLGN_MOUSE","Calmegin (A2/6) (Calnexin-T) (MEG 1 antigen)","Clgn Meg1","Mus musculus (Mouse)",611,"GO:0005509; GO:0005635; GO:0005783; GO:0005789; GO:0007283; GO:0007338; GO:0007339; GO:0030154; GO:0044183; GO:0051082; GO:0051321; GO:0065003","binding of sperm to zona pellucida [GO:0007339]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; protein-containing complex assembly [GO:0065003]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; calcium ion binding [GO:0005509]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; protein-containing complex assembly [GO:0065003]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Specifically expressed during male meiotic germ cell development. First detected in early pachytene spermatocytes. Expression is highest in elongating and round spermatids and decreases thereafter. Not detectable in mature spermatids. {ECO:0000269|PubMed:10495883, ECO:0000269|PubMed:8126001}.","","","TISSUE SPECIFICITY: Detected in testis (at protein level). Detected in testis. {ECO:0000269|PubMed:11784061, ECO:0000269|PubMed:8126001, ECO:0000269|PubMed:8188695, ECO:0000269|PubMed:9177349, ECO:0000269|PubMed:9434179}."
"186","sp|Q9BY67|CADM1_HUMAN","lcl|NC_088854.1_cds_XP_065930327.1_10669",3.23e-15,77.4,"Q9BY67","CADM1_HUMAN","Cell adhesion molecule 1 (Immunoglobulin superfamily member 4) (IgSF4) (Nectin-like protein 2) (NECL-2) (Spermatogenic immunoglobulin superfamily) (SgIgSF) (Synaptic cell adhesion molecule) (SynCAM) (Tumor suppressor in lung cancer 1) (TSLC-1)","CADM1 IGSF4 IGSF4A NECL2 SYNCAM TSLC1","Homo sapiens (Human)",442,"GO:0001819; GO:0002376; GO:0005102; GO:0005886; GO:0005911; GO:0006915; GO:0007156; GO:0007157; GO:0007283; GO:0008037; GO:0016323; GO:0030154; GO:0030165; GO:0042271; GO:0042803; GO:0043005; GO:0045202; GO:0045954; GO:0051606","apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell recognition [GO:0008037]; detection of stimulus [GO:0051606]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; immune system process [GO:0002376]; positive regulation of cytokine production [GO:0001819]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; spermatogenesis [GO:0007283]; susceptibility to natural killer cell mediated cytotoxicity [GO:0042271]","basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell recognition [GO:0008037]; detection of stimulus [GO:0051606]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; immune system process [GO:0002376]; positive regulation of cytokine production [GO:0001819]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; spermatogenesis [GO:0007283]; susceptibility to natural killer cell mediated cytotoxicity [GO:0042271]","","","",""
"187","sp|P41934|HM18_CAEEL","lcl|NC_088854.1_cds_XP_065930468.1_3848",2.44e-51,186,"P41934","HM18_CAEEL","Homeobox protein ceh-18","ceh-18 ZC64.3","Caenorhabditis elegans",542,"GO:0000978; GO:0000981; GO:0001556; GO:0003700; GO:0005634; GO:0006357; GO:0008340; GO:0008354; GO:0008544; GO:0030728; GO:1900194","determination of adult lifespan [GO:0008340]; epidermis development [GO:0008544]; germ cell migration [GO:0008354]; negative regulation of oocyte maturation [GO:1900194]; oocyte maturation [GO:0001556]; ovulation [GO:0030728]; regulation of transcription by RNA polymerase II [GO:0006357]","nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; determination of adult lifespan [GO:0008340]; epidermis development [GO:0008544]; germ cell migration [GO:0008354]; negative regulation of oocyte maturation [GO:1900194]; oocyte maturation [GO:0001556]; ovulation [GO:0030728]; regulation of transcription by RNA polymerase II [GO:0006357]","DEVELOPMENTAL STAGE: First expressed in embryos at the three-fold stage (PubMed:7958868). After hatching expressed in the syncytial hypodermal cells located throughout the body, pharyngeal muscle, seam cells P hypodermal blast cells, body muscle and anterior touch cells (PubMed:7958868). Expressed in the distal tip cell of the somatic ginad from the L2 stage of larval development through to the adult stage (PubMed:7958868). {ECO:0000269|PubMed:7958868}.","","","TISSUE SPECIFICITY: Expressed in the gonadal sheath cells that signal the oocyte, but not in the oocyte. {ECO:0000269|PubMed:7958868}."
"188","sp|Q9VAW5|LARP_DROME","lcl|NC_088854.1_cds_XP_065930576.1_4096",9.29e-105,367,"Q9VAW5","LARP_DROME","La-related protein 1 (dLarp)","larp CG42551","Drosophila melanogaster (Fruit fly)",1673,"GO:0000001; GO:0000339; GO:0003723; GO:0005737; GO:0005829; GO:0007053; GO:0007140; GO:0008187; GO:0010494; GO:0031315; GO:0035186; GO:0045727; GO:0048027; GO:0048255; GO:0090297; GO:1903955; GO:2000766; GO:2000767","male meiotic nuclear division [GO:0007140]; mitochondrion inheritance [GO:0000001]; mRNA stabilization [GO:0048255]; negative regulation of cytoplasmic translation [GO:2000766]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of translation [GO:0045727]; spindle assembly involved in male meiosis [GO:0007053]; syncytial blastoderm mitotic cell cycle [GO:0035186]","cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extrinsic component of mitochondrial outer membrane [GO:0031315]; mRNA 5'-UTR binding [GO:0048027]; poly-pyrimidine tract binding [GO:0008187]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; male meiotic nuclear division [GO:0007140]; mitochondrion inheritance [GO:0000001]; mRNA stabilization [GO:0048255]; negative regulation of cytoplasmic translation [GO:2000766]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of translation [GO:0045727]; spindle assembly involved in male meiosis [GO:0007053]; syncytial blastoderm mitotic cell cycle [GO:0035186]","DEVELOPMENTAL STAGE: At the end of embryogenesis, accumulates in the gut and muscles. {ECO:0000269|PubMed:10878606}.","","",""
"189","sp|P13808|B3A2_MOUSE","lcl|NC_088854.1_cds_XP_065930661.1_4221",0,729,"P13808","B3A2_MOUSE","Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Band 3-related protein) (B3RP) (Non-erythroid band 3-like protein) (Solute carrier family 4 member 2)","Slc4a2 Ae2","Mus musculus (Mouse)",1237,"GO:0006821; GO:0007283; GO:0015108; GO:0016020; GO:0016323; GO:0016324; GO:0022853; GO:0030316; GO:0032956; GO:0043377; GO:0045124; GO:0070175; GO:0097186; GO:0140900; GO:2000565","amelogenesis [GO:0097186]; chloride transport [GO:0006821]; negative regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043377]; negative regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000565]; osteoclast differentiation [GO:0030316]; positive regulation of enamel mineralization [GO:0070175]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of bone resorption [GO:0045124]; spermatogenesis [GO:0007283]","apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; active monoatomic ion transmembrane transporter activity [GO:0022853]; chloride transmembrane transporter activity [GO:0015108]; chloride:bicarbonate antiporter activity [GO:0140900]; amelogenesis [GO:0097186]; chloride transport [GO:0006821]; negative regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043377]; negative regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000565]; osteoclast differentiation [GO:0030316]; positive regulation of enamel mineralization [GO:0070175]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of bone resorption [GO:0045124]; spermatogenesis [GO:0007283]","","INDUCTION: Up-regulated during osteoclast differentiation. {ECO:0000269|PubMed:18971331}.","INDUCTION: Up-regulated during osteoclast differentiation. {ECO:0000269|PubMed:18971331}.","TISSUE SPECIFICITY: Expressed in the choroid plexus epithelium (at protein level) (PubMed:2371270). Expressed in the parotid gland and sublingual salivary gland acinar cells (at protein level) (PubMed:12958022). {ECO:0000269|PubMed:12958022, ECO:0000269|PubMed:2371270}.; TISSUE SPECIFICITY: [Isoform A]: Widely expressed at similar levels in all tissues examined (PubMed:11006093). Expressed in the testis (PubMed:14673081). {ECO:0000269|PubMed:11006093, ECO:0000269|PubMed:14673081}.; TISSUE SPECIFICITY: [Isoform B1]: Predominantly expressed in stomach although they are also detected at lower levels in other tissues (PubMed:11006093). Expressed in the testis (PubMed:14673081). {ECO:0000269|PubMed:11006093, ECO:0000269|PubMed:14673081}.; TISSUE SPECIFICITY: [Isoform B2]: Predominantly expressed in stomach although they are also detected at lower levels in other tissues (PubMed:11006093). Expressed in the testis (PubMed:14673081). {ECO:0000269|PubMed:11006093, ECO:0000269|PubMed:14673081}.; TISSUE SPECIFICITY: [Isoform C1]: Stomach-specific. {ECO:0000269|PubMed:11006093}.; TISSUE SPECIFICITY: [Isoform C2]: Expressed at slightly higher levels in lung and stomach than in other tissues. {ECO:0000269|PubMed:11006093}."
"190","sp|Q8VIF2|PRS42_MOUSE","lcl|NC_088854.1_cds_XP_065930668.1_4233",2.76e-49,167,"Q8VIF2","PRS42_MOUSE","Serine protease 42 (EC 3.4.21.-) (Testis serine protease 2)","Prss42 Tessp2","Mus musculus (Mouse)",335,"GO:0004252; GO:0005737; GO:0005886; GO:0006508; GO:0007281; GO:0007283; GO:0098552","germ cell development [GO:0007281]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; serine-type endopeptidase activity [GO:0004252]; germ cell development [GO:0007281]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: In testis, expressed at all stages from the late pachytene primary spermatocyte to the secondary spermatocyte. Not detected at day 7 after birth. Expression is detected at day 14 and increases dramatically at day 21 and reach a peak at day 28 to remain high until day 56. {ECO:0000269|PubMed:23536369}.","","","TISSUE SPECIFICITY: Testis-specific (PubMed:23536369). Mainly detected in round spermatids at all the eminiferous epithelial stages (at protein level) (PubMed:23536369). {ECO:0000269|PubMed:23536369}."
"191","sp|Q3UMC0|AFG2A_MOUSE","lcl|NC_088854.1_cds_XP_065930902.1_4689",0,691,"Q3UMC0","AFG2A_MOUSE","ATPase family gene 2 protein homolog A (EC 3.6.4.10) (AFG2 AAA ATPase homolog A) (Ribosome biogenesis protein SPATA5) (Spermatogenesis-associated factor protein) (Spermatogenesis-associated protein 5)","Afg2a Spaf Spata5","Mus musculus (Mouse)",893,"GO:0005524; GO:0005737; GO:0005739; GO:0005819; GO:0005829; GO:0007283; GO:0007420; GO:0016887; GO:0030154; GO:0042273; GO:1990275","brain development [GO:0007420]; cell differentiation [GO:0030154]; ribosomal large subunit biogenesis [GO:0042273]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; preribosome binding [GO:1990275]; brain development [GO:0007420]; cell differentiation [GO:0030154]; ribosomal large subunit biogenesis [GO:0042273]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in testis; with localization to spermatogonia and early spermatocytes in the basal compartment of the seminiferous tubules (at early stages of spermatogenesis). Very weak signals observed in spleen and skin. {ECO:0000269|PubMed:10734318}."
"192","sp|A2AAE1|BLTP1_MOUSE","lcl|NC_088854.1_cds_XP_065930910.1_4704",0,878,"A2AAE1","BLTP1_MOUSE","Bridge-like lipid transfer protein family member 1 (Fragile site-associated protein homolog)","Bltp1 Fsa Kiaa1109 Kiaa1371","Mus musculus (Mouse)",5005,"GO:0001558; GO:0005634; GO:0005789; GO:0005886; GO:0006629; GO:0006869; GO:0006909; GO:0007283; GO:0009409; GO:0016197; GO:0019915; GO:0031966; GO:0032456; GO:0045444; GO:0051647; GO:0060612; GO:0120009; GO:0140268; GO:1904121","adipose tissue development [GO:0060612]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; fat cell differentiation [GO:0045444]; intermembrane lipid transfer [GO:0120009]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; lipid transport [GO:0006869]; nucleus localization [GO:0051647]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; response to cold [GO:0009409]; spermatogenesis [GO:0007283]","endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphatidylethanolamine transfer activity [GO:1904121]; adipose tissue development [GO:0060612]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; fat cell differentiation [GO:0045444]; intermembrane lipid transfer [GO:0120009]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; lipid transport [GO:0006869]; nucleus localization [GO:0051647]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; response to cold [GO:0009409]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed during spermatogenesis and adipogenesis. {ECO:0000269|PubMed:16545529}.","","","TISSUE SPECIFICITY: Highly expressed in testis and ovary. Weakly or not expressed in other tissues. {ECO:0000269|PubMed:16545529}."
"193","sp|Q95LP5|AXDN1_MACFA","lcl|NC_088854.1_cds_XP_065930919.1_4726",9.56e-149,467,"Q95LP5","AXDN1_MACFA","Axonemal dynein light chain domain-containing protein 1","AXDND1 QtsA-11085 QtsA-15492 QtsA-19166","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)",855,"GO:0005737; GO:0007283; GO:1905198","manchette assembly [GO:1905198]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; manchette assembly [GO:1905198]; spermatogenesis [GO:0007283]","","","",""
"194","sp|Q960V3|MILT_DROME","lcl|NC_088854.1_cds_XP_065930964.1_4794",5.97e-53,201,"Q960V3","MILT_DROME","Trafficking kinesin-binding protein milt (Protein milton)","milt CG43227","Drosophila melanogaster (Fruit fly)",1122,"GO:0005739; GO:0006605; GO:0007287; GO:0007310; GO:0017022; GO:0019896; GO:0030382; GO:0030674; GO:0031410; GO:0047496; GO:0048311; GO:0051654; GO:1904115","axonal transport of mitochondrion [GO:0019896]; establishment of mitochondrion localization [GO:0051654]; mitochondrion distribution [GO:0048311]; Nebenkern assembly [GO:0007287]; oocyte dorsal/ventral axis specification [GO:0007310]; protein targeting [GO:0006605]; sperm mitochondrion organization [GO:0030382]; vesicle transport along microtubule [GO:0047496]","axon cytoplasm [GO:1904115]; cytoplasmic vesicle [GO:0031410]; mitochondrion [GO:0005739]; myosin binding [GO:0017022]; protein-macromolecule adaptor activity [GO:0030674]; axonal transport of mitochondrion [GO:0019896]; establishment of mitochondrion localization [GO:0051654]; mitochondrion distribution [GO:0048311]; Nebenkern assembly [GO:0007287]; oocyte dorsal/ventral axis specification [GO:0007310]; protein targeting [GO:0006605]; sperm mitochondrion organization [GO:0030382]; vesicle transport along microtubule [GO:0047496]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. {ECO:0000269|PubMed:12495622}.","","","TISSUE SPECIFICITY: Expressed primarily in axons and synapses. {ECO:0000269|PubMed:12495622}."
"195","sp|O08550|KMT2B_MOUSE","lcl|NC_088854.1_cds_XP_065930988.1_4862",8.65e-117,419,"O08550","KMT2B_MOUSE","Histone-lysine N-methyltransferase 2B (Lysine N-methyltransferase 2B) (EC 2.1.1.364) (Myeloid/lymphoid or mixed-lineage leukemia protein 4 homolog) (Trithorax homolog 2) (WW domain-binding protein 7) (WBP-7)","Kmt2b Mll2 Trx2 Wbp7","Mus musculus (Mouse)",2713,"GO:0001541; GO:0005634; GO:0005829; GO:0006346; GO:0006355; GO:0008270; GO:0030728; GO:0032259; GO:0035097; GO:0042800; GO:0045322; GO:0048599; GO:0140945; GO:0140999; GO:0160021","DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; maternal-to-zygotic transition of gene expression [GO:0160021]; methylation [GO:0032259]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; regulation of DNA-templated transcription [GO:0006355]","cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone H3K4 trimethyltransferase activity [GO:0140999]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; maternal-to-zygotic transition of gene expression [GO:0160021]; methylation [GO:0032259]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; regulation of DNA-templated transcription [GO:0006355]","","","",""
"196","sp|Q27601|PUR1_DROME","lcl|NC_088854.1_cds_XP_065931037.1_4961",0,588,"Q27601","PUR1_DROME","Amidophosphoribosyltransferase (ATase) (EC 2.4.2.14) (Glutamine phosphoribosylpyrophosphate amidotransferase) (GPAT) (Phosphoribosylamidotransferase) (PRAT)","Prat CG2867","Drosophila melanogaster (Fruit fly)",546,"GO:0004044; GO:0006164; GO:0006189; GO:0008340; GO:0009113; GO:0040016; GO:0046872; GO:0048477; GO:0051539","'de novo' IMP biosynthetic process [GO:0006189]; determination of adult lifespan [GO:0008340]; embryonic cleavage [GO:0040016]; oogenesis [GO:0048477]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]","4 iron, 4 sulfur cluster binding [GO:0051539]; amidophosphoribosyltransferase activity [GO:0004044]; metal ion binding [GO:0046872]; 'de novo' IMP biosynthetic process [GO:0006189]; determination of adult lifespan [GO:0008340]; embryonic cleavage [GO:0040016]; oogenesis [GO:0048477]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]","","","",""
"197","sp|B3M6I4|PLK4_DROAN","lcl|NC_088854.1_cds_XP_065931073.1_5050",2.31e-114,371,"B3M6I4","PLK4_DROAN","Serine/threonine-protein kinase PLK4 (EC 2.7.11.21) (Polo-like kinase 4) (PLK-4) (Serine/threonine-protein kinase SAK)","SAK GF10707","Drosophila ananassae (Fruit fly)",770,"GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005814; GO:0007099; GO:0007140; GO:0007288; GO:0031647; GO:0035186; GO:0042802; GO:0045732; GO:0046599; GO:0106310","centriole replication [GO:0007099]; male meiotic nuclear division [GO:0007140]; positive regulation of protein catabolic process [GO:0045732]; regulation of centriole replication [GO:0046599]; regulation of protein stability [GO:0031647]; sperm axoneme assembly [GO:0007288]; syncytial blastoderm mitotic cell cycle [GO:0035186]","centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; centriole replication [GO:0007099]; male meiotic nuclear division [GO:0007140]; positive regulation of protein catabolic process [GO:0045732]; regulation of centriole replication [GO:0046599]; regulation of protein stability [GO:0031647]; sperm axoneme assembly [GO:0007288]; syncytial blastoderm mitotic cell cycle [GO:0035186]","","","",""
"198","sp|Q9U1H0|CIC_DROME","lcl|NC_088854.1_cds_XP_065931201.1_5345",5.86e-36,152,"Q9U1H0","CIC_DROME","Putative transcription factor capicua (Protein fettucine)","cic fet CG43122","Drosophila melanogaster (Fruit fly)",1832,"GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005829; GO:0006355; GO:0006357; GO:0007173; GO:0007313; GO:0007362; GO:0007474; GO:0008293; GO:0009953; GO:0030308; GO:0043565; GO:0046621; GO:0046843; GO:0048190; GO:0048592; GO:0140297","dorsal appendage formation [GO:0046843]; dorsal/ventral pattern formation [GO:0009953]; epidermal growth factor receptor signaling pathway [GO:0007173]; eye morphogenesis [GO:0048592]; imaginal disc-derived wing vein specification [GO:0007474]; maternal specification of dorsal/ventral axis, oocyte, soma encoded [GO:0007313]; negative regulation of cell growth [GO:0030308]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; wing disc dorsal/ventral pattern formation [GO:0048190]","cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; dorsal appendage formation [GO:0046843]; dorsal/ventral pattern formation [GO:0009953]; epidermal growth factor receptor signaling pathway [GO:0007173]; eye morphogenesis [GO:0048592]; imaginal disc-derived wing vein specification [GO:0007474]; maternal specification of dorsal/ventral axis, oocyte, soma encoded [GO:0007313]; negative regulation of cell growth [GO:0030308]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; wing disc dorsal/ventral pattern formation [GO:0048190]","DEVELOPMENTAL STAGE: Expressed maternally in stage 1-3 blastoderm embryos. {ECO:0000269|PubMed:10652276}.","INDUCTION: Subject to local inactivation by the RAS-RAF-MAPK signal transduction pathway, which leads to relief of target gene repression. This pathway may be locally activated by a variety of ligands and receptor tyrosine kinases (RTKs) according to the developmental stage and tissue. In terminal patterning, activation of tor by the locally processed ligand trk may promote cic inactivation specifically at the embryonic terminal poles. In the developing wing, activation of Egfr by vn may lead to cic inactivation specifically in prospective vein tissue. {ECO:0000269|PubMed:10652276, ECO:0000269|PubMed:11861482}.","INDUCTION: Subject to local inactivation by the RAS-RAF-MAPK signal transduction pathway, which leads to relief of target gene repression. This pathway may be locally activated by a variety of ligands and receptor tyrosine kinases (RTKs) according to the developmental stage and tissue. In terminal patterning, activation of tor by the locally processed ligand trk may promote cic inactivation specifically at the embryonic terminal poles. In the developing wing, activation of Egfr by vn may lead to cic inactivation specifically in prospective vein tissue. {ECO:0000269|PubMed:10652276, ECO:0000269|PubMed:11861482}.","TISSUE SPECIFICITY: Expressed in the central region of embryos. Also expressed in ovarian follicle cells, the wing imaginal disks and the wing pouch. {ECO:0000269|PubMed:10652276, ECO:0000269|PubMed:11714680, ECO:0000269|PubMed:11861482}."
"199","sp|Q96KQ7|EHMT2_HUMAN","lcl|NC_088854.1_cds_XP_065931416.1_5928",0,752,"Q96KQ7","EHMT2_HUMAN","Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.367) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a)","EHMT2 BAT8 C6orf30 G9A KMT1C NG36","Homo sapiens (Human)",1210,"GO:0000122; GO:0000785; GO:0000977; GO:0001222; GO:0002039; GO:0005634; GO:0005654; GO:0006275; GO:0006346; GO:0007130; GO:0007286; GO:0008270; GO:0009267; GO:0009566; GO:0016279; GO:0016607; GO:0018027; GO:0035265; GO:0036166; GO:0040029; GO:0044027; GO:0046974; GO:0046976; GO:0048148; GO:0048599; GO:0048665; GO:0070742; GO:0071314; GO:0140759; GO:0140947; GO:1902902; GO:1990841","behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; cellular response to starvation [GO:0009267]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; epigenetic regulation of gene expression [GO:0040029]; fertilization [GO:0009566]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; oocyte development [GO:0048599]; organ growth [GO:0035265]; peptidyl-lysine dimethylation [GO:0018027]; phenotypic switching [GO:0036166]; regulation of DNA replication [GO:0006275]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130]","chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; histone H3K27 methyltransferase activity [GO:0046976]; histone H3K56 methyltransferase activity [GO:0140759]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9me2 methyltransferase activity [GO:0140947]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270]; behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; cellular response to starvation [GO:0009267]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; epigenetic regulation of gene expression [GO:0040029]; fertilization [GO:0009566]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; oocyte development [GO:0048599]; organ growth [GO:0035265]; peptidyl-lysine dimethylation [GO:0018027]; phenotypic switching [GO:0036166]; regulation of DNA replication [GO:0006275]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130]","","","","TISSUE SPECIFICITY: Expressed in all tissues examined, with high levels in fetal liver, thymus, lymph node, spleen and peripheral blood leukocytes and lower level in bone marrow. {ECO:0000269|PubMed:11707778}."
"200","sp|Q6ZU64|CFA65_HUMAN","lcl|NC_088854.1_cds_XP_065931457.1_6018",0,1170,"Q6ZU64","CFA65_HUMAN","Cilia- and flagella-associated protein 65 (Coiled-coil domain-containing protein 108)","CFAP65 CCDC108","Homo sapiens (Human)",1925,"GO:0001669; GO:0002080; GO:0003723; GO:0005737; GO:0005886; GO:0007288; GO:0030317; GO:0036126; GO:0097225","flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]","acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; RNA binding [GO:0003723]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]","","","",""
"201","sp|F1P4W9|CFA65_CHICK","lcl|NC_088854.1_cds_XP_065931458.1_6019",0,1210,"F1P4W9","CFA65_CHICK","Cilia- and flagella-associated protein 65 (Coiled-coil domain-containing protein 108)","CFAP65 CCDC108","Gallus gallus (Chicken)",1775,"GO:0001669; GO:0002080; GO:0005737; GO:0005886; GO:0007288; GO:0030317; GO:0036126; GO:0097225","flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]","acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]","","","","TISSUE SPECIFICITY: Expressed in testis. {ECO:0000269|PubMed:22761584}."
"202","sp|Q9VYD1|SET2_DROME","lcl|NC_088854.1_cds_XP_065931466.1_6033",5.72e-66,251,"Q9VYD1","SET2_DROME","Histone-lysine N-methyltransferase Set2 (dSet2) (EC 2.1.1.359)","Set2 CG1716","Drosophila melanogaster (Fruit fly)",2313,"GO:0000785; GO:0002168; GO:0003677; GO:0005634; GO:0006325; GO:0006355; GO:0007281; GO:0032259; GO:0035076; GO:0035220; GO:0046872; GO:0046975; GO:0048599; GO:0051219; GO:0140946; GO:0140955; GO:0141005","chromatin organization [GO:0006325]; ecdysone receptor signaling pathway [GO:0035076]; germ cell development [GO:0007281]; instar larval development [GO:0002168]; methylation [GO:0032259]; oocyte development [GO:0048599]; regulation of DNA-templated transcription [GO:0006355]; transposable element silencing by heterochromatin formation [GO:0141005]; wing disc development [GO:0035220]","chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone H3K36 methyltransferase activity [GO:0046975]; histone H3K36 trimethyltransferase activity [GO:0140955]; histone H3K4 dimethyltransferase activity [GO:0140946]; metal ion binding [GO:0046872]; phosphoprotein binding [GO:0051219]; chromatin organization [GO:0006325]; ecdysone receptor signaling pathway [GO:0035076]; germ cell development [GO:0007281]; instar larval development [GO:0002168]; methylation [GO:0032259]; oocyte development [GO:0048599]; regulation of DNA-templated transcription [GO:0006355]; transposable element silencing by heterochromatin formation [GO:0141005]; wing disc development [GO:0035220]","DEVELOPMENTAL STAGE: Expressed throughout development. {ECO:0000269|PubMed:17560546}.","","",""
"203","sp|Q5JU67|CF157_HUMAN","lcl|NC_088854.1_cds_XP_065931477.1_6060",8.34e-86,276,"Q5JU67","CF157_HUMAN","Cilia- and flagella-associated protein 157","CFAP157 C9orf117","Homo sapiens (Human)",520,"GO:0005737; GO:0007288; GO:0008017; GO:0036064","sperm axoneme assembly [GO:0007288]","ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule binding [GO:0008017]; sperm axoneme assembly [GO:0007288]","","","",""
"204","sp|Q9VLT5|POE_DROME","lcl|NC_088854.1_cds_XP_065931482.1_6073",0,1969,"Q9VLT5","POE_DROME","Protein purity of essence (Interaction calmodulin and colossal molecular mass protein) (Protein Calossin) (Protein pushover)","poe calo push CG14472","Drosophila melanogaster (Fruit fly)",5322,"GO:0005516; GO:0007291; GO:0007601; GO:0008270; GO:0032436; GO:0042065; GO:0042066; GO:0043186; GO:0061630; GO:0070373; GO:2000020","glial cell growth [GO:0042065]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; perineurial glial growth [GO:0042066]; positive regulation of male gonad development [GO:2000020]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; sperm individualization [GO:0007291]; visual perception [GO:0007601]","P granule [GO:0043186]; calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; glial cell growth [GO:0042065]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; perineurial glial growth [GO:0042066]; positive regulation of male gonad development [GO:2000020]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; sperm individualization [GO:0007291]; visual perception [GO:0007601]","","","","TISSUE SPECIFICITY: Expressed in embryonic central nervous system and adult testes. {ECO:0000269|PubMed:11517334}."
"205","sp|Q29L39|POE_DROPS","lcl|NC_088854.1_cds_XP_065931484.1_6074",0,1949,"Q29L39","POE_DROPS","Protein purity of essence","poe GA13010","Drosophila pseudoobscura pseudoobscura (Fruit fly)",5381,"GO:0005516; GO:0007286; GO:0007291; GO:0007399; GO:0007601; GO:0008270","nervous system development [GO:0007399]; sperm individualization [GO:0007291]; spermatid development [GO:0007286]; visual perception [GO:0007601]","calmodulin binding [GO:0005516]; zinc ion binding [GO:0008270]; nervous system development [GO:0007399]; sperm individualization [GO:0007291]; spermatid development [GO:0007286]; visual perception [GO:0007601]","","","",""
"206","sp|P50393|PA24A_RAT","lcl|NC_088854.1_cds_XP_065931495.1_6084",0,677,"P50393","PA24A_RAT","Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase (EC 3.1.1.5)]","Pla2g4a Cpla2 Pla2g4","Rattus norvegicus (Rat)",752,"GO:0000139; GO:0001516; GO:0001542; GO:0001554; GO:0002827; GO:0004622; GO:0004623; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0006071; GO:0006640; GO:0006663; GO:0008284; GO:0008374; GO:0009725; GO:0010314; GO:0010572; GO:0019369; GO:0019370; GO:0030501; GO:0031340; GO:0031394; GO:0031622; GO:0032266; GO:0032308; GO:0032496; GO:0033280; GO:0034478; GO:0034638; GO:0035035; GO:0036151; GO:0042127; GO:0042542; GO:0042588; GO:0043032; GO:0043065; GO:0043129; GO:0046456; GO:0046475; GO:0046697; GO:0047498; GO:0047499; GO:0048471; GO:0050482; GO:0051384; GO:0051592; GO:0051597; GO:0051649; GO:0070273; GO:0071236; GO:1902387; GO:1905375","arachidonate metabolic process [GO:0019369]; arachidonate secretion [GO:0050482]; cellular response to antibiotic [GO:0071236]; cellular response to homocysteine [GO:1905375]; decidualization [GO:0046697]; establishment of localization in cell [GO:0051649]; glycerol metabolic process [GO:0006071]; glycerophospholipid catabolic process [GO:0046475]; icosanoid biosynthetic process [GO:0046456]; leukotriene biosynthetic process [GO:0019370]; luteolysis [GO:0001554]; monoacylglycerol biosynthetic process [GO:0006640]; ovulation from ovarian follicle [GO:0001542]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylglycerol catabolic process [GO:0034478]; platelet activating factor biosynthetic process [GO:0006663]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fever generation [GO:0031622]; positive regulation of macrophage activation [GO:0043032]; positive regulation of platelet activation [GO:0010572]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of vesicle fusion [GO:0031340]; prostaglandin biosynthetic process [GO:0001516]; regulation of cell population proliferation [GO:0042127]; response to calcium ion [GO:0051592]; response to glucocorticoid [GO:0051384]; response to hormone [GO:0009725]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; response to methylmercury [GO:0051597]; response to vitamin D [GO:0033280]; surfactant homeostasis [GO:0043129]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; zymogen granule [GO:0042588]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; calcium-independent phospholipase A2 activity [GO:0047499]; ceramide 1-phosphate binding [GO:1902387]; histone acetyltransferase binding [GO:0035035]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phospholipase A2 activity [GO:0004623]; arachidonate metabolic process [GO:0019369]; arachidonate secretion [GO:0050482]; cellular response to antibiotic [GO:0071236]; cellular response to homocysteine [GO:1905375]; decidualization [GO:0046697]; establishment of localization in cell [GO:0051649]; glycerol metabolic process [GO:0006071]; glycerophospholipid catabolic process [GO:0046475]; icosanoid biosynthetic process [GO:0046456]; leukotriene biosynthetic process [GO:0019370]; luteolysis [GO:0001554]; monoacylglycerol biosynthetic process [GO:0006640]; ovulation from ovarian follicle [GO:0001542]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylglycerol catabolic process [GO:0034478]; platelet activating factor biosynthetic process [GO:0006663]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fever generation [GO:0031622]; positive regulation of macrophage activation [GO:0043032]; positive regulation of platelet activation [GO:0010572]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of vesicle fusion [GO:0031340]; prostaglandin biosynthetic process [GO:0001516]; regulation of cell population proliferation [GO:0042127]; response to calcium ion [GO:0051592]; response to glucocorticoid [GO:0051384]; response to hormone [GO:0009725]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; response to methylmercury [GO:0051597]; response to vitamin D [GO:0033280]; surfactant homeostasis [GO:0043129]","","INDUCTION: Levels of rat CPLA2 are increased in dentate granule cells during ischemia. {ECO:0000269|PubMed:7808237}.","INDUCTION: Levels of rat CPLA2 are increased in dentate granule cells during ischemia. {ECO:0000269|PubMed:7808237}.","TISSUE SPECIFICITY: In brain tissue, expressed in low levels in olfactory mitral and granule cells, in hippocampal pyramidal cells and in dentate and cerebellar granule cells. {ECO:0000269|PubMed:7808237}."
"207","sp|Q00729|H2B1A_RAT","lcl|NC_088854.1_cds_XP_065931550.1_6178",1.12e-58,178,"Q00729","H2B1A_RAT","Histone H2B type 1-A (Histone H2B, testis) (Testis-specific histone H2B)","H2bc1 Hist1h2ba Th2b","Rattus norvegicus (Rat)",127,"GO:0000786; GO:0001674; GO:0003677; GO:0005634; GO:0006325; GO:0006334; GO:0006337; GO:0006954; GO:0009986; GO:0030527; GO:0031639; GO:0035092; GO:0042393; GO:0046982; GO:0051276; GO:0071674","chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; inflammatory response [GO:0006954]; mononuclear cell migration [GO:0071674]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; plasminogen activation [GO:0031639]; sperm DNA condensation [GO:0035092]","cell surface [GO:0009986]; female germ cell nucleus [GO:0001674]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; inflammatory response [GO:0006954]; mononuclear cell migration [GO:0071674]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; plasminogen activation [GO:0031639]; sperm DNA condensation [GO:0035092]","","","","TISSUE SPECIFICITY: Testis. Expressed in pachytene spermatocytes during meiotic prophase I in the absence of any significant DNA synthesis. {ECO:0000269|PubMed:2725487}."
"208","sp|Q9CQ70|H2AB1_MOUSE","lcl|NC_088854.1_cds_XP_065931561.1_6193",1.17e-22,86.7,"Q9CQ70","H2AB1_MOUSE","Histone H2A-Bbd type 1 (H2A Barr body-deficient) (H2A.Bbd) (Histone H2A-like 2) (H2A.L.2) (H2AL2) (Histone H2Alike 2) (Testis-specific expressed gene 1 protein) (TSEG-1)","H2ab1 H2afb1 H2al2a","Mus musculus (Mouse)",111,"GO:0000786; GO:0003677; GO:0005634; GO:0005721; GO:0006334; GO:0030527; GO:0035092; GO:0042393; GO:0046982; GO:0051276","chromosome organization [GO:0051276]; nucleosome assembly [GO:0006334]; sperm DNA condensation [GO:0035092]","nucleosome [GO:0000786]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; chromosome organization [GO:0051276]; nucleosome assembly [GO:0006334]; sperm DNA condensation [GO:0035092]","DEVELOPMENTAL STAGE: Expressed since postnatal day (P) 21, peaks at P30, and gradually decreases in the testis of aging mouse (PubMed:20008104, PubMed:20188161). Coexpressed with transition proteins during late spermiogenesis (PubMed:28366643). Strongly enriched in step 12-16 spermatids and accumulate during late spermiogenesis, in condensing spermatids (PubMed:17261847). Remains present in mature spermatozoa isolated from epididymis (PubMed:17261847). Rapidly disappears from the paternal pericentric heterochromatin regions after sperm-egg fusion (PubMed:18703863). {ECO:0000269|PubMed:17261847, ECO:0000269|PubMed:18703863, ECO:0000269|PubMed:20008104, ECO:0000269|PubMed:20188161, ECO:0000269|PubMed:28366643}.","","","TISSUE SPECIFICITY: Highly expressed in adult testis, mainly in spermatocytes (PubMed:17261847, PubMed:20008104, PubMed:20188161). {ECO:0000269|PubMed:17261847, ECO:0000269|PubMed:20008104, ECO:0000269|PubMed:20188161}."
"209","sp|P70696|H2B1A_MOUSE","lcl|NC_088854.1_cds_XP_065931578.1_6204",7.71e-59,178,"P70696","H2B1A_MOUSE","Histone H2B type 1-A (Histone H2B, testis) (Testis-specific histone H2B)","H2bc1 Hist1h2ba Th2b","Mus musculus (Mouse)",127,"GO:0000786; GO:0001674; GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0006334; GO:0006337; GO:0006954; GO:0009986; GO:0030527; GO:0031639; GO:0035092; GO:0042393; GO:0046982; GO:0051276; GO:0071674","chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; inflammatory response [GO:0006954]; mononuclear cell migration [GO:0071674]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; plasminogen activation [GO:0031639]; sperm DNA condensation [GO:0035092]","cell surface [GO:0009986]; female germ cell nucleus [GO:0001674]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; inflammatory response [GO:0006954]; mononuclear cell migration [GO:0071674]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; plasminogen activation [GO:0031639]; sperm DNA condensation [GO:0035092]","DEVELOPMENTAL STAGE: Accumulates at 10 day postpartum (dpp), when pre-leptotene/leptotene spermatocytes first appear and when H2B expression shows a drastic decrease. Replaces H2B by 18 dpp in spermatocytes. Also present in metaphase oocytes and in the female pronucleus at fertilization and is also rapidly incorporated into the male pronucleus. {ECO:0000269|PubMed:23884607}.","","","TISSUE SPECIFICITY: Mainly expressed in testis, and the corresponding protein is also present in mature sperm. Also present in metaphase oocytes (at protein level). {ECO:0000269|PubMed:23884607, ECO:0000269|PubMed:8672246}."
"210","sp|P13395|SPTCA_DROME","lcl|NC_088854.1_cds_XP_065931683.1_6387",0,3385,"P13395","SPTCA_DROME","Spectrin alpha chain","alpha-Spec SPEC-A CG1977","Drosophila melanogaster (Fruit fly)",2415,"GO:0003779; GO:0005509; GO:0005516; GO:0005794; GO:0005886; GO:0005938; GO:0007009; GO:0007010; GO:0007026; GO:0007274; GO:0007294; GO:0007308; GO:0007417; GO:0008017; GO:0008360; GO:0016199; GO:0016323; GO:0016324; GO:0016328; GO:0030036; GO:0030054; GO:0030723; GO:0030727; GO:0030864; GO:0031514; GO:0031594; GO:0035332; GO:0042062; GO:0042995; GO:0045169; GO:0045170; GO:0045478; GO:0048790; GO:0050807; GO:0051015; GO:0051693","actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; cytoskeleton organization [GO:0007010]; fusome organization [GO:0045478]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian fusome organization [GO:0030723]; plasma membrane organization [GO:0007009]; positive regulation of hippo signaling [GO:0035332]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]","apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; motile cilium [GO:0031514]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrosome [GO:0045170]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; cytoskeleton organization [GO:0007010]; fusome organization [GO:0045478]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian fusome organization [GO:0030723]; plasma membrane organization [GO:0007009]; positive regulation of hippo signaling [GO:0035332]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]","DEVELOPMENTAL STAGE: Expressed in elongating spermatid cysts during spermatogenesis (at protein level) (PubMed:20237161). Expressed both maternally and zygotically. {ECO:0000269|PubMed:20237161}.","","","TISSUE SPECIFICITY: A substantial pool of maternal protein in the egg undergoes dynamic changes in distribution early in embryogenesis. In gastrulated embryo, the highest level of protein is found in the respiratory tract cells and the lowest in parts of the forming gut. {ECO:0000269|PubMed:2497103}."
"211","sp|O62136|INX14_CAEEL","lcl|NC_088854.1_cds_XP_065931737.1_6503",8.07e-25,107,"O62136","INX14_CAEEL","Innexin-14 (Protein opu-14)","inx-14 opu-14 F07A5.1","Caenorhabditis elegans",434,"GO:0001556; GO:0005243; GO:0005886; GO:0005921; GO:0034220; GO:0036093; GO:0055077","germ cell proliferation [GO:0036093]; monoatomic ion transmembrane transport [GO:0034220]; oocyte maturation [GO:0001556]","gap junction [GO:0005921]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; germ cell proliferation [GO:0036093]; monoatomic ion transmembrane transport [GO:0034220]; oocyte maturation [GO:0001556]","","","",""
"212","sp|G5EGQ6|TEN1_CAEEL","lcl|NC_088854.1_cds_XP_065931819.1_6664",0,630,"G5EGQ6","TEN1_CAEEL","Teneurin-1","ten-1 R13F6.4","Caenorhabditis elegans",2684,"GO:0005634; GO:0005886; GO:0007276; GO:0007411; GO:0007413; GO:0008045; GO:0008406; GO:0008584; GO:0008585; GO:0009792; GO:0009887; GO:0010172; GO:0016477; GO:0019953; GO:0030421; GO:0040032; GO:0040039; GO:0071711; GO:0160094; GO:2001197","animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; basement membrane assembly involved in embryonic body morphogenesis [GO:2001197]; basement membrane organization [GO:0071711]; cell migration [GO:0016477]; defecation [GO:0030421]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic body morphogenesis [GO:0010172]; female gonad development [GO:0008585]; gamete generation [GO:0007276]; gonad development [GO:0008406]; inductive cell migration [GO:0040039]; male gonad development [GO:0008584]; motor neuron axon guidance [GO:0008045]; nematode pharynx development [GO:0160094]; post-embryonic body morphogenesis [GO:0040032]; sexual reproduction [GO:0019953]","nucleus [GO:0005634]; plasma membrane [GO:0005886]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; basement membrane assembly involved in embryonic body morphogenesis [GO:2001197]; basement membrane organization [GO:0071711]; cell migration [GO:0016477]; defecation [GO:0030421]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic body morphogenesis [GO:0010172]; female gonad development [GO:0008585]; gamete generation [GO:0007276]; gonad development [GO:0008406]; inductive cell migration [GO:0040039]; male gonad development [GO:0008584]; motor neuron axon guidance [GO:0008045]; nematode pharynx development [GO:0160094]; post-embryonic body morphogenesis [GO:0040032]; sexual reproduction [GO:0019953]","DEVELOPMENTAL STAGE: Isoform 1 is expressed in a cluster of cells in the anterior half at 2.5 hours post fertilization (hpf), in hypodermal cells at 5 hpf, in pharyngeal cells, intestinal and some neurons at 6 hpf. Isoform 1 is expressed in pharyngeal cells at L1 larval stage. Isoform 1 is expressed in somatic gonad precursor cells (SGPs) during the L2 larval stage. Isoform 2 is expressed in anterior neuronal cells and posterior hypodermal cells at 5 hpf, in neurons of the head at 7.6 hpf (at protein level). Expressed in somatic gonad founder cells Z1 and Z4, pharynx and muscles. {ECO:0000269|PubMed:15936327, ECO:0000269|PubMed:18632986, ECO:0000269|PubMed:20497576}.","","","TISSUE SPECIFICITY: Isoform 1 is mainly expressed in organs derived from the mesoderm, including the pharynx, vulva muscles, gonad distal tip cells, intestine and several tail neurons. Isoform 2 is mainly expressed in the organs derived from the ectoderm, including hypodermal cells, head ganglion neurons and tail neurons (at protein level). {ECO:0000269|PubMed:18632986, ECO:0000269|PubMed:20497576}."
"213","sp|Q96MT7|CFA44_HUMAN","lcl|NC_088854.1_cds_XP_065931884.1_6810",0,671,"Q96MT7","CFA44_HUMAN","Cilia- and flagella-associated protein 44 (WD repeat-containing protein 52)","CFAP44 WDR52","Homo sapiens (Human)",1854,"GO:0000226; GO:0000902; GO:0005737; GO:0005856; GO:0006997; GO:0007288; GO:0008233; GO:0031514","cell morphogenesis [GO:0000902]; microtubule cytoskeleton organization [GO:0000226]; nucleus organization [GO:0006997]; sperm axoneme assembly [GO:0007288]","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; peptidase activity [GO:0008233]; cell morphogenesis [GO:0000902]; microtubule cytoskeleton organization [GO:0000226]; nucleus organization [GO:0006997]; sperm axoneme assembly [GO:0007288]","","","","TISSUE SPECIFICITY: Testis-specific. {ECO:0000269|PubMed:29449551}."
"214","sp|Q5XI14|MCMD2_RAT","lcl|NC_088854.1_cds_XP_065931905.1_6879",6.23e-87,287,"Q5XI14","MCMD2_RAT","Minichromosome maintenance domain-containing protein 2 (MCM domain-containing protein 2)","Mcmdc2","Rattus norvegicus (Rat)",681,"GO:0000727; GO:0003677; GO:0005524; GO:0005634; GO:0007130; GO:0007146; GO:0007283; GO:0042140; GO:0048477; GO:1990918","double-strand break repair involved in meiotic recombination [GO:1990918]; double-strand break repair via break-induced replication [GO:0000727]; late meiotic recombination nodule assembly [GO:0042140]; meiotic recombination nodule assembly [GO:0007146]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]","nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; double-strand break repair involved in meiotic recombination [GO:1990918]; double-strand break repair via break-induced replication [GO:0000727]; late meiotic recombination nodule assembly [GO:0042140]; meiotic recombination nodule assembly [GO:0007146]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]","","","",""
"215","sp|Q5FC64|ZDHCS_CAEEL","lcl|NC_088854.1_cds_XP_065931959.1_6978",9.59e-41,147,"Q5FC64","ZDHCS_CAEEL","Palmitoyltransferase spe-10 (EC 2.3.1.225) (Defective spermatogenesis protein 10)","spe-10 AC3.10","Caenorhabditis elegans",351,"GO:0005783; GO:0005794; GO:0006612; GO:0007097; GO:0007286; GO:0016020; GO:0019706; GO:0031268; GO:0045793; GO:0061025; GO:0097723","amoeboid sperm motility [GO:0097723]; membrane fusion [GO:0061025]; nuclear migration [GO:0007097]; positive regulation of cell size [GO:0045793]; protein targeting to membrane [GO:0006612]; pseudopodium organization [GO:0031268]; spermatid development [GO:0007286]","endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; amoeboid sperm motility [GO:0097723]; membrane fusion [GO:0061025]; nuclear migration [GO:0007097]; positive regulation of cell size [GO:0045793]; protein targeting to membrane [GO:0006612]; pseudopodium organization [GO:0031268]; spermatid development [GO:0007286]","DEVELOPMENTAL STAGE: Only expressed during spermatogenesis in adult males and in hermaphrodites in the larval stage 4. {ECO:0000269|PubMed:16143610}.","","","TISSUE SPECIFICITY: Expressed during spermatogenesis in budding and budded spermatids. {ECO:0000269|PubMed:16143610}."
"216","sp|Q15506|SP17_HUMAN","lcl|NC_088854.1_cds_XP_065932198.1_7484",8.8e-29,110,"Q15506","SP17_HUMAN","Sperm surface protein Sp17 (Cancer/testis antigen 22) (CT22) (Sp17-1) (Sperm autoantigenic protein 17) (Sperm protein 17)","SPA17 SP17","Homo sapiens (Human)",151,"GO:0003351; GO:0005516; GO:0005576; GO:0005737; GO:0005929; GO:0007283; GO:0007338; GO:0007339; GO:0009897; GO:0031514; GO:0035686; GO:0043005; GO:0097228","binding of sperm to zona pellucida [GO:0007339]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]","cilium [GO:0005929]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; sperm fibrous sheath [GO:0035686]; sperm principal piece [GO:0097228]; calmodulin binding [GO:0005516]; binding of sperm to zona pellucida [GO:0007339]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Testis and sperm specific."
"217","sp|O95714|HERC2_HUMAN","lcl|NC_088854.1_cds_XP_065932278.1_7648",0,4881,"O95714","HERC2_HUMAN","E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)","HERC2","Homo sapiens (Human)",4834,"GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0061630","DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]","centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]","","","",""
"218","sp|Q4U2R1|HERC2_MOUSE","lcl|NC_088854.1_cds_XP_065932279.1_7652",0,4884,"Q4U2R1","HERC2_MOUSE","E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)","Herc2 Jdf2 Kiaa0393 Rjs","Mus musculus (Mouse)",4836,"GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0061630","DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]","centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Highest levels are found in brain and testis with lower levels in heart, lung, liver, skeletal muscle and kidney. Little expression detected in spleen. {ECO:0000269|PubMed:9689098}."
"219","sp|E9Q8T7|DYH1_MOUSE","lcl|NC_088854.1_cds_XP_065932299.1_7678",0,3158,"E9Q8T7","DYH1_MOUSE","Dynein axonemal heavy chain 1 (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) (mDHC7)","Dnah1 Dhc7 Dnahc1","Mus musculus (Mouse)",4250,"GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005874; GO:0007288; GO:0008569; GO:0030317; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060294","cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; sperm axoneme assembly [GO:0007288]","extracellular region [GO:0005576]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; sperm axoneme assembly [GO:0007288]","","","",""
"220","sp|Q95YJ5|TXND3_CIOIN","lcl|NC_088854.1_cds_XP_065932305.1_7698",0,637,"Q95YJ5","TXND3_CIOIN","Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)","CiIC3","Ciona intestinalis (Transparent sea squirt) (Ascidia intestinalis)",653,"GO:0004550; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0030154","cell differentiation [GO:0030154]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]","nucleoside diphosphate kinase activity [GO:0004550]; cell differentiation [GO:0030154]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]","","","","TISSUE SPECIFICITY: Testis-specific."
"221","sp|Q715S9|TXND3_RAT","lcl|NC_088854.1_cds_XP_065932307.1_7691",7.08e-98,317,"Q715S9","TXND3_RAT","Thioredoxin domain-containing protein 3 (3'-5' exonuclease NME8) (EC 3.1.-.-) (NME/NM23 family member 8) (Spermatid-specific thioredoxin-2) (Sptrx-2)","Nme8 Sptrx2 Txndc3","Rattus norvegicus (Rat)",587,"GO:0005634; GO:0005737; GO:0005930; GO:0007286; GO:0008017; GO:0008408; GO:0030317; GO:0034614; GO:0035686; GO:0036157; GO:0060271; GO:0097225; GO:0097228; GO:0097598","cellular response to reactive oxygen species [GO:0034614]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; spermatid development [GO:0007286]","axoneme [GO:0005930]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; outer dynein arm [GO:0036157]; sperm cytoplasmic droplet [GO:0097598]; sperm fibrous sheath [GO:0035686]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; 3'-5' exonuclease activity [GO:0008408]; microtubule binding [GO:0008017]; cellular response to reactive oxygen species [GO:0034614]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; spermatid development [GO:0007286]","DEVELOPMENTAL STAGE: Prominently detected in the cytoplasmic lobe of step 15-18 spermatids and diminishes in step 19 just before spermiation. In the spermatid tail, it increases from step 15 to 19 and is confined to the principal piece. First detected scattered throughout the cytoplasm of the axoneme in step 14-15 spermatids, but begins to be incorporated by step 16 into the FS. During steps 17-18, it increases over the ribs and columns of the assembled FS. It peaks in step 19 and remains in the FS of epididymal spermatozoa. {ECO:0000269|PubMed:12909633}.","","","TISSUE SPECIFICITY: Testis-specific. {ECO:0000269|PubMed:12909633}."
"222","sp|Q8N427|TXND3_HUMAN","lcl|NC_088854.1_cds_XP_065932311.1_7689",8.13e-125,387,"Q8N427","TXND3_HUMAN","Thioredoxin domain-containing protein 3 (3'-5' exonuclease NME8) (EC 3.1.-.-) (NM23-H8) (NME/NM23 family member 8) (Spermatid-specific thioredoxin-2) (Sptrx-2)","NME8 SPTRX2 TXNDC3","Homo sapiens (Human)",588,"GO:0005634; GO:0005737; GO:0005829; GO:0005930; GO:0007283; GO:0008017; GO:0008408; GO:0016607; GO:0030154; GO:0030317; GO:0034614; GO:0036157; GO:0060271; GO:0097225; GO:0097228; GO:0097598","cell differentiation [GO:0030154]; cellular response to reactive oxygen species [GO:0034614]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283]","axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; outer dynein arm [GO:0036157]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; 3'-5' exonuclease activity [GO:0008408]; microtubule binding [GO:0008017]; cell differentiation [GO:0030154]; cellular response to reactive oxygen species [GO:0034614]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Restricted to spermiogenesis, starting at the pachytene spermatocyte level and peaking at the round and elongating spermatid stage.","","","TISSUE SPECIFICITY: Testis-specific. Expressed only in primary spermatocytes and round spermatids. {ECO:0000269|PubMed:11737268}."
"223","sp|Q715T0|TXND3_MOUSE","lcl|NC_088854.1_cds_XP_065932316.1_7693",5.42e-101,324,"Q715T0","TXND3_MOUSE","Thioredoxin domain-containing protein 3 (3'-5' exonuclease NME8) (EC 3.1.-.-) (NME/NM23 family member 8) (Spermatid-specific thioredoxin-2) (Sptrx-2)","Nme8 Sptrx2 Txndc3","Mus musculus (Mouse)",586,"GO:0005737; GO:0005829; GO:0005930; GO:0007283; GO:0008017; GO:0008408; GO:0016607; GO:0030154; GO:0030317; GO:0034614; GO:0035686; GO:0036157; GO:0060271; GO:0097225; GO:0097228; GO:0097598","cell differentiation [GO:0030154]; cellular response to reactive oxygen species [GO:0034614]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283]","axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; outer dynein arm [GO:0036157]; sperm cytoplasmic droplet [GO:0097598]; sperm fibrous sheath [GO:0035686]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; 3'-5' exonuclease activity [GO:0008408]; microtubule binding [GO:0008017]; cell differentiation [GO:0030154]; cellular response to reactive oxygen species [GO:0034614]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: First expressed after puberty. {ECO:0000269|PubMed:15781233}.","","","TISSUE SPECIFICITY: Testis-specific. Expressed mainly in round spermatids. {ECO:0000269|PubMed:12909633}."
"224","sp|P90666|TXND3_HELCR","lcl|NC_088854.1_cds_XP_065932317.1_7700",2.74e-133,416,"P90666","TXND3_HELCR","Thioredoxin domain-containing protein 3 homolog (3'-5' exonuclease NME8) (EC 3.1.-.-) (Intermediate chain 1) (NME/NM23 family member 8)","NME8 IC1","Heliocidaris crassispina (Sea urchin) (Anthocidaris crassispina)",837,"GO:0004550; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0008408; GO:0030154","cell differentiation [GO:0030154]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]","3'-5' exonuclease activity [GO:0008408]; nucleoside diphosphate kinase activity [GO:0004550]; cell differentiation [GO:0030154]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]","","","","TISSUE SPECIFICITY: Testis-specific. In sperm, it is a component of the arm dynein of sperm axoneme. {ECO:0000269|PubMed:8970153}."
"225","sp|A6NG13|MGT4D_HUMAN","lcl|NC_088854.1_cds_XP_065932392.1_7868",3.47e-76,246,"A6NG13","MGT4D_HUMAN","Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like protein MGAT4D (N-acetylglucosaminyltransferase MGAT1 inhibitory protein) (GlcNAcT-I inhibitory protein) (GnT1IP)","MGAT4D","Homo sapiens (Human)",374,"GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005795; GO:0006487; GO:0007283; GO:0008375; GO:0030154; GO:0060051","cell differentiation [GO:0030154]; negative regulation of protein glycosylation [GO:0060051]; protein N-linked glycosylation [GO:0006487]; spermatogenesis [GO:0007283]","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; acetylglucosaminyltransferase activity [GO:0008375]; cell differentiation [GO:0030154]; negative regulation of protein glycosylation [GO:0060051]; protein N-linked glycosylation [GO:0006487]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in testis. Poorly expressed in testis biopsies from men with impaired spermatogenesis. {ECO:0000269|PubMed:16773575, ECO:0000269|PubMed:26371870}."
"226","sp|Q4R786|MAEL_MACFA","lcl|NC_088854.1_cds_XP_065932473.1_8072",1.08e-40,154,"Q4R786","MAEL_MACFA","Protein maelstrom homolog","MAEL QtsA-15923","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)",434,"GO:0005634; GO:0005737; GO:0007140; GO:0007283; GO:0030154; GO:0031047; GO:0034587; GO:0043186; GO:0043565; GO:0045892; GO:0060964; GO:0071547","cell differentiation [GO:0030154]; male meiotic nuclear division [GO:0007140]; negative regulation of DNA-templated transcription [GO:0045892]; piRNA processing [GO:0034587]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulatory ncRNA-mediated gene silencing [GO:0031047]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; piP-body [GO:0071547]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; male meiotic nuclear division [GO:0007140]; negative regulation of DNA-templated transcription [GO:0045892]; piRNA processing [GO:0034587]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulatory ncRNA-mediated gene silencing [GO:0031047]; spermatogenesis [GO:0007283]","","","",""
"227","sp|Q9VJN5|WEK_DROME","lcl|NC_088854.1_cds_XP_065932527.1_8188",2.92e-28,119,"Q9VJN5","WEK_DROME","Zinc finger protein weckle","wek l(2)35Ea CG4148","Drosophila melanogaster (Fruit fly)",470,"GO:0005634; GO:0005829; GO:0007311; GO:0008063; GO:0008270; GO:0009898; GO:0009950; GO:0035591; GO:0042803","dorsal/ventral axis specification [GO:0009950]; maternal specification of dorsal/ventral axis, oocyte, germ-line encoded [GO:0007311]; Toll signaling pathway [GO:0008063]","cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein homodimerization activity [GO:0042803]; signaling adaptor activity [GO:0035591]; zinc ion binding [GO:0008270]; dorsal/ventral axis specification [GO:0009950]; maternal specification of dorsal/ventral axis, oocyte, germ-line encoded [GO:0007311]; Toll signaling pathway [GO:0008063]","","","",""
"228","sp|F1LVW7|DIAP3_RAT","lcl|NC_088854.1_cds_XP_065932615.1_8410",5.66e-107,362,"F1LVW7","DIAP3_RAT","Protein diaphanous homolog 3 (Diaphanous-related formin-3) (DRF3) (mDIA2)","Diaph3","Rattus norvegicus (Rat)",1172,"GO:0000226; GO:0000813; GO:0000922; GO:0001701; GO:0003779; GO:0005634; GO:0005737; GO:0005815; GO:0005884; GO:0007010; GO:0007015; GO:0007026; GO:0007059; GO:0007229; GO:0007283; GO:0007605; GO:0008017; GO:0008092; GO:0010467; GO:0016197; GO:0030010; GO:0030030; GO:0030036; GO:0030041; GO:0030182; GO:0030218; GO:0030225; GO:0031267; GO:0031941; GO:0032154; GO:0032432; GO:0034367; GO:0042803; GO:0043131; GO:0045010; GO:0046785; GO:0051017; GO:0051764; GO:0060113; GO:0060322; GO:0061909; GO:0071800; GO:0097470; GO:1990427","actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; autophagosome-lysosome fusion [GO:0061909]; cell projection organization [GO:0030030]; chromosome segregation [GO:0007059]; cytoskeleton organization [GO:0007010]; endosomal transport [GO:0016197]; erythrocyte differentiation [GO:0030218]; erythrocyte enucleation [GO:0043131]; establishment of cell polarity [GO:0030010]; gene expression [GO:0010467]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; inner ear receptor cell differentiation [GO:0060113]; integrin-mediated signaling pathway [GO:0007229]; macrophage differentiation [GO:0030225]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; negative regulation of microtubule depolymerization [GO:0007026]; neuron differentiation [GO:0030182]; podosome assembly [GO:0071800]; protein-containing complex remodeling [GO:0034367]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]","actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; ESCRT I complex [GO:0000813]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ribbon synapse [GO:0097470]; spindle pole [GO:0000922]; stereocilia tip-link density [GO:1990427]; actin binding [GO:0003779]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; autophagosome-lysosome fusion [GO:0061909]; cell projection organization [GO:0030030]; chromosome segregation [GO:0007059]; cytoskeleton organization [GO:0007010]; endosomal transport [GO:0016197]; erythrocyte differentiation [GO:0030218]; erythrocyte enucleation [GO:0043131]; establishment of cell polarity [GO:0030010]; gene expression [GO:0010467]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; inner ear receptor cell differentiation [GO:0060113]; integrin-mediated signaling pathway [GO:0007229]; macrophage differentiation [GO:0030225]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; negative regulation of microtubule depolymerization [GO:0007026]; neuron differentiation [GO:0030182]; podosome assembly [GO:0071800]; protein-containing complex remodeling [GO:0034367]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in testis (PubMed:18651670). Present in Sertoli cells (at protein level) (PubMed:18651670). {ECO:0000269|PubMed:18651670}."
"229","sp|Q9NHV9|VAV_DROME","lcl|NC_088854.1_cds_XP_065932652.1_8477",5.77e-144,447,"Q9NHV9","VAV_DROME","Protein vav (DroVav) (dVAV)","Vav CG7893","Drosophila melanogaster (Fruit fly)",793,"GO:0001745; GO:0005085; GO:0005737; GO:0005829; GO:0007173; GO:0007264; GO:0007298; GO:0007391; GO:0007409; GO:0007411; GO:0007417; GO:0007424; GO:0007520; GO:0008270; GO:0016477; GO:0030036; GO:0032956; GO:0035011; GO:0042059; GO:0044351; GO:0045887; GO:0048010; GO:0070374; GO:0072499; GO:1903391","actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell migration [GO:0016477]; central nervous system development [GO:0007417]; compound eye morphogenesis [GO:0001745]; dorsal closure [GO:0007391]; epidermal growth factor receptor signaling pathway [GO:0007173]; macropinocytosis [GO:0044351]; melanotic encapsulation of foreign target [GO:0035011]; myoblast fusion [GO:0007520]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of adherens junction organization [GO:1903391]; small GTPase-mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; zinc ion binding [GO:0008270]; actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell migration [GO:0016477]; central nervous system development [GO:0007417]; compound eye morphogenesis [GO:0001745]; dorsal closure [GO:0007391]; epidermal growth factor receptor signaling pathway [GO:0007173]; macropinocytosis [GO:0044351]; melanotic encapsulation of foreign target [GO:0035011]; myoblast fusion [GO:0007520]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of adherens junction organization [GO:1903391]; small GTPase-mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically in all stages of development. {ECO:0000269|PubMed:10781813}.","","","TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10781813}."
"230","sp|Q9BZW7|TSG10_HUMAN","lcl|NC_088854.1_cds_XP_065932700.1_8587",1.52e-145,451,"Q9BZW7","TSG10_HUMAN","Testis-specific gene 10 protein (Testis development protein NYD-SP7)","TSGA10 CEP4L","Homo sapiens (Human)",698,"GO:0005737; GO:0005814; GO:0007283; GO:0030031; GO:0031514; GO:0035686; GO:0043005; GO:0097228","cell projection assembly [GO:0030031]; spermatogenesis [GO:0007283]","centriole [GO:0005814]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; sperm fibrous sheath [GO:0035686]; sperm principal piece [GO:0097228]; cell projection assembly [GO:0030031]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in the testis, in spermatozoa (at protein level) (PubMed:11179690, PubMed:28905369). Expressed in actively dividing fetal tissues, including sternum, intestine, limb, kidney and stomach (PubMed:14585816). {ECO:0000269|PubMed:11179690, ECO:0000269|PubMed:14585816, ECO:0000269|PubMed:28905369}."
"231","sp|B4QMF4|CUE_DROSI","lcl|NC_088854.1_cds_XP_065932810.1_8822",5.29e-28,122,"B4QMF4","CUE_DROSI","Protein cueball","cue GD13471","Drosophila simulans (Fruit fly)",644,"GO:0005509; GO:0005886; GO:0007283; GO:0017147; GO:0042813; GO:0045938; GO:0048477; GO:0060070; GO:0070328","canonical Wnt signaling pathway [GO:0060070]; oogenesis [GO:0048477]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; spermatogenesis [GO:0007283]; triglyceride homeostasis [GO:0070328]","plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; oogenesis [GO:0048477]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; spermatogenesis [GO:0007283]; triglyceride homeostasis [GO:0070328]","","","",""
"232","sp|Q16YE7|CUE_AEDAE","lcl|NC_088854.1_cds_XP_065932813.1_8824",2.83e-30,129,"Q16YE7","CUE_AEDAE","Protein cueball","cue AAEL008564","Aedes aegypti (Yellowfever mosquito) (Culex aegypti)",664,"GO:0005886; GO:0007283; GO:0017147; GO:0042813; GO:0048477; GO:0060070","canonical Wnt signaling pathway [GO:0060070]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]","plasma membrane [GO:0005886]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]","","","",""
"233","sp|Q8IRY7|CASP8_DROME","lcl|NC_088854.1_cds_XP_065932928.1_9309",8.94e-21,97.4,"Q8IRY7","CASP8_DROME","Caspase-8 (EC 3.4.22.61) (Death-related ced-3/NEDD2-like protein) [Cleaved into: Caspase-8 subunit p15; Caspase-8 subunit p10]","Dredd DCP2 CG7486","Drosophila melanogaster (Fruit fly)",494,"GO:0002230; GO:0004197; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006952; GO:0006955; GO:0006963; GO:0006964; GO:0007291; GO:0008047; GO:0008656; GO:0016485; GO:0043069; GO:0043525; GO:0045087; GO:0045089; GO:0048935; GO:0050829; GO:0061057; GO:0097194","apoptotic process [GO:0006915]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; execution phase of apoptosis [GO:0097194]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of programmed cell death [GO:0043069]; peptidoglycan recognition protein signaling pathway [GO:0061057]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of innate immune response [GO:0045089]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; sperm individualization [GO:0007291]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; enzyme activator activity [GO:0008047]; apoptotic process [GO:0006915]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; execution phase of apoptosis [GO:0097194]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of programmed cell death [GO:0043069]; peptidoglycan recognition protein signaling pathway [GO:0061057]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of innate immune response [GO:0045089]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; sperm individualization [GO:0007291]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. Embryos exhibit ubiquitous low level of expression until stage 11 and then expression becomes spatially and temporally restricted to areas of PCD. {ECO:0000269|PubMed:9740659}.","","","TISSUE SPECIFICITY: Constitutively expressed in fat bodies of larvae and adults. {ECO:0000269|PubMed:11269502}."
"234","sp|Q2MJU7|ODFP2_MESAU","lcl|NC_088854.1_cds_XP_065932960.1_9411",4.73e-17,77,"Q2MJU7","ODFP2_MESAU","Outer dense fiber protein 2 (84 kDa outer dense fiber protein) (Cenexin) (Outer dense fiber of sperm tails protein 2)","ODF2","Mesocricetus auratus (Golden hamster)",124,"GO:0000922; GO:0005737; GO:0005813; GO:0005814; GO:0005874; GO:0007283; GO:0030154; GO:0036126; GO:0097225; GO:0097228; GO:1902017","cell differentiation [GO:0030154]; regulation of cilium assembly [GO:1902017]; spermatogenesis [GO:0007283]","centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; spindle pole [GO:0000922]; cell differentiation [GO:0030154]; regulation of cilium assembly [GO:1902017]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Detected in sperm flagella (at protein level). {ECO:0000269|PubMed:19953638}."
"235","sp|Q6AYX5|ODFP2_RAT","lcl|NC_088854.1_cds_XP_065932974.1_9416",0,556,"Q6AYX5","ODFP2_RAT","Outer dense fiber protein 2 (84 kDa outer dense fiber protein) (Cenexin) (Outer dense fiber of sperm tails protein 2)","Odf2 Odf84 KKT4","Rattus norvegicus (Rat)",825,"GO:0000922; GO:0001520; GO:0005737; GO:0005813; GO:0005814; GO:0005874; GO:0005929; GO:0007286; GO:0008104; GO:0010457; GO:0036126; GO:0044782; GO:0097225; GO:0097228; GO:0097539; GO:0120103; GO:1902017","centriole-centriole cohesion [GO:0010457]; cilium organization [GO:0044782]; protein localization [GO:0008104]; regulation of cilium assembly [GO:1902017]; spermatid development [GO:0007286]","centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; outer dense fiber [GO:0001520]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; spindle pole [GO:0000922]; centriole-centriole cohesion [GO:0010457]; cilium organization [GO:0044782]; protein localization [GO:0008104]; regulation of cilium assembly [GO:1902017]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Testis-specific (PubMed:9045620). Expressed in the proximal compartment of the elongated spermatid tail; later expression progresses to the distal spermatid tail compartment located in the lumen of the seminiferous epithelium (PubMed:9698445). In spermatids (stages II-III) expression of the tails peaks and remains strong during the remaining steps of spermiogenesis (at protein level) (PubMed:9698445). Expression correlates with the onset of spermatogenesis and is first detected at 30 days. Higher expression is seen in testis of 40-day-old and adults that are older than 50 days (PubMed:9092585). No expression is seen in 10- and 20-day-old testes (PubMed:9092585). {ECO:0000269|PubMed:9045620, ECO:0000269|PubMed:9092585, ECO:0000269|PubMed:9369191, ECO:0000269|PubMed:9698445}."
"236","sp|G5EEH9|NUP98_CAEEL","lcl|NC_088854.1_cds_XP_065932981.1_9436",1.12e-66,251,"G5EEH9","NUP98_CAEEL","Nuclear pore complex protein Nup98-Nup96 (EC 3.4.21.-) [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (CeNup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (CeNup96)]","npp-10 ZK328.5","Caenorhabditis elegans",1678,"GO:0000776; GO:0000973; GO:0003723; GO:0005635; GO:0005643; GO:0005737; GO:0006405; GO:0006508; GO:0006606; GO:0006997; GO:0008139; GO:0008236; GO:0009792; GO:0015031; GO:0017056; GO:0030719; GO:0031965; GO:0034398; GO:0034501; GO:0043186; GO:0044614; GO:0051028; GO:0051301; GO:0051664; GO:0090435; GO:1990893","cell division [GO:0051301]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic chromosome centromere condensation [GO:1990893]; mRNA transport [GO:0051028]; nuclear pore localization [GO:0051664]; nucleus organization [GO:0006997]; P granule organization [GO:0030719]; post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; protein localization to kinetochore [GO:0034501]; protein localization to nuclear envelope [GO:0090435]; protein transport [GO:0015031]; proteolysis [GO:0006508]; RNA export from nucleus [GO:0006405]; telomere tethering at nuclear periphery [GO:0034398]","cytoplasm [GO:0005737]; kinetochore [GO:0000776]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; P granule [GO:0043186]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; cell division [GO:0051301]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic chromosome centromere condensation [GO:1990893]; mRNA transport [GO:0051028]; nuclear pore localization [GO:0051664]; nucleus organization [GO:0006997]; P granule organization [GO:0030719]; post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; protein localization to kinetochore [GO:0034501]; protein localization to nuclear envelope [GO:0090435]; protein transport [GO:0015031]; proteolysis [GO:0006508]; RNA export from nucleus [GO:0006405]; telomere tethering at nuclear periphery [GO:0034398]","DEVELOPMENTAL STAGE: Expressed in embryos (at protein level). {ECO:0000269|PubMed:12937276, ECO:0000269|PubMed:22238360}.","","",""
"237","sp|Q9ESC8|AFF4_MOUSE","lcl|NC_088854.1_cds_XP_065933001.1_9488",2.78e-26,118,"Q9ESC8","AFF4_MOUSE","AF4/FMR2 family member 4","Aff4 Alf4","Mus musculus (Mouse)",1160,"GO:0000791; GO:0001650; GO:0005634; GO:0007286; GO:0008023; GO:0010468; GO:0016604; GO:0034976","regulation of gene expression [GO:0010468]; response to endoplasmic reticulum stress [GO:0034976]; spermatid development [GO:0007286]","euchromatin [GO:0000791]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; regulation of gene expression [GO:0010468]; response to endoplasmic reticulum stress [GO:0034976]; spermatid development [GO:0007286]","DEVELOPMENTAL STAGE: Expressed throughout embryogenesis with maximum expression at 10.5 and 12.5 dpc. {ECO:0000269|PubMed:16024815}.","","","TISSUE SPECIFICITY: Highly expressed in testis by Sertoli cells, and at low levels in other tissues. {ECO:0000269|PubMed:16024815}."
"238","sp|A2AL36|CNTRL_MOUSE","lcl|NC_088854.1_cds_XP_065933167.1_9818",5.98e-121,431,"A2AL36","CNTRL_MOUSE","Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa) (Cep110)","Cntrl Cep1 Cep110","Mus musculus (Mouse)",2334,"GO:0001822; GO:0003279; GO:0003281; GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0034451; GO:0035904; GO:0036064; GO:0048132; GO:0048471; GO:0060976; GO:0072687; GO:0090543; GO:0090619; GO:0097431; GO:0120103","aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; female germ-line stem cell asymmetric division [GO:0048132]; kidney development [GO:0001822]; ventricular septum development [GO:0003281]","centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Flemming body [GO:0090543]; Golgi apparatus [GO:0005794]; meiotic spindle [GO:0072687]; meiotic spindle pole [GO:0090619]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; female germ-line stem cell asymmetric division [GO:0048132]; kidney development [GO:0001822]; ventricular septum development [GO:0003281]","","","","TISSUE SPECIFICITY: Highly expressed in liver. {ECO:0000269|PubMed:10688839}."
"239","sp|Q5K6N0|TM232_MOUSE","lcl|NC_088854.1_cds_XP_065933242.1_9953",3.22e-48,183,"Q5K6N0","TM232_MOUSE","Transmembrane protein 232 (Testis-specific protein 13)","Tmem232 Tes13","Mus musculus (Mouse)",675,"GO:0001520; GO:0007283; GO:0016020; GO:0030030; GO:0030317; GO:0098544; GO:0160087","cell projection organization [GO:0030030]; flagellated sperm motility [GO:0030317]; maintenance of protein complex location [GO:0098544]; spermatid cytoplasm removal during spermiation of flagellated sperm [GO:0160087]; spermatogenesis [GO:0007283]","membrane [GO:0016020]; outer dense fiber [GO:0001520]; cell projection organization [GO:0030030]; flagellated sperm motility [GO:0030317]; maintenance of protein complex location [GO:0098544]; spermatid cytoplasm removal during spermiation of flagellated sperm [GO:0160087]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: High expression in the testis and weak expression levels in the spleen, liver, brain, uterus, lung, epididymis and kidney. Not detected in the heart or ovary. {ECO:0000269|PubMed:37371084}."
"240","sp|Q9VW71|FAT2_DROME","lcl|NC_088854.1_cds_XP_065933246.1_9956",0,2499,"Q9VW71","FAT2_DROME","Fat-like cadherin-related tumor suppressor homolog (Protein kugelei)","kug fat2 CG7749","Drosophila melanogaster (Fruit fly)",4699,"GO:0005509; GO:0005886; GO:0005925; GO:0007156; GO:0007295; GO:0007424; GO:0007431; GO:0007440; GO:0007442; GO:0009925; GO:0016339; GO:0030950; GO:0031254; GO:0042247; GO:0044331; GO:0044877; GO:0045089; GO:0048477; GO:0050829; GO:0050839; GO:0051491; GO:0060269; GO:0098609; GO:0098858; GO:1902463","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; centripetally migrating follicle cell migration [GO:0060269]; defense response to Gram-negative bacterium [GO:0050829]; establishment of planar polarity of follicular epithelium [GO:0042247]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; foregut morphogenesis [GO:0007440]; growth of a germarium-derived egg chamber [GO:0007295]; hindgut morphogenesis [GO:0007442]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of innate immune response [GO:0045089]; protein localization to cell leading edge [GO:1902463]; salivary gland development [GO:0007431]","actin-based cell projection [GO:0098858]; basal plasma membrane [GO:0009925]; cell trailing edge [GO:0031254]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein-containing complex binding [GO:0044877]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; centripetally migrating follicle cell migration [GO:0060269]; defense response to Gram-negative bacterium [GO:0050829]; establishment of planar polarity of follicular epithelium [GO:0042247]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; foregut morphogenesis [GO:0007440]; growth of a germarium-derived egg chamber [GO:0007295]; hindgut morphogenesis [GO:0007442]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of innate immune response [GO:0045089]; protein localization to cell leading edge [GO:1902463]; salivary gland development [GO:0007431]","","","","TISSUE SPECIFICITY: Localizes where basal actin filaments terminate. {ECO:0000269|PubMed:19906848}."
"241","sp|G5EF60|STIM1_CAEEL","lcl|NC_088854.1_cds_XP_065933290.1_10078",4.82e-39,152,"G5EF60","STIM1_CAEEL","Stromal interaction molecule 1","stim-1 Y55B1BM.1","Caenorhabditis elegans",530,"GO:0002115; GO:0005246; GO:0005262; GO:0005509; GO:0005737; GO:0005783; GO:0005886; GO:0006874; GO:0022414; GO:0030425; GO:0030728; GO:0042802; GO:0043025; GO:0043229; GO:0045987; GO:1901076","intracellular calcium ion homeostasis [GO:0006874]; ovulation [GO:0030728]; positive regulation of engulfment of apoptotic cell [GO:1901076]; positive regulation of smooth muscle contraction [GO:0045987]; reproductive process [GO:0022414]; store-operated calcium entry [GO:0002115]","cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; intracellular organelle [GO:0043229]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; intracellular calcium ion homeostasis [GO:0006874]; ovulation [GO:0030728]; positive regulation of engulfment of apoptotic cell [GO:1901076]; positive regulation of smooth muscle contraction [GO:0045987]; reproductive process [GO:0022414]; store-operated calcium entry [GO:0002115]","","","","TISSUE SPECIFICITY: Coexpressed with orai-1 in spermatheca, gonad sheath cells and intestine. Also detected in neurons in the head and in the uterine epithelial cells. Heterogeneously expressed in the intestine with strong presence in the anterior and posterior intestine and weaker in the midsection. {ECO:0000269|PubMed:16966474, ECO:0000269|PubMed:17218360}."
"242","sp|Q23989|QUAI_DROME","lcl|NC_088854.1_cds_XP_065933317.1_10133",6.65e-111,361,"Q23989","QUAI_DROME","Villin-like protein quail","qua CG6433","Drosophila melanogaster (Fruit fly)",888,"GO:0003779; GO:0005509; GO:0005546; GO:0005737; GO:0007300; GO:0008154; GO:0015629; GO:0035317; GO:0051014; GO:0051015; GO:0051016","actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; imaginal disc-derived wing hair organization [GO:0035317]; ovarian nurse cell to oocyte transport [GO:0007300]","actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; imaginal disc-derived wing hair organization [GO:0035317]; ovarian nurse cell to oocyte transport [GO:0007300]","","","","TISSUE SPECIFICITY: Germline specific in adult flies. {ECO:0000269|PubMed:8044841}."
"243","sp|Q9VT28|FRY_DROME","lcl|NC_088854.1_cds_XP_065933346.1_10237",0,803,"Q9VT28","FRY_DROME","Protein furry","fry CG32045","Drosophila melanogaster (Fruit fly)",3479,"GO:0000902; GO:0005737; GO:0005938; GO:0007476; GO:0008407; GO:0030424; GO:0030425; GO:0030427; GO:0031175; GO:0035316; GO:0035317; GO:0042052; GO:0044297; GO:0045177; GO:0045860; GO:0045893; GO:0048601; GO:0048800; GO:0048814; GO:0050773; GO:0051012; GO:0070593; GO:0071902; GO:0150013","antennal morphogenesis [GO:0048800]; cell morphogenesis [GO:0000902]; chaeta morphogenesis [GO:0008407]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; neuron projection development [GO:0031175]; non-sensory hair organization [GO:0035316]; oocyte morphogenesis [GO:0048601]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; rhabdomere development [GO:0042052]","apical part of cell [GO:0045177]; axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; site of polarized growth [GO:0030427]; antennal morphogenesis [GO:0048800]; cell morphogenesis [GO:0000902]; chaeta morphogenesis [GO:0008407]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; neuron projection development [GO:0031175]; non-sensory hair organization [GO:0035316]; oocyte morphogenesis [GO:0048601]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; rhabdomere development [GO:0042052]","DEVELOPMENTAL STAGE: Expression is very low in embryonic and early larval stages, increases to be high from third larval instar to adults. {ECO:0000269|PubMed:11526084}.","","","TISSUE SPECIFICITY: Co-expressed with trc in all da neurons in third instar wild-type larvae; axons and dendritic branches. {ECO:0000269|PubMed:15479641}."
"244","sp|P11416|RARA_MOUSE","lcl|NC_088854.1_cds_XP_065933415.1_10401",7.5e-142,414,"P11416","RARA_MOUSE","Retinoic acid receptor alpha (RAR-alpha) (Nuclear receptor subfamily 1 group B member 1)","Rara Nr1b1","Mus musculus (Mouse)",462,"GO:0000122; GO:0000785; GO:0000900; GO:0000976; GO:0000977; GO:0001217; GO:0001223; GO:0001657; GO:0001843; GO:0001889; GO:0001972; GO:0002068; GO:0003148; GO:0003417; GO:0003677; GO:0003700; GO:0004879; GO:0005102; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006355; GO:0007281; GO:0007283; GO:0007565; GO:0008270; GO:0008284; GO:0008285; GO:0010628; GO:0010629; GO:0015629; GO:0019904; GO:0021766; GO:0030425; GO:0030850; GO:0030852; GO:0030853; GO:0031076; GO:0031490; GO:0031641; GO:0032355; GO:0032526; GO:0032689; GO:0032720; GO:0032736; GO:0032753; GO:0032754; GO:0033189; GO:0034097; GO:0035264; GO:0042789; GO:0042826; GO:0043025; GO:0043066; GO:0043277; GO:0043422; GO:0043565; GO:0044323; GO:0045471; GO:0045596; GO:0045630; GO:0045666; GO:0045787; GO:0045892; GO:0045944; GO:0045947; GO:0048027; GO:0048167; GO:0048384; GO:0048471; GO:0051018; GO:0051393; GO:0055012; GO:0060010; GO:0060173; GO:0060324; GO:0060348; GO:0060534; GO:0060591; GO:0061037; GO:0071222; GO:0071300; GO:0071391; GO:0090575; GO:1901363; GO:1901532; GO:1902894","apoptotic cell clearance [GO:0043277]; bone development [GO:0060348]; cellular response to estrogen stimulus [GO:0071391]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; chondroblast differentiation [GO:0060591]; embryonic camera-type eye development [GO:0031076]; face development [GO:0060324]; female pregnancy [GO:0007565]; germ cell development [GO:0007281]; glandular epithelial cell development [GO:0002068]; growth plate cartilage development [GO:0003417]; hippocampus development [GO:0021766]; limb development [GO:0060173]; liver development [GO:0001889]; mRNA transcription by RNA polymerase II [GO:0042789]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type II interferon production [GO:0032689]; neural tube closure [GO:0001843]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland development [GO:0030850]; regulation of DNA-templated transcription [GO:0006355]; regulation of granulocyte differentiation [GO:0030852]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; regulation of myelination [GO:0031641]; regulation of synaptic plasticity [GO:0048167]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoic acid receptor signaling pathway [GO:0048384]; Sertoli cell fate commitment [GO:0060010]; spermatogenesis [GO:0007283]; trachea cartilage development [GO:0060534]; ureteric bud development [GO:0001657]; ventricular cardiac muscle cell differentiation [GO:0055012]","actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]; alpha-actinin binding [GO:0051393]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity [GO:0001217]; heterocyclic compound binding [GO:1901363]; histone deacetylase binding [GO:0042826]; mRNA 5'-UTR binding [GO:0048027]; mRNA regulatory element binding translation repressor activity [GO:0000900]; nuclear receptor activity [GO:0004879]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase B binding [GO:0043422]; retinoic acid binding [GO:0001972]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; signaling receptor binding [GO:0005102]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]; apoptotic cell clearance [GO:0043277]; bone development [GO:0060348]; cellular response to estrogen stimulus [GO:0071391]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; chondroblast differentiation [GO:0060591]; embryonic camera-type eye development [GO:0031076]; face development [GO:0060324]; female pregnancy [GO:0007565]; germ cell development [GO:0007281]; glandular epithelial cell development [GO:0002068]; growth plate cartilage development [GO:0003417]; hippocampus development [GO:0021766]; limb development [GO:0060173]; liver development [GO:0001889]; mRNA transcription by RNA polymerase II [GO:0042789]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type II interferon production [GO:0032689]; neural tube closure [GO:0001843]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland development [GO:0030850]; regulation of DNA-templated transcription [GO:0006355]; regulation of granulocyte differentiation [GO:0030852]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; regulation of myelination [GO:0031641]; regulation of synaptic plasticity [GO:0048167]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoic acid receptor signaling pathway [GO:0048384]; Sertoli cell fate commitment [GO:0060010]; spermatogenesis [GO:0007283]; trachea cartilage development [GO:0060534]; ureteric bud development [GO:0001657]; ventricular cardiac muscle cell differentiation [GO:0055012]","","INDUCTION: By retinoic acid. {ECO:0000269|PubMed:17905941}.","INDUCTION: By retinoic acid. {ECO:0000269|PubMed:17905941}.","TISSUE SPECIFICITY: Expressed in Sertoli cells and germ cells. {ECO:0000269|PubMed:17905941}."
"245","sp|P10276|RARA_HUMAN","lcl|NC_088854.1_cds_XP_065933416.1_10402",3.19e-142,415,"P10276","RARA_HUMAN","Retinoic acid receptor alpha (RAR-alpha) (Nuclear receptor subfamily 1 group B member 1)","RARA NR1B1","Homo sapiens (Human)",462,"GO:0000122; GO:0000785; GO:0000900; GO:0000977; GO:0000978; GO:0000981; GO:0001217; GO:0001223; GO:0001657; GO:0001843; GO:0001889; GO:0001972; GO:0002068; GO:0003148; GO:0003417; GO:0003682; GO:0003700; GO:0004879; GO:0005102; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007281; GO:0007283; GO:0007565; GO:0008270; GO:0008284; GO:0008285; GO:0015629; GO:0019899; GO:0019904; GO:0021766; GO:0030154; GO:0030425; GO:0030850; GO:0030853; GO:0031076; GO:0031490; GO:0031641; GO:0032355; GO:0032526; GO:0032689; GO:0032720; GO:0032736; GO:0032753; GO:0032754; GO:0032991; GO:0033189; GO:0034097; GO:0035264; GO:0042789; GO:0042826; GO:0043066; GO:0043277; GO:0043422; GO:0044323; GO:0045471; GO:0045630; GO:0045666; GO:0045787; GO:0045892; GO:0045893; GO:0045944; GO:0048027; GO:0048167; GO:0048384; GO:0048471; GO:0051018; GO:0051099; GO:0051393; GO:0055012; GO:0060010; GO:0060173; GO:0060324; GO:0060534; GO:0060591; GO:0061037; GO:0071222; GO:0071300; GO:0071391; GO:0090575; GO:1901363; GO:1901532; GO:1902894; GO:1990837","apoptotic cell clearance [GO:0043277]; cell differentiation [GO:0030154]; cellular response to estrogen stimulus [GO:0071391]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; chondroblast differentiation [GO:0060591]; embryonic camera-type eye development [GO:0031076]; face development [GO:0060324]; female pregnancy [GO:0007565]; germ cell development [GO:0007281]; glandular epithelial cell development [GO:0002068]; growth plate cartilage development [GO:0003417]; hippocampus development [GO:0021766]; limb development [GO:0060173]; liver development [GO:0001889]; mRNA transcription by RNA polymerase II [GO:0042789]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type II interferon production [GO:0032689]; neural tube closure [GO:0001843]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of binding [GO:0051099]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland development [GO:0030850]; protein phosphorylation [GO:0006468]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; regulation of myelination [GO:0031641]; regulation of synaptic plasticity [GO:0048167]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoic acid receptor signaling pathway [GO:0048384]; Sertoli cell fate commitment [GO:0060010]; spermatogenesis [GO:0007283]; trachea cartilage development [GO:0060534]; ureteric bud development [GO:0001657]; ventricular cardiac muscle cell differentiation [GO:0055012]","actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]; alpha-actinin binding [GO:0051393]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; enzyme binding [GO:0019899]; heterocyclic compound binding [GO:1901363]; histone deacetylase binding [GO:0042826]; mRNA 5'-UTR binding [GO:0048027]; mRNA regulatory element binding translation repressor activity [GO:0000900]; nuclear receptor activity [GO:0004879]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase B binding [GO:0043422]; retinoic acid binding [GO:0001972]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; signaling receptor binding [GO:0005102]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]; apoptotic cell clearance [GO:0043277]; cell differentiation [GO:0030154]; cellular response to estrogen stimulus [GO:0071391]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; chondroblast differentiation [GO:0060591]; embryonic camera-type eye development [GO:0031076]; face development [GO:0060324]; female pregnancy [GO:0007565]; germ cell development [GO:0007281]; glandular epithelial cell development [GO:0002068]; growth plate cartilage development [GO:0003417]; hippocampus development [GO:0021766]; limb development [GO:0060173]; liver development [GO:0001889]; mRNA transcription by RNA polymerase II [GO:0042789]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type II interferon production [GO:0032689]; neural tube closure [GO:0001843]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of binding [GO:0051099]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland development [GO:0030850]; protein phosphorylation [GO:0006468]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; regulation of myelination [GO:0031641]; regulation of synaptic plasticity [GO:0048167]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoic acid receptor signaling pathway [GO:0048384]; Sertoli cell fate commitment [GO:0060010]; spermatogenesis [GO:0007283]; trachea cartilage development [GO:0060534]; ureteric bud development [GO:0001657]; ventricular cardiac muscle cell differentiation [GO:0055012]","","INDUCTION: Expression is induced ba retinoic acid (PubMed:19398580). Down-regulated by aging (PubMed:26463675). Induced by pulsatile shear stress (PubMed:28167758). {ECO:0000269|PubMed:19398580, ECO:0000269|PubMed:26463675, ECO:0000269|PubMed:28167758}.","INDUCTION: Expression is induced ba retinoic acid (PubMed:19398580). Down-regulated by aging (PubMed:26463675). Induced by pulsatile shear stress (PubMed:28167758). {ECO:0000269|PubMed:19398580, ECO:0000269|PubMed:26463675, ECO:0000269|PubMed:28167758}.","TISSUE SPECIFICITY: Expressed in monocytes. {ECO:0000269|PubMed:26463675}."
"246","sp|Q00981|UCHL1_RAT","lcl|NC_088854.1_cds_XP_065933505.1_10574",1.58e-61,192,"Q00981","UCHL1_RAT","Ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCH-L1) (EC 3.4.19.12) (Neuron cytoplasmic protein 9.5) (PGP 9.5) (PGP9.5) (Ubiquitin thioesterase L1)","Uchl1","Rattus norvegicus (Rat)",223,"GO:0002176; GO:0002931; GO:0004197; GO:0004843; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006511; GO:0007409; GO:0007412; GO:0007628; GO:0008242; GO:0016579; GO:0019896; GO:0030163; GO:0030424; GO:0031625; GO:0031694; GO:0042755; GO:0043022; GO:0043025; GO:0043130; GO:0044306; GO:0045821; GO:0050905; GO:0055001; GO:0071466; GO:1904115","adult walking behavior [GO:0007628]; axon target recognition [GO:0007412]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cellular response to xenobiotic stimulus [GO:0071466]; eating behavior [GO:0042755]; male germ cell proliferation [GO:0002176]; muscle cell development [GO:0055001]; neuromuscular process [GO:0050905]; positive regulation of glycolytic process [GO:0045821]; protein catabolic process [GO:0030163]; protein deubiquitination [GO:0016579]; response to ischemia [GO:0002931]; ubiquitin-dependent protein catabolic process [GO:0006511]","axon [GO:0030424]; axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; alpha-2A adrenergic receptor binding [GO:0031694]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; omega peptidase activity [GO:0008242]; ribosome binding [GO:0043022]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; adult walking behavior [GO:0007628]; axon target recognition [GO:0007412]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cellular response to xenobiotic stimulus [GO:0071466]; eating behavior [GO:0042755]; male germ cell proliferation [GO:0002176]; muscle cell development [GO:0055001]; neuromuscular process [GO:0050905]; positive regulation of glycolytic process [GO:0045821]; protein catabolic process [GO:0030163]; protein deubiquitination [GO:0016579]; response to ischemia [GO:0002931]; ubiquitin-dependent protein catabolic process [GO:0006511]","","","",""
"247","sp|P80201|ACVR1_RAT","lcl|NC_088854.1_cds_XP_065933577.1_10754",1.22e-169,489,"P80201","ACVR1_RAT","Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (ACTR-I) (Serine/threonine-protein kinase receptor R1) (SKR1) (TGF-B superfamily receptor type I) (TSR-I)","Acvr1 Acvrlk2","Rattus norvegicus (Rat)",509,"GO:0001569; GO:0001649; GO:0001655; GO:0001701; GO:0001702; GO:0001707; GO:0001755; GO:0002526; GO:0003143; GO:0003181; GO:0003183; GO:0003272; GO:0003274; GO:0003289; GO:0004672; GO:0004674; GO:0004675; GO:0005025; GO:0005524; GO:0005886; GO:0007179; GO:0007281; GO:0007368; GO:0007369; GO:0007498; GO:0007507; GO:0009953; GO:0009968; GO:0016361; GO:0019838; GO:0030154; GO:0030278; GO:0030335; GO:0030501; GO:0030509; GO:0032924; GO:0032926; GO:0042803; GO:0045177; GO:0045296; GO:0045669; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0048179; GO:0048185; GO:0048641; GO:0050431; GO:0051145; GO:0060037; GO:0060391; GO:0060412; GO:0060923; GO:0061445; GO:0062043; GO:0070724; GO:0071363; GO:0071385; GO:0071773; GO:0098821; GO:1902533; GO:1990782; GO:2000017; GO:2000134; GO:2001237","activin receptor signaling pathway [GO:0032924]; acute inflammatory response [GO:0002526]; atrial septum primum morphogenesis [GO:0003289]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac muscle cell fate commitment [GO:0060923]; cell differentiation [GO:0030154]; cellular response to BMP stimulus [GO:0071773]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion cell fate commitment [GO:0061445]; endocardial cushion formation [GO:0003272]; endocardial cushion fusion [GO:0003274]; gastrulation [GO:0007369]; gastrulation with mouth forming second [GO:0001702]; germ cell development [GO:0007281]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; mesoderm development [GO:0007498]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of signal transduction [GO:0009968]; neural crest cell migration [GO:0001755]; osteoblast differentiation [GO:0001649]; pharyngeal system development [GO:0060037]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cell migration [GO:0030335]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of ossification [GO:0030278]; regulation of skeletal muscle tissue development [GO:0048641]; smooth muscle cell differentiation [GO:0051145]; transforming growth factor beta receptor signaling pathway [GO:0007179]; urogenital system development [GO:0001655]; ventricular septum morphogenesis [GO:0060412]","activin receptor complex [GO:0048179]; apical part of cell [GO:0045177]; BMP receptor complex [GO:0070724]; plasma membrane [GO:0005886]; activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase binding [GO:1990782]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; activin receptor signaling pathway [GO:0032924]; acute inflammatory response [GO:0002526]; atrial septum primum morphogenesis [GO:0003289]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac muscle cell fate commitment [GO:0060923]; cell differentiation [GO:0030154]; cellular response to BMP stimulus [GO:0071773]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion cell fate commitment [GO:0061445]; endocardial cushion formation [GO:0003272]; endocardial cushion fusion [GO:0003274]; gastrulation [GO:0007369]; gastrulation with mouth forming second [GO:0001702]; germ cell development [GO:0007281]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; mesoderm development [GO:0007498]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of signal transduction [GO:0009968]; neural crest cell migration [GO:0001755]; osteoblast differentiation [GO:0001649]; pharyngeal system development [GO:0060037]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cell migration [GO:0030335]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of ossification [GO:0030278]; regulation of skeletal muscle tissue development [GO:0048641]; smooth muscle cell differentiation [GO:0051145]; transforming growth factor beta receptor signaling pathway [GO:0007179]; urogenital system development [GO:0001655]; ventricular septum morphogenesis [GO:0060412]","","","","TISSUE SPECIFICITY: Urogenital ridge, testis, ovary, brain and lungs."
"248","sp|Q68FQ2|JAM3_RAT","lcl|NC_088854.1_cds_XP_065933685.1_10971",1.11e-13,73.2,"Q68FQ2","JAM3_RAT","Junctional adhesion molecule C (JAM-C) (Junctional adhesion molecule 3) (JAM-3) [Cleaved into: Soluble form of JAM-C (sJAM-C)]","Jam3","Rattus norvegicus (Rat)",310,"GO:0001525; GO:0001780; GO:0002250; GO:0002318; GO:0002523; GO:0005178; GO:0005615; GO:0005886; GO:0005902; GO:0005911; GO:0005923; GO:0007155; GO:0007160; GO:0007283; GO:0007286; GO:0016477; GO:0019226; GO:0030010; GO:0030057; GO:0031103; GO:0031941; GO:0033010; GO:0033624; GO:0033629; GO:0034113; GO:0034333; GO:0034394; GO:0042552; GO:0042802; GO:0042803; GO:0043220; GO:0044291; GO:0045176; GO:0046982; GO:0070160; GO:0090022; GO:0090138; GO:0097241; GO:0097530; GO:0098609; GO:0098632; GO:0098636; GO:1902414; GO:1905710; GO:2000439","adaptive immune response [GO:0002250]; adherens junction assembly [GO:0034333]; angiogenesis [GO:0001525]; apical protein localization [GO:0045176]; axon regeneration [GO:0031103]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; establishment of cell polarity [GO:0030010]; granulocyte migration [GO:0097530]; hematopoietic stem cell migration to bone marrow [GO:0097241]; heterotypic cell-cell adhesion [GO:0034113]; leukocyte migration involved in inflammatory response [GO:0002523]; myelination [GO:0042552]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of integrin activation [GO:0033624]; neutrophil homeostasis [GO:0001780]; positive regulation of membrane permeability [GO:1905710]; positive regulation of monocyte extravasation [GO:2000439]; protein localization to cell junction [GO:1902414]; protein localization to cell surface [GO:0034394]; regulation of actin cytoskeleton organization by cell-cell adhesion [GO:0090138]; regulation of neutrophil chemotaxis [GO:0090022]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; transmission of nerve impulse [GO:0019226]","bicellular tight junction [GO:0005923]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; desmosome [GO:0030057]; extracellular space [GO:0005615]; filamentous actin [GO:0031941]; microvillus [GO:0005902]; paranodal junction [GO:0033010]; plasma membrane [GO:0005886]; protein complex involved in cell adhesion [GO:0098636]; Schmidt-Lanterman incisure [GO:0043220]; tight junction [GO:0070160]; cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; adaptive immune response [GO:0002250]; adherens junction assembly [GO:0034333]; angiogenesis [GO:0001525]; apical protein localization [GO:0045176]; axon regeneration [GO:0031103]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; establishment of cell polarity [GO:0030010]; granulocyte migration [GO:0097530]; hematopoietic stem cell migration to bone marrow [GO:0097241]; heterotypic cell-cell adhesion [GO:0034113]; leukocyte migration involved in inflammatory response [GO:0002523]; myelination [GO:0042552]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of integrin activation [GO:0033624]; neutrophil homeostasis [GO:0001780]; positive regulation of membrane permeability [GO:1905710]; positive regulation of monocyte extravasation [GO:2000439]; protein localization to cell junction [GO:1902414]; protein localization to cell surface [GO:0034394]; regulation of actin cytoskeleton organization by cell-cell adhesion [GO:0090138]; regulation of neutrophil chemotaxis [GO:0090022]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; transmission of nerve impulse [GO:0019226]","","","",""
"249","sp|Q8MPP3|D2MP_DROME","lcl|NC_088855.1_cds_NP_001292229.1_16668",9.8e-52,191,"Q8MPP3","D2MP_DROME","Matrix metalloproteinase-2 (Dm2-MMP) (EC 3.4.24.-)","Mmp2 CG1794","Drosophila melanogaster (Fruit fly)",758,"GO:0002218; GO:0003144; GO:0003319; GO:0004175; GO:0004222; GO:0005615; GO:0005886; GO:0006929; GO:0007419; GO:0007424; GO:0007426; GO:0007505; GO:0007561; GO:0008045; GO:0008270; GO:0009897; GO:0016485; GO:0030198; GO:0030425; GO:0030574; GO:0030728; GO:0031012; GO:0034769; GO:0035202; GO:0040037; GO:0042060; GO:0045216; GO:0046331; GO:0046529; GO:0071711; GO:0090090; GO:0097156; GO:1901202; GO:2000647","activation of innate immune response [GO:0002218]; adult fat body development [GO:0007505]; basement membrane disassembly [GO:0034769]; basement membrane organization [GO:0071711]; cardioblast migration to the midline involved in heart rudiment formation [GO:0003319]; cell-cell junction organization [GO:0045216]; collagen catabolic process [GO:0030574]; embryonic heart tube formation [GO:0003144]; extracellular matrix organization [GO:0030198]; fasciculation of motor neuron axon [GO:0097156]; imaginal disc eversion [GO:0007561]; imaginal disc fusion, thorax closure [GO:0046529]; lateral inhibition [GO:0046331]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of extracellular matrix assembly [GO:1901202]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of stem cell proliferation [GO:2000647]; open tracheal system development [GO:0007424]; ovulation [GO:0030728]; protein processing [GO:0016485]; substrate-dependent cell migration [GO:0006929]; tracheal outgrowth, open tracheal system [GO:0007426]; tracheal pit formation in open tracheal system [GO:0035202]; ventral cord development [GO:0007419]; wound healing [GO:0042060]","dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; activation of innate immune response [GO:0002218]; adult fat body development [GO:0007505]; basement membrane disassembly [GO:0034769]; basement membrane organization [GO:0071711]; cardioblast migration to the midline involved in heart rudiment formation [GO:0003319]; cell-cell junction organization [GO:0045216]; collagen catabolic process [GO:0030574]; embryonic heart tube formation [GO:0003144]; extracellular matrix organization [GO:0030198]; fasciculation of motor neuron axon [GO:0097156]; imaginal disc eversion [GO:0007561]; imaginal disc fusion, thorax closure [GO:0046529]; lateral inhibition [GO:0046331]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of extracellular matrix assembly [GO:1901202]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of stem cell proliferation [GO:2000647]; open tracheal system development [GO:0007424]; ovulation [GO:0030728]; protein processing [GO:0016485]; substrate-dependent cell migration [GO:0006929]; tracheal outgrowth, open tracheal system [GO:0007426]; tracheal pit formation in open tracheal system [GO:0035202]; ventral cord development [GO:0007419]; wound healing [GO:0042060]","DEVELOPMENTAL STAGE: Expressed in embryos beginning at 8-12 hours, in first instar larvae, in pupae and in male and female adults with highest expression in early pupae (PubMed:11967260, PubMed:12530966). In epithelial cells, weakly expressed at late pupal stages with significantly elevated expression at the early adult stage of 0-4 hours after eclosion and levels returning to normal by 3 days after eclosion (PubMed:20412776). {ECO:0000269|PubMed:11967260, ECO:0000269|PubMed:12530966, ECO:0000269|PubMed:20412776}.","INDUCTION: In fat body cells induced by sorbitol and galactitol produced by hemocytes in the hemolymph, probably in response to Gram-negative bacterial infection. {ECO:0000269|PubMed:31350199}.","INDUCTION: In fat body cells induced by sorbitol and galactitol produced by hemocytes in the hemolymph, probably in response to Gram-negative bacterial infection. {ECO:0000269|PubMed:31350199}.","TISSUE SPECIFICITY: Widely expressed during embryogenesis including in the mesoderm, developing gut, central and peripheral nervous systems and imaginal disks (PubMed:12530966). In the embryonic nervous system, expressed in neurons and glia (PubMed:18045838). In third instar larvae, strongly expressed in the morphogenetic furrow of eye imaginal disks and in the optic lobe region of the brain (PubMed:11967260). Expressed in posterior follicle cells in all mature stage 14 follicles but not in earlier follicles and is also expressed in some anterior follicle cells that help form dorsal eggshell structures (PubMed:25695427). {ECO:0000269|PubMed:11967260, ECO:0000269|PubMed:12530966, ECO:0000269|PubMed:18045838, ECO:0000269|PubMed:25695427}."
"250","sp|Q9XYF4|DRONC_DROME","lcl|NC_088855.1_cds_NP_001292299.1_11946",4.06e-25,108,"Q9XYF4","DRONC_DROME","Caspase Dronc (EC 3.4.22.62) (Death regulator NEDD2-like caspase) [Cleaved into: Caspase Nc subunit 1; Caspase Nc subunit 2]","Dronc Nc CG8091","Drosophila melanogaster (Fruit fly)",450,"GO:0004197; GO:0005634; GO:0005737; GO:0005886; GO:0006915; GO:0007291; GO:0007417; GO:0007516; GO:0007552; GO:0008258; GO:0008285; GO:0008340; GO:0010623; GO:0012501; GO:0016322; GO:0016540; GO:0022416; GO:0031638; GO:0035006; GO:0035070; GO:0035234; GO:0042803; GO:0043293; GO:0045476; GO:0046667; GO:0048749; GO:0048813; GO:0050700; GO:0097194; GO:0097300; GO:2001235","apoptotic process [GO:0006915]; central nervous system development [GO:0007417]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; compound eye retinal cell programmed cell death [GO:0046667]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; ectopic germ cell programmed cell death [GO:0035234]; execution phase of apoptosis [GO:0097194]; head involution [GO:0008258]; hemocyte development [GO:0007516]; melanization defense response [GO:0035006]; metamorphosis [GO:0007552]; negative regulation of cell population proliferation [GO:0008285]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of apoptotic signaling pathway [GO:2001235]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; programmed necrotic cell death [GO:0097300]; protein autoprocessing [GO:0016540]; salivary gland histolysis [GO:0035070]; sperm individualization [GO:0007291]; zymogen activation [GO:0031638]","apoptosome [GO:0043293]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; CARD domain binding [GO:0050700]; cysteine-type endopeptidase activity [GO:0004197]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; central nervous system development [GO:0007417]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; compound eye retinal cell programmed cell death [GO:0046667]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; ectopic germ cell programmed cell death [GO:0035234]; execution phase of apoptosis [GO:0097194]; head involution [GO:0008258]; hemocyte development [GO:0007516]; melanization defense response [GO:0035006]; metamorphosis [GO:0007552]; negative regulation of cell population proliferation [GO:0008285]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of apoptotic signaling pathway [GO:2001235]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; programmed necrotic cell death [GO:0097300]; protein autoprocessing [GO:0016540]; salivary gland histolysis [GO:0035070]; sperm individualization [GO:0007291]; zymogen activation [GO:0031638]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. {ECO:0000269|PubMed:10200258}.","INDUCTION: By ecdysone; exposure of salivary glands and midgut isolated from second instar larvae results in a massive increase in levels. {ECO:0000269|PubMed:10200258}.","INDUCTION: By ecdysone; exposure of salivary glands and midgut isolated from second instar larvae results in a massive increase in levels. {ECO:0000269|PubMed:10200258}.","TISSUE SPECIFICITY: Ubiquitously expressed in embryos during early stages of development. In late third instar larvae, dramatic up-regulation in salivary glands and midgut before histolysis of these tissues. {ECO:0000269|PubMed:10200258}."
"251","sp|P38532|HSF1_MOUSE","lcl|NC_088855.1_cds_NP_001292306.1_16098",3.88e-90,286,"P38532","HSF1_MOUSE","Heat shock factor protein 1 (HSF 1) (Heat shock transcription factor 1) (HSTF 1)","Hsf1","Mus musculus (Mouse)",525,"GO:0000122; GO:0000165; GO:0000776; GO:0000791; GO:0000792; GO:0000978; GO:0001162; GO:0001227; GO:0001228; GO:0001701; GO:0001892; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006281; GO:0006397; GO:0006952; GO:0007143; GO:0007283; GO:0007584; GO:0008283; GO:0009408; GO:0010628; GO:0010667; GO:0014823; GO:0016605; GO:0019901; GO:0031072; GO:0031333; GO:0031490; GO:0032496; GO:0032720; GO:0032991; GO:0033574; GO:0034605; GO:0034620; GO:0035865; GO:0040018; GO:0042802; GO:0043565; GO:0045120; GO:0045651; GO:0045931; GO:0045944; GO:0046982; GO:0048471; GO:0050673; GO:0050680; GO:0051028; GO:0051879; GO:0060136; GO:0061770; GO:0062029; GO:0065003; GO:0070301; GO:0071222; GO:0071276; GO:0071280; GO:0071392; GO:0071466; GO:0071480; GO:0072738; GO:0090084; GO:0090261; GO:0097165; GO:0097431; GO:0097677; GO:0098847; GO:0101031; GO:0120162; GO:0140296; GO:1900034; GO:1901652; GO:1902512; GO:1903936; GO:1904385; GO:1904843; GO:1904845; GO:1990841; GO:1990904; GO:1990910; GO:1990911; GO:2001033; GO:2001235","cell population proliferation [GO:0008283]; cellular response to angiotensin [GO:1904385]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to estradiol stimulus [GO:0071392]; cellular response to gamma radiation [GO:0071480]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-glutamine [GO:1904845]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nitroglycerin [GO:1904843]; cellular response to potassium ion [GO:0035865]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; cellular response to xenobiotic stimulus [GO:0071466]; defense response [GO:0006952]; DNA repair [GO:0006281]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; epithelial cell proliferation [GO:0050673]; female meiotic nuclear division [GO:0007143]; in utero embryonic development [GO:0001701]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of stress granule assembly [GO:0062029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; response to activity [GO:0014823]; response to heat [GO:0009408]; response to hypobaric hypoxia [GO:1990910]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to peptide [GO:1901652]; response to psychosocial stress [GO:1990911]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283]","centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; pronucleus [GO:0045120]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; general transcription initiation factor binding [GO:0140296]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific DNA binding [GO:0043565]; sequence-specific single stranded DNA binding [GO:0098847]; STAT family protein binding [GO:0097677]; translation elongation factor binding [GO:0061770]; cell population proliferation [GO:0008283]; cellular response to angiotensin [GO:1904385]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to estradiol stimulus [GO:0071392]; cellular response to gamma radiation [GO:0071480]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-glutamine [GO:1904845]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nitroglycerin [GO:1904843]; cellular response to potassium ion [GO:0035865]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; cellular response to xenobiotic stimulus [GO:0071466]; defense response [GO:0006952]; DNA repair [GO:0006281]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; epithelial cell proliferation [GO:0050673]; female meiotic nuclear division [GO:0007143]; in utero embryonic development [GO:0001701]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of stress granule assembly [GO:0062029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; response to activity [GO:0014823]; response to heat [GO:0009408]; response to hypobaric hypoxia [GO:1990910]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to peptide [GO:1901652]; response to psychosocial stress [GO:1990911]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283]","","","",""
"252","sp|P58012|FOXL2_HUMAN","lcl|NC_088855.1_cds_NP_001295827.1_13721",6.16e-55,186,"P58012","FOXL2_HUMAN","Forkhead box protein L2","FOXL2","Homo sapiens (Human)",376,"GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001541; GO:0001555; GO:0002074; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006309; GO:0006357; GO:0007338; GO:0009653; GO:0019101; GO:0030154; GO:0030331; GO:0031624; GO:0033686; GO:0043028; GO:0043065; GO:0045892; GO:0045893; GO:0046881; GO:0048048; GO:0060014; GO:0060065; GO:0090543; GO:1990837","anatomical structure morphogenesis [GO:0009653]; apoptotic DNA fragmentation [GO:0006309]; cell differentiation [GO:0030154]; embryonic eye morphogenesis [GO:0048048]; extraocular skeletal muscle development [GO:0002074]; female somatic sex determination [GO:0019101]; granulosa cell differentiation [GO:0060014]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oocyte growth [GO:0001555]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of luteinizing hormone secretion [GO:0033686]; regulation of transcription by RNA polymerase II [GO:0006357]; single fertilization [GO:0007338]; uterus development [GO:0060065]","chromatin [GO:0000785]; Flemming body [GO:0090543]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase regulator activity involved in apoptotic process [GO:0043028]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear estrogen receptor binding [GO:0030331]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; ubiquitin conjugating enzyme binding [GO:0031624]; anatomical structure morphogenesis [GO:0009653]; apoptotic DNA fragmentation [GO:0006309]; cell differentiation [GO:0030154]; embryonic eye morphogenesis [GO:0048048]; extraocular skeletal muscle development [GO:0002074]; female somatic sex determination [GO:0019101]; granulosa cell differentiation [GO:0060014]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oocyte growth [GO:0001555]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of luteinizing hormone secretion [GO:0033686]; regulation of transcription by RNA polymerase II [GO:0006357]; single fertilization [GO:0007338]; uterus development [GO:0060065]","","INDUCTION: In granulosa-like cells, up-regulated at transcript and protein levels under oxidative stress and heat-shock conditions. Down-regulated by SIRT1. {ECO:0000269|PubMed:19010791}.","INDUCTION: In granulosa-like cells, up-regulated at transcript and protein levels under oxidative stress and heat-shock conditions. Down-regulated by SIRT1. {ECO:0000269|PubMed:19010791}.","TISSUE SPECIFICITY: In addition to its expression in the developing eyelid, it is transcribed very early in somatic cells of the developing gonad (before sex determination) and its expression persists in the follicular cells of the adult ovary."
"253","sp|Q9GZV4|IF5A2_HUMAN","lcl|NC_088855.1_cds_XP_011413205.3_16553",1.84e-66,201,"Q9GZV4","IF5A2_HUMAN","Eukaryotic translation initiation factor 5A-2 (eIF-5A-2) (eIF-5A2) (Eukaryotic initiation factor 5A isoform 2)","EIF5A2","Homo sapiens (Human)",153,"GO:0003723; GO:0003746; GO:0005634; GO:0005789; GO:0005829; GO:0006414; GO:0007283; GO:0043022; GO:0043231; GO:0045901; GO:0045905","positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; spermatogenesis [GO:0007283]; translational elongation [GO:0006414]","cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; spermatogenesis [GO:0007283]; translational elongation [GO:0006414]","","","","TISSUE SPECIFICITY: Expressed in ovarian and colorectal cancer cell lines (at protein level). Highly expressed in testis. Overexpressed in some cancer cells. {ECO:0000269|PubMed:11161802, ECO:0000269|PubMed:16519677}."
"254","sp|P34563|IF5A1_CAEEL","lcl|NC_088855.1_cds_XP_011413206.1_16555",2.77e-56,174,"P34563","IF5A1_CAEEL","Eukaryotic translation initiation factor 5A-1 (eIF-5A-1) (Initiation factor five protein 1)","iff-1 T05G5.10","Caenorhabditis elegans",161,"GO:0003723; GO:0003746; GO:0005737; GO:0006414; GO:0007276; GO:0008104; GO:0043022; GO:0045901; GO:0045905","gamete generation [GO:0007276]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein localization [GO:0008104]; translational elongation [GO:0006414]","cytoplasm [GO:0005737]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; gamete generation [GO:0007276]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein localization [GO:0008104]; translational elongation [GO:0006414]","DEVELOPMENTAL STAGE: Present at late larval stages and adults. {ECO:0000269|PubMed:15003625}.","","","TISSUE SPECIFICITY: Expressed specifically in the germline in the distal region of gonads where germ cells actively proliferate. {ECO:0000269|PubMed:15003625}."
"255","sp|P16989|YBOX3_HUMAN","lcl|NC_088855.1_cds_XP_011413207.3_16551",1.5e-45,159,"P16989","YBOX3_HUMAN","Y-box-binding protein 3 (Cold shock domain-containing protein A) (DNA-binding protein A) (Single-strand DNA-binding protein NF-GMB)","YBX3 CSDA DBPA","Homo sapiens (Human)",372,"GO:0000122; GO:0000977; GO:0001701; GO:0003676; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005923; GO:0006915; GO:0007283; GO:0008584; GO:0009566; GO:0010468; GO:0031267; GO:0035234; GO:0043021; GO:0045202; GO:0046622; GO:0048471; GO:0048642; GO:0060546; GO:0070935; GO:0071356; GO:0071474; GO:1902219; GO:2000242; GO:2000767","3'-UTR-mediated mRNA stabilization [GO:0070935]; apoptotic process [GO:0006915]; cellular hyperosmotic response [GO:0071474]; cellular response to tumor necrosis factor [GO:0071356]; ectopic germ cell programmed cell death [GO:0035234]; fertilization [GO:0009566]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of necroptotic process [GO:0060546]; negative regulation of reproductive process [GO:2000242]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of organ growth [GO:0046622]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]","bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; mRNA 3'-UTR binding [GO:0003730]; nucleic acid binding [GO:0003676]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; small GTPase binding [GO:0031267]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; apoptotic process [GO:0006915]; cellular hyperosmotic response [GO:0071474]; cellular response to tumor necrosis factor [GO:0071356]; ectopic germ cell programmed cell death [GO:0035234]; fertilization [GO:0009566]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of necroptotic process [GO:0060546]; negative regulation of reproductive process [GO:2000242]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of organ growth [GO:0046622]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Highly expressed in skeletal muscle and heart."
"256","sp|Q9NW38|FANCL_HUMAN","lcl|NC_088855.1_cds_XP_011413348.2_15003",1.16e-115,342,"Q9NW38","FANCL_HUMAN","E3 ubiquitin-protein ligase FANCL (EC 2.3.2.27) (Fanconi anemia group L protein) (Fanconi anemia-associated polypeptide of 43 kDa) (FAAP43) (RING-type E3 ubiquitin transferase FANCL)","FANCL PHF9","Homo sapiens (Human)",375,"GO:0000785; GO:0004842; GO:0005634; GO:0005635; GO:0005654; GO:0005829; GO:0006281; GO:0006513; GO:0006974; GO:0007276; GO:0008270; GO:0016604; GO:0031625; GO:0036297; GO:0042127; GO:0043231; GO:0043240; GO:0061630","DNA damage response [GO:0006974]; DNA repair [GO:0006281]; gamete generation [GO:0007276]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]; regulation of cell population proliferation [GO:0042127]","chromatin [GO:0000785]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; gamete generation [GO:0007276]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]; regulation of cell population proliferation [GO:0042127]","","","",""
"257","sp|Q9W0E3|IML1_DROME","lcl|NC_088855.1_cds_XP_011413844.3_16841",0,776,"Q9W0E3","IML1_DROME","GATOR complex protein Iml1 (Increased minichromosome loss 1)","Iml1 DEPDC5 SEA1 CG12090","Drosophila melanogaster (Fruit fly)",1544,"GO:0005096; GO:0005764; GO:0005765; GO:0010508; GO:0032007; GO:0034198; GO:0035859; GO:0045792; GO:0048142; GO:0051321; GO:0051729; GO:1904262; GO:1990130","cellular response to amino acid starvation [GO:0034198]; germarium-derived cystoblast division [GO:0048142]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; negative regulation of cell size [GO:0045792]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508]","GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; Seh1-associated complex [GO:0035859]; GTPase activator activity [GO:0005096]; cellular response to amino acid starvation [GO:0034198]; germarium-derived cystoblast division [GO:0048142]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; negative regulation of cell size [GO:0045792]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508]","","","",""
"258","sp|O61267|LOK_DROME","lcl|NC_088855.1_cds_XP_011414264.3_11255",7.96e-118,355,"O61267","LOK_DROME","Ovarian-specific serine/threonine-protein kinase Lok (EC 2.7.11.1) (Protein loki) (dMNK)","lok CG10895","Drosophila melanogaster (Fruit fly)",476,"GO:0000077; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006282; GO:0006468; GO:0006915; GO:0006974; GO:0007281; GO:0008630; GO:0016607; GO:0030717; GO:0035234; GO:0044773; GO:0045944; GO:0050321; GO:0071480; GO:0071481; GO:0072332; GO:0106310","apoptotic process [GO:0006915]; cellular response to gamma radiation [GO:0071480]; cellular response to X-ray [GO:0071481]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; ectopic germ cell programmed cell death [GO:0035234]; germ cell development [GO:0007281]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic DNA damage checkpoint signaling [GO:0044773]; oocyte karyosome formation [GO:0030717]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]","cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; apoptotic process [GO:0006915]; cellular response to gamma radiation [GO:0071480]; cellular response to X-ray [GO:0071481]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; ectopic germ cell programmed cell death [GO:0035234]; germ cell development [GO:0007281]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic DNA damage checkpoint signaling [GO:0044773]; oocyte karyosome formation [GO:0030717]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically in adult females. Levels of the long isoform remain fairly constant from ovaries to embryos, the levels of short isoform decrease dramatically. {ECO:0000269|PubMed:9507063}.","","","TISSUE SPECIFICITY: In stage 3 embryos, both isoforms are expressed in both somatic and pole cell nuclei. Expression in pole cell nuclei is sustained until stage 9 and weakly expressed after pole cell invagination into the abdominal cavity. {ECO:0000269|PubMed:9507063}."
"259","sp|P83351|SNA29_CAEEL","lcl|NC_088855.1_cds_XP_011415111.3_11862",4.41e-19,85.1,"P83351","SNA29_CAEEL","Soluble NSF attachment protein 29","snap-29 phi-28 K02D10.5","Caenorhabditis elegans",277,"GO:0005484; GO:0005886; GO:0006887; GO:0016082; GO:0016324; GO:0019905; GO:0030728; GO:0031201; GO:0031629; GO:0043005; GO:0046903; GO:0055037; GO:0065002; GO:0098793","exocytosis [GO:0006887]; intracellular protein transmembrane transport [GO:0065002]; ovulation [GO:0030728]; secretion [GO:0046903]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]","apical plasma membrane [GO:0016324]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; intracellular protein transmembrane transport [GO:0065002]; ovulation [GO:0030728]; secretion [GO:0046903]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]","","","",""
"260","sp|P30904|MIF_RAT","lcl|NC_088855.1_cds_XP_011415194.2_14388",2.89e-22,85.1,"P30904","MIF_RAT","Macrophage migration inhibitory factor (MIF) (EC 5.3.2.1) (Glutathione-binding 13 kDa protein) (L-dopachrome isomerase) (L-dopachrome tautomerase) (EC 5.3.3.12) (Phenylpyruvate tautomerase)","Mif","Rattus norvegicus (Rat)",115,"GO:0001516; GO:0001819; GO:0001942; GO:0002020; GO:0002035; GO:0002675; GO:0002906; GO:0004167; GO:0005125; GO:0005126; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0006954; GO:0007166; GO:0007283; GO:0008284; GO:0009410; GO:0009612; GO:0009725; GO:0009986; GO:0010629; GO:0010760; GO:0014911; GO:0019752; GO:0030330; GO:0030336; GO:0030890; GO:0031666; GO:0032355; GO:0032496; GO:0032570; GO:0032572; GO:0032760; GO:0032868; GO:0033033; GO:0033197; GO:0042056; GO:0042127; GO:0042327; GO:0042756; GO:0042802; GO:0043066; GO:0043268; GO:0043518; GO:0043588; GO:0044877; GO:0045087; GO:0045821; GO:0046326; GO:0048146; GO:0048680; GO:0050178; GO:0050778; GO:0051248; GO:0051384; GO:0061078; GO:0061081; GO:0070207; GO:0070301; GO:0070374; GO:0071456; GO:0090238; GO:0090398; GO:0141163; GO:1902166; GO:2000343; GO:2000773","brain renin-angiotensin system [GO:0002035]; carboxylic acid metabolic process [GO:0019752]; cell surface receptor signaling pathway [GO:0007166]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular senescence [GO:0090398]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; drinking behavior [GO:0042756]; hair follicle development [GO:0001942]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of macrophage chemotaxis [GO:0010760]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of myeloid cell apoptotic process [GO:0033033]; negative regulation of protein metabolic process [GO:0051248]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of arachidonate secretion [GO:0090238]; positive regulation of axon regeneration [GO:0048680]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cAMP/PKA signal transduction [GO:0141163]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cytokine production [GO:0001819]; positive regulation of D-glucose import [GO:0046326]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of glycolytic process [GO:0045821]; positive regulation of immune response [GO:0050778]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of myeloid leukocyte cytokine production involved in immune response [GO:0061081]; positive regulation of phosphorylation [GO:0042327]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of prostaglandin secretion involved in immune response [GO:0061078]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of tumor necrosis factor production [GO:0032760]; prostaglandin biosynthetic process [GO:0001516]; protein homotrimerization [GO:0070207]; regulation of cell population proliferation [GO:0042127]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to menaquinone [GO:0032572]; response to progesterone [GO:0032570]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; skin development [GO:0043588]; spermatogenesis [GO:0007283]","cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; dopachrome isomerase activity [GO:0004167]; identical protein binding [GO:0042802]; phenylpyruvate tautomerase activity [GO:0050178]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; brain renin-angiotensin system [GO:0002035]; carboxylic acid metabolic process [GO:0019752]; cell surface receptor signaling pathway [GO:0007166]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular senescence [GO:0090398]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; drinking behavior [GO:0042756]; hair follicle development [GO:0001942]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of macrophage chemotaxis [GO:0010760]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of myeloid cell apoptotic process [GO:0033033]; negative regulation of protein metabolic process [GO:0051248]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of arachidonate secretion [GO:0090238]; positive regulation of axon regeneration [GO:0048680]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cAMP/PKA signal transduction [GO:0141163]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cytokine production [GO:0001819]; positive regulation of D-glucose import [GO:0046326]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of glycolytic process [GO:0045821]; positive regulation of immune response [GO:0050778]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of myeloid leukocyte cytokine production involved in immune response [GO:0061081]; positive regulation of phosphorylation [GO:0042327]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of prostaglandin secretion involved in immune response [GO:0061078]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of tumor necrosis factor production [GO:0032760]; prostaglandin biosynthetic process [GO:0001516]; protein homotrimerization [GO:0070207]; regulation of cell population proliferation [GO:0042127]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to menaquinone [GO:0032572]; response to progesterone [GO:0032570]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; skin development [GO:0043588]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in a wide variety of organs including brain, spleen, liver, muscle and kidney. {ECO:0000269|PubMed:7951062}."
"261","sp|F6PHZ6|FKBP6_HORSE","lcl|NC_088855.1_cds_XP_011415211.3_14403",1.15e-49,173,"F6PHZ6","FKBP6_HORSE","Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (Inactive PPIase FKBP6) (36 kDa FK506-binding protein) (FK506-binding protein 6) (FKBP-6) (Immunophilin FKBP36)","FKBP6 FKBP36","Equus caballus (Horse)",316,"GO:0000795; GO:0005737; GO:0005829; GO:0006457; GO:0007283; GO:0030154; GO:0031047; GO:0034587; GO:0051321; GO:0051879; GO:0141196","cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; piRNA processing [GO:0034587]; protein folding [GO:0006457]; regulatory ncRNA-mediated gene silencing [GO:0031047]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; synaptonemal complex [GO:0000795]; Hsp90 protein binding [GO:0051879]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; piRNA processing [GO:0034587]; protein folding [GO:0006457]; regulatory ncRNA-mediated gene silencing [GO:0031047]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]","","","","TISSUE SPECIFICITY: Specifically expressed in testis and sperm. {ECO:0000269|PubMed:23284302}."
"262","sp|Q9V877|SUB_DROME","lcl|NC_088855.1_cds_XP_011416803.3_15407",7.94e-42,164,"Q9V877","SUB_DROME","Kinesin-like protein subito (Protein double or nothing)","sub Dub CG12298","Drosophila melanogaster (Fruit fly)",628,"GO:0000212; GO:0000278; GO:0000922; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005871; GO:0005874; GO:0005875; GO:0007018; GO:0007020; GO:0007052; GO:0007056; GO:0007091; GO:0007140; GO:0008017; GO:0016321; GO:0016887; GO:0033566; GO:0040016; GO:0051233; GO:0051257; GO:0140496; GO:1990385","embryonic cleavage [GO:0040016]; female meiosis chromosome segregation [GO:0016321]; gamma-tubulin complex localization [GO:0033566]; male meiotic nuclear division [GO:0007140]; meiotic spindle midzone assembly [GO:0051257]; meiotic spindle organization [GO:0000212]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; microtubule nucleation [GO:0007020]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; spindle assembly involved in female meiosis [GO:0007056]","cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; meiotic spindle midzone [GO:1990385]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; gamma-tubulin complex binding [GO:0140496]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; embryonic cleavage [GO:0040016]; female meiosis chromosome segregation [GO:0016321]; gamma-tubulin complex localization [GO:0033566]; male meiotic nuclear division [GO:0007140]; meiotic spindle midzone assembly [GO:0051257]; meiotic spindle organization [GO:0000212]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; microtubule nucleation [GO:0007020]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; spindle assembly involved in female meiosis [GO:0007056]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. {ECO:0000269|PubMed:11973304}.","","",""
"263","sp|Q12948|FOXC1_HUMAN","lcl|NC_088855.1_cds_XP_011417585.2_11561",2.96e-59,206,"Q12948","FOXC1_HUMAN","Forkhead box protein C1 (Forkhead-related protein FKHL7) (Forkhead-related transcription factor 3) (FREAC-3)","FOXC1 FKHL7 FREAC3","Homo sapiens (Human)",553,"GO:0000122; GO:0000785; GO:0000792; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0001541; GO:0001654; GO:0001657; GO:0001701; GO:0001756; GO:0001822; GO:0001945; GO:0001958; GO:0001974; GO:0003275; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0007219; GO:0007507; GO:0008283; GO:0008301; GO:0008354; GO:0009653; GO:0010628; GO:0010718; GO:0014031; GO:0014032; GO:0016477; GO:0016525; GO:0021549; GO:0030154; GO:0030199; GO:0030203; GO:0032808; GO:0035050; GO:0036438; GO:0038084; GO:0042475; GO:0043010; GO:0043388; GO:0043565; GO:0045618; GO:0045893; GO:0045930; GO:0045944; GO:0046620; GO:0048010; GO:0048341; GO:0048844; GO:0055010; GO:0060038; GO:0061629; GO:0070098; GO:0071364; GO:0072010; GO:0097746; GO:0140297; GO:1901491; GO:1901534; GO:1902038; GO:1902257; GO:1904798; GO:1990841; GO:1990869","anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; apoptotic process involved in outflow tract morphogenesis [GO:0003275]; artery morphogenesis [GO:0048844]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; camera-type eye development [GO:0043010]; cardiac muscle cell proliferation [GO:0060038]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cellular response to chemokine [GO:1990869]; cellular response to epidermal growth factor stimulus [GO:0071364]; cerebellum development [GO:0021549]; chemokine-mediated signaling pathway [GO:0070098]; collagen fibril organization [GO:0030199]; embryonic heart tube development [GO:0035050]; endochondral ossification [GO:0001958]; eye development [GO:0001654]; germ cell migration [GO:0008354]; glomerular epithelium development [GO:0072010]; glycosaminoglycan metabolic process [GO:0030203]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lacrimal gland development [GO:0032808]; lymph vessel development [GO:0001945]; maintenance of lens transparency [GO:0036438]; mesenchymal cell development [GO:0014031]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process involved in outflow tract morphogenesis [GO:1902257]; negative regulation of lymphangiogenesis [GO:1901491]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell development [GO:0014032]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; paraxial mesoderm formation [GO:0048341]; positive regulation of core promoter binding [GO:1904798]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of hematopoietic stem cell differentiation [GO:1902038]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of organ growth [GO:0046620]; regulation of transcription by RNA polymerase II [GO:0006357]; somitogenesis [GO:0001756]; ureteric bud development [GO:0001657]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]","chromatin [GO:0000785]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; apoptotic process involved in outflow tract morphogenesis [GO:0003275]; artery morphogenesis [GO:0048844]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; camera-type eye development [GO:0043010]; cardiac muscle cell proliferation [GO:0060038]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cellular response to chemokine [GO:1990869]; cellular response to epidermal growth factor stimulus [GO:0071364]; cerebellum development [GO:0021549]; chemokine-mediated signaling pathway [GO:0070098]; collagen fibril organization [GO:0030199]; embryonic heart tube development [GO:0035050]; endochondral ossification [GO:0001958]; eye development [GO:0001654]; germ cell migration [GO:0008354]; glomerular epithelium development [GO:0072010]; glycosaminoglycan metabolic process [GO:0030203]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lacrimal gland development [GO:0032808]; lymph vessel development [GO:0001945]; maintenance of lens transparency [GO:0036438]; mesenchymal cell development [GO:0014031]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process involved in outflow tract morphogenesis [GO:1902257]; negative regulation of lymphangiogenesis [GO:1901491]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell development [GO:0014032]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; paraxial mesoderm formation [GO:0048341]; positive regulation of core promoter binding [GO:1904798]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of hematopoietic stem cell differentiation [GO:1902038]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of organ growth [GO:0046620]; regulation of transcription by RNA polymerase II [GO:0006357]; somitogenesis [GO:0001756]; ureteric bud development [GO:0001657]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]","","INDUCTION: Up-regulated during the progression of epidermal keratinocyte differentiation (at protein level) (PubMed:27907090). Up-regulated upon calcium-mediated keratinocyte differentiation (PubMed:27907090). Up-regulated by transforming growth factor TGFB1 (PubMed:12408963). {ECO:0000269|PubMed:12408963, ECO:0000269|PubMed:27907090}.","INDUCTION: Up-regulated during the progression of epidermal keratinocyte differentiation (at protein level) (PubMed:27907090). Up-regulated upon calcium-mediated keratinocyte differentiation (PubMed:27907090). Up-regulated by transforming growth factor TGFB1 (PubMed:12408963). {ECO:0000269|PubMed:12408963, ECO:0000269|PubMed:27907090}.","TISSUE SPECIFICITY: Expressed in keratinocytes of epidermis and hair follicle (PubMed:27907090). Expressed strongly in microvascular invasion (MVI) formation, basal-like breast cancer (BLBC) and hepatocellular tumors (PubMed:20406990, PubMed:22991501). Expressed in breast cancers (at protein level) (PubMed:26565916). Expressed in hematopoietic cells (PubMed:8499623). {ECO:0000269|PubMed:20406990, ECO:0000269|PubMed:22991501, ECO:0000269|PubMed:26565916, ECO:0000269|PubMed:27907090, ECO:0000269|PubMed:8499623}."
"264","sp|Q9VMW9|GMDS_DROME","lcl|NC_088855.1_cds_XP_011417588.3_11563",0,535,"Q9VMW9","GMDS_DROME","GDP-mannose 4,6 dehydratase (EC 4.2.1.47) (GDP-D-mannose dehydratase) (Dm-gmd) (GDP-mannose dehydratase)","Gmd CG8890","Drosophila melanogaster (Fruit fly)",395,"GO:0008446; GO:0042351; GO:0045165; GO:0045747; GO:0048477","'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; cell fate commitment [GO:0045165]; oogenesis [GO:0048477]; positive regulation of Notch signaling pathway [GO:0045747]","GDP-mannose 4,6-dehydratase activity [GO:0008446]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; cell fate commitment [GO:0045165]; oogenesis [GO:0048477]; positive regulation of Notch signaling pathway [GO:0045747]","","","",""
"265","sp|P55054|FABP9_RAT","lcl|NC_088855.1_cds_XP_011417633.2_11626",8.29e-19,77.8,"P55054","FABP9_RAT","Fatty acid-binding protein 9 (15 kDa perforatorial protein) (PERF 15) (Testis lipid-binding protein) (TLBP) (Testis-type fatty acid-binding protein) (T-FABP)","Fabp9 Perf15","Rattus norvegicus (Rat)",132,"GO:0001669; GO:0001675; GO:0005634; GO:0005829; GO:0015909; GO:0036041","acrosome assembly [GO:0001675]; long-chain fatty acid transport [GO:0015909]","acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; nucleus [GO:0005634]; long-chain fatty acid binding [GO:0036041]; acrosome assembly [GO:0001675]; long-chain fatty acid transport [GO:0015909]","","","","TISSUE SPECIFICITY: Testis."
"266","sp|Q9D411|TSSK4_MOUSE","lcl|NC_088855.1_cds_XP_011417668.3_17544",2.01e-96,289,"Q9D411","TSSK4_MOUSE","Testis-specific serine/threonine-protein kinase 4 (TSK-4) (TSSK-4) (Testis-specific kinase 4) (EC 2.7.11.1)","Tssk4 Tssk5","Mus musculus (Mouse)",328,"GO:0000287; GO:0001669; GO:0004672; GO:0004674; GO:0005524; GO:0006468; GO:0007286; GO:0009566; GO:0018105; GO:0030317; GO:0031514; GO:0032793; GO:0036126; GO:0042802; GO:0042803; GO:0044877; GO:0106310; GO:1990443","fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of CREB transcription factor activity [GO:0032793]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286]","acrosomal vesicle [GO:0001669]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of CREB transcription factor activity [GO:0032793]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286]","DEVELOPMENTAL STAGE: Detected throughout spermiogenesis, in round spermatids, elongated spermatids, and mature spermatozoa (PubMed:20729278, PubMed:23054012, PubMed:26940607). Detected at low levels on postnatal day 14, with significantly increased expression on postnatal day 16. Expression levels are unchanged after postnatal day 16 (PubMed:17927909, PubMed:20729278). {ECO:0000269|PubMed:17927909, ECO:0000269|PubMed:20729278, ECO:0000269|PubMed:23054012, ECO:0000269|PubMed:26940607}.","","","TISSUE SPECIFICITY: [Isoform 1]: Expressed in spermatocytes and mature sperm (at protein level) (PubMed:20729278, PubMed:23054012, PubMed:25361759, PubMed:26940607). Highly expressed in the spleen, heart and testis (PubMed:17927909, PubMed:20729278, PubMed:23054012). Isoform 2, isoform 3, and isoform 4: Expressed at highest level in testis and heart and at low levels in the liver, spleen, kidney, brain and thymus (PubMed:17927909). {ECO:0000269|PubMed:17927909, ECO:0000269|PubMed:20729278, ECO:0000269|PubMed:23054012, ECO:0000269|PubMed:25361759, ECO:0000269|PubMed:26940607}."
"267","sp|Q9BSE4|HERP2_HUMAN","lcl|NC_088855.1_cds_XP_011417669.3_17545",3.92e-23,101,"Q9BSE4","HERP2_HUMAN","Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein","HERPUD2","Homo sapiens (Human)",406,"GO:0007283; GO:0016020; GO:0030968","endoplasmic reticulum unfolded protein response [GO:0030968]; spermatogenesis [GO:0007283]","membrane [GO:0016020]; endoplasmic reticulum unfolded protein response [GO:0030968]; spermatogenesis [GO:0007283]","","","",""
"268","sp|F4IH25|BOP1_ARATH","lcl|NC_088855.1_cds_XP_011417865.3_11020",0,556,"F4IH25","BOP1_ARATH","Ribosome biogenesis protein BOP1 homolog (Pescadillo-interacting protein 1) (AtPEIP1) (Protein BLOCK OF CELL PROLIFERATION 1)","BOP1 PEIP1 At2g40360","Arabidopsis thaliana (Mouse-ear cress)",753,"GO:0000463; GO:0000466; GO:0005654; GO:0005730; GO:0007276; GO:0030687; GO:0043021; GO:0051302","gamete generation [GO:0007276]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; regulation of cell division [GO:0051302]","nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; gamete generation [GO:0007276]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; regulation of cell division [GO:0051302]","","","",""
"269","sp|P42208|SEPT2_MOUSE","lcl|NC_088855.1_cds_XP_011418073.3_17450",9.28e-174,489,"P42208","SEPT2_MOUSE","Septin-2 (Neural precursor cell expressed developmentally down-regulated protein 5) (NEDD-5)","Septin2 Nedd5 Sept2","Mus musculus (Mouse)",361,"GO:0000776; GO:0002036; GO:0003924; GO:0005525; GO:0005654; GO:0005737; GO:0005826; GO:0005876; GO:0005886; GO:0005930; GO:0005938; GO:0007224; GO:0007283; GO:0009986; GO:0015629; GO:0015630; GO:0030154; GO:0030234; GO:0030496; GO:0031105; GO:0032154; GO:0032391; GO:0032880; GO:0035869; GO:0042802; GO:0042995; GO:0043209; GO:0045171; GO:0045202; GO:0051258; GO:0060090; GO:0060170; GO:0060271; GO:0061640; GO:0097227","cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; protein polymerization [GO:0051258]; regulation of L-glutamate import across plasma membrane [GO:0002036]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]","actin cytoskeleton [GO:0015629]; actomyosin contractile ring [GO:0005826]; axoneme [GO:0005930]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; sperm annulus [GO:0097227]; spindle microtubule [GO:0005876]; synapse [GO:0045202]; enzyme regulator activity [GO:0030234]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; protein polymerization [GO:0051258]; regulation of L-glutamate import across plasma membrane [GO:0002036]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed at 17 dpc in the brain with levels remaining relatively stable up to adulthood (at protein level). {ECO:0000269|PubMed:11739749}.","","","TISSUE SPECIFICITY: Widely expressed."
"270","sp|P92177|1433E_DROME","lcl|NC_088855.1_cds_XP_011418135.1_17514",5.25e-150,420,"P92177","1433E_DROME","14-3-3 protein epsilon (Suppressor of Ras1 3-9)","14-3-3epsilon 14-3-3e SR3-9 CG31196","Drosophila melanogaster (Fruit fly)",262,"GO:0000077; GO:0001223; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0007088; GO:0007165; GO:0007294; GO:0007346; GO:0007411; GO:0007460; GO:0008103; GO:0008104; GO:0008340; GO:0008354; GO:0009411; GO:0035332; GO:0040008; GO:0045172; GO:0045927; GO:0046579; GO:0046982; GO:0048190; GO:0050815; GO:0051012; GO:0140313; GO:0150013","axon guidance [GO:0007411]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint signaling [GO:0000077]; germ cell migration [GO:0008354]; germarium-derived oocyte fate determination [GO:0007294]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; oocyte microtubule cytoskeleton polarization [GO:0008103]; positive regulation of growth [GO:0045927]; positive regulation of hippo signaling [GO:0035332]; positive regulation of Ras protein signal transduction [GO:0046579]; protein localization [GO:0008104]; R8 cell fate commitment [GO:0007460]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; response to UV [GO:0009411]; signal transduction [GO:0007165]; wing disc dorsal/ventral pattern formation [GO:0048190]","centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; germline ring canal [GO:0045172]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; molecular sequestering activity [GO:0140313]; phosphoserine residue binding [GO:0050815]; protein heterodimerization activity [GO:0046982]; transcription coactivator binding [GO:0001223]; axon guidance [GO:0007411]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint signaling [GO:0000077]; germ cell migration [GO:0008354]; germarium-derived oocyte fate determination [GO:0007294]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; oocyte microtubule cytoskeleton polarization [GO:0008103]; positive regulation of growth [GO:0045927]; positive regulation of hippo signaling [GO:0035332]; positive regulation of Ras protein signal transduction [GO:0046579]; protein localization [GO:0008104]; R8 cell fate commitment [GO:0007460]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; response to UV [GO:0009411]; signal transduction [GO:0007165]; wing disc dorsal/ventral pattern formation [GO:0048190]","","","",""
"271","sp|Q9VH19|LMLN_DROME","lcl|NC_088855.1_cds_XP_011418435.3_11836",0,536,"Q9VH19","LMLN_DROME","Leishmanolysin-like peptidase (EC 3.4.24.-) (Invadolysin)","Invadolysin l(3)IX-14 CG3953","Drosophila melanogaster (Fruit fly)",683,"GO:0004222; GO:0005737; GO:0006338; GO:0006508; GO:0007052; GO:0007076; GO:0007100; GO:0007155; GO:0007420; GO:0007444; GO:0008233; GO:0008354; GO:0008406; GO:0016020; GO:0019915; GO:0022900; GO:0045842; GO:0046872; GO:0051298; GO:0051301; GO:0051881","brain development [GO:0007420]; cell adhesion [GO:0007155]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromatin remodeling [GO:0006338]; electron transport chain [GO:0022900]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; imaginal disc development [GO:0007444]; lipid storage [GO:0019915]; mitotic centrosome separation [GO:0007100]; mitotic chromosome condensation [GO:0007076]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteolysis [GO:0006508]; regulation of mitochondrial membrane potential [GO:0051881]","cytoplasm [GO:0005737]; membrane [GO:0016020]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromatin remodeling [GO:0006338]; electron transport chain [GO:0022900]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; imaginal disc development [GO:0007444]; lipid storage [GO:0019915]; mitotic centrosome separation [GO:0007100]; mitotic chromosome condensation [GO:0007076]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteolysis [GO:0006508]; regulation of mitochondrial membrane potential [GO:0051881]","","","",""
"272","sp|Q8IKD3|PDED_PLAF7","lcl|NC_088855.1_cds_XP_011418591.1_14014",2.66e-22,103,"Q8IKD3","PDED_PLAF7","cGMP-specific 3',5'-cyclic phosphodiesterase delta (PfPDEdelta) (EC 3.1.4.35)","PDEdelta PDE4 PF3D7_1470500","Plasmodium falciparum (isolate 3D7)",815,"GO:0004114; GO:0004115; GO:0007276; GO:0009187; GO:0016020; GO:0019933; GO:0030552; GO:0046069; GO:0046872; GO:0047555","cAMP-mediated signaling [GO:0019933]; cGMP catabolic process [GO:0046069]; cyclic nucleotide metabolic process [GO:0009187]; gamete generation [GO:0007276]","membrane [GO:0016020]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872]; cAMP-mediated signaling [GO:0019933]; cGMP catabolic process [GO:0046069]; cyclic nucleotide metabolic process [GO:0009187]; gamete generation [GO:0007276]","DEVELOPMENTAL STAGE: Expressed during the asexual blood stage, probably in gametocytes. {ECO:0000269|PubMed:18452584, ECO:0000269|PubMed:18590734}.","","",""
"273","sp|Q0KHQ5|TAO_DROME","lcl|NC_088855.1_cds_XP_011418604.2_14026",4.04e-172,528,"Q0KHQ5","TAO_DROME","Serine/threonine-protein kinase Tao (EC 2.7.11.1)","Tao Tao-1 CG14217","Drosophila melanogaster (Fruit fly)",1039,"GO:0001894; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005819; GO:0005874; GO:0005886; GO:0005938; GO:0006915; GO:0007460; GO:0016020; GO:0016319; GO:0030424; GO:0030514; GO:0030707; GO:0032874; GO:0035094; GO:0035332; GO:0036335; GO:0042220; GO:0043204; GO:0045178; GO:0045471; GO:0045807; GO:0045886; GO:0046330; GO:0046621; GO:0048036; GO:0106310","apoptotic process [GO:0006915]; central complex development [GO:0048036]; follicle cell of egg chamber development [GO:0030707]; intestinal stem cell homeostasis [GO:0036335]; mushroom body development [GO:0016319]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of organ growth [GO:0046621]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; positive regulation of endocytosis [GO:0045807]; positive regulation of hippo signaling [GO:0035332]; positive regulation of JNK cascade [GO:0046330]; positive regulation of stress-activated MAPK cascade [GO:0032874]; R8 cell fate commitment [GO:0007460]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; tissue homeostasis [GO:0001894]","axon [GO:0030424]; basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule [GO:0005874]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; central complex development [GO:0048036]; follicle cell of egg chamber development [GO:0030707]; intestinal stem cell homeostasis [GO:0036335]; mushroom body development [GO:0016319]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of organ growth [GO:0046621]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; positive regulation of endocytosis [GO:0045807]; positive regulation of hippo signaling [GO:0035332]; positive regulation of JNK cascade [GO:0046330]; positive regulation of stress-activated MAPK cascade [GO:0032874]; R8 cell fate commitment [GO:0007460]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; tissue homeostasis [GO:0001894]","DEVELOPMENTAL STAGE: Isoform A: Enriched in germ plasm but is degraded in pole cells immediately after pole cell formation. Isoform D: Enriched in germ plasm, partitions into pole cells and remains detectable in pole cells until they migrate through the midgut epithelium toward the overlying mesoderm. {ECO:0000269|PubMed:25589578}.","","","TISSUE SPECIFICITY: In the posterior midgut, expressed in almost all intestinal cell types including intestinal stem cells and enterocytes (at protein level). Maternally expressed, ubiquitously distributed in the egg and early embryo and enriched in the germ plasm at the posterior pole of the early embryo including the pole cells. {ECO:0000269|PubMed:25160975}."
"274","sp|Q9VKK1|EDC4_DROME","lcl|NC_088855.1_cds_XP_011419500.3_14761",1.7e-68,255,"Q9VKK1","EDC4_DROME","Enhancer of mRNA-decapping protein 4 homolog","Ge-1 CG6181","Drosophila melanogaster (Fruit fly)",1354,"GO:0000290; GO:0000932; GO:0006402; GO:0031087; GO:0033962; GO:0035195; GO:0045451; GO:0045495","deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; mRNA catabolic process [GO:0006402]; P-body assembly [GO:0033962]; pole plasm oskar mRNA localization [GO:0045451]","P-body [GO:0000932]; pole plasm [GO:0045495]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; mRNA catabolic process [GO:0006402]; P-body assembly [GO:0033962]; pole plasm oskar mRNA localization [GO:0045451]","","","",""
"275","sp|Q9U6Y9|ANM5_DROME","lcl|NC_088855.1_cds_XP_011420415.3_14768",2.17e-124,382,"Q9U6Y9","ANM5_DROME","Protein arginine N-methyltransferase 5 (EC 2.1.1.-) (JBP1 homolog) (Protein capsuleen)","csul DART5 CG3730","Drosophila melanogaster (Fruit fly)",610,"GO:0005634; GO:0005829; GO:0006355; GO:0007315; GO:0007318; GO:0008276; GO:0008298; GO:0008469; GO:0016274; GO:0018216; GO:0030719; GO:0035243","intracellular mRNA localization [GO:0008298]; P granule organization [GO:0030719]; peptidyl-arginine methylation [GO:0018216]; pole plasm assembly [GO:0007315]; pole plasm protein localization [GO:0007318]; regulation of DNA-templated transcription [GO:0006355]","cytosol [GO:0005829]; nucleus [GO:0005634]; histone arginine N-methyltransferase activity [GO:0008469]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; intracellular mRNA localization [GO:0008298]; P granule organization [GO:0030719]; peptidyl-arginine methylation [GO:0018216]; pole plasm assembly [GO:0007315]; pole plasm protein localization [GO:0007318]; regulation of DNA-templated transcription [GO:0006355]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. Expressed from stage 3 egg chambers onward, becoming restricted to the cortex of the oocytes at stage 10. Evenly distributed in preblastoderm embryos. {ECO:0000269|Ref.6}.","","","TISSUE SPECIFICITY: Expressed only in ovaries. {ECO:0000269|PubMed:14705965}."
"276","sp|P67999|KS6B1_RAT","lcl|NC_088855.1_cds_XP_011422352.1_13783",0,619,"P67999","KS6B1_RAT","Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA)","Rps6kb1","Rattus norvegicus (Rat)",525,"GO:0000082; GO:0001662; GO:0003009; GO:0004672; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0006915; GO:0007281; GO:0007584; GO:0007616; GO:0009410; GO:0009612; GO:0009636; GO:0009749; GO:0009986; GO:0014732; GO:0014878; GO:0014911; GO:0016477; GO:0018105; GO:0030165; GO:0031667; GO:0031670; GO:0031929; GO:0032496; GO:0032868; GO:0032869; GO:0032870; GO:0033574; GO:0033762; GO:0034612; GO:0038202; GO:0042277; GO:0042802; GO:0043005; GO:0043066; GO:0043200; GO:0043201; GO:0043434; GO:0044539; GO:0045202; GO:0045471; GO:0045727; GO:0045931; GO:0045948; GO:0046324; GO:0046627; GO:0048471; GO:0048633; GO:0048661; GO:0050804; GO:0051384; GO:0051721; GO:0071346; GO:0071363; GO:0071549; GO:0098794; GO:0098978; GO:0106310; GO:1903940; GO:1904263; GO:1904313; GO:2001237","apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cell migration [GO:0016477]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to nutrient [GO:0031670]; cellular response to type II interferon [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; long-chain fatty acid import into cell [GO:0044539]; long-term memory [GO:0007616]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of TORC2 signaling [GO:1903940]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; regulation of D-glucose import [GO:0046324]; response to amino acid [GO:0043200]; response to electrical stimulus involved in regulation of muscle adaptation [GO:0014878]; response to ethanol [GO:0045471]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to L-leucine [GO:0043201]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to methamphetamine hydrochloride [GO:1904313]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; response to peptide hormone [GO:0043434]; response to testosterone [GO:0033574]; response to toxic substance [GO:0009636]; response to tumor necrosis factor [GO:0034612]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle atrophy [GO:0014732]; skeletal muscle contraction [GO:0003009]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]","cell surface [GO:0009986]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; synapse [GO:0045202]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein phosphatase 2A binding [GO:0051721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cell migration [GO:0016477]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to nutrient [GO:0031670]; cellular response to type II interferon [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; long-chain fatty acid import into cell [GO:0044539]; long-term memory [GO:0007616]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of TORC2 signaling [GO:1903940]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; regulation of D-glucose import [GO:0046324]; response to amino acid [GO:0043200]; response to electrical stimulus involved in regulation of muscle adaptation [GO:0014878]; response to ethanol [GO:0045471]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to L-leucine [GO:0043201]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to methamphetamine hydrochloride [GO:1904313]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; response to peptide hormone [GO:0043434]; response to testosterone [GO:0033574]; response to toxic substance [GO:0009636]; response to tumor necrosis factor [GO:0034612]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle atrophy [GO:0014732]; skeletal muscle contraction [GO:0003009]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]","","","","TISSUE SPECIFICITY: Brain."
"277","sp|Q95078|CP18A_DROME","lcl|NC_088855.1_cds_XP_011422377.3_15232",6.61e-93,293,"Q95078","CP18A_DROME","Cytochrome P450 18a1 (EC 1.14.-.-) (CYPXVIIIA1)","Cyp18a1 CYP18 Eig17-1 CG6816","Drosophila melanogaster (Fruit fly)",538,"GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0007304; GO:0007480; GO:0007552; GO:0008395; GO:0016712; GO:0020037; GO:0035074; GO:0035210; GO:0043231; GO:0046344","chorion-containing eggshell formation [GO:0007304]; ecdysteroid catabolic process [GO:0046344]; imaginal disc-derived leg morphogenesis [GO:0007480]; metamorphosis [GO:0007552]; organic acid metabolic process [GO:0006082]; prepupal development [GO:0035210]; pupation [GO:0035074]; xenobiotic metabolic process [GO:0006805]","cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; chorion-containing eggshell formation [GO:0007304]; ecdysteroid catabolic process [GO:0046344]; imaginal disc-derived leg morphogenesis [GO:0007480]; metamorphosis [GO:0007552]; organic acid metabolic process [GO:0006082]; prepupal development [GO:0035210]; pupation [GO:0035074]; xenobiotic metabolic process [GO:0006805]","DEVELOPMENTAL STAGE: Low levels throughout postembryonic development.","INDUCTION: By 20-hydroxyecdysone during the three larval stages, at pupariation and in pupae. {ECO:0000269|PubMed:9256362}.","INDUCTION: By 20-hydroxyecdysone during the three larval stages, at pupariation and in pupae. {ECO:0000269|PubMed:9256362}.","TISSUE SPECIFICITY: Expressed in body wall (epidermal and muscle cells) and mid- and hind-gut. {ECO:0000269|PubMed:9256362}."
"278","sp|Q20937|CNOT1_CAEEL","lcl|NC_088855.1_cds_XP_011422455.3_16680",0,1096,"Q20937","CNOT1_CAEEL","CCR4-NOT transcription complex subunit let-711 (CCR4-associated factor let-711) (Lethal protein 711) (Negative regulator of transcription subunit 1 homolog) (NOT1)","let-711 ntl-1 spn-3 F57B9.2","Caenorhabditis elegans",2641,"GO:0000288; GO:0000289; GO:0000932; GO:0000956; GO:0002119; GO:0005634; GO:0005737; GO:0010468; GO:0017148; GO:0030014; GO:0030015; GO:0030953; GO:0031047; GO:0032968; GO:0040001; GO:0048477; GO:0060090","astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; negative regulation of translation [GO:0017148]; nematode larval development [GO:0002119]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oogenesis [GO:0048477]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of gene expression [GO:0010468]; regulatory ncRNA-mediated gene silencing [GO:0031047]","CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; molecular adaptor activity [GO:0060090]; astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; negative regulation of translation [GO:0017148]; nematode larval development [GO:0002119]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oogenesis [GO:0048477]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of gene expression [GO:0010468]; regulatory ncRNA-mediated gene silencing [GO:0031047]","DEVELOPMENTAL STAGE: Highly expressed in embryos. {ECO:0000269|PubMed:23843623}.","","","TISSUE SPECIFICITY: Highly expressed in the germline of hermaphrodites. {ECO:0000269|PubMed:23843623}."
"279","sp|Q8BUR3|FOXJ3_MOUSE","lcl|NC_088855.1_cds_XP_011422959.2_13932",1.05e-67,228,"Q8BUR3","FOXJ3_MOUSE","Forkhead box protein J3","Foxj3 Kiaa1041","Mus musculus (Mouse)",623,"GO:0001228; GO:0005634; GO:0007141; GO:0007283; GO:0030154; GO:1990837","cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; spermatogenesis [GO:0007283]","nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Accumulates in the testis starting at postnatal day 3, and remains at a steady level from 1 to 3 weeks in age. {ECO:0000269|PubMed:27739607}.","INDUCTION: Increased markedly during skeletal muscle differentiation (at protein level). {ECO:0000269|PubMed:23047984}.","INDUCTION: Increased markedly during skeletal muscle differentiation (at protein level). {ECO:0000269|PubMed:23047984}.","TISSUE SPECIFICITY: Highly expressed in spermatogonia, spermatocytes, and round spermatids within the testis (at protein level). {ECO:0000269|PubMed:27739607}."
"280","sp|P55937|GOGA3_MOUSE","lcl|NC_088855.1_cds_XP_011423022.3_13926",2.53e-70,262,"P55937","GOGA3_MOUSE","Golgin subfamily A member 3 (Golgin-160) (Male-enhanced antigen 2) (MEA-2)","Golga3 Mea2","Mus musculus (Mouse)",1487,"GO:0000139; GO:0005793; GO:0007283; GO:0030154; GO:0032580","cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Highly expressed in testis. Transcripts can be found in spermatids during spermatogenesis. No expression in Leydig cells, spermatogonia or spermatocytes. Detected at low levels in all tissues."
"281","sp|P41182|BCL6_HUMAN","lcl|NC_088855.1_cds_XP_011424085.3_14843",5.76e-42,154,"P41182","BCL6_HUMAN","B-cell lymphoma 6 protein (BCL-6) (B-cell lymphoma 5 protein) (BCL-5) (Protein LAZ-3) (Zinc finger and BTB domain-containing protein 27) (Zinc finger protein 51)","BCL6 BCL5 LAZ3 ZBTB27 ZNF51","Homo sapiens (Human)",706,"GO:0000122; GO:0000902; GO:0000978; GO:0001161; GO:0001222; GO:0001227; GO:0001817; GO:0001953; GO:0002317; GO:0002467; GO:0002634; GO:0002682; GO:0002903; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0006366; GO:0006954; GO:0006974; GO:0007160; GO:0007266; GO:0007283; GO:0008104; GO:0008270; GO:0021859; GO:0030036; GO:0030308; GO:0030890; GO:0031490; GO:0031507; GO:0032764; GO:0032945; GO:0035024; GO:0042092; GO:0042100; GO:0042127; GO:0042129; GO:0042382; GO:0042802; GO:0043065; GO:0043380; GO:0043565; GO:0045064; GO:0045591; GO:0045595; GO:0045629; GO:0045666; GO:0045746; GO:0045892; GO:0048289; GO:0048294; GO:0048821; GO:0048870; GO:0050727; GO:0050776; GO:0140297; GO:1900099; GO:1903464; GO:1990837; GO:2000147; GO:2000773","actin cytoskeleton organization [GO:0030036]; B cell proliferation [GO:0042100]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; cell-matrix adhesion [GO:0007160]; DNA damage response [GO:0006974]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; heterochromatin formation [GO:0031507]; inflammatory response [GO:0006954]; isotype switching to IgE isotypes [GO:0048289]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cell growth [GO:0030308]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mitotic cell cycle DNA replication [GO:1903464]; negative regulation of mononuclear cell proliferation [GO:0032945]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of plasma cell differentiation [GO:1900099]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; plasma cell differentiation [GO:0002317]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell motility [GO:2000147]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein localization [GO:0008104]; pyramidal neuron differentiation [GO:0021859]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of germinal center formation [GO:0002634]; regulation of immune response [GO:0050776]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; regulation of memory T cell differentiation [GO:0043380]; regulation of T cell proliferation [GO:0042129]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; T-helper 2 cell differentiation [GO:0045064]; transcription by RNA polymerase II [GO:0006366]; type 2 immune response [GO:0042092]","Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270]; actin cytoskeleton organization [GO:0030036]; B cell proliferation [GO:0042100]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; cell-matrix adhesion [GO:0007160]; DNA damage response [GO:0006974]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; heterochromatin formation [GO:0031507]; inflammatory response [GO:0006954]; isotype switching to IgE isotypes [GO:0048289]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cell growth [GO:0030308]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mitotic cell cycle DNA replication [GO:1903464]; negative regulation of mononuclear cell proliferation [GO:0032945]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of plasma cell differentiation [GO:1900099]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; plasma cell differentiation [GO:0002317]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell motility [GO:2000147]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein localization [GO:0008104]; pyramidal neuron differentiation [GO:0021859]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of germinal center formation [GO:0002634]; regulation of immune response [GO:0050776]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; regulation of memory T cell differentiation [GO:0043380]; regulation of T cell proliferation [GO:0042129]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; T-helper 2 cell differentiation [GO:0045064]; transcription by RNA polymerase II [GO:0006366]; type 2 immune response [GO:0042092]","","INDUCTION: Down-regulated during maturation of dendritic cells by selective stimuli such as bacterial lipopolysaccharides (LPS), CD40LG and zymosan. Protein levels decreases upon genotoxic stress in a dose- and time-dependent way. {ECO:0000269|PubMed:16455075, ECO:0000269|PubMed:17828269}.","INDUCTION: Down-regulated during maturation of dendritic cells by selective stimuli such as bacterial lipopolysaccharides (LPS), CD40LG and zymosan. Protein levels decreases upon genotoxic stress in a dose- and time-dependent way. {ECO:0000269|PubMed:16455075, ECO:0000269|PubMed:17828269}.","TISSUE SPECIFICITY: Expressed in germinal center T- and B-cells and in primary immature dendritic cells. {ECO:0000269|PubMed:10981963, ECO:0000269|PubMed:12402037, ECO:0000269|PubMed:15454082, ECO:0000269|PubMed:16142238, ECO:0000269|PubMed:16455075, ECO:0000269|PubMed:17828269, ECO:0000269|PubMed:18212045, ECO:0000269|PubMed:9649500}."
"282","sp|A6QQM8|CCD42_BOVIN","lcl|NC_088855.1_cds_XP_011424090.1_16127",8.92e-80,246,"A6QQM8","CCD42_BOVIN","Coiled-coil domain-containing protein 42","CCDC42","Bos taurus (Bovine)",316,"GO:0001675; GO:0002177; GO:0005813; GO:0007098; GO:0007286; GO:0048471; GO:0060271; GO:0097228; GO:0120212","acrosome assembly [GO:0001675]; centrosome cycle [GO:0007098]; cilium assembly [GO:0060271]; spermatid development [GO:0007286]","centrosome [GO:0005813]; manchette [GO:0002177]; perinuclear region of cytoplasm [GO:0048471]; sperm head-tail coupling apparatus [GO:0120212]; sperm principal piece [GO:0097228]; acrosome assembly [GO:0001675]; centrosome cycle [GO:0007098]; cilium assembly [GO:0060271]; spermatid development [GO:0007286]","","","",""
"283","sp|A6NFT4|CFA73_HUMAN","lcl|NC_088855.1_cds_XP_011424091.1_16126",3.63e-54,180,"A6NFT4","CFA73_HUMAN","Cilia- and flagella-associated protein 73 (Coiled-coil domain-containing protein 42B)","CFAP73 CCDC42B","Homo sapiens (Human)",308,"GO:0003341; GO:0031514; GO:0036159; GO:0070840; GO:0097545","cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]","axonemal doublet microtubule [GO:0097545]; motile cilium [GO:0031514]; dynein complex binding [GO:0070840]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]","","","",""
"284","sp|P05153|PCKGC_CHICK","lcl|NC_088855.1_cds_XP_011424185.2_17309",0,854,"P05153","PCKGC_CHICK","Phosphoenolpyruvate carboxykinase, cytosolic [GTP] (PEPCK-C) (EC 4.1.1.32) (Serine-protein kinase PCK1) (EC 2.7.11.-)","PCK1","Gallus gallus (Chicken)",622,"GO:0004550; GO:0004613; GO:0005525; GO:0005739; GO:0005783; GO:0005829; GO:0006089; GO:0006090; GO:0006094; GO:0006107; GO:0006111; GO:0006522; GO:0006531; GO:0006536; GO:0006541; GO:0006544; GO:0006560; GO:0007296; GO:0007586; GO:0008343; GO:0009069; GO:0009792; GO:0018105; GO:0018991; GO:0019543; GO:0019563; GO:0019953; GO:0030145; GO:0030703; GO:0032496; GO:0032869; GO:0033993; GO:0042149; GO:0042594; GO:0043382; GO:0045722; GO:0045912; GO:0045913; GO:0046015; GO:0046327; GO:0046890; GO:0046898; GO:0048562; GO:0048589; GO:0050892; GO:0051379; GO:0051384; GO:0051591; GO:0060259; GO:0070365; GO:0070741; GO:0071300; GO:0071320; GO:0071332; GO:0071333; GO:0071347; GO:0071356; GO:0071361; GO:0071374; GO:0071377; GO:0071456; GO:0071549; GO:0106264; GO:1904640","adult feeding behavior [GO:0008343]; alanine metabolic process [GO:0006522]; aspartate metabolic process [GO:0006531]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to fructose stimulus [GO:0071332]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-1 [GO:0071347]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to retinoic acid [GO:0071300]; cellular response to tumor necrosis factor [GO:0071356]; developmental growth [GO:0048589]; digestion [GO:0007586]; egg-laying behavior [GO:0018991]; eggshell formation [GO:0030703]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic organ morphogenesis [GO:0048562]; gluconeogenesis [GO:0006094]; glutamate metabolic process [GO:0006536]; glutamine metabolic process [GO:0006541]; glycerol biosynthetic process from pyruvate [GO:0046327]; glycerol catabolic process [GO:0019563]; glycine metabolic process [GO:0006544]; hepatocyte differentiation [GO:0070365]; intestinal absorption [GO:0050892]; lactate metabolic process [GO:0006089]; negative regulation of carbohydrate metabolic process [GO:0045912]; oxaloacetate metabolic process [GO:0006107]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of carbohydrate metabolic process [GO:0045913]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of memory T cell differentiation [GO:0043382]; proline metabolic process [GO:0006560]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; regulation of feeding behavior [GO:0060259]; regulation of gluconeogenesis [GO:0006111]; regulation of lipid biosynthetic process [GO:0046890]; regulation of transcription by glucose [GO:0046015]; response to cAMP [GO:0051591]; response to cycloheximide [GO:0046898]; response to glucocorticoid [GO:0051384]; response to interleukin-6 [GO:0070741]; response to lipid [GO:0033993]; response to lipopolysaccharide [GO:0032496]; response to methionine [GO:1904640]; response to starvation [GO:0042594]; serine family amino acid metabolic process [GO:0009069]; sexual reproduction [GO:0019953]; vitellogenesis [GO:0007296]","cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; epinephrine binding [GO:0051379]; GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; nucleoside diphosphate kinase activity [GO:0004550]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; protein serine kinase activity (using GTP as donor) [GO:0106264]; adult feeding behavior [GO:0008343]; alanine metabolic process [GO:0006522]; aspartate metabolic process [GO:0006531]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to fructose stimulus [GO:0071332]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-1 [GO:0071347]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to retinoic acid [GO:0071300]; cellular response to tumor necrosis factor [GO:0071356]; developmental growth [GO:0048589]; digestion [GO:0007586]; egg-laying behavior [GO:0018991]; eggshell formation [GO:0030703]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic organ morphogenesis [GO:0048562]; gluconeogenesis [GO:0006094]; glutamate metabolic process [GO:0006536]; glutamine metabolic process [GO:0006541]; glycerol biosynthetic process from pyruvate [GO:0046327]; glycerol catabolic process [GO:0019563]; glycine metabolic process [GO:0006544]; hepatocyte differentiation [GO:0070365]; intestinal absorption [GO:0050892]; lactate metabolic process [GO:0006089]; negative regulation of carbohydrate metabolic process [GO:0045912]; oxaloacetate metabolic process [GO:0006107]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of carbohydrate metabolic process [GO:0045913]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of memory T cell differentiation [GO:0043382]; proline metabolic process [GO:0006560]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; regulation of feeding behavior [GO:0060259]; regulation of gluconeogenesis [GO:0006111]; regulation of lipid biosynthetic process [GO:0046890]; regulation of transcription by glucose [GO:0046015]; response to cAMP [GO:0051591]; response to cycloheximide [GO:0046898]; response to glucocorticoid [GO:0051384]; response to interleukin-6 [GO:0070741]; response to lipid [GO:0033993]; response to lipopolysaccharide [GO:0032496]; response to methionine [GO:1904640]; response to starvation [GO:0042594]; serine family amino acid metabolic process [GO:0009069]; sexual reproduction [GO:0019953]; vitellogenesis [GO:0007296]","","","",""
"285","sp|P21642|PCKGM_CHICK","lcl|NC_088855.1_cds_XP_011424195.2_17310",0,736,"P21642","PCKGM_CHICK","Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)","PCK2","Gallus gallus (Chicken)",641,"GO:0004613; GO:0005525; GO:0005739; GO:0005759; GO:0006089; GO:0006090; GO:0006094; GO:0006107; GO:0006111; GO:0007296; GO:0009792; GO:0018991; GO:0019543; GO:0019563; GO:0019661; GO:0030145; GO:0030703; GO:0032869; GO:0042594; GO:0046327; GO:0048562; GO:0050792; GO:0051591; GO:0070365; GO:0071333; GO:0071361; GO:0071549","cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; egg-laying behavior [GO:0018991]; eggshell formation [GO:0030703]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic organ morphogenesis [GO:0048562]; gluconeogenesis [GO:0006094]; glucose catabolic process to lactate via pyruvate [GO:0019661]; glycerol biosynthetic process from pyruvate [GO:0046327]; glycerol catabolic process [GO:0019563]; hepatocyte differentiation [GO:0070365]; lactate metabolic process [GO:0006089]; oxaloacetate metabolic process [GO:0006107]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; regulation of gluconeogenesis [GO:0006111]; regulation of viral process [GO:0050792]; response to cAMP [GO:0051591]; response to starvation [GO:0042594]; vitellogenesis [GO:0007296]","mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; egg-laying behavior [GO:0018991]; eggshell formation [GO:0030703]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic organ morphogenesis [GO:0048562]; gluconeogenesis [GO:0006094]; glucose catabolic process to lactate via pyruvate [GO:0019661]; glycerol biosynthetic process from pyruvate [GO:0046327]; glycerol catabolic process [GO:0019563]; hepatocyte differentiation [GO:0070365]; lactate metabolic process [GO:0006089]; oxaloacetate metabolic process [GO:0006107]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; regulation of gluconeogenesis [GO:0006111]; regulation of viral process [GO:0050792]; response to cAMP [GO:0051591]; response to starvation [GO:0042594]; vitellogenesis [GO:0007296]","","INDUCTION: Appears to be constitutively expressed.","INDUCTION: Appears to be constitutively expressed.","TISSUE SPECIFICITY: Present in liver and kidney. {ECO:0000269|PubMed:2110163}."
"286","sp|P36873|PP1G_HUMAN","lcl|NC_088855.1_cds_XP_011424397.1_14267",0,628,"P36873","PP1G_HUMAN","Serine/threonine-protein phosphatase PP1-gamma catalytic subunit (PP-1G) (EC 3.1.3.16) (Protein phosphatase 1C catalytic subunit)","PPP1CC","Homo sapiens (Human)",323,"GO:0000070; GO:0000165; GO:0000776; GO:0001824; GO:0003723; GO:0004721; GO:0004722; GO:0005521; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005741; GO:0005815; GO:0005829; GO:0005925; GO:0005977; GO:0006470; GO:0007283; GO:0008157; GO:0016607; GO:0016791; GO:0019901; GO:0019904; GO:0030182; GO:0030496; GO:0032154; GO:0032922; GO:0032991; GO:0042752; GO:0043153; GO:0043197; GO:0044877; GO:0046822; GO:0046872; GO:0051301; GO:0060252; GO:0072357; GO:0098793; GO:0098978","blastocyst development [GO:0001824]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; MAPK cascade [GO:0000165]; mitotic sister chromatid segregation [GO:0000070]; neuron differentiation [GO:0030182]; positive regulation of glial cell proliferation [GO:0060252]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]; regulation of nucleocytoplasmic transport [GO:0046822]; spermatogenesis [GO:0007283]","cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; PTW/PP1 phosphatase complex [GO:0072357]; lamin binding [GO:0005521]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; blastocyst development [GO:0001824]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; MAPK cascade [GO:0000165]; mitotic sister chromatid segregation [GO:0000070]; neuron differentiation [GO:0030182]; positive regulation of glial cell proliferation [GO:0060252]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]; regulation of nucleocytoplasmic transport [GO:0046822]; spermatogenesis [GO:0007283]","","INDUCTION: Up-regulated in synovial fluid mononuclear cells and peripheral blood mononuclear cells from patients with rheumatoid arthritis. {ECO:0000269|PubMed:23396208}.","INDUCTION: Up-regulated in synovial fluid mononuclear cells and peripheral blood mononuclear cells from patients with rheumatoid arthritis. {ECO:0000269|PubMed:23396208}.",""
"287","sp|Q9ERS8|SEBOX_RAT","lcl|NC_088855.1_cds_XP_011424860.3_12585",4.25e-18,82.4,"Q9ERS8","SEBOX_RAT","Homeobox protein SEBOX (Homeobox OG-9) (Skin-, embryo-, brain- and oocyte-specific homeobox)","Sebox Og9x","Rattus norvegicus (Rat)",188,"GO:0003677; GO:0005634; GO:0009792; GO:0048477","embryo development ending in birth or egg hatching [GO:0009792]; oogenesis [GO:0048477]","nucleus [GO:0005634]; DNA binding [GO:0003677]; embryo development ending in birth or egg hatching [GO:0009792]; oogenesis [GO:0048477]","","","",""
"288","sp|P70368|SEBOX_MOUSE","lcl|NC_088855.1_cds_XP_011424861.3_12584",1.87e-18,83.2,"P70368","SEBOX_MOUSE","Homeobox protein SEBOX (Homeobox OG-9) (Skin-, embryo-, brain- and oocyte-specific homeobox)","Sebox Og9x","Mus musculus (Mouse)",190,"GO:0003677; GO:0005634; GO:0009792; GO:0048477","embryo development ending in birth or egg hatching [GO:0009792]; oogenesis [GO:0048477]","nucleus [GO:0005634]; DNA binding [GO:0003677]; embryo development ending in birth or egg hatching [GO:0009792]; oogenesis [GO:0048477]","DEVELOPMENTAL STAGE: Expressed in embryos from day 7. Expression is low in 12 day embryos and higher in 18 and 19 day embryos. {ECO:0000269|PubMed:10922053, ECO:0000269|PubMed:8855241}.","","","TISSUE SPECIFICITY: Expressed in brain, skin, ovary and liver. Also expressed in maturing oocytes, eggs, zygotes and 2-cell embryos, but not 4-cell embryos. {ECO:0000269|PubMed:10922053, ECO:0000269|PubMed:8855241}."
"289","sp|Q9Y232|CDYL_HUMAN","lcl|NC_088855.1_cds_XP_011427845.3_12210",2.11e-74,255,"Q9Y232","CDYL_HUMAN","Chromodomain Y-like protein (CDY-like) (Crotonyl-CoA hydratase) (EC 4.2.1.-)","CDYL CDYL1","Homo sapiens (Human)",598,"GO:0003682; GO:0003714; GO:0005634; GO:0005694; GO:0005737; GO:0007283; GO:0007286; GO:0016607; GO:0030674; GO:0042802; GO:0060816; GO:0120092; GO:0120094","negative regulation of peptidyl-lysine crotonylation [GO:0120094]; random inactivation of X chromosome [GO:0060816]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; crotonyl-CoA hydratase activity [GO:0120092]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; transcription corepressor activity [GO:0003714]; negative regulation of peptidyl-lysine crotonylation [GO:0120094]; random inactivation of X chromosome [GO:0060816]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in the hippocampus with reduced expression in epileptic tissue compared to normal adjacent tissue (at protein level) (PubMed:28842554). Ubiquitous (PubMed:19808672). Expressed at moderate levels in all tissues examined (PubMed:19808672). Isoform 2: Most abundantly expressed isoform (PubMed:19808672). {ECO:0000269|PubMed:19808672, ECO:0000269|PubMed:28842554}."
"290","sp|Q21629|EGG2_CAEEL","lcl|NC_088855.1_cds_XP_011427908.3_13525",5.15e-34,139,"Q21629","EGG2_CAEEL","LDL receptor repeat-containing protein egg-2 (Egg sterile protein 2)","egg-2 R01H2.3","Caenorhabditis elegans",548,"GO:0005886; GO:0007338; GO:0010008; GO:0030703; GO:0038023; GO:1903078; GO:1904778","eggshell formation [GO:0030703]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of protein localization to plasma membrane [GO:1903078]; single fertilization [GO:0007338]","endosome membrane [GO:0010008]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; eggshell formation [GO:0030703]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of protein localization to plasma membrane [GO:1903078]; single fertilization [GO:0007338]","","","",""
"291","sp|Q9CWH6|PSMA8_MOUSE","lcl|NC_088855.1_cds_XP_011427924.3_13542",1.03e-132,375,"Q9CWH6","PSMA8_MOUSE","Proteasome subunit alpha type-8 (Proteasome alpha 4 subunit) (Alpha4s) (Proteasome subunit alpha-type 7-like)","Psma8 Psma7l","Mus musculus (Mouse)",250,"GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0007283; GO:0010498; GO:0019773; GO:0030154; GO:0051321; GO:0060631; GO:1990111","cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; proteasomal protein catabolic process [GO:0010498]; regulation of meiosis I [GO:0060631]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]","cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome core complex, alpha-subunit complex [GO:0019773]; spermatoproteasome complex [GO:1990111]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; proteasomal protein catabolic process [GO:0010498]; regulation of meiosis I [GO:0060631]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]","DEVELOPMENTAL STAGE: In testes, expressed in spermatocytes at the pachytene stage (weakly in early pachynema and strongly in late pachynema), and its expression persisted thereafter throughout spermatogenesis. {ECO:0000269|PubMed:23706739, ECO:0000269|PubMed:31358751, ECO:0000269|PubMed:31437213}.","","",""
"292","sp|Q6P1G2|KDM2B_MOUSE","lcl|NC_088855.1_cds_XP_011427933.3_13549",1.24e-137,454,"Q6P1G2","KDM2B_MOUSE","Lysine-specific demethylase 2B (EC 1.14.11.27) (F-box and leucine-rich repeat protein 10) (F-box protein FBL10) (F-box/LRR-repeat protein 10) (JmjC domain-containing histone demethylation protein 1B) ([Histone-H3]-lysine-36 demethylase 1B)","Kdm2b Fbl10 Fbxl10 Jhdm1b Kiaa3014","Mus musculus (Mouse)",1309,"GO:0000122; GO:0000978; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0007283; GO:0008270; GO:0019843; GO:0021555; GO:0021592; GO:0021670; GO:0021678; GO:0021993; GO:0030307; GO:0030900; GO:0030901; GO:0030902; GO:0031519; GO:0032452; GO:0043524; GO:0045322; GO:0048596; GO:0051864; GO:0140680; GO:1902459; GO:2000178","embryonic camera-type eye morphogenesis [GO:0048596]; forebrain development [GO:0030900]; fourth ventricle development [GO:0021592]; hindbrain development [GO:0030902]; initiation of neural tube closure [GO:0021993]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of stem cell population maintenance [GO:1902459]; spermatogenesis [GO:0007283]; third ventricle development [GO:0021678]","chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; histone demethylase activity [GO:0032452]; histone H3K36 demethylase activity [GO:0051864]; histone H3K36me/H3K36me2 demethylase activity [GO:0140680]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; rRNA binding [GO:0019843]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; embryonic camera-type eye morphogenesis [GO:0048596]; forebrain development [GO:0030900]; fourth ventricle development [GO:0021592]; hindbrain development [GO:0030902]; initiation of neural tube closure [GO:0021993]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of stem cell population maintenance [GO:1902459]; spermatogenesis [GO:0007283]; third ventricle development [GO:0021678]","","","",""
"293","sp|Q00972|BCKD_RAT","lcl|NC_088855.1_cds_XP_011427938.3_13550",1.88e-150,433,"Q00972","BCKD_RAT","Branched-chain alpha-ketoacid dehydrogenase kinase (BCKDH kinase) (BCKDHKIN) (BDK) (EC 2.7.11.1) ([3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial) (EC 2.7.11.4)","Bckdk","Rattus norvegicus (Rat)",412,"GO:0004672; GO:0004674; GO:0004722; GO:0004740; GO:0005524; GO:0005739; GO:0005759; GO:0006550; GO:0006552; GO:0006574; GO:0007283; GO:0008610; GO:0009083; GO:0010510; GO:0010906; GO:0045252; GO:0047323; GO:0106310","branched-chain amino acid catabolic process [GO:0009083]; isoleucine catabolic process [GO:0006550]; L-leucine catabolic process [GO:0006552]; lipid biosynthetic process [GO:0008610]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; spermatogenesis [GO:0007283]; valine catabolic process [GO:0006574]","mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxoglutarate dehydrogenase complex [GO:0045252]; [3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine phosphatase activity [GO:0004722]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; branched-chain amino acid catabolic process [GO:0009083]; isoleucine catabolic process [GO:0006550]; L-leucine catabolic process [GO:0006552]; lipid biosynthetic process [GO:0008610]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; spermatogenesis [GO:0007283]; valine catabolic process [GO:0006574]","","","","TISSUE SPECIFICITY: Expressed in heart and liver. {ECO:0000269|PubMed:1377677}."
"294","sp|O44342|WBL_DROME","lcl|NC_088855.1_cds_XP_011428502.3_15756",1.25e-30,115,"O44342","WBL_DROME","Protein windbeutel (Erp29 homolog)","wbl wind CG7225","Drosophila melanogaster (Fruit fly)",257,"GO:0005783; GO:0005788; GO:0007313; GO:0009306; GO:0009792; GO:0009950; GO:0012505; GO:0034975; GO:0040014; GO:0042803","dorsal/ventral axis specification [GO:0009950]; embryo development ending in birth or egg hatching [GO:0009792]; maternal specification of dorsal/ventral axis, oocyte, soma encoded [GO:0007313]; protein folding in endoplasmic reticulum [GO:0034975]; protein secretion [GO:0009306]; regulation of multicellular organism growth [GO:0040014]","endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; protein homodimerization activity [GO:0042803]; dorsal/ventral axis specification [GO:0009950]; embryo development ending in birth or egg hatching [GO:0009792]; maternal specification of dorsal/ventral axis, oocyte, soma encoded [GO:0007313]; protein folding in endoplasmic reticulum [GO:0034975]; protein secretion [GO:0009306]; regulation of multicellular organism growth [GO:0040014]","DEVELOPMENTAL STAGE: Expressed in ovaries, early embryo (0-4 hours) and adult males. Almost undetectable in female carcasses. In ovaries, it is not detected in the germarium or early stage egg-chambers and is first detectable in the follicle cells of stage 8 egg-chambers. The peak of expression occurs in the follicle cells of stages 9 and early 10, and it disappears completely before stage 11. Not expressed in the germline cells (nurse cells and oocyte), with the possible exception of late stage 10 nurse cells. {ECO:0000269|PubMed:9420336}.","","","TISSUE SPECIFICITY: Briefly expressed in the follicle cells of the ovary, at around the time when the dorsoventral axis of the egg chamber is first established. {ECO:0000269|PubMed:9420336}."
"295","sp|Q9VRM7|CP307_DROME","lcl|NC_088855.1_cds_XP_011428522.3_15783",2.8e-42,159,"Q9VRM7","CP307_DROME","Cytochrome P450 307a1 (EC 1.14.-.-) (CYPCCCVIIA1) (Protein spook)","spo Cyp307a1 CG10594","Drosophila melanogaster (Fruit fly)",543,"GO:0001700; GO:0004497; GO:0005506; GO:0005783; GO:0005789; GO:0006697; GO:0007391; GO:0007417; GO:0007494; GO:0008258; GO:0016491; GO:0016705; GO:0020037; GO:0042335; GO:0048477; GO:0048566","central nervous system development [GO:0007417]; cuticle development [GO:0042335]; dorsal closure [GO:0007391]; ecdysone biosynthetic process [GO:0006697]; embryonic development via the syncytial blastoderm [GO:0001700]; embryonic digestive tract development [GO:0048566]; head involution [GO:0008258]; midgut development [GO:0007494]; oogenesis [GO:0048477]","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; central nervous system development [GO:0007417]; cuticle development [GO:0042335]; dorsal closure [GO:0007391]; ecdysone biosynthetic process [GO:0006697]; embryonic development via the syncytial blastoderm [GO:0001700]; embryonic digestive tract development [GO:0048566]; head involution [GO:0008258]; midgut development [GO:0007494]; oogenesis [GO:0048477]","","","",""
"296","sp|Q86U44|MTA70_HUMAN","lcl|NC_088855.1_cds_XP_011428532.3_12818",0,575,"Q86U44","MTA70_HUMAN","N(6)-adenosine-methyltransferase catalytic subunit METTL3 (EC 2.1.1.348) (Methyltransferase-like protein 3) (hMETTL3) (N(6)-adenosine-methyltransferase 70 kDa subunit) (MT-A70)","METTL3 MTA70","Homo sapiens (Human)",580,"GO:0000398; GO:0001510; GO:0001734; GO:0003729; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006397; GO:0006974; GO:0007283; GO:0007623; GO:0008173; GO:0009048; GO:0016556; GO:0016604; GO:0016607; GO:0019827; GO:0021861; GO:0031053; GO:0034644; GO:0036396; GO:0042063; GO:0045087; GO:0045580; GO:0045727; GO:0045746; GO:0046982; GO:0048477; GO:0051445; GO:0060339; GO:0061157; GO:0098508; GO:1902036; GO:1903679; GO:1904047; GO:1990204","cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; dosage compensation by inactivation of X chromosome [GO:0009048]; endothelial to hematopoietic transition [GO:0098508]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; innate immune response [GO:0045087]; mRNA destabilization [GO:0061157]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oogenesis [GO:0048477]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translation [GO:0045727]; primary miRNA processing [GO:0031053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of T cell differentiation [GO:0045580]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]","cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; oxidoreductase complex [GO:1990204]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA binding [GO:0003729]; mRNA m(6)A methyltransferase activity [GO:0001734]; protein heterodimerization activity [GO:0046982]; RNA methyltransferase activity [GO:0008173]; S-adenosyl-L-methionine binding [GO:1904047]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; dosage compensation by inactivation of X chromosome [GO:0009048]; endothelial to hematopoietic transition [GO:0098508]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; innate immune response [GO:0045087]; mRNA destabilization [GO:0061157]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oogenesis [GO:0048477]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translation [GO:0045727]; primary miRNA processing [GO:0031053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of T cell differentiation [GO:0045580]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]","","INDUCTION: Overexpressed in a number of cancer tissues, such as lung adenocarcinoma and colon adenocarcinoma (PubMed:27117702). {ECO:0000269|PubMed:27117702}.","INDUCTION: Overexpressed in a number of cancer tissues, such as lung adenocarcinoma and colon adenocarcinoma (PubMed:27117702). {ECO:0000269|PubMed:27117702}.","TISSUE SPECIFICITY: Widely expressed at low level. Expressed in spleen, thymus, prostate, testis, ovary, small intestine, colon and peripheral blood leukocytes. {ECO:0000269|PubMed:9409616}."
"297","sp|Q99P25|TXIP1_MOUSE","lcl|NC_088855.1_cds_XP_011428738.3_12112",5.16e-129,399,"Q99P25","TXIP1_MOUSE","Translin-associated factor X-interacting protein 1 (Trax-interacting protein 1)","Tsnaxip1 Txi1","Mus musculus (Mouse)",704,"GO:0005737; GO:0007283; GO:0030154; GO:0048471","cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Specifically expressed in testes. Predominantly detected in the post-meiotic stages of germ cells. {ECO:0000269|PubMed:12036294}."
"298","sp|Q6P4W8|PCH2_XENTR","lcl|NC_088855.1_cds_XP_011430033.3_15486",0,562,"Q6P4W8","PCH2_XENTR","Pachytene checkpoint protein 2 homolog (Thyroid hormone receptor interactor 13 homolog) (Thyroid receptor-interacting protein 13 homolog) (TR-interacting protein 13 homolog) (TRIP-13 homolog)","trip13 pch2","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)",432,"GO:0005524; GO:0006302; GO:0007130; GO:0007131; GO:0007283; GO:0016887; GO:0048477","double-strand break repair [GO:0006302]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-strand break repair [GO:0006302]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]","","","",""
"299","sp|B4QHS6|AKTP1_DROSI","lcl|NC_088855.1_cds_XP_011430945.1_15065",7.78e-44,150,"B4QHS6","AKTP1_DROSI","Protein crossbronx","cbx GD10043","Drosophila simulans (Fruit fly)",244,"GO:0007291; GO:0042742","defense response to bacterium [GO:0042742]; sperm individualization [GO:0007291]","defense response to bacterium [GO:0042742]; sperm individualization [GO:0007291]","","","",""
"300","sp|Q2T9Q1|TBC20_BOVIN","lcl|NC_088855.1_cds_XP_011431807.3_12617",5.95e-106,318,"Q2T9Q1","TBC20_BOVIN","TBC1 domain family member 20","TBC1D20","Bos taurus (Bovine)",403,"GO:0000139; GO:0001675; GO:0005096; GO:0005789; GO:0006888; GO:0007030; GO:0019068; GO:0031267; GO:0031965; GO:0034389; GO:0044829; GO:0046726; GO:0070309; GO:0072520; GO:0090110; GO:1902953","acrosome assembly [GO:0001675]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; lens fiber cell morphogenesis [GO:0070309]; lipid droplet organization [GO:0034389]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; seminiferous tubule development [GO:0072520]; virion assembly [GO:0019068]","endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nuclear membrane [GO:0031965]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; acrosome assembly [GO:0001675]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; lens fiber cell morphogenesis [GO:0070309]; lipid droplet organization [GO:0034389]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; seminiferous tubule development [GO:0072520]; virion assembly [GO:0019068]","","","",""
"301","sp|Q9VAD6|COG7_DROME","lcl|NC_088855.1_cds_XP_011431811.3_12621",3.07e-92,305,"Q9VAD6","COG7_DROME","Conserved oligomeric Golgi complex subunit 7 (COG complex subunit 7) (Component of oligomeric Golgi complex 7)","Cog7 CG31040","Drosophila melanogaster (Fruit fly)",742,"GO:0000139; GO:0000916; GO:0005794; GO:0006886; GO:0006890; GO:0006891; GO:0007030; GO:0007112; GO:0017119; GO:0036063; GO:1903292","actomyosin contractile ring contraction [GO:0000916]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; male meiosis cytokinesis [GO:0007112]; protein localization to Golgi membrane [GO:1903292]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","acroblast [GO:0036063]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; actomyosin contractile ring contraction [GO:0000916]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; male meiosis cytokinesis [GO:0007112]; protein localization to Golgi membrane [GO:1903292]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","","","",""
"302","sp|Q99L45|IF2B_MOUSE","lcl|NC_088855.1_cds_XP_011432160.3_11719",1.22e-106,315,"Q99L45","IF2B_MOUSE","Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta) (eIF2-beta)","Eif2s2","Mus musculus (Mouse)",331,"GO:0001701; GO:0002176; GO:0002183; GO:0003743; GO:0005829; GO:0005850; GO:0008270; GO:0008584; GO:0045202","cytoplasmic translational initiation [GO:0002183]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584]","cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; synapse [GO:0045202]; translation initiation factor activity [GO:0003743]; zinc ion binding [GO:0008270]; cytoplasmic translational initiation [GO:0002183]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584]","","","",""
"303","sp|Q9V3U9|SLMO_DROME","lcl|NC_088855.1_cds_XP_011432462.3_16954",2.55e-48,158,"Q9V3U9","SLMO_DROME","Protein slowmo","slmo kisir CG9131","Drosophila melanogaster (Fruit fly)",215,"GO:0005739; GO:0005758; GO:0007283; GO:0008345; GO:0015914; GO:0030432; GO:0030706; GO:1990050","germarium-derived oocyte differentiation [GO:0030706]; larval locomotory behavior [GO:0008345]; peristalsis [GO:0030432]; phospholipid transport [GO:0015914]; spermatogenesis [GO:0007283]","mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; phosphatidic acid transfer activity [GO:1990050]; germarium-derived oocyte differentiation [GO:0030706]; larval locomotory behavior [GO:0008345]; peristalsis [GO:0030432]; phospholipid transport [GO:0015914]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed from stage 16 embryos.","","","TISSUE SPECIFICITY: Expressed in specific tissues such as the developing central nervous system (CNS) and both the male and female germline. In the CNS, it is restricted in a subset of cells during embryogenesis and early larval development. In embryos, it is also expressed in salivary glands. In the testis, expressed in somatic cyst cells throughout the distal region where the mitotic cysts develop, extending through to meiotic cysts. {ECO:0000269|PubMed:14673704, ECO:0000269|PubMed:17245774}."
"304","sp|Q9XTT4|ANI1_CAEEL","lcl|NC_088855.1_cds_XP_011432719.3_14770",3.16e-32,137,"Q9XTT4","ANI1_CAEEL","Anillin-like protein 1","ani-1 Y49E10.19","Caenorhabditis elegans",1159,"GO:0000281; GO:0000915; GO:0005634; GO:0005737; GO:0005819; GO:0005826; GO:0005874; GO:0005938; GO:0008017; GO:0008104; GO:0009792; GO:0030426; GO:0030496; GO:0030590; GO:0030865; GO:0031106; GO:0031252; GO:0031267; GO:0032154; GO:0040002; GO:0040011; GO:0040038; GO:0045138; GO:0051015; GO:0051017","actin filament bundle assembly [GO:0051017]; actomyosin contractile ring assembly [GO:0000915]; collagen and cuticulin-based cuticle development [GO:0040002]; cortical cytoskeleton organization [GO:0030865]; embryo development ending in birth or egg hatching [GO:0009792]; first cell cycle pseudocleavage [GO:0030590]; locomotion [GO:0040011]; mitotic cytokinesis [GO:0000281]; nematode male tail tip morphogenesis [GO:0045138]; polar body extrusion after meiotic divisions [GO:0040038]; protein localization [GO:0008104]; septin ring organization [GO:0031106]","actomyosin contractile ring [GO:0005826]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; actin filament binding [GO:0051015]; microtubule binding [GO:0008017]; small GTPase binding [GO:0031267]; actin filament bundle assembly [GO:0051017]; actomyosin contractile ring assembly [GO:0000915]; collagen and cuticulin-based cuticle development [GO:0040002]; cortical cytoskeleton organization [GO:0030865]; embryo development ending in birth or egg hatching [GO:0009792]; first cell cycle pseudocleavage [GO:0030590]; locomotion [GO:0040011]; mitotic cytokinesis [GO:0000281]; nematode male tail tip morphogenesis [GO:0045138]; polar body extrusion after meiotic divisions [GO:0040038]; protein localization [GO:0008104]; septin ring organization [GO:0031106]","DEVELOPMENTAL STAGE: Enriched in embryos, where it localizes predominantly to cortical regions and the cytokinetic furrow in telophase. {ECO:0000269|PubMed:15930113}.","","","TISSUE SPECIFICITY: Strongly expressed in dividing neuroblasts under the ventral epidermal cells during ventral enclosure. {ECO:0000269|PubMed:24016757}."
"305","sp|O14965|AURKA_HUMAN","lcl|NC_088855.1_cds_XP_011432819.1_16174",2.41e-155,442,"O14965","AURKA_HUMAN","Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Breast tumor-amplified kinase) (Ipl1- and aurora-related kinase 1) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase Ayk1) (Serine/threonine-protein kinase aurora-A)","AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6","Homo sapiens (Human)",403,"GO:0000086; GO:0000278; GO:0000776; GO:0000922; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0006468; GO:0006915; GO:0007051; GO:0007052; GO:0007057; GO:0007100; GO:0009611; GO:0009948; GO:0010389; GO:0010629; GO:0014069; GO:0015630; GO:0016323; GO:0018105; GO:0019901; GO:0030496; GO:0031616; GO:0031625; GO:0031647; GO:0032091; GO:0032133; GO:0032436; GO:0032465; GO:0035175; GO:0036064; GO:0042585; GO:0043066; GO:0043161; GO:0043203; GO:0045120; GO:0045840; GO:0045931; GO:0046605; GO:0046777; GO:0046982; GO:0048471; GO:0051233; GO:0051301; GO:0051642; GO:0061523; GO:0071539; GO:0072686; GO:0072687; GO:0090141; GO:0097421; GO:0097431; GO:0098978; GO:0106310; GO:0140677; GO:1900195; GO:1901796; GO:1990138","anterior/posterior axis specification [GO:0009948]; apoptotic process [GO:0006915]; cell division [GO:0051301]; centrosome localization [GO:0051642]; cilium disassembly [GO:0061523]; G2/M transition of mitotic cell cycle [GO:0000086]; liver regeneration [GO:0097421]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; neuron projection extension [GO:1990138]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein localization to centrosome [GO:0071539]; protein phosphorylation [GO:0006468]; regulation of centrosome cycle [GO:0046605]; regulation of cytokinesis [GO:0032465]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to wounding [GO:0009611]; spindle assembly involved in female meiosis I [GO:0007057]; spindle organization [GO:0007051]","axon hillock [GO:0043203]; basolateral plasma membrane [GO:0016323]; centriole [GO:0005814]; centrosome [GO:0005813]; chromosome passenger complex [GO:0032133]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; germinal vesicle [GO:0042585]; glutamatergic synapse [GO:0098978]; kinetochore [GO:0000776]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; spindle pole centrosome [GO:0031616]; ATP binding [GO:0005524]; histone H3S10 kinase activity [GO:0035175]; molecular function activator activity [GO:0140677]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625]; anterior/posterior axis specification [GO:0009948]; apoptotic process [GO:0006915]; cell division [GO:0051301]; centrosome localization [GO:0051642]; cilium disassembly [GO:0061523]; G2/M transition of mitotic cell cycle [GO:0000086]; liver regeneration [GO:0097421]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; neuron projection extension [GO:1990138]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein localization to centrosome [GO:0071539]; protein phosphorylation [GO:0006468]; regulation of centrosome cycle [GO:0046605]; regulation of cytokinesis [GO:0032465]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to wounding [GO:0009611]; spindle assembly involved in female meiosis I [GO:0007057]; spindle organization [GO:0007051]","","INDUCTION: Expression is cell-cycle regulated, low in G1/S, accumulates during G2/M, and decreases rapidly after. {ECO:0000269|PubMed:11790771, ECO:0000269|PubMed:12390251, ECO:0000269|PubMed:15987997, ECO:0000269|PubMed:9153231, ECO:0000269|PubMed:9606188}.","INDUCTION: Expression is cell-cycle regulated, low in G1/S, accumulates during G2/M, and decreases rapidly after. {ECO:0000269|PubMed:11790771, ECO:0000269|PubMed:12390251, ECO:0000269|PubMed:15987997, ECO:0000269|PubMed:9153231, ECO:0000269|PubMed:9606188}.","TISSUE SPECIFICITY: Highly expressed in testis and weakly in skeletal muscle, thymus and spleen. Also highly expressed in colon, ovarian, prostate, neuroblastoma, breast and cervical cancer cell lines."
"306","sp|P54733|CCNE_DROME","lcl|NC_088855.1_cds_XP_011433151.1_12399",9.38e-96,304,"P54733","CCNE_DROME","G1/S-specific cyclin-E (DmCycE)","CycE CG3938","Drosophila melanogaster (Fruit fly)",709,"GO:0000082; GO:0005634; GO:0005737; GO:0005815; GO:0006275; GO:0007096; GO:0007277; GO:0007307; GO:0007400; GO:0007419; GO:0007422; GO:0016538; GO:0035019; GO:0035220; GO:0035736; GO:0042127; GO:0043065; GO:0045035; GO:0046427; GO:0048665; GO:0090210; GO:0097134; GO:1900087","cell proliferation involved in compound eye morphogenesis [GO:0035736]; eggshell chorion gene amplification [GO:0007307]; G1/S transition of mitotic cell cycle [GO:0000082]; neuroblast fate determination [GO:0007400]; neuron fate specification [GO:0048665]; peripheral nervous system development [GO:0007422]; pole cell development [GO:0007277]; positive regulation of apoptotic process [GO:0043065]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of cell population proliferation [GO:0042127]; regulation of DNA replication [GO:0006275]; regulation of establishment of blood-brain barrier [GO:0090210]; regulation of exit from mitosis [GO:0007096]; sensory organ precursor cell division [GO:0045035]; somatic stem cell population maintenance [GO:0035019]; ventral cord development [GO:0007419]; wing disc development [GO:0035220]","cyclin E1-CDK2 complex [GO:0097134]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; cell proliferation involved in compound eye morphogenesis [GO:0035736]; eggshell chorion gene amplification [GO:0007307]; G1/S transition of mitotic cell cycle [GO:0000082]; neuroblast fate determination [GO:0007400]; neuron fate specification [GO:0048665]; peripheral nervous system development [GO:0007422]; pole cell development [GO:0007277]; positive regulation of apoptotic process [GO:0043065]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of cell population proliferation [GO:0042127]; regulation of DNA replication [GO:0006275]; regulation of establishment of blood-brain barrier [GO:0090210]; regulation of exit from mitosis [GO:0007096]; sensory organ precursor cell division [GO:0045035]; somatic stem cell population maintenance [GO:0035019]; ventral cord development [GO:0007419]; wing disc development [GO:0035220]","DEVELOPMENTAL STAGE: Isoform II is expressed maternally and isoform I zygotically in larvae. {ECO:0000269|PubMed:8187637}.","","","TISSUE SPECIFICITY: Isoform II is ubiquitous in early embryos and, prior to mitosis 14, is rapidly degraded in all cells except the pole (germ) cells. Expressed during G1 phase in proliferating peripheral nervous system cells. Constitutive expression in embryonic cycles lacking a G1 phase. {ECO:0000269|PubMed:8187637}."
"307","sp|Q9V3Y2|DRE2_DROME","lcl|NC_088855.1_cds_XP_011433904.2_13109",1.15e-49,167,"Q9V3Y2","DRE2_DROME","Anamorsin homolog (Fe-S cluster assembly protein DRE2 homolog)","CIAPIN1 l(2)35Bg CG4180","Drosophila melanogaster (Fruit fly)",248,"GO:0005737; GO:0005758; GO:0005829; GO:0009055; GO:0016226; GO:0043066; GO:0046872; GO:0051537; GO:0051539","iron-sulfur cluster assembly [GO:0016226]; negative regulation of apoptotic process [GO:0043066]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of apoptotic process [GO:0043066]","","","",""
"308","sp|A6PWD2|FHAD1_MOUSE","lcl|NC_088855.1_cds_XP_011434247.3_15665",2.41e-53,207,"A6PWD2","FHAD1_MOUSE","Forkhead-associated domain-containing protein 1 (FHA domain-containing protein 1)","Fhad1","Mus musculus (Mouse)",1420,"GO:0006915; GO:0007283; GO:0030154; GO:0036126; GO:0051321","apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; spermatogenesis [GO:0007283]","sperm flagellum [GO:0036126]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Highly expressed in the testis (at protein level). {ECO:0000269|PubMed:38563001}."
"309","sp|Q9H0C1|ZMY12_HUMAN","lcl|NC_088855.1_cds_XP_011434471.1_15933",1.06e-121,357,"Q9H0C1","ZMY12_HUMAN","Zinc finger MYND domain-containing protein 12","ZMYND12","Homo sapiens (Human)",365,"GO:0007288; GO:0008270; GO:0030317; GO:0036126","flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]","sperm flagellum [GO:0036126]; zinc ion binding [GO:0008270]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]","","","","TISSUE SPECIFICITY: Expressed predominantly in the testis. {ECO:0000269|PubMed:37934199}."
"310","sp|P48603|CAPZB_DROME","lcl|NC_088855.1_cds_XP_011436257.1_15687",4.55e-168,467,"P48603","CAPZB_DROME","F-actin-capping protein subunit beta","cpb ANCP-BETA CG17158","Drosophila melanogaster (Fruit fly)",276,"GO:0000902; GO:0005869; GO:0007015; GO:0007018; GO:0007298; GO:0007300; GO:0008290; GO:0010591; GO:0030036; GO:0030832; GO:0035220; GO:0045887; GO:0046329; GO:0046982; GO:0051015; GO:0051016; GO:0051490; GO:0071203; GO:0140591","actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; barbed-end actin filament capping [GO:0051016]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; microtubule-based movement [GO:0007018]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of JNK cascade [GO:0046329]; nuclear envelope budding [GO:0140591]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; regulation of actin filament length [GO:0030832]; regulation of lamellipodium assembly [GO:0010591]; wing disc development [GO:0035220]","dynactin complex [GO:0005869]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]; actin filament binding [GO:0051015]; protein heterodimerization activity [GO:0046982]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; barbed-end actin filament capping [GO:0051016]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; microtubule-based movement [GO:0007018]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of JNK cascade [GO:0046329]; nuclear envelope budding [GO:0140591]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; regulation of actin filament length [GO:0030832]; regulation of lamellipodium assembly [GO:0010591]; wing disc development [GO:0035220]","","","",""
"311","sp|Q8TDB8|GTR14_HUMAN","lcl|NC_088855.1_cds_XP_011436264.3_15677",3.79e-116,355,"Q8TDB8","GTR14_HUMAN","Solute carrier family 2, facilitated glucose transporter member 14 (Glucose transporter type 14) (GLUT-14)","SLC2A14 GLUT14","Homo sapiens (Human)",520,"GO:0005634; GO:0005886; GO:0007283; GO:0016235; GO:0030154; GO:0033300; GO:0046323; GO:0055056; GO:0070837; GO:1904659","cell differentiation [GO:0030154]; D-glucose import [GO:0046323]; D-glucose transmembrane transport [GO:1904659]; dehydroascorbic acid transport [GO:0070837]; spermatogenesis [GO:0007283]","aggresome [GO:0016235]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; cell differentiation [GO:0030154]; D-glucose import [GO:0046323]; D-glucose transmembrane transport [GO:1904659]; dehydroascorbic acid transport [GO:0070837]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Mainly expressed in testis (PubMed:12504846, PubMed:27460888). Also expressed in small intestine, liver and kidney (PubMed:27460888). {ECO:0000269|PubMed:12504846, ECO:0000269|PubMed:27460888}."
"312","sp|Q9UII6|DS13B_HUMAN","lcl|NC_088855.1_cds_XP_011436556.3_12068",1.61e-37,130,"Q9UII6","DS13B_HUMAN","Dual specificity protein phosphatase 13B (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity phosphatase SKRP4) (Testis- and skeletal-muscle-specific DSP)","DUSP13B DUSP13 SKRP4 TMDP","Homo sapiens (Human)",198,"GO:0004722; GO:0004725; GO:0005737; GO:0006470; GO:0007283; GO:0008138; GO:0016311; GO:0016791; GO:0033549; GO:0043409; GO:0051321","dephosphorylation [GO:0016311]; meiotic cell cycle [GO:0051321]; negative regulation of MAPK cascade [GO:0043409]; protein dephosphorylation [GO:0006470]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dephosphorylation [GO:0016311]; meiotic cell cycle [GO:0051321]; negative regulation of MAPK cascade [GO:0043409]; protein dephosphorylation [GO:0006470]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Highly expressed in the testis (at protein level) (PubMed:10585869, PubMed:15252030). Also found in the skeletal muscle (PubMed:15252030). {ECO:0000269|PubMed:10585869, ECO:0000269|PubMed:15252030}."
"313","sp|Q9XZ06|NU931_DROME","lcl|NC_088855.1_cds_XP_011436562.3_12065",1.88e-170,514,"Q9XZ06","NU931_DROME","Nuclear pore complex protein Nup93-1 (Nucleoporin 93kD-1) (Nucleoporin Nup93-1)","Nup93-1 CG11092","Drosophila melanogaster (Fruit fly)",823,"GO:0003682; GO:0005643; GO:0005654; GO:0006606; GO:0006999; GO:0016973; GO:0017056; GO:0030717; GO:0031490; GO:0031965; GO:0034399; GO:0036228; GO:0044615; GO:0045814; GO:0097240; GO:0097298","chromosome attachment to the nuclear envelope [GO:0097240]; negative regulation of gene expression, epigenetic [GO:0045814]; nuclear pore organization [GO:0006999]; oocyte karyosome formation [GO:0030717]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; regulation of nucleus size [GO:0097298]","nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; structural constituent of nuclear pore [GO:0017056]; chromosome attachment to the nuclear envelope [GO:0097240]; negative regulation of gene expression, epigenetic [GO:0045814]; nuclear pore organization [GO:0006999]; oocyte karyosome formation [GO:0030717]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; regulation of nucleus size [GO:0097298]","","","",""
"314","sp|P55965|BYN_DROME","lcl|NC_088855.1_cds_XP_011436726.1_14582",1.06e-59,211,"P55965","BYN_DROME","T-related protein (Trp) (Protein brachyenteron)","byn trg CG7260","Drosophila melanogaster (Fruit fly)",697,"GO:0000785; GO:0000978; GO:0000981; GO:0001707; GO:0001708; GO:0001709; GO:0003007; GO:0003677; GO:0005634; GO:0006357; GO:0007442; GO:0007443; GO:0007494; GO:0007509; GO:0008354; GO:0042803; GO:0045944","cell fate determination [GO:0001709]; cell fate specification [GO:0001708]; germ cell migration [GO:0008354]; heart morphogenesis [GO:0003007]; hindgut morphogenesis [GO:0007442]; Malpighian tubule morphogenesis [GO:0007443]; mesoderm formation [GO:0001707]; mesoderm migration involved in gastrulation [GO:0007509]; midgut development [GO:0007494]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell fate determination [GO:0001709]; cell fate specification [GO:0001708]; germ cell migration [GO:0008354]; heart morphogenesis [GO:0003007]; hindgut morphogenesis [GO:0007442]; Malpighian tubule morphogenesis [GO:0007443]; mesoderm formation [GO:0001707]; mesoderm migration involved in gastrulation [GO:0007509]; midgut development [GO:0007494]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","DEVELOPMENTAL STAGE: First expressed at the beginning of nuclear cycle 14 in the posterior terminal region. As cellularization proceeds, expression becomes confined to a ring area encompassing the primordium of the hindgut and anal pads. Expression is maintained in this region until the end of embryogenesis. {ECO:0000269|PubMed:7958884}.","","",""
"315","sp|Q9VTH0|PLOD_DROME","lcl|NC_088855.1_cds_XP_011437798.3_15334",0,736,"Q9VTH0","PLOD_DROME","Procollagen-lysine,2-oxoglutarate 5-dioxygenase (Procollagen lysyl hydroxylase) (EC 1.14.11.4)","Plod CG6199","Drosophila melanogaster (Fruit fly)",721,"GO:0005506; GO:0005615; GO:0005783; GO:0005794; GO:0006493; GO:0008475; GO:0030199; GO:0031418; GO:0033823; GO:0048471; GO:0050211; GO:0062023","collagen fibril organization [GO:0030199]; protein O-linked glycosylation [GO:0006493]","collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; collagen fibril organization [GO:0030199]; protein O-linked glycosylation [GO:0006493]","DEVELOPMENTAL STAGE: Expressed throughout embryogenesis (at protein level). First detected at stage 12 in the haemocytes and in the fat body at stage 13 (at protein level). High levels also detected in the anal pads of stage 16 embryos (at protein level). {ECO:0000269|PubMed:20888931}.","","",""
"316","sp|P43247|MSH2_MOUSE","lcl|NC_088855.1_cds_XP_011437807.3_15351",0,1160,"P43247","MSH2_MOUSE","DNA mismatch repair protein Msh2 (MutS protein homolog 2)","Msh2","Mus musculus (Mouse)",935,"GO:0000287; GO:0000400; GO:0001701; GO:0002204; GO:0003677; GO:0003682; GO:0003684; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0006119; GO:0006281; GO:0006298; GO:0006301; GO:0006302; GO:0006974; GO:0007281; GO:0008340; GO:0008584; GO:0008630; GO:0010165; GO:0010224; GO:0016446; GO:0016447; GO:0016887; GO:0019237; GO:0019724; GO:0030183; GO:0030983; GO:0031573; GO:0032137; GO:0032142; GO:0032143; GO:0032181; GO:0032301; GO:0032302; GO:0032357; GO:0032405; GO:0042771; GO:0042803; GO:0043524; GO:0043531; GO:0043570; GO:0045190; GO:0045910; GO:0048298; GO:0048304; GO:0051726; GO:0140664","B cell differentiation [GO:0030183]; B cell mediated immunity [GO:0019724]; determination of adult lifespan [GO:0008340]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; regulation of cell cycle [GO:0051726]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204]","chromosome [GO:0005694]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide repeat insertion binding [GO:0032181]; DNA binding [GO:0003677]; four-way junction DNA binding [GO:0000400]; guanine/thymine mispair binding [GO:0032137]; magnesium ion binding [GO:0000287]; mismatched DNA binding [GO:0030983]; MutLalpha complex binding [GO:0032405]; oxidized purine DNA binding [GO:0032357]; protein homodimerization activity [GO:0042803]; single guanine insertion binding [GO:0032142]; single thymine insertion binding [GO:0032143]; single-stranded DNA binding [GO:0003697]; B cell differentiation [GO:0030183]; B cell mediated immunity [GO:0019724]; determination of adult lifespan [GO:0008340]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; regulation of cell cycle [GO:0051726]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204]","","","",""
"317","sp|Q6YZ49|RFA1A_ORYSJ","lcl|NC_088855.1_cds_XP_011437861.3_13187",6.54e-105,333,"Q6YZ49","RFA1A_ORYSJ","Replication protein A 70 kDa DNA-binding subunit A (OsRPA70a) (Replication factor A protein 1A) (Replication protein A 1A)","RPA1A RPA70A Os02g0776800 LOC_Os02g53680 OJ1534_E09.2 OsJ_08582 OSJNBb0013K01.36","Oryza sativa subsp. japonica (Rice)",656,"GO:0000724; GO:0000785; GO:0003684; GO:0005662; GO:0006260; GO:0006281; GO:0006289; GO:0007004; GO:0007140; GO:0007141; GO:0008270; GO:0009555; GO:0043047; GO:0051026; GO:0051321","chiasma assembly [GO:0051026]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; meiotic cell cycle [GO:0051321]; nucleotide-excision repair [GO:0006289]; pollen development [GO:0009555]; telomere maintenance via telomerase [GO:0007004]","chromatin [GO:0000785]; DNA replication factor A complex [GO:0005662]; damaged DNA binding [GO:0003684]; single-stranded telomeric DNA binding [GO:0043047]; zinc ion binding [GO:0008270]; chiasma assembly [GO:0051026]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; meiotic cell cycle [GO:0051321]; nucleotide-excision repair [GO:0006289]; pollen development [GO:0009555]; telomere maintenance via telomerase [GO:0007004]","","INDUCTION: Repressed by sucrose starvation. {ECO:0000269|PubMed:11470540}.","INDUCTION: Repressed by sucrose starvation. {ECO:0000269|PubMed:11470540}.","TISSUE SPECIFICITY: Expressed in root tips, roots, shoot apical meristem (SAM), young leaves, flag leaves and ears, and at lower levels in mature leaves. {ECO:0000269|PubMed:11470540}."
"318","sp|Q9SKI4|RFA1A_ARATH","lcl|NC_088855.1_cds_XP_011437862.3_13186",2.23e-109,343,"Q9SKI4","RFA1A_ARATH","Replication protein A 70 kDa DNA-binding subunit A (AtRPA70A) (AtRPA1-3) (Replication factor A protein 1A) (Replication protein A 1A) (AtRPA1A)","RPA1A RPA70A At2g06510 T12H3.6","Arabidopsis thaliana (Mouse-ear cress)",640,"GO:0000785; GO:0003677; GO:0005634; GO:0006260; GO:0006281; GO:0007131; GO:0007141; GO:0008270; GO:0009555; GO:0048232; GO:0051026","chiasma assembly [GO:0051026]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; male gamete generation [GO:0048232]; male meiosis I [GO:0007141]; pollen development [GO:0009555]; reciprocal meiotic recombination [GO:0007131]","chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; chiasma assembly [GO:0051026]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; male gamete generation [GO:0048232]; male meiosis I [GO:0007141]; pollen development [GO:0009555]; reciprocal meiotic recombination [GO:0007131]","","INDUCTION: By the genotoxic agents methyl methanesulfonate (MMS) and bleomycin. {ECO:0000269|PubMed:19812063}.","INDUCTION: By the genotoxic agents methyl methanesulfonate (MMS) and bleomycin. {ECO:0000269|PubMed:19812063}.","TISSUE SPECIFICITY: Expressed in roots, leaves, stalks and flower buds. {ECO:0000269|PubMed:19812063}."
"319","sp|Q6NZQ0|CF119_MOUSE","lcl|NC_088855.1_cds_XP_011438393.3_16585",6.71e-50,169,"Q6NZQ0","CF119_MOUSE","Cilia- and flagella-associated protein 119 (Coiled-coil domain-containing protein 189)","Cfap119 Ccdc189 Gm166","Mus musculus (Mouse)",333,"GO:0001534; GO:0001669; GO:0005737; GO:0005930; GO:0007338; GO:0010467; GO:0097228; GO:0120316","gene expression [GO:0010467]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316]","acrosomal vesicle [GO:0001669]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; radial spoke [GO:0001534]; sperm principal piece [GO:0097228]; gene expression [GO:0010467]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316]","","","",""
"320","sp|Q587J7|TDR12_HUMAN","lcl|NC_088855.1_cds_XP_011438508.3_15856",1.34e-94,335,"Q587J7","TDR12_HUMAN","Putative ATP-dependent RNA helicase TDRD12 (EC 3.6.4.13) (ES cell-associated transcript 8 protein) (Tudor domain-containing protein 12)","TDRD12 ECAT8","Homo sapiens (Human)",1177,"GO:0003676; GO:0003724; GO:0005524; GO:0007140; GO:0007283; GO:0009566; GO:0016887; GO:0034587; GO:0042078; GO:0141196; GO:1990923","fertilization [GO:0009566]; germ-line stem cell division [GO:0042078]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]","PET complex [GO:1990923]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; fertilization [GO:0009566]; germ-line stem cell division [GO:0042078]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]","","","",""
"321","sp|Q16181|SEPT7_HUMAN","lcl|NC_088855.1_cds_XP_011440681.3_16083",0,570,"Q16181","SEPT7_HUMAN","Septin-7 (CDC10 protein homolog)","SEPTIN7 CDC10 SEPT7","Homo sapiens (Human)",437,"GO:0000776; GO:0001725; GO:0003924; GO:0005198; GO:0005525; GO:0005634; GO:0005819; GO:0005829; GO:0005930; GO:0005940; GO:0007283; GO:0008104; GO:0015630; GO:0016476; GO:0030154; GO:0030496; GO:0031105; GO:0032153; GO:0032154; GO:0042802; GO:0045296; GO:0060090; GO:0060271; GO:0061640; GO:0070062; GO:0097227; GO:0097730; GO:1902857","cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857]; protein localization [GO:0008104]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]","axoneme [GO:0005930]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857]; protein localization [GO:0008104]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:15915442}."
"322","sp|A5D7Q3|SEP12_BOVIN","lcl|NC_088855.1_cds_XP_011440687.1_16086",8.04e-94,289,"A5D7Q3","SEP12_BOVIN","Septin-12","SEPTIN12 SEPT12","Bos taurus (Bovine)",361,"GO:0001725; GO:0003924; GO:0005525; GO:0005819; GO:0005940; GO:0007283; GO:0008104; GO:0015630; GO:0019003; GO:0030154; GO:0030496; GO:0031105; GO:0032153; GO:0032154; GO:0035091; GO:0048471; GO:0060090; GO:0061640; GO:0097227","cell differentiation [GO:0030154]; cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104]; spermatogenesis [GO:0007283]","cell division site [GO:0032153]; cleavage furrow [GO:0032154]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; phosphatidylinositol binding [GO:0035091]; cell differentiation [GO:0030154]; cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104]; spermatogenesis [GO:0007283]","","","",""
"323","sp|Q5SUE7|ADAD1_MOUSE","lcl|NC_088855.1_cds_XP_011441313.3_15877",6.58e-40,155,"Q5SUE7","ADAD1_MOUSE","Adenosine deaminase domain-containing protein 1 (Testis nuclear RNA-binding protein)","Adad1 Tenr","Mus musculus (Mouse)",619,"GO:0001673; GO:0003723; GO:0004000; GO:0006396; GO:0007286","RNA processing [GO:0006396]; spermatid development [GO:0007286]","male germ cell nucleus [GO:0001673]; adenosine deaminase activity [GO:0004000]; RNA binding [GO:0003723]; RNA processing [GO:0006396]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Testis-specific. Detected in round spermatid cells from stage II-XI (at protein level). Expressed in germ cells from mid-pachytene spermatocytes to mid-round spermatids. {ECO:0000269|PubMed:32665638, ECO:0000269|PubMed:7543294}."
"324","sp|Q9U489|LIN41_CAEEL","lcl|NC_088855.1_cds_XP_011441784.3_14714",4.02e-116,380,"Q9U489","LIN41_CAEEL","Protein lin-41 (Abnormal cell lineage protein 41)","lin-41 C12C8.3","Caenorhabditis elegans",1147,"GO:0000932; GO:0003723; GO:0003729; GO:0004842; GO:0005737; GO:0006402; GO:0007276; GO:0008270; GO:0009957; GO:0010629; GO:0017148; GO:0019538; GO:0030371; GO:0035198; GO:0035770; GO:0040034; GO:0045138; GO:0045604; GO:0045944; GO:0060282; GO:0090727; GO:0110037","epidermal cell fate specification [GO:0009957]; gamete generation [GO:0007276]; mRNA catabolic process [GO:0006402]; negative regulation of gene expression [GO:0010629]; negative regulation of translation [GO:0017148]; nematode male tail tip morphogenesis [GO:0045138]; positive regulation of brood size [GO:0090727]; positive regulation of oocyte development [GO:0060282]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein metabolic process [GO:0019538]; regulation of development, heterochronic [GO:0040034]; regulation of epidermal cell differentiation [GO:0045604]; regulation of nematode male tail tip morphogenesis [GO:0110037]","cytoplasm [GO:0005737]; P-body [GO:0000932]; ribonucleoprotein granule [GO:0035770]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; epidermal cell fate specification [GO:0009957]; gamete generation [GO:0007276]; mRNA catabolic process [GO:0006402]; negative regulation of gene expression [GO:0010629]; negative regulation of translation [GO:0017148]; nematode male tail tip morphogenesis [GO:0045138]; positive regulation of brood size [GO:0090727]; positive regulation of oocyte development [GO:0060282]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein metabolic process [GO:0019538]; regulation of development, heterochronic [GO:0040034]; regulation of epidermal cell differentiation [GO:0045604]; regulation of nematode male tail tip morphogenesis [GO:0110037]","DEVELOPMENTAL STAGE: Expressed in body wall muscles, pharyngeal muscles and most neurons at all stages from late embryogenesis until adulthood. Expressed in hypodermal seam cells until the L4 stage. {ECO:0000269|PubMed:10882102, ECO:0000269|PubMed:16122423}.","INDUCTION: Negatively regulated by the microRNA (miRNA) let-7 which causes degradation of the mRNA encoding this protein. This requires a let-7 complementary site (LCS) in the 3'-UTR of the mRNA encoding this protein. {ECO:0000269|PubMed:10882102, ECO:0000269|PubMed:16122423}.","INDUCTION: Negatively regulated by the microRNA (miRNA) let-7 which causes degradation of the mRNA encoding this protein. This requires a let-7 complementary site (LCS) in the 3'-UTR of the mRNA encoding this protein. {ECO:0000269|PubMed:10882102, ECO:0000269|PubMed:16122423}.",""
"325","sp|Q9W420|SPT6H_DROME","lcl|NC_088855.1_cds_XP_011441942.3_11071",0,1315,"Q9W420","SPT6H_DROME","Transcription elongation factor SPT6","Spt6 CG12225","Drosophila melanogaster (Fruit fly)",1831,"GO:0000775; GO:0000791; GO:0000993; GO:0003677; GO:0003682; GO:0005634; GO:0005703; GO:0005705; GO:0006368; GO:0006963; GO:0008023; GO:0030707; GO:0031491; GO:0034728; GO:0035363; GO:0042393; GO:0140673","follicle cell of egg chamber development [GO:0030707]; nucleosome organization [GO:0034728]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; transcription elongation by RNA polymerase II [GO:0006368]; transcription elongation-coupled chromatin remodeling [GO:0140673]","chromosome, centromeric region [GO:0000775]; euchromatin [GO:0000791]; histone locus body [GO:0035363]; nucleus [GO:0005634]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]; transcription elongation factor complex [GO:0008023]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA polymerase II complex binding [GO:0000993]; follicle cell of egg chamber development [GO:0030707]; nucleosome organization [GO:0034728]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; transcription elongation by RNA polymerase II [GO:0006368]; transcription elongation-coupled chromatin remodeling [GO:0140673]","","","",""
"326","sp|Q9XZ14|GOE_DROME","lcl|NC_088855.1_cds_XP_011442273.3_16275",2.8e-32,136,"Q9XZ14","GOE_DROME","Protein gone early","goe CG9634","Drosophila melanogaster (Fruit fly)",879,"GO:0005886; GO:0006508; GO:0048477; GO:2000737","negative regulation of stem cell differentiation [GO:2000737]; oogenesis [GO:0048477]; proteolysis [GO:0006508]","plasma membrane [GO:0005886]; negative regulation of stem cell differentiation [GO:2000737]; oogenesis [GO:0048477]; proteolysis [GO:0006508]","DEVELOPMENTAL STAGE: In the larva, becomes detectable at the late second larval instar stage and continues to be expressed throughout the larval period. {ECO:0000269|PubMed:25420147}.","","","TISSUE SPECIFICITY: In late third larval instar ovaries, detected in germ cells but not in somatic intermingled cells and is expressed uniformly in the wing disk. In the embryo, expressed in the ventral midline, tracheal placodes, and cells forming the anterior-most row in each segment. {ECO:0000269|PubMed:25420147}."
"327","sp|Q969R2|OSBP2_HUMAN","lcl|NC_088855.1_cds_XP_011442354.3_17596",0,773,"Q969R2","OSBP2_HUMAN","Oxysterol-binding protein 2 (Oxysterol-binding protein-related protein 4) (ORP-4) (OSBP-related protein 4)","OSBP2 KIAA1664 ORP4 OSBPL4","Homo sapiens (Human)",916,"GO:0001669; GO:0005829; GO:0005886; GO:0006869; GO:0007286; GO:0015485; GO:0097038; GO:0097440","lipid transport [GO:0006869]; spermatid development [GO:0007286]","acrosomal vesicle [GO:0001669]; apical dendrite [GO:0097440]; cytosol [GO:0005829]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; lipid transport [GO:0006869]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Expressed mainly in retina, testis, and fetal liver. {ECO:0000269|PubMed:11278871}."
"328","sp|Q9BG93|NR0B1_MACMU","lcl|NC_088855.1_cds_XP_011442427.3_16293",4.64e-19,90.9,"Q9BG93","NR0B1_MACMU","Nuclear receptor subfamily 0 group B member 1 (Nuclear receptor DAX-1)","NR0B1 DAX1","Macaca mulatta (Rhesus macaque)",470,"GO:0000122; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005840; GO:0007283; GO:0008104; GO:0008406; GO:0008584; GO:0010894; GO:0016020; GO:0016922; GO:0019904; GO:0030325; GO:0032448; GO:0033144; GO:0042803; GO:0045892","adrenal gland development [GO:0030325]; gonad development [GO:0008406]; male gonad development [GO:0008584]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein localization [GO:0008104]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840]; DNA hairpin binding [GO:0032448]; nuclear receptor binding [GO:0016922]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; adrenal gland development [GO:0030325]; gonad development [GO:0008406]; male gonad development [GO:0008584]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein localization [GO:0008104]; spermatogenesis [GO:0007283]","","","",""
"329","sp|Q9W148|URI_DROME","lcl|NC_088855.1_cds_XP_011442483.3_12713",5.46e-11,66.6,"Q9W148","URI_DROME","Unconventional prefoldin RPB5 interactor-like protein","uri ori CG11416","Drosophila melanogaster (Fruit fly)",731,"GO:0000122; GO:0003682; GO:0003714; GO:0004864; GO:0005634; GO:0005700; GO:0005737; GO:0007283; GO:0019212; GO:0042771; GO:2001243","intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; chromatin binding [GO:0003682]; phosphatase inhibitor activity [GO:0019212]; protein phosphatase inhibitor activity [GO:0004864]; transcription corepressor activity [GO:0003714]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Most abundant in early embryo, pupa and adult gonads (at protein level). In testis, expressed in mitotically proliferating spermatogonia and early primary spermatocytes with levels decreasing as spermatocytes mature and no expression in postmitotic stages. {ECO:0000269|PubMed:18412953}.","","",""
"330","sp|P29742|CLH_DROME","lcl|NC_088855.1_cds_XP_011444198.1_16443",0,2696,"P29742","CLH_DROME","Clathrin heavy chain","Chc CG9012","Drosophila melanogaster (Fruit fly)",1678,"GO:0005198; GO:0005802; GO:0005886; GO:0005905; GO:0005938; GO:0006886; GO:0006897; GO:0006898; GO:0007268; GO:0007291; GO:0008103; GO:0010508; GO:0016079; GO:0030130; GO:0030132; GO:0030136; GO:0030141; GO:0030198; GO:0031410; GO:0031623; GO:0032051; GO:0033363; GO:0035002; GO:0035159; GO:0040008; GO:0045334; GO:0045451; GO:0045807; GO:0046667; GO:0048471; GO:0048749; GO:0071439; GO:0098793","chemical synaptic transmission [GO:0007268]; compound eye development [GO:0048749]; compound eye retinal cell programmed cell death [GO:0046667]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; intracellular protein transport [GO:0006886]; liquid clearance, open tracheal system [GO:0035002]; oocyte microtubule cytoskeleton polarization [GO:0008103]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of autophagy [GO:0010508]; positive regulation of endocytosis [GO:0045807]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of growth [GO:0040008]; regulation of tube length, open tracheal system [GO:0035159]; secretory granule organization [GO:0033363]; sperm individualization [GO:0007291]; synaptic vesicle exocytosis [GO:0016079]","cell cortex [GO:0005938]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; clathrin light chain binding [GO:0032051]; structural molecule activity [GO:0005198]; chemical synaptic transmission [GO:0007268]; compound eye development [GO:0048749]; compound eye retinal cell programmed cell death [GO:0046667]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; intracellular protein transport [GO:0006886]; liquid clearance, open tracheal system [GO:0035002]; oocyte microtubule cytoskeleton polarization [GO:0008103]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of autophagy [GO:0010508]; positive regulation of endocytosis [GO:0045807]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of growth [GO:0040008]; regulation of tube length, open tracheal system [GO:0035159]; secretory granule organization [GO:0033363]; sperm individualization [GO:0007291]; synaptic vesicle exocytosis [GO:0016079]","","","",""
"331","sp|Q9D995|CNTD1_MOUSE","lcl|NC_088855.1_cds_XP_011444423.3_14835",7.35e-44,154,"Q9D995","CNTD1_MOUSE","Cyclin N-terminal domain-containing protein 1","Cntd1 Cntd","Mus musculus (Mouse)",334,"GO:0005634; GO:0005694; GO:0005737; GO:0007131; GO:0007283; GO:0051445","reciprocal meiotic recombination [GO:0007131]; regulation of meiotic cell cycle [GO:0051445]; spermatogenesis [GO:0007283]","chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; reciprocal meiotic recombination [GO:0007131]; regulation of meiotic cell cycle [GO:0051445]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Isoform 2 is expressed in spermatocyte. {ECO:0000269|PubMed:32640224}."
"332","sp|Q9JJP6|P63_RAT","lcl|NC_088855.1_cds_XP_011444791.1_13736",3e-107,338,"Q9JJP6","P63_RAT","Tumor protein 63 (p63) (Keratinocyte transcription factor KET) (Transformation-related protein 63) (TP63) (Tumor protein p73-like) (p73L)","Tp63 Ket P63 Tp73l Trp63","Rattus norvegicus (Rat)",680,"GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001501; GO:0001736; GO:0001738; GO:0001942; GO:0002039; GO:0002064; GO:0003677; GO:0003682; GO:0003684; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006357; GO:0006366; GO:0007219; GO:0007283; GO:0007389; GO:0007499; GO:0008284; GO:0008340; GO:0008544; GO:0009887; GO:0009913; GO:0009954; GO:0010481; GO:0010482; GO:0010838; GO:0019904; GO:0030216; GO:0030326; GO:0030425; GO:0030850; GO:0030855; GO:0030859; GO:0031069; GO:0032991; GO:0033147; GO:0035115; GO:0035116; GO:0036342; GO:0042475; GO:0042771; GO:0042802; GO:0043565; GO:0043589; GO:0043616; GO:0045617; GO:0045669; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048485; GO:0048646; GO:0048807; GO:0048863; GO:0050699; GO:0051262; GO:0051402; GO:0060197; GO:0060513; GO:0060529; GO:0061436; GO:0072089; GO:0090398; GO:0097371; GO:0098773; GO:1904674; GO:1904888; GO:1990841; GO:2000271; GO:2000381; GO:2000648; GO:2001235","anatomical structure formation involved in morphogenesis [GO:0048646]; animal organ morphogenesis [GO:0009887]; cellular senescence [GO:0090398]; chromatin remodeling [GO:0006338]; cloacal septation [GO:0060197]; cranial skeletal system development [GO:1904888]; determination of adult lifespan [GO:0008340]; ectoderm and mesoderm interaction [GO:0007499]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; epidermal cell differentiation [GO:0009913]; epidermal cell division [GO:0010481]; epidermis development [GO:0008544]; epithelial cell development [GO:0002064]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; female genitalia morphogenesis [GO:0048807]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mesoderm development [GO:2000381]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; pattern specification process [GO:0007389]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of somatic stem cell population maintenance [GO:1904674]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; prostate gland development [GO:0030850]; prostatic bud formation [GO:0060513]; protein tetramerization [GO:0051262]; proximal/distal pattern formation [GO:0009954]; regulation of epidermal cell division [GO:0010482]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; skin epidermis development [GO:0098773]; skin morphogenesis [GO:0043589]; spermatogenesis [GO:0007283]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; sympathetic nervous system development [GO:0048485]; transcription by RNA polymerase II [GO:0006366]","chromatin [GO:0000785]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; WW domain binding [GO:0050699]; anatomical structure formation involved in morphogenesis [GO:0048646]; animal organ morphogenesis [GO:0009887]; cellular senescence [GO:0090398]; chromatin remodeling [GO:0006338]; cloacal septation [GO:0060197]; cranial skeletal system development [GO:1904888]; determination of adult lifespan [GO:0008340]; ectoderm and mesoderm interaction [GO:0007499]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; epidermal cell differentiation [GO:0009913]; epidermal cell division [GO:0010481]; epidermis development [GO:0008544]; epithelial cell development [GO:0002064]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; female genitalia morphogenesis [GO:0048807]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mesoderm development [GO:2000381]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; pattern specification process [GO:0007389]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of somatic stem cell population maintenance [GO:1904674]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; prostate gland development [GO:0030850]; prostatic bud formation [GO:0060513]; protein tetramerization [GO:0051262]; proximal/distal pattern formation [GO:0009954]; regulation of epidermal cell division [GO:0010482]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; skin epidermis development [GO:0098773]; skin morphogenesis [GO:0043589]; spermatogenesis [GO:0007283]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; sympathetic nervous system development [GO:0048485]; transcription by RNA polymerase II [GO:0006366]","","","","TISSUE SPECIFICITY: Widely expressed, notably in thymus, prostate, placenta, and skeletal muscle, although the precise isoform varies according to tissue type. Progenitor cell layers of skin, breast and prostate express high levels of DeltaN-type isoforms. {ECO:0000269|PubMed:11470269, ECO:0000269|PubMed:9315105}."
"333","sp|P79734|P53_DANRE","lcl|NC_088855.1_cds_XP_011444808.1_13737",1.46e-68,225,"P79734","P53_DANRE","Cellular tumor antigen p53 (Tumor suppressor p53)","tp53 drp53","Danio rerio (Zebrafish) (Brachydanio rerio)",373,"GO:0000077; GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005737; GO:0005739; GO:0006357; GO:0006914; GO:0006915; GO:0006974; GO:0007179; GO:0007283; GO:0009411; GO:0010165; GO:0010526; GO:0010623; GO:0016525; GO:0030330; GO:0031647; GO:0042127; GO:0042771; GO:0043065; GO:0043249; GO:0043525; GO:0043565; GO:0045786; GO:0045787; GO:0045893; GO:0045944; GO:0046872; GO:0048730; GO:0048821; GO:0051262; GO:0051597; GO:0051782; GO:0060216; GO:0060729; GO:0061484; GO:0071425; GO:0071456; GO:0090398; GO:0097193; GO:0140693; GO:1902253; GO:1902262; GO:1902742; GO:1905879; GO:1990841; GO:2000779","apoptotic process [GO:0006915]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; apoptotic process involved in development [GO:1902742]; autophagy [GO:0006914]; cellular response to hypoxia [GO:0071456]; cellular senescence [GO:0090398]; definitive hemopoiesis [GO:0060216]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; epidermis morphogenesis [GO:0048730]; erythrocyte development [GO:0048821]; erythrocyte maturation [GO:0043249]; hematopoietic stem cell homeostasis [GO:0061484]; hematopoietic stem cell proliferation [GO:0071425]; intestinal epithelial structure maintenance [GO:0060729]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell division [GO:0051782]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell cycle [GO:0045787]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; programmed cell death involved in cell development [GO:0010623]; protein tetramerization [GO:0051262]; regulation of cell population proliferation [GO:0042127]; regulation of double-strand break repair [GO:2000779]; regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902253]; regulation of oogenesis [GO:1905879]; regulation of protein stability [GO:0031647]; regulation of transcription by RNA polymerase II [GO:0006357]; response to methylmercury [GO:0051597]; response to UV [GO:0009411]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transposable element silencing [GO:0010526]","chromatin [GO:0000785]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; molecular condensate scaffold activity [GO:0140693]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; apoptotic process [GO:0006915]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; apoptotic process involved in development [GO:1902742]; autophagy [GO:0006914]; cellular response to hypoxia [GO:0071456]; cellular senescence [GO:0090398]; definitive hemopoiesis [GO:0060216]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; epidermis morphogenesis [GO:0048730]; erythrocyte development [GO:0048821]; erythrocyte maturation [GO:0043249]; hematopoietic stem cell homeostasis [GO:0061484]; hematopoietic stem cell proliferation [GO:0071425]; intestinal epithelial structure maintenance [GO:0060729]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell division [GO:0051782]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell cycle [GO:0045787]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; programmed cell death involved in cell development [GO:0010623]; protein tetramerization [GO:0051262]; regulation of cell population proliferation [GO:0042127]; regulation of double-strand break repair [GO:2000779]; regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902253]; regulation of oogenesis [GO:1905879]; regulation of protein stability [GO:0031647]; regulation of transcription by RNA polymerase II [GO:0006357]; response to methylmercury [GO:0051597]; response to UV [GO:0009411]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transposable element silencing [GO:0010526]","","","",""
"334","sp|P30189|TOP1_DROME","lcl|NC_088855.1_cds_XP_011445669.3_16921",0,712,"P30189","TOP1_DROME","DNA topoisomerase 1 (EC 5.6.2.1) (DNA topoisomerase I)","Top1 CG6146","Drosophila melanogaster (Fruit fly)",972,"GO:0000785; GO:0000791; GO:0002168; GO:0003677; GO:0003916; GO:0003917; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006260; GO:0006265; GO:0007059; GO:0030261; GO:0030874; GO:0045995; GO:0048477","chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; instar larval development [GO:0002168]; oogenesis [GO:0048477]; regulation of embryonic development [GO:0045995]","chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; nucleolar chromatin [GO:0030874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; instar larval development [GO:0002168]; oogenesis [GO:0048477]; regulation of embryonic development [GO:0045995]","DEVELOPMENTAL STAGE: Detected in germline and follicle cells. Expressed in follicle cells throughout oogenesis. In germline cells, expression levels increase as cells develop and move to the posterior region of the germarium, then at stage 5 of egg chamber development levels decrease until it is no longer detected (at protein level). {ECO:0000269|PubMed:10885744}.","","",""
"335","sp|Q8NA47|CCD63_HUMAN","lcl|NC_088855.1_cds_XP_011446696.1_16274",8.96e-71,238,"Q8NA47","CCD63_HUMAN","Coiled-coil domain-containing protein 63","CCDC63","Homo sapiens (Human)",563,"GO:0003341; GO:0005930; GO:0007286; GO:0036158","cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; spermatid development [GO:0007286]","axoneme [GO:0005930]; cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; spermatid development [GO:0007286]","","","",""
"336","sp|Q2T9W3|CCD63_BOVIN","lcl|NC_088855.1_cds_XP_011446697.1_16273",9.51e-79,259,"Q2T9W3","CCD63_BOVIN","Coiled-coil domain-containing protein 63","CCDC63","Bos taurus (Bovine)",558,"GO:0003341; GO:0005930; GO:0007286; GO:0036158","cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; spermatid development [GO:0007286]","axoneme [GO:0005930]; cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; spermatid development [GO:0007286]","","","",""
"337","sp|Q94890|H15_DROME","lcl|NC_088855.1_cds_XP_011446708.3_16261",7.91e-79,259,"Q94890","H15_DROME","T-box protein H15","H15 CG6604","Drosophila melanogaster (Fruit fly)",660,"GO:0000785; GO:0000978; GO:0000981; GO:0001708; GO:0003015; GO:0005634; GO:0006357; GO:0007507; GO:0030381; GO:0035050; GO:0035223; GO:0042659; GO:0042684; GO:0045944","cardioblast cell fate commitment [GO:0042684]; cell fate specification [GO:0001708]; chorion-containing eggshell pattern formation [GO:0030381]; embryonic heart tube development [GO:0035050]; heart development [GO:0007507]; heart process [GO:0003015]; leg disc pattern formation [GO:0035223]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell fate specification [GO:0042659]; regulation of transcription by RNA polymerase II [GO:0006357]","chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cardioblast cell fate commitment [GO:0042684]; cell fate specification [GO:0001708]; chorion-containing eggshell pattern formation [GO:0030381]; embryonic heart tube development [GO:0035050]; heart development [GO:0007507]; heart process [GO:0003015]; leg disc pattern formation [GO:0035223]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell fate specification [GO:0042659]; regulation of transcription by RNA polymerase II [GO:0006357]","","","",""
"338","sp|Q6IR42|ZCPW1_MOUSE","lcl|NC_088855.1_cds_XP_011448235.3_12441",2.01e-37,150,"Q6IR42","ZCPW1_MOUSE","Zinc finger CW-type PWWP domain protein 1","Zcwpw1 Gm1053","Mus musculus (Mouse)",630,"GO:0001741; GO:0005634; GO:0007127; GO:0007129; GO:0007283; GO:0008270; GO:0030154; GO:0045911; GO:0140002; GO:0140003; GO:0140566; GO:1990918; GO:2000781","cell differentiation [GO:0030154]; double-strand break repair involved in meiotic recombination [GO:1990918]; homologous chromosome pairing at meiosis [GO:0007129]; meiosis I [GO:0007127]; positive regulation of DNA recombination [GO:0045911]; positive regulation of double-strand break repair [GO:2000781]; spermatogenesis [GO:0007283]","nucleus [GO:0005634]; XY body [GO:0001741]; histone H3K36me3 reader activity [GO:0140003]; histone H3K4me3 reader activity [GO:0140002]; histone reader activity [GO:0140566]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; double-strand break repair involved in meiotic recombination [GO:1990918]; homologous chromosome pairing at meiosis [GO:0007129]; meiosis I [GO:0007127]; positive regulation of DNA recombination [GO:0045911]; positive regulation of double-strand break repair [GO:2000781]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Testis (at protein level) (PubMed:31453335, PubMed:32352380, PubMed:32374261, PubMed:32744506). Expressed in thymus, brain, lung, ovary, oviduct and uterus (PubMed:31453335). {ECO:0000269|PubMed:31453335, ECO:0000269|PubMed:32352380, ECO:0000269|PubMed:32374261, ECO:0000269|PubMed:32744506}."
"339","sp|P56705|WNT4_HUMAN","lcl|NC_088855.1_cds_XP_011448637.1_14918",6.75e-158,447,"P56705","WNT4_HUMAN","Protein Wnt-4","WNT4 UNQ426/PRO864","Homo sapiens (Human)",351,"GO:0001658; GO:0001822; GO:0001837; GO:0001838; GO:0001889; GO:0003714; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005737; GO:0005788; GO:0005796; GO:0005886; GO:0008543; GO:0008584; GO:0008585; GO:0009267; GO:0009986; GO:0010629; GO:0010894; GO:0022407; GO:0030182; GO:0030237; GO:0030325; GO:0030336; GO:0030501; GO:0030666; GO:0031012; GO:0032349; GO:0032967; GO:0033080; GO:0035567; GO:0040037; GO:0042445; GO:0043410; GO:0045165; GO:0045596; GO:0045669; GO:0045836; GO:0045892; GO:0045893; GO:0048018; GO:0048599; GO:0051145; GO:0051496; GO:0051894; GO:0060008; GO:0060070; GO:0060126; GO:0060129; GO:0060231; GO:0060748; GO:0061045; GO:0061180; GO:0061184; GO:0061205; GO:0061369; GO:0070062; GO:0071560; GO:0072033; GO:0072034; GO:0072162; GO:0072174; GO:0072273; GO:0097190; GO:0140013; GO:1904238; GO:2000019; GO:2000066; GO:2000180; GO:2000225; GO:2001234","adrenal gland development [GO:0030325]; apoptotic signaling pathway [GO:0097190]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic epithelial tube formation [GO:0001838]; epithelial to mesenchymal transition [GO:0001837]; female gonad development [GO:0008585]; female sex determination [GO:0030237]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hormone metabolic process [GO:0042445]; immature T cell proliferation in thymus [GO:0033080]; kidney development [GO:0001822]; liver development [GO:0001889]; male gonad development [GO:0008584]; mammary gland epithelium development [GO:0061180]; meiotic nuclear division [GO:0140013]; mesenchymal to epithelial transition [GO:0060231]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric nephron morphogenesis [GO:0072273]; metanephric tubule formation [GO:0072174]; negative regulation of androgen biosynthetic process [GO:2000180]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression [GO:0010629]; negative regulation of male gonad development [GO:2000019]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of testicular blood vessel morphogenesis [GO:0061369]; negative regulation of testosterone biosynthetic process [GO:2000225]; negative regulation of wound healing [GO:0061045]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; oocyte development [GO:0048599]; paramesonephric duct development [GO:0061205]; pericyte cell differentiation [GO:1904238]; positive regulation of aldosterone biosynthetic process [GO:0032349]; positive regulation of bone mineralization [GO:0030501]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cortisol biosynthetic process [GO:2000066]; positive regulation of dermatome development [GO:0061184]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell-cell adhesion [GO:0022407]; renal vesicle formation [GO:0072033]; renal vesicle induction [GO:0072034]; Sertoli cell differentiation [GO:0060008]; smooth muscle cell differentiation [GO:0051145]; somatotropin secreting cell differentiation [GO:0060126]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]","cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; transcription corepressor activity [GO:0003714]; adrenal gland development [GO:0030325]; apoptotic signaling pathway [GO:0097190]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic epithelial tube formation [GO:0001838]; epithelial to mesenchymal transition [GO:0001837]; female gonad development [GO:0008585]; female sex determination [GO:0030237]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hormone metabolic process [GO:0042445]; immature T cell proliferation in thymus [GO:0033080]; kidney development [GO:0001822]; liver development [GO:0001889]; male gonad development [GO:0008584]; mammary gland epithelium development [GO:0061180]; meiotic nuclear division [GO:0140013]; mesenchymal to epithelial transition [GO:0060231]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric nephron morphogenesis [GO:0072273]; metanephric tubule formation [GO:0072174]; negative regulation of androgen biosynthetic process [GO:2000180]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression [GO:0010629]; negative regulation of male gonad development [GO:2000019]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of testicular blood vessel morphogenesis [GO:0061369]; negative regulation of testosterone biosynthetic process [GO:2000225]; negative regulation of wound healing [GO:0061045]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; oocyte development [GO:0048599]; paramesonephric duct development [GO:0061205]; pericyte cell differentiation [GO:1904238]; positive regulation of aldosterone biosynthetic process [GO:0032349]; positive regulation of bone mineralization [GO:0030501]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cortisol biosynthetic process [GO:2000066]; positive regulation of dermatome development [GO:0061184]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell-cell adhesion [GO:0022407]; renal vesicle formation [GO:0072033]; renal vesicle induction [GO:0072034]; Sertoli cell differentiation [GO:0060008]; smooth muscle cell differentiation [GO:0051145]; somatotropin secreting cell differentiation [GO:0060126]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]","","","",""
"340","sp|Q05856|RSMB_DROME","lcl|NC_088855.1_cds_XP_011448842.1_15177",3.85e-43,143,"Q05856","RSMB_DROME","Small nuclear ribonucleoprotein-associated protein B (snRNP-B) (Sm protein B) (Sm-B) (SmB)","SmB CG5352","Drosophila melanogaster (Fruit fly)",199,"GO:0000398; GO:0003723; GO:0005634; GO:0005681; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005737; GO:0005829; GO:0007281; GO:0007283; GO:0008406; GO:0015030; GO:0030532; GO:0045495; GO:0046540; GO:0070990; GO:0071004; GO:0071011; GO:0071013","germ cell development [GO:0007281]; gonad development [GO:0008406]; mRNA splicing, via spliceosome [GO:0000398]; spermatogenesis [GO:0007283]","Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; pole plasm [GO:0045495]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; snRNP binding [GO:0070990]; germ cell development [GO:0007281]; gonad development [GO:0008406]; mRNA splicing, via spliceosome [GO:0000398]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Maternally and zygotically expressed. In early stages of egg chamber development, predominantly accumulated in the nuclei of nurse cells and oocyte. Enriched at the posterior of stage 10 oocytes which persists after fertilization, at the posterior of pre-blastoderm stage embryos. {ECO:0000269|PubMed:20570937, ECO:0000269|PubMed:20659974}.","","","TISSUE SPECIFICITY: Expressed in the posterior part of the oocyte and embryo. Expressed in the pole plasm (at protein level), colocalizing with SmD3. {ECO:0000269|PubMed:17164419, ECO:0000269|PubMed:20570937}."
"341","sp|P53671|LIMK2_HUMAN","lcl|NC_088855.1_cds_XP_011448889.3_15968",1.87e-172,513,"P53671","LIMK2_HUMAN","LIM domain kinase 2 (LIMK-2) (EC 2.7.11.1)","LIMK2","Homo sapiens (Human)",638,"GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005801; GO:0005813; GO:0006468; GO:0007283; GO:0030036; GO:0030953; GO:0046872; GO:0048471; GO:0051650; GO:0060322; GO:0061303; GO:0072686; GO:0106310; GO:1900182; GO:1902018","actin cytoskeleton organization [GO:0030036]; astral microtubule organization [GO:0030953]; cornea development in camera-type eye [GO:0061303]; establishment of vesicle localization [GO:0051650]; head development [GO:0060322]; negative regulation of cilium assembly [GO:1902018]; positive regulation of protein localization to nucleus [GO:1900182]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]","centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton organization [GO:0030036]; astral microtubule organization [GO:0030953]; cornea development in camera-type eye [GO:0061303]; establishment of vesicle localization [GO:0051650]; head development [GO:0060322]; negative regulation of cilium assembly [GO:1902018]; positive regulation of protein localization to nucleus [GO:1900182]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]","","","",""
"342","sp|O54785|LIMK2_MOUSE","lcl|NC_088855.1_cds_XP_011448893.3_15974",1.9e-114,359,"O54785","LIMK2_MOUSE","LIM domain kinase 2 (LIMK-2) (EC 2.7.11.1)","Limk2","Mus musculus (Mouse)",638,"GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005801; GO:0005813; GO:0006468; GO:0007283; GO:0030953; GO:0046872; GO:0048471; GO:0051650; GO:0060322; GO:0061303; GO:0072686; GO:0106310; GO:1900182; GO:1902018","astral microtubule organization [GO:0030953]; cornea development in camera-type eye [GO:0061303]; establishment of vesicle localization [GO:0051650]; head development [GO:0060322]; negative regulation of cilium assembly [GO:1902018]; positive regulation of protein localization to nucleus [GO:1900182]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]","centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; astral microtubule organization [GO:0030953]; cornea development in camera-type eye [GO:0061303]; establishment of vesicle localization [GO:0051650]; head development [GO:0060322]; negative regulation of cilium assembly [GO:1902018]; positive regulation of protein localization to nucleus [GO:1900182]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: [Isoform 3]: Specifically expressed in the testes. {ECO:0000269|PubMed:9705845}."
"343","sp|Q9N6P4|FZO_DROSI","lcl|NC_088855.1_cds_XP_011449173.3_13987",9.28e-42,159,"Q9N6P4","FZO_DROSI","Transmembrane GTPase fzo (EC 3.6.5.-) (Protein fuzzy onions)","fzo","Drosophila simulans (Fruit fly)",454,"GO:0003924; GO:0005525; GO:0005740; GO:0005741; GO:0007287; GO:0008053; GO:0010636; GO:0030382; GO:0051646","mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; Nebenkern assembly [GO:0007287]; positive regulation of mitochondrial fusion [GO:0010636]; sperm mitochondrion organization [GO:0030382]","mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; Nebenkern assembly [GO:0007287]; positive regulation of mitochondrial fusion [GO:0010636]; sperm mitochondrion organization [GO:0030382]","","","",""
"344","sp|Q8R500|MFN2_RAT","lcl|NC_088855.1_cds_XP_011449174.3_13986",0,710,"Q8R500","MFN2_RAT","Mitofusin-2 (EC 3.6.5.-) (Mitochondrial transmembrane GTPase FZO1A) (Protein HSG) (Transmembrane GTPase MFN2)","Mfn2 Fzo1a","Rattus norvegicus (Rat)",757,"GO:0001825; GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0005829; GO:0006626; GO:0006915; GO:0006986; GO:0007005; GO:0007006; GO:0007283; GO:0008053; GO:0008285; GO:0008584; GO:0009060; GO:0010628; GO:0010667; GO:0010729; GO:0010918; GO:0014850; GO:0015630; GO:0031267; GO:0031625; GO:0031667; GO:0033574; GO:0034497; GO:0042802; GO:0043394; GO:0045786; GO:0045792; GO:0046326; GO:0046580; GO:0046628; GO:0046686; GO:0048312; GO:0048593; GO:0048662; GO:0048678; GO:0051020; GO:0051560; GO:0051592; GO:0051602; GO:0051646; GO:0060253; GO:0060299; GO:0061003; GO:0061734; GO:0070542; GO:0071287; GO:0071333; GO:0071394; GO:0071404; GO:0071456; GO:0071479; GO:0071549; GO:0072705; GO:0090201; GO:0090258; GO:0120162; GO:1901857; GO:1903427; GO:1903428; GO:1903576; GO:1904706; GO:1904707; GO:1905232; GO:1905377; GO:1905395; GO:1905461; GO:1990910; GO:2000386; GO:2000866; GO:2000872","aerobic respiration [GO:0009060]; apoptotic process [GO:0006915]; blastocyst formation [GO:0001825]; camera-type eye morphogenesis [GO:0048593]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to L-glutamate [GO:1905232]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to manganese ion [GO:0071287]; cellular response to mercaptoethanol [GO:0072705]; cellular response to testosterone stimulus [GO:0071394]; intracellular distribution of mitochondria [GO:0048312]; male gonad development [GO:0008584]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial membrane organization [GO:0007006]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of sarcomere organization [GO:0060299]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of cellular respiration [GO:1901857]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of D-glucose import [GO:0046326]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of estradiol secretion [GO:2000866]; positive regulation of gene expression [GO:0010628]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of progesterone secretion [GO:2000872]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein localization to phagophore assembly site [GO:0034497]; protein targeting to mitochondrion [GO:0006626]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to calcium ion [GO:0051592]; response to D-galactose [GO:1905377]; response to electrical stimulus [GO:0051602]; response to fatty acid [GO:0070542]; response to flavonoid [GO:1905395]; response to hypobaric hypoxia [GO:1990910]; response to L-arginine [GO:1903576]; response to muscle activity [GO:0014850]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; type 2 mitophagy [GO:0061734]","cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proteoglycan binding [GO:0043394]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625]; aerobic respiration [GO:0009060]; apoptotic process [GO:0006915]; blastocyst formation [GO:0001825]; camera-type eye morphogenesis [GO:0048593]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to L-glutamate [GO:1905232]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to manganese ion [GO:0071287]; cellular response to mercaptoethanol [GO:0072705]; cellular response to testosterone stimulus [GO:0071394]; intracellular distribution of mitochondria [GO:0048312]; male gonad development [GO:0008584]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial membrane organization [GO:0007006]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of sarcomere organization [GO:0060299]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of cellular respiration [GO:1901857]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of D-glucose import [GO:0046326]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of estradiol secretion [GO:2000866]; positive regulation of gene expression [GO:0010628]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of progesterone secretion [GO:2000872]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein localization to phagophore assembly site [GO:0034497]; protein targeting to mitochondrion [GO:0006626]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to calcium ion [GO:0051592]; response to D-galactose [GO:1905377]; response to electrical stimulus [GO:0051602]; response to fatty acid [GO:0070542]; response to flavonoid [GO:1905395]; response to hypobaric hypoxia [GO:1990910]; response to L-arginine [GO:1903576]; response to muscle activity [GO:0014850]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; type 2 mitophagy [GO:0061734]","","","","TISSUE SPECIFICITY: Ubiquitous. In brain, it is more expressed than MFN1, while it is expressed at a weaker level than MFN1 in heart and testis. Expressed at high level in elongating spermatids of seminiferous tubules. Expression is markedly down-regulated in highly proliferative vascular smooth muscle cells (VSMCs) from the genetic hypertensive animal model SHR, as well as in balloon-injured Wistar Kyoto arteries. {ECO:0000269|PubMed:14561718, ECO:0000269|PubMed:14592431, ECO:0000269|PubMed:15322553}."
"345","sp|O77051|E2F2_DROME","lcl|NC_088855.1_cds_XP_011449296.2_11685",2.08e-17,84,"O77051","E2F2_DROME","Transcription factor E2F2 (dE2F2) (E2F transcription factor 2) (E2F-like transcription factor E2F2)","E2f2 CG1071","Drosophila melanogaster (Fruit fly)",370,"GO:0000082; GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007113; GO:0007444; GO:0008156; GO:0031523; GO:0035189; GO:0042023; GO:0043066; GO:0045892; GO:0048477; GO:0070176; GO:0090575; GO:2000134","DNA endoreduplication [GO:0042023]; endomitotic cell cycle [GO:0007113]; G1/S transition of mitotic cell cycle [GO:0000082]; imaginal disc development [GO:0007444]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA replication [GO:0008156]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; regulation of transcription by RNA polymerase II [GO:0006357]","chromatin [GO:0000785]; DRM complex [GO:0070176]; Myb complex [GO:0031523]; nucleus [GO:0005634]; Rb-E2F complex [GO:0035189]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; DNA endoreduplication [GO:0042023]; endomitotic cell cycle [GO:0007113]; G1/S transition of mitotic cell cycle [GO:0000082]; imaginal disc development [GO:0007444]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA replication [GO:0008156]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; regulation of transcription by RNA polymerase II [GO:0006357]","DEVELOPMENTAL STAGE: Expressed throughout embryonic development, with highest levels detected in cycling cells including in mitotically active cells during germ-band extended stages, as well as proliferating cells of the CNS and endoreduplicating cells of tissues such as the midgut at later embryonic stages. Maternal mRNA detected in syncytial stage embryos and disappears by the cellular blastoderm stage. A single transcript of 1.4 kb is detected at the highest level in 4 to 8 hour embryos, and at a relatively high level in 0 to 2 hour embryos. Lower levels of the transcript are detected in unfertilized eggs, larvae, pupae and adult. {ECO:0000269|PubMed:11748144, ECO:0000269|PubMed:9792788}.","","","TISSUE SPECIFICITY: Ubiquitously expressed in eye disk. {ECO:0000269|PubMed:11511545}."
"346","sp|Q1HFZ0|NSUN2_MOUSE","lcl|NC_088855.1_cds_XP_011449489.3_14487",0,639,"Q1HFZ0","NSUN2_MOUSE","RNA cytosine C(5)-methyltransferase NSUN2 (EC 2.1.1.-) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (mRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (tRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-, EC 2.1.1.203)","Nsun2 D13Wsu123e Misu","Mus musculus (Mouse)",757,"GO:0000049; GO:0001701; GO:0005730; GO:0005739; GO:0005819; GO:0006397; GO:0007286; GO:0008033; GO:0010793; GO:0016428; GO:0030488; GO:0033313; GO:0033391; GO:0036416; GO:0048820; GO:0051301; GO:0062152; GO:0070062; GO:2000736","cell division [GO:0051301]; hair follicle maturation [GO:0048820]; in utero embryonic development [GO:0001701]; meiotic cell cycle checkpoint signaling [GO:0033313]; mRNA processing [GO:0006397]; regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; spermatid development [GO:0007286]; tRNA methylation [GO:0030488]; tRNA processing [GO:0008033]; tRNA stabilization [GO:0036416]","chromatoid body [GO:0033391]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; spindle [GO:0005819]; mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; tRNA (cytidine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; cell division [GO:0051301]; hair follicle maturation [GO:0048820]; in utero embryonic development [GO:0001701]; meiotic cell cycle checkpoint signaling [GO:0033313]; mRNA processing [GO:0006397]; regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; spermatid development [GO:0007286]; tRNA methylation [GO:0030488]; tRNA processing [GO:0008033]; tRNA stabilization [GO:0036416]","DEVELOPMENTAL STAGE: Detected from 3.5 dpc in the inner cell mass of the blastocyst (PubMed:22144916). Expressed throughout the extra-embryonic ectoderm, which gives rise to the nervous system and epidermis, after implantation and gastrulation (PubMed:22144916). Starting from 9.5 dpc, expression becomes more restricted and at 13.5 and 14.5 dpc it is enriched in developing whiskers and eyes (PubMed:22144916). From 15.5 dpc, when the interfollicular epidermis begins to stratify and follicular morphogenesis starts by forming hair placodes, highest expression is observed in the suprabasal layer of interfollicular epidermis (PubMed:22144916). {ECO:0000269|PubMed:22144916}.","INDUCTION: By Myc (at protein level). {ECO:0000269|PubMed:16713953}.","INDUCTION: By Myc (at protein level). {ECO:0000269|PubMed:16713953}.","TISSUE SPECIFICITY: Ubiquitously expressed at low level (PubMed:16713953). Up-regulated in tumors (PubMed:16713953). Dynamically expressed during morphogenesis and in adult skin: in adult skin, expression is up-regulated in the bulge and hair germ as soon as the hair follicle enters its growing phase (anagen) (PubMed:22144916). During anagen, expressed at highest level in cells of the hair germ that give rise to the hair matrix (PubMed:22144916). {ECO:0000269|PubMed:16713953, ECO:0000269|PubMed:22144916}."
"347","sp|Q76I76|SSH2_HUMAN","lcl|NC_088855.1_cds_XP_011450067.3_12875",1.84e-131,441,"Q76I76","SSH2_HUMAN","Protein phosphatase Slingshot homolog 2 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 2) (SSH-2L) (hSSH-2L)","SSH2 KIAA1725 SSH2L","Homo sapiens (Human)",1423,"GO:0001669; GO:0003779; GO:0004721; GO:0004722; GO:0004725; GO:0005615; GO:0005737; GO:0005856; GO:0005925; GO:0006470; GO:0007283; GO:0030036; GO:0030154; GO:0030837","actin cytoskeleton organization [GO:0030036]; cell differentiation [GO:0030154]; negative regulation of actin filament polymerization [GO:0030837]; protein dephosphorylation [GO:0006470]; spermatogenesis [GO:0007283]","acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; actin cytoskeleton organization [GO:0030036]; cell differentiation [GO:0030154]; negative regulation of actin filament polymerization [GO:0030837]; protein dephosphorylation [GO:0006470]; spermatogenesis [GO:0007283]","","","",""
"348","sp|Q8BZT7|PA2G3_MOUSE","lcl|NC_088855.1_cds_XP_011450370.3_16671",4.73e-28,116,"Q8BZT7","PA2G3_MOUSE","Group 3 secretory phospholipase A2 (EC 3.1.1.4) (Group III secretory phospholipase A2) (GIII sPLA2) (sPLA2-III) (Phosphatidylcholine 2-acylhydrolase 3)","Pla2g3","Mus musculus (Mouse)",504,"GO:0001675; GO:0002532; GO:0004620; GO:0005576; GO:0005814; GO:0005886; GO:0006644; GO:0006658; GO:0007288; GO:0010629; GO:0010744; GO:0010976; GO:0019372; GO:0031394; GO:0032308; GO:0034374; GO:0034375; GO:0042116; GO:0043303; GO:0043524; GO:0046337; GO:0046470; GO:0046471; GO:0046473; GO:0046488; GO:0046872; GO:0047498; GO:0048468; GO:0048469; GO:0050482; GO:0055037; GO:0060376; GO:1900017; GO:1900222; GO:1903595; GO:2001135","acrosome assembly [GO:0001675]; arachidonate secretion [GO:0050482]; cell development [GO:0048468]; cell maturation [GO:0048469]; high-density lipoprotein particle remodeling [GO:0034375]; lipoxygenase pathway [GO:0019372]; low-density lipoprotein particle remodeling [GO:0034374]; macrophage activation [GO:0042116]; mast cell degranulation [GO:0043303]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine metabolic process [GO:0046337]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylserine metabolic process [GO:0006658]; phospholipid metabolic process [GO:0006644]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of histamine secretion by mast cell [GO:1903595]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of mast cell differentiation [GO:0060376]; positive regulation of neuron projection development [GO:0010976]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of prostaglandin secretion [GO:0032308]; production of molecular mediator involved in inflammatory response [GO:0002532]; regulation of endocytic recycling [GO:2001135]; sperm axoneme assembly [GO:0007288]","centriole [GO:0005814]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; calcium-dependent phospholipase A2 activity [GO:0047498]; metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; acrosome assembly [GO:0001675]; arachidonate secretion [GO:0050482]; cell development [GO:0048468]; cell maturation [GO:0048469]; high-density lipoprotein particle remodeling [GO:0034375]; lipoxygenase pathway [GO:0019372]; low-density lipoprotein particle remodeling [GO:0034374]; macrophage activation [GO:0042116]; mast cell degranulation [GO:0043303]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine metabolic process [GO:0046337]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylserine metabolic process [GO:0006658]; phospholipid metabolic process [GO:0006644]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of histamine secretion by mast cell [GO:1903595]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of mast cell differentiation [GO:0060376]; positive regulation of neuron projection development [GO:0010976]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of prostaglandin secretion [GO:0032308]; production of molecular mediator involved in inflammatory response [GO:0002532]; regulation of endocytic recycling [GO:2001135]; sperm axoneme assembly [GO:0007288]","DEVELOPMENTAL STAGE: Highly expressed in dorsal root ganglia of the developing brain at 12.5 dpc (at protein level). {ECO:0000269|PubMed:17868035}.","","","TISSUE SPECIFICITY: Expressed in dermal mast cells (at protein level) (PubMed:23624557). Highly expressed in EPCAM-positive colonic epithelial cells throughout the proximal to distal colon (at protein level) (PubMed:28947740). Expressed at lower levels in ileum section of small intestine and immune organs including bone marrow, spleen and lymph nodes (PubMed:20424323, PubMed:28947740). Expressed in stomach and lung (at protein level) (PubMed:17868035). Expressed in testis and epididymis and to a lesser extent in the seminal vesicles and prostate (PubMed:20424323). Detected in ovary, oviduct and uterus (PubMed:20424323). Expressed in Sertoli and Leydig cells as well as in epididymal epithelium particularly in apical border of principal cells in the corpus (at protein level) (PubMed:20424323). Present in cauda epididymal fluid (at protein level) (PubMed:20424323). Expressed in central nervous system, with high levels in spinal cord and at a lesser extent in brain (at protein level) (PubMed:17868035, PubMed:20424323). {ECO:0000269|PubMed:17868035, ECO:0000269|PubMed:20424323, ECO:0000269|PubMed:23624557, ECO:0000269|PubMed:28947740}."
"349","sp|Q8SWR8|ATX2_DROME","lcl|NC_088855.1_cds_XP_011450877.2_13276",5.95e-34,142,"Q8SWR8","ATX2_DROME","Ataxin-2 homolog (Datx2)","Atx2 CG5166","Drosophila melanogaster (Fruit fly)",1084,"GO:0003723; GO:0003729; GO:0005737; GO:0007616; GO:0009994; GO:0010494; GO:0022416; GO:0030833; GO:0034063; GO:0035195; GO:0035770; GO:0042051; GO:0045475; GO:0046959; GO:0048749; GO:0051823; GO:0062029; GO:0090328; GO:0097167","chaeta development [GO:0022416]; circadian regulation of translation [GO:0097167]; compound eye development [GO:0048749]; compound eye photoreceptor development [GO:0042051]; habituation [GO:0046959]; locomotor rhythm [GO:0045475]; long-term memory [GO:0007616]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; oocyte differentiation [GO:0009994]; positive regulation of stress granule assembly [GO:0062029]; regulation of actin filament polymerization [GO:0030833]; regulation of olfactory learning [GO:0090328]; regulation of synapse structural plasticity [GO:0051823]; stress granule assembly [GO:0034063]","cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; ribonucleoprotein granule [GO:0035770]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; chaeta development [GO:0022416]; circadian regulation of translation [GO:0097167]; compound eye development [GO:0048749]; compound eye photoreceptor development [GO:0042051]; habituation [GO:0046959]; locomotor rhythm [GO:0045475]; long-term memory [GO:0007616]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; oocyte differentiation [GO:0009994]; positive regulation of stress granule assembly [GO:0062029]; regulation of actin filament polymerization [GO:0030833]; regulation of olfactory learning [GO:0090328]; regulation of synapse structural plasticity [GO:0051823]; stress granule assembly [GO:0034063]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. Zygotic expression is seen in third larval instar, pupae, and adults. {ECO:0000269|PubMed:12524342}.","","",""
"350","sp|Q9UGV2|NDRG3_HUMAN","lcl|NC_088855.1_cds_XP_011451232.1_12131",1.66e-82,256,"Q9UGV2","NDRG3_HUMAN","Protein NDRG3 (N-myc downstream-regulated gene 3 protein)","NDRG3","Homo sapiens (Human)",375,"GO:0005737; GO:0007165; GO:0007283; GO:0030154; GO:0030308; GO:0070062","cell differentiation [GO:0030154]; negative regulation of cell growth [GO:0030308]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; cell differentiation [GO:0030154]; negative regulation of cell growth [GO:0030308]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Ubiquitous. Highly expressed in brain. {ECO:0000269|PubMed:11352569}."
"351","sp|O60393|NOBOX_HUMAN","lcl|NC_088855.1_cds_XP_011452256.3_11287",4.24e-11,65.5,"O60393","NOBOX_HUMAN","Homeobox protein NOBOX","NOBOX","Homo sapiens (Human)",691,"GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0048477","oogenesis [GO:0048477]; regulation of transcription by RNA polymerase II [GO:0006357]","chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; oogenesis [GO:0048477]; regulation of transcription by RNA polymerase II [GO:0006357]","","","","TISSUE SPECIFICITY: Expressed in ovaries, testes and pancreas. Expressed within all stages of the adult female germline, from primordial follicles through to MII oocytes. {ECO:0000269|PubMed:16597639}."
"352","sp|Q9VXA0|NPRL2_DROME","lcl|NC_088855.1_cds_XP_011452427.3_17014",1.68e-99,302,"Q9VXA0","NPRL2_DROME","GATOR complex protein NPRL2 (Nitrogen permease regulator 2-like protein)","Nprl2 CG9104","Drosophila melanogaster (Fruit fly)",412,"GO:0005634; GO:0005737; GO:0005774; GO:0007293; GO:0009267; GO:0010508; GO:0010898; GO:0032007; GO:0034198; GO:0035859; GO:0044754; GO:0045792; GO:0048477; GO:0051301; GO:0051321; GO:0051729; GO:1904262; GO:1990130","cell division [GO:0051301]; cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; germarium-derived egg chamber formation [GO:0007293]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; negative regulation of cell size [GO:0045792]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; oogenesis [GO:0048477]; positive regulation of autophagy [GO:0010508]; positive regulation of triglyceride catabolic process [GO:0010898]","autolysosome [GO:0044754]; cytoplasm [GO:0005737]; GATOR1 complex [GO:1990130]; nucleus [GO:0005634]; Seh1-associated complex [GO:0035859]; vacuolar membrane [GO:0005774]; cell division [GO:0051301]; cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; germarium-derived egg chamber formation [GO:0007293]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; negative regulation of cell size [GO:0045792]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; oogenesis [GO:0048477]; positive regulation of autophagy [GO:0010508]; positive regulation of triglyceride catabolic process [GO:0010898]","","","",""
"353","sp|P31044|PEBP1_RAT","lcl|NC_088855.1_cds_XP_011452435.1_17020",1.26e-17,80.9,"P31044","PEBP1_RAT","Phosphatidylethanolamine-binding protein 1 (PEBP-1) (23 kDa morphine-binding protein) (HCNPpp) (P23K) [Cleaved into: Hippocampal cholinergic neurostimulating peptide (HCNP)]","Pebp1 Pbp Pebp","Rattus norvegicus (Rat)",187,"GO:0000165; GO:0002026; GO:0004867; GO:0005102; GO:0005524; GO:0005615; GO:0005741; GO:0006979; GO:0007286; GO:0008021; GO:0008289; GO:0009410; GO:0009636; GO:0009986; GO:0014823; GO:0019899; GO:0019900; GO:0019901; GO:0021766; GO:0033612; GO:0042755; GO:0043025; GO:0043409; GO:0043679; GO:0045177; GO:0045471; GO:0045840; GO:0048240; GO:0051019; GO:0051412; GO:0051591; GO:0051592; GO:0051602; GO:0060409; GO:0141163; GO:1905923","eating behavior [GO:0042755]; hippocampus development [GO:0021766]; MAPK cascade [GO:0000165]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of acetylcholine biosynthetic process [GO:1905923]; positive regulation of acetylcholine metabolic process [GO:0060409]; positive regulation of cAMP/PKA signal transduction [GO:0141163]; positive regulation of mitotic nuclear division [GO:0045840]; regulation of the force of heart contraction [GO:0002026]; response to activity [GO:0014823]; response to calcium ion [GO:0051592]; response to cAMP [GO:0051591]; response to corticosterone [GO:0051412]; response to electrical stimulus [GO:0051602]; response to ethanol [GO:0045471]; response to oxidative stress [GO:0006979]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; sperm capacitation [GO:0048240]; spermatid development [GO:0007286]","apical part of cell [GO:0045177]; axon terminus [GO:0043679]; cell surface [GO:0009986]; extracellular space [GO:0005615]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; kinase binding [GO:0019900]; lipid binding [GO:0008289]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase binding [GO:0019901]; receptor serine/threonine kinase binding [GO:0033612]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]; eating behavior [GO:0042755]; hippocampus development [GO:0021766]; MAPK cascade [GO:0000165]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of acetylcholine biosynthetic process [GO:1905923]; positive regulation of acetylcholine metabolic process [GO:0060409]; positive regulation of cAMP/PKA signal transduction [GO:0141163]; positive regulation of mitotic nuclear division [GO:0045840]; regulation of the force of heart contraction [GO:0002026]; response to activity [GO:0014823]; response to calcium ion [GO:0051592]; response to cAMP [GO:0051591]; response to corticosterone [GO:0051412]; response to electrical stimulus [GO:0051602]; response to ethanol [GO:0045471]; response to oxidative stress [GO:0006979]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; sperm capacitation [GO:0048240]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Major component of epididymal secretions and sperm plasma membranes. It is present in cytosols from a variety of other tissues. Highly expressed in brain."
"354","sp|Q24025|SOG_DROME","lcl|NC_088855.1_cds_XP_011452499.3_15419",1.27e-82,289,"Q24025","SOG_DROME","Dorsal-ventral patterning protein Sog (Short gastrulation protein)","sog CG9224","Drosophila melanogaster (Fruit fly)",1038,"GO:0000139; GO:0005518; GO:0005615; GO:0005886; GO:0007313; GO:0007378; GO:0008083; GO:0008586; GO:0009953; GO:0030513; GO:0030514; GO:0035271; GO:0035592; GO:0036122; GO:0061328; GO:0110107; GO:0140311","amnioserosa formation [GO:0007378]; dorsal/ventral pattern formation [GO:0009953]; establishment of protein localization to extracellular region [GO:0035592]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maternal specification of dorsal/ventral axis, oocyte, soma encoded [GO:0007313]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of BMP signaling pathway [GO:0030513]; posterior Malpighian tubule development [GO:0061328]; regulation of imaginal disc-derived wing vein specification [GO:0110107]; ring gland development [GO:0035271]","extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; BMP binding [GO:0036122]; collagen binding [GO:0005518]; growth factor activity [GO:0008083]; protein sequestering activity [GO:0140311]; amnioserosa formation [GO:0007378]; dorsal/ventral pattern formation [GO:0009953]; establishment of protein localization to extracellular region [GO:0035592]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maternal specification of dorsal/ventral axis, oocyte, soma encoded [GO:0007313]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of BMP signaling pathway [GO:0030513]; posterior Malpighian tubule development [GO:0061328]; regulation of imaginal disc-derived wing vein specification [GO:0110107]; ring gland development [GO:0035271]","DEVELOPMENTAL STAGE: Embryogenesis. {ECO:0000269|PubMed:7958919}.","","","TISSUE SPECIFICITY: Abuts the dorsal dpp-expressing cells in a lateral stripe 14-16 cells wide. Later in embryogenesis it is expressed in neuroectoderm and in the endoderm spaced along the anterior-posterior axis of the developing gut. {ECO:0000269|PubMed:7958919}."
"355","sp|Q99496|RING2_HUMAN","lcl|NC_088855.1_cds_XP_011453568.1_12214",1.23e-134,387,"Q99496","RING2_HUMAN","E3 ubiquitin-protein ligase RING2 (EC 2.3.2.27) (Huntingtin-interacting protein 2-interacting protein 3) (HIP2-interacting protein 3) (Protein DinG) (RING finger protein 1B) (RING1b) (RING finger protein 2) (RING finger protein BAP-1) (RING-type E3 ubiquitin transferase RING2)","RNF2 BAP1 DING HIPI3 RING1B","Homo sapiens (Human)",336,"GO:0000122; GO:0000151; GO:0000278; GO:0000791; GO:0001702; GO:0001739; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0007281; GO:0008270; GO:0009948; GO:0010467; GO:0016567; GO:0016604; GO:0031519; GO:0035102; GO:0040029; GO:0043433; GO:0061630; GO:0071339; GO:0071535; GO:0140862","anterior/posterior axis specification [GO:0009948]; chromatin remodeling [GO:0006338]; epigenetic regulation of gene expression [GO:0040029]; gastrulation with mouth forming second [GO:0001702]; gene expression [GO:0010467]; germ cell development [GO:0007281]; mitotic cell cycle [GO:0000278]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]","cytoplasm [GO:0005737]; euchromatin [GO:0000791]; MLL1 complex [GO:0071339]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; sex chromatin [GO:0001739]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; histone H2AK119 ubiquitin ligase activity [GO:0140862]; RING-like zinc finger domain binding [GO:0071535]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; anterior/posterior axis specification [GO:0009948]; chromatin remodeling [GO:0006338]; epigenetic regulation of gene expression [GO:0040029]; gastrulation with mouth forming second [GO:0001702]; gene expression [GO:0010467]; germ cell development [GO:0007281]; mitotic cell cycle [GO:0000278]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]","","","",""
"356","sp|Q95QG8|FCP1_CAEEL","lcl|NC_088855.1_cds_XP_011453573.3_12219",1.34e-75,260,"Q95QG8","FCP1_CAEEL","RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16)","fcp-1 F36F2.6","Caenorhabditis elegans",659,"GO:0000122; GO:0005634; GO:0008420; GO:0048477","negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]","nucleus [GO:0005634]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]","","","",""
"357","sp|Q9VUF8|CP314_DROME","lcl|NC_088855.1_cds_XP_011453578.3_12224",4.71e-51,184,"Q9VUF8","CP314_DROME","Ecdysone 20-monooxygenase (E20MO) (EC 1.14.99.22) (CYPCCCXIVA1) (Cytochrome P450 314a1, mitochondrial) (Protein shade)","shd CYP314A1 CG13478","Drosophila melanogaster (Fruit fly)",540,"GO:0004501; GO:0005506; GO:0005739; GO:0007295; GO:0007298; GO:0007391; GO:0007417; GO:0007494; GO:0008258; GO:0020037; GO:0031966; GO:0035074; GO:0045456","border follicle cell migration [GO:0007298]; central nervous system development [GO:0007417]; dorsal closure [GO:0007391]; ecdysteroid biosynthetic process [GO:0045456]; growth of a germarium-derived egg chamber [GO:0007295]; head involution [GO:0008258]; midgut development [GO:0007494]; pupation [GO:0035074]","mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ecdysone 20-monooxygenase activity [GO:0004501]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; border follicle cell migration [GO:0007298]; central nervous system development [GO:0007417]; dorsal closure [GO:0007391]; ecdysteroid biosynthetic process [GO:0045456]; growth of a germarium-derived egg chamber [GO:0007295]; head involution [GO:0008258]; midgut development [GO:0007494]; pupation [GO:0035074]","","","","TISSUE SPECIFICITY: Strong expression by embryonic stage 10 in epidermis, decreases significantly in older embryos. Third instar larvae show expression in the midgut copper cells, Malpighian tubules and fat body. In the adult ovaries, expression is seen in both nurse cells and centripetally migrating follicle cells. {ECO:0000269|PubMed:14610274}."
"358","sp|Q9PTR5|LIS1_CHICK","lcl|NC_088855.1_cds_XP_011454155.1_15613",0,668,"Q9PTR5","LIS1_CHICK","Lissencephaly-1 homolog","PAFAH1B1 LIS1","Gallus gallus (Chicken)",410,"GO:0000132; GO:0000235; GO:0000776; GO:0001667; GO:0001675; GO:0001961; GO:0005635; GO:0005813; GO:0005875; GO:0005881; GO:0005938; GO:0007097; GO:0007254; GO:0007268; GO:0007281; GO:0007405; GO:0007611; GO:0008090; GO:0008247; GO:0008344; GO:0009306; GO:0019226; GO:0021819; GO:0030036; GO:0031023; GO:0031252; GO:0031514; GO:0032420; GO:0036035; GO:0038026; GO:0040019; GO:0042249; GO:0042802; GO:0043005; GO:0043025; GO:0043622; GO:0046329; GO:0046982; GO:0047496; GO:0048471; GO:0048854; GO:0050804; GO:0050885; GO:0051010; GO:0051012; GO:0051081; GO:0051219; GO:0051301; GO:0051661; GO:0060117; GO:0061003; GO:0070507; GO:0070840; GO:0090102; GO:0090176; GO:0097529; GO:0098685; GO:0098978; GO:0140650; GO:1904115; GO:1904936","acrosome assembly [GO:0001675]; actin cytoskeleton organization [GO:0030036]; adult locomotory behavior [GO:0008344]; ameboidal-type cell migration [GO:0001667]; auditory receptor cell development [GO:0060117]; brain morphogenesis [GO:0048854]; cell division [GO:0051301]; chemical synaptic transmission [GO:0007268]; cochlea development [GO:0090102]; cortical microtubule organization [GO:0043622]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity of embryonic epithelium [GO:0042249]; germ cell development [GO:0007281]; interneuron migration [GO:1904936]; JNK cascade [GO:0007254]; layer formation in cerebral cortex [GO:0021819]; learning or memory [GO:0007611]; maintenance of centrosome location [GO:0051661]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; modulation of chemical synaptic transmission [GO:0050804]; myeloid leukocyte migration [GO:0097529]; negative regulation of JNK cascade [GO:0046329]; neuroblast proliferation [GO:0007405]; neuromuscular process controlling balance [GO:0050885]; nuclear membrane disassembly [GO:0051081]; nuclear migration [GO:0007097]; osteoclast development [GO:0036035]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of embryonic development [GO:0040019]; protein secretion [GO:0009306]; radial glia-guided pyramidal neuron migration [GO:0140650]; reelin-mediated signaling pathway [GO:0038026]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde axonal transport [GO:0008090]; transmission of nerve impulse [GO:0019226]; vesicle transport along microtubule [GO:0047496]","1-alkyl-2-acetylglycerophosphocholine esterase complex [GO:0008247]; astral microtubule [GO:0000235]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; glutamatergic synapse [GO:0098978]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; Schaffer collateral - CA1 synapse [GO:0098685]; stereocilium [GO:0032420]; dynein complex binding [GO:0070840]; identical protein binding [GO:0042802]; microtubule plus-end binding [GO:0051010]; phosphoprotein binding [GO:0051219]; protein heterodimerization activity [GO:0046982]; acrosome assembly [GO:0001675]; actin cytoskeleton organization [GO:0030036]; adult locomotory behavior [GO:0008344]; ameboidal-type cell migration [GO:0001667]; auditory receptor cell development [GO:0060117]; brain morphogenesis [GO:0048854]; cell division [GO:0051301]; chemical synaptic transmission [GO:0007268]; cochlea development [GO:0090102]; cortical microtubule organization [GO:0043622]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity of embryonic epithelium [GO:0042249]; germ cell development [GO:0007281]; interneuron migration [GO:1904936]; JNK cascade [GO:0007254]; layer formation in cerebral cortex [GO:0021819]; learning or memory [GO:0007611]; maintenance of centrosome location [GO:0051661]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; modulation of chemical synaptic transmission [GO:0050804]; myeloid leukocyte migration [GO:0097529]; negative regulation of JNK cascade [GO:0046329]; neuroblast proliferation [GO:0007405]; neuromuscular process controlling balance [GO:0050885]; nuclear membrane disassembly [GO:0051081]; nuclear migration [GO:0007097]; osteoclast development [GO:0036035]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of embryonic development [GO:0040019]; protein secretion [GO:0009306]; radial glia-guided pyramidal neuron migration [GO:0140650]; reelin-mediated signaling pathway [GO:0038026]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde axonal transport [GO:0008090]; transmission of nerve impulse [GO:0019226]; vesicle transport along microtubule [GO:0047496]","DEVELOPMENTAL STAGE: Expressed in the intermediate and lateral mesoderm, posterior neural tube, notochord and somites of stage 9 embryos. Expressed in the neural tube, roof plate, notochord, somites, dermomymotomes and eye of stage 20 embryos. This expression pattern persists in stage 27 embryos, where expression is also seen in the heart, intestine and dorsal aorta. Weakly and uniformly expressed in the stage 35 embryo. {ECO:0000269|PubMed:10603088}.","","",""
"359","sp|Q9V535|RBM8A_DROME","lcl|NC_088855.1_cds_XP_011456624.1_16008",1.11e-67,204,"Q9V535","RBM8A_DROME","RNA-binding protein 8A (Protein tsunagi)","tsu Y14 CG8781","Drosophila melanogaster (Fruit fly)",165,"GO:0000226; GO:0000398; GO:0003729; GO:0005634; GO:0005737; GO:0007294; GO:0007310; GO:0007314; GO:0007317; GO:0008380; GO:0035145; GO:0042564; GO:0045451; GO:0046595; GO:0051028; GO:0051170; GO:0051663; GO:0071013","establishment of pole plasm mRNA localization [GO:0046595]; germarium-derived oocyte fate determination [GO:0007294]; import into nucleus [GO:0051170]; microtubule cytoskeleton organization [GO:0000226]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pole plasm oskar mRNA localization [GO:0045451]; regulation of pole plasm oskar mRNA localization [GO:0007317]; RNA splicing [GO:0008380]","catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; establishment of pole plasm mRNA localization [GO:0046595]; germarium-derived oocyte fate determination [GO:0007294]; import into nucleus [GO:0051170]; microtubule cytoskeleton organization [GO:0000226]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pole plasm oskar mRNA localization [GO:0045451]; regulation of pole plasm oskar mRNA localization [GO:0007317]; RNA splicing [GO:0008380]","DEVELOPMENTAL STAGE: Expressed throughout development. Localizes to the posterior pole of the oocyte during stages 1-9 of oogenesis. {ECO:0000269|PubMed:11691839}.","","",""
"360","sp|Q96RK4|BBS4_HUMAN","lcl|NC_088855.1_cds_XP_011457123.1_12747",0,569,"Q96RK4","BBS4_HUMAN","BBSome complex member BBS4 (Bardet-Biedl syndrome 4 protein)","BBS4","Homo sapiens (Human)",519,"GO:0000226; GO:0000242; GO:0000281; GO:0001750; GO:0001764; GO:0001782; GO:0001843; GO:0001895; GO:0001917; GO:0001947; GO:0003085; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0007098; GO:0007286; GO:0007601; GO:0007608; GO:0010467; GO:0010629; GO:0015031; GO:0016055; GO:0016358; GO:0019216; GO:0021591; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0030674; GO:0030837; GO:0031514; GO:0032391; GO:0032402; GO:0032465; GO:0033365; GO:0034101; GO:0034451; GO:0034452; GO:0034454; GO:0034464; GO:0035176; GO:0035845; GO:0035869; GO:0036064; GO:0038108; GO:0040018; GO:0043014; GO:0045444; GO:0045494; GO:0045724; GO:0046548; GO:0046907; GO:0048487; GO:0048854; GO:0050893; GO:0051457; GO:0051492; GO:0060170; GO:0060271; GO:0060296; GO:0060324; GO:0060613; GO:0061512; GO:0061629; GO:0071539; GO:0097730; GO:0120316; GO:1902855; GO:1903546; GO:1905515","adult behavior [GO:0030534]; B cell homeostasis [GO:0001782]; brain morphogenesis [GO:0048854]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; erythrocyte homeostasis [GO:0034101]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; gene expression [GO:0010467]; heart looping [GO:0001947]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; maintenance of protein location in nucleus [GO:0051457]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of systemic arterial blood pressure [GO:0003085]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cilium assembly [GO:0045724]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to organelle [GO:0033365]; protein localization to photoreceptor outer segment [GO:1903546]; protein transport [GO:0015031]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of cytokinesis [GO:0032465]; regulation of lipid metabolic process [GO:0019216]; regulation of non-motile cilium assembly [GO:1902855]; regulation of stress fiber assembly [GO:0051492]; retina homeostasis [GO:0001895]; retinal rod cell development [GO:0046548]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893]; social behavior [GO:0035176]; sperm flagellum assembly [GO:0120316]; spermatid development [GO:0007286]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; adult behavior [GO:0030534]; B cell homeostasis [GO:0001782]; brain morphogenesis [GO:0048854]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; erythrocyte homeostasis [GO:0034101]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; gene expression [GO:0010467]; heart looping [GO:0001947]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; maintenance of protein location in nucleus [GO:0051457]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of systemic arterial blood pressure [GO:0003085]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cilium assembly [GO:0045724]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to organelle [GO:0033365]; protein localization to photoreceptor outer segment [GO:1903546]; protein transport [GO:0015031]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of cytokinesis [GO:0032465]; regulation of lipid metabolic process [GO:0019216]; regulation of non-motile cilium assembly [GO:1902855]; regulation of stress fiber assembly [GO:0051492]; retina homeostasis [GO:0001895]; retinal rod cell development [GO:0046548]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893]; social behavior [GO:0035176]; sperm flagellum assembly [GO:0120316]; spermatid development [GO:0007286]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","","","","TISSUE SPECIFICITY: Ubiquitously expressed. The highest level of expression is found in the kidney."
"361","sp|B4IB36|MAEL_DROSE","lcl|NC_088855.1_cds_XP_011457249.3_16150",2.14e-11,66.2,"B4IB36","MAEL_DROSE","Protein maelstrom","mael GM22468","Drosophila sechellia (Fruit fly)",394,"GO:0000976; GO:0005634; GO:0005737; GO:0007140; GO:0007283; GO:0030718; GO:0031047; GO:0034587; GO:0043186; GO:0045892; GO:0048471; GO:0048477; GO:0060964","germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; negative regulation of DNA-templated transcription [GO:0045892]; oogenesis [GO:0048477]; piRNA processing [GO:0034587]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulatory ncRNA-mediated gene silencing [GO:0031047]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; perinuclear region of cytoplasm [GO:0048471]; transcription cis-regulatory region binding [GO:0000976]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; negative regulation of DNA-templated transcription [GO:0045892]; oogenesis [GO:0048477]; piRNA processing [GO:0034587]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulatory ncRNA-mediated gene silencing [GO:0031047]; spermatogenesis [GO:0007283]","","","",""
"362","sp|Q6GVH4|GGNB2_CHICK","lcl|NC_088855.1_cds_XP_019920257.2_13996",5.07e-179,526,"Q6GVH4","GGNB2_CHICK","Gametogenetin-binding protein 2 (Protein ZNF403)","GGNBP2 ZNF403 RCJMB04_15h5","Gallus gallus (Chicken)",698,"GO:0005634; GO:0005737; GO:0007283; GO:0030154","cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","","","",""
"363","sp|B4J613|AKTP1_DROGR","lcl|NC_088855.1_cds_XP_019923869.1_15068",1.26e-31,119,"B4J613","AKTP1_DROGR","Protein crossbronx","cbx GH20212","Drosophila grimshawi (Hawaiian fruit fly) (Idiomyia grimshawi)",246,"GO:0007291; GO:0042742","defense response to bacterium [GO:0042742]; sperm individualization [GO:0007291]","defense response to bacterium [GO:0042742]; sperm individualization [GO:0007291]","","","",""
"364","sp|Q9C0J8|WDR33_HUMAN","lcl|NC_088855.1_cds_XP_019924870.3_15929",0,691,"Q9C0J8","WDR33_HUMAN","pre-mRNA 3' end processing protein WDR33 (WD repeat-containing protein 33) (WD repeat-containing protein of 146 kDa)","WDR33 WDC146","Homo sapiens (Human)",1336,"GO:0001650; GO:0003723; GO:0005581; GO:0005634; GO:0005654; GO:0005847; GO:0006301; GO:0007283; GO:0031124","mRNA 3'-end processing [GO:0031124]; postreplication repair [GO:0006301]; spermatogenesis [GO:0007283]","collagen trimer [GO:0005581]; fibrillar center [GO:0001650]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; postreplication repair [GO:0006301]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Most highly expressed in testis. {ECO:0000269|PubMed:11162572}."
"365","sp|P48809|RB27C_DROME","lcl|NC_088855.1_cds_XP_019926166.1_12640",3.74e-50,174,"P48809","RB27C_DROME","Heterogeneous nuclear ribonucleoprotein 27C (Hrb27-C) (HRP48.1) (hnRNP 48)","Hrb27C hrp48 Rbp7 CG10377","Drosophila melanogaster (Fruit fly)",421,"GO:0003697; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0007283; GO:0007319; GO:0030371; GO:0032991; GO:0034046; GO:0043186; GO:0045451; GO:0045727; GO:0048024; GO:0048026; GO:0048027; GO:1903688; GO:1990904","negative regulation of oskar mRNA translation [GO:0007319]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; single-stranded DNA binding [GO:0003697]; translation repressor activity [GO:0030371]; negative regulation of oskar mRNA translation [GO:0007319]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283]","","","",""
"366","sp|Q1RMV9|CNEP1_BOVIN","lcl|NC_088855.1_cds_XP_019927747.1_13749",2.08e-123,351,"Q1RMV9","CNEP1_BOVIN","CTD nuclear envelope phosphatase 1 (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard)","CTDNEP1 DULLARD","Bos taurus (Bovine)",244,"GO:0004721; GO:0004722; GO:0005635; GO:0005737; GO:0005789; GO:0005811; GO:0006998; GO:0007276; GO:0007498; GO:0010867; GO:0031965; GO:0034504; GO:0060070; GO:0071595; GO:0090263","canonical Wnt signaling pathway [GO:0060070]; gamete generation [GO:0007276]; mesoderm development [GO:0007498]; nuclear envelope organization [GO:0006998]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of triglyceride biosynthetic process [GO:0010867]; protein localization to nucleus [GO:0034504]","cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; Nem1-Spo7 phosphatase complex [GO:0071595]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; canonical Wnt signaling pathway [GO:0060070]; gamete generation [GO:0007276]; mesoderm development [GO:0007498]; nuclear envelope organization [GO:0006998]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of triglyceride biosynthetic process [GO:0010867]; protein localization to nucleus [GO:0034504]","","","",""
"367","sp|Q8TE57|ATS16_HUMAN","lcl|NC_088855.1_cds_XP_019929071.3_14489",0,931,"Q8TE57","ATS16_HUMAN","A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-)","ADAMTS16 KIAA2029","Homo sapiens (Human)",1224,"GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0031012; GO:0046872; GO:0048232; GO:1902017","branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073]","extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073]","","","","TISSUE SPECIFICITY: Expressed in fetal lung and kidney and in adult prostate and ovary."
"368","sp|Q39024|MPK4_ARATH","lcl|NC_088855.1_cds_XP_034298918.2_15944",3.15e-120,372,"Q39024","MPK4_ARATH","Mitogen-activated protein kinase 4 (AtMPK4) (MAP kinase 4) (EC 2.7.11.24)","MPK4 At4g01370 F2N1.1 F2N1_2-t","Arabidopsis thaliana (Mouse-ear cress)",376,"GO:0000911; GO:0004672; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0005874; GO:0006468; GO:0006972; GO:0007112; GO:0009409; GO:0009504; GO:0009555; GO:0009620; GO:0009651; GO:0009737; GO:0009861; GO:0009862; GO:0009868; GO:0010119; GO:0016301; GO:0016310; GO:0042539; GO:0043622; GO:0045087; GO:0071244; GO:0090333; GO:0106310","cellular response to carbon dioxide [GO:0071244]; cortical microtubule organization [GO:0043622]; cytokinesis by cell plate formation [GO:0000911]; hyperosmotic response [GO:0006972]; hypotonic salinity response [GO:0042539]; innate immune response [GO:0045087]; jasmonic acid and ethylene-dependent systemic resistance [GO:0009861]; jasmonic acid and ethylene-dependent systemic resistance, jasmonic acid mediated signaling pathway [GO:0009868]; male meiosis cytokinesis [GO:0007112]; phosphorylation [GO:0016310]; pollen development [GO:0009555]; protein phosphorylation [GO:0006468]; regulation of stomatal closure [GO:0090333]; regulation of stomatal movement [GO:0010119]; response to abscisic acid [GO:0009737]; response to cold [GO:0009409]; response to fungus [GO:0009620]; response to salt stress [GO:0009651]; systemic acquired resistance, salicylic acid mediated signaling pathway [GO:0009862]","cell plate [GO:0009504]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; cellular response to carbon dioxide [GO:0071244]; cortical microtubule organization [GO:0043622]; cytokinesis by cell plate formation [GO:0000911]; hyperosmotic response [GO:0006972]; hypotonic salinity response [GO:0042539]; innate immune response [GO:0045087]; jasmonic acid and ethylene-dependent systemic resistance [GO:0009861]; jasmonic acid and ethylene-dependent systemic resistance, jasmonic acid mediated signaling pathway [GO:0009868]; male meiosis cytokinesis [GO:0007112]; phosphorylation [GO:0016310]; pollen development [GO:0009555]; protein phosphorylation [GO:0006468]; regulation of stomatal closure [GO:0090333]; regulation of stomatal movement [GO:0010119]; response to abscisic acid [GO:0009737]; response to cold [GO:0009409]; response to fungus [GO:0009620]; response to salt stress [GO:0009651]; systemic acquired resistance, salicylic acid mediated signaling pathway [GO:0009862]","DEVELOPMENTAL STAGE: Observed in root epidermal cells and root hairs, especially in the root hair formation zone. During root hair development, both observed in root hair bulges and in young outgrowing root hairs. {ECO:0000269|PubMed:20215588}.","","","TISSUE SPECIFICITY: Ubiquitous. Expressed in the veins and stomatal guard cells of leaf plates, petioles, stem, roots and flowers. {ECO:0000269|PubMed:11163186, ECO:0000269|PubMed:20215588, ECO:0000269|PubMed:21575092}."
"369","sp|Q9GQQ0|SPIN_DROME","lcl|NC_088855.1_cds_XP_034298985.2_16036",1.9e-157,463,"Q9GQQ0","SPIN_DROME","Protein spinster (Protein benchwarmer) (Protein diphthong)","spin bnch CG8428","Drosophila melanogaster (Fruit fly)",605,"GO:0005765; GO:0006869; GO:0006897; GO:0007040; GO:0007619; GO:0008333; GO:0008347; GO:0008582; GO:0009267; GO:0010001; GO:0012501; GO:0016020; GO:0022857; GO:0030514; GO:0031902; GO:0031982; GO:0035193; GO:0040011; GO:0043067; GO:0045476; GO:0045477; GO:0045924; GO:0048477; GO:0048488; GO:0051124; GO:0055085; GO:0098793","cellular response to starvation [GO:0009267]; courtship behavior [GO:0007619]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; glial cell differentiation [GO:0010001]; glial cell migration [GO:0008347]; larval central nervous system remodeling [GO:0035193]; lipid transport [GO:0006869]; locomotion [GO:0040011]; lysosome organization [GO:0007040]; negative regulation of BMP signaling pathway [GO:0030514]; nurse cell apoptotic process [GO:0045476]; oogenesis [GO:0048477]; programmed cell death [GO:0012501]; regulation of female receptivity [GO:0045924]; regulation of nurse cell apoptotic process [GO:0045477]; regulation of programmed cell death [GO:0043067]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; synaptic assembly at neuromuscular junction [GO:0051124]; synaptic vesicle endocytosis [GO:0048488]; transmembrane transport [GO:0055085]","late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; presynapse [GO:0098793]; vesicle [GO:0031982]; transmembrane transporter activity [GO:0022857]; cellular response to starvation [GO:0009267]; courtship behavior [GO:0007619]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; glial cell differentiation [GO:0010001]; glial cell migration [GO:0008347]; larval central nervous system remodeling [GO:0035193]; lipid transport [GO:0006869]; locomotion [GO:0040011]; lysosome organization [GO:0007040]; negative regulation of BMP signaling pathway [GO:0030514]; nurse cell apoptotic process [GO:0045476]; oogenesis [GO:0048477]; programmed cell death [GO:0012501]; regulation of female receptivity [GO:0045924]; regulation of nurse cell apoptotic process [GO:0045477]; regulation of programmed cell death [GO:0043067]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; synaptic assembly at neuromuscular junction [GO:0051124]; synaptic vesicle endocytosis [GO:0048488]; transmembrane transport [GO:0055085]","DEVELOPMENTAL STAGE: Expressed in both motoneurons and muscle throughout the period of synaptic growth and development at the neuromuscular junction. Expressed throughout the CNS, including motoneurons. Weak expression is observed in embryonic muscle as well as other tissues. Expressed throughout the larval CNS with pronounced expression in motoneurons. Also strongly expressed in all body wall muscle as well as other tissues, including a subset of epithelial cells and the salivary glands. {ECO:0000269|PubMed:12408844}.","","","TISSUE SPECIFICITY: Enriched in brain (at protein level). {ECO:0000269|PubMed:12408844, ECO:0000269|PubMed:15998804}."
"370","sp|O75934|SPF27_HUMAN","lcl|NC_088855.1_cds_XP_034299202.1_13993",4.22e-99,288,"O75934","SPF27_HUMAN","Pre-mRNA-splicing factor SPF27 (Breast carcinoma-amplified sequence 2) (DNA amplified in mammary carcinoma 1 protein) (Spliceosome-associated protein SPF 27)","BCAS2 DAM1","Homo sapiens (Human)",225,"GO:0000375; GO:0000380; GO:0000398; GO:0000974; GO:0001541; GO:0005634; GO:0005654; GO:0005681; GO:0005730; GO:0005813; GO:0008380; GO:0016607; GO:0030163; GO:0048599; GO:0051225; GO:0071007; GO:0071013","alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splicing, via spliceosome [GO:0000398]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; protein catabolic process [GO:0030163]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spindle assembly [GO:0051225]","catalytic step 2 spliceosome [GO:0071013]; centrosome [GO:0005813]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splicing, via spliceosome [GO:0000398]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; protein catabolic process [GO:0030163]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spindle assembly [GO:0051225]","","","","TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:10403562}."
"371","sp|O15360|FANCA_HUMAN","lcl|NC_088855.1_cds_XP_034299281.2_15529",4.57e-45,178,"O15360","FANCA_HUMAN","Fanconi anemia group A protein (Protein FACA)","FANCA FAA FACA FANCH","Homo sapiens (Human)",1455,"GO:0000785; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0007140; GO:0008584; GO:0008585; GO:0036297; GO:0043240; GO:0045589; GO:0050727; GO:0065003; GO:1905936; GO:2000348","DNA repair [GO:0006281]; female gonad development [GO:0008585]; interstrand cross-link repair [GO:0036297]; male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; protein-containing complex assembly [GO:0065003]; regulation of CD40 signaling pathway [GO:2000348]; regulation of germ cell proliferation [GO:1905936]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]","chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA repair [GO:0006281]; female gonad development [GO:0008585]; interstrand cross-link repair [GO:0036297]; male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; protein-containing complex assembly [GO:0065003]; regulation of CD40 signaling pathway [GO:2000348]; regulation of germ cell proliferation [GO:1905936]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]","","","",""
"372","sp|Q3TUL7|DCA17_MOUSE","lcl|NC_088855.1_cds_XP_034317398.2_11925",5.05e-75,249,"Q3TUL7","DCA17_MOUSE","DDB1- and CUL4-associated factor 17","Dcaf17","Mus musculus (Mouse)",519,"GO:0000902; GO:0001675; GO:0005654; GO:0005730; GO:0005829; GO:0007283; GO:0016020; GO:0016567; GO:0080008","acrosome assembly [GO:0001675]; cell morphogenesis [GO:0000902]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]","Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; acrosome assembly [GO:0001675]; cell morphogenesis [GO:0000902]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Ubiquitously expressed in the embryo, with higher expression in brain, liver and skin tissues. {ECO:0000269|PubMed:19026396}."
"373","sp|Q8C5W4|MOR2B_MOUSE","lcl|NC_088855.1_cds_XP_034317959.2_14584",0,736,"Q8C5W4","MOR2B_MOUSE","ATPase MORC2B (EC 3.6.1.-) (MORC family CW-type zinc finger protein 2B) (TCE6)","Morc2b Tce6","Mus musculus (Mouse)",1022,"GO:0005524; GO:0005634; GO:0007129; GO:0007276; GO:0008270; GO:0016887; GO:1990918","double-strand break repair involved in meiotic recombination [GO:1990918]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]","nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; zinc ion binding [GO:0008270]; double-strand break repair involved in meiotic recombination [GO:1990918]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]","DEVELOPMENTAL STAGE: In juvenile testes, expression is absent prior to postnatal day 12, is detected at a low level at day 12, and increased significantly at day 14 and beyond. In adul testes, expressed in meiotic spermatocytes, abundant in post-meiotic haploid round spermatids, and absent from elongated spermatids. {ECO:0000269|PubMed:29329290}.","","","TISSUE SPECIFICITY: Protein is abundant in testes but not detected in other adult tissues examined (at protein level). Detected in germ cells with a distinct developmental-specific expression pattern but not in somatic cells such as Sertoli cells. {ECO:0000269|PubMed:29329290}."
"374","sp|Q9VNV3|DDX1_DROME","lcl|NC_088855.1_cds_XP_034335895.2_14872",0,934,"Q9VNV3","DDX1_DROME","ATP-dependent RNA helicase Ddx1 (DEAD box protein 1) (EC 3.6.4.13)","Ddx1 CG9054","Drosophila melanogaster (Fruit fly)",727,"GO:0001700; GO:0003682; GO:0003712; GO:0003724; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0006302; GO:0007283; GO:0008033; GO:0008143; GO:0016887; GO:0033677; GO:0048477; GO:0072669","double-strand break repair [GO:0006302]; embryonic development via the syncytial blastoderm [GO:0001700]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]; tRNA processing [GO:0008033]","nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA/RNA helicase activity [GO:0033677]; exonuclease activity [GO:0004527]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]; double-strand break repair [GO:0006302]; embryonic development via the syncytial blastoderm [GO:0001700]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]; tRNA processing [GO:0008033]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically throughout development. Expression is highest in early embryos. {ECO:0000269|PubMed:8666277}.","","",""
"375","sp|P40793|CDC42_DROME","lcl|NC_088855.1_cds_XP_034335968.1_15014",9.01e-126,353,"P40793","CDC42_DROME","Cdc42 homolog (EC 3.6.5.2)","Cdc42 CG12530","Drosophila melanogaster (Fruit fly)",191,"GO:0003924; GO:0003925; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0005938; GO:0006897; GO:0006909; GO:0007015; GO:0007165; GO:0007266; GO:0007274; GO:0007286; GO:0007298; GO:0007349; GO:0007391; GO:0007409; GO:0007411; GO:0008045; GO:0008360; GO:0008582; GO:0009611; GO:0010592; GO:0016028; GO:0016192; GO:0016318; GO:0019901; GO:0030010; GO:0030011; GO:0030027; GO:0030030; GO:0030031; GO:0030036; GO:0030041; GO:0030424; GO:0030426; GO:0030833; GO:0030866; GO:0031175; GO:0032794; GO:0035010; GO:0035011; GO:0035099; GO:0035147; GO:0035318; GO:0042060; GO:0045177; GO:0045185; GO:0045200; GO:0045202; GO:0045860; GO:0046330; GO:0046843; GO:0046928; GO:0048010; GO:0048477; GO:0048675; GO:0048812; GO:0048813; GO:0050770; GO:0050975; GO:0051491; GO:0051601; GO:0060446; GO:0072659; GO:0090303; GO:0097206","actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; cell projection assembly [GO:0030031]; cell projection organization [GO:0030030]; cellularization [GO:0007349]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; encapsulation of foreign target [GO:0035010]; endocytosis [GO:0006897]; establishment of cell polarity [GO:0030010]; establishment of neuroblast polarity [GO:0045200]; exocyst localization [GO:0051601]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair outgrowth [GO:0035318]; maintenance of cell polarity [GO:0030011]; maintenance of protein location [GO:0045185]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; nephrocyte filtration [GO:0097206]; neuromuscular synaptic transmission [GO:0007274]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; ommatidial rotation [GO:0016318]; oogenesis [GO:0048477]; phagocytosis [GO:0006909]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of wound healing [GO:0090303]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]; sensory perception of touch [GO:0050975]; signal transduction [GO:0007165]; spermatid development [GO:0007286]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vesicle-mediated transport [GO:0016192]; wound healing [GO:0042060]","adherens junction [GO:0005912]; apical part of cell [GO:0045177]; axon [GO:0030424]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; synapse [GO:0045202]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; cell projection assembly [GO:0030031]; cell projection organization [GO:0030030]; cellularization [GO:0007349]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; encapsulation of foreign target [GO:0035010]; endocytosis [GO:0006897]; establishment of cell polarity [GO:0030010]; establishment of neuroblast polarity [GO:0045200]; exocyst localization [GO:0051601]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair outgrowth [GO:0035318]; maintenance of cell polarity [GO:0030011]; maintenance of protein location [GO:0045185]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; nephrocyte filtration [GO:0097206]; neuromuscular synaptic transmission [GO:0007274]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; ommatidial rotation [GO:0016318]; oogenesis [GO:0048477]; phagocytosis [GO:0006909]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of wound healing [GO:0090303]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]; sensory perception of touch [GO:0050975]; signal transduction [GO:0007165]; spermatid development [GO:0007286]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vesicle-mediated transport [GO:0016192]; wound healing [GO:0042060]","","","",""
"376","sp|Q8VHK9|DHX36_MOUSE","lcl|NC_088855.1_cds_XP_034336006.2_15144",0,845,"Q8VHK9","DHX36_MOUSE","ATP-dependent DNA/RNA helicase DHX36 (EC 3.6.4.13) (DEAD/H box polypeptide 36) (DEAH box protein 36) (MLE-like protein 1) (RNA helicase associated with AU-rich element ARE)","Dhx36 Ddx36 Kiaa1488 Mlel1","Mus musculus (Mouse)",1001,"GO:0000287; GO:0000781; GO:0000976; GO:0000978; GO:0001503; GO:0002151; GO:0002735; GO:0003678; GO:0003697; GO:0003724; GO:0003725; GO:0003730; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006359; GO:0007283; GO:0008094; GO:0009615; GO:0010494; GO:0016607; GO:0016887; GO:0017148; GO:0030154; GO:0030424; GO:0030425; GO:0031442; GO:0032206; GO:0032727; GO:0034605; GO:0034644; GO:0035925; GO:0042826; GO:0043123; GO:0043204; GO:0043330; GO:0043488; GO:0045087; GO:0045944; GO:0045995; GO:0048027; GO:0051607; GO:0051880; GO:0051891; GO:0060261; GO:0061003; GO:0061158; GO:0070034; GO:0070883; GO:0090669; GO:0140640; GO:1900153; GO:1901534; GO:1903843; GO:1904358; GO:1904582; GO:2000767","3'-UTR-mediated mRNA destabilization [GO:0061158]; cell differentiation [GO:0030154]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]","axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; catalytic activity, acting on a nucleic acid [GO:0140640]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; transcription cis-regulatory region binding [GO:0000976]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cell differentiation [GO:0030154]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]","DEVELOPMENTAL STAGE: Expressed in the embryonic heart at 10.5 and increases from 14.5 to 16.5 dpc, and then gradually decreases until postnal day 7 (PubMed:26489465). Expressed during the testicular development from embryonic day 18.5 to postnatal day 35 (PubMed:25611385). {ECO:0000269|PubMed:25611385, ECO:0000269|PubMed:26489465}.","","","TISSUE SPECIFICITY: Expressed in spermatogonia stem cells and primary spermatocytes (at protein level) (PubMed:25611385). Expressed strongly in testis. Weakly expressed in heart, lung, liver, kidney, small intestine, spleen, lymphe node and thymus (PubMed:25611385). {ECO:0000269|PubMed:25611385}."
"377","sp|Q5NCX5|NEUL4_MOUSE","lcl|NC_088855.1_cds_XP_034336320.2_17117",0,1364,"Q5NCX5","NEUL4_MOUSE","Neuralized-like protein 4","Neurl4 Kiaa1787","Mus musculus (Mouse)",1563,"GO:0005739; GO:0005814; GO:0007283; GO:0043504","mitochondrial DNA repair [GO:0043504]; spermatogenesis [GO:0007283]","centriole [GO:0005814]; mitochondrion [GO:0005739]; mitochondrial DNA repair [GO:0043504]; spermatogenesis [GO:0007283]","","","",""
"378","sp|Q20168|COPB2_CAEEL","lcl|NC_088855.1_cds_XP_034336384.2_17191",0,1192,"Q20168","COPB2_CAEEL","Probable coatomer subunit beta' (Beta'-coat protein) (Beta'-COP)","copb-2 F38E11.5","Caenorhabditis elegans",1000,"GO:0000139; GO:0005198; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0009792; GO:0030126; GO:0048599","embryo development ending in birth or egg hatching [GO:0009792]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; oocyte development [GO:0048599]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; structural molecule activity [GO:0005198]; embryo development ending in birth or egg hatching [GO:0009792]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; oocyte development [GO:0048599]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","","","",""
"379","sp|P51140|DSH_DROME","lcl|NC_088855.1_cds_XP_034336874.1_11497",5.96e-105,333,"P51140","DSH_DROME","Segment polarity protein dishevelled","dsh CG18361","Drosophila melanogaster (Fruit fly)",623,"GO:0000132; GO:0001736; GO:0001737; GO:0001745; GO:0001751; GO:0005109; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007298; GO:0007367; GO:0007391; GO:0007435; GO:0008045; GO:0008585; GO:0008587; GO:0016201; GO:0016477; GO:0019904; GO:0030159; GO:0030707; GO:0031290; GO:0035019; GO:0035159; GO:0035309; GO:0035317; GO:0035556; GO:0042067; GO:0045179; GO:0045773; GO:0048076; GO:0048477; GO:0048675; GO:0048730; GO:0050770; GO:0060070; GO:0060250; GO:0060914; GO:0070300; GO:0090163; GO:1902669; GO:1990909","axon extension [GO:0048675]; border follicle cell migration [GO:0007298]; canonical Wnt signaling pathway [GO:0060070]; cell migration [GO:0016477]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; dorsal closure [GO:0007391]; epidermis morphogenesis [GO:0048730]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of mitotic spindle orientation [GO:0000132]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; follicle cell of egg chamber development [GO:0030707]; germ-line stem-cell niche homeostasis [GO:0060250]; heart formation [GO:0060914]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; intracellular signal transduction [GO:0035556]; motor neuron axon guidance [GO:0008045]; oogenesis [GO:0048477]; positive regulation of axon extension [GO:0045773]; positive regulation of axon guidance [GO:1902669]; regulation of axonogenesis [GO:0050770]; regulation of compound eye pigmentation [GO:0048076]; regulation of tube length, open tracheal system [GO:0035159]; retinal ganglion cell axon guidance [GO:0031290]; salivary gland morphogenesis [GO:0007435]; segment polarity determination [GO:0007367]; somatic stem cell population maintenance [GO:0035019]; synaptic target inhibition [GO:0016201]; wing and notum subfield formation [GO:0035309]","apical cortex [GO:0045179]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909]; frizzled binding [GO:0005109]; phosphatidic acid binding [GO:0070300]; protein domain specific binding [GO:0019904]; signaling receptor complex adaptor activity [GO:0030159]; axon extension [GO:0048675]; border follicle cell migration [GO:0007298]; canonical Wnt signaling pathway [GO:0060070]; cell migration [GO:0016477]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; dorsal closure [GO:0007391]; epidermis morphogenesis [GO:0048730]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of mitotic spindle orientation [GO:0000132]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; follicle cell of egg chamber development [GO:0030707]; germ-line stem-cell niche homeostasis [GO:0060250]; heart formation [GO:0060914]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; intracellular signal transduction [GO:0035556]; motor neuron axon guidance [GO:0008045]; oogenesis [GO:0048477]; positive regulation of axon extension [GO:0045773]; positive regulation of axon guidance [GO:1902669]; regulation of axonogenesis [GO:0050770]; regulation of compound eye pigmentation [GO:0048076]; regulation of tube length, open tracheal system [GO:0035159]; retinal ganglion cell axon guidance [GO:0031290]; salivary gland morphogenesis [GO:0007435]; segment polarity determination [GO:0007367]; somatic stem cell population maintenance [GO:0035019]; synaptic target inhibition [GO:0016201]; wing and notum subfield formation [GO:0035309]","DEVELOPMENTAL STAGE: Expressed at high levels at 0-1 hour and from 5-17 hours. Also expressed at high levels in early pupae. {ECO:0000269|PubMed:8288125}.","","","TISSUE SPECIFICITY: Found in egg chambers of the ovary and ubiquitously throughout embryogenesis and in disks. Expression is not seen in salivary glands, muscles or ventral ganglia but is observed in brain lobes."
"380","sp|Q24564|MERH_DROME","lcl|NC_088855.1_cds_XP_034337019.1_13188",0,564,"Q24564","MERH_DROME","Moesin/ezrin/radixin homolog 2 (Ezrin-moesin-radixin 2) (Merlin) (dMerlin)","Mer EMR2 CG14228","Drosophila melanogaster (Fruit fly)",635,"GO:0001558; GO:0001745; GO:0001751; GO:0003779; GO:0005178; GO:0005737; GO:0005856; GO:0005886; GO:0005912; GO:0005938; GO:0006897; GO:0007112; GO:0007267; GO:0007283; GO:0007291; GO:0008285; GO:0008360; GO:0009798; GO:0009966; GO:0010669; GO:0014013; GO:0016006; GO:0016020; GO:0016028; GO:0016324; GO:0019094; GO:0022409; GO:0030175; GO:0032456; GO:0035329; GO:0035330; GO:0035332; GO:0036375; GO:0042127; GO:0042802; GO:0043065; GO:0043495; GO:0045177; GO:0045463; GO:0045464; GO:0045595; GO:0046621; GO:0046669; GO:0051307; GO:0060253; GO:0072659; GO:0098592; GO:0106037; GO:0120219; GO:1902115; GO:1902966; GO:2000643","axis specification [GO:0009798]; cell-cell signaling [GO:0007267]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; epithelial structure maintenance [GO:0010669]; hippo signaling [GO:0035329]; male meiosis cytokinesis [GO:0007112]; meiotic chromosome separation [GO:0051307]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of organ growth [GO:0046621]; pole plasm mRNA localization [GO:0019094]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of hippo signaling [GO:0035332]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization to plasma membrane [GO:0072659]; R8 cell development [GO:0045463]; R8 cell fate specification [GO:0045464]; regulation of cell differentiation [GO:0045595]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of compound eye retinal cell programmed cell death [GO:0046669]; regulation of gliogenesis [GO:0014013]; regulation of hippo signaling [GO:0035330]; regulation of organelle assembly [GO:1902115]; regulation of signal transduction [GO:0009966]; sperm individualization [GO:0007291]; spermatogenesis [GO:0007283]","adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; Kibra-Ex-Mer complex [GO:0036375]; membrane [GO:0016020]; Nebenkern [GO:0016006]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; subapical part of cell [GO:0120219]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-membrane adaptor activity [GO:0043495]; axis specification [GO:0009798]; cell-cell signaling [GO:0007267]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; epithelial structure maintenance [GO:0010669]; hippo signaling [GO:0035329]; male meiosis cytokinesis [GO:0007112]; meiotic chromosome separation [GO:0051307]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of organ growth [GO:0046621]; pole plasm mRNA localization [GO:0019094]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of hippo signaling [GO:0035332]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization to plasma membrane [GO:0072659]; R8 cell development [GO:0045463]; R8 cell fate specification [GO:0045464]; regulation of cell differentiation [GO:0045595]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of compound eye retinal cell programmed cell death [GO:0046669]; regulation of gliogenesis [GO:0014013]; regulation of hippo signaling [GO:0035330]; regulation of organelle assembly [GO:1902115]; regulation of signal transduction [GO:0009966]; sperm individualization [GO:0007291]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed maternally and zygotically in embryos. {ECO:0000269|PubMed:8666669}.","","","TISSUE SPECIFICITY: Expressed predominantly in the germline. Expressed in the developing oocyte from stage 6 to the end of oogenesis and in the apical ends of follical cells from stage 10. Ubiquitous expression throughout embryogenesis with enhanced expression in mesoderm of early embryos and midgut of late embryos. In embryonic CNS, expression is seen in neuropil and developing brain and is enhanced in neuronal cell bodies. In embryonic PNS, expression is seen within the cell body. In third instar larvae, expression is uniform in the eye imaginal disk and is enhanced at the morphogenetic furrow. In pupal eyes, expression is seen in the cytoplasm of secondary and tertiary pigment cells, bristle precursor cells and rhabdomeres. {ECO:0000269|PubMed:8666669}."
"381","sp|Q05344|SSRP1_DROME","lcl|NC_088855.1_cds_XP_034337141.2_17482",0,539,"Q05344","SSRP1_DROME","FACT complex subunit Ssrp1 (Chorion-factor 5) (Facilitates chromatin transcription complex subunit Ssrp1) (Recombination signal sequence recognition protein) (Single-strand recognition protein) (dSSRP1)","Ssrp CF5 SSRP1 CG4817","Drosophila melanogaster (Fruit fly)",723,"GO:0001933; GO:0003723; GO:0005634; GO:0005730; GO:0005829; GO:0006260; GO:0006281; GO:0030707; GO:0030838; GO:0031491; GO:0031492; GO:0035101; GO:0042393; GO:0046982; GO:0070087; GO:1902275","DNA repair [GO:0006281]; DNA replication [GO:0006260]; follicle cell of egg chamber development [GO:0030707]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of actin filament polymerization [GO:0030838]; regulation of chromatin organization [GO:1902275]","cytosol [GO:0005829]; FACT complex [GO:0035101]; nucleolus [GO:0005730]; nucleus [GO:0005634]; chromo shadow domain binding [GO:0070087]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; follicle cell of egg chamber development [GO:0030707]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of actin filament polymerization [GO:0030838]; regulation of chromatin organization [GO:1902275]","DEVELOPMENTAL STAGE: Abundant throughout oogenesis and embryogenesis, decreases during larval stages and increases again in pupae.","","","TISSUE SPECIFICITY: Expressed at highest levels in nurse cells of the ovary."
"382","sp|Q09437|CD111_CAEEL","lcl|NC_088855.1_cds_XP_034337425.2_15337",1.56e-142,434,"Q09437","CD111_CAEEL","Cyclin-dependent kinase 11.1 (EC 2.7.11.22)","cdk-11.1 B0495.2","Caenorhabditis elegans",719,"GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0007276; GO:0040019; GO:0051726; GO:0106310","gamete generation [GO:0007276]; positive regulation of embryonic development [GO:0040019]; regulation of cell cycle [GO:0051726]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; gamete generation [GO:0007276]; positive regulation of embryonic development [GO:0040019]; regulation of cell cycle [GO:0051726]","DEVELOPMENTAL STAGE: Ubiquitously expressed during all stages of embryogenesis, but expression is low during the first few cell cycles (at protein level). {ECO:0000269|PubMed:29886128}.","","","TISSUE SPECIFICITY: Broadly expressed in somatic and germ line cells (at protein level) (PubMed:29886128). Not expressed in sperm (at protein level) (PubMed:29886128). {ECO:0000269|PubMed:29886128}."
"383","sp|A2AV36|ANM7_DANRE","lcl|NC_088855.1_cds_XP_034337703.2_12125",0,568,"A2AV36","ANM7_DANRE","Protein arginine N-methyltransferase 7 (EC 2.1.1.321) (Histone-arginine N-methyltransferase PRMT7) ([Myelin basic protein]-arginine N-methyltransferase PRMT7)","prmt7 ch211-51l3.2","Danio rerio (Zebrafish) (Brachydanio rerio)",683,"GO:0000387; GO:0005634; GO:0005829; GO:0006338; GO:0006355; GO:0007010; GO:0008757; GO:0016274; GO:0018216; GO:0035241; GO:0035243; GO:0042054; GO:0044020; GO:0051607; GO:0071514","chromatin remodeling [GO:0006338]; cytoskeleton organization [GO:0007010]; defense response to virus [GO:0051607]; genomic imprinting [GO:0071514]; peptidyl-arginine methylation [GO:0018216]; regulation of DNA-templated transcription [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]","cytosol [GO:0005829]; nucleus [GO:0005634]; histone H4R3 methyltransferase activity [GO:0044020]; histone methyltransferase activity [GO:0042054]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; chromatin remodeling [GO:0006338]; cytoskeleton organization [GO:0007010]; defense response to virus [GO:0051607]; genomic imprinting [GO:0071514]; peptidyl-arginine methylation [GO:0018216]; regulation of DNA-templated transcription [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]","","","",""
"384","sp|Q4Z8K6|RBP9X_DROME","lcl|NC_088855.1_cds_XP_034337709.2_12114",3.29e-134,417,"Q4Z8K6","RBP9X_DROME","Ran-binding proteins 9/10 homolog (Ran-binding protein M)","RanBPM CG42236","Drosophila melanogaster (Fruit fly)",962,"GO:0005634; GO:0005737; GO:0007010; GO:0007162; GO:0007299; GO:0016020; GO:0030536; GO:0031267; GO:0032436; GO:0034657; GO:0046827; GO:0046843; GO:0060250","cytoskeleton organization [GO:0007010]; dorsal appendage formation [GO:0046843]; follicle cell of egg chamber-cell adhesion [GO:0007299]; germ-line stem-cell niche homeostasis [GO:0060250]; larval feeding behavior [GO:0030536]; negative regulation of cell adhesion [GO:0007162]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein export from nucleus [GO:0046827]","cytoplasm [GO:0005737]; GID complex [GO:0034657]; membrane [GO:0016020]; nucleus [GO:0005634]; small GTPase binding [GO:0031267]; cytoskeleton organization [GO:0007010]; dorsal appendage formation [GO:0046843]; follicle cell of egg chamber-cell adhesion [GO:0007299]; germ-line stem-cell niche homeostasis [GO:0060250]; larval feeding behavior [GO:0030536]; negative regulation of cell adhesion [GO:0007162]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein export from nucleus [GO:0046827]","","","","TISSUE SPECIFICITY: Expressed in the GSCs and in dividing cysts. Expression is reduced in the germline as individual egg chambers are formed. Isoform C is expressed in all somatic and germline cells of the ovary. Isoform D is expressed in the GSC niche. {ECO:0000269|PubMed:18762575}."
"385","sp|Q9WTK8|SPO11_MOUSE","lcl|NC_088855.1_cds_XP_034337713.2_12103",4.68e-130,379,"Q9WTK8","SPO11_MOUSE","Meiotic recombination protein SPO11 (EC 5.6.2.2)","Spo11","Mus musculus (Mouse)",396,"GO:0000781; GO:0001541; GO:0003677; GO:0003918; GO:0005524; GO:0005654; GO:0007129; GO:0007130; GO:0007131; GO:0007141; GO:0007286; GO:0034502; GO:0042138; GO:0045141; GO:0046872; GO:0048477; GO:1990918","double-strand break repair involved in meiotic recombination [GO:1990918]; homologous chromosome pairing at meiosis [GO:0007129]; male meiosis I [GO:0007141]; meiotic DNA double-strand break formation [GO:0042138]; meiotic telomere clustering [GO:0045141]; oogenesis [GO:0048477]; ovarian follicle development [GO:0001541]; protein localization to chromosome [GO:0034502]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130]","chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]; double-strand break repair involved in meiotic recombination [GO:1990918]; homologous chromosome pairing at meiosis [GO:0007129]; male meiosis I [GO:0007141]; meiotic DNA double-strand break formation [GO:0042138]; meiotic telomere clustering [GO:0045141]; oogenesis [GO:0048477]; ovarian follicle development [GO:0001541]; protein localization to chromosome [GO:0034502]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130]","DEVELOPMENTAL STAGE: Not detected at day 7 postpartum (dpp). Levels are low at 12 dpp but increase by 17 dpp. High levels are maintained throughout the remainder of testis development. {ECO:0000269|PubMed:10622720, ECO:0000269|PubMed:10855504}.","","","TISSUE SPECIFICITY: High levels are found only in the testis where expression is restricted primarily to meiotic germ cells. Not expressed in spermatogonia. Highest levels are found in pachytene spermatocytes. Very low levels are found in thymus, brain and oocytes of embryonic ovary. Not detected in adult ovary (PubMed:10622720, PubMed:10855504). Isoform 1: Expressed early in meiosis, when most double-strand breaks (DSB) are formed (PubMed:21330546). {ECO:0000269|PubMed:10534401, ECO:0000269|PubMed:10622720, ECO:0000269|PubMed:10855504, ECO:0000269|PubMed:21330546}."
"386","sp|Q9STX9|TIP51_ARATH","lcl|NC_088855.1_cds_XP_034337791.2_12232",6.98e-24,98.6,"Q9STX9","TIP51_ARATH","Probable aquaporin TIP5-1 (Tonoplast intrinsic protein 5-1) (AtTIP5;1)","TIP5-1 At3g47440 T21L8.190","Arabidopsis thaliana (Mouse-ear cress)",256,"GO:0005739; GO:0015204; GO:0015250; GO:0015840; GO:0016020; GO:0048235; GO:0090406","pollen sperm cell differentiation [GO:0048235]; urea transport [GO:0015840]","membrane [GO:0016020]; mitochondrion [GO:0005739]; pollen tube [GO:0090406]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]; pollen sperm cell differentiation [GO:0048235]; urea transport [GO:0015840]","","","",""
"387","sp|Q8CGC4|LS14B_MOUSE","lcl|NC_088855.1_cds_XP_034337819.1_13499",2.57e-44,160,"Q8CGC4","LS14B_MOUSE","Protein LSM14 homolog B (RNA-associated protein 55B) (mRAP55B)","Lsm14b Fam61b Rap55b","Mus musculus (Mouse)",385,"GO:0001541; GO:0003723; GO:0006417; GO:0036464; GO:0048477; GO:0140694; GO:0141065; GO:1903537; GO:1990904","maternal mRNA clearance [GO:0141065]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; membraneless organelle assembly [GO:0140694]; oogenesis [GO:0048477]; ovarian follicle development [GO:0001541]; regulation of translation [GO:0006417]","cytoplasmic ribonucleoprotein granule [GO:0036464]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; maternal mRNA clearance [GO:0141065]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; membraneless organelle assembly [GO:0140694]; oogenesis [GO:0048477]; ovarian follicle development [GO:0001541]; regulation of translation [GO:0006417]","","","","TISSUE SPECIFICITY: Highly expressed in oocytes (at protein level). {ECO:0000269|PubMed:37083226, ECO:0000269|PubMed:37481122, ECO:0000269|PubMed:37578641, ECO:0000269|PubMed:37889087}."
"388","sp|Q66I67|IFT20_DANRE","lcl|NC_088855.1_cds_XP_034337829.1_13510",2.08e-61,186,"Q66I67","IFT20_DANRE","Intraflagellar transport protein 20 homolog","ift20 zgc:103674","Danio rerio (Zebrafish) (Brachydanio rerio)",132,"GO:0001669; GO:0005737; GO:0005794; GO:0005813; GO:0005814; GO:0005930; GO:0007283; GO:0030154; GO:0030990; GO:0030992; GO:0036064; GO:0042073; GO:0043005; GO:0060271; GO:0061512; GO:0097546; GO:0097730; GO:2000583","cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; protein localization to cilium [GO:0061512]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; spermatogenesis [GO:0007283]","acrosomal vesicle [GO:0001669]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intraciliary transport particle [GO:0030990]; intraciliary transport particle B [GO:0030992]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; protein localization to cilium [GO:0061512]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; spermatogenesis [GO:0007283]","","","",""
"389","sp|Q09967|EGG1_CAEEL","lcl|NC_088855.1_cds_XP_034337832.2_13530",1.89e-31,131,"Q09967","EGG1_CAEEL","LDL receptor repeat-containing protein egg-1 (Egg sterile protein 1)","egg-1 B0244.8","Caenorhabditis elegans",551,"GO:0005886; GO:0007338; GO:0010008; GO:0030703; GO:0038023; GO:1903078; GO:1904778","eggshell formation [GO:0030703]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of protein localization to plasma membrane [GO:1903078]; single fertilization [GO:0007338]","endosome membrane [GO:0010008]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; eggshell formation [GO:0030703]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of protein localization to plasma membrane [GO:1903078]; single fertilization [GO:0007338]","","","","TISSUE SPECIFICITY: Specifically expressed in developing oocytes of adult germ line. {ECO:0000269|PubMed:16360684}."
"390","sp|Q09232|ORAI_CAEEL","lcl|NC_088855.1_cds_XP_034337844.1_13548",1.5e-26,105,"Q09232","ORAI_CAEEL","Protein orai (Store-operated calcium channel)","orai-1 C09F5.2","Caenorhabditis elegans",293,"GO:0002115; GO:0005886; GO:0005891; GO:0015279; GO:0016020; GO:0016323; GO:0016324; GO:0019953; GO:0030728; GO:0045087","innate immune response [GO:0045087]; ovulation [GO:0030728]; sexual reproduction [GO:0019953]; store-operated calcium entry [GO:0002115]","apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; store-operated calcium channel activity [GO:0015279]; innate immune response [GO:0045087]; ovulation [GO:0030728]; sexual reproduction [GO:0019953]; store-operated calcium entry [GO:0002115]","","","","TISSUE SPECIFICITY: Expressed in gonad sheath cells, hypodermis, intestine and spermatheca. Coexpressed with stim-1. {ECO:0000269|PubMed:17218360, ECO:0000269|PubMed:17376526}."
"391","sp|Q9CQ29|RN151_MOUSE","lcl|NC_088855.1_cds_XP_034338087.2_11138",1.25e-25,102,"Q9CQ29","RN151_MOUSE","RING finger protein 151","Rnf151","Mus musculus (Mouse)",239,"GO:0005634; GO:0005737; GO:0007283; GO:0008270; GO:0030154","cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expression begins in the testis at day 15 and increases dramatically from day 21 and thereafter. {ECO:0000269|PubMed:35831855}.","","","TISSUE SPECIFICITY: Expressed in testis (PubMed:17577571, PubMed:35831855). Expressed in round spermatids of the stages VII-VIII semniniferous tubules. Expressed in elongating spermatids of stages VIII-IX seminiferous tubules (at protein level) (PubMed:17577571). {ECO:0000269|PubMed:17577571, ECO:0000269|PubMed:35831855}."
"392","sp|Q9NDJ2|DOM_DROME","lcl|NC_088855.1_cds_XP_034338376.2_13766",0,723,"Q9NDJ2","DOM_DROME","Helicase domino (EC 3.6.4.-)","dom CG9696","Drosophila melanogaster (Fruit fly)",3198,"GO:0000123; GO:0000381; GO:0000812; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006325; GO:0006338; GO:0008094; GO:0010629; GO:0016887; GO:0030097; GO:0035019; GO:0035207; GO:0035222; GO:0035267; GO:0036098; GO:0042393; GO:0045815; GO:0048477; GO:0048813; GO:0070983; GO:0140713; GO:0140849; GO:0140861","chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; DNA repair-dependent chromatin remodeling [GO:0140861]; hemopoiesis [GO:0030097]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; somatic stem cell population maintenance [GO:0035019]; transcription initiation-coupled chromatin remodeling [GO:0045815]; wing disc pattern formation [GO:0035222]","histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent H2AZ histone chaperone activity [GO:0140849]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; DNA repair-dependent chromatin remodeling [GO:0140861]; hemopoiesis [GO:0030097]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; somatic stem cell population maintenance [GO:0035019]; transcription initiation-coupled chromatin remodeling [GO:0045815]; wing disc pattern formation [GO:0035222]","DEVELOPMENTAL STAGE: Isoform A and isoform B are present in 0-12 hours embryonic extracts. During embryonic development, isoform A expression is restricted to the developing nervous system, whereas isoform B is ubiquitously expressed. During postembryonic development, isoform B is found in brain, imaginal disks, lymph glands and salivary glands and isoform A is found in some brain regions, photoreceptor cells and sensory organ precursors (at protein level). {ECO:0000269|PubMed:11262242}.","","","TISSUE SPECIFICITY: Isoform B is present at high levels in ovary, in follicle cells, nurse cells and oocyte. Isoform B is also present in germline and somatic stem cells from the germarium. Isoform A is undetectable in adult ovary (at protein level). {ECO:0000269|PubMed:11262242, ECO:0000269|PubMed:16322456}."
"393","sp|Q96J94|PIWL1_HUMAN","lcl|NC_088855.1_cds_XP_034338426.1_17592",0,889,"Q96J94","PIWL1_HUMAN","Piwi-like protein 1 (EC 3.1.26.-)","PIWIL1 HIWI","Homo sapiens (Human)",861,"GO:0003727; GO:0003729; GO:0004521; GO:0005634; GO:0005737; GO:0006417; GO:0007283; GO:0007286; GO:0019901; GO:0031047; GO:0033391; GO:0034584; GO:0034587; GO:0035092; GO:0043186; GO:0046872; GO:0051321; GO:0097433; GO:0140262; GO:0140990; GO:0140991; GO:0141006","meiotic cell cycle [GO:0051321]; piRNA processing [GO:0034587]; piRNA-mediated gene silencing by mRNA destabilization [GO:0140991]; primary piRNA processing [GO:0140990]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; sperm DNA condensation [GO:0035092]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006]","chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; dense body [GO:0097433]; nucleus [GO:0005634]; P granule [GO:0043186]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA cap binding complex binding [GO:0140262]; piRNA binding [GO:0034584]; protein kinase binding [GO:0019901]; RNA endonuclease activity [GO:0004521]; single-stranded RNA binding [GO:0003727]; meiotic cell cycle [GO:0051321]; piRNA processing [GO:0034587]; piRNA-mediated gene silencing by mRNA destabilization [GO:0140991]; primary piRNA processing [GO:0140990]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; sperm DNA condensation [GO:0035092]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006]","","INDUCTION: [Isoform 3]: Down-regulated in CD34(+) hematopoietic cells during differentiation. {ECO:0000269|PubMed:11154219}.","INDUCTION: [Isoform 3]: Down-regulated in CD34(+) hematopoietic cells during differentiation. {ECO:0000269|PubMed:11154219}.","TISSUE SPECIFICITY: Expressed in spermatocytes and spermatids. Also detected in prostate cancer (at protein level). Detected in most fetal and adult tissues. Expressed in testes, specifically in germline cells; detected in spermatocytes and spermatids during spermatogenesis. Increased expression in testicular tumors originating from embryonic germ cells with retention of germ cells phenotype. No expression in testicular tumors of somatic origin, such as Sertoli cell and Leydig cell tumors. Overexpressed in gastric cancer cells. Isoform 3: Ubiquitously expressed, and specifically in CD34(+) hematopoietic progenitor cells but not in more differentiated cells. {ECO:0000269|PubMed:11154219, ECO:0000269|PubMed:12037681, ECO:0000269|PubMed:12906857, ECO:0000269|PubMed:23436708}."
"394","sp|Q13315|ATM_HUMAN","lcl|NC_088855.1_cds_XP_034338539.2_13673",0,1411,"Q13315","ATM_HUMAN","Serine-protein kinase ATM (EC 2.7.11.1) (Ataxia telangiectasia mutated) (A-T mutated)","ATM","Homo sapiens (Human)",3056,"GO:0000077; GO:0000425; GO:0000723; GO:0000724; GO:0000729; GO:0001541; GO:0001756; GO:0002331; GO:0003677; GO:0004674; GO:0004677; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005782; GO:0005813; GO:0005819; GO:0005829; GO:0006302; GO:0006303; GO:0006468; GO:0006974; GO:0007094; GO:0007095; GO:0007131; GO:0007140; GO:0007143; GO:0007165; GO:0007420; GO:0007507; GO:0008340; GO:0008630; GO:0009791; GO:0010212; GO:0010506; GO:0010628; GO:0016303; GO:0030330; GO:0030335; GO:0030889; GO:0032210; GO:0032212; GO:0033151; GO:0033554; GO:0034614; GO:0035264; GO:0035861; GO:0035979; GO:0036289; GO:0042159; GO:0042770; GO:0042802; GO:0042981; GO:0043065; GO:0043231; GO:0043517; GO:0043525; GO:0044877; GO:0045141; GO:0045785; GO:0045944; GO:0046777; GO:0048538; GO:0048599; GO:0051402; GO:0051726; GO:0071044; GO:0071300; GO:0071480; GO:0071481; GO:0071500; GO:0090398; GO:0090399; GO:0097694; GO:0097695; GO:0098850; GO:0106310; GO:1900034; GO:1901796; GO:1904262; GO:1904354; GO:1904358; GO:1904884; GO:1990391; GO:2000781; GO:2000785","brain development [GO:0007420]; cellular response to gamma radiation [GO:0071480]; cellular response to nitrosative stress [GO:0071500]; cellular response to reactive oxygen species [GO:0034614]; cellular response to retinoic acid [GO:0071300]; cellular response to stress [GO:0033554]; cellular response to X-ray [GO:0071481]; cellular senescence [GO:0090398]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; female meiotic nuclear division [GO:0007143]; heart development [GO:0007507]; histone mRNA catabolic process [GO:0071044]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lipoprotein catabolic process [GO:0042159]; male meiotic nuclear division [GO:0007140]; meiotic telomere clustering [GO:0045141]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic spindle assembly checkpoint signaling [GO:0007094]; multicellular organism growth [GO:0035264]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of telomere capping [GO:1904354]; negative regulation of TORC1 signaling [GO:1904262]; neuron apoptotic process [GO:0051402]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; peptidyl-serine autophosphorylation [GO:0036289]; pexophagy [GO:0000425]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; pre-B cell allelic exclusion [GO:0002331]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; reciprocal meiotic recombination [GO:0007131]; regulation of apoptotic process [GO:0042981]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of cell cycle [GO:0051726]; regulation of cellular response to heat [GO:1900034]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere maintenance via telomerase [GO:0032210]; replicative senescence [GO:0090399]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165]; signal transduction in response to DNA damage [GO:0042770]; somitogenesis [GO:0001756]; telomere maintenance [GO:0000723]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151]","centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; extrinsic component of synaptic vesicle membrane [GO:0098850]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; site of double-strand break [GO:0035861]; spindle [GO:0005819]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; histone H2AXS139 kinase activity [GO:0035979]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; brain development [GO:0007420]; cellular response to gamma radiation [GO:0071480]; cellular response to nitrosative stress [GO:0071500]; cellular response to reactive oxygen species [GO:0034614]; cellular response to retinoic acid [GO:0071300]; cellular response to stress [GO:0033554]; cellular response to X-ray [GO:0071481]; cellular senescence [GO:0090398]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; female meiotic nuclear division [GO:0007143]; heart development [GO:0007507]; histone mRNA catabolic process [GO:0071044]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lipoprotein catabolic process [GO:0042159]; male meiotic nuclear division [GO:0007140]; meiotic telomere clustering [GO:0045141]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic spindle assembly checkpoint signaling [GO:0007094]; multicellular organism growth [GO:0035264]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of telomere capping [GO:1904354]; negative regulation of TORC1 signaling [GO:1904262]; neuron apoptotic process [GO:0051402]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; peptidyl-serine autophosphorylation [GO:0036289]; pexophagy [GO:0000425]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; pre-B cell allelic exclusion [GO:0002331]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; reciprocal meiotic recombination [GO:0007131]; regulation of apoptotic process [GO:0042981]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of cell cycle [GO:0051726]; regulation of cellular response to heat [GO:1900034]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere maintenance via telomerase [GO:0032210]; replicative senescence [GO:0090399]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165]; signal transduction in response to DNA damage [GO:0042770]; somitogenesis [GO:0001756]; telomere maintenance [GO:0000723]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151]","","INDUCTION: By ionizing radiation.","INDUCTION: By ionizing radiation.","TISSUE SPECIFICITY: Found in pancreas, kidney, skeletal muscle, liver, lung, placenta, brain, heart, spleen, thymus, testis, ovary, small intestine, colon and leukocytes."
"395","sp|Q8C1R0|TSSK5_MOUSE","lcl|NC_088855.1_cds_XP_034338545.2_13692",6.79e-67,227,"Q8C1R0","TSSK5_MOUSE","Testis-specific serine/threonine-protein kinase 5 (TSK-5) (TSSK-5) (Testis-specific kinase 5) (EC 2.7.11.1)","Tssk5","Mus musculus (Mouse)",372,"GO:0000287; GO:0004674; GO:0005524; GO:0006468; GO:0007283; GO:0030154; GO:0106310","cell differentiation [GO:0030154]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]","ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell differentiation [GO:0030154]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]","","","",""
"396","sp|Q64654|CP51A_RAT","lcl|NC_088855.1_cds_XP_034338589.2_13905",7.64e-23,103,"Q64654","CP51A_RAT","Lanosterol 14-alpha demethylase (LDM) (EC 1.14.14.154) (CYPLI) (Cytochrome P450 51A1) (CYP51) (Cytochrome P450-14DM) (Cytochrome P45014DM) (Cytochrome P450LI) (Sterol 14-alpha demethylase P450)","Cyp51a1 Cyp51","Rattus norvegicus (Rat)",503,"GO:0001669; GO:0005506; GO:0005789; GO:0006694; GO:0007283; GO:0008398; GO:0010288; GO:0016491; GO:0020037; GO:0032868; GO:0033488; GO:0042177; GO:0044752; GO:0045540; GO:0050709; GO:0060282; GO:1900222","cholesterol biosynthetic process via 24,25-dihydrolanosterol [GO:0033488]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein secretion [GO:0050709]; positive regulation of oocyte development [GO:0060282]; regulation of cholesterol biosynthetic process [GO:0045540]; response to human chorionic gonadotropin [GO:0044752]; response to insulin [GO:0032868]; response to lead ion [GO:0010288]; spermatogenesis [GO:0007283]; steroid biosynthetic process [GO:0006694]","acrosomal vesicle [GO:0001669]; endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; sterol 14-demethylase activity [GO:0008398]; cholesterol biosynthetic process via 24,25-dihydrolanosterol [GO:0033488]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein secretion [GO:0050709]; positive regulation of oocyte development [GO:0060282]; regulation of cholesterol biosynthetic process [GO:0045540]; response to human chorionic gonadotropin [GO:0044752]; response to insulin [GO:0032868]; response to lead ion [GO:0010288]; spermatogenesis [GO:0007283]; steroid biosynthetic process [GO:0006694]","","","",""
"397","sp|A0A0G2K344|PK3CA_RAT","lcl|NC_088855.1_cds_XP_034338626.1_13966",0,1183,"A0A0G2K344","PK3CA_RAT","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3-kinase subunit alpha) (PI3K-alpha) (PI3Kalpha) (PtdIns-3-kinase subunit alpha) (EC 2.7.1.137) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha) (PtdIns-3-kinase subunit p110-alpha) (p110alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine/threonine protein kinase PIK3CA) (EC 2.7.11.1)","Pik3ca","Rattus norvegicus (Rat)",1068,"GO:0001525; GO:0001889; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0005944; GO:0006006; GO:0006909; GO:0008286; GO:0010468; GO:0010629; GO:0014704; GO:0014823; GO:0014870; GO:0016303; GO:0016477; GO:0030027; GO:0030036; GO:0030295; GO:0030835; GO:0032869; GO:0035005; GO:0035994; GO:0036092; GO:0038084; GO:0040014; GO:0043201; GO:0043457; GO:0043491; GO:0043524; GO:0043560; GO:0046854; GO:0046934; GO:0048009; GO:0048015; GO:0048661; GO:0051897; GO:0055119; GO:0060612; GO:0071333; GO:0071464; GO:0071548; GO:0086003; GO:0097009; GO:0106310; GO:0110053; GO:0141068; GO:1903544; GO:1905477; GO:2000270; GO:2000811","actin cytoskeleton organization [GO:0030036]; adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; autosome genomic imprinting [GO:0141068]; cardiac muscle cell contraction [GO:0086003]; cell migration [GO:0016477]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrostatic pressure [GO:0071464]; cellular response to insulin stimulus [GO:0032869]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; liver development [GO:0001889]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of anoikis [GO:2000811]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; phagocytosis [GO:0006909]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of actin filament organization [GO:0110053]; regulation of cellular respiration [GO:0043457]; regulation of gene expression [GO:0010468]; regulation of multicellular organism growth [GO:0040014]; relaxation of cardiac muscle [GO:0055119]; response to activity [GO:0014823]; response to butyrate [GO:1903544]; response to dexamethasone [GO:0071548]; response to L-leucine [GO:0043201]; response to muscle inactivity [GO:0014870]; response to muscle stretch [GO:0035994]; vascular endothelial growth factor signaling pathway [GO:0038084]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; protein kinase activator activity [GO:0030295]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton organization [GO:0030036]; adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; autosome genomic imprinting [GO:0141068]; cardiac muscle cell contraction [GO:0086003]; cell migration [GO:0016477]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrostatic pressure [GO:0071464]; cellular response to insulin stimulus [GO:0032869]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; liver development [GO:0001889]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of anoikis [GO:2000811]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; phagocytosis [GO:0006909]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of actin filament organization [GO:0110053]; regulation of cellular respiration [GO:0043457]; regulation of gene expression [GO:0010468]; regulation of multicellular organism growth [GO:0040014]; relaxation of cardiac muscle [GO:0055119]; response to activity [GO:0014823]; response to butyrate [GO:1903544]; response to dexamethasone [GO:0071548]; response to L-leucine [GO:0043201]; response to muscle inactivity [GO:0014870]; response to muscle stretch [GO:0035994]; vascular endothelial growth factor signaling pathway [GO:0038084]","","","","TISSUE SPECIFICITY: Detected in the hypothalamus (at protein level). {ECO:0000269|PubMed:20236230}."
"398","sp|P39745|MPK1_CAEEL","lcl|NC_088855.1_cds_XP_034338700.1_17740",0,594,"P39745","MPK1_CAEEL","Mitogen-activated protein kinase mpk-1 (EC 2.7.11.24) (MAP kinase sur-1)","mpk-1 sur-1 F43C1.2","Caenorhabditis elegans",444,"GO:0000165; GO:0001556; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0007166; GO:0007265; GO:0032436; GO:0035556; GO:0040025; GO:0045944; GO:0046872; GO:0050830; GO:0051321; GO:0106310","cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-positive bacterium [GO:0050830]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; meiotic cell cycle [GO:0051321]; oocyte maturation [GO:0001556]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; vulval development [GO:0040025]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-positive bacterium [GO:0050830]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; meiotic cell cycle [GO:0051321]; oocyte maturation [GO:0001556]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; vulval development [GO:0040025]","DEVELOPMENTAL STAGE: The phosphorylated form is present in early to mid pachytene, is absent in late pachytene and diplotene/diakinesis stages and is again present in oocytes when they reach the spermatheca (PubMed:19826475, PubMed:21901106, PubMed:22820175). The phosphorylated form is also present in sperm (PubMed:22820175). {ECO:0000269|PubMed:19826475, ECO:0000269|PubMed:21901106, ECO:0000269|PubMed:22820175}.","","","TISSUE SPECIFICITY: Expressed in cells lining the rectum (PubMed:15268855, PubMed:20624915). Isoform a is expressed in nervous system, body wall muscles and posterior intestine (PubMed:20624915). Isoform b expression may be restricted to germline (PubMed:22820175). {ECO:0000269|PubMed:15268855, ECO:0000269|PubMed:20624915, ECO:0000269|PubMed:22820175}."
"399","sp|Q6J1I8|RN114_PIG","lcl|NC_088855.1_cds_XP_034338802.1_12685",7e-58,184,"Q6J1I8","RN114_PIG","E3 ubiquitin-protein ligase RNF114 (EC 2.3.2.27) (RING finger protein 114) (RING-type E3 ubiquitin transferase RNF114) (Zinc finger protein 313)","RNF114 ZNF313","Sus scrofa (Pig)",228,"GO:0000209; GO:0005634; GO:0005829; GO:0005886; GO:0006511; GO:0007283; GO:0008270; GO:0030154; GO:0061630","cell differentiation [GO:0030154]; protein polyubiquitination [GO:0000209]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]","cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; protein polyubiquitination [GO:0000209]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]","","","",""
"400","sp|Q9VQQ9|EXOC2_DROME","lcl|NC_088855.1_cds_XP_034338915.1_16411",2.78e-163,501,"Q9VQQ9","EXOC2_DROME","Exocyst complex component 2 (Exocyst complex component Sec5)","Sec5 CG8843","Drosophila melanogaster (Fruit fly)",894,"GO:0000145; GO:0005642; GO:0005737; GO:0005886; GO:0005938; GO:0006887; GO:0006893; GO:0007269; GO:0007298; GO:0007349; GO:0016028; GO:0016080; GO:0016081; GO:0016192; GO:0030136; GO:0031267; GO:0031594; GO:0032456; GO:0035003; GO:0035147; GO:0043001; GO:0045056; GO:0045087; GO:0048215; GO:0048599; GO:0055037; GO:0071896; GO:0072657; GO:0072659; GO:0072697; GO:0090128; GO:0098793; GO:0099641; GO:1904115","anterograde axonal protein transport [GO:0099641]; border follicle cell migration [GO:0007298]; branch fusion, open tracheal system [GO:0035147]; cellularization [GO:0007349]; endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; innate immune response [GO:0045087]; neurotransmitter secretion [GO:0007269]; oocyte development [GO:0048599]; positive regulation of Golgi vesicle fusion to target membrane [GO:0048215]; protein localization to adherens junction [GO:0071896]; protein localization to cell cortex [GO:0072697]; protein localization to membrane [GO:0072657]; protein localization to plasma membrane [GO:0072659]; regulation of synapse maturation [GO:0090128]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; transcytosis [GO:0045056]; vesicle-mediated transport [GO:0016192]","annulate lamellae [GO:0005642]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; exocyst [GO:0000145]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; rhabdomere [GO:0016028]; subapical complex [GO:0035003]; small GTPase binding [GO:0031267]; anterograde axonal protein transport [GO:0099641]; border follicle cell migration [GO:0007298]; branch fusion, open tracheal system [GO:0035147]; cellularization [GO:0007349]; endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; innate immune response [GO:0045087]; neurotransmitter secretion [GO:0007269]; oocyte development [GO:0048599]; positive regulation of Golgi vesicle fusion to target membrane [GO:0048215]; protein localization to adherens junction [GO:0071896]; protein localization to cell cortex [GO:0072697]; protein localization to membrane [GO:0072657]; protein localization to plasma membrane [GO:0072659]; regulation of synapse maturation [GO:0090128]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; transcytosis [GO:0045056]; vesicle-mediated transport [GO:0016192]","","","",""
"401","sp|Q8T0Q4|CHM4_DROME","lcl|NC_088855.1_cds_XP_034338923.1_16420",1.47e-40,139,"Q8T0Q4","CHM4_DROME","Charged multivesicular body protein 4 (CHMP4) (ESCRT-III complex core component shrb) (Protein Shrub)","shrb Shrub Snf7 Vps32 CG8055","Drosophila melanogaster (Fruit fly)",226,"GO:0000281; GO:0000815; GO:0005771; GO:0006900; GO:0006914; GO:0009898; GO:0016322; GO:0030496; GO:0032509; GO:0032511; GO:0043025; GO:0043162; GO:0045169; GO:0046718; GO:0048132; GO:0048813; GO:0070938; GO:1990635","autophagy [GO:0006914]; dendrite morphogenesis [GO:0048813]; endosome transport via multivesicular body sorting pathway [GO:0032509]; female germ-line stem cell asymmetric division [GO:0048132]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; symbiont entry into host cell [GO:0046718]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle budding from membrane [GO:0006900]","contractile ring [GO:0070938]; cytoplasmic side of plasma membrane [GO:0009898]; ESCRT III complex [GO:0000815]; fusome [GO:0045169]; midbody [GO:0030496]; multivesicular body [GO:0005771]; neuronal cell body [GO:0043025]; proximal dendrite [GO:1990635]; autophagy [GO:0006914]; dendrite morphogenesis [GO:0048813]; endosome transport via multivesicular body sorting pathway [GO:0032509]; female germ-line stem cell asymmetric division [GO:0048132]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; symbiont entry into host cell [GO:0046718]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle budding from membrane [GO:0006900]","DEVELOPMENTAL STAGE: In the pupal notum expressed in both epidermal cells and sensory organ precursor cells (at protein level) (PubMed:37226981). Low expression levels during embryogenesis (PubMed:33660341). Expression increases during larval development, peaking at the third instar larval stage and decreasing during pupation (PubMed:33660341). Increased expression levels in 1 day old adult males but not 1 day old adult females (PubMed:33660341). {ECO:0000269|PubMed:33660341, ECO:0000269|PubMed:37226981}.","","","TISSUE SPECIFICITY: Expressed at considerably higher levels in testis than in ovary (PubMed:33660341). Expressed in midgut, eye, mouthparts and male accessory gland (PubMed:33660341). {ECO:0000269|PubMed:33660341}."
"402","sp|Q9Y149|MED15_DROME","lcl|NC_088855.1_cds_XP_034338960.2_16452",1.86e-58,210,"Q9Y149","MED15_DROME","Mediator of RNA polymerase II transcription subunit 15 (Mediator complex subunit 15) (dARC105)","MED15 Arc105 CG4184","Drosophila melanogaster (Fruit fly)",749,"GO:0003712; GO:0005634; GO:0006357; GO:0016592; GO:0030707; GO:0070847","follicle cell of egg chamber development [GO:0030707]; regulation of transcription by RNA polymerase II [GO:0006357]","core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; follicle cell of egg chamber development [GO:0030707]; regulation of transcription by RNA polymerase II [GO:0006357]","","","",""
"403","sp|P22700|ATC1_DROME","lcl|NC_088855.1_cds_XP_034338962.2_16462",0,1472,"P22700","ATC1_DROME","Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium ATPase at 60A) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)","SERCA Ca-P60A CG3725","Drosophila melanogaster (Fruit fly)",1020,"GO:0005388; GO:0005524; GO:0005783; GO:0005789; GO:0006874; GO:0007274; GO:0007629; GO:0012505; GO:0016020; GO:0016529; GO:0016887; GO:0030322; GO:0030707; GO:0033017; GO:0036335; GO:0045202; GO:0046872; GO:0048863; GO:0051282; GO:0060047; GO:0070588; GO:1903515; GO:1990845","adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; flight behavior [GO:0007629]; follicle cell of egg chamber development [GO:0030707]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; intracellular calcium ion homeostasis [GO:0006874]; neuromuscular synaptic transmission [GO:0007274]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]","endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; flight behavior [GO:0007629]; follicle cell of egg chamber development [GO:0030707]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; intracellular calcium ion homeostasis [GO:0006874]; neuromuscular synaptic transmission [GO:0007274]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]","","","",""
"404","sp|Q5U2X5|ACK1_RAT","lcl|NC_088855.1_cds_XP_034339016.2_16540",0,573,"Q5U2X5","ACK1_RAT","Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Tyrosine kinase non-receptor protein 2)","Tnk2 Ack1","Rattus norvegicus (Rat)",1040,"GO:0004674; GO:0004712; GO:0004713; GO:0004715; GO:0005154; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005886; GO:0005905; GO:0005912; GO:0006897; GO:0007165; GO:0007286; GO:0016310; GO:0030136; GO:0030424; GO:0030425; GO:0030426; GO:0030659; GO:0031625; GO:0042802; GO:0043025; GO:0046872; GO:0050699; GO:0070436; GO:0097268; GO:0099523; GO:0099524; GO:0106310; GO:2000369","endocytosis [GO:0006897]; phosphorylation [GO:0016310]; regulation of clathrin-dependent endocytosis [GO:2000369]; signal transduction [GO:0007165]; spermatid development [GO:0007286]","adherens junction [GO:0005912]; axon [GO:0030424]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; endosome [GO:0005768]; Grb2-EGFR complex [GO:0070436]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; endocytosis [GO:0006897]; phosphorylation [GO:0016310]; regulation of clathrin-dependent endocytosis [GO:2000369]; signal transduction [GO:0007165]; spermatid development [GO:0007286]","","","",""
"405","sp|Q22307|DHX9_CAEEL","lcl|NC_088855.1_cds_XP_034339033.2_16589",0,950,"Q22307","DHX9_CAEEL","ATP-dependent RNA helicase A (EC 3.6.4.13) (Nuclear DNA helicase II) (NDH II)","rha-1 T07D4.3","Caenorhabditis elegans",1301,"GO:0003678; GO:0003690; GO:0003723; GO:0003724; GO:0003725; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0006260; GO:0006325; GO:0006353; GO:0006397; GO:0006417; GO:0007281; GO:0008380; GO:0016887; GO:0031047; GO:0043138; GO:0045814; GO:0045944; GO:0046872; GO:0050684; GO:0051028; GO:0051301; GO:1990904","cell division [GO:0051301]; chromatin organization [GO:0006325]; DNA replication [GO:0006260]; DNA-templated transcription termination [GO:0006353]; germ cell development [GO:0007281]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of gene expression, epigenetic [GO:0045814]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mRNA processing [GO:0050684]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; RNA splicing [GO:0008380]","centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell division [GO:0051301]; chromatin organization [GO:0006325]; DNA replication [GO:0006260]; DNA-templated transcription termination [GO:0006353]; germ cell development [GO:0007281]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of gene expression, epigenetic [GO:0045814]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mRNA processing [GO:0050684]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; RNA splicing [GO:0008380]","","","","TISSUE SPECIFICITY: Expressed in the pachytene region of the gonad and in the oocytes. {ECO:0000269|PubMed:15817227}."
"406","sp|Q924H5|RA51C_MOUSE","lcl|NC_088855.1_cds_XP_034339038.2_16586",6.43e-129,375,"Q924H5","RA51C_MOUSE","DNA repair protein RAD51 homolog 3 (R51H3) (RAD51 homolog C) (RAD51-like protein 2)","Rad51c Rad51l2","Mus musculus (Mouse)",366,"GO:0000400; GO:0000722; GO:0000724; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005739; GO:0005829; GO:0006281; GO:0007066; GO:0007131; GO:0007141; GO:0007283; GO:0008821; GO:0010971; GO:0030054; GO:0033063; GO:0033065; GO:0048471; GO:0048476; GO:0140664","DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; female meiosis sister chromatid cohesion [GO:0007066]; male meiosis I [GO:0007141]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722]","cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Holliday junction resolvase complex [GO:0048476]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; Rad51C-XRCC3 complex [GO:0033065]; replication fork [GO:0005657]; ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; crossover junction DNA endonuclease activity [GO:0008821]; four-way junction DNA binding [GO:0000400]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; female meiosis sister chromatid cohesion [GO:0007066]; male meiosis I [GO:0007141]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722]","DEVELOPMENTAL STAGE: Expressed in embryos at various developmental stages. The expression is found to be higher between 11 and 15 days of gestation compared to day 7 or 17. {ECO:0000269|PubMed:11410366}.","","","TISSUE SPECIFICITY: Expressed in the heart, brain, spleen, lung, liver, kidney and testis but not detected in skeletal muscle. {ECO:0000269|PubMed:11410366}."
"407","sp|P29349|CSW_DROME","lcl|NC_088855.1_cds_XP_034339100.2_14045",8.85e-139,426,"P29349","CSW_DROME","Tyrosine-protein phosphatase corkscrew (EC 3.1.3.48)","csw CG3954","Drosophila melanogaster (Fruit fly)",845,"GO:0000165; GO:0000278; GO:0001784; GO:0004726; GO:0005068; GO:0005737; GO:0006911; GO:0007173; GO:0007362; GO:0007418; GO:0007424; GO:0007427; GO:0007444; GO:0007465; GO:0007498; GO:0008069; GO:0008293; GO:0008543; GO:0030154; GO:0042461; GO:0045314; GO:0045500","cell differentiation [GO:0030154]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc development [GO:0007444]; MAPK cascade [GO:0000165]; mesoderm development [GO:0007498]; mitotic cell cycle [GO:0000278]; open tracheal system development [GO:0007424]; phagocytosis, engulfment [GO:0006911]; photoreceptor cell development [GO:0042461]; R7 cell fate commitment [GO:0007465]; regulation of compound eye photoreceptor development [GO:0045314]; sevenless signaling pathway [GO:0045500]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; ventral midline development [GO:0007418]","cytoplasm [GO:0005737]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphotyrosine residue binding [GO:0001784]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; cell differentiation [GO:0030154]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc development [GO:0007444]; MAPK cascade [GO:0000165]; mesoderm development [GO:0007498]; mitotic cell cycle [GO:0000278]; open tracheal system development [GO:0007424]; phagocytosis, engulfment [GO:0006911]; photoreceptor cell development [GO:0042461]; R7 cell fate commitment [GO:0007465]; regulation of compound eye photoreceptor development [GO:0045314]; sevenless signaling pathway [GO:0045500]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; ventral midline development [GO:0007418]","DEVELOPMENTAL STAGE: Expressed throughout development. {ECO:0000269|PubMed:1638629}.","","","TISSUE SPECIFICITY: Expressed uniformly throughout all tissues during embryogenesis. {ECO:0000269|PubMed:1638629}."
"408","sp|P63094|GNAS2_MOUSE","lcl|NC_088855.1_cds_XP_034339346.1_12041",0,605,"P63094","GNAS2_MOUSE","Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (EC 3.6.5.-) (Adenylate cyclase-stimulating G alpha protein)","Gnas Gnas1 MNCb-5546","Mus musculus (Mouse)",394,"GO:0001501; GO:0001894; GO:0001958; GO:0003924; GO:0003925; GO:0005525; GO:0005834; GO:0005886; GO:0006112; GO:0007186; GO:0007189; GO:0007191; GO:0009410; GO:0009791; GO:0010854; GO:0010856; GO:0016020; GO:0030425; GO:0031683; GO:0032024; GO:0035116; GO:0035264; GO:0040032; GO:0043588; GO:0045669; GO:0045672; GO:0046872; GO:0047391; GO:0048701; GO:0051216; GO:0071377; GO:0071514; GO:0071880; GO:0120162; GO:2000828","adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cartilage development [GO:0051216]; cellular response to glucagon stimulus [GO:0071377]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic hindlimb morphogenesis [GO:0035116]; endochondral ossification [GO:0001958]; energy reserve metabolic process [GO:0006112]; G protein-coupled receptor signaling pathway [GO:0007186]; genomic imprinting [GO:0071514]; multicellular organism growth [GO:0035264]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of insulin secretion [GO:0032024]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast differentiation [GO:0045672]; post-embryonic body morphogenesis [GO:0040032]; post-embryonic development [GO:0009791]; regulation of parathyroid hormone secretion [GO:2000828]; response to xenobiotic stimulus [GO:0009410]; skeletal system development [GO:0001501]; skin development [GO:0043588]; tissue homeostasis [GO:0001894]","dendrite [GO:0030425]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; plasma membrane [GO:0005886]; adenylate cyclase activator activity [GO:0010856]; adenylate cyclase regulator activity [GO:0010854]; alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; G protein activity [GO:0003925]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cartilage development [GO:0051216]; cellular response to glucagon stimulus [GO:0071377]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic hindlimb morphogenesis [GO:0035116]; endochondral ossification [GO:0001958]; energy reserve metabolic process [GO:0006112]; G protein-coupled receptor signaling pathway [GO:0007186]; genomic imprinting [GO:0071514]; multicellular organism growth [GO:0035264]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of insulin secretion [GO:0032024]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast differentiation [GO:0045672]; post-embryonic body morphogenesis [GO:0040032]; post-embryonic development [GO:0009791]; regulation of parathyroid hormone secretion [GO:2000828]; response to xenobiotic stimulus [GO:0009410]; skeletal system development [GO:0001501]; skin development [GO:0043588]; tissue homeostasis [GO:0001894]","","","",""
"409","sp|P38533|HSF2_MOUSE","lcl|NC_088855.1_cds_XP_065933719.1_16104",5.89e-65,218,"P38533","HSF2_MOUSE","Heat shock factor protein 2 (HSF 2) (Heat shock transcription factor 2) (HSTF 2)","Hsf2","Mus musculus (Mouse)",535,"GO:0000978; GO:0001162; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0007283; GO:0042802; GO:0043565; GO:0045944","positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: In the 7-day-old testis, isoform beta is expressed at significantly higher levels than isoform alpha. As development proceeds, the levels of isoform alpha gradually increase so that it is the predominant isoform in mature testes. {ECO:0000269|PubMed:7565677}.","","","TISSUE SPECIFICITY: Isoform alpha is expressed predominantly in testis while isoform beta is expressed predominantly in heart and brain. {ECO:0000269|PubMed:7565677}."
"410","sp|P08253|MMP2_HUMAN","lcl|NC_088855.1_cds_XP_065933723.1_16669",4.83e-49,180,"P08253","MMP2_HUMAN","72 kDa type IV collagenase (EC 3.4.24.24) (72 kDa gelatinase) (Gelatinase A) (Matrix metalloproteinase-2) (MMP-2) (TBE-1) [Cleaved into: PEX]","MMP2 CLG4A","Homo sapiens (Human)",660,"GO:0001525; GO:0001541; GO:0001542; GO:0001553; GO:0001666; GO:0001955; GO:0001957; GO:0001968; GO:0004175; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0005634; GO:0005739; GO:0005886; GO:0006508; GO:0007162; GO:0007507; GO:0007567; GO:0008237; GO:0008270; GO:0009410; GO:0009612; GO:0014012; GO:0014823; GO:0016477; GO:0022617; GO:0030017; GO:0030163; GO:0030198; GO:0030335; GO:0030574; GO:0032526; GO:0034614; GO:0035094; GO:0035987; GO:0042542; GO:0043627; GO:0045906; GO:0048013; GO:0048246; GO:0048771; GO:0051602; GO:0055093; GO:0060325; GO:0060346; GO:0060740; GO:0061450; GO:0062023; GO:0071230; GO:0071347; GO:0071392; GO:0071492; GO:0071498; GO:1903378; GO:1904645; GO:1904707","angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; bone trabecula formation [GO:0060346]; cell migration [GO:0016477]; cellular response to amino acid stimulus [GO:0071230]; cellular response to estradiol stimulus [GO:0071392]; cellular response to fluid shear stress [GO:0071498]; cellular response to interleukin-1 [GO:0071347]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; endodermal cell differentiation [GO:0035987]; ephrin receptor signaling pathway [GO:0048013]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; heart development [GO:0007507]; intramembranous ossification [GO:0001957]; luteinization [GO:0001553]; macrophage chemotaxis [GO:0048246]; negative regulation of cell adhesion [GO:0007162]; negative regulation of vasoconstriction [GO:0045906]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; parturition [GO:0007567]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell migration [GO:0030335]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to activity [GO:0014823]; response to amyloid-beta [GO:1904645]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to nicotine [GO:0035094]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; tissue remodeling [GO:0048771]; trophoblast cell migration [GO:0061450]","collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; bone trabecula formation [GO:0060346]; cell migration [GO:0016477]; cellular response to amino acid stimulus [GO:0071230]; cellular response to estradiol stimulus [GO:0071392]; cellular response to fluid shear stress [GO:0071498]; cellular response to interleukin-1 [GO:0071347]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; endodermal cell differentiation [GO:0035987]; ephrin receptor signaling pathway [GO:0048013]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; heart development [GO:0007507]; intramembranous ossification [GO:0001957]; luteinization [GO:0001553]; macrophage chemotaxis [GO:0048246]; negative regulation of cell adhesion [GO:0007162]; negative regulation of vasoconstriction [GO:0045906]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; parturition [GO:0007567]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell migration [GO:0030335]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to activity [GO:0014823]; response to amyloid-beta [GO:1904645]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to nicotine [GO:0035094]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; tissue remodeling [GO:0048771]; trophoblast cell migration [GO:0061450]","","INDUCTION: Aspirin appears to inhibit expression. {ECO:0000269|PubMed:18971601}.","INDUCTION: Aspirin appears to inhibit expression. {ECO:0000269|PubMed:18971601}.","TISSUE SPECIFICITY: Produced by normal skin fibroblasts. PEX is expressed in a number of tumors including gliomas, breast and prostate. {ECO:0000269|PubMed:11751392}."
"411","sp|Q8TDI0|CHD5_HUMAN","lcl|NC_088855.1_cds_XP_065934158.1_11300",0,1541,"Q8TDI0","CHD5_HUMAN","Chromodomain-helicase-DNA-binding protein 5 (CHD-5) (EC 3.6.4.-) (ATP-dependent helicase CHD5)","CHD5 KIAA0444","Homo sapiens (Human)",1954,"GO:0000785; GO:0000792; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006357; GO:0008270; GO:0008285; GO:0016020; GO:0016581; GO:0016607; GO:0016887; GO:0021895; GO:0035092; GO:0042393; GO:0061628; GO:0140658; GO:1901798","cerebral cortex neuron differentiation [GO:0021895]; chromatin remodeling [GO:0006338]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of transcription by RNA polymerase II [GO:0006357]; sperm DNA condensation [GO:0035092]","chromatin [GO:0000785]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; histone H3K27me3 reader activity [GO:0061628]; zinc ion binding [GO:0008270]; cerebral cortex neuron differentiation [GO:0021895]; chromatin remodeling [GO:0006338]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of transcription by RNA polymerase II [GO:0006357]; sperm DNA condensation [GO:0035092]","","","","TISSUE SPECIFICITY: Preferentially expressed in total brain, fetal brain, and cerebellum. It is also moderately expressed in the adrenal gland and detected in testis. {ECO:0000269|PubMed:12592387, ECO:0000269|PubMed:21931736}."
"412","sp|P42345|MTOR_HUMAN","lcl|NC_088855.1_cds_XP_065934317.1_11725",0,3153,"P42345","MTOR_HUMAN","Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1) (Tyrosine-protein kinase mTOR) (EC 2.7.10.2)","MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1","Homo sapiens (Human)",2549,"GO:0000139; GO:0000822; GO:0001002; GO:0001003; GO:0001006; GO:0001156; GO:0001558; GO:0002296; GO:0003007; GO:0003179; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0006112; GO:0006207; GO:0006954; GO:0006974; GO:0007010; GO:0007281; GO:0008361; GO:0009267; GO:0009408; GO:0009615; GO:0009791; GO:0010507; GO:0010592; GO:0010718; GO:0010831; GO:0012505; GO:0016020; GO:0016236; GO:0016241; GO:0016242; GO:0016605; GO:0019228; GO:0030307; GO:0030425; GO:0030838; GO:0031295; GO:0031529; GO:0031641; GO:0031648; GO:0031667; GO:0031669; GO:0031670; GO:0031929; GO:0031931; GO:0031932; GO:0032869; GO:0032956; GO:0033173; GO:0034198; GO:0035264; GO:0038202; GO:0038203; GO:0042752; GO:0042802; GO:0043022; GO:0043066; GO:0043200; GO:0043276; GO:0044325; GO:0045335; GO:0045670; GO:0045727; GO:0045792; GO:0045821; GO:0045945; GO:0045948; GO:0046627; GO:0046889; GO:0048266; GO:0048709; GO:0048714; GO:0050821; GO:0050882; GO:0051219; GO:0051496; GO:0051549; GO:0051897; GO:0055013; GO:0060048; GO:0061431; GO:0070885; GO:0071230; GO:0071233; GO:0071456; GO:0071470; GO:0090559; GO:0097700; GO:0106310; GO:1900034; GO:1900181; GO:1901796; GO:1901838; GO:1902554; GO:1903691; GO:1904059; GO:1904690; GO:1905671; GO:1905672; GO:1905857; GO:1990253; GO:2000060; GO:2000785","'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; anoikis [GO:0043276]; behavioral response to pain [GO:0048266]; calcineurin-NFAT signaling cascade [GO:0033173]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to L-leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to methionine [GO:0061431]; cellular response to nutrient [GO:0031670]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; cytoskeleton organization [GO:0007010]; DNA damage response [GO:0006974]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; inflammatory response [GO:0006954]; macroautophagy [GO:0016236]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lysosome organization [GO:1905672]; negative regulation of macroautophagy [GO:0016242]; negative regulation of protein localization to nucleus [GO:1900181]; neuronal action potential [GO:0019228]; oligodendrocyte differentiation [GO:0048709]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of glycolytic process [GO:0045821]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of autophagosome assembly [GO:2000785]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of locomotor rhythm [GO:1904059]; regulation of lysosome organization [GO:1905671]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to amino acid [GO:0043200]; response to heat [GO:0009408]; response to nutrient levels [GO:0031667]; response to virus [GO:0009615]; ruffle organization [GO:0031529]; T cell costimulation [GO:0031295]; T-helper 1 cell lineage commitment [GO:0002296]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; TORC2 signaling [GO:0038203]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]; voluntary musculoskeletal movement [GO:0050882]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; PML body [GO:0016605]; serine/threonine protein kinase complex [GO:1902554]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; inositol hexakisphosphate binding [GO:0000822]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]; transmembrane transporter binding [GO:0044325]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; anoikis [GO:0043276]; behavioral response to pain [GO:0048266]; calcineurin-NFAT signaling cascade [GO:0033173]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to L-leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to methionine [GO:0061431]; cellular response to nutrient [GO:0031670]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; cytoskeleton organization [GO:0007010]; DNA damage response [GO:0006974]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; inflammatory response [GO:0006954]; macroautophagy [GO:0016236]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lysosome organization [GO:1905672]; negative regulation of macroautophagy [GO:0016242]; negative regulation of protein localization to nucleus [GO:1900181]; neuronal action potential [GO:0019228]; oligodendrocyte differentiation [GO:0048709]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of glycolytic process [GO:0045821]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of autophagosome assembly [GO:2000785]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of locomotor rhythm [GO:1904059]; regulation of lysosome organization [GO:1905671]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to amino acid [GO:0043200]; response to heat [GO:0009408]; response to nutrient levels [GO:0031667]; response to virus [GO:0009615]; ruffle organization [GO:0031529]; T cell costimulation [GO:0031295]; T-helper 1 cell lineage commitment [GO:0002296]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; TORC2 signaling [GO:0038203]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]; voluntary musculoskeletal movement [GO:0050882]","","","","TISSUE SPECIFICITY: Expressed in numerous tissues, with highest levels in testis. {ECO:0000269|PubMed:12408816, ECO:0000269|PubMed:7809080}."
"413","sp|E9PSL7|CTRO_RAT","lcl|NC_088855.1_cds_XP_065934408.1_11993",2.76e-146,506,"E9PSL7","CTRO_RAT","Citron rho-interacting kinase (CRIK) (EC 2.7.11.1) (Rho-interacting, serine/threonine-protein kinase 21)","Cit CRIK","Rattus norvegicus (Rat)",2055,"GO:0000070; GO:0000086; GO:0000278; GO:0000281; GO:0001223; GO:0001726; GO:0001889; GO:0004674; GO:0005524; GO:0005737; GO:0005773; GO:0005829; GO:0007030; GO:0007091; GO:0007214; GO:0007283; GO:0008064; GO:0008270; GO:0015629; GO:0016358; GO:0019901; GO:0030165; GO:0030291; GO:0030496; GO:0031985; GO:0032154; GO:0032467; GO:0032956; GO:0035331; GO:0043025; GO:0048699; GO:0050774; GO:0051402; GO:0097110; GO:0097119; GO:0098982; GO:0099092; GO:0099188; GO:0099573; GO:0106310","dendrite development [GO:0016358]; G2/M transition of mitotic cell cycle [GO:0000086]; gamma-aminobutyric acid signaling pathway [GO:0007214]; generation of neurons [GO:0048699]; Golgi organization [GO:0007030]; liver development [GO:0001889]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of hippo signaling [GO:0035331]; neuron apoptotic process [GO:0051402]; positive regulation of cytokinesis [GO:0032467]; postsynaptic cytoskeleton organization [GO:0099188]; postsynaptic density protein 95 clustering [GO:0097119]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; spermatogenesis [GO:0007283]","actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; glutamatergic postsynaptic density [GO:0099573]; Golgi cisterna [GO:0031985]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; postsynaptic density, intracellular component [GO:0099092]; ruffle [GO:0001726]; vacuole [GO:0005773]; ATP binding [GO:0005524]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; scaffold protein binding [GO:0097110]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]; dendrite development [GO:0016358]; G2/M transition of mitotic cell cycle [GO:0000086]; gamma-aminobutyric acid signaling pathway [GO:0007214]; generation of neurons [GO:0048699]; Golgi organization [GO:0007030]; liver development [GO:0001889]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of hippo signaling [GO:0035331]; neuron apoptotic process [GO:0051402]; positive regulation of cytokinesis [GO:0032467]; postsynaptic cytoskeleton organization [GO:0099188]; postsynaptic density protein 95 clustering [GO:0097119]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; spermatogenesis [GO:0007283]","","","",""
"414","sp|P49025|CTRO_MOUSE","lcl|NC_088855.1_cds_XP_065934409.1_11995",1.79e-145,504,"P49025","CTRO_MOUSE","Citron Rho-interacting kinase (CRIK) (EC 2.7.11.1) (Rho-interacting, serine/threonine-protein kinase 21)","Cit Crik","Mus musculus (Mouse)",2055,"GO:0000070; GO:0000278; GO:0000281; GO:0001726; GO:0004674; GO:0005524; GO:0005737; GO:0005773; GO:0005829; GO:0007091; GO:0007283; GO:0008270; GO:0015629; GO:0016358; GO:0017124; GO:0030517; GO:0045665; GO:0048699; GO:0050774; GO:0051402; GO:0106310","dendrite development [GO:0016358]; generation of neurons [GO:0048699]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of axon extension [GO:0030517]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of neuron differentiation [GO:0045665]; neuron apoptotic process [GO:0051402]; spermatogenesis [GO:0007283]","actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle [GO:0001726]; vacuole [GO:0005773]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]; zinc ion binding [GO:0008270]; dendrite development [GO:0016358]; generation of neurons [GO:0048699]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of axon extension [GO:0030517]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of neuron differentiation [GO:0045665]; neuron apoptotic process [GO:0051402]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Detected at 10.5 dpc with highest expression in the developing central nervous system. After 16.5 dpc expression decreases and at two weeks after birth is restricted to the proliferating neuronal precursor cells in the external germinal layer of the cerebellum and subventricular migratory stream. {ECO:0000269|PubMed:11086988}.","","","TISSUE SPECIFICITY: A major signal was observed in testis and brain, but it was also detected in thymus, spleen, kidney, heart and lung. {ECO:0000269|PubMed:11086988, ECO:0000269|PubMed:9792683}."
"415","sp|Q99MI9|ANM7_CRILO","lcl|NC_088855.1_cds_XP_065934484.1_12126",0,543,"Q99MI9","ANM7_CRILO","Protein arginine N-methyltransferase 7 (EC 2.1.1.321) (Histone-arginine N-methyltransferase PRMT7) ([Myelin basic protein]-arginine N-methyltransferase PRMT7)","Prmt7","Cricetulus longicaudatus (Long-tailed dwarf hamster)",692,"GO:0000387; GO:0005634; GO:0005829; GO:0018216; GO:0035241; GO:0035243; GO:0044020; GO:0071514","genomic imprinting [GO:0071514]; peptidyl-arginine methylation [GO:0018216]; spliceosomal snRNP assembly [GO:0000387]","cytosol [GO:0005829]; nucleus [GO:0005634]; histone H4R3 methyltransferase activity [GO:0044020]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; genomic imprinting [GO:0071514]; peptidyl-arginine methylation [GO:0018216]; spliceosomal snRNP assembly [GO:0000387]","","","",""
"416","sp|Q8L7Y8|KN12B_ARATH","lcl|NC_088855.1_cds_XP_065934494.1_12160",2.3e-103,358,"Q8L7Y8","KN12B_ARATH","Kinesin-like protein KIN-12B (Phragmoplast-associated kinesin-related protein 1-like protein) (AtPAKRP1L)","KIN12B PAKRP1L At3g23670 MDB19.16","Arabidopsis thaliana (Mouse-ear cress)",1313,"GO:0003777; GO:0005524; GO:0005874; GO:0007018; GO:0007112; GO:0008017; GO:0009524; GO:0055046; GO:0080175","male meiosis cytokinesis [GO:0007112]; microgametogenesis [GO:0055046]; microtubule-based movement [GO:0007018]; phragmoplast microtubule organization [GO:0080175]","microtubule [GO:0005874]; phragmoplast [GO:0009524]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; male meiosis cytokinesis [GO:0007112]; microgametogenesis [GO:0055046]; microtubule-based movement [GO:0007018]; phragmoplast microtubule organization [GO:0080175]","","","",""
"417","sp|Q9LDN0|KN12A_ARATH","lcl|NC_088855.1_cds_XP_065934495.1_12159",3.46e-98,343,"Q9LDN0","KN12A_ARATH","Kinesin-like protein KIN-12A (Phragmoplast-associated kinesin-related protein 1) (AtPAKRP1)","KIN12A PAKRP1 At4g14150 dl3115c FCAALL.159","Arabidopsis thaliana (Mouse-ear cress)",1292,"GO:0003777; GO:0005524; GO:0005874; GO:0007018; GO:0007112; GO:0008017; GO:0009507; GO:0009524; GO:0055046; GO:0080175","male meiosis cytokinesis [GO:0007112]; microgametogenesis [GO:0055046]; microtubule-based movement [GO:0007018]; phragmoplast microtubule organization [GO:0080175]","chloroplast [GO:0009507]; microtubule [GO:0005874]; phragmoplast [GO:0009524]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; male meiosis cytokinesis [GO:0007112]; microgametogenesis [GO:0055046]; microtubule-based movement [GO:0007018]; phragmoplast microtubule organization [GO:0080175]","","","",""
"418","sp|Q7K2X8|SEH1_DROME","lcl|NC_088855.1_cds_XP_065934516.1_12191",1.33e-121,355,"Q7K2X8","SEH1_DROME","Nucleoporin seh1 (GATOR complex protein seh1) (Nucleoporin complex protein 44A)","Nup44A seh1 CG8722","Drosophila melanogaster (Fruit fly)",354,"GO:0005198; GO:0005635; GO:0005764; GO:0007293; GO:0007346; GO:0010507; GO:0010508; GO:0015031; GO:0031080; GO:0032008; GO:0032991; GO:0034198; GO:0035859; GO:0044754; GO:0045793; GO:0048477; GO:0051301; GO:0051321; GO:0051445; GO:0061700; GO:1904263","cell division [GO:0051301]; cellular response to amino acid starvation [GO:0034198]; germarium-derived egg chamber formation [GO:0007293]; meiotic cell cycle [GO:0051321]; negative regulation of autophagy [GO:0010507]; oogenesis [GO:0048477]; positive regulation of autophagy [GO:0010508]; positive regulation of cell size [GO:0045793]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein transport [GO:0015031]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]","autolysosome [GO:0044754]; GATOR2 complex [GO:0061700]; lysosome [GO:0005764]; nuclear envelope [GO:0005635]; nuclear pore outer ring [GO:0031080]; protein-containing complex [GO:0032991]; Seh1-associated complex [GO:0035859]; structural molecule activity [GO:0005198]; cell division [GO:0051301]; cellular response to amino acid starvation [GO:0034198]; germarium-derived egg chamber formation [GO:0007293]; meiotic cell cycle [GO:0051321]; negative regulation of autophagy [GO:0010507]; oogenesis [GO:0048477]; positive regulation of autophagy [GO:0010508]; positive regulation of cell size [GO:0045793]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein transport [GO:0015031]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]","","","","TISSUE SPECIFICITY: Expressed in ovarian cysts. {ECO:0000269|PubMed:21521741}."
"419","sp|Q9Y2E8|SL9A8_HUMAN","lcl|NC_088855.1_cds_XP_065934563.1_12301",0,526,"Q9Y2E8","SL9A8_HUMAN","Sodium/hydrogen exchanger 8 (Na(+)/H(+) exchanger 8) (NHE-8) (Solute carrier family 9 member 8)","SLC9A8 KIAA0939 NHE8","Homo sapiens (Human)",581,"GO:0000139; GO:0001669; GO:0001675; GO:0006811; GO:0015385; GO:0015386; GO:0016324; GO:0032585; GO:0032588; GO:0035725; GO:0051453; GO:0071805; GO:1902600; GO:1905526","acrosome assembly [GO:0001675]; monoatomic ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; proton transmembrane transport [GO:1902600]; regulation of Golgi lumen acidification [GO:1905526]; regulation of intracellular pH [GO:0051453]; sodium ion transmembrane transport [GO:0035725]","acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; Golgi membrane [GO:0000139]; multivesicular body membrane [GO:0032585]; trans-Golgi network membrane [GO:0032588]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; acrosome assembly [GO:0001675]; monoatomic ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; proton transmembrane transport [GO:1902600]; regulation of Golgi lumen acidification [GO:1905526]; regulation of intracellular pH [GO:0051453]; sodium ion transmembrane transport [GO:0035725]","","","","TISSUE SPECIFICITY: Ubiquitous. Strongly expressed in skeletal muscle and kidney (PubMed:15522866). Detected throughout the entire gastrointestinal tract, with high expression detected in stomach, duodenum and ascending colon (PubMed:18209477). {ECO:0000269|PubMed:15522866, ECO:0000269|PubMed:18209477}."
"420","sp|Q9BX63|FANCJ_HUMAN","lcl|NC_088855.1_cds_XP_065934696.1_12649",0,639,"Q9BX63","FANCJ_HUMAN","Fanconi anemia group J protein (EC 5.6.2.3) (BRCA1-associated C-terminal helicase 1) (BRCA1-interacting protein C-terminal helicase 1) (BRCA1-interacting protein 1) (DNA 5'-3' helicase FANCJ)","BRIP1 BACH1 FANCJ","Homo sapiens (Human)",1249,"GO:0000077; GO:0003677; GO:0003678; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0006281; GO:0006289; GO:0006302; GO:0006357; GO:0007284; GO:0007286; GO:0010705; GO:0016887; GO:0031965; GO:0035825; GO:0043139; GO:0046872; GO:0051026; GO:0051539; GO:0070532; GO:0072520; GO:0106300; GO:0140640; GO:1990918","chiasma assembly [GO:0051026]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; homologous recombination [GO:0035825]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; nucleotide-excision repair [GO:0006289]; protein-DNA covalent cross-linking repair [GO:0106300]; regulation of transcription by RNA polymerase II [GO:0006357]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284]","BRCA1-B complex [GO:0070532]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; 4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; catalytic activity, acting on a nucleic acid [GO:0140640]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]; chiasma assembly [GO:0051026]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; homologous recombination [GO:0035825]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; nucleotide-excision repair [GO:0006289]; protein-DNA covalent cross-linking repair [GO:0106300]; regulation of transcription by RNA polymerase II [GO:0006357]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284]","","","","TISSUE SPECIFICITY: Ubiquitously expressed, with highest levels in testis. {ECO:0000269|PubMed:11301010}."
"421","sp|Q24298|CADE_DROME","lcl|NC_088855.1_cds_XP_065934772.1_12837",8.34e-113,397,"Q24298","CADE_DROME","DE-cadherin (Protein shotgun)","shg E-cadherin CG3722","Drosophila melanogaster (Fruit fly)",1507,"GO:0000902; GO:0001738; GO:0001745; GO:0001748; GO:0003151; GO:0005509; GO:0005886; GO:0005912; GO:0005914; GO:0005938; GO:0007155; GO:0007156; GO:0007281; GO:0007298; GO:0007370; GO:0007379; GO:0007399; GO:0007409; GO:0007420; GO:0007424; GO:0007435; GO:0007506; GO:0007507; GO:0008013; GO:0008258; GO:0008354; GO:0008356; GO:0008406; GO:0010004; GO:0016318; GO:0016324; GO:0016339; GO:0016342; GO:0017022; GO:0030031; GO:0030175; GO:0030720; GO:0035019; GO:0035099; GO:0035147; GO:0035160; GO:0035212; GO:0035262; GO:0036099; GO:0042060; GO:0042803; GO:0043296; GO:0044331; GO:0045176; GO:0045186; GO:0046427; GO:0048477; GO:0055037; GO:0071907; GO:0090254; GO:0098609; GO:0098730; GO:1903688","apical protein localization [GO:0045176]; asymmetric cell division [GO:0008356]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; brain development [GO:0007420]; branch fusion, open tracheal system [GO:0035147]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell competition in a multicellular organism [GO:0035212]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; compound eye morphogenesis [GO:0001745]; determination of digestive tract left/right asymmetry [GO:0071907]; female germ-line stem cell population maintenance [GO:0036099]; gastrulation involving germ band extension [GO:0010004]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; gonad morphogenesis [GO:0035262]; gonadal mesoderm development [GO:0007506]; head involution [GO:0008258]; heart development [GO:0007507]; hemocyte migration [GO:0035099]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; insect visual primordium development [GO:0001748]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; male germline stem cell symmetric division [GO:0098730]; morphogenesis of a polarized epithelium [GO:0001738]; nervous system development [GO:0007399]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; outflow tract morphogenesis [GO:0003151]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; salivary gland morphogenesis [GO:0007435]; segment specification [GO:0007379]; somatic stem cell population maintenance [GO:0035019]; ventral furrow formation [GO:0007370]; wound healing [GO:0042060]; zonula adherens assembly [GO:0045186]","adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; filopodium [GO:0030175]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; spot adherens junction [GO:0005914]; beta-catenin binding [GO:0008013]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; protein homodimerization activity [GO:0042803]; apical protein localization [GO:0045176]; asymmetric cell division [GO:0008356]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; brain development [GO:0007420]; branch fusion, open tracheal system [GO:0035147]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell competition in a multicellular organism [GO:0035212]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; compound eye morphogenesis [GO:0001745]; determination of digestive tract left/right asymmetry [GO:0071907]; female germ-line stem cell population maintenance [GO:0036099]; gastrulation involving germ band extension [GO:0010004]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; gonad morphogenesis [GO:0035262]; gonadal mesoderm development [GO:0007506]; head involution [GO:0008258]; heart development [GO:0007507]; hemocyte migration [GO:0035099]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; insect visual primordium development [GO:0001748]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; male germline stem cell symmetric division [GO:0098730]; morphogenesis of a polarized epithelium [GO:0001738]; nervous system development [GO:0007399]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; outflow tract morphogenesis [GO:0003151]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; salivary gland morphogenesis [GO:0007435]; segment specification [GO:0007379]; somatic stem cell population maintenance [GO:0035019]; ventral furrow formation [GO:0007370]; wound healing [GO:0042060]; zonula adherens assembly [GO:0045186]","","","","TISSUE SPECIFICITY: In early stage 9 and stage 10 oocytes, expressed in border cells, strongly expressed in polar cells and very weakly expressed in the nurse cells (at protein level) (PubMed:24855950). In the embryo, expressed in the leading edge cells of the dorsal epidermis (at protein level) (PubMed:16831834, PubMed:30763317). Stage 10 embryos exhibit intense expression in epithelial cells (PubMed:7958432). Stage 14 embryos show expression in the hindgut (at the apical poles of cell-cell boundaries), at the apical junctions of tracheal cells and in the dorsal longitudinal trunk (PubMed:7958432). In stage 16 embryos the glial midline cells of the central nervous system show strong expression (PubMed:7958432). {ECO:0000269|PubMed:16831834, ECO:0000269|PubMed:24855950, ECO:0000269|PubMed:30763317, ECO:0000269|PubMed:7958432}."
"422","sp|Q3V0F0|RIMB3_MOUSE","lcl|NC_088855.1_cds_XP_065934803.1_12929",6.79e-33,141,"Q3V0F0","RIMB3_MOUSE","RIMS-binding protein 3 (RIM-BP3)","Rimbp3 Gm603 Kiaa1666","Mus musculus (Mouse)",1606,"GO:0005634; GO:0005737; GO:0005856; GO:0007286; GO:0009566","fertilization [GO:0009566]; spermatid development [GO:0007286]","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; fertilization [GO:0009566]; spermatid development [GO:0007286]","DEVELOPMENTAL STAGE: Detected in testis from postnatal day 20 onwards (at protein level). In developing spermatozoa, weakly expressed in pachytene spermatocytes and round spermatids, and highly expressed in elongating spermatids (at protein level). Detected in residual bodies but not mature sperm (at protein level). {ECO:0000269|PubMed:19091768}.","","","TISSUE SPECIFICITY: Specifically expressed in testis, where it localizes to postmeiotic germ cells (at protein level). {ECO:0000269|PubMed:19091768}."
"423","sp|A6NJZ7|RIM3C_HUMAN","lcl|NC_088855.1_cds_XP_065934806.1_12924",9.11e-37,154,"A6NJZ7","RIM3C_HUMAN","RIMS-binding protein 3C (RIM-BP3.C) (RIMS-binding protein 3.3) (RIM-BP3.3)","RIMBP3C","Homo sapiens (Human)",1639,"GO:0005634; GO:0005737; GO:0005856; GO:0007286; GO:0009566; GO:0030156","fertilization [GO:0009566]; spermatid development [GO:0007286]","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; benzodiazepine receptor binding [GO:0030156]; fertilization [GO:0009566]; spermatid development [GO:0007286]","","","",""
"424","sp|Q9W3Y4|GA2PE_DROME","lcl|NC_088855.1_cds_XP_065934823.1_12952",1.59e-78,282,"Q9W3Y4","GA2PE_DROME","GAS2-like protein pickled eggs","pigs CG3973","Drosophila melanogaster (Fruit fly)",977,"GO:0001578; GO:0005737; GO:0005856; GO:0005938; GO:0008017; GO:0016255; GO:0030707; GO:0030713; GO:0031110; GO:0045746; GO:0051015; GO:0051764; GO:1904825","actin crosslink formation [GO:0051764]; attachment of GPI anchor to protein [GO:0016255]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber stalk formation [GO:0030713]; microtubule bundle formation [GO:0001578]; negative regulation of Notch signaling pathway [GO:0045746]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization or depolymerization [GO:0031110]","cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; microtubule binding [GO:0008017]; actin crosslink formation [GO:0051764]; attachment of GPI anchor to protein [GO:0016255]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber stalk formation [GO:0030713]; microtubule bundle formation [GO:0001578]; negative regulation of Notch signaling pathway [GO:0045746]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization or depolymerization [GO:0031110]","","","","TISSUE SPECIFICITY: Expressed in the ovary and the ring canals of the germline cells. In larvae, expressed in the notal region of the wing disk. {ECO:0000269|PubMed:20150280}."
"425","sp|P08181|CSK2A_DROME","lcl|NC_088855.1_cds_XP_065934857.1_13082",0,543,"P08181","CSK2A_DROME","Casein kinase II subunit alpha (CK II subunit alpha) (EC 2.7.11.1)","CkIIalpha Cask-II-a CG17520","Drosophila melanogaster (Fruit fly)",336,"GO:0000278; GO:0002118; GO:0004674; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005956; GO:0006974; GO:0007310; GO:0007623; GO:0016055; GO:0022416; GO:0031647; GO:0032435; GO:0045475; GO:0045880; GO:0046331; GO:0048749; GO:0051726; GO:0060810; GO:0106310","aggressive behavior [GO:0002118]; chaeta development [GO:0022416]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; DNA damage response [GO:0006974]; intracellular mRNA localization involved in pattern specification process [GO:0060810]; lateral inhibition [GO:0046331]; locomotor rhythm [GO:0045475]; mitotic cell cycle [GO:0000278]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; oocyte dorsal/ventral axis specification [GO:0007310]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of cell cycle [GO:0051726]; regulation of protein stability [GO:0031647]; Wnt signaling pathway [GO:0016055]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein kinase CK2 complex [GO:0005956]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; aggressive behavior [GO:0002118]; chaeta development [GO:0022416]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; DNA damage response [GO:0006974]; intracellular mRNA localization involved in pattern specification process [GO:0060810]; lateral inhibition [GO:0046331]; locomotor rhythm [GO:0045475]; mitotic cell cycle [GO:0000278]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; oocyte dorsal/ventral axis specification [GO:0007310]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of cell cycle [GO:0051726]; regulation of protein stability [GO:0031647]; Wnt signaling pathway [GO:0016055]","","","",""
"426","sp|Q9VKV8|CFA20_DROME","lcl|NC_088855.1_cds_XP_065934869.1_13084",1.91e-136,383,"Q9VKV8","CFA20_DROME","Cilia- and flagella-associated protein 20 (Basal body up-regulated protein 22)","Bug22 CFAP20 CG5343","Drosophila melanogaster (Fruit fly)",199,"GO:0000398; GO:0005634; GO:0005730; GO:0005814; GO:0005879; GO:0005929; GO:0007288; GO:0007291; GO:0018094; GO:0031514; GO:0036064; GO:0036126; GO:0040011; GO:0044782; GO:0060271; GO:0060296; GO:0071011; GO:0071013; GO:1902093; GO:2000147","cilium assembly [GO:0060271]; cilium organization [GO:0044782]; locomotion [GO:0040011]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cell motility [GO:2000147]; positive regulation of flagellated sperm motility [GO:1902093]; protein polyglycylation [GO:0018094]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; sperm axoneme assembly [GO:0007288]; sperm individualization [GO:0007291]","axonemal microtubule [GO:0005879]; catalytic step 2 spliceosome [GO:0071013]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; motile cilium [GO:0031514]; nucleolus [GO:0005730]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; locomotion [GO:0040011]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cell motility [GO:2000147]; positive regulation of flagellated sperm motility [GO:1902093]; protein polyglycylation [GO:0018094]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; sperm axoneme assembly [GO:0007288]; sperm individualization [GO:0007291]","","","","TISSUE SPECIFICITY: Expressed in spermatocytes and chordotonal organs in sensory neurons of the antenna. {ECO:0000269|PubMed:24414207}."
"427","sp|P07314|GGT1_RAT","lcl|NC_088855.1_cds_XP_065934969.1_13343",2e-171,500,"P07314","GGT1_RAT","Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]","Ggt1 Ggt","Rattus norvegicus (Rat)",568,"GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006691; GO:0006750; GO:0006751; GO:0007283; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0103068; GO:1901750","amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638]","extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; aminoacyltransferase activity [GO:0016755]; glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048]; amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638]","","","","TISSUE SPECIFICITY: Detected in adult kidney and mammary gland, and in fetal liver. {ECO:0000269|PubMed:2869484}."
"428","sp|Q99MH6|NKD1_MOUSE","lcl|NC_088855.1_cds_XP_065935025.1_13444",5.38e-22,100,"Q99MH6","NKD1_MOUSE","Protein naked cuticle homolog 1 (Naked-1) (mNkd) (mNkd1)","Nkd1","Mus musculus (Mouse)",471,"GO:0000159; GO:0003401; GO:0005509; GO:0005737; GO:0005886; GO:0007283; GO:0016055; GO:0030154; GO:0030165; GO:0030178; GO:0043410; GO:0045732; GO:0060026; GO:0090090; GO:2000052; GO:2000096","axis elongation [GO:0003401]; cell differentiation [GO:0030154]; convergent extension [GO:0060026]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; spermatogenesis [GO:0007283]; Wnt signaling pathway [GO:0016055]","cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159]; calcium ion binding [GO:0005509]; PDZ domain binding [GO:0030165]; axis elongation [GO:0003401]; cell differentiation [GO:0030154]; convergent extension [GO:0060026]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; spermatogenesis [GO:0007283]; Wnt signaling pathway [GO:0016055]","DEVELOPMENTAL STAGE: Expressed throughout embryonic development. Expressed in the presomitic mesoderm (PSM) and the neural folds along the entire rostrocaudal axis at 8.5 days post-coitum (dpc). Expressed in the forelimb buds, the branchial arches, and at the anterior and posterior of each somite boundary at 9.5 dpc. Expressed in the neural tube, the PSM, somites and the dorsal limb bud mesenchyme at 10.5 dpc. At 11.5 dpc three distinct phases of expression can be seen; expression is initially low in the tailbud, rises in the PSM and then shifts anteriorly. These oscillations require the activity of HES7. {ECO:0000269|PubMed:11274398, ECO:0000269|PubMed:11356022, ECO:0000269|PubMed:15511637, ECO:0000269|PubMed:17438140}.","INDUCTION: Expression is induced by activation of the Wnt signaling pathway. {ECO:0000269|PubMed:11274398, ECO:0000269|PubMed:16488995}.","INDUCTION: Expression is induced by activation of the Wnt signaling pathway. {ECO:0000269|PubMed:11274398, ECO:0000269|PubMed:16488995}.","TISSUE SPECIFICITY: Highly expressed in lung. Also expressed in brain, heart, kidney, liver, skin, stomach and testis. Within the testis expression is found in the seminiferous epithelium and round and elongating spermatids. {ECO:0000269|PubMed:11274398, ECO:0000269|PubMed:11356022, ECO:0000269|PubMed:15546883}."
"429","sp|G5E8Z2|TAF4B_MOUSE","lcl|NC_088855.1_cds_XP_065935048.1_13492",3.54e-78,273,"G5E8Z2","TAF4B_MOUSE","Transcription initiation factor TFIID subunit 4B (Transcription initiation factor TFIID 105 kDa subunit) (TAF(II)105) (TAFII-105) (TAFII105)","Taf4b Taf2c2 Tafii105","Mus musculus (Mouse)",850,"GO:0005634; GO:0005667; GO:0005669; GO:0005737; GO:0006357; GO:0006366; GO:0007283; GO:0042789; GO:0046982; GO:0048477; GO:0051123; GO:0060261; GO:2000648","mRNA transcription by RNA polymerase II [GO:0042789]; oogenesis [GO:0048477]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription regulator complex [GO:0005667]; protein heterodimerization activity [GO:0046982]; mRNA transcription by RNA polymerase II [GO:0042789]; oogenesis [GO:0048477]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]","","","","TISSUE SPECIFICITY: Highly expressed in the testes and ovary, whereas lower levels are detected in most other tissues. {ECO:0000269|PubMed:11557891}."
"430","sp|P50093|PHB2_CAEEL","lcl|NC_088855.1_cds_XP_065935054.1_13534",1.49e-120,348,"P50093","PHB2_CAEEL","Mitochondrial prohibitin complex protein 2 (Prohibitin-2)","phb-2 T24H7.1","Caenorhabditis elegans",294,"GO:0000423; GO:0002082; GO:0005739; GO:0005743; GO:0005886; GO:0006979; GO:0007005; GO:0007283; GO:0008406; GO:0009792; GO:0009986; GO:0030421; GO:0031966; GO:0035632; GO:0040018; GO:0042803; GO:0043051; GO:0048477; GO:0050821","defecation [GO:0030421]; embryo development ending in birth or egg hatching [GO:0009792]; gonad development [GO:0008406]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; oogenesis [GO:0048477]; positive regulation of multicellular organism growth [GO:0040018]; protein stabilization [GO:0050821]; regulation of nematode pharyngeal pumping [GO:0043051]; regulation of oxidative phosphorylation [GO:0002082]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]","cell surface [GO:0009986]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial prohibitin complex [GO:0035632]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803]; defecation [GO:0030421]; embryo development ending in birth or egg hatching [GO:0009792]; gonad development [GO:0008406]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; oogenesis [GO:0048477]; positive regulation of multicellular organism growth [GO:0040018]; protein stabilization [GO:0050821]; regulation of nematode pharyngeal pumping [GO:0043051]; regulation of oxidative phosphorylation [GO:0002082]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]","","","",""
"431","sp|Q9VVX5|MBOA5_DROME","lcl|NC_088855.1_cds_XP_065935060.1_13569",1.03e-93,293,"Q9VVX5","MBOA5_DROME","Lysophospholipid acyltransferase 5 (LPLAT 5) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylserine acyltransferase) (LPSAT) (Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 5) (O-acyltransferase domain-containing protein 5) (Protein nessy) (Nes)","nes nessy CG9655","Drosophila melanogaster (Fruit fly)",497,"GO:0005783; GO:0006656; GO:0007009; GO:0007291; GO:0008354; GO:0016020; GO:0030258; GO:0036152; GO:0047184; GO:0071617; GO:0106263","germ cell migration [GO:0008354]; lipid modification [GO:0030258]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; plasma membrane organization [GO:0007009]; sperm individualization [GO:0007291]","endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; lysophospholipid acyltransferase activity [GO:0071617]; germ cell migration [GO:0008354]; lipid modification [GO:0030258]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; plasma membrane organization [GO:0007009]; sperm individualization [GO:0007291]","DEVELOPMENTAL STAGE: Expressed throughout development with highest levels in adult females and preblastoderm embryos. {ECO:0000269|PubMed:10446276}.","","","TISSUE SPECIFICITY: During gastrulation, expressed mainly along the midline in the presumptive mesoderm. During germ band elongation, expressed in mesoderm and endoderm primordia and in the cephalic furrow. Expression in mesoderm and endoderm lineages continues during germ band shortening. At the end of this process, no longer detected in somatic mesoderm or endoderm layer with expression restricted to anterior and posterior domains of the visceral mesoderm. {ECO:0000269|PubMed:10446276}."
"432","sp|Q9V4S8|CSN7_DROME","lcl|NC_088855.1_cds_XP_065935127.1_13719",9.08e-57,184,"Q9V4S8","CSN7_DROME","COP9 signalosome complex subunit 7 (Dch7) (Signalosome subunit 7)","CSN7 CG2038","Drosophila melanogaster (Fruit fly)",278,"GO:0000338; GO:0005737; GO:0007281; GO:0008180; GO:0010387; GO:0034399; GO:0036099; GO:0048140; GO:0048142; GO:0050821","COP9 signalosome assembly [GO:0010387]; female germ-line stem cell population maintenance [GO:0036099]; germ cell development [GO:0007281]; germarium-derived cystoblast division [GO:0048142]; male germ-line cyst encapsulation [GO:0048140]; protein deneddylation [GO:0000338]; protein stabilization [GO:0050821]","COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; nuclear periphery [GO:0034399]; COP9 signalosome assembly [GO:0010387]; female germ-line stem cell population maintenance [GO:0036099]; germ cell development [GO:0007281]; germarium-derived cystoblast division [GO:0048142]; male germ-line cyst encapsulation [GO:0048140]; protein deneddylation [GO:0000338]; protein stabilization [GO:0050821]","","","",""
"433","sp|Q28068|CALI_BOVIN","lcl|NC_088855.1_cds_XP_065935152.1_13824",1.42e-32,134,"Q28068","CALI_BOVIN","Calicin","CCIN","Bos taurus (Bovine)",588,"GO:0005737; GO:0005856; GO:0007283; GO:0030154; GO:0031463; GO:0033150; GO:0043161; GO:1990756","cell differentiation [GO:0030154]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; spermatogenesis [GO:0007283]","Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeletal calyx [GO:0033150]; cytoskeleton [GO:0005856]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; cell differentiation [GO:0030154]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in testis and in spermatozoa (at protein level). {ECO:0000269|PubMed:7641791}."
"434","sp|G5EC24|PTP2_CAEEL","lcl|NC_088855.1_cds_XP_065935230.1_14050",1.2e-122,379,"G5EC24","PTP2_CAEEL","Tyrosine-protein phosphatase non-receptor type ptp-2 (EC 3.1.3.48) (Protein-tyrosine phosphatase 2)","ptp-2 F59G1.5","Caenorhabditis elegans",668,"GO:0000165; GO:0000278; GO:0001784; GO:0002119; GO:0004726; GO:0005737; GO:0007517; GO:0030154; GO:0031344; GO:0031410; GO:0040026; GO:0045742; GO:0046579; GO:0048477","cell differentiation [GO:0030154]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; muscle organ development [GO:0007517]; nematode larval development [GO:0002119]; oogenesis [GO:0048477]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of vulval development [GO:0040026]; regulation of cell projection organization [GO:0031344]","cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphotyrosine residue binding [GO:0001784]; cell differentiation [GO:0030154]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; muscle organ development [GO:0007517]; nematode larval development [GO:0002119]; oogenesis [GO:0048477]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of vulval development [GO:0040026]; regulation of cell projection organization [GO:0031344]","","","","TISSUE SPECIFICITY: Expressed in embryonic cells, developing vulva, body wall muscles, head neurons and gonadal sheath cells. {ECO:0000269|PubMed:20380830}."
"435","sp|Q9V4P1|ANLN_DROME","lcl|NC_088855.1_cds_XP_065935509.1_14772",1.86e-80,291,"Q9V4P1","ANLN_DROME","Anillin (Actin-binding protein 8) (ABP8) (Protein scraps)","scra ani CG2092","Drosophila melanogaster (Fruit fly)",1239,"GO:0000281; GO:0000915; GO:0003779; GO:0005634; GO:0005737; GO:0005826; GO:0007009; GO:0007105; GO:0007112; GO:0007279; GO:0007349; GO:0007423; GO:0008017; GO:0008104; GO:0008356; GO:0017022; GO:0030726; GO:0031106; GO:0031514; GO:0032154; GO:0032465; GO:0035323; GO:0042060; GO:0043063; GO:0044837; GO:0045035; GO:0045172; GO:0048477; GO:0051015; GO:0070938","actomyosin contractile ring assembly [GO:0000915]; actomyosin contractile ring organization [GO:0044837]; asymmetric cell division [GO:0008356]; cellularization [GO:0007349]; cytokinesis, division site positioning [GO:0007105]; intercellular bridge organization [GO:0043063]; male germline ring canal formation [GO:0030726]; male meiosis cytokinesis [GO:0007112]; mitotic cytokinesis [GO:0000281]; oogenesis [GO:0048477]; plasma membrane organization [GO:0007009]; pole cell formation [GO:0007279]; protein localization [GO:0008104]; regulation of cytokinesis [GO:0032465]; sensory organ development [GO:0007423]; sensory organ precursor cell division [GO:0045035]; septin ring organization [GO:0031106]; wound healing [GO:0042060]","actomyosin contractile ring [GO:0005826]; cleavage furrow [GO:0032154]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; germline ring canal [GO:0045172]; male germline ring canal [GO:0035323]; motile cilium [GO:0031514]; nucleus [GO:0005634]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; microtubule binding [GO:0008017]; myosin binding [GO:0017022]; actomyosin contractile ring assembly [GO:0000915]; actomyosin contractile ring organization [GO:0044837]; asymmetric cell division [GO:0008356]; cellularization [GO:0007349]; cytokinesis, division site positioning [GO:0007105]; intercellular bridge organization [GO:0043063]; male germline ring canal formation [GO:0030726]; male meiosis cytokinesis [GO:0007112]; mitotic cytokinesis [GO:0000281]; oogenesis [GO:0048477]; plasma membrane organization [GO:0007009]; pole cell formation [GO:0007279]; protein localization [GO:0008104]; regulation of cytokinesis [GO:0032465]; sensory organ development [GO:0007423]; sensory organ precursor cell division [GO:0045035]; septin ring organization [GO:0031106]; wound healing [GO:0042060]","DEVELOPMENTAL STAGE: Expressed in elongating spermatid cysts during spermatogenesis (at protein level) (PubMed:20237161). Expressed throughout development and at reduced levels late in embryogenesis. Localizes to the embryonic cortex and to the metaphase furrows which separate mitotic nuclei in the syncytial embryo prior to cellularization. Concentrates in the leading edges of the furrow canals at the onset of cellularization. {ECO:0000269|PubMed:10751177, ECO:0000269|PubMed:14736750, ECO:0000269|PubMed:20237161, ECO:0000269|PubMed:7559773}.","","","TISSUE SPECIFICITY: Accumulates in the ring canals that interconnect cells of the germline cysts in males and the ovarian follicles in females. These structures develop from arrested contractile rings after a specialized cytokinesis in which the closing of the invaginating plasma membrane is incomplete. Also concentrates in the arrested cleavage furrows that initially link the oocyte to its 15 nurse cells in the early egg chamber and is subsequently lost from these furrows as germline cell division is completed. {ECO:0000269|PubMed:10381388, ECO:0000269|PubMed:12538517, ECO:0000269|PubMed:9013326, ECO:0000269|PubMed:9655801}."
"436","sp|O61460|VAB1_CAEEL","lcl|NC_088855.1_cds_XP_065935578.1_14942",9.78e-100,341,"O61460","VAB1_CAEEL","Ephrin receptor 1 (EC 2.7.10.1) (Tyrosine-protein kinase Eph receptor) (Variable abnormal protein 1)","vab-1 M03A1.1","Caenorhabditis elegans",1122,"GO:0001556; GO:0004713; GO:0004714; GO:0005003; GO:0005524; GO:0005886; GO:0007169; GO:0007409; GO:0007411; GO:0009792; GO:0010172; GO:0016331; GO:0019904; GO:0030424; GO:0043235; GO:1902667","axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic body morphogenesis [GO:0010172]; morphogenesis of embryonic epithelium [GO:0016331]; oocyte maturation [GO:0001556]; regulation of axon guidance [GO:1902667]","axon [GO:0030424]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; protein domain specific binding [GO:0019904]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic body morphogenesis [GO:0010172]; morphogenesis of embryonic epithelium [GO:0016331]; oocyte maturation [GO:0001556]; regulation of axon guidance [GO:1902667]","DEVELOPMENTAL STAGE: Expressed in larval stage L4. {ECO:0000269|PubMed:25529479}.","","","TISSUE SPECIFICITY: During ventral enclosure of the epidermis, expression is seen in clusters of presumptive head neuronal cells and several cells in the tail region. Early larvae show expression in the nerve ring and ventral nerve cord. Strong expression is also seen in the procorpus and terminal bulb of the pharynx. Expression in the nervous system is seen through to adulthood (PubMed:19853560, PubMed:9506518). Expressed in Z2/Z3 germline precursor cells and in oocytes (at protein level). Expressed in the vulva and in the spermatheca with accumulation in the apical regions of the organ (PubMed:25529479). Expressed in oocytes and sheath cells (PubMed:12533508). {ECO:0000269|PubMed:12533508, ECO:0000269|PubMed:19853560, ECO:0000269|PubMed:25529479, ECO:0000269|PubMed:9506518}."
"437","sp|Q8IXK0|PHC2_HUMAN","lcl|NC_088855.1_cds_XP_065935616.1_15024",5.39e-24,110,"Q8IXK0","PHC2_HUMAN","Polyhomeotic-like protein 2 (hPH2) (Early development regulatory protein 2)","PHC2 EDR2 PH2","Homo sapiens (Human)",858,"GO:0000792; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0007283; GO:0008270; GO:0031519; GO:0035102; GO:0042393; GO:0042802; GO:0045892","negative regulation of DNA-templated transcription [GO:0045892]; spermatogenesis [GO:0007283]","heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; negative regulation of DNA-templated transcription [GO:0045892]; spermatogenesis [GO:0007283]","","","",""
"438","sp|Q96A08|H2B1A_HUMAN","lcl|NC_088855.1_cds_XP_065935686.1_15132",3.2e-57,174,"Q96A08","H2B1A_HUMAN","Histone H2B type 1-A (Histone H2B, testis) (TSH2B.1) (hTSH2B) (Testis-specific histone H2B)","H2BC1 HIST1H2BA TSH2B","Homo sapiens (Human)",127,"GO:0000781; GO:0000786; GO:0001674; GO:0003677; GO:0005634; GO:0005654; GO:0006334; GO:0006337; GO:0006954; GO:0009986; GO:0030527; GO:0031639; GO:0035092; GO:0042393; GO:0046982; GO:0051276; GO:0071674","chromosome organization [GO:0051276]; inflammatory response [GO:0006954]; mononuclear cell migration [GO:0071674]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; plasminogen activation [GO:0031639]; sperm DNA condensation [GO:0035092]","cell surface [GO:0009986]; chromosome, telomeric region [GO:0000781]; female germ cell nucleus [GO:0001674]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; chromosome organization [GO:0051276]; inflammatory response [GO:0006954]; mononuclear cell migration [GO:0071674]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; plasminogen activation [GO:0031639]; sperm DNA condensation [GO:0035092]","","","","TISSUE SPECIFICITY: Mainly expressed in testis, and the corresponding protein is also present in mature sperm (at protein level). Also found in some fat cells. {ECO:0000269|PubMed:12213818, ECO:0000269|PubMed:21249133}."
"439","sp|Q9FXI7|H3L2_ARATH","lcl|NC_088855.1_cds_XP_065935692.1_15135",9.32e-83,240,"Q9FXI7","H3L2_ARATH","Histone H3-like 2 (Male gamete-specific histone H3)","MGH3 At1g19890 F6F9.5","Arabidopsis thaliana (Mouse-ear cress)",137,"GO:0000786; GO:0003677; GO:0005634; GO:0009567; GO:0030527; GO:0046982; GO:0048235; GO:0048555","double fertilization forming a zygote and endosperm [GO:0009567]; pollen sperm cell differentiation [GO:0048235]","generative cell nucleus [GO:0048555]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; double fertilization forming a zygote and endosperm [GO:0009567]; pollen sperm cell differentiation [GO:0048235]","DEVELOPMENTAL STAGE: Detected only in the generative cell and the sperm-cell of late bicellular and tricellular pollen. Not detected in pollen vegetative cells. Replication-independent expression. {ECO:0000269|PubMed:16262706}.","","","TISSUE SPECIFICITY: Pollen specific. {ECO:0000269|PubMed:16262706}."
"440","sp|P10180|CUT_DROME","lcl|NC_088855.1_cds_XP_065935751.1_15225",7.42e-55,213,"P10180","CUT_DROME","Homeobox protein cut","ct CG11387","Drosophila melanogaster (Fruit fly)",2175,"GO:0000122; GO:0000976; GO:0000977; GO:0000981; GO:0001745; GO:0003677; GO:0005634; GO:0006355; GO:0006357; GO:0007417; GO:0007422; GO:0007424; GO:0007443; GO:0007469; GO:0007605; GO:0008585; GO:0008587; GO:0035277; GO:0048098; GO:0048477; GO:0048813; GO:0060288; GO:0061332; GO:0070983; GO:0140059","antennal development [GO:0007469]; antennal joint development [GO:0048098]; central nervous system development [GO:0007417]; compound eye morphogenesis [GO:0001745]; dendrite arborization [GO:0140059]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; female gonad development [GO:0008585]; formation of a compartment boundary [GO:0060288]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]; spiracle morphogenesis, open tracheal system [GO:0035277]","nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; antennal development [GO:0007469]; antennal joint development [GO:0048098]; central nervous system development [GO:0007417]; compound eye morphogenesis [GO:0001745]; dendrite arborization [GO:0140059]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; female gonad development [GO:0008585]; formation of a compartment boundary [GO:0060288]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]; spiracle morphogenesis, open tracheal system [GO:0035277]","DEVELOPMENTAL STAGE: Cell-specific pattern of expression. Broadly expressed during embryonic development.","","","TISSUE SPECIFICITY: Detected in many cells in the central nervous system, all external sensory organs, some peripheral neurons, and in the non-neural cells of the spiracles and the Malpighian tubules."
"441","sp|O43432|IF4G3_HUMAN","lcl|NC_088855.1_cds_XP_065935827.1_15435",0,790,"O43432","IF4G3_HUMAN","Eukaryotic translation initiation factor 4 gamma 3 (eIF-4-gamma 3) (eIF-4G 3) (eIF4G 3) (eIF-4-gamma II) (eIF4GII)","EIF4G3","Homo sapiens (Human)",1585,"GO:0000339; GO:0003723; GO:0003729; GO:0003743; GO:0005829; GO:0006413; GO:0006446; GO:0007286; GO:0008135; GO:0016281; GO:0043232; GO:0045727","positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446]; spermatid development [GO:0007286]; translational initiation [GO:0006413]","cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; intracellular membraneless organelle [GO:0043232]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446]; spermatid development [GO:0007286]; translational initiation [GO:0006413]","","","",""
"442","sp|Q60665|SKIL_MOUSE","lcl|NC_088855.1_cds_XP_065935884.1_15582",1.71e-73,251,"Q60665","SKIL_MOUSE","Ski-like protein (Ski-related oncogene) (Ski-related protein)","Skil Skir Sno","Mus musculus (Mouse)",675,"GO:0000122; GO:0000978; GO:0001227; GO:0001669; GO:0001825; GO:0002260; GO:0003682; GO:0005634; GO:0007179; GO:0007283; GO:0008625; GO:0008630; GO:0030154; GO:0030512; GO:0032991; GO:0034097; GO:0045596; GO:0046332; GO:0050772; GO:0051726; GO:0070306; GO:1902043; GO:1902231","blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lens fiber cell differentiation [GO:0070306]; lymphocyte homeostasis [GO:0002260]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of axonogenesis [GO:0050772]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; regulation of cell cycle [GO:0051726]; response to cytokine [GO:0034097]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]","acrosomal vesicle [GO:0001669]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; SMAD binding [GO:0046332]; blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lens fiber cell differentiation [GO:0070306]; lymphocyte homeostasis [GO:0002260]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of axonogenesis [GO:0050772]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; regulation of cell cycle [GO:0051726]; response to cytokine [GO:0034097]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]","","","",""
"443","sp|Q6P9F0|CCD62_HUMAN","lcl|NC_088855.1_cds_XP_065935891.1_15592",2.43e-40,159,"Q6P9F0","CCD62_HUMAN","Coiled-coil domain-containing protein 62 (Protein TSP-NY) (Protein aaa)","CCDC62","Homo sapiens (Human)",684,"GO:0001669; GO:0001835; GO:0003713; GO:0005634; GO:0005815; GO:0007286; GO:0030331; GO:0030520; GO:0045944; GO:0071392","blastocyst hatching [GO:0001835]; cellular response to estradiol stimulus [GO:0071392]; estrogen receptor signaling pathway [GO:0030520]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatid development [GO:0007286]","acrosomal vesicle [GO:0001669]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; nuclear estrogen receptor binding [GO:0030331]; transcription coactivator activity [GO:0003713]; blastocyst hatching [GO:0001835]; cellular response to estradiol stimulus [GO:0071392]; estrogen receptor signaling pathway [GO:0030520]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Highly expressed in adult testis. Expressed in both prostate epithelial and stromal cells, with predominant expression in epithelial cells (at protein level) (PubMed:19126643). Not detected in prostate by RT-PCR (PubMed:19165854). Overexpressed in various cancers. {ECO:0000269|PubMed:19126643, ECO:0000269|PubMed:19165854, ECO:0000269|Ref.1, ECO:0000269|Ref.4}."
"444","sp|A1Z9X0|APKC_DROME","lcl|NC_088855.1_cds_XP_065935908.1_15688",0,822,"A1Z9X0","APKC_DROME","Atypical protein kinase C (EC 2.7.11.13)","aPKC CG30475","Drosophila melanogaster (Fruit fly)",606,"GO:0000132; GO:0001738; GO:0002052; GO:0003382; GO:0004674; GO:0004697; GO:0005524; GO:0005938; GO:0007043; GO:0007163; GO:0007283; GO:0007294; GO:0007314; GO:0007416; GO:0007423; GO:0007430; GO:0007613; GO:0008270; GO:0010592; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0017022; GO:0030010; GO:0030011; GO:0030165; GO:0030860; GO:0034332; GO:0035003; GO:0035011; GO:0035331; GO:0035556; GO:0043296; GO:0045167; GO:0045176; GO:0045179; GO:0045186; GO:0045196; GO:0045197; GO:0045198; GO:0045880; GO:0046667; GO:0051491; GO:0051601; GO:0055059; GO:0060446; GO:0072659; GO:0090163; GO:0106310; GO:0120157; GO:0140591; GO:1904580","adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; branching involved in open tracheal system development [GO:0060446]; cell-cell junction assembly [GO:0007043]; compound eye retinal cell programmed cell death [GO:0046667]; epithelial cell morphogenesis [GO:0003382]; establishment of cell polarity [GO:0030010]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocyst localization [GO:0051601]; germarium-derived oocyte fate determination [GO:0007294]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of hippo signaling [GO:0035331]; nuclear envelope budding [GO:0140591]; oocyte anterior/posterior axis specification [GO:0007314]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular mRNA localization [GO:1904580]; regulation of polarized epithelial cell differentiation [GO:0030860]; sensory organ development [GO:0007423]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; terminal branching, open tracheal system [GO:0007430]; zonula adherens assembly [GO:0045186]","apical cortex [GO:0045179]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; PAR polarity complex [GO:0120157]; subapical complex [GO:0035003]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; branching involved in open tracheal system development [GO:0060446]; cell-cell junction assembly [GO:0007043]; compound eye retinal cell programmed cell death [GO:0046667]; epithelial cell morphogenesis [GO:0003382]; establishment of cell polarity [GO:0030010]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocyst localization [GO:0051601]; germarium-derived oocyte fate determination [GO:0007294]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of hippo signaling [GO:0035331]; nuclear envelope budding [GO:0140591]; oocyte anterior/posterior axis specification [GO:0007314]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular mRNA localization [GO:1904580]; regulation of polarized epithelial cell differentiation [GO:0030860]; sensory organ development [GO:0007423]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; terminal branching, open tracheal system [GO:0007430]; zonula adherens assembly [GO:0045186]","","","","TISSUE SPECIFICITY: Expressed in the testis. In spermatid cysts, localizes near the tips of spermatid flagellar axonemes (at protein level). Detectable in freshly laid eggs before onset of zygotic transcription so is deposited in the egg during oogenesis. At the cellular blastoderm stage, present in all cells except the pole cells. During gastrulation, strongly expressed in tissues undergoing morphogenetic movements such as invaginating mesoderm, proctodeum and cephalic furrow. Strongly expressed in neuroblasts. {ECO:0000269|PubMed:10995441, ECO:0000269|PubMed:24830287}."
"445","sp|Q9Z221|PMFBP_RAT","lcl|NC_088855.1_cds_XP_065935932.1_15758",5.84e-18,91.3,"Q9Z221","PMFBP_RAT","Polyamine-modulated factor 1-binding protein 1 (PMF-1-binding protein) (Outer dense fiber protein 3)","Pmfbp1 Odf3","Rattus norvegicus (Rat)",971,"GO:0001520; GO:0005737; GO:0007010; GO:0007283; GO:0007286; GO:0008104; GO:0010467; GO:0032880; GO:0036126; GO:0061827; GO:0065003; GO:0120212","cytoskeleton organization [GO:0007010]; gene expression [GO:0010467]; protein localization [GO:0008104]; protein-containing complex assembly [GO:0065003]; regulation of protein localization [GO:0032880]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; outer dense fiber [GO:0001520]; sperm flagellum [GO:0036126]; sperm head [GO:0061827]; sperm head-tail coupling apparatus [GO:0120212]; cytoskeleton organization [GO:0007010]; gene expression [GO:0010467]; protein localization [GO:0008104]; protein-containing complex assembly [GO:0065003]; regulation of protein localization [GO:0032880]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in testis and more specifically in ODF, the sperm tail specific cytoskeletal structure. Also expressed in epididymides and brain. {ECO:0000269|PubMed:11774381}."
"446","sp|Q8TBY8|PMFBP_HUMAN","lcl|NC_088855.1_cds_XP_065935944.1_15772",1.08e-11,70.9,"Q8TBY8","PMFBP_HUMAN","Polyamine-modulated factor 1-binding protein 1 (PMF-1-binding protein)","PMFBP1","Homo sapiens (Human)",1007,"GO:0005737; GO:0007283; GO:0007286; GO:0008104; GO:0010467; GO:0032880; GO:0036126; GO:0061827; GO:0065003; GO:0120212","gene expression [GO:0010467]; protein localization [GO:0008104]; protein-containing complex assembly [GO:0065003]; regulation of protein localization [GO:0032880]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; sperm flagellum [GO:0036126]; sperm head [GO:0061827]; sperm head-tail coupling apparatus [GO:0120212]; gene expression [GO:0010467]; protein localization [GO:0008104]; protein-containing complex assembly [GO:0065003]; regulation of protein localization [GO:0032880]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","","","",""
"447","sp|Q9WVQ0|PMFBP_MOUSE","lcl|NC_088855.1_cds_XP_065935953.1_15779",1.39e-16,87,"Q9WVQ0","PMFBP_MOUSE","Polyamine-modulated factor 1-binding protein 1 (PMF-1-binding protein) (Sperm tail-associated protein)","Pmfbp1 Stap","Mus musculus (Mouse)",1022,"GO:0005737; GO:0007283; GO:0007286; GO:0008104; GO:0010467; GO:0032880; GO:0036126; GO:0061827; GO:0065003; GO:0120212","gene expression [GO:0010467]; protein localization [GO:0008104]; protein-containing complex assembly [GO:0065003]; regulation of protein localization [GO:0032880]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; sperm flagellum [GO:0036126]; sperm head [GO:0061827]; sperm head-tail coupling apparatus [GO:0120212]; gene expression [GO:0010467]; protein localization [GO:0008104]; protein-containing complex assembly [GO:0065003]; regulation of protein localization [GO:0032880]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in the testis. {ECO:0000269|PubMed:11468771, ECO:0000269|PubMed:30032984}."
"448","sp|A1Z6E0|GUS_DROME","lcl|NC_088855.1_cds_XP_065936007.1_15903",5.99e-150,421,"A1Z6E0","GUS_DROME","Protein gustavus","gus CG2944","Drosophila melanogaster (Fruit fly)",279,"GO:0005634; GO:0005737; GO:0005938; GO:0007281; GO:0007314; GO:0007315; GO:0007472; GO:0008104; GO:0008354; GO:0019005; GO:0031466; GO:0035017; GO:0035556; GO:0043161; GO:0045495; GO:0045732; GO:0046843; GO:0048471; GO:0070449","cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; wing disc morphogenesis [GO:0007472]","cell cortex [GO:0005938]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; elongin complex [GO:0070449]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005]; cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; wing disc morphogenesis [GO:0007472]","DEVELOPMENTAL STAGE: Expressed during oogenesis, in early embryos (0 to 4 hours) and in fertile adult females (at protein level). {ECO:0000269|PubMed:12479811, ECO:0000269|PubMed:20123973}.","","","TISSUE SPECIFICITY: Expressed in ovaries, primarily in nurse cells and oocytes (at protein level). {ECO:0000269|PubMed:12479811, ECO:0000269|PubMed:20123973}."
"449","sp|P49711|CTCF_HUMAN","lcl|NC_088855.1_cds_XP_065936045.1_16004",7.84e-109,352,"P49711","CTCF_HUMAN","Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog)","CTCF","Homo sapiens (Human)",727,"GO:0000122; GO:0000775; GO:0000793; GO:0000976; GO:0000978; GO:0001221; GO:0001227; GO:0001673; GO:0001701; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0006346; GO:0006357; GO:0007005; GO:0007059; GO:0008270; GO:0008285; GO:0010467; GO:0010628; GO:0040029; GO:0043035; GO:0043565; GO:0044027; GO:0045892; GO:0045893; GO:0045944; GO:0055013; GO:0070602; GO:0071459; GO:0071514; GO:0140587; GO:0140588; GO:1990837","cardiac muscle cell development [GO:0055013]; chromatin looping [GO:0140588]; chromosome segregation [GO:0007059]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; epigenetic regulation of gene expression [GO:0040029]; gene expression [GO:0010467]; genomic imprinting [GO:0071514]; in utero embryonic development [GO:0001701]; mitochondrion organization [GO:0007005]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to chromosome, centromeric region [GO:0071459]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of transcription by RNA polymerase II [GO:0006357]","chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; male germ cell nucleus [GO:0001673]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin insulator sequence binding [GO:0043035]; chromatin loop anchoring activity [GO:0140587]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]; cardiac muscle cell development [GO:0055013]; chromatin looping [GO:0140588]; chromosome segregation [GO:0007059]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; epigenetic regulation of gene expression [GO:0040029]; gene expression [GO:0010467]; genomic imprinting [GO:0071514]; in utero embryonic development [GO:0001701]; mitochondrion organization [GO:0007005]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to chromosome, centromeric region [GO:0071459]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of transcription by RNA polymerase II [GO:0006357]","","","","TISSUE SPECIFICITY: Ubiquitous. Absent in primary spermatocytes. {ECO:0000269|PubMed:9591631}."
"450","sp|P47727|CBR1_RAT","lcl|NC_088855.1_cds_XP_065936075.1_16133",3.09e-108,315,"P47727","CBR1_RAT","Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196, EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (Alcohol dehydrogenase [NAD(P)+] CBR1) (EC 1.1.1.71) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)","Cbr1 Cbr","Rattus norvegicus (Rat)",277,"GO:0001542; GO:0004090; GO:0005737; GO:0005902; GO:0006706; GO:0006805; GO:0008211; GO:0016616; GO:0016655; GO:0030855; GO:0032355; GO:0032496; GO:0032570; GO:0033574; GO:0034698; GO:0042373; GO:0042376; GO:0047020; GO:0047021; GO:0050221; GO:0160163; GO:1905344; GO:2000379","epithelial cell differentiation [GO:0030855]; glucocorticoid metabolic process [GO:0008211]; ovulation from ovarian follicle [GO:0001542]; phylloquinone catabolic process [GO:0042376]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; prostaglandin catabolic process [GO:1905344]; response to estradiol [GO:0032355]; response to gonadotropin [GO:0034698]; response to lipopolysaccharide [GO:0032496]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; steroid catabolic process [GO:0006706]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805]","cytoplasm [GO:0005737]; microvillus [GO:0005902]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin E2 9-reductase activity [GO:0050221]; S-nitrosoglutathione reductase (NADPH) activity [GO:0160163]; epithelial cell differentiation [GO:0030855]; glucocorticoid metabolic process [GO:0008211]; ovulation from ovarian follicle [GO:0001542]; phylloquinone catabolic process [GO:0042376]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; prostaglandin catabolic process [GO:1905344]; response to estradiol [GO:0032355]; response to gonadotropin [GO:0034698]; response to lipopolysaccharide [GO:0032496]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; steroid catabolic process [GO:0006706]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805]","","","",""
"451","sp|Q9UHL0|DDX25_HUMAN","lcl|NC_088855.1_cds_XP_065936139.1_16301",0,559,"Q9UHL0","DDX25_HUMAN","ATP-dependent RNA helicase DDX25 (EC 3.6.4.13) (DEAD box protein 25) (Gonadotropin-regulated testicular RNA helicase)","DDX25 GRTH","Homo sapiens (Human)",483,"GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005737; GO:0006406; GO:0006417; GO:0007286; GO:0010494; GO:0016887; GO:0016973; GO:0033391","mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of translation [GO:0006417]; spermatid development [GO:0007286]","chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of translation [GO:0006417]; spermatid development [GO:0007286]","","INDUCTION: Up-regulated at transcriptional level by chorionic gonadotropin via cyclic AMP-induced androgen formation in the Leydig cell. {ECO:0000269|PubMed:10608860}.","INDUCTION: Up-regulated at transcriptional level by chorionic gonadotropin via cyclic AMP-induced androgen formation in the Leydig cell. {ECO:0000269|PubMed:10608860}.","TISSUE SPECIFICITY: Highly expressed in the Leydig and germ cells of the testis and weakly expressed in the pituitary and hypothalamus. {ECO:0000269|PubMed:10608860, ECO:0000269|Ref.2}."
"452","sp|Q62600|NOS3_RAT","lcl|NC_088855.1_cds_XP_065936227.1_16572",0,1051,"Q62600","NOS3_RAT","Nitric oxide synthase 3 (EC 1.14.13.39) (Constitutive NOS) (cNOS) (EC-NOS) (NOS type III) (NOSIII) (Nitric oxide synthase, endothelial) (Endothelial NOS) (eNOS)","Nos3","Rattus norvegicus (Rat)",1202,"GO:0001525; GO:0001542; GO:0001666; GO:0001701; GO:0001974; GO:0002028; GO:0003057; GO:0003100; GO:0003180; GO:0003184; GO:0003203; GO:0003779; GO:0003785; GO:0004517; GO:0005516; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0006527; GO:0006809; GO:0006813; GO:0006816; GO:0007263; GO:0007565; GO:0008013; GO:0008285; GO:0009410; GO:0009612; GO:0009725; GO:0009743; GO:0009750; GO:0010038; GO:0010181; GO:0010288; GO:0010628; GO:0014740; GO:0014806; GO:0014823; GO:0019430; GO:0020037; GO:0030324; GO:0031644; GO:0031663; GO:0031667; GO:0032355; GO:0032496; GO:0032869; GO:0034097; GO:0034405; GO:0034605; GO:0034617; GO:0034618; GO:0035094; GO:0036017; GO:0042311; GO:0042383; GO:0043065; GO:0043200; GO:0043267; GO:0043434; GO:0043536; GO:0043542; GO:0045177; GO:0045296; GO:0045471; GO:0045766; GO:0045776; GO:0046209; GO:0046689; GO:0046872; GO:0048662; GO:0048678; GO:0048873; GO:0050660; GO:0050661; GO:0050998; GO:0051412; GO:0051649; GO:0051879; GO:0051926; GO:0055093; GO:0060041; GO:0060348; GO:0060412; GO:0070168; GO:0071000; GO:0071260; GO:0071286; GO:0071320; GO:0071356; GO:0071363; GO:0071403; GO:0071404; GO:0071560; GO:0097110; GO:0097746; GO:1901652; GO:1901654; GO:1902074; GO:1903576; GO:1904648; GO:1990478","angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; arginine catabolic process [GO:0006527]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; bone development [GO:0060348]; calcium ion transport [GO:0006816]; cellular response to cAMP [GO:0071320]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heat [GO:0034605]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; cellular response to insulin stimulus [GO:0032869]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to magnesium ion [GO:0071286]; cellular response to mechanical stimulus [GO:0071260]; cellular response to rotenone [GO:1904648]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; endocardial cushion morphogenesis [GO:0003203]; endothelial cell migration [GO:0043542]; establishment of localization in cell [GO:0051649]; female pregnancy [GO:0007565]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lung development [GO:0030324]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of blood pressure [GO:0045776]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of muscle hyperplasia [GO:0014740]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; nitric oxide metabolic process [GO:0046209]; ovulation from ovarian follicle [GO:0001542]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of gene expression [GO:0010628]; potassium ion transport [GO:0006813]; pulmonary valve morphogenesis [GO:0003184]; regulation of nervous system process [GO:0031644]; regulation of sodium ion transport [GO:0002028]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of the force of heart contraction by chemical signal [GO:0003057]; removal of superoxide radicals [GO:0019430]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to carbohydrate [GO:0009743]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to erythropoietin [GO:0036017]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fluid shear stress [GO:0034405]; response to fructose [GO:0009750]; response to hormone [GO:0009725]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to ketone [GO:1901654]; response to L-arginine [GO:1903576]; response to lead ion [GO:0010288]; response to lipopolysaccharide [GO:0032496]; response to magnetism [GO:0071000]; response to mechanical stimulus [GO:0009612]; response to mercury ion [GO:0046689]; response to metal ion [GO:0010038]; response to nicotine [GO:0035094]; response to nutrient levels [GO:0031667]; response to peptide [GO:1901652]; response to peptide hormone [GO:0043434]; response to salt [GO:1902074]; response to ultrasound [GO:1990478]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; smooth muscle hyperplasia [GO:0014806]; vasodilation [GO:0042311]; ventricular septum morphogenesis [GO:0060412]","apical part of cell [GO:0045177]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; actin binding [GO:0003779]; actin monomer binding [GO:0003785]; arginine binding [GO:0034618]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; nitric-oxide synthase binding [GO:0050998]; scaffold protein binding [GO:0097110]; tetrahydrobiopterin binding [GO:0034617]; angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; arginine catabolic process [GO:0006527]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; bone development [GO:0060348]; calcium ion transport [GO:0006816]; cellular response to cAMP [GO:0071320]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heat [GO:0034605]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; cellular response to insulin stimulus [GO:0032869]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to magnesium ion [GO:0071286]; cellular response to mechanical stimulus [GO:0071260]; cellular response to rotenone [GO:1904648]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; endocardial cushion morphogenesis [GO:0003203]; endothelial cell migration [GO:0043542]; establishment of localization in cell [GO:0051649]; female pregnancy [GO:0007565]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lung development [GO:0030324]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of blood pressure [GO:0045776]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of muscle hyperplasia [GO:0014740]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; nitric oxide metabolic process [GO:0046209]; ovulation from ovarian follicle [GO:0001542]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of gene expression [GO:0010628]; potassium ion transport [GO:0006813]; pulmonary valve morphogenesis [GO:0003184]; regulation of nervous system process [GO:0031644]; regulation of sodium ion transport [GO:0002028]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of the force of heart contraction by chemical signal [GO:0003057]; removal of superoxide radicals [GO:0019430]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to carbohydrate [GO:0009743]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to erythropoietin [GO:0036017]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fluid shear stress [GO:0034405]; response to fructose [GO:0009750]; response to hormone [GO:0009725]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to ketone [GO:1901654]; response to L-arginine [GO:1903576]; response to lead ion [GO:0010288]; response to lipopolysaccharide [GO:0032496]; response to magnetism [GO:0071000]; response to mechanical stimulus [GO:0009612]; response to mercury ion [GO:0046689]; response to metal ion [GO:0010038]; response to nicotine [GO:0035094]; response to nutrient levels [GO:0031667]; response to peptide [GO:1901652]; response to peptide hormone [GO:0043434]; response to salt [GO:1902074]; response to ultrasound [GO:1990478]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; smooth muscle hyperplasia [GO:0014806]; vasodilation [GO:0042311]; ventricular septum morphogenesis [GO:0060412]","DEVELOPMENTAL STAGE: Detected at high levels in lung during the late fetal and postnatal period and at lower levels in adult.","","","TISSUE SPECIFICITY: Expressed constitutively by vascular endothelium. Detected in alveolar and serosal epithelial cells as well as in endothelial cells in one day old rat. In adult lung, detected in rare endothelial cells."
"453","sp|P70313|NOS3_MOUSE","lcl|NC_088855.1_cds_XP_065936228.1_16573",0,1087,"P70313","NOS3_MOUSE","Nitric oxide synthase 3 (EC 1.14.13.39) (Constitutive NOS) (cNOS) (EC-NOS) (NOS type III) (NOSIII) (Nitric oxide synthase, endothelial) (Endothelial NOS) (eNOS)","Nos3 Ecnos","Mus musculus (Mouse)",1202,"GO:0001525; GO:0001542; GO:0001701; GO:0001974; GO:0002028; GO:0003057; GO:0003100; GO:0003180; GO:0003184; GO:0003203; GO:0003785; GO:0004517; GO:0005516; GO:0005634; GO:0005737; GO:0005794; GO:0005856; GO:0005901; GO:0006527; GO:0006809; GO:0006813; GO:0006816; GO:0008285; GO:0010181; GO:0010628; GO:0014740; GO:0014806; GO:0019430; GO:0020037; GO:0030324; GO:0031644; GO:0031663; GO:0034405; GO:0034617; GO:0034618; GO:0043267; GO:0043536; GO:0043542; GO:0045766; GO:0046872; GO:0048662; GO:0048873; GO:0050660; GO:0050661; GO:0051649; GO:0051926; GO:0060412; GO:0070168; GO:0097110; GO:0097746","angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; arginine catabolic process [GO:0006527]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; calcium ion transport [GO:0006816]; endocardial cushion morphogenesis [GO:0003203]; endothelial cell migration [GO:0043542]; establishment of localization in cell [GO:0051649]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lung development [GO:0030324]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of muscle hyperplasia [GO:0014740]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nitric oxide biosynthetic process [GO:0006809]; ovulation from ovarian follicle [GO:0001542]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of gene expression [GO:0010628]; potassium ion transport [GO:0006813]; pulmonary valve morphogenesis [GO:0003184]; regulation of nervous system process [GO:0031644]; regulation of sodium ion transport [GO:0002028]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of the force of heart contraction by chemical signal [GO:0003057]; removal of superoxide radicals [GO:0019430]; response to fluid shear stress [GO:0034405]; smooth muscle hyperplasia [GO:0014806]; ventricular septum morphogenesis [GO:0060412]","caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; actin monomer binding [GO:0003785]; arginine binding [GO:0034618]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; scaffold protein binding [GO:0097110]; tetrahydrobiopterin binding [GO:0034617]; angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; arginine catabolic process [GO:0006527]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; calcium ion transport [GO:0006816]; endocardial cushion morphogenesis [GO:0003203]; endothelial cell migration [GO:0043542]; establishment of localization in cell [GO:0051649]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lung development [GO:0030324]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of muscle hyperplasia [GO:0014740]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nitric oxide biosynthetic process [GO:0006809]; ovulation from ovarian follicle [GO:0001542]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of gene expression [GO:0010628]; potassium ion transport [GO:0006813]; pulmonary valve morphogenesis [GO:0003184]; regulation of nervous system process [GO:0031644]; regulation of sodium ion transport [GO:0002028]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of the force of heart contraction by chemical signal [GO:0003057]; removal of superoxide radicals [GO:0019430]; response to fluid shear stress [GO:0034405]; smooth muscle hyperplasia [GO:0014806]; ventricular septum morphogenesis [GO:0060412]","","","",""
"454","sp|B2RXZ1|PNDC1_MOUSE","lcl|NC_088855.1_cds_XP_065936263.1_16744",1.36e-100,314,"B2RXZ1","PNDC1_MOUSE","Poly(A)-specific ribonuclease PNLDC1 (EC 3.1.13.4) (PARN-like domain-containing protein 1) (Poly(A)-specific ribonuclease domain-containing protein 1)","Pnldc1","Mus musculus (Mouse)",531,"GO:0000184; GO:0000289; GO:0001825; GO:0003723; GO:0004535; GO:0005783; GO:0005789; GO:0007283; GO:0034587; GO:0046872","blastocyst formation [GO:0001825]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; blastocyst formation [GO:0001825]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed during early embryo development and fades during differentiation. {ECO:0000269|PubMed:27515512}.","INDUCTION: Down-regulated in differentiated cells, due to methylation of its promoter by the methyltransferase DNMT3B. {ECO:0000269|PubMed:27515512}.","INDUCTION: Down-regulated in differentiated cells, due to methylation of its promoter by the methyltransferase DNMT3B. {ECO:0000269|PubMed:27515512}.","TISSUE SPECIFICITY: Specifically expressed in embryonic stem cells (PubMed:27515512). Highly expressed in testis (PubMed:26919431, PubMed:27515512). {ECO:0000269|PubMed:26919431, ECO:0000269|PubMed:27515512}."
"455","sp|P48612|PELO_DROME","lcl|NC_088855.1_cds_XP_065936372.1_16908",0,558,"P48612","PELO_DROME","Protein pelota","pelo CG3959","Drosophila melanogaster (Fruit fly)",395,"GO:0000212; GO:0001745; GO:0004521; GO:0005634; GO:0005737; GO:0005829; GO:0006417; GO:0007291; GO:0016441; GO:0030718; GO:0032790; GO:0036098; GO:0046872; GO:0048132; GO:0048137; GO:0051078; GO:0051321; GO:0070481; GO:0070651; GO:0070966; GO:0071025; GO:0072344; GO:1990533","compound eye morphogenesis [GO:0001745]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male germ-line stem cell population maintenance [GO:0036098]; meiotic cell cycle [GO:0051321]; meiotic nuclear membrane disassembly [GO:0051078]; meiotic spindle organization [GO:0000212]; nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; post-transcriptional gene silencing [GO:0016441]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]; sperm individualization [GO:0007291]; spermatocyte division [GO:0048137]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; Dom34-Hbs1 complex [GO:1990533]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA endonuclease activity [GO:0004521]; compound eye morphogenesis [GO:0001745]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male germ-line stem cell population maintenance [GO:0036098]; meiotic cell cycle [GO:0051321]; meiotic nuclear membrane disassembly [GO:0051078]; meiotic spindle organization [GO:0000212]; nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; post-transcriptional gene silencing [GO:0016441]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]; sperm individualization [GO:0007291]; spermatocyte division [GO:0048137]","DEVELOPMENTAL STAGE: Highest levels in early embryo (0-2h) and adult stages. {ECO:0000269|PubMed:7588080}.","","","TISSUE SPECIFICITY: Expressed in ovaries and muscles (at protein level) (PubMed:26124316, PubMed:29861391). Expressed throughout all development stages (PubMed:7588080). {ECO:0000269|PubMed:26124316, ECO:0000269|PubMed:29861391, ECO:0000269|PubMed:7588080}."
"456","sp|G5ECH5|PP4R1_CAEEL","lcl|NC_088855.1_cds_XP_065936377.1_16938",4.95e-44,176,"G5ECH5","PP4R1_CAEEL","Serine/threonine-protein phosphatase 4 regulatory subunit 1","ppfr-1 F16A11.3","Caenorhabditis elegans",1562,"GO:0000132; GO:0005737; GO:0009792; GO:0019888; GO:0019904; GO:0032888; GO:0040038; GO:0072542; GO:1902120","embryo development ending in birth or egg hatching [GO:0009792]; establishment of mitotic spindle orientation [GO:0000132]; negative regulation of meiotic spindle elongation [GO:1902120]; polar body extrusion after meiotic divisions [GO:0040038]; regulation of mitotic spindle elongation [GO:0032888]","cytoplasm [GO:0005737]; protein domain specific binding [GO:0019904]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of mitotic spindle orientation [GO:0000132]; negative regulation of meiotic spindle elongation [GO:1902120]; polar body extrusion after meiotic divisions [GO:0040038]; regulation of mitotic spindle elongation [GO:0032888]","DEVELOPMENTAL STAGE: Expressed in embryos. {ECO:0000269|PubMed:23918937}.","","",""
"457","sp|Q7M6Y6|MRO2B_MOUSE","lcl|NC_088855.1_cds_XP_065936427.1_17033",2.99e-97,348,"Q7M6Y6","MRO2B_MOUSE","Maestro heat-like repeat-containing protein family member 2B (HEAT repeat-containing protein 7B2) (Sperm PKA-interacting factor) (SPIF)","Mroh2b Heatr7b2","Mus musculus (Mouse)",1581,"GO:0001669; GO:0005737; GO:0007283; GO:0010737; GO:0030154; GO:0036126; GO:0097225","cell differentiation [GO:0030154]; protein kinase A signaling [GO:0010737]; spermatogenesis [GO:0007283]","acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; cell differentiation [GO:0030154]; protein kinase A signaling [GO:0010737]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed strongly in round spermatids and fully mature spermatozoa. Expressed weakly in pachytene spermatocytes (at protein level). Isoform 2 is specifically expressed in the testis. Isoform 2 is expressed in pachytene spermatocytes and round spermatids. Isoform 3 is weakly expressed in testis. {ECO:0000269|PubMed:27105888}."
"458","sp|Q9VY77|AJUBA_DROME","lcl|NC_088855.1_cds_XP_065936573.1_17325",2.78e-123,385,"Q9VY77","AJUBA_DROME","LIM domain-containing protein jub","jub CG11063","Drosophila melanogaster (Fruit fly)",728,"GO:0000278; GO:0000932; GO:0001666; GO:0003714; GO:0005634; GO:0005667; GO:0005912; GO:0006355; GO:0007010; GO:0030707; GO:0035331; GO:0045179; GO:0045572; GO:0046872; GO:0071539; GO:0140311","cytoskeleton organization [GO:0007010]; follicle cell of egg chamber development [GO:0030707]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; positive regulation of imaginal disc growth [GO:0045572]; protein localization to centrosome [GO:0071539]; regulation of DNA-templated transcription [GO:0006355]; response to hypoxia [GO:0001666]","adherens junction [GO:0005912]; apical cortex [GO:0045179]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription regulator complex [GO:0005667]; metal ion binding [GO:0046872]; protein sequestering activity [GO:0140311]; transcription corepressor activity [GO:0003714]; cytoskeleton organization [GO:0007010]; follicle cell of egg chamber development [GO:0030707]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; positive regulation of imaginal disc growth [GO:0045572]; protein localization to centrosome [GO:0071539]; regulation of DNA-templated transcription [GO:0006355]; response to hypoxia [GO:0001666]","","","",""
"459","sp|O43236|SEPT4_HUMAN","lcl|NC_088855.1_cds_XP_065936654.1_17460",2e-158,457,"O43236","SEPT4_HUMAN","Septin-4 (Bradeion beta) (Brain protein H5) (CE5B3 beta) (Cell division control-related protein 2) (hCDCREL-2) (Peanut-like protein 2)","SEPTIN4 C17orf47 PNUTL2 SEP4 SEPT4 hucep-7","Homo sapiens (Human)",478,"GO:0000287; GO:0001764; GO:0003924; GO:0005198; GO:0005525; GO:0005634; GO:0005739; GO:0005741; GO:0005829; GO:0005940; GO:0006915; GO:0008021; GO:0008104; GO:0015630; GO:0017157; GO:0030317; GO:0030424; GO:0030425; GO:0031105; GO:0031398; GO:0032153; GO:0042802; GO:0042981; GO:0043065; GO:0043204; GO:0048515; GO:0060090; GO:0061484; GO:0061640; GO:0097227; GO:0098691; GO:0098793; GO:2001244","apoptotic process [GO:0006915]; cytoskeleton-dependent cytokinesis [GO:0061640]; flagellated sperm motility [GO:0030317]; hematopoietic stem cell homeostasis [GO:0061484]; neuron migration [GO:0001764]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein ubiquitination [GO:0031398]; protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]; regulation of exocytosis [GO:0017157]; spermatid differentiation [GO:0048515]","axon [GO:0030424]; cell division site [GO:0032153]; cytosol [GO:0005829]; dendrite [GO:0030425]; dopaminergic synapse [GO:0098691]; microtubule cytoskeleton [GO:0015630]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perikaryon [GO:0043204]; presynapse [GO:0098793]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198]; apoptotic process [GO:0006915]; cytoskeleton-dependent cytokinesis [GO:0061640]; flagellated sperm motility [GO:0030317]; hematopoietic stem cell homeostasis [GO:0061484]; neuron migration [GO:0001764]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein ubiquitination [GO:0031398]; protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]; regulation of exocytosis [GO:0017157]; spermatid differentiation [GO:0048515]","","","","TISSUE SPECIFICITY: Widely expressed in adult and fetal tissues with highest expression in adult brain (at protein level), heart, liver and adrenal gland and fetal heart, kidney, liver and lung. Expressed in presynaptic terminals of dopaminergic neurons projecting from the substantia nigra pars compacta to the striatum (at protein level) (PubMed:17296554). Expressed in axonal varicosities in dopaminergic nerve terminals (at protein level) (PubMed:17296554). Expressed in the putamen and in the adjacent cerebral cortex (at protein level) (PubMed:17296554). Expressed in colonic crypts (at protein level) (PubMed:30389919). Also expressed in colorectal cancers and malignant melanomas. Expressed in platelets. {ECO:0000269|PubMed:11146656, ECO:0000269|PubMed:11167005, ECO:0000269|PubMed:11511094, ECO:0000269|PubMed:15116257, ECO:0000269|PubMed:15915442, ECO:0000269|PubMed:17296554, ECO:0000269|PubMed:30389919, ECO:0000269|PubMed:9889007}.; TISSUE SPECIFICITY: [Isoform ARTS]: Highly expressed in the brain and heart. {ECO:0000269|PubMed:11146656}."
"460","sp|Q2NKY7|SEPT2_BOVIN","lcl|NC_088855.1_cds_XP_065936656.1_17458",5.04e-179,503,"Q2NKY7","SEPT2_BOVIN","Septin-2","SEPTIN2 SEPT2","Bos taurus (Bovine)",361,"GO:0000776; GO:0003924; GO:0005525; GO:0005737; GO:0005819; GO:0005940; GO:0007224; GO:0007283; GO:0008104; GO:0015630; GO:0030154; GO:0030496; GO:0031105; GO:0031514; GO:0032153; GO:0032154; GO:0060090; GO:0060170; GO:0060271; GO:0061640","cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]","cell division site [GO:0032153]; ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; motile cilium [GO:0031514]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]","","","",""
"461","sp|Q08AE8|SPIR1_HUMAN","lcl|NC_088855.1_cds_XP_065936686.1_17561",3.8e-78,275,"Q08AE8","SPIR1_HUMAN","Protein spire homolog 1 (Spir-1)","SPIRE1 KIAA1135 SPIR1","Homo sapiens (Human)",756,"GO:0003779; GO:0005654; GO:0005741; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0008017; GO:0015031; GO:0016192; GO:0030036; GO:0030659; GO:0036089; GO:0040038; GO:0045010; GO:0045087; GO:0046907; GO:0048193; GO:0048471; GO:0051295; GO:0051639; GO:0070649; GO:0090141; GO:2000781","actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; Golgi vesicle transport [GO:0048193]; innate immune response [GO:0045087]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of mitochondrial fission [GO:0090141]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]","cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; Golgi vesicle transport [GO:0048193]; innate immune response [GO:0045087]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of mitochondrial fission [GO:0090141]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]","","","",""
"462","sp|Q3UXZ9|KDM5A_MOUSE","lcl|NC_088856.1_cds_NP_001292230.1_20207",0,1673,"Q3UXZ9","KDM5A_MOUSE","Lysine-specific demethylase 5A (EC 1.14.11.67) (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2) (RBBP-2) ([histone H3]-trimethyl-L-lysine(4) demethylase 5A)","Kdm5a Jarid1a Rbp2","Mus musculus (Mouse)",1690,"GO:0000122; GO:0000976; GO:0003682; GO:0003713; GO:0004857; GO:0005634; GO:0005654; GO:0005730; GO:0007283; GO:0008270; GO:0008584; GO:0031490; GO:0032453; GO:0032922; GO:0032993; GO:0034647; GO:0036211; GO:0042393; GO:0140718","circadian regulation of gene expression [GO:0032922]; facultative heterochromatin formation [GO:0140718]; male gonad development [GO:0008584]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein modification process [GO:0036211]; spermatogenesis [GO:0007283]","nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone H3K4 demethylase activity [GO:0032453]; histone H3K4me/H3K4me2/H3K4me3 demethylase activity [GO:0034647]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; facultative heterochromatin formation [GO:0140718]; male gonad development [GO:0008584]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein modification process [GO:0036211]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in the brain, with very high levels in the hippocampus. {ECO:0000269|PubMed:33350388}."
"463","sp|P62325|BTG1_MOUSE","lcl|NC_088856.1_cds_NP_001295821.1_19946",3.41e-47,153,"P62325","BTG1_MOUSE","Protein BTG1 (B-cell translocation gene 1 protein)","Btg1","Mus musculus (Mouse)",171,"GO:0005634; GO:0005737; GO:0006979; GO:0007283; GO:0008283; GO:0008285; GO:0019899; GO:0043085; GO:0043434; GO:0045603; GO:0045663; GO:0045766; GO:2000271","cell population proliferation [GO:0008283]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of angiogenesis [GO:0045766]; positive regulation of catalytic activity [GO:0043085]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of myoblast differentiation [GO:0045663]; response to oxidative stress [GO:0006979]; response to peptide hormone [GO:0043434]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; cell population proliferation [GO:0008283]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of angiogenesis [GO:0045766]; positive regulation of catalytic activity [GO:0043085]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of myoblast differentiation [GO:0045663]; response to oxidative stress [GO:0006979]; response to peptide hormone [GO:0043434]; spermatogenesis [GO:0007283]","","","",""
"464","sp|P57097|MERTK_RAT","lcl|NC_088856.1_cds_XP_011412768.3_21352",3.05e-66,244,"P57097","MERTK_RAT","Tyrosine-protein kinase Mer (EC 2.7.10.1) (Proto-oncogene c-Mer) (Receptor tyrosine kinase MerTK)","Mertk Mer","Rattus norvegicus (Rat)",994,"GO:0001750; GO:0001779; GO:0001818; GO:0004714; GO:0005524; GO:0005615; GO:0005737; GO:0005886; GO:0006909; GO:0007169; GO:0007283; GO:0007399; GO:0016477; GO:0030168; GO:0032940; GO:0034446; GO:0043235; GO:0043277; GO:0046649; GO:0050766; GO:0051250; GO:0051649; GO:0051897; GO:0060041; GO:0060068; GO:0097350; GO:2000107","apoptotic cell clearance [GO:0043277]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; establishment of localization in cell [GO:0051649]; lymphocyte activation [GO:0046649]; natural killer cell differentiation [GO:0001779]; negative regulation of cytokine production [GO:0001818]; negative regulation of leukocyte apoptotic process [GO:2000107]; negative regulation of lymphocyte activation [GO:0051250]; nervous system development [GO:0007399]; neutrophil clearance [GO:0097350]; phagocytosis [GO:0006909]; platelet activation [GO:0030168]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; retina development in camera-type eye [GO:0060041]; secretion by cell [GO:0032940]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; vagina development [GO:0060068]","cytoplasm [GO:0005737]; extracellular space [GO:0005615]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; apoptotic cell clearance [GO:0043277]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; establishment of localization in cell [GO:0051649]; lymphocyte activation [GO:0046649]; natural killer cell differentiation [GO:0001779]; negative regulation of cytokine production [GO:0001818]; negative regulation of leukocyte apoptotic process [GO:2000107]; negative regulation of lymphocyte activation [GO:0051250]; nervous system development [GO:0007399]; neutrophil clearance [GO:0097350]; phagocytosis [GO:0006909]; platelet activation [GO:0030168]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; retina development in camera-type eye [GO:0060041]; secretion by cell [GO:0032940]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; vagina development [GO:0060068]","","","",""
"465","sp|P28515|ELT1_CAEEL","lcl|NC_088856.1_cds_XP_011412781.1_18066",7.12e-56,191,"P28515","ELT1_CAEEL","Transcription factor elt-1","elt-1 W09C2.1","Caenorhabditis elegans",416,"GO:0000122; GO:0000978; GO:0000981; GO:0001162; GO:0005634; GO:0007286; GO:0008270; GO:0009957; GO:0019827; GO:0030424; GO:0043204; GO:0045165; GO:0045944","cell fate commitment [GO:0045165]; epidermal cell fate specification [GO:0009957]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatid development [GO:0007286]; stem cell population maintenance [GO:0019827]","axon [GO:0030424]; nucleus [GO:0005634]; perikaryon [GO:0043204]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; zinc ion binding [GO:0008270]; cell fate commitment [GO:0045165]; epidermal cell fate specification [GO:0009957]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatid development [GO:0007286]; stem cell population maintenance [GO:0019827]","DEVELOPMENTAL STAGE: Expressed from the 28 cell stage of embryogenesis in hypodermal and muscle precursor cells (at protein level) (PubMed:9224715). Expressed from the 20-30 cell stage of embryogenesis onwards (PubMed:16303852). At the beginning of the comma stage, expression decreases in the dorsal and ventral hypodermis, but remains high in the seam cells until the pretzel stage of embryogenesis (PubMed:16303852). Expressed in neuronal cells of the retrovesicular ganglion during the threefold stage of embryogenesis (PubMed:16303852). Expressed highly in seam cells and retrovesicular ganglion and ventral cord neuronal cells from the L1 stage of larval development to adult (PubMed:16303852). Expressed in the sperm-producing germ line in spermatogenesis during the L4 stage of larval development (PubMed:19591818). {ECO:0000269|PubMed:16303852, ECO:0000269|PubMed:19591818, ECO:0000269|PubMed:9224715}.","","","TISSUE SPECIFICITY: Expressed in ventral cord and retrovesicular ganglion neurons. Expressed in vulval muscles of hermaphrodites and lateral seam and tail seam cells of males. Expressed in spermatozoa within the spermatheca of hermaphrodites. {ECO:0000269|PubMed:16303852}."
"466","sp|Q9Y265|RUVB1_HUMAN","lcl|NC_088856.1_cds_XP_011412783.3_18072",0,830,"Q9Y265","RUVB1_HUMAN","RuvB-like 1 (EC 3.6.4.12) (49 kDa TATA box-binding protein-interacting protein) (49 kDa TBP-interacting protein) (54 kDa erythrocyte cytosolic protein) (ECP-54) (INO80 complex subunit H) (Nuclear matrix protein 238) (NMP 238) (Pontin 52) (TIP49a) (TIP60-associated protein 54-alpha) (TAP54-alpha)","RUVBL1 INO80H NMP238 TIP49 TIP49A","Homo sapiens (Human)",456,"GO:0000492; GO:0000723; GO:0000786; GO:0000812; GO:0001094; GO:0003678; GO:0003713; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0006355; GO:0006357; GO:0007283; GO:0016020; GO:0016363; GO:0016607; GO:0016887; GO:0017025; GO:0031011; GO:0033044; GO:0035267; GO:0036064; GO:0042981; GO:0043531; GO:0045296; GO:0045739; GO:0045893; GO:0045995; GO:0050821; GO:0051117; GO:0051301; GO:0051726; GO:0060382; GO:0070062; GO:0071339; GO:0090263; GO:0090671; GO:0097255; GO:0101031; GO:0120293; GO:1904507; GO:1905168; GO:1990062; GO:1990904; GO:2000779","box C/D snoRNP assembly [GO:0000492]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair [GO:2000779]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; telomerase RNA localization to Cajal body [GO:0090671]; telomere maintenance [GO:0000723]","centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular exosome [GO:0070062]; Ino80 complex [GO:0031011]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein folding chaperone complex [GO:0101031]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; Swr1 complex [GO:0000812]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; DNA helicase activity [GO:0003678]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713]; box C/D snoRNP assembly [GO:0000492]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair [GO:2000779]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; telomerase RNA localization to Cajal body [GO:0090671]; telomere maintenance [GO:0000723]","","","","TISSUE SPECIFICITY: Ubiquitously expressed with high expression in heart, skeletal muscle and testis."
"467","sp|Q8IYE0|CC146_HUMAN","lcl|NC_088856.1_cds_XP_011412785.1_18073",0,656,"Q8IYE0","CC146_HUMAN","Coiled-coil domain-containing protein 146","CCDC146 KIAA1505","Homo sapiens (Human)",955,"GO:0000902; GO:0005813; GO:0005814; GO:0005856; GO:0005930; GO:0006997; GO:0007286; GO:0007288; GO:0007338; GO:0008283; GO:0010467; GO:0030496; GO:0036064; GO:0036126; GO:0044877; GO:0120212; GO:0120316; GO:1905198","cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; gene expression [GO:0010467]; manchette assembly [GO:1905198]; nucleus organization [GO:0006997]; single fertilization [GO:0007338]; sperm axoneme assembly [GO:0007288]; sperm flagellum assembly [GO:0120316]; spermatid development [GO:0007286]","axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; midbody [GO:0030496]; sperm flagellum [GO:0036126]; sperm head-tail coupling apparatus [GO:0120212]; protein-containing complex binding [GO:0044877]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; gene expression [GO:0010467]; manchette assembly [GO:1905198]; nucleus organization [GO:0006997]; single fertilization [GO:0007338]; sperm axoneme assembly [GO:0007288]; sperm flagellum assembly [GO:0120316]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:38441556}."
"468","sp|Q9XTF3|MBK2_CAEEL","lcl|NC_088856.1_cds_XP_011415240.1_18856",0,644,"Q9XTF3","MBK2_CAEEL","Dual specificity tyrosine-phosphorylation-regulated kinase mbk-2 (EC 2.7.12.1) (Dual specificity Yak1-related kinase mbk-2) (Minibrain Kinase 2)","mbk-2 F49E11.1","Caenorhabditis elegans",817,"GO:0000281; GO:0000793; GO:0001556; GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0005813; GO:0005856; GO:0005938; GO:0007017; GO:0009792; GO:0009880; GO:0018108; GO:0032436; GO:0043186; GO:0045167; GO:0045732; GO:0072686; GO:0106310; GO:1903864","asymmetric protein localization involved in cell fate determination [GO:0045167]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic pattern specification [GO:0009880]; microtubule-based process [GO:0007017]; mitotic cytokinesis [GO:0000281]; oocyte maturation [GO:0001556]; P granule disassembly [GO:1903864]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]","cell cortex [GO:0005938]; centrosome [GO:0005813]; chromosome [GO:0005694]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; asymmetric protein localization involved in cell fate determination [GO:0045167]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic pattern specification [GO:0009880]; microtubule-based process [GO:0007017]; mitotic cytokinesis [GO:0000281]; oocyte maturation [GO:0001556]; P granule disassembly [GO:1903864]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. {ECO:0000269|PubMed:12618396}.","","","TISSUE SPECIFICITY: In L1 larvae, expressed widely in the nervous system, including head neurons and the ventral nerve cord. In adult animals, continues to be expressed in the nervous system and is also expressed in body wall muscle. {ECO:0000269|PubMed:12618396}."
"469","sp|P07664|SRYD_DROME","lcl|NC_088856.1_cds_XP_011416007.3_22017",4.81e-23,102,"P07664","SRYD_DROME","Serendipity locus protein delta (Serendipity-delta)","Sry-delta Sry-d CG17958","Drosophila melanogaster (Fruit fly)",433,"GO:0000977; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0005705; GO:0005829; GO:0006357; GO:0008270; GO:0008595; GO:0019953; GO:0045450; GO:0045944; GO:0048477","anterior/posterior axis specification, embryo [GO:0008595]; bicoid mRNA localization [GO:0045450]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sexual reproduction [GO:0019953]","cytosol [GO:0005829]; nucleus [GO:0005634]; polytene chromosome interband [GO:0005705]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; anterior/posterior axis specification, embryo [GO:0008595]; bicoid mRNA localization [GO:0045450]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sexual reproduction [GO:0019953]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. Found in ovaries and abundant in early embryos. Also found in variable amounts at every stage of the life cycle. {ECO:0000269|PubMed:2081456, ECO:0000269|PubMed:3935797, ECO:0000269|PubMed:6329730}.","","","TISSUE SPECIFICITY: Predominantly localized to the sub- and supraesophagal ganglia and the ventral nerve cord in the embryo, after dorsal closure. {ECO:0000269|PubMed:2081456}."
"470","sp|Q9D5S7|LRGUK_MOUSE","lcl|NC_088856.1_cds_XP_011416265.3_17924",1.43e-167,506,"Q9D5S7","LRGUK_MOUSE","Leucine-rich repeat and guanylate kinase domain-containing protein","Lrguk","Mus musculus (Mouse)",820,"GO:0001669; GO:0002177; GO:0005524; GO:0007283; GO:0016301; GO:0030154; GO:0035082; GO:0042995","axoneme assembly [GO:0035082]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","acrosomal vesicle [GO:0001669]; cell projection [GO:0042995]; manchette [GO:0002177]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; axoneme assembly [GO:0035082]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Detectable at low levels from birth, up-regulated at day 14 coincident with the appearance of pachytene spermatocytes, then maximal from day 18 coincident with the appearance of haploid germ cells (PubMed:25781171). {ECO:0000269|PubMed:25781171}.","","","TISSUE SPECIFICITY: Highly expressed in the testis (PubMed:25781171). During spermatid development is initially localized to a supra-nuclear region of round spermatids, and is particularly evident at the leading edge of the developing acrosome and acroplaxome. As maturation proceeded and nuclear elongation initiated, LRGUK moves distally to ultimately reside on the microtubules of the manchette. LRGUK is also evident in the sperm basal body and the sperm tail (PubMed:25781171). {ECO:0000269|PubMed:25781171}."
"471","sp|Q9R1M3|TSPY1_RAT","lcl|NC_088856.1_cds_XP_011419314.2_20598",5.48e-38,139,"Q9R1M3","TSPY1_RAT","Testis-specific Y-encoded protein 1 (rTSPY)","Tspy1 Tspy","Rattus norvegicus (Rat)",334,"GO:0000785; GO:0003682; GO:0005634; GO:0005737; GO:0006334; GO:0007283; GO:0007506; GO:0030154; GO:0042393","cell differentiation [GO:0030154]; gonadal mesoderm development [GO:0007506]; nucleosome assembly [GO:0006334]; spermatogenesis [GO:0007283]","chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; cell differentiation [GO:0030154]; gonadal mesoderm development [GO:0007506]; nucleosome assembly [GO:0006334]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Testis. {ECO:0000269|PubMed:9467017}."
"472","sp|Q95JL6|CCD38_MACFA","lcl|NC_088856.1_cds_XP_011420958.1_19194",1.16e-42,162,"Q95JL6","CCD38_MACFA","Coiled-coil domain-containing protein 38","CCDC38 QtsA-14402 QtsA-15696","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)",563,"GO:0001675; GO:0005813; GO:0031514; GO:0048471; GO:0061649; GO:0120316","acrosome assembly [GO:0001675]; sperm flagellum assembly [GO:0120316]","centrosome [GO:0005813]; motile cilium [GO:0031514]; perinuclear region of cytoplasm [GO:0048471]; ubiquitin-modified histone reader activity [GO:0061649]; acrosome assembly [GO:0001675]; sperm flagellum assembly [GO:0120316]","","","",""
"473","sp|Q9QYP2|CELR2_RAT","lcl|NC_088856.1_cds_XP_011424008.3_20012",0,1215,"Q9QYP2","CELR2_RAT","Cadherin EGF LAG seven-pass G-type receptor 2 (Multiple epidermal growth factor-like domains protein 3) (Multiple EGF-like domains protein 3)","Celsr2 Megf3","Rattus norvegicus (Rat)",2144,"GO:0003341; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0006355; GO:0007156; GO:0007283; GO:0016055; GO:0021591; GO:0021999; GO:0022407; GO:0032880; GO:0033326; GO:0048813; GO:0060271; GO:0097475","cerebrospinal fluid secretion [GO:0033326]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; dendrite morphogenesis [GO:0048813]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; motor neuron migration [GO:0097475]; neural plate anterior/posterior regionalization [GO:0021999]; regulation of cell-cell adhesion [GO:0022407]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein localization [GO:0032880]; spermatogenesis [GO:0007283]; ventricular system development [GO:0021591]; Wnt signaling pathway [GO:0016055]","cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; cerebrospinal fluid secretion [GO:0033326]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; dendrite morphogenesis [GO:0048813]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; motor neuron migration [GO:0097475]; neural plate anterior/posterior regionalization [GO:0021999]; regulation of cell-cell adhesion [GO:0022407]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein localization [GO:0032880]; spermatogenesis [GO:0007283]; ventricular system development [GO:0021591]; Wnt signaling pathway [GO:0016055]","","","","TISSUE SPECIFICITY: Expressed in the brain. High expression in cerebellum and olfactory bulb. Weaker expression in cerebral cortex, hippocampus and brain stem."
"474","sp|Q32LI5|MEIG1_BOVIN","lcl|NC_088856.1_cds_XP_011424191.3_21888",4.73e-28,98.2,"Q32LI5","MEIG1_BOVIN","Meiosis expressed gene 1 protein homolog","MEIG1","Bos taurus (Bovine)",88,"GO:0005634; GO:0007283; GO:0030154","cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","nucleus [GO:0005634]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","","","",""
"475","sp|Q6IV83|TAZ_GORGO","lcl|NC_088856.1_cds_XP_011427769.3_19417",1.13e-77,237,"Q6IV83","TAZ_GORGO","Tafazzin (Taz) (EC 2.3.1.-)","TAFAZZIN TAZ","Gorilla gorilla gorilla (Western lowland gorilla)",262,"GO:0005739; GO:0005741; GO:0005743; GO:0007007; GO:0031966; GO:0032048; GO:0035965; GO:0047184","cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin metabolic process [GO:0032048]; inner mitochondrial membrane organization [GO:0007007]","mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin metabolic process [GO:0032048]; inner mitochondrial membrane organization [GO:0007007]","","","",""
"476","sp|P25233|NECD_MOUSE","lcl|NC_088856.1_cds_XP_011427770.3_19416",1.66e-31,120,"P25233","NECD_MOUSE","Necdin","Ndn","Mus musculus (Mouse)",325,"GO:0000122; GO:0001764; GO:0003016; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006355; GO:0007409; GO:0007413; GO:0007417; GO:0007585; GO:0008347; GO:0009791; GO:0016363; GO:0019233; GO:0030182; GO:0032991; GO:0042995; GO:0043015; GO:0045944; GO:0048011; GO:0048666; GO:0048675; GO:0048871; GO:0071514; GO:1990841","axon extension [GO:0048675]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; genomic imprinting [GO:0071514]; glial cell migration [GO:0008347]; multicellular organismal-level homeostasis [GO:0048871]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of DNA-templated transcription [GO:0006355]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory system process [GO:0003016]; sensory perception of pain [GO:0019233]","cell projection [GO:0042995]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; gamma-tubulin binding [GO:0043015]; promoter-specific chromatin binding [GO:1990841]; axon extension [GO:0048675]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; genomic imprinting [GO:0071514]; glial cell migration [GO:0008347]; multicellular organismal-level homeostasis [GO:0048871]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of DNA-templated transcription [GO:0006355]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory system process [GO:0003016]; sensory perception of pain [GO:0019233]","DEVELOPMENTAL STAGE: Expression levels were high during embryonic and neonatal periods (14 dpc to P7) and decreased thereafter.","","","TISSUE SPECIFICITY: Brain specific. Not detected in other tissues. Expressed in postmitotic neurons. In adult brain the highest expression is in hypothalamus. Highly expressed in thalamus and midbrain. Relatively low levels are in cerebral cortex, hippocampus, striatum, olfactory bulb, cerebellum, pons and spinal cord. Also detected in neurally differentiated embryonal carcinoma cells."
"477","sp|P49953|WT1_SMIMA","lcl|NC_088856.1_cds_XP_011428991.3_19534",1.51e-31,119,"P49953","WT1_SMIMA","Wilms tumor protein homolog","WT1","Sminthopsis macroura (Stripe-faced dunnart)",239,"GO:0000976; GO:0000978; GO:0001228; GO:0001570; GO:0001657; GO:0001658; GO:0003156; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0007281; GO:0007356; GO:0007507; GO:0007530; GO:0008270; GO:0008380; GO:0008406; GO:0009888; GO:0010385; GO:0016607; GO:0017148; GO:0030308; GO:0030325; GO:0030539; GO:0030855; GO:0032835; GO:0035802; GO:0043010; GO:0043065; GO:0043066; GO:0043565; GO:0044729; GO:0045892; GO:0045893; GO:0060231; GO:0060421; GO:0060539; GO:0061032; GO:0071371; GO:0072075; GO:0072112; GO:0072166; GO:0072284; GO:0072302; GO:2000020; GO:2000195; GO:2001076","adrenal cortex formation [GO:0035802]; adrenal gland development [GO:0030325]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye development [GO:0043010]; cellular response to gonadotropin stimulus [GO:0071371]; diaphragm development [GO:0060539]; epithelial cell differentiation [GO:0030855]; germ cell development [GO:0007281]; glomerulus development [GO:0032835]; gonad development [GO:0008406]; heart development [GO:0007507]; male genitalia development [GO:0030539]; mesenchymal to epithelial transition [GO:0060231]; metanephric mesenchyme development [GO:0072075]; metanephric S-shaped body morphogenesis [GO:0072284]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of female gonad development [GO:2000195]; negative regulation of metanephric glomerular mesangial cell proliferation [GO:0072302]; negative regulation of translation [GO:0017148]; podocyte differentiation [GO:0072112]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of heart growth [GO:0060421]; positive regulation of male gonad development [GO:2000020]; positive regulation of metanephric ureteric bud development [GO:2001076]; posterior mesonephric tubule development [GO:0072166]; regulation of animal organ formation [GO:0003156]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]; sex determination [GO:0007530]; thorax and anterior abdomen determination [GO:0007356]; tissue development [GO:0009888]; ureteric bud development [GO:0001657]; vasculogenesis [GO:0001570]; visceral serous pericardium development [GO:0061032]","cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; adrenal cortex formation [GO:0035802]; adrenal gland development [GO:0030325]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye development [GO:0043010]; cellular response to gonadotropin stimulus [GO:0071371]; diaphragm development [GO:0060539]; epithelial cell differentiation [GO:0030855]; germ cell development [GO:0007281]; glomerulus development [GO:0032835]; gonad development [GO:0008406]; heart development [GO:0007507]; male genitalia development [GO:0030539]; mesenchymal to epithelial transition [GO:0060231]; metanephric mesenchyme development [GO:0072075]; metanephric S-shaped body morphogenesis [GO:0072284]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of female gonad development [GO:2000195]; negative regulation of metanephric glomerular mesangial cell proliferation [GO:0072302]; negative regulation of translation [GO:0017148]; podocyte differentiation [GO:0072112]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of heart growth [GO:0060421]; positive regulation of male gonad development [GO:2000020]; positive regulation of metanephric ureteric bud development [GO:2001076]; posterior mesonephric tubule development [GO:0072166]; regulation of animal organ formation [GO:0003156]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]; sex determination [GO:0007530]; thorax and anterior abdomen determination [GO:0007356]; tissue development [GO:0009888]; ureteric bud development [GO:0001657]; vasculogenesis [GO:0001570]; visceral serous pericardium development [GO:0061032]","","","",""
"478","sp|Q9WUQ1|ATS1_RAT","lcl|NC_088856.1_cds_XP_011434412.3_19037",1.35e-178,568,"Q9WUQ1","ATS1_RAT","A disintegrin and metalloproteinase with thrombospondin motifs 1 (ADAM-TS 1) (ADAM-TS1) (ADAMTS-1) (EC 3.4.24.-)","Adamts1","Rattus norvegicus (Rat)",967,"GO:0001542; GO:0001822; GO:0004222; GO:0005576; GO:0005604; GO:0006508; GO:0008201; GO:0008270; GO:0010976; GO:0016525; GO:0030198; GO:0031012; GO:0031410; GO:0060347; GO:0071305; GO:0071374; GO:0071380; GO:1900087; GO:1904707; GO:1904754","cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to vitamin D [GO:0071305]; extracellular matrix organization [GO:0030198]; heart trabecula formation [GO:0060347]; kidney development [GO:0001822]; negative regulation of angiogenesis [GO:0016525]; ovulation from ovarian follicle [GO:0001542]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of neuron projection development [GO:0010976]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; proteolysis [GO:0006508]","basement membrane [GO:0005604]; cytoplasmic vesicle [GO:0031410]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to vitamin D [GO:0071305]; extracellular matrix organization [GO:0030198]; heart trabecula formation [GO:0060347]; kidney development [GO:0001822]; negative regulation of angiogenesis [GO:0016525]; ovulation from ovarian follicle [GO:0001542]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of neuron projection development [GO:0010976]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; proteolysis [GO:0006508]","","INDUCTION: Down-regulated in endothelial cells derived from cirrhotic liver.","INDUCTION: Down-regulated in endothelial cells derived from cirrhotic liver.",""
"479","sp|P18105|NOD_DROME","lcl|NC_088856.1_cds_XP_011436794.3_20540",1.74e-51,194,"P18105","NOD_DROME","Kinesin-like protein Nod","nod NODA CG1763","Drosophila melanogaster (Fruit fly)",666,"GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0007057; GO:0007143; GO:0008017; GO:0016887; GO:0031116; GO:0032837; GO:0045132; GO:0051010; GO:0051296","distributive segregation [GO:0032837]; establishment of meiotic spindle orientation [GO:0051296]; female meiotic nuclear division [GO:0007143]; meiotic chromosome segregation [GO:0045132]; microtubule-based movement [GO:0007018]; positive regulation of microtubule polymerization [GO:0031116]; spindle assembly involved in female meiosis I [GO:0007057]","cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; distributive segregation [GO:0032837]; establishment of meiotic spindle orientation [GO:0051296]; female meiotic nuclear division [GO:0007143]; meiotic chromosome segregation [GO:0045132]; microtubule-based movement [GO:0007018]; positive regulation of microtubule polymerization [GO:0031116]; spindle assembly involved in female meiosis I [GO:0007057]","DEVELOPMENTAL STAGE: Embryonic, larval, and pupal stages. Only expressed in female adults.","","","TISSUE SPECIFICITY: In adult female, found in meiotically active ovaries."
"480","sp|Q9W2N0|CAPZA_DROME","lcl|NC_088856.1_cds_XP_011436798.1_20549",5.62e-141,399,"Q9W2N0","CAPZA_DROME","F-actin-capping protein subunit alpha","cpa CG10540","Drosophila melanogaster (Fruit fly)",286,"GO:0003779; GO:0007015; GO:0007294; GO:0008290; GO:0010591; GO:0016324; GO:0030018; GO:0030036; GO:0030837; GO:0035220; GO:0046329; GO:0046982; GO:0051016; GO:0051489; GO:0051490; GO:0051491; GO:0071203; GO:0140591","actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; barbed-end actin filament capping [GO:0051016]; germarium-derived oocyte fate determination [GO:0007294]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of JNK cascade [GO:0046329]; nuclear envelope budding [GO:0140591]; positive regulation of filopodium assembly [GO:0051491]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; wing disc development [GO:0035220]","apical plasma membrane [GO:0016324]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]; Z disc [GO:0030018]; actin binding [GO:0003779]; protein heterodimerization activity [GO:0046982]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; barbed-end actin filament capping [GO:0051016]; germarium-derived oocyte fate determination [GO:0007294]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of JNK cascade [GO:0046329]; nuclear envelope budding [GO:0140591]; positive regulation of filopodium assembly [GO:0051491]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; wing disc development [GO:0035220]","","","",""
"481","sp|A4D7T3|ASZ1_NOTEU","lcl|NC_088856.1_cds_XP_011444398.2_19152",4.09e-55,193,"A4D7T3","ASZ1_NOTEU","Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein)","ASZ1 GASZ","Notamacropus eugenii (Tammar wallaby) (Macropus eugenii)",475,"GO:0007140; GO:0007283; GO:0010526; GO:0030154; GO:0031047; GO:0071546","cell differentiation [GO:0030154]; male meiotic nuclear division [GO:0007140]; regulatory ncRNA-mediated gene silencing [GO:0031047]; spermatogenesis [GO:0007283]; transposable element silencing [GO:0010526]","pi-body [GO:0071546]; cell differentiation [GO:0030154]; male meiotic nuclear division [GO:0007140]; regulatory ncRNA-mediated gene silencing [GO:0031047]; spermatogenesis [GO:0007283]; transposable element silencing [GO:0010526]","","","",""
"482","sp|Q9U3V9|XMAS_DROME","lcl|NC_088856.1_cds_XP_011444408.2_19162",1.39e-85,314,"Q9U3V9","XMAS_DROME","Protein xmas","xmas xmas-1 xmas-2 CG46386","Drosophila melanogaster (Fruit fly)",2079,"GO:0003723; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0006406; GO:0007283; GO:0016973; GO:0031965; GO:0034399; GO:0043021; GO:0045944; GO:0048477; GO:0070390","mRNA export from nucleus [GO:0006406]; oogenesis [GO:0048477]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; oogenesis [GO:0048477]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Detected in embryos (at protein level). {ECO:0000269|PubMed:18034162, ECO:0000269|PubMed:27016737}.; DEVELOPMENTAL STAGE: [Isoform C]: Not detected in embryos (at protein level). {ECO:0000269|PubMed:29779104}.; DEVELOPMENTAL STAGE: [Isoform A]: Detected in embryos (at protein level). {ECO:0000269|PubMed:29779104}.","","","TISSUE SPECIFICITY: Expressed in ovaries (at protein level). {ECO:0000269|PubMed:28472469}.; TISSUE SPECIFICITY: [Isoform C]: Detected in the testes and ovaries, with expression levels higher in oocytes than in testicular cells (at protein level). {ECO:0000269|PubMed:29779104}.; TISSUE SPECIFICITY: [Isoform A]: Detected in the testes and ovaries (at protein level). {ECO:0000269|PubMed:29779104}.; TISSUE SPECIFICITY: [Isoform B]: Detected in the testes. {ECO:0000269|PubMed:29779104}."
"483","sp|Q8ICR0|CDPK2_PLAF7","lcl|NC_088856.1_cds_XP_011444543.1_19493",4.73e-67,220,"Q8ICR0","CDPK2_PLAF7","Calcium-dependent protein kinase 2 (EC 2.7.11.1) (PfCDPK2)","CDPK2 CPK2 MAL6P1.108 PF3D7_0610600 PFF0520w","Plasmodium falciparum (isolate 3D7)",513,"GO:0004683; GO:0005509; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0009931; GO:0035556; GO:0048232; GO:0106310","intracellular signal transduction [GO:0035556]; male gamete generation [GO:0048232]; protein phosphorylation [GO:0006468]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; protein serine kinase activity [GO:0106310]; intracellular signal transduction [GO:0035556]; male gamete generation [GO:0048232]; protein phosphorylation [GO:0006468]","DEVELOPMENTAL STAGE: During the asexual blood stage, expressed in schizonts and to a lower extend in trophozoites (at protein level) (PubMed:29042501). Expressed in gametocytes during the sexual blood stage (at protein level) (PubMed:10760601, PubMed:29042501). {ECO:0000269|PubMed:10760601, ECO:0000269|PubMed:29042501}.","","",""
"484","sp|P30121|TIMP2_RAT","lcl|NC_088856.1_cds_XP_011447814.3_20381",1.02e-19,85.9,"P30121","TIMP2_RAT","Metalloproteinase inhibitor 2 (Tissue inhibitor of metalloproteinases 2) (TIMP-2)","Timp2 Timp-2","Rattus norvegicus (Rat)",220,"GO:0002020; GO:0005178; GO:0005604; GO:0005615; GO:0007283; GO:0008047; GO:0008191; GO:0008270; GO:0008285; GO:0009410; GO:0009725; GO:0009986; GO:0030414; GO:0030426; GO:0031012; GO:0032487; GO:0034097; GO:0043025; GO:0043408; GO:0043410; GO:0045664; GO:0045666; GO:0045861; GO:0045930; GO:0046580; GO:0051045; GO:0140678","negative regulation of cell population proliferation [GO:0008285]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of proteolysis [GO:0045861]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; regulation of MAPK cascade [GO:0043408]; regulation of neuron differentiation [GO:0045664]; regulation of Rap protein signal transduction [GO:0032487]; response to cytokine [GO:0034097]; response to hormone [GO:0009725]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]","basement membrane [GO:0005604]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; enzyme activator activity [GO:0008047]; integrin binding [GO:0005178]; metalloendopeptidase inhibitor activity [GO:0008191]; molecular function inhibitor activity [GO:0140678]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; zinc ion binding [GO:0008270]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of proteolysis [GO:0045861]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; regulation of MAPK cascade [GO:0043408]; regulation of neuron differentiation [GO:0045664]; regulation of Rap protein signal transduction [GO:0032487]; response to cytokine [GO:0034097]; response to hormone [GO:0009725]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]","","","",""
"485","sp|Q9Z2D6|MECP2_MOUSE","lcl|NC_088856.1_cds_XP_011447845.3_20402",1.15e-18,90.9,"Q9Z2D6","MECP2_MOUSE","Methyl-CpG-binding protein 2 (MeCp-2 protein) (MeCp2)","Mecp2","Mus musculus (Mouse)",484,"GO:0000122; GO:0000792; GO:0001662; GO:0001666; GO:0001964; GO:0001976; GO:0002087; GO:0003677; GO:0003682; GO:0003714; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006020; GO:0006357; GO:0006541; GO:0006576; GO:0006641; GO:0007219; GO:0007268; GO:0007416; GO:0007420; GO:0007585; GO:0007612; GO:0007613; GO:0007616; GO:0008104; GO:0008211; GO:0008283; GO:0008306; GO:0008327; GO:0008344; GO:0008542; GO:0009791; GO:0010385; GO:0010467; GO:0010468; GO:0014009; GO:0016358; GO:0016525; GO:0019230; GO:0019233; GO:0021549; GO:0021591; GO:0030182; GO:0031175; GO:0031507; GO:0032048; GO:0033555; GO:0035176; GO:0035197; GO:0040029; GO:0042551; GO:0043524; GO:0043537; GO:0044027; GO:0045892; GO:0045893; GO:0045944; GO:0046470; GO:0048167; GO:0050432; GO:0050884; GO:0050905; GO:0051151; GO:0051707; GO:0060079; GO:0060252; GO:0060291; GO:0071514; GO:0090063; GO:0098794; GO:0099191; GO:0140566; GO:0140693; GO:1990841","adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; behavioral fear response [GO:0001662]; biogenic amine metabolic process [GO:0006576]; brain development [GO:0007420]; cardiolipin metabolic process [GO:0032048]; catecholamine secretion [GO:0050432]; cell population proliferation [GO:0008283]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; dendrite development [GO:0016358]; epigenetic regulation of gene expression [GO:0040029]; excitatory postsynaptic potential [GO:0060079]; gene expression [GO:0010467]; genomic imprinting [GO:0071514]; glial cell proliferation [GO:0014009]; glucocorticoid metabolic process [GO:0008211]; glutamine metabolic process [GO:0006541]; heterochromatin formation [GO:0031507]; inositol metabolic process [GO:0006020]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuromuscular process [GO:0050905]; neuromuscular process controlling posture [GO:0050884]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; Notch signaling pathway [GO:0007219]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; proprioception [GO:0019230]; protein localization [GO:0008104]; regulation of gene expression [GO:0010468]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to hypoxia [GO:0001666]; response to other organism [GO:0051707]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; startle response [GO:0001964]; synapse assembly [GO:0007416]; trans-synaptic signaling by BDNF [GO:0099191]; triglyceride metabolic process [GO:0006641]; ventricular system development [GO:0021591]; visual learning [GO:0008542]","centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; histone reader activity [GO:0140566]; methyl-CpG binding [GO:0008327]; molecular condensate scaffold activity [GO:0140693]; mRNA binding [GO:0003729]; promoter-specific chromatin binding [GO:1990841]; siRNA binding [GO:0035197]; transcription corepressor activity [GO:0003714]; adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; behavioral fear response [GO:0001662]; biogenic amine metabolic process [GO:0006576]; brain development [GO:0007420]; cardiolipin metabolic process [GO:0032048]; catecholamine secretion [GO:0050432]; cell population proliferation [GO:0008283]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; dendrite development [GO:0016358]; epigenetic regulation of gene expression [GO:0040029]; excitatory postsynaptic potential [GO:0060079]; gene expression [GO:0010467]; genomic imprinting [GO:0071514]; glial cell proliferation [GO:0014009]; glucocorticoid metabolic process [GO:0008211]; glutamine metabolic process [GO:0006541]; heterochromatin formation [GO:0031507]; inositol metabolic process [GO:0006020]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuromuscular process [GO:0050905]; neuromuscular process controlling posture [GO:0050884]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; Notch signaling pathway [GO:0007219]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; proprioception [GO:0019230]; protein localization [GO:0008104]; regulation of gene expression [GO:0010468]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to hypoxia [GO:0001666]; response to other organism [GO:0051707]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; startle response [GO:0001964]; synapse assembly [GO:0007416]; trans-synaptic signaling by BDNF [GO:0099191]; triglyceride metabolic process [GO:0006641]; ventricular system development [GO:0021591]; visual learning [GO:0008542]","","","",""
"486","sp|Q9EQQ0|SUV92_MOUSE","lcl|NC_088856.1_cds_XP_011449544.3_21203",4.35e-106,330,"Q9EQQ0","SUV92_MOUSE","Histone-lysine N-methyltransferase SUV39H2 (EC 2.1.1.355) (Histone H3-K9 methyltransferase 2) (H3-K9-HMTase 2) (Suppressor of variegation 3-9 homolog 2) (Su(var)3-9 homolog 2)","Suv39h2","Mus musculus (Mouse)",477,"GO:0000122; GO:0000775; GO:0000785; GO:0000792; GO:0000976; GO:0000977; GO:0003682; GO:0005634; GO:0006325; GO:0006338; GO:0007140; GO:0007623; GO:0008270; GO:0008276; GO:0030154; GO:0032259; GO:0045814; GO:0045892; GO:0046974; GO:0071456; GO:0140938; GO:0140947; GO:0140949","cell differentiation [GO:0030154]; cellular response to hypoxia [GO:0071456]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; circadian rhythm [GO:0007623]; male meiotic nuclear division [GO:0007140]; methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]","chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; heterochromatin [GO:0000792]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone H3 methyltransferase activity [GO:0140938]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9 trimethyltransferase activity [GO:0140949]; histone H3K9me2 methyltransferase activity [GO:0140947]; protein methyltransferase activity [GO:0008276]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cellular response to hypoxia [GO:0071456]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; circadian rhythm [GO:0007623]; male meiotic nuclear division [GO:0007140]; methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]","DEVELOPMENTAL STAGE: Strong expression in early embryos with a peak at 10.5 dpc. Expression is down-regulated at 17.5 dpc, and is nearly absent during postnatal development. In adult testes, prominent expression in late but not early spermatocytes.","","","TISSUE SPECIFICITY: Testis specific; predominant expression in type B spermatogonia and preleptotene spermatocytes."
"487","sp|Q9NDM2|GUTR1_DROME","lcl|NC_088856.1_cds_XP_011453334.3_18184",2.35e-21,95.1,"Q9NDM2","GUTR1_DROME","Protein trapped in endoderm-1","Tre1 CG3171","Drosophila melanogaster (Fruit fly)",392,"GO:0004930; GO:0005886; GO:0005938; GO:0007186; GO:0007281; GO:0008354; GO:0016020; GO:0035234","ectopic germ cell programmed cell death [GO:0035234]; G protein-coupled receptor signaling pathway [GO:0007186]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]","cell cortex [GO:0005938]; membrane [GO:0016020]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; ectopic germ cell programmed cell death [GO:0035234]; G protein-coupled receptor signaling pathway [GO:0007186]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically throughout embryo to adult stages. {ECO:0000269|PubMed:14691551}.","","","TISSUE SPECIFICITY: In embryos, expression is seen at highest levels in the cuprophilic cells and at lower levels in the amnioserosa, developing CNS, cardiac mesoderm primordium and midline glia. {ECO:0000269|PubMed:14691551}."
"488","sp|T2HG31|OXDA_DUGRY","lcl|NC_088856.1_cds_XP_011453356.3_18209",1.43e-63,206,"T2HG31","OXDA_DUGRY","D-amino acid oxidase (DAAO) (DAMOX) (DAO) (EC 1.4.3.3) (DrDAO)","daao","Dugesia ryukyuensis (Freshwater planarian flatworm)",332,"GO:0003884; GO:0005782; GO:0019478; GO:0043799; GO:0048599; GO:0071949; GO:1905939","D-amino acid catabolic process [GO:0019478]; oocyte development [GO:0048599]; regulation of gonad development [GO:1905939]","peroxisomal matrix [GO:0005782]; D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949]; glycine oxidase activity [GO:0043799]; D-amino acid catabolic process [GO:0019478]; oocyte development [GO:0048599]; regulation of gonad development [GO:1905939]","DEVELOPMENTAL STAGE: More highly expressed in asexual worms than sexual worms (PubMed:24434168). Highly expressed in the developing ovaries (PubMed:24434168). {ECO:0000269|PubMed:24434168}.","","",""
"489","sp|Q8CIW6|S26A6_MOUSE","lcl|NC_088856.1_cds_XP_011454958.3_20695",3.98e-111,357,"Q8CIW6","S26A6_MOUSE","Solute carrier family 26 member 6 (Anion exchange transporter) (Chloride-formate exchanger) (Pendrin-L1) (Pendrin-like protein 1) (Putative anion transporter-1) (Pat-1)","Slc26a6 Cfex Pat1","Mus musculus (Mouse)",758,"GO:0005254; GO:0005452; GO:0005783; GO:0005829; GO:0005886; GO:0006821; GO:0008271; GO:0012506; GO:0015106; GO:0015108; GO:0015116; GO:0015499; GO:0015562; GO:0015701; GO:0015724; GO:0015797; GO:0016020; GO:0016323; GO:0016324; GO:0019531; GO:0019532; GO:0030165; GO:0030321; GO:0030659; GO:0031526; GO:0031982; GO:0034707; GO:0038166; GO:0042045; GO:0044849; GO:0046724; GO:0048240; GO:0050892; GO:0051453; GO:0051454; GO:0051649; GO:0070528; GO:0070633; GO:0071320; GO:0071332; GO:0071346; GO:0097225; GO:0140900; GO:1902358; GO:2001150","angiotensin-activated signaling pathway [GO:0038166]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to fructose stimulus [GO:0071332]; cellular response to type II interferon [GO:0071346]; chloride transport [GO:0006821]; epithelial fluid transport [GO:0042045]; establishment of localization in cell [GO:0051649]; estrous cycle [GO:0044849]; formate transport [GO:0015724]; intestinal absorption [GO:0050892]; intracellular pH elevation [GO:0051454]; mannitol transmembrane transport [GO:0015797]; oxalate transport [GO:0019532]; oxalic acid secretion [GO:0046724]; positive regulation of dipeptide transmembrane transport [GO:2001150]; protein kinase C signaling [GO:0070528]; regulation of intracellular pH [GO:0051453]; sperm capacitation [GO:0048240]; sulfate transmembrane transport [GO:1902358]; transepithelial chloride transport [GO:0030321]; transepithelial transport [GO:0070633]","apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; chloride:bicarbonate antiporter activity [GO:0140900]; efflux transmembrane transporter activity [GO:0015562]; formate transmembrane transporter activity [GO:0015499]; oxalate transmembrane transporter activity [GO:0019531]; PDZ domain binding [GO:0030165]; secondary active sulfate transmembrane transporter activity [GO:0008271]; solute:inorganic anion antiporter activity [GO:0005452]; sulfate transmembrane transporter activity [GO:0015116]; angiotensin-activated signaling pathway [GO:0038166]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to fructose stimulus [GO:0071332]; cellular response to type II interferon [GO:0071346]; chloride transport [GO:0006821]; epithelial fluid transport [GO:0042045]; establishment of localization in cell [GO:0051649]; estrous cycle [GO:0044849]; formate transport [GO:0015724]; intestinal absorption [GO:0050892]; intracellular pH elevation [GO:0051454]; mannitol transmembrane transport [GO:0015797]; oxalate transport [GO:0019532]; oxalic acid secretion [GO:0046724]; positive regulation of dipeptide transmembrane transport [GO:2001150]; protein kinase C signaling [GO:0070528]; regulation of intracellular pH [GO:0051453]; sperm capacitation [GO:0048240]; sulfate transmembrane transport [GO:1902358]; transepithelial chloride transport [GO:0030321]; transepithelial transport [GO:0070633]","","INDUCTION: Up-regulated by dietary fructose intake (at protein level). {ECO:0000269|PubMed:18496516}.","INDUCTION: Up-regulated by dietary fructose intake (at protein level). {ECO:0000269|PubMed:18496516}.","TISSUE SPECIFICITY: Expressed in kidney (at protein level). Expressed in spermatogenic cells. Expressed in intestine, kidney, testis, brain, muscle, heart, and stomach. Expressed in the submandibular and sublingual salivary glands. {ECO:0000269|PubMed:11842009, ECO:0000269|PubMed:12217875, ECO:0000269|PubMed:17170027, ECO:0000269|PubMed:21976599, ECO:0000269|PubMed:23933580, ECO:0000269|PubMed:29530983}.; TISSUE SPECIFICITY: [Isoform 2]: Highly expressed in stomach, kidney, heart and small intestine, low in the lung, liver, testis, brain, skeletal muscle and colon. {ECO:0000269|PubMed:11459928, ECO:0000269|PubMed:23933580}.; TISSUE SPECIFICITY: [Isoform 4]: Expressed in the heart. {ECO:0000269|PubMed:23933580}.; TISSUE SPECIFICITY: [Isoform 5]: Expressed in the heart. {ECO:0000269|PubMed:23933580}."
"490","sp|O76742|RAB7_DROME","lcl|NC_088856.1_cds_XP_011455069.1_18457",5.77e-113,322,"O76742","RAB7_DROME","Ras-related protein Rab7 (DRab7) (EC 3.6.5.2) (Small monomeric GTPase Rab7) (Small ras-like GTPase)","Rab7 Rab-7 Rab-r7 Rab7A CG5915","Drosophila melanogaster (Fruit fly)",207,"GO:0000421; GO:0003924; GO:0005525; GO:0005764; GO:0005770; GO:0005886; GO:0005938; GO:0006897; GO:0006909; GO:0007298; GO:0008333; GO:0015031; GO:0016192; GO:0016197; GO:0031901; GO:0031902; GO:0031982; GO:0032456; GO:0032482; GO:0032510; GO:0033292; GO:0034058; GO:0042995; GO:0043025; GO:0043204; GO:0044877; GO:0045202; GO:0045335; GO:0046718; GO:0048190; GO:0061883; GO:0061909; GO:0090385; GO:0098793; GO:0120281; GO:0160156; GO:1990182","autophagosome-lysosome fusion [GO:0061909]; border follicle cell migration [GO:0007298]; clathrin-dependent endocytosis involved in vitellogenesis [GO:0061883]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; exosomal secretion [GO:1990182]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; secretory granule-lysosome fusion [GO:0160156]; symbiont entry into host cell [GO:0046718]; T-tubule organization [GO:0033292]; vesicle-mediated transport [GO:0016192]; wing disc dorsal/ventral pattern formation [GO:0048190]","autolysosome membrane [GO:0120281]; autophagosome membrane [GO:0000421]; cell cortex [GO:0005938]; cell projection [GO:0042995]; early endosome membrane [GO:0031901]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex binding [GO:0044877]; autophagosome-lysosome fusion [GO:0061909]; border follicle cell migration [GO:0007298]; clathrin-dependent endocytosis involved in vitellogenesis [GO:0061883]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; exosomal secretion [GO:1990182]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; secretory granule-lysosome fusion [GO:0160156]; symbiont entry into host cell [GO:0046718]; T-tubule organization [GO:0033292]; vesicle-mediated transport [GO:0016192]; wing disc dorsal/ventral pattern formation [GO:0048190]","DEVELOPMENTAL STAGE: During pupal development expressed in the brain (at protein level) (PubMed:24327558). Enriched in the presynaptic boutons of larval motor neurons and in the surrounding muscle cells (at protein level) (PubMed:24327558, PubMed:32658990). Expressed in 3rd instar larvae (at protein level) (PubMed:27559127). {ECO:0000269|PubMed:24327558, ECO:0000269|PubMed:27559127, ECO:0000269|PubMed:32658990}.","","","TISSUE SPECIFICITY: Expressed in eye (at protein level). {ECO:0000269|PubMed:24327558}."
"491","sp|Q9U3A0|PAN1_CAEEL","lcl|NC_088856.1_cds_XP_011457141.3_18658",3.1e-20,97.1,"Q9U3A0","PAN1_CAEEL","P-granule-associated novel protein 1","pan-1 M88.6","Caenorhabditis elegans",594,"GO:0005737; GO:0005886; GO:0007281; GO:0016324; GO:0017151; GO:0018996; GO:0043186","germ cell development [GO:0007281]; molting cycle, collagen and cuticulin-based cuticle [GO:0018996]","apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; P granule [GO:0043186]; plasma membrane [GO:0005886]; DEAD/H-box RNA helicase binding [GO:0017151]; germ cell development [GO:0007281]; molting cycle, collagen and cuticulin-based cuticle [GO:0018996]","DEVELOPMENTAL STAGE: Expressed at all developmental stages from embryos undergoing morphogenesis to gravid adults (PubMed:23682709). Broadly expressed in embryos and early larvae, but expression decreases in late larvae and adults (PubMed:33950834). Expressed in seam cells during larval development (PubMed:33950834). Expressed in DD GABAergic motor neurons in L1 and L2 stage larva (PubMed:33950834). During larval stage L1, expressed in the pharynx and in intestinal cells (PubMed:22342905). Expressed most strongly during mid-to-late intermolt periods (at protein level) (PubMed:23682709). {ECO:0000269|PubMed:22342905, ECO:0000269|PubMed:23682709, ECO:0000269|PubMed:33950834}.","","","TISSUE SPECIFICITY: [Isoform a]: Expressed in the germline and somatic cells (PubMed:22342905). {ECO:0000269|PubMed:22342905}.; TISSUE SPECIFICITY: [Isoform b]: Expressed in the germline and somatic cells (PubMed:22342905). Expressed at higher levels in germline cells relative to somatic cells (PubMed:22342905). {ECO:0000269|PubMed:22342905}.; TISSUE SPECIFICITY: [Isoform c]: Expressed in germline cells (PubMed:22342905). {ECO:0000269|PubMed:22342905}.; TISSUE SPECIFICITY: Highly expressed in the pharynx and at lower levels in the intestine, but not detected in other tissues (PubMed:22342905). Other studies suggest a broader expression pattern in somatic tissues: from embryogenesis to adult stages, expressed strongly in body wall muscle, vulva, somatic gonad and pharynx, at lower levels in the nerve ring, hypodermis, and rectal epithelia, and very weakly in the intestine (PubMed:23682709). {ECO:0000269|PubMed:22342905, ECO:0000269|PubMed:23682709}."
"492","sp|Q9V6G5|TAZ_DROME","lcl|NC_088856.1_cds_XP_019922906.3_19418",1.15e-67,216,"Q9V6G5","TAZ_DROME","Tafazzin (TAZ) (dTAZ) (EC 2.3.1.-)","Taz CG8766","Drosophila melanogaster (Fruit fly)",378,"GO:0000139; GO:0005739; GO:0005741; GO:0005743; GO:0005758; GO:0005783; GO:0005789; GO:0005794; GO:0006644; GO:0007006; GO:0007007; GO:0007291; GO:0008374; GO:0016746; GO:0031966; GO:0032048; GO:0032049; GO:0032577; GO:0035965; GO:0047184","cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin biosynthetic process [GO:0032049]; cardiolipin metabolic process [GO:0032048]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial membrane organization [GO:0007006]; phospholipid metabolic process [GO:0006644]; sperm individualization [GO:0007291]","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; acyltransferase activity [GO:0016746]; O-acyltransferase activity [GO:0008374]; phosphatidylcholine:cardiolipin O-linoleoyltransferase activity [GO:0032577]; cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin biosynthetic process [GO:0032049]; cardiolipin metabolic process [GO:0032048]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial membrane organization [GO:0007006]; phospholipid metabolic process [GO:0006644]; sperm individualization [GO:0007291]","","","",""
"493","sp|Q6B966|NAL14_MOUSE","lcl|NC_088856.1_cds_XP_019923778.3_19544",3.11e-23,107,"Q6B966","NAL14_MOUSE","NACHT, LRR and PYD domains-containing protein 14 (NALP-iota) (Germ cell specific leucine-rich repeat NTPase)","Nlrp14 Nalp14","Mus musculus (Mouse)",993,"GO:0005524; GO:0005737; GO:0007283; GO:0030154","cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Not detected in ovaries from neonates. First detected in ovaries three days after birth, and expression in ovaries increases dramatically to reach a much higher level eight days after birth. {ECO:0000269|PubMed:15590904}.","","","TISSUE SPECIFICITY: Detected in adult ovary and testis. Detected in oocytes and in germ cell elements in seminiferous tubules in adult testis (at protein level). {ECO:0000269|PubMed:15590904}."
"494","sp|Q32P12|HROB_MOUSE","lcl|NC_088856.1_cds_XP_019930216.3_18210",8.64e-29,123,"Q32P12","HROB_MOUSE","Homologous recombination OB-fold protein","Hrob","Mus musculus (Mouse)",615,"GO:0000725; GO:0000731; GO:0003697; GO:0005634; GO:0007292; GO:0036297; GO:0048232; GO:0090734","DNA synthesis involved in DNA repair [GO:0000731]; female gamete generation [GO:0007292]; interstrand cross-link repair [GO:0036297]; male gamete generation [GO:0048232]; recombinational repair [GO:0000725]","nucleus [GO:0005634]; site of DNA damage [GO:0090734]; single-stranded DNA binding [GO:0003697]; DNA synthesis involved in DNA repair [GO:0000731]; female gamete generation [GO:0007292]; interstrand cross-link repair [GO:0036297]; male gamete generation [GO:0048232]; recombinational repair [GO:0000725]","","","",""
"495","sp|Q9JMD2|SMBT1_RAT","lcl|NC_088856.1_cds_XP_034304535.2_19290",0,560,"Q9JMD2","SMBT1_RAT","Scm-like with four MBT domains protein 1","Sfmbt1","Rattus norvegicus (Rat)",863,"GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635","cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; spermatogenesis [GO:0007283]","nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Highly expressed in the testis, low expression was detected in brain, kidney, heart and lung. {ECO:0000269|PubMed:10806358}."
"496","sp|P05154|IPSP_HUMAN","lcl|NC_088856.1_cds_XP_034304753.2_21667",7.96e-44,157,"P05154","IPSP_HUMAN","Plasma serine protease inhibitor (Acrosomal serine protease inhibitor) (Plasminogen activator inhibitor 3) (PAI-3) (PAI3) (Protein C inhibitor) (PCI) (Serpin A5)","SERPINA5 PCI PLANH3 PROCI","Homo sapiens (Human)",406,"GO:0001972; GO:0002020; GO:0002080; GO:0004867; GO:0005539; GO:0005576; GO:0005615; GO:0006869; GO:0007283; GO:0007342; GO:0008201; GO:0009897; GO:0016020; GO:0031091; GO:0031094; GO:0031210; GO:0032190; GO:0032991; GO:0036024; GO:0036025; GO:0036026; GO:0036027; GO:0036028; GO:0036029; GO:0036030; GO:0051346; GO:0070062; GO:0097181; GO:0097182; GO:0097183","fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; lipid transport [GO:0006869]; negative regulation of hydrolase activity [GO:0051346]; spermatogenesis [GO:0007283]","acrosomal membrane [GO:0002080]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule [GO:0031091]; platelet dense tubular network [GO:0031094]; protein C inhibitor-coagulation factor V complex [GO:0097181]; protein C inhibitor-coagulation factor Xa complex [GO:0097182]; protein C inhibitor-coagulation factor XI complex [GO:0097183]; protein C inhibitor-KLK3 complex [GO:0036029]; protein C inhibitor-plasma kallikrein complex [GO:0036030]; protein C inhibitor-PLAT complex [GO:0036026]; protein C inhibitor-PLAU complex [GO:0036027]; protein C inhibitor-thrombin complex [GO:0036028]; protein C inhibitor-TMPRSS11E complex [GO:0036025]; protein C inhibitor-TMPRSS7 complex [GO:0036024]; protein-containing complex [GO:0032991]; acrosin binding [GO:0032190]; glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201]; phosphatidylcholine binding [GO:0031210]; protease binding [GO:0002020]; retinoic acid binding [GO:0001972]; serine-type endopeptidase inhibitor activity [GO:0004867]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; lipid transport [GO:0006869]; negative regulation of hydrolase activity [GO:0051346]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Predominantly expressed in the epithelium of seminal vesicles. Expressed in the proximal tubular epithelium of the kidney. Expressed in the superficial and more differentiated epidermal keratinocytes of the skin. Expressed in megakaryocytes and platelets. Expressed poorly in kidney tumor cells compared to non tumor kidney tissues. Expressed in spermatozoa. Present in very high concentration in seminal plasma. Present in high concentration in plasma, synovial and Graaf follicle fluids. Present in low concentration in breast milk and in amniotic fluids. Present in very low concentration in urine, cerebrospinal fluids, saliva and tears (at protein level). Strongly expressed in liver. Expressed in kidney, spleen, pancreas, skeletal muscle, heart, testes, ovary, interstitial Leydig cells, epididymal glands, seminal vesicles and prostate. {ECO:0000269|PubMed:1372913, ECO:0000269|PubMed:14696115, ECO:0000269|PubMed:15140131, ECO:0000269|PubMed:17706750, ECO:0000269|PubMed:18467335, ECO:0000269|PubMed:9510955, ECO:0000269|PubMed:9556620}."
"497","sp|P48148|RHO1_DROME","lcl|NC_088856.1_cds_XP_034304815.1_21586",5.61e-127,356,"P48148","RHO1_DROME","Ras-like GTP-binding protein Rho1","Rho1 CG8416","Drosophila melanogaster (Fruit fly)",192,"GO:0000281; GO:0001745; GO:0003383; GO:0003779; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006897; GO:0007015; GO:0007165; GO:0007264; GO:0007298; GO:0007349; GO:0007368; GO:0007370; GO:0007374; GO:0007377; GO:0007391; GO:0007395; GO:0007405; GO:0007411; GO:0007422; GO:0007424; GO:0007435; GO:0007480; GO:0007601; GO:0008045; GO:0008104; GO:0008347; GO:0009611; GO:0010004; GO:0016324; GO:0016328; GO:0016476; GO:0016477; GO:0019900; GO:0019901; GO:0030030; GO:0030036; GO:0030334; GO:0030589; GO:0030866; GO:0030950; GO:0032456; GO:0032956; GO:0034334; GO:0035006; GO:0035099; GO:0035149; GO:0035159; GO:0035202; GO:0035277; GO:0035298; GO:0035317; GO:0042060; GO:0042249; GO:0044291; GO:0045179; GO:0045184; GO:0045199; GO:0046663; GO:0048812; GO:0048813; GO:0050770; GO:0051017; GO:0051489; GO:0051493; GO:0070252; GO:0070451; GO:0070593; GO:0071896; GO:0071902; GO:0090090; GO:0090251; GO:0090254; GO:0090303; GO:0090688; GO:0110020; GO:1901739; GO:1902408; GO:1903475; GO:1904059","actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin-mediated cell contraction [GO:0070252]; adherens junction maintenance [GO:0034334]; apical constriction [GO:0003383]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell migration [GO:0016477]; cell projection organization [GO:0030030]; cellularization [GO:0007349]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; determination of left/right symmetry [GO:0007368]; dorsal closure [GO:0007391]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of planar polarity of embryonic epithelium [GO:0042249]; establishment of protein localization [GO:0045184]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; gastrulation involving germ band extension [GO:0010004]; germ-band extension [GO:0007377]; glial cell migration [GO:0008347]; hemocyte migration [GO:0035099]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing hair organization [GO:0035317]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; melanization defense response [GO:0035006]; mitotic actomyosin contractile ring assembly [GO:1903475]; mitotic cytokinesis [GO:0000281]; mitotic cytokinesis, division site positioning [GO:1902408]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neuroblast proliferation [GO:0007405]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; posterior midgut invagination [GO:0007374]; protein localization [GO:0008104]; protein localization involved in establishment of planar polarity [GO:0090251]; protein localization to adherens junction [GO:0071896]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actomyosin structure organization [GO:0110020]; regulation of axonogenesis [GO:0050770]; regulation of cell migration [GO:0030334]; regulation of cytoskeleton organization [GO:0051493]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; regulation of locomotor rhythm [GO:1904059]; regulation of Malpighian tubule size [GO:0035298]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; response to wounding [GO:0009611]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264]; spiracle morphogenesis, open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]; ventral furrow formation [GO:0007370]; visual perception [GO:0007601]; wound healing [GO:0042060]","apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cell hair [GO:0070451]; cell-cell contact zone [GO:0044291]; cleavage furrow rim [GO:0090688]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin-mediated cell contraction [GO:0070252]; adherens junction maintenance [GO:0034334]; apical constriction [GO:0003383]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell migration [GO:0016477]; cell projection organization [GO:0030030]; cellularization [GO:0007349]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; determination of left/right symmetry [GO:0007368]; dorsal closure [GO:0007391]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of planar polarity of embryonic epithelium [GO:0042249]; establishment of protein localization [GO:0045184]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; gastrulation involving germ band extension [GO:0010004]; germ-band extension [GO:0007377]; glial cell migration [GO:0008347]; hemocyte migration [GO:0035099]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing hair organization [GO:0035317]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; melanization defense response [GO:0035006]; mitotic actomyosin contractile ring assembly [GO:1903475]; mitotic cytokinesis [GO:0000281]; mitotic cytokinesis, division site positioning [GO:1902408]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neuroblast proliferation [GO:0007405]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; posterior midgut invagination [GO:0007374]; protein localization [GO:0008104]; protein localization involved in establishment of planar polarity [GO:0090251]; protein localization to adherens junction [GO:0071896]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actomyosin structure organization [GO:0110020]; regulation of axonogenesis [GO:0050770]; regulation of cell migration [GO:0030334]; regulation of cytoskeleton organization [GO:0051493]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; regulation of locomotor rhythm [GO:1904059]; regulation of Malpighian tubule size [GO:0035298]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; response to wounding [GO:0009611]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264]; spiracle morphogenesis, open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]; ventral furrow formation [GO:0007370]; visual perception [GO:0007601]; wound healing [GO:0042060]","","","","TISSUE SPECIFICITY: Expressed in hemocytes (at protein level). {ECO:0000269|PubMed:25739458}."
"498","sp|P08645|RAP1_DROME","lcl|NC_088856.1_cds_XP_034304844.1_21569",3.28e-105,301,"P08645","RAP1_DROME","Ras-related protein Rap1 (EC 3.6.5.2) (Rap1 GTPase) (Ras-like protein 3)","Rap1 R RAP ras3 CG1956","Drosophila melanogaster (Fruit fly)",184,"GO:0003924; GO:0003925; GO:0005525; GO:0005634; GO:0005829; GO:0005886; GO:0006930; GO:0007298; GO:0007391; GO:0007465; GO:0007601; GO:0008293; GO:0016318; GO:0016476; GO:0019003; GO:0019901; GO:0022409; GO:0030718; GO:0031252; GO:0032486; GO:0034333; GO:0035099; GO:0035317; GO:0035331; GO:0045874; GO:0045880; GO:0070374; GO:0071320; GO:2000301","adherens junction assembly [GO:0034333]; border follicle cell migration [GO:0007298]; cellular response to cAMP [GO:0071320]; dorsal closure [GO:0007391]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair organization [GO:0035317]; negative regulation of hippo signaling [GO:0035331]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; ommatidial rotation [GO:0016318]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; positive regulation of smoothened signaling pathway [GO:0045880]; R7 cell fate commitment [GO:0007465]; Rap protein signal transduction [GO:0032486]; regulation of embryonic cell shape [GO:0016476]; substrate-dependent cell migration, cell extension [GO:0006930]; torso signaling pathway [GO:0008293]; visual perception [GO:0007601]","cell leading edge [GO:0031252]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; adherens junction assembly [GO:0034333]; border follicle cell migration [GO:0007298]; cellular response to cAMP [GO:0071320]; dorsal closure [GO:0007391]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair organization [GO:0035317]; negative regulation of hippo signaling [GO:0035331]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; ommatidial rotation [GO:0016318]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; positive regulation of smoothened signaling pathway [GO:0045880]; R7 cell fate commitment [GO:0007465]; Rap protein signal transduction [GO:0032486]; regulation of embryonic cell shape [GO:0016476]; substrate-dependent cell migration, cell extension [GO:0006930]; torso signaling pathway [GO:0008293]; visual perception [GO:0007601]","","","",""
"499","sp|Q9VJD3|COG5_DROME","lcl|NC_088856.1_cds_XP_034305422.2_21334",7.07e-74,257,"Q9VJD3","COG5_DROME","Conserved oligomeric Golgi complex subunit 5 (COG complex subunit 5) (Component of oligomeric Golgi complex 5) (Protein four way stop)","fws CG6549","Drosophila melanogaster (Fruit fly)",751,"GO:0000139; GO:0000212; GO:0000916; GO:0001675; GO:0005794; GO:0006891; GO:0007110; GO:0007111; GO:0007112; GO:0007290; GO:0015031; GO:0017119; GO:0070971","acrosome assembly [GO:0001675]; actomyosin contractile ring contraction [GO:0000916]; intra-Golgi vesicle-mediated transport [GO:0006891]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; meiotic spindle organization [GO:0000212]; protein transport [GO:0015031]; spermatid nucleus elongation [GO:0007290]","endoplasmic reticulum exit site [GO:0070971]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; acrosome assembly [GO:0001675]; actomyosin contractile ring contraction [GO:0000916]; intra-Golgi vesicle-mediated transport [GO:0006891]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; meiotic spindle organization [GO:0000212]; protein transport [GO:0015031]; spermatid nucleus elongation [GO:0007290]","DEVELOPMENTAL STAGE: Expressed in embryos, and adult males and females. {ECO:0000269|PubMed:12529436}.","","",""
"500","sp|Q9GZV8|PRD14_HUMAN","lcl|NC_088856.1_cds_XP_034305780.2_20776",3.88e-171,494,"Q9GZV8","PRD14_HUMAN","PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14)","PRDM14","Homo sapiens (Human)",571,"GO:0000122; GO:0000902; GO:0000977; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0007281; GO:0007566; GO:0008168; GO:0008270; GO:0008543; GO:0009566; GO:0030718; GO:0031490; GO:0032259; GO:0040037; GO:0043231; GO:0045814; GO:0048873; GO:0141107; GO:1902093; GO:1902459; GO:1990226","cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; homeostasis of number of cells within a tissue [GO:0048873]; inner cell mass cell fate commitment [GO:0001827]; methylation [GO:0032259]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription by RNA polymerase II [GO:0006357]","intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; histone methyltransferase binding [GO:1990226]; methyltransferase activity [GO:0008168]; methyltransferase regulator activity [GO:0141107]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; homeostasis of number of cells within a tissue [GO:0048873]; inner cell mass cell fate commitment [GO:0001827]; methylation [GO:0032259]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription by RNA polymerase II [GO:0006357]","","","","TISSUE SPECIFICITY: Expressed in embryonic stem cells. Tends to be overexpressed in breast cancer (at protein level). {ECO:0000269|PubMed:17942894, ECO:0000269|PubMed:20953172}."
"501","sp|P23634|AT2B4_HUMAN","lcl|NC_088856.1_cds_XP_034306059.2_18769",0,1342,"P23634","AT2B4_HUMAN","Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4)","ATP2B4 ATP2B2 MXRA1","Homo sapiens (Human)",1241,"GO:0003407; GO:0005388; GO:0005516; GO:0005524; GO:0005739; GO:0005886; GO:0005901; GO:0005929; GO:0006357; GO:0006874; GO:0007283; GO:0010629; GO:0014832; GO:0015085; GO:0016020; GO:0016323; GO:0016525; GO:0016887; GO:0017080; GO:0019901; GO:0021766; GO:0030018; GO:0030165; GO:0030315; GO:0030317; GO:0030346; GO:0032991; GO:0034220; GO:0036064; GO:0036126; GO:0036487; GO:0038060; GO:0043231; GO:0043537; GO:0045019; GO:0045121; GO:0046872; GO:0048787; GO:0050998; GO:0051480; GO:0051599; GO:0070588; GO:0070885; GO:0071872; GO:0071878; GO:0097110; GO:0097228; GO:0097553; GO:0098703; GO:0098736; GO:0098978; GO:0150104; GO:1900082; GO:1901660; GO:1902305; GO:1902548; GO:1902806; GO:1903078; GO:1903243; GO:1903249; GO:1903779; GO:1905145","calcium ion export [GO:1901660]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of angiogenesis [GO:0016525]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; nitric oxide-cGMP-mediated signaling [GO:0038060]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of cardiac conduction [GO:1903779]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104]; urinary bladder smooth muscle contraction [GO:0014832]","basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; P-type calcium transporter activity [GO:0005388]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080]; calcium ion export [GO:1901660]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of angiogenesis [GO:0016525]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; nitric oxide-cGMP-mediated signaling [GO:0038060]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of cardiac conduction [GO:1903779]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104]; urinary bladder smooth muscle contraction [GO:0014832]","","","","TISSUE SPECIFICITY: Isoform XB is the most abundant isoform and is expressed ubiquitously. Isoforms containing segment Z have only been detected in heart, while isoforms containing segment a have been found in heart, stomach and brain cortex. {ECO:0000269|PubMed:1531651}."
"502","sp|Q6Q477|AT2B4_MOUSE","lcl|NC_088856.1_cds_XP_034306061.2_18773",0,1306,"Q6Q477","AT2B4_MOUSE","Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10)","Atp2b4","Mus musculus (Mouse)",1205,"GO:0003407; GO:0005388; GO:0005516; GO:0005524; GO:0005739; GO:0005886; GO:0006357; GO:0006816; GO:0006874; GO:0007283; GO:0010629; GO:0014832; GO:0016323; GO:0016525; GO:0016887; GO:0019901; GO:0021766; GO:0030018; GO:0030165; GO:0030315; GO:0030317; GO:0030346; GO:0036064; GO:0036126; GO:0036487; GO:0038060; GO:0042383; GO:0043537; GO:0045019; GO:0045121; GO:0046872; GO:0048787; GO:0050998; GO:0051599; GO:0070885; GO:0071872; GO:0071878; GO:0097228; GO:0098736; GO:0098978; GO:1900082; GO:1901660; GO:1902548; GO:1902806; GO:1903078; GO:1903243; GO:1903249; GO:1905145","calcium ion export [GO:1901660]; calcium ion transport [GO:0006816]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; intracellular calcium ion homeostasis [GO:0006874]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of angiogenesis [GO:0016525]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; nitric oxide-cGMP-mediated signaling [GO:0038060]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; urinary bladder smooth muscle contraction [GO:0014832]","basolateral plasma membrane [GO:0016323]; ciliary basal body [GO:0036064]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; sarcolemma [GO:0042383]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; P-type calcium transporter activity [GO:0005388]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; calcium ion export [GO:1901660]; calcium ion transport [GO:0006816]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; intracellular calcium ion homeostasis [GO:0006874]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of angiogenesis [GO:0016525]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; nitric oxide-cGMP-mediated signaling [GO:0038060]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; urinary bladder smooth muscle contraction [GO:0014832]","","","","TISSUE SPECIFICITY: Specifically expressed by sperm in testis (at protein level). {ECO:0000269|PubMed:15078889}."
"503","sp|P07992|ERCC1_HUMAN","lcl|NC_088856.1_cds_XP_034306165.2_21114",3.24e-102,303,"P07992","ERCC1_HUMAN","DNA excision repair protein ERCC-1","ERCC1","Homo sapiens (Human)",297,"GO:0000109; GO:0000110; GO:0000720; GO:0000781; GO:0001094; GO:0003684; GO:0003697; GO:0005654; GO:0005737; GO:0006281; GO:0006289; GO:0006303; GO:0006312; GO:0006949; GO:0006979; GO:0007283; GO:0008283; GO:0008340; GO:0008584; GO:0009650; GO:0010165; GO:0032205; GO:0035166; GO:0035264; GO:0036297; GO:0045190; GO:0048009; GO:0048477; GO:0060261; GO:0061819; GO:0070522; GO:0070914; GO:0090399; GO:0090656; GO:1904431; GO:1905765; GO:1990841","cell population proliferation [GO:0008283]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; male gonad development [GO:0008584]; mitotic recombination [GO:0006312]; multicellular organism growth [GO:0035264]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; nucleotide-excision repair [GO:0006289]; oogenesis [GO:0048477]; positive regulation of t-circle formation [GO:1904431]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; post-embryonic hemopoiesis [GO:0035166]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; replicative senescence [GO:0090399]; response to oxidative stress [GO:0006979]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; syncytium formation [GO:0006949]; t-circle formation [GO:0090656]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914]","chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ERCC4-ERCC1 complex [GO:0070522]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]; damaged DNA binding [GO:0003684]; promoter-specific chromatin binding [GO:1990841]; single-stranded DNA binding [GO:0003697]; TFIID-class transcription factor complex binding [GO:0001094]; cell population proliferation [GO:0008283]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; male gonad development [GO:0008584]; mitotic recombination [GO:0006312]; multicellular organism growth [GO:0035264]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; nucleotide-excision repair [GO:0006289]; oogenesis [GO:0048477]; positive regulation of t-circle formation [GO:1904431]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; post-embryonic hemopoiesis [GO:0035166]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; replicative senescence [GO:0090399]; response to oxidative stress [GO:0006979]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; syncytium formation [GO:0006949]; t-circle formation [GO:0090656]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914]","","","",""
"504","sp|Q5SV06|SPT22_MOUSE","lcl|NC_088856.1_cds_XP_034306185.2_21244",1.32e-20,94.4,"Q5SV06","SPT22_MOUSE","Spermatogenesis-associated protein 22","Spata22 Gm882 Repro42","Mus musculus (Mouse)",358,"GO:0000711; GO:0005694; GO:0007129; GO:0007276; GO:0009566; GO:0048137; GO:0051445; GO:0061458","fertilization [GO:0009566]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic DNA repair synthesis [GO:0000711]; regulation of meiotic cell cycle [GO:0051445]; reproductive system development [GO:0061458]; spermatocyte division [GO:0048137]","chromosome [GO:0005694]; fertilization [GO:0009566]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic DNA repair synthesis [GO:0000711]; regulation of meiotic cell cycle [GO:0051445]; reproductive system development [GO:0061458]; spermatocyte division [GO:0048137]","DEVELOPMENTAL STAGE: In testis, weakly present from 8 dpp, and readily detectable from 10 dpp, with expression sustained through adulthood. Present in all populations of spermatocytes (at protein level). {ECO:0000269|PubMed:22011390}.","","","TISSUE SPECIFICITY: Specifically expressed in gonadal germ cells, when male and female germ cells progress through prophase of meiosis I. {ECO:0000269|PubMed:22011390}."
"505","sp|Q8I0G5|COPG_DROME","lcl|NC_088856.1_cds_XP_034306248.1_18995",0,1058,"Q8I0G5","COPG_DROME","Coatomer subunit gamma (Gamma-coat protein) (Gamma-COP)","gammaCOP copg gamma-Cop CG1528","Drosophila melanogaster (Fruit fly)",883,"GO:0000139; GO:0005198; GO:0005783; GO:0005793; GO:0005794; GO:0005801; GO:0006886; GO:0006888; GO:0006891; GO:0007112; GO:0007424; GO:0007436; GO:0008362; GO:0009306; GO:0010883; GO:0030126; GO:0030198; GO:0035147; GO:0035149; GO:0035158; GO:0036063; GO:0072384","branch fusion, open tracheal system [GO:0035147]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; extracellular matrix organization [GO:0030198]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; larval salivary gland morphogenesis [GO:0007436]; lumen formation, open tracheal system [GO:0035149]; male meiosis cytokinesis [GO:0007112]; open tracheal system development [GO:0007424]; organelle transport along microtubule [GO:0072384]; protein secretion [GO:0009306]; regulation of lipid storage [GO:0010883]; regulation of tube diameter, open tracheal system [GO:0035158]","acroblast [GO:0036063]; cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; structural molecule activity [GO:0005198]; branch fusion, open tracheal system [GO:0035147]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; extracellular matrix organization [GO:0030198]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; larval salivary gland morphogenesis [GO:0007436]; lumen formation, open tracheal system [GO:0035149]; male meiosis cytokinesis [GO:0007112]; open tracheal system development [GO:0007424]; organelle transport along microtubule [GO:0072384]; protein secretion [GO:0009306]; regulation of lipid storage [GO:0010883]; regulation of tube diameter, open tracheal system [GO:0035158]","DEVELOPMENTAL STAGE: Expressed during spermatogenesis and at later stages of oogenesis. During embryonic and larval development, expressed ubiquitously. Starting at stage 10 embryos and lasting until the end of embryonic development, strongly expressed in the salivary glands and in cells of the presumptive proventriculus. Maternal expression abundant in early embryos. Zygotic expression commences in the epidermis and salivary glands from stage 11, initiates in the trachea at stage 13, and at early stage 15 is also detected in the foregut and hindgut tubes. {ECO:0000269|PubMed:16169286, ECO:0000269|PubMed:18398480}.","","","TISSUE SPECIFICITY: Expressed in ovary, testis, testis tip, young spermatocytes, germ cells and follicle cells. Up-regulated expression within centrally to posteriorly located germarial cysts and in migrating follicle cells. Widespread expression in imaginal disks including eye-antennal disk, wing disk, third leg and haltere disk. {ECO:0000269|PubMed:16169286}."
"506","sp|Q8TC44|POC1B_HUMAN","lcl|NC_088856.1_cds_XP_034306516.2_19186",1.74e-174,499,"Q8TC44","POC1B_HUMAN","POC1 centriolar protein homolog B (Pix1) (Proteome of centriole protein 1B) (WD repeat-containing protein 51B)","POC1B WDR51B","Homo sapiens (Human)",478,"GO:0000902; GO:0000922; GO:0001675; GO:0001895; GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0007338; GO:0008283; GO:0036064; GO:0048872; GO:0060271; GO:0120316; GO:1903724","acrosome assembly [GO:0001675]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; centriole replication [GO:0007099]; cilium assembly [GO:0060271]; homeostasis of number of cells [GO:0048872]; positive regulation of centriole elongation [GO:1903724]; retina homeostasis [GO:0001895]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316]","centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]; acrosome assembly [GO:0001675]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; centriole replication [GO:0007099]; cilium assembly [GO:0060271]; homeostasis of number of cells [GO:0048872]; positive regulation of centriole elongation [GO:1903724]; retina homeostasis [GO:0001895]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316]","","","","TISSUE SPECIFICITY: Expressed in the retina. {ECO:0000269|PubMed:25044745}."
"507","sp|Q8JZX3|POC1A_MOUSE","lcl|NC_088856.1_cds_XP_034306517.2_19187",0,552,"Q8JZX3","POC1A_MOUSE","POC1 centriolar protein homolog A (WD repeat-containing protein 51A)","Poc1a Wdr51a","Mus musculus (Mouse)",405,"GO:0000922; GO:0003431; GO:0005737; GO:0005813; GO:0005814; GO:0007052; GO:0007283; GO:0010825; GO:0036064; GO:0060348; GO:1905515","bone development [GO:0060348]; growth plate cartilage chondrocyte development [GO:0003431]; mitotic spindle organization [GO:0007052]; non-motile cilium assembly [GO:1905515]; positive regulation of centrosome duplication [GO:0010825]; spermatogenesis [GO:0007283]","centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]; bone development [GO:0060348]; growth plate cartilage chondrocyte development [GO:0003431]; mitotic spindle organization [GO:0007052]; non-motile cilium assembly [GO:1905515]; positive regulation of centrosome duplication [GO:0010825]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Widely expressed in embryonic and adult tissues. {ECO:0000269|PubMed:22840364}."
"508","sp|A8E0R9|GRIP2_XENLA","lcl|NC_088856.1_cds_XP_034306737.2_19782",0,607,"A8E0R9","GRIP2_XENLA","Glutamate receptor-interacting protein 2 (xGRIP2) (xGRIP2.1)","grip2 grip2.1","Xenopus laevis (African clawed frog)",1083,"GO:0005737; GO:0005938; GO:0007281; GO:0008354; GO:0032019; GO:0045495; GO:0098887","germ cell development [GO:0007281]; germ cell migration [GO:0008354]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]","cell cortex [GO:0005938]; cytoplasm [GO:0005737]; mitochondrial cloud [GO:0032019]; pole plasm [GO:0045495]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]","DEVELOPMENTAL STAGE: Expressed maternally. Prominent in the egg and during early cleavage stages. Expression decreases slightly between neurula and late tailbud stage before elevating again at the tadpole stages. {ECO:0000269|PubMed:17320814, ECO:0000269|PubMed:17924960, ECO:0000269|PubMed:17936745}.","","","TISSUE SPECIFICITY: Enriched in the mitochondrial cloud of stage I oocytes, before becoming concentrated at the tip of the vegetal cortex in stage II oocytes. Expression becomes localized to the germ plasm of stage III-IV oocytes and early cleavage stages. At the tailbud stage, localizes to the migrating primordial germ cells (PGCs) until PGC migration is complete (stage 40), at which point expression disappears. In the adult, expressed in the brain, ovary, eye, muscle, spinal cord and very weakly in adipocytes. {ECO:0000269|PubMed:17320814, ECO:0000269|PubMed:17924960, ECO:0000269|PubMed:17936745}."
"509","sp|P11346|KRAF1_DROME","lcl|NC_088856.1_cds_XP_034306749.1_19774",0,550,"P11346","KRAF1_DROME","Raf homolog serine/threonine-protein kinase Raf (D-Raf) (dRAF-1) (EC 2.7.11.1) (Protein pole-hole)","Raf ph phl CG2845","Drosophila melanogaster (Fruit fly)",739,"GO:0000165; GO:0002168; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007173; GO:0007265; GO:0007283; GO:0007298; GO:0007362; GO:0007369; GO:0007427; GO:0007430; GO:0007465; GO:0007472; GO:0007474; GO:0007476; GO:0007552; GO:0008069; GO:0008270; GO:0008284; GO:0008293; GO:0008543; GO:0009267; GO:0016242; GO:0019900; GO:0030641; GO:0035171; GO:0035309; GO:0040014; GO:0042051; GO:0042386; GO:0042461; GO:0045500; GO:0046530; GO:0046534; GO:0046843; GO:0048010; GO:0070371; GO:0070374; GO:0106310; GO:2001234","border follicle cell migration [GO:0007298]; cellular response to starvation [GO:0009267]; compound eye photoreceptor development [GO:0042051]; dorsal appendage formation [GO:0046843]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gastrulation [GO:0007369]; hemocyte differentiation [GO:0042386]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; instar larval development [GO:0002168]; lamellocyte differentiation [GO:0035171]; MAPK cascade [GO:0000165]; metamorphosis [GO:0007552]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of macroautophagy [GO:0016242]; photoreceptor cell development [GO:0042461]; photoreceptor cell differentiation [GO:0046530]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of photoreceptor cell differentiation [GO:0046534]; R7 cell fate commitment [GO:0007465]; Ras protein signal transduction [GO:0007265]; regulation of cellular pH [GO:0030641]; regulation of multicellular organism growth [GO:0040014]; sevenless signaling pathway [GO:0045500]; spermatogenesis [GO:0007283]; terminal branching, open tracheal system [GO:0007430]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wing and notum subfield formation [GO:0035309]; wing disc morphogenesis [GO:0007472]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; kinase binding [GO:0019900]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; border follicle cell migration [GO:0007298]; cellular response to starvation [GO:0009267]; compound eye photoreceptor development [GO:0042051]; dorsal appendage formation [GO:0046843]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gastrulation [GO:0007369]; hemocyte differentiation [GO:0042386]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; instar larval development [GO:0002168]; lamellocyte differentiation [GO:0035171]; MAPK cascade [GO:0000165]; metamorphosis [GO:0007552]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of macroautophagy [GO:0016242]; photoreceptor cell development [GO:0042461]; photoreceptor cell differentiation [GO:0046530]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of photoreceptor cell differentiation [GO:0046534]; R7 cell fate commitment [GO:0007465]; Ras protein signal transduction [GO:0007265]; regulation of cellular pH [GO:0030641]; regulation of multicellular organism growth [GO:0040014]; sevenless signaling pathway [GO:0045500]; spermatogenesis [GO:0007283]; terminal branching, open tracheal system [GO:0007430]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wing and notum subfield formation [GO:0035309]; wing disc morphogenesis [GO:0007472]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. Zygotically expressed throughout embryogenesis. {ECO:0000269|PubMed:3135183, ECO:0000269|PubMed:8423783}.","","",""
"510","sp|Q07292|KRAF1_CAEEL","lcl|NC_088856.1_cds_XP_034306751.1_19776",1.27e-118,375,"Q07292","KRAF1_CAEEL","Raf homolog serine/threonine-protein kinase (EC 2.7.11.1) (Abnormal cell lineage protein 45)","lin-45 raf-1 Y73B6A.5","Caenorhabditis elegans",813,"GO:0000165; GO:0001708; GO:0002119; GO:0004709; GO:0005524; GO:0005737; GO:0007265; GO:0008270; GO:0022414; GO:0031267; GO:0040025; GO:0048477; GO:0050830; GO:0051321; GO:0106310","cell fate specification [GO:0001708]; defense response to Gram-positive bacterium [GO:0050830]; MAPK cascade [GO:0000165]; meiotic cell cycle [GO:0051321]; nematode larval development [GO:0002119]; oogenesis [GO:0048477]; Ras protein signal transduction [GO:0007265]; reproductive process [GO:0022414]; vulval development [GO:0040025]","cytoplasm [GO:0005737]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]; cell fate specification [GO:0001708]; defense response to Gram-positive bacterium [GO:0050830]; MAPK cascade [GO:0000165]; meiotic cell cycle [GO:0051321]; nematode larval development [GO:0002119]; oogenesis [GO:0048477]; Ras protein signal transduction [GO:0007265]; reproductive process [GO:0022414]; vulval development [GO:0040025]","","","",""
"511","sp|F1N206|DLDH_BOVIN","lcl|NC_088856.1_cds_XP_034307071.1_20500",0,741,"F1N206","DLDH_BOVIN","Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase)","DLD","Bos taurus (Bovine)",509,"GO:0004148; GO:0005634; GO:0005739; GO:0005759; GO:0006090; GO:0006103; GO:0006120; GO:0006508; GO:0007369; GO:0009083; GO:0031514; GO:0034604; GO:0042391; GO:0043159; GO:0045252; GO:0045254; GO:0047101; GO:0048240; GO:0050660; GO:0160157; GO:0160167; GO:1902493","2-oxoglutarate metabolic process [GO:0006103]; branched-chain amino acid catabolic process [GO:0009083]; gastrulation [GO:0007369]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proteolysis [GO:0006508]; pyruvate metabolic process [GO:0006090]; regulation of membrane potential [GO:0042391]; sperm capacitation [GO:0048240]","acetyltransferase complex [GO:1902493]; acrosomal matrix [GO:0043159]; branched-chain alpha-ketoacid dehydrogenase complex [GO:0160157]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxoadipate dehydrogenase complex [GO:0160167]; oxoglutarate dehydrogenase complex [GO:0045252]; pyruvate dehydrogenase complex [GO:0045254]; branched-chain alpha-keto acid dehydrogenase activity [GO:0047101]; dihydrolipoyl dehydrogenase (NADH) activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]; 2-oxoglutarate metabolic process [GO:0006103]; branched-chain amino acid catabolic process [GO:0009083]; gastrulation [GO:0007369]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proteolysis [GO:0006508]; pyruvate metabolic process [GO:0006090]; regulation of membrane potential [GO:0042391]; sperm capacitation [GO:0048240]","","","",""
"512","sp|Q9H000|MKRN2_HUMAN","lcl|NC_088856.1_cds_XP_034307215.2_18870",1.22e-103,314,"Q9H000","MKRN2_HUMAN","E3 ubiquitin-protein ligase makorin-2 (EC 2.3.2.27) (RING finger protein 62) (RING-type E3 ubiquitin transferase makorin-2)","MKRN2 RNF62 HSPC070","Homo sapiens (Human)",416,"GO:0000209; GO:0002862; GO:0003723; GO:0005634; GO:0005737; GO:0006351; GO:0006511; GO:0007283; GO:0008270; GO:0016567; GO:0030154; GO:0043491; GO:0045944; GO:0061630; GO:1901223","cell differentiation [GO:0030154]; DNA-templated transcription [GO:0006351]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; DNA-templated transcription [GO:0006351]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]","","","","TISSUE SPECIFICITY: Expressed in sperm, with significantly reduced expression in sperm of patients with oligoasthenoteratozoospermia (at protein level) (PubMed:28008940). Widely expressed with expression in testis, ovary, small intestine, colon, peripheral blood leukocytes, fetal liver, bone marrow, thymus, lymph node and spleen (PubMed:11597136). {ECO:0000269|PubMed:11597136, ECO:0000269|PubMed:28008940}."
"513","sp|Q8IZP9|AGRG2_HUMAN","lcl|NC_088856.1_cds_XP_034307541.2_18684",1.04e-52,203,"Q8IZP9","AGRG2_HUMAN","Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Human epididymis-specific protein 6) (He6) [Cleaved into: Adhesion G-protein coupled receptor G2, N-terminal fragment (ADGRG2 N-terminal fragment); Adhesion G-protein coupled receptor G2, C-terminal fragment (ADGRG2 C-terminal fragment)]","ADGRG2 GPR64 HE6 TM7LN2","Homo sapiens (Human)",1017,"GO:0004930; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0007200; GO:0007283; GO:0007286; GO:0009986; GO:0016020; GO:0016324; GO:0070062","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Epididymis-specific expression (at protein level). Both subunits are associated with apical membranes of efferent ductule and proximal epididymal duct epithelia. Mainly expressed in the nonciliated principal cells of the proximal excurrent ducts. Specifically over-expressed in Ewing sarcomas but also up-regulated in a number of carcinomas derived from prostate, kidney or lung. {ECO:0000269|PubMed:12420295, ECO:0000269|PubMed:18469038, ECO:0000269|PubMed:23338946, ECO:0000269|PubMed:27476656, ECO:0000269|PubMed:9150425}."
"514","sp|Q9VH14|TIMP_DROME","lcl|NC_088856.1_cds_XP_034316998.2_21222",1.32e-17,78.6,"Q9VH14","TIMP_DROME","Tissue inhibitor of metalloproteinase","Timp CG6281","Drosophila melanogaster (Fruit fly)",210,"GO:0005615; GO:0007155; GO:0007419; GO:0007426; GO:0007472; GO:0008191; GO:0008270; GO:0030425; GO:0031012; GO:0035202; GO:0042331; GO:0048477; GO:0048526; GO:0051045; GO:0060232; GO:0071711","basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; delamination [GO:0060232]; imaginal disc-derived wing expansion [GO:0048526]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; oogenesis [GO:0048477]; phototaxis [GO:0042331]; tracheal outgrowth, open tracheal system [GO:0007426]; tracheal pit formation in open tracheal system [GO:0035202]; ventral cord development [GO:0007419]; wing disc morphogenesis [GO:0007472]","dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; metalloendopeptidase inhibitor activity [GO:0008191]; zinc ion binding [GO:0008270]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; delamination [GO:0060232]; imaginal disc-derived wing expansion [GO:0048526]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; oogenesis [GO:0048477]; phototaxis [GO:0042331]; tracheal outgrowth, open tracheal system [GO:0007426]; tracheal pit formation in open tracheal system [GO:0035202]; ventral cord development [GO:0007419]; wing disc morphogenesis [GO:0007472]","DEVELOPMENTAL STAGE: Expressed throughout development in larvae and pupae. Expressed at embryonic stage 14-17 in a small constriction of the gut, in the full complement of cardial cells and in a paired anterior structure, possibly belonging to the antenno-maxillary complex. {ECO:0000269|PubMed:10961449}.","","","TISSUE SPECIFICITY: Expressed in heads of female and male adult flies (PubMed:10961449). Expressed at the time of eclosion in unopened wings of adult flies (PubMed:16962574). Strongly expressed at the tip of ovarian germarium region 1 where germline stem cells (GSCs) and cystoblasts reside and in region 2 of the germarium (PubMed:26808525). {ECO:0000269|PubMed:10961449, ECO:0000269|PubMed:16962574, ECO:0000269|PubMed:26808525}."
"515","sp|B4K5S8|INT13_DROMO","lcl|NC_088856.1_cds_XP_065936894.1_17888",2.02e-132,407,"B4K5S8","INT13_DROMO","Protein asunder (Cell cycle regulator Mat89Bb) (Maternal transcript 89Bb) (Set apart in position or space protein)","asun Mat89Bb GI22939","Drosophila mojavensis (Fruit fly)",679,"GO:0005634; GO:0005737; GO:0007283; GO:0007346; GO:0030317; GO:0032039; GO:0034472; GO:0046843; GO:0048471; GO:0051301; GO:0051321; GO:0051642; GO:0051663; GO:0060814; GO:0080154; GO:0160232; GO:0160240","cell division [GO:0051301]; centrosome localization [GO:0051642]; dorsal appendage formation [GO:0046843]; flagellated sperm motility [GO:0030317]; meiotic cell cycle [GO:0051321]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; posterior mRNA localization involved in anterior/posterior axis specification [GO:0060814]; regulation of fertilization [GO:0080154]; regulation of mitotic cell cycle [GO:0007346]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA 3'-end processing [GO:0034472]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cell division [GO:0051301]; centrosome localization [GO:0051642]; dorsal appendage formation [GO:0046843]; flagellated sperm motility [GO:0030317]; meiotic cell cycle [GO:0051321]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; posterior mRNA localization involved in anterior/posterior axis specification [GO:0060814]; regulation of fertilization [GO:0080154]; regulation of mitotic cell cycle [GO:0007346]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA 3'-end processing [GO:0034472]; spermatogenesis [GO:0007283]","","","",""
"516","sp|B4JHB4|INT13_DROGR","lcl|NC_088856.1_cds_XP_065936895.1_17885",2.68e-130,401,"B4JHB4","INT13_DROGR","Protein asunder (Cell cycle regulator Mat89Bb) (Maternal transcript 89Bb) (Set apart in position or space protein)","asun Mat89Bb GH19540","Drosophila grimshawi (Hawaiian fruit fly) (Idiomyia grimshawi)",678,"GO:0005634; GO:0005737; GO:0007283; GO:0007346; GO:0030317; GO:0032039; GO:0034472; GO:0046843; GO:0048471; GO:0051301; GO:0051321; GO:0051642; GO:0051663; GO:0060814; GO:0080154; GO:0160232; GO:0160240","cell division [GO:0051301]; centrosome localization [GO:0051642]; dorsal appendage formation [GO:0046843]; flagellated sperm motility [GO:0030317]; meiotic cell cycle [GO:0051321]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; posterior mRNA localization involved in anterior/posterior axis specification [GO:0060814]; regulation of fertilization [GO:0080154]; regulation of mitotic cell cycle [GO:0007346]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA 3'-end processing [GO:0034472]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cell division [GO:0051301]; centrosome localization [GO:0051642]; dorsal appendage formation [GO:0046843]; flagellated sperm motility [GO:0030317]; meiotic cell cycle [GO:0051321]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; posterior mRNA localization involved in anterior/posterior axis specification [GO:0060814]; regulation of fertilization [GO:0080154]; regulation of mitotic cell cycle [GO:0007346]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA 3'-end processing [GO:0034472]; spermatogenesis [GO:0007283]","","","",""
"517","sp|P42282|TTKA_DROME","lcl|NC_088856.1_cds_XP_065936896.1_17893",1.04e-11,69.7,"P42282","TTKA_DROME","Protein tramtrack, alpha isoform (Repressor protein fushi tarazu) (Tramtrack p88)","ttk FTZ-F2 CG1856","Drosophila melanogaster (Fruit fly)",813,"GO:0000122; GO:0000978; GO:0001227; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007173; GO:0007307; GO:0007422; GO:0007426; GO:0008270; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0031104; GO:0031208; GO:0035001; GO:0035147; GO:0035151; GO:0035883; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0045500; GO:0045677; GO:0045892; GO:0045944; GO:0046533; GO:0046843; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688","branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dendrite regeneration [GO:0031104]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; eggshell chorion gene amplification [GO:0007307]; enteroendocrine cell differentiation [GO:0035883]; epidermal growth factor receptor signaling pathway [GO:0007173]; follicle cell of egg chamber development [GO:0030707]; myoblast fate specification [GO:0048626]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]","nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dendrite regeneration [GO:0031104]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; eggshell chorion gene amplification [GO:0007307]; enteroendocrine cell differentiation [GO:0035883]; epidermal growth factor receptor signaling pathway [GO:0007173]; follicle cell of egg chamber development [GO:0030707]; myoblast fate specification [GO:0048626]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. Expressed in preblastoderm embryos, followed by complete decay upon formation of the cellular blastoderm when ftz striped expression is at its peak.","","",""
"518","sp|Q00536|CDK16_HUMAN","lcl|NC_088856.1_cds_XP_065936913.1_17909",0,555,"Q00536","CDK16_HUMAN","Cyclin-dependent kinase 16 (EC 2.7.11.22) (Cell division protein kinase 16) (PCTAIRE-motif protein kinase 1) (Serine/threonine-protein kinase PCTAIRE-1)","CDK16 PCTAIRE1 PCTK1","Homo sapiens (Human)",496,"GO:0000307; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006887; GO:0007283; GO:0008021; GO:0009898; GO:0010508; GO:0015630; GO:0030252; GO:0031175; GO:0043005; GO:0061178; GO:0106310; GO:1901987","exocytosis [GO:0006887]; growth hormone secretion [GO:0030252]; neuron projection development [GO:0031175]; positive regulation of autophagy [GO:0010508]; protein phosphorylation [GO:0006468]; regulation of cell cycle phase transition [GO:1901987]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; spermatogenesis [GO:0007283]","cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; exocytosis [GO:0006887]; growth hormone secretion [GO:0030252]; neuron projection development [GO:0031175]; positive regulation of autophagy [GO:0010508]; protein phosphorylation [GO:0006468]; regulation of cell cycle phase transition [GO:1901987]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Detected in pancreas islets (at protein level). Detected in brain and pancreas. {ECO:0000269|PubMed:22798068}."
"519","sp|Q96N23|CFA54_HUMAN","lcl|NC_088856.1_cds_XP_065936929.1_17942",0,881,"Q96N23","CFA54_HUMAN","Cilia- and flagella-associated protein 54","CFAP54 C12orf55 C12orf63","Homo sapiens (Human)",3096,"GO:0005576; GO:0005930; GO:0007283; GO:0051649; GO:0060271; GO:0060294; GO:0090660; GO:0120197; GO:0120316","cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; establishment of localization in cell [GO:0051649]; mucociliary clearance [GO:0120197]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283]","axoneme [GO:0005930]; extracellular region [GO:0005576]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; establishment of localization in cell [GO:0051649]; mucociliary clearance [GO:0120197]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283]","","","",""
"520","sp|Q8C6S9|CFA54_MOUSE","lcl|NC_088856.1_cds_XP_065936930.1_17943",0,1148,"Q8C6S9","CFA54_MOUSE","Cilia- and flagella-associated protein 54","Cfap54","Mus musculus (Mouse)",3106,"GO:0005576; GO:0005930; GO:0007283; GO:0051649; GO:0060271; GO:0060294; GO:0090660; GO:0120197; GO:0120316","cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; establishment of localization in cell [GO:0051649]; mucociliary clearance [GO:0120197]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283]","axoneme [GO:0005930]; extracellular region [GO:0005576]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; establishment of localization in cell [GO:0051649]; mucociliary clearance [GO:0120197]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed at high level in the testis and at a low level in the lung and brain. {ECO:0000269|PubMed:26224312}."
"521","sp|Q96SB4|SRPK1_HUMAN","lcl|NC_088856.1_cds_XP_065937122.1_18277",7.77e-93,302,"Q96SB4","SRPK1_HUMAN","SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1)","SRPK1","Homo sapiens (Human)",655,"GO:0000245; GO:0000287; GO:0000785; GO:0003723; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006468; GO:0007059; GO:0008380; GO:0016363; GO:0016607; GO:0035092; GO:0035556; GO:0045070; GO:0045071; GO:0045087; GO:0048024; GO:0050684; GO:0106310","chromosome segregation [GO:0007059]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sperm DNA condensation [GO:0035092]; spliceosomal complex assembly [GO:0000245]","chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sperm DNA condensation [GO:0035092]; spliceosomal complex assembly [GO:0000245]","","","","TISSUE SPECIFICITY: Isoform 2 is predominantly expressed in the testis but is also present at lower levels in heart, ovary, small intestine, liver, kidney, pancreas and skeletal muscle. Isoform 1 is only seen in the testis, at lower levels than isoform 2. Highly expressed in different erythroid and lymphoid cell lines, with isoform 2 being far more abundant than isoform 1. {ECO:0000269|PubMed:10390541, ECO:0000269|PubMed:11509566, ECO:0000269|PubMed:20708644}."
"522","sp|Q9JHE4|G3ST1_MOUSE","lcl|NC_088856.1_cds_XP_065937139.1_18309",6.89e-34,131,"Q9JHE4","G3ST1_MOUSE","Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase)","Gal3st1 Cst Gcst","Mus musculus (Mouse)",423,"GO:0000139; GO:0001733; GO:0006681; GO:0006682; GO:0007283; GO:0009247; GO:0016020; GO:0042552; GO:0046486","galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283]","Golgi membrane [GO:0000139]; membrane [GO:0016020]; galactosylceramide sulfotransferase activity [GO:0001733]; galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in brain, testis, kidney, stomach, small intestine, liver, and lung. Not detected in heart, skeletal muscle, and spleen. {ECO:0000269|PubMed:10727929}."
"523","sp|Q8BPT6|IMP2L_MOUSE","lcl|NC_088856.1_cds_XP_065937152.1_18337",3.08e-36,125,"Q8BPT6","IMP2L_MOUSE","Mitochondrial inner membrane protease subunit 2 (EC 3.4.21.-) (IMP2-like protein)","Immp2l","Mus musculus (Mouse)",175,"GO:0001541; GO:0004252; GO:0005739; GO:0005743; GO:0006465; GO:0006627; GO:0006801; GO:0006974; GO:0007283; GO:0007420; GO:0008015; GO:0008104; GO:0008233; GO:0022904; GO:0030728; GO:0033108; GO:0042720; GO:0061300","blood circulation [GO:0008015]; brain development [GO:0007420]; cerebellum vasculature development [GO:0061300]; DNA damage response [GO:0006974]; mitochondrial respiratory chain complex assembly [GO:0033108]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; protein localization [GO:0008104]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; respiratory electron transport chain [GO:0022904]; signal peptide processing [GO:0006465]; spermatogenesis [GO:0007283]; superoxide metabolic process [GO:0006801]","mitochondrial inner membrane [GO:0005743]; mitochondrial inner membrane peptidase complex [GO:0042720]; mitochondrion [GO:0005739]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; blood circulation [GO:0008015]; brain development [GO:0007420]; cerebellum vasculature development [GO:0061300]; DNA damage response [GO:0006974]; mitochondrial respiratory chain complex assembly [GO:0033108]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; protein localization [GO:0008104]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; respiratory electron transport chain [GO:0022904]; signal peptide processing [GO:0006465]; spermatogenesis [GO:0007283]; superoxide metabolic process [GO:0006801]","","","",""
"524","sp|Q21086|GNL3_CAEEL","lcl|NC_088856.1_cds_XP_065937222.1_18479",9.41e-128,387,"Q21086","GNL3_CAEEL","Guanine nucleotide-binding protein-like 3 homolog (Nucleostemin-1)","nst-1 K01C8.9","Caenorhabditis elegans",556,"GO:0002119; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0007281; GO:0040014; GO:0042127","germ cell development [GO:0007281]; nematode larval development [GO:0002119]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014]","nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; germ cell development [GO:0007281]; nematode larval development [GO:0002119]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014]","","","",""
"525","sp|Q9Y4R7|TTLL3_HUMAN","lcl|NC_088856.1_cds_XP_065937246.1_18514",3.43e-127,413,"Q9Y4R7","TTLL3_HUMAN","Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (HOTTL) (Tubulin--tyrosine ligase-like protein 3)","TTLL3 PRO0207","Homo sapiens (Human)",772,"GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0005930; GO:0007283; GO:0015630; GO:0030317; GO:0035082; GO:0036126; GO:0036211; GO:0046872; GO:0060271; GO:0070735; GO:0070736","axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; protein modification process [GO:0036211]; spermatogenesis [GO:0007283]","axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, initiating [GO:0070736]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; protein modification process [GO:0036211]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in brain, heart, kidney, testis, liver, lung, muscle, spleen, trachea and colon. {ECO:0000269|PubMed:25180231}."
"526","sp|Q8VDD8|WASH1_MOUSE","lcl|NC_088856.1_cds_XP_065937260.1_18538",6.76e-64,215,"Q8VDD8","WASH1_MOUSE","WASH complex subunit 1 (WAS protein family homolog 1)","Washc1 Orf19 Wash Wash1","Mus musculus (Mouse)",475,"GO:0001556; GO:0002468; GO:0003779; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0005813; GO:0005814; GO:0005829; GO:0007032; GO:0010507; GO:0016197; GO:0030833; GO:0031396; GO:0031901; GO:0032456; GO:0034314; GO:0034315; GO:0034383; GO:0034394; GO:0040038; GO:0042098; GO:0042147; GO:0043014; GO:0043015; GO:0050750; GO:0050776; GO:0055037; GO:0055038; GO:0071203; GO:0090306; GO:0099638; GO:0141039; GO:1904109; GO:2000010","Arp2/3 complex-mediated actin nucleation [GO:0034314]; dendritic cell antigen processing and presentation [GO:0002468]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; endosome to plasma membrane protein transport [GO:0099638]; low-density lipoprotein particle clearance [GO:0034383]; meiotic spindle assembly [GO:0090306]; negative regulation of autophagy [GO:0010507]; oocyte maturation [GO:0001556]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of cholesterol import [GO:1904109]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to cell surface [GO:0034394]; regulation of actin filament polymerization [GO:0030833]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of immune response [GO:0050776]; regulation of protein ubiquitination [GO:0031396]; retrograde transport, endosome to Golgi [GO:0042147]; T cell proliferation [GO:0042098]","autophagosome [GO:0005776]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; WASH complex [GO:0071203]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol 3-kinase inhibitor activity [GO:0141039]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; dendritic cell antigen processing and presentation [GO:0002468]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; endosome to plasma membrane protein transport [GO:0099638]; low-density lipoprotein particle clearance [GO:0034383]; meiotic spindle assembly [GO:0090306]; negative regulation of autophagy [GO:0010507]; oocyte maturation [GO:0001556]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of cholesterol import [GO:1904109]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to cell surface [GO:0034394]; regulation of actin filament polymerization [GO:0030833]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of immune response [GO:0050776]; regulation of protein ubiquitination [GO:0031396]; retrograde transport, endosome to Golgi [GO:0042147]; T cell proliferation [GO:0042098]","","","","TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:19922875}."
"527","sp|Q9Y0A1|ITPR_CAEEL","lcl|NC_088856.1_cds_XP_065937297.1_18614",0,1691,"Q9Y0A1","ITPR_CAEEL","Inositol 1,4,5-trisphosphate receptor itr-1 (IP3 receptor) (IP3R) (InsP3R) (LET-23 fertility effector 1)","itr-1 dec-4 lfe-1 F33D4.2","Caenorhabditis elegans",2892,"GO:0001556; GO:0005220; GO:0005509; GO:0005783; GO:0005789; GO:0005886; GO:0006936; GO:0007204; GO:0007622; GO:0008340; GO:0012501; GO:0016020; GO:0016529; GO:0017022; GO:0030334; GO:0030421; GO:0030667; GO:0035091; GO:0042713; GO:0043051; GO:0048598; GO:0048609; GO:0051209; GO:0051489; GO:0060179; GO:0070679; GO:1903746","defecation [GO:0030421]; determination of adult lifespan [GO:0008340]; embryonic morphogenesis [GO:0048598]; male mating behavior [GO:0060179]; multicellular organismal reproductive process [GO:0048609]; muscle contraction [GO:0006936]; oocyte maturation [GO:0001556]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of nematode pharyngeal pumping [GO:1903746]; programmed cell death [GO:0012501]; regulation of cell migration [GO:0030334]; regulation of filopodium assembly [GO:0051489]; regulation of nematode pharyngeal pumping [GO:0043051]; release of sequestered calcium ion into cytosol [GO:0051209]; rhythmic behavior [GO:0007622]; sperm ejaculation [GO:0042713]","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; secretory granule membrane [GO:0030667]; calcium ion binding [GO:0005509]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-gated calcium channel activity [GO:0005220]; myosin binding [GO:0017022]; phosphatidylinositol binding [GO:0035091]; defecation [GO:0030421]; determination of adult lifespan [GO:0008340]; embryonic morphogenesis [GO:0048598]; male mating behavior [GO:0060179]; multicellular organismal reproductive process [GO:0048609]; muscle contraction [GO:0006936]; oocyte maturation [GO:0001556]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of nematode pharyngeal pumping [GO:1903746]; programmed cell death [GO:0012501]; regulation of cell migration [GO:0030334]; regulation of filopodium assembly [GO:0051489]; regulation of nematode pharyngeal pumping [GO:0043051]; release of sequestered calcium ion into cytosol [GO:0051209]; rhythmic behavior [GO:0007622]; sperm ejaculation [GO:0042713]","","","","TISSUE SPECIFICITY: Isoform a is expressed in the anterior cells of the pharyngeal terminal bulb, vulva, rectal epithelial cells, spicule protractor muscles of the proctodeum and male-specific neuron CP8 or CP9. Isoform d is expressed in the spermatheca, excretory cell, amphid socket cells, PDA motor neuron, spicule retractor muscles, gubernaculum retractor muscles, posterior oblique muscles, diagonal muscles and the vas deferens. Also expressed in the intestine, pharynx, pharyngeal isthmus, pharyngeal intestinal valve, somatic gonad, hypodermal cells of the vulva, uterine sheath cells, tail, head, LUA motor neuron and the embryonic epidermis (at protein level). {ECO:0000269|PubMed:10499793, ECO:0000269|PubMed:10610772, ECO:0000269|PubMed:11237590, ECO:0000269|PubMed:15498499, ECO:0000269|PubMed:15958491}."
"528","sp|Q9VEN1|FLNA_DROME","lcl|NC_088856.1_cds_XP_065937343.1_18697",0,2212,"Q9VEN1","FLNA_DROME","Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)","cher cheerio sko CG3937","Drosophila melanogaster (Fruit fly)",2210,"GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051015; GO:0051495; GO:0051764; GO:0110069","actin crosslink formation [GO:0051764]; behavioral response to ethanol [GO:0048149]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]; syncytial embryo cellularization [GO:0110069]","actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin crosslink formation [GO:0051764]; behavioral response to ethanol [GO:0048149]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]; syncytial embryo cellularization [GO:0110069]","DEVELOPMENTAL STAGE: Expressed throughout the egg-chamber development (at protein level). Expressed in the embryo. {ECO:0000269|PubMed:10477759, ECO:0000269|PubMed:10556087}.","","","TISSUE SPECIFICITY: Germline-specific in females (at protein level). Expressed in ovary. {ECO:0000269|PubMed:10477759, ECO:0000269|PubMed:10556087}."
"529","sp|H1UBK1|MAP2_CAEEL","lcl|NC_088856.1_cds_XP_065937416.1_18894",0,557,"H1UBK1","MAP2_CAEEL","Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Peptidase M)","map-2 Y116A8A.9","Caenorhabditis elegans",468,"GO:0004177; GO:0004239; GO:0005737; GO:0006508; GO:0008235; GO:0008238; GO:0036093; GO:0046872; GO:0070006","germ cell proliferation [GO:0036093]; proteolysis [GO:0006508]","cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]; exopeptidase activity [GO:0008238]; initiator methionyl aminopeptidase activity [GO:0004239]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; germ cell proliferation [GO:0036093]; proteolysis [GO:0006508]","","","",""
"530","sp|Q9BXW9|FACD2_HUMAN","lcl|NC_088856.1_cds_XP_065937579.1_19253",0,1059,"Q9BXW9","FACD2_HUMAN","Fanconi anemia group D2 protein (Protein FACD2)","FANCD2 FACD","Homo sapiens (Human)",1451,"GO:0000785; GO:0000793; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007129; GO:0007276; GO:0010332; GO:0016604; GO:0031573; GO:0034599; GO:0036297; GO:0045589; GO:0048854; GO:0050727; GO:0070182; GO:0097150; GO:1990391; GO:1990918; GO:2000348","brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; double-strand break repair involved in meiotic recombination [GO:1990918]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; interstrand cross-link repair [GO:0036297]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332]","chromatin [GO:0000785]; condensed chromosome [GO:0000793]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA polymerase binding [GO:0070182]; brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; double-strand break repair involved in meiotic recombination [GO:1990918]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; interstrand cross-link repair [GO:0036297]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332]","DEVELOPMENTAL STAGE: Highly expressed in fetal oocytes, and in hematopoietic cells of the fetal liver and bone marrow (at protein level). {ECO:0000269|PubMed:14517836}.","","","TISSUE SPECIFICITY: Highly expressed in germinal center cells of the spleen, tonsil, and reactive lymph nodes, and in the proliferating basal layer of squamous epithelium of tonsil, esophagus, oropharynx, larynx and cervix. Expressed in cytotrophoblastic cells of the placenta and exocrine cells of the pancreas (at protein level). Highly expressed in testis, where expression is restricted to maturing spermatocytes. {ECO:0000269|PubMed:11239453, ECO:0000269|PubMed:14517836, ECO:0000269|PubMed:15454491}."
"531","sp|Q9JJY4|DDX20_MOUSE","lcl|NC_088856.1_cds_XP_065937702.1_19506",2.42e-165,502,"Q9JJY4","DDX20_MOUSE","Probable ATP-dependent RNA helicase DDX20 (EC 3.6.1.15) (EC 3.6.4.13) (Component of gems 3) (DEAD box protein 20) (DEAD box protein DP 103) (Gemin-3) (Regulator of steroidogenic factor 1) (ROSF-1)","Ddx20 Dp103 Gemin3","Mus musculus (Mouse)",825,"GO:0000122; GO:0000387; GO:0003677; GO:0003724; GO:0005524; GO:0005829; GO:0008285; GO:0016887; GO:0017053; GO:0019904; GO:0030674; GO:0032797; GO:0034719; GO:0042826; GO:0043065; GO:0048477; GO:0050810; GO:0090571; GO:0097504; GO:0140297","negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of apoptotic process [GO:0043065]; regulation of steroid biosynthetic process [GO:0050810]; spliceosomal snRNP assembly [GO:0000387]","cytosol [GO:0005829]; Gemini of Cajal bodies [GO:0097504]; RNA polymerase II transcription repressor complex [GO:0090571]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; transcription repressor complex [GO:0017053]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; RNA helicase activity [GO:0003724]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of apoptotic process [GO:0043065]; regulation of steroid biosynthetic process [GO:0050810]; spliceosomal snRNP assembly [GO:0000387]","","","",""
"532","sp|Q9VFM9|TWF_DROME","lcl|NC_088856.1_cds_XP_065937703.1_19504",1.29e-120,352,"Q9VFM9","TWF_DROME","Twinfilin","twf CG3172","Drosophila melanogaster (Fruit fly)",343,"GO:0003779; GO:0003785; GO:0005737; GO:0005884; GO:0005886; GO:0005938; GO:0007274; GO:0007298; GO:0008407; GO:0010591; GO:0010976; GO:0016319; GO:0030016; GO:0030042; GO:0030833; GO:0030837; GO:0048488; GO:0051015; GO:0051016; GO:0098793","actin filament depolymerization [GO:0030042]; barbed-end actin filament capping [GO:0051016]; border follicle cell migration [GO:0007298]; chaeta morphogenesis [GO:0008407]; mushroom body development [GO:0016319]; negative regulation of actin filament polymerization [GO:0030837]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of neuron projection development [GO:0010976]; regulation of actin filament polymerization [GO:0030833]; regulation of lamellipodium assembly [GO:0010591]; synaptic vesicle endocytosis [GO:0048488]","actin filament [GO:0005884]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; myofibril [GO:0030016]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; actin filament depolymerization [GO:0030042]; barbed-end actin filament capping [GO:0051016]; border follicle cell migration [GO:0007298]; chaeta morphogenesis [GO:0008407]; mushroom body development [GO:0016319]; negative regulation of actin filament polymerization [GO:0030837]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of neuron projection development [GO:0010976]; regulation of actin filament polymerization [GO:0030833]; regulation of lamellipodium assembly [GO:0010591]; synaptic vesicle endocytosis [GO:0048488]","DEVELOPMENTAL STAGE: Maternally expressed. Ubiquitously expressed in embryos and throughout development. {ECO:0000269|PubMed:11724820}.","","",""
"533","sp|A0A0B4K7J2|RBP2_DROME","lcl|NC_088856.1_cds_XP_065937717.1_19550",6.18e-64,236,"A0A0B4K7J2","RBP2_DROME","E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358)","Nup358 RanBP2 CG11856","Drosophila melanogaster (Fruit fly)",2718,"GO:0005642; GO:0005643; GO:0005737; GO:0006606; GO:0006607; GO:0007281; GO:0007419; GO:0008270; GO:0008284; GO:0010628; GO:0019789; GO:0032880; GO:0035626; GO:0046833; GO:0051028; GO:0051292; GO:1900182","germ cell development [GO:0007281]; juvenile hormone mediated signaling pathway [GO:0035626]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore complex assembly [GO:0051292]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of RNA export from nucleus [GO:0046833]; protein import into nucleus [GO:0006606]; regulation of protein localization [GO:0032880]; ventral cord development [GO:0007419]","annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; juvenile hormone mediated signaling pathway [GO:0035626]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore complex assembly [GO:0051292]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of RNA export from nucleus [GO:0046833]; protein import into nucleus [GO:0006606]; regulation of protein localization [GO:0032880]; ventral cord development [GO:0007419]","DEVELOPMENTAL STAGE: Expressed during embryogenesis (at protein level). {ECO:0000269|PubMed:31626769}.","","","TISSUE SPECIFICITY: Expressed in both oocytes and nurse cells (at protein level). {ECO:0000269|PubMed:29735528, ECO:0000269|PubMed:31626769}."
"534","sp|Q9BXT6|M10L1_HUMAN","lcl|NC_088856.1_cds_XP_065937841.1_19791",0,653,"Q9BXT6","M10L1_HUMAN","RNA helicase Mov10l1 (EC 3.6.4.13) (Moloney leukemia virus 10-like protein 1) (MOV10-like protein 1)","MOV10L1","Homo sapiens (Human)",1211,"GO:0000287; GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0007141; GO:0007281; GO:0007283; GO:0016887; GO:0034587; GO:0035194; GO:0043186; GO:0071546; GO:0141196","germ cell development [GO:0007281]; male meiosis I [GO:0007141]; piRNA processing [GO:0034587]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]","cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; germ cell development [GO:0007281]; male meiosis I [GO:0007141]; piRNA processing [GO:0034587]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]","","","","TISSUE SPECIFICITY: [Isoform 1]: Specifically expressed in testis. {ECO:0000269|PubMed:11279525}."
"535","sp|P90838|RTCB_CAEEL","lcl|NC_088856.1_cds_XP_065937894.1_19876",0,798,"P90838","RTCB_CAEEL","RNA-splicing ligase RtcB homolog (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase)","rtcb-1 F16A11.2","Caenorhabditis elegans",505,"GO:0003972; GO:0005525; GO:0005634; GO:0005635; GO:0005737; GO:0005789; GO:0006388; GO:0007281; GO:0036498; GO:0040025; GO:0046872; GO:0072669; GO:0170057","germ cell development [GO:0007281]; IRE1-mediated unfolded protein response [GO:0036498]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; vulval development [GO:0040025]","cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA ligase (ATP) activity [GO:0003972]; RNA ligase (GTP) activity [GO:0170057]; germ cell development [GO:0007281]; IRE1-mediated unfolded protein response [GO:0036498]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; vulval development [GO:0040025]","","","",""
"536","sp|Q9QXK2|RAD18_MOUSE","lcl|NC_088856.1_cds_XP_065937906.1_19890",3.66e-53,194,"Q9QXK2","RAD18_MOUSE","E3 ubiquitin-protein ligase RAD18 (EC 2.3.2.27) (Postreplication repair protein RAD18) (mRAD18Sc) (RING-type E3 ubiquitin transferase RAD18)","Rad18 Rad18sc","Mus musculus (Mouse)",509,"GO:0000785; GO:0001673; GO:0001741; GO:0003697; GO:0005634; GO:0005737; GO:0005813; GO:0006301; GO:0006513; GO:0006974; GO:0007283; GO:0008270; GO:0009411; GO:0031593; GO:0035861; GO:0042405; GO:0042802; GO:0045910; GO:0051865; GO:0051984; GO:0061630","DNA damage response [GO:0006974]; negative regulation of DNA recombination [GO:0045910]; positive regulation of chromosome segregation [GO:0051984]; postreplication repair [GO:0006301]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; response to UV [GO:0009411]; spermatogenesis [GO:0007283]","centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nuclear inclusion body [GO:0042405]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; XY body [GO:0001741]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; DNA damage response [GO:0006974]; negative regulation of DNA recombination [GO:0045910]; positive regulation of chromosome segregation [GO:0051984]; postreplication repair [GO:0006301]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; response to UV [GO:0009411]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in thymus, spleen, brain, and ovary."
"537","sp|P49117|NR2C2_MOUSE","lcl|NC_088856.1_cds_XP_065937975.1_20039",6.18e-179,524,"P49117","NR2C2_MOUSE","Nuclear receptor subfamily 2 group C member 2 (Orphan nuclear receptor TAK1) (Orphan nuclear receptor TR4) (Testicular receptor 4)","Nr2c2 Mtr2r1 Tak1 Tr4","Mus musculus (Mouse)",596,"GO:0003700; GO:0005634; GO:0007283; GO:0008270; GO:0021549; GO:0030154; GO:0031663; GO:0038066; GO:0040019; GO:0043565; GO:0045663; GO:0048520; GO:0051321","cell differentiation [GO:0030154]; cerebellum development [GO:0021549]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; meiotic cell cycle [GO:0051321]; p38MAPK cascade [GO:0038066]; positive regulation of behavior [GO:0048520]; positive regulation of embryonic development [GO:0040019]; positive regulation of myoblast differentiation [GO:0045663]; spermatogenesis [GO:0007283]","nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cerebellum development [GO:0021549]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; meiotic cell cycle [GO:0051321]; p38MAPK cascade [GO:0038066]; positive regulation of behavior [GO:0048520]; positive regulation of embryonic development [GO:0040019]; positive regulation of myoblast differentiation [GO:0045663]; spermatogenesis [GO:0007283]","","INDUCTION: Induced by retinoic acid. {ECO:0000269|PubMed:19131575}.","INDUCTION: Induced by retinoic acid. {ECO:0000269|PubMed:19131575}.","TISSUE SPECIFICITY: Expressed, during embryogenesis, in perichondrium, developing glomeruli structures and tubules of kidney, as well as in intestiinal villi. Also expressed in lung and hair follicles. {ECO:0000269|PubMed:10347174, ECO:0000269|PubMed:15199144, ECO:0000269|PubMed:17706948}."
"538","sp|P49116|NR2C2_HUMAN","lcl|NC_088856.1_cds_XP_065937976.1_20040",1.17e-179,525,"P49116","NR2C2_HUMAN","Nuclear receptor subfamily 2 group C member 2 (Orphan nuclear receptor TAK1) (Orphan nuclear receptor TR4) (Testicular receptor 4)","NR2C2 TAK1 TR4","Homo sapiens (Human)",596,"GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0004879; GO:0005654; GO:0006355; GO:0007283; GO:0007399; GO:0008270; GO:0030154; GO:0033209; GO:0040019; GO:0043123; GO:0043565; GO:0045944; GO:0046330; GO:1990837","cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of embryonic development [GO:0040019]; positive regulation of JNK cascade [GO:0046330]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; spermatogenesis [GO:0007283]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of embryonic development [GO:0040019]; positive regulation of JNK cascade [GO:0046330]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; spermatogenesis [GO:0007283]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","DEVELOPMENTAL STAGE: Transiently repressed during the meiotic phase of spermatogenesis.","INDUCTION: Induced by oxidative stress via FOXO3 activation. {ECO:0000269|PubMed:18388194}.","INDUCTION: Induced by oxidative stress via FOXO3 activation. {ECO:0000269|PubMed:18388194}.",""
"539","sp|P70503|NR0B1_RAT","lcl|NC_088856.1_cds_XP_065937977.1_20041",7e-19,90.9,"P70503","NR0B1_RAT","Nuclear receptor subfamily 0 group B member 1 (Nuclear receptor DAX-1)","Nr0b1 Ahch Dax1","Rattus norvegicus (Rat)",472,"GO:0000122; GO:0003677; GO:0003690; GO:0003714; GO:0003723; GO:0005634; GO:0005737; GO:0005840; GO:0007283; GO:0007530; GO:0008104; GO:0008406; GO:0008584; GO:0010894; GO:0016020; GO:0016922; GO:0019904; GO:0030238; GO:0030325; GO:0032448; GO:0032526; GO:0033144; GO:0033327; GO:0035902; GO:0035987; GO:0042803; GO:0043434; GO:0043565; GO:0045892; GO:0050810; GO:0060008; GO:0061629; GO:0080021","adrenal gland development [GO:0030325]; endodermal cell differentiation [GO:0035987]; gonad development [GO:0008406]; Leydig cell differentiation [GO:0033327]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein localization [GO:0008104]; regulation of steroid biosynthetic process [GO:0050810]; response to benzoic acid [GO:0080021]; response to immobilization stress [GO:0035902]; response to peptide hormone [GO:0043434]; response to retinoic acid [GO:0032526]; Sertoli cell differentiation [GO:0060008]; sex determination [GO:0007530]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; ribosome [GO:0005840]; DNA binding [GO:0003677]; DNA hairpin binding [GO:0032448]; double-stranded DNA binding [GO:0003690]; nuclear receptor binding [GO:0016922]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; adrenal gland development [GO:0030325]; endodermal cell differentiation [GO:0035987]; gonad development [GO:0008406]; Leydig cell differentiation [GO:0033327]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein localization [GO:0008104]; regulation of steroid biosynthetic process [GO:0050810]; response to benzoic acid [GO:0080021]; response to immobilization stress [GO:0035902]; response to peptide hormone [GO:0043434]; response to retinoic acid [GO:0032526]; Sertoli cell differentiation [GO:0060008]; sex determination [GO:0007530]; spermatogenesis [GO:0007283]","","","",""
"540","sp|P30530|UFO_HUMAN","lcl|NC_088856.1_cds_XP_065938215.1_20409",5.11e-69,251,"P30530","UFO_HUMAN","Tyrosine-protein kinase receptor UFO (EC 2.7.10.1) (AXL oncogene)","AXL UFO","Homo sapiens (Human)",894,"GO:0001618; GO:0001764; GO:0001779; GO:0001786; GO:0001961; GO:0001974; GO:0004713; GO:0004714; GO:0005524; GO:0005615; GO:0005886; GO:0006909; GO:0006954; GO:0007165; GO:0007169; GO:0007283; GO:0007399; GO:0009986; GO:0010936; GO:0015629; GO:0016477; GO:0021885; GO:0030168; GO:0032689; GO:0032720; GO:0032825; GO:0032940; GO:0034101; GO:0034446; GO:0035457; GO:0042698; GO:0043066; GO:0043231; GO:0043235; GO:0043524; GO:0045087; GO:0046718; GO:0048010; GO:0048469; GO:0048549; GO:0051250; GO:0051402; GO:0051649; GO:0051897; GO:0060068; GO:0070062; GO:0071222; GO:0097028; GO:0097350; GO:1903902; GO:2000669","blood vessel remodeling [GO:0001974]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interferon-alpha [GO:0035457]; cellular response to lipopolysaccharide [GO:0071222]; dendritic cell differentiation [GO:0097028]; erythrocyte homeostasis [GO:0034101]; establishment of localization in cell [GO:0051649]; forebrain cell migration [GO:0021885]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of lymphocyte activation [GO:0051250]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type II interferon production [GO:0032689]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; neuron migration [GO:0001764]; neutrophil clearance [GO:0097350]; ovulation cycle [GO:0042698]; phagocytosis [GO:0006909]; platelet activation [GO:0030168]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of pinocytosis [GO:0048549]; positive regulation of viral life cycle [GO:1903902]; secretion by cell [GO:0032940]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; symbiont entry into host cell [GO:0046718]; vagina development [GO:0060068]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; phosphatidylserine binding [GO:0001786]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; virus receptor activity [GO:0001618]; blood vessel remodeling [GO:0001974]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interferon-alpha [GO:0035457]; cellular response to lipopolysaccharide [GO:0071222]; dendritic cell differentiation [GO:0097028]; erythrocyte homeostasis [GO:0034101]; establishment of localization in cell [GO:0051649]; forebrain cell migration [GO:0021885]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of lymphocyte activation [GO:0051250]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type II interferon production [GO:0032689]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; neuron migration [GO:0001764]; neutrophil clearance [GO:0097350]; ovulation cycle [GO:0042698]; phagocytosis [GO:0006909]; platelet activation [GO:0030168]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of pinocytosis [GO:0048549]; positive regulation of viral life cycle [GO:1903902]; secretion by cell [GO:0032940]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; symbiont entry into host cell [GO:0046718]; vagina development [GO:0060068]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","","INDUCTION: (Microbial infection) Up-regulated by Aedes aegypti lymphotoxin beta receptor inhibitor during Zika virus infection. {ECO:0000269|PubMed:29507355}.","INDUCTION: (Microbial infection) Up-regulated by Aedes aegypti lymphotoxin beta receptor inhibitor during Zika virus infection. {ECO:0000269|PubMed:29507355}.","TISSUE SPECIFICITY: Highly expressed in metastatic colon tumors. Expressed in primary colon tumors. Weakly expressed in normal colon tissue. {ECO:0000269|PubMed:7896447}."
"541","sp|Q5S007|LRRK2_HUMAN","lcl|NC_088856.1_cds_XP_065938327.1_18179",0,939,"Q5S007","LRRK2_HUMAN","Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-) (Dardarin)","LRRK2 PARK8","Homo sapiens (Human)",2527,"GO:0000139; GO:0000149; GO:0000165; GO:0000287; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0005096; GO:0005524; GO:0005525; GO:0005615; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0006979; GO:0007005; GO:0007029; GO:0007030; GO:0007040; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008017; GO:0008104; GO:0008340; GO:0009267; GO:0010506; GO:0010508; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016242; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0021772; GO:0022028; GO:0030159; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031344; GO:0031398; GO:0031410; GO:0031647; GO:0031965; GO:0031966; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034260; GO:0034599; GO:0034614; GO:0035542; GO:0035556; GO:0035564; GO:0035640; GO:0035641; GO:0035751; GO:0036064; GO:0036479; GO:0039706; GO:0040012; GO:0042391; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0043231; GO:0043410; GO:0044325; GO:0044753; GO:0044754; GO:0045335; GO:0045746; GO:0046039; GO:0046777; GO:0048312; GO:0048812; GO:0051018; GO:0051646; GO:0051900; GO:0051966; GO:0060070; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070062; GO:0070585; GO:0070971; GO:0070973; GO:0071287; GO:0090140; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:0141161; GO:1900242; GO:1900244; GO:1901030; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902823; GO:1902902; GO:1903215; GO:1903217; GO:1903351; GO:1903980; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377","autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of GTPase activity [GO:0034260]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to mitochondrion [GO:0070585]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell projection organization [GO:0031344]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of mitochondrial fission [GO:0090140]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]","amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]; actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; co-receptor binding [GO:0039706]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; microtubule binding [GO:0008017]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631]; autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of GTPase activity [GO:0034260]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to mitochondrion [GO:0070585]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell projection organization [GO:0031344]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of mitochondrial fission [GO:0090140]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]","","","","TISSUE SPECIFICITY: Expressed in pyramidal neurons in all cortical laminae of the visual cortex, in neurons of the substantia nigra pars compacta and caudate putamen (at protein level). Expressed in neutrophils (at protein level) (PubMed:29127255). Expressed in the brain. Expressed throughout the adult brain, but at a lower level than in heart and liver. Also expressed in placenta, lung, skeletal muscle, kidney and pancreas. In the brain, expressed in the cerebellum, cerebral cortex, medulla, spinal cord occipital pole, frontal lobe, temporal lobe and putamen. Expression is particularly high in brain dopaminoceptive areas. {ECO:0000269|PubMed:15541308, ECO:0000269|PubMed:15541309, ECO:0000269|PubMed:16532471, ECO:0000269|PubMed:17120249, ECO:0000269|PubMed:29127255}."
"542","sp|P16568|BICD_DROME","lcl|NC_088856.1_cds_XP_065938337.1_20653",5.5e-146,448,"P16568","BICD_DROME","Protein bicaudal D","BicD CG6605","Drosophila melanogaster (Fruit fly)",782,"GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0007293; GO:0007294; GO:0007309; GO:0007312; GO:0008093; GO:0008103; GO:0008298; GO:0022416; GO:0030100; GO:0031267; GO:0032050; GO:0033365; GO:0034452; GO:0048477; GO:0048488; GO:0050658; GO:0051028; GO:0070507; GO:0070727; GO:0070840; GO:0072393; GO:0098793; GO:0098840; GO:0140312; GO:2000302; GO:2000370","cellular macromolecule localization [GO:0070727]; chaeta development [GO:0022416]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; microtubule anchoring at microtubule organizing center [GO:0072393]; mRNA transport [GO:0051028]; oocyte axis specification [GO:0007309]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; protein localization to organelle [GO:0033365]; protein transport along microtubule [GO:0098840]; regulation of endocytosis [GO:0030100]; regulation of microtubule cytoskeleton organization [GO:0070507]; RNA transport [GO:0050658]; synaptic vesicle endocytosis [GO:0048488]","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; presynapse [GO:0098793]; cargo adaptor activity [GO:0140312]; clathrin heavy chain binding [GO:0032050]; cytoskeletal anchor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; small GTPase binding [GO:0031267]; cellular macromolecule localization [GO:0070727]; chaeta development [GO:0022416]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; microtubule anchoring at microtubule organizing center [GO:0072393]; mRNA transport [GO:0051028]; oocyte axis specification [GO:0007309]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; protein localization to organelle [GO:0033365]; protein transport along microtubule [GO:0098840]; regulation of endocytosis [GO:0030100]; regulation of microtubule cytoskeleton organization [GO:0070507]; RNA transport [GO:0050658]; synaptic vesicle endocytosis [GO:0048488]","DEVELOPMENTAL STAGE: Expressed maternally and zygotically (PubMed:2576013). Expressed during oogenesis and throughout development (PubMed:11546740, PubMed:2576013). {ECO:0000269|PubMed:11546740, ECO:0000269|PubMed:2576013}.","","","TISSUE SPECIFICITY: In ovaries, expressed in oocyte and nurse cells. {ECO:0000269|PubMed:2576013}."
"543","sp|Q9BXS9|S26A6_HUMAN","lcl|NC_088856.1_cds_XP_065938358.1_20699",1.83e-117,372,"Q9BXS9","S26A6_HUMAN","Solute carrier family 26 member 6 (Anion exchange transporter) (Pendrin-like protein 1) (Pendrin-L1)","SLC26A6","Homo sapiens (Human)",759,"GO:0005254; GO:0005452; GO:0005783; GO:0005829; GO:0005886; GO:0006811; GO:0006821; GO:0008271; GO:0012506; GO:0015106; GO:0015108; GO:0015116; GO:0015383; GO:0015499; GO:0015562; GO:0015701; GO:0015724; GO:0015797; GO:0016020; GO:0016323; GO:0016324; GO:0016740; GO:0019531; GO:0019532; GO:0030165; GO:0030321; GO:0030659; GO:0031526; GO:0031982; GO:0034707; GO:0038166; GO:0042045; GO:0042802; GO:0044849; GO:0046724; GO:0048240; GO:0050892; GO:0051453; GO:0051454; GO:0051649; GO:0070528; GO:0070633; GO:0071320; GO:0071332; GO:0071346; GO:0097225; GO:0140900; GO:1902358; GO:1902476; GO:2001150","angiotensin-activated signaling pathway [GO:0038166]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to fructose stimulus [GO:0071332]; cellular response to type II interferon [GO:0071346]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; epithelial fluid transport [GO:0042045]; establishment of localization in cell [GO:0051649]; estrous cycle [GO:0044849]; formate transport [GO:0015724]; intestinal absorption [GO:0050892]; intracellular pH elevation [GO:0051454]; mannitol transmembrane transport [GO:0015797]; monoatomic ion transport [GO:0006811]; oxalate transport [GO:0019532]; oxalic acid secretion [GO:0046724]; positive regulation of dipeptide transmembrane transport [GO:2001150]; protein kinase C signaling [GO:0070528]; regulation of intracellular pH [GO:0051453]; sperm capacitation [GO:0048240]; sulfate transmembrane transport [GO:1902358]; transepithelial chloride transport [GO:0030321]; transepithelial transport [GO:0070633]","apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; chloride:bicarbonate antiporter activity [GO:0140900]; efflux transmembrane transporter activity [GO:0015562]; formate transmembrane transporter activity [GO:0015499]; identical protein binding [GO:0042802]; oxalate transmembrane transporter activity [GO:0019531]; PDZ domain binding [GO:0030165]; secondary active sulfate transmembrane transporter activity [GO:0008271]; solute:inorganic anion antiporter activity [GO:0005452]; sulfate transmembrane transporter activity [GO:0015116]; sulfate:bicarbonate antiporter activity [GO:0015383]; transferase activity [GO:0016740]; angiotensin-activated signaling pathway [GO:0038166]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to fructose stimulus [GO:0071332]; cellular response to type II interferon [GO:0071346]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; epithelial fluid transport [GO:0042045]; establishment of localization in cell [GO:0051649]; estrous cycle [GO:0044849]; formate transport [GO:0015724]; intestinal absorption [GO:0050892]; intracellular pH elevation [GO:0051454]; mannitol transmembrane transport [GO:0015797]; monoatomic ion transport [GO:0006811]; oxalate transport [GO:0019532]; oxalic acid secretion [GO:0046724]; positive regulation of dipeptide transmembrane transport [GO:2001150]; protein kinase C signaling [GO:0070528]; regulation of intracellular pH [GO:0051453]; sperm capacitation [GO:0048240]; sulfate transmembrane transport [GO:1902358]; transepithelial chloride transport [GO:0030321]; transepithelial transport [GO:0070633]","","INDUCTION: Down-regulated by pro-inflammatory cytokine IFN gamma. {ECO:0000269|PubMed:18655181}.","INDUCTION: Down-regulated by pro-inflammatory cytokine IFN gamma. {ECO:0000269|PubMed:18655181}.","TISSUE SPECIFICITY: Ubiquitous. Highest levels in kidney and pancreas. Lower expression in heart, skeletal muscle, liver and placenta. Also found in lung and brain. {ECO:0000269|PubMed:11087667, ECO:0000269|PubMed:11247665}.; TISSUE SPECIFICITY: [Isoform 4]: Ubiquitously expressed. Highest levels expressed in the kidney and pancreas. {ECO:0000269|PubMed:11087667, ECO:0000269|PubMed:12444019}.; TISSUE SPECIFICITY: [Isoform 5]: Expressed weakly in placenta, lung, liver and pancreas. {ECO:0000269|PubMed:12444019}.; TISSUE SPECIFICITY: [Isoform 6]: Expressed in heart, brain, placenta, lung, liver, kidney, pancreas, spleen, thymus, prostate, testis and ovary. {ECO:0000269|PubMed:12444019}."
"544","sp|P51572|BAP31_HUMAN","lcl|NC_088856.1_cds_XP_065938475.1_20867",1.7e-43,148,"P51572","BAP31_HUMAN","B-cell receptor-associated protein 31 (BCR-associated protein 31) (Bap31) (6C6-AG tumor-associated antigen) (Protein CDM) (p28)","BCAP31 BAP31 DXS1357E","Homo sapiens (Human)",246,"GO:0000139; GO:0005783; GO:0005789; GO:0005811; GO:0005829; GO:0005886; GO:0006626; GO:0006886; GO:0006888; GO:0006915; GO:0007283; GO:0016020; GO:0030136; GO:0032580; GO:0033116; GO:0034976; GO:0042288; GO:0044233; GO:0044877; GO:0070973; GO:0097038; GO:0098553; GO:1904154; GO:1904294; GO:2000060; GO:2001244","apoptotic process [GO:0006915]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein targeting to mitochondrion [GO:0006626]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283]","clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; lipid droplet [GO:0005811]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; MHC class I protein binding [GO:0042288]; protein-containing complex binding [GO:0044877]; apoptotic process [GO:0006915]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein targeting to mitochondrion [GO:0006626]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Ubiquitous. Highly expressed in neurons and discrete endocrine cells. {ECO:0000269|PubMed:11561007}."
"545","sp|P11046|LAMB1_DROME","lcl|NC_088856.1_cds_XP_065938563.1_21020",0,1371,"P11046","LAMB1_DROME","Laminin subunit beta-1 (Laminin B1 chain)","LanB1 lamB1 CG7123","Drosophila melanogaster (Fruit fly)",1788,"GO:0003143; GO:0005201; GO:0005576; GO:0005604; GO:0005925; GO:0007297; GO:0007476; GO:0008406; GO:0016477; GO:0030198; GO:0031012; GO:0033627; GO:0034446; GO:0045089; GO:0048513; GO:0050829; GO:0055013; GO:0070831; GO:0071711","animal organ development [GO:0048513]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cardiac muscle cell development [GO:0055013]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; defense response to Gram-negative bacterium [GO:0050829]; embryonic heart tube morphogenesis [GO:0003143]; extracellular matrix organization [GO:0030198]; follicle cell of egg chamber migration [GO:0007297]; gonad development [GO:0008406]; imaginal disc-derived wing morphogenesis [GO:0007476]; positive regulation of innate immune response [GO:0045089]; substrate adhesion-dependent cell spreading [GO:0034446]","basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; extracellular matrix structural constituent [GO:0005201]; animal organ development [GO:0048513]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cardiac muscle cell development [GO:0055013]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; defense response to Gram-negative bacterium [GO:0050829]; embryonic heart tube morphogenesis [GO:0003143]; extracellular matrix organization [GO:0030198]; follicle cell of egg chamber migration [GO:0007297]; gonad development [GO:0008406]; imaginal disc-derived wing morphogenesis [GO:0007476]; positive regulation of innate immune response [GO:0045089]; substrate adhesion-dependent cell spreading [GO:0034446]","DEVELOPMENTAL STAGE: In the larva, expressed mainly by fat body adipocytes and blood cells and secreted in the basal membranes that surround the fat body, imaginal disks, tracheae, salivary glands, midgut, mature muscles and heart (at protein level). {ECO:0000269|PubMed:30260959}.","","","TISSUE SPECIFICITY: Found in the basement membranes (major component)."
"546","sp|Q9VLT1|MON2_DROME","lcl|NC_088856.1_cds_XP_065938904.1_21629",0,1573,"Q9VLT1","MON2_DROME","Protein MON2 homolog","mon2 CG8683","Drosophila melanogaster (Fruit fly)",1684,"GO:0005519; GO:0005768; GO:0005794; GO:0007318; GO:0015031; GO:0030036","actin cytoskeleton organization [GO:0030036]; pole plasm protein localization [GO:0007318]; protein transport [GO:0015031]","endosome [GO:0005768]; Golgi apparatus [GO:0005794]; cytoskeletal regulatory protein binding [GO:0005519]; actin cytoskeleton organization [GO:0030036]; pole plasm protein localization [GO:0007318]; protein transport [GO:0015031]","","","",""
"547","sp|Q99MD6|TRXR3_MOUSE","lcl|NC_088856.1_cds_XP_065938908.1_21661",0,739,"Q99MD6","TRXR3_MOUSE","Thioredoxin reductase 3 (EC 1.8.1.9) (Thioredoxin and glutathione reductase) (Thioredoxin reductase TR2)","Txnrd3 Tgr Trxr3","Mus musculus (Mouse)",652,"GO:0001825; GO:0004791; GO:0005634; GO:0005783; GO:0006749; GO:0007283; GO:0030154; GO:0045454; GO:0050660","blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283]","endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; flavin adenine dinucleotide binding [GO:0050660]; thioredoxin-disulfide reductase (NADPH) activity [GO:0004791]; blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Accumulates in the testis after puberty. Not detected in 20-day-old mice but highly expressed in testes of 7-month-old mice. {ECO:0000269|PubMed:15901730}.","","","TISSUE SPECIFICITY: Expressed preferentially in testis where it is found in spermatids and spermatocytes but not in sperm. In elongating spermatids, expressed at the site of mitochondrial sheath formation. Low levels in other tissues including heart, lung, liver, kidney, brain, muscle and prostate. {ECO:0000269|PubMed:10455115, ECO:0000269|PubMed:15901730, ECO:0000269|PubMed:20018845}."
"548","sp|P27037|AVR2A_HUMAN","lcl|NC_088857.1_cds_NP_001292259.1_25060",1.43e-140,416,"P27037","AVR2A_HUMAN","Activin receptor type-2A (EC 2.7.11.30) (Activin receptor type IIA) (ACTR-IIA) (ACTRIIA)","ACVR2A ACVR2","Homo sapiens (Human)",513,"GO:0001649; GO:0001702; GO:0001934; GO:0004674; GO:0004675; GO:0005524; GO:0005737; GO:0005886; GO:0007178; GO:0007283; GO:0007368; GO:0007389; GO:0007498; GO:0009952; GO:0009986; GO:0015026; GO:0016361; GO:0016362; GO:0017002; GO:0019838; GO:0030165; GO:0030501; GO:0030509; GO:0032924; GO:0032927; GO:0034673; GO:0034711; GO:0042475; GO:0042713; GO:0042802; GO:0043084; GO:0043235; GO:0045428; GO:0045648; GO:0045669; GO:0045944; GO:0046872; GO:0048179; GO:0048185; GO:0048706; GO:0060011; GO:0060391; GO:0071363; GO:0071773; GO:0098821","activin receptor signaling pathway [GO:0032924]; anterior/posterior pattern specification [GO:0009952]; BMP signaling pathway [GO:0030509]; cell surface receptor protein serine/threonine kinase signaling pathway [GO:0007178]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; embryonic skeletal system development [GO:0048706]; gastrulation with mouth forming second [GO:0001702]; mesoderm development [GO:0007498]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pattern specification process [GO:0007389]; penile erection [GO:0043084]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of bone mineralization [GO:0030501]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of nitric oxide biosynthetic process [GO:0045428]; Sertoli cell proliferation [GO:0060011]; sperm ejaculation [GO:0042713]; spermatogenesis [GO:0007283]","activin receptor complex [GO:0048179]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; inhibin-betaglycan-ActRII complex [GO:0034673]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin receptor activity [GO:0017002]; activin receptor activity, type I [GO:0016361]; activin receptor activity, type II [GO:0016362]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; coreceptor activity [GO:0015026]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; inhibin binding [GO:0034711]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine/threonine kinase activity [GO:0004674]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; activin receptor signaling pathway [GO:0032924]; anterior/posterior pattern specification [GO:0009952]; BMP signaling pathway [GO:0030509]; cell surface receptor protein serine/threonine kinase signaling pathway [GO:0007178]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; embryonic skeletal system development [GO:0048706]; gastrulation with mouth forming second [GO:0001702]; mesoderm development [GO:0007498]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pattern specification process [GO:0007389]; penile erection [GO:0043084]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of bone mineralization [GO:0030501]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of nitric oxide biosynthetic process [GO:0045428]; Sertoli cell proliferation [GO:0060011]; sperm ejaculation [GO:0042713]; spermatogenesis [GO:0007283]","","","",""
"549","sp|F1MLX5|LGR4_BOVIN","lcl|NC_088857.1_cds_NP_001292277.1_23676",3.44e-132,426,"F1MLX5","LGR4_BOVIN","Leucine-rich repeat-containing G-protein coupled receptor 4","LGR4","Bos taurus (Bovine)",951,"GO:0001649; GO:0001818; GO:0001942; GO:0004888; GO:0005615; GO:0005886; GO:0007186; GO:0007283; GO:0016055; GO:0016500; GO:0030282; GO:0030539; GO:0031012; GO:0032922; GO:0034122; GO:0036335; GO:0045087; GO:0046849; GO:0048565; GO:0072224; GO:0072282; GO:0090190; GO:0090263; GO:0120163; GO:2001013","bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; circadian regulation of gene expression [GO:0032922]; digestive tract development [GO:0048565]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; G protein-coupled receptor signaling pathway [GO:0007186]; hair follicle development [GO:0001942]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; male genitalia development [GO:0030539]; metanephric glomerulus development [GO:0072224]; metanephric nephron tubule morphogenesis [GO:0072282]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine production [GO:0001818]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; osteoblast differentiation [GO:0001649]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; spermatogenesis [GO:0007283]; Wnt signaling pathway [GO:0016055]","extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; circadian regulation of gene expression [GO:0032922]; digestive tract development [GO:0048565]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; G protein-coupled receptor signaling pathway [GO:0007186]; hair follicle development [GO:0001942]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; male genitalia development [GO:0030539]; metanephric glomerulus development [GO:0072224]; metanephric nephron tubule morphogenesis [GO:0072282]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine production [GO:0001818]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; osteoblast differentiation [GO:0001649]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; spermatogenesis [GO:0007283]; Wnt signaling pathway [GO:0016055]","","","",""
"550","sp|Q6UL01|MORN2_MOUSE","lcl|NC_088857.1_cds_XP_011412450.1_22865",4.85e-25,91.7,"Q6UL01","MORN2_MOUSE","MORN repeat-containing protein 2 (MORN motif protein in testis)","Morn2 Mopt","Mus musculus (Mouse)",79,"GO:0001669; GO:0005634; GO:0007283; GO:0030154","cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","acrosomal vesicle [GO:0001669]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Detected from postnatal day 15 onwards, with high levels of expression by postnatal day 28. {ECO:0000269|PubMed:19913896}.","","","TISSUE SPECIFICITY: Expressed strongly in testis, where it is specifically detected in haploid germ cells (at protein level). Also expressed strongly in skeletal muscle. {ECO:0000269|PubMed:19913896}."
"551","sp|P97698|SMO_RAT","lcl|NC_088857.1_cds_XP_011413302.3_24088",0,568,"P97698","SMO_RAT","Protein smoothened","Smo Smoh","Rattus norvegicus (Rat)",793,"GO:0000122; GO:0001503; GO:0001570; GO:0001649; GO:0001701; GO:0001708; GO:0001755; GO:0001933; GO:0001942; GO:0001947; GO:0002052; GO:0002053; GO:0003007; GO:0003140; GO:0003323; GO:0004862; GO:0004930; GO:0005113; GO:0005737; GO:0005770; GO:0005783; GO:0005793; GO:0005794; GO:0005814; GO:0005886; GO:0005901; GO:0005929; GO:0006606; GO:0006915; GO:0007224; GO:0007283; GO:0007368; GO:0007371; GO:0007389; GO:0007405; GO:0007417; GO:0007494; GO:0008142; GO:0008283; GO:0008284; GO:0009952; GO:0009953; GO:0010467; GO:0010468; GO:0010508; GO:0010628; GO:0010629; GO:0021513; GO:0021542; GO:0021561; GO:0021696; GO:0021794; GO:0021904; GO:0021953; GO:0021987; GO:0030335; GO:0030425; GO:0030855; GO:0030857; GO:0031069; GO:0031102; GO:0034236; GO:0034504; GO:0035264; GO:0040018; GO:0042307; GO:0042475; GO:0043025; GO:0043066; GO:0043231; GO:0043392; GO:0043524; GO:0044294; GO:0044295; GO:0045880; GO:0045892; GO:0045893; GO:0045944; GO:0046622; GO:0048143; GO:0048468; GO:0048565; GO:0048568; GO:0048589; GO:0048741; GO:0048745; GO:0048846; GO:0048853; GO:0048873; GO:0050673; GO:0050679; GO:0050821; GO:0051451; GO:0051799; GO:0060170; GO:0060231; GO:0060242; GO:0060413; GO:0060644; GO:0060684; GO:0061053; GO:0061113; GO:0070986; GO:0071397; GO:0071542; GO:0071679; GO:0072285; GO:0090190; GO:0097731; GO:0098794; GO:0140311; GO:1902140; GO:1904672; GO:1904754; GO:2000179; GO:2000346; GO:2000491; GO:2000826","anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; astrocyte activation [GO:0048143]; atrial septum morphogenesis [GO:0060413]; axon extension involved in axon guidance [GO:0048846]; cell development [GO:0048468]; cell fate specification [GO:0001708]; cell population proliferation [GO:0008283]; cellular response to cholesterol [GO:0071397]; central nervous system development [GO:0007417]; central nervous system neuron differentiation [GO:0021953]; cerebellar cortex morphogenesis [GO:0021696]; cerebral cortex development [GO:0021987]; commissural neuron axon guidance [GO:0071679]; contact inhibition [GO:0060242]; dentate gyrus development [GO:0021542]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of left/right symmetry [GO:0007368]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; embryonic organ development [GO:0048568]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; epithelial-mesenchymal cell signaling [GO:0060684]; facial nerve development [GO:0021561]; forebrain morphogenesis [GO:0048853]; gene expression [GO:0010467]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mammary gland epithelial cell differentiation [GO:0060644]; mesenchymal to epithelial transition [GO:0060231]; mesenchymal to epithelial transition involved in metanephric renal vesicle formation [GO:0072285]; midgut development [GO:0007494]; multicellular organism growth [GO:0035264]; myoblast migration [GO:0051451]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of gene expression [GO:0010629]; negative regulation of hair follicle development [GO:0051799]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neuroblast proliferation [GO:0007405]; neuron projection regeneration [GO:0031102]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; pancreas morphogenesis [GO:0061113]; pattern specification process [GO:0007389]; positive regulation of autophagy [GO:0010508]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of organ growth [GO:0046622]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein import into nucleus [GO:0006606]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of gene expression [GO:0010468]; regulation of heart morphogenesis [GO:2000826]; regulation of somatic stem cell population maintenance [GO:1904672]; response to inositol [GO:1902140]; skeletal muscle fiber development [GO:0048741]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; somite development [GO:0061053]; spermatogenesis [GO:0007283]; spinal cord dorsal/ventral patterning [GO:0021513]; thalamus development [GO:0021794]; type B pancreatic cell development [GO:0003323]; vasculogenesis [GO:0001570]; ventral midline determination [GO:0007371]","9+0 non-motile cilium [GO:0097731]; axonal growth cone [GO:0044295]; caveola [GO:0005901]; centriole [GO:0005814]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; G protein-coupled receptor activity [GO:0004930]; oxysterol binding [GO:0008142]; patched binding [GO:0005113]; protein kinase A catalytic subunit binding [GO:0034236]; protein sequestering activity [GO:0140311]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; astrocyte activation [GO:0048143]; atrial septum morphogenesis [GO:0060413]; axon extension involved in axon guidance [GO:0048846]; cell development [GO:0048468]; cell fate specification [GO:0001708]; cell population proliferation [GO:0008283]; cellular response to cholesterol [GO:0071397]; central nervous system development [GO:0007417]; central nervous system neuron differentiation [GO:0021953]; cerebellar cortex morphogenesis [GO:0021696]; cerebral cortex development [GO:0021987]; commissural neuron axon guidance [GO:0071679]; contact inhibition [GO:0060242]; dentate gyrus development [GO:0021542]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of left/right symmetry [GO:0007368]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; embryonic organ development [GO:0048568]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; epithelial-mesenchymal cell signaling [GO:0060684]; facial nerve development [GO:0021561]; forebrain morphogenesis [GO:0048853]; gene expression [GO:0010467]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mammary gland epithelial cell differentiation [GO:0060644]; mesenchymal to epithelial transition [GO:0060231]; mesenchymal to epithelial transition involved in metanephric renal vesicle formation [GO:0072285]; midgut development [GO:0007494]; multicellular organism growth [GO:0035264]; myoblast migration [GO:0051451]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of gene expression [GO:0010629]; negative regulation of hair follicle development [GO:0051799]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neuroblast proliferation [GO:0007405]; neuron projection regeneration [GO:0031102]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; pancreas morphogenesis [GO:0061113]; pattern specification process [GO:0007389]; positive regulation of autophagy [GO:0010508]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of organ growth [GO:0046622]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein import into nucleus [GO:0006606]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of gene expression [GO:0010468]; regulation of heart morphogenesis [GO:2000826]; regulation of somatic stem cell population maintenance [GO:1904672]; response to inositol [GO:1902140]; skeletal muscle fiber development [GO:0048741]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; somite development [GO:0061053]; spermatogenesis [GO:0007283]; spinal cord dorsal/ventral patterning [GO:0021513]; thalamus development [GO:0021794]; type B pancreatic cell development [GO:0003323]; vasculogenesis [GO:0001570]; ventral midline determination [GO:0007371]","","","","TISSUE SPECIFICITY: In embryo, found in the early neural folds and neural tube, pre-somitic mesoderm and somites, developing limb bud, gut, eye, testes, cartilage, muscle, lung, epiglottis, thymus, tongue, jaw, taste buds, teeth, and skin. In adult, found in multiple tissues including heart, brain, liver, lung, skeletal muscle, kidney and testis."
"552","sp|Q9NV06|DCA13_HUMAN","lcl|NC_088857.1_cds_XP_011413306.1_24091",0,650,"Q9NV06","DCA13_HUMAN","DDB1- and CUL4-associated factor 13 (WD repeat and SOF domain-containing protein 1)","DCAF13 WDSOF1 HSPC064","Homo sapiens (Human)",445,"GO:0000462; GO:0001555; GO:0003723; GO:0005654; GO:0005730; GO:0005813; GO:0005829; GO:0006364; GO:0007056; GO:0016567; GO:0030054; GO:0030331; GO:0032040; GO:0043161; GO:0044725; GO:0046697; GO:0080008; GO:1990756","decidualization [GO:0046697]; epigenetic programming in the zygotic pronuclei [GO:0044725]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; oocyte growth [GO:0001555]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; rRNA processing [GO:0006364]; spindle assembly involved in female meiosis [GO:0007056]","cell junction [GO:0030054]; centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; nuclear estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; decidualization [GO:0046697]; epigenetic programming in the zygotic pronuclei [GO:0044725]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; oocyte growth [GO:0001555]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; rRNA processing [GO:0006364]; spindle assembly involved in female meiosis [GO:0007056]","DEVELOPMENTAL STAGE: Transiently expressed during four-cell to morula stages in embryo. {ECO:0000269|PubMed:30111536}.","","","TISSUE SPECIFICITY: Expressed in the endometrium during decidualization. Expression is down-regulated in preeclampsia decidual tissues. {ECO:0000269|PubMed:35932979}."
"553","sp|Q3ZBL4|LZTL1_BOVIN","lcl|NC_088857.1_cds_XP_011413648.3_23844",5.84e-92,276,"Q3ZBL4","LZTL1_BOVIN","Leucine zipper transcription factor-like protein 1","LZTFL1","Bos taurus (Bovine)",299,"GO:0002177; GO:0005737; GO:0005829; GO:0005929; GO:0007283; GO:0030317; GO:0042802; GO:0044877; GO:1903565; GO:1903568","flagellated sperm motility [GO:0030317]; negative regulation of protein localization to ciliary membrane [GO:1903568]; negative regulation of protein localization to cilium [GO:1903565]; spermatogenesis [GO:0007283]","cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; manchette [GO:0002177]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; flagellated sperm motility [GO:0030317]; negative regulation of protein localization to ciliary membrane [GO:1903568]; negative regulation of protein localization to cilium [GO:1903565]; spermatogenesis [GO:0007283]","","","",""
"554","sp|Q9CWH4|RE114_MOUSE","lcl|NC_088857.1_cds_XP_011414339.3_27836",1.33e-13,69.3,"Q9CWH4","RE114_MOUSE","Meiotic recombination protein REC114","Rec114","Mus musculus (Mouse)",259,"GO:0005694; GO:0006310; GO:0007283; GO:0042138; GO:0048477","DNA recombination [GO:0006310]; meiotic DNA double-strand break formation [GO:0042138]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]","chromosome [GO:0005694]; DNA recombination [GO:0006310]; meiotic DNA double-strand break formation [GO:0042138]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: In the testis, expression is detected at 4 days postpartum (dpp) with a peak at day 10. Levels decrease between 14-18 dpp with an increase in the adult. {ECO:0000269|PubMed:20551173}.","","","TISSUE SPECIFICITY: Expressed in adult testis and embryonic ovary. Also expressed at low levels in liver. {ECO:0000269|PubMed:20551173}."
"555","sp|P08171|EST6_DROME","lcl|NC_088857.1_cds_XP_011414448.3_22750",6.61e-49,179,"P08171","EST6_DROME","Esterase-6 (Est-6) (EC 3.1.1.1) (Carboxylic-ester hydrolase 6) (Carboxylesterase-6)","Est-6 EST6 CG6917","Drosophila melanogaster (Fruit fly)",544,"GO:0005576; GO:0005615; GO:0007618; GO:0007619; GO:0017171; GO:0019953; GO:0030728; GO:0034338; GO:0042811; GO:0046008; GO:0046662; GO:0046693; GO:0106435; GO:1990834","courtship behavior [GO:0007619]; mating [GO:0007618]; ovulation [GO:0030728]; pheromone biosynthetic process [GO:0042811]; regulation of egg-laying behavior [GO:0046662]; regulation of female receptivity, post-mating [GO:0046008]; response to odorant [GO:1990834]; sexual reproduction [GO:0019953]; sperm storage [GO:0046693]","extracellular region [GO:0005576]; extracellular space [GO:0005615]; carboxylesterase activity [GO:0106435]; serine hydrolase activity [GO:0017171]; short-chain carboxylesterase activity [GO:0034338]; courtship behavior [GO:0007619]; mating [GO:0007618]; ovulation [GO:0030728]; pheromone biosynthetic process [GO:0042811]; regulation of egg-laying behavior [GO:0046662]; regulation of female receptivity, post-mating [GO:0046008]; response to odorant [GO:1990834]; sexual reproduction [GO:0019953]; sperm storage [GO:0046693]","","","","TISSUE SPECIFICITY: Specifically expressed in the ejaculatory bulbs of male."
"556","sp|Q7ZV84|DAAF1_DANRE","lcl|NC_088857.1_cds_XP_011414831.3_22966",9.52e-101,319,"Q7ZV84","DAAF1_DANRE","Dynein axonemal assembly factor 1 (Leucine-rich repeat-containing protein 50)","dnaaf1 lrrc50 zgc:56169","Danio rerio (Zebrafish) (Brachydanio rerio)",555,"GO:0001947; GO:0003143; GO:0003146; GO:0003305; GO:0003314; GO:0005930; GO:0007283; GO:0007368; GO:0007369; GO:0035082; GO:0048793; GO:0060027; GO:0060271; GO:0061371; GO:0070840","axoneme assembly [GO:0035082]; cell migration involved in heart jogging [GO:0003305]; cilium assembly [GO:0060271]; convergent extension involved in gastrulation [GO:0060027]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; embryonic heart tube morphogenesis [GO:0003143]; gastrulation [GO:0007369]; heart jogging [GO:0003146]; heart looping [GO:0001947]; heart rudiment morphogenesis [GO:0003314]; pronephros development [GO:0048793]; spermatogenesis [GO:0007283]","axoneme [GO:0005930]; dynein complex binding [GO:0070840]; axoneme assembly [GO:0035082]; cell migration involved in heart jogging [GO:0003305]; cilium assembly [GO:0060271]; convergent extension involved in gastrulation [GO:0060027]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; embryonic heart tube morphogenesis [GO:0003143]; gastrulation [GO:0007369]; heart jogging [GO:0003146]; heart looping [GO:0001947]; heart rudiment morphogenesis [GO:0003314]; pronephros development [GO:0048793]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed in ciliated tissues throughout development. At gastrula stages, it is highly expressed in dorsal forerunner cells, which aggregate to form the ciliated Kupffer's vesicle. At the 12-somite stage (14 hpf), expression is restricted to the otic placode, pronephric duct primordia and floorplate. At 20 hpf, it is expressed in the pronephric duct, neural tube, nose and diffusely in the brain. Expression becomes restricted to the nose and lateral line organs at 72 hpf. {ECO:0000269|PubMed:18385425}.","","","TISSUE SPECIFICITY: Specifically expressed in all ciliated tissues. {ECO:0000269|PubMed:18385425}."
"557","sp|Q71MB6|SO4C1_RAT","lcl|NC_088857.1_cds_XP_011415178.3_24721",3.25e-150,454,"Q71MB6","SO4C1_RAT","Solute carrier organic anion transporter family member 4C1 (SLCO4C1) (Organic anion transporting polypeptide 4C1) (OATP4C1) (Solute carrier family 21 member 20)","Slco4c1 Oatp4c1 Slc21a20","Rattus norvegicus (Rat)",724,"GO:0006811; GO:0007283; GO:0008514; GO:0015347; GO:0015711; GO:0016323; GO:0016324; GO:0030154; GO:0043252","cell differentiation [GO:0030154]; monoatomic ion transport [GO:0006811]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283]","apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; cell differentiation [GO:0030154]; monoatomic ion transport [GO:0006811]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283]","","INDUCTION: Expression is significantly decreased in renal failure. {ECO:0000269|PubMed:14993604}.","INDUCTION: Expression is significantly decreased in renal failure. {ECO:0000269|PubMed:14993604}.","TISSUE SPECIFICITY: Predominantly expressed in kidney and lung but also weakly expressed in brain (PubMed:14993604). Localizes primarily in the proximal straight tubules, the S3 fraction of the nephron (PubMed:22768102). {ECO:0000269|PubMed:14993604, ECO:0000269|PubMed:22768102}."
"558","sp|Q9DAN9|CF97D_MOUSE","lcl|NC_088857.1_cds_XP_011415663.1_27317",3.79e-24,95.1,"Q9DAN9","CF97D_MOUSE","Sperm axonemal maintenance protein CFAP97D1 (CFAP97 domain-containing protein 1)","Cfap97d1","Mus musculus (Mouse)",164,"GO:0007288","sperm axoneme assembly [GO:0007288]","sperm axoneme assembly [GO:0007288]","DEVELOPMENTAL STAGE: Expression starts at postnatal day 20 and continues throughout adulthood. {ECO:0000269|PubMed:32785227}.","","","TISSUE SPECIFICITY: Expressed exclusively in testis. {ECO:0000269|PubMed:32785227}."
"559","sp|Q8VIH1|NOBOX_MOUSE","lcl|NC_088857.1_cds_XP_011415664.1_27318",1.4e-16,81.6,"Q8VIH1","NOBOX_MOUSE","Homeobox protein NOBOX (Homeodomain-containing protein OG-2) (Newborn ovary homeobox protein) (Oocyte-specific homeobox protein)","Nobox Og2x","Mus musculus (Mouse)",527,"GO:0000978; GO:0001228; GO:0001541; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006366; GO:0043565; GO:0045944; GO:0048477","oogenesis [GO:0048477]; ovarian follicle development [GO:0001541]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; oogenesis [GO:0048477]; ovarian follicle development [GO:0001541]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]","DEVELOPMENTAL STAGE: Expressed from 15.5 dpc. {ECO:0000269|PubMed:8855241}.","","","TISSUE SPECIFICITY: Specifically expressed in ovaries and testes. In ovaries, expressed in oocytes from primordial through antral follicles but not in granulosa cells, theca cells and corpora lutea. {ECO:0000269|PubMed:11804785}."
"560","sp|Q6NN55|MBOA6_DROME","lcl|NC_088857.1_cds_XP_011416786.2_22231",7.1e-108,337,"Q6NN55","MBOA6_DROME","Lysophospholipid acyltransferase 6 (LPLAT 6) (EC 2.3.1.-) (EC 2.3.1.23) (EC 2.3.1.n6) (EC 2.3.1.n7) (Membrane-bound acyltransferase 6) (MBOA 6) (Oysgedart) (Oys)","oys CG18445","Drosophila melanogaster (Fruit fly)",722,"GO:0005783; GO:0006644; GO:0007009; GO:0007291; GO:0008354; GO:0016020; GO:0016746; GO:0030258; GO:0071617","germ cell migration [GO:0008354]; lipid modification [GO:0030258]; phospholipid metabolic process [GO:0006644]; plasma membrane organization [GO:0007009]; sperm individualization [GO:0007291]","endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; acyltransferase activity [GO:0016746]; lysophospholipid acyltransferase activity [GO:0071617]; germ cell migration [GO:0008354]; lipid modification [GO:0030258]; phospholipid metabolic process [GO:0006644]; plasma membrane organization [GO:0007009]; sperm individualization [GO:0007291]","","","",""
"561","sp|Q94230|PLP1_CAEEL","lcl|NC_088857.1_cds_XP_011419104.1_26439",8.86e-46,153,"Q94230","PLP1_CAEEL","Transcriptional activator plp-1 (Pur-alpha-like protein 1)","plp-1 F45E4.2","Caenorhabditis elegans",226,"GO:0000977; GO:0000981; GO:0003690; GO:0003691; GO:0005634; GO:0005694; GO:0006357; GO:0007281; GO:0032422; GO:0040012; GO:0043186; GO:0043565","germ cell development [GO:0007281]; regulation of locomotion [GO:0040012]; regulation of transcription by RNA polymerase II [GO:0006357]","chromosome [GO:0005694]; nucleus [GO:0005634]; P granule [GO:0043186]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; double-stranded telomeric DNA binding [GO:0003691]; purine-rich negative regulatory element binding [GO:0032422]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; germ cell development [GO:0007281]; regulation of locomotion [GO:0040012]; regulation of transcription by RNA polymerase II [GO:0006357]","DEVELOPMENTAL STAGE: First expressed in blastomeres at the two cell stage of embryogenesis (PubMed:19084000). Also expressed in germline-specific P granules of early embryos (PubMed:19084000). {ECO:0000269|PubMed:19084000}.","","",""
"562","sp|Q9UJA3|MCM8_HUMAN","lcl|NC_088857.1_cds_XP_011419900.3_26282",0,970,"Q9UJA3","MCM8_HUMAN","DNA helicase MCM8 (EC 3.6.4.12) (Minichromosome maintenance 8)","MCM8 C20orf154","Homo sapiens (Human)",840,"GO:0000724; GO:0003682; GO:0003697; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0006974; GO:0007292; GO:0016887; GO:0019899; GO:0032406; GO:0032407; GO:0032408; GO:0036298; GO:0042555; GO:0048232; GO:0050821; GO:0070716; GO:0071168; GO:0097362","DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; male gamete generation [GO:0048232]; mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication [GO:0070716]; protein localization to chromatin [GO:0071168]; protein stabilization [GO:0050821]; recombinational interstrand cross-link repair [GO:0036298]","chromosome [GO:0005694]; MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; helicase activity [GO:0004386]; MutLbeta complex binding [GO:0032406]; MutSalpha complex binding [GO:0032407]; MutSbeta complex binding [GO:0032408]; single-stranded DNA binding [GO:0003697]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; male gamete generation [GO:0048232]; mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication [GO:0070716]; protein localization to chromatin [GO:0071168]; protein stabilization [GO:0050821]; recombinational interstrand cross-link repair [GO:0036298]","","INDUCTION: By E2F1. {ECO:0000269|PubMed:16325355}.","INDUCTION: By E2F1. {ECO:0000269|PubMed:16325355}.","TISSUE SPECIFICITY: Highest levels in placenta, lung and pancreas. Low levels in skeletal muscle and kidney. Expressed in various tumors with highest levels in colon and lung cancers. {ECO:0000269|PubMed:12771218}."
"563","sp|P08151|GLI1_HUMAN","lcl|NC_088857.1_cds_XP_011419956.3_23631",2.5e-81,293,"P08151","GLI1_HUMAN","Zinc finger protein GLI1 (Glioma-associated oncogene) (Oncogene GLI)","GLI1 GLI","Homo sapiens (Human)",1106,"GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001649; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005930; GO:0006355; GO:0006357; GO:0007224; GO:0007286; GO:0007418; GO:0008017; GO:0008270; GO:0008284; GO:0008589; GO:0009611; GO:0009913; GO:0009953; GO:0009954; GO:0021696; GO:0021983; GO:0030324; GO:0030335; GO:0030850; GO:0036064; GO:0043565; GO:0045667; GO:0045740; GO:0045880; GO:0045893; GO:0045944; GO:0048546; GO:0060032; GO:0060045; GO:0090090; GO:0097421; GO:0097542; GO:0097546; GO:1902808; GO:1990788; GO:2000345","cerebellar cortex morphogenesis [GO:0021696]; digestive tract morphogenesis [GO:0048546]; dorsal/ventral pattern formation [GO:0009953]; epidermal cell differentiation [GO:0009913]; liver regeneration [GO:0097421]; lung development [GO:0030324]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; notochord regression [GO:0060032]; osteoblast differentiation [GO:0001649]; pituitary gland development [GO:0021983]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland development [GO:0030850]; proximal/distal pattern formation [GO:0009954]; regulation of DNA-templated transcription [GO:0006355]; regulation of hepatocyte proliferation [GO:2000345]; regulation of osteoblast differentiation [GO:0045667]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; response to wounding [GO:0009611]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286]; ventral midline development [GO:0007418]","axoneme [GO:0005930]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GLI-SUFU complex [GO:1990788]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; microtubule binding [GO:0008017]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; cerebellar cortex morphogenesis [GO:0021696]; digestive tract morphogenesis [GO:0048546]; dorsal/ventral pattern formation [GO:0009953]; epidermal cell differentiation [GO:0009913]; liver regeneration [GO:0097421]; lung development [GO:0030324]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; notochord regression [GO:0060032]; osteoblast differentiation [GO:0001649]; pituitary gland development [GO:0021983]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland development [GO:0030850]; proximal/distal pattern formation [GO:0009954]; regulation of DNA-templated transcription [GO:0006355]; regulation of hepatocyte proliferation [GO:2000345]; regulation of osteoblast differentiation [GO:0045667]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; response to wounding [GO:0009611]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286]; ventral midline development [GO:0007418]","","INDUCTION: Isoform 1 and isoform 2 are amplified in glioblastoma cells. {ECO:0000269|PubMed:19706761}.","INDUCTION: Isoform 1 and isoform 2 are amplified in glioblastoma cells. {ECO:0000269|PubMed:19706761}.","TISSUE SPECIFICITY: Detected in testis (at protein level) (PubMed:2105456). Testis, myometrium and fallopian tube. Also expressed in the brain with highest expression in the cerebellum, optic nerve and olfactory tract (PubMed:19878745). Isoform 1 is detected in brain, spleen, pancreas, liver, kidney and placenta; isoform 2 is not detectable in these tissues (PubMed:19706761). {ECO:0000269|PubMed:19706761, ECO:0000269|PubMed:19878745, ECO:0000269|PubMed:2105456}."
"564","sp|P09087|ABDB_DROME","lcl|NC_088857.1_cds_XP_011420625.1_22564",9.57e-19,87.4,"P09087","ABDB_DROME","Homeobox protein abdominal-B (Infraabdominal 7) (IAB-7) (P3) (PH189)","Abd-B CG10291","Drosophila melanogaster (Fruit fly)",493,"GO:0000976; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005704; GO:0006357; GO:0007379; GO:0007385; GO:0007424; GO:0007486; GO:0007494; GO:0007506; GO:0007621; GO:0008354; GO:0008584; GO:0009997; GO:0030539; GO:0030540; GO:0035224; GO:0035225; GO:0035261; GO:0035263; GO:0035277; GO:0045705; GO:0045843; GO:0045944; GO:0046693; GO:0048094; GO:0061101; GO:1902339","determination of genital disc primordium [GO:0035225]; external genitalia morphogenesis [GO:0035261]; female genitalia development [GO:0030540]; genital disc anterior/posterior pattern formation [GO:0035224]; genital disc sexually dimorphic development [GO:0035263]; germ cell migration [GO:0008354]; gonadal mesoderm development [GO:0007506]; imaginal disc-derived female genitalia development [GO:0007486]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; male pigmentation [GO:0048094]; midgut development [GO:0007494]; negative regulation of cardioblast cell fate specification [GO:0009997]; negative regulation of female receptivity [GO:0007621]; negative regulation of salivary gland boundary specification [GO:0045705]; negative regulation of striated muscle tissue development [GO:0045843]; neuroendocrine cell differentiation [GO:0061101]; open tracheal system development [GO:0007424]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]; specification of segmental identity, abdomen [GO:0007385]; sperm storage [GO:0046693]; spiracle morphogenesis, open tracheal system [GO:0035277]","nucleus [GO:0005634]; polytene chromosome band [GO:0005704]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; determination of genital disc primordium [GO:0035225]; external genitalia morphogenesis [GO:0035261]; female genitalia development [GO:0030540]; genital disc anterior/posterior pattern formation [GO:0035224]; genital disc sexually dimorphic development [GO:0035263]; germ cell migration [GO:0008354]; gonadal mesoderm development [GO:0007506]; imaginal disc-derived female genitalia development [GO:0007486]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; male pigmentation [GO:0048094]; midgut development [GO:0007494]; negative regulation of cardioblast cell fate specification [GO:0009997]; negative regulation of female receptivity [GO:0007621]; negative regulation of salivary gland boundary specification [GO:0045705]; negative regulation of striated muscle tissue development [GO:0045843]; neuroendocrine cell differentiation [GO:0061101]; open tracheal system development [GO:0007424]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]; specification of segmental identity, abdomen [GO:0007385]; sperm storage [GO:0046693]; spiracle morphogenesis, open tracheal system [GO:0035277]","DEVELOPMENTAL STAGE: Highly expressed during embryogenesis, lower expression in larvae, pupae and adults. {ECO:0000269|PubMed:2903050}.","","","TISSUE SPECIFICITY: Isoform M and isoform R are expressed in ectodermal and mesodermal tissues and central nervous system of fourth to ninth embryonic abdominal segments. Later in embryogenesis, expression is seen in visceral mesoderm surrounding hindgut and in two Malpighian tubules. {ECO:0000269|PubMed:2903050}."
"565","sp|O45876|APH1_CAEEL","lcl|NC_088857.1_cds_XP_011420643.2_26530",4.37e-18,83.6,"O45876","APH1_CAEEL","Gamma-secretase subunit aph-1 (Anterior-pharynx-defective protein 1) (Presenilin enhancer protein 1)","aph-1 pen-1 VF36H2L.1","Caenorhabditis elegans",308,"GO:0005783; GO:0007219; GO:0007220; GO:0009792; GO:0016485; GO:0030674; GO:0034394; GO:0045165; GO:0048598; GO:0048599; GO:0060581; GO:0070765; GO:0160094","cell fate commitment [GO:0045165]; cell fate commitment involved in pattern specification [GO:0060581]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic morphogenesis [GO:0048598]; nematode pharynx development [GO:0160094]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; oocyte development [GO:0048599]; protein localization to cell surface [GO:0034394]; protein processing [GO:0016485]","endoplasmic reticulum [GO:0005783]; gamma-secretase complex [GO:0070765]; protein-macromolecule adaptor activity [GO:0030674]; cell fate commitment [GO:0045165]; cell fate commitment involved in pattern specification [GO:0060581]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic morphogenesis [GO:0048598]; nematode pharynx development [GO:0160094]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; oocyte development [GO:0048599]; protein localization to cell surface [GO:0034394]; protein processing [GO:0016485]","","","",""
"566","sp|O18209|PMY13_CAEEL","lcl|NC_088857.1_cds_XP_011420649.3_26523",9.48e-87,283,"O18209","PMY13_CAEEL","Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase wee-1.3 (EC 2.7.11.1) (Lethal protein 37) (Myt1 kinase)","wee-1.3 let-37 myt-1 spe-37 Y53C12A.1","Caenorhabditis elegans",677,"GO:0000139; GO:0000793; GO:0001556; GO:0002119; GO:0004672; GO:0004674; GO:0004861; GO:0005524; GO:0005634; GO:0005635; GO:0005737; GO:0005886; GO:0007283; GO:0009792; GO:0010972; GO:0019898; GO:0045138; GO:0046872; GO:0048477; GO:0051078; GO:0051321; GO:0060280; GO:0097038; GO:0106310; GO:0110031; GO:1904145","embryo development ending in birth or egg hatching [GO:0009792]; meiotic cell cycle [GO:0051321]; meiotic nuclear membrane disassembly [GO:0051078]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of G2/MI transition of meiotic cell cycle [GO:0110031]; negative regulation of meiotic cell cycle process involved in oocyte maturation [GO:1904145]; negative regulation of ovulation [GO:0060280]; nematode larval development [GO:0002119]; nematode male tail tip morphogenesis [GO:0045138]; oocyte maturation [GO:0001556]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]","condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; embryo development ending in birth or egg hatching [GO:0009792]; meiotic cell cycle [GO:0051321]; meiotic nuclear membrane disassembly [GO:0051078]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of G2/MI transition of meiotic cell cycle [GO:0110031]; negative regulation of meiotic cell cycle process involved in oocyte maturation [GO:1904145]; negative regulation of ovulation [GO:0060280]; nematode larval development [GO:0002119]; nematode male tail tip morphogenesis [GO:0045138]; oocyte maturation [GO:0001556]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed during both germline and early embryonic development. In larvae, it is expressed in the distal region, germline, and in some neurons and hypodermal cells. Not expressed in distal region of the adult. {ECO:0000269|PubMed:12397109}.","","",""
"567","sp|Q6IBW4|CNDH2_HUMAN","lcl|NC_088857.1_cds_XP_011420661.3_26509",3.01e-97,311,"Q6IBW4","CNDH2_HUMAN","Condensin-2 complex subunit H2 (Chromosome-associated protein H2) (hCAP-H2) (Kleisin-beta) (Non-SMC condensin II complex subunit H2)","NCAPH2 CAPH2","Homo sapiens (Human)",605,"GO:0000794; GO:0000796; GO:0003682; GO:0005634; GO:0005654; GO:0007076; GO:0010032; GO:0016020; GO:0030054; GO:0033077; GO:0045171; GO:0051306; GO:0051309; GO:0051984; GO:1905820; GO:1905821","female meiosis chromosome separation [GO:0051309]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid separation [GO:0051306]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; T cell differentiation in thymus [GO:0033077]","cell junction [GO:0030054]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; female meiosis chromosome separation [GO:0051309]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid separation [GO:0051306]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; T cell differentiation in thymus [GO:0033077]","","","",""
"568","sp|Q9VSL7|FOI_DROME","lcl|NC_088857.1_cds_XP_011421651.3_26070",6.06e-52,192,"Q9VSL7","FOI_DROME","Zinc transporter foi (Protein fear-of-intimacy) (Protein kastchen)","foi CG6817","Drosophila melanogaster (Fruit fly)",706,"GO:0005385; GO:0005886; GO:0006829; GO:0006882; GO:0007417; GO:0007506; GO:0008354; GO:0008406; GO:0009986; GO:0016323; GO:0016477; GO:0030003; GO:0030154; GO:0035147; GO:0035262; GO:0071577; GO:0071578; GO:0140410","branch fusion, open tracheal system [GO:0035147]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; central nervous system development [GO:0007417]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; gonad morphogenesis [GO:0035262]; gonadal mesoderm development [GO:0007506]; intracellular monoatomic cation homeostasis [GO:0030003]; intracellular zinc ion homeostasis [GO:0006882]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]","basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; plasma membrane [GO:0005886]; monoatomic cation:bicarbonate symporter activity [GO:0140410]; zinc ion transmembrane transporter activity [GO:0005385]; branch fusion, open tracheal system [GO:0035147]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; central nervous system development [GO:0007417]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; gonad morphogenesis [GO:0035262]; gonadal mesoderm development [GO:0007506]; intracellular monoatomic cation homeostasis [GO:0030003]; intracellular zinc ion homeostasis [GO:0006882]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. {ECO:0000269|PubMed:15464587}.","","","TISSUE SPECIFICITY: Maternal foi has almost completely disappeared by embryonic stage 3 except in the pole cells. In stage 6 embryos, expression is enriched in the invaginating mesoderm. In stage 9 embryos, high levels in the anterior and posterior midgut primordia. In stage 14 embryos, broad expression with low levels in the epidermis. {ECO:0000269|PubMed:12702650}."
"569","sp|Q8W1W6|MYB33_ARATH","lcl|NC_088857.1_cds_XP_011422250.3_26012",3.34e-28,120,"Q8W1W6","MYB33_ARATH","Transcription factor MYB33 (Myb-related protein 33) (AtMYB33)","MYB33 At5g06100 K16F4.6","Arabidopsis thaliana (Mouse-ear cress)",520,"GO:0003700; GO:0005634; GO:0008285; GO:0009723; GO:0009735; GO:0009739; GO:0009740; GO:0009789; GO:0043068; GO:0043565; GO:0045893; GO:0045926; GO:0048235; GO:0048653; GO:0048655; GO:1990019","anther development [GO:0048653]; anther wall tapetum morphogenesis [GO:0048655]; gibberellic acid mediated signaling pathway [GO:0009740]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; pollen sperm cell differentiation [GO:0048235]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of programmed cell death [GO:0043068]; protein storage vacuole organization [GO:1990019]; response to cytokinin [GO:0009735]; response to ethylene [GO:0009723]; response to gibberellin [GO:0009739]","nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; anther development [GO:0048653]; anther wall tapetum morphogenesis [GO:0048655]; gibberellic acid mediated signaling pathway [GO:0009740]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; pollen sperm cell differentiation [GO:0048235]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of programmed cell death [GO:0043068]; protein storage vacuole organization [GO:1990019]; response to cytokinin [GO:0009735]; response to ethylene [GO:0009723]; response to gibberellin [GO:0009739]","DEVELOPMENTAL STAGE: In germinating seeds, present in the root tip and in a linear array of up to 20 to 30 cells above the root tip. Weak expression in the vegetative shoot apex. High levels in primordial leaves. Strongly expressed in the inflorescence apex, and, to some extent, in the inflorescence stem, the vascular tissue, and the vascular tissue in leaf primordia. In the gynoecium, confined to ovules. In developing anthers detected in developing locules of immature anthers and later, at low levels, in pollen grains (PubMed:11743113). In flowers, expressed in sepals, style, receptacle, anther filaments, especially in young anthers, and connective but not in anthers themselves (PubMed:15722475). {ECO:0000269|PubMed:11743113, ECO:0000269|PubMed:15722475}.","INDUCTION: Accumulates at the shoot apex upon the transition from short- to long-day photoperiods leading to flowering and after gibberellins (GAs) treatment (PubMed:11743113). Repressed by microRNA159 (miR159a and miR159b) in vegetative tissues (PubMed:15226253, PubMed:17916625, PubMed:20699403). Specific expression in floral organs and in the shoot apices is regulated via miR159-mediated degradation (PubMed:15722475). Repressed in germinating seeds by miR159-mediated cleavage in an abscisic acid (ABA) and ABI3-dependent manner, probably to desensitize hormone signaling during seedling stress responses (PubMed:17217461, PubMed:18305205). Slightly induced by ethylene and cytokinins (PubMed:9839469). {ECO:0000269|PubMed:11743113, ECO:0000269|PubMed:15226253, ECO:0000269|PubMed:15722475, ECO:0000269|PubMed:17217461, ECO:0000269|PubMed:17916625, ECO:0000269|PubMed:18305205, ECO:0000269|PubMed:20699403, ECO:0000269|PubMed:9839469}.","INDUCTION: Accumulates at the shoot apex upon the transition from short- to long-day photoperiods leading to flowering and after gibberellins (GAs) treatment (PubMed:11743113). Repressed by microRNA159 (miR159a and miR159b) in vegetative tissues (PubMed:15226253, PubMed:17916625, PubMed:20699403). Specific expression in floral organs and in the shoot apices is regulated via miR159-mediated degradation (PubMed:15722475). Repressed in germinating seeds by miR159-mediated cleavage in an abscisic acid (ABA) and ABI3-dependent manner, probably to desensitize hormone signaling during seedling stress responses (PubMed:17217461, PubMed:18305205). Slightly induced by ethylene and cytokinins (PubMed:9839469). {ECO:0000269|PubMed:11743113, ECO:0000269|PubMed:15226253, ECO:0000269|PubMed:15722475, ECO:0000269|PubMed:17217461, ECO:0000269|PubMed:17916625, ECO:0000269|PubMed:18305205, ECO:0000269|PubMed:20699403, ECO:0000269|PubMed:9839469}.","TISSUE SPECIFICITY: Mostly expressed in stems, shoot apices, flowers and floral shoot tips, and, to a lower extent, in roots (e.g. root tips), seedlings, leaves and siliques. {ECO:0000269|PubMed:11743113, ECO:0000269|PubMed:15722475, ECO:0000269|PubMed:24278028, ECO:0000269|PubMed:9839469}."
"570","sp|Q13263|TIF1B_HUMAN","lcl|NC_088857.1_cds_XP_011422593.3_23677",1.06e-38,156,"Q13263","TIF1B_HUMAN","Transcription intermediary factor 1-beta (TIF1-beta) (E3 SUMO-protein ligase TRIM28) (EC 2.3.2.27) (KRAB-associated protein 1) (KAP-1) (KRAB-interacting protein 1) (KRIP-1) (Nuclear corepressor KAP-1) (RING finger protein 96) (RING-type E3 ubiquitin transferase TIF1-beta) (Tripartite motif-containing protein 28)","TRIM28 KAP1 RNF96 TIF1B","Homo sapiens (Human)",835,"GO:0000122; GO:0000791; GO:0000792; GO:0001837; GO:0003677; GO:0003682; GO:0003713; GO:0003714; GO:0003723; GO:0004672; GO:0004842; GO:0005634; GO:0005654; GO:0006281; GO:0006325; GO:0006346; GO:0007566; GO:0008270; GO:0016925; GO:0019789; GO:0031625; GO:0032991; GO:0035851; GO:0042307; GO:0043161; GO:0044790; GO:0045087; GO:0045739; GO:0045869; GO:0045892; GO:0045893; GO:0060028; GO:0060669; GO:0061630; GO:0070087; GO:0071514; GO:0090575; GO:1990841","chromatin organization [GO:0006325]; convergent extension involved in axis elongation [GO:0060028]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; DNA repair [GO:0006281]; embryo implantation [GO:0007566]; embryonic placenta morphogenesis [GO:0060669]; epithelial to mesenchymal transition [GO:0001837]; genomic imprinting [GO:0071514]; innate immune response [GO:0045087]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein import into nucleus [GO:0042307]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein sumoylation [GO:0016925]; suppression of viral release by host [GO:0044790]","euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; Krueppel-associated box domain binding [GO:0035851]; promoter-specific chromatin binding [GO:1990841]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; convergent extension involved in axis elongation [GO:0060028]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; DNA repair [GO:0006281]; embryo implantation [GO:0007566]; embryonic placenta morphogenesis [GO:0060669]; epithelial to mesenchymal transition [GO:0001837]; genomic imprinting [GO:0071514]; innate immune response [GO:0045087]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein import into nucleus [GO:0042307]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein sumoylation [GO:0016925]; suppression of viral release by host [GO:0044790]","","","","TISSUE SPECIFICITY: Expressed in all tissues tested including spleen, thymus, prostate, testis, ovary, small intestine, colon and peripheral blood leukocytes. {ECO:0000269|PubMed:9016654}."
"571","sp|Q2VB19|PUM1_CHICK","lcl|NC_088857.1_cds_XP_011422894.2_25009",0,622,"Q2VB19","PUM1_CHICK","Pumilio homolog 1","PUM1 RCJMB04_1f11","Gallus gallus (Chicken)",1189,"GO:0000932; GO:0003730; GO:0005737; GO:0005829; GO:0006417; GO:0007283; GO:0008344; GO:0016441; GO:0035196; GO:0043488; GO:0048863; GO:0051726; GO:0061157; GO:2000637","adult locomotory behavior [GO:0008344]; miRNA processing [GO:0035196]; mRNA destabilization [GO:0061157]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; post-transcriptional gene silencing [GO:0016441]; regulation of cell cycle [GO:0051726]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; P-body [GO:0000932]; mRNA 3'-UTR binding [GO:0003730]; adult locomotory behavior [GO:0008344]; miRNA processing [GO:0035196]; mRNA destabilization [GO:0061157]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; post-transcriptional gene silencing [GO:0016441]; regulation of cell cycle [GO:0051726]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]","","","","TISSUE SPECIFICITY: Detected in embryonic male and female gonads, heart, liver and muscle. Detected in adult brain, testis, ovary, heart, lung, spleen, kidney and muscle. {ECO:0000269|PubMed:17474090}."
"572","sp|Q9V730|EXT1_DROME","lcl|NC_088857.1_cds_XP_011423304.3_23944",0,688,"Q9V730","EXT1_DROME","Exostosin-1 (EC 2.4.1.224) (EC 2.4.1.225) (Protein tout-velu) (TTV)","ttv DEXT1 CG10117","Drosophila melanogaster (Fruit fly)",760,"GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0006024; GO:0006486; GO:0008354; GO:0008375; GO:0015012; GO:0015020; GO:0016020; GO:0016055; GO:0030210; GO:0046872; GO:0050508; GO:0050509; GO:0120504","germ cell migration [GO:0008354]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; protein glycosylation [GO:0006486]; Wnt signaling pathway [GO:0016055]","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; EXT1-EXT2 complex [GO:0120504]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; germ cell migration [GO:0008354]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; protein glycosylation [GO:0006486]; Wnt signaling pathway [GO:0016055]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. {ECO:0000269|PubMed:9665133}.","","","TISSUE SPECIFICITY: Ubiquitously expressed in early embryos. Later (in stage 10 embryos), it is expressed at higher level in the nervous system. Ubiquitously expressed in wing imaginal disk. {ECO:0000269|PubMed:10549295, ECO:0000269|PubMed:14645127}."
"573","sp|P47820|ACE_RAT","lcl|NC_088857.1_cds_XP_011423378.3_26297",0,1266,"P47820","ACE_RAT","Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form]","Ace Dcp1","Rattus norvegicus (Rat)",1313,"GO:0001666; GO:0001822; GO:0002003; GO:0002446; GO:0003081; GO:0003084; GO:0004175; GO:0004181; GO:0004222; GO:0005516; GO:0005576; GO:0005615; GO:0005737; GO:0005764; GO:0005768; GO:0005886; GO:0006518; GO:0007283; GO:0007565; GO:0008217; GO:0008233; GO:0008237; GO:0008238; GO:0008240; GO:0008241; GO:0008270; GO:0008584; GO:0009410; GO:0009792; GO:0009897; GO:0009925; GO:0010608; GO:0010629; GO:0010814; GO:0010815; GO:0014910; GO:0030324; GO:0031100; GO:0031404; GO:0031434; GO:0031526; GO:0031667; GO:0031711; GO:0031982; GO:0032496; GO:0034616; GO:0038166; GO:0042310; GO:0042445; GO:0042447; GO:0042755; GO:0043065; GO:0043171; GO:0045777; GO:0045907; GO:0046325; GO:0048167; GO:0048286; GO:0050435; GO:0050482; GO:0050769; GO:0051019; GO:0060047; GO:0060177; GO:0060978; GO:0070062; GO:0070573; GO:0071333; GO:0071548; GO:0071838; GO:0086091; GO:0090281; GO:0097066; GO:0097225; GO:1901363; GO:1902033; GO:1903597; GO:1904045","amyloid-beta metabolic process [GO:0050435]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; angiotensin maturation [GO:0002003]; angiotensin-activated signaling pathway [GO:0038166]; animal organ regeneration [GO:0031100]; arachidonate secretion [GO:0050482]; bradykinin catabolic process [GO:0010815]; cell proliferation in bone marrow [GO:0071838]; cellular response to aldosterone [GO:1904045]; cellular response to glucose stimulus [GO:0071333]; eating behavior [GO:0042755]; embryo development ending in birth or egg hatching [GO:0009792]; female pregnancy [GO:0007565]; heart contraction [GO:0060047]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; male gonad development [GO:0008584]; negative regulation of calcium ion import [GO:0090281]; negative regulation of D-glucose import [GO:0046325]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; peptide metabolic process [GO:0006518]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood pressure [GO:0045777]; positive regulation of neurogenesis [GO:0050769]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of smooth muscle cell migration [GO:0014910]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; response to dexamethasone [GO:0071548]; response to hypoxia [GO:0001666]; response to laminar fluid shear stress [GO:0034616]; response to lipopolysaccharide [GO:0032496]; response to nutrient levels [GO:0031667]; response to thyroid hormone [GO:0097066]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]; substance P catabolic process [GO:0010814]; vasoconstriction [GO:0042310]","basal plasma membrane [GO:0009925]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; bradykinin receptor binding [GO:0031711]; calmodulin binding [GO:0005516]; chloride ion binding [GO:0031404]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; heterocyclic compound binding [GO:1901363]; metallocarboxypeptidase activity [GO:0004181]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidase activity [GO:0008233]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270]; amyloid-beta metabolic process [GO:0050435]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; angiotensin maturation [GO:0002003]; angiotensin-activated signaling pathway [GO:0038166]; animal organ regeneration [GO:0031100]; arachidonate secretion [GO:0050482]; bradykinin catabolic process [GO:0010815]; cell proliferation in bone marrow [GO:0071838]; cellular response to aldosterone [GO:1904045]; cellular response to glucose stimulus [GO:0071333]; eating behavior [GO:0042755]; embryo development ending in birth or egg hatching [GO:0009792]; female pregnancy [GO:0007565]; heart contraction [GO:0060047]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; male gonad development [GO:0008584]; negative regulation of calcium ion import [GO:0090281]; negative regulation of D-glucose import [GO:0046325]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; peptide metabolic process [GO:0006518]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood pressure [GO:0045777]; positive regulation of neurogenesis [GO:0050769]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of smooth muscle cell migration [GO:0014910]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; response to dexamethasone [GO:0071548]; response to hypoxia [GO:0001666]; response to laminar fluid shear stress [GO:0034616]; response to lipopolysaccharide [GO:0032496]; response to nutrient levels [GO:0031667]; response to thyroid hormone [GO:0097066]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]; substance P catabolic process [GO:0010814]; vasoconstriction [GO:0042310]","","INDUCTION: Up-regulated after myocardial infarction. {ECO:0000269|PubMed:15671045}.","INDUCTION: Up-regulated after myocardial infarction. {ECO:0000269|PubMed:15671045}.","TISSUE SPECIFICITY: Expressed in brain, kidney, lung, skeletal muscle and heart. {ECO:0000269|PubMed:12963491}.; TISSUE SPECIFICITY: [Isoform Testis-specific]: Testis-specific isoform is expressed in spermatocytes, adult testis. {ECO:0000269|PubMed:12963491}."
"574","sp|P12821|ACE_HUMAN","lcl|NC_088857.1_cds_XP_011423379.3_26296",0,1288,"P12821","ACE_HUMAN","Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form]","ACE DCP DCP1","Homo sapiens (Human)",1306,"GO:0001822; GO:0001974; GO:0002003; GO:0002019; GO:0002446; GO:0002474; GO:0003081; GO:0003084; GO:0003779; GO:0004175; GO:0004181; GO:0004222; GO:0005516; GO:0005576; GO:0005615; GO:0005764; GO:0005768; GO:0005886; GO:0006508; GO:0007283; GO:0008217; GO:0008233; GO:0008237; GO:0008238; GO:0008240; GO:0008241; GO:0008270; GO:0008584; GO:0009897; GO:0010608; GO:0010629; GO:0010814; GO:0010815; GO:0014910; GO:0019229; GO:0031404; GO:0031434; GO:0031711; GO:0032943; GO:0038166; GO:0042445; GO:0042447; GO:0043171; GO:0048167; GO:0050435; GO:0050482; GO:0051019; GO:0060047; GO:0060177; GO:0060218; GO:0070062; GO:0070573; GO:0071838; GO:0086091; GO:0097746; GO:1902033; GO:1903597","amyloid-beta metabolic process [GO:0050435]; angiotensin maturation [GO:0002003]; angiotensin-activated signaling pathway [GO:0038166]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; arachidonate secretion [GO:0050482]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; bradykinin catabolic process [GO:0010815]; cell proliferation in bone marrow [GO:0071838]; heart contraction [GO:0060047]; hematopoietic stem cell differentiation [GO:0060218]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; male gonad development [GO:0008584]; mononuclear cell proliferation [GO:0032943]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; positive regulation of systemic arterial blood pressure [GO:0003084]; post-transcriptional regulation of gene expression [GO:0010608]; proteolysis [GO:0006508]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of renal output by angiotensin [GO:0002019]; regulation of smooth muscle cell migration [GO:0014910]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of vasoconstriction [GO:0019229]; spermatogenesis [GO:0007283]; substance P catabolic process [GO:0010814]","endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; calmodulin binding [GO:0005516]; chloride ion binding [GO:0031404]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metallocarboxypeptidase activity [GO:0004181]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidase activity [GO:0008233]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270]; amyloid-beta metabolic process [GO:0050435]; angiotensin maturation [GO:0002003]; angiotensin-activated signaling pathway [GO:0038166]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; arachidonate secretion [GO:0050482]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; bradykinin catabolic process [GO:0010815]; cell proliferation in bone marrow [GO:0071838]; heart contraction [GO:0060047]; hematopoietic stem cell differentiation [GO:0060218]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; male gonad development [GO:0008584]; mononuclear cell proliferation [GO:0032943]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; positive regulation of systemic arterial blood pressure [GO:0003084]; post-transcriptional regulation of gene expression [GO:0010608]; proteolysis [GO:0006508]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of renal output by angiotensin [GO:0002019]; regulation of smooth muscle cell migration [GO:0014910]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of vasoconstriction [GO:0019229]; spermatogenesis [GO:0007283]; substance P catabolic process [GO:0010814]","","INDUCTION: Up-regulated in failing heart. {ECO:0000269|PubMed:15151696, ECO:0000269|PubMed:15671045}.","INDUCTION: Up-regulated in failing heart. {ECO:0000269|PubMed:15151696, ECO:0000269|PubMed:15671045}.","TISSUE SPECIFICITY: Ubiquitously expressed, with highest levels in lung, kidney, heart, gastrointestinal system and prostate. {ECO:0000269|PubMed:10924499, ECO:0000269|PubMed:10969042, ECO:0000269|PubMed:12459472, ECO:0000269|PubMed:15671045}.; TISSUE SPECIFICITY: [Isoform Testis-specific]: Specifically expressed in spermatocytes and adult testis. {ECO:0000269|PubMed:2547653, ECO:0000269|PubMed:2554286}."
"575","sp|P41212|ETV6_HUMAN","lcl|NC_088857.1_cds_XP_011423430.3_24250",7.01e-33,131,"P41212","ETV6_HUMAN","Transcription factor ETV6 (ETS translocation variant 6) (ETS-related protein Tel1) (Tel)","ETV6 TEL TEL1","Homo sapiens (Human)",452,"GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0005730; GO:0005829; GO:0005886; GO:0006357; GO:0007296; GO:0019904; GO:0022008; GO:0030154; GO:0071425; GO:0097152","cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; mesenchymal cell apoptotic process [GO:0097152]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of transcription by RNA polymerase II [GO:0006357]; vitellogenesis [GO:0007296]","chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; mesenchymal cell apoptotic process [GO:0097152]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of transcription by RNA polymerase II [GO:0006357]; vitellogenesis [GO:0007296]","","","","TISSUE SPECIFICITY: Ubiquitous."
"576","sp|P97360|ETV6_MOUSE","lcl|NC_088857.1_cds_XP_011423431.3_24252",1.42e-33,133,"P97360","ETV6_MOUSE","Transcription factor ETV6 (ETS translocation variant 6) (ETS-related protein Tel1) (Tel)","Etv6 Tel Tel1","Mus musculus (Mouse)",485,"GO:0000978; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0005730; GO:0005829; GO:0006355; GO:0007296; GO:0019904; GO:0022008; GO:0030154; GO:0045944; GO:0071425; GO:0097152","cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; mesenchymal cell apoptotic process [GO:0097152]; neurogenesis [GO:0022008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; vitellogenesis [GO:0007296]","cytosol [GO:0005829]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; mesenchymal cell apoptotic process [GO:0097152]; neurogenesis [GO:0022008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; vitellogenesis [GO:0007296]","","","",""
"577","sp|Q01842|POK_DROME","lcl|NC_088857.1_cds_XP_011423434.3_24255",1.62e-24,108,"Q01842","POK_DROME","Ets DNA-binding protein pokkuri (Protein anterior open) (Protein yan)","aop pok Yan CG3166","Drosophila melanogaster (Fruit fly)",732,"GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001709; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006897; GO:0007173; GO:0007298; GO:0007391; GO:0007464; GO:0008340; GO:0008406; GO:0008543; GO:0010628; GO:0010629; GO:0019904; GO:0030154; GO:0035155; GO:0035157; GO:0045500; GO:0045677; GO:0045892; GO:0048010; GO:0050767; GO:0055001; GO:0060233; GO:0090090; GO:0090175; GO:0110118; GO:1903688","border follicle cell migration [GO:0007298]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gonad development [GO:0008406]; muscle cell development [GO:0055001]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of compound eye photoreceptor cell differentiation [GO:0110118]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fusion cell fate specification [GO:0035157]; negative regulation of gene expression [GO:0010629]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of terminal cell fate specification, open tracheal system [GO:0035155]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oenocyte delamination [GO:0060233]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; R3/R4 cell fate commitment [GO:0007464]; regulation of establishment of planar polarity [GO:0090175]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sevenless signaling pathway [GO:0045500]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; border follicle cell migration [GO:0007298]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gonad development [GO:0008406]; muscle cell development [GO:0055001]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of compound eye photoreceptor cell differentiation [GO:0110118]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fusion cell fate specification [GO:0035157]; negative regulation of gene expression [GO:0010629]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of terminal cell fate specification, open tracheal system [GO:0035155]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oenocyte delamination [GO:0060233]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; R3/R4 cell fate commitment [GO:0007464]; regulation of establishment of planar polarity [GO:0090175]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sevenless signaling pathway [GO:0045500]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","DEVELOPMENTAL STAGE: Expressed in the embryo. {ECO:0000269|PubMed:1505027}.","","","TISSUE SPECIFICITY: Expressed in R7 and cone cells of the eye. {ECO:0000269|PubMed:1505027}."
"578","sp|A2AG06|MEIOC_MOUSE","lcl|NC_088857.1_cds_XP_011423981.2_27909",7.25e-56,209,"A2AG06","MEIOC_MOUSE","Meiosis-specific coiled-coil domain-containing protein MEIOC (Meiosis-specific with coiled-coil domain protein)","Meioc Gm1564","Mus musculus (Mouse)",965,"GO:0005634; GO:0005737; GO:0006302; GO:0007130; GO:0007141; GO:0007144; GO:0007283; GO:0007286; GO:0048255; GO:0048599; GO:0051310; GO:0051729; GO:0070192","chromosome organization involved in meiotic cell cycle [GO:0070192]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; male meiosis I [GO:0007141]; metaphase chromosome alignment [GO:0051310]; mRNA stabilization [GO:0048255]; oocyte development [GO:0048599]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromosome organization involved in meiotic cell cycle [GO:0070192]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; male meiosis I [GO:0007141]; metaphase chromosome alignment [GO:0051310]; mRNA stabilization [GO:0048255]; oocyte development [GO:0048599]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]","DEVELOPMENTAL STAGE: In the ovary appears at 13.5 dpc and disappears shortly after. In postnatal testes, expression increases between 5 and 10 dpp and is maintained through adulthood. In male and female germal cells present from preleptotene to diplotene stages of meiosis prophase I. {ECO:0000269|PubMed:26742488, ECO:0000269|PubMed:28380054}.","","","TISSUE SPECIFICITY: Expressed specifically in fetal ovary and postnatal and adult testes (at protein level) (PubMed:26742488). In adult testis expressed in spermatocytes, beginning in preleptotene and extending through most stages of meiotic prophase I, including leptotene, zygotene, and pachytene (PubMed:28380054). {ECO:0000269|PubMed:26742488, ECO:0000269|PubMed:28380054}."
"579","sp|Q5F3K4|WDR48_CHICK","lcl|NC_088857.1_cds_XP_011424046.1_23693",0,742,"Q5F3K4","WDR48_CHICK","WD repeat-containing protein 48 (USP1-associated factor 1)","WDR48 UAF1 RCJMB04_14o15","Gallus gallus (Chicken)",678,"GO:0000724; GO:0003677; GO:0003690; GO:0003697; GO:0005634; GO:0005764; GO:0005770; GO:0006974; GO:0007283; GO:0007338; GO:0035264; GO:0035800; GO:0043130; GO:0043588; GO:0046427; GO:0048568; GO:0048705; GO:0048872; GO:0050679; GO:0072520; GO:1902525; GO:1905168","DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; embryonic organ development [GO:0048568]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of protein monoubiquitination [GO:1902525]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; spermatogenesis [GO:0007283]","late endosome [GO:0005770]; lysosome [GO:0005764]; nucleus [GO:0005634]; deubiquitinase activator activity [GO:0035800]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; embryonic organ development [GO:0048568]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of protein monoubiquitination [GO:1902525]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; spermatogenesis [GO:0007283]","","","",""
"580","sp|Q07812|BAX_HUMAN","lcl|NC_088857.1_cds_XP_011424482.1_26914",4.01e-38,131,"Q07812","BAX_HUMAN","Apoptosis regulator BAX (Bcl-2-like protein 4) (Bcl2-L-4)","BAX BCL2L4","Homo sapiens (Human)",192,"GO:0001541; GO:0001764; GO:0001777; GO:0001782; GO:0001783; GO:0001822; GO:0001836; GO:0001974; GO:0002262; GO:0002352; GO:0002358; GO:0002904; GO:0005634; GO:0005635; GO:0005737; GO:0005739; GO:0005741; GO:0005757; GO:0005783; GO:0005789; GO:0005829; GO:0006687; GO:0006808; GO:0006915; GO:0007281; GO:0008053; GO:0008289; GO:0008625; GO:0008630; GO:0008637; GO:0009566; GO:0009636; GO:0009651; GO:0010248; GO:0010332; GO:0010524; GO:0010917; GO:0015267; GO:0016020; GO:0021854; GO:0021987; GO:0030544; GO:0031334; GO:0032091; GO:0032469; GO:0032471; GO:0032976; GO:0033599; GO:0034620; GO:0034644; GO:0035234; GO:0042475; GO:0042802; GO:0042803; GO:0042981; GO:0043065; GO:0043524; GO:0043525; GO:0043653; GO:0045136; GO:0046666; GO:0046930; GO:0046982; GO:0048087; GO:0048147; GO:0048515; GO:0048597; GO:0048678; GO:0048873; GO:0051204; GO:0051209; GO:0051281; GO:0051434; GO:0051726; GO:0051881; GO:0060011; GO:0060041; GO:0060057; GO:0060058; GO:0060068; GO:0060402; GO:0070059; GO:0070062; GO:0070242; GO:0072332; GO:0090200; GO:0097049; GO:0097136; GO:0097144; GO:0097145; GO:0097190; GO:0097191; GO:0097192; GO:0097193; GO:0097194; GO:0097435; GO:0098586; GO:1902110; GO:1902262; GO:1902263; GO:1902445; GO:1902512; GO:1903896; GO:1904019; GO:1904037; GO:1990117; GO:2000243; GO:2000673; GO:2001234; GO:2001244","apoptotic mitochondrial changes [GO:0008637]; apoptotic process [GO:0006915]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; apoptotic process involved in mammary gland involution [GO:0060057]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell homeostatic proliferation [GO:0002358]; B cell negative selection [GO:0002352]; B cell receptor apoptotic signaling pathway [GO:1990117]; blood vessel remodeling [GO:0001974]; calcium ion transport into cytosol [GO:0060402]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; cellular response to virus [GO:0098586]; cerebral cortex development [GO:0021987]; development of secondary sexual characteristics [GO:0045136]; ectopic germ cell programmed cell death [GO:0035234]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial cell apoptotic process [GO:1904019]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; fertilization [GO:0009566]; germ cell development [GO:0007281]; glycosphingolipid metabolic process [GO:0006687]; homeostasis of number of cells within a tissue [GO:0048873]; hypothalamus development [GO:0021854]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; motor neuron apoptotic process [GO:0097049]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; neuron migration [GO:0001764]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of developmental pigmentation [GO:0048087]; positive regulation of epithelial cell apoptotic process [GO:1904037]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902110]; positive regulation of motor neuron apoptotic process [GO:2000673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of reproductive process [GO:2000243]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein insertion into mitochondrial membrane [GO:0051204]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of nitrogen utilization [GO:0006808]; release of cytochrome c from mitochondria [GO:0001836]; release of matrix enzymes from mitochondria [GO:0032976]; release of sequestered calcium ion into cytosol [GO:0051209]; response to axon injury [GO:0048678]; response to gamma radiation [GO:0010332]; response to salt stress [GO:0009651]; response to toxic substance [GO:0009636]; retina development in camera-type eye [GO:0060041]; retinal cell programmed cell death [GO:0046666]; Sertoli cell proliferation [GO:0060011]; spermatid differentiation [GO:0048515]; supramolecular fiber organization [GO:0097435]; T cell homeostatic proliferation [GO:0001777]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068]","BAK complex [GO:0097145]; BAX complex [GO:0097144]; Bcl-2 family protein complex [GO:0097136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pore complex [GO:0046930]; BH3 domain binding [GO:0051434]; channel activity [GO:0015267]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; apoptotic mitochondrial changes [GO:0008637]; apoptotic process [GO:0006915]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; apoptotic process involved in mammary gland involution [GO:0060057]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell homeostatic proliferation [GO:0002358]; B cell negative selection [GO:0002352]; B cell receptor apoptotic signaling pathway [GO:1990117]; blood vessel remodeling [GO:0001974]; calcium ion transport into cytosol [GO:0060402]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; cellular response to virus [GO:0098586]; cerebral cortex development [GO:0021987]; development of secondary sexual characteristics [GO:0045136]; ectopic germ cell programmed cell death [GO:0035234]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial cell apoptotic process [GO:1904019]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; fertilization [GO:0009566]; germ cell development [GO:0007281]; glycosphingolipid metabolic process [GO:0006687]; homeostasis of number of cells within a tissue [GO:0048873]; hypothalamus development [GO:0021854]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; motor neuron apoptotic process [GO:0097049]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; neuron migration [GO:0001764]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of developmental pigmentation [GO:0048087]; positive regulation of epithelial cell apoptotic process [GO:1904037]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902110]; positive regulation of motor neuron apoptotic process [GO:2000673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of reproductive process [GO:2000243]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein insertion into mitochondrial membrane [GO:0051204]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of nitrogen utilization [GO:0006808]; release of cytochrome c from mitochondria [GO:0001836]; release of matrix enzymes from mitochondria [GO:0032976]; release of sequestered calcium ion into cytosol [GO:0051209]; response to axon injury [GO:0048678]; response to gamma radiation [GO:0010332]; response to salt stress [GO:0009651]; response to toxic substance [GO:0009636]; retina development in camera-type eye [GO:0060041]; retinal cell programmed cell death [GO:0046666]; Sertoli cell proliferation [GO:0060011]; spermatid differentiation [GO:0048515]; supramolecular fiber organization [GO:0097435]; T cell homeostatic proliferation [GO:0001777]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068]","","","","TISSUE SPECIFICITY: Expressed in a wide variety of tissues. Isoform Psi is found in glial tumors. Isoform Alpha is expressed in spleen, breast, ovary, testis, colon and brain, and at low levels in skin and lung. Isoform Sigma is expressed in spleen, breast, ovary, testis, lung, colon, brain and at low levels in skin. Isoform Alpha and isoform Sigma are expressed in pro-myelocytic leukemia, histiocytic lymphoma, Burkitt's lymphoma, T-cell lymphoma, lymphoblastic leukemia, breast adenocarcinoma, ovary adenocarcinoma, prostate carcinoma, prostate adenocarcinoma, lung carcinoma, epidermoid carcinoma, small cell lung carcinoma and colon adenocarcinoma cell lines. {ECO:0000269|PubMed:10772918, ECO:0000269|PubMed:11912183}."
"581","sp|Q8NCV1|ADAD2_HUMAN","lcl|NC_088857.1_cds_XP_011424769.3_22526",4.07e-20,95.9,"Q8NCV1","ADAD2_HUMAN","Adenosine deaminase domain-containing protein 2 (Testis nuclear RNA-binding protein-like)","ADAD2 TENRL","Homo sapiens (Human)",583,"GO:0003725; GO:0003726; GO:0005634; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0007286; GO:0008251","adenosine to inosine editing [GO:0006382]; RNA processing [GO:0006396]; spermatid development [GO:0007286]","cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; RNA processing [GO:0006396]; spermatid development [GO:0007286]","","","",""
"582","sp|P02835|FTZ_DROME","lcl|NC_088857.1_cds_XP_011424786.2_22546",5.07e-21,92.8,"P02835","FTZ_DROME","Segmentation protein fushi tarazu","ftz CG2047","Drosophila melanogaster (Fruit fly)",410,"GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0001708; GO:0005634; GO:0006355; GO:0007366; GO:0007417; GO:0007506; GO:0008354; GO:0009952; GO:0035282; GO:0045944","anterior/posterior pattern specification [GO:0009952]; cell fate specification [GO:0001708]; central nervous system development [GO:0007417]; germ cell migration [GO:0008354]; gonadal mesoderm development [GO:0007506]; negative regulation of transcription by RNA polymerase II [GO:0000122]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; segmentation [GO:0035282]","nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anterior/posterior pattern specification [GO:0009952]; cell fate specification [GO:0001708]; central nervous system development [GO:0007417]; germ cell migration [GO:0008354]; gonadal mesoderm development [GO:0007506]; negative regulation of transcription by RNA polymerase II [GO:0000122]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; segmentation [GO:0035282]","DEVELOPMENTAL STAGE: Expressed during embryonic development. {ECO:0000269|PubMed:3049237}.","","","TISSUE SPECIFICITY: Expressed early in development in a striped pattern at the blastoderm stage. Later expressed in a specific subset of neuronal precursor cells, neurons and glia in the developing CNS. Between 5 and 6 hours of development, found in the midline precursor-2 cells in a segmentally repeating pattern. Expression in many other neuronal precursors follows and reaches a second peak of abundance at 9 hours of development. Expressed in the hindgut between 11-15 hours of development."
"583","sp|P31310|HXA10_MOUSE","lcl|NC_088857.1_cds_XP_011424791.1_22552",1.34e-22,97.8,"P31310","HXA10_MOUSE","Homeobox protein Hox-A10 (Homeobox protein Hox-1.8)","Hoxa10 Hox-1.8 Hoxa-10","Mus musculus (Mouse)",416,"GO:0000978; GO:0001228; GO:0001501; GO:0003677; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0007283; GO:0007338; GO:0008584; GO:0009952; GO:0009954; GO:0010468; GO:0030326; GO:0030850; GO:0033574; GO:0042826; GO:0043627; GO:0060065","anterior/posterior pattern specification [GO:0009952]; embryonic limb morphogenesis [GO:0030326]; male gonad development [GO:0008584]; prostate gland development [GO:0030850]; proximal/distal pattern formation [GO:0009954]; regulation of gene expression [GO:0010468]; response to estrogen [GO:0043627]; response to testosterone [GO:0033574]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]; spermatogenesis [GO:0007283]; uterus development [GO:0060065]","cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anterior/posterior pattern specification [GO:0009952]; embryonic limb morphogenesis [GO:0030326]; male gonad development [GO:0008584]; prostate gland development [GO:0030850]; proximal/distal pattern formation [GO:0009954]; regulation of gene expression [GO:0010468]; response to estrogen [GO:0043627]; response to testosterone [GO:0033574]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]; spermatogenesis [GO:0007283]; uterus development [GO:0060065]","DEVELOPMENTAL STAGE: Embryonic expression increases from day 9 to day 12 and then declines to day 15.","","","TISSUE SPECIFICITY: Expressed in the developing limb bud where it is restricted to the mesenchyme along the proximal-distal axis. Also found in developing gut and urogenital tract. In adult tissue, both forms found in kidney but only isoform 1 is expressed in skeletal muscle."
"584","sp|Q9JMB5|ADRM1_RAT","lcl|NC_088857.1_cds_XP_011425386.2_23286",2.13e-63,209,"Q9JMB5","ADRM1_RAT","Proteasomal ubiquitin receptor ADRM1 (110 kDa cell membrane glycoprotein) (Gp110) (Adhesion-regulating molecule 1) (ARM-1) (Rpn13 homolog)","Adrm1 Gp110","Rattus norvegicus (Rat)",407,"GO:0000502; GO:0001541; GO:0002020; GO:0005634; GO:0005737; GO:0006368; GO:0007286; GO:0008541; GO:0033081; GO:0042699; GO:0043248; GO:0048477; GO:0048538; GO:0060009; GO:0060399; GO:0060612; GO:0061133; GO:0070628; GO:0072520; GO:0140678","adipose tissue development [GO:0060612]; follicle-stimulating hormone signaling pathway [GO:0042699]; oogenesis [GO:0048477]; ovarian follicle development [GO:0001541]; positive regulation of growth hormone receptor signaling pathway [GO:0060399]; proteasome assembly [GO:0043248]; regulation of T cell differentiation in thymus [GO:0033081]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286]; thymus development [GO:0048538]; transcription elongation by RNA polymerase II [GO:0006368]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; endopeptidase activator activity [GO:0061133]; molecular function inhibitor activity [GO:0140678]; protease binding [GO:0002020]; proteasome binding [GO:0070628]; adipose tissue development [GO:0060612]; follicle-stimulating hormone signaling pathway [GO:0042699]; oogenesis [GO:0048477]; ovarian follicle development [GO:0001541]; positive regulation of growth hormone receptor signaling pathway [GO:0060399]; proteasome assembly [GO:0043248]; regulation of T cell differentiation in thymus [GO:0033081]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286]; thymus development [GO:0048538]; transcription elongation by RNA polymerase II [GO:0006368]","","","","TISSUE SPECIFICITY: Widely expressed."
"585","sp|Q5CZC0|FSIP2_HUMAN","lcl|NC_088857.1_cds_XP_011426085.3_22294",1.41e-18,97.1,"Q5CZC0","FSIP2_HUMAN","Fibrous sheath-interacting protein 2","FSIP2","Homo sapiens (Human)",6907,"GO:0007288; GO:0030317; GO:0061512; GO:0097225; GO:0097228; GO:0097229; GO:0120212","flagellated sperm motility [GO:0030317]; protein localization to cilium [GO:0061512]; sperm axoneme assembly [GO:0007288]","sperm end piece [GO:0097229]; sperm head-tail coupling apparatus [GO:0120212]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; flagellated sperm motility [GO:0030317]; protein localization to cilium [GO:0061512]; sperm axoneme assembly [GO:0007288]","","","","TISSUE SPECIFICITY: Predominantly expressed in testis. {ECO:0000269|PubMed:30137358}."
"586","sp|P27091|60A_DROME","lcl|NC_088857.1_cds_XP_011428157.1_27293",7.12e-82,259,"P27091","60A_DROME","Protein 60A (Protein glass bottom boat)","gbb 60A gbb-60A TGFb-60A CG5562","Drosophila melanogaster (Fruit fly)",455,"GO:0005125; GO:0005160; GO:0005615; GO:0007274; GO:0007391; GO:0007419; GO:0007474; GO:0007504; GO:0007528; GO:0008083; GO:0008586; GO:0012505; GO:0016015; GO:0030509; GO:0030707; GO:0031045; GO:0035222; GO:0036099; GO:0045202; GO:0045464; GO:0045887; GO:0046928; GO:0046982; GO:0048018; GO:0048557; GO:0048636; GO:0050806; GO:0098917; GO:0099558; GO:2000736","BMP signaling pathway [GO:0030509]; dorsal closure [GO:0007391]; embryonic digestive tract morphogenesis [GO:0048557]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; larval fat body development [GO:0007504]; maintenance of synapse structure [GO:0099558]; neuromuscular junction development [GO:0007528]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of muscle organ development [GO:0048636]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of synaptic transmission [GO:0050806]; R8 cell fate specification [GO:0045464]; regulation of neurotransmitter secretion [GO:0046928]; regulation of stem cell differentiation [GO:2000736]; retrograde trans-synaptic signaling [GO:0098917]; ventral cord development [GO:0007419]; wing disc pattern formation [GO:0035222]","dense core granule [GO:0031045]; endomembrane system [GO:0012505]; extracellular space [GO:0005615]; synapse [GO:0045202]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; morphogen activity [GO:0016015]; protein heterodimerization activity [GO:0046982]; receptor ligand activity [GO:0048018]; transforming growth factor beta receptor binding [GO:0005160]; BMP signaling pathway [GO:0030509]; dorsal closure [GO:0007391]; embryonic digestive tract morphogenesis [GO:0048557]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; larval fat body development [GO:0007504]; maintenance of synapse structure [GO:0099558]; neuromuscular junction development [GO:0007528]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of muscle organ development [GO:0048636]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of synaptic transmission [GO:0050806]; R8 cell fate specification [GO:0045464]; regulation of neurotransmitter secretion [GO:0046928]; regulation of stem cell differentiation [GO:2000736]; retrograde trans-synaptic signaling [GO:0098917]; ventral cord development [GO:0007419]; wing disc pattern formation [GO:0035222]","DEVELOPMENTAL STAGE: Expressed throughout development with peaks of transcription during early embryogenesis, in pupae, and in adult males. {ECO:0000269|PubMed:1601181, ECO:0000269|PubMed:1924384}.","","","TISSUE SPECIFICITY: Expressed in cells of the developing foregut and hindgut during germ band retraction and later embryonic stages. Expressed in the wing disk, mainly in the posterior compartment in the pteropleural and medial regions extending into the progenitors of the scutellum. High levels are found within the posterior and anterior compartments of the wing pouch and low levels in the hinge region. In the eye/antennal disk, expression is highest anterior to the morphogenetic furrow and in the medial regions with lower levels of expression posterior to the morphogenetic furrow. Expressed throughout the posterior compartment of the leg imaginal disks and within the ventral anterior compartment. {ECO:0000269|PubMed:1601181, ECO:0000269|PubMed:9636086}."
"587","sp|Q9N2W5|UBXN2_CAEEL","lcl|NC_088857.1_cds_XP_011428159.3_27292",4.35e-38,139,"Q9N2W5","UBXN2_CAEEL","UBX domain-containing protein 2","ubxn-2 Y94H6A.9","Caenorhabditis elegans",301,"GO:0000045; GO:0000132; GO:0005634; GO:0005737; GO:0005829; GO:0007030; GO:0007283; GO:0019901; GO:0030154; GO:0031468; GO:0031616; GO:0036435; GO:0042006; GO:0043130; GO:0043161; GO:0045732; GO:0048471; GO:0061025; GO:1904780","autophagosome assembly [GO:0000045]; cell differentiation [GO:0030154]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; masculinization of hermaphroditic germ-line [GO:0042006]; membrane fusion [GO:0061025]; negative regulation of protein localization to centrosome [GO:1904780]; nuclear membrane reassembly [GO:0031468]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle pole centrosome [GO:0031616]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130]; autophagosome assembly [GO:0000045]; cell differentiation [GO:0030154]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; masculinization of hermaphroditic germ-line [GO:0042006]; membrane fusion [GO:0061025]; negative regulation of protein localization to centrosome [GO:1904780]; nuclear membrane reassembly [GO:0031468]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed in embryos, larvae and adults. {ECO:0000269|PubMed:17498661}.","","","TISSUE SPECIFICITY: Expressed in the germline (at protein level) (PubMed:20977550). Expressed in spermatocytes but not in mature sperm (at protein level) (PubMed:20977550). Ubiquitously expressed (PubMed:17498661). Predominantly expressed in the spermatheca (PubMed:17498661). {ECO:0000269|PubMed:17498661, ECO:0000269|PubMed:20977550}."
"588","sp|P00787|CATB_RAT","lcl|NC_088857.1_cds_XP_011428259.3_25308",4.39e-139,399,"P00787","CATB_RAT","Cathepsin B (EC 3.4.22.1) (Cathepsin B1) (RSG-2) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain]","Ctsb","Rattus norvegicus (Rat)",339,"GO:0004175; GO:0004197; GO:0005518; GO:0005576; GO:0005615; GO:0005764; GO:0005901; GO:0006508; GO:0006590; GO:0006914; GO:0007283; GO:0007519; GO:0008233; GO:0008234; GO:0009612; GO:0009749; GO:0009897; GO:0009986; GO:0014075; GO:0016324; GO:0030163; GO:0030574; GO:0030855; GO:0030984; GO:0034097; GO:0042277; GO:0042383; GO:0042470; GO:0042802; GO:0043394; GO:0043434; GO:0044877; GO:0045471; GO:0046697; GO:0046718; GO:0048471; GO:0051402; GO:0051603; GO:0070670; GO:0071260; GO:0071548; GO:0097067; GO:1904090; GO:1904373","autophagy [GO:0006914]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; neuron apoptotic process [GO:0051402]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; response to amine [GO:0014075]; response to cytokine [GO:0034097]; response to dexamethasone [GO:0071548]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to interleukin-4 [GO:0070670]; response to kainic acid [GO:1904373]; response to mechanical stimulus [GO:0009612]; response to peptide hormone [GO:0043434]; skeletal muscle tissue development [GO:0007519]; spermatogenesis [GO:0007283]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590]","apical plasma membrane [GO:0016324]; caveola [GO:0005901]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; peptidase inhibitor complex [GO:1904090]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; kininogen binding [GO:0030984]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; proteoglycan binding [GO:0043394]; autophagy [GO:0006914]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; neuron apoptotic process [GO:0051402]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; response to amine [GO:0014075]; response to cytokine [GO:0034097]; response to dexamethasone [GO:0071548]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to interleukin-4 [GO:0070670]; response to kainic acid [GO:1904373]; response to mechanical stimulus [GO:0009612]; response to peptide hormone [GO:0043434]; skeletal muscle tissue development [GO:0007519]; spermatogenesis [GO:0007283]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590]","","INDUCTION: Expression is low in the lactacting mammary gland but increases after weaning to a peak 4 days post weaning. Expression returns to baseline levels 6 days post weaning. {ECO:0000269|PubMed:8001549}.","INDUCTION: Expression is low in the lactacting mammary gland but increases after weaning to a peak 4 days post weaning. Expression returns to baseline levels 6 days post weaning. {ECO:0000269|PubMed:8001549}.","TISSUE SPECIFICITY: Expressed in the epithelial cells of the prostate and mammary gland. {ECO:0000269|PubMed:8001549}."
"589","sp|Q9HCK5|AGO4_HUMAN","lcl|NC_088857.1_cds_XP_011429115.1_22278",0,1278,"Q9HCK5","AGO4_HUMAN","Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4)","AGO4 EIF2C4 KIAA1567","Homo sapiens (Human)",861,"GO:0000932; GO:0003725; GO:0003727; GO:0004521; GO:0005634; GO:0005737; GO:0005829; GO:0006402; GO:0007130; GO:0007140; GO:0008584; GO:0010586; GO:0016020; GO:0016442; GO:0022604; GO:0031054; GO:0035194; GO:0035196; GO:0035198; GO:0035278; GO:0036464; GO:0043066; GO:0070578; GO:0070922","male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]; negative regulation of apoptotic process [GO:0043066]; pre-miRNA processing [GO:0031054]; regulation of cell morphogenesis [GO:0022604]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; RISC complex assembly [GO:0070922]; synaptonemal complex assembly [GO:0007130]","cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; RNA endonuclease activity [GO:0004521]; single-stranded RNA binding [GO:0003727]; male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]; negative regulation of apoptotic process [GO:0043066]; pre-miRNA processing [GO:0031054]; regulation of cell morphogenesis [GO:0022604]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; RISC complex assembly [GO:0070922]; synaptonemal complex assembly [GO:0007130]","","","",""
"590","sp|Q09249|HRDE1_CAEEL","lcl|NC_088857.1_cds_XP_011429116.1_22277",2.8e-37,153,"Q09249","HRDE1_CAEEL","Argonaute protein hrde-1 (Heritable RNAi deficient 1) (Nuclear Argonaute HRDE-1)","hrde-1 wago-9 C16C10.3","Caenorhabditis elegans",1032,"GO:0003727; GO:0004521; GO:0005634; GO:0005737; GO:0007281; GO:0016442; GO:0031332; GO:0035194; GO:0035198; GO:0036464","germ cell development [GO:0007281]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]","cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNAi effector complex [GO:0031332]; miRNA binding [GO:0035198]; RNA endonuclease activity [GO:0004521]; single-stranded RNA binding [GO:0003727]; germ cell development [GO:0007281]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]","","","","TISSUE SPECIFICITY: Expressed in the nuclei of male and female germ cells. {ECO:0000269|PubMed:22810588}."
"591","sp|O88767|PARK7_RAT","lcl|NC_088857.1_cds_XP_011430131.3_24351",2.97e-66,202,"O88767","PARK7_RAT","Parkinson disease protein 7 homolog (Contraception-associated protein 1) (Protein CAP1) (Fertility protein SP22) (Maillard deglycase) (Parkinsonism-associated deglycase) (Protein DJ-1) (DJ-1) (Protein/nucleic acid deglycase DJ-1) (EC 3.1.2.-, EC 3.5.1.-, EC 3.5.1.124)","Park7 Cap1","Rattus norvegicus (Rat)",189,"GO:0000785; GO:0001963; GO:0002866; GO:0003713; GO:0003729; GO:0005102; GO:0005507; GO:0005634; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005783; GO:0005829; GO:0005886; GO:0006281; GO:0006508; GO:0006914; GO:0006954; GO:0006979; GO:0007005; GO:0007283; GO:0007338; GO:0008021; GO:0008047; GO:0008233; GO:0008344; GO:0009410; GO:0009438; GO:0009566; GO:0010273; GO:0010628; GO:0010629; GO:0014912; GO:0016532; GO:0016605; GO:0016684; GO:0019249; GO:0019430; GO:0019826; GO:0019899; GO:0019900; GO:0019955; GO:0030073; GO:0030091; GO:0030414; GO:0030424; GO:0030521; GO:0030546; GO:0031334; GO:0031397; GO:0032435; GO:0032757; GO:0033234; GO:0033864; GO:0034599; GO:0034614; GO:0036470; GO:0036471; GO:0036478; GO:0036524; GO:0042177; GO:0042542; GO:0042593; GO:0042743; GO:0042802; GO:0042803; GO:0043005; GO:0043523; GO:0043524; GO:0044297; GO:0044388; GO:0044390; GO:0045121; GO:0045340; GO:0045944; GO:0046295; GO:0046826; GO:0048471; GO:0050681; GO:0050727; GO:0050787; GO:0050821; GO:0051583; GO:0051881; GO:0051897; GO:0051899; GO:0051920; GO:0055105; GO:0060081; GO:0060135; GO:0060765; GO:0061691; GO:0061727; GO:0061827; GO:0070062; GO:0070301; GO:0070994; GO:0071222; GO:0071456; GO:0097110; GO:0106044; GO:0106045; GO:0106046; GO:0110095; GO:0140041; GO:0140297; GO:1900182; GO:1900242; GO:1902176; GO:1902177; GO:1902236; GO:1902958; GO:1903073; GO:1903094; GO:1903122; GO:1903135; GO:1903136; GO:1903181; GO:1903189; GO:1903197; GO:1903376; GO:1903377; GO:1903384; GO:1903427; GO:1903428; GO:1903751; GO:1904706; GO:1905259; GO:1905516; GO:1990381; GO:1990422; GO:2000277; GO:2000379; GO:2001237","adult locomotory behavior [GO:0008344]; androgen receptor signaling pathway [GO:0030521]; autophagy [GO:0006914]; cellular detoxification of aldehyde [GO:0110095]; cellular detoxification of methylglyoxal [GO:0140041]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; detection of oxidative stress [GO:0070994]; detoxification of copper ion [GO:0010273]; detoxification of hydrogen peroxide [GO:0061691]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; fertilization [GO:0009566]; glucose homeostasis [GO:0042593]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; maternal process involved in female pregnancy [GO:0060135]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal catabolic process to lactate [GO:0061727]; methylglyoxal metabolic process [GO:0009438]; mitochondrion organization [GO:0007005]; negative regulation of death-inducing signaling complex assembly [GO:1903073]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of fertilization [GO:1905516]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein repair [GO:0030091]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of synaptic vesicle endocytosis [GO:1900242]; removal of superoxide radicals [GO:0019430]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; synaptic transmission, dopaminergic [GO:0001963]","axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; PML body [GO:0016605]; sperm head [GO:0061827]; synaptic vesicle [GO:0008021]; copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; cytokine binding [GO:0019955]; DNA-binding transcription factor binding [GO:0140297]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; glyoxalase (glycolic acid-forming) activity [GO:1990422]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-dopa decarboxylase activator activity [GO:0036478]; mercury ion binding [GO:0045340]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; oxygen sensor activity [GO:0019826]; peptidase activity [GO:0008233]; peptidase inhibitor activity [GO:0030414]; peroxiredoxin activity [GO:0051920]; protein deglycase activity [GO:0036524]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; signaling receptor activator activity [GO:0030546]; signaling receptor binding [GO:0005102]; small protein activating enzyme binding [GO:0044388]; superoxide dismutase copper chaperone activity [GO:0016532]; transcription coactivator activity [GO:0003713]; tyrosine 3-monooxygenase activator activity [GO:0036470]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-protein transferase inhibitor activity [GO:0055105]; ubiquitin-specific protease binding [GO:1990381]; adult locomotory behavior [GO:0008344]; androgen receptor signaling pathway [GO:0030521]; autophagy [GO:0006914]; cellular detoxification of aldehyde [GO:0110095]; cellular detoxification of methylglyoxal [GO:0140041]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; detection of oxidative stress [GO:0070994]; detoxification of copper ion [GO:0010273]; detoxification of hydrogen peroxide [GO:0061691]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; fertilization [GO:0009566]; glucose homeostasis [GO:0042593]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; maternal process involved in female pregnancy [GO:0060135]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal catabolic process to lactate [GO:0061727]; methylglyoxal metabolic process [GO:0009438]; mitochondrion organization [GO:0007005]; negative regulation of death-inducing signaling complex assembly [GO:1903073]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of fertilization [GO:1905516]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein repair [GO:0030091]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of synaptic vesicle endocytosis [GO:1900242]; removal of superoxide radicals [GO:0019430]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; synaptic transmission, dopaminergic [GO:0001963]","","","","TISSUE SPECIFICITY: Ubiquitous. Detected on epididymal sperm. Highly expressed in testis and prostate. Detected at lower levels in heart, lung, brain, liver, kidney, seminal vesicle, caput and corpus epididymis. {ECO:0000269|PubMed:9792810}."
"592","sp|Q9D2F7|P210L_MOUSE","lcl|NC_088857.1_cds_XP_011430290.3_26267",0,977,"Q9D2F7","P210L_MOUSE","Nuclear pore membrane glycoprotein 210-like (Nucleoporin 210 kDa-like) (Nucleoporin Nup210-like)","Nup210l","Mus musculus (Mouse)",1881,"GO:0007286; GO:0016020; GO:0060009","Sertoli cell development [GO:0060009]; spermatid development [GO:0007286]","membrane [GO:0016020]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Expressed in testis. {ECO:0000269|PubMed:38129135}."
"593","sp|Q9XYM0|CRK_DROME","lcl|NC_088857.1_cds_XP_011430292.1_26266",3.07e-87,261,"Q9XYM0","CRK_DROME","Adapter molecule Crk","Crk CG1587","Drosophila melanogaster (Fruit fly)",271,"GO:0005737; GO:0006911; GO:0007167; GO:0007298; GO:0007520; GO:0016477; GO:0030971; GO:0032956; GO:0035591; GO:0043087; GO:0046330; GO:0046529; GO:0048010; GO:0048013","border follicle cell migration [GO:0007298]; cell migration [GO:0016477]; enzyme-linked receptor protein signaling pathway [GO:0007167]; ephrin receptor signaling pathway [GO:0048013]; imaginal disc fusion, thorax closure [GO:0046529]; myoblast fusion [GO:0007520]; phagocytosis, engulfment [GO:0006911]; positive regulation of JNK cascade [GO:0046330]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","cytoplasm [GO:0005737]; receptor tyrosine kinase binding [GO:0030971]; signaling adaptor activity [GO:0035591]; border follicle cell migration [GO:0007298]; cell migration [GO:0016477]; enzyme-linked receptor protein signaling pathway [GO:0007167]; ephrin receptor signaling pathway [GO:0048013]; imaginal disc fusion, thorax closure [GO:0046529]; myoblast fusion [GO:0007520]; phagocytosis, engulfment [GO:0006911]; positive regulation of JNK cascade [GO:0046330]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically throughout embryogenesis, declines during larval stages and reappears during pupation. {ECO:0000269|PubMed:10072777}.","","","TISSUE SPECIFICITY: Embryonic zygotic expression is seen in invaginating presumptive mesoderm and ectodermally derived tissues during gastrulation. At stage 8, expression is also seen in anterior and posterior midgut and cephalic furrow. By stage 9, expression is highest in visceral mesoderm of anterior and posterior midgut, ventral nerve cord and somatic mesoderm. {ECO:0000269|PubMed:10072777}."
"594","sp|P19075|TSN8_HUMAN","lcl|NC_088857.1_cds_XP_011430305.3_26248",2.17e-39,137,"P19075","TSN8_HUMAN","Tetraspanin-8 (Tspan-8) (Transmembrane 4 superfamily member 3) (Tumor-associated antigen CO-029)","TSPAN8 TM4SF3","Homo sapiens (Human)",237,"GO:0005178; GO:0005886; GO:0007283; GO:0009986; GO:0010468; GO:0030195; GO:0070062","negative regulation of blood coagulation [GO:0030195]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]","cell surface [GO:0009986]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; negative regulation of blood coagulation [GO:0030195]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Gastric, colon, rectal, and pancreatic carcinomas."
"595","sp|Q9VA38|WARTS_DROME","lcl|NC_088857.1_cds_XP_011431585.1_25905",6.5e-131,407,"Q9VA38","WARTS_DROME","Serine/threonine-protein kinase Warts (EC 2.7.11.1)","wts CG12072","Drosophila melanogaster (Fruit fly)",1105,"GO:0000082; GO:0001708; GO:0004674; GO:0005524; GO:0005813; GO:0005829; GO:0007298; GO:0007406; GO:0007424; GO:0007446; GO:0008285; GO:0008360; GO:0010212; GO:0035329; GO:0042308; GO:0042771; GO:0043065; GO:0045463; GO:0045464; GO:0045571; GO:0046620; GO:0046872; GO:0048814; GO:0060253; GO:0072089; GO:0090090; GO:0106037; GO:0106310; GO:1904504","border follicle cell migration [GO:0007298]; cell fate specification [GO:0001708]; G1/S transition of mitotic cell cycle [GO:0000082]; hippo signaling [GO:0035329]; imaginal disc growth [GO:0007446]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of protein import into nucleus [GO:0042308]; open tracheal system development [GO:0007424]; positive regulation of apoptotic process [GO:0043065]; positive regulation of lipophagy [GO:1904504]; R8 cell development [GO:0045463]; R8 cell fate specification [GO:0045464]; regulation of cell shape [GO:0008360]; regulation of dendrite morphogenesis [GO:0048814]; regulation of organ growth [GO:0046620]; response to ionizing radiation [GO:0010212]; stem cell proliferation [GO:0072089]","apicomedial cortex [GO:0106037]; centrosome [GO:0005813]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; border follicle cell migration [GO:0007298]; cell fate specification [GO:0001708]; G1/S transition of mitotic cell cycle [GO:0000082]; hippo signaling [GO:0035329]; imaginal disc growth [GO:0007446]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of protein import into nucleus [GO:0042308]; open tracheal system development [GO:0007424]; positive regulation of apoptotic process [GO:0043065]; positive regulation of lipophagy [GO:1904504]; R8 cell development [GO:0045463]; R8 cell fate specification [GO:0045464]; regulation of cell shape [GO:0008360]; regulation of dendrite morphogenesis [GO:0048814]; regulation of organ growth [GO:0046620]; response to ionizing radiation [GO:0010212]; stem cell proliferation [GO:0072089]","","","",""
"596","sp|O95922|TTLL1_HUMAN","lcl|NC_088857.1_cds_XP_011432022.2_26416",0,620,"O95922","TTLL1_HUMAN","Polyglutamylase complex subunit TTLL1 (EC 6.3.2.-) (Tubulin polyglutamylase TTLL1) (Tubulin polyglutamylase complex subunit 3) (PGs3) (Tubulin--tyrosine ligase-like protein 1)","TTLL1 C22orf7","Homo sapiens (Human)",423,"GO:0000226; GO:0002395; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0007288; GO:0015631; GO:0018095; GO:0021702; GO:0031514; GO:0036064; GO:0046872; GO:0070740; GO:0106438; GO:0120197; GO:0120222","cerebellar Purkinje cell differentiation [GO:0021702]; immune response in nasopharyngeal-associated lymphoid tissue [GO:0002395]; microtubule cytoskeleton organization [GO:0000226]; mucociliary clearance [GO:0120197]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222]; sperm axoneme assembly [GO:0007288]","ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]; cerebellar Purkinje cell differentiation [GO:0021702]; immune response in nasopharyngeal-associated lymphoid tissue [GO:0002395]; microtubule cytoskeleton organization [GO:0000226]; mucociliary clearance [GO:0120197]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222]; sperm axoneme assembly [GO:0007288]","","","","TISSUE SPECIFICITY: Expressed in a wide range of tissues. Has a stronger expression in heart, brain and testis. {ECO:0000269|PubMed:11054573}."
"597","sp|Q8SWX0|ASTRX_DROME","lcl|NC_088857.1_cds_XP_011434337.3_23186",1.14e-12,65.5,"Q8SWX0","ASTRX_DROME","Gametocyte-specific factor 1 homolog (Protein asterix)","arx Gtsf1 CG3893","Drosophila melanogaster (Fruit fly)",167,"GO:0000049; GO:0005634; GO:0008270; GO:0031047; GO:0045892; GO:0048477; GO:0141006","negative regulation of DNA-templated transcription [GO:0045892]; oogenesis [GO:0048477]; regulatory ncRNA-mediated gene silencing [GO:0031047]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006]","nucleus [GO:0005634]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; negative regulation of DNA-templated transcription [GO:0045892]; oogenesis [GO:0048477]; regulatory ncRNA-mediated gene silencing [GO:0031047]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006]","","","",""
"598","sp|Q8WW33|GTSF1_HUMAN","lcl|NC_088857.1_cds_XP_011434341.3_23185",2.95e-22,92.8,"Q8WW33","GTSF1_HUMAN","Gametocyte-specific factor 1 (Protein FAM112B)","GTSF1 FAM112B","Homo sapiens (Human)",167,"GO:0000049; GO:0007283; GO:0008270; GO:0030154; GO:0071547; GO:0140965; GO:0140991","cell differentiation [GO:0030154]; piRNA-mediated gene silencing by mRNA destabilization [GO:0140991]; secondary piRNA processing [GO:0140965]; spermatogenesis [GO:0007283]","piP-body [GO:0071547]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; piRNA-mediated gene silencing by mRNA destabilization [GO:0140991]; secondary piRNA processing [GO:0140965]; spermatogenesis [GO:0007283]","","","",""
"599","sp|P52757|CHIO_HUMAN","lcl|NC_088857.1_cds_XP_011434695.3_25542",1.01e-152,445,"P52757","CHIO_HUMAN","Beta-chimaerin (Beta-chimerin) (Rho GTPase-activating protein 3)","CHN2 ARHGAP3 BCH","Homo sapiens (Human)",468,"GO:0001675; GO:0005096; GO:0005829; GO:0007165; GO:0008270; GO:0016020; GO:0045202; GO:0051056","acrosome assembly [GO:0001675]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]","cytosol [GO:0005829]; membrane [GO:0016020]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]; acrosome assembly [GO:0001675]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]","","","","TISSUE SPECIFICITY: Highest levels in the brain and pancreas. Also expressed in the heart, placenta, and weakly in the kidney and liver. Expression is much reduced in the malignant gliomas, compared to normal brain or low-grade astrocytomas."
"600","sp|Q03070|CHIO_RAT","lcl|NC_088857.1_cds_XP_011434697.3_25541",2.23e-94,289,"Q03070","CHIO_RAT","Beta-chimaerin (Beta-chimerin) (Rho GTPase-activating protein 3)","Chn2 Arhgap3 Bch","Rattus norvegicus (Rat)",295,"GO:0001565; GO:0001675; GO:0005096; GO:0007165; GO:0008270; GO:0016020; GO:0045202","acrosome assembly [GO:0001675]; signal transduction [GO:0007165]","membrane [GO:0016020]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; phorbol ester receptor activity [GO:0001565]; zinc ion binding [GO:0008270]; acrosome assembly [GO:0001675]; signal transduction [GO:0007165]","DEVELOPMENTAL STAGE: Expressed specifically in late stage spermatocytes. In the cerebellum, emergence of beta-2 isoform coincides with granule cells maturation and exhibits postnatal developmental increases. Expression is specifically reduced in weaver mutant.","","","TISSUE SPECIFICITY: Found in cerebellum and testis."
"601","sp|P61092|SIA1A_MOUSE","lcl|NC_088857.1_cds_XP_011434753.1_23121",2.94e-163,456,"P61092","SIA1A_MOUSE","E3 ubiquitin-protein ligase SIAH1A (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1A) (Seven in absentia homolog 1a) (Siah-1a) (Siah1a) (mSiah-1a)","Siah1a","Mus musculus (Mouse)",282,"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007141; GO:0007283; GO:0008270; GO:0009791; GO:0016567; GO:0019005; GO:0030154; GO:0040014; GO:0042803; GO:0043161; GO:0051402; GO:0060070; GO:0061630; GO:0097718","canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; neuron apoptotic process [GO:0051402]; post-embryonic development [GO:0009791]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]","cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; disordered domain specific binding [GO:0097718]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; neuron apoptotic process [GO:0051402]; post-embryonic development [GO:0009791]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]","","INDUCTION: May be induced by p53/TP53, suggesting that it may be required to modulate p53/TP53 response (PubMed:12417719). The relevance of such activity in vivo is however unclear and may not exist (PubMed:12417719). Induced by ATF4 in response to the unfolded protein response (UPR) (PubMed:24809345). {ECO:0000269|PubMed:12417719, ECO:0000269|PubMed:24809345}.","INDUCTION: May be induced by p53/TP53, suggesting that it may be required to modulate p53/TP53 response (PubMed:12417719). The relevance of such activity in vivo is however unclear and may not exist (PubMed:12417719). Induced by ATF4 in response to the unfolded protein response (UPR) (PubMed:24809345). {ECO:0000269|PubMed:12417719, ECO:0000269|PubMed:24809345}.","TISSUE SPECIFICITY: Widely expressed at low level in embryos and adults. Expressed at higher level in testis. Due to the high similarity between SIAH1A and SIAH1B, it is difficult to distinguish its own tissue specificity. {ECO:0000269|PubMed:8404535}."
"602","sp|O15123|ANGP2_HUMAN","lcl|NC_088857.1_cds_XP_011434970.3_26629",2.09e-55,190,"O15123","ANGP2_HUMAN","Angiopoietin-2 (ANG-2)","ANGPT2","Homo sapiens (Human)",496,"GO:0001525; GO:0001666; GO:0005102; GO:0005576; GO:0005615; GO:0007165; GO:0007281; GO:0007596; GO:0009612; GO:0009749; GO:0010467; GO:0010812; GO:0014823; GO:0016525; GO:0030971; GO:0031100; GO:0042995; GO:0043537; GO:0045766; GO:0046872; GO:0048014; GO:0048018; GO:0050820; GO:0050928; GO:0060135; GO:0062023; GO:0071363; GO:0072012","angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; blood coagulation [GO:0007596]; cellular response to growth factor stimulus [GO:0071363]; gene expression [GO:0010467]; germ cell development [GO:0007281]; glomerulus vasculature development [GO:0072012]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of positive chemotaxis [GO:0050928]; positive regulation of angiogenesis [GO:0045766]; positive regulation of coagulation [GO:0050820]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; signal transduction [GO:0007165]; Tie signaling pathway [GO:0048014]","cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; blood coagulation [GO:0007596]; cellular response to growth factor stimulus [GO:0071363]; gene expression [GO:0010467]; germ cell development [GO:0007281]; glomerulus vasculature development [GO:0072012]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of positive chemotaxis [GO:0050928]; positive regulation of angiogenesis [GO:0045766]; positive regulation of coagulation [GO:0050820]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; signal transduction [GO:0007165]; Tie signaling pathway [GO:0048014]","","","",""
"603","sp|O14645|IDLC_HUMAN","lcl|NC_088857.1_cds_XP_011434996.1_26647",9.26e-132,374,"O14645","IDLC_HUMAN","Axonemal dynein light intermediate polypeptide 1 (Inner dynein arm light chain, axonemal) (hp28)","DNALI1","Homo sapiens (Human)",258,"GO:0005654; GO:0005737; GO:0005929; GO:0005930; GO:0015630; GO:0030175; GO:0030286; GO:0031514; GO:0036126; GO:0045171; GO:0045504; GO:0072686; GO:0097546; GO:0097729; GO:0120293; GO:0120316","sperm flagellum assembly [GO:0120316]","9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein axonemal particle [GO:0120293]; dynein complex [GO:0030286]; filopodium [GO:0030175]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; sperm flagellum [GO:0036126]; dynein heavy chain binding [GO:0045504]; sperm flagellum assembly [GO:0120316]","","","","TISSUE SPECIFICITY: Expressed in many tissues. A smaller 0.9 kb and a larger 2.5 kb transcripts were detected at the highest level in the testis, at medium levels in the prostate, heart, liver, lung and pancreas, at low levels in the ovary, skeletal muscle and small intestine. Not detected in spleen, colon epithelium, thymus or peripheral blood leukocytes. The 0.9 kb transcript is expressed at a 20-fold higher level than the 2.5 kb transcript in the testis. Expressed in spermatozoa and airway epithelial cells (at protein level) (PubMed:31178125). {ECO:0000269|PubMed:31178125}."
"604","sp|Q9WVC8|S26A3_MOUSE","lcl|NC_088857.1_cds_XP_011439977.2_26753",1.58e-67,240,"Q9WVC8","S26A3_MOUSE","Chloride anion exchanger (Down-regulated in adenoma) (Protein DRA) (Solute carrier family 26 member 3)","Slc26a3 Dra","Mus musculus (Mouse)",757,"GO:0005886; GO:0008271; GO:0015106; GO:0015108; GO:0016020; GO:0016324; GO:0031526; GO:0048240; GO:0051454; GO:0060081; GO:0071320; GO:0097225; GO:0140900","cellular response to cAMP [GO:0071320]; intracellular pH elevation [GO:0051454]; membrane hyperpolarization [GO:0060081]; sperm capacitation [GO:0048240]","apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; chloride:bicarbonate antiporter activity [GO:0140900]; secondary active sulfate transmembrane transporter activity [GO:0008271]; cellular response to cAMP [GO:0071320]; intracellular pH elevation [GO:0051454]; membrane hyperpolarization [GO:0060081]; sperm capacitation [GO:0048240]","","","","TISSUE SPECIFICITY: Expressed in spermatogenic cells (PubMed:21976599). Expressed at high levels in cecum and colon and at lower levels in small intestine (PubMed:10428871). {ECO:0000269|PubMed:10428871, ECO:0000269|PubMed:21976599}."
"605","sp|Q8N0X2|SPG16_HUMAN","lcl|NC_088857.1_cds_XP_011440339.2_26225",0,563,"Q8N0X2","SPG16_HUMAN","Sperm-associated antigen 16 protein (Pf20 protein homolog)","SPAG16 PF20","Homo sapiens (Human)",631,"GO:0005576; GO:0005930; GO:0007288; GO:0035082; GO:0036126; GO:0060271; GO:0090660; GO:0120197; GO:1990716","axoneme assembly [GO:0035082]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; mucociliary clearance [GO:0120197]; sperm axoneme assembly [GO:0007288]","axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; extracellular region [GO:0005576]; sperm flagellum [GO:0036126]; axoneme assembly [GO:0035082]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; mucociliary clearance [GO:0120197]; sperm axoneme assembly [GO:0007288]","","","","TISSUE SPECIFICITY: Isoform 1 is detected in testis. Isoform 4 is detected in testis and brain, and at lower levels in kidney, heart, pancreas, thyroid, ovary, adrenal gland, spinal cord, trachea and liver. {ECO:0000269|PubMed:11867345, ECO:0000269|PubMed:12391165}."
"606","sp|Q9VIL0|BRUN_DROME","lcl|NC_088857.1_cds_XP_011440427.3_24957",4.25e-106,365,"Q9VIL0","BRUN_DROME","Protein brunelleschi (NIK- and IKBKB-binding protein)","brun bru CG2478","Drosophila melanogaster (Fruit fly)",1320,"GO:0000212; GO:0000916; GO:0005737; GO:0005794; GO:0005802; GO:0006891; GO:0007110; GO:0007111; GO:0007112; GO:0030008; GO:0036063; GO:0048137; GO:0048193; GO:1990071","actomyosin contractile ring contraction [GO:0000916]; Golgi vesicle transport [GO:0048193]; intra-Golgi vesicle-mediated transport [GO:0006891]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; meiotic spindle organization [GO:0000212]; spermatocyte division [GO:0048137]","acroblast [GO:0036063]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; actomyosin contractile ring contraction [GO:0000916]; Golgi vesicle transport [GO:0048193]; intra-Golgi vesicle-mediated transport [GO:0006891]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; meiotic spindle organization [GO:0000212]; spermatocyte division [GO:0048137]","DEVELOPMENTAL STAGE: Expressed in embryos and adults of males and females. {ECO:0000269|PubMed:19934220}.","","",""
"607","sp|Q66IC9|ROP1L_DANRE","lcl|NC_088857.1_cds_XP_011441362.1_23790",8.89e-88,259,"Q66IC9","ROP1L_DANRE","Ropporin-1-like protein","ropn1l si:rp71-1f1.7","Danio rerio (Zebrafish) (Brachydanio rerio)",218,"GO:0001534; GO:0007286; GO:0031514","spermatid development [GO:0007286]","motile cilium [GO:0031514]; radial spoke [GO:0001534]; spermatid development [GO:0007286]","","","",""
"608","sp|Q9V785|3BP5H_DROME","lcl|NC_088857.1_cds_XP_011441617.2_25467",4.26e-64,217,"Q9V785","3BP5H_DROME","SH3 domain-binding protein 5 homolog (Protein parcase)","pcs CG7761","Drosophila melanogaster (Fruit fly)",477,"GO:0004860; GO:0005085; GO:0005737; GO:0005886; GO:0007301; GO:0007498; GO:0007517; GO:0009952; GO:0017124; GO:0030292; GO:0035556; GO:0042694; GO:0048644; GO:0098548","anterior/posterior pattern specification [GO:0009952]; female germline ring canal formation [GO:0007301]; intracellular signal transduction [GO:0035556]; mesoderm development [GO:0007498]; muscle cell fate specification [GO:0042694]; muscle organ development [GO:0007517]; muscle organ morphogenesis [GO:0048644]","cytoplasm [GO:0005737]; cytoplasmic side of Golgi membrane [GO:0098548]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase inhibitor activity [GO:0004860]; protein tyrosine kinase inhibitor activity [GO:0030292]; SH3 domain binding [GO:0017124]; anterior/posterior pattern specification [GO:0009952]; female germline ring canal formation [GO:0007301]; intracellular signal transduction [GO:0035556]; mesoderm development [GO:0007498]; muscle cell fate specification [GO:0042694]; muscle organ development [GO:0007517]; muscle organ morphogenesis [GO:0048644]","","","",""
"609","sp|Q8NB78|KDM1B_HUMAN","lcl|NC_088857.1_cds_XP_011443788.3_26942",0,703,"Q8NB78","KDM1B_HUMAN","Lysine-specific histone demethylase 2 (EC 1.14.99.66) (Flavin-containing amine oxidase domain-containing protein 1) (Lysine-specific histone demethylase 1B)","KDM1B AOF1 C6orf193 LSD2","Homo sapiens (Human)",822,"GO:0000785; GO:0000786; GO:0005634; GO:0005654; GO:0008270; GO:0016491; GO:0032452; GO:0042393; GO:0044726; GO:0045815; GO:0071514; GO:0071949; GO:0140682","epigenetic programing of female pronucleus [GO:0044726]; genomic imprinting [GO:0071514]; transcription initiation-coupled chromatin remodeling [GO:0045815]","chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; FAD binding [GO:0071949]; FAD-dependent H3K4me/H3K4me3 demethylase activity [GO:0140682]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]; epigenetic programing of female pronucleus [GO:0044726]; genomic imprinting [GO:0071514]; transcription initiation-coupled chromatin remodeling [GO:0045815]","","","",""
"610","sp|P07872|ACOX1_RAT","lcl|NC_088857.1_cds_XP_011443813.3_26970",0,711,"P07872","ACOX1_RAT","Peroxisomal acyl-coenzyme A oxidase 1 (ACO) (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase) (Peroxisomal fatty acyl-CoA oxidase) (Straight-chain acyl-CoA oxidase) [Cleaved into: Peroxisomal acyl-CoA oxidase 1, A chain; Peroxisomal acyl-CoA oxidase 1, B chain; Peroxisomal acyl-CoA oxidase 1, C chain]","Acox1 Acox","Rattus norvegicus (Rat)",661,"GO:0000038; GO:0003997; GO:0005504; GO:0005737; GO:0005777; GO:0005778; GO:0005782; GO:0006091; GO:0006629; GO:0006636; GO:0006693; GO:0007283; GO:0009062; GO:0016401; GO:0019395; GO:0030165; GO:0033540; GO:0036109; GO:0042759; GO:0042803; GO:0050660; GO:0050665; GO:0071949; GO:0140493; GO:1901570","alpha-linolenic acid metabolic process [GO:0036109]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; fatty acid derivative biosynthetic process [GO:1901570]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; hydrogen peroxide biosynthetic process [GO:0050665]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; prostaglandin metabolic process [GO:0006693]; spermatogenesis [GO:0007283]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid beta-oxidation [GO:0140493]; very long-chain fatty acid metabolic process [GO:0000038]","cytoplasm [GO:0005737]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; palmitoyl-CoA oxidase activity [GO:0016401]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; alpha-linolenic acid metabolic process [GO:0036109]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; fatty acid derivative biosynthetic process [GO:1901570]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; hydrogen peroxide biosynthetic process [GO:0050665]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; prostaglandin metabolic process [GO:0006693]; spermatogenesis [GO:0007283]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid beta-oxidation [GO:0140493]; very long-chain fatty acid metabolic process [GO:0000038]","","","","TISSUE SPECIFICITY: Expressed in Schwann cells (PubMed:32169171). Expressed (at protein level) in liver (PubMed:1400324). {ECO:0000269|PubMed:1400324, ECO:0000269|PubMed:32169171}."
"611","sp|Q3U1J4|DDB1_MOUSE","lcl|NC_088857.1_cds_XP_011443823.2_26133",0,1783,"Q3U1J4","DDB1_MOUSE","DNA damage-binding protein 1 (DDB p127 subunit) (Damage-specific DNA-binding protein 1) (UV-damaged DNA-binding factor)","Ddb1","Mus musculus (Mouse)",1140,"GO:0003684; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006511; GO:0006915; GO:0006974; GO:0007056; GO:0010498; GO:0016055; GO:0016567; GO:0019076; GO:0031464; GO:0031465; GO:0034644; GO:0035234; GO:0042752; GO:0043066; GO:0043161; GO:0044725; GO:0044877; GO:0045070; GO:0045722; GO:0045732; GO:0046726; GO:0048511; GO:0051093; GO:0051702; GO:0070914; GO:0071987; GO:0080008; GO:0097602; GO:0160072; GO:1901990; GO:2000242","apoptotic process [GO:0006915]; biological process involved in interaction with symbiont [GO:0051702]; cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; ectopic germ cell programmed cell death [GO:0035234]; epigenetic programming in the zygotic pronuclei [GO:0044725]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of reproductive process [GO:2000242]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral genome replication [GO:0045070]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of mitotic cell cycle phase transition [GO:1901990]; rhythmic process [GO:0048511]; spindle assembly involved in female meiosis [GO:0007056]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]; viral release from host cell [GO:0019076]; Wnt signaling pathway [GO:0016055]","Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; damaged DNA binding [GO:0003684]; protein-containing complex binding [GO:0044877]; ubiquitin ligase complex scaffold activity [GO:0160072]; WD40-repeat domain binding [GO:0071987]; apoptotic process [GO:0006915]; biological process involved in interaction with symbiont [GO:0051702]; cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; ectopic germ cell programmed cell death [GO:0035234]; epigenetic programming in the zygotic pronuclei [GO:0044725]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of reproductive process [GO:2000242]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral genome replication [GO:0045070]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of mitotic cell cycle phase transition [GO:1901990]; rhythmic process [GO:0048511]; spindle assembly involved in female meiosis [GO:0007056]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]; viral release from host cell [GO:0019076]; Wnt signaling pathway [GO:0016055]","DEVELOPMENTAL STAGE: Expressed in germinal vesicle (GV) stage and MII-stage oocytes and zygotes. Expression then decreases from 2-cell stage to blastula (PubMed:24357321). Widely expressed at 8.5 dpc, 9.5 dpc, 12.5 dpc, and 19.5 dpc (PubMed:10574459). {ECO:0000269|PubMed:10574459, ECO:0000269|PubMed:24357321}.","","","TISSUE SPECIFICITY: Widely expressed. Expressed in pregnant, lactating and involuting mammary gland. Expressed in oocytes (at protein level) (PubMed:24357321). {ECO:0000269|PubMed:10574459, ECO:0000269|PubMed:24357321, ECO:0000269|PubMed:28790135}."
"612","sp|Q9ESV6|G3PT_RAT","lcl|NC_088857.1_cds_XP_011444904.1_22804",1.47e-162,462,"Q9ESV6","G3PT_RAT","Glyceraldehyde-3-phosphate dehydrogenase, testis-specific (EC 1.2.1.12) (Spermatogenic cell-specific glyceraldehyde 3-phosphate dehydrogenase 2) (GAPDH-2) (Spermatogenic glyceraldehyde-3-phosphate dehydrogenase)","Gapdhs Gapd-s Gapds","Rattus norvegicus (Rat)",432,"GO:0001669; GO:0004365; GO:0005829; GO:0005929; GO:0006006; GO:0006096; GO:0007286; GO:0030317; GO:0031514; GO:0035686; GO:0050661; GO:0051287; GO:0097228","flagellated sperm motility [GO:0030317]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; spermatid development [GO:0007286]","acrosomal vesicle [GO:0001669]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; sperm fibrous sheath [GO:0035686]; sperm principal piece [GO:0097228]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; flagellated sperm motility [GO:0030317]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Expressed in both head and flagellum of epididymal sperm. {ECO:0000269|PubMed:19423663}."
"613","sp|P53350|PLK1_HUMAN","lcl|NC_088857.1_cds_XP_011446350.1_23267",0,791,"P53350","PLK1_HUMAN","Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13)","PLK1 PLK","Homo sapiens (Human)",603,"GO:0000070; GO:0000086; GO:0000122; GO:0000132; GO:0000278; GO:0000281; GO:0000287; GO:0000776; GO:0000785; GO:0000795; GO:0000922; GO:0000940; GO:0001578; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0006302; GO:0006468; GO:0007052; GO:0007062; GO:0007076; GO:0007077; GO:0007091; GO:0007094; GO:0007095; GO:0007098; GO:0007346; GO:0008017; GO:0010997; GO:0015630; GO:0016321; GO:0016567; GO:0018105; GO:0019901; GO:0030071; GO:0030496; GO:0031648; GO:0032436; GO:0032465; GO:0034451; GO:0042802; GO:0043066; GO:0045143; GO:0045184; GO:0045862; GO:0048313; GO:0051081; GO:0051233; GO:0051443; GO:0051726; GO:0070194; GO:0071168; GO:0090435; GO:0097431; GO:0097681; GO:0106310; GO:1900182; GO:1901673; GO:1901990; GO:1904668; GO:1904776; GO:1905784; GO:2000042","centrosome cycle [GO:0007098]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; establishment of mitotic spindle orientation [GO:0000132]; establishment of protein localization [GO:0045184]; female meiosis chromosome segregation [GO:0016321]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi inheritance [GO:0048313]; homologous chromosome segregation [GO:0045143]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076]; mitotic cytokinesis [GO:0000281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic nuclear membrane disassembly [GO:0007077]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear membrane disassembly [GO:0051081]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein destabilization [GO:0031648]; protein localization to chromatin [GO:0071168]; protein localization to nuclear envelope [GO:0090435]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of anaphase-promoting complex-dependent catabolic process [GO:1905784]; regulation of cell cycle [GO:0051726]; regulation of cytokinesis [GO:0032465]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization to cell cortex [GO:1904776]; sister chromatid cohesion [GO:0007062]; synaptonemal complex disassembly [GO:0070194]","centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; synaptonemal complex [GO:0000795]; anaphase-promoting complex binding [GO:0010997]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; centrosome cycle [GO:0007098]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; establishment of mitotic spindle orientation [GO:0000132]; establishment of protein localization [GO:0045184]; female meiosis chromosome segregation [GO:0016321]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi inheritance [GO:0048313]; homologous chromosome segregation [GO:0045143]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076]; mitotic cytokinesis [GO:0000281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic nuclear membrane disassembly [GO:0007077]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear membrane disassembly [GO:0051081]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein destabilization [GO:0031648]; protein localization to chromatin [GO:0071168]; protein localization to nuclear envelope [GO:0090435]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of anaphase-promoting complex-dependent catabolic process [GO:1905784]; regulation of cell cycle [GO:0051726]; regulation of cytokinesis [GO:0032465]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization to cell cortex [GO:1904776]; sister chromatid cohesion [GO:0007062]; synaptonemal complex disassembly [GO:0070194]","DEVELOPMENTAL STAGE: Accumulates to a maximum during the G2 and M phases, declines to a nearly undetectable level following mitosis and throughout G1 phase, and then begins to accumulate again during S phase.","INDUCTION: By growth-stimulating agents.","INDUCTION: By growth-stimulating agents.","TISSUE SPECIFICITY: Placenta and colon."
"614","sp|Q9ATL2|TIP51_MAIZE","lcl|NC_088857.1_cds_XP_011446843.3_26855",1.27e-23,98.2,"Q9ATL2","TIP51_MAIZE","Aquaporin TIP5-1 (Tonoplast intrinsic protein 5-1) (ZmTIP5-1) (ZmTIP5;1)","TIP5-1 TIP5","Zea mays (Maize)",260,"GO:0005774; GO:0006833; GO:0015250; GO:0016020","water transport [GO:0006833]","membrane [GO:0016020]; vacuolar membrane [GO:0005774]; water channel activity [GO:0015250]; water transport [GO:0006833]","","","",""
"615","sp|Q8TBY0|RBM46_HUMAN","lcl|NC_088857.1_cds_XP_011446911.1_27472",1.82e-160,470,"Q8TBY0","RBM46_HUMAN","Probable RNA-binding protein 46 (Cancer/testis antigen 68) (CT68) (RNA-binding motif protein 46)","RBM46","Homo sapiens (Human)",533,"GO:0001829; GO:0003729; GO:0005634; GO:0005737; GO:0007140; GO:0007143; GO:0007283; GO:0048255; GO:0048477; GO:0048515; GO:0051728","cell cycle switching, mitotic to meiotic cell cycle [GO:0051728]; female meiotic nuclear division [GO:0007143]; male meiotic nuclear division [GO:0007140]; mRNA stabilization [GO:0048255]; oogenesis [GO:0048477]; spermatid differentiation [GO:0048515]; spermatogenesis [GO:0007283]; trophectodermal cell differentiation [GO:0001829]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; cell cycle switching, mitotic to meiotic cell cycle [GO:0051728]; female meiotic nuclear division [GO:0007143]; male meiotic nuclear division [GO:0007140]; mRNA stabilization [GO:0048255]; oogenesis [GO:0048477]; spermatid differentiation [GO:0048515]; spermatogenesis [GO:0007283]; trophectodermal cell differentiation [GO:0001829]","","","",""
"616","sp|Q0P4R6|RBM46_XENTR","lcl|NC_088857.1_cds_XP_011446913.1_27470",7.07e-132,395,"Q0P4R6","RBM46_XENTR","Probable RNA-binding protein 46 (RNA-binding motif protein 46)","rbm46","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)",534,"GO:0003723; GO:0005737; GO:0007283; GO:0048477; GO:0051321","meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; RNA binding [GO:0003723]; meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]","","","",""
"617","sp|P22981|LET60_CAEEL","lcl|NC_088857.1_cds_XP_011447097.1_22772",9.02e-95,274,"P22981","LET60_CAEEL","Ras protein let-60 (EC 3.6.5.2) (Abnormal cell lineage protein 34) (Lethal protein 60)","let-60 lin-34 ZK792.6","Caenorhabditis elegans",184,"GO:0002119; GO:0003924; GO:0005525; GO:0005886; GO:0005938; GO:0007173; GO:0007265; GO:0007517; GO:0007614; GO:0008306; GO:0019003; GO:0022414; GO:0031344; GO:0040026; GO:0040028; GO:0042659; GO:0043274; GO:0048477; GO:0072327; GO:0120283; GO:1902685","associative learning [GO:0008306]; epidermal growth factor receptor signaling pathway [GO:0007173]; muscle organ development [GO:0007517]; nematode larval development [GO:0002119]; oogenesis [GO:0048477]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of vulval development [GO:0040026]; Ras protein signal transduction [GO:0007265]; regulation of cell fate specification [GO:0042659]; regulation of cell projection organization [GO:0031344]; regulation of vulval development [GO:0040028]; reproductive process [GO:0022414]; short-term memory [GO:0007614]; vulval cell fate specification [GO:0072327]","cell cortex [GO:0005938]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phospholipase binding [GO:0043274]; protein serine/threonine kinase binding [GO:0120283]; associative learning [GO:0008306]; epidermal growth factor receptor signaling pathway [GO:0007173]; muscle organ development [GO:0007517]; nematode larval development [GO:0002119]; oogenesis [GO:0048477]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of vulval development [GO:0040026]; Ras protein signal transduction [GO:0007265]; regulation of cell fate specification [GO:0042659]; regulation of cell projection organization [GO:0031344]; regulation of vulval development [GO:0040028]; reproductive process [GO:0022414]; short-term memory [GO:0007614]; vulval cell fate specification [GO:0072327]","","","","TISSUE SPECIFICITY: Expressed in body wall muscles and in the nervous system including ganglion, nerve ring dorsal and ventral nerve cords, motor neurons and sensory tail neurons. {ECO:0000269|PubMed:24929033}."
"618","sp|P40946|ARF6_DROME","lcl|NC_088857.1_cds_XP_011447695.1_23081",1.96e-122,343,"P40946","ARF6_DROME","ADP-ribosylation factor 6 (ARF6) (ADP ribosylation factor at 51F) (ADP-ribosylation factor 3)","Arf6 Arf3 Arf51F CG8156","Drosophila melanogaster (Fruit fly)",175,"GO:0001745; GO:0003924; GO:0005525; GO:0005737; GO:0005769; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0007112; GO:0007269; GO:0007283; GO:0007476; GO:0007520; GO:0008047; GO:0010628; GO:0016192; GO:0030036; GO:0032154; GO:0048149; GO:0048488; GO:0055037; GO:0097305; GO:0098793","actin cytoskeleton organization [GO:0030036]; behavioral response to ethanol [GO:0048149]; compound eye morphogenesis [GO:0001745]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular protein transport [GO:0006886]; male meiosis cytokinesis [GO:0007112]; myoblast fusion [GO:0007520]; neurotransmitter secretion [GO:0007269]; positive regulation of gene expression [GO:0010628]; response to alcohol [GO:0097305]; spermatogenesis [GO:0007283]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]","cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; enzyme activator activity [GO:0008047]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; actin cytoskeleton organization [GO:0030036]; behavioral response to ethanol [GO:0048149]; compound eye morphogenesis [GO:0001745]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular protein transport [GO:0006886]; male meiosis cytokinesis [GO:0007112]; myoblast fusion [GO:0007520]; neurotransmitter secretion [GO:0007269]; positive regulation of gene expression [GO:0010628]; response to alcohol [GO:0097305]; spermatogenesis [GO:0007283]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]","","","","TISSUE SPECIFICITY: Expressed in the head (at protein level). {ECO:0000269|PubMed:28607459}."
"619","sp|Q60547|SYCP3_MESAU","lcl|NC_088857.1_cds_XP_011448015.3_25700",8.85e-65,202,"Q60547","SYCP3_MESAU","Synaptonemal complex protein 3 (SCP-3) (Meiotic chromosome core protein) (Synaptonemal complex protein COR1)","SYCP3 COR1","Mesocricetus auratus (Golden hamster)",234,"GO:0000775; GO:0000800; GO:0003677; GO:0005694; GO:0007286; GO:0051301; GO:0051321","cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286]","chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; lateral element [GO:0000800]; DNA binding [GO:0003677]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Detected in spermatocytes (at protein level). {ECO:0000269|PubMed:7876343}."
"620","sp|Q8TC57|M1AP_HUMAN","lcl|NC_088857.1_cds_XP_011448054.3_25696",3.31e-73,243,"Q8TC57","M1AP_HUMAN","Meiosis 1 arrest protein (Meiosis 1-arresting protein) (Meiosis 1-associated protein) (Spermatogenesis-associated protein 37)","M1AP C2orf65 SPATA37","Homo sapiens (Human)",530,"GO:0005737; GO:0006325; GO:0006396; GO:0007127; GO:0007283; GO:0007292; GO:0016020; GO:0030154; GO:0042802; GO:0051308","cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; female gamete generation [GO:0007292]; male meiosis chromosome separation [GO:0051308]; meiosis I [GO:0007127]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; membrane [GO:0016020]; identical protein binding [GO:0042802]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; female gamete generation [GO:0007292]; male meiosis chromosome separation [GO:0051308]; meiosis I [GO:0007127]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283]","","","",""
"621","sp|A1ZB91|DAAF3_DROME","lcl|NC_088857.1_cds_XP_011448280.3_27642",7.95e-61,209,"A1ZB91","DAAF3_DROME","Dynein axonemal assembly factor 3 homolog","Dnaaf3 CG17669","Drosophila melanogaster (Fruit fly)",540,"GO:0005829; GO:0044458; GO:0070286; GO:0120293; GO:0120316; GO:1905515","axonemal dynein complex assembly [GO:0070286]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; sperm flagellum assembly [GO:0120316]","cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; axonemal dynein complex assembly [GO:0070286]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; sperm flagellum assembly [GO:0120316]","DEVELOPMENTAL STAGE: In stage 16 embryo, restricted to all differentiating mechanosensory chordotonal (Ch) neurons (lch5, v'ch1, and vchAB) (at protein level) (PubMed:34553759). In pupae, expression is restricted to the neuronal cell bodies and dendrite inner segments of Ch neurons within the Johnston's organ (at protein level) (PubMed:34553759). {ECO:0000269|PubMed:34553759}.","","","TISSUE SPECIFICITY: Expressed in mechanosensory chordotonal (Ch) neurons, spermatocytes and spermatids (at protein level). {ECO:0000269|PubMed:34553759}."
"622","sp|P52701|MSH6_HUMAN","lcl|NC_088857.1_cds_XP_011450765.3_25624",0,1244,"P52701","MSH6_HUMAN","DNA mismatch repair protein Msh6 (hMSH6) (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS protein homolog 6) (MutS-alpha 160 kDa subunit) (p160)","MSH6 GTBP","Homo sapiens (Human)",1360,"GO:0000710; GO:0000785; GO:0003682; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006281; GO:0006298; GO:0007283; GO:0008094; GO:0008340; GO:0008630; GO:0009411; GO:0016446; GO:0016447; GO:0019899; GO:0030983; GO:0032137; GO:0032301; GO:0043231; GO:0045190; GO:0045910; GO:0097193; GO:0140003; GO:0140664","determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; response to UV [GO:0009411]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; spermatogenesis [GO:0007283]","chromatin [GO:0000785]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; MutSalpha complex [GO:0032301]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; histone H3K36me3 reader activity [GO:0140003]; mismatched DNA binding [GO:0030983]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; response to UV [GO:0009411]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; spermatogenesis [GO:0007283]","","","",""
"623","sp|B4GDM5|EIF3M_DROPE","lcl|NC_088857.1_cds_XP_011451315.1_27211",6.95e-115,341,"B4GDM5","EIF3M_DROPE","Eukaryotic translation initiation factor 3 subunit M (eIF3m) (Transport and Golgi organization protein 7) (Tango-7)","Tango7 GL10828","Drosophila persimilis (Fruit fly)",387,"GO:0001732; GO:0003743; GO:0005794; GO:0005829; GO:0007030; GO:0007291; GO:0009306; GO:0016282; GO:0033290; GO:0070865; GO:0071541; GO:0089720; GO:0140608","formation of cytoplasmic translation initiation complex [GO:0001732]; Golgi organization [GO:0007030]; protein secretion [GO:0009306]; sperm individualization [GO:0007291]","cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; Golgi apparatus [GO:0005794]; investment cone [GO:0070865]; caspase binding [GO:0089720]; cysteine-type endopeptidase activator activity [GO:0140608]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; Golgi organization [GO:0007030]; protein secretion [GO:0009306]; sperm individualization [GO:0007291]","","","",""
"624","sp|O95394|AGM1_HUMAN","lcl|NC_088857.1_cds_XP_011451755.3_22885",0,596,"O95394","AGM1_HUMAN","Phosphoacetylglucosamine mutase (PAGM) (EC 5.4.2.3) (Acetylglucosamine phosphomutase) (N-acetylglucosamine-phosphate mutase) (Phosphoglucomutase-3) (PGM 3)","PGM3 AGM1","Homo sapiens (Human)",542,"GO:0000287; GO:0004610; GO:0005829; GO:0005975; GO:0006041; GO:0006048; GO:0006487; GO:0006493; GO:0007283; GO:0030097","carbohydrate metabolic process [GO:0005975]; glucosamine metabolic process [GO:0006041]; hemopoiesis [GO:0030097]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; spermatogenesis [GO:0007283]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]","cytosol [GO:0005829]; magnesium ion binding [GO:0000287]; phosphoacetylglucosamine mutase activity [GO:0004610]; carbohydrate metabolic process [GO:0005975]; glucosamine metabolic process [GO:0006041]; hemopoiesis [GO:0030097]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; spermatogenesis [GO:0007283]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]","","","","TISSUE SPECIFICITY: Found in many tissues except lung. Relatively high expression in pancreas, heart, liver, and placenta, and relatively low expression in brain, skeletal muscle and kidney. {ECO:0000269|PubMed:10721701}."
"625","sp|Q9NXK6|PAQR5_HUMAN","lcl|NC_088857.1_cds_XP_011451760.3_22892",1.61e-96,290,"Q9NXK6","PAQR5_HUMAN","Membrane progestin receptor gamma (mPR gamma) (Membrane progesterone P4 receptor gamma) (Membrane progesterone receptor gamma) (Progesterone and adipoQ receptor family member 5) (Progestin and adipoQ receptor family member 5) (Progestin and adipoQ receptor family member V)","PAQR5 MPRG","Homo sapiens (Human)",330,"GO:0005496; GO:0005886; GO:0038023; GO:0048477","oogenesis [GO:0048477]","plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; steroid binding [GO:0005496]; oogenesis [GO:0048477]","","","","TISSUE SPECIFICITY: Expressed in the brain, lung, kidney, colon, adrenal and lung. {ECO:0000269|PubMed:12601167, ECO:0000269|PubMed:16044242}."
"626","sp|Q9VNE2|PKRA_DROME","lcl|NC_088857.1_cds_XP_011452810.1_25016",2.78e-148,428,"Q9VNE2","PKRA_DROME","Protein krasavietz (Eukaryotic translation initiation factor 5C domain-containing protein) (Decp) (eIF5C domain-containing protein) (Protein extra bases)","kra ecp eIF-5C exba CG2922","Drosophila melanogaster (Fruit fly)",422,"GO:0005737; GO:0007616; GO:0016199; GO:0017148; GO:0030175; GO:0030424; GO:0030707; GO:0031369; GO:0043022; GO:0043024; GO:0043025; GO:0044295; GO:0048149; GO:0048477; GO:0051491","axon midline choice point recognition [GO:0016199]; behavioral response to ethanol [GO:0048149]; follicle cell of egg chamber development [GO:0030707]; long-term memory [GO:0007616]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; positive regulation of filopodium assembly [GO:0051491]","axon [GO:0030424]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; neuronal cell body [GO:0043025]; ribosomal small subunit binding [GO:0043024]; ribosome binding [GO:0043022]; translation initiation factor binding [GO:0031369]; axon midline choice point recognition [GO:0016199]; behavioral response to ethanol [GO:0048149]; follicle cell of egg chamber development [GO:0030707]; long-term memory [GO:0007616]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; positive regulation of filopodium assembly [GO:0051491]","","","","TISSUE SPECIFICITY: Expressed in mushroom bodies. {ECO:0000269|PubMed:12593794}."
"627","sp|P05369|FPPS_RAT","lcl|NC_088857.1_cds_XP_011453002.3_23709",4.6e-124,362,"P05369","FPPS_RAT","Farnesyl pyrophosphate synthase (FPP synthase) (FPS) (EC 2.5.1.10) ((2E,6E)-farnesyl diphosphate synthase) (Cholesterol-regulated 39 kDa protein) (CR 39) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Geranyltranstransferase)","Fdps","Rattus norvegicus (Rat)",353,"GO:0004161; GO:0004337; GO:0005737; GO:0005759; GO:0005777; GO:0006695; GO:0007283; GO:0008584; GO:0009410; GO:0033384; GO:0033574; GO:0043434; GO:0045337; GO:0045542; GO:0046872; GO:0061051; GO:0070723; GO:0071398","cellular response to fatty acid [GO:0071398]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; male gonad development [GO:0008584]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cholesterol biosynthetic process [GO:0045542]; response to cholesterol [GO:0070723]; response to peptide hormone [GO:0043434]; response to testosterone [GO:0033574]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; peroxisome [GO:0005777]; (2E,6E)-farnesyl diphosphate synthase activity [GO:0004337]; dimethylallyltranstransferase activity [GO:0004161]; metal ion binding [GO:0046872]; cellular response to fatty acid [GO:0071398]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; male gonad development [GO:0008584]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cholesterol biosynthetic process [GO:0045542]; response to cholesterol [GO:0070723]; response to peptide hormone [GO:0043434]; response to testosterone [GO:0033574]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Testis, liver, kidney, brain and adrenal gland."
"628","sp|E7FE40|NEMP1_DANRE","lcl|NC_088857.1_cds_XP_011453378.3_26557",2.78e-45,165,"E7FE40","NEMP1_DANRE","Nuclear envelope integral membrane protein 1","nemp1","Danio rerio (Zebrafish) (Brachydanio rerio)",446,"GO:0001556; GO:0005635; GO:0005637; GO:0043131; GO:0043249","erythrocyte enucleation [GO:0043131]; erythrocyte maturation [GO:0043249]; oocyte maturation [GO:0001556]","nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; erythrocyte enucleation [GO:0043131]; erythrocyte maturation [GO:0043249]; oocyte maturation [GO:0001556]","","","",""
"629","sp|Q5XI63|KIFC1_RAT","lcl|NC_088857.1_cds_XP_011454198.3_23219",1.64e-131,405,"Q5XI63","KIFC1_RAT","Kinesin-like protein KIFC1 (Kinesin-related protein 1)","Kifc1 Krp1","Rattus norvegicus (Rat)",693,"GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005769; GO:0005815; GO:0005871; GO:0005874; GO:0007018; GO:0007080; GO:0007283; GO:0008017; GO:0008569; GO:0010826; GO:0016887; GO:0030139; GO:0031616; GO:0047496; GO:0051301; GO:0072382; GO:0072686; GO:0090307","cell division [GO:0051301]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly [GO:0090307]; negative regulation of centrosome duplication [GO:0010826]; spermatogenesis [GO:0007283]; vesicle transport along microtubule [GO:0047496]","cytoplasm [GO:0005737]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; spindle pole centrosome [GO:0031616]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly [GO:0090307]; negative regulation of centrosome duplication [GO:0010826]; spermatogenesis [GO:0007283]; vesicle transport along microtubule [GO:0047496]","","","",""
"630","sp|O16844|COS_DROME","lcl|NC_088857.1_cds_XP_011454205.3_23214",2.99e-34,144,"O16844","COS_DROME","Kinesin-like protein costa (Kinesin-like protein costal2)","cos cos2 costal-2 CG1708","Drosophila melanogaster (Fruit fly)",1201,"GO:0003774; GO:0003777; GO:0005119; GO:0005524; GO:0005737; GO:0005829; GO:0005871; GO:0005874; GO:0005875; GO:0005929; GO:0007018; GO:0007224; GO:0007476; GO:0008017; GO:0016887; GO:0019901; GO:0030707; GO:0031625; GO:0035301; GO:0035591; GO:0042073; GO:0042981; GO:0045879; GO:0061629; GO:0140313","follicle cell of egg chamber development [GO:0030707]; imaginal disc-derived wing morphogenesis [GO:0007476]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; negative regulation of smoothened signaling pathway [GO:0045879]; regulation of apoptotic process [GO:0042981]; smoothened signaling pathway [GO:0007224]","cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Hedgehog signaling complex [GO:0035301]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; molecular sequestering activity [GO:0140313]; protein kinase binding [GO:0019901]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling adaptor activity [GO:0035591]; smoothened binding [GO:0005119]; ubiquitin protein ligase binding [GO:0031625]; follicle cell of egg chamber development [GO:0030707]; imaginal disc-derived wing morphogenesis [GO:0007476]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; negative regulation of smoothened signaling pathway [GO:0045879]; regulation of apoptotic process [GO:0042981]; smoothened signaling pathway [GO:0007224]","DEVELOPMENTAL STAGE: Present at high levels during the first 4 hours of embryogenesis and at moderate levels between 4-12 hours. {ECO:0000269|PubMed:9244298}.","","",""
"631","sp|P41161|ETV5_HUMAN","lcl|NC_088857.1_cds_XP_011454760.3_25318",3.34e-69,233,"P41161","ETV5_HUMAN","ETS translocation variant 5 (Ets-related protein ERM)","ETV5 ERM","Homo sapiens (Human)",510,"GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005886; GO:0006357; GO:0007274; GO:0007626; GO:0030154; GO:0034599; GO:0045202; GO:0045666; GO:0045944; GO:0048133; GO:0050807; GO:0060252; GO:0060762; GO:0071340; GO:1990837","cell differentiation [GO:0030154]; cellular response to oxidative stress [GO:0034599]; locomotory behavior [GO:0007626]; male germ-line stem cell asymmetric division [GO:0048133]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of synapse organization [GO:0050807]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]","chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cell differentiation [GO:0030154]; cellular response to oxidative stress [GO:0034599]; locomotory behavior [GO:0007626]; male germ-line stem cell asymmetric division [GO:0048133]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of synapse organization [GO:0050807]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]","","","","TISSUE SPECIFICITY: Ubiquitous."
"632","sp|P29555|ABDA_DROME","lcl|NC_088857.1_cds_XP_011455564.1_22555",3.42e-31,123,"P29555","ABDA_DROME","Homeobox protein abdominal-A","abd-A CG10325","Drosophila melanogaster (Fruit fly)",590,"GO:0000122; GO:0000978; GO:0000981; GO:0000987; GO:0001742; GO:0003700; GO:0005634; GO:0005667; GO:0005704; GO:0006355; GO:0006915; GO:0007399; GO:0007400; GO:0007422; GO:0007438; GO:0007494; GO:0007501; GO:0007506; GO:0007507; GO:0008354; GO:0008406; GO:0009952; GO:0010002; GO:0014019; GO:0035053; GO:0035224; GO:0035225; GO:0042694; GO:0043565; GO:0045893; GO:0045944; GO:0048636; GO:0048738; GO:0048806; GO:0090575; GO:0140297","anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; cardiac muscle tissue development [GO:0048738]; cardioblast differentiation [GO:0010002]; determination of genital disc primordium [GO:0035225]; dorsal vessel heart proper cell fate commitment [GO:0035053]; genital disc anterior/posterior pattern formation [GO:0035224]; genitalia development [GO:0048806]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; gonadal mesoderm development [GO:0007506]; heart development [GO:0007507]; mesodermal cell fate specification [GO:0007501]; midgut development [GO:0007494]; muscle cell fate specification [GO:0042694]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; oenocyte development [GO:0007438]; oenocyte differentiation [GO:0001742]; peripheral nervous system development [GO:0007422]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of muscle organ development [GO:0048636]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]","nucleus [GO:0005634]; polytene chromosome band [GO:0005704]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; cardiac muscle tissue development [GO:0048738]; cardioblast differentiation [GO:0010002]; determination of genital disc primordium [GO:0035225]; dorsal vessel heart proper cell fate commitment [GO:0035053]; genital disc anterior/posterior pattern formation [GO:0035224]; genitalia development [GO:0048806]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; gonadal mesoderm development [GO:0007506]; heart development [GO:0007507]; mesodermal cell fate specification [GO:0007501]; midgut development [GO:0007494]; muscle cell fate specification [GO:0042694]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; oenocyte development [GO:0007438]; oenocyte differentiation [GO:0001742]; peripheral nervous system development [GO:0007422]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of muscle organ development [GO:0048636]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]","","","",""
"633","sp|Q84M92|ARP4_ARATH","lcl|NC_088857.1_cds_XP_011456529.1_24022",6.55e-117,349,"Q84M92","ARP4_ARATH","Actin-related protein 4","ARP4 At1g18450 F15H18.8","Arabidopsis thaliana (Mouse-ear cress)",441,"GO:0000812; GO:0005200; GO:0005634; GO:0005730; GO:0005737; GO:0006325; GO:0031011; GO:0048235; GO:0048574","chromatin organization [GO:0006325]; long-day photoperiodism, flowering [GO:0048574]; pollen sperm cell differentiation [GO:0048235]","cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nucleolus [GO:0005730]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; structural constituent of cytoskeleton [GO:0005200]; chromatin organization [GO:0006325]; long-day photoperiodism, flowering [GO:0048574]; pollen sperm cell differentiation [GO:0048235]","","INDUCTION: Before cytokinesis. {ECO:0000269|PubMed:12609034}.","INDUCTION: Before cytokinesis. {ECO:0000269|PubMed:12609034}.","TISSUE SPECIFICITY: Mostly expressed in flowers, and, to a lower extent, in roots, seedlings, leaves and siliques (at protein level). {ECO:0000269|PubMed:11891255, ECO:0000269|PubMed:12609034}."
"634","sp|Q96GX5|GWL_HUMAN","lcl|NC_088857.1_cds_XP_019920029.3_22184",9.02e-80,278,"Q96GX5","GWL_HUMAN","Serine/threonine-protein kinase greatwall (GW) (GWL) (hGWL) (EC 2.7.11.1) (Microtubule-associated serine/threonine-protein kinase-like) (MAST-L)","MASTL GW GWL THC2","Homo sapiens (Human)",879,"GO:0000086; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006974; GO:0007147; GO:0007346; GO:0016301; GO:0032154; GO:0035556; GO:0043231; GO:0044325; GO:0051301; GO:0051721; GO:0051726; GO:0106310","cell division [GO:0051301]; DNA damage response [GO:0006974]; female meiosis II [GO:0007147]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]","centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein phosphatase 2A binding [GO:0051721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transmembrane transporter binding [GO:0044325]; cell division [GO:0051301]; DNA damage response [GO:0006974]; female meiosis II [GO:0007147]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]","","","",""
"635","sp|O17901|COPZ_CAEEL","lcl|NC_088857.1_cds_XP_019920789.3_22571",4.26e-65,199,"O17901","COPZ_CAEEL","Probable coatomer subunit zeta (Zeta-coat protein) (Zeta-COP)","copz-1 F59E10.3","Caenorhabditis elegans",184,"GO:0000139; GO:0006886; GO:0006890; GO:0006891; GO:0009792; GO:0030126; GO:0048599","embryo development ending in birth or egg hatching [GO:0009792]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; oocyte development [GO:0048599]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; embryo development ending in birth or egg hatching [GO:0009792]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; oocyte development [GO:0048599]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","","","",""
"636","sp|F1N2W9|MCM9_BOVIN","lcl|NC_088857.1_cds_XP_019920811.3_26540",0,823,"F1N2W9","MCM9_BOVIN","DNA helicase MCM9 (EC 3.6.4.12) (Minichromosome maintenance 9)","MCM9","Bos taurus (Bovine)",1139,"GO:0000724; GO:0003697; GO:0004386; GO:0005524; GO:0005634; GO:0005694; GO:0006974; GO:0007276; GO:0007292; GO:0016887; GO:0042555; GO:0097362","DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; gamete generation [GO:0007276]","chromosome [GO:0005694]; MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; single-stranded DNA binding [GO:0003697]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; gamete generation [GO:0007276]","","","",""
"637","sp|P31258|HXA11_CHICK","lcl|NC_088857.1_cds_XP_019920815.1_22569",1.72e-18,83.2,"P31258","HXA11_CHICK","Homeobox protein Hox-A11 (Ghox-1I) (Homeobox protein Hox-1.9) (Chox-1.9)","HOXA11 GHOX1I","Gallus gallus (Chicken)",297,"GO:0000978; GO:0000981; GO:0001656; GO:0001658; GO:0001759; GO:0002063; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0007283; GO:0007338; GO:0007501; GO:0008584; GO:0009952; GO:0009953; GO:0009954; GO:0032993; GO:0035115; GO:0042733; GO:0045893; GO:0048589; GO:0060272; GO:0060351; GO:1902761","anterior/posterior pattern specification [GO:0009952]; branching involved in ureteric bud morphogenesis [GO:0001658]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; chondrocyte development [GO:0002063]; developmental growth [GO:0048589]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic skeletal joint morphogenesis [GO:0060272]; male gonad development [GO:0008584]; mesodermal cell fate specification [GO:0007501]; metanephros development [GO:0001656]; organ induction [GO:0001759]; positive regulation of chondrocyte development [GO:1902761]; positive regulation of DNA-templated transcription [GO:0045893]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]","nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anterior/posterior pattern specification [GO:0009952]; branching involved in ureteric bud morphogenesis [GO:0001658]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; chondrocyte development [GO:0002063]; developmental growth [GO:0048589]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic skeletal joint morphogenesis [GO:0060272]; male gonad development [GO:0008584]; mesodermal cell fate specification [GO:0007501]; metanephros development [GO:0001656]; organ induction [GO:0001759]; positive regulation of chondrocyte development [GO:1902761]; positive regulation of DNA-templated transcription [GO:0045893]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]","","","",""
"638","sp|P98066|TSG6_HUMAN","lcl|NC_088857.1_cds_XP_019922397.3_22296",5.87e-26,108,"P98066","TSG6_HUMAN","Tumor necrosis factor-inducible gene 6 protein (EC 3.1.1.-) (Hyaluronate-binding protein) (TNF-stimulated gene 6 protein) (TSG-6) (Tumor necrosis factor alpha-induced protein 6) (TNF alpha-induced protein 6)","TNFAIP6 TSG6","Homo sapiens (Human)",277,"GO:0001550; GO:0001968; GO:0005509; GO:0005540; GO:0005576; GO:0005615; GO:0006954; GO:0007155; GO:0007165; GO:0007267; GO:0030212; GO:0030335; GO:0030514; GO:0045668; GO:0045671; GO:0050728; GO:0090024; GO:0106435; GO:1903911; GO:1904724; GO:1904813; GO:1905590","cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; fibronectin fibril organization [GO:1905590]; hyaluronan metabolic process [GO:0030212]; inflammatory response [GO:0006954]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoclast differentiation [GO:0045671]; ovarian cumulus expansion [GO:0001550]; positive regulation of cell migration [GO:0030335]; positive regulation of receptor clustering [GO:1903911]; signal transduction [GO:0007165]","extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]; calcium ion binding [GO:0005509]; carboxylesterase activity [GO:0106435]; fibronectin binding [GO:0001968]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; fibronectin fibril organization [GO:1905590]; hyaluronan metabolic process [GO:0030212]; inflammatory response [GO:0006954]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoclast differentiation [GO:0045671]; ovarian cumulus expansion [GO:0001550]; positive regulation of cell migration [GO:0030335]; positive regulation of receptor clustering [GO:1903911]; signal transduction [GO:0007165]","","INDUCTION: Up-regulated in peripheral blood mononuclear cells, high endothelial venules, airway epithelium and submucosal gland in response to inflammatory cytokine TNF (PubMed:16873769, PubMed:1730767). Down-regulated upon differentiation of mesenchymal stem cells to osteoblasts (PubMed:16771708). {ECO:0000269|PubMed:16771708, ECO:0000269|PubMed:16873769, ECO:0000269|PubMed:1730767}.","INDUCTION: Up-regulated in peripheral blood mononuclear cells, high endothelial venules, airway epithelium and submucosal gland in response to inflammatory cytokine TNF (PubMed:16873769, PubMed:1730767). Down-regulated upon differentiation of mesenchymal stem cells to osteoblasts (PubMed:16771708). {ECO:0000269|PubMed:16771708, ECO:0000269|PubMed:16873769, ECO:0000269|PubMed:1730767}.","TISSUE SPECIFICITY: Expressed in airway epithelium and submucosal gland (at protein level). Colocalizes with bikunin at the ciliary border. Present in bronchoalveolar lavage fluid (at protein level) (PubMed:16873769). Expressed in mesenchymal stem cells (PubMed:16771708). Found in the synovial fluid of patients with rheumatoid arthritis. {ECO:0000269|PubMed:16771708, ECO:0000269|PubMed:16873769, ECO:0000269|PubMed:7516184}."
"639","sp|Q61624|ZN148_MOUSE","lcl|NC_088857.1_cds_XP_019928432.3_22774",4.15e-24,109,"Q61624","ZN148_MOUSE","Zinc finger protein 148 (Beta enolase repressor factor 1) (G-rich box-binding protein) (Transcription factor BFCOL1) (Transcription factor ZBP-89) (Zinc finger DNA-binding protein 89)","Znf148 Zbp89 Zfp148","Mus musculus (Mouse)",794,"GO:0000978; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0007276; GO:0008270; GO:0010629; GO:0045944","gamete generation [GO:0007276]; negative regulation of gene expression [GO:0010629]; positive regulation of transcription by RNA polymerase II [GO:0045944]","Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; gamete generation [GO:0007276]; negative regulation of gene expression [GO:0010629]; positive regulation of transcription by RNA polymerase II [GO:0045944]","DEVELOPMENTAL STAGE: Detected in embryos from 7 dpc to 17 dpc. Expression decreases in developing skeletal muscles. {ECO:0000269|PubMed:8943318, ECO:0000269|PubMed:9417107}.","","","TISSUE SPECIFICITY: Strong expression detected in brain, lung, liver and kidney, with lower levels detected in spleen, skeletal muscle, testis and heart. {ECO:0000269|PubMed:9417107}."
"640","sp|Q18171|SPE44_CAEEL","lcl|NC_088857.1_cds_XP_019930738.3_24209",3.46e-20,94,"Q18171","SPE44_CAEEL","Transcription regulator spe-44 (Spermatogenesis defective 44)","spe-44 C25G4.4","Caenorhabditis elegans",424,"GO:0001228; GO:0003677; GO:0005634; GO:0007283; GO:0030849; GO:0045944; GO:0046872","positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]","autosome [GO:0030849]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed in larval stage L3 male and hermaphrodite germlines, coinciding with sperm fate specification (at protein level) (PubMed:22570621). Expression persists throughout adulthood in males, but is absent in adult hermaphrodites that are undergoing oogenesis (at protein level) (PubMed:22570621). {ECO:0000269|PubMed:22570621}.","","",""
"641","sp|Q9V8K2|EXOC3_DROME","lcl|NC_088857.1_cds_XP_034300277.2_24212",1.97e-177,527,"Q9V8K2","EXOC3_DROME","Exocyst complex component 3 (Exocyst complex component Sec6)","Sec6 CG5341","Drosophila melanogaster (Fruit fly)",738,"GO:0000145; GO:0000149; GO:0005737; GO:0005915; GO:0006887; GO:0007009; GO:0007269; GO:0007298; GO:0016020; GO:0016028; GO:0016080; GO:0016081; GO:0016192; GO:0030707; GO:0032456; GO:0043001; GO:0045313; GO:0051601; GO:0072659; GO:0072697; GO:0098793","border follicle cell migration [GO:0007298]; endocytic recycling [GO:0032456]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; follicle cell of egg chamber development [GO:0030707]; Golgi to plasma membrane protein transport [GO:0043001]; neurotransmitter secretion [GO:0007269]; plasma membrane organization [GO:0007009]; protein localization to cell cortex [GO:0072697]; protein localization to plasma membrane [GO:0072659]; rhabdomere membrane biogenesis [GO:0045313]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; vesicle-mediated transport [GO:0016192]","cytoplasm [GO:0005737]; exocyst [GO:0000145]; membrane [GO:0016020]; presynapse [GO:0098793]; rhabdomere [GO:0016028]; zonula adherens [GO:0005915]; SNARE binding [GO:0000149]; border follicle cell migration [GO:0007298]; endocytic recycling [GO:0032456]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; follicle cell of egg chamber development [GO:0030707]; Golgi to plasma membrane protein transport [GO:0043001]; neurotransmitter secretion [GO:0007269]; plasma membrane organization [GO:0007009]; protein localization to cell cortex [GO:0072697]; protein localization to plasma membrane [GO:0072659]; rhabdomere membrane biogenesis [GO:0045313]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; vesicle-mediated transport [GO:0016192]","","","",""
"642","sp|Q9DG10|STAR_DANRE","lcl|NC_088857.1_cds_XP_034305144.2_26800",1.45e-37,139,"Q9DG10","STAR_DANRE","Steroidogenic acute regulatory protein, mitochondrial (StAR) (START domain-containing protein 1) (StARD1)","star","Danio rerio (Zebrafish) (Brachydanio rerio)",285,"GO:0001556; GO:0005739; GO:0006694; GO:0008203; GO:0015485; GO:0032367; GO:0050810; GO:0120020","cholesterol metabolic process [GO:0008203]; intracellular cholesterol transport [GO:0032367]; oocyte maturation [GO:0001556]; regulation of steroid biosynthetic process [GO:0050810]; steroid biosynthetic process [GO:0006694]","mitochondrion [GO:0005739]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; cholesterol metabolic process [GO:0008203]; intracellular cholesterol transport [GO:0032367]; oocyte maturation [GO:0001556]; regulation of steroid biosynthetic process [GO:0050810]; steroid biosynthetic process [GO:0006694]","","","","TISSUE SPECIFICITY: Highly expressed in the testis and at lower levels in the ovary, kidney and head."
"643","sp|Q8K337|I5P2_MOUSE","lcl|NC_088857.1_cds_XP_034308488.2_23262",1.33e-59,224,"Q8K337","I5P2_MOUSE","Type II inositol 1,4,5-trisphosphate 5-phosphatase (EC 3.1.3.36) (Inositol polyphosphate-5-phosphatase B) (Phosphoinositide 5-phosphatase) (5PTase)","Inpp5b","Mus musculus (Mouse)",993,"GO:0001701; GO:0004439; GO:0004445; GO:0005793; GO:0005829; GO:0007165; GO:0007283; GO:0016020; GO:0030317; GO:0030670; GO:0031901; GO:0046856; GO:0046872; GO:0052658; GO:0070613","flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]","cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Detected in kidney, liver, brain, lung and testis (at protein level). Detected in kidney and liver, and at lower levels in brain, lung and testis. {ECO:0000269|PubMed:9525932}."
"644","sp|A2AU37|RD21L_MOUSE","lcl|NC_088857.1_cds_XP_034309486.2_22409",5.93e-92,296,"A2AU37","RD21L_MOUSE","Double-strand-break repair protein rad21-like protein 1","Rad21l1 Gm14160 Rad21l","Mus musculus (Mouse)",552,"GO:0000724; GO:0000794; GO:0000800; GO:0005634; GO:0005694; GO:0006302; GO:0007062; GO:0007129; GO:0007130; GO:0007283; GO:0009566; GO:0030893; GO:0070197; GO:0072520","double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; fertilization [GO:0009566]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; seminiferous tubule development [GO:0072520]; sister chromatid cohesion [GO:0007062]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]","chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; lateral element [GO:0000800]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; fertilization [GO:0009566]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; seminiferous tubule development [GO:0072520]; sister chromatid cohesion [GO:0007062]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]","","","","TISSUE SPECIFICITY: Specifically expressed in male and female gonads (at protein level). {ECO:0000269|PubMed:21242291, ECO:0000269|PubMed:21274006, ECO:0000269|PubMed:21527826}."
"645","sp|Q6P5D8|SMHD1_MOUSE","lcl|NC_088857.1_cds_XP_034311276.2_25129",0,1781,"Q6P5D8","SMHD1_MOUSE","Structural maintenance of chromosomes flexible hinge domain-containing protein 1 (SMC hinge domain-containing protein 1) (EC 3.6.1.-)","Smchd1 Kiaa0650","Mus musculus (Mouse)",2007,"GO:0000781; GO:0001740; GO:0003677; GO:0005524; GO:0006302; GO:0016604; GO:0016887; GO:0035861; GO:0042803; GO:0043584; GO:0045739; GO:0051276; GO:0060818; GO:2000042; GO:2001034","chromosome organization [GO:0051276]; double-strand break repair [GO:0006302]; inactivation of paternal X chromosome by genomic imprinting [GO:0060818]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]","Barr body [GO:0001740]; chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803]; chromosome organization [GO:0051276]; double-strand break repair [GO:0006302]; inactivation of paternal X chromosome by genomic imprinting [GO:0060818]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]","DEVELOPMENTAL STAGE: Expressed in the nasal placodes and optic vesicles at day 9.5 dpc and in the nasal epithelium at 12.5 dpc (PubMed:28067911). Expressed in the nasal cavity in 14.5 dpc animals (PubMed:28067911). {ECO:0000269|PubMed:28067911}.","INDUCTION: Expression is repressed by CDX2. {ECO:0000269|PubMed:29900695}.","INDUCTION: Expression is repressed by CDX2. {ECO:0000269|PubMed:29900695}.","TISSUE SPECIFICITY: During embryogenesis, specifically expressed in immature olfactory sensory neurons. {ECO:0000269|PubMed:28067911}."
"646","sp|Q9CYD3|CRTAP_MOUSE","lcl|NC_088857.1_cds_XP_034311512.2_27289",9.55e-33,132,"Q9CYD3","CRTAP_MOUSE","Cartilage-associated protein","Crtap Casp","Mus musculus (Mouse)",400,"GO:0005615; GO:0005783; GO:0007283; GO:0032991; GO:0050821; GO:0061077; GO:1901874","chaperone-mediated protein folding [GO:0061077]; negative regulation of post-translational protein modification [GO:1901874]; protein stabilization [GO:0050821]; spermatogenesis [GO:0007283]","endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; chaperone-mediated protein folding [GO:0061077]; negative regulation of post-translational protein modification [GO:1901874]; protein stabilization [GO:0050821]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Found in articular chondrocytes. Expressed in a variety of tissues. {ECO:0000269|PubMed:17055431}."
"647","sp|Q8T0S6|HIPPO_DROME","lcl|NC_088857.1_cds_XP_034312173.1_25272",5.57e-171,498,"Q8T0S6","HIPPO_DROME","Serine/threonine-protein kinase hippo (EC 2.7.11.1) (Drosophila homolog of MST1 and MST2) (STE20-like kinase MST) (dMST)","hpo CG11228","Drosophila melanogaster (Fruit fly)",669,"GO:0001654; GO:0001745; GO:0002011; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0007298; GO:0007406; GO:0008285; GO:0010212; GO:0016020; GO:0016324; GO:0031648; GO:0035265; GO:0035329; GO:0035556; GO:0042127; GO:0042771; GO:0043065; GO:0043408; GO:0043524; GO:0045464; GO:0046666; GO:0051262; GO:0060253; GO:0070613; GO:0072089; GO:0090090; GO:0106037; GO:0106310; GO:1901526; GO:2000059; GO:2001233","border follicle cell migration [GO:0007298]; compound eye morphogenesis [GO:0001745]; eye development [GO:0001654]; hippo signaling [GO:0035329]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; organ growth [GO:0035265]; positive regulation of apoptotic process [GO:0043065]; positive regulation of mitophagy [GO:1901526]; protein destabilization [GO:0031648]; protein phosphorylation [GO:0006468]; protein tetramerization [GO:0051262]; R8 cell fate specification [GO:0045464]; regulation of apoptotic signaling pathway [GO:2001233]; regulation of cell population proliferation [GO:0042127]; regulation of MAPK cascade [GO:0043408]; regulation of protein processing [GO:0070613]; response to ionizing radiation [GO:0010212]; retinal cell programmed cell death [GO:0046666]; stem cell proliferation [GO:0072089]","apical plasma membrane [GO:0016324]; apicomedial cortex [GO:0106037]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; border follicle cell migration [GO:0007298]; compound eye morphogenesis [GO:0001745]; eye development [GO:0001654]; hippo signaling [GO:0035329]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; organ growth [GO:0035265]; positive regulation of apoptotic process [GO:0043065]; positive regulation of mitophagy [GO:1901526]; protein destabilization [GO:0031648]; protein phosphorylation [GO:0006468]; protein tetramerization [GO:0051262]; R8 cell fate specification [GO:0045464]; regulation of apoptotic signaling pathway [GO:2001233]; regulation of cell population proliferation [GO:0042127]; regulation of MAPK cascade [GO:0043408]; regulation of protein processing [GO:0070613]; response to ionizing radiation [GO:0010212]; retinal cell programmed cell death [GO:0046666]; stem cell proliferation [GO:0072089]","","INDUCTION: Transcriptionally regulated by Gcm (Glial cells missing). {ECO:0000269|PubMed:12091301}.","INDUCTION: Transcriptionally regulated by Gcm (Glial cells missing). {ECO:0000269|PubMed:12091301}.","TISSUE SPECIFICITY: Expressed in CNS during embryogenesis. In third instar larvae, it is expressed throughout all imaginal disks. {ECO:0000269|PubMed:11900973, ECO:0000269|PubMed:12941274}."
"648","sp|Q6NZG4|DDIAS_MOUSE","lcl|NC_088857.1_cds_XP_034312723.1_27393",2.5e-16,84.7,"Q6NZG4","DDIAS_MOUSE","DNA damage-induced apoptosis suppressor protein (Nitric oxide-inducible gene protein)","Ddias Noxin","Mus musculus (Mouse)",898,"GO:0005634; GO:0005737; GO:0006974; GO:0007286; GO:0030097; GO:0034644; GO:0044346; GO:0051726; GO:0071345; GO:0071447; GO:0071480; GO:1902230; GO:2000270","cellular response to cytokine stimulus [GO:0071345]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroperoxide [GO:0071447]; cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; fibroblast apoptotic process [GO:0044346]; hemopoiesis [GO:0030097]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; regulation of cell cycle [GO:0051726]; spermatid development [GO:0007286]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; cellular response to cytokine stimulus [GO:0071345]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroperoxide [GO:0071447]; cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; fibroblast apoptotic process [GO:0044346]; hemopoiesis [GO:0030097]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; regulation of cell cycle [GO:0051726]; spermatid development [GO:0007286]","","INDUCTION: Strongly induced by a wide range of stress signals: nitric-oxide, gamma- and UV irradiation, hydrogen peroxide, adriamycin and cytokines and this induction is dependent on p53/TP53. Expression is low in resting cells and increases almost 50-fold as the cells progress through the S phase. {ECO:0000269|PubMed:17515607}.","INDUCTION: Strongly induced by a wide range of stress signals: nitric-oxide, gamma- and UV irradiation, hydrogen peroxide, adriamycin and cytokines and this induction is dependent on p53/TP53. Expression is low in resting cells and increases almost 50-fold as the cells progress through the S phase. {ECO:0000269|PubMed:17515607}.","TISSUE SPECIFICITY: Highly expressed in the testis, spleen and heart. Expressed at high levels in the primary spermatocytes and to a lesser extent in the round spermatids. Also found in the bone marrow, brain, lung, kidney and liver. {ECO:0000269|PubMed:17515607}."
"649","sp|Q9CWF6|BBS2_MOUSE","lcl|NC_088857.1_cds_XP_034314917.2_24967",0,941,"Q9CWF6","BBS2_MOUSE","BBSome complex member BBS2 (Bardet-Biedl syndrome 2 protein homolog)","Bbs2","Mus musculus (Mouse)",721,"GO:0005737; GO:0005902; GO:0007288; GO:0007601; GO:0008104; GO:0010467; GO:0010629; GO:0014824; GO:0016020; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0031514; GO:0032420; GO:0033210; GO:0033365; GO:0034451; GO:0034464; GO:0036064; GO:0038108; GO:0040015; GO:0040018; GO:0042311; GO:0043001; GO:0043005; GO:0044321; GO:0045444; GO:0045494; GO:0048854; GO:0051216; GO:0060170; GO:0060271; GO:0060296; GO:0061629; GO:1905515","adult behavior [GO:0030534]; artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; response to leptin [GO:0044321]; sperm axoneme assembly [GO:0007288]; striatum development [GO:0021756]; vasodilation [GO:0042311]; visual perception [GO:0007601]","BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; stereocilium [GO:0032420]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; adult behavior [GO:0030534]; artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; response to leptin [GO:0044321]; sperm axoneme assembly [GO:0007288]; striatum development [GO:0021756]; vasodilation [GO:0042311]; visual perception [GO:0007601]","","","",""
"650","sp|G5ED39|SEP1_CAEEL","lcl|NC_088857.1_cds_XP_034315586.2_27910",3.34e-39,161,"G5ED39","SEP1_CAEEL","Separin homolog sep-1 (EC 3.4.22.49) (Separase)","sep-1 Y47G6A.12","Caenorhabditis elegans",1262,"GO:0000281; GO:0000794; GO:0004197; GO:0005634; GO:0005635; GO:0005694; GO:0005737; GO:0005813; GO:0005819; GO:0005938; GO:0008104; GO:0009949; GO:0016485; GO:0017157; GO:0030496; GO:0030703; GO:0030997; GO:0032154; GO:0034088; GO:0034090; GO:0040012; GO:0040038; GO:0048609; GO:0051306; GO:0051307; GO:0060471; GO:0060473; GO:0061062; GO:0070090; GO:0072686; GO:0072687; GO:1990520","cortical granule exocytosis [GO:0060471]; eggshell formation [GO:0030703]; maintenance of meiotic sister chromatid cohesion [GO:0034090]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; meiotic chromosome separation [GO:0051307]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid separation [GO:0051306]; multicellular organismal reproductive process [GO:0048609]; polar body extrusion after meiotic divisions [GO:0040038]; polarity specification of anterior/posterior axis [GO:0009949]; protein localization [GO:0008104]; protein processing [GO:0016485]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of exocytosis [GO:0017157]; regulation of locomotion [GO:0040012]; regulation of nematode larval development [GO:0061062]","cell cortex [GO:0005938]; centrosome [GO:0005813]; chromosome [GO:0005694]; cleavage furrow [GO:0032154]; condensed nuclear chromosome [GO:0000794]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; metaphase plate [GO:0070090]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; separase-securin complex [GO:1990520]; spindle [GO:0005819]; cysteine-type endopeptidase activity [GO:0004197]; cortical granule exocytosis [GO:0060471]; eggshell formation [GO:0030703]; maintenance of meiotic sister chromatid cohesion [GO:0034090]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; meiotic chromosome separation [GO:0051307]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid separation [GO:0051306]; multicellular organismal reproductive process [GO:0048609]; polar body extrusion after meiotic divisions [GO:0040038]; polarity specification of anterior/posterior axis [GO:0009949]; protein localization [GO:0008104]; protein processing [GO:0016485]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of exocytosis [GO:0017157]; regulation of locomotion [GO:0040012]; regulation of nematode larval development [GO:0061062]","DEVELOPMENTAL STAGE: Expressed in embryos (at protein level). {ECO:0000269|PubMed:17913784, ECO:0000269|PubMed:20116245}.","","","TISSUE SPECIFICITY: Expressed in oocytes (PubMed:17913784). Expressed in male germline (PubMed:23401519). Expressed in spermatocytes but undetectable in spermatids (at protein level) (PubMed:23401519). {ECO:0000269|PubMed:17913784, ECO:0000269|PubMed:23401519}."
"651","sp|Q9VM95|AATF_DROME","lcl|NC_088857.1_cds_XP_034315852.2_27950",1.19e-38,149,"Q9VM95","AATF_DROME","Protein Aatf (Apoptosis antagonizing transcription factor ortholog)","Aatf CG11188","Drosophila melanogaster (Fruit fly)",488,"GO:0005634; GO:0005730; GO:0043069; GO:0048477","negative regulation of programmed cell death [GO:0043069]; oogenesis [GO:0048477]","nucleolus [GO:0005730]; nucleus [GO:0005634]; negative regulation of programmed cell death [GO:0043069]; oogenesis [GO:0048477]","","","",""
"652","sp|P20482|CNC_DROME","lcl|NC_088857.1_cds_XP_034317439.1_28117",6.21e-38,154,"P20482","CNC_DROME","Segmentation protein cap'n'collar","cnc CG43286","Drosophila melanogaster (Fruit fly)",1383,"GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005703; GO:0006357; GO:0006979; GO:0007310; GO:0007317; GO:0007350; GO:0008103; GO:0008340; GO:0008359; GO:0034976; GO:0036335; GO:0045944; GO:0046982; GO:0048813; GO:0051663; GO:0060322; GO:0160095; GO:2000378","blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; head development [GO:0060322]; insect pharynx development [GO:0160095]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bicoid mRNA localization [GO:0008359]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]","nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; head development [GO:0060322]; insect pharynx development [GO:0160095]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bicoid mRNA localization [GO:0008359]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]","DEVELOPMENTAL STAGE: Isoforms A and C are maternally and zygotically expressed in embryos. Isoform A reduced between 2-12 hours embryos and then increases. Isoform B is expressed in later embryonic stages. Isoform C has the lowest expression level of the isoforms. {ECO:0000269|PubMed:9778513}.","","","TISSUE SPECIFICITY: Embryonic expression of isoform B is localized to the mandibular segment and the hypopharyngeal and labral primordia first detectable in late blastoderm stages. Embryonic expression of isoforms B and C is ubiquitous. {ECO:0000269|PubMed:1911393, ECO:0000269|PubMed:9778513}."
"653","sp|Q0VCZ3|YTHD2_BOVIN","lcl|NC_088857.1_cds_XP_034317507.1_24284",1.22e-97,308,"Q0VCZ3","YTHD2_BOVIN","YTH domain-containing family protein 2","YTHDF2","Bos taurus (Bovine)",580,"GO:0000932; GO:0001556; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006402; GO:0007276; GO:0007284; GO:0010494; GO:0030155; GO:0034063; GO:0034451; GO:0043488; GO:0045087; GO:0045746; GO:0048598; GO:0050767; GO:0060339; GO:0061157; GO:0062153; GO:0070925; GO:0071425; GO:0098508; GO:1902036; GO:1903538; GO:1903679; GO:1990247; GO:2000232; GO:2000737","embryonic morphogenesis [GO:0048598]; endothelial to hematopoietic transition [GO:0098508]; gamete generation [GO:0007276]; hematopoietic stem cell proliferation [GO:0071425]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oocyte maturation [GO:0001556]; organelle assembly [GO:0070925]; positive regulation of cap-independent translational initiation [GO:1903679]; regulation of cell adhesion [GO:0030155]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of mRNA stability [GO:0043488]; regulation of neurogenesis [GO:0050767]; regulation of rRNA processing [GO:2000232]; spermatogonial cell division [GO:0007284]; stress granule assembly [GO:0034063]","centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; C5-methylcytidine-containing RNA reader activity [GO:0062153]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; embryonic morphogenesis [GO:0048598]; endothelial to hematopoietic transition [GO:0098508]; gamete generation [GO:0007276]; hematopoietic stem cell proliferation [GO:0071425]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oocyte maturation [GO:0001556]; organelle assembly [GO:0070925]; positive regulation of cap-independent translational initiation [GO:1903679]; regulation of cell adhesion [GO:0030155]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of mRNA stability [GO:0043488]; regulation of neurogenesis [GO:0050767]; regulation of rRNA processing [GO:2000232]; spermatogonial cell division [GO:0007284]; stress granule assembly [GO:0034063]","","","",""
"654","sp|P11147|HSP7D_DROME","lcl|NC_088857.1_cds_XP_034317555.1_27845",0,1023,"P11147","HSP7D_DROME","Heat shock 70 kDa protein cognate 4 (Heat shock 70 kDa protein 88E)","Hsc70-4 Hsc4 CG4264","Drosophila melanogaster (Fruit fly)",651,"GO:0000398; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007269; GO:0007399; GO:0007411; GO:0007413; GO:0016192; GO:0016887; GO:0030707; GO:0031072; GO:0035194; GO:0035967; GO:0042026; GO:0044183; GO:0048471; GO:0051085; GO:0051087; GO:0061077; GO:0061738; GO:0070922; GO:0071011; GO:0071013; GO:0097753; GO:0098793; GO:0140662","axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cellular response to topologically incorrect protein [GO:0035967]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein folding [GO:0061077]; follicle cell of egg chamber development [GO:0030707]; late endosomal microautophagy [GO:0061738]; membrane bending [GO:0097753]; mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]; neurotransmitter secretion [GO:0007269]; protein refolding [GO:0042026]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; RISC complex assembly [GO:0070922]; vesicle-mediated transport [GO:0016192]","catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; precatalytic spliceosome [GO:0071011]; presynapse [GO:0098793]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; protein folding chaperone [GO:0044183]; protein-folding chaperone binding [GO:0051087]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cellular response to topologically incorrect protein [GO:0035967]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein folding [GO:0061077]; follicle cell of egg chamber development [GO:0030707]; late endosomal microautophagy [GO:0061738]; membrane bending [GO:0097753]; mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]; neurotransmitter secretion [GO:0007269]; protein refolding [GO:0042026]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; RISC complex assembly [GO:0070922]; vesicle-mediated transport [GO:0016192]","DEVELOPMENTAL STAGE: Heat shock cognate proteins are expressed constitutively during normal development.","","",""
"655","sp|Q9H2F5|EPC1_HUMAN","lcl|NC_088857.1_cds_XP_034319811.2_23448",9.07e-160,485,"Q9H2F5","EPC1_HUMAN","Enhancer of polycomb homolog 1","EPC1","Homo sapiens (Human)",836,"GO:0000122; GO:0000724; GO:0000786; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006351; GO:0006357; GO:0007286; GO:0016604; GO:0031965; GO:0032777; GO:0035092; GO:0035267; GO:0035861; GO:0042981; GO:0045814; GO:0045892; GO:0045893; GO:0045944; GO:0051726; GO:0140463; GO:0140767; GO:1905168; GO:2000779","DNA-templated transcription [GO:0006351]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of transcription by RNA polymerase II [GO:0006357]; sperm DNA condensation [GO:0035092]; spermatid development [GO:0007286]","cytoplasm [GO:0005737]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; piccolo histone acetyltransferase complex [GO:0032777]; site of double-strand break [GO:0035861]; chromatin-protein adaptor activity [GO:0140463]; enzyme-substrate adaptor activity [GO:0140767]; DNA-templated transcription [GO:0006351]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of transcription by RNA polymerase II [GO:0006357]; sperm DNA condensation [GO:0035092]; spermatid development [GO:0007286]","","","",""
"656","sp|Q8K135|K319L_MOUSE","lcl|NC_088857.1_cds_XP_034322799.2_26173",1.24e-175,543,"Q8K135","K319L_MOUSE","Dyslexia-associated protein KIAA0319-like protein (Adeno-associated virus receptor) (AAVR)","Kiaa0319l Aavr","Mus musculus (Mouse)",1048,"GO:0000139; GO:0001675; GO:0001764; GO:0005730; GO:0005802; GO:0005886; GO:0007283; GO:0010996; GO:0019065; GO:0030317; GO:0031410; GO:0120211","acrosome assembly [GO:0001675]; flagellated sperm motility [GO:0030317]; neuron migration [GO:0001764]; proacrosomal vesicle fusion [GO:0120211]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; response to auditory stimulus [GO:0010996]; spermatogenesis [GO:0007283]","cytoplasmic vesicle [GO:0031410]; Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; acrosome assembly [GO:0001675]; flagellated sperm motility [GO:0030317]; neuron migration [GO:0001764]; proacrosomal vesicle fusion [GO:0120211]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; response to auditory stimulus [GO:0010996]; spermatogenesis [GO:0007283]","","","",""
"657","sp|O95793|STAU1_HUMAN","lcl|NC_088857.1_cds_XP_034323124.2_26201",4.19e-26,114,"O95793","STAU1_HUMAN","Double-stranded RNA-binding protein Staufen homolog 1","STAU1 STAU","Homo sapiens (Human)",577,"GO:0000512; GO:0003723; GO:0003725; GO:0003729; GO:0005737; GO:0005783; GO:0005791; GO:0005829; GO:0005875; GO:0005886; GO:0007281; GO:0008157; GO:0008298; GO:0010494; GO:0016020; GO:0030425; GO:0032839; GO:0034599; GO:0035418; GO:0036464; GO:0043005; GO:0043025; GO:0044297; GO:0045070; GO:0046726; GO:0070062; GO:0098964; GO:0098978; GO:0099010; GO:1900273","anterograde dendritic transport of messenger ribonucleoprotein complex [GO:0098964]; cellular response to oxidative stress [GO:0034599]; germ cell development [GO:0007281]; intracellular mRNA localization [GO:0008298]; lncRNA-mediated post-transcriptional gene silencing [GO:0000512]; modification of postsynaptic structure [GO:0099010]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of viral genome replication [GO:0045070]; protein localization to synapse [GO:0035418]","cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; protein phosphatase 1 binding [GO:0008157]; RNA binding [GO:0003723]; anterograde dendritic transport of messenger ribonucleoprotein complex [GO:0098964]; cellular response to oxidative stress [GO:0034599]; germ cell development [GO:0007281]; intracellular mRNA localization [GO:0008298]; lncRNA-mediated post-transcriptional gene silencing [GO:0000512]; modification of postsynaptic structure [GO:0099010]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of viral genome replication [GO:0045070]; protein localization to synapse [GO:0035418]","","","","TISSUE SPECIFICITY: Widely expressed. Expressed in brain, pancreas, heart, skeletal muscles, liver, lung, kidney and placenta."
"658","sp|Q3L1C9|STAUH_APLCA","lcl|NC_088857.1_cds_XP_034323127.2_26202",5.05e-172,520,"Q3L1C9","STAUH_APLCA","Double-stranded RNA-binding protein Staufen homolog","","Aplysia californica (California sea hare)",950,"GO:0003725; GO:0003729; GO:0005886; GO:0007281; GO:0008298; GO:0010494; GO:0032839; GO:0032880; GO:0035418; GO:0043005; GO:0043025; GO:0043204; GO:0098964","anterograde dendritic transport of messenger ribonucleoprotein complex [GO:0098964]; germ cell development [GO:0007281]; intracellular mRNA localization [GO:0008298]; protein localization to synapse [GO:0035418]; regulation of protein localization [GO:0032880]","cytoplasmic stress granule [GO:0010494]; dendrite cytoplasm [GO:0032839]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; anterograde dendritic transport of messenger ribonucleoprotein complex [GO:0098964]; germ cell development [GO:0007281]; intracellular mRNA localization [GO:0008298]; protein localization to synapse [GO:0035418]; regulation of protein localization [GO:0032880]","","","","TISSUE SPECIFICITY: Strongly expressed in nervous tissue (at protein level). {ECO:0000269|PubMed:16687512}."
"659","sp|Q9JMB1|SPMA2_MOUSE","lcl|NC_088857.1_cds_XP_034323213.2_25352",9.57e-14,72.4,"Q9JMB1","SPMA2_MOUSE","Sperm microtubule associated protein 2 (Testicular haploid expressed gene protein)","Spmap2 Theg","Mus musculus (Mouse)",375,"GO:0005634; GO:0005737; GO:0007283; GO:0030154","cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expression in testis detected after stage P20, when haploid germ cells appeared in testis. {ECO:0000269|PubMed:12748127}.","","","TISSUE SPECIFICITY: Testis specific (at protein level). Specifically expressed in spermatids; Sertoli cells maintain the level of expression in spermatids. If isolated spermatids are cultivated for 16 hours alone, the expression of THEG is down-regulated. May require signals from Sertoli cells to initiate changes in its gene expression through spermatogenesis. {ECO:0000269|PubMed:10330110, ECO:0000269|PubMed:10747865, ECO:0000269|PubMed:11173852, ECO:0000269|PubMed:12748127}."
"660","sp|Q9VC35|LILI_DROME","lcl|NC_088857.1_cds_XP_034323337.2_25371",1.57e-119,362,"Q9VC35","LILI_DROME","Protein Lilipod","lili CG5807","Drosophila melanogaster (Fruit fly)",527,"GO:0004888; GO:0005886; GO:0007165; GO:0030513; GO:0036099; GO:0048477","female germ-line stem cell population maintenance [GO:0036099]; oogenesis [GO:0048477]; positive regulation of BMP signaling pathway [GO:0030513]; signal transduction [GO:0007165]","plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; female germ-line stem cell population maintenance [GO:0036099]; oogenesis [GO:0048477]; positive regulation of BMP signaling pathway [GO:0030513]; signal transduction [GO:0007165]","","","","TISSUE SPECIFICITY: In the ovary, detected in germline stem cells and their progeny. Also detected in the somatic follicular epithelium. {ECO:0000269|PubMed:26512105}."
"661","sp|Q9W1F4|THOC5_DROME","lcl|NC_088857.1_cds_XP_034323348.2_25373",3.34e-52,192,"Q9W1F4","THOC5_DROME","THO complex subunit 5","thoc5 CG2980","Drosophila melanogaster (Fruit fly)",616,"GO:0000346; GO:0000347; GO:0000445; GO:0003729; GO:0005634; GO:0005737; GO:0006406; GO:0007140; GO:0031965; GO:0031990; GO:0032991; GO:0043021","male meiotic nuclear division [GO:0007140]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]","cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; mRNA binding [GO:0003729]; ribonucleoprotein complex binding [GO:0043021]; male meiotic nuclear division [GO:0007140]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]","","","","TISSUE SPECIFICITY: Expressed in ovaries (at protein level). {ECO:0000269|PubMed:28472469}."
"662","sp|P07909|ROA1_DROME","lcl|NC_088857.1_cds_XP_034324643.1_25556",1.95e-66,213,"P07909","ROA1_DROME","Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (PEN repeat clone P9) (hnRNP core protein A1-A)","Hrb98DE Pen9 CG9983","Drosophila melanogaster (Fruit fly)",365,"GO:0000381; GO:0001745; GO:0003729; GO:0003730; GO:0005634; GO:0005703; GO:0033119; GO:0034046; GO:0036099; GO:0043565; GO:0045727; GO:0048026; GO:0048027; GO:0048477; GO:1990904","compound eye morphogenesis [GO:0001745]; female germ-line stem cell population maintenance [GO:0036099]; negative regulation of RNA splicing [GO:0033119]; oogenesis [GO:0048477]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]","nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; sequence-specific DNA binding [GO:0043565]; compound eye morphogenesis [GO:0001745]; female germ-line stem cell population maintenance [GO:0036099]; negative regulation of RNA splicing [GO:0033119]; oogenesis [GO:0048477]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. Highest zygotic expression found in adult females and pupae. {ECO:0000269|PubMed:2104660}.","","",""
"663","sp|Q5XI65|DRC1_RAT","lcl|NC_088857.1_cds_XP_034327072.2_23595",1.96e-175,521,"Q5XI65","DRC1_RAT","Dynein regulatory complex protein 1 (Coiled-coil domain-containing protein 164)","Drc1 Ccdc164","Rattus norvegicus (Rat)",754,"GO:0003352; GO:0005576; GO:0005829; GO:0005858; GO:0005929; GO:0005930; GO:0007338; GO:0007368; GO:0007507; GO:0035082; GO:0036126; GO:0044782; GO:0060285; GO:0065003; GO:0070286; GO:0120197; GO:0120316","axonemal dynein complex assembly [GO:0070286]; axoneme assembly [GO:0035082]; cilium organization [GO:0044782]; cilium-dependent cell motility [GO:0060285]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; mucociliary clearance [GO:0120197]; protein-containing complex assembly [GO:0065003]; regulation of cilium movement [GO:0003352]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316]","axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; sperm flagellum [GO:0036126]; axonemal dynein complex assembly [GO:0070286]; axoneme assembly [GO:0035082]; cilium organization [GO:0044782]; cilium-dependent cell motility [GO:0060285]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; mucociliary clearance [GO:0120197]; protein-containing complex assembly [GO:0065003]; regulation of cilium movement [GO:0003352]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316]","","","",""
"664","sp|O88529|BMAL1_MESAU","lcl|NC_088857.1_cds_XP_034328887.2_23196",0,555,"O88529","BMAL1_MESAU","Basic helix-loop-helix ARNT-like protein 1 (Aryl hydrocarbon receptor nuclear translocator-like protein 1) (Brain and muscle ARNT-like 1)","BMAL1 ARNTL","Mesocricetus auratus (Golden hamster)",626,"GO:0000976; GO:0000978; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0006355; GO:0007283; GO:0016605; GO:0017162; GO:0032007; GO:0032922; GO:0033391; GO:0042634; GO:0042753; GO:0043161; GO:0043565; GO:0045599; GO:0045892; GO:0045893; GO:0045944; GO:0046983; GO:0050767; GO:0050796; GO:0051726; GO:0051775; GO:0051879; GO:0070888; GO:0090263; GO:0090403; GO:1901985; GO:1990513; GO:2000074; GO:2000323; GO:2000772; GO:2001016","circadian regulation of gene expression [GO:0032922]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of nuclear receptor-mediated glucocorticoid signaling pathway [GO:2000323]; negative regulation of TOR signaling [GO:0032007]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein acetylation [GO:1901985]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; regulation of DNA-templated transcription [GO:0006355]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283]","chromatoid body [GO:0033391]; CLOCK-BMAL transcription complex [GO:1990513]; nucleus [GO:0005634]; PML body [GO:0016605]; transcription regulator complex [GO:0005667]; aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; circadian regulation of gene expression [GO:0032922]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of nuclear receptor-mediated glucocorticoid signaling pathway [GO:2000323]; negative regulation of TOR signaling [GO:0032007]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein acetylation [GO:1901985]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; regulation of DNA-templated transcription [GO:0006355]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283]","","","",""
"665","sp|P51960|MYBA_MOUSE","lcl|NC_088857.1_cds_XP_034331005.2_26011",3.03e-73,253,"P51960","MYBA_MOUSE","Myb-related protein A (A-Myb) (Myb-like protein 1)","Mybl1 Amyb","Mus musculus (Mouse)",751,"GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0007141; GO:0007283; GO:0030154; GO:0045944; GO:0140543; GO:1990841","cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; positive regulation of piRNA transcription [GO:0140543]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]","nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; positive regulation of piRNA transcription [GO:0140543]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: During embryogenesis it is predominantly expressed in several regions of the developing central nervous system and the urogenital ridge. Expression in the CNS is confined to the neural tube, the hindbrain, the neural retina and the olfactory epithelium, and coincides with the presence of proliferating immature neuronal precursor cells. In the adult mouse, A-Myb is expressed at high levels in type A spermatogonia (stem cells), and preleptotene and pachytene spermatocytes, with concomitant down-regulation of expression upon terminal differentiation of these cells into mature spermatozoa, and in B lymphocytes located in germinal centers of the spleen (PubMed:7813437, PubMed:8084617). Present in mid-late pachytene and diplotene spermatocytes, but not in late zygotene/early pachytene cells (at protein level) (PubMed:21750041). {ECO:0000269|PubMed:21750041, ECO:0000269|PubMed:7813437, ECO:0000269|PubMed:8084617}.","","","TISSUE SPECIFICITY: Predominantly in the testis. Very low levels in the ovaries, spleen and brain. {ECO:0000269|PubMed:7813437, ECO:0000269|PubMed:8084617}."
"666","sp|Q9VUW9|HIP14_DROME","lcl|NC_088857.1_cds_XP_034331262.1_26041",1.21e-171,504,"Q9VUW9","HIP14_DROME","Palmitoyltransferase Hip14 (EC 2.3.1.225) (Huntingtin-interacting protein 14 homolog)","Hip14 CG6017","Drosophila melanogaster (Fruit fly)",637,"GO:0000139; GO:0005794; GO:0007268; GO:0007283; GO:0008021; GO:0016079; GO:0019706; GO:0042734; GO:0042995; GO:0045202; GO:0050714","chemical synaptic transmission [GO:0007268]; positive regulation of protein secretion [GO:0050714]; spermatogenesis [GO:0007283]; synaptic vesicle exocytosis [GO:0016079]","cell projection [GO:0042995]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; chemical synaptic transmission [GO:0007268]; positive regulation of protein secretion [GO:0050714]; spermatogenesis [GO:0007283]; synaptic vesicle exocytosis [GO:0016079]","","","","TISSUE SPECIFICITY: In stage 13-15 embryos, expressed in the central nervous system. At the third instar larval stage, expressed in the ventral nerve cord and is enriched in the neuropil. {ECO:0000269|PubMed:18158335}."
"667","sp|P46152|GATA4_RAT","lcl|NC_088857.1_cds_XP_034333090.1_24591",1.5e-74,242,"P46152","GATA4_RAT","Transcription factor GATA-4 (DNA-binding protein GATA-GT2) (GATA-binding factor 4)","Gata4","Rattus norvegicus (Rat)",440,"GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001216; GO:0001223; GO:0001228; GO:0001701; GO:0001702; GO:0001706; GO:0001947; GO:0003007; GO:0003180; GO:0003181; GO:0003190; GO:0003197; GO:0003215; GO:0003229; GO:0003279; GO:0003281; GO:0003289; GO:0003290; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007267; GO:0007283; GO:0007507; GO:0008270; GO:0008584; GO:0009410; GO:0009612; GO:0010468; GO:0010507; GO:0010575; GO:0010628; GO:0010629; GO:0010667; GO:0014898; GO:0016604; GO:0019901; GO:0023019; GO:0030513; GO:0032526; GO:0033189; GO:0035050; GO:0035054; GO:0035239; GO:0036302; GO:0042060; GO:0043066; GO:0043565; GO:0043627; GO:0045165; GO:0045766; GO:0045787; GO:0045893; GO:0045944; GO:0048557; GO:0048598; GO:0048617; GO:0048738; GO:0051525; GO:0055007; GO:0060008; GO:0060038; GO:0060043; GO:0060045; GO:0060290; GO:0060413; GO:0060464; GO:0060575; GO:0061026; GO:0061049; GO:0061629; GO:0070410; GO:0071333; GO:0071371; GO:0071372; GO:0072148; GO:0072520; GO:0086004; GO:0090575; GO:0140297; GO:1902176; GO:1902895; GO:1905204; GO:1990837; GO:2001234","aortic valve morphogenesis [GO:0003180]; atrial septum morphogenesis [GO:0060413]; atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; atrioventricular valve morphogenesis [GO:0003181]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue regeneration [GO:0061026]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum development [GO:0003279]; cell fate commitment [GO:0045165]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell-cell signaling [GO:0007267]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to gonadotropin stimulus [GO:0071371]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic foregut morphogenesis [GO:0048617]; embryonic heart tube anterior/posterior pattern specification [GO:0035054]; embryonic heart tube development [GO:0035050]; embryonic morphogenesis [GO:0048598]; endocardial cushion development [GO:0003197]; endoderm formation [GO:0001706]; epithelial cell fate commitment [GO:0072148]; gastrulation with mouth forming second [GO:0001702]; heart development [GO:0007507]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; intestinal epithelial cell differentiation [GO:0060575]; lung lobe formation [GO:0060464]; male gonad development [GO:0008584]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of autophagy [GO:0010507]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of connective tissue replacement [GO:1905204]; negative regulation of gene expression [GO:0010629]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]; response to mechanical stimulus [GO:0009612]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; seminiferous tubule development [GO:0072520]; Sertoli cell differentiation [GO:0060008]; signal transduction involved in regulation of gene expression [GO:0023019]; spermatogenesis [GO:0007283]; transdifferentiation [GO:0060290]; tube morphogenesis [GO:0035239]; ventricular cardiac muscle tissue development [GO:0003229]; ventricular septum development [GO:0003281]; wound healing [GO:0042060]","chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; NFAT protein binding [GO:0051525]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]; aortic valve morphogenesis [GO:0003180]; atrial septum morphogenesis [GO:0060413]; atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; atrioventricular valve morphogenesis [GO:0003181]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue regeneration [GO:0061026]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum development [GO:0003279]; cell fate commitment [GO:0045165]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell-cell signaling [GO:0007267]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to gonadotropin stimulus [GO:0071371]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic foregut morphogenesis [GO:0048617]; embryonic heart tube anterior/posterior pattern specification [GO:0035054]; embryonic heart tube development [GO:0035050]; embryonic morphogenesis [GO:0048598]; endocardial cushion development [GO:0003197]; endoderm formation [GO:0001706]; epithelial cell fate commitment [GO:0072148]; gastrulation with mouth forming second [GO:0001702]; heart development [GO:0007507]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; intestinal epithelial cell differentiation [GO:0060575]; lung lobe formation [GO:0060464]; male gonad development [GO:0008584]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of autophagy [GO:0010507]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of connective tissue replacement [GO:1905204]; negative regulation of gene expression [GO:0010629]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]; response to mechanical stimulus [GO:0009612]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; seminiferous tubule development [GO:0072520]; Sertoli cell differentiation [GO:0060008]; signal transduction involved in regulation of gene expression [GO:0023019]; spermatogenesis [GO:0007283]; transdifferentiation [GO:0060290]; tube morphogenesis [GO:0035239]; ventricular cardiac muscle tissue development [GO:0003229]; ventricular septum development [GO:0003281]; wound healing [GO:0042060]","","","","TISSUE SPECIFICITY: Expressed predominantly in gastric mucosa and at much lower levels in the intestine. Also expressed in testis."
"668","sp|O09139|E2F1_RAT","lcl|NC_088857.1_cds_XP_034333901.1_24710",2.77e-52,181,"O09139","E2F1_RAT","Transcription factor E2F1 (E2F-1)","E2f1","Rattus norvegicus (Rat)",432,"GO:0000077; GO:0000082; GO:0000122; GO:0000228; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001216; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0006351; GO:0006355; GO:0006357; GO:0007283; GO:0008630; GO:0010628; GO:0019901; GO:0030900; GO:0032496; GO:0032991; GO:0035189; GO:0043065; GO:0043276; GO:0043392; GO:0043565; GO:0045599; GO:0045892; GO:0045893; GO:0045944; GO:0046983; GO:0048146; GO:0048255; GO:0051726; GO:0060090; GO:0060252; GO:0070345; GO:0071398; GO:0071456; GO:0071466; GO:0072332; GO:0090575; GO:0140297; GO:1990086; GO:1990090; GO:1990837; GO:2000045","anoikis [GO:0043276]; cellular response to fatty acid [GO:0071398]; cellular response to hypoxia [GO:0071456]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to xenobiotic stimulus [GO:0071466]; DNA damage checkpoint signaling [GO:0000077]; DNA-templated transcription [GO:0006351]; forebrain development [GO:0030900]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lens fiber cell apoptotic process [GO:1990086]; mRNA stabilization [GO:0048255]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of DNA-templated transcription [GO:0006355]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; spermatogenesis [GO:0007283]","centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Rb-E2F complex [GO:0035189]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; molecular adaptor activity [GO:0060090]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; anoikis [GO:0043276]; cellular response to fatty acid [GO:0071398]; cellular response to hypoxia [GO:0071456]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to xenobiotic stimulus [GO:0071466]; DNA damage checkpoint signaling [GO:0000077]; DNA-templated transcription [GO:0006351]; forebrain development [GO:0030900]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lens fiber cell apoptotic process [GO:1990086]; mRNA stabilization [GO:0048255]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of DNA-templated transcription [GO:0006355]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; spermatogenesis [GO:0007283]","","","",""
"669","sp|Q7TSG3|FBX5_MOUSE","lcl|NC_088857.1_cds_XP_034336233.2_27754",9.88e-21,94.7,"Q7TSG3","FBX5_MOUSE","F-box only protein 5 (Early mitotic inhibitor 1)","Fbxo5 Emi1","Mus musculus (Mouse)",421,"GO:0001556; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0006275; GO:0006974; GO:0007057; GO:0007346; GO:0008270; GO:0008284; GO:0010971; GO:0010997; GO:0016050; GO:0016567; GO:0019901; GO:0032876; GO:0040020; GO:0045669; GO:0045835; GO:0045841; GO:0046785; GO:0051225; GO:0051301; GO:0051444; GO:0060903; GO:0070169; GO:0072687; GO:1904667; GO:1905322; GO:1990948; GO:2000773","cell division [GO:0051301]; DNA damage response [GO:0006974]; microtubule polymerization [GO:0046785]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; oocyte maturation [GO:0001556]; positive regulation of biomineral tissue development [GO:0070169]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of meiosis I [GO:0060903]; positive regulation of mesenchymal stem cell migration [GO:1905322]; positive regulation of osteoblast differentiation [GO:0045669]; protein ubiquitination [GO:0016567]; regulation of DNA replication [GO:0006275]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225]; spindle assembly involved in female meiosis I [GO:0007057]; vesicle organization [GO:0016050]","cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; anaphase-promoting complex binding [GO:0010997]; protein kinase binding [GO:0019901]; ubiquitin ligase inhibitor activity [GO:1990948]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; DNA damage response [GO:0006974]; microtubule polymerization [GO:0046785]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; oocyte maturation [GO:0001556]; positive regulation of biomineral tissue development [GO:0070169]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of meiosis I [GO:0060903]; positive regulation of mesenchymal stem cell migration [GO:1905322]; positive regulation of osteoblast differentiation [GO:0045669]; protein ubiquitination [GO:0016567]; regulation of DNA replication [GO:0006275]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225]; spindle assembly involved in female meiosis I [GO:0007057]; vesicle organization [GO:0016050]","DEVELOPMENTAL STAGE: Detected at the germinal vesicle (GV) stage. During maturation, decreases to barely detectable levels in meiosis I- and meiosis II-stage oocytes. {ECO:0000269|PubMed:17190794}.","","","TISSUE SPECIFICITY: Expressed in oocytes and granulosa cells (PubMed:15526037, PubMed:17190794). Expressed in proliferating cells compartments in hair follicle and skin epidermis, spermatogonia, and intestinal crypts (PubMed:17875940). {ECO:0000269|PubMed:15526037, ECO:0000269|PubMed:17190794, ECO:0000269|PubMed:17875940}."
"670","sp|B4JCS7|RAD54_DROGR","lcl|NC_088857.1_cds_XP_034337080.2_23104",0,857,"B4JCS7","RAD54_DROGR","DNA repair and recombination protein RAD54-like (EC 3.6.4.-) (Protein okra)","okr GH10642","Drosophila grimshawi (Hawaiian fruit fly) (Idiomyia grimshawi)",786,"GO:0000711; GO:0000724; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006338; GO:0007131; GO:0010212; GO:0015616; GO:0016887; GO:0030716; GO:0043150; GO:0045003; GO:0048477; GO:0051301; GO:0140658","cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA synthesis involved in double-strand break repair via homologous recombination [GO:0043150]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; meiotic DNA repair synthesis [GO:0000711]; oocyte fate determination [GO:0030716]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212]","nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA translocase activity [GO:0015616]; helicase activity [GO:0004386]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA synthesis involved in double-strand break repair via homologous recombination [GO:0043150]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; meiotic DNA repair synthesis [GO:0000711]; oocyte fate determination [GO:0030716]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212]","","","",""
"671","sp|Q9VEZ3|MSPS_DROME","lcl|NC_088857.1_cds_XP_034337666.2_26861",0,1031,"Q9VEZ3","MSPS_DROME","Protein mini spindles","msps CG5000","Drosophila melanogaster (Fruit fly)",2042,"GO:0000022; GO:0000132; GO:0000278; GO:0000776; GO:0000922; GO:0005813; GO:0005819; GO:0007029; GO:0007052; GO:0007143; GO:0007344; GO:0007411; GO:0008017; GO:0015631; GO:0016325; GO:0030951; GO:0031122; GO:0035371; GO:0045196; GO:0045450; GO:0046785; GO:0048471; GO:0048477; GO:0051010; GO:0051298; GO:0061863; GO:0090063","axon guidance [GO:0007411]; bicoid mRNA localization [GO:0045450]; centrosome duplication [GO:0051298]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum organization [GO:0007029]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; establishment or maintenance of neuroblast polarity [GO:0045196]; female meiotic nuclear division [GO:0007143]; microtubule polymerization [GO:0046785]; mitotic cell cycle [GO:0000278]; mitotic spindle elongation [GO:0000022]; mitotic spindle organization [GO:0007052]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; positive regulation of microtubule nucleation [GO:0090063]; pronuclear fusion [GO:0007344]","centrosome [GO:0005813]; kinetochore [GO:0000776]; microtubule plus-end [GO:0035371]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; microtubule plus end polymerase [GO:0061863]; microtubule plus-end binding [GO:0051010]; tubulin binding [GO:0015631]; axon guidance [GO:0007411]; bicoid mRNA localization [GO:0045450]; centrosome duplication [GO:0051298]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum organization [GO:0007029]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; establishment or maintenance of neuroblast polarity [GO:0045196]; female meiotic nuclear division [GO:0007143]; microtubule polymerization [GO:0046785]; mitotic cell cycle [GO:0000278]; mitotic spindle elongation [GO:0000022]; mitotic spindle organization [GO:0007052]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; positive regulation of microtubule nucleation [GO:0090063]; pronuclear fusion [GO:0007344]","DEVELOPMENTAL STAGE: Expressed in embryos (at protein level). {ECO:0000269|PubMed:33725482}.","","",""
"672","sp|Q7ZVH1|MPRGA_DANRE","lcl|NC_088857.1_cds_XP_034339366.2_22888",7.26e-90,274,"Q7ZVH1","MPRGA_DANRE","Membrane progestin receptor gamma-A (mPR gamma-A) (Progestin and adipoQ receptor family member V-A)","paqr5a mprg paqr5 zgc:56016","Danio rerio (Zebrafish) (Brachydanio rerio)",345,"GO:0005496; GO:0016020; GO:0038023; GO:0048477","oogenesis [GO:0048477]","membrane [GO:0016020]; signaling receptor activity [GO:0038023]; steroid binding [GO:0005496]; oogenesis [GO:0048477]","","","",""
"673","sp|Q28Z18|SETB1_DROPS","lcl|NC_088857.1_cds_XP_065939593.1_24599",1.96e-73,269,"Q28Z18","SETB1_DROPS","Histone-lysine N-methyltransferase eggless (EC 2.1.1.355) (SETDB1 homolog)","egg GA30484","Drosophila pseudoobscura pseudoobscura (Fruit fly)",1254,"GO:0003677; GO:0005634; GO:0005694; GO:0008270; GO:0010629; GO:0032259; GO:0048477; GO:0070828; GO:0140949","heterochromatin organization [GO:0070828]; methylation [GO:0032259]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]","chromosome [GO:0005694]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone H3K9 trimethyltransferase activity [GO:0140949]; zinc ion binding [GO:0008270]; heterochromatin organization [GO:0070828]; methylation [GO:0032259]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]","","","",""
"674","sp|Q8MSX1|ENC_DROME","lcl|NC_088857.1_cds_XP_065939633.1_22662",1.42e-30,133,"Q8MSX1","ENC_DROME","Protein encore","enc CG10847","Drosophila melanogaster (Fruit fly)",1818,"GO:0003676; GO:0005737; GO:0007282; GO:0007293; GO:0007294; GO:0007310; GO:0007317; GO:0030717; GO:0048134; GO:0048477","cystoblast division [GO:0007282]; germ-line cyst formation [GO:0048134]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived oocyte fate determination [GO:0007294]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; regulation of pole plasm oskar mRNA localization [GO:0007317]","cytoplasm [GO:0005737]; nucleic acid binding [GO:0003676]; cystoblast division [GO:0007282]; germ-line cyst formation [GO:0048134]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived oocyte fate determination [GO:0007294]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; regulation of pole plasm oskar mRNA localization [GO:0007317]","DEVELOPMENTAL STAGE: In the germarium, it begins to accumulate preferentially within the future oocyte shortly after formation of the 16-cell cyst. In midoogenesis, it can be seen transiently at the posterior edge of the oocyte, but by stage 9 assumes an anterior localization, and appears to be more concentrated at the dorsal side of the oocyte, above the oocyte nucleus. This pattern of localization is similar to that seen for grk mRNA and protein, though not tightly restricted to the dorsal side.","","","TISSUE SPECIFICITY: Expressed in all germline cells of the germarium including the stem cells and dividing cystocytes."
"675","sp|Q7Z7G8|VP13B_HUMAN","lcl|NC_088857.1_cds_XP_065939638.1_22666",0,1290,"Q7Z7G8","VP13B_HUMAN","Intermembrane lipid transfer protein VPS13B (Cohen syndrome protein 1) (Vacuolar protein sorting-associated protein 13B)","VPS13B CHS1 COH1 KIAA0532","Homo sapiens (Human)",4022,"GO:0000139; GO:0001675; GO:0002080; GO:0005765; GO:0006869; GO:0007030; GO:0007399; GO:0007417; GO:0007517; GO:0007613; GO:0016192; GO:0021542; GO:0031175; GO:0031901; GO:0032266; GO:0032458; GO:0032588; GO:0033106; GO:0033116; GO:0035176; GO:0035264; GO:0036438; GO:0055038; GO:0060323; GO:0060612; GO:0090168","acrosome assembly [GO:0001675]; adipose tissue development [GO:0060612]; central nervous system development [GO:0007417]; dentate gyrus development [GO:0021542]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; head morphogenesis [GO:0060323]; lipid transport [GO:0006869]; maintenance of lens transparency [GO:0036438]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; slow endocytic recycling [GO:0032458]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192]","acrosomal membrane [GO:0002080]; cis-Golgi network membrane [GO:0033106]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; phosphatidylinositol-3-phosphate binding [GO:0032266]; acrosome assembly [GO:0001675]; adipose tissue development [GO:0060612]; central nervous system development [GO:0007417]; dentate gyrus development [GO:0021542]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; head morphogenesis [GO:0060323]; lipid transport [GO:0006869]; maintenance of lens transparency [GO:0036438]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; slow endocytic recycling [GO:0032458]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192]","","","","TISSUE SPECIFICITY: Widely expressed (PubMed:12730828). There is apparent differential expression of different transcripts (PubMed:12730828, PubMed:19006247). In fetal brain, lung, liver, and kidney, two transcripts of 2 and 5 kb are identified (PubMed:12730828). These transcripts are also seen in all adult tissues analyzed (PubMed:12730828). A larger transcript (12-14 kb) is expressed in prostate, testis, ovary, and colon in the adult (PubMed:12730828). Expression is very low in adult brain tissue (PubMed:12730828). Expressed in peripheral blood lymphocytes (PubMed:33025479). Isoform 1 and isoform 2 are expressed in brain and retina (PubMed:12730828, PubMed:19006247). Isoform 2 is expressed ubiquitously (PubMed:12730828, PubMed:19006247). {ECO:0000269|PubMed:12730828, ECO:0000269|PubMed:19006247, ECO:0000269|PubMed:33025479}."
"676","sp|B4HWI2|IRS1_DROSE","lcl|NC_088857.1_cds_XP_065939739.1_28002",2.68e-39,160,"B4HWI2","IRS1_DROSE","Insulin receptor substrate 1 (Protein chico)","chico GM11923","Drosophila sechellia (Fruit fly)",964,"GO:0005158; GO:0005159; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0007285; GO:0007295; GO:0007296; GO:0008284; GO:0008286; GO:0008340; GO:0008355; GO:0009267; GO:0010897; GO:0034059; GO:0035159; GO:0035264; GO:0040018; GO:0042593; GO:0043231; GO:0043548; GO:0045793; GO:0046622; GO:0048009; GO:0048133; GO:0050778; GO:0051897; GO:0055088; GO:0060250; GO:0060291; GO:0061964; GO:1903688","cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; germ-line stem-cell niche homeostasis [GO:0060250]; glucose homeostasis [GO:0042593]; growth of a germarium-derived egg chamber [GO:0007295]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; lipid homeostasis [GO:0055088]; long-term synaptic potentiation [GO:0060291]; male germ-line stem cell asymmetric division [GO:0048133]; multicellular organism growth [GO:0035264]; negative regulation of entry into reproductive diapause [GO:0061964]; negative regulation of triglyceride catabolic process [GO:0010897]; olfactory learning [GO:0008355]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of immune response [GO:0050778]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; primary spermatocyte growth [GO:0007285]; regulation of tube length, open tracheal system [GO:0035159]; response to anoxia [GO:0034059]; vitellogenesis [GO:0007296]","cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; germ-line stem-cell niche homeostasis [GO:0060250]; glucose homeostasis [GO:0042593]; growth of a germarium-derived egg chamber [GO:0007295]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; lipid homeostasis [GO:0055088]; long-term synaptic potentiation [GO:0060291]; male germ-line stem cell asymmetric division [GO:0048133]; multicellular organism growth [GO:0035264]; negative regulation of entry into reproductive diapause [GO:0061964]; negative regulation of triglyceride catabolic process [GO:0010897]; olfactory learning [GO:0008355]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of immune response [GO:0050778]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; primary spermatocyte growth [GO:0007285]; regulation of tube length, open tracheal system [GO:0035159]; response to anoxia [GO:0034059]; vitellogenesis [GO:0007296]","","","",""
"677","sp|B3N946|IRS1_DROER","lcl|NC_088857.1_cds_XP_065939740.1_28003",3.22e-40,163,"B3N946","IRS1_DROER","Insulin receptor substrate 1 (Protein chico)","chico GG23965","Drosophila erecta (Fruit fly)",948,"GO:0005158; GO:0005159; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0007285; GO:0007295; GO:0007296; GO:0008284; GO:0008286; GO:0008340; GO:0008355; GO:0009267; GO:0010897; GO:0034059; GO:0035159; GO:0035264; GO:0040018; GO:0042593; GO:0043231; GO:0043548; GO:0045793; GO:0046622; GO:0048009; GO:0048133; GO:0050778; GO:0051897; GO:0055088; GO:0060250; GO:0060291; GO:0061964; GO:1903688","cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; germ-line stem-cell niche homeostasis [GO:0060250]; glucose homeostasis [GO:0042593]; growth of a germarium-derived egg chamber [GO:0007295]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; lipid homeostasis [GO:0055088]; long-term synaptic potentiation [GO:0060291]; male germ-line stem cell asymmetric division [GO:0048133]; multicellular organism growth [GO:0035264]; negative regulation of entry into reproductive diapause [GO:0061964]; negative regulation of triglyceride catabolic process [GO:0010897]; olfactory learning [GO:0008355]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of immune response [GO:0050778]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; primary spermatocyte growth [GO:0007285]; regulation of tube length, open tracheal system [GO:0035159]; response to anoxia [GO:0034059]; vitellogenesis [GO:0007296]","cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; germ-line stem-cell niche homeostasis [GO:0060250]; glucose homeostasis [GO:0042593]; growth of a germarium-derived egg chamber [GO:0007295]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; lipid homeostasis [GO:0055088]; long-term synaptic potentiation [GO:0060291]; male germ-line stem cell asymmetric division [GO:0048133]; multicellular organism growth [GO:0035264]; negative regulation of entry into reproductive diapause [GO:0061964]; negative regulation of triglyceride catabolic process [GO:0010897]; olfactory learning [GO:0008355]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of immune response [GO:0050778]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; primary spermatocyte growth [GO:0007285]; regulation of tube length, open tracheal system [GO:0035159]; response to anoxia [GO:0034059]; vitellogenesis [GO:0007296]","","","",""
"678","sp|B4NZ70|IRS1_DROYA","lcl|NC_088857.1_cds_XP_065939742.1_28004",9.94e-40,161,"B4NZ70","IRS1_DROYA","Insulin receptor substrate 1 (Protein chico)","chico GE26285","Drosophila yakuba (Fruit fly)",949,"GO:0005158; GO:0005159; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007296; GO:0008286; GO:0043231; GO:0043548; GO:0048009; GO:0048477","insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; oogenesis [GO:0048477]; vitellogenesis [GO:0007296]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; oogenesis [GO:0048477]; vitellogenesis [GO:0007296]","","","",""
"679","sp|Q24246|DYIN_DROME","lcl|NC_088857.1_cds_XP_065939757.1_28055",0,612,"Q24246","DYIN_DROME","Cytoplasmic dynein 1 intermediate chain (DH IC) (Dynein intermediate chain, cytosolic) (Protein short wing)","sw Cdic Dic19B CG18000","Drosophila melanogaster (Fruit fly)",663,"GO:0000226; GO:0001754; GO:0005765; GO:0005868; GO:0005874; GO:0007018; GO:0007051; GO:0007291; GO:0007349; GO:0008088; GO:0010970; GO:0031965; GO:0032991; GO:0034452; GO:0034501; GO:0043005; GO:0045503; GO:0045504; GO:0051642; GO:0060090","axo-dendritic transport [GO:0008088]; cellularization [GO:0007349]; centrosome localization [GO:0051642]; eye photoreceptor cell differentiation [GO:0001754]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; protein localization to kinetochore [GO:0034501]; sperm individualization [GO:0007291]; spindle organization [GO:0007051]; transport along microtubule [GO:0010970]","cytoplasmic dynein complex [GO:0005868]; lysosomal membrane [GO:0005765]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; protein-containing complex [GO:0032991]; dynactin binding [GO:0034452]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; molecular adaptor activity [GO:0060090]; axo-dendritic transport [GO:0008088]; cellularization [GO:0007349]; centrosome localization [GO:0051642]; eye photoreceptor cell differentiation [GO:0001754]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; protein localization to kinetochore [GO:0034501]; sperm individualization [GO:0007291]; spindle organization [GO:0007051]; transport along microtubule [GO:0010970]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. Abundant in embryos and adults, low levels in larva and pupae. Isoform 1a, isoform 2a and isoform 2b are constitutively expressed at high levels and isoform 2c at low levels in embryos and adults. {ECO:0000269|PubMed:9774695}.","","","TISSUE SPECIFICITY: High levels of isoform 1b, isoform 1c, isoform 3a and isoform 4 accumulate in early egg chambers and at stage 9 become concentrated at the posterior of the oocyte. Isoform 5a and isoform 5b are highly expressed in adult head and to a lesser extent in adult torso. Isoform 1a, isoform 2a and isoform 2b are found in all tissues examined, including ovaries, midgut, torso and head. {ECO:0000269|PubMed:11071907, ECO:0000269|PubMed:9774695}."
"680","sp|P91926|AP2A_DROME","lcl|NC_088857.1_cds_XP_065939919.1_25001",0,1317,"P91926","AP2A_DROME","AP-2 complex subunit alpha (Alpha-adaptin)","AP-2alpha CG4260","Drosophila melanogaster (Fruit fly)",940,"GO:0005886; GO:0005905; GO:0006886; GO:0006897; GO:0008104; GO:0008356; GO:0010508; GO:0015031; GO:0030100; GO:0030122; GO:0030707; GO:0031623; GO:0035615; GO:0038010; GO:0045807; GO:0048488; GO:0048489; GO:0072583; GO:0098793; GO:1990386","asymmetric cell division [GO:0008356]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; follicle cell of egg chamber development [GO:0030707]; intracellular protein transport [GO:0006886]; mitotic cleavage furrow ingression [GO:1990386]; positive regulation of autophagy [GO:0010508]; positive regulation of endocytosis [GO:0045807]; positive regulation of signal transduction by receptor internalization [GO:0038010]; protein localization [GO:0008104]; protein transport [GO:0015031]; receptor internalization [GO:0031623]; regulation of endocytosis [GO:0030100]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]","AP-2 adaptor complex [GO:0030122]; clathrin-coated pit [GO:0005905]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; clathrin adaptor activity [GO:0035615]; asymmetric cell division [GO:0008356]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; follicle cell of egg chamber development [GO:0030707]; intracellular protein transport [GO:0006886]; mitotic cleavage furrow ingression [GO:1990386]; positive regulation of autophagy [GO:0010508]; positive regulation of endocytosis [GO:0045807]; positive regulation of signal transduction by receptor internalization [GO:0038010]; protein localization [GO:0008104]; protein transport [GO:0015031]; receptor internalization [GO:0031623]; regulation of endocytosis [GO:0030100]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]","","","","TISSUE SPECIFICITY: Expressed in the Garland cells, imaginal disks, adult midgut precursors, the antenno-maxillary complex, the endoderm, the fat bodies, and the visceral mesoderm and cells of the CNS and PNS including neuroblasts, the presumptive stomatogastric nervous system, and the lateral chordotonal sense organs. {ECO:0000269|PubMed:9118220, ECO:0000269|PubMed:9285813}."
"681","sp|Q24592|JAK_DROME","lcl|NC_088857.1_cds_XP_065939973.1_25151",1.47e-51,201,"Q24592","JAK_DROME","Tyrosine-protein kinase hopscotch (EC 2.7.10.2)","hop HD-160 CG1594","Drosophila melanogaster (Fruit fly)",1177,"GO:0001745; GO:0001751; GO:0004713; GO:0004715; GO:0005126; GO:0005524; GO:0005829; GO:0005856; GO:0007259; GO:0007298; GO:0007350; GO:0007365; GO:0007399; GO:0007424; GO:0007442; GO:0007455; GO:0007472; GO:0007478; GO:0007481; GO:0007538; GO:0007616; GO:0009898; GO:0012505; GO:0016318; GO:0016476; GO:0019100; GO:0019221; GO:0019827; GO:0030154; GO:0030707; GO:0030713; GO:0031453; GO:0035167; GO:0035206; GO:0035556; GO:0042067; GO:0042386; GO:0045317; GO:0045475; GO:0048749; GO:0051607; GO:0060031; GO:0071907","blastoderm segmentation [GO:0007350]; border follicle cell migration [GO:0007298]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; determination of digestive tract left/right asymmetry [GO:0071907]; equator specification [GO:0045317]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc morphogenesis [GO:0007455]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber stalk formation [GO:0030713]; haltere disc morphogenesis [GO:0007481]; hemocyte differentiation [GO:0042386]; hindgut morphogenesis [GO:0007442]; intracellular signal transduction [GO:0035556]; larval lymph gland hemopoiesis [GO:0035167]; leg disc morphogenesis [GO:0007478]; locomotor rhythm [GO:0045475]; long-term memory [GO:0007616]; male germ-line sex determination [GO:0019100]; mediolateral intercalation [GO:0060031]; nervous system development [GO:0007399]; ommatidial rotation [GO:0016318]; open tracheal system development [GO:0007424]; periodic partitioning [GO:0007365]; positive regulation of heterochromatin formation [GO:0031453]; primary sex determination [GO:0007538]; regulation of embryonic cell shape [GO:0016476]; regulation of hemocyte proliferation [GO:0035206]; stem cell population maintenance [GO:0019827]; wing disc morphogenesis [GO:0007472]","cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; ATP binding [GO:0005524]; cytokine receptor binding [GO:0005126]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; blastoderm segmentation [GO:0007350]; border follicle cell migration [GO:0007298]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; determination of digestive tract left/right asymmetry [GO:0071907]; equator specification [GO:0045317]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc morphogenesis [GO:0007455]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber stalk formation [GO:0030713]; haltere disc morphogenesis [GO:0007481]; hemocyte differentiation [GO:0042386]; hindgut morphogenesis [GO:0007442]; intracellular signal transduction [GO:0035556]; larval lymph gland hemopoiesis [GO:0035167]; leg disc morphogenesis [GO:0007478]; locomotor rhythm [GO:0045475]; long-term memory [GO:0007616]; male germ-line sex determination [GO:0019100]; mediolateral intercalation [GO:0060031]; nervous system development [GO:0007399]; ommatidial rotation [GO:0016318]; open tracheal system development [GO:0007424]; periodic partitioning [GO:0007365]; positive regulation of heterochromatin formation [GO:0031453]; primary sex determination [GO:0007538]; regulation of embryonic cell shape [GO:0016476]; regulation of hemocyte proliferation [GO:0035206]; stem cell population maintenance [GO:0019827]; wing disc morphogenesis [GO:0007472]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically throughout development. {ECO:0000269|PubMed:8314084}.","","",""
"682","sp|P25822|PUM_DROME","lcl|NC_088857.1_cds_XP_065940015.1_25010",1.03e-177,559,"P25822","PUM_DROME","Maternal protein pumilio","pum CG9755","Drosophila melanogaster (Fruit fly)",1533,"GO:0000278; GO:0000288; GO:0000900; GO:0003723; GO:0003730; GO:0005634; GO:0005635; GO:0005737; GO:0007268; GO:0007281; GO:0007616; GO:0008258; GO:0008354; GO:0008582; GO:0008595; GO:0010608; GO:0016441; GO:0016477; GO:0017148; GO:0031594; GO:0042059; GO:0045727; GO:0045786; GO:0045892; GO:0048149; GO:0048477; GO:0048813; GO:0050804; GO:0060213; GO:0061176; GO:0061177; GO:0071598; GO:0097482; GO:1900153; GO:1901835; GO:1905762; GO:1990825","anterior/posterior axis specification, embryo [GO:0008595]; behavioral response to ethanol [GO:0048149]; cell migration [GO:0016477]; chemical synaptic transmission [GO:0007268]; dendrite morphogenesis [GO:0048813]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; head involution [GO:0008258]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; oogenesis [GO:0048477]; positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA [GO:1901835]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translation [GO:0045727]; post-transcriptional gene silencing [GO:0016441]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]","cytoplasm [GO:0005737]; muscle cell postsynaptic specialization [GO:0097482]; neuromuscular junction [GO:0031594]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; type Ib terminal bouton [GO:0061176]; type Is terminal bouton [GO:0061177]; CCR4-NOT complex binding [GO:1905762]; mRNA 3'-UTR binding [GO:0003730]; mRNA regulatory element binding translation repressor activity [GO:0000900]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; anterior/posterior axis specification, embryo [GO:0008595]; behavioral response to ethanol [GO:0048149]; cell migration [GO:0016477]; chemical synaptic transmission [GO:0007268]; dendrite morphogenesis [GO:0048813]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; head involution [GO:0008258]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; oogenesis [GO:0048477]; positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA [GO:1901835]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translation [GO:0045727]; post-transcriptional gene silencing [GO:0016441]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically in embryos. {ECO:0000269|PubMed:1459455, ECO:0000269|PubMed:1576962}.","","",""
"683","sp|P32019|I5P2_HUMAN","lcl|NC_088857.1_cds_XP_065940096.1_23263",2.94e-61,229,"P32019","I5P2_HUMAN","Type II inositol 1,4,5-trisphosphate 5-phosphatase (EC 3.1.3.36) (75 kDa inositol polyphosphate-5-phosphatase) (Phosphoinositide 5-phosphatase) (5PTase)","INPP5B OCRL2","Homo sapiens (Human)",993,"GO:0001701; GO:0004439; GO:0005737; GO:0005793; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0007283; GO:0016020; GO:0030317; GO:0030670; GO:0031901; GO:0043005; GO:0043647; GO:0046856; GO:0046872; GO:0052658; GO:0052659; GO:0070613","flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuron projection [GO:0043005]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Platelets."
"684","sp|Q9WTL8|BMAL1_MOUSE","lcl|NC_088857.1_cds_XP_065940218.1_23195",0,550,"Q9WTL8","BMAL1_MOUSE","Basic helix-loop-helix ARNT-like protein 1 (Arnt3) (Aryl hydrocarbon receptor nuclear translocator-like protein 1) (Brain and muscle ARNT-like 1)","Bmal1 Arntl","Mus musculus (Mouse)",632,"GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0003712; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006606; GO:0006914; GO:0007283; GO:0007623; GO:0010467; GO:0016604; GO:0016605; GO:0032007; GO:0032922; GO:0033391; GO:0042176; GO:0042634; GO:0042753; GO:0043161; GO:0043425; GO:0043565; GO:0045599; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0050767; GO:0050796; GO:0051726; GO:0051775; GO:0060137; GO:0070888; GO:0090263; GO:0090403; GO:0097009; GO:0120163; GO:1901985; GO:1990513; GO:2000074; GO:2000323; GO:2000772; GO:2001016","autophagy [GO:0006914]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; energy homeostasis [GO:0097009]; gene expression [GO:0010467]; maternal process involved in parturition [GO:0060137]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of nuclear receptor-mediated glucocorticoid signaling pathway [GO:2000323]; negative regulation of TOR signaling [GO:0032007]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein acetylation [GO:1901985]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; regulation of DNA-templated transcription [GO:0006355]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of protein catabolic process [GO:0042176]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283]","chromatoid body [GO:0033391]; CLOCK-BMAL transcription complex [GO:1990513]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; transcription regulator complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator activity [GO:0003712]; autophagy [GO:0006914]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; energy homeostasis [GO:0097009]; gene expression [GO:0010467]; maternal process involved in parturition [GO:0060137]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of nuclear receptor-mediated glucocorticoid signaling pathway [GO:2000323]; negative regulation of TOR signaling [GO:0032007]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein acetylation [GO:1901985]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; regulation of DNA-templated transcription [GO:0006355]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of protein catabolic process [GO:0042176]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283]","","INDUCTION: Expressed in a circadian manner in the liver. {ECO:0000269|PubMed:16790549, ECO:0000269|PubMed:20385766, ECO:0000269|PubMed:23531614, ECO:0000269|PubMed:24603368}.","INDUCTION: Expressed in a circadian manner in the liver. {ECO:0000269|PubMed:16790549, ECO:0000269|PubMed:20385766, ECO:0000269|PubMed:23531614, ECO:0000269|PubMed:24603368}.","TISSUE SPECIFICITY: Expressed in liver and testis (at protein level). Expressed in the suprachiasmatic nucleus (SCN) in a circadian manner (PubMed:29138967). {ECO:0000269|PubMed:16790549, ECO:0000269|PubMed:22900038, ECO:0000269|PubMed:23531614, ECO:0000269|PubMed:24154698, ECO:0000269|PubMed:24603368, ECO:0000269|PubMed:28903391, ECO:0000269|PubMed:29138967}."
"685","sp|Q4U0Y4|NPL1A_XENLA","lcl|NC_088857.1_cds_XP_065940294.1_23484",3.62e-104,314,"Q4U0Y4","NPL1A_XENLA","Nucleosome assembly protein 1-like 1-A (xNAP1L-A) (Nucleosome assembly protein 1) (NAP-1) (NAP1) (xNAP-1) (xNAP1)","nap1l1-a nap1-a","Xenopus laevis (African clawed frog)",392,"GO:0000785; GO:0003682; GO:0005634; GO:0005737; GO:0006334; GO:0007283; GO:0030332; GO:0042393; GO:0042802; GO:0045944; GO:0060215","nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive hemopoiesis [GO:0060215]; spermatogenesis [GO:0007283]","chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cyclin binding [GO:0030332]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive hemopoiesis [GO:0060215]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. Expression levels remain constant during embryonic development, increasing at the swimming tadpole stage. {ECO:0000269|PubMed:14550533}.","","","TISSUE SPECIFICITY: Initially expressed throughout the embryo with expression higher at the animal pole. Becomes localized to presumptive ectoderm by gastrula stages. By stage 18 (neurula), expressed in the neural plate and posterior to the cement gland. In late neurula/early tailbud stages, expressed in the neural crest, neural tube, eyes, tailbud and ventral blood islands. Adult expression is predominantly in ovaries. {ECO:0000269|PubMed:14550533}."
"686","sp|P28166|ZFH1_DROME","lcl|NC_088857.1_cds_XP_065940303.1_25386",8.03e-40,161,"P28166","ZFH1_DROME","Zinc finger protein 1 (Zinc finger homeodomain protein 1)","zfh1 zfh-1 CG1322","Drosophila melanogaster (Fruit fly)",1054,"GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001837; GO:0005634; GO:0006357; GO:0007399; GO:0007413; GO:0007417; GO:0007498; GO:0007516; GO:0008045; GO:0008270; GO:0008354; GO:0035019; GO:0046716; GO:0048103; GO:0048542; GO:0051148; GO:0061321","axonal fasciculation [GO:0007413]; central nervous system development [GO:0007417]; epithelial to mesenchymal transition [GO:0001837]; garland nephrocyte differentiation [GO:0061321]; germ cell migration [GO:0008354]; hemocyte development [GO:0007516]; lymph gland development [GO:0048542]; mesoderm development [GO:0007498]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]","nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; axonal fasciculation [GO:0007413]; central nervous system development [GO:0007417]; epithelial to mesenchymal transition [GO:0001837]; garland nephrocyte differentiation [GO:0061321]; germ cell migration [GO:0008354]; hemocyte development [GO:0007516]; lymph gland development [GO:0048542]; mesoderm development [GO:0007498]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]","","","","TISSUE SPECIFICITY: Mesoderm and mesodermally-derived structures in the embryo including the dorsal vessel, support cells of the gonads, and segment-specific arrays of adult muscle precursor. Also identified in motor neurons of developing CNS. {ECO:0000269|PubMed:1680376}."
"687","sp|Q2KIY6|HORM1_BOVIN","lcl|NC_088857.1_cds_XP_065940450.1_23788",1.12e-71,236,"Q2KIY6","HORM1_BOVIN","HORMA domain-containing protein 1","HORMAD1","Bos taurus (Bovine)",393,"GO:0000795; GO:0001824; GO:0005634; GO:0005694; GO:0007130; GO:0007283; GO:0042138; GO:0048477; GO:0051177; GO:0051321; GO:0051598; GO:0060629","blastocyst development [GO:0001824]; meiotic cell cycle [GO:0051321]; meiotic DNA double-strand break formation [GO:0042138]; meiotic recombination checkpoint signaling [GO:0051598]; meiotic sister chromatid cohesion [GO:0051177]; oogenesis [GO:0048477]; regulation of homologous chromosome segregation [GO:0060629]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]","chromosome [GO:0005694]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; blastocyst development [GO:0001824]; meiotic cell cycle [GO:0051321]; meiotic DNA double-strand break formation [GO:0042138]; meiotic recombination checkpoint signaling [GO:0051598]; meiotic sister chromatid cohesion [GO:0051177]; oogenesis [GO:0048477]; regulation of homologous chromosome segregation [GO:0060629]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]","","","",""
"688","sp|G5EET5|CBXH1_CAEEL","lcl|NC_088857.1_cds_XP_065940458.1_25564",1.89e-22,90.5,"G5EET5","CBXH1_CAEEL","Chromobox protein homolog hpl-1 (HP1-like heterochromatin protein 1)","hpl-1 K08H2.6","Caenorhabditis elegans",184,"GO:0000792; GO:0002119; GO:0003682; GO:0005634; GO:0005721; GO:0007281; GO:0008406; GO:0010629; GO:0019899; GO:0022414; GO:0031507; GO:0035064; GO:0040010; GO:0040027; GO:0045595; GO:0046580","germ cell development [GO:0007281]; gonad development [GO:0008406]; heterochromatin formation [GO:0031507]; negative regulation of gene expression [GO:0010629]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of vulval development [GO:0040027]; nematode larval development [GO:0002119]; positive regulation of growth rate [GO:0040010]; regulation of cell differentiation [GO:0045595]; reproductive process [GO:0022414]","heterochromatin [GO:0000792]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; methylated histone binding [GO:0035064]; germ cell development [GO:0007281]; gonad development [GO:0008406]; heterochromatin formation [GO:0031507]; negative regulation of gene expression [GO:0010629]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of vulval development [GO:0040027]; nematode larval development [GO:0002119]; positive regulation of growth rate [GO:0040010]; regulation of cell differentiation [GO:0045595]; reproductive process [GO:0022414]","DEVELOPMENTAL STAGE: Expressed in embryos at about the 50 cell stage (PubMed:16905130). Expressed in most, but not all cells of larvae and adults, especially in neuronal and hypodermal cells (PubMed:16905130). {ECO:0000269|PubMed:16905130}.","","",""
"689","sp|Q6ZMY3|SPOC1_HUMAN","lcl|NC_088857.1_cds_XP_065940480.1_24219",1.19e-42,172,"Q6ZMY3","SPOC1_HUMAN","SPOC domain-containing protein 1","SPOCD1","Homo sapiens (Human)",1216,"GO:0005634; GO:0005694; GO:0006351; GO:0006357; GO:0007283; GO:0030154; GO:0030674; GO:0141006; GO:0141196","cell differentiation [GO:0030154]; DNA-templated transcription [GO:0006351]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006]","chromosome [GO:0005694]; nucleus [GO:0005634]; protein-macromolecule adaptor activity [GO:0030674]; cell differentiation [GO:0030154]; DNA-templated transcription [GO:0006351]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006]","","","",""
"690","sp|A7YWH3|KCD19_BOVIN","lcl|NC_088857.1_cds_XP_065940500.1_25651",1.68e-11,66.6,"A7YWH3","KCD19_BOVIN","BTB/POZ domain-containing protein KCTD19","KCTD19","Bos taurus (Bovine)",927,"GO:0005634; GO:0007140; GO:0007283; GO:0030154; GO:0051260","cell differentiation [GO:0030154]; male meiotic nuclear division [GO:0007140]; protein homooligomerization [GO:0051260]; spermatogenesis [GO:0007283]","nucleus [GO:0005634]; cell differentiation [GO:0030154]; male meiotic nuclear division [GO:0007140]; protein homooligomerization [GO:0051260]; spermatogenesis [GO:0007283]","","","",""
"691","sp|Q562E2|KCD19_MOUSE","lcl|NC_088857.1_cds_XP_065940503.1_25655",1.34e-12,69.7,"Q562E2","KCD19_MOUSE","BTB/POZ domain-containing protein KCTD19","Kctd19","Mus musculus (Mouse)",927,"GO:0005634; GO:0007140; GO:0051260","male meiotic nuclear division [GO:0007140]; protein homooligomerization [GO:0051260]","nucleus [GO:0005634]; male meiotic nuclear division [GO:0007140]; protein homooligomerization [GO:0051260]","DEVELOPMENTAL STAGE: Not detected in testis from neonates. Expression in testis is first detected 14 days after birth and increases thereafter. Highly expressed 30 and 84 days after birth. {ECO:0000269|PubMed:18849567}.","","","TISSUE SPECIFICITY: Detected in adult testis. {ECO:0000269|PubMed:18849567, ECO:0000269|PubMed:33961623, ECO:0000269|PubMed:34075040}."
"692","sp|O95248|MTMR5_HUMAN","lcl|NC_088857.1_cds_XP_065940668.1_25725",0,1420,"O95248","MTMR5_HUMAN","Myotubularin-related protein 5 (Inactive phosphatidylinositol 3-phosphatase 5) (SET-binding factor 1) (Sbf1)","SBF1 MTMR5","Homo sapiens (Human)",1868,"GO:0005085; GO:0005737; GO:0005789; GO:0005829; GO:0006470; GO:0007286; GO:0008138; GO:0016020; GO:0016604; GO:0043005; GO:0048471","protein dephosphorylation [GO:0006470]; spermatid development [GO:0007286]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein dephosphorylation [GO:0006470]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Expressed in neurons within the frontal cortex, in neurons of the deep cerebellar nuclei, stellate and basket cells of the molecular layer, and Golgi cells of the granular layer (at protein level). {ECO:0000269|PubMed:35580604}."
"693","sp|Q24151|STAT_DROME","lcl|NC_088857.1_cds_XP_065940741.1_24899",7.05e-102,333,"Q24151","STAT_DROME","Signal transducer and transcription activator (d-STAT) (Protein marelle)","Stat92E MARE mrL Stat CG4257","Drosophila melanogaster (Fruit fly)",761,"GO:0000978; GO:0000981; GO:0001228; GO:0002230; GO:0003677; GO:0005126; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006952; GO:0007259; GO:0007298; GO:0007350; GO:0007379; GO:0007399; GO:0007424; GO:0007442; GO:0007455; GO:0007472; GO:0007526; GO:0007538; GO:0007616; GO:0008284; GO:0008348; GO:0017145; GO:0019100; GO:0019827; GO:0030713; GO:0030718; GO:0030720; GO:0031453; GO:0035167; GO:0035171; GO:0036335; GO:0042060; GO:0042127; GO:0042246; GO:0042393; GO:0043697; GO:0048477; GO:0048542; GO:0071222; GO:0071481; GO:0071907; GO:0097696; GO:0098592; GO:0140374; GO:2000737","antiviral innate immune response [GO:0140374]; blastoderm segmentation [GO:0007350]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cell surface receptor signaling pathway via STAT [GO:0097696]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to X-ray [GO:0071481]; defense response [GO:0006952]; determination of digestive tract left/right asymmetry [GO:0071907]; eye-antennal disc morphogenesis [GO:0007455]; follicle cell of egg chamber stalk formation [GO:0030713]; germ-line stem cell population maintenance [GO:0030718]; hindgut morphogenesis [GO:0007442]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; male germ-line sex determination [GO:0019100]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of stem cell differentiation [GO:2000737]; nervous system development [GO:0007399]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of heterochromatin formation [GO:0031453]; primary sex determination [GO:0007538]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]; stem cell division [GO:0017145]; stem cell population maintenance [GO:0019827]; tissue regeneration [GO:0042246]; wing disc morphogenesis [GO:0007472]; wound healing [GO:0042060]","cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cytokine receptor binding [GO:0005126]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone binding [GO:0042393]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; antiviral innate immune response [GO:0140374]; blastoderm segmentation [GO:0007350]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cell surface receptor signaling pathway via STAT [GO:0097696]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to X-ray [GO:0071481]; defense response [GO:0006952]; determination of digestive tract left/right asymmetry [GO:0071907]; eye-antennal disc morphogenesis [GO:0007455]; follicle cell of egg chamber stalk formation [GO:0030713]; germ-line stem cell population maintenance [GO:0030718]; hindgut morphogenesis [GO:0007442]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; male germ-line sex determination [GO:0019100]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of stem cell differentiation [GO:2000737]; nervous system development [GO:0007399]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of heterochromatin formation [GO:0031453]; primary sex determination [GO:0007538]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]; stem cell division [GO:0017145]; stem cell population maintenance [GO:0019827]; tissue regeneration [GO:0042246]; wing disc morphogenesis [GO:0007472]; wound healing [GO:0042060]","DEVELOPMENTAL STAGE: Expressed throughout embryonic, larval, pupal, and adult stages, with some decrease in the late embryonic stages. The expression is uniform in unfertilized or just fertilized eggs, suggesting maternally deposited mRNA. At blastoderm stage, expression pattern shows stripes, that are reminiscent of many pair rule genes pattern.","","",""
"694","sp|P17133|RU17_DROME","lcl|NC_088857.1_cds_XP_065940851.1_23805",4.31e-76,243,"P17133","RU17_DROME","U1 small nuclear ribonucleoprotein 70 kDa (U1 snRNP 70 kDa) (U1-70K) (snRNP70)","snRNP-U1-70K snRNP27D snRNP70K CG8749","Drosophila melanogaster (Fruit fly)",448,"GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005681; GO:0005685; GO:0007283; GO:0016607; GO:0030619; GO:0043484; GO:0048025; GO:0048477; GO:0071004; GO:0071011; GO:0071013","mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; spermatogenesis [GO:0007283]","catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically throughout all development. {ECO:0000269|PubMed:1692955}.","","",""
"695","sp|O43929|ORC4_HUMAN","lcl|NC_088857.1_cds_XP_065940864.1_22942",5.28e-169,483,"O43929","ORC4_HUMAN","Origin recognition complex subunit 4","ORC4 ORC4L","Homo sapiens (Human)",436,"GO:0000166; GO:0000781; GO:0000808; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005730; GO:0005829; GO:0006270; GO:0016887; GO:0040038; GO:0051258","DNA replication initiation [GO:0006270]; polar body extrusion after meiotic divisions [GO:0040038]; protein polymerization [GO:0051258]","chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nuclear origin of replication recognition complex [GO:0005664]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]; DNA replication initiation [GO:0006270]; polar body extrusion after meiotic divisions [GO:0040038]; protein polymerization [GO:0051258]","","","",""
"696","sp|Q612A4|VATC_CAEBR","lcl|NC_088857.1_cds_XP_065940871.1_22968",7.49e-154,440,"Q612A4","VATC_CAEBR","V-type proton ATPase subunit C (V-ATPase subunit C) (Vacuolar proton pump subunit C)","vha-11 CBG16826","Caenorhabditis briggsae",385,"GO:0000221; GO:0009792; GO:0030728; GO:0046961","embryo development ending in birth or egg hatching [GO:0009792]; ovulation [GO:0030728]","vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; embryo development ending in birth or egg hatching [GO:0009792]; ovulation [GO:0030728]","","","",""
"697","sp|Q9QZ81|AGO2_RAT","lcl|NC_088857.1_cds_XP_065940935.1_22280",0,1363,"Q9QZ81","AGO2_RAT","Protein argonaute-2 (Argonaute2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (Golgi ER protein 95 kDa) (GERp95) (Protein slicer)","Ago2 Eif2c2","Rattus norvegicus (Rat)",860,"GO:0000340; GO:0000932; GO:0000993; GO:0001046; GO:0001666; GO:0003723; GO:0003725; GO:0003727; GO:0003729; GO:0004521; GO:0005634; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0007283; GO:0009791; GO:0010494; GO:0010586; GO:0010628; GO:0016020; GO:0016442; GO:0030154; GO:0030422; GO:0030425; GO:0030544; GO:0031047; GO:0031054; GO:0033391; GO:0033962; GO:0035194; GO:0035196; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0035925; GO:0036464; GO:0042220; GO:0042985; GO:0043186; GO:0043278; GO:0043488; GO:0045727; GO:0045766; GO:0045944; GO:0045947; GO:0046872; GO:0051879; GO:0060213; GO:0070062; GO:0070551; GO:0070578; GO:0070922; GO:0071277; GO:0071546; GO:0090128; GO:0090624; GO:0090625; GO:0098794; GO:0098808; GO:0098978; GO:1900153; GO:1900370; GO:1901165; GO:1905172; GO:1990904","cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of translational initiation [GO:0045947]; P-body assembly [GO:0033962]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of post-transcriptional gene silencing by RNA [GO:1900370]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; regulation of mRNA stability [GO:0043488]; regulation of synapse maturation [GO:0090128]; regulatory ncRNA-mediated gene silencing [GO:0031047]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; response to cocaine [GO:0042220]; response to hypoxia [GO:0001666]; response to morphine [GO:0043278]; RISC complex assembly [GO:0070922]; siRNA processing [GO:0030422]; siRNA-mediated gene silencing by mRNA destabilization [GO:0090625]; spermatogenesis [GO:0007283]","chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; P granule [GO:0043186]; P-body [GO:0000932]; pi-body [GO:0071546]; postsynapse [GO:0098794]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; mRNA cap binding [GO:0098808]; RISC complex binding [GO:1905172]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of translational initiation [GO:0045947]; P-body assembly [GO:0033962]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of post-transcriptional gene silencing by RNA [GO:1900370]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; regulation of mRNA stability [GO:0043488]; regulation of synapse maturation [GO:0090128]; regulatory ncRNA-mediated gene silencing [GO:0031047]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; response to cocaine [GO:0042220]; response to hypoxia [GO:0001666]; response to morphine [GO:0043278]; RISC complex assembly [GO:0070922]; siRNA processing [GO:0030422]; siRNA-mediated gene silencing by mRNA destabilization [GO:0090625]; spermatogenesis [GO:0007283]","","","",""
"698","sp|Q851R2|MEL1_ORYSJ","lcl|NC_088857.1_cds_XP_065940937.1_22282",0,640,"Q851R2","MEL1_ORYSJ","Protein argonaute MEL1 (Protein MEIOSIS ARRESTED AT LEPTOTENE 1) (OsMEL1)","MEL1 MEAL1 Os03g0800200 LOC_Os03g58600 OSJNBa0052F07.11","Oryza sativa subsp. japonica (Rice)",1058,"GO:0003723; GO:0004521; GO:0005634; GO:0005730; GO:0005731; GO:0005737; GO:0007140; GO:0007143; GO:0009561; GO:0010468; GO:0031047; GO:0055046; GO:1903343","female meiotic nuclear division [GO:0007143]; male meiotic nuclear division [GO:0007140]; megagametogenesis [GO:0009561]; microgametogenesis [GO:0055046]; positive regulation of meiotic DNA double-strand break formation [GO:1903343]; regulation of gene expression [GO:0010468]; regulatory ncRNA-mediated gene silencing [GO:0031047]","cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleolus organizer region [GO:0005731]; nucleus [GO:0005634]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521]; female meiotic nuclear division [GO:0007143]; male meiotic nuclear division [GO:0007140]; megagametogenesis [GO:0009561]; microgametogenesis [GO:0055046]; positive regulation of meiotic DNA double-strand break formation [GO:1903343]; regulation of gene expression [GO:0010468]; regulatory ncRNA-mediated gene silencing [GO:0031047]","DEVELOPMENTAL STAGE: Expressed specifically in male and female archesporial cells and sporogenous cells (SC) before meiosis but not in the nursery cells supporting SC. {ECO:0000269|PubMed:17675402}.","","",""
"699","sp|Q6NU04|TDRD7_XENLA","lcl|NC_088857.1_cds_XP_065941039.1_26150",3.49e-20,98.6,"Q6NU04","TDRD7_XENLA","Tudor domain-containing protein 7","tdrd7","Xenopus laevis (African clawed frog)",1079,"GO:0002089; GO:0003729; GO:0007283; GO:0010608; GO:0030719; GO:0034587; GO:0035770; GO:0043186; GO:0070306","lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; post-transcriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283]","P granule [GO:0043186]; ribonucleoprotein granule [GO:0035770]; mRNA binding [GO:0003729]; lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; post-transcriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283]","","","",""
"700","sp|Q27371|TNNT_CAEEL","lcl|NC_088857.1_cds_XP_065941071.1_26180",3.03e-20,92,"Q27371","TNNT_CAEEL","Troponin T","mup-2 T22E5.5","Caenorhabditis elegans",405,"GO:0005523; GO:0005861; GO:0006936; GO:0006937; GO:0007413; GO:0007526; GO:0030728; GO:0045214; GO:0048598","axonal fasciculation [GO:0007413]; embryonic morphogenesis [GO:0048598]; larval somatic muscle development [GO:0007526]; muscle contraction [GO:0006936]; ovulation [GO:0030728]; regulation of muscle contraction [GO:0006937]; sarcomere organization [GO:0045214]","troponin complex [GO:0005861]; tropomyosin binding [GO:0005523]; axonal fasciculation [GO:0007413]; embryonic morphogenesis [GO:0048598]; larval somatic muscle development [GO:0007526]; muscle contraction [GO:0006936]; ovulation [GO:0030728]; regulation of muscle contraction [GO:0006937]; sarcomere organization [GO:0045214]","","","",""
"701","sp|Q24314|VPS18_DROME","lcl|NC_088857.1_cds_XP_065941113.1_24012",0,576,"Q24314","VPS18_DROME","Vacuolar protein sorting-associated protein 18 homolog (Protein deep orange)","dor Vps18 CG3093","Drosophila melanogaster (Fruit fly)",1002,"GO:0000421; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0006622; GO:0006897; GO:0006898; GO:0006904; GO:0007032; GO:0007040; GO:0007041; GO:0007220; GO:0007298; GO:0008057; GO:0008270; GO:0008333; GO:0008340; GO:0009267; GO:0016197; GO:0016567; GO:0030674; GO:0030897; GO:0031594; GO:0031902; GO:0032456; GO:0033263; GO:0033292; GO:0034058; GO:0035542; GO:0045022; GO:0045202; GO:0048072; GO:0048284; GO:0051301; GO:0061357; GO:0061630; GO:0097352; GO:0098693; GO:0160156","autophagosome maturation [GO:0097352]; border follicle cell migration [GO:0007298]; cell division [GO:0051301]; cellular response to starvation [GO:0009267]; compound eye pigmentation [GO:0048072]; determination of adult lifespan [GO:0008340]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; eye pigment granule organization [GO:0008057]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; Notch receptor processing [GO:0007220]; organelle fusion [GO:0048284]; positive regulation of Wnt protein secretion [GO:0061357]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; receptor-mediated endocytosis [GO:0006898]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic vesicle cycle [GO:0098693]; secretory granule-lysosome fusion [GO:0160156]; T-tubule organization [GO:0033292]; vesicle docking involved in exocytosis [GO:0006904]","autophagosome membrane [GO:0000421]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuromuscular junction [GO:0031594]; synapse [GO:0045202]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; autophagosome maturation [GO:0097352]; border follicle cell migration [GO:0007298]; cell division [GO:0051301]; cellular response to starvation [GO:0009267]; compound eye pigmentation [GO:0048072]; determination of adult lifespan [GO:0008340]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; eye pigment granule organization [GO:0008057]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; Notch receptor processing [GO:0007220]; organelle fusion [GO:0048284]; positive regulation of Wnt protein secretion [GO:0061357]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; receptor-mediated endocytosis [GO:0006898]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic vesicle cycle [GO:0098693]; secretory granule-lysosome fusion [GO:0160156]; T-tubule organization [GO:0033292]; vesicle docking involved in exocytosis [GO:0006904]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically in all stages of development (PubMed:9065698). Highest expression is in third larval instar (PubMed:10549280, PubMed:9065698). Expressed in the larval Garland nephrocytes and in the adult (at protein level) (PubMed:10549280, PubMed:27253064). {ECO:0000269|PubMed:10549280, ECO:0000269|PubMed:27253064, ECO:0000269|PubMed:9065698}.","","",""
"702","sp|Q5EA33|ANR49_BOVIN","lcl|NC_088857.1_cds_XP_065941119.1_24010",2.77e-51,169,"Q5EA33","ANR49_BOVIN","Ankyrin repeat domain-containing protein 49","ANKRD49","Bos taurus (Bovine)",238,"GO:0005634; GO:0007283; GO:0030154; GO:0045893","cell differentiation [GO:0030154]; positive regulation of DNA-templated transcription [GO:0045893]; spermatogenesis [GO:0007283]","nucleus [GO:0005634]; cell differentiation [GO:0030154]; positive regulation of DNA-templated transcription [GO:0045893]; spermatogenesis [GO:0007283]","","","",""
"703","sp|Q6UJY2|SL9C1_MOUSE","lcl|NC_088857.1_cds_XP_065941177.1_22307",7.02e-118,395,"Q6UJY2","SL9C1_MOUSE","Solute carrier family 9 member C1 (Na(+)/H(+) exchanger 10) (NHE-10) (Sodium/hydrogen exchanger 10) (Solute carrier family 10 member 10) (Sperm-specific Na(+)/H(+) exchanger) (sNHE)","Slc9c1 Gm610 Slc9a10","Mus musculus (Mouse)",1175,"GO:0005216; GO:0007283; GO:0015385; GO:0030154; GO:0030317; GO:0031514; GO:0060170","cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283]","ciliary membrane [GO:0060170]; motile cilium [GO:0031514]; monoatomic ion channel activity [GO:0005216]; sodium:proton antiporter activity [GO:0015385]; cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Testis-specific. Specifically present in the principal piece of sperm tail (at protein level). {ECO:0000269|PubMed:14634667}."
"704","sp|Q9NBD7|CLASP_DROME","lcl|NC_088857.1_cds_XP_065941448.1_23906",7.54e-145,482,"Q9NBD7","CLASP_DROME","CLIP-associating protein (Misexpression suppressor of ras 7) (Protein Multiple asters) (Mast) (Protein Orbit) (Protein chromosome bows)","chb CLASP Mast MESR7 orbit CG32435","Drosophila melanogaster (Fruit fly)",1491,"GO:0000022; GO:0000070; GO:0000278; GO:0000775; GO:0000776; GO:0000922; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005815; GO:0005819; GO:0005827; GO:0005875; GO:0005876; GO:0005881; GO:0007051; GO:0007052; GO:0007282; GO:0007411; GO:0008017; GO:0016325; GO:0019827; GO:0030426; GO:0030723; GO:0031116; GO:0031965; GO:0032154; GO:0035099; GO:0035371; GO:0040001; GO:0045169; GO:0045170; GO:0045172; GO:0045180; GO:0046602; GO:0048477; GO:0051225; GO:0051315; GO:0070732; GO:0070938; GO:0072686; GO:0090307","attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; axon guidance [GO:0007411]; cystoblast division [GO:0007282]; establishment of mitotic spindle localization [GO:0040001]; hemocyte migration [GO:0035099]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle elongation [GO:0000022]; mitotic spindle organization [GO:0007052]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; positive regulation of microtubule polymerization [GO:0031116]; regulation of mitotic centrosome separation [GO:0046602]; spindle assembly [GO:0051225]; spindle organization [GO:0007051]; stem cell population maintenance [GO:0019827]","basal cortex [GO:0045180]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cleavage furrow [GO:0032154]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; fusome [GO:0045169]; germline ring canal [GO:0045172]; growth cone [GO:0030426]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; polar microtubule [GO:0005827]; spectrosome [GO:0045170]; spindle [GO:0005819]; spindle envelope [GO:0070732]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; axon guidance [GO:0007411]; cystoblast division [GO:0007282]; establishment of mitotic spindle localization [GO:0040001]; hemocyte migration [GO:0035099]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle elongation [GO:0000022]; mitotic spindle organization [GO:0007052]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; positive regulation of microtubule polymerization [GO:0031116]; regulation of mitotic centrosome separation [GO:0046602]; spindle assembly [GO:0051225]; spindle organization [GO:0007051]; stem cell population maintenance [GO:0019827]","DEVELOPMENTAL STAGE: Expressed throughout development, although expression is low in pupae. At late developmental stages expression becomes pronounced in muscles and the nervous system, particularly within the intersegmental nerve b (ISNb). {ECO:0000269|PubMed:10747094, ECO:0000269|PubMed:10899121, ECO:0000269|PubMed:15207236}.","","","TISSUE SPECIFICITY: Expressed in testis and ovary. {ECO:0000269|PubMed:10899121, ECO:0000269|PubMed:12538517}."
"705","sp|P43332|SNRPA_DROME","lcl|NC_088857.1_cds_XP_065941467.1_26445",6.79e-91,267,"P43332","SNRPA_DROME","U1 small nuclear ribonucleoprotein A (U1 snRNP A) (U1-A) (U1A) (Sex determination protein snf)","snf D25 fs(1)1621 liz CG4528","Drosophila melanogaster (Fruit fly)",216,"GO:0000381; GO:0000398; GO:0003729; GO:0005634; GO:0005681; GO:0005685; GO:0005686; GO:0007539; GO:0008266; GO:0008380; GO:0019099; GO:0030532; GO:0030619; GO:0030620; GO:0032991; GO:0035614; GO:0042802; GO:0048477; GO:0071011; GO:0071013; GO:0097158; GO:1990904","female germ-line sex determination [GO:0019099]; mRNA splicing, via spliceosome [GO:0000398]; oogenesis [GO:0048477]; primary sex determination, soma [GO:0007539]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]","catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]; pre-mRNA intronic pyrimidine-rich binding [GO:0097158]; snRNA stem-loop binding [GO:0035614]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; female germ-line sex determination [GO:0019099]; mRNA splicing, via spliceosome [GO:0000398]; oogenesis [GO:0048477]; primary sex determination, soma [GO:0007539]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]","","","",""
"706","sp|Q8C0S4|TT21A_MOUSE","lcl|NC_088857.1_cds_XP_065941511.1_23813",0,1228,"Q8C0S4","TT21A_MOUSE","Tetratricopeptide repeat protein 21A (TPR repeat protein 21A) (Tetratricopeptide repeat-containing hedgehog modulator 2)","Ttc21a Thm2","Mus musculus (Mouse)",1314,"GO:0007286; GO:0030317","flagellated sperm motility [GO:0030317]; spermatid development [GO:0007286]","flagellated sperm motility [GO:0030317]; spermatid development [GO:0007286]","","","",""
"707","sp|Q9V637|PSMF1_DROME","lcl|NC_088857.1_cds_XP_065941617.1_26650",6.79e-14,71.2,"Q9V637","PSMF1_DROME","Proteasome inhibitor PI31 subunit","PI31 CG8979","Drosophila melanogaster (Fruit fly)",270,"GO:0000502; GO:0004866; GO:0005737; GO:0006511; GO:0007140; GO:0008584; GO:0032436; GO:0043161; GO:0070628; GO:0070864; GO:0090364","male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteasome assembly [GO:0090364]; ubiquitin-dependent protein catabolic process [GO:0006511]","cytoplasm [GO:0005737]; proteasome complex [GO:0000502]; sperm individualization complex [GO:0070864]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteasome assembly [GO:0090364]; ubiquitin-dependent protein catabolic process [GO:0006511]","DEVELOPMENTAL STAGE: Expressed in adults. {ECO:0000269|PubMed:21529711}.","","","TISSUE SPECIFICITY: In testis, expressed in germline stem cells and primary spermatocytes (at protein level). {ECO:0000269|PubMed:21529711}."
"708","sp|P51993|FUT6_HUMAN","lcl|NC_088857.1_cds_XP_065941619.1_24975",8.49e-45,160,"P51993","FUT6_HUMAN","4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 (EC 2.4.1.152) (Fucosyltransferase 6) (Fucosyltransferase VI) (Fuc-TVI) (FucT-VI) (Galactoside 3-L-fucosyltransferase)","FUT6 FCT3A","Homo sapiens (Human)",359,"GO:0000139; GO:0005576; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006672; GO:0006688; GO:0007309; GO:0008417; GO:0009312; GO:0017083; GO:0032580; GO:0034709; GO:0036071; GO:0042355; GO:0046920; GO:0070062","ceramide metabolic process [GO:0006672]; glycosphingolipid biosynthetic process [GO:0006688]; L-fucose catabolic process [GO:0042355]; N-glycan fucosylation [GO:0036071]; oligosaccharide biosynthetic process [GO:0009312]; oocyte axis specification [GO:0007309]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]","extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; methylosome [GO:0034709]; 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity [GO:0017083]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; ceramide metabolic process [GO:0006672]; glycosphingolipid biosynthetic process [GO:0006688]; L-fucose catabolic process [GO:0042355]; N-glycan fucosylation [GO:0036071]; oligosaccharide biosynthetic process [GO:0009312]; oocyte axis specification [GO:0007309]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]","","","","TISSUE SPECIFICITY: Kidney, liver, colon, small intestine, bladder, uterus and salivary gland."
"709","sp|V6CLJ5|LAG1_CAEEL","lcl|NC_088857.1_cds_XP_065941642.1_22407",3.82e-167,494,"V6CLJ5","LAG1_CAEEL","Suppressor of hairless protein homolog (CSL transcription factor lag-1) (Lin-12 and glp-1 phenotype protein)","lag-1 K08B4.1","Caenorhabditis elegans",790,"GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001223; GO:0001228; GO:0001555; GO:0001708; GO:0001709; GO:0002119; GO:0003690; GO:0005112; GO:0005634; GO:0006357; GO:0007219; GO:0010468; GO:0018991; GO:0040026; GO:0042078; GO:0042659; GO:0042661; GO:0043054; GO:0043565; GO:0045893; GO:0045944; GO:0048858; GO:0048867; GO:0090575; GO:1902895; GO:1990433","cell fate determination [GO:0001709]; cell fate specification [GO:0001708]; cell projection morphogenesis [GO:0048858]; dauer exit [GO:0043054]; egg-laying behavior [GO:0018991]; germ-line stem cell division [GO:0042078]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nematode larval development [GO:0002119]; Notch signaling pathway [GO:0007219]; oocyte growth [GO:0001555]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vulval development [GO:0040026]; regulation of cell fate specification [GO:0042659]; regulation of gene expression [GO:0010468]; regulation of mesodermal cell fate specification [GO:0042661]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell fate determination [GO:0048867]","chromatin [GO:0000785]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; Notch binding [GO:0005112]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; cell fate determination [GO:0001709]; cell fate specification [GO:0001708]; cell projection morphogenesis [GO:0048858]; dauer exit [GO:0043054]; egg-laying behavior [GO:0018991]; germ-line stem cell division [GO:0042078]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nematode larval development [GO:0002119]; Notch signaling pathway [GO:0007219]; oocyte growth [GO:0001555]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vulval development [GO:0040026]; regulation of cell fate specification [GO:0042659]; regulation of gene expression [GO:0010468]; regulation of mesodermal cell fate specification [GO:0042661]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell fate determination [GO:0048867]","DEVELOPMENTAL STAGE: Expressed in the precursor anchor cell and ventral uterine precursor cell (Z1.ppp, Z1.ppa, Z4.aaa, and Z4.aap) before cell specification, at early larval stage L2 (PubMed:23615264). Expressed in the ventral uterine cell (VU), but not in the anchor cell (AC), after specification, at late larval stage L2 (PubMed:23615264). Expressed in a dynamic pattern in the vulval precursor cells (VPCs) during vulval induction in larval stage L3 (PubMed:32839181). Expressed in somatic gonad cells, the distal tip cell (DTC), and all sheath and spermathecal cells, as well as in polyploid intestinal cells, in both the larval L4 and adult stages. {ECO:0000269|PubMed:23615264, ECO:0000269|PubMed:32196486, ECO:0000269|PubMed:32839181}.","","","TISSUE SPECIFICITY: In young adults, expressed in germ cells in the distal most ~10 cell diameters of the progenitor zone (PZ), and also in late pachytene, diplotene and diakinesis of oogenesis. {ECO:0000269|PubMed:32196486}."
"710","sp|F1M8G0|PHTF1_RAT","lcl|NC_088857.1_cds_XP_065941713.1_22242",2.58e-80,274,"F1M8G0","PHTF1_RAT","Protein PHTF1","Phtf1","Rattus norvegicus (Rat)",762,"GO:0005789; GO:0007283; GO:0033106","spermatogenesis [GO:0007283]","cis-Golgi network membrane [GO:0033106]; endoplasmic reticulum membrane [GO:0005789]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: The protein first appears in meiotic spermatocytes and becomes abundant in spermatids around stage III-IV (at protein level). {ECO:0000269|PubMed:12604659}.","","","TISSUE SPECIFICITY: Highly expressed in testis. {ECO:0000269|PubMed:12604659}."
"711","sp|Q98938|IHH_CHICK","lcl|NC_088857.1_cds_XP_065941952.1_27088",4.58e-130,381,"Q98938","IHH_CHICK","Indian hedgehog protein (IHH) (EC 3.1.-.-) [Cleaved into: Indian hedgehog protein N-product]","IHH","Gallus gallus (Chicken)",408,"GO:0000139; GO:0001569; GO:0001649; GO:0001708; GO:0001947; GO:0002053; GO:0003382; GO:0003406; GO:0003413; GO:0003420; GO:0005113; GO:0005509; GO:0005615; GO:0005789; GO:0005886; GO:0006029; GO:0007224; GO:0007267; GO:0008233; GO:0009880; GO:0010468; GO:0010628; GO:0010694; GO:0016540; GO:0030704; GO:0031012; GO:0031016; GO:0032331; GO:0032967; GO:0033088; GO:0033089; GO:0034189; GO:0035264; GO:0035988; GO:0042733; GO:0045453; GO:0045669; GO:0045880; GO:0045944; GO:0046638; GO:0046639; GO:0048074; GO:0048469; GO:0048557; GO:0048596; GO:0048666; GO:0048745; GO:0051216; GO:0060220; GO:0060323; GO:0060591; GO:0061053; GO:0072498; GO:0090136; GO:0097264; GO:0140853; GO:1902730; GO:1902733; GO:1902738; GO:1903042","bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; camera-type eye photoreceptor cell fate commitment [GO:0060220]; cartilage development [GO:0051216]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell-cell signaling [GO:0007267]; chondroblast differentiation [GO:0060591]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; chondrocyte proliferation [GO:0035988]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic digit morphogenesis [GO:0042733]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint development [GO:0072498]; epithelial cell morphogenesis [GO:0003382]; epithelial cell-cell adhesion [GO:0090136]; head morphogenesis [GO:0060323]; heart looping [GO:0001947]; multicellular organism growth [GO:0035264]; negative regulation of alpha-beta T cell differentiation [GO:0046639]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of chondrocyte hypertrophy [GO:1903042]; negative regulation of eye pigmentation [GO:0048074]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; neuron development [GO:0048666]; osteoblast differentiation [GO:0001649]; pancreas development [GO:0031016]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of proteoglycan biosynthetic process [GO:1902730]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoprocessing [GO:0016540]; proteoglycan metabolic process [GO:0006029]; regulation of chondrocyte differentiation involved in endochondral bone morphogenesis [GO:1902738]; regulation of gene expression [GO:0010468]; regulation of growth plate cartilage chondrocyte differentiation [GO:1902733]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; retinal pigment epithelium development [GO:0003406]; self proteolysis [GO:0097264]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; somite development [GO:0061053]; vitelline membrane formation [GO:0030704]","endoplasmic reticulum membrane [GO:0005789]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cholesterol-protein transferase activity [GO:0140853]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; very-low-density lipoprotein particle binding [GO:0034189]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; camera-type eye photoreceptor cell fate commitment [GO:0060220]; cartilage development [GO:0051216]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell-cell signaling [GO:0007267]; chondroblast differentiation [GO:0060591]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; chondrocyte proliferation [GO:0035988]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic digit morphogenesis [GO:0042733]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint development [GO:0072498]; epithelial cell morphogenesis [GO:0003382]; epithelial cell-cell adhesion [GO:0090136]; head morphogenesis [GO:0060323]; heart looping [GO:0001947]; multicellular organism growth [GO:0035264]; negative regulation of alpha-beta T cell differentiation [GO:0046639]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of chondrocyte hypertrophy [GO:1903042]; negative regulation of eye pigmentation [GO:0048074]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; neuron development [GO:0048666]; osteoblast differentiation [GO:0001649]; pancreas development [GO:0031016]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of proteoglycan biosynthetic process [GO:1902730]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoprocessing [GO:0016540]; proteoglycan metabolic process [GO:0006029]; regulation of chondrocyte differentiation involved in endochondral bone morphogenesis [GO:1902738]; regulation of gene expression [GO:0010468]; regulation of growth plate cartilage chondrocyte differentiation [GO:1902733]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; retinal pigment epithelium development [GO:0003406]; self proteolysis [GO:0097264]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; somite development [GO:0061053]; vitelline membrane formation [GO:0030704]","","","","TISSUE SPECIFICITY: Expressed in developing midgut, lung and cartilage of developing long bones in the limb. {ECO:0000269|PubMed:8662546}."
"712","sp|B4MA12|WUHO_DROVI","lcl|NC_088857.1_cds_XP_065942219.1_27456",5.07e-23,100,"B4MA12","WUHO_DROVI","tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit wuho","wuho GJ15762","Drosophila virilis (Fruit fly)",397,"GO:0001673; GO:0001674; GO:0005634; GO:0005829; GO:0007283; GO:0043527; GO:0048477; GO:0106004","oogenesis [GO:0048477]; spermatogenesis [GO:0007283]; tRNA (guanine-N7)-methylation [GO:0106004]","cytosol [GO:0005829]; female germ cell nucleus [GO:0001674]; male germ cell nucleus [GO:0001673]; nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]; tRNA (guanine-N7)-methylation [GO:0106004]","","","","TISSUE SPECIFICITY: In testis, it is present at high level in hub cells, a niche for germline stem cells of testis. Ubiquitously expressed in all testicular cells throughout spermatogenesis. Ubiquitously expressed in all germline and somatic cells of the ovary. {ECO:0000250|UniProtKB:Q9W415}."
"713","sp|Q80WG5|LRC8A_MOUSE","lcl|NC_088857.1_cds_XP_065942294.1_27526",1.57e-24,112,"Q80WG5","LRC8A_MOUSE","Volume-regulated anion channel subunit LRRC8A (Leucine-rich repeat-containing protein 8A) (Protein ebouriffe) (ebo) (Swelling protein 1)","Lrrc8a Lrrc8 Swell1","Mus musculus (Mouse)",810,"GO:0001678; GO:0002329; GO:0005225; GO:0005765; GO:0005886; GO:0006820; GO:0006884; GO:0006970; GO:0007283; GO:0009986; GO:0015734; GO:0015810; GO:0032024; GO:0034214; GO:0034702; GO:0042802; GO:0045663; GO:0098656; GO:0140360; GO:0140361; GO:1902476","aspartate transmembrane transport [GO:0015810]; cell volume homeostasis [GO:0006884]; chloride transmembrane transport [GO:1902476]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361]; intracellular glucose homeostasis [GO:0001678]; monoatomic anion transmembrane transport [GO:0098656]; monoatomic anion transport [GO:0006820]; positive regulation of insulin secretion [GO:0032024]; positive regulation of myoblast differentiation [GO:0045663]; pre-B cell differentiation [GO:0002329]; protein hexamerization [GO:0034214]; response to osmotic stress [GO:0006970]; spermatogenesis [GO:0007283]; taurine transmembrane transport [GO:0015734]","cell surface [GO:0009986]; lysosomal membrane [GO:0005765]; monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886]; cyclic-GMP-AMP transmembrane transporter activity [GO:0140360]; identical protein binding [GO:0042802]; volume-sensitive anion channel activity [GO:0005225]; aspartate transmembrane transport [GO:0015810]; cell volume homeostasis [GO:0006884]; chloride transmembrane transport [GO:1902476]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361]; intracellular glucose homeostasis [GO:0001678]; monoatomic anion transmembrane transport [GO:0098656]; monoatomic anion transport [GO:0006820]; positive regulation of insulin secretion [GO:0032024]; positive regulation of myoblast differentiation [GO:0045663]; pre-B cell differentiation [GO:0002329]; protein hexamerization [GO:0034214]; response to osmotic stress [GO:0006970]; spermatogenesis [GO:0007283]; taurine transmembrane transport [GO:0015734]","","","","TISSUE SPECIFICITY: Ubiquitously expressed (PubMed:24725410, PubMed:30135305). High levels detected in the bone marrow; lower levels found in peripheral blood cells (PubMed:14660746, PubMed:15094057, PubMed:24752297). Highly expressed in pancreatic beta cells (PubMed:29773801). {ECO:0000269|PubMed:14660746, ECO:0000269|PubMed:15094057, ECO:0000269|PubMed:24725410, ECO:0000269|PubMed:24752297, ECO:0000269|PubMed:29773801, ECO:0000269|PubMed:30135305}."
"714","sp|Q7KRY7|SCRIB_DROME","lcl|NC_088857.1_cds_XP_065942298.1_27529",1.95e-169,564,"Q7KRY7","SCRIB_DROME","Protein lap4 (Protein scribble) (Protein smell-impaired)","scrib smi vart CG5462","Drosophila melanogaster (Fruit fly)",1851,"GO:0000902; GO:0001708; GO:0001737; GO:0001738; GO:0005912; GO:0005918; GO:0005938; GO:0007318; GO:0007391; GO:0007464; GO:0007472; GO:0007608; GO:0007613; GO:0008285; GO:0014069; GO:0016323; GO:0016327; GO:0016328; GO:0016331; GO:0016332; GO:0016333; GO:0016334; GO:0016335; GO:0016336; GO:0019901; GO:0019991; GO:0030100; GO:0030707; GO:0030714; GO:0031594; GO:0035088; GO:0042048; GO:0042067; GO:0043113; GO:0045169; GO:0045175; GO:0045179; GO:0045186; GO:0045197; GO:0045198; GO:0045571; GO:0048749; GO:0048863; GO:0050680; GO:0050803; GO:0060581; GO:0072002; GO:0072089; GO:0098609; GO:0098887; GO:1990794","anterior/posterior axis specification, follicular epithelium [GO:0030714]; basal protein localization [GO:0045175]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; follicle cell of egg chamber development [GO:0030707]; Malpighian tubule development [GO:0072002]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of imaginal disc growth [GO:0045571]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; olfactory behavior [GO:0042048]; pole plasm protein localization [GO:0007318]; R3/R4 cell fate commitment [GO:0007464]; receptor clustering [GO:0043113]; regulation of endocytosis [GO:0030100]; regulation of synapse structure or activity [GO:0050803]; sensory perception of smell [GO:0007608]; septate junction assembly [GO:0019991]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186]","adherens junction [GO:0005912]; apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; basolateral part of cell [GO:1990794]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; postsynaptic density [GO:0014069]; septate junction [GO:0005918]; protein kinase binding [GO:0019901]; anterior/posterior axis specification, follicular epithelium [GO:0030714]; basal protein localization [GO:0045175]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; follicle cell of egg chamber development [GO:0030707]; Malpighian tubule development [GO:0072002]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of imaginal disc growth [GO:0045571]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; olfactory behavior [GO:0042048]; pole plasm protein localization [GO:0007318]; R3/R4 cell fate commitment [GO:0007464]; receptor clustering [GO:0043113]; regulation of endocytosis [GO:0030100]; regulation of synapse structure or activity [GO:0050803]; sensory perception of smell [GO:0007608]; septate junction assembly [GO:0019991]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186]","DEVELOPMENTAL STAGE: Expressed both zygotically and maternally in embryos. Isoform A and isoform C have high expression throughout embryonic development and very low expression in later developmental stages. In adults, isoform A is a male-specific isoform and isoform C a female specific. {ECO:0000269|PubMed:10688207, ECO:0000269|PubMed:11578873, ECO:0000269|PubMed:12930751}.","","","TISSUE SPECIFICITY: During germ band extension, expression of isoform A occurs predominantly in neuroblasts derived from the neuro-ectoderm and later is restricted to CNS neurons and pole cells. Isoform C is strongly expressed in PNS and a subset of CNS neurons. In the adult, expressed in third antennal segment and maxillary palps, major olfactory organs and in Johnstons organ in the second antennal segment. Expression is also observed in cortical regions of the brain. Isoforms expressed in epithelia are coexpressed with dlg1 throughout development. {ECO:0000269|PubMed:10884224, ECO:0000269|PubMed:11578873, ECO:0000269|PubMed:12930751}."
"715","sp|Q8IWT6|LRC8A_HUMAN","lcl|NC_088857.1_cds_XP_065942307.1_27519",5.93e-24,110,"Q8IWT6","LRC8A_HUMAN","Volume-regulated anion channel subunit LRRC8A (Leucine-rich repeat-containing protein 8A) (HsLRRC8A) (Swelling protein 1)","LRRC8A KIAA1437 LRRC8 SWELL1 UNQ221/PRO247","Homo sapiens (Human)",810,"GO:0001678; GO:0002329; GO:0005225; GO:0005737; GO:0005765; GO:0005886; GO:0006820; GO:0006884; GO:0006970; GO:0007283; GO:0009986; GO:0015734; GO:0015810; GO:0016020; GO:0032024; GO:0034214; GO:0034702; GO:0035556; GO:0042802; GO:0045663; GO:0098656; GO:0140360; GO:0140361; GO:1902476","aspartate transmembrane transport [GO:0015810]; cell volume homeostasis [GO:0006884]; chloride transmembrane transport [GO:1902476]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361]; intracellular glucose homeostasis [GO:0001678]; intracellular signal transduction [GO:0035556]; monoatomic anion transmembrane transport [GO:0098656]; monoatomic anion transport [GO:0006820]; positive regulation of insulin secretion [GO:0032024]; positive regulation of myoblast differentiation [GO:0045663]; pre-B cell differentiation [GO:0002329]; protein hexamerization [GO:0034214]; response to osmotic stress [GO:0006970]; spermatogenesis [GO:0007283]; taurine transmembrane transport [GO:0015734]","cell surface [GO:0009986]; cytoplasm [GO:0005737]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886]; cyclic-GMP-AMP transmembrane transporter activity [GO:0140360]; identical protein binding [GO:0042802]; volume-sensitive anion channel activity [GO:0005225]; aspartate transmembrane transport [GO:0015810]; cell volume homeostasis [GO:0006884]; chloride transmembrane transport [GO:1902476]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361]; intracellular glucose homeostasis [GO:0001678]; intracellular signal transduction [GO:0035556]; monoatomic anion transmembrane transport [GO:0098656]; monoatomic anion transport [GO:0006820]; positive regulation of insulin secretion [GO:0032024]; positive regulation of myoblast differentiation [GO:0045663]; pre-B cell differentiation [GO:0002329]; protein hexamerization [GO:0034214]; response to osmotic stress [GO:0006970]; spermatogenesis [GO:0007283]; taurine transmembrane transport [GO:0015734]","","","","TISSUE SPECIFICITY: Expressed in brain, kidney, ovary, lung, liver, heart, and fetal brain and liver. Found at high levels in bone marrow; lower levels are detected in peripheral blood cells. Expressed on T-cells as well as on B-lineage cells. {ECO:0000269|PubMed:10718198, ECO:0000269|PubMed:14660746}."
"716","sp|P21187|PABP_DROME","lcl|NC_088857.1_cds_XP_065942361.1_24312",0,619,"P21187","PABP_DROME","Polyadenylate-binding protein (PABP) (Poly(A)-binding protein)","pAbp CG5119","Drosophila melanogaster (Fruit fly)",634,"GO:0000398; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0007112; GO:0007140; GO:0007268; GO:0007283; GO:0007289; GO:0008143; GO:0008266; GO:0009953; GO:0010494; GO:0045202; GO:0045314; GO:0045727; GO:0048477; GO:0048599; GO:0071011; GO:0071013; GO:1990904","chemical synaptic transmission [GO:0007268]; dorsal/ventral pattern formation [GO:0009953]; male meiosis cytokinesis [GO:0007112]; male meiotic nuclear division [GO:0007140]; mRNA splicing, via spliceosome [GO:0000398]; oocyte development [GO:0048599]; oogenesis [GO:0048477]; positive regulation of translation [GO:0045727]; regulation of compound eye photoreceptor development [GO:0045314]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]","catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; chemical synaptic transmission [GO:0007268]; dorsal/ventral pattern formation [GO:0009953]; male meiosis cytokinesis [GO:0007112]; male meiotic nuclear division [GO:0007140]; mRNA splicing, via spliceosome [GO:0000398]; oocyte development [GO:0048599]; oogenesis [GO:0048477]; positive regulation of translation [GO:0045727]; regulation of compound eye photoreceptor development [GO:0045314]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed during the first 5 hrs of embryogenesis (at protein level) (PubMed:28875934). Expressed both maternally and zygotically throughout development (PubMed:2125288). {ECO:0000269|PubMed:2125288, ECO:0000269|PubMed:28875934}.","","",""
"717","sp|Q8I7C3|LASP1_DROME","lcl|NC_088857.1_cds_XP_065942403.1_22512",3.6e-56,195,"Q8I7C3","LASP1_DROME","LIM and SH3 domain protein Lasp","Lasp CG3849","Drosophila melanogaster (Fruit fly)",657,"GO:0003779; GO:0005829; GO:0005925; GO:0007279; GO:0007283; GO:0007291; GO:0014881; GO:0030018; GO:0031672; GO:0045214; GO:0045856; GO:0046872; GO:0051015; GO:0070864; GO:0071689","muscle thin filament assembly [GO:0071689]; pole cell formation [GO:0007279]; positive regulation of pole plasm oskar mRNA localization [GO:0045856]; regulation of myofibril size [GO:0014881]; sarcomere organization [GO:0045214]; sperm individualization [GO:0007291]; spermatogenesis [GO:0007283]","A band [GO:0031672]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; sperm individualization complex [GO:0070864]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; muscle thin filament assembly [GO:0071689]; pole cell formation [GO:0007279]; positive regulation of pole plasm oskar mRNA localization [GO:0045856]; regulation of myofibril size [GO:0014881]; sarcomere organization [GO:0045214]; sperm individualization [GO:0007291]; spermatogenesis [GO:0007283]","","","",""
"718","sp|P51592|HYD_DROME","lcl|NC_088857.1_cds_XP_065942454.1_27703",0,639,"P51592","HYD_DROME","E3 ubiquitin-protein ligase hyd (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase hyd) (Protein hyperplastic discs)","hyd l(3)C43 CG9484","Drosophila melanogaster (Fruit fly)",2885,"GO:0000209; GO:0003723; GO:0005634; GO:0005737; GO:0007112; GO:0007283; GO:0007289; GO:0007444; GO:0007446; GO:0007455; GO:0008270; GO:0008585; GO:0034450; GO:0035220; GO:0043130; GO:0061059; GO:0061630; GO:0070534; GO:0070936; GO:0090263","eye-antennal disc morphogenesis [GO:0007455]; female gonad development [GO:0008585]; imaginal disc development [GO:0007444]; imaginal disc growth [GO:0007446]; male meiosis cytokinesis [GO:0007112]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of peptidoglycan recognition protein signaling pathway [GO:0061059]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]; wing disc development [GO:0035220]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; eye-antennal disc morphogenesis [GO:0007455]; female gonad development [GO:0008585]; imaginal disc development [GO:0007444]; imaginal disc growth [GO:0007446]; male meiosis cytokinesis [GO:0007112]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of peptidoglycan recognition protein signaling pathway [GO:0061059]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]; wing disc development [GO:0035220]","DEVELOPMENTAL STAGE: Expressed at all stages of development, with high levels at the embryonic and pupal stages (at protein level). {ECO:0000269|PubMed:7958417}.","","",""
"719","sp|Q03017|CACT_DROME","lcl|NC_088858.1_cds_NP_001292264.1_32505",4.31e-37,141,"Q03017","CACT_DROME","NF-kappa-B inhibitor cactus","cact CG5848","Drosophila melanogaster (Fruit fly)",500,"GO:0002789; GO:0005737; GO:0005829; GO:0009950; GO:0009953; GO:0019730; GO:0031594; GO:0043124; GO:0045611; GO:0045751; GO:0046843; GO:0048477; GO:0051059; GO:0071212; GO:0140311","antimicrobial humoral response [GO:0019730]; dorsal appendage formation [GO:0046843]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of antifungal peptide production [GO:0002789]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of hemocyte differentiation [GO:0045611]; negative regulation of Toll signaling pathway [GO:0045751]; oogenesis [GO:0048477]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; subsynaptic reticulum [GO:0071212]; NF-kappaB binding [GO:0051059]; protein sequestering activity [GO:0140311]; antimicrobial humoral response [GO:0019730]; dorsal appendage formation [GO:0046843]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of antifungal peptide production [GO:0002789]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of hemocyte differentiation [GO:0045611]; negative regulation of Toll signaling pathway [GO:0045751]; oogenesis [GO:0048477]","DEVELOPMENTAL STAGE: Expressed during embryogenesis (at protein level). Isoform A is expressed in ovaries and 0-1 hour embryos. After 2-3 hours unphosphorylated zygotic protein is expressed. Between 4-8 hours phosphorylated zygotic protein is expressed. After 12 hours the amount of unphosphorylated zygotic protein increases until, by the end of embryogenesis, it is the most abundant form of cactus. {ECO:0000269|PubMed:1423619}.","","","TISSUE SPECIFICITY: Expressed in ovary (at protein level)."
"720","sp|Q24167|SIMA_DROME","lcl|NC_088858.1_cds_NP_001292266.1_28662",1.85e-88,305,"Q24167","SIMA_DROME","Protein similar","sima CG45051","Drosophila melanogaster (Fruit fly)",1507,"GO:0000977; GO:0000981; GO:0001228; GO:0005634; GO:0005829; GO:0006355; GO:0006357; GO:0008286; GO:0010628; GO:0016239; GO:0030308; GO:0030334; GO:0032869; GO:0045088; GO:0045821; GO:0045944; GO:0046983; GO:0048477; GO:0060438; GO:0071456; GO:0090575","cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell growth [GO:0030308]; oogenesis [GO:0048477]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of DNA-templated transcription [GO:0006355]; regulation of innate immune response [GO:0045088]; regulation of transcription by RNA polymerase II [GO:0006357]; trachea development [GO:0060438]","cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell growth [GO:0030308]; oogenesis [GO:0048477]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of DNA-templated transcription [GO:0006355]; regulation of innate immune response [GO:0045088]; regulation of transcription by RNA polymerase II [GO:0006357]; trachea development [GO:0060438]","","INDUCTION: By hypoxia. {ECO:0000269|PubMed:12215541, ECO:0000269|PubMed:9731218}.","INDUCTION: By hypoxia. {ECO:0000269|PubMed:12215541, ECO:0000269|PubMed:9731218}.","TISSUE SPECIFICITY: Ubiquitously expressed in the embryo. {ECO:0000269|PubMed:8682312}."
"721","sp|P02828|HSP83_DROME","lcl|NC_088858.1_cds_NP_001292284.1_32648",0,630,"P02828","HSP83_DROME","Heat shock protein 83 (HSP 82)","Hsp83 Hsp82 Hsp90 CG1242","Drosophila melanogaster (Fruit fly)",717,"GO:0002052; GO:0005158; GO:0005524; GO:0005705; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0006457; GO:0007098; GO:0008285; GO:0009408; GO:0009631; GO:0016887; GO:0019094; GO:0030911; GO:0032991; GO:0034605; GO:0034663; GO:0043248; GO:0045187; GO:0046628; GO:0048471; GO:0048477; GO:0050821; GO:0051082; GO:0070922; GO:0097753; GO:0098866; GO:0101031; GO:0140662","cellular response to heat [GO:0034605]; centrosome cycle [GO:0007098]; cold acclimation [GO:0009631]; membrane bending [GO:0097753]; multivesicular body fusion to apical plasma membrane [GO:0098866]; negative regulation of cell population proliferation [GO:0008285]; oogenesis [GO:0048477]; pole plasm mRNA localization [GO:0019094]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of neuroblast proliferation [GO:0002052]; proteasome assembly [GO:0043248]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; response to heat [GO:0009408]; RISC complex assembly [GO:0070922]","centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum chaperone complex [GO:0034663]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; polytene chromosome interband [GO:0005705]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; insulin receptor binding [GO:0005158]; TPR domain binding [GO:0030911]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; centrosome cycle [GO:0007098]; cold acclimation [GO:0009631]; membrane bending [GO:0097753]; multivesicular body fusion to apical plasma membrane [GO:0098866]; negative regulation of cell population proliferation [GO:0008285]; oogenesis [GO:0048477]; pole plasm mRNA localization [GO:0019094]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of neuroblast proliferation [GO:0002052]; proteasome assembly [GO:0043248]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; response to heat [GO:0009408]; RISC complex assembly [GO:0070922]","","INDUCTION: In contrast to other major heat shock proteins, this one is also expressed at normal growth temperatures. It is also developmentally expressed during oogenesis.","INDUCTION: In contrast to other major heat shock proteins, this one is also expressed at normal growth temperatures. It is also developmentally expressed during oogenesis.",""
"722","sp|P29332|CCNB2_CHICK","lcl|NC_088858.1_cds_XP_011412035.1_32475",1.42e-125,370,"P29332","CCNB2_CHICK","G2/mitotic-specific cyclin-B2","CCNB2 CYCB2","Gallus gallus (Chicken)",399,"GO:0000082; GO:0000307; GO:0005634; GO:0005737; GO:0005813; GO:0005815; GO:0005829; GO:0007057; GO:0008315; GO:0016020; GO:0016538; GO:0040008; GO:0043029; GO:0048538; GO:0051301; GO:0060317","cardiac epithelial to mesenchymal transition [GO:0060317]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/MI transition of meiotic cell cycle [GO:0008315]; regulation of growth [GO:0040008]; spindle assembly involved in female meiosis I [GO:0007057]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]","centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/MI transition of meiotic cell cycle [GO:0008315]; regulation of growth [GO:0040008]; spindle assembly involved in female meiosis I [GO:0007057]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]","DEVELOPMENTAL STAGE: Accumulates steadily during G2 and is abruptly destroyed at mitosis.","","",""
"723","sp|Q96M91|CFA53_HUMAN","lcl|NC_088858.1_cds_XP_011412039.1_32470",7.39e-30,124,"Q96M91","CFA53_HUMAN","Cilia- and flagella-associated protein 53 (Coiled-coil domain-containing protein 11)","CFAP53 CCDC11","Homo sapiens (Human)",514,"GO:0000922; GO:0002177; GO:0003341; GO:0005576; GO:0005814; GO:0005879; GO:0005929; GO:0005930; GO:0007368; GO:0030317; GO:0034451; GO:0035869; GO:0036126; GO:0060271; GO:0060287; GO:0120316; GO:0160111; GO:1905198","cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; flagellated sperm motility [GO:0030317]; manchette assembly [GO:1905198]; sperm flagellum assembly [GO:0120316]","axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; extracellular region [GO:0005576]; manchette [GO:0002177]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; flagellated sperm motility [GO:0030317]; manchette assembly [GO:1905198]; sperm flagellum assembly [GO:0120316]","","","","TISSUE SPECIFICITY: Expressed in skin fibroblasts (at protein level) (PubMed:22577226, PubMed:28621423). Expressed in nasal respiratory epithelial cells (at protein level) (PubMed:25504577). Expressed in airway epithelial cells (PubMed:36191189). {ECO:0000269|PubMed:22577226, ECO:0000269|PubMed:25504577, ECO:0000269|PubMed:28621423, ECO:0000269|PubMed:36191189}."
"724","sp|Q9VQ93|GOLP3_DROME","lcl|NC_088858.1_cds_XP_011412550.1_32669",2.95e-138,393,"Q9VQ93","GOLP3_DROME","Golgi phosphoprotein 3 homolog sauron (Protein rotini)","sau GOLPH3 l(2)s5379 rti CG7085","Drosophila melanogaster (Fruit fly)",294,"GO:0000139; GO:0000281; GO:0000301; GO:0000915; GO:0005794; GO:0005802; GO:0005829; GO:0006890; GO:0007030; GO:0007053; GO:0007110; GO:0007111; GO:0007112; GO:0010314; GO:0031267; GO:0031410; GO:0031985; GO:0032154; GO:0032266; GO:0036089; GO:0043001; GO:0046718; GO:0048194; GO:0051225; GO:0070273; GO:0070300; GO:0090307; GO:0140312; GO:0140450","actomyosin contractile ring assembly [GO:0000915]; cleavage furrow formation [GO:0036089]; Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly [GO:0090307]; protein targeting to Golgi apparatus [GO:0140450]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spindle assembly [GO:0051225]; spindle assembly involved in male meiosis [GO:0007053]; symbiont entry into host cell [GO:0046718]","cleavage furrow [GO:0032154]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; cargo adaptor activity [GO:0140312]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; small GTPase binding [GO:0031267]; actomyosin contractile ring assembly [GO:0000915]; cleavage furrow formation [GO:0036089]; Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly [GO:0090307]; protein targeting to Golgi apparatus [GO:0140450]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spindle assembly [GO:0051225]; spindle assembly involved in male meiosis [GO:0007053]; symbiont entry into host cell [GO:0046718]","","","",""
"725","sp|Q9W4X9|ZW10_DROME","lcl|NC_088858.1_cds_XP_011412552.3_30095",8.9e-48,181,"Q9W4X9","ZW10_DROME","Centromere/kinetochore protein zw10 (Mitotic 15 protein)","Zw10 mit(1)15 CG9900","Drosophila melanogaster (Fruit fly)",721,"GO:0000070; GO:0000776; GO:0005634; GO:0005783; GO:0005795; GO:0005828; GO:0006888; GO:0007030; GO:0007060; GO:0007094; GO:0007107; GO:0007112; GO:0031267; GO:0036063; GO:0036090; GO:0048193; GO:0051233; GO:0070939; GO:1990423","cleavage furrow ingression [GO:0036090]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; male meiosis chromosome segregation [GO:0007060]; male meiosis cytokinesis [GO:0007112]; membrane addition at site of cytokinesis [GO:0007107]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]","acroblast [GO:0036063]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; Golgi stack [GO:0005795]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; nucleus [GO:0005634]; RZZ complex [GO:1990423]; spindle midzone [GO:0051233]; small GTPase binding [GO:0031267]; cleavage furrow ingression [GO:0036090]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; male meiosis chromosome segregation [GO:0007060]; male meiosis cytokinesis [GO:0007112]; membrane addition at site of cytokinesis [GO:0007107]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]","DEVELOPMENTAL STAGE: Highest levels are found in embryo and adult. Levels decrease during the first and second larval instar and then decrease in third instar larvae and early pupae. {ECO:0000269|PubMed:1339459}.","","",""
"726","sp|P32183|FOXA3_RAT","lcl|NC_088858.1_cds_XP_011413445.1_33347",1.16e-65,214,"P32183","FOXA3_RAT","Hepatocyte nuclear factor 3-gamma (HNF-3-gamma) (HNF-3G) (Forkhead box protein A3)","Foxa3 Hnf3g Tcf-3g Tcf3g","Rattus norvegicus (Rat)",354,"GO:0000976; GO:0000978; GO:0000981; GO:0001678; GO:0003677; GO:0003700; GO:0005634; GO:0006325; GO:0006355; GO:0006357; GO:0006366; GO:0007283; GO:0008285; GO:0009267; GO:0009653; GO:0019904; GO:0030154; GO:0031667; GO:0043565; GO:0045944; GO:0061484; GO:0070368; GO:1990837","anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cellular response to starvation [GO:0009267]; chromatin organization [GO:0006325]; hematopoietic stem cell homeostasis [GO:0061484]; intracellular glucose homeostasis [GO:0001678]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of hepatocyte differentiation [GO:0070368]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nutrient levels [GO:0031667]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]","nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cellular response to starvation [GO:0009267]; chromatin organization [GO:0006325]; hematopoietic stem cell homeostasis [GO:0061484]; intracellular glucose homeostasis [GO:0001678]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of hepatocyte differentiation [GO:0070368]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nutrient levels [GO:0031667]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]","","","","TISSUE SPECIFICITY: Liver."
"727","sp|Q8VHG5|OBOX4_MOUSE","lcl|NC_088858.1_cds_XP_011415946.1_28805",4.79e-11,64.7,"Q8VHG5","OBOX4_MOUSE","Oocyte-specific homeobox protein 4","Obox4","Mus musculus (Mouse)",380,"GO:0001556; GO:0003677; GO:0005634; GO:0006357; GO:0045835; GO:0048863; GO:0160021; GO:1900194; GO:1990946","maternal-to-zygotic transition of gene expression [GO:0160021]; meiosis I/meiosis II transition [GO:1990946]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of oocyte maturation [GO:1900194]; oocyte maturation [GO:0001556]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell differentiation [GO:0048863]","nucleus [GO:0005634]; DNA binding [GO:0003677]; maternal-to-zygotic transition of gene expression [GO:0160021]; meiosis I/meiosis II transition [GO:1990946]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of oocyte maturation [GO:1900194]; oocyte maturation [GO:0001556]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell differentiation [GO:0048863]","DEVELOPMENTAL STAGE: Expression is low in oocytes (PubMed:37459895). Expressed zygotically with expression peaking in early-two-cell stage embryos, during minor zygotic genome activation (ZGA), and declining in late two-cell stage embryos (PubMed:37459895). {ECO:0000269|PubMed:37459895}.","","","TISSUE SPECIFICITY: Specifically expressed in early embryos. {ECO:0000269|PubMed:20004198, ECO:0000269|PubMed:37459895}."
"728","sp|Q4FZQ0|YF1BB_XENLA","lcl|NC_088858.1_cds_XP_011416185.2_32880",2.42e-86,262,"Q4FZQ0","YF1BB_XENLA","Protein YIF1B-B (YIP1-interacting factor homolog B-B)","yif1b-b","Xenopus laevis (African clawed frog)",300,"GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006888; GO:0015031; GO:0030134; GO:0033116; GO:0060271; GO:0120316","cilium assembly [GO:0060271]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; sperm flagellum assembly [GO:0120316]","COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; cilium assembly [GO:0060271]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; sperm flagellum assembly [GO:0120316]","","","",""
"729","sp|Q8T4F7|ENA_DROME","lcl|NC_088858.1_cds_XP_011416189.3_32871",6.33e-46,173,"Q8T4F7","ENA_DROME","Protein enabled","ena enb CG15112","Drosophila melanogaster (Fruit fly)",980,"GO:0003382; GO:0003779; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0007015; GO:0007298; GO:0007300; GO:0007390; GO:0007391; GO:0007396; GO:0007409; GO:0007411; GO:0008154; GO:0008258; GO:0010591; GO:0017124; GO:0030027; GO:0030036; GO:0030335; GO:0030424; GO:0030425; GO:0031252; GO:0031346; GO:0032433; GO:0032956; GO:0035262; GO:0045886; GO:0046847; GO:0048749; GO:0048813; GO:0051489; GO:0051491; GO:0060288; GO:0071212; GO:1990255","actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin polymerization or depolymerization [GO:0008154]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; compound eye development [GO:0048749]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; epithelial cell morphogenesis [GO:0003382]; filopodium assembly [GO:0046847]; formation of a compartment boundary [GO:0060288]; germ-band shortening [GO:0007390]; gonad morphogenesis [GO:0035262]; head involution [GO:0008258]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of cell migration [GO:0030335]; positive regulation of cell projection organization [GO:0031346]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; subsynaptic reticulum organization [GO:1990255]; suture of dorsal opening [GO:0007396]","axon [GO:0030424]; cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium tip [GO:0032433]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; subsynaptic reticulum [GO:0071212]; actin binding [GO:0003779]; SH3 domain binding [GO:0017124]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin polymerization or depolymerization [GO:0008154]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; compound eye development [GO:0048749]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; epithelial cell morphogenesis [GO:0003382]; filopodium assembly [GO:0046847]; formation of a compartment boundary [GO:0060288]; germ-band shortening [GO:0007390]; gonad morphogenesis [GO:0035262]; head involution [GO:0008258]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of cell migration [GO:0030335]; positive regulation of cell projection organization [GO:0031346]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; subsynaptic reticulum organization [GO:1990255]; suture of dorsal opening [GO:0007396]","","","","TISSUE SPECIFICITY: Expressed in axons of the embryonic nervous system. {ECO:0000269|PubMed:7535279}."
"730","sp|P25490|TYY1_HUMAN","lcl|NC_088858.1_cds_XP_011416360.1_28533",8.96e-113,336,"P25490","TYY1_HUMAN","Transcriptional repressor protein YY1 (Delta transcription factor) (INO80 complex subunit S) (NF-E1) (Yin and yang 1) (YY-1)","YY1 INO80S","Homo sapiens (Human)",414,"GO:0000122; GO:0000400; GO:0000723; GO:0000724; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001217; GO:0001227; GO:0001228; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005677; GO:0006275; GO:0006282; GO:0006338; GO:0006357; GO:0006403; GO:0006974; GO:0007283; GO:0008270; GO:0009952; GO:0010225; GO:0010628; GO:0010629; GO:0016363; GO:0030183; GO:0031011; GO:0031519; GO:0032688; GO:0033044; GO:0034644; GO:0034696; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0046332; GO:0048593; GO:0051726; GO:0060382; GO:0061052; GO:0071347; GO:0071707; GO:0140297; GO:1902894; GO:1904507; GO:1990837","anterior/posterior pattern specification [GO:0009952]; B cell differentiation [GO:0030183]; camera-type eye morphogenesis [GO:0048593]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283]; telomere maintenance [GO:0000723]","chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; Ino80 complex [GO:0031011]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; anterior/posterior pattern specification [GO:0009952]; B cell differentiation [GO:0030183]; camera-type eye morphogenesis [GO:0048593]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283]; telomere maintenance [GO:0000723]","","","",""
"731","sp|P18475|TORSO_DROME","lcl|NC_088858.1_cds_XP_011416623.3_29827",6.49e-51,195,"P18475","TORSO_DROME","Tyrosine-protein kinase receptor torso (EC 2.7.10.1)","tor CG1389","Drosophila melanogaster (Fruit fly)",923,"GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0007278; GO:0007362; GO:0007369; GO:0007552; GO:0008293; GO:0008354; GO:0030381; GO:0035331; GO:0040015; GO:0043235; GO:0043410; GO:0046579; GO:0046872; GO:0046957","cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; chorion-containing eggshell pattern formation [GO:0030381]; gastrulation [GO:0007369]; germ cell migration [GO:0008354]; metamorphosis [GO:0007552]; negative phototaxis [GO:0046957]; negative regulation of hippo signaling [GO:0035331]; negative regulation of multicellular organism growth [GO:0040015]; pole cell fate determination [GO:0007278]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Ras protein signal transduction [GO:0046579]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]","plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; chorion-containing eggshell pattern formation [GO:0030381]; gastrulation [GO:0007369]; germ cell migration [GO:0008354]; metamorphosis [GO:0007552]; negative phototaxis [GO:0046957]; negative regulation of hippo signaling [GO:0035331]; negative regulation of multicellular organism growth [GO:0040015]; pole cell fate determination [GO:0007278]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Ras protein signal transduction [GO:0046579]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. Expressed throughout the embryo but is activated specifically at the poles (PubMed:19965758, PubMed:2927509, PubMed:8423783). Expressed in the prothoracic gland in wandering L3 larvae (PubMed:19965758). {ECO:0000269|PubMed:19965758, ECO:0000269|PubMed:2927509, ECO:0000269|PubMed:8423783}.","","",""
"732","sp|Q15406|NR6A1_HUMAN","lcl|NC_088858.1_cds_XP_011416690.2_30761",1.18e-37,144,"Q15406","NR6A1_HUMAN","Nuclear receptor subfamily 6 group A member 1 (Germ cell nuclear factor) (GCNF) (hGCNF) (Retinoid receptor-related testis-specific receptor) (RTR) (hRTR)","NR6A1 GCNF","Homo sapiens (Human)",480,"GO:0000122; GO:0000785; GO:0000981; GO:0001217; GO:0001228; GO:0003677; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0007276; GO:0008270; GO:0034056; GO:0042803; GO:0043565; GO:1990837; GO:2000741","gamete generation [GO:0007276]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; regulation of transcription by RNA polymerase II [GO:0006357]","chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; estrogen response element binding [GO:0034056]; nuclear receptor activity [GO:0004879]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; gamete generation [GO:0007276]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; regulation of transcription by RNA polymerase II [GO:0006357]","","","","TISSUE SPECIFICITY: Shows highest expression in the germ cells of the adult testis. {ECO:0000269|PubMed:8982251, ECO:0000269|PubMed:9134503, ECO:0000269|PubMed:9177477, ECO:0000269|PubMed:9493564, ECO:0000269|PubMed:9537518}."
"733","sp|P14773|HMDH_DROME","lcl|NC_088858.1_cds_XP_011417214.3_31638",0,674,"P14773","HMDH_DROME","3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) (EC 1.1.1.34)","Hmgcr HmG-CoAR CG10367","Drosophila melanogaster (Fruit fly)",920,"GO:0004420; GO:0005778; GO:0005789; GO:0007626; GO:0008299; GO:0008354; GO:0008406; GO:0015936; GO:0016126; GO:0018990; GO:0035050; GO:0035232; GO:0046579; GO:0050661","coenzyme A metabolic process [GO:0015936]; ecdysis, chitin-based cuticle [GO:0018990]; embryonic heart tube development [GO:0035050]; germ cell attraction [GO:0035232]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; isoprenoid biosynthetic process [GO:0008299]; locomotory behavior [GO:0007626]; positive regulation of Ras protein signal transduction [GO:0046579]; sterol biosynthetic process [GO:0016126]","endoplasmic reticulum membrane [GO:0005789]; peroxisomal membrane [GO:0005778]; hydroxymethylglutaryl-CoA reductase (NADPH) activity [GO:0004420]; NADP binding [GO:0050661]; coenzyme A metabolic process [GO:0015936]; ecdysis, chitin-based cuticle [GO:0018990]; embryonic heart tube development [GO:0035050]; germ cell attraction [GO:0035232]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; isoprenoid biosynthetic process [GO:0008299]; locomotory behavior [GO:0007626]; positive regulation of Ras protein signal transduction [GO:0046579]; sterol biosynthetic process [GO:0016126]","","","","TISSUE SPECIFICITY: Highly expressed in embryonic gonadal mesoderm, where expression is initially broad, and then becomes restricted to a segmental pattern at stage 11. Expression is then further restricted to a cluster of cells in each of parasegments 10, 11 and 12, corresponding to the developing gonadal mesoderm. Not expressed in pole cells. {ECO:0000269|PubMed:9853754}."
"734","sp|P59282|TPPP2_HUMAN","lcl|NC_088858.1_cds_XP_011418007.2_33303",2.65e-22,89.4,"P59282","TPPP2_HUMAN","Tubulin polymerization-promoting protein family member 2 (Protein p25-beta) (TPPP/p18)","TPPP2 C14orf8","Homo sapiens (Human)",170,"GO:0005829; GO:0007283; GO:0015631; GO:0030154; GO:0032273; GO:0036126; GO:0046785; GO:1901317","cell differentiation [GO:0030154]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273]; regulation of flagellated sperm motility [GO:1901317]; spermatogenesis [GO:0007283]","cytosol [GO:0005829]; sperm flagellum [GO:0036126]; tubulin binding [GO:0015631]; cell differentiation [GO:0030154]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273]; regulation of flagellated sperm motility [GO:1901317]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in spermatids (PubMed:23436708). Detected in liver cancer (at protein level) (PubMed:23436708). {ECO:0000269|PubMed:23436708}."
"735","sp|Q14320|FA50A_HUMAN","lcl|NC_088858.1_cds_XP_011418059.3_33457",6.86e-116,340,"Q14320","FA50A_HUMAN","Protein FAM50A (Protein HXC-26) (Protein XAP-5)","FAM50A DXS9928E HXC26 XAP5","Homo sapiens (Human)",339,"GO:0003723; GO:0005634; GO:0005654; GO:0006325; GO:0006397; GO:0007283; GO:0008380; GO:0043484","chromatin organization [GO:0006325]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]","nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; chromatin organization [GO:0006325]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Widely expressed in fetal and adult tissues. Mostly abundant in fetal brain, liver and kidney; in the adult, high levels were also observed in heart, skeletal muscle, spleen, thymus, prostate and small intestine. Expressed in fetal cerebellum and hypothalamus. Low expression is observed in fetal temporal lobe (PubMed:32703943). {ECO:0000269|PubMed:32703943, ECO:0000269|PubMed:9339379}."
"736","sp|O15945|ARNT_DROME","lcl|NC_088858.1_cds_XP_011419461.2_31967",0,579,"O15945","ARNT_DROME","Aryl hydrocarbon receptor nuclear translocator homolog (dARNT) (Hypoxia-inducible factor 1-beta) (Protein tango)","tgo ARNT HIF-1-beta CG11987","Drosophila melanogaster (Fruit fly)",642,"GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0007417; GO:0007420; GO:0008286; GO:0008347; GO:0016348; GO:0017022; GO:0032869; GO:0032991; GO:0034751; GO:0043565; GO:0045676; GO:0045944; GO:0046982; GO:0048477; GO:0048736; GO:0071456; GO:0090575","appendage development [GO:0048736]; brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; insulin receptor signaling pathway [GO:0008286]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of R7 cell differentiation [GO:0045676]; regulation of transcription by RNA polymerase II [GO:0006357]","aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; myosin binding [GO:0017022]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; appendage development [GO:0048736]; brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; insulin receptor signaling pathway [GO:0008286]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of R7 cell differentiation [GO:0045676]; regulation of transcription by RNA polymerase II [GO:0006357]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically in pupae at a low level. {ECO:0000269|PubMed:10581393, ECO:0000269|PubMed:9409674}.","","","TISSUE SPECIFICITY: At stage 11, expression is detected in tracheal pits. At later stages, strong expression is also detected in the CNS. {ECO:0000269|PubMed:9284047, ECO:0000269|PubMed:9409674}."
"737","sp|Q9VEI3|S35B2_DROME","lcl|NC_088858.1_cds_XP_011419595.1_31298",3.57e-139,407,"Q9VEI3","S35B2_DROME","Adenosine 3'-phospho 5'-phosphosulfate transporter 1 (PAPS transporter 1) (Protein slalom)","sll PAPST1 CG7623","Drosophila melanogaster (Fruit fly)",465,"GO:0000139; GO:0005789; GO:0005794; GO:0007310; GO:0015012; GO:0016020; GO:0046963; GO:0046964; GO:0055085","3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; oocyte dorsal/ventral axis specification [GO:0007310]; transmembrane transport [GO:0055085]","endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; 3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; oocyte dorsal/ventral axis specification [GO:0007310]; transmembrane transport [GO:0055085]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. {ECO:0000269|PubMed:12853478}.","","","TISSUE SPECIFICITY: Expressed throughout embryogenesis. During oogenesis, it is expressed strongly in the nurse cells of the germline. Maternally expressed at the syncytial blastoderm stage. Zygotically expressed, from after germ-band elongation in the invaginating salivary gland placodes. Remains expressed predominantly in this tissue throughout embryogenesis, but low-level expression may also be present throughout the embryo. {ECO:0000269|PubMed:12853478}."
"738","sp|Q9VLU0|BAF_DROME","lcl|NC_088858.1_cds_XP_011419832.2_30570",4.15e-49,151,"Q9VLU0","BAF_DROME","Barrier-to-autointegration factor","baf CG7380","Drosophila melanogaster (Fruit fly)",90,"GO:0000793; GO:0003677; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0030261; GO:0030717; GO:0051276","chromosome condensation [GO:0030261]; chromosome organization [GO:0051276]; oocyte karyosome formation [GO:0030717]","condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; chromosome condensation [GO:0030261]; chromosome organization [GO:0051276]; oocyte karyosome formation [GO:0030717]","","","",""
"739","sp|Q9VW15|ASH1_DROME","lcl|NC_088858.1_cds_XP_011419914.3_31104",2.13e-180,611,"Q9VW15","ASH1_DROME","Histone-lysine N-methyltransferase ash1 (EC 2.1.1.354) (Absent small and homeotic disks protein 1) (Lysine N-methyltransferase 2H)","ash1 KMT2H CG8887","Drosophila melanogaster (Fruit fly)",2226,"GO:0000785; GO:0001700; GO:0003682; GO:0005634; GO:0005654; GO:0005700; GO:0006355; GO:0008270; GO:0010628; GO:0018991; GO:0032259; GO:0032991; GO:0035035; GO:0035097; GO:0042054; GO:0042800; GO:0042802; GO:0045815; GO:0046975; GO:0048477; GO:0140954; GO:0140999; GO:0141005","egg-laying behavior [GO:0018991]; embryonic development via the syncytial blastoderm [GO:0001700]; methylation [GO:0032259]; oogenesis [GO:0048477]; positive regulation of gene expression [GO:0010628]; regulation of DNA-templated transcription [GO:0006355]; transcription initiation-coupled chromatin remodeling [GO:0045815]; transposable element silencing by heterochromatin formation [GO:0141005]","chromatin [GO:0000785]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone H3K36 dimethyltransferase activity [GO:0140954]; histone H3K36 methyltransferase activity [GO:0046975]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 trimethyltransferase activity [GO:0140999]; histone methyltransferase activity [GO:0042054]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; egg-laying behavior [GO:0018991]; embryonic development via the syncytial blastoderm [GO:0001700]; methylation [GO:0032259]; oogenesis [GO:0048477]; positive regulation of gene expression [GO:0010628]; regulation of DNA-templated transcription [GO:0006355]; transcription initiation-coupled chromatin remodeling [GO:0045815]; transposable element silencing by heterochromatin formation [GO:0141005]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. During oogenesis it accumulates in the nurse cells of developing egg chambers. {ECO:0000269|PubMed:7982557}.","","","TISSUE SPECIFICITY: Expressed throughout development but is present at higher levels during the embryonic and pupal stages than during the larval stages. During the larval stages it accumulates primarily in imaginal disks. {ECO:0000269|PubMed:7982557}."
"740","sp|Q8N196|SIX5_HUMAN","lcl|NC_088858.1_cds_XP_011419940.2_30470",8.48e-78,255,"Q8N196","SIX5_HUMAN","Homeobox protein SIX5 (DM locus-associated homeodomain protein) (Sine oculis homeobox homolog 5)","SIX5 DMAHP","Homo sapiens (Human)",739,"GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0002088; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006357; GO:0007286; GO:0043231; GO:0045892; GO:0160024; GO:1902723","lens development in camera-type eye [GO:0002088]; Leydig cell proliferation [GO:0160024]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286]","chromatin [GO:0000785]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; lens development in camera-type eye [GO:0002088]; Leydig cell proliferation [GO:0160024]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286]","DEVELOPMENTAL STAGE: At the begin of fourth week of development detected in cytoplasm of somite cells, and at the end of fourth week is accumulated in the nucleus. Between the sixth and eighth week of development detected in the nucleus of limb bud cells. {ECO:0000269|PubMed:12500905}.","","","TISSUE SPECIFICITY: Expressed in adult but not in fetal eyes. Found in corneal epithelium and endothelium, lens epithelium, ciliary body epithelia, cellular layers of the retina and the sclera. {ECO:0000269|PubMed:9949207}."
"741","sp|Q5FVJ6|BSCL2_RAT","lcl|NC_088858.1_cds_XP_011421951.3_30260",3.34e-69,223,"Q5FVJ6","BSCL2_RAT","Seipin (Bernardinelli-Seip congenital lipodystrophy type 2 protein homolog)","Bscl2","Rattus norvegicus (Rat)",377,"GO:0001501; GO:0001894; GO:0001942; GO:0005543; GO:0005737; GO:0005783; GO:0005789; GO:0005811; GO:0005829; GO:0007005; GO:0007417; GO:0008340; GO:0010467; GO:0019915; GO:0022904; GO:0034389; GO:0035264; GO:0045444; GO:0048515; GO:0048741; GO:0050995; GO:0051276; GO:0051651; GO:0060612; GO:0061725; GO:0072593; GO:0120162; GO:0140042; GO:1905693","adipose tissue development [GO:0060612]; central nervous system development [GO:0007417]; chromosome organization [GO:0051276]; cytosolic lipolysis [GO:0061725]; determination of adult lifespan [GO:0008340]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; hair follicle development [GO:0001942]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; maintenance of location in cell [GO:0051651]; mitochondrion organization [GO:0007005]; multicellular organism growth [GO:0035264]; negative regulation of lipid catabolic process [GO:0050995]; positive regulation of cold-induced thermogenesis [GO:0120162]; reactive oxygen species metabolic process [GO:0072593]; regulation of phosphatidic acid biosynthetic process [GO:1905693]; respiratory electron transport chain [GO:0022904]; skeletal muscle fiber development [GO:0048741]; skeletal system development [GO:0001501]; spermatid differentiation [GO:0048515]; tissue homeostasis [GO:0001894]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; phospholipid binding [GO:0005543]; adipose tissue development [GO:0060612]; central nervous system development [GO:0007417]; chromosome organization [GO:0051276]; cytosolic lipolysis [GO:0061725]; determination of adult lifespan [GO:0008340]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; hair follicle development [GO:0001942]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; maintenance of location in cell [GO:0051651]; mitochondrion organization [GO:0007005]; multicellular organism growth [GO:0035264]; negative regulation of lipid catabolic process [GO:0050995]; positive regulation of cold-induced thermogenesis [GO:0120162]; reactive oxygen species metabolic process [GO:0072593]; regulation of phosphatidic acid biosynthetic process [GO:1905693]; respiratory electron transport chain [GO:0022904]; skeletal muscle fiber development [GO:0048741]; skeletal system development [GO:0001501]; spermatid differentiation [GO:0048515]; tissue homeostasis [GO:0001894]","","","",""
"742","sp|M9MRD5|B9D2_DROME","lcl|NC_088858.1_cds_XP_011423723.1_32496",3.57e-49,158,"M9MRD5","B9D2_DROME","B9 domain-containing protein 2 (MKS1-related protein 2)","B9d2 CG42730","Drosophila melanogaster (Fruit fly)",177,"GO:0005737; GO:0005856; GO:0007288; GO:0035869; GO:0036038; GO:0060271; GO:1905349","ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; sperm axoneme assembly [GO:0007288]","ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; MKS complex [GO:0036038]; ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; sperm axoneme assembly [GO:0007288]","","","","TISSUE SPECIFICITY: Expressed in chordotonal neurons in the antennae (at protein level) (PubMed:27646273). Expressed in spermatids (at protein level) (PubMed:25447994, PubMed:27577095). {ECO:0000269|PubMed:25447994, ECO:0000269|PubMed:27577095, ECO:0000269|PubMed:27646273}."
"743","sp|P10041|DL_DROME","lcl|NC_088858.1_cds_XP_011423844.3_28545",3.08e-170,513,"P10041","DL_DROME","Neurogenic locus protein delta","Delta Dl CG3619","Drosophila melanogaster (Fruit fly)",833,"GO:0001708; GO:0005112; GO:0005509; GO:0005768; GO:0005769; GO:0005886; GO:0007015; GO:0007219; GO:0007298; GO:0007400; GO:0007422; GO:0007423; GO:0007475; GO:0007476; GO:0007480; GO:0007498; GO:0008284; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009986; GO:0016020; GO:0016330; GO:0030139; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0031410; GO:0036011; GO:0042051; GO:0043208; GO:0045179; GO:0045466; GO:0045746; GO:0045931; GO:0046331; GO:0046667; GO:0048018; GO:0048056; GO:0048100; GO:0048190; GO:0048477; GO:0048665; GO:0048800; GO:0048863; GO:0090175","actin filament organization [GO:0007015]; antennal morphogenesis [GO:0048800]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; asymmetric cell division [GO:0008356]; border follicle cell migration [GO:0007298]; cell fate specification [GO:0001708]; chaeta morphogenesis [GO:0008407]; compound eye photoreceptor development [GO:0042051]; compound eye retinal cell programmed cell death [GO:0046667]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber stalk formation [GO:0030713]; germ-line stem cell population maintenance [GO:0030718]; glial cell migration [GO:0008347]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; lateral inhibition [GO:0046331]; mesoderm development [GO:0007498]; negative regulation of Notch signaling pathway [GO:0045746]; neuroblast fate determination [GO:0007400]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mitotic cell cycle [GO:0045931]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of establishment of planar polarity [GO:0090175]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; stem cell differentiation [GO:0048863]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc dorsal/ventral pattern formation [GO:0048190]","apical cortex [GO:0045179]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; glycosphingolipid binding [GO:0043208]; Notch binding [GO:0005112]; receptor ligand activity [GO:0048018]; actin filament organization [GO:0007015]; antennal morphogenesis [GO:0048800]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; asymmetric cell division [GO:0008356]; border follicle cell migration [GO:0007298]; cell fate specification [GO:0001708]; chaeta morphogenesis [GO:0008407]; compound eye photoreceptor development [GO:0042051]; compound eye retinal cell programmed cell death [GO:0046667]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber stalk formation [GO:0030713]; germ-line stem cell population maintenance [GO:0030718]; glial cell migration [GO:0008347]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; lateral inhibition [GO:0046331]; mesoderm development [GO:0007498]; negative regulation of Notch signaling pathway [GO:0045746]; neuroblast fate determination [GO:0007400]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mitotic cell cycle [GO:0045931]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of establishment of planar polarity [GO:0090175]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; stem cell differentiation [GO:0048863]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc dorsal/ventral pattern formation [GO:0048190]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. Expression is highest early in embryonic development (stage 5) and reduces to a low level during larval stages. {ECO:0000269|PubMed:16453806}.","","","TISSUE SPECIFICITY: Detected in all areas with neurogenic abilities, for example the neurogenic ectoderm and the primordia of the sense organs. Later expression is restricted to those cells that have adopted a neural fate. {ECO:0000269|PubMed:16453806}."
"744","sp|Q24573|DRI_DROME","lcl|NC_088858.1_cds_XP_011424664.2_32792",3.19e-73,251,"Q24573","DRI_DROME","Protein dead ringer (Protein retained)","retn dri CG5403","Drosophila melanogaster (Fruit fly)",911,"GO:0000122; GO:0000976; GO:0003677; GO:0005634; GO:0006357; GO:0007411; GO:0007431; GO:0007517; GO:0008049; GO:0009880; GO:0009952; GO:0042063; GO:0045893; GO:0045924; GO:0048477; GO:0048813; GO:0140297","anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; dendrite morphogenesis [GO:0048813]; embryonic pattern specification [GO:0009880]; gliogenesis [GO:0042063]; male courtship behavior [GO:0008049]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of female receptivity [GO:0045924]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland development [GO:0007431]","nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; transcription cis-regulatory region binding [GO:0000976]; anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; dendrite morphogenesis [GO:0048813]; embryonic pattern specification [GO:0009880]; gliogenesis [GO:0042063]; male courtship behavior [GO:0008049]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of female receptivity [GO:0045924]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland development [GO:0007431]","DEVELOPMENTAL STAGE: Expressed maternally throughout the embryo at the syncytial cleavage divisions and zygotically at the termini and in a broad central band during cellularization. At germ band extension, the protein is found in the mesoderm. Expressed in a subset of neurons from larva and pupa. {ECO:0000269|PubMed:15576402, ECO:0000269|PubMed:8622680}.","","","TISSUE SPECIFICITY: Present in the pharyngeal muscles, hindgut epithelium, amnioserosa, ring gland, midgut-hindgut junction, posterior region of each brain lobe, longitudinal glial cells of the CNS and the salivary gland duct of germ-band retracted embryos. {ECO:0000269|PubMed:12620977, ECO:0000269|PubMed:8622680}."
"745","sp|Q9JII5|DAZP1_MOUSE","lcl|NC_088858.1_cds_XP_011424949.1_29096",1.81e-57,195,"Q9JII5","DAZP1_MOUSE","DAZ-associated protein 1 (Deleted in azoospermia-associated protein 1)","Dazap1","Mus musculus (Mouse)",406,"GO:0001673; GO:0001893; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007283; GO:0008266; GO:0030154; GO:0034046; GO:0035613; GO:0048026; GO:0048144; GO:1990904","cell differentiation [GO:0030154]; fibroblast proliferation [GO:0048144]; maternal placenta development [GO:0001893]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; cell differentiation [GO:0030154]; fibroblast proliferation [GO:0048144]; maternal placenta development [GO:0001893]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: First expressed in midpachytene spermatocytes in stage VII tubules.","","","TISSUE SPECIFICITY: Mainly expressed in testis. Expressed at much lower level in liver, heart and brain. Also expressed in ovary. Expressed throughout testes development, in both the prenatal and postnatal periods. {ECO:0000269|PubMed:11604102}."
"746","sp|Q8TEY5|CR3L4_HUMAN","lcl|NC_088858.1_cds_XP_011425093.3_34126",1.56e-27,115,"Q8TEY5","CR3L4_HUMAN","Cyclic AMP-responsive element-binding protein 3-like protein 4 (cAMP-responsive element-binding protein 3-like protein 4) (Androgen-induced basic leucine zipper protein) (AIbZIP) (Attaching to CRE-like 1) (ATCE1) (Cyclic AMP-responsive element-binding protein 4) (CREB-4) (cAMP-responsive element-binding protein 4) (Transcript induced in spermiogenesis protein 40) (Tisp40) (hJAL) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 4]","CREB3L4 AIBZIP CREB4 JAL","Homo sapiens (Human)",395,"GO:0000139; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005739; GO:0005783; GO:0005789; GO:0005794; GO:0006357; GO:0006986; GO:0007283; GO:0031965; GO:0045944; GO:1990837","positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]","chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]","","INDUCTION: By androgens.","INDUCTION: By androgens.","TISSUE SPECIFICITY: According to PubMed:11830526, exclusively expressed in the prostate. Expressed in breast and prostate cancer cell lines. Expressed in prostatic luminal epithelial cells (at protein level). Expression is significantly more abundant in prostate cancer than in benign prostatic tissue (prostatic hyperplasia). According to PubMed:12111373, also expressed in brain, pancreas and skeletal muscle, and at lower levels in small intestine, testis, leukocyte and thymus. {ECO:0000269|PubMed:11830526, ECO:0000269|PubMed:12111373, ECO:0000269|PubMed:17270658}."
"747","sp|Q9SL67|PRS4B_ARATH","lcl|NC_088858.1_cds_XP_011425280.1_33497",0,664,"Q9SL67","PRS4B_ARATH","26S proteasome regulatory subunit 4 homolog B (26S proteasome AAA-ATPase subunit RPT2b) (26S proteasome subunit 4 homolog B) (Regulatory particle triple-A ATPase subunit 2b)","RPT2B At2g20140 T2G17.6","Arabidopsis thaliana (Mouse-ear cress)",443,"GO:0000502; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0007292; GO:0010078; GO:0016887; GO:0048232","female gamete generation [GO:0007292]; maintenance of root meristem identity [GO:0010078]; male gamete generation [GO:0048232]","cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; female gamete generation [GO:0007292]; maintenance of root meristem identity [GO:0010078]; male gamete generation [GO:0048232]","","","","TISSUE SPECIFICITY: Preferentially expressed in the root and shoot apical meristem. {ECO:0000269|PubMed:19500299}."
"748","sp|Q23120|RSP2_CAEEL","lcl|NC_088858.1_cds_XP_011425562.1_33449",2.29e-55,181,"Q23120","RSP2_CAEEL","Probable splicing factor, arginine/serine-rich 2 (CeSRp40) (RNA-binding protein srp-4)","rsp-2 srp-4 W02B12.2","Caenorhabditis elegans",281,"GO:0000398; GO:0002119; GO:0003723; GO:0005634; GO:0007283; GO:0007506; GO:0008380; GO:0008406; GO:0016607; GO:0030154; GO:0040009","cell differentiation [GO:0030154]; gonad development [GO:0008406]; gonadal mesoderm development [GO:0007506]; mRNA splicing, via spliceosome [GO:0000398]; nematode larval development [GO:0002119]; regulation of growth rate [GO:0040009]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]","nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; gonad development [GO:0008406]; gonadal mesoderm development [GO:0007506]; mRNA splicing, via spliceosome [GO:0000398]; nematode larval development [GO:0002119]; regulation of growth rate [GO:0040009]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]","","","",""
"749","sp|Q5R746|YTDC2_PONAB","lcl|NC_088858.1_cds_XP_011425711.3_32034",0,1372,"Q5R746","YTDC2_PONAB","3'-5' RNA helicase YTHDC2 (EC 3.6.4.13) (YTH domain-containing protein C2)","YTHDC2","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)",1430,"GO:0003723; GO:0005524; GO:0005737; GO:0007286; GO:0016887; GO:0034458; GO:0035770; GO:0048471; GO:0048599; GO:0051321; GO:0051729; GO:1990247","germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; spermatid development [GO:0007286]","cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein granule [GO:0035770]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; RNA binding [GO:0003723]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; spermatid development [GO:0007286]","","","",""
"750","sp|Q9Y3Y4|PYGO1_HUMAN","lcl|NC_088858.1_cds_XP_011425713.1_32036",1.49e-21,95.1,"Q9Y3Y4","PYGO1_HUMAN","Pygopus homolog 1","PYGO1","Homo sapiens (Human)",419,"GO:0001822; GO:0002244; GO:0005654; GO:0007289; GO:0008270; GO:0034504; GO:0045944; GO:0060070; GO:0140002","canonical Wnt signaling pathway [GO:0060070]; hematopoietic progenitor cell differentiation [GO:0002244]; kidney development [GO:0001822]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]; spermatid nucleus differentiation [GO:0007289]","nucleoplasm [GO:0005654]; histone H3K4me3 reader activity [GO:0140002]; zinc ion binding [GO:0008270]; canonical Wnt signaling pathway [GO:0060070]; hematopoietic progenitor cell differentiation [GO:0002244]; kidney development [GO:0001822]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]; spermatid nucleus differentiation [GO:0007289]","","","",""
"751","sp|Q9UHC1|MLH3_HUMAN","lcl|NC_088858.1_cds_XP_011425896.3_32739",1.01e-87,317,"Q9UHC1","MLH3_HUMAN","DNA mismatch repair protein Mlh3 (MutL protein homolog 3)","MLH3","Homo sapiens (Human)",1453,"GO:0000795; GO:0001673; GO:0003682; GO:0003696; GO:0005524; GO:0005634; GO:0005654; GO:0005712; GO:0006298; GO:0007130; GO:0007131; GO:0007140; GO:0007144; GO:0008104; GO:0016887; GO:0019237; GO:0030983; GO:0032300; GO:0140664","female meiosis I [GO:0007144]; male meiotic nuclear division [GO:0007140]; mismatch repair [GO:0006298]; protein localization [GO:0008104]; reciprocal meiotic recombination [GO:0007131]; synaptonemal complex assembly [GO:0007130]","chiasma [GO:0005712]; male germ cell nucleus [GO:0001673]; mismatch repair complex [GO:0032300]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; mismatched DNA binding [GO:0030983]; satellite DNA binding [GO:0003696]; female meiosis I [GO:0007144]; male meiotic nuclear division [GO:0007140]; mismatch repair [GO:0006298]; protein localization [GO:0008104]; reciprocal meiotic recombination [GO:0007131]; synaptonemal complex assembly [GO:0007130]","","","","TISSUE SPECIFICITY: Ubiquitous."
"752","sp|P62821|RAB1A_MOUSE","lcl|NC_088858.1_cds_XP_011426295.1_32079",1.09e-133,374,"P62821","RAB1A_MOUSE","Ras-related protein Rab-1A (EC 3.6.5.2) (YPT1-related protein)","Rab1a Rab1","Mus musculus (Mouse)",205,"GO:0000045; GO:0001675; GO:0003924; GO:0003925; GO:0005525; GO:0005769; GO:0005783; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006897; GO:0006914; GO:0007030; GO:0016020; GO:0016477; GO:0019068; GO:0030252; GO:0032402; GO:0032757; GO:0034446; GO:0042470; GO:0042742; GO:0047496; GO:0090110; GO:1903020","acrosome assembly [GO:0001675]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell migration [GO:0016477]; COPII-coated vesicle cargo loading [GO:0090110]; defense response to bacterium [GO:0042742]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; growth hormone secretion [GO:0030252]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; positive regulation of glycoprotein metabolic process [GO:1903020]; positive regulation of interleukin-8 production [GO:0032757]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle transport along microtubule [GO:0047496]; virion assembly [GO:0019068]","cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; acrosome assembly [GO:0001675]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell migration [GO:0016477]; COPII-coated vesicle cargo loading [GO:0090110]; defense response to bacterium [GO:0042742]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; growth hormone secretion [GO:0030252]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; positive regulation of glycoprotein metabolic process [GO:1903020]; positive regulation of interleukin-8 production [GO:0032757]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle transport along microtubule [GO:0047496]; virion assembly [GO:0019068]","","","",""
"753","sp|Q99932|SPAG8_HUMAN","lcl|NC_088858.1_cds_XP_011426991.1_31541",1.66e-30,119,"Q99932","SPAG8_HUMAN","Sperm-associated antigen 8 (HSD-1) (Sperm membrane protein 1) (SMP-1) (Sperm membrane protein BS-84)","SPAG8","Homo sapiens (Human)",485,"GO:0001669; GO:0001673; GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0005819; GO:0005829; GO:0005879; GO:0005929; GO:0007283; GO:0007338; GO:0008017; GO:0016020; GO:0030154; GO:0030317; GO:0036126; GO:0045944; GO:0160111","cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; positive regulation of transcription by RNA polymerase II [GO:0045944]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]","acrosomal vesicle [GO:0001669]; axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; spindle [GO:0005819]; microtubule binding [GO:0008017]; cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; positive regulation of transcription by RNA polymerase II [GO:0045944]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in testis (germ cells), but not in liver, kidney, prostate and small intestine. Expressed in airway epithelial cells (PubMed:36191189). {ECO:0000269|PubMed:36191189, ECO:0000269|PubMed:8788182}."
"754","sp|Q3SZW1|TSSK1_BOVIN","lcl|NC_088858.1_cds_XP_011427699.1_28869",2.49e-108,321,"Q3SZW1","TSSK1_BOVIN","Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1)","TSSK1B TSSK1","Bos taurus (Bovine)",367,"GO:0000226; GO:0000287; GO:0001669; GO:0004674; GO:0005524; GO:0005737; GO:0007286; GO:0031514; GO:0035556; GO:0050321; GO:0106310","intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; spermatid development [GO:0007286]","acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; spermatid development [GO:0007286]","","","",""
"755","sp|P23945|FSHR_HUMAN","lcl|NC_088858.1_cds_XP_011429100.3_30957",1.79e-149,460,"P23945","FSHR_HUMAN","Follicle-stimulating hormone receptor (FSH-R) (Follitropin receptor)","FSHR LGR1","Homo sapiens (Human)",695,"GO:0001545; GO:0003073; GO:0004963; GO:0005768; GO:0005886; GO:0007186; GO:0007189; GO:0007193; GO:0007200; GO:0007283; GO:0007292; GO:0007626; GO:0008406; GO:0008528; GO:0008584; GO:0008585; GO:0009755; GO:0009986; GO:0009992; GO:0010640; GO:0010738; GO:0016020; GO:0017046; GO:0031175; GO:0032350; GO:0033044; GO:0033148; GO:0035092; GO:0042699; GO:0043235; GO:0045056; GO:0045670; GO:0045779; GO:0051897; GO:0060009; GO:0060011; GO:0060065; GO:0060408; GO:0070374; GO:0071372; GO:0071711","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; basement membrane organization [GO:0071711]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; female gamete generation [GO:0007292]; female gonad development [GO:0008585]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; gonad development [GO:0008406]; hormone-mediated signaling pathway [GO:0009755]; intracellular water homeostasis [GO:0009992]; locomotory behavior [GO:0007626]; male gonad development [GO:0008584]; negative regulation of bone resorption [GO:0045779]; neuron projection development [GO:0031175]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; primary ovarian follicle growth [GO:0001545]; regulation of acetylcholine metabolic process [GO:0060408]; regulation of chromosome organization [GO:0033044]; regulation of hormone metabolic process [GO:0032350]; regulation of osteoclast differentiation [GO:0045670]; regulation of platelet-derived growth factor receptor signaling pathway [GO:0010640]; regulation of protein kinase A signaling [GO:0010738]; regulation of systemic arterial blood pressure [GO:0003073]; Sertoli cell development [GO:0060009]; Sertoli cell proliferation [GO:0060011]; sperm DNA condensation [GO:0035092]; spermatogenesis [GO:0007283]; transcytosis [GO:0045056]; uterus development [GO:0060065]","cell surface [GO:0009986]; endosome [GO:0005768]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; follicle-stimulating hormone receptor activity [GO:0004963]; G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; basement membrane organization [GO:0071711]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; female gamete generation [GO:0007292]; female gonad development [GO:0008585]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; gonad development [GO:0008406]; hormone-mediated signaling pathway [GO:0009755]; intracellular water homeostasis [GO:0009992]; locomotory behavior [GO:0007626]; male gonad development [GO:0008584]; negative regulation of bone resorption [GO:0045779]; neuron projection development [GO:0031175]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; primary ovarian follicle growth [GO:0001545]; regulation of acetylcholine metabolic process [GO:0060408]; regulation of chromosome organization [GO:0033044]; regulation of hormone metabolic process [GO:0032350]; regulation of osteoclast differentiation [GO:0045670]; regulation of platelet-derived growth factor receptor signaling pathway [GO:0010640]; regulation of protein kinase A signaling [GO:0010738]; regulation of systemic arterial blood pressure [GO:0003073]; Sertoli cell development [GO:0060009]; Sertoli cell proliferation [GO:0060011]; sperm DNA condensation [GO:0035092]; spermatogenesis [GO:0007283]; transcytosis [GO:0045056]; uterus development [GO:0060065]","","","","TISSUE SPECIFICITY: Sertoli cells and ovarian granulosa cells."
"756","sp|Q9HB65|ELL3_HUMAN","lcl|NC_088858.1_cds_XP_011430358.3_33872",4.49e-20,93.6,"Q9HB65","ELL3_HUMAN","RNA polymerase II elongation factor ELL3","ELL3","Homo sapiens (Human)",397,"GO:0000987; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0006354; GO:0006366; GO:0006368; GO:0007283; GO:0008023; GO:0010717; GO:0016607; GO:0030054; GO:0032786; GO:0032968; GO:0042771; GO:0042795; GO:0045944; GO:0048863; GO:0050769; GO:0061351; GO:0072089; GO:1902166; GO:2000179; GO:2000648","DNA-templated transcription elongation [GO:0006354]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; neural precursor cell proliferation [GO:0061351]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of epithelial to mesenchymal transition [GO:0010717]; snRNA transcription by RNA polymerase II [GO:0042795]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; transcription by RNA polymerase II [GO:0006366]; transcription elongation by RNA polymerase II [GO:0006368]","cell junction [GO:0030054]; chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-templated transcription elongation [GO:0006354]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; neural precursor cell proliferation [GO:0061351]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of epithelial to mesenchymal transition [GO:0010717]; snRNA transcription by RNA polymerase II [GO:0042795]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; transcription by RNA polymerase II [GO:0006366]; transcription elongation by RNA polymerase II [GO:0006368]","","","","TISSUE SPECIFICITY: Testis specific. {ECO:0000269|PubMed:10882741}."
"757","sp|Q9QZE7|TSNAX_MOUSE","lcl|NC_088858.1_cds_XP_011432857.3_30206",5.8e-84,254,"Q9QZE7","TSNAX_MOUSE","Translin-associated protein X (Translin-associated factor X)","Tsnax Trax","Mus musculus (Mouse)",290,"GO:0003697; GO:0005654; GO:0005737; GO:0005794; GO:0007283; GO:0030154; GO:0030422; GO:0031687; GO:0035194; GO:0043565; GO:0044877; GO:0046872; GO:0048471; GO:1902555","cell differentiation [GO:0030154]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; siRNA processing [GO:0030422]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; endoribonuclease complex [GO:1902555]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; A2A adenosine receptor binding [GO:0031687]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; cell differentiation [GO:0030154]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; siRNA processing [GO:0030422]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Detected in heart, brain, lung, liver, kidney and testis. {ECO:0000269|PubMed:10790540}."
"758","sp|Q9WUT3|KS6A2_MOUSE","lcl|NC_088858.1_cds_XP_011432877.3_30184",3.7e-176,528,"Q9WUT3","KS6A2_MOUSE","Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Protein-tyrosine kinase Mpk-9) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3)","Rps6ka2 Mapkapk1c Rsk3","Mus musculus (Mouse)",733,"GO:0000287; GO:0001556; GO:0002035; GO:0004672; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0007507; GO:0008285; GO:0010628; GO:0010659; GO:0035556; GO:0043065; GO:0045786; GO:0045835; GO:0060047; GO:0070613; GO:0071322; GO:0072687; GO:0106310","brain renin-angiotensin system [GO:0002035]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to carbohydrate stimulus [GO:0071322]; heart contraction [GO:0060047]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of meiotic nuclear division [GO:0045835]; oocyte maturation [GO:0001556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; regulation of protein processing [GO:0070613]","cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; brain renin-angiotensin system [GO:0002035]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to carbohydrate stimulus [GO:0071322]; heart contraction [GO:0060047]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of meiotic nuclear division [GO:0045835]; oocyte maturation [GO:0001556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; regulation of protein processing [GO:0070613]","","","",""
"759","sp|Q6AZ28|PIAS2_RAT","lcl|NC_088858.1_cds_XP_011433032.2_31162",8.58e-154,456,"Q6AZ28","PIAS2_RAT","E3 SUMO-protein ligase PIAS2 (EC 2.3.2.-) (Androgen receptor-interacting protein 3) (ARIP3) (DAB2-interacting protein) (DIP) (E3 SUMO-protein transferase PIAS2) (Msx-interacting-zinc finger protein) (Protein inhibitor of activated STAT x) (Protein inhibitor of activated STAT2)","Pias2 Miz1 Piasx","Rattus norvegicus (Rat)",572,"GO:0000785; GO:0003677; GO:0003712; GO:0005634; GO:0006351; GO:0006355; GO:0006357; GO:0007283; GO:0008270; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0019904; GO:0030331; GO:0030521; GO:0031625; GO:0033574; GO:0035259; GO:0045893; GO:0050681; GO:0050775; GO:0060765; GO:0060766; GO:0061629; GO:0061665","androgen receptor signaling pathway [GO:0030521]; DNA-templated transcription [GO:0006351]; negative regulation of androgen receptor signaling pathway [GO:0060766]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of DNA-templated transcription [GO:0045893]; protein sumoylation [GO:0016925]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283]","chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; nuclear androgen receptor binding [GO:0050681]; nuclear estrogen receptor binding [GO:0030331]; nuclear glucocorticoid receptor binding [GO:0035259]; protein domain specific binding [GO:0019904]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; androgen receptor signaling pathway [GO:0030521]; DNA-templated transcription [GO:0006351]; negative regulation of androgen receptor signaling pathway [GO:0060766]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of DNA-templated transcription [GO:0045893]; protein sumoylation [GO:0016925]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed in spermatogonia and in primary spermatocytes up to late pachytene stage (at protein level).","","","TISSUE SPECIFICITY: Mainly expressed in testis. {ECO:0000269|PubMed:9920921}."
"760","sp|O75925|PIAS1_HUMAN","lcl|NC_088858.1_cds_XP_011433033.2_31161",1.32e-155,464,"O75925","PIAS1_HUMAN","E3 SUMO-protein ligase PIAS1 (EC 2.3.2.-) (DEAD/H box-binding protein 1) (E3 SUMO-protein transferase PIAS1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein)","PIAS1 DDXBP1","Homo sapiens (Human)",651,"GO:0000082; GO:0000122; GO:0000785; GO:0000976; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0005856; GO:0006357; GO:0006974; GO:0007259; GO:0007283; GO:0008270; GO:0008542; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0019899; GO:0019904; GO:0031625; GO:0032436; GO:0033235; GO:0034399; GO:0042127; GO:0043066; GO:0045444; GO:0045893; GO:0051152; GO:0061665; GO:0065004; GO:0098978; GO:0099523; GO:0099524; GO:0140297; GO:1904377","cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; DNA damage response [GO:0006974]; fat cell differentiation [GO:0045444]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell periphery [GO:1904377]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of smooth muscle cell differentiation [GO:0051152]; protein sumoylation [GO:0016925]; protein-DNA complex assembly [GO:0065004]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; visual learning [GO:0008542]","chromatin [GO:0000785]; cytoskeleton [GO:0005856]; glutamatergic synapse [GO:0098978]; nuclear periphery [GO:0034399]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; DNA damage response [GO:0006974]; fat cell differentiation [GO:0045444]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell periphery [GO:1904377]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of smooth muscle cell differentiation [GO:0051152]; protein sumoylation [GO:0016925]; protein-DNA complex assembly [GO:0065004]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; visual learning [GO:0008542]","","","","TISSUE SPECIFICITY: Expressed in numerous tissues with highest level in testis. {ECO:0000269|PubMed:11439351, ECO:0000269|PubMed:9177271}."
"761","sp|Q9NZ56|FMN2_HUMAN","lcl|NC_088858.1_cds_XP_011433041.3_31179",2.31e-105,374,"Q9NZ56","FMN2_HUMAN","Formin-2","FMN2","Homo sapiens (Human)",1722,"GO:0003779; GO:0005634; GO:0005730; GO:0005783; GO:0005789; GO:0005819; GO:0005829; GO:0005886; GO:0005902; GO:0005938; GO:0006974; GO:0015031; GO:0015629; GO:0016192; GO:0016477; GO:0030036; GO:0030659; GO:0035556; GO:0040038; GO:0042177; GO:0043066; GO:0046907; GO:0048471; GO:0048477; GO:0051295; GO:0051758; GO:0070649; GO:0071456; GO:2000781","actin cytoskeleton organization [GO:0030036]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; DNA damage response [GO:0006974]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; homologous chromosome movement towards spindle pole in meiosis I anaphase [GO:0051758]; intracellular signal transduction [GO:0035556]; intracellular transport [GO:0046907]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]","actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; microvillus [GO:0005902]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; DNA damage response [GO:0006974]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; homologous chromosome movement towards spindle pole in meiosis I anaphase [GO:0051758]; intracellular signal transduction [GO:0035556]; intracellular transport [GO:0046907]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]","","INDUCTION: Up-regulated in response to cellular stress, hypoxia and DNA damage via NF-kappa-B. {ECO:0000269|PubMed:23375502}.","INDUCTION: Up-regulated in response to cellular stress, hypoxia and DNA damage via NF-kappa-B. {ECO:0000269|PubMed:23375502}.","TISSUE SPECIFICITY: Expressed almost exclusively in the developing and mature central nervous system. {ECO:0000269|PubMed:10781961}."
"762","sp|Q27297|RAD51_DROME","lcl|NC_088858.1_cds_XP_011433322.1_31480",2.29e-147,419,"Q27297","RAD51_DROME","DNA repair protein Rad51 homolog (Protein spindle-A) (RecA protein homolog)","spn-A DMR Rad51 CG7948","Drosophila melanogaster (Fruit fly)",336,"GO:0000150; GO:0000730; GO:0000794; GO:0003690; GO:0003697; GO:0005524; GO:0005737; GO:0006281; GO:0006302; GO:0006310; GO:0006312; GO:0007131; GO:0007143; GO:0007294; GO:0008094; GO:0008298; GO:0009949; GO:0009951; GO:0010569; GO:0016887; GO:0030716; GO:0030717; GO:0042148; GO:0045003; GO:0048477; GO:0070192; GO:0140664; GO:1990426","chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand invasion [GO:0042148]; double-strand break repair [GO:0006302]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; female meiotic nuclear division [GO:0007143]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; mitotic recombination [GO:0006312]; mitotic recombination-dependent replication fork processing [GO:1990426]; oocyte fate determination [GO:0030716]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; polarity specification of anterior/posterior axis [GO:0009949]; polarity specification of dorsal/ventral axis [GO:0009951]; reciprocal meiotic recombination [GO:0007131]; regulation of double-strand break repair via homologous recombination [GO:0010569]","condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA strand exchange activity [GO:0000150]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand invasion [GO:0042148]; double-strand break repair [GO:0006302]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; female meiotic nuclear division [GO:0007143]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; mitotic recombination [GO:0006312]; mitotic recombination-dependent replication fork processing [GO:1990426]; oocyte fate determination [GO:0030716]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; polarity specification of anterior/posterior axis [GO:0009949]; polarity specification of dorsal/ventral axis [GO:0009951]; reciprocal meiotic recombination [GO:0007131]; regulation of double-strand break repair via homologous recombination [GO:0010569]","","","","TISSUE SPECIFICITY: Highly expressed in ovaries. {ECO:0000269|PubMed:8625736}."
"763","sp|P12644|BMP4_HUMAN","lcl|NC_088858.1_cds_XP_011434597.1_30155",1.11e-91,283,"P12644","BMP4_HUMAN","Bone morphogenetic protein 4 (BMP-4) (Bone morphogenetic protein 2B) (BMP-2B)","BMP4 BMP2B DVR4","Homo sapiens (Human)",408,"GO:0000122; GO:0001649; GO:0001656; GO:0001657; GO:0001658; GO:0001822; GO:0001823; GO:0001843; GO:0001934; GO:0001938; GO:0001958; GO:0002043; GO:0002062; GO:0002244; GO:0002320; GO:0003007; GO:0003014; GO:0003129; GO:0003139; GO:0003148; GO:0003149; GO:0003163; GO:0003180; GO:0003184; GO:0003197; GO:0003279; GO:0003323; GO:0005125; GO:0005576; GO:0005615; GO:0005788; GO:0006366; GO:0007281; GO:0007492; GO:0007500; GO:0008083; GO:0008201; GO:0008284; GO:0008285; GO:0009791; GO:0009948; GO:0010159; GO:0010453; GO:0010628; GO:0010629; GO:0010718; GO:0021537; GO:0021904; GO:0021978; GO:0021983; GO:0030218; GO:0030224; GO:0030225; GO:0030501; GO:0030509; GO:0030513; GO:0032092; GO:0032331; GO:0032967; GO:0033085; GO:0033088; GO:0035116; GO:0035990; GO:0035993; GO:0036305; GO:0039706; GO:0042056; GO:0042306; GO:0042475; GO:0042476; GO:0042487; GO:0042491; GO:0042733; GO:0043065; GO:0043068; GO:0043539; GO:0045603; GO:0045606; GO:0045662; GO:0045666; GO:0045669; GO:0045778; GO:0045786; GO:0045839; GO:0045843; GO:0045892; GO:0045893; GO:0045944; GO:0048286; GO:0048392; GO:0048661; GO:0048663; GO:0048701; GO:0048745; GO:0048863; GO:0050679; GO:0050680; GO:0051145; GO:0051150; GO:0055007; GO:0055020; GO:0060235; GO:0060272; GO:0060363; GO:0060391; GO:0060425; GO:0060426; GO:0060433; GO:0060438; GO:0060440; GO:0060441; GO:0060442; GO:0060449; GO:0060502; GO:0060503; GO:0060513; GO:0060592; GO:0060684; GO:0060686; GO:0060687; GO:0060976; GO:0061036; GO:0061047; GO:0061626; GO:0070244; GO:0070374; GO:0070700; GO:0071773; GO:0072104; GO:0072125; GO:0072179; GO:0072197; GO:0072200; GO:0090191; GO:0090194; GO:1900182; GO:1900745; GO:1901331; GO:1902894; GO:1904238; GO:1904706; GO:1904753; GO:1905312; GO:1905770; GO:2000005; GO:2000007; GO:2000636; GO:2001237","ameloblast differentiation [GO:0036305]; anterior/posterior axis specification [GO:0009948]; aortic valve morphogenesis [GO:0003180]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; BMP signaling pathway [GO:0030509]; branching involved in prostate gland morphogenesis [GO:0060442]; branching involved in ureteric bud morphogenesis [GO:0001658]; bronchus development [GO:0060433]; bud dilation involved in lung branching [GO:0060503]; bud elongation involved in lung branching [GO:0060449]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum development [GO:0003279]; cellular response to BMP stimulus [GO:0071773]; chondrocyte differentiation [GO:0002062]; coronary vasculature development [GO:0060976]; cranial suture morphogenesis [GO:0060363]; deltoid tuberosity development [GO:0035993]; dorsal/ventral neural tube patterning [GO:0021904]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion development [GO:0003197]; endochondral ossification [GO:0001958]; endoderm development [GO:0007492]; epithelial cell proliferation involved in lung morphogenesis [GO:0060502]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; epithelial-mesenchymal cell signaling [GO:0060684]; erythrocyte differentiation [GO:0030218]; germ cell development [GO:0007281]; glomerular capillary formation [GO:0072104]; heart induction [GO:0003129]; heart morphogenesis [GO:0003007]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear auditory receptor cell differentiation [GO:0042491]; intermediate mesodermal cell differentiation [GO:0048392]; kidney development [GO:0001822]; lens induction in camera-type eye [GO:0060235]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; lung vasculature development [GO:0060426]; lymphoid progenitor cell differentiation [GO:0002320]; macrophage differentiation [GO:0030225]; mammary gland formation [GO:0060592]; membranous septum morphogenesis [GO:0003149]; mesodermal cell fate determination [GO:0007500]; mesonephros development [GO:0001823]; metanephros development [GO:0001656]; monocyte differentiation [GO:0030224]; negative regulation of branching involved in ureteric bud morphogenesis [GO:0090191]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of glomerulus development [GO:0090194]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; negative regulation of mesenchymal cell proliferation involved in ureter development [GO:0072200]; negative regulation of metanephric comma-shaped body morphogenesis [GO:2000007]; negative regulation of metanephric S-shaped body morphogenesis [GO:2000005]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of thymocyte apoptotic process [GO:0070244]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; nephric duct formation [GO:0072179]; neural tube closure [GO:0001843]; neuron fate commitment [GO:0048663]; odontogenesis [GO:0042476]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; pericyte cell differentiation [GO:1904238]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cardiac muscle fiber development [GO:0055020]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of odontoblast differentiation [GO:1901331]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of primary miRNA processing [GO:2000636]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; prostatic bud formation [GO:0060513]; pulmonary valve morphogenesis [GO:0003184]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of cell fate commitment [GO:0010453]; regulation of mesodermal cell differentiation [GO:1905770]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein import into nucleus [GO:0042306]; regulation of smooth muscle cell differentiation [GO:0051150]; renal system process [GO:0003014]; secondary heart field specification [GO:0003139]; sinoatrial node development [GO:0003163]; smooth muscle cell differentiation [GO:0051145]; smooth muscle tissue development [GO:0048745]; specification of animal organ position [GO:0010159]; stem cell differentiation [GO:0048863]; telencephalon development [GO:0021537]; telencephalon regionalization [GO:0021978]; tendon cell differentiation [GO:0035990]; trachea development [GO:0060438]; trachea formation [GO:0060440]; transcription by RNA polymerase II [GO:0006366]; type B pancreatic cell development [GO:0003323]; ureter morphogenesis [GO:0072197]; ureteric bud development [GO:0001657]","endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; BMP receptor binding [GO:0070700]; chemoattractant activity [GO:0042056]; co-receptor binding [GO:0039706]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; protein serine/threonine kinase activator activity [GO:0043539]; ameloblast differentiation [GO:0036305]; anterior/posterior axis specification [GO:0009948]; aortic valve morphogenesis [GO:0003180]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; BMP signaling pathway [GO:0030509]; branching involved in prostate gland morphogenesis [GO:0060442]; branching involved in ureteric bud morphogenesis [GO:0001658]; bronchus development [GO:0060433]; bud dilation involved in lung branching [GO:0060503]; bud elongation involved in lung branching [GO:0060449]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum development [GO:0003279]; cellular response to BMP stimulus [GO:0071773]; chondrocyte differentiation [GO:0002062]; coronary vasculature development [GO:0060976]; cranial suture morphogenesis [GO:0060363]; deltoid tuberosity development [GO:0035993]; dorsal/ventral neural tube patterning [GO:0021904]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion development [GO:0003197]; endochondral ossification [GO:0001958]; endoderm development [GO:0007492]; epithelial cell proliferation involved in lung morphogenesis [GO:0060502]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; epithelial-mesenchymal cell signaling [GO:0060684]; erythrocyte differentiation [GO:0030218]; germ cell development [GO:0007281]; glomerular capillary formation [GO:0072104]; heart induction [GO:0003129]; heart morphogenesis [GO:0003007]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear auditory receptor cell differentiation [GO:0042491]; intermediate mesodermal cell differentiation [GO:0048392]; kidney development [GO:0001822]; lens induction in camera-type eye [GO:0060235]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; lung vasculature development [GO:0060426]; lymphoid progenitor cell differentiation [GO:0002320]; macrophage differentiation [GO:0030225]; mammary gland formation [GO:0060592]; membranous septum morphogenesis [GO:0003149]; mesodermal cell fate determination [GO:0007500]; mesonephros development [GO:0001823]; metanephros development [GO:0001656]; monocyte differentiation [GO:0030224]; negative regulation of branching involved in ureteric bud morphogenesis [GO:0090191]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of glomerulus development [GO:0090194]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; negative regulation of mesenchymal cell proliferation involved in ureter development [GO:0072200]; negative regulation of metanephric comma-shaped body morphogenesis [GO:2000007]; negative regulation of metanephric S-shaped body morphogenesis [GO:2000005]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of thymocyte apoptotic process [GO:0070244]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; nephric duct formation [GO:0072179]; neural tube closure [GO:0001843]; neuron fate commitment [GO:0048663]; odontogenesis [GO:0042476]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; pericyte cell differentiation [GO:1904238]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cardiac muscle fiber development [GO:0055020]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of odontoblast differentiation [GO:1901331]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of primary miRNA processing [GO:2000636]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; prostatic bud formation [GO:0060513]; pulmonary valve morphogenesis [GO:0003184]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of cell fate commitment [GO:0010453]; regulation of mesodermal cell differentiation [GO:1905770]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein import into nucleus [GO:0042306]; regulation of smooth muscle cell differentiation [GO:0051150]; renal system process [GO:0003014]; secondary heart field specification [GO:0003139]; sinoatrial node development [GO:0003163]; smooth muscle cell differentiation [GO:0051145]; smooth muscle tissue development [GO:0048745]; specification of animal organ position [GO:0010159]; stem cell differentiation [GO:0048863]; telencephalon development [GO:0021537]; telencephalon regionalization [GO:0021978]; tendon cell differentiation [GO:0035990]; trachea development [GO:0060438]; trachea formation [GO:0060440]; transcription by RNA polymerase II [GO:0006366]; type B pancreatic cell development [GO:0003323]; ureter morphogenesis [GO:0072197]; ureteric bud development [GO:0001657]","","","","TISSUE SPECIFICITY: Expressed in the lung and lower levels seen in the kidney. Present also in normal and neoplastic prostate tissues, and prostate cancer cell lines."
"764","sp|P49858|CNI_DROME","lcl|NC_088858.1_cds_XP_011434817.1_33709",1.58e-67,202,"P49858","CNI_DROME","Protein cornichon","cni CG5855","Drosophila melanogaster (Fruit fly)",144,"GO:0005102; GO:0005789; GO:0006888; GO:0007310; GO:0007350; GO:0009952; GO:0015031; GO:0016192; GO:0030134; GO:0046843","anterior/posterior pattern specification [GO:0009952]; blastoderm segmentation [GO:0007350]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; oocyte dorsal/ventral axis specification [GO:0007310]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]","COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum membrane [GO:0005789]; signaling receptor binding [GO:0005102]; anterior/posterior pattern specification [GO:0009952]; blastoderm segmentation [GO:0007350]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; oocyte dorsal/ventral axis specification [GO:0007310]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]","DEVELOPMENTAL STAGE: Detectable in the germline from germarium stages onwards and becomes enriched within the oocyte during early and middle stages of oogenesis. In early stages, it is present in the nurse cell oocyte cluster. It is highly expressed in stage 1-6 egg chambers, expression ceases during stage 7 and cannot be detected in stages 8 and 9. During stage 10, it is reexpressed in the nurse cells. {ECO:0000269|PubMed:16396907, ECO:0000269|PubMed:7540118}.","","","TISSUE SPECIFICITY: Expressed in male and female somatic tissues. {ECO:0000269|PubMed:16396907}."
"765","sp|Q9VNJ5|DISP_DROME","lcl|NC_088858.1_cds_XP_011434820.3_33712",2.37e-151,485,"Q9VNJ5","DISP_DROME","Protein dispatched","disp CG2019","Drosophila melanogaster (Fruit fly)",1218,"GO:0005886; GO:0007224; GO:0007225; GO:0007367; GO:0008354; GO:0016020; GO:0035222; GO:0035230","germ cell migration [GO:0008354]; patched ligand maturation [GO:0007225]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc pattern formation [GO:0035222]","cytoneme [GO:0035230]; membrane [GO:0016020]; plasma membrane [GO:0005886]; germ cell migration [GO:0008354]; patched ligand maturation [GO:0007225]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc pattern formation [GO:0035222]","DEVELOPMENTAL STAGE: Ubiquitously expressed throughout the embryo and the imaginal discs. {ECO:0000269|PubMed:10619433}.","","",""
"766","sp|P0CG53|UBB_BOVIN","lcl|NC_088858.1_cds_XP_011436382.3_29390",0,602,"P0CG53","UBB_BOVIN","Polyubiquitin-B [Cleaved into: Ubiquitin]","UBB","Bos taurus (Bovine)",305,"GO:0003735; GO:0005634; GO:0005737; GO:0005741; GO:0007141; GO:0007144; GO:0008585; GO:0016567; GO:0019941; GO:0021888; GO:0031386; GO:0031625; GO:0043005; GO:0043025; GO:0043523; GO:0047497; GO:0048812; GO:0051881; GO:0060613; GO:0061136; GO:0072520; GO:0097009; GO:1902255; GO:1902527","energy homeostasis [GO:0097009]; fat pad development [GO:0060613]; female gonad development [GO:0008585]; female meiosis I [GO:0007144]; hypothalamus gonadotrophin-releasing hormone neuron development [GO:0021888]; male meiosis I [GO:0007141]; mitochondrion transport along microtubule [GO:0047497]; modification-dependent protein catabolic process [GO:0019941]; neuron projection morphogenesis [GO:0048812]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; positive regulation of protein monoubiquitination [GO:1902527]; protein ubiquitination [GO:0016567]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; regulation of proteasomal protein catabolic process [GO:0061136]; seminiferous tubule development [GO:0072520]","cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; protein tag activity [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]; energy homeostasis [GO:0097009]; fat pad development [GO:0060613]; female gonad development [GO:0008585]; female meiosis I [GO:0007144]; hypothalamus gonadotrophin-releasing hormone neuron development [GO:0021888]; male meiosis I [GO:0007141]; mitochondrion transport along microtubule [GO:0047497]; modification-dependent protein catabolic process [GO:0019941]; neuron projection morphogenesis [GO:0048812]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; positive regulation of protein monoubiquitination [GO:1902527]; protein ubiquitination [GO:0016567]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; regulation of proteasomal protein catabolic process [GO:0061136]; seminiferous tubule development [GO:0072520]","","","",""
"767","sp|P04629|NTRK1_HUMAN","lcl|NC_088858.1_cds_XP_011436389.2_29397",8.4e-153,468,"P04629","NTRK1_HUMAN","High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (TRK1-transforming tyrosine kinase protein) (Tropomyosin-related kinase A) (Tyrosine kinase receptor) (Tyrosine kinase receptor A) (Trk-A) (gp140trk) (p140-TrkA)","NTRK1 MTC TRK TRKA","Homo sapiens (Human)",796,"GO:0004713; GO:0004714; GO:0005004; GO:0005030; GO:0005166; GO:0005524; GO:0005739; GO:0005769; GO:0005770; GO:0005886; GO:0006468; GO:0007169; GO:0007283; GO:0007411; GO:0007611; GO:0007623; GO:0008285; GO:0009410; GO:0009986; GO:0010008; GO:0010465; GO:0010623; GO:0010976; GO:0018108; GO:0019900; GO:0021553; GO:0030183; GO:0030424; GO:0030425; GO:0031175; GO:0031667; GO:0031901; GO:0031902; GO:0032991; GO:0038083; GO:0038180; GO:0042490; GO:0042802; GO:0042803; GO:0043025; GO:0043066; GO:0043068; GO:0043121; GO:0043235; GO:0043524; GO:0043547; GO:0045766; GO:0046579; GO:0046777; GO:0048011; GO:0048406; GO:0048485; GO:0048666; GO:0048678; GO:0050965; GO:0050966; GO:0051092; GO:0051402; GO:0051599; GO:0051602; GO:0051897; GO:0051965; GO:0051968; GO:0055038; GO:0060009; GO:0060385; GO:0061368; GO:0070374; GO:0071316; GO:1990090","axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; B cell differentiation [GO:0030183]; behavioral response to formalin induced pain [GO:0061368]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to nicotine [GO:0071316]; circadian rhythm [GO:0007623]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; learning or memory [GO:0007611]; mechanoreceptor differentiation [GO:0042490]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; nerve growth factor signaling pathway [GO:0038180]; neuron apoptotic process [GO:0051402]; neuron development [GO:0048666]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; olfactory nerve development [GO:0021553]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of programmed cell death [GO:0043068]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; programmed cell death involved in cell development [GO:0010623]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to axon injury [GO:0048678]; response to electrical stimulus [GO:0051602]; response to hydrostatic pressure [GO:0051599]; response to nutrient levels [GO:0031667]; response to xenobiotic stimulus [GO:0009410]; Sertoli cell development [GO:0060009]; spermatogenesis [GO:0007283]; sympathetic nervous system development [GO:0048485]","axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; GPI-linked ephrin receptor activity [GO:0005004]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; nerve growth factor binding [GO:0048406]; nerve growth factor receptor activity [GO:0010465]; neurotrophin binding [GO:0043121]; neurotrophin p75 receptor binding [GO:0005166]; neurotrophin receptor activity [GO:0005030]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; B cell differentiation [GO:0030183]; behavioral response to formalin induced pain [GO:0061368]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to nicotine [GO:0071316]; circadian rhythm [GO:0007623]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; learning or memory [GO:0007611]; mechanoreceptor differentiation [GO:0042490]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; nerve growth factor signaling pathway [GO:0038180]; neuron apoptotic process [GO:0051402]; neuron development [GO:0048666]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; olfactory nerve development [GO:0021553]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of programmed cell death [GO:0043068]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; programmed cell death involved in cell development [GO:0010623]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to axon injury [GO:0048678]; response to electrical stimulus [GO:0051602]; response to hydrostatic pressure [GO:0051599]; response to nutrient levels [GO:0031667]; response to xenobiotic stimulus [GO:0009410]; Sertoli cell development [GO:0060009]; spermatogenesis [GO:0007283]; sympathetic nervous system development [GO:0048485]","","INDUCTION: Isoform TrkA-III is up-regulated upon hypoxia in cells normally expressing it. {ECO:0000269|PubMed:15488758}.","INDUCTION: Isoform TrkA-III is up-regulated upon hypoxia in cells normally expressing it. {ECO:0000269|PubMed:15488758}.","TISSUE SPECIFICITY: Isoform TrkA-I is found in most non-neuronal tissues. Isoform TrkA-II is primarily expressed in neuronal cells. TrkA-III is specifically expressed by pluripotent neural stem and neural crest progenitors. {ECO:0000269|PubMed:15488758, ECO:0000269|PubMed:8325889}."
"768","sp|Q7JXF7|SEELE_DROME","lcl|NC_088858.1_cds_XP_011436412.3_29382",2.75e-15,72.4,"Q7JXF7","SEELE_DROME","Protein seele","sel CG12918","Drosophila melanogaster (Fruit fly)",189,"GO:0005783; GO:0007311; GO:0009951; GO:0012505; GO:0050708; GO:0051087; GO:0061077; GO:0070613","chaperone-mediated protein folding [GO:0061077]; maternal specification of dorsal/ventral axis, oocyte, germ-line encoded [GO:0007311]; polarity specification of dorsal/ventral axis [GO:0009951]; regulation of protein processing [GO:0070613]; regulation of protein secretion [GO:0050708]","endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; protein-folding chaperone binding [GO:0051087]; chaperone-mediated protein folding [GO:0061077]; maternal specification of dorsal/ventral axis, oocyte, germ-line encoded [GO:0007311]; polarity specification of dorsal/ventral axis [GO:0009951]; regulation of protein processing [GO:0070613]; regulation of protein secretion [GO:0050708]","DEVELOPMENTAL STAGE: Expressed in blastoderm embryos (at protein level). Abundantly expressed in late-stage embryos including in the developing salivary glands (at protein level). {ECO:0000269|PubMed:20970335}.","","",""
"769","sp|Q9VHS8|IF4A3_DROME","lcl|NC_088858.1_cds_XP_011437948.1_32259",0,752,"Q9VHS8","IF4A3_DROME","Eukaryotic initiation factor 4A-III (eIF-4A-III) (eIF4A-III) (EC 3.6.4.13)","CG7483","Drosophila melanogaster (Fruit fly)",399,"GO:0000398; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005730; GO:0006325; GO:0008380; GO:0010628; GO:0016887; GO:0045451; GO:0045495; GO:0051028; GO:0071011; GO:0071013; GO:1903040","chromatin organization [GO:0006325]; exon-exon junction complex assembly [GO:1903040]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of gene expression [GO:0010628]; RNA splicing [GO:0008380]","catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleus [GO:0005634]; pole plasm [GO:0045495]; precatalytic spliceosome [GO:0071011]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]; chromatin organization [GO:0006325]; exon-exon junction complex assembly [GO:1903040]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of gene expression [GO:0010628]; RNA splicing [GO:0008380]","DEVELOPMENTAL STAGE: Localizes to the posterior pole of the oocyte during stages 1-9 of oogenesis, where it colocalizes with mago. {ECO:0000269|PubMed:14973490}.","","",""
"770","sp|O61789|EGG5_CAEEL","lcl|NC_088858.1_cds_XP_011439449.3_29410",4.69e-21,99.8,"O61789","EGG5_CAEEL","Inactive protein-tyrosine phosphatase egg-5 (Egg sterile protein 5) (Protein-tyrosine phosphatase-like protein egg-5)","egg-5 R12E2.10","Caenorhabditis elegans",753,"GO:0001556; GO:0004725; GO:0005634; GO:0005938; GO:0007165; GO:0019901; GO:0030703; GO:0030866; GO:0040038; GO:1904778","cortical actin cytoskeleton organization [GO:0030866]; eggshell formation [GO:0030703]; oocyte maturation [GO:0001556]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of protein localization to cell cortex [GO:1904778]; signal transduction [GO:0007165]","cell cortex [GO:0005938]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cortical actin cytoskeleton organization [GO:0030866]; eggshell formation [GO:0030703]; oocyte maturation [GO:0001556]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of protein localization to cell cortex [GO:1904778]; signal transduction [GO:0007165]","","","",""
"771","sp|Q9TXH9|UBXN1_CAEEL","lcl|NC_088858.1_cds_XP_011439544.3_30863",2.42e-43,152,"Q9TXH9","UBXN1_CAEEL","UBX domain-containing protein 1","ubxn-1 F23C8.4","Caenorhabditis elegans",299,"GO:0005634; GO:0005737; GO:0007283; GO:0030154; GO:0031397; GO:0032435; GO:0036435; GO:0036498; GO:0042006; GO:0045732; GO:0048471; GO:1903094","cell differentiation [GO:0030154]; IRE1-mediated unfolded protein response [GO:0036498]; masculinization of hermaphroditic germ-line [GO:0042006]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein catabolic process [GO:0045732]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; cell differentiation [GO:0030154]; IRE1-mediated unfolded protein response [GO:0036498]; masculinization of hermaphroditic germ-line [GO:0042006]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein catabolic process [GO:0045732]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed in embryos, L4 larvae and adults. Expressed to a lesser extent between L1 and L3 larval stages. {ECO:0000269|PubMed:17498661}.","","","TISSUE SPECIFICITY: Expressed in the germline (at protein level) (PubMed:17498661, PubMed:20977550). Expressed in spermatocytes but not in mature sperm (at protein level) (PubMed:20977550). Ubiquitously expressed (PubMed:17498661). Predominantly expressed in the spermatheca (PubMed:17498661). {ECO:0000269|PubMed:17498661, ECO:0000269|PubMed:20977550}."
"772","sp|Q9HB31|SEBOX_HUMAN","lcl|NC_088858.1_cds_XP_011439562.2_30841",5.14e-14,69.3,"Q9HB31","SEBOX_HUMAN","Homeobox protein SEBOX (Homeobox OG-9) (Skin-, embryo-, brain- and oocyte-specific homeobox)","SEBOX OG9X","Homo sapiens (Human)",190,"GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0009792; GO:0048477","embryo development ending in birth or egg hatching [GO:0009792]; oogenesis [GO:0048477]; regulation of transcription by RNA polymerase II [GO:0006357]","nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; embryo development ending in birth or egg hatching [GO:0009792]; oogenesis [GO:0048477]; regulation of transcription by RNA polymerase II [GO:0006357]","","","",""
"773","sp|Q8SXY6|TMEDA_DROME","lcl|NC_088858.1_cds_XP_011439598.1_29883",1.13e-79,238,"Q8SXY6","TMEDA_DROME","Transmembrane emp24 domain-containing protein bai (Protein baiser)","bai CG11785","Drosophila melanogaster (Fruit fly)",206,"GO:0005783; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0007311; GO:0009953; GO:0012505; GO:0016020; GO:0030134; GO:0038024; GO:0048193","dorsal/ventral pattern formation [GO:0009953]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; maternal specification of dorsal/ventral axis, oocyte, germ-line encoded [GO:0007311]","COPII-coated ER to Golgi transport vesicle [GO:0030134]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; cargo receptor activity [GO:0038024]; dorsal/ventral pattern formation [GO:0009953]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; maternal specification of dorsal/ventral axis, oocyte, germ-line encoded [GO:0007311]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. {ECO:0000269|PubMed:15327786}.","","",""
"774","sp|G5EC86|MOE1_CAEEL","lcl|NC_088858.1_cds_XP_011439615.3_29899",2.49e-15,78.6,"G5EC86","MOE1_CAEEL","CCCH-type zinc finger protein oma-1 (Maturation oocyte expansion protein 1) (Oocyte maturation defective protein 1)","oma-1 moe-1 C09G9.6","Caenorhabditis elegans",407,"GO:0000900; GO:0001555; GO:0001556; GO:0003730; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0008270; GO:0009880; GO:0017148; GO:0035770; GO:0035925; GO:0036464; GO:0040019; GO:0043186; GO:0043406; GO:0048601; GO:0051078; GO:0051303; GO:0060280; GO:0060282; GO:0071168; GO:1900195; GO:1904145; GO:1904146; GO:1905516; GO:1990904","embryonic pattern specification [GO:0009880]; establishment of chromosome localization [GO:0051303]; meiotic nuclear membrane disassembly [GO:0051078]; negative regulation of meiotic cell cycle process involved in oocyte maturation [GO:1904145]; negative regulation of ovulation [GO:0060280]; negative regulation of translation [GO:0017148]; oocyte growth [GO:0001555]; oocyte maturation [GO:0001556]; oocyte morphogenesis [GO:0048601]; positive regulation of embryonic development [GO:0040019]; positive regulation of fertilization [GO:1905516]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of meiotic cell cycle process involved in oocyte maturation [GO:1904146]; positive regulation of oocyte development [GO:0060282]; positive regulation of oocyte maturation [GO:1900195]; protein localization to chromatin [GO:0071168]","centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA regulatory element binding translation repressor activity [GO:0000900]; zinc ion binding [GO:0008270]; embryonic pattern specification [GO:0009880]; establishment of chromosome localization [GO:0051303]; meiotic nuclear membrane disassembly [GO:0051078]; negative regulation of meiotic cell cycle process involved in oocyte maturation [GO:1904145]; negative regulation of ovulation [GO:0060280]; negative regulation of translation [GO:0017148]; oocyte growth [GO:0001555]; oocyte maturation [GO:0001556]; oocyte morphogenesis [GO:0048601]; positive regulation of embryonic development [GO:0040019]; positive regulation of fertilization [GO:1905516]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of meiotic cell cycle process involved in oocyte maturation [GO:1904146]; positive regulation of oocyte development [GO:0060282]; positive regulation of oocyte maturation [GO:1900195]; protein localization to chromatin [GO:0071168]","DEVELOPMENTAL STAGE: Expressed in newly fertilized embryos, but is rapidly degraded after initiation of the first mitotic division (PubMed:12781695, PubMed:16611242, PubMed:18417623). Highly expressed in one-cell embryos (PubMed:18854162). Expressed in P-granules in blastula-stage embryos (PubMed:16611242). Weak, if any, expression during larval stages (PubMed:11702779). {ECO:0000269|PubMed:11702779, ECO:0000269|PubMed:12781695, ECO:0000269|PubMed:16611242, ECO:0000269|PubMed:18417623, ECO:0000269|PubMed:18854162}.","","","TISSUE SPECIFICITY: Exclusively expressed in the hermaphrodite gonad (PubMed:11702779, PubMed:12296824, PubMed:16611242). Expressed prior to oocyte division (PubMed:11702779). Widely distributed throughout gonadal oocytes from the mitotic stage to the developing diakinesis stage (PubMed:12296824). Expressed in sperm (PubMed:25261697). {ECO:0000269|PubMed:11702779, ECO:0000269|PubMed:12296824, ECO:0000269|PubMed:16611242, ECO:0000269|PubMed:25261697}."
"775","sp|Q8R418|DICER_MOUSE","lcl|NC_088858.1_cds_XP_011439629.3_29912",0,756,"Q8R418","DICER_MOUSE","Endoribonuclease Dicer (EC 3.1.26.3) (Double-strand-specific ribonuclease mDCR-1)","Dicer1 Dicer Mdcr","Mus musculus (Mouse)",1916,"GO:0000122; GO:0000212; GO:0001525; GO:0001834; GO:0001942; GO:0003677; GO:0004386; GO:0004525; GO:0005524; GO:0005737; GO:0005829; GO:0006364; GO:0006396; GO:0007284; GO:0008283; GO:0008593; GO:0009791; GO:0010070; GO:0010467; GO:0010468; GO:0010626; GO:0010628; GO:0010660; GO:0014040; GO:0014835; GO:0016442; GO:0019827; GO:0021522; GO:0021675; GO:0021889; GO:0021987; GO:0030324; GO:0030326; GO:0030422; GO:0030856; GO:0031054; GO:0031069; GO:0031508; GO:0031641; GO:0031643; GO:0032290; GO:0035116; GO:0035194; GO:0035196; GO:0035198; GO:0035264; GO:0042487; GO:0045069; GO:0045589; GO:0045664; GO:0045944; GO:0046872; GO:0048255; GO:0048471; GO:0048536; GO:0048565; GO:0048608; GO:0048713; GO:0048730; GO:0048754; GO:0048812; GO:0050727; GO:0050767; GO:0051216; GO:0051225; GO:0051252; GO:0051607; GO:0051726; GO:0055013; GO:0060119; GO:0060253; GO:0060576; GO:0061309; GO:0061548; GO:0070173; GO:0070578; GO:0070922; GO:0071335; GO:0098795; GO:0098978; GO:0099092; GO:2000628; GO:2000630; GO:2000736","angiogenesis [GO:0001525]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cartilage development [GO:0051216]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; defense response to virus [GO:0051607]; digestive tract development [GO:0048565]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; epidermis morphogenesis [GO:0048730]; ganglion development [GO:0061548]; gene expression [GO:0010467]; global gene silencing by mRNA cleavage [GO:0098795]; hair follicle cell proliferation [GO:0071335]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; inner ear receptor cell development [GO:0060119]; intestinal epithelial cell development [GO:0060576]; lung development [GO:0030324]; meiotic spindle organization [GO:0000212]; miRNA processing [GO:0035196]; mRNA stabilization [GO:0048255]; multicellular organism growth [GO:0035264]; myoblast differentiation involved in skeletal muscle regeneration [GO:0014835]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nerve development [GO:0021675]; neuron projection morphogenesis [GO:0048812]; olfactory bulb interneuron differentiation [GO:0021889]; pericentric heterochromatin formation [GO:0031508]; peripheral nervous system myelin formation [GO:0032290]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of myelination [GO:0031643]; positive regulation of Schwann cell differentiation [GO:0014040]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; regulation of cell cycle [GO:0051726]; regulation of enamel mineralization [GO:0070173]; regulation of epithelial cell differentiation [GO:0030856]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of muscle cell apoptotic process [GO:0010660]; regulation of myelination [GO:0031641]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of Notch signaling pathway [GO:0008593]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of oligodendrocyte differentiation [GO:0048713]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of RNA metabolic process [GO:0051252]; regulation of stem cell differentiation [GO:2000736]; regulation of viral genome replication [GO:0045069]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; reproductive structure development [GO:0048608]; RISC complex assembly [GO:0070922]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; siRNA processing [GO:0030422]; spermatogonial cell division [GO:0007284]; spinal cord motor neuron differentiation [GO:0021522]; spindle assembly [GO:0051225]; spleen development [GO:0048536]; stem cell population maintenance [GO:0019827]; trophectodermal cell proliferation [GO:0001834]; zygote asymmetric cell division [GO:0010070]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density, intracellular component [GO:0099092]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; ribonuclease III activity [GO:0004525]; angiogenesis [GO:0001525]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cartilage development [GO:0051216]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; defense response to virus [GO:0051607]; digestive tract development [GO:0048565]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; epidermis morphogenesis [GO:0048730]; ganglion development [GO:0061548]; gene expression [GO:0010467]; global gene silencing by mRNA cleavage [GO:0098795]; hair follicle cell proliferation [GO:0071335]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; inner ear receptor cell development [GO:0060119]; intestinal epithelial cell development [GO:0060576]; lung development [GO:0030324]; meiotic spindle organization [GO:0000212]; miRNA processing [GO:0035196]; mRNA stabilization [GO:0048255]; multicellular organism growth [GO:0035264]; myoblast differentiation involved in skeletal muscle regeneration [GO:0014835]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nerve development [GO:0021675]; neuron projection morphogenesis [GO:0048812]; olfactory bulb interneuron differentiation [GO:0021889]; pericentric heterochromatin formation [GO:0031508]; peripheral nervous system myelin formation [GO:0032290]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of myelination [GO:0031643]; positive regulation of Schwann cell differentiation [GO:0014040]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; regulation of cell cycle [GO:0051726]; regulation of enamel mineralization [GO:0070173]; regulation of epithelial cell differentiation [GO:0030856]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of muscle cell apoptotic process [GO:0010660]; regulation of myelination [GO:0031641]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of Notch signaling pathway [GO:0008593]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of oligodendrocyte differentiation [GO:0048713]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of RNA metabolic process [GO:0051252]; regulation of stem cell differentiation [GO:2000736]; regulation of viral genome replication [GO:0045069]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; reproductive structure development [GO:0048608]; RISC complex assembly [GO:0070922]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; siRNA processing [GO:0030422]; spermatogonial cell division [GO:0007284]; spinal cord motor neuron differentiation [GO:0021522]; spindle assembly [GO:0051225]; spleen development [GO:0048536]; stem cell population maintenance [GO:0019827]; trophectodermal cell proliferation [GO:0001834]; zygote asymmetric cell division [GO:0010070]","","","","TISSUE SPECIFICITY: Isoform 1 is expressed in a wide variety of tissues. Isoform 2 is specifically expressed in oocytes during their growth (at protein level)."
"776","sp|P45594|CADF_DROME","lcl|NC_088858.1_cds_XP_011439806.1_32087",1.34e-21,85.9,"P45594","CADF_DROME","Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)","tsr Cadf CG4254","Drosophila melanogaster (Fruit fly)",148,"GO:0000281; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0050714; GO:0051014; GO:0051015; GO:0051299","actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]","actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]","DEVELOPMENTAL STAGE: Expressed during all stages of development and peaks in late larval and pupal stages. Expressed in both male and female adults. {ECO:0000269|PubMed:8522587}.","","",""
"777","sp|Q9R0A3|SPAT7_RAT","lcl|NC_088858.1_cds_XP_011441058.3_28755",6.69e-12,69.7,"Q9R0A3","SPAT7_RAT","Spermatogenesis-associated protein 7 homolog (Fertility-related protein WMP1) (Rat sperm DNA no.3) (RSD-3)","Spata7 Rsd3","Rattus norvegicus (Rat)",526,"GO:0000226; GO:0005930; GO:0007283; GO:0015630; GO:0032391; GO:0036064; GO:0045494; GO:0120200; GO:0120206; GO:1903546; GO:1903621","microtubule cytoskeleton organization [GO:0000226]; photoreceptor cell maintenance [GO:0045494]; protein localization to photoreceptor connecting cilium [GO:1903621]; protein localization to photoreceptor outer segment [GO:1903546]; spermatogenesis [GO:0007283]","axoneme [GO:0005930]; ciliary basal body [GO:0036064]; microtubule cytoskeleton [GO:0015630]; photoreceptor connecting cilium [GO:0032391]; photoreceptor distal connecting cilium [GO:0120206]; rod photoreceptor outer segment [GO:0120200]; microtubule cytoskeleton organization [GO:0000226]; photoreceptor cell maintenance [GO:0045494]; protein localization to photoreceptor connecting cilium [GO:1903621]; protein localization to photoreceptor outer segment [GO:1903546]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: In early prophase of primary spermatocytes. {ECO:0000269|PubMed:12736779}."
"778","sp|Q01608|SPE4_CAEEL","lcl|NC_088858.1_cds_XP_011441079.2_28778",3.71e-13,72.8,"Q01608","SPE4_CAEEL","Presenilin spe-4","spe-4 ZK524.1","Caenorhabditis elegans",465,"GO:0004175; GO:0005789; GO:0005794; GO:0006509; GO:0006996; GO:0007219; GO:0007286; GO:0008104; GO:0016485; GO:0034205; GO:0042500; GO:0043231; GO:0048515; GO:0055074; GO:0061024; GO:0070765","amyloid-beta formation [GO:0034205]; calcium ion homeostasis [GO:0055074]; membrane organization [GO:0061024]; membrane protein ectodomain proteolysis [GO:0006509]; Notch signaling pathway [GO:0007219]; organelle organization [GO:0006996]; protein localization [GO:0008104]; protein processing [GO:0016485]; spermatid development [GO:0007286]; spermatid differentiation [GO:0048515]","endoplasmic reticulum membrane [GO:0005789]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; endopeptidase activity [GO:0004175]; amyloid-beta formation [GO:0034205]; calcium ion homeostasis [GO:0055074]; membrane organization [GO:0061024]; membrane protein ectodomain proteolysis [GO:0006509]; Notch signaling pathway [GO:0007219]; organelle organization [GO:0006996]; protein localization [GO:0008104]; protein processing [GO:0016485]; spermatid development [GO:0007286]; spermatid differentiation [GO:0048515]","DEVELOPMENTAL STAGE: Expressed during L4 stage, during spermatogenesis, when hermaphrodites produces sperm.","","",""
"779","sp|P48462|PP1B_DROME","lcl|NC_088858.1_cds_XP_011441164.1_28480",0,581,"P48462","PP1B_DROME","Serine/threonine-protein phosphatase beta isoform (EC 3.1.3.16) (Protein flap wing)","flw PP1-9C PP1-BETA-9C CG2096","Drosophila melanogaster (Fruit fly)",330,"GO:0000164; GO:0004722; GO:0005634; GO:0005737; GO:0005829; GO:0005979; GO:0005981; GO:0007059; GO:0007155; GO:0007300; GO:0007301; GO:0007312; GO:0007476; GO:0007498; GO:0014706; GO:0017018; GO:0030514; GO:0031991; GO:0045879; GO:0046329; GO:0046872; GO:0090263; GO:1905330","cell adhesion [GO:0007155]; chromosome segregation [GO:0007059]; female germline ring canal formation [GO:0007301]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesoderm development [GO:0007498]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of JNK cascade [GO:0046329]; negative regulation of smoothened signaling pathway [GO:0045879]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of actomyosin contractile ring contraction [GO:0031991]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981]; regulation of morphogenesis of an epithelium [GO:1905330]; striated muscle tissue development [GO:0014706]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; cell adhesion [GO:0007155]; chromosome segregation [GO:0007059]; female germline ring canal formation [GO:0007301]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesoderm development [GO:0007498]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of JNK cascade [GO:0046329]; negative regulation of smoothened signaling pathway [GO:0045879]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of actomyosin contractile ring contraction [GO:0031991]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981]; regulation of morphogenesis of an epithelium [GO:1905330]; striated muscle tissue development [GO:0014706]","","","",""
"780","sp|Q9Z1T1|AP3B1_MOUSE","lcl|NC_088858.1_cds_XP_011442219.3_32440",0,924,"Q9Z1T1","AP3B1_MOUSE","AP-3 complex subunit beta-1 (Adaptor protein complex AP-3 subunit beta-1) (Adaptor-related protein complex 3 subunit beta-1) (Beta-3A-adaptin) (Clathrin assembly protein complex 3 beta-1 large chain)","Ap3b1","Mus musculus (Mouse)",1105,"GO:0000902; GO:0002224; GO:0002244; GO:0003016; GO:0005739; GO:0005769; GO:0005802; GO:0006605; GO:0006622; GO:0006882; GO:0006886; GO:0006954; GO:0007040; GO:0007283; GO:0007338; GO:0007596; GO:0008089; GO:0016192; GO:0019882; GO:0019903; GO:0030123; GO:0030131; GO:0030324; GO:0030665; GO:0030742; GO:0030851; GO:0032438; GO:0034394; GO:0035654; GO:0036211; GO:0042789; GO:0043473; GO:0045944; GO:0046907; GO:0048007; GO:0048490; GO:0048872; GO:0051138; GO:0060155; GO:0060425; GO:0061024; GO:0090152; GO:0098773; GO:1903232; GO:1904115; GO:1990742","anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation [GO:0019882]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; granulocyte differentiation [GO:0030851]; hematopoietic progenitor cell differentiation [GO:0002244]; homeostasis of number of cells [GO:0048872]; inflammatory response [GO:0006954]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; intracellular zinc ion homeostasis [GO:0006882]; lung development [GO:0030324]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; membrane organization [GO:0061024]; mRNA transcription by RNA polymerase II [GO:0042789]; pigmentation [GO:0043473]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to cell surface [GO:0034394]; protein modification process [GO:0036211]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; respiratory system process [GO:0003016]; single fertilization [GO:0007338]; skin epidermis development [GO:0098773]; spermatogenesis [GO:0007283]; toll-like receptor signaling pathway [GO:0002224]; vesicle-mediated transport [GO:0016192]","AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; early endosome [GO:0005769]; microvesicle [GO:1990742]; mitochondrion [GO:0005739]; trans-Golgi network [GO:0005802]; GTP-dependent protein binding [GO:0030742]; protein phosphatase binding [GO:0019903]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation [GO:0019882]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; granulocyte differentiation [GO:0030851]; hematopoietic progenitor cell differentiation [GO:0002244]; homeostasis of number of cells [GO:0048872]; inflammatory response [GO:0006954]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; intracellular zinc ion homeostasis [GO:0006882]; lung development [GO:0030324]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; membrane organization [GO:0061024]; mRNA transcription by RNA polymerase II [GO:0042789]; pigmentation [GO:0043473]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to cell surface [GO:0034394]; protein modification process [GO:0036211]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; respiratory system process [GO:0003016]; single fertilization [GO:0007338]; skin epidermis development [GO:0098773]; spermatogenesis [GO:0007283]; toll-like receptor signaling pathway [GO:0002224]; vesicle-mediated transport [GO:0016192]","","","","TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:9931340}."
"781","sp|P56403|AQP7_RAT","lcl|NC_088858.1_cds_XP_011442305.3_32456",4.24e-68,214,"P56403","AQP7_RAT","Aquaporin-7 (AQP-7) (Aquaglyceroporin-7)","Aqp7","Rattus norvegicus (Rat)",269,"GO:0005737; GO:0005811; GO:0005886; GO:0005911; GO:0006833; GO:0007283; GO:0009410; GO:0015204; GO:0015250; GO:0015254; GO:0015265; GO:0015793; GO:0015840; GO:0016323; GO:0030659; GO:0031526; GO:0070295; GO:1990904","glycerol transmembrane transport [GO:0015793]; renal water absorption [GO:0070295]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]; urea transport [GO:0015840]; water transport [GO:0006833]","basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; glycerol channel activity [GO:0015254]; urea channel activity [GO:0015265]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]; glycerol transmembrane transport [GO:0015793]; renal water absorption [GO:0070295]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]; urea transport [GO:0015840]; water transport [GO:0006833]","DEVELOPMENTAL STAGE: Expressed at late stages of spermatogenesis, from late to maturing spermatids (at protein level). {ECO:0000269|PubMed:9252401}.","","","TISSUE SPECIFICITY: Detected in heart, kidney and testis. {ECO:0000269|PubMed:9252401}."
"782","sp|Q8CDL9|CCD87_MOUSE","lcl|NC_088858.1_cds_XP_011442346.3_32452",5.34e-28,123,"Q8CDL9","CCD87_MOUSE","Coiled-coil domain-containing protein 87","Ccdc87","Mus musculus (Mouse)",855,"GO:0007283; GO:0007338; GO:0030154; GO:1905516; GO:2000344","cell differentiation [GO:0030154]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]","cell differentiation [GO:0030154]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Detected from postnatal day 14 onwards. Maintained at high levels through to adulthood. {ECO:0000269|PubMed:29733332}.","","","TISSUE SPECIFICITY: Specifically expressed in testis (at protein level). Not detected in other tissues tested (at protein level). In the testis, localizes to pachytene spermatocytes and spermatids. {ECO:0000269|PubMed:29733332}."
"783","sp|Q9H0K4|RSH6A_HUMAN","lcl|NC_088858.1_cds_XP_011442475.2_29175",4e-135,409,"Q9H0K4","RSH6A_HUMAN","Radial spoke head protein 6 homolog A (Radial spoke head-like protein 1)","RSPH6A RSHL1","Homo sapiens (Human)",717,"GO:0001535; GO:0003341; GO:0005930; GO:0035082; GO:0036126; GO:0120316; GO:1905199","axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; manchette disassembly [GO:1905199]; sperm flagellum assembly [GO:0120316]","axoneme [GO:0005930]; radial spoke head [GO:0001535]; sperm flagellum [GO:0036126]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; manchette disassembly [GO:1905199]; sperm flagellum assembly [GO:0120316]","","","",""
"784","sp|Q24324|DSOR1_DROME","lcl|NC_088858.1_cds_XP_011443360.3_33370",2.62e-176,498,"Q24324","DSOR1_DROME","Dual specificity mitogen-activated protein kinase kinase dSOR1 (Downstream of RAF) (MAPKK) (EC 2.7.12.2)","Dsor1 CG15793","Drosophila melanogaster (Fruit fly)",396,"GO:0000165; GO:0000793; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005829; GO:0007095; GO:0007173; GO:0007298; GO:0007362; GO:0007430; GO:0007465; GO:0008286; GO:0008293; GO:0008340; GO:0008543; GO:0009953; GO:0019900; GO:0033314; GO:0042386; GO:0042461; GO:0045500; GO:0048010; GO:0051607; GO:0070371; GO:0071481; GO:0106310","border follicle cell migration [GO:0007298]; cellular response to X-ray [GO:0071481]; defense response to virus [GO:0051607]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hemocyte differentiation [GO:0042386]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; photoreceptor cell development [GO:0042461]; R7 cell fate commitment [GO:0007465]; sevenless signaling pathway [GO:0045500]; terminal branching, open tracheal system [GO:0007430]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","condensed chromosome [GO:0000793]; cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase binding [GO:0019900]; MAP kinase kinase activity [GO:0004708]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; border follicle cell migration [GO:0007298]; cellular response to X-ray [GO:0071481]; defense response to virus [GO:0051607]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hemocyte differentiation [GO:0042386]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; photoreceptor cell development [GO:0042461]; R7 cell fate commitment [GO:0007465]; sevenless signaling pathway [GO:0045500]; terminal branching, open tracheal system [GO:0007430]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. {ECO:0000269|PubMed:8381718}.","","",""
"785","sp|Q5QN75|M2K1_ORYSJ","lcl|NC_088858.1_cds_XP_011443365.3_33371",2.23e-75,239,"Q5QN75","M2K1_ORYSJ","Mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK1) (EC 2.7.12.2) (OsMEK1)","MKK1 MEK1 Os01g0510100 LOC_Os01g32660 P0455H03.45 P0520B06.8","Oryza sativa subsp. japonica (Rice)",355,"GO:0002229; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005737; GO:0007112; GO:0009524; GO:0010311; GO:0031435; GO:0051019; GO:0106310","defense response to oomycetes [GO:0002229]; lateral root formation [GO:0010311]; male meiosis cytokinesis [GO:0007112]","cytoplasm [GO:0005737]; phragmoplast [GO:0009524]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; defense response to oomycetes [GO:0002229]; lateral root formation [GO:0010311]; male meiosis cytokinesis [GO:0007112]","","INDUCTION: By low temperature (12 degrees Celsius) treatment. {ECO:0000269|PubMed:12177502}.","INDUCTION: By low temperature (12 degrees Celsius) treatment. {ECO:0000269|PubMed:12177502}.","TISSUE SPECIFICITY: Expressed in roots, leaf sheaths and panicles. {ECO:0000269|PubMed:12177502}."
"786","sp|Q95Q89|SIR24_CAEEL","lcl|NC_088858.1_cds_XP_011444265.3_29266",4.44e-65,211,"Q95Q89","SIR24_CAEEL","NAD-dependent protein deacetylase sir-2.4 (EC 2.3.1.286) (Regulatory protein SIR2 homolog 4) (SIR2-like protein 4)","sir-2.4 C06A5.11","Caenorhabditis elegans",292,"GO:0000122; GO:0003714; GO:0005634; GO:0005635; GO:0005643; GO:0009408; GO:0010494; GO:0034979; GO:0043186; GO:0046872; GO:0046969; GO:0061629; GO:0070403; GO:1903863","negative regulation of transcription by RNA polymerase II [GO:0000122]; P granule assembly [GO:1903863]; response to heat [GO:0009408]","cytoplasmic stress granule [GO:0010494]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; P granule [GO:0043186]; histone H3K9 deacetylase activity, NAD-dependent [GO:0046969]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; negative regulation of transcription by RNA polymerase II [GO:0000122]; P granule assembly [GO:1903863]; response to heat [GO:0009408]","","","",""
"787","sp|Q9YHV4|FSTA_DANRE","lcl|NC_088858.1_cds_XP_011444673.3_29006",4.97e-59,195,"Q9YHV4","FSTA_DANRE","Follistatin-A (FS) (Activin-binding protein) (Follistatin-1) (zFst1)","fsta fst fst1 si:dkey-111k10.2 si:dkeyp-88a5.1","Danio rerio (Zebrafish) (Brachydanio rerio)",322,"GO:0005576; GO:0005615; GO:0009953; GO:0009994; GO:0030154; GO:0030510; GO:0030901; GO:0032926; GO:0043049; GO:0048185; GO:0048263; GO:0048703","cell differentiation [GO:0030154]; determination of dorsal identity [GO:0048263]; dorsal/ventral pattern formation [GO:0009953]; embryonic viscerocranium morphogenesis [GO:0048703]; midbrain development [GO:0030901]; negative regulation of activin receptor signaling pathway [GO:0032926]; oocyte differentiation [GO:0009994]; otic placode formation [GO:0043049]; regulation of BMP signaling pathway [GO:0030510]","extracellular region [GO:0005576]; extracellular space [GO:0005615]; activin binding [GO:0048185]; cell differentiation [GO:0030154]; determination of dorsal identity [GO:0048263]; dorsal/ventral pattern formation [GO:0009953]; embryonic viscerocranium morphogenesis [GO:0048703]; midbrain development [GO:0030901]; negative regulation of activin receptor signaling pathway [GO:0032926]; oocyte differentiation [GO:0009994]; otic placode formation [GO:0043049]; regulation of BMP signaling pathway [GO:0030510]","DEVELOPMENTAL STAGE: First expressed at mid-gastrulation. {ECO:0000269|PubMed:9882485}.","","","TISSUE SPECIFICITY: Not expressed in the organizer region. Expression in gastrulating embryos is confined to anterior and paraxial regions, which give rise to head mesoderm and the first five somites. In addition, expressed transiently in a subset of cells in the posterior notochord anlage. Later, expression is seen in brain, eyes and somites. {ECO:0000269|PubMed:16890217, ECO:0000269|PubMed:9882485}."
"788","sp|Q24509|STX5_DROME","lcl|NC_088858.1_cds_XP_011445169.2_29758",1.27e-98,300,"Q24509","STX5_DROME","Syntaxin-5 (Sed5 protein) (dSed5)","Syx5 Sed5 CG4214","Drosophila melanogaster (Fruit fly)",467,"GO:0000139; GO:0000149; GO:0005484; GO:0005794; GO:0005801; GO:0006878; GO:0006886; GO:0006887; GO:0006888; GO:0006906; GO:0007112; GO:0007283; GO:0012505; GO:0031201; GO:0035167; GO:0042803; GO:0048278; GO:0055070","copper ion homeostasis [GO:0055070]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; intracellular copper ion homeostasis [GO:0006878]; intracellular protein transport [GO:0006886]; larval lymph gland hemopoiesis [GO:0035167]; male meiosis cytokinesis [GO:0007112]; spermatogenesis [GO:0007283]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]","cis-Golgi network [GO:0005801]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; SNARE complex [GO:0031201]; protein homodimerization activity [GO:0042803]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; copper ion homeostasis [GO:0055070]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; intracellular copper ion homeostasis [GO:0006878]; intracellular protein transport [GO:0006886]; larval lymph gland hemopoiesis [GO:0035167]; male meiosis cytokinesis [GO:0007112]; spermatogenesis [GO:0007283]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]","","","",""
"789","sp|Q0V9S9|DRC7_XENTR","lcl|NC_088858.1_cds_XP_011446078.2_29315",0,752,"Q0V9S9","DRC7_XENTR","Dynein regulatory complex subunit 7 (Coiled-coil domain-containing protein 135) (Coiled-coil domain-containing protein lobo homolog)","drc7 ccdc135","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)",856,"GO:0005737; GO:0005856; GO:0007283; GO:0007288; GO:0030317; GO:0031514","flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]","","","",""
"790","sp|P62753|RS6_HUMAN","lcl|NC_088858.1_cds_XP_011446088.1_30344",8.53e-117,335,"P62753","RS6_HUMAN","Small ribosomal subunit protein eS6 (40S ribosomal protein S6) (Phosphoprotein NP33)","RPS6 OK/SW-cl.2","Homo sapiens (Human)",249,"GO:0000028; GO:0002181; GO:0003723; GO:0003729; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005829; GO:0006364; GO:0006412; GO:0008284; GO:0015935; GO:0016020; GO:0019901; GO:0022626; GO:0022627; GO:0030425; GO:0031929; GO:0032040; GO:0032868; GO:0036464; GO:0042274; GO:0042593; GO:0043065; GO:0044297; GO:0071361; GO:0098793; GO:0098982; GO:1903347; GO:1990904","cellular response to ethanol [GO:0071361]; cytoplasmic translation [GO:0002181]; glucose homeostasis [GO:0042593]; negative regulation of bicellular tight junction assembly [GO:1903347]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; response to insulin [GO:0032868]; ribosomal small subunit assembly [GO:0000028]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; TOR signaling [GO:0031929]; translation [GO:0006412]","cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; GABA-ergic synapse [GO:0098982]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynapse [GO:0098793]; ribonucleoprotein complex [GO:1990904]; small ribosomal subunit [GO:0015935]; small-subunit processome [GO:0032040]; mRNA binding [GO:0003729]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to ethanol [GO:0071361]; cytoplasmic translation [GO:0002181]; glucose homeostasis [GO:0042593]; negative regulation of bicellular tight junction assembly [GO:1903347]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; response to insulin [GO:0032868]; ribosomal small subunit assembly [GO:0000028]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; TOR signaling [GO:0031929]; translation [GO:0006412]","","","",""
"791","sp|Q6V3W6|DRC7_MOUSE","lcl|NC_088858.1_cds_XP_011446093.2_29312",0,657,"Q6V3W6","DRC7_MOUSE","Dynein regulatory complex subunit 7 (Coiled-coil domain-containing protein 135) (Coiled-coil domain-containing protein lobo homolog) (Spermatogenesis-related gene in late stages of spermatogenesis cells protein)","Drc7 Ccdc135 Gm770 Srgl","Mus musculus (Mouse)",876,"GO:0005737; GO:0005856; GO:0007283; GO:0007288; GO:0030317; GO:0031514","flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: [Isoform 1]: Expressed in diplotene and pachytene spermytocytes, and in round and elongating spermatids (at protein level). Strongly expressed in spleen and testis, faintly expressed in kidney, ovary and thymus. {ECO:0000269|PubMed:15156272, ECO:0000269|PubMed:16804880}.; TISSUE SPECIFICITY: Abundantly expressed in the testis and is weakly expressed in the brain, thymus, lung and ovary (PubMed:31961863). Expressed in ciliated cells (PubMed:17971504). {ECO:0000269|PubMed:17971504, ECO:0000269|PubMed:31961863}."
"792","sp|Q27350|SO_DROME","lcl|NC_088858.1_cds_XP_011446126.1_29311",3.64e-117,346,"Q27350","SO_DROME","Protein sine oculis","so CG11121","Drosophila melanogaster (Fruit fly)",416,"GO:0000978; GO:0000981; GO:0001222; GO:0001223; GO:0001744; GO:0001745; GO:0001746; GO:0005634; GO:0005667; GO:0006357; GO:0007283; GO:0007623; GO:0008347; GO:0009649; GO:0035271; GO:0043565; GO:0045944; GO:0048749","Bolwig's organ morphogenesis [GO:0001746]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; entrainment of circadian clock [GO:0009649]; glial cell migration [GO:0008347]; insect visual primordium formation [GO:0001744]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; ring gland development [GO:0035271]; spermatogenesis [GO:0007283]","nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]; Bolwig's organ morphogenesis [GO:0001746]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; entrainment of circadian clock [GO:0009649]; glial cell migration [GO:0008347]; insect visual primordium formation [GO:0001744]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; ring gland development [GO:0035271]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: In the eye imaginal disk, first expressed at the onset of the third instar and continues throughout this stage. Expression in the optic lobe primordium begins at stage 5 and disappears when invagination is completed (stage 12). Further expression is noted in optic lobe ganglia in late third instar. {ECO:0000269|PubMed:7910468}.","","","TISSUE SPECIFICITY: In developing embryos, expressed in the eye disk epithelium, bolwig's organ and the optic lobe primordium at areas of invagination. In adults, present in photoreceptor cells in the apical regions of the retina, and in optic lobes. {ECO:0000269|PubMed:7910468}."
"793","sp|Q9V5C6|PSA3_DROME","lcl|NC_088858.1_cds_XP_011446139.2_30291",6.37e-103,300,"Q9V5C6","PSA3_DROME","Proteasome subunit alpha type-3 (20S proteasome subunit alpha-7)","Prosalpha7 CG1519","Drosophila melanogaster (Fruit fly)",253,"GO:0000502; GO:0005634; GO:0005654; GO:0005829; GO:0005839; GO:0019773; GO:0030707; GO:0043161","follicle cell of egg chamber development [GO:0030707]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]","cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; follicle cell of egg chamber development [GO:0030707]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]","","","",""
"794","sp|Q801D8|MPRA_CYNNE","lcl|NC_088858.1_cds_XP_011446167.1_29308",7.78e-38,139,"Q801D8","MPRA_CYNNE","Membrane progestin receptor alpha (mPR alpha) (Membrane progesterone receptor)","mpra","Cynoscion nebulosus (Spotted seatrout) (Otolithus nebulosus)",352,"GO:0003707; GO:0005496; GO:0005886; GO:0048477","oogenesis [GO:0048477]","plasma membrane [GO:0005886]; nuclear steroid receptor activity [GO:0003707]; steroid binding [GO:0005496]; oogenesis [GO:0048477]","DEVELOPMENTAL STAGE: Expressed at low expression in fully grown oocytes, highly expressed in maturing oocytes undergoing germinal vesicle breakdown (GVBD) and weakly expressed in ovulated oocytes.","INDUCTION: By progestin in ovarian tissues and human chorionic gonadotropin (hCG) in oocytes undergoing meiotic maturation. {ECO:0000269|PubMed:12574519}.","INDUCTION: By progestin in ovarian tissues and human chorionic gonadotropin (hCG) in oocytes undergoing meiotic maturation. {ECO:0000269|PubMed:12574519}.","TISSUE SPECIFICITY: Strongly expressed in ovary and brain; lower expression in testis and pituitary. Not detected in heart, kidney, spleen, intestine, gill and muscle. {ECO:0000269|PubMed:12574519}."
"795","sp|Q9VKW2|PIE_DROME","lcl|NC_088858.1_cds_XP_011446781.3_32364",6.62e-43,166,"Q9VKW2","PIE_DROME","Pineapple eye protein","pie l(2)31Ek l(2)54 mat(2)ea-E mat(2)earlyQM47 mat(2)QM47 CG5354","Drosophila melanogaster (Fruit fly)",582,"GO:0005634; GO:0008270; GO:0035019; GO:0036335; GO:0042078; GO:0048749; GO:2000035","compound eye development [GO:0048749]; germ-line stem cell division [GO:0042078]; intestinal stem cell homeostasis [GO:0036335]; regulation of stem cell division [GO:2000035]; somatic stem cell population maintenance [GO:0035019]","nucleus [GO:0005634]; zinc ion binding [GO:0008270]; compound eye development [GO:0048749]; germ-line stem cell division [GO:0042078]; intestinal stem cell homeostasis [GO:0036335]; regulation of stem cell division [GO:2000035]; somatic stem cell population maintenance [GO:0035019]","","","",""
"796","sp|A2CG63|ARI4B_MOUSE","lcl|NC_088858.1_cds_XP_011447626.3_33420",1.18e-85,309,"A2CG63","ARI4B_MOUSE","AT-rich interactive domain-containing protein 4B (ARID domain-containing protein 4B) (180 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p180) (Histone deacetylase complex subunit SAP180)","Arid4b Sap180","Mus musculus (Mouse)",1314,"GO:0000122; GO:0003677; GO:0005634; GO:0005739; GO:0005829; GO:0006325; GO:0006366; GO:0007283; GO:0030336; GO:0030512; GO:0045944; GO:0070822; GO:0071514; GO:0097368; GO:1902455; GO:1902459","chromatin organization [GO:0006325]; establishment of Sertoli cell barrier [GO:0097368]; genomic imprinting [GO:0071514]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]","cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822]; DNA binding [GO:0003677]; chromatin organization [GO:0006325]; establishment of Sertoli cell barrier [GO:0097368]; genomic imprinting [GO:0071514]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]","","","","TISSUE SPECIFICITY: Expressed in Sertoli cells of the testis. {ECO:0000269|PubMed:23487765}."
"797","sp|Q94899|CSN2_DROME","lcl|NC_088858.1_cds_XP_011447888.1_33808",0,735,"Q94899","CSN2_DROME","COP9 signalosome complex subunit 2 (Dch2) (Signalosome subunit 2) (Alien protein)","alien CSN2 CG9556","Drosophila melanogaster (Fruit fly)",444,"GO:0000338; GO:0003714; GO:0005737; GO:0007281; GO:0007562; GO:0008180; GO:0008231; GO:0016922; GO:0036099; GO:0045892; GO:0048140; GO:0048142; GO:0050821","eclosion [GO:0007562]; female germ-line stem cell population maintenance [GO:0036099]; germ cell development [GO:0007281]; germarium-derived cystoblast division [GO:0048142]; male germ-line cyst encapsulation [GO:0048140]; negative regulation of DNA-templated transcription [GO:0045892]; protein deneddylation [GO:0000338]; protein stabilization [GO:0050821]","COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; repressor ecdysone receptor complex [GO:0008231]; nuclear receptor binding [GO:0016922]; transcription corepressor activity [GO:0003714]; eclosion [GO:0007562]; female germ-line stem cell population maintenance [GO:0036099]; germ cell development [GO:0007281]; germarium-derived cystoblast division [GO:0048142]; male germ-line cyst encapsulation [GO:0048140]; negative regulation of DNA-templated transcription [GO:0045892]; protein deneddylation [GO:0000338]; protein stabilization [GO:0050821]","DEVELOPMENTAL STAGE: Expressed both maternally with high levels during oogenesis, and zygotically. {ECO:0000269|PubMed:8817453}.","","","TISSUE SPECIFICITY: Expressed during embryonic stages 11-14 in the muscle attachment sites (apodemes); pharynx attachment to the roof of the mouth and in the epidermis of the head for the dorsal and ventral prothoracic pharyngeal muscle attachment. From stage 16 onwards expression is seen in all thoracic and abdominal apodemes. {ECO:0000269|PubMed:8817453}."
"798","sp|Q5TYV4|SPE39_DANRE","lcl|NC_088858.1_cds_XP_011448447.1_28702",5.44e-92,289,"Q5TYV4","SPE39_DANRE","Spermatogenesis-defective protein 39 homolog (hSPE-39) (VPS33B-interacting protein in apical-basolateral polarity regulator) (VPS33B-interacting protein in polarity and apical restriction)","vipas39 spe39 vipar si:ch211-20b12.1","Danio rerio (Zebrafish) (Brachydanio rerio)",483,"GO:0005737; GO:0005769; GO:0005770; GO:0006886; GO:0007034; GO:0007283; GO:0030154; GO:0055037; GO:0061008","cell differentiation [GO:0030154]; hepaticobiliary system development [GO:0061008]; intracellular protein transport [GO:0006886]; spermatogenesis [GO:0007283]; vacuolar transport [GO:0007034]","cytoplasm [GO:0005737]; early endosome [GO:0005769]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; cell differentiation [GO:0030154]; hepaticobiliary system development [GO:0061008]; intracellular protein transport [GO:0006886]; spermatogenesis [GO:0007283]; vacuolar transport [GO:0007034]","","","","TISSUE SPECIFICITY: High levels detected in liver and small intestine of larvae at 5 days post-fertilization. {ECO:0000269|PubMed:20190753}."
"799","sp|Q60969|STYX_MOUSE","lcl|NC_088858.1_cds_XP_011448463.3_28715",6.76e-77,231,"Q60969","STYX_MOUSE","Serine/threonine/tyrosine-interacting protein (Inactive tyrosine-protein phosphatase Styx) (Phosphoserine/threonine/tyrosine interaction protein)","Styx","Mus musculus (Mouse)",223,"GO:0005634; GO:0005737; GO:0005829; GO:0007283; GO:0070372","regulation of ERK1 and ERK2 cascade [GO:0070372]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; regulation of ERK1 and ERK2 cascade [GO:0070372]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Widely expressed with highest levels in muscle, testis and brain (PubMed:7592916). In testis, expression starts 13-14 days after birth and is limited to the seminiferous tubule and to round and elongating spermatids (PubMed:11842224). Expression is low in condensing spermatids and pachytene spermatocytes, and absent in spermatogonia, spermatozoa and somatic Sertoli cells (PubMed:11842224). {ECO:0000269|PubMed:11842224, ECO:0000269|PubMed:7592916}."
"800","sp|P20226|TBP_HUMAN","lcl|NC_088858.1_cds_XP_011448465.1_28717",7.68e-116,337,"P20226","TBP_HUMAN","TATA-box-binding protein (TATA sequence-binding protein) (TATA-binding factor) (TATA-box factor) (Transcription initiation factor TFIID TBP subunit)","TBP GTF2D1 TF2D TFIID","Homo sapiens (Human)",339,"GO:0000785; GO:0000791; GO:0000976; GO:0000978; GO:0000979; GO:0000995; GO:0001046; GO:0001091; GO:0001093; GO:0001164; GO:0001673; GO:0001674; GO:0001939; GO:0001940; GO:0005634; GO:0005654; GO:0005668; GO:0005669; GO:0005672; GO:0005829; GO:0006352; GO:0006366; GO:0006367; GO:0006383; GO:0007283; GO:0016251; GO:0017162; GO:0019899; GO:0032991; GO:0042789; GO:0051123; GO:0060261; GO:0140297","DNA-templated transcription initiation [GO:0006352]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]; transcription initiation at RNA polymerase II promoter [GO:0006367]","chromatin [GO:0000785]; cytosol [GO:0005829]; euchromatin [GO:0000791]; female germ cell nucleus [GO:0001674]; female pronucleus [GO:0001939]; male germ cell nucleus [GO:0001673]; male pronucleus [GO:0001940]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase transcription factor SL1 complex [GO:0005668]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]; aryl hydrocarbon receptor binding [GO:0017162]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; TFIIB-class transcription factor binding [GO:0001093]; transcription cis-regulatory region binding [GO:0000976]; DNA-templated transcription initiation [GO:0006352]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]; transcription initiation at RNA polymerase II promoter [GO:0006367]","","","","TISSUE SPECIFICITY: Widely expressed, with levels highest in the testis and ovary. {ECO:0000269|PubMed:17570761}."
"801","sp|Q94981|ARI1_DROME","lcl|NC_088858.1_cds_XP_011449090.1_31036",0,711,"Q94981","ARI1_DROME","E3 ubiquitin-protein ligase ariadne-1 (EC 2.3.2.31) (Protein ariadne-1) (RING-type E3 ubiquitin transferase ariadne-1)","ari-1 ari ari-1a CG5659","Drosophila melanogaster (Fruit fly)",503,"GO:0000151; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006513; GO:0007029; GO:0008270; GO:0016567; GO:0031624; GO:0048477; GO:0050769; GO:0061630; GO:1901800","endoplasmic reticulum organization [GO:0007029]; oogenesis [GO:0048477]; positive regulation of neurogenesis [GO:0050769]; positive regulation of proteasomal protein catabolic process [GO:1901800]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; endoplasmic reticulum organization [GO:0007029]; oogenesis [GO:0048477]; positive regulation of neurogenesis [GO:0050769]; positive regulation of proteasomal protein catabolic process [GO:1901800]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","DEVELOPMENTAL STAGE: Expressed in all tissues throughout development, with maximum levels reached during metamorphosis and maintained in the adult. {ECO:0000269|PubMed:10880484}.","","","TISSUE SPECIFICITY: Widely expressed, with prominent levels in the nervous system and female gonads. {ECO:0000269|PubMed:10880484, ECO:0000269|PubMed:29689197}."
"802","sp|Q9VLC0|VPS54_DROME","lcl|NC_088858.1_cds_XP_011449692.2_28582",0,632,"Q9VLC0","VPS54_DROME","Vacuolar protein sorting-associated protein 54 (Protein scattered)","scat CG3766","Drosophila melanogaster (Fruit fly)",940,"GO:0000138; GO:0000938; GO:0001675; GO:0005794; GO:0005829; GO:0006896; GO:0007290; GO:0007291; GO:0015031; GO:0019905; GO:0032456; GO:0042147","acrosome assembly [GO:0001675]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; sperm individualization [GO:0007291]; spermatid nucleus elongation [GO:0007290]","cytosol [GO:0005829]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; Golgi trans cisterna [GO:0000138]; syntaxin binding [GO:0019905]; acrosome assembly [GO:0001675]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; sperm individualization [GO:0007291]; spermatid nucleus elongation [GO:0007290]","","","",""
"803","sp|Q9VWR5|CP306_DROME","lcl|NC_088858.1_cds_XP_011449922.3_32801",2.13e-30,125,"Q9VWR5","CP306_DROME","Cytochrome P450 306a1 (CYPCCCVIA1) (EC 1.14.15.-) (Protein phantom) (Dmphm)","phtm Cyp306a1 CG6578","Drosophila melanogaster (Fruit fly)",574,"GO:0001700; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006697; GO:0006805; GO:0007298; GO:0008395; GO:0016712; GO:0020037; GO:0035302; GO:0043231; GO:0048477","border follicle cell migration [GO:0007298]; ecdysone biosynthetic process [GO:0006697]; embryonic development via the syncytial blastoderm [GO:0001700]; oogenesis [GO:0048477]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]","cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; ecdysteroid 25-hydroxylase activity [GO:0035302]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; border follicle cell migration [GO:0007298]; ecdysone biosynthetic process [GO:0006697]; embryonic development via the syncytial blastoderm [GO:0001700]; oogenesis [GO:0048477]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. {ECO:0000269|PubMed:15350618}.","","","TISSUE SPECIFICITY: First seen at the early (syncytial) blastoderm stage 4. During cellularization of the blastoderm (stage 5), stripes of expression appear and remain through to stage 10. Expression becomes undetectable during germ band retraction (stages 11-14). By stage 15, some expression resumes in the primordium of the ring gland, so that by stage 17 strong expression is seen, but only in the ring gland. This specific localization continues throughout the larval instars (at protein level). Expressed in the prothoracic gland cells of the larval ring gland (RG). Levels decline just after the molt to the third instar then increase later during the wandering stage. Low levels of expression are seen in the larval brain and fat body. In the adult, majority of expression is restricted to the ovaries, with low levels in the head and carcass of both sexes. {ECO:0000269|PubMed:15350618}."
"804","sp|Q96PN6|ADCYA_HUMAN","lcl|NC_088858.1_cds_XP_011450184.3_32981",4.69e-71,265,"Q96PN6","ADCYA_HUMAN","Adenylate cyclase type 10 (EC 4.6.1.1) (AH-related protein) (Adenylate cyclase homolog) (Germ cell soluble adenylyl cyclase) (hsAC) (sAC) (Testicular soluble adenylyl cyclase)","ADCY10 SAC","Homo sapiens (Human)",1610,"GO:0000287; GO:0003351; GO:0004016; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0006007; GO:0006171; GO:0007286; GO:0010613; GO:0010666; GO:0010917; GO:0030145; GO:0030425; GO:0035556; GO:0043025; GO:0045177; GO:0045178; GO:0045773; GO:0045778; GO:0045819; GO:0048471; GO:0051117; GO:0051901; GO:0060306; GO:0071890; GO:0090724; GO:0097450; GO:0106028; GO:0106135; GO:1901524; GO:1903378; GO:1903427; GO:1903428; GO:1903955; GO:1905461; GO:1990138; GO:1990535; GO:1990544; GO:2001171","cAMP biosynthetic process [GO:0006171]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; glucose catabolic process [GO:0006007]; intracellular signal transduction [GO:0035556]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of cardiac muscle cell contraction [GO:0106135]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection extension [GO:1990138]; neuron projection maintenance [GO:1990535]; neuron projection retraction [GO:0106028]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of glycogen catabolic process [GO:0045819]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of ossification [GO:0045778]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of membrane repolarization [GO:0060306]; regulation of mitophagy [GO:1901524]; spermatid development [GO:0007286]","apical part of cell [GO:0045177]; astrocyte end-foot [GO:0097450]; basal part of cell [GO:0045178]; central region of growth cone [GO:0090724]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; bicarbonate binding [GO:0071890]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; cAMP biosynthetic process [GO:0006171]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; glucose catabolic process [GO:0006007]; intracellular signal transduction [GO:0035556]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of cardiac muscle cell contraction [GO:0106135]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection extension [GO:1990138]; neuron projection maintenance [GO:1990535]; neuron projection retraction [GO:0106028]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of glycogen catabolic process [GO:0045819]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of ossification [GO:0045778]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of membrane repolarization [GO:0060306]; regulation of mitophagy [GO:1901524]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Detected in airway epithelial cells and testis (at protein level) (PubMed:17591988). Weakly expressed in multiple tissues. Expressed in brain, heart, kidney, liver, lung, pancreas, peripheral blood leukocytes, placenta, skeletal muscle, stomach, thymus, airway epithelial cells, duodenum, jejunum and ileum. Very low level of expression in bone. {ECO:0000269|PubMed:11932268, ECO:0000269|PubMed:15659711, ECO:0000269|PubMed:17591988}."
"805","sp|P18572|BASI_MOUSE","lcl|NC_088858.1_cds_XP_011450189.3_32975",2.63e-19,90.1,"P18572","BASI_MOUSE","Basigin (Basic immunoglobulin superfamily) (HT7 antigen) (Membrane glycoprotein gp42) (CD antigen CD147)","Bsg","Mus musculus (Mouse)",389,"GO:0001525; GO:0001750; GO:0001917; GO:0002080; GO:0003407; GO:0005537; GO:0005789; GO:0005886; GO:0007283; GO:0007566; GO:0010575; GO:0010595; GO:0016323; GO:0030154; GO:0030593; GO:0038023; GO:0042383; GO:0042475; GO:0043434; GO:0045494; GO:0046689; GO:0046697; GO:0051591; GO:0061154; GO:0072659","angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; endothelial tube morphogenesis [GO:0061154]; neural retina development [GO:0003407]; neutrophil chemotaxis [GO:0030593]; odontogenesis of dentin-containing tooth [GO:0042475]; photoreceptor cell maintenance [GO:0045494]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein localization to plasma membrane [GO:0072659]; response to cAMP [GO:0051591]; response to mercury ion [GO:0046689]; response to peptide hormone [GO:0043434]; spermatogenesis [GO:0007283]","acrosomal membrane [GO:0002080]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; endothelial tube morphogenesis [GO:0061154]; neural retina development [GO:0003407]; neutrophil chemotaxis [GO:0030593]; odontogenesis of dentin-containing tooth [GO:0042475]; photoreceptor cell maintenance [GO:0045494]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein localization to plasma membrane [GO:0072659]; response to cAMP [GO:0051591]; response to mercury ion [GO:0046689]; response to peptide hormone [GO:0043434]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: In developing eye expressed at embryonic days 12 dpc, 15 dpc and 18 dpc, and at postnatal days P1, P7, P14, and P21. Expression progressed from a more generalized distribution throughout the undifferentiated neural retina to specific staining of retina-pigmented epithilia, the MCs, photoreceptor cells and the ciliary apparatus. Expression is highest at P21. Isoform 1 and isoform 2 are expressed at equivalent levels at P7, isoform 1 is more abundant at P14, P21 and P28. In uterus during the peri-implantation period strongly expressed in luminal and glandular epithelium on day 1 of pregnancy and gradually decreased to a basal level from day 2-4 of pregnancy. Expression in the sub-luminal stroma was first detected on day 3 of pregnancy and increased on day 4 of pregnancy. On day 5 of pregnancy, the expression of basigin protein and mRNA was only detected in the implanting embryos, and the luminal epithelium and sub-luminal stroma surrounding the embryos. In ovary during sexual maturation expressed in the granulosa cells of preantral follicles at days 20 and 25 after birth. Expressed during corpus luteum formation. {ECO:0000269|PubMed:12211060, ECO:0000269|PubMed:15037112, ECO:0000269|PubMed:15095333}.","INDUCTION: By estrogen in the uterine epithelium of ovariectomized animals. By eCG in ovary. {ECO:0000269|PubMed:12211060, ECO:0000269|PubMed:15095333}.","INDUCTION: By estrogen in the uterine epithelium of ovariectomized animals. By eCG in ovary. {ECO:0000269|PubMed:12211060, ECO:0000269|PubMed:15095333}.","TISSUE SPECIFICITY: [Isoform 1]: Retina-specific (PubMed:11273674, PubMed:11853760, PubMed:12939332, PubMed:25957687). Expressed in both rods and cones (at protein level) (PubMed:25957687). {ECO:0000269|PubMed:11273674, ECO:0000269|PubMed:11853760, ECO:0000269|PubMed:12939332, ECO:0000269|PubMed:25957687}.; TISSUE SPECIFICITY: [Isoform 2]: Testis and caput, corpus and cauda epididymides (at protein level) (PubMed:11882021, PubMed:21792931, PubMed:23727514). Expressed in the brain, lung, liver, kidney, heart, spleen, uterus, retina and skeletal muscle (PubMed:12601063, PubMed:12939332, PubMed:2361961). {ECO:0000269|PubMed:11882021, ECO:0000269|PubMed:12601063, ECO:0000269|PubMed:12939332, ECO:0000269|PubMed:21792931, ECO:0000269|PubMed:2361961, ECO:0000269|PubMed:23727514}."
"806","sp|Q8TEB9|RHBL4_HUMAN","lcl|NC_088858.1_cds_XP_011450400.3_31415",1.44e-82,253,"Q8TEB9","RHBL4_HUMAN","Rhomboid-related protein 4 (RRP4) (EC 3.4.21.105) (Rhomboid domain-containing protein 1) (Rhomboid-like protein 4)","RHBDD1 RHBDL4 HSD-50 HSD50","Homo sapiens (Human)",315,"GO:0004175; GO:0004252; GO:0005783; GO:0005789; GO:0006915; GO:0010954; GO:0031293; GO:0031966; GO:0033619; GO:0034620; GO:0034644; GO:0036503; GO:0043066; GO:0043687; GO:0044322; GO:0045732; GO:0048515; GO:0051047; GO:1904211","apoptotic process [GO:0006915]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; ERAD pathway [GO:0036503]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein processing [GO:0010954]; positive regulation of secretion [GO:0051047]; post-translational protein modification [GO:0043687]; spermatid differentiation [GO:0048515]","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; mitochondrial membrane [GO:0031966]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; apoptotic process [GO:0006915]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; ERAD pathway [GO:0036503]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein processing [GO:0010954]; positive regulation of secretion [GO:0051047]; post-translational protein modification [GO:0043687]; spermatid differentiation [GO:0048515]","","INDUCTION: Up-regulated by endoplasmic reticulum stress agents that induce the unfolded protein response (UPR). {ECO:0000269|PubMed:22795130}.","INDUCTION: Up-regulated by endoplasmic reticulum stress agents that induce the unfolded protein response (UPR). {ECO:0000269|PubMed:22795130}.","TISSUE SPECIFICITY: Expressed strongly in testis."
"807","sp|Q9DBR1|XRN2_MOUSE","lcl|NC_088858.1_cds_XP_011451785.3_32568",0,1034,"Q9DBR1","XRN2_MOUSE","5'-3' exoribonuclease 2 (EC 3.1.13.-) (Protein Dhm1)","Xrn2 Dhm1","Mus musculus (Mouse)",951,"GO:0001147; GO:0004534; GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0006369; GO:0006397; GO:0007017; GO:0007283; GO:0008270; GO:0008409; GO:0016070; GO:0016235; GO:0021766; GO:0030182; GO:0042802; GO:0060041","DNA recombination [GO:0006310]; DNA repair [GO:0006281]; hippocampus development [GO:0021766]; microtubule-based process [GO:0007017]; mRNA processing [GO:0006397]; neuron differentiation [GO:0030182]; retina development in camera-type eye [GO:0060041]; RNA metabolic process [GO:0016070]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]","aggresome [GO:0016235]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 5'-3' exonuclease activity [GO:0008409]; 5'-3' RNA exonuclease activity [GO:0004534]; identical protein binding [GO:0042802]; transcription termination site sequence-specific DNA binding [GO:0001147]; zinc ion binding [GO:0008270]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; hippocampus development [GO:0021766]; microtubule-based process [GO:0007017]; mRNA processing [GO:0006397]; neuron differentiation [GO:0030182]; retina development in camera-type eye [GO:0060041]; RNA metabolic process [GO:0016070]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]","","","","TISSUE SPECIFICITY: Expressed in the spleen, testis, heart, brain, lung, liver, skeletal muscle, and kidney. {ECO:0000269|PubMed:7885830}."
"808","sp|Q7ZUS1|VRK1_DANRE","lcl|NC_088858.1_cds_XP_011452120.3_29428",2.08e-130,385,"Q7ZUS1","VRK1_DANRE","Serine/threonine-protein kinase VRK1 (EC 2.7.11.1) (Vaccinia-related kinase 1)","vrk1 zgc:56266","Danio rerio (Zebrafish) (Brachydanio rerio)",425,"GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005795; GO:0006974; GO:0007165; GO:0007283; GO:0015030; GO:0051301; GO:0061351; GO:0090166; GO:0106310; GO:0120187","cell division [GO:0051301]; DNA damage response [GO:0006974]; Golgi disassembly [GO:0090166]; neural precursor cell proliferation [GO:0061351]; positive regulation of protein localization to chromatin [GO:0120187]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]","Cajal body [GO:0015030]; cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; DNA damage response [GO:0006974]; Golgi disassembly [GO:0090166]; neural precursor cell proliferation [GO:0061351]; positive regulation of protein localization to chromatin [GO:0120187]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]","","","",""
"809","sp|Q8NDG6|TDRD9_HUMAN","lcl|NC_088858.1_cds_XP_011452125.3_29432",0,1020,"Q8NDG6","TDRD9_HUMAN","ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9)","TDRD9 C14orf75","Homo sapiens (Human)",1382,"GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0007141; GO:0007283; GO:0009566; GO:0016887; GO:0030154; GO:0034587; GO:0071547; GO:0141006; GO:0141196","cell differentiation [GO:0030154]; fertilization [GO:0009566]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; piP-body [GO:0071547]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; fertilization [GO:0009566]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006]","","","",""
"810","sp|P38650|DYHC1_RAT","lcl|NC_088858.1_cds_XP_011452279.3_31818",0,7052,"P38650","DYHC1_RAT","Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) (MAP 1C)","Dync1h1 Dhc1 Dnch1 Dnchc1 Dnec1 Dyhc Map1c","Rattus norvegicus (Rat)",4644,"GO:0002177; GO:0005524; GO:0005635; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0007052; GO:0007097; GO:0007286; GO:0008090; GO:0008569; GO:0016887; GO:0030175; GO:0030286; GO:0030424; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0042802; GO:0043025; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0090235; GO:0120162; GO:1904115; GO:1905243; GO:1905832; GO:1990090","cell division [GO:0051301]; cellular response to 3,3',5-triiodo-L-thyronine [GO:1905243]; cellular response to nerve growth factor stimulus [GO:1990090]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; spermatid development [GO:0007286]; stress granule assembly [GO:0034063]","axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; filopodium [GO:0030175]; manchette [GO:0002177]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; minus-end-directed microtubule motor activity [GO:0008569]; cell division [GO:0051301]; cellular response to 3,3',5-triiodo-L-thyronine [GO:1905243]; cellular response to nerve growth factor stimulus [GO:1990090]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; spermatid development [GO:0007286]; stress granule assembly [GO:0034063]","","","",""
"811","sp|Q9H892|TTC12_HUMAN","lcl|NC_088858.1_cds_XP_011452622.3_29736",5.37e-98,319,"Q9H892","TTC12_HUMAN","Tetratricopeptide repeat protein 12 (TPR repeat protein 12)","TTC12","Homo sapiens (Human)",705,"GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007288; GO:0031965; GO:0070286","axonemal dynein complex assembly [GO:0070286]; sperm axoneme assembly [GO:0007288]","centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; axonemal dynein complex assembly [GO:0070286]; sperm axoneme assembly [GO:0007288]","","","","TISSUE SPECIFICITY: Expressed in testis and in epithelial cells of trachea and bronchial tube. {ECO:0000269|PubMed:31978331}."
"812","sp|Q3MHS2|ZN830_RAT","lcl|NC_088858.1_cds_XP_011453781.3_31083",8.25e-43,152,"Q3MHS2","ZN830_RAT","Zinc finger protein 830 (Coiled-coil domain-containing protein 16)","Znf830 Ccdc16 Zfp830","Rattus norvegicus (Rat)",370,"GO:0000278; GO:0001541; GO:0001546; GO:0001832; GO:0003676; GO:0005634; GO:0005681; GO:0005694; GO:0006396; GO:0006397; GO:0008270; GO:0008380; GO:0016607; GO:0033260; GO:0033314; GO:0043066; GO:0044773; GO:0051276; GO:0051301; GO:0060729","blastocyst growth [GO:0001832]; cell division [GO:0051301]; chromosome organization [GO:0051276]; intestinal epithelial structure maintenance [GO:0060729]; mitotic cell cycle [GO:0000278]; mitotic DNA damage checkpoint signaling [GO:0044773]; mitotic DNA replication checkpoint signaling [GO:0033314]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; nuclear DNA replication [GO:0033260]; ovarian follicle development [GO:0001541]; preantral ovarian follicle growth [GO:0001546]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]","chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; blastocyst growth [GO:0001832]; cell division [GO:0051301]; chromosome organization [GO:0051276]; intestinal epithelial structure maintenance [GO:0060729]; mitotic cell cycle [GO:0000278]; mitotic DNA damage checkpoint signaling [GO:0044773]; mitotic DNA replication checkpoint signaling [GO:0033314]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; nuclear DNA replication [GO:0033260]; ovarian follicle development [GO:0001541]; preantral ovarian follicle growth [GO:0001546]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]","","","",""
"813","sp|Q5U312|RAI14_RAT","lcl|NC_088858.1_cds_XP_011453986.3_30604",1.8e-42,169,"Q5U312","RAI14_RAT","Ankycorbin (Ankyrin repeat and coiled-coil structure-containing protein) (Retinoic acid-induced protein 14)","Rai14","Rattus norvegicus (Rat)",978,"GO:0001650; GO:0001725; GO:0003779; GO:0005654; GO:0005829; GO:0005938; GO:0007283; GO:0030154; GO:0070161","cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","anchoring junction [GO:0070161]; cell cortex [GO:0005938]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; stress fiber [GO:0001725]; actin binding [GO:0003779]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: In testis, first detected in stage VI seminiferous tubules where it is strongly expressed at the apical ectoplasmic speclialization (ES). Initially detected around the entire spermatid head, then during stage VII becomes tightly restricted to the concave side of the spermatid head. From late stage VIII through to stage XII, expressed once again around the entire spermatid head. In stage VIII-IX tubules, detected at lower levels at the basal ES associated with the blood-testis barrier. Detected at the apical spermatid-Sertoli cell junction in stage VIII-XII tubules. {ECO:0000269|PubMed:23565266}.","","","TISSUE SPECIFICITY: Detected in testis where it is highly expressed in germ cells, and also expressed at lower levels in Sertoli cells (at protein level). {ECO:0000269|PubMed:23565266}."
"814","sp|Q9EP71|RAI14_MOUSE","lcl|NC_088858.1_cds_XP_011453989.3_30606",1.12e-39,160,"Q9EP71","RAI14_MOUSE","Ankycorbin (Ankyrin repeat and coiled-coil structure-containing protein) (Novel retinal pigment epithelial cell protein) (Retinoic acid-induced protein 14) (p125)","Rai14 Kiaa1334 Norpeg","Mus musculus (Mouse)",979,"GO:0001650; GO:0001725; GO:0003779; GO:0005654; GO:0005739; GO:0005829; GO:0005938; GO:0007283; GO:0030154; GO:0070161","cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","anchoring junction [GO:0070161]; cell cortex [GO:0005938]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; stress fiber [GO:0001725]; actin binding [GO:0003779]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: At 9.5 days, expression is detected in branchial arch mesenchyme, forebrain, hindbrain, midbrain, and neural tube. At 12.5 days, is detected in the hindbrain, forebrain, lung, genital eminence, spinal ligaments around vertebrae and ribs, and around the cartilage of ribs and nasal sinuses. Also detected in frontonasal mass, mandibular arch, optic sulcus, spinal ganglia and hind limb bud. At 15.5 days, expression is detected in the ventricular layer of neurons subjacent to the neocortex, around the nasal sinuses, bronchioles of the lung, kidney, and around the vertebrae of the tail. Also seen in the olfactory bulb. {ECO:0000269|PubMed:11042181}.","","","TISSUE SPECIFICITY: Highly expressed in testis, where it localizes to seminiferous tubules (at protein level) (PubMed:11042181, PubMed:16806700). Expressed in ganglion cell layer and in Muller cell fibers of the retina (at protein level) (PubMed:11042181, PubMed:16806700). In small intestine highly expressed at the apical and lateral borders of absorptive epithelia (at protein level) (PubMed:11168586). In liver highly expressed along the bile canaliculi (at protein level) (PubMed:11168586). {ECO:0000269|PubMed:11042181, ECO:0000269|PubMed:11168586, ECO:0000269|PubMed:16806700}."
"815","sp|Q8WUU4|ZN296_HUMAN","lcl|NC_088858.1_cds_XP_011455110.2_32064",1.86e-25,111,"Q8WUU4","ZN296_HUMAN","Zinc finger protein 296 (ZFP296) (Zinc finger protein 342)","ZNF296 ZNF342","Homo sapiens (Human)",475,"GO:0000122; GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0007283; GO:0008270; GO:1990837; GO:2000171","negative regulation of dendrite development [GO:2000171]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; negative regulation of dendrite development [GO:2000171]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","","","",""
"816","sp|O08699|PGDH_RAT","lcl|NC_088858.1_cds_XP_011455466.2_28923",2.15e-56,182,"O08699","PGDH_RAT","15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Eicosanoid/docosanoid dehydrogenase [NAD(+)]) (EC 1.1.1.-, EC 1.1.1.232) (Prostaglandin dehydrogenase 1)","Hpgd Pgdh1","Rattus norvegicus (Rat)",266,"GO:0001822; GO:0004957; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0016616; GO:0030728; GO:0032355; GO:0032496; GO:0042802; GO:0043065; GO:0045471; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1904707; GO:1905828","ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; regulation of prostaglandin catabolic process [GO:1905828]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]","basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; regulation of prostaglandin catabolic process [GO:1905828]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]","","","",""
"817","sp|Q62245|SOS1_MOUSE","lcl|NC_088858.1_cds_XP_011455479.3_31749",0,1103,"Q62245","SOS1_MOUSE","Son of sevenless homolog 1 (SOS-1) (mSOS-1)","Sos1","Mus musculus (Mouse)",1319,"GO:0001782; GO:0001942; GO:0002260; GO:0002931; GO:0003007; GO:0003209; GO:0003344; GO:0005085; GO:0005154; GO:0005829; GO:0006357; GO:0007173; GO:0007264; GO:0007265; GO:0007296; GO:0008286; GO:0008543; GO:0014044; GO:0014069; GO:0017124; GO:0019901; GO:0033081; GO:0035264; GO:0038133; GO:0042110; GO:0042127; GO:0042129; GO:0042552; GO:0043025; GO:0045742; GO:0046579; GO:0046982; GO:0048009; GO:0048011; GO:0048514; GO:0050853; GO:0060021; GO:0061029; GO:0061384; GO:0098978; GO:0140693; GO:1904693; GO:1905360; GO:2000973","B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; blood vessel morphogenesis [GO:0048514]; cardiac atrium morphogenesis [GO:0003209]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2-ERBB3 signaling pathway [GO:0038133]; eyelid development in camera-type eye [GO:0061029]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; heart trabecula morphogenesis [GO:0061384]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; lymphocyte homeostasis [GO:0002260]; midbrain morphogenesis [GO:1904693]; multicellular organism growth [GO:0035264]; myelination [GO:0042552]; neurotrophin TRK receptor signaling pathway [GO:0048011]; pericardium morphogenesis [GO:0003344]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ischemia [GO:0002931]; roof of mouth development [GO:0060021]; Schwann cell development [GO:0014044]; small GTPase-mediated signal transduction [GO:0007264]; T cell activation [GO:0042110]; vitellogenesis [GO:0007296]","cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; GTPase complex [GO:1905360]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular condensate scaffold activity [GO:0140693]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; blood vessel morphogenesis [GO:0048514]; cardiac atrium morphogenesis [GO:0003209]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2-ERBB3 signaling pathway [GO:0038133]; eyelid development in camera-type eye [GO:0061029]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; heart trabecula morphogenesis [GO:0061384]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; lymphocyte homeostasis [GO:0002260]; midbrain morphogenesis [GO:1904693]; multicellular organism growth [GO:0035264]; myelination [GO:0042552]; neurotrophin TRK receptor signaling pathway [GO:0048011]; pericardium morphogenesis [GO:0003344]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ischemia [GO:0002931]; roof of mouth development [GO:0060021]; Schwann cell development [GO:0014044]; small GTPase-mediated signal transduction [GO:0007264]; T cell activation [GO:0042110]; vitellogenesis [GO:0007296]","","","","TISSUE SPECIFICITY: Expressed in most embryonic and adult tissues."
"818","sp|Q803C1|RNF8_DANRE","lcl|NC_088858.1_cds_XP_011455485.3_31754",1.09e-48,177,"Q803C1","RNF8_DANRE","E3 ubiquitin-protein ligase rnf8 (EC 2.3.2.27) (RING finger protein 8) (RING-type E3 ubiquitin transferase rnf8)","rnf8 zgc:55936","Danio rerio (Zebrafish) (Brachydanio rerio)",485,"GO:0000151; GO:0000781; GO:0003682; GO:0005634; GO:0005829; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0008270; GO:0010212; GO:0034244; GO:0035092; GO:0035861; GO:0040029; GO:0042393; GO:0042803; GO:0043130; GO:0045190; GO:0045739; GO:0061630; GO:0070534; GO:0070936; GO:0085020; GO:0140861; GO:1905168","DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; epigenetic regulation of gene expression [GO:0040029]; isotype switching [GO:0045190]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; response to ionizing radiation [GO:0010212]; sperm DNA condensation [GO:0035092]; ubiquitin-dependent protein catabolic process [GO:0006511]","chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; epigenetic regulation of gene expression [GO:0040029]; isotype switching [GO:0045190]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; response to ionizing radiation [GO:0010212]; sperm DNA condensation [GO:0035092]; ubiquitin-dependent protein catabolic process [GO:0006511]","","","",""
"819","sp|Q9D2H2|KAD7_MOUSE","lcl|NC_088858.1_cds_XP_011455795.2_28698",0,619,"Q9D2H2","KAD7_MOUSE","Adenylate kinase 7 (AK 7) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 7)","Ak7","Mus musculus (Mouse)",614,"GO:0002437; GO:0003351; GO:0004017; GO:0004127; GO:0004550; GO:0005524; GO:0005576; GO:0005829; GO:0007283; GO:0007420; GO:0031514; GO:0035082; GO:0051649","axoneme assembly [GO:0035082]; brain development [GO:0007420]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; inflammatory response to antigenic stimulus [GO:0002437]; spermatogenesis [GO:0007283]","cytosol [GO:0005829]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; (d)CMP kinase activity [GO:0004127]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; axoneme assembly [GO:0035082]; brain development [GO:0007420]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; inflammatory response to antigenic stimulus [GO:0002437]; spermatogenesis [GO:0007283]","","","",""
"820","sp|Q9VJL6|GMF_DROME","lcl|NC_088858.1_cds_XP_011455796.1_28699",4.81e-41,134,"Q9VJL6","GMF_DROME","Glia maturation factor","GMF CG5869","Drosophila melanogaster (Fruit fly)",138,"GO:0003779; GO:0005634; GO:0007298; GO:0030027; GO:0030833; GO:0030864; GO:0031344; GO:0034316; GO:0048471; GO:0071846; GO:0071933; GO:0071944","actin filament debranching [GO:0071846]; border follicle cell migration [GO:0007298]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; regulation of actin filament polymerization [GO:0030833]; regulation of cell projection organization [GO:0031344]","cell periphery [GO:0071944]; cortical actin cytoskeleton [GO:0030864]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; actin filament debranching [GO:0071846]; border follicle cell migration [GO:0007298]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; regulation of actin filament polymerization [GO:0030833]; regulation of cell projection organization [GO:0031344]","","","","TISSUE SPECIFICITY: In ovaries, expressed in follicular epithelium, in polar cells, migrating border cells, and centripedal cells (at protein level). {ECO:0000269|PubMed:25308079}."
"821","sp|P21525|FOSLA_DROME","lcl|NC_088858.1_cds_XP_019918193.1_33207",5.4e-12,69.3,"P21525","FOSLA_DROME","Transcription factor kayak, isoforms A/B/F (AP-1) (Fos-related antigen) (Dfos) (dFra)","kay Fra CG15509","Drosophila melanogaster (Fruit fly)",755,"GO:0000086; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006964; GO:0007163; GO:0007281; GO:0007297; GO:0007391; GO:0007464; GO:0009611; GO:0009792; GO:0016330; GO:0035220; GO:0035976; GO:0040013; GO:0042060; GO:0045475; GO:0045944; GO:0046529; GO:0046982; GO:0048674; GO:0048749; GO:0048813; GO:0051124; GO:0061057; GO:0140297; GO:1903688","collateral sprouting of injured axon [GO:0048674]; compound eye development [GO:0048749]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; embryo development ending in birth or egg hatching [GO:0009792]; establishment or maintenance of cell polarity [GO:0007163]; follicle cell of egg chamber migration [GO:0007297]; G2/M transition of mitotic cell cycle [GO:0000086]; germ cell development [GO:0007281]; imaginal disc fusion, thorax closure [GO:0046529]; locomotor rhythm [GO:0045475]; negative regulation of locomotion [GO:0040013]; peptidoglycan recognition protein signaling pathway [GO:0061057]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R3/R4 cell fate commitment [GO:0007464]; regulation of transcription by RNA polymerase II [GO:0006357]; response to wounding [GO:0009611]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; synaptic assembly at neuromuscular junction [GO:0051124]; wing disc development [GO:0035220]; wound healing [GO:0042060]","cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor AP-1 complex [GO:0035976]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; collateral sprouting of injured axon [GO:0048674]; compound eye development [GO:0048749]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; embryo development ending in birth or egg hatching [GO:0009792]; establishment or maintenance of cell polarity [GO:0007163]; follicle cell of egg chamber migration [GO:0007297]; G2/M transition of mitotic cell cycle [GO:0000086]; germ cell development [GO:0007281]; imaginal disc fusion, thorax closure [GO:0046529]; locomotor rhythm [GO:0045475]; negative regulation of locomotion [GO:0040013]; peptidoglycan recognition protein signaling pathway [GO:0061057]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R3/R4 cell fate commitment [GO:0007464]; regulation of transcription by RNA polymerase II [GO:0006357]; response to wounding [GO:0009611]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; synaptic assembly at neuromuscular junction [GO:0051124]; wing disc development [GO:0035220]; wound healing [GO:0042060]","DEVELOPMENTAL STAGE: Isoform A and isoform B are expressed both maternally and zygotically. Zygotically expressed throughout embryogenesis, until second larval instar. Isoform A is more highly expressed than isoform B. {ECO:0000269|PubMed:18571877, ECO:0000269|PubMed:2116361}.","","","TISSUE SPECIFICITY: Early expression in the embryo is mesodermal and some of this expression is localized to a region surrounding the cephalic furrow. Later in embryonic development expression is ectodermal, corresponding to muscle attachment sites. Also observed in part of the mid- and hindgut and in the anal pad. {ECO:0000269|PubMed:2116361}."
"822","sp|Q8NHU2|CFA61_HUMAN","lcl|NC_088858.1_cds_XP_019919566.3_32853",0,1205,"Q8NHU2","CFA61_HUMAN","Cilia- and flagella-associated protein 61","CFAP61 C20orf26","Homo sapiens (Human)",1237,"GO:0003341; GO:0005930; GO:0031514; GO:0036126; GO:0044782; GO:0120316","cilium movement [GO:0003341]; cilium organization [GO:0044782]; sperm flagellum assembly [GO:0120316]","axoneme [GO:0005930]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; cilium movement [GO:0003341]; cilium organization [GO:0044782]; sperm flagellum assembly [GO:0120316]","","","",""
"823","sp|Q5U3G6|YIF1B_DANRE","lcl|NC_088858.1_cds_XP_019919568.2_32883",7.62e-93,279,"Q5U3G6","YIF1B_DANRE","Protein YIF1B (YIP1-interacting factor homolog B)","yif1b zgc:103562","Danio rerio (Zebrafish) (Brachydanio rerio)",304,"GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006888; GO:0015031; GO:0030134; GO:0033116; GO:0060271; GO:0120316","cilium assembly [GO:0060271]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; sperm flagellum assembly [GO:0120316]","COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; cilium assembly [GO:0060271]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; sperm flagellum assembly [GO:0120316]","","","",""
"824","sp|Q9CX30|YIF1B_MOUSE","lcl|NC_088858.1_cds_XP_019919569.2_32882",5.14e-86,261,"Q9CX30","YIF1B_MOUSE","Protein YIF1B (YIP1-interacting factor homolog B)","Yif1b","Mus musculus (Mouse)",311,"GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006612; GO:0006888; GO:0015031; GO:0060271; GO:0120316","cilium assembly [GO:0060271]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein targeting to membrane [GO:0006612]; protein transport [GO:0015031]; sperm flagellum assembly [GO:0120316]","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; cilium assembly [GO:0060271]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein targeting to membrane [GO:0006612]; protein transport [GO:0015031]; sperm flagellum assembly [GO:0120316]","","","","TISSUE SPECIFICITY: Highly expressed in brain. Expressed in Purkinje cells of the cerebellum. {ECO:0000269|PubMed:33103737}."
"825","sp|O60613|SEP15_HUMAN","lcl|NC_088858.1_cds_XP_019921973.2_32761",1.61e-36,124,"O60613","SEP15_HUMAN","Selenoprotein F (15 kDa selenoprotein)","SELENOF SEP15","Homo sapiens (Human)",165,"GO:0005788; GO:0008379; GO:0008430; GO:0016491; GO:0035092; GO:0051084","'de novo' post-translational protein folding [GO:0051084]; sperm DNA condensation [GO:0035092]","endoplasmic reticulum lumen [GO:0005788]; oxidoreductase activity [GO:0016491]; selenium binding [GO:0008430]; thioredoxin peroxidase activity [GO:0008379]; 'de novo' post-translational protein folding [GO:0051084]; sperm DNA condensation [GO:0035092]","","","","TISSUE SPECIFICITY: Higher levels in prostate and thyroid gland. {ECO:0000269|PubMed:9535873}."
"826","sp|Q94901|LARK_DROME","lcl|NC_088858.1_cds_XP_019922130.2_31822",4.42e-31,119,"Q94901","LARK_DROME","RNA-binding protein lark","lark CG8597","Drosophila melanogaster (Fruit fly)",352,"GO:0000278; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0007300; GO:0007562; GO:0007623; GO:0008062; GO:0008104; GO:0008270; GO:0009792; GO:0016607; GO:0030036; GO:0042752; GO:0045475; GO:0045804; GO:0045995; GO:0071011; GO:0071013; GO:2000767","actin cytoskeleton organization [GO:0030036]; circadian rhythm [GO:0007623]; eclosion [GO:0007562]; eclosion rhythm [GO:0008062]; embryo development ending in birth or egg hatching [GO:0009792]; locomotor rhythm [GO:0045475]; mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of eclosion [GO:0045804]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of cytoplasmic translation [GO:2000767]; protein localization [GO:0008104]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]","catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; actin cytoskeleton organization [GO:0030036]; circadian rhythm [GO:0007623]; eclosion [GO:0007562]; eclosion rhythm [GO:0008062]; embryo development ending in birth or egg hatching [GO:0009792]; locomotor rhythm [GO:0045475]; mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of eclosion [GO:0045804]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of cytoplasmic translation [GO:2000767]; protein localization [GO:0008104]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]","","INDUCTION: Oscillates in abundance during the circadian cycle at the protein level; peaks during the subjective day. {ECO:0000269|PubMed:9491990}.","INDUCTION: Oscillates in abundance during the circadian cycle at the protein level; peaks during the subjective day. {ECO:0000269|PubMed:9491990}.","TISSUE SPECIFICITY: Expressed in the CNS and in CCAP neurons of the ventral nervous system (VNS), which control insect ecdysis. {ECO:0000269|PubMed:8307324, ECO:0000269|PubMed:9491990}."
"827","sp|O88907|PIAS1_MOUSE","lcl|NC_088858.1_cds_XP_019924455.1_31159",5.84e-154,457,"O88907","PIAS1_MOUSE","E3 SUMO-protein ligase PIAS1 (EC 2.3.2.27) (DEAD/H box-binding protein 1) (Protein inhibitor of activated STAT protein 1) (RING-type E3 ubiquitin transferase PIAS1)","Pias1 Ddxbp1","Mus musculus (Mouse)",651,"GO:0000082; GO:0000122; GO:0000976; GO:0003714; GO:0005634; GO:0005654; GO:0005856; GO:0006974; GO:0007259; GO:0007283; GO:0008270; GO:0008542; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0019904; GO:0031625; GO:0032436; GO:0033235; GO:0034399; GO:0042127; GO:0043066; GO:0045444; GO:0045893; GO:0051152; GO:0061665; GO:0065004; GO:0098978; GO:0099523; GO:0099524; GO:0140297; GO:1904377","cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; DNA damage response [GO:0006974]; fat cell differentiation [GO:0045444]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell periphery [GO:1904377]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of smooth muscle cell differentiation [GO:0051152]; protein sumoylation [GO:0016925]; protein-DNA complex assembly [GO:0065004]; regulation of cell population proliferation [GO:0042127]; spermatogenesis [GO:0007283]; visual learning [GO:0008542]","cytoskeleton [GO:0005856]; glutamatergic synapse [GO:0098978]; nuclear periphery [GO:0034399]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; DNA-binding transcription factor binding [GO:0140297]; protein domain specific binding [GO:0019904]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; DNA damage response [GO:0006974]; fat cell differentiation [GO:0045444]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell periphery [GO:1904377]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of smooth muscle cell differentiation [GO:0051152]; protein sumoylation [GO:0016925]; protein-DNA complex assembly [GO:0065004]; regulation of cell population proliferation [GO:0042127]; spermatogenesis [GO:0007283]; visual learning [GO:0008542]","DEVELOPMENTAL STAGE: Expressed as early as 7.6 dpc. Expression remains high through 15.5 dpc (PubMed:10854042). In 3T3-L1 cells, expression is transiently induced during late adipocyte differentiation (PubMed:24061474). {ECO:0000269|PubMed:10854042, ECO:0000269|PubMed:24061474}.","","","TISSUE SPECIFICITY: Expressed in kidney, heart, spleen, brain and cerebellum; weak expression, if any, in liver and lung. {ECO:0000269|PubMed:10854042}."
"828","sp|Q6RG02|VIT_PENME","lcl|NC_088858.1_cds_XP_034315520.2_33466",6.83e-95,347,"Q6RG02","VIT_PENME","Vitellogenin [Cleaved into: Vitellin]","","Penaeus merguiensis (Banana prawn) (Fenneropenaeus merguiensis)",2586,"GO:0005319; GO:0008289; GO:0045735; GO:0048477","oogenesis [GO:0048477]","lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]; oogenesis [GO:0048477]","DEVELOPMENTAL STAGE: Vitellogenin is detected in stage 1 of the ovarian cycle and protein levels increase to reach a maximum in stage 3. Thereafter vitellogen levels in the ovary decrease gradually. Vitellin is detected at low levels in stage 1 of the ovarian cycle and protein levels increase steadily in stages 2 through to 4. {ECO:0000269|PubMed:16289995}.","","","TISSUE SPECIFICITY: Expressed in the ovary and hepatopancrease of vitellogenic females. Not expressed in the muscle, heart and intestine of female or in the hepatopancrease of the male. Detected in the ovary and hemolymph of female (at protein level). Not detected in the female hepatopancreas or in the male hemolymph and testis (at protein level). {ECO:0000269|PubMed:16289995, ECO:0000269|PubMed:16432892}."
"829","sp|Q9WVB3|TLE6_MOUSE","lcl|NC_088858.1_cds_XP_034317661.1_31611",2.94e-48,179,"Q9WVB3","TLE6_MOUSE","Transducin-like enhancer protein 6 (Groucho-related protein 6)","Tle6 Grg6","Mus musculus (Mouse)",581,"GO:0000122; GO:0005634; GO:0005829; GO:0005938; GO:0007015; GO:0007283; GO:0007284; GO:0030317; GO:0032991; GO:0040019; GO:0044725; GO:0045666; GO:0050769; GO:0051293; GO:0051302; GO:0051643; GO:0051646; GO:0097225; GO:0106333; GO:0140089; GO:0140094; GO:0140095","actin filament organization [GO:0007015]; endoplasmic reticulum localization [GO:0051643]; epigenetic programming in the zygotic pronuclei [GO:0044725]; establishment of spindle localization [GO:0051293]; flagellated sperm motility [GO:0030317]; mitochondrion localization [GO:0051646]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of embryonic development [GO:0040019]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron differentiation [GO:0045666]; protein storage [GO:0140089]; regulation of cell division [GO:0051302]; spermatogenesis [GO:0007283]; spermatogonial cell division [GO:0007284]","cell cortex [GO:0005938]; cytoplasmic lattice [GO:0140095]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; sperm midpiece [GO:0097225]; subcortical maternal complex [GO:0106333]; structural constituent of cytoplasmic lattice [GO:0140094]; actin filament organization [GO:0007015]; endoplasmic reticulum localization [GO:0051643]; epigenetic programming in the zygotic pronuclei [GO:0044725]; establishment of spindle localization [GO:0051293]; flagellated sperm motility [GO:0030317]; mitochondrion localization [GO:0051646]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of embryonic development [GO:0040019]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron differentiation [GO:0045666]; protein storage [GO:0140089]; regulation of cell division [GO:0051302]; spermatogenesis [GO:0007283]; spermatogonial cell division [GO:0007284]","DEVELOPMENTAL STAGE: Transcripts first detected at 15.5 dpc and peak 1 week after birth. Transcripts accumulate during oogenesis (PubMed:18804437). During meiotic maturation, the vast majority of the transcripts are degraded and virtually none is detected by 2-cell stage embryogenesis (PubMed:18804437). The protein however persists during preimplantation up to the blastocyst stage (PubMed:18804437). At 2-cell stage, excluded from cell-cell contact regions. Continuous exclusion from these regions during preimplantation development leads to the absence of the protein from the inner cells of the morula and the inner cell mass of the blastocyst (PubMed:18804437). Expressed in the forebrain, midbrain, ventricular zone and superficial cortical plate at 14.5 dpc (PubMed:16314515). Expressed in cortical progenitors in the forebrain dorsal telencephalon and the midbrain at 15.5 dpc (PubMed:16314515). Expressed in ovaries at postnatal day 2 (P2), expression peaks at P10, expression is then decreased at P17 and further decreased at P21 (PubMed:31575650). {ECO:0000269|PubMed:16314515, ECO:0000269|PubMed:18804437, ECO:0000269|PubMed:31575650}.","INDUCTION: Induced by E2A-HLF, a chimeric transcription factor containing the transactivation domain of E2A linked to the DNA-binding and dimerization domain of HLF (PubMed:11486032). Induced during TNFSF11/RANKL-induced osteoclast differentiation (PubMed:23990468). {ECO:0000269|PubMed:11486032, ECO:0000269|PubMed:23990468}.","INDUCTION: Induced by E2A-HLF, a chimeric transcription factor containing the transactivation domain of E2A linked to the DNA-binding and dimerization domain of HLF (PubMed:11486032). Induced during TNFSF11/RANKL-induced osteoclast differentiation (PubMed:23990468). {ECO:0000269|PubMed:11486032, ECO:0000269|PubMed:23990468}.","TISSUE SPECIFICITY: Expressed in spermatogonia (at protein level) (PubMed:32823735). Expressed predominantly in ovaries, where it is restricted to growing oocytes, with greatest levels in fully grown oocytes (PubMed:18804437, PubMed:25208553). Expressed predominantly in testis, heart, lung, liver and muscle, and at very low levels in the brain, spleen and kidney (PubMed:11486032). Expressed in bone marrow-derived macrophages and osteoclasts (PubMed:23990468). {ECO:0000269|PubMed:11486032, ECO:0000269|PubMed:18804437, ECO:0000269|PubMed:23990468, ECO:0000269|PubMed:25208553, ECO:0000269|PubMed:32823735}."
"830","sp|P49455|TPM4_DROME","lcl|NC_088858.1_cds_XP_034322853.1_34045",1.16e-78,249,"P49455","TPM4_DROME","Tropomyosin-1, isoforms 33/34 (Tropomyosin II)","Tm1 TmII CG4898","Drosophila melanogaster (Fruit fly)",518,"GO:0003779; GO:0005829; GO:0005884; GO:0006936; GO:0007015; GO:0007315; GO:0010591; GO:0019894; GO:0030017; GO:0043149; GO:0043186; GO:0045451; GO:0048477; GO:0048813; GO:0051015; GO:0055093; GO:0070865","actin filament organization [GO:0007015]; dendrite morphogenesis [GO:0048813]; muscle contraction [GO:0006936]; oogenesis [GO:0048477]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; regulation of lamellipodium assembly [GO:0010591]; response to hyperoxia [GO:0055093]; stress fiber assembly [GO:0043149]","actin filament [GO:0005884]; cytosol [GO:0005829]; investment cone [GO:0070865]; P granule [GO:0043186]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; kinesin binding [GO:0019894]; actin filament organization [GO:0007015]; dendrite morphogenesis [GO:0048813]; muscle contraction [GO:0006936]; oogenesis [GO:0048477]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; regulation of lamellipodium assembly [GO:0010591]; response to hyperoxia [GO:0055093]; stress fiber assembly [GO:0043149]","DEVELOPMENTAL STAGE: Both isoforms are expressed during pupal and adult stages.","","","TISSUE SPECIFICITY: Both isoforms are only expressed in indirect flight muscles."
"831","sp|Q924X7|STK33_MOUSE","lcl|NC_088858.1_cds_XP_034322948.1_33971",5.84e-62,207,"Q924X7","STK33_MOUSE","Serine/threonine-protein kinase 33 (EC 2.7.11.1)","Stk33","Mus musculus (Mouse)",491,"GO:0002177; GO:0004674; GO:0005524; GO:0007283; GO:0046777; GO:0048471; GO:0106310; GO:1905198","manchette assembly [GO:1905198]; protein autophosphorylation [GO:0046777]; spermatogenesis [GO:0007283]","manchette [GO:0002177]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; manchette assembly [GO:1905198]; protein autophosphorylation [GO:0046777]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expression is initiated during meiosis I in primary spermatocytes during the pachytene period and is maintained during spermatogenesis. {ECO:0000269|PubMed:29155043}.","","","TISSUE SPECIFICITY: Highly expressed in testis, particularly in cells from the spermatogenic epithelia (PubMed:16176263, PubMed:29155043). Present in meiotic and post meiotic sperm cells (PubMed:29155043). Significant expression is detected in lung epithelia, alveolar macrophages, horizontal cells in the retina and in embryonic organs such as heart, brain and spinal cord (PubMed:16176263). Also expressed in pituitary gland, kidney, pancreas, trachea and thyroid gland (PubMed:16176263). {ECO:0000269|PubMed:16176263, ECO:0000269|PubMed:29155043}."
"832","sp|Q09363|SQV8_CAEEL","lcl|NC_088858.1_cds_XP_034323153.2_33618",8.94e-91,276,"Q09363","SQV8_CAEEL","Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase sqv-8 (EC 2.4.1.135) (Glucuronyl transferase I) (GlcAT-I) (Squashed vulva protein 8) (Vulval invagination protein sqv-8)","sqv-8 ZK1307.5","Caenorhabditis elegans",356,"GO:0000139; GO:0002009; GO:0005975; GO:0007286; GO:0009792; GO:0015018; GO:0015020; GO:0016020; GO:0018991; GO:0022414; GO:0040025; GO:0046872; GO:0050650; GO:0160094","carbohydrate metabolic process [GO:0005975]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; egg-laying behavior [GO:0018991]; embryo development ending in birth or egg hatching [GO:0009792]; morphogenesis of an epithelium [GO:0002009]; nematode pharynx development [GO:0160094]; reproductive process [GO:0022414]; spermatid development [GO:0007286]; vulval development [GO:0040025]","Golgi membrane [GO:0000139]; membrane [GO:0016020]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; egg-laying behavior [GO:0018991]; embryo development ending in birth or egg hatching [GO:0009792]; morphogenesis of an epithelium [GO:0002009]; nematode pharynx development [GO:0160094]; reproductive process [GO:0022414]; spermatid development [GO:0007286]; vulval development [GO:0040025]","","","",""
"833","sp|Q497L9|S22AE_MOUSE","lcl|NC_088858.1_cds_XP_034323475.2_33147",1.95e-42,162,"Q497L9","S22AE_MOUSE","Solute carrier family 22 member 14","Slc22a14 Gm1128","Mus musculus (Mouse)",629,"GO:0005743; GO:0005886; GO:0030317; GO:0032217; GO:0048240; GO:0097228","flagellated sperm motility [GO:0030317]; sperm capacitation [GO:0048240]","mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; riboflavin transmembrane transporter activity [GO:0032217]; flagellated sperm motility [GO:0030317]; sperm capacitation [GO:0048240]","","","","TISSUE SPECIFICITY: Testis-specific (at protein level) (PubMed:27811987). Specifically expressed in male germ cells (at protein level) (PubMed:27811987). {ECO:0000269|PubMed:27811987}."
"834","sp|A2AKX3|SETX_MOUSE","lcl|NC_088858.1_cds_XP_034323510.2_33099",1.59e-75,283,"A2AKX3","SETX_MOUSE","Probable helicase senataxin (EC 3.6.4.-) (Amyotrophic lateral sclerosis 4 protein homolog) (SEN1 homolog)","Setx Als4 Kiaa0625","Mus musculus (Mouse)",2646,"GO:0000228; GO:0000781; GO:0001147; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006310; GO:0006353; GO:0006369; GO:0006376; GO:0006974; GO:0007283; GO:0007399; GO:0007623; GO:0010976; GO:0016604; GO:0016787; GO:0030154; GO:0030424; GO:0030426; GO:0033120; GO:0034599; GO:0042802; GO:0045171; GO:0045944; GO:0060566; GO:0070301; GO:2000144; GO:2000806","cell differentiation [GO:0030154]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; DNA recombination [GO:0006310]; DNA-templated transcription termination [GO:0006353]; double-strand break repair [GO:0006302]; mRNA splice site recognition [GO:0006376]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription initiation [GO:2000144]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of DNA-templated transcription [GO:0060566]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]","axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; intercellular bridge [GO:0045171]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; transcription termination site sequence-specific DNA binding [GO:0001147]; cell differentiation [GO:0030154]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; DNA recombination [GO:0006310]; DNA-templated transcription termination [GO:0006353]; double-strand break repair [GO:0006302]; mRNA splice site recognition [GO:0006376]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription initiation [GO:2000144]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of DNA-templated transcription [GO:0060566]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]","","","","TISSUE SPECIFICITY: Expressed in cerebellum, hippocampus, olfactory bulb, Bergmann glial fibers, stellate cells and Purkinje cells. Expressed in the epithelial cells of the lens but not in mature lens fiber cells. Expressed in the retina (highly expressed in inner and outer segments of photoreceptors and outer plexiform layer cells but weakly expressed in the inner plexiform and ganglion cell layers). Expressed in the kidney. {ECO:0000269|PubMed:16644229}."
"835","sp|Q641A1|GLD2A_XENLA","lcl|NC_088858.1_cds_XP_034323581.1_30350",1.97e-74,243,"Q641A1","GLD2A_XENLA","Poly(A) RNA polymerase GLD2-A (EC 2.7.7.19) (PAP-associated domain-containing protein 4-A)","tent2-a gld2-a papd4-a","Xenopus laevis (African clawed frog)",509,"GO:0005524; GO:0005737; GO:0031123; GO:0031124; GO:0046872; GO:0048477; GO:1990817; GO:2000626","mRNA 3'-end processing [GO:0031124]; negative regulation of miRNA catabolic process [GO:2000626]; oogenesis [GO:0048477]; RNA 3'-end processing [GO:0031123]","cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A) RNA polymerase activity [GO:1990817]; mRNA 3'-end processing [GO:0031124]; negative regulation of miRNA catabolic process [GO:2000626]; oogenesis [GO:0048477]; RNA 3'-end processing [GO:0031123]","DEVELOPMENTAL STAGE: Present in oocytes. {ECO:0000269|PubMed:15987818}.","","",""
"836","sp|O18178|2A51_CAEEL","lcl|NC_088858.1_cds_XP_034323874.1_32334",0,631,"O18178","2A51_CAEEL","Serine/threonine-protein phosphatase 2A regulatory subunit pptr-1 (Serine/threonine-protein phosphatase 2A 56kDa regulatory subunit pptr-1) (Serine/threonine-protein phosphatase 2A regulatory subunit B' pptr-1)","pptr-1 W08G11.4","Caenorhabditis elegans",542,"GO:0000159; GO:0005634; GO:0005829; GO:0007165; GO:0008340; GO:0009408; GO:0010883; GO:0019901; GO:0040024; GO:0046627; GO:0072542; GO:1903863","dauer larval development [GO:0040024]; determination of adult lifespan [GO:0008340]; negative regulation of insulin receptor signaling pathway [GO:0046627]; P granule assembly [GO:1903863]; regulation of lipid storage [GO:0010883]; response to heat [GO:0009408]; signal transduction [GO:0007165]","cytosol [GO:0005829]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; dauer larval development [GO:0040024]; determination of adult lifespan [GO:0008340]; negative regulation of insulin receptor signaling pathway [GO:0046627]; P granule assembly [GO:1903863]; regulation of lipid storage [GO:0010883]; response to heat [GO:0009408]; signal transduction [GO:0007165]","","","","TISSUE SPECIFICITY: Expressed in pharynx, vulva and spermatheca. {ECO:0000269|PubMed:19249087}."
"837","sp|Q8MNV0|SPAST_CAEEL","lcl|NC_088858.1_cds_XP_034323899.1_32293",3.73e-103,321,"Q8MNV0","SPAST_CAEEL","Spastin homolog (EC 5.6.1.1)","spas-1 C24B5.2","Caenorhabditis elegans",512,"GO:0001578; GO:0005524; GO:0005737; GO:0005856; GO:0005874; GO:0007019; GO:0007399; GO:0008017; GO:0008568; GO:0015630; GO:0016020; GO:0016887; GO:0031117; GO:0032991; GO:0040025; GO:0042802; GO:0048471; GO:0048477; GO:0051013; GO:0051647","microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019]; microtubule severing [GO:0051013]; nervous system development [GO:0007399]; nucleus localization [GO:0051647]; oogenesis [GO:0048477]; positive regulation of microtubule depolymerization [GO:0031117]; vulval development [GO:0040025]","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule severing ATPase activity [GO:0008568]; microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019]; microtubule severing [GO:0051013]; nervous system development [GO:0007399]; nucleus localization [GO:0051647]; oogenesis [GO:0048477]; positive regulation of microtubule depolymerization [GO:0031117]; vulval development [GO:0040025]","DEVELOPMENTAL STAGE: [Isoform a]: Expressed at all developmental stages (PubMed:17531954). Highly expressed in the embryo and expressed at lower levels in L3-L4 larvae (PubMed:17531954). {ECO:0000269|PubMed:17531954}.; DEVELOPMENTAL STAGE: [Isoform c]: Highly expressed in the embryo (PubMed:17531954). Not expressed in L3-L4 larvae (PubMed:17531954). {ECO:0000269|PubMed:17531954}.","","",""
"838","sp|A9ZSY0|CNTLN_RAT","lcl|NC_088858.1_cds_XP_034324213.2_29457",3.75e-20,97.4,"A9ZSY0","CNTLN_RAT","Centlein (Centrosomal protein)","Cntln","Rattus norvegicus (Rat)",721,"GO:0005737; GO:0005814; GO:0007283; GO:0007338; GO:0008104; GO:0010457; GO:0019901; GO:0019904; GO:0030674; GO:0032880; GO:0033365; GO:0065003; GO:0120212","centriole-centriole cohesion [GO:0010457]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; protein-containing complex assembly [GO:0065003]; regulation of protein localization [GO:0032880]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]","centriole [GO:0005814]; cytoplasm [GO:0005737]; sperm head-tail coupling apparatus [GO:0120212]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; centriole-centriole cohesion [GO:0010457]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; protein-containing complex assembly [GO:0065003]; regulation of protein localization [GO:0032880]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]","","","",""
"839","sp|Q9NXG0|CNTLN_HUMAN","lcl|NC_088858.1_cds_XP_034324216.2_29455",4.87e-74,273,"Q9NXG0","CNTLN_HUMAN","Centlein (Centrosomal protein)","CNTLN C9orf101 C9orf39","Homo sapiens (Human)",1405,"GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007283; GO:0007338; GO:0010457; GO:0019901; GO:0019904; GO:0030674; GO:0032880; GO:0033365; GO:0065003; GO:0070062; GO:0120212","centriole-centriole cohesion [GO:0010457]; protein localization to organelle [GO:0033365]; protein-containing complex assembly [GO:0065003]; regulation of protein localization [GO:0032880]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]","centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; sperm head-tail coupling apparatus [GO:0120212]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; centriole-centriole cohesion [GO:0010457]; protein localization to organelle [GO:0033365]; protein-containing complex assembly [GO:0065003]; regulation of protein localization [GO:0032880]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]","","","",""
"840","sp|A7DTF0|MRG1_CAEEL","lcl|NC_088858.1_cds_XP_034324286.2_30089",1.75e-22,99,"A7DTF0","MRG1_CAEEL","Mortality factor related protein 1","mrg-1 Y37D8A.9","Caenorhabditis elegans",337,"GO:0000122; GO:0000785; GO:0000791; GO:0005634; GO:0006281; GO:0007281; GO:0009792; GO:0030849; GO:0031507; GO:0035267; GO:0045944; GO:0070192; GO:0097240; GO:1905632","chromosome attachment to the nuclear envelope [GO:0097240]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA repair [GO:0006281]; embryo development ending in birth or egg hatching [GO:0009792]; germ cell development [GO:0007281]; heterochromatin formation [GO:0031507]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to euchromatin [GO:1905632]","autosome [GO:0030849]; chromatin [GO:0000785]; euchromatin [GO:0000791]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; chromosome attachment to the nuclear envelope [GO:0097240]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA repair [GO:0006281]; embryo development ending in birth or egg hatching [GO:0009792]; germ cell development [GO:0007281]; heterochromatin formation [GO:0031507]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to euchromatin [GO:1905632]","DEVELOPMENTAL STAGE: Expressed in embryos, L1 larvae and adult hermaphrodites and decreases drastically between the L2 and L4 larval stages (at protein level) (PubMed:12175490, PubMed:17215300). In late embryos and young larvae, expressed at higher levels in the two primordial germ cells (PGCs), Z2 and Z3, than in somatic blastomeres (PubMed:17215300, PubMed:30929290). Expressed at a relatively constant level throughout the distal end of the gonad at the L1 stage, with no decrease as cells enter into meiotic prophase (PubMed:25564623). {ECO:0000269|PubMed:12175490, ECO:0000269|PubMed:17215300, ECO:0000269|PubMed:25564623, ECO:0000269|PubMed:30929290}.","","","TISSUE SPECIFICITY: Expressed in oocytes (at protein level) (PubMed:12175490). Expressed mainly in germ cells, but also at lower levels in several somatic cell types, including intestinal cells (PubMed:17215300). {ECO:0000269|PubMed:12175490, ECO:0000269|PubMed:17215300}."
"841","sp|Q22836|YGH1_CAEEL","lcl|NC_088858.1_cds_XP_034324432.2_30517",1.75e-161,471,"Q22836","YGH1_CAEEL","Uncharacterized protein T27F2.1","T27F2.1","Caenorhabditis elegans",535,"GO:0000398; GO:0002119; GO:0005681; GO:0007281; GO:0009792; GO:0010468; GO:0018991; GO:0040011; GO:0040025; GO:0042303; GO:0045893; GO:0060065","egg-laying behavior [GO:0018991]; embryo development ending in birth or egg hatching [GO:0009792]; germ cell development [GO:0007281]; locomotion [GO:0040011]; molting cycle [GO:0042303]; mRNA splicing, via spliceosome [GO:0000398]; nematode larval development [GO:0002119]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of gene expression [GO:0010468]; uterus development [GO:0060065]; vulval development [GO:0040025]","spliceosomal complex [GO:0005681]; egg-laying behavior [GO:0018991]; embryo development ending in birth or egg hatching [GO:0009792]; germ cell development [GO:0007281]; locomotion [GO:0040011]; molting cycle [GO:0042303]; mRNA splicing, via spliceosome [GO:0000398]; nematode larval development [GO:0002119]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of gene expression [GO:0010468]; uterus development [GO:0060065]; vulval development [GO:0040025]","","","",""
"842","sp|Q8IWV8|UBR2_HUMAN","lcl|NC_088858.1_cds_XP_034324457.2_30475",0,1344,"Q8IWV8","UBR2_HUMAN","E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II)","UBR2 C6orf133 KIAA0349","Homo sapiens (Human)",1755,"GO:0000151; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010526; GO:0016567; GO:0031507; GO:0032007; GO:0043161; GO:0050862; GO:0061630; GO:0070534; GO:0070728; GO:0071233; GO:0071596; GO:0141053","cellular response to L-leucine [GO:0071233]; heterochromatin formation [GO:0031507]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; positive regulation of T cell receptor signaling pathway [GO:0050862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; transposable element silencing [GO:0010526]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]","chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; histone H2A ubiquitin ligase activity [GO:0141053]; L-leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cellular response to L-leucine [GO:0071233]; heterochromatin formation [GO:0031507]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; positive regulation of T cell receptor signaling pathway [GO:0050862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; transposable element silencing [GO:0010526]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]","DEVELOPMENTAL STAGE: Expressed in fetal pancreas. {ECO:0000269|PubMed:16311597}.","","","TISSUE SPECIFICITY: Broadly expressed, with highest levels in skeletal muscle, kidney and pancreas. Present in acinar cells of the pancreas (at protein level). {ECO:0000269|PubMed:15548684, ECO:0000269|PubMed:16311597}."
"843","sp|Q86S05|LIG_DROME","lcl|NC_088858.1_cds_XP_034324515.2_32540",1.99e-15,83.6,"Q86S05","LIG_DROME","Protein lingerer","lig CG8715","Drosophila melanogaster (Fruit fly)",1375,"GO:0000932; GO:0005634; GO:0005737; GO:0007620; GO:0008069; GO:0010468; GO:0035332; GO:0045571; GO:0046426; GO:0060179","copulation [GO:0007620]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; male mating behavior [GO:0060179]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; positive regulation of hippo signaling [GO:0035332]; regulation of gene expression [GO:0010468]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; copulation [GO:0007620]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; male mating behavior [GO:0060179]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; positive regulation of hippo signaling [GO:0035332]; regulation of gene expression [GO:0010468]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically throughout development. Zygotic expression levels rise after embryonic stage 9. {ECO:0000269|PubMed:12524348}.","","","TISSUE SPECIFICITY: At stage 11, expression is restricted to the neuroblasts, predominant in the central nervous system (CNS), including the brain and ventral nerve cord, and in the PNS. Later embryonic expression is seen in the gonads. Late third instar larvae show expression in the CNS, imaginal disks (including genital, eye-antennal, leg, wing and haltere disks), and gonads. In the larval brain, it is expressed in all of the glial cells and in clusters of neurons that projected contralaterally. In the larval ventral ganglion, it is expressed in subperineurial glia, peripheral exit glia, and a number of interneurons, but not in motor neurons. Isoform B is abundantly expressed in males and females. Isoform D is male specific and expressed at low levels. {ECO:0000269|PubMed:12524348, ECO:0000269|PubMed:14668197}."
"844","sp|Q08E27|STRBP_BOVIN","lcl|NC_088858.1_cds_XP_034324582.2_32436",2.04e-105,343,"Q08E27","STRBP_BOVIN","Spermatid perinuclear RNA-binding protein","STRBP","Bos taurus (Bovine)",672,"GO:0003677; GO:0003725; GO:0003727; GO:0005737; GO:0007283; GO:0030154","cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; single-stranded RNA binding [GO:0003727]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","","","",""
"845","sp|Q4R7Y8|BBOF1_MACFA","lcl|NC_088858.1_cds_XP_034325028.1_32117",6.55e-135,402,"Q4R7Y8","BBOF1_MACFA","Basal body-orientation factor 1 (Coiled-coil domain-containing protein 176)","BBOF1 CCDC176 QtsA-11302","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)",529,"GO:0005930; GO:0007288; GO:0030317; GO:0036064; GO:0036126; GO:0044458","flagellated sperm motility [GO:0030317]; motile cilium assembly [GO:0044458]; sperm axoneme assembly [GO:0007288]","axoneme [GO:0005930]; ciliary basal body [GO:0036064]; sperm flagellum [GO:0036126]; flagellated sperm motility [GO:0030317]; motile cilium assembly [GO:0044458]; sperm axoneme assembly [GO:0007288]","","","",""
"846","sp|Q03427|LAMC_DROME","lcl|NC_088858.1_cds_XP_034325378.2_31951",2.12e-94,303,"Q03427","LAMC_DROME","Lamin-C (pG-IF)","LamC CG10119","Drosophila melanogaster (Fruit fly)",621,"GO:0005200; GO:0005635; GO:0005638; GO:0005652; GO:0006325; GO:0006998; GO:0007097; GO:0007112; GO:0030833; GO:0031507; GO:0034399; GO:0051664; GO:0060415; GO:0070732; GO:0090435","chromatin organization [GO:0006325]; heterochromatin formation [GO:0031507]; male meiosis cytokinesis [GO:0007112]; muscle tissue morphogenesis [GO:0060415]; nuclear envelope organization [GO:0006998]; nuclear migration [GO:0007097]; nuclear pore localization [GO:0051664]; protein localization to nuclear envelope [GO:0090435]; regulation of actin filament polymerization [GO:0030833]","lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear lamina [GO:0005652]; nuclear periphery [GO:0034399]; spindle envelope [GO:0070732]; structural constituent of cytoskeleton [GO:0005200]; chromatin organization [GO:0006325]; heterochromatin formation [GO:0031507]; male meiosis cytokinesis [GO:0007112]; muscle tissue morphogenesis [GO:0060415]; nuclear envelope organization [GO:0006998]; nuclear migration [GO:0007097]; nuclear pore localization [GO:0051664]; protein localization to nuclear envelope [GO:0090435]; regulation of actin filament polymerization [GO:0030833]","DEVELOPMENTAL STAGE: Expressed in 12-22 hours embryos. Expression peaks in larvae and declines in pupae and adults. {ECO:0000269|PubMed:7593280}.","","","TISSUE SPECIFICITY: First detected from late stage 12 in the oenocytes, abdominal segments, hindgut and posterior spiracles, with expression increasing in stage 13 (PubMed:7593280) (at protein level). In stage 14, also becomes detectable in the foregut (PubMed:7593280) (at protein level). Stage 15 shows expression in the epidermis, dorsal longitudinal trunk, pharynx, esophagus and proventriculus, with the dorsal pharyngeal musculature showing expression in late stage 15 (PubMed:7593280) (at protein level). In stage 16 embryos, also detected in the exit glia with increasing expression in the somatic musculature (PubMed:7593280) (at protein level). Also detected in the visceral mesoderm but not in the midgut or central nervous system until the end of embryogenesis (PubMed:7593280) (at protein level). In third instar larvae, detectable at varying levels in all cell types (PubMed:7593280) (at protein level). Expressed in spermatocytes (at protein level) (PubMed:27402967). {ECO:0000269|PubMed:27402967, ECO:0000269|PubMed:7593280}."
"847","sp|P29121|PCSK4_MOUSE","lcl|NC_088858.1_cds_XP_034325710.2_30597",0,568,"P29121","PCSK4_MOUSE","Proprotein convertase subtilisin/kexin type 4 (EC 3.4.21.-) (KEX2-like endoprotease 3) (Neuroendocrine convertase 3) (NEC 3) (Prohormone convertase 3)","Pcsk4 Nec-3 Nec3","Mus musculus (Mouse)",655,"GO:0001669; GO:0002080; GO:0004252; GO:0005788; GO:0007339; GO:0007340; GO:0009566; GO:0016485; GO:0022414; GO:0048240","acrosome reaction [GO:0007340]; binding of sperm to zona pellucida [GO:0007339]; fertilization [GO:0009566]; protein processing [GO:0016485]; reproductive process [GO:0022414]; sperm capacitation [GO:0048240]","acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; endoplasmic reticulum lumen [GO:0005788]; serine-type endopeptidase activity [GO:0004252]; acrosome reaction [GO:0007340]; binding of sperm to zona pellucida [GO:0007339]; fertilization [GO:0009566]; protein processing [GO:0016485]; reproductive process [GO:0022414]; sperm capacitation [GO:0048240]","DEVELOPMENTAL STAGE: Detected only after the 20th day of postnatal development. Mainly expressed in the round spermatids. Expressed mainly in the early stages of spermiogenesis. {ECO:0000269|PubMed:1372895}.","","","TISSUE SPECIFICITY: Expressed abundantly in the testis since postnatal Day 16 (PubMed:1372895, PubMed:16371590, PubMed:21302280). In testis, strongly detected in round and elongated spermatids as well as spermatocytes. Also observed in residual bodies engulfed by Sertoli cells at spermatogenic stages VIII and IX (PubMed:16371590). In ovaries, expressed in macrophage-like cells of the ovarian theca, interstitium and corpora lutea (PubMed:11164898). {ECO:0000269|PubMed:11164898, ECO:0000269|PubMed:1372895, ECO:0000269|PubMed:16371590, ECO:0000269|PubMed:21302280}."
"848","sp|Q6UW60|PCSK4_HUMAN","lcl|NC_088858.1_cds_XP_034325718.2_30596",0,634,"Q6UW60","PCSK4_HUMAN","Proprotein convertase subtilisin/kexin type 4 (EC 3.4.21.-) (Proprotein convertase 4) (PC4)","PCSK4 PC4 UNQ2757/PRO6496","Homo sapiens (Human)",755,"GO:0000139; GO:0001669; GO:0002080; GO:0004252; GO:0005802; GO:0007339; GO:0007340; GO:0009566; GO:0016485; GO:0016486; GO:0022414; GO:0048240","acrosome reaction [GO:0007340]; binding of sperm to zona pellucida [GO:0007339]; fertilization [GO:0009566]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; reproductive process [GO:0022414]; sperm capacitation [GO:0048240]","acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; serine-type endopeptidase activity [GO:0004252]; acrosome reaction [GO:0007340]; binding of sperm to zona pellucida [GO:0007339]; fertilization [GO:0009566]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; reproductive process [GO:0022414]; sperm capacitation [GO:0048240]","DEVELOPMENTAL STAGE: Localized predominantly in the cytotrophoblast layer of trophoblast cells during the first trimester of pregnancy, and to the syncytiotrophoblast and stroma cells during the third trimester. {ECO:0000269|PubMed:16040806}.","","","TISSUE SPECIFICITY: Placenta. {ECO:0000269|PubMed:16040806}."
"849","sp|Q8BPN8|DMXL2_MOUSE","lcl|NC_088858.1_cds_XP_034325757.2_32817",0,2056,"Q8BPN8","DMXL2_MOUSE","DmX-like protein 2 (Rabconnectin-3)","Dmxl2 Kiaa0856","Mus musculus (Mouse)",3032,"GO:0007268; GO:0007283; GO:0007420; GO:0007608; GO:0008021; GO:0022038; GO:0030672; GO:0031267; GO:0042593; GO:0098992","brain development [GO:0007420]; chemical synaptic transmission [GO:0007268]; corpus callosum development [GO:0022038]; glucose homeostasis [GO:0042593]; sensory perception of smell [GO:0007608]; spermatogenesis [GO:0007283]","neuronal dense core vesicle [GO:0098992]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; small GTPase binding [GO:0031267]; brain development [GO:0007420]; chemical synaptic transmission [GO:0007268]; corpus callosum development [GO:0022038]; glucose homeostasis [GO:0042593]; sensory perception of smell [GO:0007608]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in the brain and pituitary gland. Detected in the hippocampus, dentate gyrus, hypothalamus, pyriform cortex and the granular and molecular layers of the cerebellum of adult animals. In the hypothalamus, expression is observed in the arcuate nucleus, the ME, the organum vasculosum of the lamina terminalis, and the subfornical organ, the subcommissural organ, and the suprachiasmatic nucleus. Both tanycytes and hypothalamic neurosecretory neurons express the protein (PubMed:25248098). Expressed in the inner and outer hair cells as well as in the spiral ganglion neurons (PubMed:27657680). Expressed in insulin-secreting cells of the islets of Langerhans in the pancreas (PubMed:25248098). {ECO:0000269|PubMed:25248098, ECO:0000269|PubMed:27657680}."
"850","sp|Q9H091|ZMY15_HUMAN","lcl|NC_088858.1_cds_XP_034325765.2_32803",8.14e-46,172,"Q9H091","ZMY15_HUMAN","Zinc finger MYND domain-containing protein 15","ZMYND15","Homo sapiens (Human)",742,"GO:0001673; GO:0005737; GO:0007286; GO:0008270; GO:0042826; GO:0045892","negative regulation of DNA-templated transcription [GO:0045892]; spermatid development [GO:0007286]","cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; histone deacetylase binding [GO:0042826]; zinc ion binding [GO:0008270]; negative regulation of DNA-templated transcription [GO:0045892]; spermatid development [GO:0007286]","","","",""
"851","sp|Q6AXR4|HEXB_RAT","lcl|NC_088858.1_cds_XP_034325788.2_32752",0,531,"Q6AXR4","HEXB_RAT","Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (N-acetyl-beta-glucosaminidase subunit beta)","Hexb","Rattus norvegicus (Rat)",537,"GO:0001501; GO:0001669; GO:0004563; GO:0005615; GO:0005764; GO:0006044; GO:0006491; GO:0006687; GO:0006689; GO:0006874; GO:0007040; GO:0007338; GO:0007341; GO:0007605; GO:0007626; GO:0008049; GO:0008360; GO:0008375; GO:0008654; GO:0009313; GO:0015929; GO:0016020; GO:0016231; GO:0016787; GO:0019222; GO:0019915; GO:0019953; GO:0030203; GO:0030207; GO:0030209; GO:0030214; GO:0030246; GO:0042552; GO:0042582; GO:0042802; GO:0043615; GO:0044877; GO:0045944; GO:0048477; GO:0050885; GO:0050905; GO:0051651; GO:0060473; GO:0070050; GO:1905379","astrocyte cell migration [GO:0043615]; chondroitin sulfate proteoglycan catabolic process [GO:0030207]; dermatan sulfate proteoglycan catabolic process [GO:0030209]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan metabolic process [GO:0030203]; glycosphingolipid metabolic process [GO:0006687]; hyaluronan catabolic process [GO:0030214]; intracellular calcium ion homeostasis [GO:0006874]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; maintenance of location in cell [GO:0051651]; male courtship behavior [GO:0008049]; myelination [GO:0042552]; N-acetylglucosamine metabolic process [GO:0006044]; N-glycan processing [GO:0006491]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuron cellular homeostasis [GO:0070050]; oligosaccharide catabolic process [GO:0009313]; oogenesis [GO:0048477]; penetration of zona pellucida [GO:0007341]; phospholipid biosynthetic process [GO:0008654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; regulation of metabolic process [GO:0019222]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]","acrosomal vesicle [GO:0001669]; azurophil granule [GO:0042582]; beta-N-acetylhexosaminidase complex [GO:1905379]; cortical granule [GO:0060473]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylglucosaminidase activity [GO:0016231]; beta-N-acetylhexosaminidase activity [GO:0004563]; carbohydrate binding [GO:0030246]; hexosaminidase activity [GO:0015929]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; astrocyte cell migration [GO:0043615]; chondroitin sulfate proteoglycan catabolic process [GO:0030207]; dermatan sulfate proteoglycan catabolic process [GO:0030209]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan metabolic process [GO:0030203]; glycosphingolipid metabolic process [GO:0006687]; hyaluronan catabolic process [GO:0030214]; intracellular calcium ion homeostasis [GO:0006874]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; maintenance of location in cell [GO:0051651]; male courtship behavior [GO:0008049]; myelination [GO:0042552]; N-acetylglucosamine metabolic process [GO:0006044]; N-glycan processing [GO:0006491]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuron cellular homeostasis [GO:0070050]; oligosaccharide catabolic process [GO:0009313]; oogenesis [GO:0048477]; penetration of zona pellucida [GO:0007341]; phospholipid biosynthetic process [GO:0008654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; regulation of metabolic process [GO:0019222]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]","","","",""
"852","sp|Q9NPJ1|MKKS_HUMAN","lcl|NC_088858.1_cds_XP_034325806.2_30862",1.29e-68,233,"Q9NPJ1","MKKS_HUMAN","Molecular chaperone MKKS (Bardet-Biedl syndrome 6 protein) (McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin)","MKKS BBS6","Homo sapiens (Human)",570,"GO:0001947; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006457; GO:0007286; GO:0007368; GO:0007507; GO:0007601; GO:0007608; GO:0008406; GO:0010629; GO:0014824; GO:0021756; GO:0021766; GO:0021987; GO:0030837; GO:0031514; GO:0032402; GO:0032502; GO:0035176; GO:0036064; GO:0038108; GO:0040018; GO:0042311; GO:0045444; GO:0045494; GO:0045776; GO:0046907; GO:0048854; GO:0050910; GO:0051082; GO:0051131; GO:0051216; GO:0051492; GO:0051877; GO:0060027; GO:0060271; GO:0060296; GO:0060324; GO:0061629; GO:1902140; GO:1902636; GO:1905515","artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; chaperone-mediated protein complex assembly [GO:0051131]; cilium assembly [GO:0060271]; convergent extension involved in gastrulation [GO:0060027]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; determination of left/right symmetry [GO:0007368]; developmental process [GO:0032502]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; gonad development [GO:0008406]; heart development [GO:0007507]; heart looping [GO:0001947]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; melanosome transport [GO:0032402]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of blood pressure [GO:0045776]; negative regulation of gene expression [GO:0010629]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; pigment granule aggregation in cell center [GO:0051877]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of stress fiber assembly [GO:0051492]; response to inositol [GO:1902140]; sensory perception of smell [GO:0007608]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; vasodilation [GO:0042311]; visual perception [GO:0007601]","centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinociliary basal body [GO:1902636]; motile cilium [GO:0031514]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; unfolded protein binding [GO:0051082]; artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; chaperone-mediated protein complex assembly [GO:0051131]; cilium assembly [GO:0060271]; convergent extension involved in gastrulation [GO:0060027]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; determination of left/right symmetry [GO:0007368]; developmental process [GO:0032502]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; gonad development [GO:0008406]; heart development [GO:0007507]; heart looping [GO:0001947]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; melanosome transport [GO:0032402]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of blood pressure [GO:0045776]; negative regulation of gene expression [GO:0010629]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; pigment granule aggregation in cell center [GO:0051877]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of stress fiber assembly [GO:0051492]; response to inositol [GO:1902140]; sensory perception of smell [GO:0007608]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; vasodilation [GO:0042311]; visual perception [GO:0007601]","","","","TISSUE SPECIFICITY: Widely expressed in adult and fetal tissues."
"853","sp|Q9D4G2|HSF2B_MOUSE","lcl|NC_088858.1_cds_XP_034325956.2_34081",1.86e-48,166,"Q9D4G2","HSF2B_MOUSE","Heat shock factor 2-binding protein","Hsf2bp Meilb2","Mus musculus (Mouse)",338,"GO:0005654; GO:0005694; GO:0005829; GO:0007141; GO:0007144; GO:0007283; GO:1990918","double-strand break repair involved in meiotic recombination [GO:1990918]; female meiosis I [GO:0007144]; male meiosis I [GO:0007141]; spermatogenesis [GO:0007283]","chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-strand break repair involved in meiotic recombination [GO:1990918]; female meiosis I [GO:0007144]; male meiosis I [GO:0007141]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Detected at low levels from birth to 3 days post partum, thereafter the expression level increases from 5 days post partum to adult. In spermatocytes, shows punctate localization along chromosome axes specifically in early meiotic prophase I cells. Foci start to appear from the leptotene stage, reach their greatest number in the zygotene stage, persist until the early pachytene stage, and finally disappear in the late pachytene stage (PubMed:30760716). {ECO:0000269|PubMed:23707421, ECO:0000269|PubMed:30760716}.","","","TISSUE SPECIFICITY: Expressed in testis and, to a lesser extent, in lung and muscle. {ECO:0000269|PubMed:23707421, ECO:0000269|PubMed:32345962, ECO:0000269|PubMed:32460033}."
"854","sp|Q8INB9|AKT1_DROME","lcl|NC_088858.1_cds_XP_034326204.2_30006",0,627,"Q8INB9","AKT1_DROME","RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Protein kinase B) (PKB)","Akt Akt1 CG4006","Drosophila melanogaster (Fruit fly)",611,"GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0005938; GO:0006468; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007623; GO:0008284; GO:0008286; GO:0010884; GO:0010897; GO:0030307; GO:0031104; GO:0032869; GO:0035206; GO:0035264; GO:0035331; GO:0035556; GO:0040014; GO:0040018; GO:0042632; GO:0043025; GO:0043066; GO:0043491; GO:0043524; GO:0044319; GO:0045793; GO:0045886; GO:0046622; GO:0048010; GO:0048477; GO:0048680; GO:0050773; GO:0055088; GO:0060292; GO:0090278; GO:0106310; GO:1903688; GO:1904263","apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; cholesterol homeostasis [GO:0042632]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid homeostasis [GO:0055088]; long-term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hippo signaling [GO:0035331]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; negative regulation of triglyceride catabolic process [GO:0010897]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of axon regeneration [GO:0048680]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of lipid storage [GO:0010884]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of TORC1 signaling [GO:1904263]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing, spreading of cells [GO:0044319]","cell cortex [GO:0005938]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; cholesterol homeostasis [GO:0042632]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid homeostasis [GO:0055088]; long-term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hippo signaling [GO:0035331]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; negative regulation of triglyceride catabolic process [GO:0010897]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of axon regeneration [GO:0048680]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of lipid storage [GO:0010884]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of TORC1 signaling [GO:1904263]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing, spreading of cells [GO:0044319]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. Strongly expressed in embryo and pupa. Weakly expressed in larva. Mildly expressed in adult. {ECO:0000269|PubMed:15712201, ECO:0000269|PubMed:7876156}.","","","TISSUE SPECIFICITY: Ubiquitously expressed. Present in ovary, where it is concentrated at the basal side of follicle cells. {ECO:0000269|PubMed:7876156}."
"855","sp|Q0GGX2|ZN541_MOUSE","lcl|NC_088858.1_cds_XP_034326291.2_30967",6.32e-26,118,"Q0GGX2","ZN541_MOUSE","Zinc finger protein 541 (Spermatogenic cell HDAC-interacting protein 1)","Znf541 Ship1 Zfp541","Mus musculus (Mouse)",1363,"GO:0000118; GO:0005634; GO:0006355; GO:0007140; GO:0007283; GO:0008270; GO:0030154; GO:0045892; GO:0045893","cell differentiation [GO:0030154]; male meiotic nuclear division [GO:0007140]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; spermatogenesis [GO:0007283]","histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; male meiotic nuclear division [GO:0007140]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Germ-cell-specific. Specifically present in testicular spermatogenic cells, but not in testicular and mature sperm. During spermatogenesis, it is present in spermatocytes and round spermatids only (at protein level). {ECO:0000269|PubMed:17662146, ECO:0000269|PubMed:18849567, ECO:0000269|PubMed:34075040, ECO:0000269|PubMed:35320728, ECO:0000269|PubMed:35341968}."
"856","sp|Q9H0D2|ZN541_HUMAN","lcl|NC_088858.1_cds_XP_034326292.2_30971",1.08e-27,124,"Q9H0D2","ZN541_HUMAN","Zinc finger protein 541","ZNF541","Homo sapiens (Human)",1346,"GO:0000118; GO:0003714; GO:0005634; GO:0005667; GO:0006355; GO:0006357; GO:0007140; GO:0007283; GO:0008270; GO:0030154; GO:0045892; GO:0045893","cell differentiation [GO:0030154]; male meiotic nuclear division [GO:0007140]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; male meiotic nuclear division [GO:0007140]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","","","",""
"857","sp|P92029|DNJ60_DROME","lcl|NC_088858.1_cds_XP_065942523.1_33470",7.04e-11,61.6,"P92029","DNJ60_DROME","DnaJ-like protein 60","DnaJ-60 DmJ60 DnaJ60 CG12240","Drosophila melanogaster (Fruit fly)",217,"GO:0007283; GO:0009408; GO:0016020; GO:0030154; GO:0042026; GO:0051082","cell differentiation [GO:0030154]; protein refolding [GO:0042026]; response to heat [GO:0009408]; spermatogenesis [GO:0007283]","membrane [GO:0016020]; unfolded protein binding [GO:0051082]; cell differentiation [GO:0030154]; protein refolding [GO:0042026]; response to heat [GO:0009408]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Weakly expressed in embryos, larvae and adult females. Strong expression in adult males.","","","TISSUE SPECIFICITY: Highly expressed in testis and ejaculatory bulb."
"858","sp|O15259|NPHP1_HUMAN","lcl|NC_088858.1_cds_XP_065942525.1_33473",7.58e-111,356,"O15259","NPHP1_HUMAN","Nephrocystin-1 (Juvenile nephronophthisis 1 protein)","NPHP1 NPH1","Homo sapiens (Human)",732,"GO:0005198; GO:0005737; GO:0005829; GO:0005856; GO:0005911; GO:0005912; GO:0005923; GO:0005929; GO:0007165; GO:0007632; GO:0016020; GO:0030030; GO:0030036; GO:0031514; GO:0032391; GO:0048515; GO:0060041; GO:0090251; GO:0098609; GO:1903348","actin cytoskeleton organization [GO:0030036]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; positive regulation of bicellular tight junction assembly [GO:1903348]; protein localization involved in establishment of planar polarity [GO:0090251]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; spermatid differentiation [GO:0048515]; visual behavior [GO:0007632]","adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]; structural molecule activity [GO:0005198]; actin cytoskeleton organization [GO:0030036]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; positive regulation of bicellular tight junction assembly [GO:1903348]; protein localization involved in establishment of planar polarity [GO:0090251]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; spermatid differentiation [GO:0048515]; visual behavior [GO:0007632]","DEVELOPMENTAL STAGE: During in vitro ciliogenesis translocalizes from the cytoplasm to the ciliary transition zone during epithelial cell polarization. {ECO:0000269|PubMed:16885411}.","","","TISSUE SPECIFICITY: Widespread expression, with highest levels in pituitary gland, spinal cord, thyroid gland, testis, skeletal muscle, lymph node and trachea. Weakly expressed in heart, kidney and pancreas. Expressed in nasal epithelial cells (at protein level) (PubMed:16308564). Expressed in the renal collecting duct (at protein level) (PubMed:18477472). {ECO:0000269|PubMed:16308564, ECO:0000269|PubMed:18477472}."
"859","sp|Q9QY53|NPHP1_MOUSE","lcl|NC_088858.1_cds_XP_065942530.1_33476",6.18e-120,378,"Q9QY53","NPHP1_MOUSE","Nephrocystin-1","Nphp1 Nph1","Mus musculus (Mouse)",687,"GO:0005737; GO:0005856; GO:0005911; GO:0005912; GO:0005923; GO:0005929; GO:0008104; GO:0030030; GO:0031514; GO:0032391; GO:0035845; GO:0035869; GO:0048515; GO:0060041; GO:0097546; GO:0120206","cell projection organization [GO:0030030]; photoreceptor cell outer segment organization [GO:0035845]; protein localization [GO:0008104]; retina development in camera-type eye [GO:0060041]; spermatid differentiation [GO:0048515]","adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]; photoreceptor distal connecting cilium [GO:0120206]; cell projection organization [GO:0030030]; photoreceptor cell outer segment organization [GO:0035845]; protein localization [GO:0008104]; retina development in camera-type eye [GO:0060041]; spermatid differentiation [GO:0048515]","DEVELOPMENTAL STAGE: Widespread and uniform expression in whole embryo at all development stages (PubMed:10665934). Expressed in cell stages of the first meiotic division and thereafter (PubMed:10665934). Initially expressed at day 14 with consistent expression thereafter to day 365 (PubMed:18684731). {ECO:0000269|PubMed:10665934, ECO:0000269|PubMed:18684731}.","","","TISSUE SPECIFICITY: Expressed in the retina (at protein level) (PubMed:16885411, PubMed:19208653, PubMed:29899041). Expressed in the testis (at protein level) (PubMed:10665934). Widespread expression, with weak expression in skeletal muscle, kidney, thyroid, ovary, lung, prostate, thymus, uterus, heart, and liver (PubMed:10665934). Lowest levels in brain and spleen (PubMed:10665934). {ECO:0000269|PubMed:10665934, ECO:0000269|PubMed:16885411, ECO:0000269|PubMed:19208653, ECO:0000269|PubMed:29899041}."
"860","sp|Q8CHB8|TTLL5_MOUSE","lcl|NC_088858.1_cds_XP_065942622.1_33360",0,643,"Q8CHB8","TTLL5_MOUSE","Tubulin polyglutamylase TTLL5 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 5)","Ttll5 Kiaa0998","Mus musculus (Mouse)",1328,"GO:0005524; GO:0005634; GO:0005737; GO:0005874; GO:0005929; GO:0007283; GO:0007288; GO:0009566; GO:0030317; GO:0036064; GO:0036211; GO:0046872; GO:0060041; GO:0070740; GO:0097731; GO:0106437; GO:0106438","fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; protein modification process [GO:0036211]; retina development in camera-type eye [GO:0060041]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]","9+0 non-motile cilium [GO:0097731]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin-glutamic acid ligase activity [GO:0070740]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; protein modification process [GO:0036211]; retina development in camera-type eye [GO:0060041]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Highly expressed in brain, kidney, liver, spleen and testis (PubMed:17499049). Expressed in heart, lung, muscle and trachea (PubMed:17499049). {ECO:0000269|PubMed:17499049}."
"861","sp|P13383|NUCL_RAT","lcl|NC_088858.1_cds_XP_065942720.1_28958",1.24e-20,96.7,"P13383","NUCL_RAT","Nucleolin (Protein C23)","Ncl Nuc","Rattus norvegicus (Rat)",713,"GO:0001525; GO:0001533; GO:0001650; GO:0001651; GO:0003697; GO:0003723; GO:0005102; GO:0005509; GO:0005634; GO:0005654; GO:0005681; GO:0005730; GO:0005938; GO:0006897; GO:0007283; GO:0009986; GO:0017148; GO:0032755; GO:0032760; GO:0035368; GO:0042134; GO:0042162; GO:0042393; GO:0042731; GO:0042802; GO:0043066; GO:0043236; GO:0043560; GO:0043565; GO:0044547; GO:0045944; GO:0046627; GO:0048026; GO:0048027; GO:0071222; GO:0071364; GO:0097421; GO:1901838; GO:1990631; GO:1990830; GO:1990904; GO:2000232","angiogenesis [GO:0001525]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to lipopolysaccharide [GO:0071222]; endocytosis [GO:0006897]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of translation [GO:0017148]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of rRNA processing [GO:2000232]; spermatogenesis [GO:0007283]","cell cortex [GO:0005938]; cell surface [GO:0009986]; cornified envelope [GO:0001533]; dense fibrillar component [GO:0001651]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; calcium ion binding [GO:0005509]; DNA topoisomerase binding [GO:0044547]; ErbB-4 class receptor binding [GO:1990631]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; laminin binding [GO:0043236]; mRNA 5'-UTR binding [GO:0048027]; PH domain binding [GO:0042731]; RNA binding [GO:0003723]; rRNA primary transcript binding [GO:0042134]; selenocysteine insertion sequence binding [GO:0035368]; sequence-specific DNA binding [GO:0043565]; signaling receptor binding [GO:0005102]; single-stranded DNA binding [GO:0003697]; telomeric DNA binding [GO:0042162]; angiogenesis [GO:0001525]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to lipopolysaccharide [GO:0071222]; endocytosis [GO:0006897]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of translation [GO:0017148]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of rRNA processing [GO:2000232]; spermatogenesis [GO:0007283]","","","",""
"862","sp|Q9NVE4|CCD87_HUMAN","lcl|NC_088858.1_cds_XP_065942811.1_32453",2.43e-26,117,"Q9NVE4","CCD87_HUMAN","Coiled-coil domain-containing protein 87","CCDC87","Homo sapiens (Human)",849,"GO:0007283; GO:0007338; GO:0030154; GO:1905516; GO:2000344","cell differentiation [GO:0030154]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]","cell differentiation [GO:0030154]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]","","","",""
"863","sp|Q5U3S1|KATL1_DANRE","lcl|NC_088858.1_cds_XP_065942933.1_29700",1.09e-94,297,"Q5U3S1","KATL1_DANRE","Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 5.6.1.1) (p60 katanin-like 1)","katnal1 zgc:101696","Danio rerio (Zebrafish) (Brachydanio rerio)",488,"GO:0000922; GO:0005524; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007283; GO:0008017; GO:0008568; GO:0009653; GO:0015630; GO:0016887; GO:0051013","anatomical structure morphogenesis [GO:0009653]; microtubule severing [GO:0051013]; spermatogenesis [GO:0007283]","centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule severing ATPase activity [GO:0008568]; anatomical structure morphogenesis [GO:0009653]; microtubule severing [GO:0051013]; spermatogenesis [GO:0007283]","","","",""
"864","sp|Q5XIK7|KATL1_RAT","lcl|NC_088858.1_cds_XP_065942934.1_29701",7.81e-91,286,"Q5XIK7","KATL1_RAT","Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 5.6.1.1) (p60 katanin-like 1)","Katnal1","Rattus norvegicus (Rat)",488,"GO:0000922; GO:0005524; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007283; GO:0008017; GO:0008352; GO:0008568; GO:0015630; GO:0016887; GO:0042802; GO:0051013","microtubule severing [GO:0051013]; spermatogenesis [GO:0007283]","centrosome [GO:0005813]; cytoplasm [GO:0005737]; katanin complex [GO:0008352]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule severing ATPase activity [GO:0008568]; microtubule severing [GO:0051013]; spermatogenesis [GO:0007283]","","","",""
"865","sp|B4USW8|KATL1_OTOGA","lcl|NC_088858.1_cds_XP_065942935.1_29702",4.04e-90,285,"B4USW8","KATL1_OTOGA","Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 5.6.1.1) (p60 katanin-like 1)","KATNAL1","Otolemur garnettii (Small-eared galago) (Garnett's greater bushbaby)",490,"GO:0000922; GO:0005524; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007283; GO:0008017; GO:0008568; GO:0016887; GO:0051013","microtubule severing [GO:0051013]; spermatogenesis [GO:0007283]","centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule severing ATPase activity [GO:0008568]; microtubule severing [GO:0051013]; spermatogenesis [GO:0007283]","","","",""
"866","sp|Q91ZZ5|RXFP2_MOUSE","lcl|NC_088858.1_cds_XP_065942968.1_33890",4.1e-77,270,"Q91ZZ5","RXFP2_MOUSE","Relaxin receptor 2 (G-protein coupled receptor 106) (G-protein coupled receptor affecting testicular descent) (Leucine-rich repeat-containing G-protein coupled receptor 8) (Relaxin family peptide receptor 2)","Rxfp2 Gpr106 Great Lgr8","Mus musculus (Mouse)",737,"GO:0001556; GO:0004930; GO:0005886; GO:0007189; GO:0007193; GO:0008285; GO:0008584; GO:0016500; GO:0017046; GO:0043066","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; male gonad development [GO:0008584]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; oocyte maturation [GO:0001556]","plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; peptide hormone binding [GO:0017046]; protein-hormone receptor activity [GO:0016500]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; male gonad development [GO:0008584]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; oocyte maturation [GO:0001556]","","","","TISSUE SPECIFICITY: Expressed in embryonic and adult gonads of males and females, as well in male gubernarculum. Expressed also in brain. Not detected in kidney, spleen and heart."
"867","sp|Q01954|BNC1_HUMAN","lcl|NC_088858.1_cds_XP_065942980.1_29460",3.54e-60,223,"Q01954","BNC1_HUMAN","Zinc finger protein basonuclin-1","BNC1 BNC","Homo sapiens (Human)",994,"GO:0000182; GO:0001216; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006356; GO:0007283; GO:0008270; GO:0008284; GO:0008544; GO:0030154; GO:0045943; GO:1900195","cell differentiation [GO:0030154]; epidermis development [GO:0008544]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of transcription by RNA polymerase I [GO:0006356]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity [GO:0001216]; rDNA binding [GO:0000182]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; epidermis development [GO:0008544]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of transcription by RNA polymerase I [GO:0006356]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: In epidermis, primarily detected in cells of the basal or immediately suprabasal layers (at protein level) (PubMed:16891417). In hair follicles, mainly expressed in the outer root sheath (at protein level) (PubMed:8034748). Expressed in epidermis, testis and foreskin, and to a lower extent in thymus, spleen, mammary glands, placenta, brain and heart (PubMed:9687312). Expressed in the ovary, notably in oocytes (PubMed:30010909). {ECO:0000269|PubMed:16891417, ECO:0000269|PubMed:30010909, ECO:0000269|PubMed:8034748, ECO:0000269|PubMed:9687312}."
"868","sp|P15207|ANDR_RAT","lcl|NC_088858.1_cds_XP_065942990.1_30879",1.67e-44,174,"P15207","ANDR_RAT","Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4)","Ar Nr3c4","Rattus norvegicus (Rat)",902,"GO:0000122; GO:0000165; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001091; GO:0001223; GO:0001228; GO:0001701; GO:0003073; GO:0003382; GO:0003677; GO:0003682; GO:0003700; GO:0004879; GO:0005102; GO:0005496; GO:0005497; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006355; GO:0006357; GO:0006366; GO:0007283; GO:0007338; GO:0007620; GO:0008013; GO:0008049; GO:0008270; GO:0008284; GO:0008285; GO:0008584; GO:0009566; GO:0010467; GO:0010468; GO:0010628; GO:0014734; GO:0014850; GO:0016363; GO:0016607; GO:0019098; GO:0019102; GO:0019899; GO:0019904; GO:0030424; GO:0030425; GO:0030518; GO:0030520; GO:0030521; GO:0030522; GO:0032355; GO:0032553; GO:0032868; GO:0032991; GO:0033148; GO:0033327; GO:0033574; GO:0034056; GO:0035094; GO:0035264; GO:0040011; GO:0040017; GO:0042327; GO:0042756; GO:0043410; GO:0043565; GO:0043568; GO:0045471; GO:0045597; GO:0045720; GO:0045726; GO:0045892; GO:0045893; GO:0045944; GO:0045945; GO:0046661; GO:0048009; GO:0048545; GO:0048608; GO:0048638; GO:0048645; GO:0048808; GO:0050673; GO:0050680; GO:0050681; GO:0051117; GO:0060090; GO:0060406; GO:0060514; GO:0060571; GO:0060599; GO:0060685; GO:0060736; GO:0060740; GO:0060742; GO:0060748; GO:0060749; GO:0060769; GO:0061458; GO:0061629; GO:0070974; GO:0071372; GO:0071383; GO:0071391; GO:0071394; GO:0072520; GO:0090648; GO:0097421; GO:0110090; GO:0140693; GO:0140694; GO:1902895; GO:1903076; GO:2001237","androgen receptor signaling pathway [GO:0030521]; animal organ formation [GO:0048645]; cellular response to estrogen stimulus [GO:0071391]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to testosterone stimulus [GO:0071394]; copulation [GO:0007620]; drinking behavior [GO:0042756]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial cell morphogenesis [GO:0003382]; epithelial cell proliferation [GO:0050673]; estrogen receptor signaling pathway [GO:0030520]; fertilization [GO:0009566]; gene expression [GO:0010467]; in utero embryonic development [GO:0001701]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular receptor signaling pathway [GO:0030522]; lateral sprouting involved in mammary gland duct morphogenesis [GO:0060599]; Leydig cell differentiation [GO:0033327]; liver regeneration [GO:0097421]; locomotion [GO:0040011]; male courtship behavior [GO:0008049]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; male sex differentiation [GO:0046661]; male somatic sex determination [GO:0019102]; mammary gland alveolus development [GO:0060749]; MAPK cascade [GO:0000165]; membraneless organelle assembly [GO:0140694]; morphogenesis of an epithelial fold [GO:0060571]; multicellular organism growth [GO:0035264]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of integrin biosynthetic process [GO:0045720]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear receptor-mediated steroid hormone signaling pathway [GO:0030518]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of gene expression [GO:0010628]; positive regulation of hippocampal neuron apoptotic process [GO:0110090]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of integrin biosynthetic process [GO:0045726]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of locomotion [GO:0040017]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of penile erection [GO:0060406]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; prostate gland epithelium morphogenesis [GO:0060740]; prostate gland growth [GO:0060736]; prostate induction [GO:0060514]; regulation of developmental growth [GO:0048638]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of prostatic bud formation [GO:0060685]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of systemic arterial blood pressure [GO:0003073]; regulation of transcription by RNA polymerase II [GO:0006357]; reproductive behavior [GO:0019098]; reproductive structure development [GO:0048608]; reproductive system development [GO:0061458]; response to environmental enrichment [GO:0090648]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to muscle activity [GO:0014850]; response to nicotine [GO:0035094]; response to steroid hormone [GO:0048545]; response to testosterone [GO:0033574]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; skeletal muscle hypertrophy [GO:0014734]; spermatogenesis [GO:0007283]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748]; transcription by RNA polymerase II [GO:0006366]","axon [GO:0030424]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; androgen binding [GO:0005497]; ATPase binding [GO:0051117]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; enzyme binding [GO:0019899]; estrogen response element binding [GO:0034056]; molecular adaptor activity [GO:0060090]; molecular condensate scaffold activity [GO:0140693]; nuclear androgen receptor binding [GO:0050681]; nuclear receptor activity [GO:0004879]; POU domain binding [GO:0070974]; protein domain specific binding [GO:0019904]; ribonucleotide binding [GO:0032553]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; signaling receptor binding [GO:0005102]; steroid binding [GO:0005496]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]; androgen receptor signaling pathway [GO:0030521]; animal organ formation [GO:0048645]; cellular response to estrogen stimulus [GO:0071391]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to testosterone stimulus [GO:0071394]; copulation [GO:0007620]; drinking behavior [GO:0042756]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial cell morphogenesis [GO:0003382]; epithelial cell proliferation [GO:0050673]; estrogen receptor signaling pathway [GO:0030520]; fertilization [GO:0009566]; gene expression [GO:0010467]; in utero embryonic development [GO:0001701]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular receptor signaling pathway [GO:0030522]; lateral sprouting involved in mammary gland duct morphogenesis [GO:0060599]; Leydig cell differentiation [GO:0033327]; liver regeneration [GO:0097421]; locomotion [GO:0040011]; male courtship behavior [GO:0008049]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; male sex differentiation [GO:0046661]; male somatic sex determination [GO:0019102]; mammary gland alveolus development [GO:0060749]; MAPK cascade [GO:0000165]; membraneless organelle assembly [GO:0140694]; morphogenesis of an epithelial fold [GO:0060571]; multicellular organism growth [GO:0035264]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of integrin biosynthetic process [GO:0045720]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear receptor-mediated steroid hormone signaling pathway [GO:0030518]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of gene expression [GO:0010628]; positive regulation of hippocampal neuron apoptotic process [GO:0110090]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of integrin biosynthetic process [GO:0045726]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of locomotion [GO:0040017]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of penile erection [GO:0060406]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; prostate gland epithelium morphogenesis [GO:0060740]; prostate gland growth [GO:0060736]; prostate induction [GO:0060514]; regulation of developmental growth [GO:0048638]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of prostatic bud formation [GO:0060685]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of systemic arterial blood pressure [GO:0003073]; regulation of transcription by RNA polymerase II [GO:0006357]; reproductive behavior [GO:0019098]; reproductive structure development [GO:0048608]; reproductive system development [GO:0061458]; response to environmental enrichment [GO:0090648]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to muscle activity [GO:0014850]; response to nicotine [GO:0035094]; response to steroid hormone [GO:0048545]; response to testosterone [GO:0033574]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; skeletal muscle hypertrophy [GO:0014734]; spermatogenesis [GO:0007283]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748]; transcription by RNA polymerase II [GO:0006366]","","","","TISSUE SPECIFICITY: Highest levels in the seminal vesicle, ventral prostate and coagulating gland with lower levels in the kidney and levator ani muscle."
"869","sp|Q5MJ70|SPDYA_HUMAN","lcl|NC_088858.1_cds_XP_065943006.1_28976",7.46e-67,213,"Q5MJ70","SPDYA_HUMAN","Speedy protein A (Rapid inducer of G2/M progression in oocytes A) (RINGO A) (hSpy/Ringo A) (Speedy-1) (Spy1)","SPDYA SPDY1 SPY1","Homo sapiens (Human)",313,"GO:0000082; GO:0000781; GO:0001741; GO:0005634; GO:0005635; GO:0005654; GO:0006974; GO:0007140; GO:0007283; GO:0008284; GO:0016233; GO:0019901; GO:0030295; GO:0045860; GO:0048477; GO:0070197; GO:0070200","DNA damage response [GO:0006974]; establishment of protein localization to telomere [GO:0070200]; G1/S transition of mitotic cell cycle [GO:0000082]; male meiotic nuclear division [GO:0007140]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; oogenesis [GO:0048477]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein kinase activity [GO:0045860]; spermatogenesis [GO:0007283]; telomere capping [GO:0016233]","chromosome, telomeric region [GO:0000781]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; XY body [GO:0001741]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; DNA damage response [GO:0006974]; establishment of protein localization to telomere [GO:0070200]; G1/S transition of mitotic cell cycle [GO:0000082]; male meiotic nuclear division [GO:0007140]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; oogenesis [GO:0048477]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein kinase activity [GO:0045860]; spermatogenesis [GO:0007283]; telomere capping [GO:0016233]","","","","TISSUE SPECIFICITY: Highly expressed in testis. Expressed at a low level in wide range of tissues including bone marrow, brain, heart, kidney, colon, liver, placenta, spleen, skeletal muscle, salivary gland, thyroid gland, thymus, trachea and uterus. Expressed at a slightly higher level in adrenal gland, cerebellum, small intestine, lung, prostate and trachea. Expression is cell cycle-dependent, being restricted to cells in G1/S phase. {ECO:0000269|PubMed:11980914, ECO:0000269|PubMed:15611625}."
"870","sp|Q8VCC1|PGDH_MOUSE","lcl|NC_088858.1_cds_XP_065943077.1_33831",3.37e-69,215,"Q8VCC1","PGDH_MOUSE","15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Eicosanoid/docosanoid dehydrogenase [NAD(+)]) (EC 1.1.1.-, EC 1.1.1.232) (Prostaglandin dehydrogenase 1)","Hpgd Pgdh1","Mus musculus (Mouse)",269,"GO:0001822; GO:0004957; GO:0005615; GO:0005654; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0030728; GO:0032355; GO:0032496; GO:0042802; GO:0043065; GO:0045471; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1904707; GO:1905828","ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; regulation of prostaglandin catabolic process [GO:1905828]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]","basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; regulation of prostaglandin catabolic process [GO:1905828]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]","","","","TISSUE SPECIFICITY: Expressed in proximal convoluted tubules of the kidney, where it colocalizes with the prostaglandin transporter SLC22A22 (at protein level) (PubMed:20448048). Expressed in lung, intestine, stomach and liver (PubMed:8950170). {ECO:0000269|PubMed:20448048, ECO:0000269|PubMed:8950170}."
"871","sp|Q8NHR7|TERB2_HUMAN","lcl|NC_088858.1_cds_XP_065943124.1_31201",1.23e-13,68.6,"Q8NHR7","TERB2_HUMAN","Telomere repeats-binding bouquet formation protein 2","TERB2 C15orf43","Homo sapiens (Human)",220,"GO:0000781; GO:0005637; GO:0007129; GO:0007130; GO:0007283; GO:0045141; GO:0048477; GO:0070197; GO:1990918","double-strand break repair involved in meiotic recombination [GO:1990918]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; meiotic telomere clustering [GO:0045141]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]","chromosome, telomeric region [GO:0000781]; nuclear inner membrane [GO:0005637]; double-strand break repair involved in meiotic recombination [GO:1990918]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; meiotic telomere clustering [GO:0045141]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]","","","",""
"872","sp|D3YVL2|CFA70_MOUSE","lcl|NC_088858.1_cds_XP_065943135.1_32218",0,853,"D3YVL2","CFA70_MOUSE","Cilia- and flagella-associated protein 70 (Tetratricopeptide repeat protein 18) (TPR repeat protein 18)","Cfap70 Ttc18","Mus musculus (Mouse)",1141,"GO:0000902; GO:0002177; GO:0003341; GO:0005737; GO:0005930; GO:0007338; GO:0008104; GO:0010467; GO:0030317; GO:0031514; GO:0036126; GO:0036157; GO:0044782; GO:0048872; GO:0060271; GO:0065003; GO:0098727; GO:0120316; GO:1905198","cell morphogenesis [GO:0000902]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium organization [GO:0044782]; flagellated sperm motility [GO:0030317]; gene expression [GO:0010467]; homeostasis of number of cells [GO:0048872]; maintenance of cell number [GO:0098727]; manchette assembly [GO:1905198]; protein localization [GO:0008104]; protein-containing complex assembly [GO:0065003]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316]","axoneme [GO:0005930]; cytoplasm [GO:0005737]; manchette [GO:0002177]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; cell morphogenesis [GO:0000902]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium organization [GO:0044782]; flagellated sperm motility [GO:0030317]; gene expression [GO:0010467]; homeostasis of number of cells [GO:0048872]; maintenance of cell number [GO:0098727]; manchette assembly [GO:1905198]; protein localization [GO:0008104]; protein-containing complex assembly [GO:0065003]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316]","","","","TISSUE SPECIFICITY: Detected in ependyma, trachea, lung, testis, and oviduct, but not in whole brain, liver, kidney, and spleen (PubMed:30158508). Localizes on the epithelial cilia and sperm flagella (at protein level) (PubMed:30158508). {ECO:0000269|PubMed:30158508}."
"873","sp|Q9QYE5|JAG2_MOUSE","lcl|NC_088858.1_cds_XP_065943156.1_29665",0,1067,"Q9QYE5","JAG2_MOUSE","Protein jagged-2 (Jagged2)","Jag2","Mus musculus (Mouse)",1247,"GO:0001501; GO:0001701; GO:0001709; GO:0003016; GO:0005112; GO:0005509; GO:0005886; GO:0007219; GO:0007283; GO:0007605; GO:0008083; GO:0009912; GO:0016020; GO:0016331; GO:0030155; GO:0042127; GO:0042475; GO:0042492; GO:0045061; GO:0045747; GO:1990134","auditory receptor cell fate commitment [GO:0009912]; cell fate determination [GO:0001709]; epithelial cell apoptotic process involved in palatal shelf morphogenesis [GO:1990134]; gamma-delta T cell differentiation [GO:0042492]; in utero embryonic development [GO:0001701]; morphogenesis of embryonic epithelium [GO:0016331]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; respiratory system process [GO:0003016]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; spermatogenesis [GO:0007283]; thymic T cell selection [GO:0045061]","membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; Notch binding [GO:0005112]; auditory receptor cell fate commitment [GO:0009912]; cell fate determination [GO:0001709]; epithelial cell apoptotic process involved in palatal shelf morphogenesis [GO:1990134]; gamma-delta T cell differentiation [GO:0042492]; in utero embryonic development [GO:0001701]; morphogenesis of embryonic epithelium [GO:0016331]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; respiratory system process [GO:0003016]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; spermatogenesis [GO:0007283]; thymic T cell selection [GO:0045061]","DEVELOPMENTAL STAGE: At 13 dpc, found in paravertebral vessels and dorsal root ganglia. At 14 dpc, in oropharyngeal epithelium, developing thymus and in the muscles of the tongue. By 15 dpc, in many tissues.","","","TISSUE SPECIFICITY: Found to be highest in fetal thymus, epidermis, foregut dorsal root ganglia and inner ear. In 2-weeK-old mice, abundant in heart, lung, thymus, skeletal muscle, brain and testis. Expression overlaps partially with Notch1 expression. {ECO:0000269|PubMed:9315665}."
"874","sp|O73798|IGF1R_XENLA","lcl|NC_088858.1_cds_XP_065943216.1_32842",0,959,"O73798","IGF1R_XENLA","Insulin-like growth factor 1 receptor (xIGF-1R) (xIGFR) (EC 2.7.10.1) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain]","igf1r","Xenopus laevis (African clawed frog)",1358,"GO:0001556; GO:0004713; GO:0005009; GO:0005010; GO:0005198; GO:0005520; GO:0005524; GO:0005886; GO:0005899; GO:0008286; GO:0030424; GO:0043410; GO:0043548; GO:0043560; GO:0046328; GO:0046777; GO:0046872; GO:0048009; GO:0051897; GO:0071333","cellular response to glucose stimulus [GO:0071333]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; oocyte maturation [GO:0001556]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein autophosphorylation [GO:0046777]; regulation of JNK cascade [GO:0046328]","axon [GO:0030424]; insulin receptor complex [GO:0005899]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; insulin receptor activity [GO:0005009]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor receptor activity [GO:0005010]; metal ion binding [GO:0046872]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein tyrosine kinase activity [GO:0004713]; structural molecule activity [GO:0005198]; cellular response to glucose stimulus [GO:0071333]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; oocyte maturation [GO:0001556]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein autophosphorylation [GO:0046777]; regulation of JNK cascade [GO:0046328]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. Shows biphasic expression during early development. Expressed ubiquitously in fertilized eggs and throughout the mid-blastula transition. Expression then decreases at mid-gastrulation. Shortly after gastrulation, expression is seen throughout the dorsal side of the embryo with expression strongest in the anterior and absent ventrally. Expression increases along the dorsal midline at early neurulation and is seen in the head region as neurulation progresses, particularly in the area of the cement gland primordium. Also present in the anterior mesoderm but is absent from the neural tube and the most ventral part of the embryo. Remains expressed throughout early embryogenesis. By the tailbud stages, expression is anterior, in the head and the most rostral part of the neural tube. {ECO:0000269|PubMed:11709186, ECO:0000269|PubMed:11944947, ECO:0000269|PubMed:9492024}.","","",""
"875","sp|P26928|HGFL_MOUSE","lcl|NC_088858.1_cds_XP_065943313.1_30016",5.85e-63,216,"P26928","HGFL_MOUSE","Hepatocyte growth factor-like protein (Macrophage stimulatory protein) (MSP) [Cleaved into: Hepatocyte growth factor-like protein alpha chain; Hepatocyte growth factor-like protein beta chain]","Mst1 Hgfl","Mus musculus (Mouse)",716,"GO:0004252; GO:0005615; GO:0005773; GO:0006508; GO:0007566; GO:0010628; GO:0010758; GO:0030879; GO:0030971; GO:0033601; GO:0045721; GO:0046425; GO:0060763; GO:1904036; GO:2000479","embryo implantation [GO:0007566]; mammary duct terminal end bud growth [GO:0060763]; mammary gland development [GO:0030879]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of gluconeogenesis [GO:0045721]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; proteolysis [GO:0006508]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of macrophage chemotaxis [GO:0010758]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]","extracellular space [GO:0005615]; vacuole [GO:0005773]; receptor tyrosine kinase binding [GO:0030971]; serine-type endopeptidase activity [GO:0004252]; embryo implantation [GO:0007566]; mammary duct terminal end bud growth [GO:0060763]; mammary gland development [GO:0030879]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of gluconeogenesis [GO:0045721]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; proteolysis [GO:0006508]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of macrophage chemotaxis [GO:0010758]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]","DEVELOPMENTAL STAGE: Is expressed at low levels during gestation. Just before birth the level increases dramatically and remains stable afterwards.","","","TISSUE SPECIFICITY: Liver. Lower levels in lung, placenta and adrenal."
"876","sp|P46822|KLC_CAEEL","lcl|NC_088858.1_cds_XP_065943410.1_32150",0,592,"P46822","KLC_CAEEL","Kinesin light chain (KLC)","klc-2 C18C4.10","Caenorhabditis elegans",540,"GO:0002119; GO:0005635; GO:0005737; GO:0005874; GO:0007018; GO:0007155; GO:0008104; GO:0016938; GO:0019894; GO:0030473; GO:0040011; GO:0040038; GO:0048489; GO:0048675; GO:0051295","axon extension [GO:0048675]; cell adhesion [GO:0007155]; establishment of meiotic spindle localization [GO:0051295]; locomotion [GO:0040011]; microtubule-based movement [GO:0007018]; nematode larval development [GO:0002119]; nuclear migration along microtubule [GO:0030473]; polar body extrusion after meiotic divisions [GO:0040038]; protein localization [GO:0008104]; synaptic vesicle transport [GO:0048489]","cytoplasm [GO:0005737]; kinesin I complex [GO:0016938]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; kinesin binding [GO:0019894]; axon extension [GO:0048675]; cell adhesion [GO:0007155]; establishment of meiotic spindle localization [GO:0051295]; locomotion [GO:0040011]; microtubule-based movement [GO:0007018]; nematode larval development [GO:0002119]; nuclear migration along microtubule [GO:0030473]; polar body extrusion after meiotic divisions [GO:0040038]; protein localization [GO:0008104]; synaptic vesicle transport [GO:0048489]","","","",""
"877","sp|Q68G30|KLC3_RAT","lcl|NC_088858.1_cds_XP_065943417.1_32151",2.15e-126,381,"Q68G30","KLC3_RAT","Kinesin light chain 3 (Kinesin light chain KLCt)","Klc3","Rattus norvegicus (Rat)",505,"GO:0003777; GO:0005737; GO:0005739; GO:0005871; GO:0005874; GO:0007018; GO:0007283; GO:0007286; GO:0008017; GO:0008088; GO:0019894; GO:0031514; GO:0035253; GO:0043005; GO:0120317","axo-dendritic transport [GO:0008088]; microtubule-based movement [GO:0007018]; sperm mitochondrial sheath assembly [GO:0120317]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; axo-dendritic transport [GO:0008088]; microtubule-based movement [GO:0007018]; sperm mitochondrial sheath assembly [GO:0120317]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in postmeiotic male germ cells (at protein level). {ECO:0000269|PubMed:11319135}."
"878","sp|Q5R8E2|KLC3_PONAB","lcl|NC_088858.1_cds_XP_065943418.1_32155",1.18e-122,371,"Q5R8E2","KLC3_PONAB","Kinesin light chain 3","KLC3","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)",504,"GO:0005739; GO:0005871; GO:0005874; GO:0007283; GO:0007286; GO:0019894; GO:0120317","sperm mitochondrial sheath assembly [GO:0120317]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; kinesin binding [GO:0019894]; sperm mitochondrial sheath assembly [GO:0120317]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","","","",""
"879","sp|Q9VXG8|ATR_DROME","lcl|NC_088858.1_cds_XP_065943497.1_28408",0,760,"Q9VXG8","ATR_DROME","Serine/threonine-protein kinase ATR (EC 2.7.11.1) (Ataxia telangiectasia and Rad3-related protein homolog) (ATR homolog) (dATR) (Meiotic protein 41)","mei-41 CG4252","Drosophila melanogaster (Fruit fly)",2517,"GO:0000076; GO:0000077; GO:0000706; GO:0000723; GO:0001700; GO:0003677; GO:0004674; GO:0005524; GO:0005634; GO:0005694; GO:0006281; GO:0006302; GO:0007088; GO:0007131; GO:0007348; GO:0007349; GO:0007444; GO:0009314; GO:0016321; GO:0030261; GO:0030716; GO:0033314; GO:0045002; GO:0045003; GO:0106310; GO:1901990","cellularization [GO:0007349]; chromosome condensation [GO:0030261]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; double-strand break repair [GO:0006302]; double-strand break repair via single-strand annealing [GO:0045002]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; embryonic development via the syncytial blastoderm [GO:0001700]; female meiosis chromosome segregation [GO:0016321]; imaginal disc development [GO:0007444]; meiotic DNA double-strand break processing [GO:0000706]; mitotic DNA replication checkpoint signaling [GO:0033314]; oocyte fate determination [GO:0030716]; reciprocal meiotic recombination [GO:0007131]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic nuclear division [GO:0007088]; regulation of syncytial blastoderm mitotic cell cycle [GO:0007348]; response to radiation [GO:0009314]; telomere maintenance [GO:0000723]","chromosome [GO:0005694]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cellularization [GO:0007349]; chromosome condensation [GO:0030261]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; double-strand break repair [GO:0006302]; double-strand break repair via single-strand annealing [GO:0045002]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; embryonic development via the syncytial blastoderm [GO:0001700]; female meiosis chromosome segregation [GO:0016321]; imaginal disc development [GO:0007444]; meiotic DNA double-strand break processing [GO:0000706]; mitotic DNA replication checkpoint signaling [GO:0033314]; oocyte fate determination [GO:0030716]; reciprocal meiotic recombination [GO:0007131]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic nuclear division [GO:0007088]; regulation of syncytial blastoderm mitotic cell cycle [GO:0007348]; response to radiation [GO:0009314]; telomere maintenance [GO:0000723]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. {ECO:0000269|PubMed:10209095}.","","",""
"880","sp|Q9VT65|CANB_DROME","lcl|NC_088858.1_cds_XP_065943521.1_33190",0,739,"Q9VT65","CANB_DROME","Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2]","CalpB CG8107","Drosophila melanogaster (Fruit fly)",925,"GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540","border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]","cytoplasm [GO:0005737]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]","DEVELOPMENTAL STAGE: Expressed in all developmental stages, with highest expression in the egg, probably of maternal origin. Very low expression in the early larva, rising through larval development up to the third larval stage. Constant expression in the pupa and adult. {ECO:0000269|PubMed:14614768}.","","","TISSUE SPECIFICITY: Strongly expressed in follicular and border cells of the oocyte. Ubiquitously expressed in early embryos. Localized to the trachea and their orifices, and to the larynx of late embryos. Restricted to the salivary gland in third instar larvae. {ECO:0000269|PubMed:14614768}."
"881","sp|O35923|BRCA2_RAT","lcl|NC_088858.1_cds_XP_065943593.1_31605",5.6e-115,413,"O35923","BRCA2_RAT","Breast cancer type 2 susceptibility protein homolog (Fanconi anemia group D1 protein homolog)","Brca2 Fancd1","Rattus norvegicus (Rat)",3343,"GO:0000152; GO:0000722; GO:0000724; GO:0000781; GO:0000800; GO:0001556; GO:0001833; GO:0002020; GO:0003697; GO:0005634; GO:0005694; GO:0005737; GO:0005813; GO:0006289; GO:0006302; GO:0006310; GO:0006355; GO:0006974; GO:0007141; GO:0007283; GO:0007420; GO:0007584; GO:0008283; GO:0008585; GO:0008630; GO:0010165; GO:0010225; GO:0010332; GO:0010484; GO:0010485; GO:0030097; GO:0030141; GO:0030879; GO:0031297; GO:0031619; GO:0032355; GO:0032465; GO:0032991; GO:0033593; GO:0033600; GO:0035264; GO:0042771; GO:0042802; GO:0043009; GO:0043015; GO:0045893; GO:0045931; GO:0051276; GO:0051298; GO:0070200; GO:0071425; GO:0071479; GO:0072089; GO:0090398; GO:1990391; GO:1990426","brain development [GO:0007420]; cell population proliferation [GO:0008283]; cellular response to ionizing radiation [GO:0071479]; cellular senescence [GO:0090398]; centrosome duplication [GO:0051298]; chordate embryonic development [GO:0043009]; chromosome organization [GO:0051276]; DNA damage response [GO:0006974]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of protein localization to telomere [GO:0070200]; female gonad development [GO:0008585]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; homologous chromosome orientation in meiotic metaphase I [GO:0031619]; inner cell mass cell proliferation [GO:0001833]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; male meiosis I [GO:0007141]; mammary gland development [GO:0030879]; mitotic recombination-dependent replication fork processing [GO:1990426]; multicellular organism growth [GO:0035264]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; nucleotide-excision repair [GO:0006289]; oocyte maturation [GO:0001556]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of cytokinesis [GO:0032465]; regulation of DNA-templated transcription [GO:0006355]; replication fork processing [GO:0031297]; response to estradiol [GO:0032355]; response to gamma radiation [GO:0010332]; response to nutrient [GO:0007584]; response to UV-C [GO:0010225]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; stem cell proliferation [GO:0072089]; telomere maintenance via recombination [GO:0000722]","BRCA2-MAGE-D1 complex [GO:0033593]; centrosome [GO:0005813]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; lateral element [GO:0000800]; nuclear ubiquitin ligase complex [GO:0000152]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; gamma-tubulin binding [GO:0043015]; histone H3 acetyltransferase activity [GO:0010484]; histone H4 acetyltransferase activity [GO:0010485]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; single-stranded DNA binding [GO:0003697]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; cellular response to ionizing radiation [GO:0071479]; cellular senescence [GO:0090398]; centrosome duplication [GO:0051298]; chordate embryonic development [GO:0043009]; chromosome organization [GO:0051276]; DNA damage response [GO:0006974]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of protein localization to telomere [GO:0070200]; female gonad development [GO:0008585]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; homologous chromosome orientation in meiotic metaphase I [GO:0031619]; inner cell mass cell proliferation [GO:0001833]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; male meiosis I [GO:0007141]; mammary gland development [GO:0030879]; mitotic recombination-dependent replication fork processing [GO:1990426]; multicellular organism growth [GO:0035264]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; nucleotide-excision repair [GO:0006289]; oocyte maturation [GO:0001556]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of cytokinesis [GO:0032465]; regulation of DNA-templated transcription [GO:0006355]; replication fork processing [GO:0031297]; response to estradiol [GO:0032355]; response to gamma radiation [GO:0010332]; response to nutrient [GO:0007584]; response to UV-C [GO:0010225]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; stem cell proliferation [GO:0072089]; telomere maintenance via recombination [GO:0000722]","","","","TISSUE SPECIFICITY: Highest expression in testis. Also expressed in spleen, skeletal muscle, thymus, mammary gland, heart, ovary, prostate, liver, lung, kidney and brain."
"882","sp|Q9VKU7|GCP4_DROME","lcl|NC_088858.1_cds_XP_065943647.1_31096",4.81e-64,224,"Q9VKU7","GCP4_DROME","Gamma-tubulin complex component 4 homolog (Gamma-ring complex protein 75 kDa) (d75p) (dGrip75)","Grip75 75p CG6176","Drosophila melanogaster (Fruit fly)",650,"GO:0000278; GO:0000922; GO:0000930; GO:0000931; GO:0005200; GO:0005737; GO:0005813; GO:0005874; GO:0007020; GO:0007058; GO:0007112; GO:0031122; GO:0043015; GO:0045450; GO:0051225; GO:0051321; GO:0090221","bicoid mRNA localization [GO:0045450]; cytoplasmic microtubule organization [GO:0031122]; male meiosis cytokinesis [GO:0007112]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic spindle-templated microtubule nucleation [GO:0090221]; spindle assembly [GO:0051225]; spindle assembly involved in female meiosis II [GO:0007058]","centrosome [GO:0005813]; cytoplasm [GO:0005737]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0000931]; microtubule [GO:0005874]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200]; bicoid mRNA localization [GO:0045450]; cytoplasmic microtubule organization [GO:0031122]; male meiosis cytokinesis [GO:0007112]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic spindle-templated microtubule nucleation [GO:0090221]; spindle assembly [GO:0051225]; spindle assembly involved in female meiosis II [GO:0007058]","","","",""
"883","sp|Q2XU92|ACBG2_MOUSE","lcl|NC_088858.1_cds_XP_065943723.1_29536",0,620,"Q2XU92","ACBG2_MOUSE","Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15) (Bubblegum-related protein)","Acsbg2 Bgr","Mus musculus (Mouse)",667,"GO:0004467; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006631; GO:0006635; GO:0007283; GO:0016020; GO:0030154; GO:0047617; GO:0047676","cell differentiation [GO:0030154]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; fatty acyl-CoA hydrolase activity [GO:0047617]; long-chain fatty acid-CoA ligase activity [GO:0004467]; cell differentiation [GO:0030154]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Testis- and brainstem-specific. Expressed in pubertal and adult testis. Enriched in germ cells and Sertoli cells while present at a lower level in Leydig cells. Present in testicular Sertoli cells and large motoneurons in the medulla oblongata and cervical spinal cord (at protein level). {ECO:0000269|PubMed:16371355, ECO:0000269|PubMed:16762313}."
"884","sp|B2RR83|YTDC2_MOUSE","lcl|NC_088858.1_cds_XP_065943745.1_32035",0,1384,"B2RR83","YTDC2_MOUSE","3'-5' RNA helicase YTHDC2 (EC 3.6.4.13) (Keen to exit meiosis leaving testes under-populated protein) (Ketu) (YTH domain-containing protein C2) (mYTHDC2)","Ythdc2","Mus musculus (Mouse)",1445,"GO:0003723; GO:0005524; GO:0005737; GO:0005783; GO:0007286; GO:0016887; GO:0034458; GO:0034612; GO:0035770; GO:0044829; GO:0048471; GO:0048599; GO:0051321; GO:0051729; GO:0070063; GO:0070555; GO:1990247","germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]","cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein granule [GO:0035770]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]","DEVELOPMENTAL STAGE: Expression rises between 7 and 12 d.p.p. and remains steady through adulthood. {ECO:0000269|PubMed:28809393}.","","","TISSUE SPECIFICITY: Present in male and female germ cells (at protein level) (PubMed:29033321, PubMed:32470506). Highly expressed in testis (PubMed:28809393, PubMed:29033321, PubMed:29087293, PubMed:29360036). Not detected in spermatogonia next to the tubule wall but is strongly expressed in spermatocytes, suggesting that it is up-regulated in germ cells upon entry into meiosis (at protein level) (PubMed:29087293). {ECO:0000269|PubMed:28809393, ECO:0000269|PubMed:29033321, ECO:0000269|PubMed:29087293, ECO:0000269|PubMed:29360036, ECO:0000269|PubMed:32470506}."
"885","sp|Q8CHK4|KAT5_MOUSE","lcl|NC_088858.1_cds_XP_065943936.1_33428",0,587,"Q8CHK4","KAT5_MOUSE","Histone acetyltransferase KAT5 (EC 2.3.1.48) (60 kDa Tat-interactive protein) (Tip60) (Histone acetyltransferase HTATIP) (Lysine acetyltransferase 5) (Protein 2-hydroxyisobutyryltransferase KAT5) (EC 2.3.1.-) (Protein acetyltransferase KAT5) (EC 2.3.1.-) (Protein crotonyltransferase KAT5) (EC 2.3.1.-) (Protein lactyltransferase KAT5) (EC 2.3.1.-)","Kat5 Htatip Tip60","Mus musculus (Mouse)",513,"GO:0000122; GO:0000132; GO:0000724; GO:0000776; GO:0000786; GO:0000812; GO:0003682; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0005829; GO:0006289; GO:0006357; GO:0006915; GO:0006974; GO:0007286; GO:0008270; GO:0010212; GO:0010508; GO:0010867; GO:0018394; GO:0021915; GO:0022008; GO:0030330; GO:0032703; GO:0032777; GO:0035092; GO:0035267; GO:0035861; GO:0042149; GO:0042753; GO:0042981; GO:0043161; GO:0043998; GO:0043999; GO:0045087; GO:0045591; GO:0045663; GO:0045893; GO:0045944; GO:0046972; GO:0048471; GO:0051726; GO:0061733; GO:0062033; GO:0071333; GO:0071392; GO:0097431; GO:0106226; GO:0120300; GO:0140064; GO:0140065; GO:0140297; GO:0140861; GO:1902036; GO:1902275; GO:1902425; GO:1905168; GO:1905337; GO:1905691; GO:2000042; GO:2000779","apoptotic process [GO:0006915]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair via homologous recombination [GO:0000724]; establishment of mitotic spindle orientation [GO:0000132]; innate immune response [GO:0045087]; lipid droplet disassembly [GO:1905691]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; nucleotide-excision repair [GO:0006289]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of aggrephagy [GO:1905337]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of autophagy [GO:0010508]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of mitotic sister chromatid segregation [GO:0062033]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of chromatin organization [GO:1902275]; regulation of double-strand break repair [GO:2000779]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ionizing radiation [GO:0010212]; sperm DNA condensation [GO:0035092]; spermatid development [GO:0007286]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; piccolo histone acetyltransferase complex [GO:0032777]; site of double-strand break [GO:0035861]; Swr1 complex [GO:0000812]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone H2A acetyltransferase activity [GO:0043998]; histone H2AK5 acetyltransferase activity [GO:0043999]; histone H4K16 acetyltransferase activity [GO:0046972]; peptide 2-hydroxyisobutyryltransferase activity [GO:0106226]; peptide butyryltransferase activity [GO:0140065]; peptide crotonyltransferase activity [GO:0140064]; peptide lactyltransferase (CoA-dependent) activity [GO:0120300]; protein-lysine-acetyltransferase activity [GO:0061733]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair via homologous recombination [GO:0000724]; establishment of mitotic spindle orientation [GO:0000132]; innate immune response [GO:0045087]; lipid droplet disassembly [GO:1905691]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; nucleotide-excision repair [GO:0006289]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of aggrephagy [GO:1905337]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of autophagy [GO:0010508]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of mitotic sister chromatid segregation [GO:0062033]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of chromatin organization [GO:1902275]; regulation of double-strand break repair [GO:2000779]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ionizing radiation [GO:0010212]; sperm DNA condensation [GO:0035092]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Expressed in testis, heart, brain, kidney and liver. Weakly expressed in lung. {ECO:0000269|PubMed:12036595}."
"886","sp|Q5RBG4|KAT5_PONAB","lcl|NC_088858.1_cds_XP_065943937.1_33429",0,578,"Q5RBG4","KAT5_PONAB","Histone acetyltransferase KAT5 (EC 2.3.1.48) (60 kDa Tat-interactive protein) (Tip60) (Histone acetyltransferase HTATIP) (Lysine acetyltransferase 5) (Protein 2-hydroxyisobutyryltransferase KAT5) (EC 2.3.1.-) (Protein acetyltransferase KAT5) (EC 2.3.1.-) (Protein crotonyltransferase KAT5) (EC 2.3.1.-) (Protein lactyltransferase KAT5) (EC 2.3.1.-)","KAT5 HTATIP TIP60","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)",461,"GO:0000132; GO:0000724; GO:0000776; GO:0000812; GO:0000922; GO:0003682; GO:0003713; GO:0004402; GO:0005634; GO:0005730; GO:0005737; GO:0006289; GO:0006302; GO:0006974; GO:0007286; GO:0008270; GO:0010508; GO:0010867; GO:0018394; GO:0030330; GO:0032777; GO:0035267; GO:0042149; GO:0042753; GO:0043998; GO:0045087; GO:0045591; GO:0045663; GO:0045893; GO:0045944; GO:0046972; GO:0048471; GO:0061733; GO:0062033; GO:0106226; GO:0120300; GO:0140064; GO:0140065; GO:1902036; GO:1902425; GO:1905168; GO:1905691","cellular response to glucose starvation [GO:0042149]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of mitotic spindle orientation [GO:0000132]; innate immune response [GO:0045087]; lipid droplet disassembly [GO:1905691]; nucleotide-excision repair [GO:0006289]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of autophagy [GO:0010508]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of mitotic sister chromatid segregation [GO:0062033]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of hematopoietic stem cell differentiation [GO:1902036]; spermatid development [GO:0007286]","cytoplasm [GO:0005737]; kinetochore [GO:0000776]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; piccolo histone acetyltransferase complex [GO:0032777]; spindle pole [GO:0000922]; Swr1 complex [GO:0000812]; chromatin binding [GO:0003682]; histone acetyltransferase activity [GO:0004402]; histone H2A acetyltransferase activity [GO:0043998]; histone H4K16 acetyltransferase activity [GO:0046972]; peptide 2-hydroxyisobutyryltransferase activity [GO:0106226]; peptide butyryltransferase activity [GO:0140065]; peptide crotonyltransferase activity [GO:0140064]; peptide lactyltransferase (CoA-dependent) activity [GO:0120300]; protein-lysine-acetyltransferase activity [GO:0061733]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; cellular response to glucose starvation [GO:0042149]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of mitotic spindle orientation [GO:0000132]; innate immune response [GO:0045087]; lipid droplet disassembly [GO:1905691]; nucleotide-excision repair [GO:0006289]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of autophagy [GO:0010508]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of mitotic sister chromatid segregation [GO:0062033]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of hematopoietic stem cell differentiation [GO:1902036]; spermatid development [GO:0007286]","","","",""
"887","sp|O02658|GLC7C_CAEEL","lcl|NC_088858.1_cds_XP_065943944.1_30024",1.02e-119,348,"O02658","GLC7C_CAEEL","Serine/threonine-protein phosphatase PP1-gamma (EC 3.1.3.16) (CeGLC-7-gamma) (Glc seven-like phosphatase 3)","gsp-3 W09C3.6","Caenorhabditis elegans",305,"GO:0000785; GO:0004722; GO:0005634; GO:0005737; GO:0007060; GO:0007283; GO:0018991; GO:0022414; GO:0030154; GO:0031143; GO:0031272; GO:0046872; GO:0097723","amoeboid sperm motility [GO:0097723]; cell differentiation [GO:0030154]; egg-laying behavior [GO:0018991]; male meiosis chromosome segregation [GO:0007060]; regulation of pseudopodium assembly [GO:0031272]; reproductive process [GO:0022414]; spermatogenesis [GO:0007283]","chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; pseudopodium [GO:0031143]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; amoeboid sperm motility [GO:0097723]; cell differentiation [GO:0030154]; egg-laying behavior [GO:0018991]; male meiosis chromosome segregation [GO:0007060]; regulation of pseudopodium assembly [GO:0031272]; reproductive process [GO:0022414]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed at all stages of spermatocyte meiosis. {ECO:0000269|PubMed:16943775, ECO:0000269|PubMed:22042574}.","","","TISSUE SPECIFICITY: Expressed in male germline including spermatocytes, spermatids and spermatozoa. {ECO:0000269|PubMed:16943775, ECO:0000269|PubMed:22042574}."
"888","sp|P04114|APOB_HUMAN","lcl|NC_088858.1_cds_XP_065944118.1_33465",6.46e-63,243,"P04114","APOB_HUMAN","Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)]","APOB","Homo sapiens (Human)",4563,"GO:0001701; GO:0005543; GO:0005576; GO:0005615; GO:0005737; GO:0005769; GO:0005788; GO:0005789; GO:0005790; GO:0005811; GO:0005829; GO:0005886; GO:0006642; GO:0007283; GO:0007399; GO:0008201; GO:0008203; GO:0009566; GO:0009615; GO:0009791; GO:0010008; GO:0010628; GO:0010744; GO:0010884; GO:0010886; GO:0019433; GO:0030301; GO:0030317; GO:0030669; GO:0031904; GO:0033344; GO:0034359; GO:0034360; GO:0034361; GO:0034362; GO:0034363; GO:0034374; GO:0034379; GO:0034383; GO:0035473; GO:0042158; GO:0042159; GO:0042627; GO:0042632; GO:0042953; GO:0043025; GO:0043202; GO:0043231; GO:0045540; GO:0048018; GO:0048844; GO:0050750; GO:0051649; GO:0070062; GO:0070971; GO:0071402; GO:0071682; GO:0120020","artery morphogenesis [GO:0048844]; cellular response to lipoprotein particle stimulus [GO:0071402]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642]; very-low-density lipoprotein particle assembly [GO:0034379]","chylomicron [GO:0042627]; chylomicron remnant [GO:0034360]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intermediate-density lipoprotein particle [GO:0034363]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; lysosomal lumen [GO:0043202]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; very-low-density lipoprotein particle [GO:0034361]; cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; receptor ligand activity [GO:0048018]; artery morphogenesis [GO:0048844]; cellular response to lipoprotein particle stimulus [GO:0071402]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642]; very-low-density lipoprotein particle assembly [GO:0034379]","","INDUCTION: Up-regulated in response to enterovirus 71 (EV71) infection (at protein level). {ECO:0000269|PubMed:16548883}.","INDUCTION: Up-regulated in response to enterovirus 71 (EV71) infection (at protein level). {ECO:0000269|PubMed:16548883}.",""
"889","sp|Q95PZ9|SPE6_CAEEL","lcl|NC_088858.1_cds_XP_065944264.1_32332",3.61e-56,199,"Q95PZ9","SPE6_CAEEL","Serine/threonine-protein kinase spe-6 (EC 2.7.11.1) (Defective spermatogenesis protein 6)","spe-6 Y66D12A.20","Caenorhabditis elegans",379,"GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0007165; GO:0007283; GO:0032880; GO:0048515; GO:0051308; GO:0106310","male meiosis chromosome separation [GO:0051308]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]; spermatid differentiation [GO:0048515]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; male meiosis chromosome separation [GO:0051308]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]; spermatid differentiation [GO:0048515]; spermatogenesis [GO:0007283]","","","",""
"890","sp|Q18891|VP33B_CAEEL","lcl|NC_088858.1_cds_XP_065944295.1_30894",1.77e-74,258,"Q18891","VP33B_CAEEL","Vacuolar protein sorting-associated protein 33B","vps-33.2 C56C10.1","Caenorhabditis elegans",617,"GO:0005764; GO:0005765; GO:0006886; GO:0016192; GO:0030136; GO:0030154; GO:0031901; GO:0031902; GO:0032889; GO:0033263; GO:0048137; GO:0055037; GO:0099022","cell differentiation [GO:0030154]; intracellular protein transport [GO:0006886]; regulation of vacuole fusion, non-autophagic [GO:0032889]; spermatocyte division [GO:0048137]; vesicle tethering [GO:0099022]; vesicle-mediated transport [GO:0016192]","clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; recycling endosome [GO:0055037]; cell differentiation [GO:0030154]; intracellular protein transport [GO:0006886]; regulation of vacuole fusion, non-autophagic [GO:0032889]; spermatocyte division [GO:0048137]; vesicle tethering [GO:0099022]; vesicle-mediated transport [GO:0016192]","","","","TISSUE SPECIFICITY: Broadly expressed in somatic tissues including the pharynx, intestine, spermatheca, and in coelomocytes (PubMed:27558849). Expressed in the lining of the gut lumen (PubMed:25273556). {ECO:0000269|PubMed:25273556, ECO:0000269|PubMed:27558849}."
"891","sp|O94776|MTA2_HUMAN","lcl|NC_088858.1_cds_XP_065944350.1_32262",0,594,"O94776","MTA2_HUMAN","Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) (MTA1-L1 protein) (p53 target protein in deacetylase complex)","MTA2 MTA1L1 PID","Homo sapiens (Human)",668,"GO:0000118; GO:0000122; GO:0000781; GO:0000785; GO:0003682; GO:0003713; GO:0003714; GO:0004407; GO:0005634; GO:0005654; GO:0005667; GO:0006325; GO:0006338; GO:0008270; GO:0010762; GO:0016020; GO:0016581; GO:0032991; GO:0042659; GO:0042826; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0061629; GO:0071514; GO:2000736","chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; genomic imprinting [GO:0071514]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell fate specification [GO:0042659]; regulation of fibroblast migration [GO:0010762]; regulation of stem cell differentiation [GO:2000736]","chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; genomic imprinting [GO:0071514]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell fate specification [GO:0042659]; regulation of fibroblast migration [GO:0010762]; regulation of stem cell differentiation [GO:2000736]","","","","TISSUE SPECIFICITY: Widely expressed."
"892","sp|E9Q414|APOB_MOUSE","lcl|NC_088858.1_cds_XP_065944418.1_33467",1.47e-62,241,"E9Q414","APOB_MOUSE","Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)]","Apob","Mus musculus (Mouse)",4505,"GO:0001701; GO:0005543; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0006642; GO:0007283; GO:0007399; GO:0008201; GO:0008203; GO:0009566; GO:0009615; GO:0009791; GO:0010628; GO:0010744; GO:0010886; GO:0016042; GO:0019433; GO:0030301; GO:0030317; GO:0033344; GO:0034359; GO:0034361; GO:0034362; GO:0034363; GO:0034374; GO:0034383; GO:0035473; GO:0042157; GO:0042158; GO:0042159; GO:0042632; GO:0042953; GO:0043025; GO:0045540; GO:0048018; GO:0048844; GO:0050750; GO:0051649; GO:0070971; GO:0071402; GO:0120020","artery morphogenesis [GO:0048844]; cellular response to lipoprotein particle stimulus [GO:0071402]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642]","cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; extracellular region [GO:0005576]; intermediate-density lipoprotein particle [GO:0034363]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; very-low-density lipoprotein particle [GO:0034361]; cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; receptor ligand activity [GO:0048018]; artery morphogenesis [GO:0048844]; cellular response to lipoprotein particle stimulus [GO:0071402]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642]","","","",""
"893","sp|Q6NRP2|PSME4_XENLA","lcl|NC_088858.1_cds_XP_065944420.1_28852",0,1640,"Q6NRP2","PSME4_XENLA","Proteasome activator complex subunit 4 (Proteasome activator PA200)","psme4","Xenopus laevis (African clawed frog)",1828,"GO:0005634; GO:0005829; GO:0006281; GO:0006974; GO:0010499; GO:0016504; GO:0016607; GO:0035092; GO:0070577; GO:0070628; GO:1990111","DNA damage response [GO:0006974]; DNA repair [GO:0006281]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; sperm DNA condensation [GO:0035092]","cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spermatoproteasome complex [GO:1990111]; lysine-acetylated histone binding [GO:0070577]; peptidase activator activity [GO:0016504]; proteasome binding [GO:0070628]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; sperm DNA condensation [GO:0035092]","","","",""
"894","sp|Q9Z1B3|PLCB1_MOUSE","lcl|NC_088858.1_cds_XP_065944473.1_32276",2.19e-160,513,"Q9Z1B3","PLCB1_MOUSE","1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-beta-1) (PLC-beta-1)","Plcb1 Plcb","Mus musculus (Mouse)",1216,"GO:0000086; GO:0000785; GO:0001556; GO:0004435; GO:0005096; GO:0005509; GO:0005516; GO:0005521; GO:0005546; GO:0005634; GO:0005737; GO:0005886; GO:0006397; GO:0007155; GO:0007165; GO:0007200; GO:0007207; GO:0007213; GO:0007215; GO:0007420; GO:0007612; GO:0007613; GO:0008277; GO:0008286; GO:0010560; GO:0016607; GO:0019899; GO:0021987; GO:0030218; GO:0030225; GO:0031161; GO:0031965; GO:0032024; GO:0032735; GO:0032957; GO:0032991; GO:0035556; GO:0035722; GO:0035723; GO:0040019; GO:0042802; GO:0043209; GO:0045444; GO:0045663; GO:0045892; GO:0045893; GO:0046330; GO:0046488; GO:0048009; GO:0048639; GO:0060466; GO:0070498; GO:0071882; GO:0080154; GO:0098978; GO:0098982; GO:0099170; GO:0099178; GO:0099524; GO:1900087; GO:1902618; GO:1903140; GO:1904117; GO:1904637; GO:1905631; GO:1990806; GO:2000344; GO:2000438","activation of meiosis involved in egg activation [GO:0060466]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cellular response to fluoride [GO:1902618]; cellular response to glyceraldehyde [GO:1905631]; cellular response to ionomycin [GO:1904637]; cellular response to vasopressin [GO:1904117]; cerebral cortex development [GO:0021987]; erythrocyte differentiation [GO:0030218]; fat cell differentiation [GO:0045444]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G2/M transition of mitotic cell cycle [GO:0000086]; glutamate receptor signaling pathway [GO:0007215]; inositol trisphosphate metabolic process [GO:0032957]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; ligand-gated ion channel signaling pathway [GO:1990806]; macrophage differentiation [GO:0030225]; memory [GO:0007613]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of monocyte extravasation [GO:2000438]; oocyte maturation [GO:0001556]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol metabolic process [GO:0046488]; phospholipase C-activating adrenergic receptor signaling pathway [GO:0071882]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of developmental growth [GO:0048639]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of embryonic development [GO:0040019]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myoblast differentiation [GO:0045663]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of fertilization [GO:0080154]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178]; signal transduction [GO:0007165]","chromatin [GO:0000785]; cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; myelin sheath [GO:0043209]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]; activation of meiosis involved in egg activation [GO:0060466]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cellular response to fluoride [GO:1902618]; cellular response to glyceraldehyde [GO:1905631]; cellular response to ionomycin [GO:1904637]; cellular response to vasopressin [GO:1904117]; cerebral cortex development [GO:0021987]; erythrocyte differentiation [GO:0030218]; fat cell differentiation [GO:0045444]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G2/M transition of mitotic cell cycle [GO:0000086]; glutamate receptor signaling pathway [GO:0007215]; inositol trisphosphate metabolic process [GO:0032957]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; ligand-gated ion channel signaling pathway [GO:1990806]; macrophage differentiation [GO:0030225]; memory [GO:0007613]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of monocyte extravasation [GO:2000438]; oocyte maturation [GO:0001556]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol metabolic process [GO:0046488]; phospholipase C-activating adrenergic receptor signaling pathway [GO:0071882]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of developmental growth [GO:0048639]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of embryonic development [GO:0040019]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myoblast differentiation [GO:0045663]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of fertilization [GO:0080154]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178]; signal transduction [GO:0007165]","","","",""
"895","sp|Q8BI22|CE128_MOUSE","lcl|NC_088858.1_cds_XP_065944633.1_30852",4.4e-73,264,"Q8BI22","CE128_MOUSE","Centrosomal protein of 128 kDa (Cep128)","Cep128","Mus musculus (Mouse)",1102,"GO:0000922; GO:0005794; GO:0005813; GO:0005814; GO:0007283; GO:0008104; GO:0010468; GO:0031965; GO:0036064; GO:0044458; GO:0120103; GO:0120212; GO:0120316","motile cilium assembly [GO:0044458]; protein localization [GO:0008104]; regulation of gene expression [GO:0010468]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283]","centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; sperm head-tail coupling apparatus [GO:0120212]; spindle pole [GO:0000922]; motile cilium assembly [GO:0044458]; protein localization [GO:0008104]; regulation of gene expression [GO:0010468]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283]","","","",""
"896","sp|Q6ZU80|CE128_HUMAN","lcl|NC_088858.1_cds_XP_065944635.1_30849",2.17e-72,262,"Q6ZU80","CE128_HUMAN","Centrosomal protein of 128 kDa (Cep128)","CEP128 C14orf145 C14orf61","Homo sapiens (Human)",1094,"GO:0000922; GO:0005794; GO:0005813; GO:0005814; GO:0008104; GO:0010468; GO:0031965; GO:0120103; GO:0120316","protein localization [GO:0008104]; regulation of gene expression [GO:0010468]; sperm flagellum assembly [GO:0120316]","centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; spindle pole [GO:0000922]; protein localization [GO:0008104]; regulation of gene expression [GO:0010468]; sperm flagellum assembly [GO:0120316]","","","",""
"897","sp|Q7KU24|CHD1_DROME","lcl|NC_088858.1_cds_XP_065944657.1_33663",0,1195,"Q7KU24","CHD1_DROME","Chromodomain-helicase-DNA-binding protein 1 (CHD-1) (EC 3.6.4.-) (ATP-dependent helicase Chd1)","Chd1 CG3733","Drosophila melanogaster (Fruit fly)",1883,"GO:0000785; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005703; GO:0005705; GO:0007476; GO:0016887; GO:0034728; GO:0035041; GO:0042393; GO:0048477; GO:0140658","imaginal disc-derived wing morphogenesis [GO:0007476]; nucleosome organization [GO:0034728]; oogenesis [GO:0048477]; sperm DNA decondensation [GO:0035041]","chromatin [GO:0000785]; nucleus [GO:0005634]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; imaginal disc-derived wing morphogenesis [GO:0007476]; nucleosome organization [GO:0034728]; oogenesis [GO:0048477]; sperm DNA decondensation [GO:0035041]","","","",""
"898","sp|P27715|UNC13_CAEEL","lcl|NC_088858.1_cds_XP_065944875.1_30917",0,1558,"P27715","UNC13_CAEEL","Phorbol ester/diacylglycerol-binding protein unc-13 (Uncoordinated protein 13)","unc-13 ZK524.2","Caenorhabditis elegans",2155,"GO:0005509; GO:0005516; GO:0005543; GO:0005886; GO:0007267; GO:0007283; GO:0008270; GO:0008340; GO:0016079; GO:0016081; GO:0016082; GO:0017075; GO:0019992; GO:0030672; GO:0031594; GO:0035249; GO:0036498; GO:0042734; GO:0043051; GO:0043195; GO:0045202; GO:0046662; GO:0048786; GO:0051241; GO:0060282; GO:0061789","cell-cell signaling [GO:0007267]; dense core granule priming [GO:0061789]; determination of adult lifespan [GO:0008340]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of multicellular organismal process [GO:0051241]; positive regulation of oocyte development [GO:0060282]; regulation of egg-laying behavior [GO:0046662]; regulation of nematode pharyngeal pumping [GO:0043051]; spermatogenesis [GO:0007283]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]","neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; phospholipid binding [GO:0005543]; syntaxin-1 binding [GO:0017075]; zinc ion binding [GO:0008270]; cell-cell signaling [GO:0007267]; dense core granule priming [GO:0061789]; determination of adult lifespan [GO:0008340]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of multicellular organismal process [GO:0051241]; positive regulation of oocyte development [GO:0060282]; regulation of egg-laying behavior [GO:0046662]; regulation of nematode pharyngeal pumping [GO:0043051]; spermatogenesis [GO:0007283]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]","","","",""
"899","sp|M9MRD1|MS300_DROME","lcl|NC_088858.1_cds_XP_065944928.1_31325",0,2461,"M9MRD1","MS300_DROME","Muscle-specific protein 300 kDa (Nesprin-like protein Msp300)","Msp300 CG42768","Drosophila melanogaster (Fruit fly)",12345,"GO:0003779; GO:0005635; GO:0005640; GO:0005737; GO:0005815; GO:0006997; GO:0007015; GO:0007097; GO:0007300; GO:0007498; GO:0007523; GO:0008335; GO:0016477; GO:0019901; GO:0030018; GO:0034453; GO:0034993; GO:0040011; GO:0048471; GO:0051015; GO:0051643; GO:0051646; GO:0051647; GO:0060361","actin filament organization [GO:0007015]; cell migration [GO:0016477]; endoplasmic reticulum localization [GO:0051643]; female germline ring canal stabilization [GO:0008335]; flight [GO:0060361]; larval visceral muscle development [GO:0007523]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; microtubule anchoring [GO:0034453]; mitochondrion localization [GO:0051646]; nuclear migration [GO:0007097]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; ovarian nurse cell to oocyte transport [GO:0007300]","cytoplasm [GO:0005737]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; microtubule organizing center [GO:0005815]; nuclear envelope [GO:0005635]; nuclear outer membrane [GO:0005640]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein kinase binding [GO:0019901]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; endoplasmic reticulum localization [GO:0051643]; female germline ring canal stabilization [GO:0008335]; flight [GO:0060361]; larval visceral muscle development [GO:0007523]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; microtubule anchoring [GO:0034453]; mitochondrion localization [GO:0051646]; nuclear migration [GO:0007097]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; ovarian nurse cell to oocyte transport [GO:0007300]","","","",""
"900","sp|Q6ZWR6|SYNE1_MOUSE","lcl|NC_088858.1_cds_XP_065944929.1_31326",1.19e-147,525,"Q6ZWR6","SYNE1_MOUSE","Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1)","Syne1","Mus musculus (Mouse)",8799,"GO:0005635; GO:0005640; GO:0005856; GO:0007097; GO:0007283; GO:0030017; GO:0030154; GO:0042802; GO:0042803; GO:0051015; GO:0051642; GO:1902017","cell differentiation [GO:0030154]; centrosome localization [GO:0051642]; nuclear migration [GO:0007097]; regulation of cilium assembly [GO:1902017]; spermatogenesis [GO:0007283]","cytoskeleton [GO:0005856]; nuclear envelope [GO:0005635]; nuclear outer membrane [GO:0005640]; sarcomere [GO:0030017]; actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cell differentiation [GO:0030154]; centrosome localization [GO:0051642]; nuclear migration [GO:0007097]; regulation of cilium assembly [GO:1902017]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in C2F3 and CH310T1/2 cells, brain and skeletal muscle (at protein level). {ECO:0000269|PubMed:15093733, ECO:0000269|PubMed:22518138}."
"901","sp|Q07436|EXPA_DROME","lcl|NC_088858.1_cds_XP_065944994.1_32920",2.04e-19,96.7,"Q07436","EXPA_DROME","Protein expanded","ex CG4114","Drosophila melanogaster (Fruit fly)",1427,"GO:0001745; GO:0001751; GO:0005856; GO:0005886; GO:0007096; GO:0007298; GO:0008285; GO:0009966; GO:0016327; GO:0017124; GO:0019900; GO:0030707; GO:0032436; GO:0032456; GO:0035332; GO:0036375; GO:0040008; GO:0043065; GO:0045571; GO:0045595; GO:0046621; GO:0097009; GO:0098592; GO:0120219; GO:0140297; GO:0140311; GO:1904262","border follicle cell migration [GO:0007298]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; endocytic recycling [GO:0032456]; energy homeostasis [GO:0097009]; follicle cell of egg chamber development [GO:0030707]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of cell differentiation [GO:0045595]; regulation of exit from mitosis [GO:0007096]; regulation of growth [GO:0040008]; regulation of signal transduction [GO:0009966]","apicolateral plasma membrane [GO:0016327]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytoskeleton [GO:0005856]; Kibra-Ex-Mer complex [GO:0036375]; plasma membrane [GO:0005886]; subapical part of cell [GO:0120219]; DNA-binding transcription factor binding [GO:0140297]; kinase binding [GO:0019900]; protein sequestering activity [GO:0140311]; SH3 domain binding [GO:0017124]; border follicle cell migration [GO:0007298]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; endocytic recycling [GO:0032456]; energy homeostasis [GO:0097009]; follicle cell of egg chamber development [GO:0030707]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of cell differentiation [GO:0045595]; regulation of exit from mitosis [GO:0007096]; regulation of growth [GO:0040008]; regulation of signal transduction [GO:0009966]","DEVELOPMENTAL STAGE: Detected in wing disks (at protein level). {ECO:0000269|PubMed:27462444}.","","",""
"902","sp|Q9BY12|SCAPE_HUMAN","lcl|NC_088858.1_cds_XP_065945018.1_34085",0,639,"Q9BY12","SCAPE_HUMAN","S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291)","SCAPER KIAA1454 ZNF291 MSTP063","Homo sapiens (Human)",1400,"GO:0001547; GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0007283; GO:0008270; GO:0016607; GO:0060041; GO:0061827; GO:0072520; GO:1990917","antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283]","cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; ooplasm [GO:1990917]; sperm head [GO:0061827]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed at each stage of the cell cycle, including G0, although the expression is somewhat higher in late G1 and S phases. {ECO:0000269|PubMed:17698606}.","","","TISSUE SPECIFICITY: Widely expressed with high expression in testis. Isoform 1 is detected in various tissues, including retina, fetal and adult brain. Isoform 2 is expressed in the retina at high levels, and in the brain at very low levels (PubMed:28794130). {ECO:0000269|PubMed:17698606, ECO:0000269|PubMed:28794130}."
"903","sp|Q63132|ROS1_RAT","lcl|NC_088858.1_cds_XP_065945061.1_32400",7.78e-95,331,"Q63132","ROS1_RAT","Proto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1) (Proto-oncogene c-Ros) (Proto-oncogene c-Ros-1) (Receptor tyrosine kinase c-ros oncogene 1) (c-Ros receptor tyrosine kinase)","Ros1","Rattus norvegicus (Rat)",2338,"GO:0001558; GO:0002066; GO:0004713; GO:0004714; GO:0005524; GO:0005886; GO:0006468; GO:0007165; GO:0007169; GO:0007283; GO:0009986; GO:0010467; GO:0010629; GO:0010966; GO:0019903; GO:0030154; GO:0032006; GO:0043235; GO:0048471; GO:0070372","cell differentiation [GO:0030154]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; columnar/cuboidal epithelial cell development [GO:0002066]; gene expression [GO:0010467]; negative regulation of gene expression [GO:0010629]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of phosphate transport [GO:0010966]; regulation of TOR signaling [GO:0032006]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]","cell surface [GO:0009986]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell differentiation [GO:0030154]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; columnar/cuboidal epithelial cell development [GO:0002066]; gene expression [GO:0010467]; negative regulation of gene expression [GO:0010629]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of phosphate transport [GO:0010966]; regulation of TOR signaling [GO:0032006]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in heart, lung, kidney and testis. {ECO:0000269|PubMed:2139140}."
"904","sp|Q00724|RET4_MOUSE","lcl|NC_088858.1_cds_XP_065945096.1_29169",7.26e-19,81.6,"Q00724","RET4_MOUSE","Retinol-binding protein 4 (Plasma retinol-binding protein) (PRBP) (RBP)","Rbp4","Mus musculus (Mouse)",201,"GO:0001523; GO:0001654; GO:0002639; GO:0005576; GO:0005615; GO:0006094; GO:0007283; GO:0007507; GO:0007603; GO:0008584; GO:0016918; GO:0019841; GO:0030277; GO:0030324; GO:0032024; GO:0032526; GO:0032868; GO:0034632; GO:0034633; GO:0042572; GO:0042574; GO:0042593; GO:0048562; GO:0048706; GO:0048738; GO:0048807; GO:0050908; GO:0060041; GO:0060044; GO:0060059; GO:0060065; GO:0060068; GO:0060157; GO:0060347; GO:0071939; GO:0140104","cardiac muscle tissue development [GO:0048738]; detection of light stimulus involved in visual perception [GO:0050908]; embryonic organ morphogenesis [GO:0048562]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic skeletal system development [GO:0048706]; eye development [GO:0001654]; female genitalia morphogenesis [GO:0048807]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; lung development [GO:0030324]; maintenance of gastrointestinal epithelium [GO:0030277]; male gonad development [GO:0008584]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; phototransduction, visible light [GO:0007603]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of insulin secretion [GO:0032024]; response to insulin [GO:0032868]; response to retinoic acid [GO:0032526]; retina development in camera-type eye [GO:0060041]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; retinol transport [GO:0034633]; spermatogenesis [GO:0007283]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; vitamin A import into cell [GO:0071939]","extracellular region [GO:0005576]; extracellular space [GO:0005615]; molecular carrier activity [GO:0140104]; retinal binding [GO:0016918]; retinol binding [GO:0019841]; retinol transmembrane transporter activity [GO:0034632]; cardiac muscle tissue development [GO:0048738]; detection of light stimulus involved in visual perception [GO:0050908]; embryonic organ morphogenesis [GO:0048562]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic skeletal system development [GO:0048706]; eye development [GO:0001654]; female genitalia morphogenesis [GO:0048807]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; lung development [GO:0030324]; maintenance of gastrointestinal epithelium [GO:0030277]; male gonad development [GO:0008584]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; phototransduction, visible light [GO:0007603]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of insulin secretion [GO:0032024]; response to insulin [GO:0032868]; response to retinoic acid [GO:0032526]; retina development in camera-type eye [GO:0060041]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; retinol transport [GO:0034633]; spermatogenesis [GO:0007283]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; vitamin A import into cell [GO:0071939]","","","",""
"905","sp|Q8BVN3|CTSR4_MOUSE","lcl|NC_088858.1_cds_XP_065945188.1_32723",1.84e-12,71.2,"Q8BVN3","CTSR4_MOUSE","Cation channel sperm-associated protein 4 (CatSper4)","Catsper4","Mus musculus (Mouse)",442,"GO:0001669; GO:0005227; GO:0005245; GO:0006814; GO:0030317; GO:0036128; GO:0048240; GO:0051649; GO:0097228","establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; sodium ion transport [GO:0006814]; sperm capacitation [GO:0048240]","acrosomal vesicle [GO:0001669]; CatSper complex [GO:0036128]; sperm principal piece [GO:0097228]; calcium-activated cation channel activity [GO:0005227]; voltage-gated calcium channel activity [GO:0005245]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; sodium ion transport [GO:0006814]; sperm capacitation [GO:0048240]","DEVELOPMENTAL STAGE: Detected in hte testis during postnatal development at day 15. Restricted to the late-stage germline cells that line the seminiferous tubules. {ECO:0000269|PubMed:17347248}.","","","TISSUE SPECIFICITY: Testis-specific. {ECO:0000269|PubMed:16107607, ECO:0000269|PubMed:17227845}."
"906","sp|A2ARP9|CTSR2_MOUSE","lcl|NC_088858.1_cds_XP_065945193.1_32731",7.13e-12,70.1,"A2ARP9","CTSR2_MOUSE","Cation channel sperm-associated protein 2 (CatSper2)","Catsper2","Mus musculus (Mouse)",588,"GO:0005227; GO:0005245; GO:0006816; GO:0009566; GO:0030317; GO:0036126; GO:0036128; GO:0048240","calcium ion transport [GO:0006816]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; sperm capacitation [GO:0048240]","CatSper complex [GO:0036128]; sperm flagellum [GO:0036126]; calcium-activated cation channel activity [GO:0005227]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transport [GO:0006816]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; sperm capacitation [GO:0048240]","DEVELOPMENTAL STAGE: Present in testis of 8 day-old. Expressed in pachytene spermatocytes. {ECO:0000269|PubMed:17347248}.","","","TISSUE SPECIFICITY: Testis-specific. {ECO:0000269|PubMed:11675491}."
"907","sp|Q9CPV1|SKA1_MOUSE","lcl|NC_088858.1_cds_XP_065945214.1_32473",3.71e-40,140,"Q9CPV1","SKA1_MOUSE","SKA complex subunit 1 (Spindle and kinetochore-associated protein 1)","Ska1","Mus musculus (Mouse)",254,"GO:0000070; GO:0000278; GO:0000776; GO:0000940; GO:0005737; GO:0005813; GO:0005874; GO:0007056; GO:0007080; GO:0008017; GO:0031110; GO:0051296; GO:0051301; GO:0051315; GO:0072686; GO:0072687; GO:0140499","attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; establishment of meiotic spindle orientation [GO:0051296]; mitotic cell cycle [GO:0000278]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of mitotic spindle assembly checkpoint signaling [GO:0140499]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly involved in female meiosis [GO:0007056]","centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; outer kinetochore [GO:0000940]; microtubule binding [GO:0008017]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; establishment of meiotic spindle orientation [GO:0051296]; mitotic cell cycle [GO:0000278]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of mitotic spindle assembly checkpoint signaling [GO:0140499]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly involved in female meiosis [GO:0007056]","DEVELOPMENTAL STAGE: Expressed at a constant level in germinal vesicle (GV) stage oocytes, MI-stage oocytes, and MII-stage oocytes. {ECO:0000269|PubMed:22336914}.","","",""
"908","sp|P07686|HEXB_HUMAN","lcl|NC_088858.1_cds_XP_065945218.1_32756",0,554,"P07686","HEXB_HUMAN","Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A]","HEXB HCC7","Homo sapiens (Human)",556,"GO:0001501; GO:0001669; GO:0004563; GO:0005576; GO:0005764; GO:0006044; GO:0006491; GO:0006689; GO:0006874; GO:0007040; GO:0007338; GO:0007341; GO:0007605; GO:0007626; GO:0008049; GO:0008360; GO:0008375; GO:0008654; GO:0009313; GO:0016020; GO:0016231; GO:0019915; GO:0030203; GO:0030207; GO:0030209; GO:0030214; GO:0030246; GO:0035578; GO:0042552; GO:0042582; GO:0042802; GO:0043202; GO:0043615; GO:0044877; GO:0045944; GO:0048477; GO:0050885; GO:0060473; GO:0070050; GO:0070062; GO:1905379","astrocyte cell migration [GO:0043615]; chondroitin sulfate proteoglycan catabolic process [GO:0030207]; dermatan sulfate proteoglycan catabolic process [GO:0030209]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan metabolic process [GO:0030203]; hyaluronan catabolic process [GO:0030214]; intracellular calcium ion homeostasis [GO:0006874]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; male courtship behavior [GO:0008049]; myelination [GO:0042552]; N-acetylglucosamine metabolic process [GO:0006044]; N-glycan processing [GO:0006491]; neuromuscular process controlling balance [GO:0050885]; neuron cellular homeostasis [GO:0070050]; oligosaccharide catabolic process [GO:0009313]; oogenesis [GO:0048477]; penetration of zona pellucida [GO:0007341]; phospholipid biosynthetic process [GO:0008654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]","acrosomal vesicle [GO:0001669]; azurophil granule [GO:0042582]; azurophil granule lumen [GO:0035578]; beta-N-acetylhexosaminidase complex [GO:1905379]; cortical granule [GO:0060473]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylglucosaminidase activity [GO:0016231]; beta-N-acetylhexosaminidase activity [GO:0004563]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; astrocyte cell migration [GO:0043615]; chondroitin sulfate proteoglycan catabolic process [GO:0030207]; dermatan sulfate proteoglycan catabolic process [GO:0030209]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan metabolic process [GO:0030203]; hyaluronan catabolic process [GO:0030214]; intracellular calcium ion homeostasis [GO:0006874]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; male courtship behavior [GO:0008049]; myelination [GO:0042552]; N-acetylglucosamine metabolic process [GO:0006044]; N-glycan processing [GO:0006491]; neuromuscular process controlling balance [GO:0050885]; neuron cellular homeostasis [GO:0070050]; oligosaccharide catabolic process [GO:0009313]; oogenesis [GO:0048477]; penetration of zona pellucida [GO:0007341]; phospholipid biosynthetic process [GO:0008654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]","","","",""
"909","sp|P35875|PARP_DROME","lcl|NC_088858.1_cds_XP_065945301.1_32074",0,822,"P35875","PARP_DROME","Poly [ADP-ribose] polymerase (PARP) (EC 2.4.2.30) (NAD(+) ADP-ribosyltransferase) (ADPRT) (Poly[ADP-ribose] synthase) (Protein ADP-ribosyltransferase Parp) (EC 2.4.2.-)","Parp CG40411","Drosophila melanogaster (Fruit fly)",994,"GO:0000791; GO:0003677; GO:0003950; GO:0005694; GO:0005730; GO:0005739; GO:0006302; GO:0006325; GO:0006963; GO:0006974; GO:0007000; GO:0008069; GO:0008270; GO:0015030; GO:0016779; GO:0030576; GO:0035080; GO:0035363; GO:0042254; GO:0042393; GO:0043484; GO:0051287; GO:0051457; GO:0061059; GO:0090734; GO:0140805; GO:0140806; GO:0140807; GO:1900182; GO:1902275; GO:1902570; GO:1904867; GO:1990404","Cajal body organization [GO:0030576]; chromatin organization [GO:0006325]; DNA damage response [GO:0006974]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; double-strand break repair [GO:0006302]; heat shock-mediated polytene chromosome puffing [GO:0035080]; maintenance of protein location in nucleus [GO:0051457]; nucleolus organization [GO:0007000]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of peptidoglycan recognition protein signaling pathway [GO:0061059]; positive regulation of protein localization to nucleus [GO:1900182]; protein localization to Cajal body [GO:1904867]; protein localization to nucleolus [GO:1902570]; regulation of chromatin organization [GO:1902275]; regulation of RNA splicing [GO:0043484]; ribosome biogenesis [GO:0042254]","Cajal body [GO:0015030]; chromosome [GO:0005694]; euchromatin [GO:0000791]; histone locus body [GO:0035363]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; site of DNA damage [GO:0090734]; DNA binding [GO:0003677]; histone binding [GO:0042393]; NAD binding [GO:0051287]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; NAD+-protein-serine ADP-ribosyltransferase activity [GO:0140805]; nucleotidyltransferase activity [GO:0016779]; zinc ion binding [GO:0008270]; Cajal body organization [GO:0030576]; chromatin organization [GO:0006325]; DNA damage response [GO:0006974]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; double-strand break repair [GO:0006302]; heat shock-mediated polytene chromosome puffing [GO:0035080]; maintenance of protein location in nucleus [GO:0051457]; nucleolus organization [GO:0007000]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of peptidoglycan recognition protein signaling pathway [GO:0061059]; positive regulation of protein localization to nucleus [GO:1900182]; protein localization to Cajal body [GO:1904867]; protein localization to nucleolus [GO:1902570]; regulation of chromatin organization [GO:1902275]; regulation of RNA splicing [GO:0043484]; ribosome biogenesis [GO:0042254]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically in embryos, pupae and adults. Expression is highest in embryos. {ECO:0000269|PubMed:12183365, ECO:0000269|PubMed:9565614}.","","","TISSUE SPECIFICITY: Expressed in adult female oocytes, anal plates of stage 12 embryos and in cells around the central nervous system in later embryos. {ECO:0000269|PubMed:9565614}."
"910","sp|Q08122|TLE3_MOUSE","lcl|NC_088858.1_cds_XP_065945367.1_31610",0,697,"Q08122","TLE3_MOUSE","Transducin-like enhancer protein 3 (ESG) (Grg-3)","Tle3 Esg","Mus musculus (Mouse)",772,"GO:0005654; GO:0006355; GO:0007283; GO:0016055; GO:0030154; GO:0120163; GO:1990907","cell differentiation [GO:0030154]; negative regulation of cold-induced thermogenesis [GO:0120163]; regulation of DNA-templated transcription [GO:0006355]; spermatogenesis [GO:0007283]; Wnt signaling pathway [GO:0016055]","beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; cell differentiation [GO:0030154]; negative regulation of cold-induced thermogenesis [GO:0120163]; regulation of DNA-templated transcription [GO:0006355]; spermatogenesis [GO:0007283]; Wnt signaling pathway [GO:0016055]","","INDUCTION: Repressed during TNFSF11/RANKL-induced osteoclast differentiation. {ECO:0000269|PubMed:23990468}.","INDUCTION: Repressed during TNFSF11/RANKL-induced osteoclast differentiation. {ECO:0000269|PubMed:23990468}.","TISSUE SPECIFICITY: Expressed only in testis (PubMed:8365415). Expressed in bone marrow-derived macrophages (PubMed:23990468). {ECO:0000269|PubMed:23990468, ECO:0000269|PubMed:8365415}."
"911","sp|Q94920|VDAC_DROME","lcl|NC_088859.1_cds_NP_001292225.1_37518",6.5e-121,348,"Q94920","VDAC_DROME","Voltage-dependent anion-selective channel (DmVDAC) (Porin)","porin POR-1 VDAC CG6647","Drosophila melanogaster (Fruit fly)",282,"GO:0005739; GO:0005741; GO:0006811; GO:0007005; GO:0007291; GO:0007602; GO:0008308; GO:0015288; GO:0016006; GO:0030382; GO:0043066; GO:0046930; GO:0110099; GO:1990542","mitochondrial transmembrane transport [GO:1990542]; mitochondrion organization [GO:0007005]; monoatomic ion transport [GO:0006811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcium import into the mitochondrion [GO:0110099]; phototransduction [GO:0007602]; sperm individualization [GO:0007291]; sperm mitochondrion organization [GO:0030382]","mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; Nebenkern [GO:0016006]; pore complex [GO:0046930]; porin activity [GO:0015288]; voltage-gated monoatomic anion channel activity [GO:0008308]; mitochondrial transmembrane transport [GO:1990542]; mitochondrion organization [GO:0007005]; monoatomic ion transport [GO:0006811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcium import into the mitochondrion [GO:0110099]; phototransduction [GO:0007602]; sperm individualization [GO:0007291]; sperm mitochondrion organization [GO:0030382]","DEVELOPMENTAL STAGE: Expressed throughout development, highest levels are in embryos and pupae. {ECO:0000269|PubMed:9688565}.","","",""
"912","sp|O01382|DRICE_DROME","lcl|NC_088859.1_cds_NP_001292251.1_34476",4.87e-69,219,"O01382","DRICE_DROME","Caspase drICE (EC 3.4.22.-) (Death related ICE-like caspase) [Cleaved into: Caspase subunit p21; Caspase subunit p12]","Drice ICE CG7788","Drosophila melanogaster (Fruit fly)",339,"GO:0004197; GO:0005634; GO:0005737; GO:0005886; GO:0006508; GO:0006915; GO:0010165; GO:0010623; GO:0012501; GO:0016322; GO:0031625; GO:0035070; GO:0043525; GO:0045476; GO:0045751; GO:0046667; GO:0048515; GO:0061060; GO:0097194; GO:1990525","apoptotic process [GO:0006915]; compound eye retinal cell programmed cell death [GO:0046667]; execution phase of apoptosis [GO:0097194]; negative regulation of peptidoglycan recognition protein signaling pathway [GO:0061060]; negative regulation of Toll signaling pathway [GO:0045751]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of neuron apoptotic process [GO:0043525]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; compound eye retinal cell programmed cell death [GO:0046667]; execution phase of apoptosis [GO:0097194]; negative regulation of peptidoglycan recognition protein signaling pathway [GO:0061060]; negative regulation of Toll signaling pathway [GO:0045751]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of neuron apoptotic process [GO:0043525]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]","DEVELOPMENTAL STAGE: Expressed at all stages where apoptosis occurs.","","",""
"913","sp|Q966L9|GLH2_CAEEL","lcl|NC_088859.1_cds_NP_001292258.1_34570",6.99e-137,430,"Q966L9","GLH2_CAEEL","ATP-dependent RNA helicase glh-2 (EC 3.6.4.13) (Germline helicase 2)","glh-2 C55B7.1","Caenorhabditis elegans",974,"GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0007276; GO:0007281; GO:0008270; GO:0008432; GO:0009791; GO:0016070; GO:0016887; GO:0030154; GO:0043186","cell differentiation [GO:0030154]; gamete generation [GO:0007276]; germ cell development [GO:0007281]; post-embryonic development [GO:0009791]; RNA metabolic process [GO:0016070]","nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; JUN kinase binding [GO:0008432]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; gamete generation [GO:0007276]; germ cell development [GO:0007281]; post-embryonic development [GO:0009791]; RNA metabolic process [GO:0016070]","DEVELOPMENTAL STAGE: During germline proliferation.","","",""
"914","sp|P27797|CALR_HUMAN","lcl|NC_088859.1_cds_NP_001292262.1_38306",1.4e-163,467,"P27797","CALR_HUMAN","Calreticulin (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP) (grp60)","CALR CRTC","Homo sapiens (Human)",417,"GO:0000122; GO:0001669; GO:0001849; GO:0002502; GO:0003677; GO:0003723; GO:0003729; GO:0005049; GO:0005178; GO:0005506; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005635; GO:0005737; GO:0005739; GO:0005783; GO:0005788; GO:0005789; GO:0005790; GO:0005829; GO:0005840; GO:0005925; GO:0006355; GO:0006457; GO:0006611; GO:0006874; GO:0007283; GO:0008270; GO:0008284; GO:0009410; GO:0009897; GO:0009986; GO:0010595; GO:0010628; GO:0016020; GO:0017148; GO:0030246; GO:0030670; GO:0030866; GO:0031625; GO:0032355; GO:0033018; GO:0033116; GO:0033144; GO:0033574; GO:0034504; GO:0034975; GO:0036503; GO:0040020; GO:0042277; GO:0042562; GO:0042824; GO:0042921; GO:0042981; GO:0044183; GO:0044194; GO:0044322; GO:0045665; GO:0045787; GO:0045892; GO:0048387; GO:0048471; GO:0050681; GO:0050766; GO:0050821; GO:0051082; GO:0051087; GO:0051208; GO:0051604; GO:0055007; GO:0060473; GO:0070062; GO:0071257; GO:0071285; GO:0071682; GO:0090398; GO:0098553; GO:0098586; GO:0098794; GO:0098978; GO:0140313; GO:1900026; GO:1901164; GO:1901224; GO:1901652; GO:1903416; GO:1904614; GO:2000510","cardiac muscle cell differentiation [GO:0055007]; cellular response to electrical stimulus [GO:0071257]; cellular response to lithium ion [GO:0071285]; cellular response to virus [GO:0098586]; cellular senescence [GO:0090398]; cortical actin cytoskeleton organization [GO:0030866]; ERAD pathway [GO:0036503]; intracellular calcium ion homeostasis [GO:0006874]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; negative regulation of trophoblast cell migration [GO:1901164]; nuclear receptor-mediated glucocorticoid signaling pathway [GO:0042921]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of phagocytosis [GO:0050766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein export from nucleus [GO:0006611]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein localization to nucleus [GO:0034504]; protein maturation [GO:0051604]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of DNA-templated transcription [GO:0006355]; regulation of meiotic nuclear division [GO:0040020]; response to biphenyl [GO:1904614]; response to estradiol [GO:0032355]; response to glycoside [GO:1903416]; response to peptide [GO:1901652]; response to testosterone [GO:0033574]; response to xenobiotic stimulus [GO:0009410]; sequestering of calcium ion [GO:0051208]; spermatogenesis [GO:0007283]","acrosomal vesicle [GO:0001669]; cell surface [GO:0009986]; cortical granule [GO:0060473]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; postsynapse [GO:0098794]; ribosome [GO:0005840]; sarcoplasmic reticulum lumen [GO:0033018]; smooth endoplasmic reticulum [GO:0005790]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; complement component C1q complex binding [GO:0001849]; DNA binding [GO:0003677]; hormone binding [GO:0042562]; integrin binding [GO:0005178]; iron ion binding [GO:0005506]; molecular sequestering activity [GO:0140313]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; nuclear export signal receptor activity [GO:0005049]; peptide binding [GO:0042277]; protein folding chaperone [GO:0044183]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; cardiac muscle cell differentiation [GO:0055007]; cellular response to electrical stimulus [GO:0071257]; cellular response to lithium ion [GO:0071285]; cellular response to virus [GO:0098586]; cellular senescence [GO:0090398]; cortical actin cytoskeleton organization [GO:0030866]; ERAD pathway [GO:0036503]; intracellular calcium ion homeostasis [GO:0006874]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; negative regulation of trophoblast cell migration [GO:1901164]; nuclear receptor-mediated glucocorticoid signaling pathway [GO:0042921]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of phagocytosis [GO:0050766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein export from nucleus [GO:0006611]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein localization to nucleus [GO:0034504]; protein maturation [GO:0051604]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of DNA-templated transcription [GO:0006355]; regulation of meiotic nuclear division [GO:0040020]; response to biphenyl [GO:1904614]; response to estradiol [GO:0032355]; response to glycoside [GO:1903416]; response to peptide [GO:1901652]; response to testosterone [GO:0033574]; response to xenobiotic stimulus [GO:0009410]; sequestering of calcium ion [GO:0051208]; spermatogenesis [GO:0007283]","","","",""
"915","sp|Q4YU79|ACT2_PLABA","lcl|NC_088859.1_cds_NP_001295788.1_39354",0,607,"Q4YU79","ACT2_PLABA","Actin-2 (EC 3.6.4.-) (Actin II) (PbAct II)","ACT2 ACTII PB001050.02.0 PBANKA_1030100","Plasmodium berghei (strain Anka)",376,"GO:0005524; GO:0005737; GO:0005856; GO:0016887; GO:0035891; GO:0044129; GO:0044782; GO:0048232","cilium organization [GO:0044782]; exit from host cell [GO:0035891]; male gamete generation [GO:0048232]; positive regulation of development of symbiont in host [GO:0044129]","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cilium organization [GO:0044782]; exit from host cell [GO:0035891]; male gamete generation [GO:0048232]; positive regulation of development of symbiont in host [GO:0044129]","DEVELOPMENTAL STAGE: Expressed in ookinetes from the maternal gene (at protein level) (PubMed:24471657). Expressed in both female and male gametocytes; expression is higher in male gametocytes (PubMed:21790945). Not expressed during the asexual blood stage (PubMed:21790945). Not expressed in oocysts (PubMed:24471657). {ECO:0000269|PubMed:21790945, ECO:0000269|PubMed:24471657}.","","",""
"916","sp|F1LYL9|SOX9_RAT","lcl|NC_088859.1_cds_NP_001295801.1_37193",1.05e-67,226,"F1LYL9","SOX9_RAT","Transcription factor SOX-9","Sox9","Rattus norvegicus (Rat)",507,"GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0001501; GO:0001502; GO:0001503; GO:0001658; GO:0001708; GO:0001837; GO:0001894; GO:0001942; GO:0002009; GO:0002053; GO:0002062; GO:0002063; GO:0002067; GO:0002683; GO:0003170; GO:0003179; GO:0003180; GO:0003188; GO:0003203; GO:0003413; GO:0003415; GO:0003430; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006334; GO:0006338; GO:0006357; GO:0006366; GO:0006915; GO:0007010; GO:0007165; GO:0007173; GO:0007219; GO:0007283; GO:0007417; GO:0007507; GO:0008013; GO:0008283; GO:0008284; GO:0008584; GO:0010463; GO:0010467; GO:0010468; GO:0010564; GO:0010628; GO:0010629; GO:0010634; GO:0014032; GO:0019100; GO:0021780; GO:0030155; GO:0030198; GO:0030238; GO:0030279; GO:0030282; GO:0030502; GO:0030850; GO:0030857; GO:0030858; GO:0030879; GO:0030903; GO:0030916; GO:0031018; GO:0032331; GO:0032332; GO:0032808; GO:0032991; GO:0034236; GO:0034504; GO:0035019; GO:0035622; GO:0042127; GO:0042981; GO:0043066; GO:0043425; GO:0043565; GO:0045165; GO:0045595; GO:0045662; GO:0045668; GO:0045732; GO:0045892; GO:0045893; GO:0045944; GO:0046322; GO:0046533; GO:0048665; GO:0048709; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0051216; GO:0060008; GO:0060009; GO:0060018; GO:0060041; GO:0060070; GO:0060174; GO:0060221; GO:0060350; GO:0060441; GO:0060487; GO:0060509; GO:0060512; GO:0060517; GO:0060532; GO:0060534; GO:0060575; GO:0060729; GO:0060784; GO:0061036; GO:0061046; GO:0061138; GO:0061145; GO:0061323; GO:0065003; GO:0070168; GO:0070371; GO:0070384; GO:0070542; GO:0071260; GO:0071300; GO:0071347; GO:0071364; GO:0071504; GO:0071560; GO:0071599; GO:0072034; GO:0072089; GO:0072170; GO:0072189; GO:0072190; GO:0072193; GO:0072197; GO:0072289; GO:0085029; GO:0090090; GO:0090103; GO:0090184; GO:0090190; GO:0097065; GO:0097152; GO:0097157; GO:0098609; GO:1901203; GO:1902732; GO:1902894; GO:1904864; GO:1990837; GO:2000020; GO:2000138; GO:2000648; GO:2000741; GO:2000794; GO:2001054","anterior head development [GO:0097065]; aortic valve morphogenesis [GO:0003180]; apoptotic process [GO:0006915]; astrocyte fate commitment [GO:0060018]; bone mineralization [GO:0030282]; branching involved in ureteric bud morphogenesis [GO:0001658]; bronchus cartilage development [GO:0060532]; canonical Wnt signaling pathway [GO:0060070]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell population proliferation [GO:0008283]; cell proliferation involved in heart morphogenesis [GO:0061323]; cell-cell adhesion [GO:0098609]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to heparin [GO:0071504]; cellular response to interleukin-1 [GO:0071347]; cellular response to mechanical stimulus [GO:0071260]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system development [GO:0007417]; chondrocyte development [GO:0002063]; chondrocyte differentiation [GO:0002062]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; chondrocyte hypertrophy [GO:0003415]; chromatin remodeling [GO:0006338]; cochlea morphogenesis [GO:0090103]; cytoskeleton organization [GO:0007010]; endocardial cushion morphogenesis [GO:0003203]; endochondral bone morphogenesis [GO:0060350]; endocrine pancreas development [GO:0031018]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in prostatic bud elongation [GO:0060517]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; ERK1 and ERK2 cascade [GO:0070371]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; gene expression [GO:0010467]; glandular epithelial cell differentiation [GO:0002067]; glial cell fate specification [GO:0021780]; growth plate cartilage chondrocyte growth [GO:0003430]; hair follicle development [GO:0001942]; Harderian gland development [GO:0070384]; heart development [GO:0007507]; heart valve development [GO:0003170]; heart valve formation [GO:0003188]; heart valve morphogenesis [GO:0003179]; homeostasis of number of cells within a tissue [GO:0048873]; intestinal epithelial cell differentiation [GO:0060575]; intestinal epithelial structure maintenance [GO:0060729]; intrahepatic bile duct development [GO:0035622]; lacrimal gland development [GO:0032808]; limb bud formation [GO:0060174]; lung epithelial cell differentiation [GO:0060487]; lung smooth muscle development [GO:0061145]; male germ-line sex determination [GO:0019100]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; mammary gland development [GO:0030879]; mesenchymal cell apoptotic process [GO:0097152]; mesenchymal cell proliferation [GO:0010463]; metanephric nephron tubule formation [GO:0072289]; metanephric tubule development [GO:0072170]; morphogenesis of a branching epithelium [GO:0061138]; morphogenesis of an epithelium [GO:0002009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of beta-catenin-TCF complex assembly [GO:1904864]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of bone mineralization [GO:0030502]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fatty acid oxidation [GO:0046322]; negative regulation of gene expression [GO:0010629]; negative regulation of immune system process [GO:0002683]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell development [GO:0014032]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; notochord development [GO:0030903]; nucleosome assembly [GO:0006334]; oligodendrocyte differentiation [GO:0048709]; ossification [GO:0001503]; otic vesicle development [GO:0071599]; otic vesicle formation [GO:0030916]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation involved in heart morphogenesis [GO:2000138]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of gene expression [GO:0010628]; positive regulation of kidney development [GO:0090184]; positive regulation of male gonad development [GO:2000020]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland development [GO:0030850]; prostate gland morphogenesis [GO:0060512]; protein localization to nucleus [GO:0034504]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of branching involved in lung morphogenesis [GO:0061046]; regulation of cell adhesion [GO:0030155]; regulation of cell cycle process [GO:0010564]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cell proliferation involved in tissue homeostasis [GO:0060784]; regulation of epithelial cell proliferation involved in lung morphogenesis [GO:2000794]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; renal vesicle induction [GO:0072034]; response to fatty acid [GO:0070542]; retina development in camera-type eye [GO:0060041]; retinal rod cell differentiation [GO:0060221]; Sertoli cell development [GO:0060009]; Sertoli cell differentiation [GO:0060008]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; somatic stem cell population maintenance [GO:0035019]; spermatogenesis [GO:0007283]; stem cell proliferation [GO:0072089]; tissue homeostasis [GO:0001894]; trachea cartilage development [GO:0060534]; transcription by RNA polymerase II [GO:0006366]; type I pneumocyte differentiation [GO:0060509]; ureter development [GO:0072189]; ureter morphogenesis [GO:0072197]; ureter smooth muscle cell differentiation [GO:0072193]; ureter urothelium development [GO:0072190]","nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; beta-catenin binding [GO:0008013]; bHLH transcription factor binding [GO:0043425]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; pre-mRNA intronic binding [GO:0097157]; protein kinase A catalytic subunit binding [GO:0034236]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; anterior head development [GO:0097065]; aortic valve morphogenesis [GO:0003180]; apoptotic process [GO:0006915]; astrocyte fate commitment [GO:0060018]; bone mineralization [GO:0030282]; branching involved in ureteric bud morphogenesis [GO:0001658]; bronchus cartilage development [GO:0060532]; canonical Wnt signaling pathway [GO:0060070]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell population proliferation [GO:0008283]; cell proliferation involved in heart morphogenesis [GO:0061323]; cell-cell adhesion [GO:0098609]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to heparin [GO:0071504]; cellular response to interleukin-1 [GO:0071347]; cellular response to mechanical stimulus [GO:0071260]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system development [GO:0007417]; chondrocyte development [GO:0002063]; chondrocyte differentiation [GO:0002062]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; chondrocyte hypertrophy [GO:0003415]; chromatin remodeling [GO:0006338]; cochlea morphogenesis [GO:0090103]; cytoskeleton organization [GO:0007010]; endocardial cushion morphogenesis [GO:0003203]; endochondral bone morphogenesis [GO:0060350]; endocrine pancreas development [GO:0031018]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in prostatic bud elongation [GO:0060517]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; ERK1 and ERK2 cascade [GO:0070371]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; gene expression [GO:0010467]; glandular epithelial cell differentiation [GO:0002067]; glial cell fate specification [GO:0021780]; growth plate cartilage chondrocyte growth [GO:0003430]; hair follicle development [GO:0001942]; Harderian gland development [GO:0070384]; heart development [GO:0007507]; heart valve development [GO:0003170]; heart valve formation [GO:0003188]; heart valve morphogenesis [GO:0003179]; homeostasis of number of cells within a tissue [GO:0048873]; intestinal epithelial cell differentiation [GO:0060575]; intestinal epithelial structure maintenance [GO:0060729]; intrahepatic bile duct development [GO:0035622]; lacrimal gland development [GO:0032808]; limb bud formation [GO:0060174]; lung epithelial cell differentiation [GO:0060487]; lung smooth muscle development [GO:0061145]; male germ-line sex determination [GO:0019100]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; mammary gland development [GO:0030879]; mesenchymal cell apoptotic process [GO:0097152]; mesenchymal cell proliferation [GO:0010463]; metanephric nephron tubule formation [GO:0072289]; metanephric tubule development [GO:0072170]; morphogenesis of a branching epithelium [GO:0061138]; morphogenesis of an epithelium [GO:0002009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of beta-catenin-TCF complex assembly [GO:1904864]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of bone mineralization [GO:0030502]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fatty acid oxidation [GO:0046322]; negative regulation of gene expression [GO:0010629]; negative regulation of immune system process [GO:0002683]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell development [GO:0014032]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; notochord development [GO:0030903]; nucleosome assembly [GO:0006334]; oligodendrocyte differentiation [GO:0048709]; ossification [GO:0001503]; otic vesicle development [GO:0071599]; otic vesicle formation [GO:0030916]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation involved in heart morphogenesis [GO:2000138]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of gene expression [GO:0010628]; positive regulation of kidney development [GO:0090184]; positive regulation of male gonad development [GO:2000020]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland development [GO:0030850]; prostate gland morphogenesis [GO:0060512]; protein localization to nucleus [GO:0034504]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of branching involved in lung morphogenesis [GO:0061046]; regulation of cell adhesion [GO:0030155]; regulation of cell cycle process [GO:0010564]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cell proliferation involved in tissue homeostasis [GO:0060784]; regulation of epithelial cell proliferation involved in lung morphogenesis [GO:2000794]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; renal vesicle induction [GO:0072034]; response to fatty acid [GO:0070542]; retina development in camera-type eye [GO:0060041]; retinal rod cell differentiation [GO:0060221]; Sertoli cell development [GO:0060009]; Sertoli cell differentiation [GO:0060008]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; somatic stem cell population maintenance [GO:0035019]; spermatogenesis [GO:0007283]; stem cell proliferation [GO:0072089]; tissue homeostasis [GO:0001894]; trachea cartilage development [GO:0060534]; transcription by RNA polymerase II [GO:0006366]; type I pneumocyte differentiation [GO:0060509]; ureter development [GO:0072189]; ureter morphogenesis [GO:0072197]; ureter smooth muscle cell differentiation [GO:0072193]; ureter urothelium development [GO:0072190]","","","",""
"917","sp|Q4AE28|DMTA2_TAKRU","lcl|NC_088859.1_cds_NP_001295834.1_38199",1.09e-42,154,"Q4AE28","DMTA2_TAKRU","Doublesex- and mab-3-related transcription factor A2 (Doublesex- and mab-3-related transcription factor 5)","dmrta2 dmrt5","Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)",416,"GO:0000978; GO:0000981; GO:0005634; GO:0007281; GO:0007548; GO:0046872","germ cell development [GO:0007281]; sex differentiation [GO:0007548]","nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; germ cell development [GO:0007281]; sex differentiation [GO:0007548]","","","",""
"918","sp|Q9V629|CUFF_DROME","lcl|NC_088859.1_cds_XP_011412324.3_35220",7.02e-18,85.9,"Q9V629","CUFF_DROME","Protein cutoff","cuff CG13190","Drosophila melanogaster (Fruit fly)",384,"GO:0000956; GO:0001015; GO:0005634; GO:0005694; GO:0005737; GO:0005829; GO:0009953; GO:0030422; GO:0030717; GO:0030719; GO:0030723; GO:0030727; GO:0034587; GO:0048471; GO:0048477; GO:0110155; GO:0140543; GO:1905382; GO:1990469; GO:1990470","dorsal/ventral pattern formation [GO:0009953]; germarium-derived female germ-line cyst formation [GO:0030727]; NAD-cap decapping [GO:0110155]; nuclear-transcribed mRNA catabolic process [GO:0000956]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; positive regulation of piRNA transcription [GO:0140543]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; siRNA processing [GO:0030422]; snoRNA transcription by RNA polymerase II [GO:0001015]","chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Rhino-Deadlock-Cutoff Complex [GO:1990469]; piRNA cluster binding [GO:1990470]; dorsal/ventral pattern formation [GO:0009953]; germarium-derived female germ-line cyst formation [GO:0030727]; NAD-cap decapping [GO:0110155]; nuclear-transcribed mRNA catabolic process [GO:0000956]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; positive regulation of piRNA transcription [GO:0140543]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; siRNA processing [GO:0030422]; snoRNA transcription by RNA polymerase II [GO:0001015]","","","",""
"919","sp|P48759|PTX3_MOUSE","lcl|NC_088859.1_cds_XP_011413013.3_40203",4.78e-13,72.4,"P48759","PTX3_MOUSE","Pentraxin-related protein PTX3 (Pentaxin-related protein PTX3) (Tumor necrosis factor-inducible gene 14 protein) (TSG-14)","Ptx3 Tsg14","Mus musculus (Mouse)",381,"GO:0001550; GO:0001849; GO:0001872; GO:0001878; GO:0005615; GO:0008228; GO:0030198; GO:0031012; GO:0042802; GO:0044871; GO:0045429; GO:0046597; GO:0046790; GO:0050766","extracellular matrix organization [GO:0030198]; host-mediated suppression of symbiont invasion [GO:0046597]; negative regulation by host of viral glycoprotein metabolic process [GO:0044871]; opsonization [GO:0008228]; ovarian cumulus expansion [GO:0001550]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; response to yeast [GO:0001878]","extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; (1->3)-beta-D-glucan binding [GO:0001872]; complement component C1q complex binding [GO:0001849]; identical protein binding [GO:0042802]; virion binding [GO:0046790]; extracellular matrix organization [GO:0030198]; host-mediated suppression of symbiont invasion [GO:0046597]; negative regulation by host of viral glycoprotein metabolic process [GO:0044871]; opsonization [GO:0008228]; ovarian cumulus expansion [GO:0001550]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; response to yeast [GO:0001878]","","","",""
"920","sp|P40423|SQH_DROME","lcl|NC_088859.1_cds_XP_011413988.1_34668",5.43e-88,256,"P40423","SQH_DROME","Myosin regulatory light chain sqh (Myosin regulatory light chain, nonmuscle) (MRLC-C) (Protein spaghetti-squash)","sqh CG3595","Drosophila melanogaster (Fruit fly)",174,"GO:0000281; GO:0001671; GO:0003383; GO:0003384; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0007298; GO:0007300; GO:0007314; GO:0009791; GO:0016324; GO:0016460; GO:0030048; GO:0030496; GO:0031036; GO:0032036; GO:0032154; GO:0032956; GO:0035148; GO:0035159; GO:0035183; GO:0035191; GO:0035277; GO:0035317; GO:0040011; GO:0042060; GO:0045177; GO:0045179; GO:0045199; GO:0045879; GO:0051233; GO:0060288; GO:0060289; GO:0090254; GO:0106037; GO:0110069; GO:0110071; GO:1903144; GO:1903688","actin filament-based movement [GO:0030048]; apical constriction [GO:0003383]; apical constriction involved in gastrulation [GO:0003384]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compartment boundary maintenance [GO:0060289]; formation of a compartment boundary [GO:0060288]; imaginal disc-derived wing hair organization [GO:0035317]; locomotion [GO:0040011]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear axial expansion [GO:0035191]; oocyte anterior/posterior axis specification [GO:0007314]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of border follicle cell migration [GO:1903688]; post-embryonic development [GO:0009791]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of tube length, open tracheal system [GO:0035159]; spiracle morphogenesis, open tracheal system [GO:0035277]; syncytial embryo cellularization [GO:0110069]; tube formation [GO:0035148]; wound healing [GO:0042060]","actomyosin contractile ring actin filament [GO:1903144]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cellularization cleavage furrow invagination front [GO:0110071]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germline ring canal inner rim [GO:0035183]; midbody [GO:0030496]; myosin II complex [GO:0016460]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; ATPase activator activity [GO:0001671]; calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; actin filament-based movement [GO:0030048]; apical constriction [GO:0003383]; apical constriction involved in gastrulation [GO:0003384]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compartment boundary maintenance [GO:0060289]; formation of a compartment boundary [GO:0060288]; imaginal disc-derived wing hair organization [GO:0035317]; locomotion [GO:0040011]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear axial expansion [GO:0035191]; oocyte anterior/posterior axis specification [GO:0007314]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of border follicle cell migration [GO:1903688]; post-embryonic development [GO:0009791]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of tube length, open tracheal system [GO:0035159]; spiracle morphogenesis, open tracheal system [GO:0035277]; syncytial embryo cellularization [GO:0110069]; tube formation [GO:0035148]; wound healing [GO:0042060]","","","",""
"921","sp|Q9GZP4|PITH1_HUMAN","lcl|NC_088859.1_cds_XP_011414004.1_34679",5.47e-58,183,"Q9GZP4","PITH1_HUMAN","PITH domain-containing protein 1","PITHD1 C1orf128 AD039 HT014 PP603","Homo sapiens (Human)",211,"GO:0005634; GO:0005737; GO:0007286; GO:0007341; GO:0045654; GO:0045893; GO:0061136; GO:0061956; GO:0097598","penetration of cumulus oophorus [GO:0061956]; penetration of zona pellucida [GO:0007341]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of megakaryocyte differentiation [GO:0045654]; regulation of proteasomal protein catabolic process [GO:0061136]; spermatid development [GO:0007286]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; sperm cytoplasmic droplet [GO:0097598]; penetration of cumulus oophorus [GO:0061956]; penetration of zona pellucida [GO:0007341]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of megakaryocyte differentiation [GO:0045654]; regulation of proteasomal protein catabolic process [GO:0061136]; spermatid development [GO:0007286]","","INDUCTION: Up-regulated in K562 and HEL cells undergoing megakaryocyte differentiation induced by phorbol myristate acetate (PMA). {ECO:0000269|PubMed:25134913}.","INDUCTION: Up-regulated in K562 and HEL cells undergoing megakaryocyte differentiation induced by phorbol myristate acetate (PMA). {ECO:0000269|PubMed:25134913}.","TISSUE SPECIFICITY: Down-regulated in primary acute myeloid leukemia (AML) patients. {ECO:0000269|PubMed:25134913}."
"922","sp|Q96A70|AZIN2_HUMAN","lcl|NC_088859.1_cds_XP_011414122.1_37686",1.2e-107,328,"Q96A70","AZIN2_HUMAN","Antizyme inhibitor 2 (AzI2) (Arginine decarboxylase) (ADC) (ARGDC) (Ornithine decarboxylase-like protein) (ODC-like protein) (ornithine decarboxylase paralog) (ODC-p)","AZIN2 ADC KIAA1945 ODCP","Homo sapiens (Human)",460,"GO:0005634; GO:0005737; GO:0005739; GO:0005801; GO:0005802; GO:0005829; GO:0006591; GO:0007283; GO:0008792; GO:0030133; GO:0030424; GO:0030425; GO:0031410; GO:0033116; GO:0033387; GO:0042177; GO:0042978; GO:0043085; GO:0043204; GO:0048471; GO:0097055; GO:0098629; GO:1902269; GO:1990005","agmatine biosynthetic process [GO:0097055]; negative regulation of protein catabolic process [GO:0042177]; ornithine metabolic process [GO:0006591]; positive regulation of catalytic activity [GO:0043085]; positive regulation of polyamine transmembrane transport [GO:1902269]; putrescine biosynthetic process from arginine, via ornithine [GO:0033387]; spermatogenesis [GO:0007283]; trans-Golgi network membrane organization [GO:0098629]","axon [GO:0030424]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; granular vesicle [GO:1990005]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; arginine decarboxylase activity [GO:0008792]; ornithine decarboxylase activator activity [GO:0042978]; agmatine biosynthetic process [GO:0097055]; negative regulation of protein catabolic process [GO:0042177]; ornithine metabolic process [GO:0006591]; positive regulation of catalytic activity [GO:0043085]; positive regulation of polyamine transmembrane transport [GO:1902269]; putrescine biosynthetic process from arginine, via ornithine [GO:0033387]; spermatogenesis [GO:0007283]; trans-Golgi network membrane organization [GO:0098629]","","","","TISSUE SPECIFICITY: Expressed in the neocortex, thalamus, hippocampus, cerebellum, medulla oblongata, gray and white matter. Expressed in neurons, oligodendrocytes, basket, Purkinje and pyramidal cells. Expressed in spermatocytes and Leydig cells of the testis. Expressed in luteal theca cells lining corpus luteum cysts and in hilus cells of the ovary. Expressed in primary and neoplastic mast cells (MC) (at protein level). Highly expressed in brain. Also expressed in testis. {ECO:0000269|PubMed:11587527, ECO:0000269|PubMed:14738999, ECO:0000269|PubMed:19718454, ECO:0000269|PubMed:19756694, ECO:0000269|PubMed:19832840}."
"923","sp|Q6P0Q8|MAST2_HUMAN","lcl|NC_088859.1_cds_XP_011414913.2_35172",0,919,"Q6P0Q8","MAST2_HUMAN","Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1)","MAST2 KIAA0807 MAST205","Homo sapiens (Human)",1798,"GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0019902; GO:0032655; GO:0035556; GO:0048515; GO:0106310","cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515]","cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515]","","","","TISSUE SPECIFICITY: Abundant in the testis. {ECO:0000269|PubMed:8902215}."
"924","sp|F1SS88|CFA52_PIG","lcl|NC_088859.1_cds_XP_011416101.1_39894",0,666,"F1SS88","CFA52_PIG","Cilia- and flagella-associated protein 52 (WD repeat-containing protein 16)","CFAP52 WDR16","Sus scrofa (Pig)",620,"GO:0005879; GO:0005930; GO:0007286; GO:0007338; GO:0010467; GO:0030317; GO:0036126; GO:0051012; GO:0061966; GO:0097225; GO:0097729; GO:0160112","establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317]; gene expression [GO:0010467]; microtubule sliding [GO:0051012]; single fertilization [GO:0007338]; spermatid development [GO:0007286]","9+2 motile cilium [GO:0097729]; axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317]; gene expression [GO:0010467]; microtubule sliding [GO:0051012]; single fertilization [GO:0007338]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Expressed in respiratory cells and sperm (at protein level). {ECO:0000269|PubMed:33139725}."
"925","sp|Q9W0T1|NU301_DROME","lcl|NC_088859.1_cds_XP_011416108.3_39902",2.86e-97,354,"Q9W0T1","NU301_DROME","Nucleosome-remodeling factor subunit NURF301 (Enhancer of bithorax) (Nucleosome-remodeling factor 215 kDa subunit) (NURF-215)","E(bx) CG32346 CG7022 Nurf301","Drosophila melanogaster (Fruit fly)",2669,"GO:0000978; GO:0003713; GO:0005634; GO:0006338; GO:0006355; GO:0006357; GO:0008270; GO:0010468; GO:0016589; GO:0016922; GO:0030097; GO:0034728; GO:0035064; GO:0045824; GO:0045892; GO:0045893; GO:0045944; GO:0046426; GO:0048515; GO:0070577","chromatin remodeling [GO:0006338]; hemopoiesis [GO:0030097]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of innate immune response [GO:0045824]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; nucleosome organization [GO:0034728]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid differentiation [GO:0048515]","nucleus [GO:0005634]; NURF complex [GO:0016589]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; nuclear receptor binding [GO:0016922]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; hemopoiesis [GO:0030097]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of innate immune response [GO:0045824]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; nucleosome organization [GO:0034728]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid differentiation [GO:0048515]","","","",""
"926","sp|B2GUN4|MARF1_XENTR","lcl|NC_088859.1_cds_XP_011416545.3_37486",0,622,"B2GUN4","MARF1_XENTR","Meiosis regulator and mRNA stability factor 1 (Limkain-b1) (Meiosis arrest female protein 1 homolog)","marf1 lkap","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)",1681,"GO:0003723; GO:0004540; GO:0005777; GO:0010468; GO:0048477; GO:0051321","meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; regulation of gene expression [GO:0010468]","peroxisome [GO:0005777]; RNA binding [GO:0003723]; RNA nuclease activity [GO:0004540]; meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; regulation of gene expression [GO:0010468]","","","",""
"927","sp|Q6AXN4|NDC1_RAT","lcl|NC_088859.1_cds_XP_011416951.3_34555",3.48e-58,207,"Q6AXN4","NDC1_RAT","Nucleoporin NDC1 (Transmembrane protein 48)","Ndc1 Tmem48","Rattus norvegicus (Rat)",673,"GO:0005635; GO:0005643; GO:0005737; GO:0006999; GO:0007129; GO:0007283; GO:0015031; GO:0017056; GO:0030674; GO:0031965; GO:0051028; GO:0051292; GO:0051664; GO:0070762","homologous chromosome pairing at meiosis [GO:0007129]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore localization [GO:0051664]; nuclear pore organization [GO:0006999]; protein transport [GO:0015031]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore transmembrane ring [GO:0070762]; protein-macromolecule adaptor activity [GO:0030674]; structural constituent of nuclear pore [GO:0017056]; homologous chromosome pairing at meiosis [GO:0007129]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore localization [GO:0051664]; nuclear pore organization [GO:0006999]; protein transport [GO:0015031]; spermatogenesis [GO:0007283]","","","",""
"928","sp|Q9BW83|IFT27_HUMAN","lcl|NC_088859.1_cds_XP_011417472.1_37272",1.79e-72,218,"Q9BW83","IFT27_HUMAN","Intraflagellar transport protein 27 homolog (Putative GTP-binding protein RAY-like) (Rab-like protein 4)","IFT27 RABL4 RAYL","Homo sapiens (Human)",186,"GO:0000139; GO:0001822; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0005929; GO:0006886; GO:0007224; GO:0007283; GO:0016192; GO:0030992; GO:0031514; GO:0035720; GO:0036126; GO:0042073; GO:0060122; GO:0060271; GO:0090102; GO:0097225; GO:0097228; GO:0097542","cilium assembly [GO:0060271]; cochlea development [GO:0090102]; inner ear receptor cell stereocilium organization [GO:0060122]; intracellular protein transport [GO:0006886]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192]","centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cilium assembly [GO:0060271]; cochlea development [GO:0090102]; inner ear receptor cell stereocilium organization [GO:0060122]; intracellular protein transport [GO:0006886]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192]","","","",""
"929","sp|P40792|RAC1_DROME","lcl|NC_088859.1_cds_XP_011417514.1_37311",1.84e-123,347,"P40792","RAC1_DROME","Ras-related protein Rac1","Rac1 RacA CG2248","Drosophila melanogaster (Fruit fly)",192,"GO:0001726; GO:0001954; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006911; GO:0007015; GO:0007163; GO:0007254; GO:0007298; GO:0007390; GO:0007391; GO:0007394; GO:0007395; GO:0007411; GO:0007413; GO:0007419; GO:0007422; GO:0007424; GO:0007426; GO:0007435; GO:0007516; GO:0007520; GO:0007613; GO:0008045; GO:0008078; GO:0008258; GO:0008347; GO:0008360; GO:0009611; GO:0010593; GO:0016028; GO:0016199; GO:0016203; GO:0016358; GO:0016601; GO:0019901; GO:0030030; GO:0030031; GO:0030032; GO:0030036; GO:0030295; GO:0030865; GO:0030866; GO:0031175; GO:0031410; GO:0032794; GO:0032956; GO:0035010; GO:0035011; GO:0035099; GO:0035212; GO:0035320; GO:0036090; GO:0042052; GO:0042995; GO:0045773; GO:0045887; GO:0046330; GO:0046664; GO:0046843; GO:0048010; GO:0048615; GO:0048675; GO:0048812; GO:0048814; GO:0050770; GO:0050807; GO:0050975; GO:0051017; GO:0051450; GO:0051491; GO:0051963; GO:0055001; GO:0060326; GO:0071902; GO:0071907; GO:0090303; GO:0097206; GO:0110125; GO:1902669; GO:1903391; GO:1903688; GO:1904059","actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonal fasciculation [GO:0007413]; border follicle cell migration [GO:0007298]; cell chemotaxis [GO:0060326]; cell competition in a multicellular organism [GO:0035212]; cell projection assembly [GO:0030031]; cell projection organization [GO:0030030]; cleavage furrow ingression [GO:0036090]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; dendrite development [GO:0016358]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, elongation of leading edge cells [GO:0007394]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; encapsulation of foreign target [GO:0035010]; establishment or maintenance of cell polarity [GO:0007163]; germ-band shortening [GO:0007390]; glial cell migration [GO:0008347]; head involution [GO:0008258]; hemocyte development [GO:0007516]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair site selection [GO:0035320]; JNK cascade [GO:0007254]; lamellipodium assembly [GO:0030032]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; mesodermal cell migration [GO:0008078]; motor neuron axon guidance [GO:0008045]; muscle attachment [GO:0016203]; muscle cell development [GO:0055001]; myoblast fusion [GO:0007520]; myoblast proliferation [GO:0051450]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of myotube cell migration [GO:0110125]; nephrocyte filtration [GO:0097206]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; phagocytosis, engulfment [GO:0006911]; positive regulation of axon extension [GO:0045773]; positive regulation of axon guidance [GO:1902669]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of wound healing [GO:0090303]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of adherens junction organization [GO:1903391]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of dendrite morphogenesis [GO:0048814]; regulation of locomotor rhythm [GO:1904059]; regulation of synapse assembly [GO:0051963]; regulation of synapse organization [GO:0050807]; response to wounding [GO:0009611]; rhabdomere development [GO:0042052]; salivary gland morphogenesis [GO:0007435]; sensory perception of touch [GO:0050975]; tracheal outgrowth, open tracheal system [GO:0007426]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; ventral cord development [GO:0007419]","cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; ruffle [GO:0001726]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonal fasciculation [GO:0007413]; border follicle cell migration [GO:0007298]; cell chemotaxis [GO:0060326]; cell competition in a multicellular organism [GO:0035212]; cell projection assembly [GO:0030031]; cell projection organization [GO:0030030]; cleavage furrow ingression [GO:0036090]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; dendrite development [GO:0016358]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, elongation of leading edge cells [GO:0007394]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; encapsulation of foreign target [GO:0035010]; establishment or maintenance of cell polarity [GO:0007163]; germ-band shortening [GO:0007390]; glial cell migration [GO:0008347]; head involution [GO:0008258]; hemocyte development [GO:0007516]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair site selection [GO:0035320]; JNK cascade [GO:0007254]; lamellipodium assembly [GO:0030032]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; mesodermal cell migration [GO:0008078]; motor neuron axon guidance [GO:0008045]; muscle attachment [GO:0016203]; muscle cell development [GO:0055001]; myoblast fusion [GO:0007520]; myoblast proliferation [GO:0051450]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of myotube cell migration [GO:0110125]; nephrocyte filtration [GO:0097206]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; phagocytosis, engulfment [GO:0006911]; positive regulation of axon extension [GO:0045773]; positive regulation of axon guidance [GO:1902669]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of wound healing [GO:0090303]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of adherens junction organization [GO:1903391]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of dendrite morphogenesis [GO:0048814]; regulation of locomotor rhythm [GO:1904059]; regulation of synapse assembly [GO:0051963]; regulation of synapse organization [GO:0050807]; response to wounding [GO:0009611]; rhabdomere development [GO:0042052]; salivary gland morphogenesis [GO:0007435]; sensory perception of touch [GO:0050975]; tracheal outgrowth, open tracheal system [GO:0007426]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; ventral cord development [GO:0007419]","","","","TISSUE SPECIFICITY: Detected in oocyte border cells (BC), with increased expression at the front of the BC cluster. {ECO:0000269|PubMed:24855950}."
"930","sp|Q9NVP2|ASF1B_HUMAN","lcl|NC_088859.1_cds_XP_011418256.2_34251",4.83e-81,241,"Q9NVP2","ASF1B_HUMAN","Histone chaperone ASF1B (Anti-silencing function protein 1 homolog B) (hAsf1) (hAsf1b) (CCG1-interacting factor A-II) (CIA-II) (hCIA-II)","ASF1B","Homo sapiens (Human)",202,"GO:0000785; GO:0001835; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0006335; GO:0007283; GO:0030154; GO:0032991; GO:0042393; GO:0140713","blastocyst hatching [GO:0001835]; cell differentiation [GO:0030154]; DNA replication-dependent chromatin assembly [GO:0006335]; nucleosome assembly [GO:0006334]; spermatogenesis [GO:0007283]","chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; blastocyst hatching [GO:0001835]; cell differentiation [GO:0030154]; DNA replication-dependent chromatin assembly [GO:0006335]; nucleosome assembly [GO:0006334]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Highly expressed in testis and at lower levels in colon, small intestine and thymus. {ECO:0000269|PubMed:12842904}."
"931","sp|M9NEY8|TET_DROME","lcl|NC_088859.1_cds_XP_011419074.3_36298",1.46e-113,392,"M9NEY8","TET_DROME","Methylcytosine dioxygenase TET (EC 1.14.11.80) (DNA 6mA demethylase) (DNA N6-methyl adenine demethylase) (EC 1.14.11.51)","Tet DMAD CG2083 CG43444 CG9973","Drosophila melanogaster (Fruit fly)",2860,"GO:0003677; GO:0005634; GO:0005694; GO:0006304; GO:0007281; GO:0008270; GO:0009451; GO:0010526; GO:0045944; GO:0070579; GO:0141131; GO:0141167","chromosomal 5-methylcytosine DNA demethylation, oxidation pathway [GO:0141167]; DNA modification [GO:0006304]; germ cell development [GO:0007281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA modification [GO:0009451]; transposable element silencing [GO:0010526]","chromosome [GO:0005694]; nucleus [GO:0005634]; 5-methylcytosine dioxygenase activity [GO:0070579]; DNA binding [GO:0003677]; DNA N6-methyladenine demethylase activity [GO:0141131]; zinc ion binding [GO:0008270]; chromosomal 5-methylcytosine DNA demethylation, oxidation pathway [GO:0141167]; DNA modification [GO:0006304]; germ cell development [GO:0007281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA modification [GO:0009451]; transposable element silencing [GO:0010526]","DEVELOPMENTAL STAGE: Weakly expressed during early embryonic stages but is highly expressed during the later embryonic stages. {ECO:0000269|PubMed:25936838}.","","","TISSUE SPECIFICITY: Expressed in brain (at protein level). {ECO:0000269|PubMed:30078725}."
"932","sp|P84243|H33_HUMAN","lcl|NC_088859.1_cds_XP_011420805.1_39760",4.72e-96,273,"P84243","H33_HUMAN","Histone H3.3","H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B","Homo sapiens (Human)",136,"GO:0000781; GO:0000786; GO:0000939; GO:0000978; GO:0000979; GO:0001556; GO:0001649; GO:0001740; GO:0005576; GO:0005634; GO:0005654; GO:0006334; GO:0006997; GO:0007286; GO:0007338; GO:0007566; GO:0008283; GO:0008584; GO:0030307; GO:0030527; GO:0031492; GO:0031508; GO:0031509; GO:0032200; GO:0032991; GO:0035264; GO:0042692; GO:0046982; GO:0070062; GO:0090230; GO:1902340","cell population proliferation [GO:0008283]; embryo implantation [GO:0007566]; male gonad development [GO:0008584]; multicellular organism growth [GO:0035264]; muscle cell differentiation [GO:0042692]; negative regulation of chromosome condensation [GO:1902340]; nucleosome assembly [GO:0006334]; nucleus organization [GO:0006997]; oocyte maturation [GO:0001556]; osteoblast differentiation [GO:0001649]; pericentric heterochromatin formation [GO:0031508]; positive regulation of cell growth [GO:0030307]; regulation of centromere complex assembly [GO:0090230]; single fertilization [GO:0007338]; spermatid development [GO:0007286]; subtelomeric heterochromatin formation [GO:0031509]; telomere organization [GO:0032200]","Barr body [GO:0001740]; chromosome, telomeric region [GO:0000781]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; inner kinetochore [GO:0000939]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; structural constituent of chromatin [GO:0030527]; cell population proliferation [GO:0008283]; embryo implantation [GO:0007566]; male gonad development [GO:0008584]; multicellular organism growth [GO:0035264]; muscle cell differentiation [GO:0042692]; negative regulation of chromosome condensation [GO:1902340]; nucleosome assembly [GO:0006334]; nucleus organization [GO:0006997]; oocyte maturation [GO:0001556]; osteoblast differentiation [GO:0001649]; pericentric heterochromatin formation [GO:0031508]; positive regulation of cell growth [GO:0030307]; regulation of centromere complex assembly [GO:0090230]; single fertilization [GO:0007338]; spermatid development [GO:0007286]; subtelomeric heterochromatin formation [GO:0031509]; telomere organization [GO:0032200]","DEVELOPMENTAL STAGE: Expressed throughout the cell cycle independently of DNA synthesis.","","",""
"933","sp|O95661|DIRA3_HUMAN","lcl|NC_088859.1_cds_XP_011422081.1_34767",2.2e-61,193,"O95661","DIRA3_HUMAN","GTP-binding protein Di-Ras3 (Distinct subgroup of the Ras family member 3) (Rho-related GTP-binding protein RhoI)","DIRAS3 ARHI NOEY2 RHOI","Homo sapiens (Human)",229,"GO:0000079; GO:0003924; GO:0005525; GO:0005886; GO:0007264; GO:0019003; GO:0071514","genomic imprinting [GO:0071514]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; small GTPase-mediated signal transduction [GO:0007264]","plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; genomic imprinting [GO:0071514]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; small GTPase-mediated signal transduction [GO:0007264]","","","","TISSUE SPECIFICITY: Expressed in normal ovarian and breast epithelial cells but not in ovarian and breast cancers."
"934","sp|Q9GRC0|MOS_PATPE","lcl|NC_088859.1_cds_XP_011422084.2_34765",4.94e-77,241,"Q9GRC0","MOS_PATPE","Serine/threonine-protein kinase mos (EC 2.7.11.1) (Oocyte maturation factor mos)","mos","Patiria pectinifera (Starfish) (Asterina pectinifera)",351,"GO:0004709; GO:0005524; GO:0007147; GO:0007292; GO:0045930; GO:0106310","female gamete generation [GO:0007292]; female meiosis II [GO:0007147]; negative regulation of mitotic cell cycle [GO:0045930]","ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310]; female gamete generation [GO:0007292]; female meiosis II [GO:0007147]; negative regulation of mitotic cell cycle [GO:0045930]","DEVELOPMENTAL STAGE: Expression is first detected in immature oocytes just after germinal vesicle breakdown (GVBD). Expression remains throughout both meiotic cycles, unless fertilization occurs, and disappears after fertilization (at protein level). {ECO:0000269|PubMed:11121036}.","","",""
"935","sp|Q14106|TOB2_HUMAN","lcl|NC_088859.1_cds_XP_011423553.2_39872",8.5e-49,169,"Q14106","TOB2_HUMAN","Protein Tob2 (Protein Tob4) (Transducer of erbB-2 2)","TOB2 KIAA1663 TOB4 TROB2","Homo sapiens (Human)",344,"GO:0003714; GO:0005634; GO:0005737; GO:0005829; GO:0007292; GO:0008285; GO:0010468; GO:0030316; GO:0042809; GO:0045671; GO:0045778","female gamete generation [GO:0007292]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of osteoclast differentiation [GO:0045671]; osteoclast differentiation [GO:0030316]; positive regulation of ossification [GO:0045778]; regulation of gene expression [GO:0010468]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; nuclear vitamin D receptor binding [GO:0042809]; transcription corepressor activity [GO:0003714]; female gamete generation [GO:0007292]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of osteoclast differentiation [GO:0045671]; osteoclast differentiation [GO:0030316]; positive regulation of ossification [GO:0045778]; regulation of gene expression [GO:0010468]","","","","TISSUE SPECIFICITY: Ubiquitous."
"936","sp|P25843|PROF_DROME","lcl|NC_088859.1_cds_XP_011423689.3_37580",1.42e-18,77,"P25843","PROF_DROME","Profilin (Protein chickadee)","chic chi CG9553","Drosophila melanogaster (Fruit fly)",126,"GO:0000281; GO:0000902; GO:0000915; GO:0003785; GO:0005737; GO:0005856; GO:0005938; GO:0007015; GO:0007300; GO:0007391; GO:0007420; GO:0007436; GO:0007488; GO:0016322; GO:0030041; GO:0030717; GO:0032507; GO:0035019; GO:0035193; GO:0036098; GO:0042060; GO:0043005; GO:0045451; GO:0048471; GO:0048680; GO:0048842; GO:0051491","actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]","cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]","","","","TISSUE SPECIFICITY: Expressed in ovary and head. {ECO:0000269|PubMed:15917496}."
"937","sp|W7K139|PLP1_PLAFO","lcl|NC_088859.1_cds_XP_011424129.3_35202",9.21e-18,89.4,"W7K139","PLP1_PLAFO","Patatin-like phospholipase 1 (EC 3.1.1.4) (PfPATPL1)","PATPL1 PNPLA1 CK202_3157 PFNF54_00248","Plasmodium falciparum (isolate NF54)",679,"GO:0004623; GO:0005737; GO:0006631; GO:0007276; GO:0016020; GO:0034638","fatty acid metabolic process [GO:0006631]; gamete generation [GO:0007276]; phosphatidylcholine catabolic process [GO:0034638]","cytoplasm [GO:0005737]; membrane [GO:0016020]; phospholipase A2 activity [GO:0004623]; fatty acid metabolic process [GO:0006631]; gamete generation [GO:0007276]; phosphatidylcholine catabolic process [GO:0034638]","DEVELOPMENTAL STAGE: Expressed during the asexual blood stage, including in rings, trophozoites and schizonts (at protein level) (PubMed:31413195, PubMed:31734953). Expressed in male and female gametocytes from stage II to stage V (at protein level) (PubMed:31413195, PubMed:31734953). {ECO:0000269|PubMed:31413195, ECO:0000269|PubMed:31734953}.","","",""
"938","sp|Q6NU56|MET14_XENLA","lcl|NC_088859.1_cds_XP_011424173.3_37499",2.41e-180,513,"Q6NU56","MET14_XENLA","N(6)-adenosine-methyltransferase non-catalytic subunit METTL14 (Methyltransferase-like protein 14)","mettl14","Xenopus laevis (African clawed frog)",456,"GO:0000398; GO:0001510; GO:0001734; GO:0003729; GO:0005634; GO:0006397; GO:0007283; GO:0016556; GO:0019827; GO:0021861; GO:0036396; GO:0042063; GO:0061157","forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA destabilization [GO:0061157]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]","nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA binding [GO:0003729]; mRNA m(6)A methyltransferase activity [GO:0001734]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA destabilization [GO:0061157]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]","","","",""
"939","sp|Q13635|PTC1_HUMAN","lcl|NC_088859.1_cds_XP_011424323.3_34710",0,1006,"Q13635","PTC1_HUMAN","Protein patched homolog 1 (PTC) (PTC1)","PTCH1 PTCH","Homo sapiens (Human)",1447,"GO:0000122; GO:0001658; GO:0001701; GO:0001709; GO:0001843; GO:0003007; GO:0005113; GO:0005119; GO:0005886; GO:0005901; GO:0007165; GO:0007286; GO:0007346; GO:0007420; GO:0008158; GO:0008201; GO:0008589; GO:0009410; GO:0009612; GO:0009887; GO:0009953; GO:0009957; GO:0010157; GO:0010839; GO:0010875; GO:0015485; GO:0016485; GO:0021522; GO:0021532; GO:0021904; GO:0021997; GO:0030326; GO:0030332; GO:0030496; GO:0030666; GO:0030850; GO:0032355; GO:0032526; GO:0032880; GO:0035108; GO:0035137; GO:0040015; GO:0042593; GO:0043231; GO:0043616; GO:0044294; GO:0044295; GO:0044877; GO:0045177; GO:0045211; GO:0045606; GO:0045668; GO:0045879; GO:0045893; GO:0048471; GO:0048568; GO:0048745; GO:0051782; GO:0060037; GO:0060170; GO:0060603; GO:0060644; GO:0061005; GO:0061053; GO:0071397; GO:0071679; GO:0072089; GO:0072203; GO:0072205; GO:0072659; GO:0097108; GO:0097421; GO:2000647","animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation involved in kidney development [GO:0061005]; cell fate determination [GO:0001709]; cell proliferation involved in metanephros development [GO:0072203]; cellular response to cholesterol [GO:0071397]; commissural neuron axon guidance [GO:0071679]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; epidermal cell fate specification [GO:0009957]; glucose homeostasis [GO:0042593]; heart morphogenesis [GO:0003007]; hindlimb morphogenesis [GO:0035137]; in utero embryonic development [GO:0001701]; keratinocyte proliferation [GO:0043616]; limb morphogenesis [GO:0035108]; liver regeneration [GO:0097421]; mammary gland duct morphogenesis [GO:0060603]; mammary gland epithelial cell differentiation [GO:0060644]; metanephric collecting duct development [GO:0072205]; negative regulation of cell division [GO:0051782]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural plate axis specification [GO:0021997]; neural tube closure [GO:0001843]; neural tube patterning [GO:0021532]; pharyngeal system development [GO:0060037]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epidermal cell differentiation [GO:0045606]; prostate gland development [GO:0030850]; protein localization to plasma membrane [GO:0072659]; protein processing [GO:0016485]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization [GO:0032880]; regulation of smoothened signaling pathway [GO:0008589]; response to chlorate [GO:0010157]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; smooth muscle tissue development [GO:0048745]; somite development [GO:0061053]; spermatid development [GO:0007286]; spinal cord motor neuron differentiation [GO:0021522]; stem cell proliferation [GO:0072089]","apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; caveola [GO:0005901]; ciliary membrane [GO:0060170]; dendritic growth cone [GO:0044294]; endocytic vesicle membrane [GO:0030666]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; cholesterol binding [GO:0015485]; cyclin binding [GO:0030332]; hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; heparin binding [GO:0008201]; patched binding [GO:0005113]; protein-containing complex binding [GO:0044877]; smoothened binding [GO:0005119]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation involved in kidney development [GO:0061005]; cell fate determination [GO:0001709]; cell proliferation involved in metanephros development [GO:0072203]; cellular response to cholesterol [GO:0071397]; commissural neuron axon guidance [GO:0071679]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; epidermal cell fate specification [GO:0009957]; glucose homeostasis [GO:0042593]; heart morphogenesis [GO:0003007]; hindlimb morphogenesis [GO:0035137]; in utero embryonic development [GO:0001701]; keratinocyte proliferation [GO:0043616]; limb morphogenesis [GO:0035108]; liver regeneration [GO:0097421]; mammary gland duct morphogenesis [GO:0060603]; mammary gland epithelial cell differentiation [GO:0060644]; metanephric collecting duct development [GO:0072205]; negative regulation of cell division [GO:0051782]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural plate axis specification [GO:0021997]; neural tube closure [GO:0001843]; neural tube patterning [GO:0021532]; pharyngeal system development [GO:0060037]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epidermal cell differentiation [GO:0045606]; prostate gland development [GO:0030850]; protein localization to plasma membrane [GO:0072659]; protein processing [GO:0016485]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization [GO:0032880]; regulation of smoothened signaling pathway [GO:0008589]; response to chlorate [GO:0010157]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; smooth muscle tissue development [GO:0048745]; somite development [GO:0061053]; spermatid development [GO:0007286]; spinal cord motor neuron differentiation [GO:0021522]; stem cell proliferation [GO:0072089]","DEVELOPMENTAL STAGE: In the embryo, found in all major target tissues of sonic hedgehog, such as the ventral neural tube, somites, and tissues surrounding the zone of polarizing activity of the limb bud.","","","TISSUE SPECIFICITY: In the adult, expressed in brain, lung, liver, heart, placenta, skeletal muscle, pancreas and kidney. Expressed in tumor cells but not in normal skin."
"940","sp|Q32KZ2|ACL7A_BOVIN","lcl|NC_088859.1_cds_XP_011425175.1_39341",5.46e-110,330,"Q32KZ2","ACL7A_BOVIN","Actin-like protein 7A","ACTL7A","Bos taurus (Bovine)",438,"GO:0001669; GO:0001673; GO:0001675; GO:0005634; GO:0005737; GO:0005794; GO:0005856; GO:0007286; GO:0007338; GO:0009566; GO:0031514; GO:0032991","acrosome assembly [GO:0001675]; fertilization [GO:0009566]; single fertilization [GO:0007338]; spermatid development [GO:0007286]","acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; male germ cell nucleus [GO:0001673]; motile cilium [GO:0031514]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; acrosome assembly [GO:0001675]; fertilization [GO:0009566]; single fertilization [GO:0007338]; spermatid development [GO:0007286]","","","",""
"941","sp|Q23651|ELP3_CAEEL","lcl|NC_088859.1_cds_XP_011425652.3_38332",0,891,"Q23651","ELP3_CAEEL","Elongator complex protein 3 (EC 2.3.1.311) (tRNA uridine(34) acetyltransferase)","elpc-3 ZK863.3","Caenorhabditis elegans",547,"GO:0000049; GO:0002098; GO:0002926; GO:0005634; GO:0005737; GO:0006357; GO:0006412; GO:0007283; GO:0008355; GO:0008607; GO:0033588; GO:0040025; GO:0046872; GO:0048598; GO:0048599; GO:0051539; GO:0106261","embryonic morphogenesis [GO:0048598]; olfactory learning [GO:0008355]; oocyte development [GO:0048599]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; translation [GO:0006412]; tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation [GO:0002926]; tRNA wobble uridine modification [GO:0002098]; vulval development [GO:0040025]","cytoplasm [GO:0005737]; elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; phosphorylase kinase regulator activity [GO:0008607]; tRNA binding [GO:0000049]; tRNA uridine(34) acetyltransferase activity [GO:0106261]; embryonic morphogenesis [GO:0048598]; olfactory learning [GO:0008355]; oocyte development [GO:0048599]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; translation [GO:0006412]; tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation [GO:0002926]; tRNA wobble uridine modification [GO:0002098]; vulval development [GO:0040025]","","","",""
"942","sp|P17491|INHBB_RAT","lcl|NC_088859.1_cds_XP_011426448.3_39256",4.48e-21,95.5,"P17491","INHBB_RAT","Inhibin beta B chain (Activin beta-B chain)","Inhbb","Rattus norvegicus (Rat)",411,"GO:0005125; GO:0005179; GO:0005615; GO:0007283; GO:0008083; GO:0008584; GO:0008585; GO:0009267; GO:0009611; GO:0017085; GO:0021983; GO:0032686; GO:0032869; GO:0032924; GO:0034698; GO:0042803; GO:0044320; GO:0045444; GO:0046676; GO:0046881; GO:0046882; GO:0048471; GO:0048599; GO:0060279; GO:0071277; GO:0071320; GO:0071347; GO:0071397; GO:0071944; GO:0072520; GO:0097067; GO:0097190; GO:1904017; GO:1904628; GO:2001235","activin receptor signaling pathway [GO:0032924]; apoptotic signaling pathway [GO:0097190]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to cholesterol [GO:0071397]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-1 [GO:0071347]; cellular response to leptin stimulus [GO:0044320]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; cellular response to starvation [GO:0009267]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; cellular response to thyroid hormone stimulus [GO:0097067]; fat cell differentiation [GO:0045444]; female gonad development [GO:0008585]; male gonad development [GO:0008584]; negative regulation of follicle-stimulating hormone secretion [GO:0046882]; negative regulation of hepatocyte growth factor production [GO:0032686]; negative regulation of insulin secretion [GO:0046676]; oocyte development [GO:0048599]; pituitary gland development [GO:0021983]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of ovulation [GO:0060279]; response to gonadotropin [GO:0034698]; response to insecticide [GO:0017085]; response to wounding [GO:0009611]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283]","cell periphery [GO:0071944]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; protein homodimerization activity [GO:0042803]; activin receptor signaling pathway [GO:0032924]; apoptotic signaling pathway [GO:0097190]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to cholesterol [GO:0071397]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-1 [GO:0071347]; cellular response to leptin stimulus [GO:0044320]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; cellular response to starvation [GO:0009267]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; cellular response to thyroid hormone stimulus [GO:0097067]; fat cell differentiation [GO:0045444]; female gonad development [GO:0008585]; male gonad development [GO:0008584]; negative regulation of follicle-stimulating hormone secretion [GO:0046882]; negative regulation of hepatocyte growth factor production [GO:0032686]; negative regulation of insulin secretion [GO:0046676]; oocyte development [GO:0048599]; pituitary gland development [GO:0021983]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of ovulation [GO:0060279]; response to gonadotropin [GO:0034698]; response to insecticide [GO:0017085]; response to wounding [GO:0009611]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283]","","INDUCTION: Increased expression in methimazole-induced goiter.","INDUCTION: Increased expression in methimazole-induced goiter.","TISSUE SPECIFICITY: Alpha- and beta-B subunits are the predominant forms found in rat testis. Also expressed in ovary."
"943","sp|Q24087|XPF_DROME","lcl|NC_088859.1_cds_XP_011428185.3_36945",0,666,"Q24087","XPF_DROME","DNA repair endonuclease XPF (EC 3.1.-.-) (Protein meiotic 9)","mei-9 CG3697","Drosophila melanogaster (Fruit fly)",961,"GO:0000014; GO:0000110; GO:0000712; GO:0000724; GO:0003684; GO:0003697; GO:0006289; GO:0006298; GO:0006302; GO:0006310; GO:0006974; GO:0007131; GO:0007143; GO:0016321; GO:0030716; GO:0032991; GO:0045132; GO:0046982; GO:1901255","DNA damage response [GO:0006974]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; female meiosis chromosome segregation [GO:0016321]; female meiotic nuclear division [GO:0007143]; meiotic chromosome segregation [GO:0045132]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; oocyte fate determination [GO:0030716]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]","nucleotide-excision repair factor 1 complex [GO:0000110]; protein-containing complex [GO:0032991]; damaged DNA binding [GO:0003684]; protein heterodimerization activity [GO:0046982]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; DNA damage response [GO:0006974]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; female meiosis chromosome segregation [GO:0016321]; female meiotic nuclear division [GO:0007143]; meiotic chromosome segregation [GO:0045132]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; oocyte fate determination [GO:0030716]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]","","","",""
"944","sp|Q9WUD9|SRC_RAT","lcl|NC_088859.1_cds_XP_011428215.2_36942",0,585,"Q9WUD9","SRC_RAT","Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)","Src","Rattus norvegicus (Rat)",536,"GO:0000122; GO:0001819; GO:0002102; GO:0002376; GO:0004672; GO:0004713; GO:0004715; GO:0005080; GO:0005102; GO:0005158; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005856; GO:0005884; GO:0005886; GO:0005901; GO:0005911; GO:0005925; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007283; GO:0007611; GO:0008284; GO:0009410; GO:0009612; GO:0010447; GO:0010628; GO:0010629; GO:0010632; GO:0010634; GO:0010907; GO:0010954; GO:0014856; GO:0014911; GO:0016004; GO:0016020; GO:0016301; GO:0016477; GO:0019899; GO:0019901; GO:0019904; GO:0020037; GO:0022407; GO:0030154; GO:0030331; GO:0030424; GO:0030546; GO:0030900; GO:0031333; GO:0031648; GO:0031667; GO:0032205; GO:0032587; GO:0032869; GO:0033146; GO:0034139; GO:0034332; GO:0034446; GO:0034614; GO:0035255; GO:0035306; GO:0035331; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0038166; GO:0042169; GO:0042311; GO:0042476; GO:0042542; GO:0043025; GO:0043065; GO:0043066; GO:0043149; GO:0043274; GO:0044294; GO:0044325; GO:0044877; GO:0045056; GO:0045453; GO:0045747; GO:0045780; GO:0045785; GO:0045821; GO:0046579; GO:0046628; GO:0046875; GO:0048008; GO:0048011; GO:0048041; GO:0048148; GO:0048471; GO:0048477; GO:0050839; GO:0050847; GO:0051057; GO:0051219; GO:0051222; GO:0051385; GO:0051450; GO:0051602; GO:0051895; GO:0051897; GO:0051902; GO:0060065; GO:0060444; GO:0060491; GO:0060576; GO:0070102; GO:0070301; GO:0070374; GO:0070542; GO:0070555; GO:0070700; GO:0071222; GO:0071253; GO:0071375; GO:0071393; GO:0071398; GO:0071456; GO:0071498; GO:0071560; GO:0071803; GO:0071897; GO:0086091; GO:0090263; GO:0097060; GO:0097110; GO:0098609; GO:0098978; GO:0098984; GO:0099073; GO:0099091; GO:1900182; GO:1902533; GO:1902564; GO:1902737; GO:1904263; GO:1904385; GO:1904707; GO:1990646; GO:2000179; GO:2000256; GO:2000394; GO:2000588; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286","adherens junction organization [GO:0034332]; angiotensin-activated signaling pathway [GO:0038166]; behavioral response to cocaine [GO:0048148]; bone resorption [GO:0045453]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cellular response to angiotensin [GO:1904385]; cellular response to fatty acid [GO:0071398]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to progesterone stimulus [GO:0071393]; cellular response to prolactin [GO:1990646]; cellular response to reactive oxygen species [GO:0034614]; cellular response to transforming growth factor beta stimulus [GO:0071560]; DNA biosynthetic process [GO:0071897]; epidermal growth factor receptor signaling pathway [GO:0007173]; focal adhesion assembly [GO:0048041]; forebrain development [GO:0030900]; immune system process [GO:0002376]; integrin-mediated signaling pathway [GO:0007229]; interleukin-6-mediated signaling pathway [GO:0070102]; intestinal epithelial cell development [GO:0060576]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; myoblast proliferation [GO:0051450]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; negative regulation of hippo signaling [GO:0035331]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotrophin TRK receptor signaling pathway [GO:0048011]; odontogenesis [GO:0042476]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of dephosphorylation [GO:0035306]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycolytic process [GO:0045821]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein processing [GO:0010954]; positive regulation of protein transport [GO:0051222]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell projection assembly [GO:0060491]; regulation of cell-cell adhesion [GO:0022407]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of epithelial cell migration [GO:0010632]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of toll-like receptor 3 signaling pathway [GO:0034139]; response to acidic pH [GO:0010447]; response to electrical stimulus [GO:0051602]; response to fatty acid [GO:0070542]; response to hydrogen peroxide [GO:0042542]; response to interleukin-1 [GO:0070555]; response to mechanical stimulus [GO:0009612]; response to mineralocorticoid [GO:0051385]; response to nutrient levels [GO:0031667]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle cell proliferation [GO:0014856]; spermatogenesis [GO:0007283]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transcytosis [GO:0045056]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; vasodilation [GO:0042311]","actin filament [GO:0005884]; axon [GO:0030424]; caveola [GO:0005901]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic filopodium [GO:1902737]; dendritic growth cone [GO:0044294]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuron to neuron synapse [GO:0098984]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic specialization, intracellular component [GO:0099091]; ruffle membrane [GO:0032587]; synaptic membrane [GO:0097060]; ATP binding [GO:0005524]; BMP receptor binding [GO:0070700]; cell adhesion molecule binding [GO:0050839]; connexin binding [GO:0071253]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; heme binding [GO:0020037]; insulin receptor binding [GO:0005158]; integrin binding [GO:0005178]; ionotropic glutamate receptor binding [GO:0035255]; kinase activity [GO:0016301]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; nuclear estrogen receptor binding [GO:0030331]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; phosphoprotein binding [GO:0051219]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; signaling receptor activator activity [GO:0030546]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; adherens junction organization [GO:0034332]; angiotensin-activated signaling pathway [GO:0038166]; behavioral response to cocaine [GO:0048148]; bone resorption [GO:0045453]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cellular response to angiotensin [GO:1904385]; cellular response to fatty acid [GO:0071398]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to progesterone stimulus [GO:0071393]; cellular response to prolactin [GO:1990646]; cellular response to reactive oxygen species [GO:0034614]; cellular response to transforming growth factor beta stimulus [GO:0071560]; DNA biosynthetic process [GO:0071897]; epidermal growth factor receptor signaling pathway [GO:0007173]; focal adhesion assembly [GO:0048041]; forebrain development [GO:0030900]; immune system process [GO:0002376]; integrin-mediated signaling pathway [GO:0007229]; interleukin-6-mediated signaling pathway [GO:0070102]; intestinal epithelial cell development [GO:0060576]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; myoblast proliferation [GO:0051450]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; negative regulation of hippo signaling [GO:0035331]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotrophin TRK receptor signaling pathway [GO:0048011]; odontogenesis [GO:0042476]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of dephosphorylation [GO:0035306]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycolytic process [GO:0045821]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein processing [GO:0010954]; positive regulation of protein transport [GO:0051222]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell projection assembly [GO:0060491]; regulation of cell-cell adhesion [GO:0022407]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of epithelial cell migration [GO:0010632]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of toll-like receptor 3 signaling pathway [GO:0034139]; response to acidic pH [GO:0010447]; response to electrical stimulus [GO:0051602]; response to fatty acid [GO:0070542]; response to hydrogen peroxide [GO:0042542]; response to interleukin-1 [GO:0070555]; response to mechanical stimulus [GO:0009612]; response to mineralocorticoid [GO:0051385]; response to nutrient levels [GO:0031667]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle cell proliferation [GO:0014856]; spermatogenesis [GO:0007283]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transcytosis [GO:0045056]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; vasodilation [GO:0042311]","","INDUCTION: [Isoform 2]: Up-regulated by MK-801, an uncompetitive N-methyl-d-aspartate (NMDA) receptor antagonist, mostly in the superficial layers of the parietal, temporal, occipital and frontal cortices. {ECO:0000269|PubMed:11249956}.","INDUCTION: [Isoform 2]: Up-regulated by MK-801, an uncompetitive N-methyl-d-aspartate (NMDA) receptor antagonist, mostly in the superficial layers of the parietal, temporal, occipital and frontal cortices. {ECO:0000269|PubMed:11249956}.","TISSUE SPECIFICITY: [Isoform 1]: Expressed at very low levels in the forebrain. {ECO:0000269|PubMed:11249956}.; TISSUE SPECIFICITY: [Isoform 2]: Expressed in the brain with highest expression in the pyramidal layers of the hippocampus and the granular layer of the dentate gyrus and moderate expression in cortical regions, with higher levels in the superficial layers than in the deep layers. May be neuron-specific. {ECO:0000269|PubMed:11249956}."
"945","sp|A1L1C2|PLD6_XENLA","lcl|NC_088859.1_cds_XP_011428483.2_36917",3.75e-47,155,"A1L1C2","PLD6_XENLA","Mitochondrial cardiolipin hydrolase (EC 3.1.-.-) (Choline phosphatase 6) (Mitochondrial phospholipase) (MitoPLD) (EC 3.1.4.-) (Phosphatidylcholine-hydrolyzing phospholipase D6) (Phospholipase D6) (PLD 6)","pld6","Xenopus laevis (African clawed frog)",210,"GO:0005739; GO:0005741; GO:0007286; GO:0008053; GO:0016042; GO:0016891; GO:0030719; GO:0034587; GO:0035755; GO:0042803; GO:0046872; GO:0051321","lipid catabolic process [GO:0016042]; meiotic cell cycle [GO:0051321]; mitochondrial fusion [GO:0008053]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatid development [GO:0007286]","mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; cardiolipin hydrolase activity [GO:0035755]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA endonuclease activity, producing 5'-phosphomonoesters [GO:0016891]; lipid catabolic process [GO:0016042]; meiotic cell cycle [GO:0051321]; mitochondrial fusion [GO:0008053]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatid development [GO:0007286]","","","",""
"946","sp|Q9D180|CFA57_MOUSE","lcl|NC_088859.1_cds_XP_011429001.1_35663",0,1359,"Q9D180","CFA57_MOUSE","Cilia- and flagella-associated protein 57 (WD repeat-containing protein 65)","Cfap57 Wdr65","Mus musculus (Mouse)",1249,"GO:0005737; GO:0005856; GO:0007338; GO:0036126; GO:0044782; GO:0070286; GO:0120316","axonemal dynein complex assembly [GO:0070286]; cilium organization [GO:0044782]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316]","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126]; axonemal dynein complex assembly [GO:0070286]; cilium organization [GO:0044782]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316]","DEVELOPMENTAL STAGE: Expression in the palate increases from 12.5 up to 15.5 dpc. At 14.5, detected in the nasal epithelium and detected in the medial edge epithelium. At 15.5 dpc, very strong expression in the nasal respiratory epithelium and epidermis, but not in the oral epithelium. In the nasal epithelium, limited to the respiratory, but not the olfactory, epithelium. {ECO:0000269|PubMed:21574244}.","","","TISSUE SPECIFICITY: Predominanly expressed in testis, lung and skin. Weak expression in brain and kidney. {ECO:0000269|PubMed:21574244}."
"947","sp|Q6GPJ9|GRB2B_XENLA","lcl|NC_088859.1_cds_XP_011429050.1_35725",3.6e-90,266,"Q6GPJ9","GRB2B_XENLA","Growth factor receptor-bound protein 2-B (Adapter protein GRB2-B) (SH2/SH3 adapter GRB2-B)","grb2-b","Xenopus laevis (African clawed frog)",229,"GO:0001784; GO:0005154; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005794; GO:0005886; GO:0007143; GO:0007165; GO:0008180; GO:0008286; GO:0043408; GO:0043560","female meiotic nuclear division [GO:0007143]; insulin receptor signaling pathway [GO:0008286]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165]","COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor substrate binding [GO:0043560]; phosphotyrosine residue binding [GO:0001784]; female meiotic nuclear division [GO:0007143]; insulin receptor signaling pathway [GO:0008286]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165]","","","",""
"948","sp|Q9VDQ7|NAA25_DROME","lcl|NC_088859.1_cds_XP_011429205.3_34365",3.32e-127,409,"Q9VDQ7","NAA25_DROME","Phagocyte signaling-impaired protein (N-terminal acetyltransferase B complex subunit MDM20 homolog) (N-terminal acetyltransferase B complex subunit NAA25 homolog)","psidin CG4845","Drosophila melanogaster (Fruit fly)",948,"GO:0002253; GO:0005737; GO:0005764; GO:0006911; GO:0006955; GO:0007010; GO:0007298; GO:0010592; GO:0010698; GO:0030042; GO:0031416; GO:0043005; GO:0043524; GO:0045087; GO:0051015; GO:0097374; GO:1990761","actin filament depolymerization [GO:0030042]; activation of immune response [GO:0002253]; border follicle cell migration [GO:0007298]; cytoskeleton organization [GO:0007010]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of neuron apoptotic process [GO:0043524]; phagocytosis, engulfment [GO:0006911]; positive regulation of lamellipodium assembly [GO:0010592]; sensory neuron axon guidance [GO:0097374]","cytoplasm [GO:0005737]; growth cone lamellipodium [GO:1990761]; lysosome [GO:0005764]; NatB complex [GO:0031416]; neuron projection [GO:0043005]; acetyltransferase activator activity [GO:0010698]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; activation of immune response [GO:0002253]; border follicle cell migration [GO:0007298]; cytoskeleton organization [GO:0007010]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of neuron apoptotic process [GO:0043524]; phagocytosis, engulfment [GO:0006911]; positive regulation of lamellipodium assembly [GO:0010592]; sensory neuron axon guidance [GO:0097374]","","","","TISSUE SPECIFICITY: Expressed in the fat body after immune challenge. {ECO:0000269|PubMed:17208189}."
"949","sp|P82094|TMF1_HUMAN","lcl|NC_088859.1_cds_XP_011429212.3_34374",3.44e-120,402,"P82094","TMF1_HUMAN","TATA element modulatory factor (TMF) (Androgen receptor coactivator 160 kDa protein) (Androgen receptor-associated protein of 160 kDa)","TMF1 ARA160","Homo sapiens (Human)",1093,"GO:0000139; GO:0001675; GO:0001819; GO:0003677; GO:0003713; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0007289; GO:0010629; GO:0030317; GO:0030521; GO:0032275; GO:0033327; GO:0042742; GO:0045944; GO:0050681; GO:0061136; GO:1904019; GO:1904036; GO:2000845","acrosome assembly [GO:0001675]; androgen receptor signaling pathway [GO:0030521]; defense response to bacterium [GO:0042742]; epithelial cell apoptotic process [GO:1904019]; flagellated sperm motility [GO:0030317]; Leydig cell differentiation [GO:0033327]; luteinizing hormone secretion [GO:0032275]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of gene expression [GO:0010629]; positive regulation of cytokine production [GO:0001819]; positive regulation of testosterone secretion [GO:2000845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of proteasomal protein catabolic process [GO:0061136]; spermatid nucleus differentiation [GO:0007289]","cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; DNA binding [GO:0003677]; nuclear androgen receptor binding [GO:0050681]; transcription coactivator activity [GO:0003713]; acrosome assembly [GO:0001675]; androgen receptor signaling pathway [GO:0030521]; defense response to bacterium [GO:0042742]; epithelial cell apoptotic process [GO:1904019]; flagellated sperm motility [GO:0030317]; Leydig cell differentiation [GO:0033327]; luteinizing hormone secretion [GO:0032275]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of gene expression [GO:0010629]; positive regulation of cytokine production [GO:0001819]; positive regulation of testosterone secretion [GO:2000845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of proteasomal protein catabolic process [GO:0061136]; spermatid nucleus differentiation [GO:0007289]","","INDUCTION: Down-regulated in malignant brain tumors. {ECO:0000269|PubMed:15467733}.","INDUCTION: Down-regulated in malignant brain tumors. {ECO:0000269|PubMed:15467733}.",""
"950","sp|B9EKI3|TMF1_MOUSE","lcl|NC_088859.1_cds_XP_011429214.3_34373",6.07e-121,404,"B9EKI3","TMF1_MOUSE","TATA element modulatory factor (TMF) (Androgen receptor coactivator 160 kDa protein) (Androgen receptor-associated protein of 160 kDa)","Tmf1 Ara160 Gm153","Mus musculus (Mouse)",1091,"GO:0000139; GO:0001675; GO:0001819; GO:0003677; GO:0003713; GO:0005634; GO:0005783; GO:0005794; GO:0006915; GO:0007286; GO:0007289; GO:0008584; GO:0010629; GO:0030317; GO:0030521; GO:0032275; GO:0033327; GO:0042742; GO:0045944; GO:0050681; GO:0061136; GO:1904019; GO:1904036; GO:2000845","acrosome assembly [GO:0001675]; androgen receptor signaling pathway [GO:0030521]; apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; epithelial cell apoptotic process [GO:1904019]; flagellated sperm motility [GO:0030317]; Leydig cell differentiation [GO:0033327]; luteinizing hormone secretion [GO:0032275]; male gonad development [GO:0008584]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of gene expression [GO:0010629]; positive regulation of cytokine production [GO:0001819]; positive regulation of testosterone secretion [GO:2000845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of proteasomal protein catabolic process [GO:0061136]; spermatid development [GO:0007286]; spermatid nucleus differentiation [GO:0007289]","endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; DNA binding [GO:0003677]; nuclear androgen receptor binding [GO:0050681]; transcription coactivator activity [GO:0003713]; acrosome assembly [GO:0001675]; androgen receptor signaling pathway [GO:0030521]; apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; epithelial cell apoptotic process [GO:1904019]; flagellated sperm motility [GO:0030317]; Leydig cell differentiation [GO:0033327]; luteinizing hormone secretion [GO:0032275]; male gonad development [GO:0008584]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of gene expression [GO:0010629]; positive regulation of cytokine production [GO:0001819]; positive regulation of testosterone secretion [GO:2000845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of proteasomal protein catabolic process [GO:0061136]; spermatid development [GO:0007286]; spermatid nucleus differentiation [GO:0007289]","","","",""
"951","sp|Q9D4I2|MEII1_MOUSE","lcl|NC_088859.1_cds_XP_011429415.3_39469",2.94e-33,141,"Q9D4I2","MEII1_MOUSE","Meiosis inhibitor protein 1 (Meiosis defective protein 1)","Mei1","Mus musculus (Mouse)",1268,"GO:0000212; GO:0007141; GO:0007276; GO:0007283; GO:0007286; GO:0040038; GO:0045141; GO:0048477; GO:0051321","gamete generation [GO:0007276]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; meiotic spindle organization [GO:0000212]; meiotic telomere clustering [GO:0045141]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","gamete generation [GO:0007276]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; meiotic spindle organization [GO:0000212]; meiotic telomere clustering [GO:0045141]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Highly expressed in 17 dpc ovaries. Expression is significantly reduced in newborn ovaries, and is undetectable in ovaries from 5 day and 8 week old mice. {ECO:0000269|PubMed:14668445}.","","","TISSUE SPECIFICITY: Strongly expressed in testis, weakly in brain, and not detected in spleen, liver, kidney, small intestine or colon. {ECO:0000269|PubMed:14668445}."
"952","sp|Q7ZWE3|LARP7_DANRE","lcl|NC_088859.1_cds_XP_011429517.3_38886",3.98e-51,186,"Q7ZWE3","LARP7_DANRE","La-related protein 7 (La ribonucleoprotein domain family member 7)","larp7 zgc:56476","Danio rerio (Zebrafish) (Brachydanio rerio)",555,"GO:0000494; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0007283; GO:0008380; GO:0017070; GO:0030154; GO:0048024; GO:0060043; GO:0061026; GO:0097322; GO:1904871; GO:1905382; GO:1990438; GO:1990904","box C/D sno(s)RNA 3'-end processing [GO:0000494]; cardiac muscle tissue regeneration [GO:0061026]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; U6 2'-O-snRNA methylation [GO:1990438]","nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; 7SK snRNA binding [GO:0097322]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]; box C/D sno(s)RNA 3'-end processing [GO:0000494]; cardiac muscle tissue regeneration [GO:0061026]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; U6 2'-O-snRNA methylation [GO:1990438]","DEVELOPMENTAL STAGE: Expression reaches a peak at 48 hours post-fertilization (hpf) and then decreases at 72, 96 and 120 hpf (PubMed:26542022). In embryonic hearts, expression slightly increases between 48 and 96 hpf, and then decreases at 120 hpf (PubMed:26542022). Expressed in the adult heart (PubMed:26542022). {ECO:0000269|PubMed:26542022}.","","",""
"953","sp|Q3TSG4|ALKB5_MOUSE","lcl|NC_088859.1_cds_XP_011431161.3_34288",2.02e-117,347,"Q3TSG4","ALKB5_MOUSE","RNA demethylase ALKBH5 (EC 1.14.11.53) (Alkylated DNA repair protein alkB homolog 5) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 5)","Alkbh5 Abh5 Ofoxd","Mus musculus (Mouse)",395,"GO:0001666; GO:0005634; GO:0005794; GO:0005829; GO:0006397; GO:0006417; GO:0007283; GO:0010793; GO:0016607; GO:0016706; GO:0030154; GO:0042382; GO:0043488; GO:0046630; GO:0046872; GO:0050684; GO:0061157; GO:0140693; GO:0140694; GO:1990931","cell differentiation [GO:0030154]; gamma-delta T cell proliferation [GO:0046630]; membraneless organelle assembly [GO:0140694]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; response to hypoxia [GO:0001666]; spermatogenesis [GO:0007283]","cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]; molecular condensate scaffold activity [GO:0140693]; mRNA N6-methyladenosine dioxygenase activity [GO:1990931]; cell differentiation [GO:0030154]; gamma-delta T cell proliferation [GO:0046630]; membraneless organelle assembly [GO:0140694]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; response to hypoxia [GO:0001666]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Widely expressed, with highest expression in testis (PubMed:23177736). In testis, present in almost all testicular cell types except elongating and elongated spermatids (at protein level) (PubMed:29279410). Among spermatogenic cells, present at high level in spermatocytes; medium levels in spermatogonia and lower levels in round spermatids (at protein level) (PubMed:29279410). {ECO:0000269|PubMed:23177736, ECO:0000269|PubMed:29279410}."
"954","sp|P60483|PTEN_CANLF","lcl|NC_088859.1_cds_XP_011431710.3_38737",2.91e-135,397,"P60483","PTEN_CANLF","Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Inositol polyphosphate 3-phosphatase) (EC 3.1.3.-) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)","PTEN MMAC1","Canis lupus familiaris (Dog) (Canis familiaris)",403,"GO:0004438; GO:0004722; GO:0004725; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006470; GO:0006915; GO:0007056; GO:0007417; GO:0007507; GO:0008013; GO:0008285; GO:0009898; GO:0010719; GO:0010975; GO:0010997; GO:0014069; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0030165; GO:0030336; GO:0030351; GO:0031647; GO:0042802; GO:0042995; GO:0043197; GO:0043491; GO:0045668; GO:0045944; GO:0046856; GO:0048870; GO:0050821; GO:0051548; GO:0051717; GO:0051800; GO:0051895; GO:0051896; GO:0051898; GO:0071257; GO:1902533; GO:1903690; GO:1904706; GO:1990381; GO:2000060; GO:2000134","apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell motility [GO:0048870]; cellular response to electrical stimulus [GO:0071257]; central nervous system development [GO:0007417]; heart development [GO:0007507]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein dephosphorylation [GO:0006470]; protein stabilization [GO:0050821]; regulation of neuron projection development [GO:0010975]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; regulation of protein stability [GO:0031647]; spindle assembly involved in female meiosis [GO:0007056]","apical plasma membrane [GO:0016324]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic density [GO:0014069]; anaphase-promoting complex binding [GO:0010997]; beta-catenin binding [GO:0008013]; identical protein binding [GO:0042802]; inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity [GO:0030351]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; ubiquitin-specific protease binding [GO:1990381]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell motility [GO:0048870]; cellular response to electrical stimulus [GO:0071257]; central nervous system development [GO:0007417]; heart development [GO:0007507]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein dephosphorylation [GO:0006470]; protein stabilization [GO:0050821]; regulation of neuron projection development [GO:0010975]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; regulation of protein stability [GO:0031647]; spindle assembly involved in female meiosis [GO:0007056]","","","",""
"955","sp|B1A8Z2|CIB1_SHEEP","lcl|NC_088859.1_cds_XP_011431891.2_37599",5.05e-42,140,"B1A8Z2","CIB1_SHEEP","Calcium and integrin-binding protein 1 (Calmyrin)","CIB1","Ovis aries (Sheep)",191,"GO:0000287; GO:0001525; GO:0005509; GO:0005634; GO:0005813; GO:0006915; GO:0007155; GO:0007229; GO:0007283; GO:0016324; GO:0030027; GO:0030154; GO:0030426; GO:0032433; GO:0032587; GO:0042383; GO:0043204; GO:0043495; GO:0048471; GO:0051301; GO:0070886; GO:0071363; GO:1903078","angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cellular response to growth factor stimulus [GO:0071363]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein localization to plasma membrane [GO:1903078]; spermatogenesis [GO:0007283]","apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; protein-membrane adaptor activity [GO:0043495]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cellular response to growth factor stimulus [GO:0071363]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein localization to plasma membrane [GO:1903078]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed strongly in testis. Expressed weakly in liver, kidney and spleen. {ECO:0000269|PubMed:18989754}."
"956","sp|B4HMV9|EIF3B_DROSE","lcl|NC_088859.1_cds_XP_011432969.3_36183",0,708,"B4HMV9","EIF3B_DROSE","Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9)","eIF3b eIF3-S9 GM21793","Drosophila sechellia (Fruit fly)",690,"GO:0001732; GO:0003723; GO:0003743; GO:0005852; GO:0006446; GO:0016282; GO:0030707; GO:0031369; GO:0033290","follicle cell of egg chamber development [GO:0030707]; formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]","eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; follicle cell of egg chamber development [GO:0030707]; formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]","","","",""
"957","sp|Q09373|FZY1_CAEEL","lcl|NC_088859.1_cds_XP_011433508.1_39427",4.89e-53,188,"Q09373","FZY1_CAEEL","WD repeat-containing protein fzy-1 (CDC20 protein family homolog 1) (Fizzy protein 1)","fzy-1 ZK177.6","Caenorhabditis elegans",507,"GO:0000793; GO:0005680; GO:0005737; GO:0008356; GO:0009949; GO:0010997; GO:0031145; GO:0040038; GO:1905786; GO:1990757; GO:1990949","anaphase-promoting complex-dependent catabolic process [GO:0031145]; asymmetric cell division [GO:0008356]; metaphase/anaphase transition of meiosis I [GO:1990949]; polar body extrusion after meiotic divisions [GO:0040038]; polarity specification of anterior/posterior axis [GO:0009949]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]","anaphase-promoting complex [GO:0005680]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; asymmetric cell division [GO:0008356]; metaphase/anaphase transition of meiosis I [GO:1990949]; polar body extrusion after meiotic divisions [GO:0040038]; polarity specification of anterior/posterior axis [GO:0009949]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]","DEVELOPMENTAL STAGE: Expressed in oocytes at the prometaphase and metaphase of meiosis I (at protein level). Expressed in early embryo at the prometaphase and metaphase of mitosis (at protein level). {ECO:0000269|PubMed:12498686}.","","",""
"958","sp|O95450|ATS2_HUMAN","lcl|NC_088859.1_cds_XP_011433510.3_39422",1.49e-137,447,"O95450","ATS2_HUMAN","A disintegrin and metalloproteinase with thrombospondin motifs 2 (ADAM-TS 2) (ADAM-TS2) (ADAMTS-2) (EC 3.4.24.14) (Procollagen I N-proteinase) (PC I-NP) (Procollagen I/II amino propeptide-processing enzyme) (Procollagen N-endopeptidase) (pNPI)","ADAMTS2 PCINP PCPNI","Homo sapiens (Human)",1211,"GO:0004222; GO:0005576; GO:0006508; GO:0007283; GO:0008237; GO:0008270; GO:0016485; GO:0030198; GO:0030199; GO:0030324; GO:0030574; GO:0031012; GO:0043588","collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; lung development [GO:0030324]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skin development [GO:0043588]; spermatogenesis [GO:0007283]","extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; lung development [GO:0030324]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skin development [GO:0043588]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed at high level in skin, bone, tendon and aorta and at low levels in thymus and brain."
"959","sp|Q95RA8|MOB1_DROME","lcl|NC_088859.1_cds_XP_011434076.1_36567",2.92e-149,414,"Q95RA8","MOB1_DROME","MOB kinase activator-like 1 (Mob as tumor suppressor protein 1) (Dmob1) (Mps one binder kinase activator-like 1)","mats CG13852","Drosophila melanogaster (Fruit fly)",219,"GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006915; GO:0007059; GO:0007165; GO:0008285; GO:0019901; GO:0030295; GO:0030707; GO:0035329; GO:0046872","apoptotic process [GO:0006915]; chromosome segregation [GO:0007059]; follicle cell of egg chamber development [GO:0030707]; hippo signaling [GO:0035329]; negative regulation of cell population proliferation [GO:0008285]; signal transduction [GO:0007165]","centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; apoptotic process [GO:0006915]; chromosome segregation [GO:0007059]; follicle cell of egg chamber development [GO:0030707]; hippo signaling [GO:0035329]; negative regulation of cell population proliferation [GO:0008285]; signal transduction [GO:0007165]","","","","TISSUE SPECIFICITY: Ubiquitously expressed at low levels in developing tissues (at protein level). {ECO:0000269|PubMed:18245354}."
"960","sp|Q5XI06|KAT8_RAT","lcl|NC_088859.1_cds_XP_011434277.3_39844",0,679,"Q5XI06","KAT8_RAT","Histone acetyltransferase KAT8 (EC 2.3.1.48) (Lysine acetyltransferase 8) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1) (MYST-1) (Protein acetyltransferase KAT8) (EC 2.3.1.-) (Protein propionyltransferase KAT8) (EC 2.3.1.-)","Kat8 Myst1","Rattus norvegicus (Rat)",458,"GO:0000123; GO:0000776; GO:0003713; GO:0005634; GO:0005694; GO:0005739; GO:0008270; GO:0009048; GO:0010485; GO:0010506; GO:0010719; GO:0016363; GO:0016407; GO:0019899; GO:0022008; GO:0030099; GO:0032480; GO:0035166; GO:0035267; GO:0043995; GO:0043996; GO:0044545; GO:0045815; GO:0045892; GO:0045893; GO:0046972; GO:0048477; GO:0050684; GO:0060261; GO:0061629; GO:0061733; GO:0061920; GO:0071339; GO:0072487; GO:1902726; GO:1903108; GO:1990841","dosage compensation by inactivation of X chromosome [GO:0009048]; myeloid cell differentiation [GO:0030099]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of type I interferon production [GO:0032480]; neurogenesis [GO:0022008]; oogenesis [GO:0048477]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of skeletal muscle satellite cell differentiation [GO:1902726]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; post-embryonic hemopoiesis [GO:0035166]; regulation of autophagy [GO:0010506]; regulation of mitochondrial transcription [GO:1903108]; regulation of mRNA processing [GO:0050684]; transcription initiation-coupled chromatin remodeling [GO:0045815]","chromosome [GO:0005694]; histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; MLL1 complex [GO:0071339]; MSL complex [GO:0072487]; NSL complex [GO:0044545]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; acetyltransferase activity [GO:0016407]; enzyme binding [GO:0019899]; histone H4 acetyltransferase activity [GO:0010485]; histone H4K16 acetyltransferase activity [GO:0046972]; histone H4K5 acetyltransferase activity [GO:0043995]; histone H4K8 acetyltransferase activity [GO:0043996]; promoter-specific chromatin binding [GO:1990841]; protein propionyltransferase activity [GO:0061920]; protein-lysine-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; dosage compensation by inactivation of X chromosome [GO:0009048]; myeloid cell differentiation [GO:0030099]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of type I interferon production [GO:0032480]; neurogenesis [GO:0022008]; oogenesis [GO:0048477]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of skeletal muscle satellite cell differentiation [GO:1902726]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; post-embryonic hemopoiesis [GO:0035166]; regulation of autophagy [GO:0010506]; regulation of mitochondrial transcription [GO:1903108]; regulation of mRNA processing [GO:0050684]; transcription initiation-coupled chromatin remodeling [GO:0045815]","","","",""
"961","sp|Q9V407|AXN_DROME","lcl|NC_088859.1_cds_XP_011435602.2_35896",2.41e-16,85.1,"Q9V407","AXN_DROME","Axin (Axis inhibition protein) (d-Axin) (dAxin)","Axn CG7926","Drosophila melanogaster (Fruit fly)",745,"GO:0005102; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005977; GO:0007367; GO:0007450; GO:0007455; GO:0007507; GO:0008013; GO:0008587; GO:0016055; GO:0019901; GO:0030707; GO:0030877; GO:0031625; GO:0032436; GO:0035019; GO:0035293; GO:0042594; GO:0048468; GO:0048477; GO:0060090; GO:0090090; GO:1900117; GO:1990909","cell development [GO:0048468]; chitin-based larval cuticle pattern formation [GO:0035293]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; eye-antennal disc morphogenesis [GO:0007455]; follicle cell of egg chamber development [GO:0030707]; glycogen metabolic process [GO:0005977]; heart development [GO:0007507]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; oogenesis [GO:0048477]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of execution phase of apoptosis [GO:1900117]; response to starvation [GO:0042594]; segment polarity determination [GO:0007367]; somatic stem cell population maintenance [GO:0035019]; Wnt signaling pathway [GO:0016055]","beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909]; beta-catenin binding [GO:0008013]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; cell development [GO:0048468]; chitin-based larval cuticle pattern formation [GO:0035293]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; eye-antennal disc morphogenesis [GO:0007455]; follicle cell of egg chamber development [GO:0030707]; glycogen metabolic process [GO:0005977]; heart development [GO:0007507]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; oogenesis [GO:0048477]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of execution phase of apoptosis [GO:1900117]; response to starvation [GO:0042594]; segment polarity determination [GO:0007367]; somatic stem cell population maintenance [GO:0035019]; Wnt signaling pathway [GO:0016055]","DEVELOPMENTAL STAGE: Ubiquitously expressed throughout the development.","","",""
"962","sp|Q22006|PRO1_CAEEL","lcl|NC_088859.1_cds_XP_011435717.3_35111",1.99e-33,133,"Q22006","PRO1_CAEEL","Pre-rRNA-processing protein pro-1 (Proximal proliferation in germline protein 1)","pro-1 R166.4","Caenorhabditis elegans",529,"GO:0005654; GO:0005656; GO:0005730; GO:0006261; GO:0006364; GO:0007281; GO:0007506; GO:0008406; GO:0120330","DNA-templated DNA replication [GO:0006261]; germ cell development [GO:0007281]; gonad development [GO:0008406]; gonadal mesoderm development [GO:0007506]; rRNA processing [GO:0006364]","nuclear pre-replicative complex [GO:0005656]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; rixosome complex [GO:0120330]; DNA-templated DNA replication [GO:0006261]; germ cell development [GO:0007281]; gonad development [GO:0008406]; gonadal mesoderm development [GO:0007506]; rRNA processing [GO:0006364]","","","",""
"963","sp|P48379|RFX2_MOUSE","lcl|NC_088859.1_cds_XP_011436652.3_36088",0,641,"P48379","RFX2_MOUSE","DNA-binding protein RFX2 (Regulatory factor X 2)","Rfx2","Mus musculus (Mouse)",717,"GO:0000977; GO:0000978; GO:0001228; GO:0001675; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0007286; GO:0045944; GO:0060271; GO:1990830","acrosome assembly [GO:0001675]; cellular response to leukemia inhibitory factor [GO:1990830]; cilium assembly [GO:0060271]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; acrosome assembly [GO:0001675]; cellular response to leukemia inhibitory factor [GO:1990830]; cilium assembly [GO:0060271]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286]","DEVELOPMENTAL STAGE: Detected in the anterior primitive streak preceding the morphological appearance of the node at 7.0 dpc. Expressed in the node and in the midline notochordal plate cells extending anteriorly from the node at 7.5 dpc. At 8.5 dpc, expressed in the node now located in the tail region. At 9.5 dpc, detected in the floor plate and in the dorsal portion of the neural tube, with highest expression in the anterior portion of the spinal cord. Also expressed in the developing gut. At 10.5 dpc, also observed in the telencephalon region of the brain and in the anterior portion of the limb bud at 12.5 dpc (PubMed:26248850). Localizes to cells at the posterior margin of the ciliated organ of asymmetry (PubMed:22233545). {ECO:0000269|PubMed:22233545, ECO:0000269|PubMed:26248850}.","","",""
"964","sp|Q5ZMV2|SAS6_CHICK","lcl|NC_088859.1_cds_XP_011437043.3_37260",1.52e-157,469,"Q5ZMV2","SAS6_CHICK","Spindle assembly abnormal protein 6 homolog","SASS6 SAS6 RCJMB04_1b15","Gallus gallus (Chicken)",640,"GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0007283; GO:0098536","centriole replication [GO:0007099]; spermatogenesis [GO:0007283]","centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; deuterosome [GO:0098536]; centriole replication [GO:0007099]; spermatogenesis [GO:0007283]","","","",""
"965","sp|Q26365|ADT_DROME","lcl|NC_088859.1_cds_XP_011437055.1_34852",2.13e-88,268,"Q26365","ADT_DROME","ADP,ATP carrier protein (ADP/ATP translocase) (Adenine nucleotide translocator) (ANT) (Stress-sensitive protein B)","sesB A/A-T CG16944","Drosophila melanogaster (Fruit fly)",312,"GO:0001508; GO:0005471; GO:0005739; GO:0005743; GO:0006839; GO:0007268; GO:0008340; GO:0010507; GO:0034599; GO:0040011; GO:0045202; GO:0046716; GO:0048477; GO:0048489; GO:0051124; GO:0051480; GO:0051560; GO:0051900; GO:0070050; GO:0140021; GO:1901029; GO:1990544; GO:2001171","action potential [GO:0001508]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; locomotion [GO:0040011]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial transport [GO:0006839]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagy [GO:0010507]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; neuron cellular homeostasis [GO:0070050]; oogenesis [GO:0048477]; positive regulation of ATP biosynthetic process [GO:2001171]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitochondrial depolarization [GO:0051900]; synaptic assembly at neuromuscular junction [GO:0051124]; synaptic vesicle transport [GO:0048489]","mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; synapse [GO:0045202]; ATP:ADP antiporter activity [GO:0005471]; action potential [GO:0001508]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; locomotion [GO:0040011]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial transport [GO:0006839]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagy [GO:0010507]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; neuron cellular homeostasis [GO:0070050]; oogenesis [GO:0048477]; positive regulation of ATP biosynthetic process [GO:2001171]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitochondrial depolarization [GO:0051900]; synaptic assembly at neuromuscular junction [GO:0051124]; synaptic vesicle transport [GO:0048489]","","","",""
"966","sp|Q9VUB4|NPRL3_DROME","lcl|NC_088859.1_cds_XP_011437061.2_34845",1.12e-100,318,"Q9VUB4","NPRL3_DROME","GATOR complex protein NPRL3 (Nitrogen permease regulator 3-like protein)","Nprl3 CG8783","Drosophila melanogaster (Fruit fly)",610,"GO:0005634; GO:0005737; GO:0005764; GO:0007293; GO:0009267; GO:0010508; GO:0010898; GO:0016239; GO:0032007; GO:0034198; GO:0035859; GO:0044754; GO:0045792; GO:0048477; GO:0051301; GO:0051321; GO:0061700; GO:1904262; GO:1990130","cell division [GO:0051301]; cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; germarium-derived egg chamber formation [GO:0007293]; meiotic cell cycle [GO:0051321]; negative regulation of cell size [GO:0045792]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; oogenesis [GO:0048477]; positive regulation of autophagy [GO:0010508]; positive regulation of macroautophagy [GO:0016239]; positive regulation of triglyceride catabolic process [GO:0010898]","autolysosome [GO:0044754]; cytoplasm [GO:0005737]; GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; lysosome [GO:0005764]; nucleus [GO:0005634]; Seh1-associated complex [GO:0035859]; cell division [GO:0051301]; cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; germarium-derived egg chamber formation [GO:0007293]; meiotic cell cycle [GO:0051321]; negative regulation of cell size [GO:0045792]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; oogenesis [GO:0048477]; positive regulation of autophagy [GO:0010508]; positive regulation of macroautophagy [GO:0016239]; positive regulation of triglyceride catabolic process [GO:0010898]","","","",""
"967","sp|Q24524|SING_DROME","lcl|NC_088859.1_cds_XP_011437075.3_34838",5.92e-133,396,"Q24524","SING_DROME","Protein singed","sn CG1536","Drosophila melanogaster (Fruit fly)",512,"GO:0003779; GO:0005737; GO:0007163; GO:0008407; GO:0009913; GO:0015629; GO:0016358; GO:0016477; GO:0030034; GO:0030036; GO:0030674; GO:0035017; GO:0035099; GO:0035317; GO:0042060; GO:0043005; GO:0043025; GO:0046847; GO:0048477; GO:0048800; GO:0048812; GO:0051015; GO:0051017","actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; antennal morphogenesis [GO:0048800]; cell migration [GO:0016477]; chaeta morphogenesis [GO:0008407]; cuticle pattern formation [GO:0035017]; dendrite development [GO:0016358]; epidermal cell differentiation [GO:0009913]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair organization [GO:0035317]; microvillar actin bundle assembly [GO:0030034]; neuron projection morphogenesis [GO:0048812]; oogenesis [GO:0048477]; wound healing [GO:0042060]","actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein-macromolecule adaptor activity [GO:0030674]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; antennal morphogenesis [GO:0048800]; cell migration [GO:0016477]; chaeta morphogenesis [GO:0008407]; cuticle pattern formation [GO:0035017]; dendrite development [GO:0016358]; epidermal cell differentiation [GO:0009913]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair organization [GO:0035317]; microvillar actin bundle assembly [GO:0030034]; neuron projection morphogenesis [GO:0048812]; oogenesis [GO:0048477]; wound healing [GO:0042060]","","","",""
"968","sp|Q9WTK7|STK11_MOUSE","lcl|NC_088859.1_cds_XP_011437359.1_34597",7.85e-150,433,"Q9WTK7","STK11_MOUSE","Serine/threonine-protein kinase STK11 (EC 2.7.11.1) (Liver kinase B1 homolog) (LKB1) (mLKB1)","Stk11 Lkb1","Mus musculus (Mouse)",436,"GO:0000287; GO:0001558; GO:0001894; GO:0001944; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005929; GO:0006468; GO:0006470; GO:0006914; GO:0006974; GO:0007283; GO:0007286; GO:0007409; GO:0008285; GO:0010212; GO:0010508; GO:0016020; GO:0030010; GO:0030111; GO:0030275; GO:0030295; GO:0030308; GO:0030511; GO:0034504; GO:0036398; GO:0036399; GO:0042593; GO:0043276; GO:0045059; GO:0046777; GO:0048814; GO:0050772; GO:0050852; GO:0051055; GO:0051645; GO:0051896; GO:0060767; GO:0060770; GO:0070314; GO:0071493; GO:0072332; GO:0090090; GO:0097484; GO:0106310; GO:0120163; GO:0140535; GO:1900182; GO:1901610; GO:1902554; GO:1904262","anoikis [GO:0043276]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to UV-B [GO:0071493]; dendrite extension [GO:0097484]; DNA damage response [GO:0006974]; epithelial cell proliferation involved in prostate gland development [GO:0060767]; establishment of cell polarity [GO:0030010]; G1 to G0 transition [GO:0070314]; glucose homeostasis [GO:0042593]; Golgi localization [GO:0051645]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of lipid biosynthetic process [GO:0051055]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508]; positive regulation of axonogenesis [GO:0050772]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of vesicle transport along microtubule [GO:1901610]; positive thymic T cell selection [GO:0045059]; protein autophosphorylation [GO:0046777]; protein dephosphorylation [GO:0006470]; protein localization to nucleus [GO:0034504]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of dendrite morphogenesis [GO:0048814]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; regulation of Wnt signaling pathway [GO:0030111]; response to ionizing radiation [GO:0010212]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]; TCR signalosome assembly [GO:0036399]; tissue homeostasis [GO:0001894]; vasculature development [GO:0001944]","centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular protein-containing complex [GO:0140535]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; serine/threonine protein kinase complex [GO:1902554]; TCR signalosome [GO:0036398]; ATP binding [GO:0005524]; LRR domain binding [GO:0030275]; magnesium ion binding [GO:0000287]; p53 binding [GO:0002039]; protein kinase activator activity [GO:0030295]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; anoikis [GO:0043276]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to UV-B [GO:0071493]; dendrite extension [GO:0097484]; DNA damage response [GO:0006974]; epithelial cell proliferation involved in prostate gland development [GO:0060767]; establishment of cell polarity [GO:0030010]; G1 to G0 transition [GO:0070314]; glucose homeostasis [GO:0042593]; Golgi localization [GO:0051645]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of lipid biosynthetic process [GO:0051055]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508]; positive regulation of axonogenesis [GO:0050772]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of vesicle transport along microtubule [GO:1901610]; positive thymic T cell selection [GO:0045059]; protein autophosphorylation [GO:0046777]; protein dephosphorylation [GO:0006470]; protein localization to nucleus [GO:0034504]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of dendrite morphogenesis [GO:0048814]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; regulation of Wnt signaling pathway [GO:0030111]; response to ionizing radiation [GO:0010212]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]; TCR signalosome assembly [GO:0036399]; tissue homeostasis [GO:0001894]; vasculature development [GO:0001944]","DEVELOPMENTAL STAGE: Ubiquitously expressed 7-11 dpc. Present in nucleated embryonic blood cells from 9 dpc. Restricted to gastrointestinal tract, testis and lung from days 15-19 dpc. {ECO:0000269|PubMed:10381580, ECO:0000269|PubMed:12060709}.","","","TISSUE SPECIFICITY: [Isoform 1]: Widely expressed. {ECO:0000269|PubMed:10642527, ECO:0000269|PubMed:18774945, ECO:0000269|PubMed:18854309}.; TISSUE SPECIFICITY: [Isoform 2]: Predominantly expressed in testis (at protein level). {ECO:0000269|PubMed:18774945}.; TISSUE SPECIFICITY: [Isoform 3]: Expressed in adult brain and liver and absent from tissues derived from postnatal day 7. {ECO:0000269|PubMed:29777910}."
"969","sp|A0A182C2Z2|OVCH_HALRO","lcl|NC_088859.1_cds_XP_011437724.3_39205",7.5e-72,261,"A0A182C2Z2","OVCH_HALRO","Ovochymase (HrOVCH) (EC 3.4.21.-)","OVCH","Halocynthia roretzi (Sea squirt) (Cynthia roretzi)",1575,"GO:0004252; GO:0005576; GO:0006508; GO:0009566; GO:0048477","fertilization [GO:0009566]; oogenesis [GO:0048477]; proteolysis [GO:0006508]","extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; fertilization [GO:0009566]; oogenesis [GO:0048477]; proteolysis [GO:0006508]","","","","TISSUE SPECIFICITY: Expressed in the testis and ovary. Expressed in the gonads and gametes. Expressed in the follicle cells covering the vitelline coat of ovarian egg. {ECO:0000269|PubMed:26896838}."
"970","sp|O95453|PARN_HUMAN","lcl|NC_088859.1_cds_XP_011438149.3_36648",6.09e-177,516,"O95453","PARN_HUMAN","Poly(A)-specific ribonuclease PARN (EC 3.1.13.4) (Deadenylating nuclease) (Deadenylation nuclease) (Polyadenylate-specific ribonuclease)","PARN DAN","Homo sapiens (Human)",639,"GO:0000175; GO:0000184; GO:0000289; GO:0000495; GO:0003723; GO:0003730; GO:0004518; GO:0004535; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0007292; GO:0009451; GO:0010587; GO:0016607; GO:0019901; GO:0032212; GO:0043169; GO:0046872; GO:0070034; GO:0071051; GO:0090669; GO:0098794; GO:0098978; GO:0180035; GO:1904872; GO:1990431; GO:1990432","box H/ACA sno(s)RNA 3'-end processing [GO:0000495]; female gamete generation [GO:0007292]; lncRNA processing [GO:0180035]; miRNA catabolic process [GO:0010587]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of telomere maintenance via telomerase [GO:0032212]; priRNA 3'-end processing [GO:1990431]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; RNA modification [GO:0009451]; siRNA 3'-end processing [GO:1990432]; telomerase RNA stabilization [GO:0090669]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynapse [GO:0098794]; 3'-5'-RNA exonuclease activity [GO:0000175]; cation binding [GO:0043169]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; nuclease activity [GO:0004518]; poly(A)-specific ribonuclease activity [GO:0004535]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; box H/ACA sno(s)RNA 3'-end processing [GO:0000495]; female gamete generation [GO:0007292]; lncRNA processing [GO:0180035]; miRNA catabolic process [GO:0010587]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of telomere maintenance via telomerase [GO:0032212]; priRNA 3'-end processing [GO:1990431]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; RNA modification [GO:0009451]; siRNA 3'-end processing [GO:1990432]; telomerase RNA stabilization [GO:0090669]","","","","TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10640832, ECO:0000269|PubMed:9736620}."
"971","sp|P90978|U2AF2_CAEEL","lcl|NC_088859.1_cds_XP_011438167.1_39931",1.2e-155,451,"P90978","U2AF2_CAEEL","Splicing factor U2AF 65 kDa subunit (U2 auxiliary factor 65 kDa subunit) (U2AF65) (U2 snRNP auxiliary factor large subunit)","uaf-1 Y92C3B.2","Caenorhabditis elegans",496,"GO:0000243; GO:0000245; GO:0000389; GO:0002119; GO:0005654; GO:0005681; GO:0007281; GO:0008187; GO:0009792; GO:0010172; GO:0016607; GO:0030628; GO:0048024; GO:0048589; GO:0071004; GO:0089701","developmental growth [GO:0048589]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic body morphogenesis [GO:0010172]; germ cell development [GO:0007281]; mRNA 3'-splice site recognition [GO:0000389]; nematode larval development [GO:0002119]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spliceosomal complex assembly [GO:0000245]","commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF complex [GO:0089701]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; developmental growth [GO:0048589]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic body morphogenesis [GO:0010172]; germ cell development [GO:0007281]; mRNA 3'-splice site recognition [GO:0000389]; nematode larval development [GO:0002119]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spliceosomal complex assembly [GO:0000245]","","","",""
"972","sp|P0C605|KGP1_MOUSE","lcl|NC_088859.1_cds_XP_011438172.1_39926",0,845,"P0C605","KGP1_MOUSE","cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI)","Prkg1 Prkg1b Prkgr1a Prkgr1b","Mus musculus (Mouse)",671,"GO:0001669; GO:0001764; GO:0004672; GO:0004674; GO:0004692; GO:0005246; GO:0005524; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0006468; GO:0007165; GO:0007204; GO:0007286; GO:0010920; GO:0014050; GO:0016358; GO:0019934; GO:0021549; GO:0030553; GO:0030900; GO:0042383; GO:0042753; GO:0042802; GO:0043087; GO:0045986; GO:0048273; GO:0048668; GO:0060087; GO:0061049; GO:0090331; GO:0106310; GO:1904706; GO:1904753; GO:2000224","cell growth involved in cardiac muscle cell development [GO:0061049]; cerebellum development [GO:0021549]; cGMP-mediated signaling [GO:0019934]; collateral sprouting [GO:0048668]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of inositol phosphate biosynthetic process [GO:0010920]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; protein phosphorylation [GO:0006468]; regulation of GTPase activity [GO:0043087]; regulation of testosterone biosynthetic process [GO:2000224]; relaxation of vascular associated smooth muscle [GO:0060087]; signal transduction [GO:0007165]; spermatid development [GO:0007286]","acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell growth involved in cardiac muscle cell development [GO:0061049]; cerebellum development [GO:0021549]; cGMP-mediated signaling [GO:0019934]; collateral sprouting [GO:0048668]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of inositol phosphate biosynthetic process [GO:0010920]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; protein phosphorylation [GO:0006468]; regulation of GTPase activity [GO:0043087]; regulation of testosterone biosynthetic process [GO:2000224]; relaxation of vascular associated smooth muscle [GO:0060087]; signal transduction [GO:0007165]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Detected in cerebellum, hippocampus, dorsomedial hypothalamus, medulla, subcommissural organ, cerebral cortex, amygdala, habenulae, various hypothalamic regions, olfactory bulb, pituitary gland, and retina. Isoform alpha is prominent in the cerebellum and medulla, whereas isoform Beta is predominant in the cortex, hippocampus, hypothalamus, and olfactory bulb. {ECO:0000269|PubMed:16154279}."
"973","sp|Q8I719|KGP_PLAF7","lcl|NC_088859.1_cds_XP_011438173.2_39928",1.4e-89,299,"Q8I719","KGP_PLAF7","cGMP-dependent protein kinase (EC 2.7.11.12) (PfPKG)","PKG PF3D7_1436600","Plasmodium falciparum (isolate 3D7)",853,"GO:0004691; GO:0004692; GO:0005524; GO:0005737; GO:0005783; GO:0005789; GO:0005952; GO:0006468; GO:0007165; GO:0007276; GO:0019898; GO:0030553; GO:0046872; GO:0106310","gamete generation [GO:0007276]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]","cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; gamete generation [GO:0007276]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]","DEVELOPMENTAL STAGE: Expressed during the parasite blood stage, expression is low at the ring stage and in early trophozoites, then increases during the parasite maturation to peak at the late schizont stage (at protein level) (PubMed:12068803, PubMed:19915077, PubMed:23139764, PubMed:31239348). Expression is low in gametocytes (at protein level) (PubMed:23139764). {ECO:0000269|PubMed:12068803, ECO:0000269|PubMed:19915077, ECO:0000269|PubMed:23139764, ECO:0000269|PubMed:31239348}.","","",""
"974","sp|Q9Y4I5|MTL5_HUMAN","lcl|NC_088859.1_cds_XP_011438423.1_38216",5.29e-62,217,"Q9Y4I5","MTL5_HUMAN","Tesmin (Metallothionein-like 5, testis-specific) (Testis-specific metallothionein-like protein)","TESMIN MTL5","Homo sapiens (Human)",508,"GO:0001673; GO:0005634; GO:0005737; GO:0006355; GO:0007140; GO:0007283; GO:0010038; GO:0030003; GO:0030154; GO:0046872","cell differentiation [GO:0030154]; intracellular monoatomic cation homeostasis [GO:0030003]; male meiotic nuclear division [GO:0007140]; regulation of DNA-templated transcription [GO:0006355]; response to metal ion [GO:0010038]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; intracellular monoatomic cation homeostasis [GO:0030003]; male meiotic nuclear division [GO:0007140]; regulation of DNA-templated transcription [GO:0006355]; response to metal ion [GO:0010038]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed specifically in testis."
"975","sp|Q9V345|CSN4_DROME","lcl|NC_088859.1_cds_XP_011438424.1_38217",0,580,"Q9V345","CSN4_DROME","COP9 signalosome complex subunit 4 (Dch4) (Signalosome subunit 4)","CSN4 CG8725","Drosophila melanogaster (Fruit fly)",407,"GO:0000338; GO:0000976; GO:0001751; GO:0005737; GO:0007281; GO:0008180; GO:0032435; GO:0036099; GO:0048140; GO:0048477; GO:0050821","compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell population maintenance [GO:0036099]; germ cell development [GO:0007281]; male germ-line cyst encapsulation [GO:0048140]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; oogenesis [GO:0048477]; protein deneddylation [GO:0000338]; protein stabilization [GO:0050821]","COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; transcription cis-regulatory region binding [GO:0000976]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell population maintenance [GO:0036099]; germ cell development [GO:0007281]; male germ-line cyst encapsulation [GO:0048140]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; oogenesis [GO:0048477]; protein deneddylation [GO:0000338]; protein stabilization [GO:0050821]","","","",""
"976","sp|P05132|KAPCA_MOUSE","lcl|NC_088859.1_cds_XP_011439334.1_37670",0,627,"P05132","KAPCA_MOUSE","cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11)","Prkaca Pkaca","Mus musculus (Mouse)",351,"GO:0000122; GO:0000287; GO:0001669; GO:0001707; GO:0001843; GO:0004672; GO:0004674; GO:0004691; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005930; GO:0005952; GO:0006397; GO:0006611; GO:0007189; GO:0007193; GO:0016607; GO:0018105; GO:0019901; GO:0019904; GO:0030007; GO:0030145; GO:0031594; GO:0031625; GO:0032024; GO:0034237; GO:0034605; GO:0036126; GO:0044853; GO:0045542; GO:0045667; GO:0045722; GO:0045879; GO:0046827; GO:0048240; GO:0048471; GO:0050766; GO:0050804; GO:0051726; GO:0061136; GO:0070417; GO:0070613; GO:0071333; GO:0071374; GO:0071377; GO:0097225; GO:0097546; GO:0098794; GO:0098978; GO:0099170; GO:0106310; GO:0141156; GO:1904262; GO:1904539; GO:1990044; GO:2000810","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP/PKA signal transduction [GO:0141156]; cellular response to cold [GO:0070417]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; cellular response to parathyroid hormone stimulus [GO:0071374]; intracellular potassium ion homeostasis [GO:0030007]; mesoderm formation [GO:0001707]; modulation of chemical synaptic transmission [GO:0050804]; mRNA processing [GO:0006397]; negative regulation of glycolytic process through fructose-6-phosphate [GO:1904539]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of insulin secretion [GO:0032024]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein export from nucleus [GO:0046827]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein export from nucleus [GO:0006611]; protein localization to lipid droplet [GO:1990044]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cell cycle [GO:0051726]; regulation of osteoblast differentiation [GO:0045667]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein processing [GO:0070613]; sperm capacitation [GO:0048240]","acrosomal vesicle [GO:0001669]; axoneme [GO:0005930]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynapse [GO:0098794]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP/PKA signal transduction [GO:0141156]; cellular response to cold [GO:0070417]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; cellular response to parathyroid hormone stimulus [GO:0071374]; intracellular potassium ion homeostasis [GO:0030007]; mesoderm formation [GO:0001707]; modulation of chemical synaptic transmission [GO:0050804]; mRNA processing [GO:0006397]; negative regulation of glycolytic process through fructose-6-phosphate [GO:1904539]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of insulin secretion [GO:0032024]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein export from nucleus [GO:0046827]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein export from nucleus [GO:0006611]; protein localization to lipid droplet [GO:1990044]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cell cycle [GO:0051726]; regulation of osteoblast differentiation [GO:0045667]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein processing [GO:0070613]; sperm capacitation [GO:0048240]","DEVELOPMENTAL STAGE: Accumulates in oocytes before fertilization but fades out after fertilization. {ECO:0000269|PubMed:18367160}.","","","TISSUE SPECIFICITY: [Isoform 2]: Sperm-specific. {ECO:0000269|PubMed:10982398}."
"977","sp|Q9W2E7|RAE1_DROME","lcl|NC_088859.1_cds_XP_011439349.1_37997",0,525,"Q9W2E7","RAE1_DROME","Protein Rae1","Rae1 CG9862","Drosophila melanogaster (Fruit fly)",346,"GO:0000278; GO:0000972; GO:0003723; GO:0005634; GO:0005635; GO:0005643; GO:0005694; GO:0005737; GO:0006405; GO:0007141; GO:0007283; GO:0010506; GO:0010628; GO:0016006; GO:0030154; GO:0035329; GO:0035330; GO:0035332; GO:0036126; GO:0042127; GO:0043130; GO:0045886; GO:0048471; GO:0048638; GO:0051301; GO:0071944; GO:1900087; GO:2000045","cell differentiation [GO:0030154]; cell division [GO:0051301]; hippo signaling [GO:0035329]; male meiosis I [GO:0007141]; mitotic cell cycle [GO:0000278]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; regulation of autophagy [GO:0010506]; regulation of cell population proliferation [GO:0042127]; regulation of developmental growth [GO:0048638]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of hippo signaling [GO:0035330]; RNA export from nucleus [GO:0006405]; spermatogenesis [GO:0007283]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]","cell periphery [GO:0071944]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; Nebenkern [GO:0016006]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sperm flagellum [GO:0036126]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; cell differentiation [GO:0030154]; cell division [GO:0051301]; hippo signaling [GO:0035329]; male meiosis I [GO:0007141]; mitotic cell cycle [GO:0000278]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; regulation of autophagy [GO:0010506]; regulation of cell population proliferation [GO:0042127]; regulation of developmental growth [GO:0048638]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of hippo signaling [GO:0035330]; RNA export from nucleus [GO:0006405]; spermatogenesis [GO:0007283]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]","DEVELOPMENTAL STAGE: Larval brain (at protein level). {ECO:0000269|PubMed:21874015}.","","","TISSUE SPECIFICITY: Head (at protein level). {ECO:0000269|PubMed:21874015}."
"978","sp|Q15493|RGN_HUMAN","lcl|NC_088859.1_cds_XP_011439357.3_38009",9.34e-86,260,"Q15493","RGN_HUMAN","Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17) (Senescence marker protein 30) (SMP-30)","RGN SMP30","Homo sapiens (Human)",299,"GO:0004341; GO:0005509; GO:0005634; GO:0005737; GO:0006874; GO:0008270; GO:0030234; GO:0032781; GO:0050848","intracellular calcium ion homeostasis [GO:0006874]; positive regulation of ATP-dependent activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; intracellular calcium ion homeostasis [GO:0006874]; positive regulation of ATP-dependent activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848]","","","",""
"979","sp|P61327|MGN_MOUSE","lcl|NC_088859.1_cds_XP_011441186.1_39312",9.83e-100,283,"P61327","MGN_MOUSE","Protein mago nashi homolog","Magoh","Mus musculus (Mouse)",146,"GO:0000184; GO:0000381; GO:0003723; GO:0005634; GO:0005829; GO:0006397; GO:0006406; GO:0006417; GO:0007292; GO:0008380; GO:0016607; GO:0035145; GO:0050684; GO:0071013; GO:1990501; GO:2000622","female gamete generation [GO:0007292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA processing [GO:0050684]; regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000622]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]","catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; exon-exon junction subcomplex mago-y14 [GO:1990501]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; female gamete generation [GO:0007292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA processing [GO:0050684]; regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000622]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]","","","","TISSUE SPECIFICITY: Ubiquitous. Detected in brain, heart, liver, lung, spleen and testis. {ECO:0000269|PubMed:23917022}."
"980","sp|P03966|MYCN_MOUSE","lcl|NC_088859.1_cds_XP_011441199.3_39328",2.38e-14,75.9,"P03966","MYCN_MOUSE","N-myc proto-oncogene protein","Mycn Nmyc Nmyc1","Mus musculus (Mouse)",462,"GO:0000978; GO:0001228; GO:0001502; GO:0002053; GO:0005634; GO:0005654; GO:0005730; GO:0008283; GO:0010628; GO:0010629; GO:0019900; GO:0030324; GO:0042733; GO:0043068; GO:0045607; GO:0045893; GO:0045944; GO:0046983; GO:0048704; GO:0048708; GO:0048712; GO:0048754; GO:0050673; GO:0050679; GO:0141068; GO:2000378","astrocyte differentiation [GO:0048708]; autosome genomic imprinting [GO:0141068]; branching morphogenesis of an epithelial tube [GO:0048754]; cartilage condensation [GO:0001502]; cell population proliferation [GO:0008283]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system morphogenesis [GO:0048704]; epithelial cell proliferation [GO:0050673]; lung development [GO:0030324]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of gene expression [GO:0010629]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]","nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; kinase binding [GO:0019900]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; astrocyte differentiation [GO:0048708]; autosome genomic imprinting [GO:0141068]; branching morphogenesis of an epithelial tube [GO:0048754]; cartilage condensation [GO:0001502]; cell population proliferation [GO:0008283]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system morphogenesis [GO:0048704]; epithelial cell proliferation [GO:0050673]; lung development [GO:0030324]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of gene expression [GO:0010629]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]","DEVELOPMENTAL STAGE: Highly expressed in the developing brain at embryonic day 13.5 dpc, then expression gradually decreases to its lowest level by postnatal day P15 (PubMed:30573562). In the spinal cord at embryonic days 10.5, 11.5 and 12.5 dpc, expressed in the proliferating cells of the ventricular zone of the neural tube and is expressed at reduced levels in the intermediate zone. At 14.5 dpc, found in regions containing differentiating post-mitotic neurons. In the developing epidermis at 17 dpc, expression is restricted to primary hair germ cells only. {ECO:0000269|PubMed:30573562, ECO:0000269|PubMed:8521822}.","","",""
"981","sp|O44959|RIOK1_CAEEL","lcl|NC_088859.1_cds_XP_011442348.2_37711",2.42e-120,365,"O44959","RIOK1_CAEEL","Serine/threonine-protein kinase RIO1 (EC 2.7.11.1)","riok-1 M01B12.5","Caenorhabditis elegans",506,"GO:0002119; GO:0004674; GO:0005524; GO:0005829; GO:0007281; GO:0008406; GO:0016787; GO:0030490; GO:0030688; GO:0036093; GO:0040026; GO:0043409; GO:0046579; GO:0046872; GO:0048477; GO:0051321; GO:0106310","germ cell development [GO:0007281]; germ cell proliferation [GO:0036093]; gonad development [GO:0008406]; maturation of SSU-rRNA [GO:0030490]; meiotic cell cycle [GO:0051321]; negative regulation of MAPK cascade [GO:0043409]; nematode larval development [GO:0002119]; oogenesis [GO:0048477]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of vulval development [GO:0040026]","cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; germ cell development [GO:0007281]; germ cell proliferation [GO:0036093]; gonad development [GO:0008406]; maturation of SSU-rRNA [GO:0030490]; meiotic cell cycle [GO:0051321]; negative regulation of MAPK cascade [GO:0043409]; nematode larval development [GO:0002119]; oogenesis [GO:0048477]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of vulval development [GO:0040026]","DEVELOPMENTAL STAGE: Expressed in the nervous system at all larval stages. Expressed in somatic gonad and in the ventral nerve cord at L2 larval stage. Expressed in somatic gonad, in ventral uterine (VU/AC) cells and in the committed anchor cell at L3 larval stage. Expressed in vulF cells of the vulva, uterine cells and in uterine seam cells (utse) at L4 larval stage. {ECO:0000269|PubMed:24929033}.","","","TISSUE SPECIFICITY: Expressed in vulva and uterine cells, uterine seam cells (utse), spermatheca and in the nervous system including chemosensory neurons in the head, nerve ring neurons (RID/RIF), inhibitory motor neurons (DA/DD/VA/VD), mechanosensory neurons (ALML/PLML) and tail sensory neurons (DVA//PDA) (PubMed:24929033, PubMed:25688864). Also expressed in intestine and pharynx (procorpus) and rectal valve and gland (PubMed:25688864). {ECO:0000269|PubMed:24929033, ECO:0000269|PubMed:25688864}."
"982","sp|O44408|KGB1_CAEEL","lcl|NC_088859.1_cds_XP_011442372.1_37735",1.98e-129,378,"O44408","KGB1_CAEEL","GLH-binding kinase 1 (EC 2.7.11.24)","kgb-1 T07A9.3","Caenorhabditis elegans",390,"GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005634; GO:0005737; GO:0006986; GO:0007140; GO:0007254; GO:0007283; GO:0008340; GO:0010628; GO:0010629; GO:0017151; GO:0022414; GO:0031333; GO:0033120; GO:0034976; GO:0042594; GO:0046686; GO:0046688; GO:0048599; GO:0050829; GO:0061629; GO:0093002; GO:0097237; GO:0106310; GO:1900180; GO:1900181; GO:1900425; GO:1903843; GO:1990169","cellular response to arsenite ion [GO:1903843]; cellular response to toxic substance [GO:0097237]; defense response to Gram-negative bacterium [GO:0050829]; determination of adult lifespan [GO:0008340]; JNK cascade [GO:0007254]; male meiotic nuclear division [GO:0007140]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of gene expression [GO:0010629]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of protein-containing complex assembly [GO:0031333]; oocyte development [GO:0048599]; positive regulation of gene expression [GO:0010628]; positive regulation of RNA splicing [GO:0033120]; regulation of protein localization to nucleus [GO:1900180]; reproductive process [GO:0022414]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to endoplasmic reticulum stress [GO:0034976]; response to nematicide [GO:0093002]; response to starvation [GO:0042594]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; stress response to copper ion [GO:1990169]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DEAD/H-box RNA helicase binding [GO:0017151]; JUN kinase activity [GO:0004705]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; cellular response to arsenite ion [GO:1903843]; cellular response to toxic substance [GO:0097237]; defense response to Gram-negative bacterium [GO:0050829]; determination of adult lifespan [GO:0008340]; JNK cascade [GO:0007254]; male meiotic nuclear division [GO:0007140]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of gene expression [GO:0010629]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of protein-containing complex assembly [GO:0031333]; oocyte development [GO:0048599]; positive regulation of gene expression [GO:0010628]; positive regulation of RNA splicing [GO:0033120]; regulation of protein localization to nucleus [GO:1900180]; reproductive process [GO:0022414]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to endoplasmic reticulum stress [GO:0034976]; response to nematicide [GO:0093002]; response to starvation [GO:0042594]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; stress response to copper ion [GO:1990169]","","INDUCTION: By B.thuringiensis pore-forming toxin Cry5B. {ECO:0000269|PubMed:15256590}.","INDUCTION: By B.thuringiensis pore-forming toxin Cry5B. {ECO:0000269|PubMed:15256590}.","TISSUE SPECIFICITY: Expressed in somatic and germline tissues. {ECO:0000269|PubMed:12435362}."
"983","sp|P19018|TRA2_DROME","lcl|NC_088859.1_cds_XP_011442788.3_36725",2.18e-37,135,"P19018","TRA2_DROME","Transformer-2 sex-determining protein","tra2 tra-2 CG10128","Drosophila melanogaster (Fruit fly)",264,"GO:0000245; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005681; GO:0006397; GO:0007283; GO:0007530; GO:0007548; GO:0019101; GO:0019102; GO:0022414; GO:0030154; GO:0030237; GO:0036002; GO:0042802; GO:0048026; GO:0071011","cell differentiation [GO:0030154]; female sex determination [GO:0030237]; female somatic sex determination [GO:0019101]; male somatic sex determination [GO:0019102]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; reproductive process [GO:0022414]; sex determination [GO:0007530]; sex differentiation [GO:0007548]; spermatogenesis [GO:0007283]; spliceosomal complex assembly [GO:0000245]","precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; female sex determination [GO:0030237]; female somatic sex determination [GO:0019101]; male somatic sex determination [GO:0019102]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; reproductive process [GO:0022414]; sex determination [GO:0007530]; sex differentiation [GO:0007548]; spermatogenesis [GO:0007283]; spliceosomal complex assembly [GO:0000245]","","","","TISSUE SPECIFICITY: Isoform Tmaj and isoform Tmin are expressed in males and females. Isoform msTmaj and isoform msTmin are present only in male germ cells. {ECO:0000269|PubMed:2116360, ECO:0000269|PubMed:2120049, ECO:0000269|PubMed:3144434}."
"984","sp|P25101|EDNRA_HUMAN","lcl|NC_088859.1_cds_XP_011442849.3_38441",8.14e-23,101,"P25101","EDNRA_HUMAN","Endothelin-1 receptor (Endothelin receptor type A) (ET-A) (ETA-R) (hET-AR)","EDNRA ETA ETRA","Homo sapiens (Human)",427,"GO:0000278; GO:0001569; GO:0001666; GO:0001701; GO:0001974; GO:0001975; GO:0002027; GO:0003094; GO:0003207; GO:0003220; GO:0003228; GO:0003253; GO:0003357; GO:0004435; GO:0004962; GO:0005886; GO:0006874; GO:0006939; GO:0007005; GO:0007165; GO:0007186; GO:0007190; GO:0007193; GO:0007200; GO:0007204; GO:0007585; GO:0008217; GO:0008283; GO:0009611; GO:0010467; GO:0010827; GO:0014034; GO:0014824; GO:0016322; GO:0030202; GO:0030878; GO:0034599; GO:0035050; GO:0035904; GO:0042310; GO:0042415; GO:0042474; GO:0043123; GO:0044751; GO:0048066; GO:0048484; GO:0048485; GO:0048675; GO:0048706; GO:0050905; GO:0055078; GO:0060070; GO:0060324; GO:0060385; GO:0061028; GO:0061626; GO:0070294; GO:0070588; GO:0071372; GO:0071373; GO:0071806; GO:0072011; GO:0072112; GO:0086100; GO:0086101; GO:0097018; GO:0097084; GO:0097152; GO:0097237; GO:0097492; GO:0141156; GO:1902287; GO:1903210; GO:1903537; GO:1904888; GO:1905144; GO:1905871; GO:2001259","activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; artery smooth muscle contraction [GO:0014824]; atrial cardiac muscle tissue development [GO:0003228]; axon extension [GO:0048675]; axonogenesis involved in innervation [GO:0060385]; blood vessel remodeling [GO:0001974]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium ion transmembrane transport [GO:0070588]; cAMP/PKA signal transduction [GO:0141156]; canonical Wnt signaling pathway [GO:0060070]; cardiac chamber formation [GO:0003207]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cell population proliferation [GO:0008283]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to human chorionic gonadotropin stimulus [GO:0044751]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to oxidative stress [GO:0034599]; cellular response to toxic substance [GO:0097237]; cranial skeletal system development [GO:1904888]; developmental pigmentation [GO:0048066]; embryonic heart tube development [GO:0035050]; embryonic skeletal system development [GO:0048706]; endothelin receptor signaling pathway [GO:0086100]; endothelin receptor signaling pathway involved in heart process [GO:0086101]; enteric nervous system development [GO:0048484]; establishment of endothelial barrier [GO:0061028]; face development [GO:0060324]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glomerular endothelium development [GO:0072011]; glomerular filtration [GO:0003094]; heparin proteoglycan metabolic process [GO:0030202]; in utero embryonic development [GO:0001701]; intracellular calcium ion homeostasis [GO:0006874]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; mesenchymal cell apoptotic process [GO:0097152]; middle ear morphogenesis [GO:0042474]; mitochondrion organization [GO:0007005]; mitotic cell cycle [GO:0000278]; neural crest cell fate commitment [GO:0014034]; neuromuscular process [GO:0050905]; neuron remodeling [GO:0016322]; noradrenergic neuron differentiation [GO:0003357]; norepinephrine metabolic process [GO:0042415]; pharyngeal arch artery morphogenesis [GO:0061626]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; podocyte apoptotic process [GO:1903210]; podocyte differentiation [GO:0072112]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; protein transmembrane transport [GO:0071806]; regulation of blood pressure [GO:0008217]; regulation of D-glucose transmembrane transport [GO:0010827]; regulation of heart rate [GO:0002027]; regulation of protein localization to cell leading edge [GO:1905871]; renal albumin absorption [GO:0097018]; renal sodium ion absorption [GO:0070294]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to acetylcholine [GO:1905144]; response to amphetamine [GO:0001975]; response to hypoxia [GO:0001666]; response to wounding [GO:0009611]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; sodium ion homeostasis [GO:0055078]; sympathetic nervous system development [GO:0048485]; sympathetic neuron axon guidance [GO:0097492]; thyroid gland development [GO:0030878]; vascular associated smooth muscle cell development [GO:0097084]; vasoconstriction [GO:0042310]","plasma membrane [GO:0005886]; endothelin receptor activity [GO:0004962]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; artery smooth muscle contraction [GO:0014824]; atrial cardiac muscle tissue development [GO:0003228]; axon extension [GO:0048675]; axonogenesis involved in innervation [GO:0060385]; blood vessel remodeling [GO:0001974]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium ion transmembrane transport [GO:0070588]; cAMP/PKA signal transduction [GO:0141156]; canonical Wnt signaling pathway [GO:0060070]; cardiac chamber formation [GO:0003207]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cell population proliferation [GO:0008283]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to human chorionic gonadotropin stimulus [GO:0044751]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to oxidative stress [GO:0034599]; cellular response to toxic substance [GO:0097237]; cranial skeletal system development [GO:1904888]; developmental pigmentation [GO:0048066]; embryonic heart tube development [GO:0035050]; embryonic skeletal system development [GO:0048706]; endothelin receptor signaling pathway [GO:0086100]; endothelin receptor signaling pathway involved in heart process [GO:0086101]; enteric nervous system development [GO:0048484]; establishment of endothelial barrier [GO:0061028]; face development [GO:0060324]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glomerular endothelium development [GO:0072011]; glomerular filtration [GO:0003094]; heparin proteoglycan metabolic process [GO:0030202]; in utero embryonic development [GO:0001701]; intracellular calcium ion homeostasis [GO:0006874]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; mesenchymal cell apoptotic process [GO:0097152]; middle ear morphogenesis [GO:0042474]; mitochondrion organization [GO:0007005]; mitotic cell cycle [GO:0000278]; neural crest cell fate commitment [GO:0014034]; neuromuscular process [GO:0050905]; neuron remodeling [GO:0016322]; noradrenergic neuron differentiation [GO:0003357]; norepinephrine metabolic process [GO:0042415]; pharyngeal arch artery morphogenesis [GO:0061626]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; podocyte apoptotic process [GO:1903210]; podocyte differentiation [GO:0072112]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; protein transmembrane transport [GO:0071806]; regulation of blood pressure [GO:0008217]; regulation of D-glucose transmembrane transport [GO:0010827]; regulation of heart rate [GO:0002027]; regulation of protein localization to cell leading edge [GO:1905871]; renal albumin absorption [GO:0097018]; renal sodium ion absorption [GO:0070294]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to acetylcholine [GO:1905144]; response to amphetamine [GO:0001975]; response to hypoxia [GO:0001666]; response to wounding [GO:0009611]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; sodium ion homeostasis [GO:0055078]; sympathetic nervous system development [GO:0048485]; sympathetic neuron axon guidance [GO:0097492]; thyroid gland development [GO:0030878]; vascular associated smooth muscle cell development [GO:0097084]; vasoconstriction [GO:0042310]","","","","TISSUE SPECIFICITY: Isoform 1, isoform 3 and isoform 4 are expressed in a variety of tissues, with highest levels in the aorta and cerebellum, followed by lung, atrium and cerebral cortex, lower levels in the placenta, kidney, adrenal gland, duodenum, colon, ventricle and liver but no expression in umbilical vein endothelial cells. Within the placenta, isoform 1, isoform 2, isoform 3 and isoform 4 are expressed in the villi and stem villi vessels. {ECO:0000269|PubMed:8611157, ECO:0000269|PubMed:9284755}."
"985","sp|Q923E4|SIR1_MOUSE","lcl|NC_088859.1_cds_XP_011442932.3_37761",2.37e-162,487,"Q923E4","SIR1_MOUSE","NAD-dependent protein deacetylase sirtuin-1 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-1) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (SIR2alpha) (Sir2) (mSIR2a) [Cleaved into: SirtT1 75 kDa fragment (75SirT1)]","Sirt1 Sir2l1","Mus musculus (Mouse)",737,"GO:0000012; GO:0000122; GO:0000183; GO:0000720; GO:0000731; GO:0000785; GO:0000791; GO:0000792; GO:0000978; GO:0001525; GO:0001542; GO:0001650; GO:0001678; GO:0001934; GO:0001938; GO:0002039; GO:0002821; GO:0003713; GO:0003714; GO:0004857; GO:0005634; GO:0005637; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006476; GO:0006642; GO:0007179; GO:0007283; GO:0007346; GO:0007517; GO:0007623; GO:0008047; GO:0008284; GO:0008630; GO:0009267; GO:0010824; GO:0010868; GO:0010875; GO:0010883; GO:0010906; GO:0016239; GO:0016567; GO:0016605; GO:0016922; GO:0017136; GO:0019213; GO:0019899; GO:0019904; GO:0030225; GO:0030512; GO:0031393; GO:0031507; GO:0031648; GO:0032007; GO:0032041; GO:0032071; GO:0032088; GO:0032436; GO:0032868; GO:0032922; GO:0032991; GO:0033210; GO:0033553; GO:0033558; GO:0034391; GO:0034979; GO:0035098; GO:0035331; GO:0035356; GO:0035358; GO:0042149; GO:0042326; GO:0042393; GO:0042542; GO:0042595; GO:0042632; GO:0042771; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0043124; GO:0043161; GO:0043398; GO:0043425; GO:0043433; GO:0043518; GO:0043524; GO:0043536; GO:0044321; GO:0045348; GO:0045599; GO:0045722; GO:0045739; GO:0045766; GO:0045786; GO:0045892; GO:0045944; GO:0046015; GO:0046628; GO:0046872; GO:0046969; GO:0046970; GO:0050872; GO:0051019; GO:0051152; GO:0051658; GO:0051897; GO:0051898; GO:0055089; GO:0060766; GO:0060907; GO:0061773; GO:0070301; GO:0070403; GO:0070857; GO:0070914; GO:0071356; GO:0071456; GO:0071479; GO:0090335; GO:0090400; GO:0097009; GO:0106230; GO:0106231; GO:0140416; GO:0140861; GO:0140937; GO:0141208; GO:0160012; GO:1902166; GO:1902176; GO:1902237; GO:1904179; GO:1990254; GO:1990830; GO:1990841; GO:2000111; GO:2000481; GO:2000655; GO:2000757; GO:2000773; GO:2000774; GO:2000781","angiogenesis [GO:0001525]; behavioral response to starvation [GO:0042595]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol homeostasis [GO:0042632]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA repair-dependent chromatin remodeling [GO:0140861]; DNA synthesis involved in DNA repair [GO:0000731]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; heterochromatin formation [GO:0031507]; intracellular glucose homeostasis [GO:0001678]; intracellular triglyceride homeostasis [GO:0035356]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage differentiation [GO:0030225]; maintenance of nucleus location [GO:0051658]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of hippo signaling [GO:0035331]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of triglyceride biosynthetic process [GO:0010868]; ovulation from ovarian follicle [GO:0001542]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; protein depropionylation [GO:0106230]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; rDNA heterochromatin formation [GO:0000183]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of centrosome duplication [GO:0010824]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of smooth muscle cell apoptotic process [GO:0034391]; regulation of transcription by glucose [GO:0046015]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to leptin [GO:0044321]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; transforming growth factor beta receptor signaling pathway [GO:0007179]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; white fat cell differentiation [GO:0050872]","chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eNoSc complex [GO:0061773]; ESC/E(Z) complex [GO:0035098]; euchromatin [GO:0000791]; fibrillar center [GO:0001650]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; rDNA heterochromatin [GO:0033553]; bHLH transcription factor binding [GO:0043425]; deacetylase activity [GO:0019213]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone deacetylase activity, NAD-dependent [GO:0017136]; histone H3K14 deacetylase activity, NAD-dependent [GO:0032041]; histone H3K9 deacetylase activity, NAD-dependent [GO:0046969]; histone H4K12 deacetylase activity, hydrolytic mechanism [GO:0140937]; histone H4K16 deacetylase activity, NAD-dependent [GO:0046970]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; NAD+ binding [GO:0070403]; NAD-dependent histone decrotonylase activity [GO:0160012]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; NAD-dependent protein lysine delactylase activity [GO:0141208]; NAD-dependent protein-lysine depropionylase activity [GO:0106231]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416]; angiogenesis [GO:0001525]; behavioral response to starvation [GO:0042595]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol homeostasis [GO:0042632]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA repair-dependent chromatin remodeling [GO:0140861]; DNA synthesis involved in DNA repair [GO:0000731]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; heterochromatin formation [GO:0031507]; intracellular glucose homeostasis [GO:0001678]; intracellular triglyceride homeostasis [GO:0035356]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage differentiation [GO:0030225]; maintenance of nucleus location [GO:0051658]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of hippo signaling [GO:0035331]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of triglyceride biosynthetic process [GO:0010868]; ovulation from ovarian follicle [GO:0001542]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; protein depropionylation [GO:0106230]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; rDNA heterochromatin formation [GO:0000183]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of centrosome duplication [GO:0010824]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of smooth muscle cell apoptotic process [GO:0034391]; regulation of transcription by glucose [GO:0046015]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to leptin [GO:0044321]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; transforming growth factor beta receptor signaling pathway [GO:0007179]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; white fat cell differentiation [GO:0050872]","","INDUCTION: By calorie restriction which induces endothelial nitric oxide synthase (eNOS) expression. Induced in liver by pyruvate during fasting. Expressed in a circadian manner in the liver with maximal and minimal levels reached at around Zeitgeber time (ZT) 16 and ZT4, respectively. Its deacetylase activity in the liver is also regulated in a circadian manner, with a peak at ZT15. Down-regulated by palmitate; palmitate down-regulation is mediated by the induction of miR-195 that directly targets SIRT1. {ECO:0000269|PubMed:15744310, ECO:0000269|PubMed:16224023, ECO:0000269|PubMed:18662546, ECO:0000269|PubMed:18662547, ECO:0000269|PubMed:21622680}.","INDUCTION: By calorie restriction which induces endothelial nitric oxide synthase (eNOS) expression. Induced in liver by pyruvate during fasting. Expressed in a circadian manner in the liver with maximal and minimal levels reached at around Zeitgeber time (ZT) 16 and ZT4, respectively. Its deacetylase activity in the liver is also regulated in a circadian manner, with a peak at ZT15. Down-regulated by palmitate; palmitate down-regulation is mediated by the induction of miR-195 that directly targets SIRT1. {ECO:0000269|PubMed:15744310, ECO:0000269|PubMed:16224023, ECO:0000269|PubMed:18662546, ECO:0000269|PubMed:18662547, ECO:0000269|PubMed:21622680}.","TISSUE SPECIFICITY: Widely expressed. Weakly expressed in liver and skeletal muscle. {ECO:0000269|PubMed:12482959}."
"986","sp|Q8BIL5|HOOK1_MOUSE","lcl|NC_088859.1_cds_XP_011444240.3_38915",1.41e-160,481,"Q8BIL5","HOOK1_MOUSE","Protein Hook homolog 1 (mHK1)","Hook1","Mus musculus (Mouse)",728,"GO:0003779; GO:0005737; GO:0005874; GO:0007030; GO:0007032; GO:0007040; GO:0007286; GO:0008017; GO:0008333; GO:0015031; GO:0015630; GO:0030705; GO:0030897; GO:0031122; GO:0042803; GO:0045022; GO:0070695; GO:1905198; GO:1905719","cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi organization [GO:0007030]; lysosome organization [GO:0007040]; manchette assembly [GO:1905198]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031]; spermatid development [GO:0007286]","cytoplasm [GO:0005737]; FHF complex [GO:0070695]; HOPS complex [GO:0030897]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi organization [GO:0007030]; lysosome organization [GO:0007040]; manchette assembly [GO:1905198]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Mainly expressed in testis. {ECO:0000269|PubMed:12075009}."
"987","sp|Q9V853|SMUF1_DROME","lcl|NC_088859.1_cds_XP_011444560.1_35740",0,622,"Q9V853","SMUF1_DROME","E3 ubiquitin-protein ligase Smurf1 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase Smurf1) (Lethal with a checkpoint kinase protein) (SMAD ubiquitination regulatory factor 1 homolog) (DSmurf)","Smurf lack Smurf1 CG4943","Drosophila melanogaster (Fruit fly)",1061,"GO:0000151; GO:0001700; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0007293; GO:0016567; GO:0030514; GO:0035331; GO:0040008; GO:0043161; GO:0045879; GO:0045880; GO:0048232; GO:0048260; GO:0048619; GO:0061630","embryonic development via the syncytial blastoderm [GO:0001700]; embryonic hindgut morphogenesis [GO:0048619]; germarium-derived egg chamber formation [GO:0007293]; male gamete generation [GO:0048232]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of hippo signaling [GO:0035331]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smoothened signaling pathway [GO:0045880]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]; ubiquitin-dependent protein catabolic process [GO:0006511]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; embryonic development via the syncytial blastoderm [GO:0001700]; embryonic hindgut morphogenesis [GO:0048619]; germarium-derived egg chamber formation [GO:0007293]; male gamete generation [GO:0048232]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of hippo signaling [GO:0035331]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smoothened signaling pathway [GO:0045880]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]; ubiquitin-dependent protein catabolic process [GO:0006511]","DEVELOPMENTAL STAGE: Uniformly expressed at blastoderm stage. Weakly but broadly expressed at later stages of embryogenesis. {ECO:0000269|PubMed:11703946}.","","",""
"988","sp|Q641W9|ACL7A_RAT","lcl|NC_088859.1_cds_XP_011444815.1_39355",2.67e-109,328,"Q641W9","ACL7A_RAT","Actin-like protein 7A","Actl7a","Rattus norvegicus (Rat)",440,"GO:0001669; GO:0001673; GO:0001675; GO:0005634; GO:0005737; GO:0005794; GO:0005856; GO:0007286; GO:0007338; GO:0009566; GO:0031514; GO:0032991","acrosome assembly [GO:0001675]; fertilization [GO:0009566]; single fertilization [GO:0007338]; spermatid development [GO:0007286]","acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; male germ cell nucleus [GO:0001673]; motile cilium [GO:0031514]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; acrosome assembly [GO:0001675]; fertilization [GO:0009566]; single fertilization [GO:0007338]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Detected in testis. Detected at the acrosome of round spermatids (at protein level). {ECO:0000269|PubMed:21278383}."
"989","sp|P81299|CDC14_CAEEL","lcl|NC_088859.1_cds_XP_011445102.1_37172",1.91e-111,348,"P81299","CDC14_CAEEL","Tyrosine-protein phosphatase cdc-14 (EC 3.1.3.48) (Cell division cycle-related protein 14)","cdc-14 C17G10.4","Caenorhabditis elegans",709,"GO:0000226; GO:0000235; GO:0000281; GO:0000922; GO:0004721; GO:0004722; GO:0004725; GO:0005634; GO:0005730; GO:0005737; GO:0005813; GO:0005819; GO:0007096; GO:0016311; GO:0016791; GO:0030496; GO:0032467; GO:0040028; GO:0040038; GO:0045786; GO:0051233; GO:0051256; GO:0060271; GO:0060284; GO:0072686; GO:1902636; GO:1902807; GO:1903452; GO:1990023","cilium assembly [GO:0060271]; dephosphorylation [GO:0016311]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of cytokinesis [GO:0032467]; positive regulation of G1 to G0 transition [GO:1903452]; regulation of cell development [GO:0060284]; regulation of exit from mitosis [GO:0007096]; regulation of vulval development [GO:0040028]","astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinociliary basal body [GO:1902636]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle midzone [GO:1990023]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; cilium assembly [GO:0060271]; dephosphorylation [GO:0016311]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of cytokinesis [GO:0032467]; positive regulation of G1 to G0 transition [GO:1903452]; regulation of cell development [GO:0060284]; regulation of exit from mitosis [GO:0007096]; regulation of vulval development [GO:0040028]","DEVELOPMENTAL STAGE: Expressed in the soma during early embryogenesis, and widely expressed after hatching. Isoform C: Expressed in the soma during early embryogenesis, but after hatching, expression in larvae is restricted to V and P lineages, the postembryonic lineages that contribute to the seam cells and vulval precursor cells, respectively. {ECO:0000269|PubMed:21723944}.","","",""
"990","sp|P0C6A0|ZGLP1_HUMAN","lcl|NC_088859.1_cds_XP_011445224.4_39082",2.36e-26,108,"P0C6A0","ZGLP1_HUMAN","GATA-type zinc finger protein 1 (GATA-like protein 1) (GLP-1)","ZGLP1 GLP1","Homo sapiens (Human)",273,"GO:0000122; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0007283; GO:0008270; GO:0043565; GO:0045944; GO:0048599","negative regulation of transcription by RNA polymerase II [GO:0000122]; oocyte development [GO:0048599]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oocyte development [GO:0048599]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","","","",""
"991","sp|Q92949|FOXJ1_HUMAN","lcl|NC_088859.1_cds_XP_011445235.1_39062",1.09e-57,196,"Q92949","FOXJ1_HUMAN","Forkhead box protein J1 (Forkhead-related protein FKHL13) (Hepatocyte nuclear factor 3 forkhead homolog 4) (HFH-4)","FOXJ1 FKHL13 HFH4","Homo sapiens (Human)",421,"GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0002508; GO:0002635; GO:0002897; GO:0002924; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0006959; GO:0007283; GO:0007368; GO:0007389; GO:0007420; GO:0007507; GO:0008104; GO:0030036; GO:0032053; GO:0032715; GO:0033085; GO:0035082; GO:0035089; GO:0035502; GO:0042130; GO:0044458; GO:0045944; GO:0048469; GO:0050869; GO:0050900; GO:0060271; GO:0060428; GO:0060429; GO:0072016; GO:1901223; GO:1901248","actin cytoskeleton organization [GO:0030036]; axoneme assembly [GO:0035082]; brain development [GO:0007420]; cell maturation [GO:0048469]; central tolerance induction [GO:0002508]; ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; epithelium development [GO:0060429]; establishment of apical/basal cell polarity [GO:0035089]; glomerular parietal epithelial cell development [GO:0072016]; heart development [GO:0007507]; humoral immune response [GO:0006959]; leukocyte migration [GO:0050900]; lung epithelium development [GO:0060428]; metanephric part of ureteric bud development [GO:0035502]; motile cilium assembly [GO:0044458]; negative regulation of B cell activation [GO:0050869]; negative regulation of germinal center formation [GO:0002635]; negative regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002924]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pattern specification process [GO:0007389]; positive regulation of central B cell tolerance induction [GO:0002897]; positive regulation of lung ciliated cell differentiation [GO:1901248]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; actin cytoskeleton organization [GO:0030036]; axoneme assembly [GO:0035082]; brain development [GO:0007420]; cell maturation [GO:0048469]; central tolerance induction [GO:0002508]; ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; epithelium development [GO:0060429]; establishment of apical/basal cell polarity [GO:0035089]; glomerular parietal epithelial cell development [GO:0072016]; heart development [GO:0007507]; humoral immune response [GO:0006959]; leukocyte migration [GO:0050900]; lung epithelium development [GO:0060428]; metanephric part of ureteric bud development [GO:0035502]; motile cilium assembly [GO:0044458]; negative regulation of B cell activation [GO:0050869]; negative regulation of germinal center formation [GO:0002635]; negative regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002924]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pattern specification process [GO:0007389]; positive regulation of central B cell tolerance induction [GO:0002897]; positive regulation of lung ciliated cell differentiation [GO:1901248]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed in developing lung, kidney and central nervous system.","","","TISSUE SPECIFICITY: Testis, oviduct, lung and brain cortex."
"992","sp|Q95LM0|PDILT_MACFA","lcl|NC_088859.1_cds_XP_011445708.2_36496",1.12e-82,268,"Q95LM0","PDILT_MACFA","Protein disulfide-isomerase-like protein of the testis","PDILT QtsA-10382 QtsA-15920 QtsA-20110","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)",583,"GO:0005783; GO:0006457; GO:0007283; GO:0016853; GO:0030154","cell differentiation [GO:0030154]; protein folding [GO:0006457]; spermatogenesis [GO:0007283]","endoplasmic reticulum [GO:0005783]; isomerase activity [GO:0016853]; cell differentiation [GO:0030154]; protein folding [GO:0006457]; spermatogenesis [GO:0007283]","","","",""
"993","sp|Q27889|PP2B2_DROME","lcl|NC_088859.1_cds_XP_011445772.3_36559",0,832,"Q27889","PP2B2_DROME","Serine/threonine-protein phosphatase 2B catalytic subunit 2 (EC 3.1.3.16) (Calmodulin-dependent calcineurin A2 subunit)","Pp2B-14D CG9842","Drosophila melanogaster (Fruit fly)",570,"GO:0004722; GO:0004723; GO:0005516; GO:0005737; GO:0005955; GO:0007143; GO:0030431; GO:0033192; GO:0035220; GO:0045995; GO:0046872; GO:0051321; GO:0097720","calcineurin-mediated signaling [GO:0097720]; female meiotic nuclear division [GO:0007143]; meiotic cell cycle [GO:0051321]; regulation of embryonic development [GO:0045995]; sleep [GO:0030431]; wing disc development [GO:0035220]","calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; calcineurin-mediated signaling [GO:0097720]; female meiotic nuclear division [GO:0007143]; meiotic cell cycle [GO:0051321]; regulation of embryonic development [GO:0045995]; sleep [GO:0030431]; wing disc development [GO:0035220]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically in embryos, larvae and adults. {ECO:0000269|PubMed:8313960, ECO:0000269|PubMed:8849894}.","","","TISSUE SPECIFICITY: Expressed in CNS and PNS. {ECO:0000269|PubMed:8849894}."
"994","sp|O18640|GBLP_DROME","lcl|NC_088859.1_cds_XP_011445926.1_40417",0,503,"O18640","GBLP_DROME","Small ribosomal subunit protein RACK1 (Guanine nucleotide-binding protein subunit beta-like protein) (Receptor of activated protein kinase C homolog)","Rack1 CG7111","Drosophila melanogaster (Fruit fly)",318,"GO:0000423; GO:0001933; GO:0002181; GO:0002188; GO:0003735; GO:0005080; GO:0005634; GO:0005737; GO:0005776; GO:0005829; GO:0007626; GO:0009267; GO:0016243; GO:0018991; GO:0022626; GO:0030674; GO:0030838; GO:0031398; GO:0035220; GO:0042335; GO:0043022; GO:0044829; GO:0045182; GO:0045725; GO:0045879; GO:0046716; GO:0048477; GO:0072344; GO:0075522; GO:1903003; GO:1990904; GO:2001125","cellular response to starvation [GO:0009267]; cuticle development [GO:0042335]; cytoplasmic translation [GO:0002181]; egg-laying behavior [GO:0018991]; IRES-dependent viral translational initiation [GO:0075522]; locomotory behavior [GO:0007626]; mitophagy [GO:0000423]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of translational frameshifting [GO:2001125]; oogenesis [GO:0048477]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome size [GO:0016243]; rescue of stalled ribosome [GO:0072344]; translation reinitiation [GO:0002188]; wing disc development [GO:0035220]","autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; protein kinase C binding [GO:0005080]; protein-macromolecule adaptor activity [GO:0030674]; ribosome binding [GO:0043022]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; cellular response to starvation [GO:0009267]; cuticle development [GO:0042335]; cytoplasmic translation [GO:0002181]; egg-laying behavior [GO:0018991]; IRES-dependent viral translational initiation [GO:0075522]; locomotory behavior [GO:0007626]; mitophagy [GO:0000423]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of translational frameshifting [GO:2001125]; oogenesis [GO:0048477]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome size [GO:0016243]; rescue of stalled ribosome [GO:0072344]; translation reinitiation [GO:0002188]; wing disc development [GO:0035220]","","","","TISSUE SPECIFICITY: Highest expression in the mesodermal and endodermal lineages. {ECO:0000269|PubMed:9296523}."
"995","sp|P23696|PP2A_DROME","lcl|NC_088859.1_cds_XP_011445936.1_40418",0,619,"P23696","PP2A_DROME","Serine/threonine-protein phosphatase PP2A (EC 3.1.3.16) (Protein microtubule star)","mts PP2A Pp2A-28D CG7109","Drosophila melanogaster (Fruit fly)",309,"GO:0000159; GO:0000226; GO:0000278; GO:0000785; GO:0004722; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007051; GO:0007059; GO:0007098; GO:0007099; GO:0007168; GO:0007406; GO:0007460; GO:0007465; GO:0008420; GO:0009416; GO:0016239; GO:0019208; GO:0035331; GO:0045752; GO:0045879; GO:0045880; GO:0046627; GO:0046872; GO:0048190; GO:0048477; GO:0051225; GO:0051898; GO:0055059; GO:0090162; GO:0090263; GO:0090443; GO:0160232; GO:0160240","asymmetric neuroblast division [GO:0055059]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; establishment of epithelial cell polarity [GO:0090162]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of smoothened signaling pathway [GO:0045879]; oogenesis [GO:0048477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of macroautophagy [GO:0016239]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of Toll signaling pathway [GO:0045752]; R7 cell fate commitment [GO:0007465]; R8 cell fate commitment [GO:0007460]; receptor guanylyl cyclase signaling pathway [GO:0007168]; response to light stimulus [GO:0009416]; RNA polymerase II transcription initiation surveillance [GO:0160240]; spindle assembly [GO:0051225]; spindle organization [GO:0007051]; wing disc dorsal/ventral pattern formation [GO:0048190]","chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FAR/SIN/STRIPAK complex [GO:0090443]; INTAC complex [GO:0160232]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; metal ion binding [GO:0046872]; phosphatase regulator activity [GO:0019208]; protein serine/threonine phosphatase activity [GO:0004722]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; asymmetric neuroblast division [GO:0055059]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; establishment of epithelial cell polarity [GO:0090162]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of smoothened signaling pathway [GO:0045879]; oogenesis [GO:0048477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of macroautophagy [GO:0016239]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of Toll signaling pathway [GO:0045752]; R7 cell fate commitment [GO:0007465]; R8 cell fate commitment [GO:0007460]; receptor guanylyl cyclase signaling pathway [GO:0007168]; response to light stimulus [GO:0009416]; RNA polymerase II transcription initiation surveillance [GO:0160240]; spindle assembly [GO:0051225]; spindle organization [GO:0007051]; wing disc dorsal/ventral pattern formation [GO:0048190]","","","",""
"996","sp|P43021|NODAL_MOUSE","lcl|NC_088859.1_cds_XP_011447085.3_38220",2.48e-26,108,"P43021","NODAL_MOUSE","Nodal","Nodal","Mus musculus (Mouse)",354,"GO:0000122; GO:0001701; GO:0001702; GO:0001707; GO:0001829; GO:0001831; GO:0001842; GO:0001889; GO:0001892; GO:0001893; GO:0001944; GO:0001947; GO:0002085; GO:0003140; GO:0005125; GO:0005576; GO:0005615; GO:0007179; GO:0007281; GO:0007368; GO:0007369; GO:0007399; GO:0007420; GO:0007492; GO:0007507; GO:0008083; GO:0008283; GO:0008284; GO:0009880; GO:0009948; GO:0009952; GO:0009966; GO:0010085; GO:0010470; GO:0010575; GO:0010721; GO:0016477; GO:0019827; GO:0022409; GO:0030154; GO:0030324; GO:0033505; GO:0035019; GO:0035050; GO:0035987; GO:0038092; GO:0042074; GO:0045165; GO:0045596; GO:0045766; GO:0045944; GO:0048018; GO:0048327; GO:0048382; GO:0048546; GO:0048646; GO:0048701; GO:0048729; GO:0048859; GO:0050679; GO:0055123; GO:0060136; GO:0060137; GO:0060391; GO:0060460; GO:0060766; GO:0060802; GO:0070374; GO:0070698; GO:0090009; GO:0097190; GO:1901164; GO:1901383; GO:2000242","anatomical structure formation involved in morphogenesis [GO:0048646]; anterior/posterior axis specification [GO:0009948]; anterior/posterior pattern specification [GO:0009952]; apoptotic signaling pathway [GO:0097190]; axial mesodermal cell fate specification [GO:0048327]; brain development [GO:0007420]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cell migration [GO:0016477]; cell migration involved in gastrulation [GO:0042074]; cell population proliferation [GO:0008283]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of left/right symmetry [GO:0007368]; digestive system development [GO:0055123]; digestive tract morphogenesis [GO:0048546]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic heart tube development [GO:0035050]; embryonic pattern specification [GO:0009880]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; endoderm development [GO:0007492]; endodermal cell differentiation [GO:0035987]; epiblast cell-extraembryonic ectoderm cell signaling [GO:0060802]; floor plate morphogenesis [GO:0033505]; formation of anatomical boundary [GO:0048859]; gastrulation [GO:0007369]; gastrulation with mouth forming second [GO:0001702]; germ cell development [GO:0007281]; heart development [GO:0007507]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; inhibition of neuroepithelial cell differentiation [GO:0002085]; left lung morphogenesis [GO:0060460]; liver development [GO:0001889]; lung development [GO:0030324]; maternal placenta development [GO:0001893]; maternal process involved in parturition [GO:0060137]; mesendoderm development [GO:0048382]; mesoderm formation [GO:0001707]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of cell development [GO:0010721]; negative regulation of cell differentiation [GO:0045596]; negative regulation of chorionic trophoblast cell proliferation [GO:1901383]; negative regulation of reproductive process [GO:2000242]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of trophoblast cell migration [GO:1901164]; nervous system development [GO:0007399]; neural fold formation [GO:0001842]; nodal signaling pathway [GO:0038092]; polarity specification of proximal/distal axis [GO:0010085]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; primitive streak formation [GO:0090009]; regulation of gastrulation [GO:0010470]; regulation of signal transduction [GO:0009966]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tissue morphogenesis [GO:0048729]; transforming growth factor beta receptor signaling pathway [GO:0007179]; trophectodermal cell differentiation [GO:0001829]; trophectodermal cellular morphogenesis [GO:0001831]; vasculature development [GO:0001944]","extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; type I activin receptor binding [GO:0070698]; anatomical structure formation involved in morphogenesis [GO:0048646]; anterior/posterior axis specification [GO:0009948]; anterior/posterior pattern specification [GO:0009952]; apoptotic signaling pathway [GO:0097190]; axial mesodermal cell fate specification [GO:0048327]; brain development [GO:0007420]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cell migration [GO:0016477]; cell migration involved in gastrulation [GO:0042074]; cell population proliferation [GO:0008283]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of left/right symmetry [GO:0007368]; digestive system development [GO:0055123]; digestive tract morphogenesis [GO:0048546]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic heart tube development [GO:0035050]; embryonic pattern specification [GO:0009880]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; endoderm development [GO:0007492]; endodermal cell differentiation [GO:0035987]; epiblast cell-extraembryonic ectoderm cell signaling [GO:0060802]; floor plate morphogenesis [GO:0033505]; formation of anatomical boundary [GO:0048859]; gastrulation [GO:0007369]; gastrulation with mouth forming second [GO:0001702]; germ cell development [GO:0007281]; heart development [GO:0007507]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; inhibition of neuroepithelial cell differentiation [GO:0002085]; left lung morphogenesis [GO:0060460]; liver development [GO:0001889]; lung development [GO:0030324]; maternal placenta development [GO:0001893]; maternal process involved in parturition [GO:0060137]; mesendoderm development [GO:0048382]; mesoderm formation [GO:0001707]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of cell development [GO:0010721]; negative regulation of cell differentiation [GO:0045596]; negative regulation of chorionic trophoblast cell proliferation [GO:1901383]; negative regulation of reproductive process [GO:2000242]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of trophoblast cell migration [GO:1901164]; nervous system development [GO:0007399]; neural fold formation [GO:0001842]; nodal signaling pathway [GO:0038092]; polarity specification of proximal/distal axis [GO:0010085]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; primitive streak formation [GO:0090009]; regulation of gastrulation [GO:0010470]; regulation of signal transduction [GO:0009966]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tissue morphogenesis [GO:0048729]; transforming growth factor beta receptor signaling pathway [GO:0007179]; trophectodermal cell differentiation [GO:0001829]; trophectodermal cellular morphogenesis [GO:0001831]; vasculature development [GO:0001944]","DEVELOPMENTAL STAGE: Expressed in the node during gastrulation. Expression is first detected in primitive streak-stage embryos at about the time of mesoderm formation. It then becomes highly localized in the node at the anterior of the primitive streak. {ECO:0000269|PubMed:8429908}.","","",""
"997","sp|Q86WS5|TMPSC_HUMAN","lcl|NC_088859.1_cds_XP_011447092.4_38241",1.57e-45,167,"Q86WS5","TMPSC_HUMAN","Transmembrane protease serine 12 (EC 3.4.21.-)","TMPRSS12","Homo sapiens (Human)",348,"GO:0001669; GO:0001675; GO:0004252; GO:0005886; GO:0007283; GO:0007339; GO:0016485; GO:1902492","acrosome assembly [GO:0001675]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of sperm capacitation [GO:1902492]; protein processing [GO:0016485]; spermatogenesis [GO:0007283]","acrosomal vesicle [GO:0001669]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; acrosome assembly [GO:0001675]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of sperm capacitation [GO:1902492]; protein processing [GO:0016485]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: In testis, expressed in spermatocytes and spermatids (at protein level). {ECO:0000269|PubMed:23436708}."
"998","sp|Q96MU7|YTDC1_HUMAN","lcl|NC_088859.1_cds_XP_011447601.3_37565",3.74e-78,264,"Q96MU7","YTDC1_HUMAN","YTH domain-containing protein 1 (Splicing factor YT521) (YT521-B)","YTHDC1 KIAA1966 YT521","Homo sapiens (Human)",727,"GO:0000381; GO:0000398; GO:0001701; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005886; GO:0006376; GO:0006406; GO:0007283; GO:0009048; GO:0010608; GO:0016607; GO:0048024; GO:0048160; GO:0110104; GO:1990247","dosage compensation by inactivation of X chromosome [GO:0009048]; in utero embryonic development [GO:0001701]; mRNA alternative polyadenylation [GO:0110104]; mRNA export from nucleus [GO:0006406]; mRNA splice site recognition [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; post-transcriptional regulation of gene expression [GO:0010608]; primary follicle stage [GO:0048160]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283]","nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; RNA binding [GO:0003723]; dosage compensation by inactivation of X chromosome [GO:0009048]; in utero embryonic development [GO:0001701]; mRNA alternative polyadenylation [GO:0110104]; mRNA export from nucleus [GO:0006406]; mRNA splice site recognition [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; post-transcriptional regulation of gene expression [GO:0010608]; primary follicle stage [GO:0048160]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283]","","","",""
"999","sp|Q9Y547|IFT25_HUMAN","lcl|NC_088859.1_cds_XP_011448714.1_37233",3.66e-42,137,"Q9Y547","IFT25_HUMAN","Intraflagellar transport protein 25 homolog (Heat shock protein beta-11) (Hspb11) (Heat shock protein family B member 11) (Placental protein 25) (PP25)","IFT25 C1orf41 HSPB11 HSPC034","Homo sapiens (Human)",144,"GO:0001501; GO:0001822; GO:0005813; GO:0005929; GO:0007224; GO:0007283; GO:0007507; GO:0015031; GO:0030154; GO:0030324; GO:0030992; GO:0035720; GO:0046872; GO:0060271; GO:0070986; GO:0097542","cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; heart development [GO:0007507]; intraciliary anterograde transport [GO:0035720]; kidney development [GO:0001822]; left/right axis specification [GO:0070986]; lung development [GO:0030324]; protein transport [GO:0015031]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]","centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; heart development [GO:0007507]; intraciliary anterograde transport [GO:0035720]; kidney development [GO:0001822]; left/right axis specification [GO:0070986]; lung development [GO:0030324]; protein transport [GO:0015031]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Detected in placenta. {ECO:0000269|PubMed:2018407}."
"1000","sp|Q960Z0|KI10A_DROME","lcl|NC_088859.1_cds_XP_011448850.1_37217",0,602,"Q960Z0","KI10A_DROME","Kinesin-like protein Klp10A (Kinesin-like protein at cytological position 10A)","Klp10A CG1453","Drosophila melanogaster (Fruit fly)",805,"GO:0000212; GO:0000775; GO:0000922; GO:0003774; GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005819; GO:0005828; GO:0005871; GO:0005874; GO:0007018; GO:0007019; GO:0007051; GO:0007052; GO:0007057; GO:0008017; GO:0008574; GO:0016887; GO:0045167; GO:0051296; GO:0051298; GO:0051301; GO:0055028; GO:0061673; GO:0061867; GO:0070462; GO:0072687; GO:0090619; GO:0097431; GO:0098534; GO:1905515","asymmetric protein localization involved in cell fate determination [GO:0045167]; cell division [GO:0051301]; centriole assembly [GO:0098534]; centrosome duplication [GO:0051298]; establishment of meiotic spindle orientation [GO:0051296]; establishment of mitotic spindle asymmetry [GO:0061867]; meiotic spindle organization [GO:0000212]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; non-motile cilium assembly [GO:1905515]; plus-end specific microtubule depolymerization [GO:0070462]; spindle assembly involved in female meiosis I [GO:0007057]; spindle organization [GO:0007051]","centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cortical microtubule [GO:0055028]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; kinetochore microtubule [GO:0005828]; meiotic spindle [GO:0072687]; meiotic spindle pole [GO:0090619]; microtubule [GO:0005874]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle pole [GO:0097431]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; asymmetric protein localization involved in cell fate determination [GO:0045167]; cell division [GO:0051301]; centriole assembly [GO:0098534]; centrosome duplication [GO:0051298]; establishment of meiotic spindle orientation [GO:0051296]; establishment of mitotic spindle asymmetry [GO:0061867]; meiotic spindle organization [GO:0000212]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; non-motile cilium assembly [GO:1905515]; plus-end specific microtubule depolymerization [GO:0070462]; spindle assembly involved in female meiosis I [GO:0007057]; spindle organization [GO:0007051]","","","","TISSUE SPECIFICITY: Expressed in male germline stem cells and spermatogonia (at protein level). {ECO:0000269|PubMed:32965218}."
"1001","sp|P56597|NDK5_HUMAN","lcl|NC_088859.1_cds_XP_011449580.1_34861",1.5e-108,311,"P56597","NDK5_HUMAN","Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (3'-5' exonuclease NME5) (EC 3.1.-.-) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)","NME5","Homo sapiens (Human)",212,"GO:0001534; GO:0003341; GO:0003351; GO:0004550; GO:0005576; GO:0005929; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0008408; GO:0009116; GO:0021591; GO:0036126; GO:0051649; GO:0060271; GO:0097729; GO:1902176","cilium assembly [GO:0060271]; cilium movement [GO:0003341]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]","9+2 motile cilium [GO:0097729]; cilium [GO:0005929]; extracellular region [GO:0005576]; radial spoke [GO:0001534]; sperm flagellum [GO:0036126]; 3'-5' exonuclease activity [GO:0008408]; nucleoside diphosphate kinase activity [GO:0004550]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]","","","","TISSUE SPECIFICITY: Specifically expressed in testis germinal cells. {ECO:0000269|PubMed:9742940}."
"1002","sp|Q9D513|MEIOB_MOUSE","lcl|NC_088859.1_cds_XP_011451904.3_40022",4.88e-99,308,"Q9D513","MEIOB_MOUSE","Meiosis-specific with OB domain-containing protein (EC 3.1.-.-) (Protein expressed in male leptotene and zygotene spermatocytes 675) (MLZ-675)","Meiob","Mus musculus (Mouse)",470,"GO:0000712; GO:0000724; GO:0003682; GO:0003697; GO:0005634; GO:0005694; GO:0005737; GO:0007129; GO:0007140; GO:0007141; GO:0007144; GO:0008310; GO:0009566","double-strand break repair via homologous recombination [GO:0000724]; female meiosis I [GO:0007144]; fertilization [GO:0009566]; homologous chromosome pairing at meiosis [GO:0007129]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; resolution of meiotic recombination intermediates [GO:0000712]","chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; single-stranded DNA 3'-5' DNA exonuclease activity [GO:0008310]; single-stranded DNA binding [GO:0003697]; double-strand break repair via homologous recombination [GO:0000724]; female meiosis I [GO:0007144]; fertilization [GO:0009566]; homologous chromosome pairing at meiosis [GO:0007129]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; resolution of meiotic recombination intermediates [GO:0000712]","DEVELOPMENTAL STAGE: Detected only during early meiosis prophase I (early 4N-fraction containing leptotene, zygotene and few pachytenes spermatocytes) and not during later stages of meiosis (at protein level). {ECO:0000269|PubMed:24068956, ECO:0000269|PubMed:24240703}.","","","TISSUE SPECIFICITY: Sprecifically expressed in early meiotic germ cells: in adult and fetal tissues, detected in fetal ovary, postnatal testis and liver. In the ovary, expression starts at 12.5 dpc, reaches a maximum at 15.5 dpc and decreases to become undetectable in post natal life. In testis, expression starts at 10 days post partum (dpp), reaches a maximum at 20 dpp and is maintained throughout adult life. {ECO:0000269|PubMed:24068956, ECO:0000269|PubMed:24240703}."
"1003","sp|Q69AB1|TXND8_RAT","lcl|NC_088859.1_cds_XP_011451922.3_40037",3.81e-22,85.5,"Q69AB1","TXND8_RAT","Thioredoxin domain-containing protein 8 (Spermatid-specific thioredoxin-3) (Sptrx-3)","Txndc8 Sptrx3","Rattus norvegicus (Rat)",127,"GO:0001669; GO:0001675; GO:0005737; GO:0005794; GO:0007283; GO:0036126","acrosome assembly [GO:0001675]; spermatogenesis [GO:0007283]","acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; sperm flagellum [GO:0036126]; acrosome assembly [GO:0001675]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Testis-specific. Expressed in spermatozoa, sperm tail, elongated and round spermatids. {ECO:0000269|PubMed:15181017}."
"1004","sp|P08111|L2GL_DROME","lcl|NC_088859.1_cds_XP_011454118.3_37010",0,632,"P08111","L2GL_DROME","Lethal(2) giant larvae protein","l(2)gl CG2671","Drosophila melanogaster (Fruit fly)",1161,"GO:0000132; GO:0000139; GO:0000149; GO:0004860; GO:0005096; GO:0005737; GO:0005886; GO:0005920; GO:0005938; GO:0006887; GO:0006893; GO:0007314; GO:0007391; GO:0007399; GO:0007406; GO:0007423; GO:0008593; GO:0016325; GO:0016327; GO:0016333; GO:0016334; GO:0016360; GO:0017022; GO:0019901; GO:0019905; GO:0019991; GO:0030036; GO:0030863; GO:0030864; GO:0030866; GO:0031012; GO:0031256; GO:0032878; GO:0035070; GO:0035212; GO:0035293; GO:0035332; GO:0042734; GO:0045159; GO:0045167; GO:0045175; GO:0045176; GO:0045184; GO:0045196; GO:0045464; GO:0045571; GO:0045746; GO:0048102; GO:0048730; GO:0051294; GO:0051668; GO:0055059; GO:0072697; GO:0090163; GO:0098725; GO:1904580","actin cytoskeleton organization [GO:0030036]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; autophagic cell death [GO:0048102]; basal protein localization [GO:0045175]; cell competition in a multicellular organism [GO:0035212]; chitin-based larval cuticle pattern formation [GO:0035293]; cortical actin cytoskeleton organization [GO:0030866]; dorsal closure [GO:0007391]; epidermis morphogenesis [GO:0048730]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment of protein localization [GO:0045184]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; localization within membrane [GO:0051668]; morphogenesis of follicular epithelium [GO:0016333]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; nervous system development [GO:0007399]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte microtubule cytoskeleton organization [GO:0016325]; positive regulation of hippo signaling [GO:0035332]; protein localization to cell cortex [GO:0072697]; R8 cell fate specification [GO:0045464]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of intracellular mRNA localization [GO:1904580]; regulation of Notch signaling pathway [GO:0008593]; salivary gland histolysis [GO:0035070]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; septate junction assembly [GO:0019991]; symmetric cell division [GO:0098725]","apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; Golgi membrane [GO:0000139]; leading edge membrane [GO:0031256]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; smooth septate junction [GO:0005920]; GTPase activator activity [GO:0005096]; myosin binding [GO:0017022]; myosin II binding [GO:0045159]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; actin cytoskeleton organization [GO:0030036]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; autophagic cell death [GO:0048102]; basal protein localization [GO:0045175]; cell competition in a multicellular organism [GO:0035212]; chitin-based larval cuticle pattern formation [GO:0035293]; cortical actin cytoskeleton organization [GO:0030866]; dorsal closure [GO:0007391]; epidermis morphogenesis [GO:0048730]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment of protein localization [GO:0045184]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; localization within membrane [GO:0051668]; morphogenesis of follicular epithelium [GO:0016333]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; nervous system development [GO:0007399]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte microtubule cytoskeleton organization [GO:0016325]; positive regulation of hippo signaling [GO:0035332]; protein localization to cell cortex [GO:0072697]; R8 cell fate specification [GO:0045464]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of intracellular mRNA localization [GO:1904580]; regulation of Notch signaling pathway [GO:0008593]; salivary gland histolysis [GO:0035070]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; septate junction assembly [GO:0019991]; symmetric cell division [GO:0098725]","DEVELOPMENTAL STAGE: Expressed abundantly in early embryogenesis. Moderate expression is found in larval and adult stages. In the egg chamber during late stages of oogenesis expressed in oocyte and nurse cells, but not in follicle cells (PubMed:18948416). {ECO:0000269|PubMed:18948416}.","","","TISSUE SPECIFICITY: Expressed in the epithelial cells of the digestive tract and in gonads."
"1005","sp|Q08473|SQD_DROME","lcl|NC_088859.1_cds_XP_011454413.1_36036",1.05e-44,156,"Q08473","SQD_DROME","RNA-binding protein squid (Heterogeneous nuclear ribonucleoprotein 40) (HNRNP 40)","sqd hrp40 CG16901","Drosophila melanogaster (Fruit fly)",344,"GO:0000184; GO:0000381; GO:0000398; GO:0000785; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005703; GO:0005737; GO:0006405; GO:0006406; GO:0007293; GO:0007297; GO:0007314; GO:0008069; GO:0008298; GO:0009953; GO:0010468; GO:0016325; GO:0017148; GO:0019094; GO:0030720; GO:0033119; GO:0035062; GO:0045451; GO:0048477; GO:0071011; GO:0071013","dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal/ventral pattern formation [GO:0009953]; follicle cell of egg chamber migration [GO:0007297]; germarium-derived egg chamber formation [GO:0007293]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of RNA splicing [GO:0033119]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; pole plasm mRNA localization [GO:0019094]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; RNA export from nucleus [GO:0006405]","catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; precatalytic spliceosome [GO:0071011]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal/ventral pattern formation [GO:0009953]; follicle cell of egg chamber migration [GO:0007297]; germarium-derived egg chamber formation [GO:0007293]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of RNA splicing [GO:0033119]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; pole plasm mRNA localization [GO:0019094]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; RNA export from nucleus [GO:0006405]","","","",""
"1006","sp|Q9W074|HBS1_DROME","lcl|NC_088859.1_cds_XP_011454783.3_38667",0,546,"Q9W074","HBS1_DROME","Protein HBS1 (EC 3.6.5.-)","HBS1 CG1898","Drosophila melanogaster (Fruit fly)",670,"GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006417; GO:0007291; GO:0016441; GO:0045089; GO:0048137; GO:0050829","defense response to Gram-negative bacterium [GO:0050829]; positive regulation of innate immune response [GO:0045089]; post-transcriptional gene silencing [GO:0016441]; regulation of translation [GO:0006417]; sperm individualization [GO:0007291]; spermatocyte division [GO:0048137]; translation [GO:0006412]","cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; defense response to Gram-negative bacterium [GO:0050829]; positive regulation of innate immune response [GO:0045089]; post-transcriptional gene silencing [GO:0016441]; regulation of translation [GO:0006417]; sperm individualization [GO:0007291]; spermatocyte division [GO:0048137]; translation [GO:0006412]","","","","TISSUE SPECIFICITY: Expressed in ovaries (at protein level). {ECO:0000269|PubMed:26124316}."
"1007","sp|P62340|TBPL1_MOUSE","lcl|NC_088859.1_cds_XP_011454834.2_38606",3.16e-76,231,"P62340","TBPL1_MOUSE","TATA box-binding protein-like 1 (TBP-like 1) (21 kDa TBP-like protein) (TATA box-binding protein-related factor 2) (TBP-related factor 2) (TBP-like factor) (TBP-related protein)","Tbpl1 Tlf Tlp Tlp21 Trf2 Trp","Mus musculus (Mouse)",186,"GO:0000979; GO:0001673; GO:0001675; GO:0005634; GO:0005672; GO:0005737; GO:0006235; GO:0006352; GO:0007283; GO:0007289; GO:0016251","acrosome assembly [GO:0001675]; DNA-templated transcription initiation [GO:0006352]; dTTP biosynthetic process [GO:0006235]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nucleus [GO:0005634]; transcription factor TFIIA complex [GO:0005672]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; acrosome assembly [GO:0001675]; DNA-templated transcription initiation [GO:0006352]; dTTP biosynthetic process [GO:0006235]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:16412700, ECO:0000269|PubMed:9889269}."
"1008","sp|Q9W032|ECD_DROME","lcl|NC_088859.1_cds_XP_011454854.3_38590",2.16e-94,308,"Q9W032","ECD_DROME","Protein ecdysoneless","ecd CG5714","Drosophila melanogaster (Fruit fly)",684,"GO:0000398; GO:0002165; GO:0002168; GO:0005634; GO:0005737; GO:0006697; GO:0007030; GO:0007281; GO:0007390; GO:0007443; GO:0007458; GO:0007591; GO:0008258; GO:0008362; GO:0009608; GO:0016319; GO:0048477; GO:0048542; GO:0070990","chitin-based embryonic cuticle biosynthetic process [GO:0008362]; ecdysone biosynthetic process [GO:0006697]; germ cell development [GO:0007281]; germ-band shortening [GO:0007390]; Golgi organization [GO:0007030]; head involution [GO:0008258]; instar larval development [GO:0002168]; instar larval or pupal development [GO:0002165]; lymph gland development [GO:0048542]; Malpighian tubule morphogenesis [GO:0007443]; molting cycle, chitin-based cuticle [GO:0007591]; mRNA splicing, via spliceosome [GO:0000398]; mushroom body development [GO:0016319]; oogenesis [GO:0048477]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; response to symbiont [GO:0009608]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; snRNP binding [GO:0070990]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; ecdysone biosynthetic process [GO:0006697]; germ cell development [GO:0007281]; germ-band shortening [GO:0007390]; Golgi organization [GO:0007030]; head involution [GO:0008258]; instar larval development [GO:0002168]; instar larval or pupal development [GO:0002165]; lymph gland development [GO:0048542]; Malpighian tubule morphogenesis [GO:0007443]; molting cycle, chitin-based cuticle [GO:0007591]; mRNA splicing, via spliceosome [GO:0000398]; mushroom body development [GO:0016319]; oogenesis [GO:0048477]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; response to symbiont [GO:0009608]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically throughout development. {ECO:0000269|PubMed:15128659}.","","","TISSUE SPECIFICITY: Expressed in the ecdysone-producing larval ring gland, nervous system, imaginal disks and gonads. {ECO:0000269|PubMed:15128659}."
"1009","sp|Q9Z132|RSPO1_MOUSE","lcl|NC_088859.1_cds_XP_011454875.2_38568",2.57e-44,152,"Q9Z132","RSPO1_MOUSE","R-spondin-1 (Cysteine-rich and single thrombospondin domain-containing protein 3) (Cristin-3) (mCristin-3) (Roof plate-specific spondin-1)","Rspo1","Mus musculus (Mouse)",265,"GO:0005102; GO:0005615; GO:0005634; GO:0007140; GO:0008201; GO:0010468; GO:0016055; GO:0030177; GO:0090263; GO:2000052; GO:2000254","male meiotic nuclear division [GO:0007140]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of gene expression [GO:0010468]; regulation of male germ cell proliferation [GO:2000254]; Wnt signaling pathway [GO:0016055]","extracellular space [GO:0005615]; nucleus [GO:0005634]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]; male meiotic nuclear division [GO:0007140]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of gene expression [GO:0010468]; regulation of male germ cell proliferation [GO:2000254]; Wnt signaling pathway [GO:0016055]","DEVELOPMENTAL STAGE: Transiently expressed in the central nervous system (CNS) during development. Predominantly expressed in the tailbud of embryos. Also detected in the primitive streak, dorsal neural tube, forebrain and migrating neural crests of embryos. Detected from day 9.5, in various neural and mesodermal derivatives, mainly along dorsal neural tube and diencephalon. Strongly expressed in limb buds, particularly in the morphogenetically active region such as the apical ectodermal ridge (AER). The developing skin showed expression in patches of the developing dermis at 12.5 dpc and at lower levels at 14.5 dpc. By 18.5 dpc expression is restricted to the dermal papilla of the developing hair, which persisted into adulthood. In the developing kidney, strong expression at 11.5 dpc in the uninduced metanephric mesenchyme is observed. By 14.5 dpc this expression is restricted to the condensing mesenchyme surrounding the ureter and the developing nephrons. Specific expression in the urogenital ridge as early as 10.5 dpc in the coelomic epithelium. Sex-specific differences of expression began to appear starting at 12.5 dpc, with an increase in the somatic cells of the XX gonad. {ECO:0000269|PubMed:14732490, ECO:0000269|PubMed:15469841, ECO:0000269|PubMed:16543246, ECO:0000269|PubMed:17041600}.","","","TISSUE SPECIFICITY: Expressed in the dorsal part of the neural tube on 10 and 12 dpc, especially in the boundary region between roof plate and neuroepithelium. This expression is enhanced in the rostral part. Also expressed in other tissues such as truncal region neighboring forelimbs and mesenchymal tissues around the nasal cavity. {ECO:0000269|PubMed:14732490}."
"1010","sp|Q8SYG2|CSN3_DROME","lcl|NC_088859.1_cds_XP_011456276.3_34319",4.91e-142,414,"Q8SYG2","CSN3_DROME","COP9 signalosome complex subunit 3 (Dch3) (Signalosome subunit 3)","CSN3 CG18332","Drosophila melanogaster (Fruit fly)",445,"GO:0000338; GO:0005737; GO:0006511; GO:0007281; GO:0008180; GO:0036099; GO:0048140; GO:0048142; GO:0050821","female germ-line stem cell population maintenance [GO:0036099]; germ cell development [GO:0007281]; germarium-derived cystoblast division [GO:0048142]; male germ-line cyst encapsulation [GO:0048140]; protein deneddylation [GO:0000338]; protein stabilization [GO:0050821]; ubiquitin-dependent protein catabolic process [GO:0006511]","COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; female germ-line stem cell population maintenance [GO:0036099]; germ cell development [GO:0007281]; germarium-derived cystoblast division [GO:0048142]; male germ-line cyst encapsulation [GO:0048140]; protein deneddylation [GO:0000338]; protein stabilization [GO:0050821]; ubiquitin-dependent protein catabolic process [GO:0006511]","","","",""
"1011","sp|Q61880|DMC1_MOUSE","lcl|NC_088859.1_cds_XP_011456676.1_39026",0,596,"Q61880","DMC1_MOUSE","Meiotic recombination protein DMC1/LIM15 homolog","Dmc1 Dmc1h Lim15","Mus musculus (Mouse)",340,"GO:0000150; GO:0000724; GO:0000781; GO:0000794; GO:0000800; GO:0001541; GO:0001556; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0007129; GO:0007131; GO:0007141; GO:0007276; GO:0007283; GO:0007286; GO:0016887; GO:0035861; GO:0042802; GO:0048477; GO:0140664; GO:1990918","double-strand break repair involved in meiotic recombination [GO:1990918]; double-strand break repair via homologous recombination [GO:0000724]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; male meiosis I [GO:0007141]; oocyte maturation [GO:0001556]; oogenesis [GO:0048477]; ovarian follicle development [GO:0001541]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; lateral element [GO:0000800]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA strand exchange activity [GO:0000150]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]; double-strand break repair involved in meiotic recombination [GO:1990918]; double-strand break repair via homologous recombination [GO:0000724]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; male meiosis I [GO:0007141]; oocyte maturation [GO:0001556]; oogenesis [GO:0048477]; ovarian follicle development [GO:0001541]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: In spermatocytes, shows punctate localization along chromosome axes specifically in early meiotic prophase I cells. Foci start to appear from the leptotene stage, reach their greatest number in the zygotene stage, in the early pachytene stage, the DMC1 foci mostly disappeared from autosomes and became restricted to the sex chromosomes. {ECO:0000269|PubMed:30760716}.","","","TISSUE SPECIFICITY: Testis. {ECO:0000269|PubMed:30760716, ECO:0000269|PubMed:8581742}."
"1012","sp|P70187|MF14A_MOUSE","lcl|NC_088859.1_cds_XP_011456710.3_38175",1.27e-179,514,"P70187","MF14A_MOUSE","Hippocampus abundant transcript 1 protein (Major facilitator superfamily domain-containing 14A)","Mfsd14a Hiat1","Mus musculus (Mouse)",490,"GO:0001675; GO:0007283; GO:0007286; GO:0007289; GO:0016020; GO:0022857; GO:0030382","acrosome assembly [GO:0001675]; sperm mitochondrion organization [GO:0030382]; spermatid development [GO:0007286]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]","membrane [GO:0016020]; transmembrane transporter activity [GO:0022857]; acrosome assembly [GO:0001675]; sperm mitochondrion organization [GO:0030382]; spermatid development [GO:0007286]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Evenly distributed throughout the neonatal brain. {ECO:0000269|PubMed:9299464}.","","","TISSUE SPECIFICITY: Expressed in various tissues. {ECO:0000269|PubMed:9299464}."
"1013","sp|Q9NR21|PAR11_HUMAN","lcl|NC_088859.1_cds_XP_011456876.3_39719",3.79e-44,163,"Q9NR21","PAR11_HUMAN","Protein mono-ADP-ribosyltransferase PARP11 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 11) (ARTD11) (Poly [ADP-ribose] polymerase 11) (PARP-11)","PARP11 C12orf6","Homo sapiens (Human)",338,"GO:0003950; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006998; GO:0007283; GO:0015031; GO:0016604; GO:0016779; GO:0030154; GO:0051028; GO:0070213; GO:0140803; GO:0140804; GO:0140806; GO:0140807; GO:1990404","cell differentiation [GO:0030154]; mRNA transport [GO:0051028]; nuclear envelope organization [GO:0006998]; protein auto-ADP-ribosylation [GO:0070213]; protein transport [GO:0015031]; spermatogenesis [GO:0007283]","cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; NAD+-protein-lysine ADP-ribosyltransferase activity [GO:0140804]; nucleotidyltransferase activity [GO:0016779]; cell differentiation [GO:0030154]; mRNA transport [GO:0051028]; nuclear envelope organization [GO:0006998]; protein auto-ADP-ribosylation [GO:0070213]; protein transport [GO:0015031]; spermatogenesis [GO:0007283]","","INDUCTION: By type I interferon or viral infection including zika virus infection. {ECO:0000269|PubMed:34187568}.","INDUCTION: By type I interferon or viral infection including zika virus infection. {ECO:0000269|PubMed:34187568}.",""
"1014","sp|Q5VYS8|TUT7_HUMAN","lcl|NC_088859.1_cds_XP_011457156.3_38262",1.83e-148,492,"Q5VYS8","TUT7_HUMAN","Terminal uridylyltransferase 7 (TUTase 7) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 6)","TUT7 HS2 KIAA1711 ZCCHC6","Homo sapiens (Human)",1495,"GO:0001556; GO:0003723; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0010586; GO:0031054; GO:0031123; GO:0035198; GO:0050265; GO:0070569; GO:0141008; GO:1990074","miRNA metabolic process [GO:0010586]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3'-end processing [GO:0031123]; transposable element silencing by mRNA destabilization [GO:0141008]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270]; miRNA metabolic process [GO:0010586]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3'-end processing [GO:0031123]; transposable element silencing by mRNA destabilization [GO:0141008]","","","",""
"1015","sp|Q5TAX3|TUT4_HUMAN","lcl|NC_088859.1_cds_XP_019918224.3_38263",0,701,"Q5TAX3","TUT4_HUMAN","Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11)","TUT4 KIAA0191 ZCCHC11","Homo sapiens (Human)",1644,"GO:0001556; GO:0003723; GO:0005615; GO:0005730; GO:0005737; GO:0005829; GO:0008270; GO:0010586; GO:0010587; GO:0019827; GO:0031054; GO:0031123; GO:0035198; GO:0036464; GO:0050265; GO:0070062; GO:0141008; GO:1990074","miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]; transposable element silencing by mRNA destabilization [GO:0141008]","cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; zinc ion binding [GO:0008270]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]; transposable element silencing by mRNA destabilization [GO:0141008]","","","",""
"1016","sp|Q05201|EYA_DROME","lcl|NC_088859.1_cds_XP_019918887.3_37817",1.52e-141,428,"Q05201","EYA_DROME","Protein phosphatase eya (EC 3.1.3.48) (Developmental protein eyes absent) (Protein Clift)","eya cli CG9554","Drosophila melanogaster (Fruit fly)",766,"GO:0001744; GO:0001746; GO:0003713; GO:0004721; GO:0004725; GO:0004726; GO:0005634; GO:0005737; GO:0005829; GO:0007283; GO:0007411; GO:0007419; GO:0007435; GO:0007455; GO:0007498; GO:0007526; GO:0008406; GO:0008584; GO:0009416; GO:0009996; GO:0010628; GO:0030154; GO:0030707; GO:0030946; GO:0042051; GO:0042675; GO:0045087; GO:0045739; GO:0045944; GO:0046872; GO:0048749; GO:0070285; GO:0072499; GO:0140297; GO:2001240","axon guidance [GO:0007411]; Bolwig's organ morphogenesis [GO:0001746]; cell differentiation [GO:0030154]; compound eye cone cell differentiation [GO:0042675]; compound eye development [GO:0048749]; compound eye photoreceptor development [GO:0042051]; eye-antennal disc morphogenesis [GO:0007455]; follicle cell of egg chamber development [GO:0030707]; gonad development [GO:0008406]; innate immune response [GO:0045087]; insect visual primordium formation [GO:0001744]; larval somatic muscle development [GO:0007526]; male gonad development [GO:0008584]; mesoderm development [GO:0007498]; negative regulation of cell fate specification [GO:0009996]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; photoreceptor cell axon guidance [GO:0072499]; pigment cell development [GO:0070285]; positive regulation of DNA repair [GO:0045739]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to light stimulus [GO:0009416]; salivary gland morphogenesis [GO:0007435]; spermatogenesis [GO:0007283]; ventral cord development [GO:0007419]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine phosphatase activity, metal-dependent [GO:0030946]; transcription coactivator activity [GO:0003713]; axon guidance [GO:0007411]; Bolwig's organ morphogenesis [GO:0001746]; cell differentiation [GO:0030154]; compound eye cone cell differentiation [GO:0042675]; compound eye development [GO:0048749]; compound eye photoreceptor development [GO:0042051]; eye-antennal disc morphogenesis [GO:0007455]; follicle cell of egg chamber development [GO:0030707]; gonad development [GO:0008406]; innate immune response [GO:0045087]; insect visual primordium formation [GO:0001744]; larval somatic muscle development [GO:0007526]; male gonad development [GO:0008584]; mesoderm development [GO:0007498]; negative regulation of cell fate specification [GO:0009996]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; photoreceptor cell axon guidance [GO:0072499]; pigment cell development [GO:0070285]; positive regulation of DNA repair [GO:0045739]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to light stimulus [GO:0009416]; salivary gland morphogenesis [GO:0007435]; spermatogenesis [GO:0007283]; ventral cord development [GO:0007419]","","","",""
"1017","sp|P20272|CNR1_RAT","lcl|NC_088859.1_cds_XP_019921655.1_39833",3.07e-21,95.5,"P20272","CNR1_RAT","Cannabinoid receptor 1 (CB-R) (CB1) (Brain-type cannabinoid receptor)","Cnr1 Skr6","Rattus norvegicus (Rat)",473,"GO:0002866; GO:0004930; GO:0004949; GO:0005737; GO:0005739; GO:0005741; GO:0005886; GO:0007186; GO:0007188; GO:0007189; GO:0007283; GO:0007413; GO:0007584; GO:0007611; GO:0007613; GO:0010976; GO:0014063; GO:0019216; GO:0019222; GO:0030424; GO:0030426; GO:0031622; GO:0031999; GO:0032228; GO:0032496; GO:0033004; GO:0033602; GO:0035094; GO:0038171; GO:0042220; GO:0042593; GO:0042734; GO:0042802; GO:0043065; GO:0043271; GO:0045121; GO:0045471; GO:0045759; GO:0045776; GO:0045777; GO:0050796; GO:0051966; GO:0060135; GO:0060259; GO:0060405; GO:0098921; GO:0098978; GO:0098982; GO:0099509; GO:1900452","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; axonal fasciculation [GO:0007413]; cannabinoid signaling pathway [GO:0038171]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; learning or memory [GO:0007611]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of action potential [GO:0045759]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of mast cell activation [GO:0033004]; negative regulation of monoatomic ion transport [GO:0043271]; negative regulation of serotonin secretion [GO:0014063]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood pressure [GO:0045777]; positive regulation of fever generation [GO:0031622]; positive regulation of neuron projection development [GO:0010976]; regulation of feeding behavior [GO:0060259]; regulation of insulin secretion [GO:0050796]; regulation of lipid metabolic process [GO:0019216]; regulation of long-term synaptic depression [GO:1900452]; regulation of metabolic process [GO:0019222]; regulation of penile erection [GO:0060405]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to nutrient [GO:0007584]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]; spermatogenesis [GO:0007283]","axon [GO:0030424]; cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; cannabinoid receptor activity [GO:0004949]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; axonal fasciculation [GO:0007413]; cannabinoid signaling pathway [GO:0038171]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; learning or memory [GO:0007611]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of action potential [GO:0045759]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of mast cell activation [GO:0033004]; negative regulation of monoatomic ion transport [GO:0043271]; negative regulation of serotonin secretion [GO:0014063]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood pressure [GO:0045777]; positive regulation of fever generation [GO:0031622]; positive regulation of neuron projection development [GO:0010976]; regulation of feeding behavior [GO:0060259]; regulation of insulin secretion [GO:0050796]; regulation of lipid metabolic process [GO:0019216]; regulation of long-term synaptic depression [GO:1900452]; regulation of metabolic process [GO:0019222]; regulation of penile erection [GO:0060405]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to nutrient [GO:0007584]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in the brain, in the striatum, medial septum, descending arm of the band of Broca, the amygdaloid nucleus, the hippocampus and cortex (at protein level). High levels in the lateral striatum. In rostral brain regions, high expression levels in the dorsal lateral striatum, while in the caudal brain regions, high levels are observed in the ventral lateral striatum (PubMed:10362691, PubMed:10891614, PubMed:16033894, PubMed:2165569). Expressed in monocytes/macrophages (at protein level) (PubMed:23955712). Expressed in striated muscles and in vascular smooth muscles cells (at protein level) (PubMed:10362691, PubMed:26671069). {ECO:0000269|PubMed:10362691, ECO:0000269|PubMed:10891614, ECO:0000269|PubMed:16033894, ECO:0000269|PubMed:2165569, ECO:0000269|PubMed:23955712, ECO:0000269|PubMed:26671069}."
"1018","sp|Q9VKJ9|C2D1_DROME","lcl|NC_088859.1_cds_XP_019921704.3_37386",1.23e-99,330,"Q9VKJ9","C2D1_DROME","Coiled-coil and C2 domain-containing protein 1-like (Lethal (2) giant discs 1 protein)","l(2)gd1 lgd CG4713","Drosophila melanogaster (Fruit fly)",816,"GO:0000281; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005737; GO:0005829; GO:0005938; GO:0006357; GO:0006886; GO:0007219; GO:0007423; GO:0007472; GO:0008586; GO:0010008; GO:0016197; GO:0016327; GO:0032509; GO:0045035; GO:0045746; GO:0048132; GO:0048749; GO:0098592; GO:1901981; GO:1905367","compound eye development [GO:0048749]; endosomal transport [GO:0016197]; endosome transport via multivesicular body sorting pathway [GO:0032509]; female germ-line stem cell asymmetric division [GO:0048132]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; positive regulation of intralumenal vesicle formation [GO:1905367]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; sensory organ precursor cell division [GO:0045035]; wing disc morphogenesis [GO:0007472]","apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; phosphatidylinositol phosphate binding [GO:1901981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; compound eye development [GO:0048749]; endosomal transport [GO:0016197]; endosome transport via multivesicular body sorting pathway [GO:0032509]; female germ-line stem cell asymmetric division [GO:0048132]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; positive regulation of intralumenal vesicle formation [GO:1905367]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; sensory organ precursor cell division [GO:0045035]; wing disc morphogenesis [GO:0007472]","DEVELOPMENTAL STAGE: Expressed in embryo cells, including epithelial and neuroblast cells, but not in larval or pupal cells (at protein level) (PubMed:17084357). Expressed in wing and eye imaginal disks (PubMed:12648493, PubMed:17088062). {ECO:0000269|PubMed:12648493, ECO:0000269|PubMed:17084357, ECO:0000269|PubMed:17088062}.","","",""
"1019","sp|Q9V576|WUN_DROME","lcl|NC_088859.1_cds_XP_019922525.3_39261",2.99e-72,228,"Q9V576","WUN_DROME","Putative phosphatidate phosphatase (EC 3.1.3.4) (Germ cell guidance factor) (Phosphatidic acid phosphatase type 2) (Protein wunen)","wun CG8804","Drosophila melanogaster (Fruit fly)",379,"GO:0005886; GO:0005918; GO:0006644; GO:0007165; GO:0007424; GO:0008195; GO:0008354; GO:0016328; GO:0016791; GO:0019991; GO:0030703; GO:0035233; GO:0035234; GO:0045177; GO:0045824; GO:0046839; GO:0050829","defense response to Gram-negative bacterium [GO:0050829]; ectopic germ cell programmed cell death [GO:0035234]; eggshell formation [GO:0030703]; germ cell migration [GO:0008354]; germ cell repulsion [GO:0035233]; negative regulation of innate immune response [GO:0045824]; open tracheal system development [GO:0007424]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; septate junction assembly [GO:0019991]; signal transduction [GO:0007165]","apical part of cell [GO:0045177]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; defense response to Gram-negative bacterium [GO:0050829]; ectopic germ cell programmed cell death [GO:0035234]; eggshell formation [GO:0030703]; germ cell migration [GO:0008354]; germ cell repulsion [GO:0035233]; negative regulation of innate immune response [GO:0045824]; open tracheal system development [GO:0007424]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; septate junction assembly [GO:0019991]; signal transduction [GO:0007165]","","","","TISSUE SPECIFICITY: Expressed in embryonic gut in a pattern that guides germ cells towards mesoderm (initially in hindgut and then on lower side of gut). During extended germ band stage, expressed in ectoderm as a medial band throughout the trunk. {ECO:0000269|PubMed:8985246}."
"1020","sp|P30874|SSR2_HUMAN","lcl|NC_088859.1_cds_XP_019923471.3_38845",3.05e-80,253,"P30874","SSR2_HUMAN","Somatostatin receptor type 2 (SS-2-R) (SS2-R) (SS2R) (SST2) (SRIF-1)","SSTR2","Homo sapiens (Human)",369,"GO:0004994; GO:0005654; GO:0005829; GO:0005886; GO:0007187; GO:0007193; GO:0007218; GO:0008285; GO:0030165; GO:0042923; GO:0043005; GO:0071385; GO:0071392","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucocorticoid stimulus [GO:0071385]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]","cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; neuropeptide binding [GO:0042923]; PDZ domain binding [GO:0030165]; somatostatin receptor activity [GO:0004994]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucocorticoid stimulus [GO:0071385]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]","","","","TISSUE SPECIFICITY: Expressed in both pancreatic alpha- and beta-cells (at protein level). Expressed at higher levels in the pancreas than other somatostatin receptors. Also expressed in the cerebrum and kidney and, in lesser amounts, in the jejunum, colon and liver. In the developing nervous system, expressed in the cortex where it is located in the preplate at early stages and is enriched in the outer part of the germinal zone at later stages. In the cerebellum, expressed in the deep part of the external granular layer at gestational week 19. This pattern persists until birth but disappears at adulthood. {ECO:0000269|PubMed:19434240, ECO:0000269|PubMed:22932785}."
"1021","sp|P31009|RS2_DROME","lcl|NC_088859.1_cds_XP_019924446.1_36180",2.01e-129,369,"P31009","RS2_DROME","Small ribosomal subunit protein uS5 (40S ribosomal protein S2) (Protein strings of pearls)","RpS2 sop CG5920","Drosophila melanogaster (Fruit fly)",267,"GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0006412; GO:0022626; GO:0022627; GO:0048477","cytoplasmic translation [GO:0002181]; oogenesis [GO:0048477]; translation [GO:0006412]","cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; oogenesis [GO:0048477]; translation [GO:0006412]","","","",""
"1022","sp|P92208|JNK_DROME","lcl|NC_088859.1_cds_XP_019927193.1_37732",0,644,"P92208","JNK_DROME","Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)","bsk JNK CG5680","Drosophila melanogaster (Fruit fly)",372,"GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006979; GO:0007254; GO:0007391; GO:0007395; GO:0007411; GO:0007616; GO:0008284; GO:0009408; GO:0010508; GO:0010628; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0033209; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043065; GO:0043068; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048010; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0050829; GO:0061057; GO:0071243; GO:0071276; GO:0071907; GO:0071963; GO:0106310; GO:0140255; GO:1903688; GO:1903689; GO:1904801","antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; chorion micropyle formation [GO:0046844]; collateral sprouting of injured axon [GO:0048674]; defense response to Gram-negative bacterium [GO:0050829]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; follicle cell of egg chamber development [GO:0030707]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; JNK cascade [GO:0007254]; long-term memory [GO:0007616]; melanization defense response [GO:0035006]; mushroom body development [GO:0016319]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; peptidoglycan recognition protein signaling pathway [GO:0061057]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron remodeling [GO:1904801]; positive regulation of programmed cell death [GO:0043068]; regulation of cellular response to phosphate starvation [GO:0140255]; regulation of wound healing, spreading of epidermal cells [GO:1903689]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]","axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; chorion micropyle formation [GO:0046844]; collateral sprouting of injured axon [GO:0048674]; defense response to Gram-negative bacterium [GO:0050829]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; follicle cell of egg chamber development [GO:0030707]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; JNK cascade [GO:0007254]; long-term memory [GO:0007616]; melanization defense response [GO:0035006]; mushroom body development [GO:0016319]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; peptidoglycan recognition protein signaling pathway [GO:0061057]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron remodeling [GO:1904801]; positive regulation of programmed cell death [GO:0043068]; regulation of cellular response to phosphate starvation [GO:0140255]; regulation of wound healing, spreading of epidermal cells [GO:1903689]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]","DEVELOPMENTAL STAGE: Expressed maternally and zygotically through to adult (male and female). {ECO:0000269|PubMed:8946915}.","INDUCTION: In neuronal cells by wounding of the integument (at protein level) (PubMed:22227521). Activated by increased levels of reactive oxygen species (ROS) (PubMed:25594180). {ECO:0000269|PubMed:22227521, ECO:0000269|PubMed:25594180}.","INDUCTION: In neuronal cells by wounding of the integument (at protein level) (PubMed:22227521). Activated by increased levels of reactive oxygen species (ROS) (PubMed:25594180). {ECO:0000269|PubMed:22227521, ECO:0000269|PubMed:25594180}.","TISSUE SPECIFICITY: During gastrulation, expression is seen in cells undergoing morphogenetic movements. By stage 9 of embryonic development, expression is ubiquitous. At stages 12-14, expression occurs in epidermis and central nervous system. At stage 15, expression is restricted to ventral nerve cord, brain and some peripheral neurons. In larvae, expression is seen in all imaginal disks, with highest levels in wing and eye disks, and in the CNS. Adults express the protein in fat body and hemocytes. {ECO:0000269|PubMed:8946915, ECO:0000269|PubMed:8946916}."
"1023","sp|Q9XZ58|CSN5_DROME","lcl|NC_088859.1_cds_XP_019928707.1_35499",1.13e-179,501,"Q9XZ58","CSN5_DROME","COP9 signalosome complex subunit 5 (Dch5) (Signalosome subunit 5) (EC 3.4.-.-) (JAB1 homolog)","CSN5 quo CG14884","Drosophila melanogaster (Fruit fly)",327,"GO:0000338; GO:0001751; GO:0005737; GO:0006508; GO:0007281; GO:0007310; GO:0007314; GO:0007409; GO:0008180; GO:0008237; GO:0008347; GO:0019784; GO:0032435; GO:0034399; GO:0035204; GO:0035207; GO:0036099; GO:0045732; GO:0045787; GO:0046872; GO:0048140; GO:0048142; GO:0050821; GO:0051726; GO:0140758","axonogenesis [GO:0007409]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell population maintenance [GO:0036099]; germ cell development [GO:0007281]; germarium-derived cystoblast division [GO:0048142]; glial cell migration [GO:0008347]; male germ-line cyst encapsulation [GO:0048140]; negative regulation of hemocyte proliferation [GO:0035207]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte dorsal/ventral axis specification [GO:0007310]; positive regulation of cell cycle [GO:0045787]; positive regulation of protein catabolic process [GO:0045732]; protein deneddylation [GO:0000338]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726]","COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; nuclear periphery [GO:0034399]; deNEDDylase activity [GO:0019784]; metal ion binding [GO:0046872]; metal-dependent deNEDDylase activity [GO:0140758]; metallopeptidase activity [GO:0008237]; axonogenesis [GO:0007409]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell population maintenance [GO:0036099]; germ cell development [GO:0007281]; germarium-derived cystoblast division [GO:0048142]; glial cell migration [GO:0008347]; male germ-line cyst encapsulation [GO:0048140]; negative regulation of hemocyte proliferation [GO:0035207]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte dorsal/ventral axis specification [GO:0007310]; positive regulation of cell cycle [GO:0045787]; positive regulation of protein catabolic process [GO:0045732]; protein deneddylation [GO:0000338]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726]","","","","TISSUE SPECIFICITY: Expressed in the optic lobe neuropil."
"1024","sp|Q4KMA2|RD23B_RAT","lcl|NC_088859.1_cds_XP_019930556.2_38619",4.79e-57,193,"Q4KMA2","RD23B_RAT","UV excision repair protein RAD23 homolog B","Rad23b","Rattus norvegicus (Rat)",415,"GO:0000502; GO:0000976; GO:0000978; GO:0003684; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006289; GO:0006974; GO:0007283; GO:0031593; GO:0032434; GO:0043130; GO:0043161; GO:0048568; GO:0061629; GO:0070628; GO:0071942; GO:0098761; GO:0140612","cellular response to interleukin-7 [GO:0098761]; DNA damage response [GO:0006974]; embryonic organ development [GO:0048568]; nucleotide-excision repair [GO:0006289]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; XPC complex [GO:0071942]; damaged DNA binding [GO:0003684]; DNA damage sensor activity [GO:0140612]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin binding [GO:0043130]; cellular response to interleukin-7 [GO:0098761]; DNA damage response [GO:0006974]; embryonic organ development [GO:0048568]; nucleotide-excision repair [GO:0006289]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; spermatogenesis [GO:0007283]","","","",""
"1025","sp|Q61425|HCDH_MOUSE","lcl|NC_088859.1_cds_XP_034310997.1_39481",3.45e-140,399,"Q61425","HCDH_MOUSE","Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (HCDH) (EC 1.1.1.35) (Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase) (Short-chain 3-hydroxyacyl-CoA dehydrogenase)","Hadh Hadhsc Mschad Schad","Mus musculus (Mouse)",314,"GO:0003857; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006635; GO:0007283; GO:0009410; GO:0014823; GO:0030154; GO:0032868; GO:0042802; GO:0046676; GO:0050796; GO:0070403; GO:0120162","cell differentiation [GO:0030154]; fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of insulin secretion [GO:0050796]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]","cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; identical protein binding [GO:0042802]; NAD+ binding [GO:0070403]; cell differentiation [GO:0030154]; fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of insulin secretion [GO:0050796]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in liver, kidney, brain, and pancreatic islets. {ECO:0000269|PubMed:20670938}."
"1026","sp|A2CEI6|PIWL2_DANRE","lcl|NC_088859.1_cds_XP_034311101.1_39653",0,778,"A2CEI6","PIWL2_DANRE","Piwi-like protein 2 (EC 3.1.26.-)","piwil2 zili si:dkey-88f5.1","Danio rerio (Zebrafish) (Brachydanio rerio)",1046,"GO:0004521; GO:0005634; GO:0005737; GO:0006417; GO:0007276; GO:0007283; GO:0010628; GO:0030718; GO:0031047; GO:0034584; GO:0034587; GO:0043186; GO:0046872; GO:0048477; GO:0048511; GO:0051321; GO:0060392; GO:0071546; GO:0140965; GO:0141005; GO:0141196; GO:1990923","gamete generation [GO:0007276]; germ-line stem cell population maintenance [GO:0030718]; meiotic cell cycle [GO:0051321]; negative regulation of SMAD protein signal transduction [GO:0060392]; oogenesis [GO:0048477]; piRNA processing [GO:0034587]; positive regulation of gene expression [GO:0010628]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; rhythmic process [GO:0048511]; secondary piRNA processing [GO:0140965]; spermatogenesis [GO:0007283]; transposable element silencing by heterochromatin formation [GO:0141005]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; PET complex [GO:1990923]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; piRNA binding [GO:0034584]; RNA endonuclease activity [GO:0004521]; gamete generation [GO:0007276]; germ-line stem cell population maintenance [GO:0030718]; meiotic cell cycle [GO:0051321]; negative regulation of SMAD protein signal transduction [GO:0060392]; oogenesis [GO:0048477]; piRNA processing [GO:0034587]; positive regulation of gene expression [GO:0010628]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; rhythmic process [GO:0048511]; secondary piRNA processing [GO:0140965]; spermatogenesis [GO:0007283]; transposable element silencing by heterochromatin formation [GO:0141005]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]","","","","TISSUE SPECIFICITY: Detected in primordial germ cells (PGCs) from 3 dpf. In adult, it is found in both the female and male gonad. In the ovary, it is present in all stages of germ cell differentiation. In testis, it is present in mitotic and meiotic germ cells. No protein has been detected in the fully differentiated sperm cell. {ECO:0000269|PubMed:18833190}."
"1027","sp|P09456|KAP0_RAT","lcl|NC_088859.1_cds_XP_034311126.1_39703",0,575,"P09456","KAP0_RAT","cAMP-dependent protein kinase type I-alpha regulatory subunit [Cleaved into: cAMP-dependent protein kinase type I-alpha regulatory subunit, N-terminally processed]","Prkar1a","Rattus norvegicus (Rat)",381,"GO:0001707; GO:0001772; GO:0004862; GO:0005737; GO:0005771; GO:0005813; GO:0005829; GO:0005930; GO:0005952; GO:0007143; GO:0007189; GO:0007507; GO:0008603; GO:0010629; GO:0019904; GO:0030552; GO:0031588; GO:0031594; GO:0031625; GO:0032024; GO:0034236; GO:0044853; GO:0045202; GO:0045214; GO:0045835; GO:0046007; GO:0060038; GO:0071377; GO:0098978; GO:0120212; GO:0141162; GO:1903538","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cardiac muscle cell proliferation [GO:0060038]; cellular response to glucagon stimulus [GO:0071377]; female meiotic nuclear division [GO:0007143]; heart development [GO:0007507]; mesoderm formation [GO:0001707]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of gene expression [GO:0010629]; negative regulation of meiotic nuclear division [GO:0045835]; positive regulation of insulin secretion [GO:0032024]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; sarcomere organization [GO:0045214]","axoneme [GO:0005930]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; multivesicular body [GO:0005771]; neuromuscular junction [GO:0031594]; nucleotide-activated protein kinase complex [GO:0031588]; plasma membrane raft [GO:0044853]; sperm head-tail coupling apparatus [GO:0120212]; synapse [GO:0045202]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; protein domain specific binding [GO:0019904]; protein kinase A catalytic subunit binding [GO:0034236]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cardiac muscle cell proliferation [GO:0060038]; cellular response to glucagon stimulus [GO:0071377]; female meiotic nuclear division [GO:0007143]; heart development [GO:0007507]; mesoderm formation [GO:0001707]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of gene expression [GO:0010629]; negative regulation of meiotic nuclear division [GO:0045835]; positive regulation of insulin secretion [GO:0032024]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; sarcomere organization [GO:0045214]","","","",""
"1028","sp|Q5PQN1|HERC4_RAT","lcl|NC_088859.1_cds_XP_034311237.2_39913",0,1041,"Q5PQN1","HERC4_RAT","Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4)","Herc4","Rattus norvegicus (Rat)",1057,"GO:0001650; GO:0005737; GO:0005829; GO:0006511; GO:0007283; GO:0016567; GO:0030154; GO:0045879; GO:0061630","cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; ubiquitin protein ligase activity [GO:0061630]; cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]","","","",""
"1029","sp|Q9VS46|RINT1_DROME","lcl|NC_088859.1_cds_XP_034311255.2_39950",3.77e-87,291,"Q9VS46","RINT1_DROME","RINT1-like protein (DmRINT-1)","Rint1 CG8605","Drosophila melanogaster (Fruit fly)",724,"GO:0005783; GO:0006888; GO:0006890; GO:0007030; GO:0007112; GO:0036090; GO:0048193; GO:0060628; GO:0070939","cleavage furrow ingression [GO:0036090]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; male meiosis cytokinesis [GO:0007112]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; cleavage furrow ingression [GO:0036090]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; male meiosis cytokinesis [GO:0007112]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","","","",""
"1030","sp|Q9VVU5|CSN1_DROME","lcl|NC_088859.1_cds_XP_034311297.1_39981",0,530,"Q9VVU5","CSN1_DROME","COP9 signalosome complex subunit 1b (Dch1-2) (Signalosome subunit 1b)","CSN1b CG3889","Drosophila melanogaster (Fruit fly)",525,"GO:0005737; GO:0007281; GO:0008180; GO:0036099; GO:0048140; GO:0048142; GO:0050821","female germ-line stem cell population maintenance [GO:0036099]; germ cell development [GO:0007281]; germarium-derived cystoblast division [GO:0048142]; male germ-line cyst encapsulation [GO:0048140]; protein stabilization [GO:0050821]","COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; female germ-line stem cell population maintenance [GO:0036099]; germ cell development [GO:0007281]; germarium-derived cystoblast division [GO:0048142]; male germ-line cyst encapsulation [GO:0048140]; protein stabilization [GO:0050821]","","","",""
"1031","sp|Q14432|PDE3A_HUMAN","lcl|NC_088859.1_cds_XP_034311428.2_34666",6.7e-44,171,"Q14432","PDE3A_HUMAN","cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A (EC 3.1.4.17) (Cyclic GMP-inhibited phosphodiesterase A) (CGI-PDE A) (cGMP-inhibited cAMP phosphodiesterase) (cGI-PDE)","PDE3A","Homo sapiens (Human)",1141,"GO:0001556; GO:0004114; GO:0004115; GO:0004119; GO:0005829; GO:0006629; GO:0007186; GO:0009410; GO:0016020; GO:0019933; GO:0019934; GO:0030284; GO:0040020; GO:0043066; GO:0043116; GO:0043117; GO:0046872; GO:0047555; GO:0060282; GO:0060700; GO:0071321; GO:0071560; GO:0097190; GO:0099130; GO:0106072; GO:0141162","apoptotic signaling pathway [GO:0097190]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of vascular permeability [GO:0043116]; oocyte maturation [GO:0001556]; positive regulation of oocyte development [GO:0060282]; positive regulation of vascular permeability [GO:0043117]; regulation of meiotic nuclear division [GO:0040020]; regulation of ribonuclease activity [GO:0060700]; response to xenobiotic stimulus [GO:0009410]","cytosol [GO:0005829]; membrane [GO:0016020]; 3',5'-cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; estrogen binding [GO:0099130]; metal ion binding [GO:0046872]; nuclear estrogen receptor activity [GO:0030284]; apoptotic signaling pathway [GO:0097190]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of vascular permeability [GO:0043116]; oocyte maturation [GO:0001556]; positive regulation of oocyte development [GO:0060282]; positive regulation of vascular permeability [GO:0043117]; regulation of meiotic nuclear division [GO:0040020]; regulation of ribonuclease activity [GO:0060700]; response to xenobiotic stimulus [GO:0009410]","","","",""
"1032","sp|Q6PIW4|FIGL1_HUMAN","lcl|NC_088859.1_cds_XP_034311523.2_34485",0,588,"Q6PIW4","FIGL1_HUMAN","Fidgetin-like protein 1 (EC 3.6.4.-)","FIGNL1","Homo sapiens (Human)",674,"GO:0000228; GO:0000287; GO:0001649; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0007140; GO:0008568; GO:0010569; GO:0016787; GO:0016887; GO:0033687; GO:0043066; GO:0046034; GO:0048471; GO:0051726; GO:0070062; GO:0071479; GO:2001243","ATP metabolic process [GO:0046034]; cellular response to ionizing radiation [GO:0071479]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair via homologous recombination [GO:0010569]","cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; microtubule severing ATPase activity [GO:0008568]; ATP metabolic process [GO:0046034]; cellular response to ionizing radiation [GO:0071479]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair via homologous recombination [GO:0010569]","","","",""
"1033","sp|Q9D666|SUN1_MOUSE","lcl|NC_088859.1_cds_XP_034311551.2_34411",6.72e-69,249,"Q9D666","SUN1_MOUSE","SUN domain-containing protein 1 (Protein unc-84 homolog A) (Sad1/unc-84 protein-like 1)","Sun1 Unc84a","Mus musculus (Mouse)",913,"GO:0000781; GO:0002080; GO:0002081; GO:0005521; GO:0005634; GO:0005635; GO:0005637; GO:0005737; GO:0006998; GO:0007129; GO:0007283; GO:0016020; GO:0021817; GO:0034993; GO:0042802; GO:0051642; GO:0070197; GO:0090292; GO:0140444","centrosome localization [GO:0051642]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; spermatogenesis [GO:0007283]","acrosomal membrane [GO:0002080]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; centrosome localization [GO:0051642]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Widely expressed. Expressed in cochlear outer hair cells (at protein level). Seven isoforms are expressed in testis including testis-specific isoform 5. Isoform 5 is the only isoform expressed at the end of sperm differentiation. Six isoforms are expressed in muscle, heart and brain, four isoforms in kidney and three isoforms in liver. {ECO:0000269|PubMed:12036294, ECO:0000269|PubMed:16380439, ECO:0000269|PubMed:17132086, ECO:0000269|PubMed:23348741}."
"1034","sp|P23572|CDK1_DROME","lcl|NC_088859.1_cds_XP_034311681.1_35404",1.6e-167,468,"P23572","CDK1_DROME","Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase)","Cdk1 cdc2 CG5363","Drosophila melanogaster (Fruit fly)",297,"GO:0000082; GO:0000086; GO:0001700; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0007095; GO:0007140; GO:0007284; GO:0008353; GO:0030174; GO:0030707; GO:0032880; GO:0044818; GO:0045169; GO:0048142; GO:0055059; GO:0106310; GO:1901990","asymmetric neuroblast division [GO:0055059]; embryonic development via the syncytial blastoderm [GO:0001700]; follicle cell of egg chamber development [GO:0030707]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; germarium-derived cystoblast division [GO:0048142]; male meiotic nuclear division [GO:0007140]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; regulation of DNA-templated DNA replication initiation [GO:0030174]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of protein localization [GO:0032880]; spermatogonial cell division [GO:0007284]","fusome [GO:0045169]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; asymmetric neuroblast division [GO:0055059]; embryonic development via the syncytial blastoderm [GO:0001700]; follicle cell of egg chamber development [GO:0030707]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; germarium-derived cystoblast division [GO:0048142]; male meiotic nuclear division [GO:0007140]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; regulation of DNA-templated DNA replication initiation [GO:0030174]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of protein localization [GO:0032880]; spermatogonial cell division [GO:0007284]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically (PubMed:2120044, PubMed:8405984). High levels of expression when mitosis is elevated; highest levels of expression are in early embryos with levels decreasing during embryogenesis and remaining low throughout most of larval development, and expression levels are also increased in unfertilized eggs and adult females (PubMed:2120044). {ECO:0000269|PubMed:2120044, ECO:0000269|PubMed:8405984}.","","",""
"1035","sp|P25867|UBCD1_DROME","lcl|NC_088859.1_cds_XP_034311777.1_35239",1.09e-101,288,"P25867","UBCD1_DROME","Ubiquitin-conjugating enzyme E2-17 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D1) (Protein effete) (Ubiquitin carrier protein) (Ubiquitin-protein ligase)","eff UbcD1 CG7425","Drosophila melanogaster (Fruit fly)",147,"GO:0000209; GO:0000278; GO:0001745; GO:0001751; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0007140; GO:0016322; GO:0016567; GO:0030718; GO:0031145; GO:0031625; GO:0031647; GO:0045676; GO:0045879; GO:0048132; GO:0051276; GO:0061057; GO:0061631; GO:0097039","anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; peptidoglycan recognition protein signaling pathway [GO:0061057]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511]","cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; peptidoglycan recognition protein signaling pathway [GO:0061057]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511]","","","",""
"1036","sp|P63170|DYL1_RAT","lcl|NC_088859.1_cds_XP_034311809.1_35195",1.68e-15,66.6,"P63170","DYL1_RAT","Dynein light chain 1, cytoplasmic (8 kDa dynein light chain) (DLC8) (Dynein light chain LC8-type 1) (Protein inhibitor of neuronal nitric oxide synthase) (PIN)","Dynll1 Dncl1 Dnclc1 Pin","Rattus norvegicus (Rat)",89,"GO:0000776; GO:0004857; GO:0005634; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005856; GO:0005868; GO:0005874; GO:0005929; GO:0006915; GO:0006974; GO:0007286; GO:0008180; GO:0016020; GO:0019899; GO:0019904; GO:0030141; GO:0030235; GO:0030286; GO:0035721; GO:0035774; GO:0035861; GO:0036487; GO:0042802; GO:0044458; GO:0044877; GO:0045019; GO:0045505; GO:0051881; GO:0060703; GO:0072686; GO:0097110; GO:0110027; GO:0160040; GO:1902857; GO:1904115","apoptotic process [GO:0006915]; DNA damage response [GO:0006974]; intraciliary retrograde transport [GO:0035721]; mitocytosis [GO:0160040]; motile cilium assembly [GO:0044458]; negative regulation of DNA strand resection involved in replication fork processing [GO:0110027]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of mitochondrial membrane potential [GO:0051881]; spermatid development [GO:0007286]","axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cilium [GO:0005929]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; secretory granule [GO:0030141]; site of double-strand break [GO:0035861]; deoxyribonuclease inhibitor activity [GO:0060703]; dynein intermediate chain binding [GO:0045505]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; nitric-oxide synthase inhibitor activity [GO:0036487]; nitric-oxide synthase regulator activity [GO:0030235]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; apoptotic process [GO:0006915]; DNA damage response [GO:0006974]; intraciliary retrograde transport [GO:0035721]; mitocytosis [GO:0160040]; motile cilium assembly [GO:0044458]; negative regulation of DNA strand resection involved in replication fork processing [GO:0110027]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of mitochondrial membrane potential [GO:0051881]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Weaker expression in the cerebellum and spinal cord compared with other brain regions."
"1037","sp|Q94517|HDAC1_DROME","lcl|NC_088859.1_cds_XP_034312098.2_37097",0,703,"Q94517","HDAC1_DROME","Histone deacetylase HDAC1 (HD) (EC 3.5.1.98)","HDAC1 Rpd3 CG7471","Drosophila melanogaster (Fruit fly)",521,"GO:0000118; GO:0000122; GO:0000785; GO:0003714; GO:0004407; GO:0005634; GO:0005654; GO:0005700; GO:0005705; GO:0005737; GO:0006325; GO:0006355; GO:0007350; GO:0008340; GO:0010629; GO:0016581; GO:0017053; GO:0030261; GO:0031507; GO:0031523; GO:0034739; GO:0035098; GO:0045664; GO:0045814; GO:0045879; GO:0045892; GO:0048477; GO:0050771; GO:0070822; GO:0070983; GO:0140297; GO:0140937; GO:0141006; GO:0180032; GO:0180033; GO:1902692; GO:2001229","blastoderm segmentation [GO:0007350]; chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; dendrite guidance [GO:0070983]; determination of adult lifespan [GO:0008340]; heterochromatin formation [GO:0031507]; negative regulation of axonogenesis [GO:0050771]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of response to gamma radiation [GO:2001229]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; regulation of DNA-templated transcription [GO:0006355]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron differentiation [GO:0045664]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006]","chromatin [GO:0000785]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; histone deacetylase complex [GO:0000118]; Myb complex [GO:0031523]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; polytene chromosome [GO:0005700]; polytene chromosome interband [GO:0005705]; Sin3-type complex [GO:0070822]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone H4K12 deacetylase activity, hydrolytic mechanism [GO:0140937]; histone H4K16 deacetylase activity, hydrolytic mechanism [GO:0034739]; histone H4K5 deacetylase activity, hydrolytic mechanism [GO:0180032]; histone H4K8 deacetylase activity, hydrolytic mechanism [GO:0180033]; transcription corepressor activity [GO:0003714]; blastoderm segmentation [GO:0007350]; chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; dendrite guidance [GO:0070983]; determination of adult lifespan [GO:0008340]; heterochromatin formation [GO:0031507]; negative regulation of axonogenesis [GO:0050771]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of response to gamma radiation [GO:2001229]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; regulation of DNA-templated transcription [GO:0006355]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron differentiation [GO:0045664]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006]","","","",""
"1038","sp|O00238|BMR1B_HUMAN","lcl|NC_088859.1_cds_XP_034312252.2_37255",4.04e-177,510,"O00238","BMR1B_HUMAN","Bone morphogenetic protein receptor type-1B (BMP type-1B receptor) (BMPR-1B) (EC 2.7.11.30) (CD antigen CDw293)","BMPR1B","Homo sapiens (Human)",502,"GO:0001502; GO:0001550; GO:0001649; GO:0001654; GO:0002063; GO:0004674; GO:0004675; GO:0004888; GO:0005025; GO:0005524; GO:0005886; GO:0006954; GO:0009953; GO:0010628; GO:0021953; GO:0030154; GO:0030166; GO:0030425; GO:0030501; GO:0030509; GO:0031290; GO:0032332; GO:0036122; GO:0042698; GO:0043025; GO:0043235; GO:0045669; GO:0045944; GO:0046332; GO:0046872; GO:0060041; GO:0060350; GO:0061036; GO:0071363; GO:0071773; GO:0098821; GO:1902043; GO:1902731; GO:1990712","BMP signaling pathway [GO:0030509]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; central nervous system neuron differentiation [GO:0021953]; chondrocyte development [GO:0002063]; dorsal/ventral pattern formation [GO:0009953]; endochondral bone morphogenesis [GO:0060350]; eye development [GO:0001654]; inflammatory response [GO:0006954]; negative regulation of chondrocyte proliferation [GO:1902731]; osteoblast differentiation [GO:0001649]; ovarian cumulus expansion [GO:0001550]; ovulation cycle [GO:0042698]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of gene expression [GO:0010628]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteoglycan biosynthetic process [GO:0030166]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]","dendrite [GO:0030425]; HFE-transferrin receptor complex [GO:1990712]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; transmembrane signaling receptor activity [GO:0004888]; BMP signaling pathway [GO:0030509]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; central nervous system neuron differentiation [GO:0021953]; chondrocyte development [GO:0002063]; dorsal/ventral pattern formation [GO:0009953]; endochondral bone morphogenesis [GO:0060350]; eye development [GO:0001654]; inflammatory response [GO:0006954]; negative regulation of chondrocyte proliferation [GO:1902731]; osteoblast differentiation [GO:0001649]; ovarian cumulus expansion [GO:0001550]; ovulation cycle [GO:0042698]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of gene expression [GO:0010628]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteoglycan biosynthetic process [GO:0030166]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]","","","",""
"1039","sp|B2RQC2|UBP42_MOUSE","lcl|NC_088859.1_cds_XP_034312287.2_37322",2.31e-119,400,"B2RQC2","UBP42_MOUSE","Ubiquitin carboxyl-terminal hydrolase 42 (EC 3.4.19.12) (Deubiquitinating enzyme 42) (Ubiquitin thioesterase 42) (Ubiquitin-specific-processing protease 42)","Usp42","Mus musculus (Mouse)",1324,"GO:0004843; GO:0006508; GO:0007283; GO:0016579; GO:0030154","cell differentiation [GO:0030154]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]","cysteine-type deubiquitinase activity [GO:0004843]; cell differentiation [GO:0030154]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed in the midbrain, forebrain, optic vesicles and eyes of embryos at 10.5 dpc and a more pronounced expression is seen at 12.5 dpc. {ECO:0000269|PubMed:16904385}.","","","TISSUE SPECIFICITY: Highest expression seen in the testis. Also expressed in brain, lung and thymus. The expression level gradually increases from 2 weeks after birth and then decreases from the pachytene spermatocyte (PS) stage during spermatogenesis. {ECO:0000269|PubMed:16904385}."
"1040","sp|Q99323|MYSN_DROME","lcl|NC_088859.1_cds_XP_034312345.2_36905",0,2071,"Q99323","MYSN_DROME","Myosin heavy chain, non-muscle (Myosin II) (Non-muscle MHC) (Zipper protein)","zip CG15792","Drosophila melanogaster (Fruit fly)",2057,"GO:0000146; GO:0000281; GO:0005516; GO:0005524; GO:0005737; GO:0005826; GO:0005829; GO:0005929; GO:0005938; GO:0006936; GO:0007298; GO:0007391; GO:0007395; GO:0007435; GO:0007443; GO:0007455; GO:0007496; GO:0007605; GO:0008258; GO:0016460; GO:0030018; GO:0030239; GO:0031036; GO:0031252; GO:0032027; GO:0032154; GO:0032507; GO:0032982; GO:0035017; GO:0035159; GO:0035277; GO:0035317; GO:0042060; GO:0042802; GO:0044291; GO:0045180; GO:0045214; GO:0046663; GO:0046664; GO:0051015; GO:0060289; GO:0060571; GO:0061640; GO:0070986; GO:0071260; GO:0090175; GO:0106037; GO:1901739; GO:1903688","anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; cytoskeleton-dependent cytokinesis [GO:0061640]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; sensory perception of sound [GO:0007605]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]","actomyosin contractile ring [GO:0005826]; apicomedial cortex [GO:0106037]; basal cortex [GO:0045180]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027]; anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; cytoskeleton-dependent cytokinesis [GO:0061640]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; sensory perception of sound [GO:0007605]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]","DEVELOPMENTAL STAGE: At germband retraction (stage 12), expression is high in the embryo amnioserosa and relatively low at the apical edge of the leading edge/ dorsalmost epidermal (DME) cells (PubMed:18816840, PubMed:23579691). Whereas at dorsal closure (stage 13), expression is relatively low in the amnioserosa and high in the DME cells (PubMed:18816840, PubMed:23579691). Isoforms containing exon 7 are detected in all stages of development and are expressed in embryos, early and late larvae, and adults (PubMed:8568878). {ECO:0000269|PubMed:18816840, ECO:0000269|PubMed:23579691, ECO:0000269|PubMed:8568878}.","","","TISSUE SPECIFICITY: In Johnston's organ, expressed in neurons and scolopale cells. {ECO:0000269|PubMed:27331610}."
"1041","sp|P36970|GPX4_RAT","lcl|NC_088859.1_cds_XP_034312378.1_36957",5.09e-69,210,"P36970","GPX4_RAT","Phospholipid hydroperoxide glutathione peroxidase (PHGPx) (EC 1.11.1.12) (Glutathione peroxidase 4) (GPx-4) (GSHPx-4) (EC 1.11.1.9)","Gpx4","Rattus norvegicus (Rat)",197,"GO:0004602; GO:0005634; GO:0005635; GO:0005730; GO:0005739; GO:0005829; GO:0006325; GO:0006915; GO:0006979; GO:0007283; GO:0008430; GO:0016358; GO:0019369; GO:0019372; GO:0021549; GO:0032355; GO:0032496; GO:0032991; GO:0035264; GO:0042802; GO:0047066; GO:0051258; GO:0110076","apoptotic process [GO:0006915]; arachidonate metabolic process [GO:0019369]; cerebellum development [GO:0021549]; chromatin organization [GO:0006325]; dendrite development [GO:0016358]; lipoxygenase pathway [GO:0019372]; multicellular organism growth [GO:0035264]; negative regulation of ferroptosis [GO:0110076]; protein polymerization [GO:0051258]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]","cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; selenium binding [GO:0008430]; apoptotic process [GO:0006915]; arachidonate metabolic process [GO:0019369]; cerebellum development [GO:0021549]; chromatin organization [GO:0006325]; dendrite development [GO:0016358]; lipoxygenase pathway [GO:0019372]; multicellular organism growth [GO:0035264]; negative regulation of ferroptosis [GO:0110076]; protein polymerization [GO:0051258]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Present primarily in testis (PubMed:1556123). Expressed in flagella of epididymal sperm (PubMed:19423663). Isoform Cytoplasmic: Highly expressed in testis (PubMed:14575705). Present in spermatogonia, spermatocyte and spermatid (at protein level) (PubMed:14575705). {ECO:0000269|PubMed:14575705, ECO:0000269|PubMed:1556123, ECO:0000269|PubMed:19423663}."
"1042","sp|Q9N2J2|GPX4_BOVIN","lcl|NC_088859.1_cds_XP_034312381.1_36960",3.58e-68,207,"Q9N2J2","GPX4_BOVIN","Phospholipid hydroperoxide glutathione peroxidase (PHGPx) (EC 1.11.1.12) (Glutathione peroxidase 4) (GPx-4) (GSHPx-4) (EC 1.11.1.9)","GPX4","Bos taurus (Bovine)",197,"GO:0004602; GO:0005634; GO:0005635; GO:0005739; GO:0005829; GO:0006325; GO:0006915; GO:0006979; GO:0007283; GO:0016358; GO:0019369; GO:0019372; GO:0021549; GO:0032496; GO:0032991; GO:0035264; GO:0042802; GO:0047066; GO:0051258; GO:0110076","apoptotic process [GO:0006915]; arachidonate metabolic process [GO:0019369]; cerebellum development [GO:0021549]; chromatin organization [GO:0006325]; dendrite development [GO:0016358]; lipoxygenase pathway [GO:0019372]; multicellular organism growth [GO:0035264]; negative regulation of ferroptosis [GO:0110076]; protein polymerization [GO:0051258]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]","cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; apoptotic process [GO:0006915]; arachidonate metabolic process [GO:0019369]; cerebellum development [GO:0021549]; chromatin organization [GO:0006325]; dendrite development [GO:0016358]; lipoxygenase pathway [GO:0019372]; multicellular organism growth [GO:0035264]; negative regulation of ferroptosis [GO:0110076]; protein polymerization [GO:0051258]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]","","","",""
"1043","sp|Q8BJ34|MARF1_MOUSE","lcl|NC_088859.1_cds_XP_034312459.2_37485",0,598,"Q8BJ34","MARF1_MOUSE","Meiosis regulator and mRNA stability factor 1 (Limkain-b1) (Meiosis arrest female protein 1)","Marf1 Kiaa0430 Lkap","Mus musculus (Mouse)",1730,"GO:0003723; GO:0004540; GO:0005777; GO:0005794; GO:0006302; GO:0007143; GO:0010468; GO:0048477","double-strand break repair [GO:0006302]; female meiotic nuclear division [GO:0007143]; oogenesis [GO:0048477]; regulation of gene expression [GO:0010468]","Golgi apparatus [GO:0005794]; peroxisome [GO:0005777]; RNA binding [GO:0003723]; RNA nuclease activity [GO:0004540]; double-strand break repair [GO:0006302]; female meiotic nuclear division [GO:0007143]; oogenesis [GO:0048477]; regulation of gene expression [GO:0010468]","DEVELOPMENTAL STAGE: Detected in germ cells in quiescent oocytes isolated from newborn P0 ovaries that have not yet commenced the growth phase. Protein levels increase after oocytes initiate growth, and follicular development reach the primary follicle stage at P6. Thereafter, protein levels remain at the similar levels (at protein level). {ECO:0000269|PubMed:23090997}.","","","TISSUE SPECIFICITY: Predominantly present in oocytes and barely detectable in granulosa cells (at protein level). {ECO:0000269|PubMed:22442484}."
"1044","sp|Q8BS45|IFT56_MOUSE","lcl|NC_088859.1_cds_XP_034312496.1_37532",0,934,"Q8BS45","IFT56_MOUSE","Intraflagellar transport protein 56 (Protein hop-sterile) (Tetratricopeptide repeat protein 26) (TPR repeat protein 26)","Ift56 Hop Ttc26","Mus musculus (Mouse)",554,"GO:0005813; GO:0005929; GO:0007224; GO:0007286; GO:0008594; GO:0015031; GO:0030992; GO:0035082; GO:0035720; GO:0036064; GO:0042073; GO:0043005; GO:0046530; GO:0060271; GO:0061512; GO:0120170; GO:1905198","axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; manchette assembly [GO:1905198]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell morphogenesis [GO:0008594]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286]","centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; neuron projection [GO:0043005]; intraciliary transport particle B binding [GO:0120170]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; manchette assembly [GO:1905198]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell morphogenesis [GO:0008594]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286]","DEVELOPMENTAL STAGE: Expressed during early development stages (12.5 dpc, 13.5 dpc, and 14.5 dpc). {ECO:0000269|PubMed:31595528}.","","","TISSUE SPECIFICITY: High expression detected in testis. Detected also retina, kidney, lung and brain tissue. The expression level is low in spleen (PubMed:22718903). Expressed in the developing liver (PubMed:31595528). Present in the airway epithelial cells and the testes (at protein level) (PubMed:25340710). {ECO:0000269|PubMed:22718903, ECO:0000269|PubMed:25340710, ECO:0000269|PubMed:31595528}."
"1045","sp|Q8K1P7|SMCA4_RAT","lcl|NC_088859.1_cds_XP_034312553.1_37607",0,1480,"Q8K1P7","SMCA4_RAT","SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4 (SMARCA4) (EC 3.6.4.-) (BRG1-associated factor 190A) (BAF190A) (Protein brahma homolog 1) (SNF2-beta) (Transcription activator BRG1)","Smarca4 Baf190a Brg1 Snf2b Snf2l4","Rattus norvegicus (Rat)",1613,"GO:0000122; GO:0000785; GO:0000791; GO:0000902; GO:0000977; GO:0000978; GO:0001188; GO:0001221; GO:0001568; GO:0001570; GO:0001673; GO:0001701; GO:0001832; GO:0001835; GO:0001889; GO:0002039; GO:0003151; GO:0003281; GO:0003407; GO:0003677; GO:0003682; GO:0003713; GO:0003714; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0006337; GO:0006338; GO:0006366; GO:0007286; GO:0007399; GO:0007403; GO:0007507; GO:0008094; GO:0008284; GO:0010467; GO:0016514; GO:0016887; GO:0019827; GO:0022008; GO:0030177; GO:0030198; GO:0030216; GO:0030308; GO:0030334; GO:0030900; GO:0030902; GO:0030957; GO:0035116; GO:0035887; GO:0035904; GO:0042393; GO:0043066; GO:0043923; GO:0044877; GO:0045597; GO:0045815; GO:0045892; GO:0045893; GO:0045944; GO:0048562; GO:0048730; GO:0050681; GO:0060318; GO:0060319; GO:0060347; GO:0060766; GO:0060976; GO:0061626; GO:0070182; GO:0070307; GO:0071564; GO:0071565; GO:0106222; GO:0120162; GO:0140658; GO:0140750; GO:1901838; GO:1902661; GO:1902895","aorta development [GO:0035904]; aortic smooth muscle cell differentiation [GO:0035887]; blastocyst growth [GO:0001832]; blastocyst hatching [GO:0001835]; blood vessel development [GO:0001568]; cell morphogenesis [GO:0000902]; chromatin remodeling [GO:0006338]; coronary vasculature development [GO:0060976]; definitive erythrocyte differentiation [GO:0060318]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic organ morphogenesis [GO:0048562]; epidermis morphogenesis [GO:0048730]; extracellular matrix organization [GO:0030198]; forebrain development [GO:0030900]; gene expression [GO:0010467]; glial cell fate determination [GO:0007403]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hindbrain development [GO:0030902]; in utero embryonic development [GO:0001701]; keratinocyte differentiation [GO:0030216]; lens fiber cell development [GO:0070307]; liver development [GO:0001889]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; neurogenesis [GO:0022008]; nucleosome disassembly [GO:0006337]; outflow tract morphogenesis [GO:0003151]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of glucose mediated signaling pathway [GO:1902661]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of Wnt signaling pathway [GO:0030177]; primitive erythrocyte differentiation [GO:0060319]; regulation of cell migration [GO:0030334]; RNA polymerase I preinitiation complex assembly [GO:0001188]; spermatid development [GO:0007286]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription initiation-coupled chromatin remodeling [GO:0045815]; vasculogenesis [GO:0001570]; ventricular septum development [GO:0003281]","chromatin [GO:0000785]; euchromatin [GO:0000791]; male germ cell nucleus [GO:0001673]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; SWI/SNF complex [GO:0016514]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; helicase activity [GO:0004386]; histone binding [GO:0042393]; lncRNA binding [GO:0106222]; nuclear androgen receptor binding [GO:0050681]; nucleosome array spacer activity [GO:0140750]; p53 binding [GO:0002039]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; Tat protein binding [GO:0030957]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; transcription corepressor activity [GO:0003714]; aorta development [GO:0035904]; aortic smooth muscle cell differentiation [GO:0035887]; blastocyst growth [GO:0001832]; blastocyst hatching [GO:0001835]; blood vessel development [GO:0001568]; cell morphogenesis [GO:0000902]; chromatin remodeling [GO:0006338]; coronary vasculature development [GO:0060976]; definitive erythrocyte differentiation [GO:0060318]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic organ morphogenesis [GO:0048562]; epidermis morphogenesis [GO:0048730]; extracellular matrix organization [GO:0030198]; forebrain development [GO:0030900]; gene expression [GO:0010467]; glial cell fate determination [GO:0007403]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hindbrain development [GO:0030902]; in utero embryonic development [GO:0001701]; keratinocyte differentiation [GO:0030216]; lens fiber cell development [GO:0070307]; liver development [GO:0001889]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; neurogenesis [GO:0022008]; nucleosome disassembly [GO:0006337]; outflow tract morphogenesis [GO:0003151]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of glucose mediated signaling pathway [GO:1902661]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of Wnt signaling pathway [GO:0030177]; primitive erythrocyte differentiation [GO:0060319]; regulation of cell migration [GO:0030334]; RNA polymerase I preinitiation complex assembly [GO:0001188]; spermatid development [GO:0007286]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription initiation-coupled chromatin remodeling [GO:0045815]; vasculogenesis [GO:0001570]; ventricular septum development [GO:0003281]","","","",""
"1046","sp|Q9JLP1|KHDR3_RAT","lcl|NC_088859.1_cds_XP_034312614.1_37688",1.3e-52,178,"Q9JLP1","KHDR3_RAT","KH domain-containing, RNA-binding, signal transduction-associated protein 3 (Sam68-like mammalian protein 2) (SLM-2) (rSLM-2)","Khdrbs3 Slm2","Rattus norvegicus (Rat)",346,"GO:0000381; GO:0003723; GO:0003727; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0007283; GO:0017124; GO:0019904; GO:0032991; GO:0033120; GO:0042802; GO:0048024","mRNA processing [GO:0006397]; positive regulation of RNA splicing [GO:0033120]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283]","nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; single-stranded RNA binding [GO:0003727]; mRNA processing [GO:0006397]; positive regulation of RNA splicing [GO:0033120]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Ubiquitous. Highly expressed in brain, heart, testis and in Sertoli cells at all stages of spermatogenesis. Expressed in neurons. Detected in cortical layers of the forebrain and in the CA1 to CA4 regions of the hippocampus. {ECO:0000269|PubMed:10332027, ECO:0000269|PubMed:15345239}."
"1047","sp|Q8CHN6|SGPL1_RAT","lcl|NC_088859.1_cds_XP_034312645.2_37723",0,572,"Q8CHN6","SGPL1_RAT","Sphingosine-1-phosphate lyase 1 (S1PL) (SP-lyase 1) (SPL) (SPL 1) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase)","Sgpl1 Spl","Rattus norvegicus (Rat)",568,"GO:0001553; GO:0001570; GO:0001822; GO:0005783; GO:0005789; GO:0006631; GO:0006672; GO:0007283; GO:0008117; GO:0008209; GO:0008210; GO:0008585; GO:0009791; GO:0010761; GO:0030097; GO:0030149; GO:0030170; GO:0033327; GO:0040014; GO:0048008; GO:0048705; GO:0060021; GO:0060325; GO:0097190","androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid catabolic process [GO:0030149]; vasculogenesis [GO:0001570]","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid catabolic process [GO:0030149]; vasculogenesis [GO:0001570]","","","",""
"1048","sp|P09661|RU2A_HUMAN","lcl|NC_088859.1_cds_XP_034312721.1_37830",9.46e-117,335,"P09661","RU2A_HUMAN","U2 small nuclear ribonucleoprotein A' (U2 snRNP A')","SNRPA1","Homo sapiens (Human)",255,"GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0007283; GO:0008380; GO:0016604; GO:0016607; GO:0030532; GO:0030620; GO:0071005; GO:0071007; GO:0071013; GO:1903241","mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; U2-type prespliceosome assembly [GO:1903241]","catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; U2-type prespliceosome assembly [GO:1903241]","","","",""
"1049","sp|Q801G2|MPRAB_DANRE","lcl|NC_088859.1_cds_XP_034312737.2_37845",1.85e-57,191,"Q801G2","MPRAB_DANRE","Membrane progestin receptor alpha-B (mPR alpha) (Progestin and adipoQ receptor family member VII, b)","paqr7b mpra paqr7","Danio rerio (Zebrafish) (Brachydanio rerio)",354,"GO:0001556; GO:0003707; GO:0005496; GO:0005886; GO:0007165; GO:0007193; GO:0043401; GO:0043410; GO:0048545","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; oocyte maturation [GO:0001556]; positive regulation of MAPK cascade [GO:0043410]; response to steroid hormone [GO:0048545]; signal transduction [GO:0007165]; steroid hormone receptor signaling pathway [GO:0043401]","plasma membrane [GO:0005886]; nuclear steroid receptor activity [GO:0003707]; steroid binding [GO:0005496]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; oocyte maturation [GO:0001556]; positive regulation of MAPK cascade [GO:0043410]; response to steroid hormone [GO:0048545]; signal transduction [GO:0007165]; steroid hormone receptor signaling pathway [GO:0043401]","DEVELOPMENTAL STAGE: In oocytes, expression is lowest in ovarian follicles at stages I and II but gradually increases after the onset of vitellogenic growth, peaking at vitellogenic stages (stage IIIB). {ECO:0000269|PubMed:15862564}.","","",""
"1050","sp|P62345|CDPK4_PLABA","lcl|NC_088859.1_cds_XP_034312783.1_36550",1.45e-59,205,"P62345","CDPK4_PLABA","Calcium-dependent protein kinase 4 (EC 2.7.11.1) (PbCDPK4)","CDPK4 CPK4 PBANKA_0615200","Plasmodium berghei (strain Anka)",528,"GO:0003353; GO:0004674; GO:0005509; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0016020; GO:0030154; GO:0032298; GO:0048232; GO:0106310; GO:0140530; GO:1901673; GO:1904931; GO:2000147","cell differentiation [GO:0030154]; male gamete generation [GO:0048232]; MCM complex loading [GO:0140530]; positive regulation of cell motility [GO:2000147]; positive regulation of cilium movement [GO:0003353]; positive regulation of DNA-templated DNA replication initiation [GO:0032298]; regulation of mitotic spindle assembly [GO:1901673]","chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; MCM complex binding [GO:1904931]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell differentiation [GO:0030154]; male gamete generation [GO:0048232]; MCM complex loading [GO:0140530]; positive regulation of cell motility [GO:2000147]; positive regulation of cilium movement [GO:0003353]; positive regulation of DNA-templated DNA replication initiation [GO:0032298]; regulation of mitotic spindle assembly [GO:1901673]","DEVELOPMENTAL STAGE: Expressed in sporozoites and in liver stages (at protein level) (PubMed:27425827). Highly expressed in male gametocytes and exflagellated gametes, and to a lesser extent, in female gametocytes (at protein level) (PubMed:15137943, PubMed:28481199). Expressed in ookinetes (PubMed:15137943). Weakly or not expressed in asexual parasite stages (PubMed:15137943). {ECO:0000269|PubMed:15137943, ECO:0000269|PubMed:27425827, ECO:0000269|PubMed:28481199}.","","",""
"1051","sp|Q9V3L1|NDST_DROME","lcl|NC_088859.1_cds_XP_034312794.2_36576",0,954,"Q9V3L1","NDST_DROME","Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase) (Sulfateless) [Includes: Heparan sulfate N-deacetylase (EC 3.-.-.-); Heparan sulfate N-sulfotransferase (EC 2.8.2.-)]","sfl CG8339","Drosophila melanogaster (Fruit fly)",1048,"GO:0000137; GO:0000139; GO:0005783; GO:0005794; GO:0006024; GO:0006790; GO:0007283; GO:0007367; GO:0007427; GO:0007474; GO:0007509; GO:0008543; GO:0008587; GO:0015012; GO:0015016; GO:0016055; GO:0019213; GO:0030210; GO:0045570; GO:0102140","epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of imaginal disc growth [GO:0045570]; segment polarity determination [GO:0007367]; spermatogenesis [GO:0007283]; sulfur compound metabolic process [GO:0006790]; Wnt signaling pathway [GO:0016055]","endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; heparan sulfate N-sulfotransferase activity [GO:0015016]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of imaginal disc growth [GO:0045570]; segment polarity determination [GO:0007367]; spermatogenesis [GO:0007283]; sulfur compound metabolic process [GO:0006790]; Wnt signaling pathway [GO:0016055]","","","",""
"1052","sp|Q4R4D3|RL10L_MACFA","lcl|NC_088859.1_cds_XP_034312818.1_40088",5.61e-127,358,"Q4R4D3","RL10L_MACFA","Large ribosomal subunit protein uL16-like (60S ribosomal protein L10-like)","RPL10L QtsA-10847","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)",214,"GO:0000027; GO:0003735; GO:0005634; GO:0005783; GO:0005840; GO:0006412; GO:0007141; GO:0007283; GO:0022625; GO:0030154","cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; ribosomal large subunit assembly [GO:0000027]; spermatogenesis [GO:0007283]; translation [GO:0006412]","cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; ribosomal large subunit assembly [GO:0000027]; spermatogenesis [GO:0007283]; translation [GO:0006412]","","","",""
"1053","sp|O88509|DNM3B_MOUSE","lcl|NC_088859.1_cds_XP_034313469.2_35915",2.67e-121,385,"O88509","DNM3B_MOUSE","DNA (cytosine-5)-methyltransferase 3B (Dnmt3b) (EC 2.1.1.37) (DNA methyltransferase MmuIIIB) (DNA MTase MmuIIIB) (M.MmuIIIB)","Dnmt3b","Mus musculus (Mouse)",859,"GO:0000122; GO:0000775; GO:0000792; GO:0003677; GO:0003886; GO:0005634; GO:0005654; GO:0006346; GO:0008168; GO:0008270; GO:0031503; GO:0031507; GO:0032259; GO:0040029; GO:0043045; GO:0045814; GO:0051718; GO:0051719; GO:0071230; GO:0106222; GO:0141005; GO:0141068; GO:0141176","autosome genomic imprinting [GO:0141068]; cellular response to amino acid stimulus [GO:0071230]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; epigenetic programming of gene expression [GO:0043045]; epigenetic regulation of gene expression [GO:0040029]; gene silencing by piRNA-directed DNA methylation [GO:0141176]; heterochromatin formation [GO:0031507]; methylation [GO:0032259]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein-containing complex localization [GO:0031503]; transposable element silencing by heterochromatin formation [GO:0141005]","chromosome, centromeric region [GO:0000775]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates [GO:0051718]; DNA (cytosine-5-)-methyltransferase activity, acting on CpN substrates [GO:0051719]; DNA binding [GO:0003677]; lncRNA binding [GO:0106222]; methyltransferase activity [GO:0008168]; zinc ion binding [GO:0008270]; autosome genomic imprinting [GO:0141068]; cellular response to amino acid stimulus [GO:0071230]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; epigenetic programming of gene expression [GO:0043045]; epigenetic regulation of gene expression [GO:0040029]; gene silencing by piRNA-directed DNA methylation [GO:0141176]; heterochromatin formation [GO:0031507]; methylation [GO:0032259]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein-containing complex localization [GO:0031503]; transposable element silencing by heterochromatin formation [GO:0141005]","DEVELOPMENTAL STAGE: Expressed in almost all blastocysts at 3.0 dpc. Preferentially expressed in the trophectoderm (TE) in 3.5 dpc and polar TE in 4.0 dpc blastocysts. In 4.5 dpc embryos, expressed in the polar TE and some inner cell mass (ICM) embryonic lineage cells. In post-implantation embryo at 5.5 dpc, expressed in the epiblast (embryonic lineage) derived from the ICM. Highly expressed, at 7.5 dpc, in the embryonic ectoderm, neural ectoderm, and chorionic ectoderm; a weak expression is also detected in mesodermal and endodermal cells. At later stages, the expression is detected predominantly in the forebrain and eyes but weakly throughout the embryo. {ECO:0000269|PubMed:10555141, ECO:0000269|PubMed:18814855}.","","",""
"1054","sp|Q9V3P0|PRDX2_DROME","lcl|NC_088859.1_cds_XP_034313741.2_37893",5.17e-106,304,"Q9V3P0","PRDX2_DROME","Peroxiredoxin 2 (EC 1.11.1.24) (Cytosolic thioredoxin peroxidase 1) (Thioredoxin peroxidase 1) (Thioredoxin-dependent peroxide reductase 1) (Thioredoxin-dependent peroxiredoxin 2)","Prx2 DPx-4783 Jafrac1 TPX-1 CG1633","Drosophila melanogaster (Fruit fly)",194,"GO:0005829; GO:0006979; GO:0007155; GO:0007281; GO:0008340; GO:0008354; GO:0008379; GO:0019430; GO:0042594; GO:0042744; GO:0045454; GO:0051920; GO:0140824","cell adhesion [GO:0007155]; cell redox homeostasis [GO:0045454]; determination of adult lifespan [GO:0008340]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; hydrogen peroxide catabolic process [GO:0042744]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]","cytosol [GO:0005829]; peroxiredoxin activity [GO:0051920]; thioredoxin peroxidase activity [GO:0008379]; thioredoxin-dependent peroxiredoxin activity [GO:0140824]; cell adhesion [GO:0007155]; cell redox homeostasis [GO:0045454]; determination of adult lifespan [GO:0008340]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; hydrogen peroxide catabolic process [GO:0042744]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]","DEVELOPMENTAL STAGE: Highly expressed during embryogenesis, weakly expressed during larval stages. {ECO:0000269|PubMed:11677042, ECO:0000269|PubMed:11877442}.","","","TISSUE SPECIFICITY: Detected in the head and body (at protein level). {ECO:0000269|PubMed:33920774}."
"1055","sp|P25723|TLD_DROME","lcl|NC_088859.1_cds_XP_034313777.1_37925",0,890,"P25723","TLD_DROME","Dorsal-ventral patterning protein tolloid (EC 3.4.24.-)","tld CG6868","Drosophila melanogaster (Fruit fly)",1067,"GO:0004222; GO:0005509; GO:0005518; GO:0005615; GO:0006508; GO:0007313; GO:0007378; GO:0008270; GO:0008586; GO:0009953; GO:0016485; GO:0030513; GO:0032927; GO:0045464","amnioserosa formation [GO:0007378]; dorsal/ventral pattern formation [GO:0009953]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maternal specification of dorsal/ventral axis, oocyte, soma encoded [GO:0007313]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of BMP signaling pathway [GO:0030513]; protein processing [GO:0016485]; proteolysis [GO:0006508]; R8 cell fate specification [GO:0045464]","extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; amnioserosa formation [GO:0007378]; dorsal/ventral pattern formation [GO:0009953]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maternal specification of dorsal/ventral axis, oocyte, soma encoded [GO:0007313]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of BMP signaling pathway [GO:0030513]; protein processing [GO:0016485]; proteolysis [GO:0006508]; R8 cell fate specification [GO:0045464]","","","",""
"1056","sp|Q961G1|COG3_DROME","lcl|NC_088859.1_cds_XP_034313821.2_37985",0,619,"Q961G1","COG3_DROME","Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3)","Cog3 CG3248","Drosophila melanogaster (Fruit fly)",905,"GO:0000139; GO:0005801; GO:0006886; GO:0006888; GO:0006891; GO:0007030; GO:0007112; GO:0017119","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; male meiosis cytokinesis [GO:0007112]","cis-Golgi network [GO:0005801]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; male meiosis cytokinesis [GO:0007112]","","","",""
"1057","sp|Q6MG62|MSH5_RAT","lcl|NC_088859.1_cds_XP_034313946.2_38173",0,714,"Q6MG62","MSH5_RAT","MutS protein homolog 5","Msh5","Rattus norvegicus (Rat)",831,"GO:0000795; GO:0003690; GO:0005524; GO:0005634; GO:0006298; GO:0007127; GO:0007129; GO:0007292; GO:0030983; GO:0051026; GO:0140664","chiasma assembly [GO:0051026]; female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; meiosis I [GO:0007127]; mismatch repair [GO:0006298]","nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; double-stranded DNA binding [GO:0003690]; mismatched DNA binding [GO:0030983]; chiasma assembly [GO:0051026]; female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; meiosis I [GO:0007127]; mismatch repair [GO:0006298]","","","",""
"1058","sp|X1WGX5|PUM3_DANRE","lcl|NC_088859.1_cds_XP_034313951.2_38166",9.2e-161,482,"X1WGX5","PUM3_DANRE","Pumilio homolog 3","pum3 puf-a","Danio rerio (Zebrafish) (Brachydanio rerio)",629,"GO:0003677; GO:0003729; GO:0005654; GO:0005694; GO:0005730; GO:0006417; GO:0008354","germ cell migration [GO:0008354]; regulation of translation [GO:0006417]","chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; germ cell migration [GO:0008354]; regulation of translation [GO:0006417]","DEVELOPMENTAL STAGE: Expressed throughout embryogenesis. In the adult ovary, strong expression detected in primitive stage I ovarian follicles with levels declining sharply and becoming negligible in subsequent stages of oocyte development. {ECO:0000269|PubMed:19319195}.","","","TISSUE SPECIFICITY: In adult, expressed at high levels in eye and ovary and at lower levels in brain, testis and head kidney. In the adult ovary, prominently expressed in early immature follicles. {ECO:0000269|PubMed:19319195}."
"1059","sp|Q12768|WASC5_HUMAN","lcl|NC_088859.1_cds_XP_034314106.2_38357",0,1616,"Q12768","WASC5_HUMAN","WASH complex subunit 5 (Strumpellin) (WASH complex subunit strumpellin)","WASHC5 KIAA0196","Homo sapiens (Human)",1159,"GO:0001556; GO:0005768; GO:0005769; GO:0005783; GO:0005829; GO:0007032; GO:0007040; GO:0010976; GO:0015031; GO:0016197; GO:0030041; GO:0031503; GO:0031901; GO:0034315; GO:0040038; GO:0043025; GO:0051125; GO:0071203; GO:0090306; GO:0097494; GO:0140285","actin filament polymerization [GO:0030041]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome organization [GO:0007032]; lysosome organization [GO:0007040]; meiotic spindle assembly [GO:0090306]; oocyte maturation [GO:0001556]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031]; protein-containing complex localization [GO:0031503]; regulation of actin nucleation [GO:0051125]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of vesicle size [GO:0097494]","cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; neuronal cell body [GO:0043025]; WASH complex [GO:0071203]; actin filament polymerization [GO:0030041]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome organization [GO:0007032]; lysosome organization [GO:0007040]; meiotic spindle assembly [GO:0090306]; oocyte maturation [GO:0001556]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031]; protein-containing complex localization [GO:0031503]; regulation of actin nucleation [GO:0051125]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of vesicle size [GO:0097494]","","","","TISSUE SPECIFICITY: Expressed ubiquitously. {ECO:0000269|PubMed:20833645}."
"1060","sp|O45551|IF4E1_CAEEL","lcl|NC_088859.1_cds_XP_034314163.1_38448",9.4e-48,157,"O45551","IF4E1_CAEEL","Eukaryotic translation initiation factor 4E-1 (eIF-4E-1) (eIF4E-1) (eIF-4F 25 kDa subunit) (mRNA cap-binding protein)","ife-1 F53A2.6","Caenorhabditis elegans",212,"GO:0000340; GO:0000341; GO:0001556; GO:0003743; GO:0005737; GO:0006413; GO:0006417; GO:0007286; GO:0009792; GO:0016281; GO:0043186","embryo development ending in birth or egg hatching [GO:0009792]; oocyte maturation [GO:0001556]; regulation of translation [GO:0006417]; spermatid development [GO:0007286]; translational initiation [GO:0006413]","cytoplasm [GO:0005737]; eukaryotic translation initiation factor 4F complex [GO:0016281]; P granule [GO:0043186]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA trimethylguanosine cap binding [GO:0000341]; translation initiation factor activity [GO:0003743]; embryo development ending in birth or egg hatching [GO:0009792]; oocyte maturation [GO:0001556]; regulation of translation [GO:0006417]; spermatid development [GO:0007286]; translational initiation [GO:0006413]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. Ubiquitous embryonic expression until the 100-200 cell stage then disappears by the 300-400 cell stage. Expressed again in L3 larvae through to adulthood. {ECO:0000269|PubMed:11641215}.","","","TISSUE SPECIFICITY: Enriched in the germline from L3 larvae to adults; regions of the gonad undergoing spermatogenesis. Expressed in germ granules (P granules); when associated with pgl-1. {ECO:0000269|PubMed:11641215}."
"1061","sp|Q24009|BICC_DROME","lcl|NC_088859.1_cds_XP_034314178.2_36885",9.06e-82,285,"Q24009","BICC_DROME","Protein bicaudal C","BicC CG4824","Drosophila melanogaster (Fruit fly)",905,"GO:0000226; GO:0000278; GO:0003729; GO:0005737; GO:0007297; GO:0007319; GO:0030036; GO:0048477","actin cytoskeleton organization [GO:0030036]; follicle cell of egg chamber migration [GO:0007297]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of oskar mRNA translation [GO:0007319]; oogenesis [GO:0048477]","cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; actin cytoskeleton organization [GO:0030036]; follicle cell of egg chamber migration [GO:0007297]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of oskar mRNA translation [GO:0007319]; oogenesis [GO:0048477]","DEVELOPMENTAL STAGE: Expressed in the developing ovary. First detectable at stages 3 and 4 of oogenesis but remains very faint until stage 5, when the protein level increases substantially. In stages 4 to 6 is visible throughout the oocyte cytoplasm but is enriched at the osterior pole of the oocyte. During stages 7 to 9 is abundant in the oocyte cytoplasm, with some enrichment at the anterior of the oocyte and around the oocyte cortex. In stage 10 and in later stages is expressed at high levels in the nurse cells (at protein level). {ECO:0000269|PubMed:9671494}.","","","TISSUE SPECIFICITY: Abundantly expressed in ovaries and early embryos. {ECO:0000269|PubMed:7538070}."
"1062","sp|Q7KN62|TERA_DROME","lcl|NC_088859.1_cds_XP_034314513.1_34711",0,1289,"Q7KN62","TERA_DROME","Transitional endoplasmic reticulum ATPase TER94 (EC 3.6.4.6) (Valosin-containing protein homolog)","TER94 VCP CG2331","Drosophila melanogaster (Fruit fly)",801,"GO:0000226; GO:0005524; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0006508; GO:0006511; GO:0007029; GO:0007030; GO:0007040; GO:0007279; GO:0007317; GO:0016320; GO:0016887; GO:0030970; GO:0031593; GO:0031965; GO:0032436; GO:0034098; GO:0035096; GO:0035331; GO:0043161; GO:0043186; GO:0043523; GO:0043525; GO:0044754; GO:0045169; GO:0045879; GO:0046598; GO:0046716; GO:0048477; GO:0048813; GO:0051228; GO:0061909; GO:0090090; GO:0097212; GO:0097352; GO:0098586; GO:0140311","autophagosome maturation [GO:0097352]; autophagosome-lysosome fusion [GO:0061909]; cellular response to virus [GO:0098586]; dendrite morphogenesis [GO:0048813]; endoplasmic reticulum membrane fusion [GO:0016320]; endoplasmic reticulum organization [GO:0007029]; Golgi organization [GO:0007030]; larval midgut cell programmed cell death [GO:0035096]; lysosomal membrane organization [GO:0097212]; lysosome organization [GO:0007040]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle disassembly [GO:0051228]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hippo signaling [GO:0035331]; negative regulation of smoothened signaling pathway [GO:0045879]; oogenesis [GO:0048477]; pole cell formation [GO:0007279]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of viral entry into host cell [GO:0046598]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis [GO:0006508]; regulation of neuron apoptotic process [GO:0043523]; regulation of pole plasm oskar mRNA localization [GO:0007317]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]","autolysosome [GO:0044754]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fusome [GO:0045169]; lysosomal membrane [GO:0005765]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; P granule [GO:0043186]; plasma membrane [GO:0005886]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein sequestering activity [GO:0140311]; autophagosome maturation [GO:0097352]; autophagosome-lysosome fusion [GO:0061909]; cellular response to virus [GO:0098586]; dendrite morphogenesis [GO:0048813]; endoplasmic reticulum membrane fusion [GO:0016320]; endoplasmic reticulum organization [GO:0007029]; Golgi organization [GO:0007030]; larval midgut cell programmed cell death [GO:0035096]; lysosomal membrane organization [GO:0097212]; lysosome organization [GO:0007040]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle disassembly [GO:0051228]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hippo signaling [GO:0035331]; negative regulation of smoothened signaling pathway [GO:0045879]; oogenesis [GO:0048477]; pole cell formation [GO:0007279]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of viral entry into host cell [GO:0046598]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis [GO:0006508]; regulation of neuron apoptotic process [GO:0043523]; regulation of pole plasm oskar mRNA localization [GO:0007317]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]","DEVELOPMENTAL STAGE: Present in egg, pupa and imago but not larva (at protein level). {ECO:0000269|PubMed:9639875}.","","","TISSUE SPECIFICITY: Present in the mushroom bodies of the protocerebrum and in the glomeruli of the antennal lobe. Present in nurse cells, oocytes and sperm bundles (at protein level). {ECO:0000269|PubMed:10564274, ECO:0000269|PubMed:10656772, ECO:0000269|PubMed:9639875}."
"1063","sp|H2L056|UBXN3_CAEEL","lcl|NC_088859.1_cds_XP_034314590.2_38753",7.78e-27,117,"H2L056","UBXN3_CAEEL","UBX domain-containing protein 3","ubxn-3 F48A11.5","Caenorhabditis elegans",613,"GO:0000785; GO:0005634; GO:0005737; GO:0005783; GO:0007283; GO:0030154; GO:0036435; GO:0036503; GO:0042006; GO:0043130; GO:0044877; GO:0045732; GO:0045977; GO:0048471; GO:1905634","cell differentiation [GO:0030154]; ERAD pathway [GO:0036503]; masculinization of hermaphroditic germ-line [GO:0042006]; positive regulation of mitotic cell cycle, embryonic [GO:0045977]; positive regulation of protein catabolic process [GO:0045732]; regulation of protein localization to chromatin [GO:1905634]; spermatogenesis [GO:0007283]","chromatin [GO:0000785]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; cell differentiation [GO:0030154]; ERAD pathway [GO:0036503]; masculinization of hermaphroditic germ-line [GO:0042006]; positive regulation of mitotic cell cycle, embryonic [GO:0045977]; positive regulation of protein catabolic process [GO:0045732]; regulation of protein localization to chromatin [GO:1905634]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed in embryos (at protein level) (PubMed:17498661, PubMed:26842564). Also expressed in L4 larvae and adults (PubMed:17498661). Expressed to a lesser extent between L1 and L3 larval stages (PubMed:17498661). {ECO:0000269|PubMed:17498661, ECO:0000269|PubMed:26842564}.","","","TISSUE SPECIFICITY: Expressed in the germline (at protein level) (PubMed:17498661, PubMed:20977550). Expressed in spermatocytes but not in mature sperm (at protein level) (PubMed:20977550). Expressed in the spermatheca and nerve cells (PubMed:17498661). {ECO:0000269|PubMed:17498661, ECO:0000269|PubMed:20977550}."
"1064","sp|Q9VT70|NDE1_DROME","lcl|NC_088859.1_cds_XP_034314630.2_39159",5.05e-32,122,"Q9VT70","NDE1_DROME","Nuclear distribution protein nudE homolog","nudE CG8104","Drosophila melanogaster (Fruit fly)",317,"GO:0000132; GO:0000776; GO:0005635; GO:0005737; GO:0005813; GO:0005819; GO:0005871; GO:0005874; GO:0007020; GO:0007052; GO:0007059; GO:0007060; GO:0007080; GO:0007100; GO:0007294; GO:0007298; GO:0007409; GO:0008017; GO:0016477; GO:0030424; GO:0030425; GO:0030951; GO:0031616; GO:0047496; GO:0048813; GO:0050775; GO:0051298; GO:0051301; GO:0051303; GO:0051642; GO:0051647; GO:0070732","axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell division [GO:0051301]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; centrosome localization [GO:0051642]; chromosome segregation [GO:0007059]; dendrite morphogenesis [GO:0048813]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; germarium-derived oocyte fate determination [GO:0007294]; male meiosis chromosome segregation [GO:0007060]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle organization [GO:0007052]; nucleus localization [GO:0051647]; positive regulation of dendrite morphogenesis [GO:0050775]; vesicle transport along microtubule [GO:0047496]","axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; spindle [GO:0005819]; spindle envelope [GO:0070732]; spindle pole centrosome [GO:0031616]; microtubule binding [GO:0008017]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell division [GO:0051301]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; centrosome localization [GO:0051642]; chromosome segregation [GO:0007059]; dendrite morphogenesis [GO:0048813]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; germarium-derived oocyte fate determination [GO:0007294]; male meiosis chromosome segregation [GO:0007060]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle organization [GO:0007052]; nucleus localization [GO:0051647]; positive regulation of dendrite morphogenesis [GO:0050775]; vesicle transport along microtubule [GO:0047496]","","","",""
"1065","sp|Q62036|CP131_MOUSE","lcl|NC_088859.1_cds_XP_034314773.2_39398",7.31e-100,342,"Q62036","CP131_MOUSE","Centrosomal protein of 131 kDa (5-azacytidine-induced protein 1) (Pre-acrosome localization protein 1)","Cep131 Az1 Azi Azi1","Mus musculus (Mouse)",1060,"GO:0001669; GO:0002177; GO:0005813; GO:0005814; GO:0007283; GO:0007286; GO:0007288; GO:0008284; GO:0010824; GO:0034451; GO:0035735; GO:0035869; GO:0036064; GO:0042073; GO:0042803; GO:0044877; GO:0045171; GO:0071539; GO:0090316; GO:0120212; GO:1905198; GO:1905515; GO:1990953","intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; non-motile cilium assembly [GO:1905515]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]; regulation of centrosome duplication [GO:0010824]; sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; intercellular bridge [GO:0045171]; manchette [GO:0002177]; sperm head-tail coupling apparatus [GO:0120212]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; non-motile cilium assembly [GO:1905515]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]; regulation of centrosome duplication [GO:0010824]; sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Widely expressed during development, with strong expression in tissues with high levels of cilia-dependent developmental signaling such as the limbs, eyes, somite derivatives and brain. Significant amounts are found in the testis of 16 day old mice, at a late stage of pachytene spermatocytes when meiosis occurs. The level increases thereafter. {ECO:0000269|PubMed:24415959}.","INDUCTION: By 5-azacytidine.","INDUCTION: By 5-azacytidine.","TISSUE SPECIFICITY: Localized to the pre-acrosome region of round and elongated spermatids in testis but also present in ovary, brain and adipose tissue. {ECO:0000269|PubMed:8529672}."
"1066","sp|Q8MKW7|RNZ_DROME","lcl|NC_088859.1_cds_XP_034314775.2_39405",3.89e-32,134,"Q8MKW7","RNZ_DROME","Ribonuclease Z, mitochondrial (RNase Z) (EC 3.1.26.11) (Juvenile hormone-inducible protein 1) (dRNAse Z) (tRNA 3 endonuclease) (DmeZ) (tRNase Z)","RNaseZ JhI-1 CG3298","Drosophila melanogaster (Fruit fly)",766,"GO:0001558; GO:0005634; GO:0005739; GO:0005829; GO:0006388; GO:0007419; GO:0016891; GO:0030307; GO:0036093; GO:0042645; GO:0042780; GO:0042781; GO:0045727; GO:0046872; GO:0140040; GO:1990180","germ cell proliferation [GO:0036093]; mitochondrial polycistronic RNA processing [GO:0140040]; mitochondrial tRNA 3'-end processing [GO:1990180]; positive regulation of cell growth [GO:0030307]; positive regulation of translation [GO:0045727]; regulation of cell growth [GO:0001558]; tRNA 3'-end processing [GO:0042780]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; ventral cord development [GO:0007419]","cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 3'-tRNA processing endoribonuclease activity [GO:0042781]; metal ion binding [GO:0046872]; RNA endonuclease activity, producing 5'-phosphomonoesters [GO:0016891]; germ cell proliferation [GO:0036093]; mitochondrial polycistronic RNA processing [GO:0140040]; mitochondrial tRNA 3'-end processing [GO:1990180]; positive regulation of cell growth [GO:0030307]; positive regulation of translation [GO:0045727]; regulation of cell growth [GO:0001558]; tRNA 3'-end processing [GO:0042780]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; ventral cord development [GO:0007419]","DEVELOPMENTAL STAGE: Maternally expressed. Highly expressed in ovarian nurse cells and transferred into the nascent oocyte. {ECO:0000269|PubMed:14715923}.","INDUCTION: By juvenile hormone (JH). {ECO:0000269|PubMed:10926782}.","INDUCTION: By juvenile hormone (JH). {ECO:0000269|PubMed:10926782}.",""
"1067","sp|P00528|SRC64_DROME","lcl|NC_088859.1_cds_XP_034314807.1_38840",1.05e-174,504,"P00528","SRC64_DROME","Tyrosine-protein kinase Src64B (Dsrc64) (EC 2.7.10.2)","Src64B Src1 CG7524","Drosophila melanogaster (Fruit fly)",552,"GO:0004715; GO:0005102; GO:0005524; GO:0005829; GO:0005886; GO:0005917; GO:0007169; GO:0007293; GO:0007300; GO:0007301; GO:0007349; GO:0007411; GO:0007424; GO:0007435; GO:0007616; GO:0008064; GO:0008302; GO:0008335; GO:0016319; GO:0030036; GO:0030046; GO:0030154; GO:0030708; GO:0030717; GO:0030723; GO:0034332; GO:0035331; GO:0036058; GO:0036059; GO:0045172; GO:0045742; GO:0045743; GO:0045874; GO:0045886; GO:0048167; GO:0048477; GO:0090136; GO:0120176","actin cytoskeleton organization [GO:0030036]; adherens junction organization [GO:0034332]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellularization [GO:0007349]; epithelial cell-cell adhesion [GO:0090136]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; female germline ring canal stabilization [GO:0008335]; filtration diaphragm assembly [GO:0036058]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; long-term memory [GO:0007616]; mushroom body development [GO:0016319]; negative regulation of hippo signaling [GO:0035331]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; nephrocyte diaphragm assembly [GO:0036059]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian fusome organization [GO:0030723]; ovarian nurse cell to oocyte transport [GO:0007300]; parallel actin filament bundle assembly [GO:0030046]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of sevenless signaling pathway [GO:0045874]; positive regulation of torso signaling pathway [GO:0120176]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]","cytosol [GO:0005829]; germline ring canal [GO:0045172]; nephrocyte diaphragm [GO:0005917]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; adherens junction organization [GO:0034332]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellularization [GO:0007349]; epithelial cell-cell adhesion [GO:0090136]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; female germline ring canal stabilization [GO:0008335]; filtration diaphragm assembly [GO:0036058]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; long-term memory [GO:0007616]; mushroom body development [GO:0016319]; negative regulation of hippo signaling [GO:0035331]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; nephrocyte diaphragm assembly [GO:0036059]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian fusome organization [GO:0030723]; ovarian nurse cell to oocyte transport [GO:0007300]; parallel actin filament bundle assembly [GO:0030046]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of sevenless signaling pathway [GO:0045874]; positive regulation of torso signaling pathway [GO:0120176]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]","DEVELOPMENTAL STAGE: Abundant in embryos and pupae, rare in larvae and adults. {ECO:0000269|PubMed:2996778}.","","","TISSUE SPECIFICITY: After the first 8 hours of development, accumulates almost exclusively in neural tissues such as the brain, ventral nerve chord, and eye-antennal disks, and in differentiating smooth muscle. {ECO:0000269|PubMed:2996778}."
"1068","sp|Q9V463|NU154_DROME","lcl|NC_088859.1_cds_XP_034314876.2_38980",0,734,"Q9V463","NU154_DROME","Nuclear pore complex protein Nup154 (154 kDa nucleoporin) (Nucleoporin Nup154) (Tulipan)","Nup154 Nup155 CG4579","Drosophila melanogaster (Fruit fly)",1365,"GO:0000972; GO:0001555; GO:0001654; GO:0003682; GO:0005634; GO:0005635; GO:0005643; GO:0005694; GO:0005737; GO:0006405; GO:0006606; GO:0007015; GO:0007140; GO:0007281; GO:0007283; GO:0007295; GO:0007300; GO:0017056; GO:0030715; GO:0030717; GO:0031965; GO:0034399; GO:0035220; GO:0036228; GO:0042307; GO:0044611; GO:0045477; GO:0048477; GO:0051028; GO:1900182; GO:1905475; GO:1905879; GO:1905938","actin filament organization [GO:0007015]; eye development [GO:0001654]; germ cell development [GO:0007281]; growth of a germarium-derived egg chamber [GO:0007295]; male meiotic nuclear division [GO:0007140]; mRNA transport [GO:0051028]; oocyte growth [GO:0001555]; oocyte growth in germarium-derived egg chamber [GO:0030715]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of germ cell proliferation [GO:1905938]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to nucleus [GO:1900182]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; regulation of nurse cell apoptotic process [GO:0045477]; regulation of oogenesis [GO:1905879]; regulation of protein localization to membrane [GO:1905475]; RNA export from nucleus [GO:0006405]; spermatogenesis [GO:0007283]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; wing disc development [GO:0035220]","chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; structural constituent of nuclear pore [GO:0017056]; actin filament organization [GO:0007015]; eye development [GO:0001654]; germ cell development [GO:0007281]; growth of a germarium-derived egg chamber [GO:0007295]; male meiotic nuclear division [GO:0007140]; mRNA transport [GO:0051028]; oocyte growth [GO:0001555]; oocyte growth in germarium-derived egg chamber [GO:0030715]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of germ cell proliferation [GO:1905938]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to nucleus [GO:1900182]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; regulation of nurse cell apoptotic process [GO:0045477]; regulation of oogenesis [GO:1905879]; regulation of protein localization to membrane [GO:1905475]; RNA export from nucleus [GO:0006405]; spermatogenesis [GO:0007283]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; wing disc development [GO:0035220]","DEVELOPMENTAL STAGE: Expressed in embryo (at protein level) (PubMed:9732281). Expressed in ovaries; more specifically in the germarium and throughout egg chamber development both in germ line and nurse cells (at protein level) (PubMed:17277377, PubMed:17410542, PubMed:9732281). Expressed in spermatocytes (at protein level) (PubMed:9732281). In embryos, detected during germ-band elongation and in the developing mesoderm (PubMed:10511559). At stage 11, mostly prominent in the central nervous system and gut (PubMed:10511559). By stage 14, detected in the brain and dorsal vessel (PubMed:10511559). At the end of embryogenesis restricted to lymph glands (hematopoietic organ), gonadal germline and specific neurons in the brain (PubMed:10511559). In larvae, detected in the imaginal disks, certain regions of the brain and all tissues containing dividing cells (PubMed:10511559). In larval, detected in testes and in all germline cells up through the meiotic stages (PubMed:10511559). In adult, detected in testes, ovaries in germanium region 2 and throughout later stage of oogenesis (PubMed:10511559). {ECO:0000269|PubMed:10511559, ECO:0000269|PubMed:17277377, ECO:0000269|PubMed:17410542, ECO:0000269|PubMed:9732281}.","","",""
"1069","sp|Q8BIW9|CTF18_MOUSE","lcl|NC_088859.1_cds_XP_034314878.1_38984",6.47e-167,513,"Q8BIW9","CTF18_MOUSE","Chromosome transmission fidelity protein 18 homolog","Chtf18 Ctf18","Mus musculus (Mouse)",969,"GO:0001673; GO:0003677; GO:0005524; GO:0005634; GO:0005737; GO:0006260; GO:0007059; GO:0007131; GO:0007140; GO:0007281; GO:0016887; GO:0031390; GO:0051985; GO:1900264","chromosome segregation [GO:0007059]; DNA replication [GO:0006260]; germ cell development [GO:0007281]; male meiotic nuclear division [GO:0007140]; negative regulation of chromosome segregation [GO:0051985]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; reciprocal meiotic recombination [GO:0007131]","Ctf18 RFC-like complex [GO:0031390]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; chromosome segregation [GO:0007059]; DNA replication [GO:0006260]; germ cell development [GO:0007281]; male meiotic nuclear division [GO:0007140]; negative regulation of chromosome segregation [GO:0051985]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; reciprocal meiotic recombination [GO:0007131]","","","",""
"1070","sp|Q9VWE0|DOME_DROME","lcl|NC_088859.1_cds_XP_034314900.2_39043",3.08e-15,83.2,"Q9VWE0","DOME_DROME","Cytokine receptor (Protein domeless)","dome CG14226","Drosophila melanogaster (Fruit fly)",1282,"GO:0001745; GO:0004896; GO:0005886; GO:0007259; GO:0007298; GO:0007350; GO:0007424; GO:0007442; GO:0007472; GO:0007616; GO:0008284; GO:0016324; GO:0016327; GO:0019221; GO:0042246; GO:0045475; GO:0046982; GO:0050829; GO:0071907; GO:0097677; GO:0097678; GO:1990782","blastoderm segmentation [GO:0007350]; border follicle cell migration [GO:0007298]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; compound eye morphogenesis [GO:0001745]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; determination of digestive tract left/right asymmetry [GO:0071907]; hindgut morphogenesis [GO:0007442]; locomotor rhythm [GO:0045475]; long-term memory [GO:0007616]; open tracheal system development [GO:0007424]; positive regulation of cell population proliferation [GO:0008284]; tissue regeneration [GO:0042246]; wing disc morphogenesis [GO:0007472]","apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; plasma membrane [GO:0005886]; cytokine receptor activity [GO:0004896]; protein heterodimerization activity [GO:0046982]; protein tyrosine kinase binding [GO:1990782]; SOCS family protein binding [GO:0097678]; STAT family protein binding [GO:0097677]; blastoderm segmentation [GO:0007350]; border follicle cell migration [GO:0007298]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; compound eye morphogenesis [GO:0001745]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; determination of digestive tract left/right asymmetry [GO:0071907]; hindgut morphogenesis [GO:0007442]; locomotor rhythm [GO:0045475]; long-term memory [GO:0007616]; open tracheal system development [GO:0007424]; positive regulation of cell population proliferation [GO:0008284]; tissue regeneration [GO:0042246]; wing disc morphogenesis [GO:0007472]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically in embryos. {ECO:0000269|PubMed:11696329}.","","","TISSUE SPECIFICITY: In stage 11 embryos, tracheal pits show highest expression, at stage 14 high expression is detected in the posterior spiracles, gut and head. {ECO:0000269|PubMed:11696329}."
"1071","sp|P29598|UROK_RAT","lcl|NC_088859.1_cds_XP_034315001.2_40293",2.2e-43,159,"P29598","UROK_RAT","Urokinase-type plasminogen activator (U-plasminogen activator) (uPA) (EC 3.4.21.73) [Cleaved into: Urokinase-type plasminogen activator long chain A; Urokinase-type plasminogen activator short chain A; Urokinase-type plasminogen activator chain B]","Plau","Rattus norvegicus (Rat)",432,"GO:0001525; GO:0001666; GO:0004252; GO:0005615; GO:0007283; GO:0007566; GO:0008233; GO:0008284; GO:0009986; GO:0014823; GO:0014909; GO:0014910; GO:0014911; GO:0030155; GO:0030335; GO:0031639; GO:0033628; GO:0035728; GO:0035729; GO:0042127; GO:0042730; GO:0043403; GO:0055093; GO:0071222; GO:0071333; GO:0071456; GO:0071498; GO:0072734; GO:0097180; GO:0098637; GO:1905370; GO:2000097; GO:2000345; GO:2000379","angiogenesis [GO:0001525]; cellular response to fluid shear stress [GO:0071498]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to staurosporine [GO:0072734]; embryo implantation [GO:0007566]; fibrinolysis [GO:0042730]; plasminogen activation [GO:0031639]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of hepatocyte proliferation [GO:2000345]; regulation of smooth muscle cell migration [GO:0014910]; regulation of smooth muscle cell-matrix adhesion [GO:2000097]; response to activity [GO:0014823]; response to hepatocyte growth factor [GO:0035728]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; skeletal muscle tissue regeneration [GO:0043403]; smooth muscle cell migration [GO:0014909]; spermatogenesis [GO:0007283]","cell surface [GO:0009986]; extracellular space [GO:0005615]; protein complex involved in cell-matrix adhesion [GO:0098637]; serine protease inhibitor complex [GO:0097180]; serine-type endopeptidase complex [GO:1905370]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; angiogenesis [GO:0001525]; cellular response to fluid shear stress [GO:0071498]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to staurosporine [GO:0072734]; embryo implantation [GO:0007566]; fibrinolysis [GO:0042730]; plasminogen activation [GO:0031639]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of hepatocyte proliferation [GO:2000345]; regulation of smooth muscle cell migration [GO:0014910]; regulation of smooth muscle cell-matrix adhesion [GO:2000097]; response to activity [GO:0014823]; response to hepatocyte growth factor [GO:0035728]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; skeletal muscle tissue regeneration [GO:0043403]; smooth muscle cell migration [GO:0014909]; spermatogenesis [GO:0007283]","","","",""
"1072","sp|Q04652|KELC_DROME","lcl|NC_088859.1_cds_XP_034315059.1_40377",0,690,"Q04652","KELC_DROME","Ring canal kelch protein [Cleaved into: Kelch short protein]","kel CG7210","Drosophila melanogaster (Fruit fly)",1477,"GO:0003779; GO:0005737; GO:0005856; GO:0007297; GO:0007300; GO:0007301; GO:0007349; GO:0030036; GO:0030717; GO:0030723; GO:0031463; GO:0035183; GO:0035324; GO:0043161; GO:0045172; GO:0048477; GO:1990756","actin cytoskeleton organization [GO:0030036]; cellularization [GO:0007349]; female germline ring canal formation [GO:0007301]; follicle cell of egg chamber migration [GO:0007297]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; ovarian nurse cell to oocyte transport [GO:0007300]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]","Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; germline ring canal [GO:0045172]; actin binding [GO:0003779]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; actin cytoskeleton organization [GO:0030036]; cellularization [GO:0007349]; female germline ring canal formation [GO:0007301]; follicle cell of egg chamber migration [GO:0007297]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; ovarian nurse cell to oocyte transport [GO:0007300]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]","DEVELOPMENTAL STAGE: Larvae, pupae and adults. {ECO:0000269|PubMed:9118811}.","","","TISSUE SPECIFICITY: Both proteins are expressed in ovaries, male testis, ovariectomized females, cuticle, salivary gland and imaginal disks. Kelch short protein is the predominant form and is also expressed in fat bodies. On entry into metamorphosis levels of full-length protein increase in testis and imaginal disks. {ECO:0000269|PubMed:9118811}."
"1073","sp|Q6AYJ3|SPA6L_RAT","lcl|NC_088859.1_cds_XP_034315099.1_40452",2.01e-29,121,"Q6AYJ3","SPA6L_RAT","Spermatogenesis associated 6-like protein","Spata6l","Rattus norvegicus (Rat)",398,"GO:0007283; GO:0032027; GO:0120212","spermatogenesis [GO:0007283]","sperm head-tail coupling apparatus [GO:0120212]; myosin light chain binding [GO:0032027]; spermatogenesis [GO:0007283]","","","",""
"1074","sp|Q3U6K5|SPAT6_MOUSE","lcl|NC_088859.1_cds_XP_034315101.1_40450",1.53e-28,119,"Q3U6K5","SPAT6_MOUSE","Spermatogenesis-associated protein 6 (Kinesin-related protein)","Spata6 Hash","Mus musculus (Mouse)",488,"GO:0005576; GO:0007283; GO:0030154; GO:0031514; GO:0032027; GO:0044458; GO:0120212","cell differentiation [GO:0030154]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283]","extracellular region [GO:0005576]; motile cilium [GO:0031514]; sperm head-tail coupling apparatus [GO:0120212]; myosin light chain binding [GO:0032027]; cell differentiation [GO:0030154]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Weak expression of isoform 1 is seen throughout testicular development. Isoform 2 and isoform 3 could not be detected until postnatal day 15. Expressed from postnatal day 20, and thereafter increased. Expressed in blastocysts and in embryos from 8.5 dpc-12.5 dpc. After 13.5 dpc, the level of expression decreases. Expressed at 9.5-10.5 dpc in the neural tube, in somites and limb buds. {ECO:0000269|PubMed:12771232}.","","","TISSUE SPECIFICITY: Specifically expressed in developing spermatids and mature spermatozoa (at protein level) (PubMed:25605924). Isoform 1 is weakly expressed in testis, ovary, thymus and placenta. Isoform 2 and isoform 3 are testis-specific. Expression isw higher in spermatids than in spermatocytes and spermatogonia (PubMed:12771232). {ECO:0000269|PubMed:12771232, ECO:0000269|PubMed:25605924}."
"1075","sp|Q108U0|CFTR_LOXAF","lcl|NC_088859.1_cds_XP_065921175.1_36861",1.67e-152,505,"Q108U0","CFTR_LOXAF","Cystic fibrosis transmembrane conductance regulator (CFTR) (ATP-binding cassette sub-family C member 7) (Channel conductance-controlling ATPase) (EC 5.6.1.6) (cAMP-dependent chloride channel)","CFTR ABCC7","Loxodonta africana (African elephant)",1482,"GO:0005254; GO:0005260; GO:0005524; GO:0005634; GO:0005769; GO:0005789; GO:0005829; GO:0005886; GO:0015106; GO:0015108; GO:0015701; GO:0016020; GO:0016324; GO:0016887; GO:0019869; GO:0031901; GO:0034707; GO:0034976; GO:0035377; GO:0048240; GO:0050891; GO:0051454; GO:0055038; GO:0060081; GO:0071320; GO:0140359; GO:1902476; GO:1904322","bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; chloride transmembrane transport [GO:1902476]; intracellular pH elevation [GO:0051454]; membrane hyperpolarization [GO:0060081]; multicellular organismal-level water homeostasis [GO:0050891]; response to endoplasmic reticulum stress [GO:0034976]; sperm capacitation [GO:0048240]; transepithelial water transport [GO:0035377]","apical plasma membrane [GO:0016324]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride channel inhibitor activity [GO:0019869]; chloride transmembrane transporter activity [GO:0015108]; intracellularly ATP-gated chloride channel activity [GO:0005260]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; chloride transmembrane transport [GO:1902476]; intracellular pH elevation [GO:0051454]; membrane hyperpolarization [GO:0060081]; multicellular organismal-level water homeostasis [GO:0050891]; response to endoplasmic reticulum stress [GO:0034976]; sperm capacitation [GO:0048240]; transepithelial water transport [GO:0035377]","","","",""
"1076","sp|P56079|CDS_DROME","lcl|NC_088859.1_cds_XP_065921203.1_36854",0,513,"P56079","CDS_DROME","Phosphatidate cytidylyltransferase, photoreceptor-specific (EC 2.7.7.41) (CDP-DAG synthase) (CDP-DG synthase) (CDP-diacylglycerol synthase) (CDS) (CDP-diglyceride pyrophosphorylase) (CDP-diglyceride synthase) (CTP:phosphatidate cytidylyltransferase)","Cds CdsA CG7962","Drosophila melanogaster (Fruit fly)",447,"GO:0004605; GO:0005789; GO:0007291; GO:0007430; GO:0007601; GO:0007602; GO:0008610; GO:0010513; GO:0010868; GO:0010883; GO:0016024; GO:0016056; GO:0043052","CDP-diacylglycerol biosynthetic process [GO:0016024]; G protein-coupled opsin signaling pathway [GO:0016056]; lipid biosynthetic process [GO:0008610]; negative regulation of triglyceride biosynthetic process [GO:0010868]; phototransduction [GO:0007602]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; regulation of lipid storage [GO:0010883]; sperm individualization [GO:0007291]; terminal branching, open tracheal system [GO:0007430]; thermotaxis [GO:0043052]; visual perception [GO:0007601]","endoplasmic reticulum membrane [GO:0005789]; phosphatidate cytidylyltransferase activity [GO:0004605]; CDP-diacylglycerol biosynthetic process [GO:0016024]; G protein-coupled opsin signaling pathway [GO:0016056]; lipid biosynthetic process [GO:0008610]; negative regulation of triglyceride biosynthetic process [GO:0010868]; phototransduction [GO:0007602]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; regulation of lipid storage [GO:0010883]; sperm individualization [GO:0007291]; terminal branching, open tracheal system [GO:0007430]; thermotaxis [GO:0043052]; visual perception [GO:0007601]","DEVELOPMENTAL STAGE: In 3rd instar larvae, expressed in various tissues including the brain, salivary glands, fat body, proventriculus, hind gut, muscle, Malpighian tubules and tracheal tubes. Relatively low levels of expression in the brain compared to expression levels in the salivary gland, fat body and gut. {ECO:0000269|PubMed:24603715}.","","","TISSUE SPECIFICITY: Retina. Localized to the photoreceptor neurons, both in the compound eyes and ocelli."
"1077","sp|Q24192|RHOL_DROME","lcl|NC_088859.1_cds_XP_065921214.1_37310",3.81e-67,204,"Q24192","RHOL_DROME","Ras-like GTP-binding protein RhoL","RhoL Drac3 CG9366","Drosophila melanogaster (Fruit fly)",190,"GO:0003924; GO:0005525; GO:0005856; GO:0005886; GO:0007015; GO:0007163; GO:0007298; GO:0007498; GO:0007516; GO:0008045; GO:0008360; GO:0016601; GO:0019901; GO:0022409; GO:0030031; GO:0030865; GO:0031410; GO:0032956; GO:0035011; GO:0035099; GO:0042995; GO:0060326","actin filament organization [GO:0007015]; border follicle cell migration [GO:0007298]; cell chemotaxis [GO:0060326]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; hemocyte development [GO:0007516]; hemocyte migration [GO:0035099]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; motor neuron axon guidance [GO:0008045]; positive regulation of cell-cell adhesion [GO:0022409]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]","cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin filament organization [GO:0007015]; border follicle cell migration [GO:0007298]; cell chemotaxis [GO:0060326]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; hemocyte development [GO:0007516]; hemocyte migration [GO:0035099]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; motor neuron axon guidance [GO:0008045]; positive regulation of cell-cell adhesion [GO:0022409]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]","DEVELOPMENTAL STAGE: Expressed at all stages of development. {ECO:0000269|PubMed:8636236}.","","","TISSUE SPECIFICITY: Highly expressed in the embryonic cephalic mesoderm starting from stage 6 and fading by stage 11. Hemocyte precursor cells. {ECO:0000269|PubMed:9197407}."
"1078","sp|O70608|SYCP2_RAT","lcl|NC_088859.1_cds_XP_065921493.1_37877",1.97e-28,126,"O70608","SYCP2_RAT","Synaptonemal complex protein 2 (SCP-2) (Synaptonemal complex lateral element protein) (rnSCP2)","Sycp2 Scp2","Rattus norvegicus (Rat)",1505,"GO:0000779; GO:0000795; GO:0000800; GO:0003677; GO:0006915; GO:0007140; GO:0007143; GO:0009566; GO:0009887; GO:0035234; GO:0043066; GO:0048808; GO:0051093; GO:0051301; GO:2000242","animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; cell division [GO:0051301]; ectopic germ cell programmed cell death [GO:0035234]; female meiotic nuclear division [GO:0007143]; fertilization [GO:0009566]; male genitalia morphogenesis [GO:0048808]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of reproductive process [GO:2000242]","condensed chromosome, centromeric region [GO:0000779]; lateral element [GO:0000800]; synaptonemal complex [GO:0000795]; DNA binding [GO:0003677]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; cell division [GO:0051301]; ectopic germ cell programmed cell death [GO:0035234]; female meiotic nuclear division [GO:0007143]; fertilization [GO:0009566]; male genitalia morphogenesis [GO:0048808]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of reproductive process [GO:2000242]","DEVELOPMENTAL STAGE: Meiosis-specific. Highly expressed in meiotic prophase cells, low expression persists in spermatids. {ECO:0000269|PubMed:9592139}.","","","TISSUE SPECIFICITY: Detected in spermatocytes and testis (at protein level) (PubMed:9592139, PubMed:9933407). Spermatocytes and oocytes. Meiotic prophase cells. {ECO:0000269|PubMed:9592139, ECO:0000269|PubMed:9933407}."
"1079","sp|Q9CUU3|SYCP2_MOUSE","lcl|NC_088859.1_cds_XP_065921494.1_37873",6.3e-29,128,"Q9CUU3","SYCP2_MOUSE","Synaptonemal complex protein 2 (SCP-2) (Synaptonemal complex lateral element protein)","Sycp2 Scp2","Mus musculus (Mouse)",1500,"GO:0000795; GO:0000800; GO:0003677; GO:0005654; GO:0006915; GO:0007140; GO:0007143; GO:0009566; GO:0009887; GO:0035234; GO:0043066; GO:0048808; GO:0051093; GO:0051301; GO:2000242","animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; cell division [GO:0051301]; ectopic germ cell programmed cell death [GO:0035234]; female meiotic nuclear division [GO:0007143]; fertilization [GO:0009566]; male genitalia morphogenesis [GO:0048808]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of reproductive process [GO:2000242]","lateral element [GO:0000800]; nucleoplasm [GO:0005654]; synaptonemal complex [GO:0000795]; DNA binding [GO:0003677]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; cell division [GO:0051301]; ectopic germ cell programmed cell death [GO:0035234]; female meiotic nuclear division [GO:0007143]; fertilization [GO:0009566]; male genitalia morphogenesis [GO:0048808]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of reproductive process [GO:2000242]","","","","TISSUE SPECIFICITY: Detected in testis and spermatocytes (at protein level). {ECO:0000269|PubMed:16717126}."
"1080","sp|Q9BX26|SYCP2_HUMAN","lcl|NC_088859.1_cds_XP_065921497.1_37879",5.44e-28,125,"Q9BX26","SYCP2_HUMAN","Synaptonemal complex protein 2 (SCP-2) (Synaptonemal complex lateral element protein) (hsSCP2)","SYCP2 SCP2","Homo sapiens (Human)",1530,"GO:0000779; GO:0000795; GO:0000800; GO:0003677; GO:0005634; GO:0006915; GO:0007130; GO:0007140; GO:0007143; GO:0009566; GO:0035234; GO:0043066; GO:0048808; GO:0051093; GO:0051301; GO:2000242","apoptotic process [GO:0006915]; cell division [GO:0051301]; ectopic germ cell programmed cell death [GO:0035234]; female meiotic nuclear division [GO:0007143]; fertilization [GO:0009566]; male genitalia morphogenesis [GO:0048808]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of reproductive process [GO:2000242]; synaptonemal complex assembly [GO:0007130]","condensed chromosome, centromeric region [GO:0000779]; lateral element [GO:0000800]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; DNA binding [GO:0003677]; apoptotic process [GO:0006915]; cell division [GO:0051301]; ectopic germ cell programmed cell death [GO:0035234]; female meiotic nuclear division [GO:0007143]; fertilization [GO:0009566]; male genitalia morphogenesis [GO:0048808]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of reproductive process [GO:2000242]; synaptonemal complex assembly [GO:0007130]","","","",""
"1081","sp|P70600|FAK2_RAT","lcl|NC_088859.1_cds_XP_065921504.1_37852",0,603,"P70600","FAK2_RAT","Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2)","Ptk2b Fak2 Pyk2","Rattus norvegicus (Rat)",1009,"GO:0000165; GO:0000302; GO:0001525; GO:0001556; GO:0001666; GO:0001954; GO:0002040; GO:0002250; GO:0002315; GO:0002931; GO:0004672; GO:0004683; GO:0004715; GO:0005524; GO:0005634; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0006968; GO:0007015; GO:0007155; GO:0007166; GO:0007172; GO:0007173; GO:0007204; GO:0007229; GO:0008284; GO:0008285; GO:0008360; GO:0009410; GO:0009612; GO:0009725; GO:0009749; GO:0010595; GO:0010656; GO:0010758; GO:0010976; GO:0014009; GO:0014069; GO:0017146; GO:0019899; GO:0030027; GO:0030154; GO:0030155; GO:0030279; GO:0030307; GO:0030335; GO:0030424; GO:0030425; GO:0030426; GO:0030502; GO:0030546; GO:0030838; GO:0030865; GO:0031175; GO:0031625; GO:0032956; GO:0033209; GO:0035235; GO:0035254; GO:0035255; GO:0035902; GO:0042220; GO:0042542; GO:0042995; GO:0043025; GO:0043066; GO:0043149; GO:0043157; GO:0043267; GO:0043423; GO:0043524; GO:0043534; GO:0044297; GO:0044877; GO:0045429; GO:0045453; GO:0045471; GO:0045638; GO:0045727; GO:0045766; GO:0045860; GO:0046330; GO:0048010; GO:0048041; GO:0048471; GO:0051247; GO:0051279; GO:0051591; GO:0051592; GO:0051897; GO:0051968; GO:0060291; GO:0060292; GO:0070098; GO:0070374; GO:0071300; GO:0071498; GO:0086100; GO:0097440; GO:0098685; GO:0098793; GO:0098794; GO:0098978; GO:0099092; GO:0099151; GO:0099170; GO:0099602; GO:2000058; GO:2000060; GO:2000379; GO:2000463; GO:2000538; GO:2000573","actin filament organization [GO:0007015]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; cellular defense response [GO:0006968]; cellular response to fluid shear stress [GO:0071498]; cellular response to retinoic acid [GO:0071300]; chemokine-mediated signaling pathway [GO:0070098]; cortical cytoskeleton organization [GO:0030865]; endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; focal adhesion assembly [GO:0048041]; glial cell proliferation [GO:0014009]; integrin-mediated signaling pathway [GO:0007229]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of ossification [GO:0030279]; negative regulation of potassium ion transport [GO:0043267]; neuron projection development [GO:0031175]; oocyte maturation [GO:0001556]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell chemotaxis [GO:2000538]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neuron projection development [GO:0010976]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of translation [GO:0045727]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell adhesion [GO:0030155]; regulation of cell shape [GO:0008360]; regulation of macrophage chemotaxis [GO:0010758]; regulation of postsynaptic density assembly [GO:0099151]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to calcium ion [GO:0051592]; response to cAMP [GO:0051591]; response to cation stress [GO:0043157]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to hormone [GO:0009725]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to ischemia [GO:0002931]; response to mechanical stimulus [GO:0009612]; response to reactive oxygen species [GO:0000302]; response to xenobiotic stimulus [GO:0009410]; signal complex assembly [GO:0007172]; sprouting angiogenesis [GO:0002040]; stress fiber assembly [GO:0043149]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","apical dendrite [GO:0097440]; axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; NMDA selective glutamate receptor complex [GO:0017146]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; 3-phosphoinositide-dependent protein kinase binding [GO:0043423]; ATP binding [GO:0005524]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; enzyme binding [GO:0019899]; glutamate receptor binding [GO:0035254]; ionotropic glutamate receptor binding [GO:0035255]; neurotransmitter receptor regulator activity [GO:0099602]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein-containing complex binding [GO:0044877]; signaling receptor activator activity [GO:0030546]; ubiquitin protein ligase binding [GO:0031625]; actin filament organization [GO:0007015]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; cellular defense response [GO:0006968]; cellular response to fluid shear stress [GO:0071498]; cellular response to retinoic acid [GO:0071300]; chemokine-mediated signaling pathway [GO:0070098]; cortical cytoskeleton organization [GO:0030865]; endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; focal adhesion assembly [GO:0048041]; glial cell proliferation [GO:0014009]; integrin-mediated signaling pathway [GO:0007229]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of ossification [GO:0030279]; negative regulation of potassium ion transport [GO:0043267]; neuron projection development [GO:0031175]; oocyte maturation [GO:0001556]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell chemotaxis [GO:2000538]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neuron projection development [GO:0010976]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of translation [GO:0045727]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell adhesion [GO:0030155]; regulation of cell shape [GO:0008360]; regulation of macrophage chemotaxis [GO:0010758]; regulation of postsynaptic density assembly [GO:0099151]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to calcium ion [GO:0051592]; response to cAMP [GO:0051591]; response to cation stress [GO:0043157]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to hormone [GO:0009725]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to ischemia [GO:0002931]; response to mechanical stimulus [GO:0009612]; response to reactive oxygen species [GO:0000302]; response to xenobiotic stimulus [GO:0009410]; signal complex assembly [GO:0007172]; sprouting angiogenesis [GO:0002040]; stress fiber assembly [GO:0043149]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","","","","TISSUE SPECIFICITY: Highly expressed in pulmonary vein endothelial cells, lung and brain (at protein level). Isoform 1 is expressed at high levels in the brain (hippocampus, cerebral cortex and olfactory bulb) and poorly in the spleen and other tissues, whereas isoforms 2 and 3 are expressed in the spleen and brain (highest in cerebellum). {ECO:0000269|PubMed:11739395}."
"1082","sp|Q8CG03|PDE5A_MOUSE","lcl|NC_088859.1_cds_XP_065921518.1_39040",0,765,"Q8CG03","PDE5A_MOUSE","cGMP-specific 3',5'-cyclic phosphodiesterase (EC 3.1.4.35) (cGMP-binding cGMP-specific phosphodiesterase) (CGB-PDE)","Pde5a Pde5","Mus musculus (Mouse)",865,"GO:0004112; GO:0004114; GO:0007165; GO:0010613; GO:0010749; GO:0030553; GO:0042098; GO:0042130; GO:0045745; GO:0046068; GO:0046069; GO:0046872; GO:0047555; GO:0048599; GO:0055118; GO:0055119; GO:0060282","cGMP catabolic process [GO:0046069]; cGMP metabolic process [GO:0046068]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of T cell proliferation [GO:0042130]; oocyte development [GO:0048599]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of oocyte development [GO:0060282]; regulation of nitric oxide mediated signal transduction [GO:0010749]; relaxation of cardiac muscle [GO:0055119]; signal transduction [GO:0007165]; T cell proliferation [GO:0042098]","3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]; cGMP catabolic process [GO:0046069]; cGMP metabolic process [GO:0046068]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of T cell proliferation [GO:0042130]; oocyte development [GO:0048599]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of oocyte development [GO:0060282]; regulation of nitric oxide mediated signal transduction [GO:0010749]; relaxation of cardiac muscle [GO:0055119]; signal transduction [GO:0007165]; T cell proliferation [GO:0042098]","","","",""
"1083","sp|Q8MIT6|ROCK1_BOVIN","lcl|NC_088859.1_cds_XP_065921523.1_34184",1.37e-49,182,"Q8MIT6","ROCK1_BOVIN","Rho-associated protein kinase 1 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p160 ROCK-1) (p160ROCK)","ROCK1","Bos taurus (Bovine)",441,"GO:0000139; GO:0000281; GO:0001726; GO:0004674; GO:0005524; GO:0005737; GO:0005814; GO:0005856; GO:0005886; GO:0007266; GO:0010494; GO:0030027; GO:0030036; GO:0030334; GO:0030866; GO:0031032; GO:0031267; GO:0032059; GO:0032956; GO:0040038; GO:0048598; GO:0051451; GO:0051894; GO:0070507; GO:0072518; GO:0090521; GO:0106310; GO:1901888; GO:1903431","actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; mitotic cytokinesis [GO:0000281]; myoblast migration [GO:0051451]; podocyte cell migration [GO:0090521]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of cell maturation [GO:1903431]; positive regulation of focal adhesion assembly [GO:0051894]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell junction assembly [GO:1901888]; regulation of cell migration [GO:0030334]; regulation of microtubule cytoskeleton organization [GO:0070507]; Rho protein signal transduction [GO:0007266]","bleb [GO:0032059]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; mitotic cytokinesis [GO:0000281]; myoblast migration [GO:0051451]; podocyte cell migration [GO:0090521]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of cell maturation [GO:1903431]; positive regulation of focal adhesion assembly [GO:0051894]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell junction assembly [GO:1901888]; regulation of cell migration [GO:0030334]; regulation of microtubule cytoskeleton organization [GO:0070507]; Rho protein signal transduction [GO:0007266]","","","",""
"1084","sp|P92199|ROCK_CAEEL","lcl|NC_088859.1_cds_XP_065921524.1_34183",3.08e-172,546,"P92199","ROCK_CAEEL","Rho-associated protein kinase let-502 (EC 2.7.11.1) (Lethal protein 502) (Rho-binding kinase let-502)","let-502 C10H11.9","Caenorhabditis elegans",1173,"GO:0000281; GO:0002119; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0005912; GO:0007266; GO:0008270; GO:0008360; GO:0009792; GO:0010172; GO:0030866; GO:0031032; GO:0031267; GO:0032154; GO:0032956; GO:0043292; GO:0048477; GO:0048598; GO:0072518; GO:0106310; GO:0160094; GO:1901888; GO:1905905","actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic body morphogenesis [GO:0010172]; embryonic morphogenesis [GO:0048598]; mitotic cytokinesis [GO:0000281]; nematode larval development [GO:0002119]; nematode pharyngeal gland morphogenesis [GO:1905905]; nematode pharynx development [GO:0160094]; oogenesis [GO:0048477]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell junction assembly [GO:1901888]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]","adherens junction [GO:0005912]; cleavage furrow [GO:0032154]; contractile muscle fiber [GO:0043292]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]; actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic body morphogenesis [GO:0010172]; embryonic morphogenesis [GO:0048598]; mitotic cytokinesis [GO:0000281]; nematode larval development [GO:0002119]; nematode pharyngeal gland morphogenesis [GO:1905905]; nematode pharynx development [GO:0160094]; oogenesis [GO:0048477]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell junction assembly [GO:1901888]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]","","","","TISSUE SPECIFICITY: Expressed in the lateral hypodermal seam cells at the onset of the elongation phase of morphogenesis (at protein level). {ECO:0000269|PubMed:9042856}."
"1085","sp|A9CPT4|TDRD1_ORYLA","lcl|NC_088859.1_cds_XP_065921555.1_34500",6.26e-48,189,"A9CPT4","TDRD1_ORYLA","Tudor domain-containing protein 1","tdrd1","Oryzias latipes (Japanese rice fish) (Japanese killifish)",1133,"GO:0007281; GO:0007283; GO:0008270; GO:0030719; GO:0034587; GO:0043186; GO:0051321; GO:0071546; GO:0141196","germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]","P granule [GO:0043186]; pi-body [GO:0071546]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]","","","","TISSUE SPECIFICITY: Expressed in both the ovary and testis in the adult. Present in migrating primordial germ cells (PGCs) and also in the germ cells in both the gonadal primordia (stage 33), and in the developing ovary and testis. {ECO:0000269|PubMed:18224712}."
"1086","sp|Q58EK5|TDRD1_DANRE","lcl|NC_088859.1_cds_XP_065921556.1_34499",2.71e-49,194,"Q58EK5","TDRD1_DANRE","Tudor domain-containing protein 1","tdrd1 im:7155161","Danio rerio (Zebrafish) (Brachydanio rerio)",1175,"GO:0005737; GO:0007281; GO:0007283; GO:0008270; GO:0030719; GO:0034584; GO:0034587; GO:0043186; GO:0051321; GO:0071546; GO:0141196","germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]","cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546]; piRNA binding [GO:0034584]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]","","","",""
"1087","sp|Q14565|DMC1_HUMAN","lcl|NC_088859.1_cds_XP_065921587.1_39022",0,599,"Q14565","DMC1_HUMAN","Meiotic recombination protein DMC1/LIM15 homolog","DMC1 DMC1H LIM15","Homo sapiens (Human)",340,"GO:0000150; GO:0000730; GO:0000781; GO:0000794; GO:0000800; GO:0001541; GO:0001556; GO:0003677; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0006312; GO:0007129; GO:0007131; GO:0007141; GO:0007283; GO:0007286; GO:0007292; GO:0008094; GO:0016887; GO:0035861; GO:0042148; GO:0042802; GO:0051321; GO:0070192; GO:0140664; GO:1990918","chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; DNA strand invasion [GO:0042148]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; oocyte maturation [GO:0001556]; ovarian follicle development [GO:0001541]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; lateral element [GO:0000800]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; DNA strand exchange activity [GO:0000150]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; DNA strand invasion [GO:0042148]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; oocyte maturation [GO:0001556]; ovarian follicle development [GO:0001541]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","","","",""
"1088","sp|O16466|ATG18_CAEEL","lcl|NC_088859.1_cds_XP_065921631.1_37449",3.62e-101,310,"O16466","ATG18_CAEEL","Autophagy-related protein 18","atg-18 atgr-18 tag-283 F41E6.13","Caenorhabditis elegans",412,"GO:0000422; GO:0000425; GO:0001778; GO:0005737; GO:0005829; GO:0006914; GO:0008340; GO:0009792; GO:0010314; GO:0010508; GO:0012501; GO:0030163; GO:0030670; GO:0030674; GO:0032266; GO:0034045; GO:0034497; GO:0036093; GO:0040024; GO:0042078; GO:0043277; GO:0044804; GO:0045335; GO:0048598; GO:0061723; GO:0070273; GO:0080025; GO:0097237; GO:0098792","apoptotic cell clearance [GO:0043277]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cellular response to toxic substance [GO:0097237]; dauer larval development [GO:0040024]; determination of adult lifespan [GO:0008340]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic morphogenesis [GO:0048598]; germ cell proliferation [GO:0036093]; germ-line stem cell division [GO:0042078]; glycophagy [GO:0061723]; nucleophagy [GO:0044804]; pexophagy [GO:0000425]; plasma membrane repair [GO:0001778]; positive regulation of autophagy [GO:0010508]; programmed cell death [GO:0012501]; protein catabolic process [GO:0030163]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protein-macromolecule adaptor activity [GO:0030674]; apoptotic cell clearance [GO:0043277]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cellular response to toxic substance [GO:0097237]; dauer larval development [GO:0040024]; determination of adult lifespan [GO:0008340]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic morphogenesis [GO:0048598]; germ cell proliferation [GO:0036093]; germ-line stem cell division [GO:0042078]; glycophagy [GO:0061723]; nucleophagy [GO:0044804]; pexophagy [GO:0000425]; plasma membrane repair [GO:0001778]; positive regulation of autophagy [GO:0010508]; programmed cell death [GO:0012501]; protein catabolic process [GO:0030163]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792]","","","","TISSUE SPECIFICITY: Expressed in neurons and intestinal cells. {ECO:0000269|PubMed:28557996}."
"1089","sp|Q24342|FNG_DROME","lcl|NC_088859.1_cds_XP_065921710.1_36372",7.05e-100,303,"Q24342","FNG_DROME","Fringe glycosyltransferase (EC 2.4.1.222) (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase)","fng CG10580","Drosophila melanogaster (Fruit fly)",412,"GO:0000139; GO:0001745; GO:0005737; GO:0005795; GO:0005797; GO:0006486; GO:0007293; GO:0007450; GO:0007476; GO:0007480; GO:0008587; GO:0008593; GO:0030707; GO:0033829; GO:0035017; GO:0036011; GO:0036099; GO:0045746; GO:0045747; GO:0046872; GO:0048100; GO:0048190; GO:0048749","compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; cuticle pattern formation [GO:0035017]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; germarium-derived egg chamber formation [GO:0007293]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; regulation of Notch signaling pathway [GO:0008593]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc dorsal/ventral pattern formation [GO:0048190]","cytoplasm [GO:0005737]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; metal ion binding [GO:0046872]; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity [GO:0033829]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; cuticle pattern formation [GO:0035017]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; germarium-derived egg chamber formation [GO:0007293]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; regulation of Notch signaling pathway [GO:0008593]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc dorsal/ventral pattern formation [GO:0048190]","","","","TISSUE SPECIFICITY: Expressed in dorsal cells."
"1090","sp|Q8NI77|KI18A_HUMAN","lcl|NC_088859.1_cds_XP_065921769.1_37382",4.35e-98,329,"Q8NI77","KI18A_HUMAN","Kinesin-like protein KIF18A (Marrow stromal KIF18A) (MS-KIF18A)","KIF18A OK/SW-cl.108","Homo sapiens (Human)",898,"GO:0000070; GO:0000776; GO:0001726; GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005828; GO:0005829; GO:0005871; GO:0005901; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0071392; GO:0072520; GO:1990023","cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; seminiferous tubule development [GO:0072520]","caveola [GO:0005901]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule cytoskeleton [GO:0015630]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; plus-end-directed microtubule motor activity [GO:0008574]; tubulin-dependent ATPase activity [GO:0070463]; cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; seminiferous tubule development [GO:0072520]","","INDUCTION: By estrogen. {ECO:0000269|PubMed:19636373}.","INDUCTION: By estrogen. {ECO:0000269|PubMed:19636373}.",""
"1091","sp|Q9VFX1|WNT8_DROME","lcl|NC_088859.1_cds_XP_065921831.1_37973",2.14e-34,129,"Q9VFX1","WNT8_DROME","Wnt inhibitor of Dorsal protein (Protein Wnt-8) (dWnt-8)","wntD Wnt8 CG8458","Drosophila melanogaster (Fruit fly)",309,"GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0007370; GO:0008354; GO:0030182; GO:0031012; GO:0035567; GO:0045165; GO:0045995; GO:0050830; GO:0060070","canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; defense response to Gram-positive bacterium [GO:0050830]; germ cell migration [GO:0008354]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; regulation of embryonic development [GO:0045995]; ventral furrow formation [GO:0007370]","extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; defense response to Gram-positive bacterium [GO:0050830]; germ cell migration [GO:0008354]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; regulation of embryonic development [GO:0045995]; ventral furrow formation [GO:0007370]","","","",""
"1092","sp|P20794|MAK_HUMAN","lcl|NC_088859.1_cds_XP_065921977.1_38575",0,533,"P20794","MAK_HUMAN","Serine/threonine-protein kinase MAK (EC 2.7.11.1) (Male germ cell-associated kinase)","MAK","Homo sapiens (Human)",623,"GO:0001750; GO:0001917; GO:0003713; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005929; GO:0005930; GO:0006468; GO:0007283; GO:0030154; GO:0030496; GO:0031514; GO:0032391; GO:0035556; GO:0036064; GO:0042073; GO:0045494; GO:0046777; GO:0046872; GO:0060271; GO:0072686; GO:0106310; GO:1902856; GO:1905515","cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary transport [GO:0042073]; negative regulation of non-motile cilium assembly [GO:1902856]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]","axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; motile cilium [GO:0031514]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary transport [GO:0042073]; negative regulation of non-motile cilium assembly [GO:1902856]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]","","INDUCTION: Up-regulated by dihydrotestosterone (DHT) in androgen-sensitive LNCaP prostate cancer cells in a dose-dependent manner. Up-regulation by DHT is transient, reaching maximum levels after 24 hours and decreases slightly after 48 hours. {ECO:0000269|PubMed:12084720}.","INDUCTION: Up-regulated by dihydrotestosterone (DHT) in androgen-sensitive LNCaP prostate cancer cells in a dose-dependent manner. Up-regulation by DHT is transient, reaching maximum levels after 24 hours and decreases slightly after 48 hours. {ECO:0000269|PubMed:12084720}.","TISSUE SPECIFICITY: Expressed in prostate cancer cell lines at generally higher levels than in normal prostate epithelial cell lines. Isoform 1 is expressed in kidney, testis, lung, trachea, and retina. Isoform 2 is retina-specific where it is expressed in rod and cone photoreceptors. {ECO:0000269|PubMed:12084720, ECO:0000269|PubMed:21825139}."
"1093","sp|P05661|MYSA_DROME","lcl|NC_088859.1_cds_XP_065922032.1_39458",0,1951,"P05661","MYSA_DROME","Myosin heavy chain, muscle","Mhc CG17927","Drosophila melanogaster (Fruit fly)",1962,"GO:0000146; GO:0005516; GO:0005524; GO:0005703; GO:0005737; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016460; GO:0030017; GO:0030239; GO:0031033; GO:0031672; GO:0032982; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689","adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]","A band [GO:0031672]; cytoplasm [GO:0005737]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]","","","","TISSUE SPECIFICITY: Expressed in larval and adult muscles. Isoforms containing exon 9a are expressed in indirect flight muscles, exons 9a and 9b are expressed in jump muscles, exons 9b and 9c are expressed in other larval and adult muscles. {ECO:0000269|PubMed:2116987}."
"1094","sp|Q9SFU0|SC24A_ARATH","lcl|NC_088859.1_cds_XP_065922037.1_39471",3.13e-146,472,"Q9SFU0","SC24A_ARATH","Protein transport protein SEC24 A (AtSec24A) (Protein G92/ENDOPLASMIC RETICULUM MORPHOLOGY 2)","SEC24A ERMO2 At3g07100 T1B9.25","Arabidopsis thaliana (Mouse-ear cress)",1038,"GO:0000139; GO:0005789; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0007029; GO:0007030; GO:0008270; GO:0008361; GO:0009555; GO:0030127; GO:0032876; GO:0046740; GO:0048232; GO:0080119; GO:0090392","endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; ER body organization [GO:0080119]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; male gamete generation [GO:0048232]; negative regulation of DNA endoreduplication [GO:0032876]; pollen development [GO:0009555]; regulation of cell size [GO:0008361]; sepal giant cell differentiation [GO:0090392]; transport of virus in host, cell to cell [GO:0046740]","COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; zinc ion binding [GO:0008270]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; ER body organization [GO:0080119]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; male gamete generation [GO:0048232]; negative regulation of DNA endoreduplication [GO:0032876]; pollen development [GO:0009555]; regulation of cell size [GO:0008361]; sepal giant cell differentiation [GO:0090392]; transport of virus in host, cell to cell [GO:0046740]","DEVELOPMENTAL STAGE: During pollen development, mainly expressed in uninucleate microspores (UNMS) and bicellular pollen (BICP), and fades out after the immature tricellular pollen (TRCP) stage (PubMed:21705385). Mostly observed in rapidly growing tissues through all developmental stages, such as shoot apices, distal root regions, and developing sepals (PubMed:25315606). {ECO:0000269|PubMed:21705385, ECO:0000269|PubMed:25315606}.","","","TISSUE SPECIFICITY: Mainly expressed in pollen, leaves, inflorescences, roots and stems, and, to a lower extent, in cotyledons, petioles and hypocotyls. {ECO:0000269|PubMed:21705385, ECO:0000269|PubMed:25315606}."
"1095","sp|P16621|LAR_DROME","lcl|NC_088859.1_cds_XP_065922049.1_35686",0,1664,"P16621","LAR_DROME","Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR)","Lar CG10443","Drosophila melanogaster (Fruit fly)",2029,"GO:0004725; GO:0005001; GO:0005158; GO:0005925; GO:0007155; GO:0007165; GO:0007283; GO:0007399; GO:0007411; GO:0007412; GO:0008045; GO:0008201; GO:0008594; GO:0009925; GO:0009986; GO:0030424; GO:0031252; GO:0031290; GO:0032093; GO:0045467; GO:0046627; GO:0048477; GO:0048675; GO:0048841; GO:0051124; GO:0051491; GO:0060269; GO:0061484; GO:0120034; GO:1903386","axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; hematopoietic stem cell homeostasis [GO:0061484]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; negative regulation of insulin receptor signaling pathway [GO:0046627]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; synaptic assembly at neuromuscular junction [GO:0051124]","axon [GO:0030424]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; heparin binding [GO:0008201]; insulin receptor binding [GO:0005158]; protein tyrosine phosphatase activity [GO:0004725]; SAM domain binding [GO:0032093]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; hematopoietic stem cell homeostasis [GO:0061484]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; negative regulation of insulin receptor signaling pathway [GO:0046627]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; synaptic assembly at neuromuscular junction [GO:0051124]","","","","TISSUE SPECIFICITY: Selectively expressed in a subset of axons and pioneer neurons in the embryo. {ECO:0000269|PubMed:8598047}."
"1096","sp|Q9W0V1|PDPK1_DROME","lcl|NC_088859.1_cds_XP_065922064.1_39782",6.33e-88,288,"Q9W0V1","PDPK1_DROME","3-phosphoinositide-dependent protein kinase 1 (dPDK-1) (EC 2.7.11.1) (Serine/threonine-protein kinase 61C) (dSTPK61)","Pdk1 Pk61C CG1210","Drosophila melanogaster (Fruit fly)",836,"GO:0004674; GO:0004676; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0007166; GO:0007283; GO:0008286; GO:0009898; GO:0030154; GO:0030295; GO:0030307; GO:0031594; GO:0035556; GO:0040018; GO:0043066; GO:0043491; GO:0045793; GO:0046622; GO:0051124; GO:0106310; GO:1904262","apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of TORC1 signaling [GO:1904262]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; spermatogenesis [GO:0007283]; synaptic assembly at neuromuscular junction [GO:0051124]","cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; protein kinase activator activity [GO:0030295]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of TORC1 signaling [GO:1904262]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; spermatogenesis [GO:0007283]; synaptic assembly at neuromuscular junction [GO:0051124]","DEVELOPMENTAL STAGE: Highly expressed in Malpighian tubule primordia from stage late 11 to 13. Expressed in hindgut at stage 13. After stage 14, ubiquitously expressed at low levels. {ECO:0000269|PubMed:11301252}.","","",""
"1097","sp|Q9VAF5|CAD99_DROME","lcl|NC_088859.1_cds_XP_065922102.1_36302",1.07e-122,432,"Q9VAF5","CAD99_DROME","Cadherin-99C","Cad99C CG31009","Drosophila melanogaster (Fruit fly)",1706,"GO:0002385; GO:0005509; GO:0005886; GO:0005902; GO:0007156; GO:0007304; GO:0007305; GO:0007605; GO:0010008; GO:0016324; GO:0016339; GO:0017022; GO:0019722; GO:0031528; GO:0032529; GO:0032533; GO:0035239; GO:0044331; GO:0045176; GO:0098609; GO:2000370","apical protein localization [GO:0045176]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-mediated signaling [GO:0019722]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; chorion-containing eggshell formation [GO:0007304]; follicle cell microvillus organization [GO:0032529]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mucosal immune response [GO:0002385]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; regulation of follicle cell microvillus length [GO:0032533]; sensory perception of sound [GO:0007605]; tube morphogenesis [GO:0035239]; vitelline membrane formation involved in chorion-containing eggshell formation [GO:0007305]","apical plasma membrane [GO:0016324]; endosome membrane [GO:0010008]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; apical protein localization [GO:0045176]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-mediated signaling [GO:0019722]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; chorion-containing eggshell formation [GO:0007304]; follicle cell microvillus organization [GO:0032529]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mucosal immune response [GO:0002385]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; regulation of follicle cell microvillus length [GO:0032533]; sensory perception of sound [GO:0007605]; tube morphogenesis [GO:0035239]; vitelline membrane formation involved in chorion-containing eggshell formation [GO:0007305]","DEVELOPMENTAL STAGE: Low expression throughout the imaginal disks of third instar larvae with higher levels of expression at the anterior-posterior boundary (at protein level) (PubMed:15708564). Detected in the germarium and stage 2 and stage 3 egg chambers (at protein level) (PubMed:16507588). From stages 2 to 8, expressed in the follicle cells at the anterior and posterior poles of the egg chambers (at protein level) (PubMed:16260500, PubMed:16507588). From stage 4 to the end of oogenesis, only detected in follicle cells that are in contact with the oocyte (at protein level) (PubMed:16260500, PubMed:16507588). From stage 11 expressed at the apical surface of several embryonic tubular organs including the salivary glands, trachea, foregut and hindgut (PubMed:24718992). {ECO:0000269|PubMed:15708564, ECO:0000269|PubMed:16260500, ECO:0000269|PubMed:16507588, ECO:0000269|PubMed:24718992}.","INDUCTION: Up-regulated in the adult anterior midgut after the ingestion of bacterial uracil. Strong up-regulation detected 1 hour, 2 hours and 16 hours after ingestion, whereas no up-regulation was detected at 4 hours. {ECO:0000269|PubMed:25639794}.","INDUCTION: Up-regulated in the adult anterior midgut after the ingestion of bacterial uracil. Strong up-regulation detected 1 hour, 2 hours and 16 hours after ingestion, whereas no up-regulation was detected at 4 hours. {ECO:0000269|PubMed:25639794}.",""
"1098","sp|A1Z8P9|TPR_DROME","lcl|NC_088859.1_cds_XP_065922145.1_38363",7.1e-93,339,"A1Z8P9","TPR_DROME","Nucleoprotein TPR (Nuclear envelope antigen Bx34) (Protein megator)","Mgtor Bx34 l(2)k03905 Mtor CG8274","Drosophila melanogaster (Fruit fly)",2346,"GO:0000022; GO:0000122; GO:0000775; GO:0000791; GO:0005634; GO:0005635; GO:0005643; GO:0005652; GO:0005654; GO:0005730; GO:0005737; GO:0005819; GO:0006325; GO:0006338; GO:0006355; GO:0006406; GO:0006606; GO:0007094; GO:0007346; GO:0007549; GO:0009408; GO:0010965; GO:0016363; GO:0017056; GO:0030496; GO:0031490; GO:0031965; GO:0034399; GO:0034976; GO:0035035; GO:0042405; GO:0043021; GO:0045840; GO:0045944; GO:0048133; GO:0051225; GO:0051233; GO:0051781; GO:0060236; GO:0060250; GO:0070090; GO:0072686; GO:0090235; GO:0090267; GO:0090316; GO:1901673; GO:1990047","chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; germ-line stem-cell niche homeostasis [GO:0060250]; male germ-line stem cell asymmetric division [GO:0048133]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle elongation [GO:0000022]; mRNA export from nucleus [GO:0006406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell division [GO:0051781]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; regulation of DNA-templated transcription [GO:0006355]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of mitotic spindle organization [GO:0060236]; response to endoplasmic reticulum stress [GO:0034976]; response to heat [GO:0009408]; sex-chromosome dosage compensation [GO:0007549]; spindle assembly [GO:0051225]","chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; metaphase plate [GO:0070090]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047]; spindle midzone [GO:0051233]; chromatin DNA binding [GO:0031490]; histone acetyltransferase binding [GO:0035035]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of nuclear pore [GO:0017056]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; germ-line stem-cell niche homeostasis [GO:0060250]; male germ-line stem cell asymmetric division [GO:0048133]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle elongation [GO:0000022]; mRNA export from nucleus [GO:0006406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell division [GO:0051781]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; regulation of DNA-templated transcription [GO:0006355]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of mitotic spindle organization [GO:0060236]; response to endoplasmic reticulum stress [GO:0034976]; response to heat [GO:0009408]; sex-chromosome dosage compensation [GO:0007549]; spindle assembly [GO:0051225]","DEVELOPMENTAL STAGE: Expressed at all developmental stages (PubMed:9152019). Expressed in embryos (at protein level) (PubMed:16543150). {ECO:0000269|PubMed:16543150, ECO:0000269|PubMed:9152019}.","","","TISSUE SPECIFICITY: Expressed in salivary glands, fat body, tracheal tube, esophageal tube and anterior ejaculatory duct (at protein level). {ECO:0000269|PubMed:9152019}."
"1099","sp|Q01063|PDE4D_MOUSE","lcl|NC_088859.1_cds_XP_065922210.1_34777",0,779,"Q01063","PDE4D_MOUSE","3',5'-cyclic-AMP phosphodiesterase 4D (EC 3.1.4.53) (DPDE3) (cAMP-specific phosphodiesterase 4D)","Pde4d","Mus musculus (Mouse)",747,"GO:0001542; GO:0002027; GO:0004114; GO:0004115; GO:0005246; GO:0005737; GO:0005813; GO:0005891; GO:0006198; GO:0006939; GO:0010880; GO:0016324; GO:0030593; GO:0034704; GO:0034705; GO:0035264; GO:0044325; GO:0045822; GO:0046872; GO:0051117; GO:0061028; GO:0071222; GO:0071320; GO:0071372; GO:0071872; GO:0086004; GO:0141156; GO:1901844; GO:1901898; GO:1902514; GO:1990266","cAMP catabolic process [GO:0006198]; cAMP/PKA signal transduction [GO:0141156]; cellular response to cAMP [GO:0071320]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to lipopolysaccharide [GO:0071222]; establishment of endothelial barrier [GO:0061028]; multicellular organism growth [GO:0035264]; negative regulation of heart contraction [GO:0045822]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; neutrophil migration [GO:1990266]; ovulation from ovarian follicle [GO:0001542]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; smooth muscle contraction [GO:0006939]","apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; potassium channel complex [GO:0034705]; voltage-gated calcium channel complex [GO:0005891]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; ATPase binding [GO:0051117]; calcium channel regulator activity [GO:0005246]; metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]; cAMP catabolic process [GO:0006198]; cAMP/PKA signal transduction [GO:0141156]; cellular response to cAMP [GO:0071320]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to lipopolysaccharide [GO:0071222]; establishment of endothelial barrier [GO:0061028]; multicellular organism growth [GO:0035264]; negative regulation of heart contraction [GO:0045822]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; neutrophil migration [GO:1990266]; ovulation from ovarian follicle [GO:0001542]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; smooth muscle contraction [GO:0006939]","","INDUCTION: Up-regulated by cAMP and follicle-stimulating hormone. {ECO:0000250}.","INDUCTION: Up-regulated by cAMP and follicle-stimulating hormone. {ECO:0000250}.","TISSUE SPECIFICITY: Expressed in brain (at protein level). Isoform 7 is detected in heart, brain, lung, kidney and testis. {ECO:0000269|PubMed:12834813, ECO:0000269|PubMed:17244609}."
"1100","sp|P14270|PDE4D_RAT","lcl|NC_088859.1_cds_XP_065922211.1_34776",0,774,"P14270","PDE4D_RAT","3',5'-cyclic-AMP phosphodiesterase 4D (EC 3.1.4.53) (DPDE3) (cAMP-specific phosphodiesterase 4D)","Pde4d","Rattus norvegicus (Rat)",803,"GO:0001542; GO:0002027; GO:0004112; GO:0004114; GO:0004115; GO:0005246; GO:0005813; GO:0005829; GO:0005891; GO:0006198; GO:0006939; GO:0007613; GO:0010460; GO:0010880; GO:0014911; GO:0016020; GO:0019899; GO:0019933; GO:0022409; GO:0030016; GO:0030324; GO:0030545; GO:0030552; GO:0030593; GO:0031698; GO:0032729; GO:0032743; GO:0032754; GO:0032991; GO:0034704; GO:0034705; GO:0035264; GO:0044325; GO:0045822; GO:0046872; GO:0047555; GO:0048661; GO:0050852; GO:0051117; GO:0061028; GO:0065003; GO:0071222; GO:0071320; GO:0071372; GO:0071872; GO:0071875; GO:0086004; GO:0097110; GO:0106072; GO:0141156; GO:0141161; GO:1901363; GO:1901844; GO:1901898; GO:1902514; GO:1990266","adrenergic receptor signaling pathway [GO:0071875]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; cAMP/PKA signal transduction [GO:0141156]; cellular response to cAMP [GO:0071320]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to lipopolysaccharide [GO:0071222]; establishment of endothelial barrier [GO:0061028]; lung development [GO:0030324]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of heart contraction [GO:0045822]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; neutrophil migration [GO:1990266]; ovulation from ovarian follicle [GO:0001542]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of heart rate [GO:0010460]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of type II interferon production [GO:0032729]; protein-containing complex assembly [GO:0065003]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; smooth muscle contraction [GO:0006939]; T cell receptor signaling pathway [GO:0050852]","calcium channel complex [GO:0034704]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; myofibril [GO:0030016]; potassium channel complex [GO:0034705]; protein-containing complex [GO:0032991]; voltage-gated calcium channel complex [GO:0005891]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; ATPase binding [GO:0051117]; beta-2 adrenergic receptor binding [GO:0031698]; calcium channel regulator activity [GO:0005246]; cAMP binding [GO:0030552]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; enzyme binding [GO:0019899]; heterocyclic compound binding [GO:1901363]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; signaling receptor regulator activity [GO:0030545]; transmembrane transporter binding [GO:0044325]; adrenergic receptor signaling pathway [GO:0071875]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; cAMP/PKA signal transduction [GO:0141156]; cellular response to cAMP [GO:0071320]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to lipopolysaccharide [GO:0071222]; establishment of endothelial barrier [GO:0061028]; lung development [GO:0030324]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of heart contraction [GO:0045822]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; neutrophil migration [GO:1990266]; ovulation from ovarian follicle [GO:0001542]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of heart rate [GO:0010460]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of type II interferon production [GO:0032729]; protein-containing complex assembly [GO:0065003]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; smooth muscle contraction [GO:0006939]; T cell receptor signaling pathway [GO:0050852]","","INDUCTION: Up-regulated by cAMP and follicle-stimulating hormone. {ECO:0000269|PubMed:2554303}.","INDUCTION: Up-regulated by cAMP and follicle-stimulating hormone. {ECO:0000269|PubMed:2554303}.","TISSUE SPECIFICITY: Expressed in epithelial cells. Isoform 33, isoform 4, isoform 5 and isoform 9 are expressed in brain. Isoform 33, isoform 5, isoform 8 and isoform 9 are expressed in heart (at protein level). Isoform 4 and isoform 6 are strongly expressed in cortex and cerebellum. Isoform 7 is strongly expressed in cortex and testis; weakly expressed in kidney, lung, spleen and cerebellum. Isoform 8 is strongly expressed in lung, heart and liver. Isoform 31, isoform 32, isoform 33, isoform 5 and isoform 9 are widely distributed. {ECO:0000269|PubMed:17244609, ECO:0000269|PubMed:17261351}."
"1101","sp|Q9DAA4|PRS37_MOUSE","lcl|NC_088859.1_cds_XP_065922318.1_38772",7.6e-11,62,"Q9DAA4","PRS37_MOUSE","Probable inactive serine protease 37 (Probable inactive trypsin-X2)","Prss37 Tryx2","Mus musculus (Mouse)",237,"GO:0001669; GO:0004252; GO:0005576; GO:0006508; GO:0007339; GO:0008354; GO:0046872; GO:0051604; GO:0070613; GO:1905516; GO:2000344","binding of sperm to zona pellucida [GO:0007339]; germ cell migration [GO:0008354]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of fertilization [GO:1905516]; protein maturation [GO:0051604]; proteolysis [GO:0006508]; regulation of protein processing [GO:0070613]","acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; binding of sperm to zona pellucida [GO:0007339]; germ cell migration [GO:0008354]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of fertilization [GO:1905516]; protein maturation [GO:0051604]; proteolysis [GO:0006508]; regulation of protein processing [GO:0070613]","DEVELOPMENTAL STAGE: Expressed exclusively in the spermatids at steps 9-14 of spermiogenesis (PubMed:23553430). {ECO:0000269|PubMed:23553430}.","","","TISSUE SPECIFICITY: Testis-specific (PubMed:23553430). Expressed in spermatids (PubMed:23553430). Weakly expressed in mature sperm (at protein level) (PubMed:23553430). {ECO:0000269|PubMed:23553430}."
"1102","sp|Q9VDE5|PPAN_DROME","lcl|NC_088859.1_cds_XP_065922378.1_40287",2.19e-89,281,"Q9VDE5","PPAN_DROME","Protein Peter pan","ppan CG5786","Drosophila melanogaster (Fruit fly)",460,"GO:0000463; GO:0002164; GO:0007292; GO:0007444; GO:0019843; GO:0030687; GO:0048477","female gamete generation [GO:0007292]; imaginal disc development [GO:0007444]; larval development [GO:0002164]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; oogenesis [GO:0048477]","preribosome, large subunit precursor [GO:0030687]; rRNA binding [GO:0019843]; female gamete generation [GO:0007292]; imaginal disc development [GO:0007444]; larval development [GO:0002164]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; oogenesis [GO:0048477]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically, highest expression level is during embryogenesis. {ECO:0000269|PubMed:10359593}.","","","TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10359593}."
"1103","sp|P18491|EMC_DROME","lcl|NC_088859.1_cds_XP_065922623.1_36691",1.13e-11,60.8,"P18491","EMC_DROME","Protein extra-macrochaetae","emc CG1007","Drosophila melanogaster (Fruit fly)",199,"GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0007368; GO:0007391; GO:0007458; GO:0007476; GO:0007494; GO:0007530; GO:0008258; GO:0008407; GO:0008586; GO:0030182; GO:0030381; GO:0042675; GO:0045466; GO:0045892; GO:0046552; GO:0046843; GO:0046983; GO:0048056; GO:0061525","chaeta morphogenesis [GO:0008407]; chorion-containing eggshell pattern formation [GO:0030381]; compound eye cone cell differentiation [GO:0042675]; determination of left/right symmetry [GO:0007368]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; head involution [GO:0008258]; hindgut development [GO:0061525]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; midgut development [GO:0007494]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; photoreceptor cell fate commitment [GO:0046552]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; sex determination [GO:0007530]","cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein dimerization activity [GO:0046983]; transcription corepressor activity [GO:0003714]; chaeta morphogenesis [GO:0008407]; chorion-containing eggshell pattern formation [GO:0030381]; compound eye cone cell differentiation [GO:0042675]; determination of left/right symmetry [GO:0007368]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; head involution [GO:0008258]; hindgut development [GO:0061525]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; midgut development [GO:0007494]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; photoreceptor cell fate commitment [GO:0046552]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; sex determination [GO:0007530]","","","",""
"1104","sp|Q9U405|GRAU_DROME","lcl|NC_088859.1_cds_XP_065922661.1_35622",1.64e-29,124,"Q9U405","GRAU_DROME","Transcription factor grauzone","grau CG3282","Drosophila melanogaster (Fruit fly)",570,"GO:0000987; GO:0003700; GO:0005634; GO:0006357; GO:0007143; GO:0007279; GO:0007343; GO:0007349; GO:0008270; GO:0045143; GO:0045944","cellularization [GO:0007349]; egg activation [GO:0007343]; female meiotic nuclear division [GO:0007143]; homologous chromosome segregation [GO:0045143]; pole cell formation [GO:0007279]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]; cellularization [GO:0007349]; egg activation [GO:0007343]; female meiotic nuclear division [GO:0007143]; homologous chromosome segregation [GO:0045143]; pole cell formation [GO:0007279]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically.","","","TISSUE SPECIFICITY: Present throughout embryogenesis, in larvae, in ovaries and other tissues of adult females, and in adult males. In ovaries, it is expressed in both follicle cells and nurse cells. Expressed from stage 9 in the germarium. Weakly or not expressed in the oocyte nucleus. {ECO:0000269|PubMed:10683177}."
"1105","sp|Q96S53|TESK2_HUMAN","lcl|NC_088859.1_cds_XP_065922891.1_36680",8.44e-117,372,"Q96S53","TESK2_HUMAN","Dual specificity testis-specific protein kinase 2 (EC 2.7.12.1) (Testicular protein kinase 2)","TESK2","Homo sapiens (Human)",571,"GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0007283; GO:0016604; GO:0030036; GO:0046872; GO:0048041; GO:0106310","actin cytoskeleton organization [GO:0030036]; focal adhesion assembly [GO:0048041]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; actin cytoskeleton organization [GO:0030036]; focal adhesion assembly [GO:0048041]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Predominantly expressed in testis and prostate. Found predominantly in non-germinal Sertoli cells. {ECO:0000269|PubMed:10512679, ECO:0000269|PubMed:11418599}."
"1106","sp|Q2IA00|SPEF2_PIG","lcl|NC_088859.1_cds_XP_065923215.1_37078",6.14e-177,587,"Q2IA00","SPEF2_PIG","Sperm flagellar protein 2 (Protein KPL2)","SPEF2 KPL2","Sus scrofa (Pig)",1812,"GO:0002177; GO:0005794; GO:0007288; GO:0036126; GO:0097225","sperm axoneme assembly [GO:0007288]","Golgi apparatus [GO:0005794]; manchette [GO:0002177]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; sperm axoneme assembly [GO:0007288]","","","","TISSUE SPECIFICITY: Predominantly expressed in ciliated tissues. Mainly expressed in testis, followed by trachea. Also expressed at lower level in lung, kidney and liver. {ECO:0000269|PubMed:16549801}."
"1107","sp|Q9V8P9|TOPRS_DROME","lcl|NC_088859.1_cds_XP_065923312.1_35099",5.56e-34,142,"Q9V8P9","TOPRS_DROME","E3 ubiquitin-protein ligase Topors (EC 2.3.2.27) (RING-type E3 ubiquitin transferase Topors) (SUMO1-protein E3 ligase Topors) (Topoisomerase I-binding RING finger protein) (Topoisomerase I-binding arginine/serine-rich protein) (dTopors)","Topors CG15104","Drosophila melanogaster (Fruit fly)",1038,"GO:0000209; GO:0005521; GO:0005634; GO:0005652; GO:0005700; GO:0006325; GO:0006355; GO:0006511; GO:0006513; GO:0006997; GO:0007060; GO:0008270; GO:0010032; GO:0019789; GO:0051299; GO:0061630; GO:0071763","centrosome separation [GO:0051299]; chromatin organization [GO:0006325]; male meiosis chromosome segregation [GO:0007060]; meiotic chromosome condensation [GO:0010032]; nuclear membrane organization [GO:0071763]; nucleus organization [GO:0006997]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; regulation of DNA-templated transcription [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]","nuclear lamina [GO:0005652]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; lamin binding [GO:0005521]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; centrosome separation [GO:0051299]; chromatin organization [GO:0006325]; male meiosis chromosome segregation [GO:0007060]; meiotic chromosome condensation [GO:0010032]; nuclear membrane organization [GO:0071763]; nucleus organization [GO:0006997]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; regulation of DNA-templated transcription [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]","","","",""
"1108","sp|C1L7Y4|ANX13_SCHJA","lcl|NC_088859.1_cds_XP_065923349.1_34299",6.72e-80,256,"C1L7Y4","ANX13_SCHJA","Annexin A13 (Annexin) (Annexin XIII) (SjANX A13)","","Schistosoma japonicum (Blood fluke)",354,"GO:0001786; GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0005886; GO:0007292; GO:0012506; GO:0016020; GO:0042802; GO:0042803; GO:0043657; GO:0070062","female gamete generation [GO:0007292]","cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; host cell [GO:0043657]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; female gamete generation [GO:0007292]","","","",""
"1109","sp|P16914|ELAV_DROME","lcl|NC_088859.1_cds_XP_065923482.1_35571",3.77e-123,366,"P16914","ELAV_DROME","Protein elav (Embryonic lethal abnormal visual protein)","elav CG4262","Drosophila melanogaster (Fruit fly)",483,"GO:0000900; GO:0003723; GO:0003729; GO:0005634; GO:0007281; GO:0007319; GO:0007399; GO:0007417; GO:0008266; GO:0009792; GO:0015030; GO:0031441; GO:1990904","central nervous system development [GO:0007417]; embryo development ending in birth or egg hatching [GO:0009792]; germ cell development [GO:0007281]; negative regulation of mRNA 3'-end processing [GO:0031441]; negative regulation of oskar mRNA translation [GO:0007319]; nervous system development [GO:0007399]","Cajal body [GO:0015030]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; mRNA regulatory element binding translation repressor activity [GO:0000900]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; central nervous system development [GO:0007417]; embryo development ending in birth or egg hatching [GO:0009792]; germ cell development [GO:0007281]; negative regulation of mRNA 3'-end processing [GO:0031441]; negative regulation of oskar mRNA translation [GO:0007319]; nervous system development [GO:0007399]","","","",""
"1110","sp|P19339|SXL_DROME","lcl|NC_088859.1_cds_XP_065923487.1_35572",4.2e-54,183,"P19339","SXL_DROME","Protein sex-lethal","Sxl Sx1 CG43770","Drosophila melanogaster (Fruit fly)",354,"GO:0000380; GO:0000381; GO:0000900; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0007131; GO:0007446; GO:0007530; GO:0007541; GO:0007548; GO:0007549; GO:0008143; GO:0008187; GO:0008266; GO:0009994; GO:0017148; GO:0018993; GO:0019099; GO:0030237; GO:0032991; GO:0033120; GO:0036002; GO:0045880; GO:0045947; GO:0046832; GO:0048024; GO:0048025; GO:0048027; GO:0048142; GO:0048477; GO:0050821; GO:1990399; GO:1990904; GO:2000035","alternative mRNA splicing, via spliceosome [GO:0000380]; epithelium regeneration [GO:1990399]; female germ-line sex determination [GO:0019099]; female sex determination [GO:0030237]; germarium-derived cystoblast division [GO:0048142]; imaginal disc growth [GO:0007446]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; oocyte differentiation [GO:0009994]; oogenesis [GO:0048477]; positive regulation of RNA splicing [GO:0033120]; positive regulation of smoothened signaling pathway [GO:0045880]; protein stabilization [GO:0050821]; reciprocal meiotic recombination [GO:0007131]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of stem cell division [GO:2000035]; sex determination [GO:0007530]; sex determination, primary response to X:A ratio [GO:0007541]; sex differentiation [GO:0007548]; sex-chromosome dosage compensation [GO:0007549]; somatic sex determination [GO:0018993]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; mRNA regulatory element binding translation repressor activity [GO:0000900]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; epithelium regeneration [GO:1990399]; female germ-line sex determination [GO:0019099]; female sex determination [GO:0030237]; germarium-derived cystoblast division [GO:0048142]; imaginal disc growth [GO:0007446]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; oocyte differentiation [GO:0009994]; oogenesis [GO:0048477]; positive regulation of RNA splicing [GO:0033120]; positive regulation of smoothened signaling pathway [GO:0045880]; protein stabilization [GO:0050821]; reciprocal meiotic recombination [GO:0007131]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of stem cell division [GO:2000035]; sex determination [GO:0007530]; sex determination, primary response to X:A ratio [GO:0007541]; sex differentiation [GO:0007548]; sex-chromosome dosage compensation [GO:0007549]; somatic sex determination [GO:0018993]","DEVELOPMENTAL STAGE: [Isoform 1]: Embryo-specific (PubMed:1547493). Expressed for a brief period during the syncytial blastoderm stage (PubMed:1547493). Expression is under the control of primary sex-determining signal, which depends on the ratio of X chromosomes relative to autosomes (X:A ratio) (PubMed:1547493). Expression occurs in 2X:2A cells, but not in X:2A cells (PubMed:1547493). The X:A ratio seems to be signaled by the relative concentration of the X-linked transcription factors SIS-A and SIS-B (PubMed:1547493). As a result, the embryo-specific product is expressed early only in female embryos and specifies female-adult specific splicing; in the male where it is not expressed, the default splicing gives rise to a truncated non-functional protein (PubMed:1547493). {ECO:0000269|PubMed:1547493}.; DEVELOPMENTAL STAGE: [Isoform CM1]: Male-specific. {ECO:0000269|PubMed:3144435}.; DEVELOPMENTAL STAGE: [Isoform MS3]: Female specific. {ECO:0000269|PubMed:1710769, ECO:0000269|PubMed:3144435}.; DEVELOPMENTAL STAGE: [Isoform MS11]: Female specific (PubMed:1710769). Isoform MS11 is expressed in 4-7 hours embryo (PubMed:1710769). {ECO:0000269|PubMed:1710769}.; DEVELOPMENTAL STAGE: [Isoform MS16]: Female specific. {ECO:0000269|PubMed:1710769}.","","","TISSUE SPECIFICITY: Expressed in somatic tissues, but not in the pole cells, which are the precursors of the germline (PubMed:1547493). Expressed in the anterior of the germarium (PubMed:23526974). {ECO:0000269|PubMed:1547493, ECO:0000269|PubMed:23526974}."
"1111","sp|Q3ULW6|CCD33_MOUSE","lcl|NC_088859.1_cds_XP_065923619.1_34466",7.63e-48,187,"Q3ULW6","CCD33_MOUSE","Coiled-coil domain-containing protein 33 (Speriolin-binding factor)","Ccdc33","Mus musculus (Mouse)",985,"GO:0005777; GO:0007283","spermatogenesis [GO:0007283]","peroxisome [GO:0005777]; spermatogenesis [GO:0007283]","","","",""
"1112","sp|G5EBL2|MES1_CAEEL","lcl|NC_088859.1_cds_XP_065923660.1_37224",1.28e-11,70.1,"G5EBL2","MES1_CAEEL","Protein mes-1 (Maternal-effect sterile protein 1)","mes-1 F54F7.5","Caenorhabditis elegans",966,"GO:0001708; GO:0003006; GO:0004713; GO:0005524; GO:0005886; GO:0007163; GO:0007276; GO:0008356; GO:0040001; GO:0045167; GO:0048557; GO:0070986","asymmetric cell division [GO:0008356]; asymmetric protein localization involved in cell fate determination [GO:0045167]; cell fate specification [GO:0001708]; developmental process involved in reproduction [GO:0003006]; embryonic digestive tract morphogenesis [GO:0048557]; establishment of mitotic spindle localization [GO:0040001]; establishment or maintenance of cell polarity [GO:0007163]; gamete generation [GO:0007276]; left/right axis specification [GO:0070986]","plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; asymmetric cell division [GO:0008356]; asymmetric protein localization involved in cell fate determination [GO:0045167]; cell fate specification [GO:0001708]; developmental process involved in reproduction [GO:0003006]; embryonic digestive tract morphogenesis [GO:0048557]; establishment of mitotic spindle localization [GO:0040001]; establishment or maintenance of cell polarity [GO:0007163]; gamete generation [GO:0007276]; left/right axis specification [GO:0070986]","DEVELOPMENTAL STAGE: Expressed at least in P2 germline cell at 4-cell stage and up to 26-cell stage embryos (PubMed:11003841, PubMed:12110172). Expressed only at L4 stage during larval development and then accumulates in adults (PubMed:11003841). {ECO:0000269|PubMed:11003841, ECO:0000269|PubMed:12110172}.","","",""
"1113","sp|Q02548|PAX5_HUMAN","lcl|NC_088859.1_cds_XP_065923726.1_35809",6.57e-76,243,"Q02548","PAX5_HUMAN","Paired box protein Pax-5 (B-cell-specific transcription factor) (BSAP)","PAX5","Homo sapiens (Human)",391,"GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005654; GO:0006357; GO:0006366; GO:0007283; GO:0007399; GO:0007423; GO:0021670; GO:0021987; GO:0030183; GO:0030534; GO:0035914; GO:0048701","adult behavior [GO:0030534]; B cell differentiation [GO:0030183]; cerebral cortex development [GO:0021987]; embryonic cranial skeleton morphogenesis [GO:0048701]; lateral ventricle development [GO:0021670]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; skeletal muscle cell differentiation [GO:0035914]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]","chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adult behavior [GO:0030534]; B cell differentiation [GO:0030183]; cerebral cortex development [GO:0021987]; embryonic cranial skeleton morphogenesis [GO:0048701]; lateral ventricle development [GO:0021670]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; skeletal muscle cell differentiation [GO:0035914]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]","DEVELOPMENTAL STAGE: Expressed at early B-cell differentiation, in the developing CNS and in adult testis.","","",""
"1114","sp|Q6RT24|CENPE_MOUSE","lcl|NC_088859.1_cds_XP_065923749.1_38177",8e-104,375,"Q6RT24","CENPE_MOUSE","Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin superfamily protein 10) (KIF10) (Motor domain of KIF10)","Cenpe","Mus musculus (Mouse)",2474,"GO:0000775; GO:0000776; GO:0000940; GO:0003777; GO:0005524; GO:0005737; GO:0005819; GO:0007018; GO:0007057; GO:0007080; GO:0007088; GO:0007094; GO:0008017; GO:0008608; GO:0019901; GO:0031647; GO:0043515; GO:0045184; GO:0045842; GO:0045860; GO:0050793; GO:0051301; GO:0051310; GO:0051315; GO:0051984; GO:0051987; GO:0099607","attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; establishment of protein localization [GO:0045184]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase chromosome alignment [GO:0051310]; microtubule-based movement [GO:0007018]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly checkpoint signaling [GO:0007094]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic nuclear division [GO:0007088]; regulation of protein stability [GO:0031647]; spindle assembly involved in female meiosis I [GO:0007057]","chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; outer kinetochore [GO:0000940]; spindle [GO:0005819]; ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; establishment of protein localization [GO:0045184]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase chromosome alignment [GO:0051310]; microtubule-based movement [GO:0007018]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly checkpoint signaling [GO:0007094]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic nuclear division [GO:0007088]; regulation of protein stability [GO:0031647]; spindle assembly involved in female meiosis I [GO:0007057]","","","","TISSUE SPECIFICITY: Expressed in hippocampus. Also detected in liver and fibroblasts (at protein level). {ECO:0000269|PubMed:12361599, ECO:0000269|PubMed:9275178}."
"1115","sp|Q24157|BRN_DROME","lcl|NC_088859.1_cds_XP_065923755.1_38181",4.43e-48,167,"Q24157","BRN_DROME","Beta-1,3-galactosyltransferase brn (EC 2.4.1.62) (Brainiac protein) (Neurogenic secreted-signaling protein brn)","brn CG4934","Drosophila melanogaster (Fruit fly)",325,"GO:0000139; GO:0001744; GO:0005795; GO:0006493; GO:0006688; GO:0007219; GO:0007293; GO:0007298; GO:0007299; GO:0008194; GO:0016333; GO:0030707; GO:0042248; GO:0046981; GO:0047915","border follicle cell migration [GO:0007298]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber-cell adhesion [GO:0007299]; germarium-derived egg chamber formation [GO:0007293]; glycosphingolipid biosynthetic process [GO:0006688]; insect visual primordium formation [GO:0001744]; maintenance of polarity of follicular epithelium [GO:0042248]; morphogenesis of follicular epithelium [GO:0016333]; Notch signaling pathway [GO:0007219]; protein O-linked glycosylation [GO:0006493]","Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; beta-1,4-mannosylglycolipid beta-1,3-N-acetylglucosaminyltransferase activity [GO:0046981]; ganglioside galactosyltransferase activity [GO:0047915]; UDP-glycosyltransferase activity [GO:0008194]; border follicle cell migration [GO:0007298]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber-cell adhesion [GO:0007299]; germarium-derived egg chamber formation [GO:0007293]; glycosphingolipid biosynthetic process [GO:0006688]; insect visual primordium formation [GO:0001744]; maintenance of polarity of follicular epithelium [GO:0042248]; morphogenesis of follicular epithelium [GO:0016333]; Notch signaling pathway [GO:0007219]; protein O-linked glycosylation [GO:0006493]","","","",""
"1116","sp|F1MJR8|TEX14_BOVIN","lcl|NC_088859.1_cds_XP_065923800.1_38227",3.06e-76,275,"F1MJR8","TEX14_BOVIN","Inactive serine/threonine-protein kinase TEX14 (Testis-expressed sequence 14) (Testis-expressed sequence 14 protein)","TEX14","Bos taurus (Bovine)",1493,"GO:0000776; GO:0004672; GO:0005524; GO:0005737; GO:0007094; GO:0007140; GO:0008608; GO:0030496; GO:0043063; GO:0045171; GO:0051301; GO:0051306","attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; intercellular bridge organization [GO:0043063]; male meiotic nuclear division [GO:0007140]; mitotic sister chromatid separation [GO:0051306]; mitotic spindle assembly checkpoint signaling [GO:0007094]","cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; midbody [GO:0030496]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; intercellular bridge organization [GO:0043063]; male meiotic nuclear division [GO:0007140]; mitotic sister chromatid separation [GO:0051306]; mitotic spindle assembly checkpoint signaling [GO:0007094]","","","",""
"1117","sp|Q61496|DDX4_MOUSE","lcl|NC_088859.1_cds_XP_065945385.1_34572",0,573,"Q61496","DDX4_MOUSE","ATP-dependent RNA helicase DDX4 (EC 3.6.4.13) (DEAD box protein 4) (Mvh) (Vasa homolog)","Ddx4 Mvh Vasa","Mus musculus (Mouse)",702,"GO:0003676; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0007140; GO:0007141; GO:0007283; GO:0016887; GO:0030154; GO:0032880; GO:0033391; GO:0034587; GO:0048471; GO:0071546; GO:0071547; GO:0140965; GO:0141006; GO:0141196; GO:1990904","cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; regulation of protein localization [GO:0032880]; secondary piRNA processing [GO:0140965]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006]","chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pi-body [GO:0071546]; piP-body [GO:0071547]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; regulation of protein localization [GO:0032880]; secondary piRNA processing [GO:0140965]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006]","DEVELOPMENTAL STAGE: Expressed in spermatogenic cells from the spermatocyte stage to the round spermatid stage. {ECO:0000269|PubMed:7991615}.","","","TISSUE SPECIFICITY: Testis-specific. {ECO:0000269|PubMed:22900038}."
"1118","sp|Q6P1E1|ZMIZ1_MOUSE","lcl|NC_088859.1_cds_XP_065945396.1_36844",6.32e-164,508,"Q6P1E1","ZMIZ1_MOUSE","Zinc finger MIZ domain-containing protein 1 (PIAS-like protein Zimp10) (Retinoic acid-induced protein 17)","Zmiz1 Rai17 Zimp10","Mus musculus (Mouse)",1072,"GO:0001570; GO:0001701; GO:0003007; GO:0003713; GO:0005654; GO:0005737; GO:0005829; GO:0007179; GO:0007296; GO:0008270; GO:0021852; GO:0030521; GO:0045582; GO:0045747; GO:0045944; GO:0046332; GO:0048146; GO:0048589; GO:0048844; GO:0060395; GO:0090398","androgen receptor signaling pathway [GO:0030521]; artery morphogenesis [GO:0048844]; cellular senescence [GO:0090398]; developmental growth [GO:0048589]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pyramidal neuron migration to cerebral cortex [GO:0021852]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis [GO:0001570]; vitellogenesis [GO:0007296]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; androgen receptor signaling pathway [GO:0030521]; artery morphogenesis [GO:0048844]; cellular senescence [GO:0090398]; developmental growth [GO:0048589]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pyramidal neuron migration to cerebral cortex [GO:0021852]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis [GO:0001570]; vitellogenesis [GO:0007296]","","","","TISSUE SPECIFICITY: Expressed in brain. {ECO:0000269|PubMed:26163108}."
"1119","sp|G5EG38|CDC16_CAEEL","lcl|NC_088860.1_cds_XP_011412106.3_40853",8.08e-42,161,"G5EG38","CDC16_CAEEL","Cell division cycle protein 16 homolog (Abnormal embryogenesis protein 27) (Anaphase-promoting complex subunit 6) (APC6)","emb-27 apc-6 pod-6 F10B5.6","Caenorhabditis elegans",655,"GO:0005680; GO:0005737; GO:0006836; GO:0007346; GO:0008356; GO:0009949; GO:0016567; GO:0030703; GO:0031145; GO:0045202; GO:0045842; GO:0051301; GO:0051321; GO:0051445; GO:0070161","anaphase-promoting complex-dependent catabolic process [GO:0031145]; asymmetric cell division [GO:0008356]; cell division [GO:0051301]; eggshell formation [GO:0030703]; meiotic cell cycle [GO:0051321]; neurotransmitter transport [GO:0006836]; polarity specification of anterior/posterior axis [GO:0009949]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]","anaphase-promoting complex [GO:0005680]; anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; synapse [GO:0045202]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; asymmetric cell division [GO:0008356]; cell division [GO:0051301]; eggshell formation [GO:0030703]; meiotic cell cycle [GO:0051321]; neurotransmitter transport [GO:0006836]; polarity specification of anterior/posterior axis [GO:0009949]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]","","","","TISSUE SPECIFICITY: Expressed in GABA motor neurons. {ECO:0000269|PubMed:24321454}."
"1120","sp|Q9VDE6|EXOC6_DROME","lcl|NC_088860.1_cds_XP_011412112.2_41292",0,596,"Q9VDE6","EXOC6_DROME","Exocyst complex component 6 (Exocyst complex component Sec15)","Sec15 CG7034","Drosophila melanogaster (Fruit fly)",766,"GO:0000145; GO:0005768; GO:0006886; GO:0006887; GO:0006893; GO:0007298; GO:0007411; GO:0016028; GO:0016192; GO:0022416; GO:0031267; GO:0031410; GO:0032456; GO:0042331; GO:0043679; GO:0055037; GO:0072659; GO:0090522","axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; chaeta development [GO:0022416]; endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; phototaxis [GO:0042331]; protein localization to plasma membrane [GO:0072659]; vesicle tethering involved in exocytosis [GO:0090522]; vesicle-mediated transport [GO:0016192]","axon terminus [GO:0043679]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; exocyst [GO:0000145]; recycling endosome [GO:0055037]; rhabdomere [GO:0016028]; small GTPase binding [GO:0031267]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; chaeta development [GO:0022416]; endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; phototaxis [GO:0042331]; protein localization to plasma membrane [GO:0072659]; vesicle tethering involved in exocytosis [GO:0090522]; vesicle-mediated transport [GO:0016192]","","","","TISSUE SPECIFICITY: Detected in developing rhabdomeres in photoreceptor cells. {ECO:0000269|PubMed:16155582}."
"1121","sp|A6NDE4|RBY1B_HUMAN","lcl|NC_088860.1_cds_XP_011412116.3_41287",1.08e-19,94.4,"A6NDE4","RBY1B_HUMAN","RNA-binding motif protein, Y chromosome, family 1 member B","RBMY1B","Homo sapiens (Human)",496,"GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005730; GO:0006397; GO:0007283; GO:0008380; GO:0008584; GO:0048026","male gonad development [GO:0008584]; mRNA processing [GO:0006397]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]","nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; male gonad development [GO:0008584]; mRNA processing [GO:0006397]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed in all of the transcriptionally active stages of germ cell development from spermatogonia through spermatocytes to round spermatids.","","","TISSUE SPECIFICITY: Testis-specific."
"1122","sp|Q9HB21|PKHA1_HUMAN","lcl|NC_088860.1_cds_XP_011412893.3_41369",2.02e-64,211,"Q9HB21","PKHA1_HUMAN","Pleckstrin homology domain-containing family A member 1 (PH domain-containing family A member 1) (Tandem PH domain-containing protein 1) (TAPP-1)","PLEKHA1 TAPP1","Homo sapiens (Human)",404,"GO:0001553; GO:0005543; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007283; GO:0008209; GO:0008210; GO:0009791; GO:0030165; GO:0031529; GO:0032587; GO:0033327; GO:0035264; GO:0043325; GO:0043491; GO:0045184; GO:0048008; GO:0048705; GO:0050853; GO:0051898; GO:0060021; GO:0060325; GO:0070062; GO:0070301","androgen metabolic process [GO:0008209]; B cell receptor signaling pathway [GO:0050853]; cellular response to hydrogen peroxide [GO:0070301]; establishment of protein localization [GO:0045184]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; multicellular organism growth [GO:0035264]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; roof of mouth development [GO:0060021]; ruffle organization [GO:0031529]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phospholipid binding [GO:0005543]; androgen metabolic process [GO:0008209]; B cell receptor signaling pathway [GO:0050853]; cellular response to hydrogen peroxide [GO:0070301]; establishment of protein localization [GO:0045184]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; multicellular organism growth [GO:0035264]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; roof of mouth development [GO:0060021]; ruffle organization [GO:0031529]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Highly expressed in skeletal muscle, thymus, pancreas, placenta and lung. Detected at low levels in brain, heart, peripheral blood leukocytes, testis, ovary, spinal cord, thyroid, kidney, liver, small intestine and colon. {ECO:0000269|PubMed:11001876, ECO:0000269|PubMed:12101241}."
"1123","sp|Q86W54|SPA24_HUMAN","lcl|NC_088860.1_cds_XP_011414581.2_40975",2.81e-23,94.7,"Q86W54","SPA24_HUMAN","Spermatogenesis-associated protein 24 (Testis protein T6441 homolog)","SPATA24","Homo sapiens (Human)",205,"GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007283; GO:0030154; GO:0042802","cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","","","",""
"1124","sp|Q7T019|DZIP1_DANRE","lcl|NC_088860.1_cds_XP_011415397.3_42318",2.81e-41,165,"Q7T019","DZIP1_DANRE","Cilium assembly protein DZIP1 (DAZ-interacting protein 1 homolog) (DAZ-interacting zinc finger protein 1) (Iguana protein)","dzip1 igu si:dz52i16.1","Danio rerio (Zebrafish) (Brachydanio rerio)",898,"GO:0001568; GO:0001947; GO:0003143; GO:0005634; GO:0005737; GO:0005814; GO:0006607; GO:0007368; GO:0008270; GO:0008589; GO:0021984; GO:0030510; GO:0031290; GO:0032053; GO:0034451; GO:0035082; GO:0036064; GO:0060090; GO:0060271; GO:0061371; GO:0062063; GO:0097730; GO:0120316; GO:0140706","adenohypophysis development [GO:0021984]; axoneme assembly [GO:0035082]; blood vessel development [GO:0001568]; ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; embryonic heart tube morphogenesis [GO:0003143]; heart looping [GO:0001947]; NLS-bearing protein import into nucleus [GO:0006607]; protein-containing complex localization to centriolar satellite [GO:0140706]; regulation of BMP signaling pathway [GO:0030510]; regulation of smoothened signaling pathway [GO:0008589]; retinal ganglion cell axon guidance [GO:0031290]; sperm flagellum assembly [GO:0120316]","centriolar satellite [GO:0034451]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; BBSome binding [GO:0062063]; molecular adaptor activity [GO:0060090]; zinc ion binding [GO:0008270]; adenohypophysis development [GO:0021984]; axoneme assembly [GO:0035082]; blood vessel development [GO:0001568]; ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; embryonic heart tube morphogenesis [GO:0003143]; heart looping [GO:0001947]; NLS-bearing protein import into nucleus [GO:0006607]; protein-containing complex localization to centriolar satellite [GO:0140706]; regulation of BMP signaling pathway [GO:0030510]; regulation of smoothened signaling pathway [GO:0008589]; retinal ganglion cell axon guidance [GO:0031290]; sperm flagellum assembly [GO:0120316]","","","","TISSUE SPECIFICITY: Expressed throughout the embryo starting at 12 hours. {ECO:0000269|PubMed:15115751}."
"1125","sp|Q09406|A16L2_CAEEL","lcl|NC_088860.1_cds_XP_011417029.3_43681",2.18e-71,239,"Q09406","A16L2_CAEEL","Autophagic-related protein 16.2","atg-16.2 K06A1.5","Caenorhabditis elegans",534,"GO:0000045; GO:0000421; GO:0005737; GO:0005886; GO:0006914; GO:0016236; GO:0034045; GO:0034274; GO:0035973; GO:0036093; GO:0042078; GO:0043495; GO:0050830","aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; defense response to Gram-positive bacterium [GO:0050830]; germ cell proliferation [GO:0036093]; germ-line stem cell division [GO:0042078]; macroautophagy [GO:0016236]","Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; phagophore assembly site membrane [GO:0034045]; plasma membrane [GO:0005886]; protein-membrane adaptor activity [GO:0043495]; aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; defense response to Gram-positive bacterium [GO:0050830]; germ cell proliferation [GO:0036093]; germ-line stem cell division [GO:0042078]; macroautophagy [GO:0016236]","DEVELOPMENTAL STAGE: Expressed throughout development. {ECO:0000305|PubMed:24185444}.","","","TISSUE SPECIFICITY: Expressed in neurons, pharyngeal muscles, body wall muscle cells and intestinal cells. {ECO:0000269|PubMed:24185444}."
"1126","sp|P70318|TIAR_MOUSE","lcl|NC_088860.1_cds_XP_011417054.1_42133",7.21e-118,349,"P70318","TIAR_MOUSE","Nucleolysin TIAR (TIA-1-related protein)","Tial1","Mus musculus (Mouse)",392,"GO:0003677; GO:0005634; GO:0005737; GO:0006915; GO:0007281; GO:0010494; GO:0017145; GO:0035925; GO:0044194; GO:0072089; GO:2000648","apoptotic process [GO:0006915]; germ cell development [GO:0007281]; positive regulation of stem cell proliferation [GO:2000648]; stem cell division [GO:0017145]; stem cell proliferation [GO:0072089]","cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; DNA binding [GO:0003677]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; apoptotic process [GO:0006915]; germ cell development [GO:0007281]; positive regulation of stem cell proliferation [GO:2000648]; stem cell division [GO:0017145]; stem cell proliferation [GO:0072089]","","","","TISSUE SPECIFICITY: Expressed both in primordial germ cells (PGCs) and in neighboring somatic cells. {ECO:0000269|PubMed:19861488}."
"1127","sp|P36877|2ABB_RAT","lcl|NC_088860.1_cds_XP_011417060.1_42132",0,712,"P36877","2ABB_RAT","Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform (PP2A subunit B isoform B55-beta) (PP2A subunit B isoform BRB) (PP2A subunit B isoform PR55-beta) (PP2A subunit B isoform R2-beta) (PP2A subunit B isoform beta)","Ppp2r2b","Rattus norvegicus (Rat)",443,"GO:0000159; GO:0000266; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0005856; GO:0006626; GO:0007286; GO:0019888; GO:0030182; GO:0043525; GO:0043653; GO:0044877","mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; neuron differentiation [GO:0030182]; positive regulation of neuron apoptotic process [GO:0043525]; protein targeting to mitochondrion [GO:0006626]; spermatid development [GO:0007286]","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; protein-containing complex binding [GO:0044877]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; neuron differentiation [GO:0030182]; positive regulation of neuron apoptotic process [GO:0043525]; protein targeting to mitochondrion [GO:0006626]; spermatid development [GO:0007286]","","INDUCTION: Up-regulated postnatally and in response to neuronal differentiation. {ECO:0000269|PubMed:12716901}.","INDUCTION: Up-regulated postnatally and in response to neuronal differentiation. {ECO:0000269|PubMed:12716901}.","TISSUE SPECIFICITY: Expressed in the brain. Isoform 1 and isoform 2 are expressed in the forbrain. Isoform 1 is more strongly expressed than isoform 2 in the olfactory bulb. Isoform 1 and isoform 2 are weakly expressed in the cerebellum. Isoform 1 is expressed in the testis. Isoform 2 expression is undetectable at birth rising to adult level at day 14. {ECO:0000269|PubMed:12716901, ECO:0000269|PubMed:8389301}."
"1128","sp|Q9R159|ADA25_MOUSE","lcl|NC_088860.1_cds_XP_011417717.3_42093",6.08e-82,286,"Q9R159","ADA25_MOUSE","Disintegrin and metalloproteinase domain-containing protein 25 (ADAM 25) (EC 3.4.24.-) (Testase-2)","Adam25","Mus musculus (Mouse)",760,"GO:0004222; GO:0005178; GO:0006508; GO:0007283; GO:0008237; GO:0016020; GO:0030154; GO:0046872","cell differentiation [GO:0030154]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]","membrane [GO:0016020]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; cell differentiation [GO:0030154]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Adult levels are reached by day 25 after birth.","","","TISSUE SPECIFICITY: Expressed specifically in testis."
"1129","sp|P22561|WT1_MOUSE","lcl|NC_088860.1_cds_XP_011420212.3_43244",7.68e-31,126,"P22561","WT1_MOUSE","Wilms tumor protein homolog","Wt1 Wt-1","Mus musculus (Mouse)",449,"GO:0000122; GO:0000976; GO:0001228; GO:0001570; GO:0001656; GO:0001657; GO:0001658; GO:0001822; GO:0001823; GO:0003156; GO:0003690; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006355; GO:0006357; GO:0006915; GO:0007281; GO:0007283; GO:0007338; GO:0007356; GO:0007507; GO:0007530; GO:0008270; GO:0008380; GO:0008406; GO:0008584; GO:0009888; GO:0010385; GO:0010468; GO:0016607; GO:0017148; GO:0030308; GO:0030317; GO:0030325; GO:0030539; GO:0030855; GO:0032835; GO:0035802; GO:0043010; GO:0043065; GO:0043066; GO:0043565; GO:0044729; GO:0045892; GO:0045893; GO:0045944; GO:0060009; GO:0060231; GO:0060421; GO:0060539; GO:0060923; GO:0060976; GO:0061032; GO:0070742; GO:0071371; GO:0072015; GO:0072075; GO:0072112; GO:0072166; GO:0072278; GO:0072284; GO:0072302; GO:0072520; GO:1900200; GO:1900212; GO:2000020; GO:2000195; GO:2001076","adrenal cortex formation [GO:0035802]; adrenal gland development [GO:0030325]; apoptotic process [GO:0006915]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye development [GO:0043010]; cardiac muscle cell fate commitment [GO:0060923]; cellular response to gonadotropin stimulus [GO:0071371]; coronary vasculature development [GO:0060976]; diaphragm development [GO:0060539]; epithelial cell differentiation [GO:0030855]; flagellated sperm motility [GO:0030317]; germ cell development [GO:0007281]; glomerulus development [GO:0032835]; gonad development [GO:0008406]; heart development [GO:0007507]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; mesenchymal cell apoptotic process involved in metanephros development [GO:1900200]; mesenchymal to epithelial transition [GO:0060231]; mesonephros development [GO:0001823]; metanephric comma-shaped body morphogenesis [GO:0072278]; metanephric mesenchyme development [GO:0072075]; metanephric S-shaped body morphogenesis [GO:0072284]; metanephros development [GO:0001656]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of female gonad development [GO:2000195]; negative regulation of mesenchymal cell apoptotic process involved in metanephros development [GO:1900212]; negative regulation of metanephric glomerular mesangial cell proliferation [GO:0072302]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; podocyte development [GO:0072015]; podocyte differentiation [GO:0072112]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of heart growth [GO:0060421]; positive regulation of male gonad development [GO:2000020]; positive regulation of metanephric ureteric bud development [GO:2001076]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior mesonephric tubule development [GO:0072166]; regulation of animal organ formation [GO:0003156]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; sex determination [GO:0007530]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; thorax and anterior abdomen determination [GO:0007356]; tissue development [GO:0009888]; ureteric bud development [GO:0001657]; vasculogenesis [GO:0001570]; visceral serous pericardium development [GO:0061032]","cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; adrenal cortex formation [GO:0035802]; adrenal gland development [GO:0030325]; apoptotic process [GO:0006915]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye development [GO:0043010]; cardiac muscle cell fate commitment [GO:0060923]; cellular response to gonadotropin stimulus [GO:0071371]; coronary vasculature development [GO:0060976]; diaphragm development [GO:0060539]; epithelial cell differentiation [GO:0030855]; flagellated sperm motility [GO:0030317]; germ cell development [GO:0007281]; glomerulus development [GO:0032835]; gonad development [GO:0008406]; heart development [GO:0007507]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; mesenchymal cell apoptotic process involved in metanephros development [GO:1900200]; mesenchymal to epithelial transition [GO:0060231]; mesonephros development [GO:0001823]; metanephric comma-shaped body morphogenesis [GO:0072278]; metanephric mesenchyme development [GO:0072075]; metanephric S-shaped body morphogenesis [GO:0072284]; metanephros development [GO:0001656]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of female gonad development [GO:2000195]; negative regulation of mesenchymal cell apoptotic process involved in metanephros development [GO:1900212]; negative regulation of metanephric glomerular mesangial cell proliferation [GO:0072302]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; podocyte development [GO:0072015]; podocyte differentiation [GO:0072112]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of heart growth [GO:0060421]; positive regulation of male gonad development [GO:2000020]; positive regulation of metanephric ureteric bud development [GO:2001076]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior mesonephric tubule development [GO:0072166]; regulation of animal organ formation [GO:0003156]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; sex determination [GO:0007530]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; thorax and anterior abdomen determination [GO:0007356]; tissue development [GO:0009888]; ureteric bud development [GO:0001657]; vasculogenesis [GO:0001570]; visceral serous pericardium development [GO:0061032]","DEVELOPMENTAL STAGE: Expressed in the coelomic epithelium and within some mesonephric tubules of the genital ridge at 10 dpc. Expressed during kidney development. {ECO:0000269|PubMed:17537799, ECO:0000269|PubMed:19457926}.","","","TISSUE SPECIFICITY: Detected in neurons of the embryonic dorsal root ganglion and in Sertoli cells of the adult testis (at protein level). Detected in kidney. {ECO:0000269|PubMed:16467207}."
"1130","sp|Q9BVM2|DPCD_HUMAN","lcl|NC_088860.1_cds_XP_011423586.3_42863",1.7e-85,252,"Q9BVM2","DPCD_HUMAN","Protein DPCD","DPCD","Homo sapiens (Human)",203,"GO:0003351; GO:0005576; GO:0005634; GO:0007283; GO:0007368; GO:0021670; GO:0021678; GO:0030317; GO:0051649","determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; lateral ventricle development [GO:0021670]; spermatogenesis [GO:0007283]; third ventricle development [GO:0021678]","extracellular region [GO:0005576]; nucleus [GO:0005634]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; lateral ventricle development [GO:0021670]; spermatogenesis [GO:0007283]; third ventricle development [GO:0021678]","","","","TISSUE SPECIFICITY: Highly expressed in the testis. Weakly expressed in pancreas, skeletal muscle and heart. Expression increases during ciliated cell differentiation. {ECO:0000269|PubMed:14630615}."
"1131","sp|Q24523|BUN2_DROME","lcl|NC_088860.1_cds_XP_011425949.3_44969",5.86e-18,90.9,"Q24523","BUN2_DROME","Protein bunched, class 2/F/G isoform (Protein shortsighted)","bun shs CG42281","Drosophila melanogaster (Fruit fly)",1331,"GO:0001751; GO:0002052; GO:0005634; GO:0005829; GO:0006357; GO:0007297; GO:0007304; GO:0008284; GO:0008340; GO:0009996; GO:0016319; GO:0030307; GO:0036335; GO:0042246; GO:0042803; GO:0043066; GO:0046843","chorion-containing eggshell formation [GO:0007304]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; follicle cell of egg chamber migration [GO:0007297]; intestinal stem cell homeostasis [GO:0036335]; mushroom body development [GO:0016319]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell fate specification [GO:0009996]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]","cytosol [GO:0005829]; nucleus [GO:0005634]; protein homodimerization activity [GO:0042803]; chorion-containing eggshell formation [GO:0007304]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; follicle cell of egg chamber migration [GO:0007297]; intestinal stem cell homeostasis [GO:0036335]; mushroom body development [GO:0016319]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell fate specification [GO:0009996]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]","","","",""
"1132","sp|Q02645|HTS_DROME","lcl|NC_088860.1_cds_XP_011425989.1_43165",5.18e-176,540,"Q02645","HTS_DROME","Protein hu-li tai shao (Adducin-like protein)","hts CG9325","Drosophila melanogaster (Fruit fly)",1156,"GO:0000212; GO:0005737; GO:0005856; GO:0005886; GO:0007098; GO:0007282; GO:0007294; GO:0007411; GO:0007527; GO:0008302; GO:0014069; GO:0016328; GO:0030723; GO:0030724; GO:0035183; GO:0045169; GO:0045170; GO:0045172; GO:0045214; GO:0045478; GO:0048134; GO:0048135; GO:0048477; GO:0051015; GO:0061572; GO:0072499; GO:0098793; GO:0098794; GO:0099173","actin filament bundle organization [GO:0061572]; adult somatic muscle development [GO:0007527]; axon guidance [GO:0007411]; centrosome cycle [GO:0007098]; cystoblast division [GO:0007282]; female germ-line cyst formation [GO:0048135]; female germline ring canal formation, actin assembly [GO:0008302]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived oocyte fate determination [GO:0007294]; meiotic spindle organization [GO:0000212]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; photoreceptor cell axon guidance [GO:0072499]; postsynapse organization [GO:0099173]; sarcomere organization [GO:0045214]; testicular fusome organization [GO:0030724]","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; female germline ring canal inner rim [GO:0035183]; fusome [GO:0045169]; germline ring canal [GO:0045172]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; spectrosome [GO:0045170]; actin filament binding [GO:0051015]; actin filament bundle organization [GO:0061572]; adult somatic muscle development [GO:0007527]; axon guidance [GO:0007411]; centrosome cycle [GO:0007098]; cystoblast division [GO:0007282]; female germ-line cyst formation [GO:0048135]; female germline ring canal formation, actin assembly [GO:0008302]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived oocyte fate determination [GO:0007294]; meiotic spindle organization [GO:0000212]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; photoreceptor cell axon guidance [GO:0072499]; postsynapse organization [GO:0099173]; sarcomere organization [GO:0045214]; testicular fusome organization [GO:0030724]","DEVELOPMENTAL STAGE: Oogenesis and early embryogenesis.","","","TISSUE SPECIFICITY: Isoform C is expressed in nurse cells. Isoform A is produced in the nurse cell but transported into the oocyte at stage 1, localizes to the oocyte cortex at stage 8 and to the anterior pole from day 9 onwards. Isoform B is expressed in the somatic follicle cells that surround the germline. {ECO:0000269|PubMed:10504343}."
"1133","sp|O61742|PSMD4_CAEEL","lcl|NC_088860.1_cds_XP_011426140.1_44439",8.55e-78,244,"O61742","PSMD4_CAEEL","26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit rpn-10)","rpn-10 B0205.3","Caenorhabditis elegans",346,"GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0007283; GO:0008540; GO:0031593; GO:0043161","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome regulatory particle, base subcomplex [GO:0008540]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]","","","","TISSUE SPECIFICITY: Broadly expressed with high expression in the pharynx, intestine, hypodermis and spermatheca and weak expression in the excretory cell, body wall muscle, vulva and somatic gonad. {ECO:0000269|PubMed:26828939}."
"1134","sp|O44406|ERI1_CAEEL","lcl|NC_088860.1_cds_XP_011426165.3_44438",1.38e-56,195,"O44406","ERI1_CAEEL","3'-5' exonuclease eri-1 (EC 3.1.-.-) (Enhanced RNAi protein)","eri-1 T07A9.5","Caenorhabditis elegans",582,"GO:0000175; GO:0000467; GO:0003676; GO:0003723; GO:0005737; GO:0006401; GO:0007281; GO:0035194; GO:0045132; GO:0048609; GO:1900369","exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; germ cell development [GO:0007281]; meiotic chromosome segregation [GO:0045132]; multicellular organismal reproductive process [GO:0048609]; negative regulation of post-transcriptional gene silencing by regulatory ncRNA [GO:1900369]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; RNA catabolic process [GO:0006401]","cytoplasm [GO:0005737]; 3'-5'-RNA exonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; germ cell development [GO:0007281]; meiotic chromosome segregation [GO:0045132]; multicellular organismal reproductive process [GO:0048609]; negative regulation of post-transcriptional gene silencing by regulatory ncRNA [GO:1900369]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; RNA catabolic process [GO:0006401]","","","","TISSUE SPECIFICITY: Expressed in the somatic developing gonads and in a subset of neurons. In adults, it is specifically expressed in neurons and in spermatheca. {ECO:0000269|PubMed:14961122}."
"1135","sp|O88846|RNF4_RAT","lcl|NC_088860.1_cds_XP_011428373.1_42536",2.47e-19,82.8,"O88846","RNF4_RAT","E3 ubiquitin-protein ligase RNF4 (EC 2.3.2.27) (RING finger protein 4) (Small nuclear ring finger protein) (Protein SNURF)","Rnf4 Snurf","Rattus norvegicus (Rat)",194,"GO:0003677; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0007283; GO:0008270; GO:0008584; GO:0016567; GO:0016605; GO:0017025; GO:0030331; GO:0031491; GO:0031624; GO:0032184; GO:0032355; GO:0042802; GO:0043161; GO:0044752; GO:0045893; GO:0045944; GO:0046685; GO:0050681; GO:0051865; GO:0061630; GO:0070534; GO:0070936; GO:0070979; GO:0071243; GO:0071345; GO:0071394; GO:0071480; GO:0072711; GO:0085020; GO:0090169; GO:0090234; GO:0120186","cellular response to arsenic-containing substance [GO:0071243]; cellular response to cytokine stimulus [GO:0071345]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to testosterone stimulus [GO:0071394]; male gonad development [GO:0008584]; negative regulation of protein localization to chromatin [GO:0120186]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169]; response to arsenic-containing substance [GO:0046685]; response to estradiol [GO:0032355]; response to human chorionic gonadotropin [GO:0044752]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; nuclear androgen receptor binding [GO:0050681]; nuclear estrogen receptor binding [GO:0030331]; nucleosome binding [GO:0031491]; SUMO polymer binding [GO:0032184]; TBP-class protein binding [GO:0017025]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cytokine stimulus [GO:0071345]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to testosterone stimulus [GO:0071394]; male gonad development [GO:0008584]; negative regulation of protein localization to chromatin [GO:0120186]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169]; response to arsenic-containing substance [GO:0046685]; response to estradiol [GO:0032355]; response to human chorionic gonadotropin [GO:0044752]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Widely expressed with highest levels in testis. {ECO:0000269|PubMed:9710597}."
"1136","sp|Q4KLH5|AGFG1_RAT","lcl|NC_088860.1_cds_XP_011431534.3_42040",1.27e-66,229,"Q4KLH5","AGFG1_RAT","Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein homolog) (Nucleoporin-like protein RIP)","Agfg1 Agfg1-ps1 Hrb Rip","Rattus norvegicus (Rat)",561,"GO:0001675; GO:0003677; GO:0005096; GO:0005634; GO:0005737; GO:0007289; GO:0008270; GO:0031410; GO:0042995; GO:0043025; GO:0045109","acrosome assembly [GO:0001675]; intermediate filament organization [GO:0045109]; spermatid nucleus differentiation [GO:0007289]","cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]; acrosome assembly [GO:0001675]; intermediate filament organization [GO:0045109]; spermatid nucleus differentiation [GO:0007289]","","","",""
"1137","sp|Q19969|IMA3_CAEEL","lcl|NC_088860.1_cds_XP_011432419.1_44916",0,630,"Q19969","IMA3_CAEEL","Importin subunit alpha-3 (Karyopherin subunit alpha-3)","ima-3 F32E10.4","Caenorhabditis elegans",514,"GO:0002119; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0006606; GO:0006607; GO:0006999; GO:0007127; GO:0007276; GO:0007292; GO:0008139; GO:0009792; GO:0022414; GO:0048477; GO:0048691; GO:0061608; GO:0140297","embryo development ending in birth or egg hatching [GO:0009792]; female gamete generation [GO:0007292]; gamete generation [GO:0007276]; meiosis I [GO:0007127]; nematode larval development [GO:0002119]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; oogenesis [GO:0048477]; positive regulation of axon extension involved in regeneration [GO:0048691]; protein import into nucleus [GO:0006606]; reproductive process [GO:0022414]","cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; embryo development ending in birth or egg hatching [GO:0009792]; female gamete generation [GO:0007292]; gamete generation [GO:0007276]; meiosis I [GO:0007127]; nematode larval development [GO:0002119]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; oogenesis [GO:0048477]; positive regulation of axon extension involved in regeneration [GO:0048691]; protein import into nucleus [GO:0006606]; reproductive process [GO:0022414]","DEVELOPMENTAL STAGE: Expressed at high levels throughout all developmental stages. {ECO:0000269|PubMed:11311162}.","","","TISSUE SPECIFICITY: Expressed in larval and adult germline and somatic tissues, including neurons. {ECO:0000269|PubMed:11311162, ECO:0000269|PubMed:31417366}."
"1138","sp|Q9JJZ1|SL2A8_RAT","lcl|NC_088860.1_cds_XP_011433649.1_40705",2.67e-99,307,"Q9JJZ1","SL2A8_RAT","Solute carrier family 2, facilitated glucose transporter member 8 (Glucose transporter type 8) (GLUT-8) (Glucose transporter type X1)","Slc2a8 Glut8 Glutx1","Rattus norvegicus (Rat)",478,"GO:0001666; GO:0005353; GO:0005536; GO:0005886; GO:0007141; GO:0008021; GO:0008286; GO:0015755; GO:0016020; GO:0030659; GO:0033300; GO:0055056; GO:0070837; GO:1904659","D-glucose transmembrane transport [GO:1904659]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; insulin receptor signaling pathway [GO:0008286]; male meiosis I [GO:0007141]; response to hypoxia [GO:0001666]","cytoplasmic vesicle membrane [GO:0030659]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; D-glucose binding [GO:0005536]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; D-glucose transmembrane transport [GO:1904659]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; insulin receptor signaling pathway [GO:0008286]; male meiosis I [GO:0007141]; response to hypoxia [GO:0001666]","","","","TISSUE SPECIFICITY: Highly expressed in adult and pubertal testis, but not prepubertal testis (PubMed:10821868). Moderate expression in hypothalamus, cerebellum, brainstem, hippocampus, and adrenal gland (PubMed:10821868). Lower amounts present in most other tissues (PubMed:10821868). {ECO:0000269|PubMed:10821868}."
"1139","sp|Q2T9V2|DRC9_BOVIN","lcl|NC_088860.1_cds_XP_011434766.1_41120",7.51e-65,214,"Q2T9V2","DRC9_BOVIN","Dynein regulatory complex protein 9 (IQ domain-containing protein G)","IQCG DRC9","Bos taurus (Bovine)",437,"GO:0002177; GO:0005516; GO:0005737; GO:0007286; GO:0007288; GO:0031514; GO:0036126; GO:0044782","cilium organization [GO:0044782]; sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286]","cytoplasm [GO:0005737]; manchette [GO:0002177]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; calmodulin binding [GO:0005516]; cilium organization [GO:0044782]; sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286]","","","",""
"1140","sp|Q9H095|DRC9_HUMAN","lcl|NC_088860.1_cds_XP_011434767.1_41121",2.29e-89,278,"Q9H095","DRC9_HUMAN","Dynein regulatory complex protein 9 (IQ domain-containing protein G)","IQCG DRC9","Homo sapiens (Human)",443,"GO:0002177; GO:0005516; GO:0005737; GO:0005829; GO:0007286; GO:0007288; GO:0015629; GO:0030544; GO:0031514; GO:0036126; GO:0044782; GO:0070062","cilium organization [GO:0044782]; sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286]","actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; manchette [GO:0002177]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; calmodulin binding [GO:0005516]; Hsp70 protein binding [GO:0030544]; cilium organization [GO:0044782]; sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286]","","","",""
"1141","sp|Q9VNX8|EIF2A_DROME","lcl|NC_088860.1_cds_XP_011435292.2_41102",2.88e-121,373,"Q9VNX8","EIF2A_DROME","Eukaryotic translation initiation factor 2A (eIF-2A)","eIF2A CG7414","Drosophila melanogaster (Fruit fly)",638,"GO:0000049; GO:0003729; GO:0003743; GO:0005737; GO:0006413; GO:0006417; GO:0007291; GO:0022627; GO:0043022","regulation of translation [GO:0006417]; sperm individualization [GO:0007291]; translational initiation [GO:0006413]","cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; mRNA binding [GO:0003729]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049]; regulation of translation [GO:0006417]; sperm individualization [GO:0007291]; translational initiation [GO:0006413]","","","",""
"1142","sp|O44081|DKC1_DROME","lcl|NC_088860.1_cds_XP_011435929.1_42510",0,580,"O44081","DKC1_DROME","H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (Nucleolar protein at 60B) (Protein minifly)","Nop60B mfl CG3333","Drosophila melanogaster (Fruit fly)",508,"GO:0000495; GO:0001522; GO:0003723; GO:0005730; GO:0006364; GO:0007281; GO:0009982; GO:0031118; GO:0031120; GO:0031429; GO:0035220; GO:0042254; GO:1990481","box H/ACA sno(s)RNA 3'-end processing [GO:0000495]; germ cell development [GO:0007281]; mRNA pseudouridine synthesis [GO:1990481]; pseudouridine synthesis [GO:0001522]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]; wing disc development [GO:0035220]","box H/ACA snoRNP complex [GO:0031429]; nucleolus [GO:0005730]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; box H/ACA sno(s)RNA 3'-end processing [GO:0000495]; germ cell development [GO:0007281]; mRNA pseudouridine synthesis [GO:1990481]; pseudouridine synthesis [GO:0001522]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]; wing disc development [GO:0035220]","DEVELOPMENTAL STAGE: During oogenesis expression increases from the cyst stage to early egg chambers (at protein level) (PubMed:37343092). Expressed in germline cells during oogenesis (PubMed:9829824). Highly expressed in embryos (PubMed:10087258). In adults expression is higher in females than in males (PubMed:10087258). {ECO:0000269|PubMed:10087258, ECO:0000269|PubMed:37343092, ECO:0000269|PubMed:9829824}.","","","TISSUE SPECIFICITY: [Isoform A]: Expressed at higher levels in females than in males. {ECO:0000269|PubMed:17328797}.; TISSUE SPECIFICITY: [Isoform MFLalpha]: Expressed almost exclusively in females with high levels of expression in the ovary. {ECO:0000269|PubMed:17328797}."
"1143","sp|Q9XYP8|GCP3_DROME","lcl|NC_088860.1_cds_XP_011436049.2_43685",2.49e-132,421,"Q9XYP8","GCP3_DROME","Gamma-tubulin complex component 3 (Gamma-ring complex protein 91 kDa)","Grip91 l(1)dd4 CG10988","Drosophila melanogaster (Fruit fly)",917,"GO:0000212; GO:0000278; GO:0000922; GO:0000930; GO:0000931; GO:0005813; GO:0005874; GO:0007020; GO:0007140; GO:0008275; GO:0031122; GO:0043015; GO:0048471; GO:0051225; GO:0051321; GO:0090221","cytoplasmic microtubule organization [GO:0031122]; male meiotic nuclear division [GO:0007140]; meiotic cell cycle [GO:0051321]; meiotic spindle organization [GO:0000212]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic spindle-templated microtubule nucleation [GO:0090221]; spindle assembly [GO:0051225]","centrosome [GO:0005813]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0000931]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; cytoplasmic microtubule organization [GO:0031122]; male meiotic nuclear division [GO:0007140]; meiotic cell cycle [GO:0051321]; meiotic spindle organization [GO:0000212]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic spindle-templated microtubule nucleation [GO:0090221]; spindle assembly [GO:0051225]","","","",""
"1144","sp|E1BHJ4|CP26B_BOVIN","lcl|NC_088860.1_cds_XP_011436768.3_43633",6.76e-117,355,"E1BHJ4","CP26B_BOVIN","Cytochrome P450 26B1 (EC 1.14.13.-)","CYP26B1","Bos taurus (Bovine)",512,"GO:0001709; GO:0001768; GO:0001972; GO:0004497; GO:0005506; GO:0005789; GO:0006805; GO:0006954; GO:0007140; GO:0007283; GO:0007417; GO:0008401; GO:0009954; GO:0010628; GO:0016709; GO:0020037; GO:0030326; GO:0034653; GO:0042573; GO:0043587; GO:0045580; GO:0048384; GO:0048387; GO:0060349; GO:0061436; GO:0062183; GO:0070268; GO:0071300; GO:2001037","bone morphogenesis [GO:0060349]; cell fate determination [GO:0001709]; cellular response to retinoic acid [GO:0071300]; central nervous system development [GO:0007417]; cornification [GO:0070268]; embryonic limb morphogenesis [GO:0030326]; establishment of skin barrier [GO:0061436]; establishment of T cell polarity [GO:0001768]; inflammatory response [GO:0006954]; male meiotic nuclear division [GO:0007140]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; positive regulation of gene expression [GO:0010628]; positive regulation of tongue muscle cell differentiation [GO:2001037]; proximal/distal pattern formation [GO:0009954]; regulation of T cell differentiation [GO:0045580]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; retinoic acid receptor signaling pathway [GO:0048384]; spermatogenesis [GO:0007283]; tongue morphogenesis [GO:0043587]; xenobiotic metabolic process [GO:0006805]","endoplasmic reticulum membrane [GO:0005789]; all-trans retinoic acid 18-hydroxylase activity [GO:0062183]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; bone morphogenesis [GO:0060349]; cell fate determination [GO:0001709]; cellular response to retinoic acid [GO:0071300]; central nervous system development [GO:0007417]; cornification [GO:0070268]; embryonic limb morphogenesis [GO:0030326]; establishment of skin barrier [GO:0061436]; establishment of T cell polarity [GO:0001768]; inflammatory response [GO:0006954]; male meiotic nuclear division [GO:0007140]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; positive regulation of gene expression [GO:0010628]; positive regulation of tongue muscle cell differentiation [GO:2001037]; proximal/distal pattern formation [GO:0009954]; regulation of T cell differentiation [GO:0045580]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; retinoic acid receptor signaling pathway [GO:0048384]; spermatogenesis [GO:0007283]; tongue morphogenesis [GO:0043587]; xenobiotic metabolic process [GO:0006805]","","","",""
"1145","sp|Q17848|I5P1_CAEEL","lcl|NC_088860.1_cds_XP_011438453.2_43568",2.29e-75,242,"Q17848","I5P1_CAEEL","Probable type I inositol 1,4,5-trisphosphate 5-phosphatase (5PTase) (EC 3.1.3.56)","ipp-5 C09B8.1","Caenorhabditis elegans",409,"GO:0004445; GO:0030728; GO:0042059; GO:0046856; GO:0052658; GO:0052659; GO:0052745","negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; ovulation [GO:0030728]; phosphatidylinositol dephosphorylation [GO:0046856]","inositol phosphate phosphatase activity [GO:0052745]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; ovulation [GO:0030728]; phosphatidylinositol dephosphorylation [GO:0046856]","","","",""
"1146","sp|P30306|MPIP2_MOUSE","lcl|NC_088860.1_cds_XP_011440891.3_40872",2.15e-73,245,"P30306","MPIP2_MOUSE","M-phase inducer phosphatase 2 (EC 3.1.3.48) (Dual specificity phosphatase Cdc25B)","Cdc25b Cdc25m2","Mus musculus (Mouse)",576,"GO:0000922; GO:0001556; GO:0004721; GO:0004725; GO:0005634; GO:0005737; GO:0005813; GO:0007144; GO:0010971; GO:0019901; GO:0032467; GO:0051301","cell division [GO:0051301]; female meiosis I [GO:0007144]; oocyte maturation [GO:0001556]; positive regulation of cytokinesis [GO:0032467]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]","centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle pole [GO:0000922]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cell division [GO:0051301]; female meiosis I [GO:0007144]; oocyte maturation [GO:0001556]; positive regulation of cytokinesis [GO:0032467]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]","DEVELOPMENTAL STAGE: Detected at the one-cell stage followed by a decrease in signal intensity at the two-cell stage. Detectable at higher level in the four-cell stage and expressed through the eight-cell, 16-cell and morula stages. Maximal expression at the blastocyst stage. {ECO:0000269|PubMed:1313771}.","","","TISSUE SPECIFICITY: Expressed predominantly in spleen, lung, heart, brain, intestine, and muscle. {ECO:0000269|PubMed:1313771}."
"1147","sp|A1A5Q4|CF206_RAT","lcl|NC_088860.1_cds_XP_011442159.1_41049",0,826,"A1A5Q4","CF206_RAT","Cilia- and flagella-associated protein 206","Cfap206","Rattus norvegicus (Rat)",622,"GO:0001534; GO:0003341; GO:0003356; GO:0005930; GO:0007288; GO:0031514; GO:0035082; GO:0036064; GO:1901317","axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; regulation of cilium beat frequency [GO:0003356]; regulation of flagellated sperm motility [GO:1901317]; sperm axoneme assembly [GO:0007288]","axoneme [GO:0005930]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514]; radial spoke [GO:0001534]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; regulation of cilium beat frequency [GO:0003356]; regulation of flagellated sperm motility [GO:1901317]; sperm axoneme assembly [GO:0007288]","","","",""
"1148","sp|O18334|RAB6_DROME","lcl|NC_088860.1_cds_XP_011443600.1_40833",5.95e-134,375,"O18334","RAB6_DROME","Ras-related protein Rab6 (Protein warthog)","Rab6 wrt CG6601","Drosophila melanogaster (Fruit fly)",208,"GO:0000139; GO:0001745; GO:0001881; GO:0003779; GO:0003924; GO:0005525; GO:0005764; GO:0005776; GO:0005794; GO:0005829; GO:0006886; GO:0006887; GO:0006890; GO:0006891; GO:0007293; GO:0007411; GO:0007602; GO:0008103; GO:0012505; GO:0016192; GO:0031410; GO:0032482; GO:0042147; GO:0043025; GO:0043204; GO:0045202; GO:0045451; GO:0045467; GO:0060078; GO:0140450","axon guidance [GO:0007411]; compound eye morphogenesis [GO:0001745]; exocytosis [GO:0006887]; germarium-derived egg chamber formation [GO:0007293]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; oocyte microtubule cytoskeleton polarization [GO:0008103]; phototransduction [GO:0007602]; pole plasm oskar mRNA localization [GO:0045451]; protein targeting to Golgi apparatus [GO:0140450]; R7 cell development [GO:0045467]; Rab protein signal transduction [GO:0032482]; receptor recycling [GO:0001881]; regulation of postsynaptic membrane potential [GO:0060078]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]","autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; axon guidance [GO:0007411]; compound eye morphogenesis [GO:0001745]; exocytosis [GO:0006887]; germarium-derived egg chamber formation [GO:0007293]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; oocyte microtubule cytoskeleton polarization [GO:0008103]; phototransduction [GO:0007602]; pole plasm oskar mRNA localization [GO:0045451]; protein targeting to Golgi apparatus [GO:0140450]; R7 cell development [GO:0045467]; Rab protein signal transduction [GO:0032482]; receptor recycling [GO:0001881]; regulation of postsynaptic membrane potential [GO:0060078]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]","","","","TISSUE SPECIFICITY: Expressed in larval eye, wing and leg imaginal disks and in salivary gland. Expressed in the larval optic lobe, showing an enrichment in the neuropil. In the adult brain, expressed in photoreceptors and mushroom body. {ECO:0000269|PubMed:21835342, ECO:0000269|PubMed:22000105}."
"1149","sp|Q9VSR3|ORB2_DROME","lcl|NC_088860.1_cds_XP_011443647.2_40475",2.63e-169,501,"Q9VSR3","ORB2_DROME","Translational regulator orb2","orb2 CG43782","Drosophila melanogaster (Fruit fly)",704,"GO:0000900; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005938; GO:0007141; GO:0007283; GO:0007288; GO:0007291; GO:0007616; GO:0008049; GO:0008135; GO:0008356; GO:0008494; GO:0017148; GO:0030424; GO:0032991; GO:0042802; GO:0043005; GO:0043022; GO:0043204; GO:0043679; GO:0044292; GO:0044297; GO:0045202; GO:0045727; GO:0048471; GO:0050821; GO:0097060; GO:0098793; GO:0098794; GO:2000766","asymmetric cell division [GO:0008356]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; male meiosis I [GO:0007141]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727]; protein stabilization [GO:0050821]; sperm axoneme assembly [GO:0007288]; sperm individualization [GO:0007291]; spermatogenesis [GO:0007283]","axon [GO:0030424]; axon terminus [GO:0043679]; cell body [GO:0044297]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite terminus [GO:0044292]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; mRNA regulatory element binding translation repressor activity [GO:0000900]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; translation factor activity, RNA binding [GO:0008135]; asymmetric cell division [GO:0008356]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; male meiosis I [GO:0007141]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727]; protein stabilization [GO:0050821]; sperm axoneme assembly [GO:0007288]; sperm individualization [GO:0007291]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed in 0- to 2-hour-old embryos (at protein level) (PubMed:29317541, PubMed:32165583). Expressed in the larval motor neuron cells in the brain (at protein level) (PubMed:29105522). Expressed throughout development in both the soma and germline. Widely expressed in early embryos with levels dropping during mid-embryogenesis and increasing again in late embryogenesis. Expression is relatively low during larval stages with lowest levels in the first and second instars and an increase during the third instar. Levels increase substantially during the pupal stage and remain relatively high in the adult. In the ovary, little expression in the germarium or previtellogenic stage chambers with levels increasing midway through oogenesis and remaining high until stage 10 (PubMed:21900268). In the testis, there is substantial up-regulation after mitosis is finished and the interconnected spermatocytes begin to grow (PubMed:23209437). Expression peaks as the mature spermatocytes go through meiosis and high levels are found in 32- and 64-cell spermatid cysts with expression persisting after the spermatids in the 64-cell cysts start differentiation and disappearing once elongation and nuclear condensation are completed (PubMed:23209437). {ECO:0000269|PubMed:21900268, ECO:0000269|PubMed:23209437, ECO:0000269|PubMed:29105522, ECO:0000269|PubMed:29317541, ECO:0000269|PubMed:32165583}.","INDUCTION: [Isoform A]: In the adult brain the mRNA is expressed as an unspliced non-protein coding mRNA; inclusion of isoform A-specific exon in the mature transcript is important for long-term memory; mRNA levels depends on behavioral stimulus and splicing depends on the activity of the splicing regulator ps. {ECO:0000305|PubMed:28525754}.","INDUCTION: [Isoform A]: In the adult brain the mRNA is expressed as an unspliced non-protein coding mRNA; inclusion of isoform A-specific exon in the mature transcript is important for long-term memory; mRNA levels depends on behavioral stimulus and splicing depends on the activity of the splicing regulator ps. {ECO:0000305|PubMed:28525754}.","TISSUE SPECIFICITY: Broadly expressed throughout the nervous system of embryo, larva and adult including the ventral nerve cord and brain (at protein level) (PubMed:23083740, PubMed:32165583). In early embryos, deposited maternally and distributed uniformly throughout the embryo until the extended germband stage (PubMed:21900268). By mid-embryogenesis, highest levels are found in the central and peripheral nervous systems with lower expression also detected in the ectoderm and mesoderm (PubMed:21900268). In adults, high levels are present in the head and body of both sexes with higher expression in testis than ovary (PubMed:21900268). In the ovary, expressed in both germ and follicle cells (PubMed:21900268). In adult head, predominantly neuronal with broad expression throughout the brain and ventral ganglia including the mushroom body (PubMed:17965711, PubMed:21900268). {ECO:0000269|PubMed:17965711, ECO:0000269|PubMed:21900268, ECO:0000269|PubMed:23083740, ECO:0000269|PubMed:32165583}."
"1150","sp|O35817|AKA14_RAT","lcl|NC_088860.1_cds_XP_011443684.1_40479",3.75e-34,128,"O35817","AKA14_RAT","A-kinase anchor protein 14 (AKAP-14) (TAKAP-1.2) (Testis-specific A-kinase-anchoring protein TAKAP-80)","Akap14 Takap80","Rattus norvegicus (Rat)",502,"GO:0005930; GO:0005952; GO:0007283; GO:0034237; GO:0035686; GO:0051018","spermatogenesis [GO:0007283]","axoneme [GO:0005930]; cAMP-dependent protein kinase complex [GO:0005952]; sperm fibrous sheath [GO:0035686]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed at detectable levels 30 days after birth and increased greatly during the next 10 days.","","","TISSUE SPECIFICITY: Testis specific. {ECO:0000269|PubMed:9208934}."
"1151","sp|Q6GVM6|DDX3Y_PANTR","lcl|NC_088860.1_cds_XP_011446932.2_44753",0,752,"Q6GVM6","DDX3Y_PANTR","ATP-dependent RNA helicase DDX3Y (EC 3.6.4.13) (DEAD box protein 3, Y-chromosomal)","DDX3Y","Pan troglodytes (Chimpanzee)",660,"GO:0003677; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005829; GO:0007276; GO:0010629; GO:0016887; GO:0030154; GO:0043186","cell differentiation [GO:0030154]; gamete generation [GO:0007276]; negative regulation of gene expression [GO:0010629]","cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; gamete generation [GO:0007276]; negative regulation of gene expression [GO:0010629]","","","",""
"1152","sp|Q24318|TFDP_DROME","lcl|NC_088860.1_cds_XP_011447524.2_41523",3.91e-79,253,"Q24318","TFDP_DROME","Transcription factor Dp","Dp CG4654","Drosophila melanogaster (Fruit fly)",445,"GO:0003677; GO:0005634; GO:0006357; GO:0007113; GO:0007307; GO:0008069; GO:0008630; GO:0010628; GO:0031523; GO:0035189; GO:0045476; GO:0045850; GO:0048477; GO:0051726; GO:0140297","dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; eggshell chorion gene amplification [GO:0007307]; endomitotic cell cycle [GO:0007113]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; nurse cell apoptotic process [GO:0045476]; oogenesis [GO:0048477]; positive regulation of gene expression [GO:0010628]; positive regulation of nurse cell apoptotic process [GO:0045850]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]","Myb complex [GO:0031523]; nucleus [GO:0005634]; Rb-E2F complex [GO:0035189]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; eggshell chorion gene amplification [GO:0007307]; endomitotic cell cycle [GO:0007113]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; nurse cell apoptotic process [GO:0045476]; oogenesis [GO:0048477]; positive regulation of gene expression [GO:0010628]; positive regulation of nurse cell apoptotic process [GO:0045850]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]","","","",""
"1153","sp|Q8WP14|TBB8_PANTR","lcl|NC_088860.1_cds_XP_011448542.1_42798",0,775,"Q8WP14","TBB8_PANTR","Tubulin beta-8 chain","TUBB8","Pan troglodytes (Chimpanzee)",444,"GO:0000226; GO:0000278; GO:0001556; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007056; GO:0045171; GO:0046872; GO:0072686; GO:0072687","microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; oocyte maturation [GO:0001556]; spindle assembly involved in female meiosis [GO:0007056]","cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; oocyte maturation [GO:0001556]; spindle assembly involved in female meiosis [GO:0007056]","","","",""
"1154","sp|P85515|ACTZ_RAT","lcl|NC_088860.1_cds_XP_011448547.1_42803",0,691,"P85515","ACTZ_RAT","Alpha-centractin (Centractin)","Actr1a Ctrn1","Rattus norvegicus (Rat)",376,"GO:0002177; GO:0005524; GO:0005813; GO:0005814; GO:0005869; GO:0005938; GO:0007283; GO:0030137","spermatogenesis [GO:0007283]","cell cortex [GO:0005938]; centriole [GO:0005814]; centrosome [GO:0005813]; COPI-coated vesicle [GO:0030137]; dynactin complex [GO:0005869]; manchette [GO:0002177]; ATP binding [GO:0005524]; spermatogenesis [GO:0007283]","","","",""
"1155","sp|Q5XI58|CALI_RAT","lcl|NC_088860.1_cds_XP_011448572.3_42817",6.52e-29,122,"Q5XI58","CALI_RAT","Calicin","Ccin","Rattus norvegicus (Rat)",588,"GO:0005737; GO:0007283; GO:0030154; GO:0031463; GO:0033150; GO:0043161; GO:1990756","cell differentiation [GO:0030154]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; spermatogenesis [GO:0007283]","Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeletal calyx [GO:0033150]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; cell differentiation [GO:0030154]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; spermatogenesis [GO:0007283]","","","",""
"1156","sp|Q27272|TAF9_DROME","lcl|NC_088860.1_cds_XP_011448610.3_44237",6.11e-45,154,"Q27272","TAF9_DROME","Transcription initiation factor TFIID subunit 9 (Protein enhancer of yellow 1) (TBP-associated factor 9) (Transcription initiation factor TFIID 42 kDa subunit) (TAFII-42) (p42)","Taf9 e(y)1 TAF40 TAFII40 CG6474","Drosophila melanogaster (Fruit fly)",278,"GO:0000124; GO:0001223; GO:0003713; GO:0005634; GO:0005669; GO:0006366; GO:0006367; GO:0030707; GO:0046982; GO:0051123","follicle cell of egg chamber development [GO:0030707]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]","nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFIID complex [GO:0005669]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; follicle cell of egg chamber development [GO:0030707]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]","","","",""
"1157","sp|Q9VCY3|CSN6_DROME","lcl|NC_088860.1_cds_XP_011448612.1_44236",9.69e-158,445,"Q9VCY3","CSN6_DROME","COP9 signalosome complex subunit 6 (Dch6) (Signalosome subunit 6)","CSN6 CG6932","Drosophila melanogaster (Fruit fly)",341,"GO:0000338; GO:0005737; GO:0007281; GO:0008180; GO:0036099; GO:0042802; GO:0048140; GO:0048477; GO:0050821","female germ-line stem cell population maintenance [GO:0036099]; germ cell development [GO:0007281]; male germ-line cyst encapsulation [GO:0048140]; oogenesis [GO:0048477]; protein deneddylation [GO:0000338]; protein stabilization [GO:0050821]","COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; female germ-line stem cell population maintenance [GO:0036099]; germ cell development [GO:0007281]; male germ-line cyst encapsulation [GO:0048140]; oogenesis [GO:0048477]; protein deneddylation [GO:0000338]; protein stabilization [GO:0050821]","","","",""
"1158","sp|Q9UMX1|SUFU_HUMAN","lcl|NC_088860.1_cds_XP_011450234.2_43197",0,530,"Q9UMX1","SUFU_HUMAN","Suppressor of fused homolog (SUFUH)","SUFU UNQ650/PRO1280","Homo sapiens (Human)",484,"GO:0000122; GO:0001843; GO:0001947; GO:0003281; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005929; GO:0006355; GO:0007165; GO:0007286; GO:0008013; GO:0019901; GO:0021775; GO:0021776; GO:0035904; GO:0042308; GO:0043588; GO:0045668; GO:0045879; GO:0060976; GO:0097542; GO:0097546; GO:1990788; GO:2000059; GO:2001040","aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; heart looping [GO:0001947]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neural tube closure [GO:0001843]; positive regulation of cellular response to drug [GO:2001040]; regulation of DNA-templated transcription [GO:0006355]; signal transduction [GO:0007165]; skin development [GO:0043588]; smoothened signaling pathway involved in spinal cord motor neuron cell fate specification [GO:0021776]; smoothened signaling pathway involved in ventral spinal cord interneuron specification [GO:0021775]; spermatid development [GO:0007286]; ventricular septum development [GO:0003281]","ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GLI-SUFU complex [GO:1990788]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; protein kinase binding [GO:0019901]; transcription corepressor activity [GO:0003714]; aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; heart looping [GO:0001947]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neural tube closure [GO:0001843]; positive regulation of cellular response to drug [GO:2001040]; regulation of DNA-templated transcription [GO:0006355]; signal transduction [GO:0007165]; skin development [GO:0043588]; smoothened signaling pathway involved in spinal cord motor neuron cell fate specification [GO:0021776]; smoothened signaling pathway involved in ventral spinal cord interneuron specification [GO:0021775]; spermatid development [GO:0007286]; ventricular septum development [GO:0003281]","","","","TISSUE SPECIFICITY: Ubiquitous in adult tissues. Detected in osteoblasts of the perichondrium in the developing limb of 12-week old embryos. Isoform 1 is detected in fetal brain, lung, kidney and testis. Isoform 2 is detected in fetal testis, and at much lower levels in fetal brain, lung and kidney. {ECO:0000269|PubMed:10559945, ECO:0000269|PubMed:10564661}."
"1159","sp|P70619|GSHR_RAT","lcl|NC_088860.1_cds_XP_011450671.3_44020",0,515,"P70619","GSHR_RAT","Glutathione reductase (GR) (GRase) (EC 1.8.1.7)","Gsr","Rattus norvegicus (Rat)",424,"GO:0002931; GO:0004362; GO:0005739; GO:0005829; GO:0006749; GO:0006979; GO:0007283; GO:0009897; GO:0010041; GO:0014823; GO:0033189; GO:0034599; GO:0035094; GO:0042802; GO:0043295; GO:0045454; GO:0045471; GO:0046686; GO:0050660; GO:0050661","cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glutathione metabolic process [GO:0006749]; response to activity [GO:0014823]; response to cadmium ion [GO:0046686]; response to ethanol [GO:0045471]; response to iron(III) ion [GO:0010041]; response to ischemia [GO:0002931]; response to nicotine [GO:0035094]; response to oxidative stress [GO:0006979]; response to vitamin A [GO:0033189]; spermatogenesis [GO:0007283]","cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; glutathione binding [GO:0043295]; glutathione-disulfide reductase (NADPH) activity [GO:0004362]; identical protein binding [GO:0042802]; NADP binding [GO:0050661]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glutathione metabolic process [GO:0006749]; response to activity [GO:0014823]; response to cadmium ion [GO:0046686]; response to ethanol [GO:0045471]; response to iron(III) ion [GO:0010041]; response to ischemia [GO:0002931]; response to nicotine [GO:0035094]; response to oxidative stress [GO:0006979]; response to vitamin A [GO:0033189]; spermatogenesis [GO:0007283]","","","",""
"1160","sp|Q9VU68|WDR1_DROME","lcl|NC_088860.1_cds_XP_011451537.3_42229",0,604,"Q9VU68","WDR1_DROME","Actin-interacting protein 1 (AIP1) (Protein flare)","flr CG10724","Drosophila melanogaster (Fruit fly)",608,"GO:0001736; GO:0005856; GO:0007298; GO:0030042; GO:0030833; GO:0030834; GO:0030864; GO:0034316; GO:0035317; GO:0040011; GO:0045214; GO:0051015","actin filament depolymerization [GO:0030042]; border follicle cell migration [GO:0007298]; establishment of planar polarity [GO:0001736]; imaginal disc-derived wing hair organization [GO:0035317]; locomotion [GO:0040011]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; regulation of actin filament depolymerization [GO:0030834]; regulation of actin filament polymerization [GO:0030833]; sarcomere organization [GO:0045214]","cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; border follicle cell migration [GO:0007298]; establishment of planar polarity [GO:0001736]; imaginal disc-derived wing hair organization [GO:0035317]; locomotion [GO:0040011]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; regulation of actin filament depolymerization [GO:0030834]; regulation of actin filament polymerization [GO:0030833]; sarcomere organization [GO:0045214]","","","","TISSUE SPECIFICITY: Expressed in pupal wing cells. {ECO:0000269|PubMed:17565945}."
"1161","sp|Q6NZC7|S23IP_MOUSE","lcl|NC_088860.1_cds_XP_011451561.3_42206",0,732,"Q6NZC7","S23IP_MOUSE","SEC23-interacting protein","Sec23ip","Mus musculus (Mouse)",998,"GO:0001675; GO:0005801; GO:0007286; GO:0007338; GO:0012507; GO:0046872; GO:0048471; GO:0070971; GO:0097038","acrosome assembly [GO:0001675]; single fertilization [GO:0007338]; spermatid development [GO:0007286]","cis-Golgi network [GO:0005801]; endoplasmic reticulum exit site [GO:0070971]; ER to Golgi transport vesicle membrane [GO:0012507]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; acrosome assembly [GO:0001675]; single fertilization [GO:0007338]; spermatid development [GO:0007286]","","","",""
"1162","sp|Q9V466|NU107_DROME","lcl|NC_088860.1_cds_XP_011453057.3_43107",4.62e-151,468,"Q9V466","NU107_DROME","Nuclear pore complex protein Nup107 (Nucleoporin Nup107)","Nup107 CG6743","Drosophila melanogaster (Fruit fly)",845,"GO:0000724; GO:0000973; GO:0003682; GO:0005635; GO:0005643; GO:0005694; GO:0005737; GO:0005819; GO:0006406; GO:0006606; GO:0007110; GO:0007112; GO:0008585; GO:0016363; GO:0017056; GO:0030703; GO:0031080; GO:0031965; GO:0034399; GO:0046822; GO:0048137; GO:1900182","double-strand break repair via homologous recombination [GO:0000724]; eggshell formation [GO:0030703]; female gonad development [GO:0008585]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; mRNA export from nucleus [GO:0006406]; positive regulation of protein localization to nucleus [GO:1900182]; post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; regulation of nucleocytoplasmic transport [GO:0046822]; spermatocyte division [GO:0048137]","chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; spindle [GO:0005819]; chromatin binding [GO:0003682]; structural constituent of nuclear pore [GO:0017056]; double-strand break repair via homologous recombination [GO:0000724]; eggshell formation [GO:0030703]; female gonad development [GO:0008585]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; mRNA export from nucleus [GO:0006406]; positive regulation of protein localization to nucleus [GO:1900182]; post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; regulation of nucleocytoplasmic transport [GO:0046822]; spermatocyte division [GO:0048137]","DEVELOPMENTAL STAGE: Expressed in embryos, larvae and adults (at protein level) (PubMed:18562695, PubMed:31626769). Expressed in embryonal and larval neuroblasts (at protein level) (PubMed:18562695). Expressed during oogenesis (at protein level) (PubMed:31626769). {ECO:0000269|PubMed:18562695, ECO:0000269|PubMed:31626769}.","","","TISSUE SPECIFICITY: Expressed in spermatocytes (at protein level). {ECO:0000269|PubMed:27402967}."
"1163","sp|P22711|TIN_DROME","lcl|NC_088860.1_cds_XP_011454993.1_41934",4.8e-21,94.7,"P22711","TIN_DROME","Muscle-specific homeobox protein tinman (Msh-2) (NK-4)","tin msh2 CG7895","Drosophila melanogaster (Fruit fly)",416,"GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0007419; GO:0007435; GO:0007498; GO:0007506; GO:0007552; GO:0008354; GO:0008406; GO:0010002; GO:0030154; GO:0035050; GO:0035051; GO:0045892; GO:0045944; GO:0048542; GO:0048615; GO:0055007; GO:0061101; GO:0061320; GO:0071907","cardiac muscle cell differentiation [GO:0055007]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cell differentiation [GO:0030154]; determination of digestive tract left/right asymmetry [GO:0071907]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; embryonic heart tube development [GO:0035050]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; gonadal mesoderm development [GO:0007506]; lymph gland development [GO:0048542]; mesoderm development [GO:0007498]; metamorphosis [GO:0007552]; negative regulation of DNA-templated transcription [GO:0045892]; neuroendocrine cell differentiation [GO:0061101]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; ventral cord development [GO:0007419]","nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cardiac muscle cell differentiation [GO:0055007]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cell differentiation [GO:0030154]; determination of digestive tract left/right asymmetry [GO:0071907]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; embryonic heart tube development [GO:0035050]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; gonadal mesoderm development [GO:0007506]; lymph gland development [GO:0048542]; mesoderm development [GO:0007498]; metamorphosis [GO:0007552]; negative regulation of DNA-templated transcription [GO:0045892]; neuroendocrine cell differentiation [GO:0061101]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; ventral cord development [GO:0007419]","DEVELOPMENTAL STAGE: Is initially expressed throughout the presumptive mesoderm and becomes restricted to cardiac and visceral muscle. {ECO:0000269|PubMed:1982429}.","","",""
"1164","sp|O70250|PGAM2_MOUSE","lcl|NC_088860.1_cds_XP_011455096.3_44683",1.64e-104,304,"O70250","PGAM2_MOUSE","Phosphoglycerate mutase 2 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 2) (Muscle-specific phosphoglycerate mutase) (Phosphoglycerate mutase isozyme M) (PGAM-M)","Pgam2","Mus musculus (Mouse)",253,"GO:0004082; GO:0004619; GO:0005829; GO:0006094; GO:0006096; GO:0006941; GO:0007219; GO:0007283; GO:0016787; GO:0042802; GO:0046689; GO:0061621","canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; Notch signaling pathway [GO:0007219]; response to mercury ion [GO:0046689]; spermatogenesis [GO:0007283]; striated muscle contraction [GO:0006941]","cytosol [GO:0005829]; bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; phosphoglycerate mutase activity [GO:0004619]; canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; Notch signaling pathway [GO:0007219]; response to mercury ion [GO:0046689]; spermatogenesis [GO:0007283]; striated muscle contraction [GO:0006941]","","","","TISSUE SPECIFICITY: Expressed in the testes (at protein level). {ECO:0000269|PubMed:23446454, ECO:0000269|PubMed:35547804}."
"1165","sp|Q10654|CCNB3_CAEEL","lcl|NC_088860.1_cds_XP_011455547.4_42028",3.63e-79,251,"Q10654","CCNB3_CAEEL","G2/mitotic-specific cyclin-B3","cyb-3 cyb-2 T06E6.2","Caenorhabditis elegans",385,"GO:0000070; GO:0000082; GO:0000278; GO:0000307; GO:0001556; GO:0001934; GO:0005634; GO:0005737; GO:0007098; GO:0016538; GO:0035046; GO:0045138; GO:0045144; GO:0045842; GO:0051301; GO:0051321; GO:0051383; GO:0051445","cell division [GO:0051301]; centrosome cycle [GO:0007098]; G1/S transition of mitotic cell cycle [GO:0000082]; kinetochore organization [GO:0051383]; meiotic cell cycle [GO:0051321]; meiotic sister chromatid segregation [GO:0045144]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; nematode male tail tip morphogenesis [GO:0045138]; oocyte maturation [GO:0001556]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein phosphorylation [GO:0001934]; pronuclear migration [GO:0035046]; regulation of meiotic cell cycle [GO:0051445]","cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; G1/S transition of mitotic cell cycle [GO:0000082]; kinetochore organization [GO:0051383]; meiotic cell cycle [GO:0051321]; meiotic sister chromatid segregation [GO:0045144]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; nematode male tail tip morphogenesis [GO:0045138]; oocyte maturation [GO:0001556]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein phosphorylation [GO:0001934]; pronuclear migration [GO:0035046]; regulation of meiotic cell cycle [GO:0051445]","","","",""
"1166","sp|P53784|SOX3_MOUSE","lcl|NC_088860.1_cds_XP_011455662.1_43707",6.78e-37,137,"P53784","SOX3_MOUSE","Transcription factor SOX-3","Sox3 Sox-3","Mus musculus (Mouse)",375,"GO:0000978; GO:0003677; GO:0005634; GO:0006355; GO:0007423; GO:0007530; GO:0009887; GO:0021854; GO:0021983; GO:0030900; GO:0045665; GO:0048515; GO:0060009; GO:0060324","animal organ morphogenesis [GO:0009887]; face development [GO:0060324]; forebrain development [GO:0030900]; hypothalamus development [GO:0021854]; negative regulation of neuron differentiation [GO:0045665]; pituitary gland development [GO:0021983]; regulation of DNA-templated transcription [GO:0006355]; sensory organ development [GO:0007423]; Sertoli cell development [GO:0060009]; sex determination [GO:0007530]; spermatid differentiation [GO:0048515]","nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; animal organ morphogenesis [GO:0009887]; face development [GO:0060324]; forebrain development [GO:0030900]; hypothalamus development [GO:0021854]; negative regulation of neuron differentiation [GO:0045665]; pituitary gland development [GO:0021983]; regulation of DNA-templated transcription [GO:0006355]; sensory organ development [GO:0007423]; Sertoli cell development [GO:0060009]; sex determination [GO:0007530]; spermatid differentiation [GO:0048515]","","","","TISSUE SPECIFICITY: Expressed in developing parathyroids of mouse embryos between 10.5 and 15.5 days post-coitum (PubMed:16167084). Expressed in the developing central nervous system (PubMed:12748963). Expressed in the developing urogenital ridge. {ECO:0000269|PubMed:12748963, ECO:0000269|PubMed:16167084}."
"1167","sp|Q8WY41|NANO1_HUMAN","lcl|NC_088860.1_cds_XP_011456725.2_42170",7.4e-23,95.5,"Q8WY41","NANO1_HUMAN","Nanos homolog 1 (NOS-1) (EC_Rep1a)","NANOS1 NOS1","Homo sapiens (Human)",292,"GO:0001558; GO:0001894; GO:0003729; GO:0005737; GO:0008047; GO:0008270; GO:0010608; GO:0010631; GO:0016477; GO:0017148; GO:0030371; GO:0048471; GO:0048477; GO:0061157; GO:0098749","cell migration [GO:0016477]; cerebellar neuron development [GO:0098749]; epithelial cell migration [GO:0010631]; mRNA destabilization [GO:0061157]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of cell growth [GO:0001558]; tissue homeostasis [GO:0001894]","cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; enzyme activator activity [GO:0008047]; mRNA binding [GO:0003729]; translation repressor activity [GO:0030371]; zinc ion binding [GO:0008270]; cell migration [GO:0016477]; cerebellar neuron development [GO:0098749]; epithelial cell migration [GO:0010631]; mRNA destabilization [GO:0061157]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of cell growth [GO:0001558]; tissue homeostasis [GO:0001894]","DEVELOPMENTAL STAGE: Fetal ovary and fetal testis (at protein level). {ECO:0000269|PubMed:21421998}.","INDUCTION: Down-regulated by E-cadherin. {ECO:0000269|PubMed:17047063}.","INDUCTION: Down-regulated by E-cadherin. {ECO:0000269|PubMed:17047063}.","TISSUE SPECIFICITY: Testis and ovary (at protein level). Predominantly expressed in testis. Specifically expressed during germline development. In adult tissues, it is mainly expressed in spermatogonia, the stem cells of the germline. Also expressed during meiosis in spermatocytes. Not present in late, post-meiotic stage germ cells. Expressed in fetal ovaries, while it is weakly or not expressed in mature postmeiotic oocytes, suggesting that it may be expressed in premeiotic female germ cells. Expressed at high levels only in the E-cadherin deficient cell lines. Highly expressed in lung carcinomas and mostly detected in invasive tumor cells and its expression correlates with tumor aggressiveness. {ECO:0000269|PubMed:12690449, ECO:0000269|PubMed:17047063, ECO:0000269|PubMed:18223680, ECO:0000269|PubMed:19168546, ECO:0000269|PubMed:21421998}."
"1168","sp|Q9UKB1|FBW1B_HUMAN","lcl|NC_088860.1_cds_XP_011456981.1_42139",0,795,"Q9UKB1","FBW1B_HUMAN","F-box/WD repeat-containing protein 11 (F-box and WD repeats protein beta-TrCP2) (F-box/WD repeat-containing protein 1B) (Homologous to Slimb protein) (HOS)","FBXW11 BTRCP2 FBW1B FBXW1B KIAA0696","Homo sapiens (Human)",542,"GO:0000132; GO:0000151; GO:0000209; GO:0000776; GO:0005634; GO:0005635; GO:0005813; GO:0005829; GO:0005875; GO:0005881; GO:0006470; GO:0007097; GO:0007281; GO:0008090; GO:0016055; GO:0016567; GO:0019005; GO:0031023; GO:0031146; GO:0031648; GO:0042753; GO:0043005; GO:0043025; GO:0043123; GO:0043161; GO:0045862; GO:0045893; GO:0046983; GO:0047496; GO:0048511; GO:0048854; GO:0051010; GO:0070840; GO:1904115; GO:1990756","brain morphogenesis [GO:0048854]; establishment of mitotic spindle orientation [GO:0000132]; germ cell development [GO:0007281]; microtubule organizing center organization [GO:0031023]; nuclear migration [GO:0007097]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of proteolysis [GO:0045862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; retrograde axonal transport [GO:0008090]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; vesicle transport along microtubule [GO:0047496]; Wnt signaling pathway [GO:0016055]","axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010]; protein dimerization activity [GO:0046983]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; brain morphogenesis [GO:0048854]; establishment of mitotic spindle orientation [GO:0000132]; germ cell development [GO:0007281]; microtubule organizing center organization [GO:0031023]; nuclear migration [GO:0007097]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of proteolysis [GO:0045862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; retrograde axonal transport [GO:0008090]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; vesicle transport along microtubule [GO:0047496]; Wnt signaling pathway [GO:0016055]","DEVELOPMENTAL STAGE: In the embryo, it is expressed in the developing eye, limbs and brain (PubMed:31402090). Expression is observed in the lens, retina, lips of the optic fissure closure and regions of the conjunctiva at Carnegie stages (CS) between CS15 and CS21. As eye development progresses, the stronger signal observed in the retina progressively shifts from the inner toward the outer retinal layers (PubMed:31402090). In the developing hand, expression is strong at CS15. At CS19 and CS21, after the digits have begun to form, strong expression is seen in the mesenchyme surrounding the developing cartilage (PubMed:31402090). In the brain, it is expressed in the primitive ventricles at CS17 and CS19, hypothalamus and medulla at CS17, and metencephalon at CS19 (PubMed:31402090). Strong expression is also observed in the pharyngeal arches, including the mandibular process and tongue at CS17 (PubMed:31402090). {ECO:0000269|PubMed:31402090}.","INDUCTION: Expression is negatively regulated by Wnt/beta-catenin pathway. {ECO:0000269|PubMed:11850814}.","INDUCTION: Expression is negatively regulated by Wnt/beta-catenin pathway. {ECO:0000269|PubMed:11850814}.",""
"1169","sp|Q4TT88|PSA_CAEEL","lcl|NC_088860.1_cds_XP_019917981.3_44062",0,687,"Q4TT88","PSA_CAEEL","Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S)","pam-1 F49E8.3","Caenorhabditis elegans",948,"GO:0000793; GO:0005615; GO:0005737; GO:0005938; GO:0006508; GO:0008270; GO:0008595; GO:0009792; GO:0016020; GO:0016285; GO:0030590; GO:0042277; GO:0043171; GO:0046662; GO:0048477; GO:0051661; GO:0070006; GO:0097431; GO:1900195; GO:1903538; GO:1990947","anterior/posterior axis specification, embryo [GO:0008595]; embryo development ending in birth or egg hatching [GO:0009792]; exit from meiosis [GO:1990947]; first cell cycle pseudocleavage [GO:0030590]; maintenance of centrosome location [GO:0051661]; oogenesis [GO:0048477]; peptide catabolic process [GO:0043171]; positive regulation of oocyte maturation [GO:1900195]; proteolysis [GO:0006508]; regulation of egg-laying behavior [GO:0046662]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]","cell cortex [GO:0005938]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitotic spindle pole [GO:0097431]; alanyl aminopeptidase activity [GO:0016285]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; anterior/posterior axis specification, embryo [GO:0008595]; embryo development ending in birth or egg hatching [GO:0009792]; exit from meiosis [GO:1990947]; first cell cycle pseudocleavage [GO:0030590]; maintenance of centrosome location [GO:0051661]; oogenesis [GO:0048477]; peptide catabolic process [GO:0043171]; positive regulation of oocyte maturation [GO:1900195]; proteolysis [GO:0006508]; regulation of egg-laying behavior [GO:0046662]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]","DEVELOPMENTAL STAGE: Expressed in the 1-cell embryos (at protein level) (PubMed:20599902). Expressed during gastrulation and throughout the larval stage and in adults (PubMed:12930831). {ECO:0000269|PubMed:12930831, ECO:0000269|PubMed:20599902}.","","","TISSUE SPECIFICITY: Expressed mainly in intestinal cells in the posterior part of the intestine and in amphid sensory neurons and nerve ring neurons (PubMed:12930831). Expressed in neurons in the male tail (PubMed:12930831). Expressed in mature spermatids (at protein level) (PubMed:20599902). {ECO:0000269|PubMed:12930831, ECO:0000269|PubMed:20599902}."
"1170","sp|Q9UKQ2|ADA28_HUMAN","lcl|NC_088860.1_cds_XP_019920007.3_42092",4.63e-102,343,"Q9UKQ2","ADA28_HUMAN","Disintegrin and metalloproteinase domain-containing protein 28 (ADAM 28) (EC 3.4.24.-) (Epididymal metalloproteinase-like, disintegrin-like, and cysteine-rich protein II) (eMDC II) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein L) (MDC-L)","ADAM28 ADAM23 MDCL","Homo sapiens (Human)",775,"GO:0004222; GO:0005576; GO:0005739; GO:0005886; GO:0006508; GO:0007283; GO:0008237; GO:0009986; GO:0034987; GO:0046872","proteolysis [GO:0006508]; spermatogenesis [GO:0007283]","cell surface [GO:0009986]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; immunoglobulin receptor binding [GO:0034987]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed predominantly in secondary lymphoid tissues, such as lymph node, spleen, small intestine, stomach, colon, appendix and trachea. The lymphocyte population is responsible for expression of this protein in these tissues. Isoform 2 is expressed preferentially in spleen."
"1171","sp|Q9UKF5|ADA29_HUMAN","lcl|NC_088860.1_cds_XP_019920008.3_42095",2.68e-69,251,"Q9UKF5","ADA29_HUMAN","Disintegrin and metalloproteinase domain-containing protein 29 (ADAM 29) (Cancer/testis antigen 73) (CT73)","ADAM29","Homo sapiens (Human)",820,"GO:0004222; GO:0005886; GO:0006508; GO:0007283; GO:0008237; GO:0008584; GO:0009897; GO:1990913","male gonad development [GO:0008584]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]","external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; male gonad development [GO:0008584]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed specifically in testes."
"1172","sp|B7ZR30|STK10_XENLA","lcl|NC_088860.1_cds_XP_019921179.3_42291",2.56e-130,423,"B7ZR30","STK10_XENLA","Serine/threonine-protein kinase 10-A (EC 2.7.11.1) (Polo-like kinase kinase 1) (XPlkk1)","stk10-a plkk1","Xenopus laevis (African clawed frog)",950,"GO:0000086; GO:0001556; GO:0004674; GO:0005524; GO:0005886; GO:0042803; GO:0046777; GO:0106310; GO:2000401","G2/M transition of mitotic cell cycle [GO:0000086]; oocyte maturation [GO:0001556]; protein autophosphorylation [GO:0046777]; regulation of lymphocyte migration [GO:2000401]","plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; G2/M transition of mitotic cell cycle [GO:0000086]; oocyte maturation [GO:0001556]; protein autophosphorylation [GO:0046777]; regulation of lymphocyte migration [GO:2000401]","","","",""
"1173","sp|Q8C156|CND2_MOUSE","lcl|NC_088860.1_cds_XP_019922236.3_41471",1.14e-108,348,"Q8C156","CND2_MOUSE","Condensin complex subunit 2 (Barren homolog protein 1) (Chromosome-associated protein H) (mCAP-H) (Non-SMC condensin I complex subunit H) (XCAP-H homolog)","Ncaph Brrn Brrn1 Caph","Mus musculus (Mouse)",731,"GO:0000794; GO:0000796; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007076; GO:0007143; GO:0010032; GO:0045132; GO:0051301; GO:0051309; GO:0051984; GO:1905820; GO:1905821","cell division [GO:0051301]; female meiosis chromosome separation [GO:0051309]; female meiotic nuclear division [GO:0007143]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]","chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; female meiosis chromosome separation [GO:0051309]; female meiotic nuclear division [GO:0007143]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]","","","",""
"1174","sp|Q8K2K6|AGFG1_MOUSE","lcl|NC_088860.1_cds_XP_019924069.3_42039",5.31e-67,229,"Q8K2K6","AGFG1_MOUSE","Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein homolog) (Nucleoporin-like protein RIP)","Agfg1 Hrb Rip","Mus musculus (Mouse)",561,"GO:0001675; GO:0003677; GO:0005096; GO:0005634; GO:0007289; GO:0008270; GO:0031410; GO:0042995; GO:0043025; GO:0045109","acrosome assembly [GO:0001675]; intermediate filament organization [GO:0045109]; spermatid nucleus differentiation [GO:0007289]","cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]; acrosome assembly [GO:0001675]; intermediate filament organization [GO:0045109]; spermatid nucleus differentiation [GO:0007289]","DEVELOPMENTAL STAGE: Highly expressed during spermiogenesis. {ECO:0000269|PubMed:11711676}.","","","TISSUE SPECIFICITY: Expressed in the testes (at protein level). {ECO:0000269|PubMed:35547804}."
"1175","sp|Q45VV3|YAP1_DROME","lcl|NC_088860.1_cds_XP_019924742.1_41649",1e-25,109,"Q45VV3","YAP1_DROME","Transcriptional coactivator yorkie (Protein yorkie) (Transcriptional coactivator YAP1 homolog)","yki CG4005","Drosophila melanogaster (Fruit fly)",395,"GO:0001708; GO:0002011; GO:0003007; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005911; GO:0007298; GO:0007560; GO:0008283; GO:0008284; GO:0009957; GO:0019900; GO:0035212; GO:0035329; GO:0040008; GO:0043066; GO:0045176; GO:0045463; GO:0045572; GO:0045927; GO:0045944; GO:0060252; GO:0071889; GO:0072089; GO:0072091; GO:0090210; GO:0090575; GO:0097575; GO:0140297; GO:2000736","apical protein localization [GO:0045176]; border follicle cell migration [GO:0007298]; cell competition in a multicellular organism [GO:0035212]; cell fate specification [GO:0001708]; cell population proliferation [GO:0008283]; epidermal cell fate specification [GO:0009957]; heart morphogenesis [GO:0003007]; hippo signaling [GO:0035329]; imaginal disc morphogenesis [GO:0007560]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of growth [GO:0045927]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R8 cell development [GO:0045463]; regulation of establishment of blood-brain barrier [GO:0090210]; regulation of growth [GO:0040008]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell proliferation [GO:0072091]; stem cell proliferation [GO:0072089]","cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; 14-3-3 protein binding [GO:0071889]; DNA-binding transcription factor binding [GO:0140297]; kinase binding [GO:0019900]; transcription coactivator activity [GO:0003713]; apical protein localization [GO:0045176]; border follicle cell migration [GO:0007298]; cell competition in a multicellular organism [GO:0035212]; cell fate specification [GO:0001708]; cell population proliferation [GO:0008283]; epidermal cell fate specification [GO:0009957]; heart morphogenesis [GO:0003007]; hippo signaling [GO:0035329]; imaginal disc morphogenesis [GO:0007560]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of growth [GO:0045927]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R8 cell development [GO:0045463]; regulation of establishment of blood-brain barrier [GO:0090210]; regulation of growth [GO:0040008]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell proliferation [GO:0072091]; stem cell proliferation [GO:0072089]","","","",""
"1176","sp|P13405|RB_MOUSE","lcl|NC_088860.1_cds_XP_034327348.2_41916",1.53e-135,429,"P13405","RB_MOUSE","Retinoblastoma-associated protein (p110-RB1) (pRb) (Rb) (pp105)","Rb1 Rb-1","Mus musculus (Mouse)",921,"GO:0000082; GO:0000122; GO:0001558; GO:0001894; GO:0002062; GO:0003180; GO:0003677; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005819; GO:0006355; GO:0006366; GO:0006469; GO:0006915; GO:0007224; GO:0007265; GO:0007283; GO:0007346; GO:0008024; GO:0008283; GO:0008285; GO:0010629; GO:0014009; GO:0016605; GO:0019899; GO:0019900; GO:0030182; GO:0030308; GO:0031134; GO:0031175; GO:0031507; GO:0031625; GO:0032869; GO:0034088; GO:0034349; GO:0035189; GO:0035914; GO:0042551; GO:0042802; GO:0043353; GO:0043550; GO:0045445; GO:0045651; GO:0045786; GO:0045842; GO:0045879; GO:0045892; GO:0045930; GO:0045944; GO:0048565; GO:0048667; GO:0050673; GO:0050680; GO:0050728; GO:0051146; GO:0051219; GO:0051301; GO:0051402; GO:0051726; GO:0060253; GO:0061629; GO:0061676; GO:0061793; GO:0071459; GO:0071466; GO:0097284; GO:0097718; GO:0120163; GO:0140297; GO:1903055; GO:1903944; GO:1904028; GO:1904761; GO:2000045; GO:2000134; GO:2001234","aortic valve morphogenesis [GO:0003180]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cell population proliferation [GO:0008283]; cellular response to insulin stimulus [GO:0032869]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; digestive tract development [GO:0048565]; enucleate erythrocyte differentiation [GO:0043353]; epithelial cell proliferation [GO:0050673]; G1/S transition of mitotic cell cycle [GO:0000082]; glial cell apoptotic process [GO:0034349]; glial cell proliferation [GO:0014009]; hepatocyte apoptotic process [GO:0097284]; heterochromatin formation [GO:0031507]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; myoblast differentiation [GO:0045445]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to chromosome, centromeric region [GO:0071459]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of DNA-templated transcription [GO:0006355]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of lipid kinase activity [GO:0043550]; regulation of mitotic cell cycle [GO:0007346]; sister chromatid biorientation [GO:0031134]; skeletal muscle cell differentiation [GO:0035914]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]; striated muscle cell differentiation [GO:0051146]; tissue homeostasis [GO:0001894]; transcription by RNA polymerase II [GO:0006366]","chromatin lock complex [GO:0061793]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; Rb-E2F complex [GO:0035189]; spindle [GO:0005819]; transcription regulator complex [GO:0005667]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; kinase binding [GO:0019900]; phosphoprotein binding [GO:0051219]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin protein ligase binding [GO:0031625]; aortic valve morphogenesis [GO:0003180]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cell population proliferation [GO:0008283]; cellular response to insulin stimulus [GO:0032869]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; digestive tract development [GO:0048565]; enucleate erythrocyte differentiation [GO:0043353]; epithelial cell proliferation [GO:0050673]; G1/S transition of mitotic cell cycle [GO:0000082]; glial cell apoptotic process [GO:0034349]; glial cell proliferation [GO:0014009]; hepatocyte apoptotic process [GO:0097284]; heterochromatin formation [GO:0031507]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; myoblast differentiation [GO:0045445]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to chromosome, centromeric region [GO:0071459]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of DNA-templated transcription [GO:0006355]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of lipid kinase activity [GO:0043550]; regulation of mitotic cell cycle [GO:0007346]; sister chromatid biorientation [GO:0031134]; skeletal muscle cell differentiation [GO:0035914]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]; striated muscle cell differentiation [GO:0051146]; tissue homeostasis [GO:0001894]; transcription by RNA polymerase II [GO:0006366]","","","","TISSUE SPECIFICITY: Expressed in the cell nuclei of renal tubules, hepatocytes and skeletal muscles. Expressed in skin (at protein level) (PubMed:20940255). {ECO:0000269|PubMed:12095676, ECO:0000269|PubMed:20940255}."
"1177","sp|Q93008|USP9X_HUMAN","lcl|NC_088860.1_cds_XP_034327395.2_41866",0,3194,"Q93008","USP9X_HUMAN","Ubiquitin carboxyl-terminal hydrolase 9X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)","USP9X DFFRX FAM USP9","Homo sapiens (Human)",2554,"GO:0000122; GO:0001764; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005929; GO:0006307; GO:0007059; GO:0007179; GO:0007292; GO:0008104; GO:0008234; GO:0016020; GO:0016477; GO:0016562; GO:0016567; GO:0016579; GO:0030426; GO:0030509; GO:0031647; GO:0032092; GO:0032435; GO:0035520; GO:0042752; GO:0048511; GO:0048675; GO:0050821; GO:0051301; GO:0060271; GO:0061578; GO:0061824; GO:0070410; GO:0070536; GO:0071947; GO:0101005; GO:0140313; GO:0180017; GO:1904515; GO:1990000; GO:1990380","amyloid fibril formation [GO:1990000]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell division [GO:0051301]; cell migration [GO:0016477]; chromosome segregation [GO:0007059]; cilium assembly [GO:0060271]; cytosolic ciliogenesis [GO:0061824]; DNA alkylation repair [GO:0006307]; female gamete generation [GO:0007292]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of protein binding [GO:0032092]; positive regulation of TORC2 signaling [GO:1904515]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein K63-linked deubiquitination [GO:0070536]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]","centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; deubiquitinase activity [GO:0101005]; K11-linked deubiquitinase activity [GO:0180017]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578]; molecular sequestering activity [GO:0140313]; amyloid fibril formation [GO:1990000]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell division [GO:0051301]; cell migration [GO:0016477]; chromosome segregation [GO:0007059]; cilium assembly [GO:0060271]; cytosolic ciliogenesis [GO:0061824]; DNA alkylation repair [GO:0006307]; female gamete generation [GO:0007292]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of protein binding [GO:0032092]; positive regulation of TORC2 signaling [GO:1904515]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein K63-linked deubiquitination [GO:0070536]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]","","INDUCTION: By growth factors. {ECO:0000269|PubMed:33378666}.","INDUCTION: By growth factors. {ECO:0000269|PubMed:33378666}.","TISSUE SPECIFICITY: Widely expressed in embryonic and adult tissues. {ECO:0000269|PubMed:8922996}."
"1178","sp|Q9VNH6|EXOC4_DROME","lcl|NC_088860.1_cds_XP_034327410.2_41857",2.34e-174,534,"Q9VNH6","EXOC4_DROME","Exocyst complex component 4 (Exocyst complex component Sec8)","Sec8 CG2095","Drosophila melanogaster (Fruit fly)",985,"GO:0000145; GO:0000212; GO:0000916; GO:0005737; GO:0005886; GO:0006887; GO:0006893; GO:0007009; GO:0007110; GO:0007111; GO:0007268; GO:0007269; GO:0007286; GO:0007298; GO:0009925; GO:0015031; GO:0016020; GO:0016028; GO:0016080; GO:0016081; GO:0016192; GO:0016324; GO:0032584; GO:0045202; GO:0045887; GO:0046718; GO:0050803; GO:0090522; GO:0098793","actomyosin contractile ring contraction [GO:0000916]; border follicle cell migration [GO:0007298]; chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; meiotic spindle organization [GO:0000212]; neurotransmitter secretion [GO:0007269]; plasma membrane organization [GO:0007009]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; protein transport [GO:0015031]; regulation of synapse structure or activity [GO:0050803]; spermatid development [GO:0007286]; symbiont entry into host cell [GO:0046718]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; vesicle tethering involved in exocytosis [GO:0090522]; vesicle-mediated transport [GO:0016192]","apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; exocyst [GO:0000145]; growth cone membrane [GO:0032584]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; rhabdomere [GO:0016028]; synapse [GO:0045202]; actomyosin contractile ring contraction [GO:0000916]; border follicle cell migration [GO:0007298]; chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; meiotic spindle organization [GO:0000212]; neurotransmitter secretion [GO:0007269]; plasma membrane organization [GO:0007009]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; protein transport [GO:0015031]; regulation of synapse structure or activity [GO:0050803]; spermatid development [GO:0007286]; symbiont entry into host cell [GO:0046718]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; vesicle tethering involved in exocytosis [GO:0090522]; vesicle-mediated transport [GO:0016192]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. {ECO:0000269|PubMed:16351720}.","","","TISSUE SPECIFICITY: Abundant in the embryonic and larval glutamatergic neuromuscular junctions (NMJs), pre and postsynaptically. {ECO:0000269|PubMed:16351720}."
"1179","sp|Q6NX65|PDC10_RAT","lcl|NC_088860.1_cds_XP_034327419.1_41847",2.81e-53,171,"Q6NX65","PDC10_RAT","Programmed cell death protein 10","Pdcd10","Rattus norvegicus (Rat)",210,"GO:0000139; GO:0001525; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007283; GO:0007614; GO:0008284; GO:0010628; GO:0010629; GO:0019901; GO:0030335; GO:0032874; GO:0035556; GO:0036481; GO:0042803; GO:0043066; GO:0043406; GO:0044319; GO:0045747; GO:0050728; GO:0050821; GO:0051683; GO:0071454; GO:0071944; GO:0090051; GO:0090168; GO:0090316; GO:0090443; GO:1903588; GO:1990830; GO:2001055","angiogenesis [GO:0001525]; cellular response to anoxia [GO:0071454]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of Golgi localization [GO:0051683]; Golgi reassembly [GO:0090168]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mesenchymal cell apoptotic process [GO:2001055]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein stabilization [GO:0050821]; short-term memory [GO:0007614]; spermatogenesis [GO:0007283]; wound healing, spreading of cells [GO:0044319]","cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; angiogenesis [GO:0001525]; cellular response to anoxia [GO:0071454]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of Golgi localization [GO:0051683]; Golgi reassembly [GO:0090168]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mesenchymal cell apoptotic process [GO:2001055]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein stabilization [GO:0050821]; short-term memory [GO:0007614]; spermatogenesis [GO:0007283]; wound healing, spreading of cells [GO:0044319]","","","",""
"1180","sp|A0A1L8GXY4|CFA43_XENLA","lcl|NC_088860.1_cds_XP_034327600.2_43359",0,682,"A0A1L8GXY4","CFA43_XENLA","Cilia- and flagella-associated protein 43","cfap43","Xenopus laevis (African clawed frog)",1621,"GO:0003351; GO:0003356; GO:0005576; GO:0005930; GO:0007288; GO:0060271","cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; regulation of cilium beat frequency [GO:0003356]; sperm axoneme assembly [GO:0007288]","axoneme [GO:0005930]; extracellular region [GO:0005576]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; regulation of cilium beat frequency [GO:0003356]; sperm axoneme assembly [GO:0007288]","DEVELOPMENTAL STAGE: Expressed in the left-right organizer and floor plate at embryonic stage 19 (ES19) (PubMed:31884020). Expressed in multiciliated cells of the larval epidermis and nephrostomes at ES33 and in dorsal lining of the branchial chamber and stomach at ES45 (PubMed:31884020). {ECO:0000269|PubMed:31884020}.","","",""
"1181","sp|Q8CDT7|CBCO1_MOUSE","lcl|NC_088860.1_cds_XP_034327669.1_40947",2.2e-32,119,"Q8CDT7","CBCO1_MOUSE","Ciliary-associated calcium-binding coiled-coil protein 1","Cabcoco1","Mus musculus (Mouse)",208,"GO:0005509; GO:0005737; GO:0005813; GO:0036126; GO:0120316","sperm flagellum assembly [GO:0120316]","centrosome [GO:0005813]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126]; calcium ion binding [GO:0005509]; sperm flagellum assembly [GO:0120316]","","","","TISSUE SPECIFICITY: Testis-specific (PubMed:26990073). Expressed in spermatocytes and round spermatids (at protein level) (PubMed:26990073). {ECO:0000269|PubMed:26990073}."
"1182","sp|Q63679|KDM3A_RAT","lcl|NC_088860.1_cds_XP_034327927.2_40499",0,716,"Q63679","KDM3A_RAT","Lysine-specific demethylase 3A (EC 1.14.11.65) (JmjC domain-containing histone demethylation protein 2A) (Jumonji domain-containing protein 1A) (Testis-specific gene A protein) (Zinc finger protein TSGA) ([histone H3]-dimethyl-L-lysine(9) demethylase 3A)","Kdm3a Jhdm2a Jmjd1a Tsga","Rattus norvegicus (Rat)",1214,"GO:0000118; GO:0000785; GO:0001666; GO:0001673; GO:0003682; GO:0003712; GO:0005506; GO:0005634; GO:0005737; GO:0006357; GO:0007283; GO:0007290; GO:0008270; GO:0008584; GO:0009755; GO:0010468; GO:0010628; GO:0030521; GO:0031490; GO:0032454; GO:0045893; GO:0045944; GO:0046293; GO:0050681; GO:0120162; GO:0140683; GO:1990830; GO:2000036; GO:2000736","androgen receptor signaling pathway [GO:0030521]; cellular response to leukemia inhibitory factor [GO:1990830]; formaldehyde biosynthetic process [GO:0046293]; hormone-mediated signaling pathway [GO:0009755]; male gonad development [GO:0008584]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; spermatid nucleus elongation [GO:0007290]; spermatogenesis [GO:0007283]","chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; male germ cell nucleus [GO:0001673]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; histone H3K9 demethylase activity [GO:0032454]; histone H3K9me/H3K9me2 demethylase activity [GO:0140683]; iron ion binding [GO:0005506]; nuclear androgen receptor binding [GO:0050681]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; androgen receptor signaling pathway [GO:0030521]; cellular response to leukemia inhibitory factor [GO:1990830]; formaldehyde biosynthetic process [GO:0046293]; hormone-mediated signaling pathway [GO:0009755]; male gonad development [GO:0008584]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; spermatid nucleus elongation [GO:0007290]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Reaches a maximum during the meiotic and the postmeiotic stages of germ cell development.","","","TISSUE SPECIFICITY: Testis specific. Expressed only in male germ cells."
"1183","sp|P32866|GPRK2_DROME","lcl|NC_088860.1_cds_XP_034328222.1_42890",0,583,"P32866","GPRK2_DROME","G protein-coupled receptor kinase 2 (EC 2.7.11.16)","Gprk2 Gprk-2 CG17998","Drosophila melanogaster (Fruit fly)",714,"GO:0003384; GO:0004672; GO:0004674; GO:0004703; GO:0005524; GO:0005737; GO:0005886; GO:0006963; GO:0007165; GO:0007476; GO:0009898; GO:0009966; GO:0045752; GO:0045879; GO:0045880; GO:0048260; GO:0048601; GO:0050830; GO:0070273","apical constriction involved in gastrulation [GO:0003384]; defense response to Gram-positive bacterium [GO:0050830]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of smoothened signaling pathway [GO:0045879]; oocyte morphogenesis [GO:0048601]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]","cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apical constriction involved in gastrulation [GO:0003384]; defense response to Gram-positive bacterium [GO:0050830]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of smoothened signaling pathway [GO:0045879]; oocyte morphogenesis [GO:0048601]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. {ECO:0000269|PubMed:9217001}.","","","TISSUE SPECIFICITY: Expressed in all larval tissues and in adult ovaries. Larval CNS staining is localized to axons projecting to the optic lobes and the mushroom bodies, in the longitudinal connectives, and in cell bodies and nerves of the ring gland corpus allatum. Adult CNS staining is detectable only in cell bodies and processes associated with the ellipsoid body of the central complex and portions of the mushroom bodies. In the wing disk, expression is confined to a stripe that parallels the anterior/posterior boundary of the wing blade and the hinge region, and weak expression in the prospective notum. {ECO:0000269|PubMed:9217001}."
"1184","sp|Q9Y5K3|PCY1B_HUMAN","lcl|NC_088860.1_cds_XP_034328462.2_42333",8.97e-113,333,"Q9Y5K3","PCY1B_HUMAN","Choline-phosphate cytidylyltransferase B (EC 2.7.7.15) (CCT-beta) (CTP:phosphocholine cytidylyltransferase B) (CCT B) (CT B) (Phosphorylcholine transferase B)","PCYT1B CCTB","Homo sapiens (Human)",369,"GO:0001541; GO:0004105; GO:0005737; GO:0005783; GO:0005789; GO:0006656; GO:0006657; GO:0007283; GO:0031210; GO:0042802","CDP-choline pathway [GO:0006657]; ovarian follicle development [GO:0001541]; phosphatidylcholine biosynthetic process [GO:0006656]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; choline-phosphate cytidylyltransferase activity [GO:0004105]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; CDP-choline pathway [GO:0006657]; ovarian follicle development [GO:0001541]; phosphatidylcholine biosynthetic process [GO:0006656]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: [Isoform 1]: Highly expressed in testis, placenta, brain, ovary, liver and fetal lung. {ECO:0000269|PubMed:10480912, ECO:0000269|PubMed:9593753}.; TISSUE SPECIFICITY: [Isoform 2]: Expressed in brain, liver and fetal lung. {ECO:0000269|PubMed:10480912}."
"1185","sp|P70458|IPSP_MOUSE","lcl|NC_088860.1_cds_XP_034328543.2_44093",1.58e-32,127,"P70458","IPSP_MOUSE","Plasma serine protease inhibitor (Plasminogen activator inhibitor 3) (PAI-3) (PAI3) (Protein C inhibitor) (PCI) (Serpin A5)","Serpina5 Pci","Mus musculus (Mouse)",405,"GO:0001972; GO:0002020; GO:0002080; GO:0004867; GO:0005615; GO:0007283; GO:0009897; GO:0031091; GO:0031094; GO:0031210; GO:0032190; GO:0036024; GO:0036025; GO:0036026; GO:0036027; GO:0036028; GO:0036029; GO:0036030; GO:0070062; GO:0097181; GO:0097182; GO:0097183","spermatogenesis [GO:0007283]","acrosomal membrane [GO:0002080]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; platelet alpha granule [GO:0031091]; platelet dense tubular network [GO:0031094]; protein C inhibitor-coagulation factor V complex [GO:0097181]; protein C inhibitor-coagulation factor Xa complex [GO:0097182]; protein C inhibitor-coagulation factor XI complex [GO:0097183]; protein C inhibitor-KLK3 complex [GO:0036029]; protein C inhibitor-plasma kallikrein complex [GO:0036030]; protein C inhibitor-PLAT complex [GO:0036026]; protein C inhibitor-PLAU complex [GO:0036027]; protein C inhibitor-thrombin complex [GO:0036028]; protein C inhibitor-TMPRSS11E complex [GO:0036025]; protein C inhibitor-TMPRSS7 complex [GO:0036024]; acrosin binding [GO:0032190]; phosphatidylcholine binding [GO:0031210]; protease binding [GO:0002020]; retinoic acid binding [GO:0001972]; serine-type endopeptidase inhibitor activity [GO:0004867]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Not detected in blood plasma (at protein level). Expressed in testis, epididymis, seminal vesicles, prostate and ovaries. {ECO:0000269|PubMed:15140131}."
"1186","sp|Q9NLA3|ANO39_PATPE","lcl|NC_088860.1_cds_XP_034328868.2_43117",3.54e-17,81.3,"Q9NLA3","ANO39_PATPE","Nucleoplasmin-like protein ANO39 (39 kDa oocyte-expressed nucleolar protein) (Nucleic acid-associated protein 36) (Nucleic acid-binding nuclear protein) (NAAP) (NAAP1) (NAAP2)","","Patiria pectinifera (Starfish) (Asterina pectinifera)",346,"GO:0000278; GO:0001556; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006338; GO:0042393","chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; oocyte maturation [GO:0001556]","cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; RNA binding [GO:0003723]; chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; oocyte maturation [GO:0001556]","DEVELOPMENTAL STAGE: Expressed maternally in immature oocytes at high levels but is scarcely detectable in mature oocytes or in embryos at the morula and blastula stages. {ECO:0000269|PubMed:10632699}.","","","TISSUE SPECIFICITY: Expressed specifically in the oocytes of the ovaries. {ECO:0000269|PubMed:10632699}."
"1187","sp|P31007|DLG1_DROME","lcl|NC_088860.1_cds_XP_034328878.1_43113",0,837,"P31007","DLG1_DROME","Disks large 1 tumor suppressor protein (Dlg)","dlg1 l(1)dlg1 CG1725","Drosophila melanogaster (Fruit fly)",970,"GO:0000132; GO:0001708; GO:0001738; GO:0004385; GO:0005856; GO:0005886; GO:0005918; GO:0005920; GO:0005938; GO:0007165; GO:0007268; GO:0007318; GO:0007391; GO:0007399; GO:0007617; GO:0008049; GO:0010669; GO:0016323; GO:0016327; GO:0016328; GO:0016333; GO:0016334; GO:0016335; GO:0016336; GO:0019901; GO:0019991; GO:0030707; GO:0030714; GO:0031256; GO:0031594; GO:0035418; GO:0042058; GO:0042332; GO:0043005; GO:0043113; GO:0043195; GO:0045167; GO:0045175; GO:0045179; GO:0045197; GO:0045202; GO:0045211; GO:0045475; GO:0045571; GO:0045887; GO:0046956; GO:0048149; GO:0048471; GO:0051124; GO:0051294; GO:0060581; GO:0061060; GO:0061174; GO:0061176; GO:0061689; GO:0071212; GO:0097120; GO:0098609; GO:0098839; GO:0099072","anterior/posterior axis specification, follicular epithelium [GO:0030714]; asymmetric protein localization involved in cell fate determination [GO:0045167]; basal protein localization [GO:0045175]; behavioral response to ethanol [GO:0048149]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; dorsal closure [GO:0007391]; epithelial structure maintenance [GO:0010669]; establishment of mitotic spindle orientation [GO:0000132]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; follicle cell of egg chamber development [GO:0030707]; gravitaxis [GO:0042332]; locomotor rhythm [GO:0045475]; male courtship behavior [GO:0008049]; mating behavior [GO:0007617]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of peptidoglycan recognition protein signaling pathway [GO:0061060]; nervous system development [GO:0007399]; pole plasm protein localization [GO:0007318]; positive phototaxis [GO:0046956]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; protein localization to synapse [GO:0035418]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; septate junction assembly [GO:0019991]; signal transduction [GO:0007165]; synaptic assembly at neuromuscular junction [GO:0051124]","apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; lateral plasma membrane [GO:0016328]; leading edge membrane [GO:0031256]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; septate junction [GO:0005918]; smooth septate junction [GO:0005920]; subsynaptic reticulum [GO:0071212]; synapse [GO:0045202]; terminal bouton [GO:0043195]; tricellular tight junction [GO:0061689]; type I terminal bouton [GO:0061174]; type Ib terminal bouton [GO:0061176]; guanylate kinase activity [GO:0004385]; protein kinase binding [GO:0019901]; anterior/posterior axis specification, follicular epithelium [GO:0030714]; asymmetric protein localization involved in cell fate determination [GO:0045167]; basal protein localization [GO:0045175]; behavioral response to ethanol [GO:0048149]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; dorsal closure [GO:0007391]; epithelial structure maintenance [GO:0010669]; establishment of mitotic spindle orientation [GO:0000132]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; follicle cell of egg chamber development [GO:0030707]; gravitaxis [GO:0042332]; locomotor rhythm [GO:0045475]; male courtship behavior [GO:0008049]; mating behavior [GO:0007617]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of peptidoglycan recognition protein signaling pathway [GO:0061060]; nervous system development [GO:0007399]; pole plasm protein localization [GO:0007318]; positive phototaxis [GO:0046956]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; protein localization to synapse [GO:0035418]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; septate junction assembly [GO:0019991]; signal transduction [GO:0007165]; synaptic assembly at neuromuscular junction [GO:0051124]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically throughout development (PubMed:1651169). Expressed in follicular epithelium in stage 9/10 of oogenesis (PubMed:24768049). {ECO:0000269|PubMed:1651169, ECO:0000269|PubMed:24768049}.","","","TISSUE SPECIFICITY: During the cellular blastoderm stage, isoform B, isoform F, isoform H, isoform I and isoform L expression is localized to the cell borders. From stage 11 onwards, expression is found predominantly in the developing nervous system: axon bundles in the ventral cord and the brain. Stage 14 and 15 embryos exhibit expression in the developing body wall muscle. Expression in neuropil regions of the CNS and at NMJs persists through to larval development. Other isoforms show expression in embryonic epithelial cells. In larvae, expression is seen as a belt around salivary glands, imaginal disks and proventriculus. Expressed in adult reproductive tissues. In epithelia, coexpressed with scrib throughout development. {ECO:0000269|PubMed:10884224, ECO:0000269|PubMed:12657668, ECO:0000269|PubMed:1651169}."
"1188","sp|Q07407|FGFR1_DROME","lcl|NC_088860.1_cds_XP_034328919.2_43060",8.34e-139,429,"Q07407","FGFR1_DROME","Fibroblast growth factor receptor homolog 1 (EC 2.7.10.1) (DmHD-38) (Protein heartless) (Tyrosine kinase 1) (dTk1)","htl FR1 Tk1 CG7223","Drosophila melanogaster (Fruit fly)",729,"GO:0001710; GO:0004713; GO:0004714; GO:0005007; GO:0005524; GO:0005886; GO:0007417; GO:0007419; GO:0007431; GO:0007493; GO:0007500; GO:0007506; GO:0007507; GO:0007509; GO:0007522; GO:0007523; GO:0007525; GO:0008078; GO:0008284; GO:0008347; GO:0008354; GO:0008360; GO:0008543; GO:0010001; GO:0010002; GO:0021782; GO:0035169; GO:0035170; GO:0042065; GO:0043235; GO:0043410; GO:0045089; GO:0045887; GO:0048542; GO:0048626; GO:0050829; GO:0055001; GO:0061320; GO:0098975; GO:0106091; GO:0110122; GO:1903977","cardioblast differentiation [GO:0010002]; central nervous system development [GO:0007417]; defense response to Gram-negative bacterium [GO:0050829]; endodermal cell fate determination [GO:0007493]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell migration [GO:0008354]; glial cell development [GO:0021782]; glial cell differentiation [GO:0010001]; glial cell growth [GO:0042065]; glial cell migration [GO:0008347]; glial cell projection elongation [GO:0106091]; gonadal mesoderm development [GO:0007506]; heart development [GO:0007507]; larval visceral muscle development [GO:0007523]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; lymph gland plasmatocyte differentiation [GO:0035169]; mesoderm migration involved in gastrulation [GO:0007509]; mesodermal cell fate commitment [GO:0001710]; mesodermal cell fate determination [GO:0007500]; mesodermal cell migration [GO:0008078]; muscle cell development [GO:0055001]; myoblast fate specification [GO:0048626]; myotube cell migration [GO:0110122]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glial cell migration [GO:1903977]; positive regulation of innate immune response [GO:0045089]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; regulation of cell shape [GO:0008360]; salivary gland development [GO:0007431]; somatic muscle development [GO:0007525]; ventral cord development [GO:0007419]; visceral muscle development [GO:0007522]","plasma membrane [GO:0005886]; postsynapse of neuromuscular junction [GO:0098975]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor receptor activity [GO:0005007]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cardioblast differentiation [GO:0010002]; central nervous system development [GO:0007417]; defense response to Gram-negative bacterium [GO:0050829]; endodermal cell fate determination [GO:0007493]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell migration [GO:0008354]; glial cell development [GO:0021782]; glial cell differentiation [GO:0010001]; glial cell growth [GO:0042065]; glial cell migration [GO:0008347]; glial cell projection elongation [GO:0106091]; gonadal mesoderm development [GO:0007506]; heart development [GO:0007507]; larval visceral muscle development [GO:0007523]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; lymph gland plasmatocyte differentiation [GO:0035169]; mesoderm migration involved in gastrulation [GO:0007509]; mesodermal cell fate commitment [GO:0001710]; mesodermal cell fate determination [GO:0007500]; mesodermal cell migration [GO:0008078]; muscle cell development [GO:0055001]; myoblast fate specification [GO:0048626]; myotube cell migration [GO:0110122]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glial cell migration [GO:1903977]; positive regulation of innate immune response [GO:0045089]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; regulation of cell shape [GO:0008360]; salivary gland development [GO:0007431]; somatic muscle development [GO:0007525]; ventral cord development [GO:0007419]; visceral muscle development [GO:0007522]","DEVELOPMENTAL STAGE: Embryogenesis. {ECO:0000269|PubMed:8330538}.","","","TISSUE SPECIFICITY: In early embryos, expression is specific to mesodermal primordium and invaginated mesodermal cells. At later stages, expression is seen in putative muscle precursor cells and in the CNS. {ECO:0000269|PubMed:8330538}."
"1189","sp|H2L099|GCK1_CAEEL","lcl|NC_088860.1_cds_XP_034329036.2_43482",7.95e-137,412,"H2L099","GCK1_CAEEL","Germinal center kinase 1 (EC 2.7.11.1)","gck-1 T19A5.2","Caenorhabditis elegans",653,"GO:0004674; GO:0005524; GO:0005737; GO:0035556; GO:0043066; GO:0043547; GO:0046872; GO:0048477; GO:0051019; GO:0051321; GO:0060281; GO:0060562; GO:0098592; GO:0106310; GO:1903358; GO:2001137","epithelial tube morphogenesis [GO:0060562]; intracellular signal transduction [GO:0035556]; meiotic cell cycle [GO:0051321]; negative regulation of apoptotic process [GO:0043066]; oogenesis [GO:0048477]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; regulation of oocyte development [GO:0060281]","cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; epithelial tube morphogenesis [GO:0060562]; intracellular signal transduction [GO:0035556]; meiotic cell cycle [GO:0051321]; negative regulation of apoptotic process [GO:0043066]; oogenesis [GO:0048477]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; regulation of oocyte development [GO:0060281]","","","",""
"1190","sp|V6CIV8|DUSL_CAEEL","lcl|NC_088860.1_cds_XP_034329413.1_44489",3.85e-35,134,"V6CIV8","DUSL_CAEEL","Dual specificity protein phosphatase lip-1 (EC 3.1.3.16) (EC 3.1.3.48) (Lateral signaling-induced phosphatase 1) (Mitogen-activated protein kinase phosphatase lip-1) (MAP kinase phosphatase lip-1)","lip-1 C05B10.1","Caenorhabditis elegans",381,"GO:0004722; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0007219; GO:0007281; GO:0008330; GO:0009792; GO:0017017; GO:0033550; GO:0040026; GO:0040028; GO:0042659; GO:0046580; GO:0048599; GO:0051301; GO:0051321; GO:0051447; GO:0070373; GO:0072327","cell division [GO:0051301]; embryo development ending in birth or egg hatching [GO:0009792]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of Ras protein signal transduction [GO:0046580]; Notch signaling pathway [GO:0007219]; oocyte development [GO:0048599]; positive regulation of vulval development [GO:0040026]; regulation of cell fate specification [GO:0042659]; regulation of vulval development [GO:0040028]; signal transduction [GO:0007165]; vulval cell fate specification [GO:0072327]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; MAP kinase tyrosine phosphatase activity [GO:0033550]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/threonine phosphatase activity [GO:0008330]; cell division [GO:0051301]; embryo development ending in birth or egg hatching [GO:0009792]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of Ras protein signal transduction [GO:0046580]; Notch signaling pathway [GO:0007219]; oocyte development [GO:0048599]; positive regulation of vulval development [GO:0040026]; regulation of cell fate specification [GO:0042659]; regulation of vulval development [GO:0040028]; signal transduction [GO:0007165]; vulval cell fate specification [GO:0072327]","DEVELOPMENTAL STAGE: Expressed at low level in the proximal mitotic region and transition zone of germline cells and at the pachytene stage of meiotic prophase I. {ECO:0000269|PubMed:12169634, ECO:0000269|PubMed:16319922}.","","","TISSUE SPECIFICITY: Expressed in vulva cell precursors. Expression is increased in P5.p and P7.p and their descendants during vulva induction. Expressed in syncytium hyp7 (PubMed:11161219). Expressed in germline cells (PubMed:12169634, PubMed:16319922). {ECO:0000269|PubMed:11161219, ECO:0000269|PubMed:12169634, ECO:0000269|PubMed:16319922}."
"1191","sp|Q24114|DALY_DROME","lcl|NC_088860.1_cds_XP_034329781.2_43770",5.21e-25,111,"Q24114","DALY_DROME","Division abnormally delayed protein (Dally protein)","dally CG4974","Drosophila melanogaster (Fruit fly)",626,"GO:0002091; GO:0005886; GO:0007367; GO:0007409; GO:0007427; GO:0007472; GO:0007480; GO:0008045; GO:0008052; GO:0008407; GO:0008586; GO:0009897; GO:0009986; GO:0016323; GO:0016324; GO:0016477; GO:0022416; GO:0030513; GO:0030718; GO:0035220; GO:0035222; GO:0035592; GO:0045570; GO:0045743; GO:0045880; GO:0048100; GO:0048132; GO:0048190; GO:0048749; GO:0048813; GO:0051726; GO:0071694; GO:0090263; GO:0098595; GO:1905475; GO:2001261","axonogenesis [GO:0007409]; cell migration [GO:0016477]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compound eye development [GO:0048749]; dendrite morphogenesis [GO:0048813]; epithelial cell migration, open tracheal system [GO:0007427]; establishment of protein localization to extracellular region [GO:0035592]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maintenance of protein location in extracellular region [GO:0071694]; motor neuron axon guidance [GO:0008045]; negative regulation of receptor internalization [GO:0002091]; negative regulation of semaphorin-plexin signaling pathway [GO:2001261]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of cell cycle [GO:0051726]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization to membrane [GO:1905475]; segment polarity determination [GO:0007367]; sensory organ boundary specification [GO:0008052]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc development [GO:0035220]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc morphogenesis [GO:0007472]; wing disc pattern formation [GO:0035222]","apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; perivitelline space [GO:0098595]; plasma membrane [GO:0005886]; axonogenesis [GO:0007409]; cell migration [GO:0016477]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compound eye development [GO:0048749]; dendrite morphogenesis [GO:0048813]; epithelial cell migration, open tracheal system [GO:0007427]; establishment of protein localization to extracellular region [GO:0035592]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maintenance of protein location in extracellular region [GO:0071694]; motor neuron axon guidance [GO:0008045]; negative regulation of receptor internalization [GO:0002091]; negative regulation of semaphorin-plexin signaling pathway [GO:2001261]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of cell cycle [GO:0051726]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization to membrane [GO:1905475]; segment polarity determination [GO:0007367]; sensory organ boundary specification [GO:0008052]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc development [GO:0035220]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc morphogenesis [GO:0007472]; wing disc pattern formation [GO:0035222]","DEVELOPMENTAL STAGE: Expressed ubiquitously with elevated signal at the anterior-posterior (A/P) and dorsoventral (D/V) compartment boundaries and in peripheral wing disk cells (at protein level). {ECO:0000269|PubMed:35301437, ECO:0000269|PubMed:35609633}.","","",""
"1192","sp|P39768|OPA_DROME","lcl|NC_088860.1_cds_XP_034329812.2_43742",9.02e-98,308,"P39768","OPA_DROME","Pair-rule protein odd-paired","opa CG1133","Drosophila melanogaster (Fruit fly)",609,"GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0007366; GO:0007417; GO:0007455; GO:0007494; GO:0008270; GO:0008354; GO:0045944","central nervous system development [GO:0007417]; eye-antennal disc morphogenesis [GO:0007455]; germ cell migration [GO:0008354]; midgut development [GO:0007494]; negative regulation of transcription by RNA polymerase II [GO:0000122]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription by RNA polymerase II [GO:0045944]","nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; central nervous system development [GO:0007417]; eye-antennal disc morphogenesis [GO:0007455]; germ cell migration [GO:0008354]; midgut development [GO:0007494]; negative regulation of transcription by RNA polymerase II [GO:0000122]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription by RNA polymerase II [GO:0045944]","DEVELOPMENTAL STAGE: The peak expression is seen between 2 and 12 hours of embryogenesis. Expression continues through the larval instars and during pupation although at lower levels compared with embryogenesis. {ECO:0000269|PubMed:7781900, ECO:0000269|PubMed:8288124}.","","","TISSUE SPECIFICITY: Expressed throughout all segment primordia; expressed ubiquitously in the ectoderm and mesoderm precursors. {ECO:0000269|PubMed:7781900, ECO:0000269|PubMed:8288124}."
"1193","sp|Q9V3U2|NHP2_DROME","lcl|NC_088860.1_cds_XP_034329842.1_43706",3.18e-31,111,"Q9V3U2","NHP2_DROME","H/ACA ribonucleoprotein complex subunit 2 (H/ACA snoRNP protein NHP2) (Nucleolar protein family A member 2-like protein)","NHP2 CG5258","Drosophila melanogaster (Fruit fly)",160,"GO:0005730; GO:0005732; GO:0031118; GO:0031120; GO:0031429; GO:0034513; GO:0048142","germarium-derived cystoblast division [GO:0048142]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]","box H/ACA snoRNP complex [GO:0031429]; nucleolus [GO:0005730]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; box H/ACA snoRNA binding [GO:0034513]; germarium-derived cystoblast division [GO:0048142]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]","","","",""
"1194","sp|O76050|NEUL1_HUMAN","lcl|NC_088860.1_cds_XP_034329851.2_43701",4.96e-80,263,"O76050","NEUL1_HUMAN","E3 ubiquitin-protein ligase NEURL1 (EC 2.3.2.27) (Neuralized-like protein 1A) (h-neu) (h-neuralized 1) (RING finger protein 67) (RING-type E3 ubiquitin transferase NEURL1)","NEURL1 NEURL NEURL1A RNF67","Homo sapiens (Human)",574,"GO:0004842; GO:0005886; GO:0006513; GO:0007219; GO:0007288; GO:0007399; GO:0007519; GO:0007595; GO:0008270; GO:0008285; GO:0014069; GO:0043065; GO:0043197; GO:0043204; GO:0045182; GO:0045746; GO:0048170; GO:0048471; GO:0051491; GO:0060999; GO:0061630; GO:0071230; GO:0090129; GO:0097440; GO:0098978; GO:0150052","cellular response to amino acid stimulus [GO:0071230]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of Notch signaling pathway [GO:0045746]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of synapse maturation [GO:0090129]; protein monoubiquitination [GO:0006513]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle tissue development [GO:0007519]; sperm axoneme assembly [GO:0007288]","apical dendrite [GO:0097440]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; translation regulator activity [GO:0045182]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to amino acid stimulus [GO:0071230]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of Notch signaling pathway [GO:0045746]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of synapse maturation [GO:0090129]; protein monoubiquitination [GO:0006513]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle tissue development [GO:0007519]; sperm axoneme assembly [GO:0007288]","","INDUCTION: Down-regulated in medulloblastoma (MB).","INDUCTION: Down-regulated in medulloblastoma (MB).","TISSUE SPECIFICITY: Expressed in brain, testis, pituitary gland, pancreas and bone marrow. Also poorly expressed in malignant astrocytomas and several neuroectodermal tumor cell lines. Weakly expressed in medulloblastoma (MB) compared with normal cerebellar tissues. {ECO:0000269|PubMed:11585928, ECO:0000269|PubMed:9519875}."
"1195","sp|Q9N5A0|VATB2_CAEEL","lcl|NC_088860.1_cds_XP_034329948.2_43038",0,832,"Q9N5A0","VATB2_CAEEL","V-type proton ATPase subunit B 2 (V-ATPase subunit B 2) (Defective spermatogenesis protein 5) (Vacuolar proton pump subunit B 2)","spe-5 Y110A7A.12","Caenorhabditis elegans",501,"GO:0005524; GO:0005737; GO:0007035; GO:0007283; GO:0033180; GO:0043068; GO:0046034; GO:0046961; GO:0048137; GO:0051452","ATP metabolic process [GO:0046034]; intracellular pH reduction [GO:0051452]; positive regulation of programmed cell death [GO:0043068]; spermatocyte division [GO:0048137]; spermatogenesis [GO:0007283]; vacuolar acidification [GO:0007035]","cytoplasm [GO:0005737]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ATP metabolic process [GO:0046034]; intracellular pH reduction [GO:0051452]; positive regulation of programmed cell death [GO:0043068]; spermatocyte division [GO:0048137]; spermatogenesis [GO:0007283]; vacuolar acidification [GO:0007035]","","","","TISSUE SPECIFICITY: Predominantly expressed in male and hermaphrodite testis (at protein level). {ECO:0000269|PubMed:22446317}."
"1196","sp|Q02748|IF4A_DROME","lcl|NC_088860.1_cds_XP_034330093.1_41132",0,599,"Q02748","IF4A_DROME","Eukaryotic initiation factor 4A (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A)","eIF4A eIF-4a l(2L)162 CG9075","Drosophila melanogaster (Fruit fly)",403,"GO:0000278; GO:0000381; GO:0002183; GO:0003723; GO:0003724; GO:0003743; GO:0005524; GO:0005634; GO:0005829; GO:0006413; GO:0007279; GO:0010494; GO:0016281; GO:0016887; GO:0030514; GO:0030718; GO:0032436; GO:0043186; GO:0046332; GO:0048132; GO:0048477","cytoplasmic translational initiation [GO:0002183]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; mitotic cell cycle [GO:0000278]; negative regulation of BMP signaling pathway [GO:0030514]; oogenesis [GO:0048477]; pole cell formation [GO:0007279]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; translational initiation [GO:0006413]","cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; mitotic cell cycle [GO:0000278]; negative regulation of BMP signaling pathway [GO:0030514]; oogenesis [GO:0048477]; pole cell formation [GO:0007279]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; translational initiation [GO:0006413]","","","",""
"1197","sp|Q8T6B9|PUF68_DROME","lcl|NC_088860.1_cds_XP_034330268.1_43962",3.24e-103,327,"Q8T6B9","PUF68_DROME","Poly(U)-binding-splicing factor hfp (68 kDa poly(U)-binding-splicing factor) (PUF60 homolog) (Protein half pint)","hfp pUf68 CG12085","Drosophila melanogaster (Fruit fly)",637,"GO:0000380; GO:0000381; GO:0000398; GO:0001558; GO:0003723; GO:0005634; GO:0006376; GO:0007282; GO:0008285; GO:0032991; GO:0045926; GO:0048477; GO:0071011; GO:0071013","alternative mRNA splicing, via spliceosome [GO:0000380]; cystoblast division [GO:0007282]; mRNA splice site recognition [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell growth [GO:0001558]","catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; cystoblast division [GO:0007282]; mRNA splice site recognition [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell growth [GO:0001558]","","","","TISSUE SPECIFICITY: Expressed in all germline cells and within the follicle cell. {ECO:0000269|PubMed:11879639}."
"1198","sp|P23647|FUSED_DROME","lcl|NC_088860.1_cds_XP_034330394.2_41735",1.37e-87,304,"P23647","FUSED_DROME","Serine/threonine-protein kinase fused (EC 2.7.11.1)","fu CG6551","Drosophila melanogaster (Fruit fly)",805,"GO:0004674; GO:0005119; GO:0005524; GO:0005737; GO:0005829; GO:0005929; GO:0007224; GO:0007293; GO:0007367; GO:0030514; GO:0031398; GO:0032991; GO:0035222; GO:0035301; GO:0042073; GO:0042803; GO:0045879; GO:0046824; GO:0106310","germarium-derived egg chamber formation [GO:0007293]; intraciliary transport [GO:0042073]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of nucleocytoplasmic transport [GO:0046824]; positive regulation of protein ubiquitination [GO:0031398]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc pattern formation [GO:0035222]","cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Hedgehog signaling complex [GO:0035301]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; smoothened binding [GO:0005119]; germarium-derived egg chamber formation [GO:0007293]; intraciliary transport [GO:0042073]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of nucleocytoplasmic transport [GO:0046824]; positive regulation of protein ubiquitination [GO:0031398]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc pattern formation [GO:0035222]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically, low expression is present in males, larvae and pupae.","","","TISSUE SPECIFICITY: Expressed in all imaginal disks, higher level in wing disk. {ECO:0000269|PubMed:8155575}."
"1199","sp|Q9H1J1|REN3A_HUMAN","lcl|NC_088860.1_cds_XP_034330408.2_41712",1.61e-37,147,"Q9H1J1","REN3A_HUMAN","Regulator of nonsense transcripts 3A (Nonsense mRNA reducing factor 3A) (Up-frameshift suppressor 3 homolog A) (hUpf3)","UPF3A RENT3A UPF3","Homo sapiens (Human)",476,"GO:0001701; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007283; GO:0035145; GO:0042162; GO:0043005; GO:0043231; GO:0045727; GO:0051028; GO:1905746; GO:2000623","in utero embryonic development [GO:0001701]; mRNA transport [GO:0051028]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; positive regulation of mRNA cis splicing, via spliceosome [GO:1905746]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; mRNA binding [GO:0003729]; telomeric DNA binding [GO:0042162]; in utero embryonic development [GO:0001701]; mRNA transport [GO:0051028]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; positive regulation of mRNA cis splicing, via spliceosome [GO:1905746]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Isoform 1 is strongly expressed in testis, uterus, muscle, fetal brain and spinal cord. Isoform 2 is strongly expressed in fetal brain and spinal cord. {ECO:0000269|PubMed:11113196}."
"1200","sp|A5PK71|PACRG_BOVIN","lcl|NC_088860.1_cds_XP_034330828.1_43292",1.16e-12,67,"A5PK71","PACRG_BOVIN","Parkin coregulated gene protein","PACRG","Bos taurus (Bovine)",257,"GO:0001664; GO:0002177; GO:0003779; GO:0005829; GO:0005879; GO:0007286; GO:0008104; GO:0030317; GO:0030544; GO:0031625; GO:0031982; GO:0043005; GO:0043014; GO:0044297; GO:0048487; GO:0051879; GO:0097225; GO:0097386; GO:0160112","flagellated sperm motility [GO:0030317]; protein localization [GO:0008104]; spermatid development [GO:0007286]","axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; cell body [GO:0044297]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; manchette [GO:0002177]; neuron projection [GO:0043005]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; ubiquitin protein ligase binding [GO:0031625]; flagellated sperm motility [GO:0030317]; protein localization [GO:0008104]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Expressed in trachea multiciliated cells. {ECO:0000269|PubMed:34715025}."
"1201","sp|Q9VUV9|U520_DROME","lcl|NC_088860.1_cds_XP_034330899.2_44114",0,3200,"Q9VUV9","U520_DROME","U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Protein lethal (3) 72Ab)","Brr2 l(3)72Ab CG5931","Drosophila melanogaster (Fruit fly)",2142,"GO:0000278; GO:0000381; GO:0000388; GO:0000398; GO:0003676; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0007283; GO:0007419; GO:0016887; GO:0030532; GO:0071011; GO:0071013","mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spermatogenesis [GO:0007283]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]; ventral cord development [GO:0007419]","catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spermatogenesis [GO:0007283]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]; ventral cord development [GO:0007419]","","","",""
"1202","sp|O08983|HPS1_MOUSE","lcl|NC_088860.1_cds_XP_065923951.1_43340",1.09e-37,152,"O08983","HPS1_MOUSE","BLOC-3 complex member HPS1 (Hermansky-Pudlak syndrome 1 protein homolog)","Hps1 Ep Hps","Mus musculus (Mouse)",704,"GO:0000902; GO:0003016; GO:0005085; GO:0005737; GO:0006629; GO:0006882; GO:0006954; GO:0007040; GO:0007283; GO:0007338; GO:0007596; GO:0009306; GO:0010467; GO:0016192; GO:0030318; GO:0030324; GO:0031085; GO:0031410; GO:0032816; GO:0033299; GO:0043473; GO:0046907; GO:0048069; GO:0055088; GO:0060041; GO:0060155; GO:0060425; GO:1903232","blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; eye pigmentation [GO:0048069]; gene expression [GO:0010467]; inflammatory response [GO:0006954]; intracellular transport [GO:0046907]; intracellular zinc ion homeostasis [GO:0006882]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; pigmentation [GO:0043473]; platelet dense granule organization [GO:0060155]; positive regulation of natural killer cell activation [GO:0032816]; protein secretion [GO:0009306]; respiratory system process [GO:0003016]; retina development in camera-type eye [GO:0060041]; secretion of lysosomal enzymes [GO:0033299]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192]","BLOC-3 complex [GO:0031085]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; guanyl-nucleotide exchange factor activity [GO:0005085]; blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; eye pigmentation [GO:0048069]; gene expression [GO:0010467]; inflammatory response [GO:0006954]; intracellular transport [GO:0046907]; intracellular zinc ion homeostasis [GO:0006882]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; pigmentation [GO:0043473]; platelet dense granule organization [GO:0060155]; positive regulation of natural killer cell activation [GO:0032816]; protein secretion [GO:0009306]; respiratory system process [GO:0003016]; retina development in camera-type eye [GO:0060041]; secretion of lysosomal enzymes [GO:0033299]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192]","","","","TISSUE SPECIFICITY: Expressed in all tissues examined with the possible exception of skeletal muscle. The highest expression was observed in lung, liver, kidney and spleen."
"1203","sp|Q9VAY3|MFRN_DROME","lcl|NC_088860.1_cds_XP_065923980.1_43329",7.66e-97,292,"Q9VAY3","MFRN_DROME","Mitoferrin (dmfrn)","mfrn CG4963","Drosophila melanogaster (Fruit fly)",379,"GO:0005381; GO:0005739; GO:0005743; GO:0015093; GO:0031966; GO:0048250; GO:0048515; GO:0060586","iron import into the mitochondrion [GO:0048250]; multicellular organismal-level iron ion homeostasis [GO:0060586]; spermatid differentiation [GO:0048515]","mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ferrous iron transmembrane transporter activity [GO:0015093]; iron ion transmembrane transporter activity [GO:0005381]; iron import into the mitochondrion [GO:0048250]; multicellular organismal-level iron ion homeostasis [GO:0060586]; spermatid differentiation [GO:0048515]","","","",""
"1204","sp|P63029|TCTP_RAT","lcl|NC_088860.1_cds_XP_065923981.1_44363",1.86e-47,153,"P63029","TCTP_RAT","Translationally-controlled tumor protein (TCTP) (Lens epithelial protein)","Tpt1 Trt","Rattus norvegicus (Rat)",172,"GO:0000922; GO:0005509; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005771; GO:0005881; GO:0007283; GO:0009615; GO:0019827; GO:0140297; GO:1902230; GO:2000384","negative regulation of ectoderm development [GO:2000384]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]","cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; extracellular space [GO:0005615]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; DNA-binding transcription factor binding [GO:0140297]; negative regulation of ectoderm development [GO:2000384]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]","","","",""
"1205","sp|P42859|HD_MOUSE","lcl|NC_088860.1_cds_XP_065924127.1_42575",0,1810,"P42859","HD_MOUSE","Huntingtin (Huntington disease protein homolog) (HD protein homolog) [Cleaved into: Huntingtin, myristoylated N-terminal fragment]","Htt Hd Hdh","Mus musculus (Mouse)",3119,"GO:0000050; GO:0000052; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005814; GO:0006839; GO:0006888; GO:0007005; GO:0007029; GO:0007212; GO:0007283; GO:0007369; GO:0007417; GO:0007420; GO:0007611; GO:0007612; GO:0007625; GO:0007626; GO:0008088; GO:0008306; GO:0008340; GO:0008542; GO:0009653; GO:0009952; GO:0010467; GO:0010468; GO:0016197; GO:0016234; GO:0019244; GO:0019805; GO:0021756; GO:0021988; GO:0021990; GO:0022008; GO:0030072; GO:0030073; GO:0030424; GO:0031410; GO:0034504; GO:0035176; GO:0042445; GO:0043066; GO:0043523; GO:0047496; GO:0048167; GO:0048341; GO:0048471; GO:0048666; GO:0050809; GO:0051592; GO:0060586; GO:0071539; GO:0090398; GO:0098978; GO:0099527; GO:1900180; GO:1902857; GO:1905291; GO:1905505","anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; associative learning [GO:0008306]; axo-dendritic transport [GO:0008088]; brain development [GO:0007420]; cellular senescence [GO:0090398]; central nervous system development [GO:0007417]; citrulline metabolic process [GO:0000052]; determination of adult lifespan [GO:0008340]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; gastrulation [GO:0007369]; gene expression [GO:0010467]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insulin secretion [GO:0030073]; lactate biosynthetic process from pyruvate [GO:0019244]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of apoptotic process [GO:0043066]; neural plate formation [GO:0021990]; neurogenesis [GO:0022008]; neuron development [GO:0048666]; olfactory lobe development [GO:0021988]; paraxial mesoderm formation [GO:0048341]; peptide hormone secretion [GO:0030072]; positive regulation of CAMKK-AMPK signaling cascade [GO:1905291]; positive regulation of motile cilium assembly [GO:1905505]; positive regulation of non-motile cilium assembly [GO:1902857]; postsynapse to nucleus signaling pathway [GO:0099527]; protein localization to centrosome [GO:0071539]; protein localization to nucleus [GO:0034504]; quinolinate biosynthetic process [GO:0019805]; regulation of gene expression [GO:0010468]; regulation of neuron apoptotic process [GO:0043523]; regulation of protein localization to nucleus [GO:1900180]; regulation of synaptic plasticity [GO:0048167]; response to calcium ion [GO:0051592]; social behavior [GO:0035176]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; urea cycle [GO:0000050]; vesicle transport along microtubule [GO:0047496]; visual learning [GO:0008542]","autophagosome [GO:0005776]; axon [GO:0030424]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; inclusion body [GO:0016234]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; diazepam binding [GO:0050809]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; associative learning [GO:0008306]; axo-dendritic transport [GO:0008088]; brain development [GO:0007420]; cellular senescence [GO:0090398]; central nervous system development [GO:0007417]; citrulline metabolic process [GO:0000052]; determination of adult lifespan [GO:0008340]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; gastrulation [GO:0007369]; gene expression [GO:0010467]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insulin secretion [GO:0030073]; lactate biosynthetic process from pyruvate [GO:0019244]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of apoptotic process [GO:0043066]; neural plate formation [GO:0021990]; neurogenesis [GO:0022008]; neuron development [GO:0048666]; olfactory lobe development [GO:0021988]; paraxial mesoderm formation [GO:0048341]; peptide hormone secretion [GO:0030072]; positive regulation of CAMKK-AMPK signaling cascade [GO:1905291]; positive regulation of motile cilium assembly [GO:1905505]; positive regulation of non-motile cilium assembly [GO:1902857]; postsynapse to nucleus signaling pathway [GO:0099527]; protein localization to centrosome [GO:0071539]; protein localization to nucleus [GO:0034504]; quinolinate biosynthetic process [GO:0019805]; regulation of gene expression [GO:0010468]; regulation of neuron apoptotic process [GO:0043523]; regulation of protein localization to nucleus [GO:1900180]; regulation of synaptic plasticity [GO:0048167]; response to calcium ion [GO:0051592]; social behavior [GO:0035176]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; urea cycle [GO:0000050]; vesicle transport along microtubule [GO:0047496]; visual learning [GO:0008542]","DEVELOPMENTAL STAGE: Predominant expression in neuronal tissues at all developmental stages. In 14.5 day old embryos, it is also detected in non-neuronal tissues. This expression is down-regulated in later stages of development.","","","TISSUE SPECIFICITY: The highest level is seen throughout the brain, but it is also found in the stomach, heart, testis, adipose tissue, muscle, spleen, liver, and kidney."
"1206","sp|Q2QAV0|TIO_ARATH","lcl|NC_088860.1_cds_XP_065924199.1_41734",2.58e-111,383,"Q2QAV0","TIO_ARATH","Serine/threonine-protein kinase TIO (EC 2.7.11.1) (Fused homolog) (AtFUSED) (Protein TWO-IN-ONE) (AtTIO)","TIO FU At1g50240 F14I3.15","Arabidopsis thaliana (Mouse-ear cress)",1322,"GO:0000911; GO:0004674; GO:0005524; GO:0005856; GO:0007112; GO:0009524; GO:0009558; GO:0019894; GO:0106310","cytokinesis by cell plate formation [GO:0000911]; embryo sac cellularization [GO:0009558]; male meiosis cytokinesis [GO:0007112]","cytoskeleton [GO:0005856]; phragmoplast [GO:0009524]; ATP binding [GO:0005524]; kinesin binding [GO:0019894]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cytokinesis by cell plate formation [GO:0000911]; embryo sac cellularization [GO:0009558]; male meiosis cytokinesis [GO:0007112]","","","","TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:16332535}."
"1207","sp|Q6AYJ4|REC8_RAT","lcl|NC_088860.1_cds_XP_065924206.1_41381",1.23e-27,119,"Q6AYJ4","REC8_RAT","Meiotic recombination protein REC8 homolog (Cohesin Rec8p)","Rec8 Rec8L1","Rattus norvegicus (Rat)",593,"GO:0000724; GO:0000776; GO:0000779; GO:0000793; GO:0000794; GO:0000795; GO:0000800; GO:0001556; GO:0001673; GO:0003682; GO:0005634; GO:0006302; GO:0007129; GO:0007130; GO:0007141; GO:0007286; GO:0009566; GO:0030893; GO:0051177; GO:0051321; GO:0072520","double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; fertilization [GO:0009566]; homologous chromosome pairing at meiosis [GO:0007129]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; meiotic sister chromatid cohesion [GO:0051177]; oocyte maturation [GO:0001556]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130]","condensed chromosome [GO:0000793]; condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome [GO:0000794]; kinetochore [GO:0000776]; lateral element [GO:0000800]; male germ cell nucleus [GO:0001673]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; chromatin binding [GO:0003682]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; fertilization [GO:0009566]; homologous chromosome pairing at meiosis [GO:0007129]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; meiotic sister chromatid cohesion [GO:0051177]; oocyte maturation [GO:0001556]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130]","","","",""
"1208","sp|Q7M753|PANK2_MOUSE","lcl|NC_088860.1_cds_XP_065924230.1_40974",2.82e-154,444,"Q7M753","PANK2_MOUSE","Pantothenate kinase 2, mitochondrial (hPanK2) (EC 2.7.1.33) (Pantothenic acid kinase 2)","Pank2","Mus musculus (Mouse)",456,"GO:0001525; GO:0004594; GO:0005524; GO:0005634; GO:0005739; GO:0005758; GO:0005829; GO:0007005; GO:0007286; GO:0009060; GO:0015937; GO:0019217; GO:0051881; GO:0090207; GO:1904251","aerobic respiration [GO:0009060]; angiogenesis [GO:0001525]; coenzyme A biosynthetic process [GO:0015937]; mitochondrion organization [GO:0007005]; regulation of bile acid metabolic process [GO:1904251]; regulation of fatty acid metabolic process [GO:0019217]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of triglyceride metabolic process [GO:0090207]; spermatid development [GO:0007286]","cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; pantothenate kinase activity [GO:0004594]; aerobic respiration [GO:0009060]; angiogenesis [GO:0001525]; coenzyme A biosynthetic process [GO:0015937]; mitochondrion organization [GO:0007005]; regulation of bile acid metabolic process [GO:1904251]; regulation of fatty acid metabolic process [GO:0019217]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of triglyceride metabolic process [GO:0090207]; spermatid development [GO:0007286]","","","",""
"1209","sp|Q5M9Q1|NKAPL_HUMAN","lcl|NC_088860.1_cds_XP_065924284.1_44503",5.31e-48,170,"Q5M9Q1","NKAPL_HUMAN","NKAP-like protein","NKAPL C6orf194","Homo sapiens (Human)",402,"GO:0003682; GO:0005634; GO:0007283; GO:0010468; GO:0030154","cell differentiation [GO:0030154]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]","nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell differentiation [GO:0030154]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]","","","",""
"1210","sp|Q9VCX1|RGS_DROME","lcl|NC_088860.1_cds_XP_065924342.1_41251",5.43e-59,226,"Q9VCX1","RGS_DROME","Regulator of G-protein signaling loco (RGS) (Locomotion defects protein) (Loco)","loco CG5248","Drosophila melanogaster (Fruit fly)",1541,"GO:0000578; GO:0001965; GO:0003015; GO:0005092; GO:0005096; GO:0005634; GO:0005737; GO:0005886; GO:0006979; GO:0007186; GO:0007300; GO:0007310; GO:0007419; GO:0008069; GO:0008277; GO:0009408; GO:0009786; GO:0010001; GO:0016324; GO:0019991; GO:0030866; GO:0032291; GO:0042594; GO:0045179; GO:0055059; GO:0060857","asymmetric neuroblast division [GO:0055059]; axon ensheathment in central nervous system [GO:0032291]; cortical actin cytoskeleton organization [GO:0030866]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; embryonic axis specification [GO:0000578]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; glial cell differentiation [GO:0010001]; heart process [GO:0003015]; oocyte dorsal/ventral axis specification [GO:0007310]; ovarian nurse cell to oocyte transport [GO:0007300]; regulation of asymmetric cell division [GO:0009786]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]","apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; asymmetric neuroblast division [GO:0055059]; axon ensheathment in central nervous system [GO:0032291]; cortical actin cytoskeleton organization [GO:0030866]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; embryonic axis specification [GO:0000578]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; glial cell differentiation [GO:0010001]; heart process [GO:0003015]; oocyte dorsal/ventral axis specification [GO:0007310]; ovarian nurse cell to oocyte transport [GO:0007300]; regulation of asymmetric cell division [GO:0009786]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. Expressed during oogenesis and embryogenesis. Isoform 3 and isoform 4 are expressed in the germarium at stage 2. Isoform 4 is expressed in the nurse cells at stage 6 until the nurse cells degenerate. Isoform 3 is expressed in the follicle cells at stage 8, in the anterior-dorsal follicles cells from stage 10 until the follicles degenerate. Isoform 2 and isoform 3 are expressed in late stage 12 embryos, onwards. Isoform 2 is expressed in tracheal cells and in lateral glial cells within the CNS in late stage 16 embryos. {ECO:0000269|PubMed:10079238, ECO:0000269|PubMed:11731228}.","","","TISSUE SPECIFICITY: Expressed in surface and longitudinal glial cells, gut and heart (at protein level). {ECO:0000269|PubMed:16213218}."
"1211","sp|Q8NDM7|CFA43_HUMAN","lcl|NC_088860.1_cds_XP_065924368.1_43355",0,888,"Q8NDM7","CFA43_HUMAN","Cilia- and flagella-associated protein 43 (WD repeat-containing protein 96)","CFAP43 C10orf79 WDR96","Homo sapiens (Human)",1665,"GO:0000902; GO:0003356; GO:0005576; GO:0005930; GO:0006997; GO:0007288; GO:0007420; GO:0051649; GO:0060271; GO:0090660; GO:0097729; GO:0120197","brain development [GO:0007420]; cell morphogenesis [GO:0000902]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; establishment of localization in cell [GO:0051649]; mucociliary clearance [GO:0120197]; nucleus organization [GO:0006997]; regulation of cilium beat frequency [GO:0003356]; sperm axoneme assembly [GO:0007288]","9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; extracellular region [GO:0005576]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; establishment of localization in cell [GO:0051649]; mucociliary clearance [GO:0120197]; nucleus organization [GO:0006997]; regulation of cilium beat frequency [GO:0003356]; sperm axoneme assembly [GO:0007288]","","","","TISSUE SPECIFICITY: Testis-specific. {ECO:0000269|PubMed:29449551}."
"1212","sp|E9Q7R9|CFA43_MOUSE","lcl|NC_088860.1_cds_XP_065924369.1_43360",0,902,"E9Q7R9","CFA43_MOUSE","Cilia- and flagella-associated protein 43","Cfap43","Mus musculus (Mouse)",1682,"GO:0000902; GO:0003351; GO:0003356; GO:0005576; GO:0005930; GO:0006997; GO:0007283; GO:0007288; GO:0007420; GO:0030317; GO:0044458; GO:0044782; GO:0051649; GO:0090660; GO:0097729; GO:0120197","brain development [GO:0007420]; cell morphogenesis [GO:0000902]; cerebrospinal fluid circulation [GO:0090660]; cilium organization [GO:0044782]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; nucleus organization [GO:0006997]; regulation of cilium beat frequency [GO:0003356]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]","9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; extracellular region [GO:0005576]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; cerebrospinal fluid circulation [GO:0090660]; cilium organization [GO:0044782]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; nucleus organization [GO:0006997]; regulation of cilium beat frequency [GO:0003356]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: During embryonic development, detected in the left-right organizer at 8.25 dpc and in 17.5 dpc embryos, detected in epithelial cells lining the respiratory tract, brain ependymal cells and the choroid plexus. {ECO:0000269|PubMed:31884020}.","","","TISSUE SPECIFICITY: Expressed in testis (PubMed:28552195). Expressed in the lung, brain, oviduct and nasal cavity (PubMed:31884020). {ECO:0000269|PubMed:28552195, ECO:0000269|PubMed:31884020}."
"1213","sp|Q2QLH0|CFTR_OTOGA","lcl|NC_088860.1_cds_XP_065924396.1_42694",1.94e-123,422,"Q2QLH0","CFTR_OTOGA","Cystic fibrosis transmembrane conductance regulator (CFTR) (ATP-binding cassette sub-family C member 7) (Channel conductance-controlling ATPase) (EC 5.6.1.6) (cAMP-dependent chloride channel)","CFTR ABCC7","Otolemur garnettii (Small-eared galago) (Garnett's greater bushbaby)",1482,"GO:0005254; GO:0005260; GO:0005524; GO:0005634; GO:0005769; GO:0005789; GO:0005829; GO:0005886; GO:0015106; GO:0015108; GO:0015701; GO:0016020; GO:0016324; GO:0016887; GO:0019869; GO:0031901; GO:0034707; GO:0034976; GO:0035377; GO:0048240; GO:0050891; GO:0051454; GO:0055038; GO:0060081; GO:0071320; GO:0140359; GO:1902476; GO:1904322","bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; chloride transmembrane transport [GO:1902476]; intracellular pH elevation [GO:0051454]; membrane hyperpolarization [GO:0060081]; multicellular organismal-level water homeostasis [GO:0050891]; response to endoplasmic reticulum stress [GO:0034976]; sperm capacitation [GO:0048240]; transepithelial water transport [GO:0035377]","apical plasma membrane [GO:0016324]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride channel inhibitor activity [GO:0019869]; chloride transmembrane transporter activity [GO:0015108]; intracellularly ATP-gated chloride channel activity [GO:0005260]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; chloride transmembrane transport [GO:1902476]; intracellular pH elevation [GO:0051454]; membrane hyperpolarization [GO:0060081]; multicellular organismal-level water homeostasis [GO:0050891]; response to endoplasmic reticulum stress [GO:0034976]; sperm capacitation [GO:0048240]; transepithelial water transport [GO:0035377]","","","",""
"1214","sp|O35594|IFT81_MOUSE","lcl|NC_088860.1_cds_XP_065924433.1_41911",0,548,"O35594","IFT81_MOUSE","Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1) (CDV-1)","Ift81 Cdv-1 Cdv1","Mus musculus (Mouse)",676,"GO:0005737; GO:0005813; GO:0005814; GO:0005929; GO:0007283; GO:0008589; GO:0015631; GO:0030992; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0060271; GO:0097225; GO:0097228; GO:0120316","cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of smoothened signaling pathway [GO:0008589]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283]","centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; tubulin binding [GO:0015631]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of smoothened signaling pathway [GO:0008589]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: First detected at postnatal day (PND) 8, its level increased dramatically from PND 16 to 42 (at protein level). {ECO:0000269|PubMed:32233951}.; DEVELOPMENTAL STAGE: [Isoform CDV-1R]: Poorly expressed in the testis 15 days after birth. Levels increase sharply between days 15 and 30 reaching a maximum by day 45 and the onset of spermatogenesis. {ECO:0000269|PubMed:12549821}.","","","TISSUE SPECIFICITY: Highly expressed in the testis (at protein level) (PubMed:32233951). Co-localizes with RABL2/RABL2A in the midpiece of elongated spermatids within the testis (at protein level) (PubMed:23055941). {ECO:0000269|PubMed:23055941, ECO:0000269|PubMed:32233951}.; TISSUE SPECIFICITY: [Isoform CDV-1R]: Expressed predominantly in the testis. {ECO:0000269|PubMed:12549821}.; TISSUE SPECIFICITY: [Isoform CDV-1]: Expressed specifically in heart and suppressed specifically in ventricles, but not in auricles, of carnitine-deficient juvenile visceral steatosis (JVS) mice. {ECO:0000269|PubMed:12549821, ECO:0000269|PubMed:9187371}."
"1215","sp|B4N937|HTRA2_DROWI","lcl|NC_088860.1_cds_XP_065924716.1_44153",4.9e-86,270,"B4N937","HTRA2_DROWI","Serine protease HTRA2, mitochondrial (EC 3.4.21.108) (High temperature requirement protein A2)","HtrA2 GK12147","Drosophila willistoni (Fruit fly)",434,"GO:0004252; GO:0005758; GO:0005829; GO:0006508; GO:0006915; GO:0007005; GO:0007283; GO:0016006; GO:0031966; GO:0035234; GO:0043065","apoptotic process [GO:0006915]; ectopic germ cell programmed cell death [GO:0035234]; mitochondrion organization [GO:0007005]; positive regulation of apoptotic process [GO:0043065]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]","cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; Nebenkern [GO:0016006]; serine-type endopeptidase activity [GO:0004252]; apoptotic process [GO:0006915]; ectopic germ cell programmed cell death [GO:0035234]; mitochondrion organization [GO:0007005]; positive regulation of apoptotic process [GO:0043065]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]","","","",""
"1216","sp|Q9VSE2|HELQ_DROME","lcl|NC_088860.1_cds_XP_065924744.1_44738",0,608,"Q9VSE2","HELQ_DROME","Helicase POLQ-like (EC 5.6.2.4) (Mutagen-sensitive protein 301) (Protein spindle-C) (Spindle-C)","mus301 spnC CG7972","Drosophila melanogaster (Fruit fly)",1051,"GO:0003677; GO:0005524; GO:0005634; GO:0005694; GO:0006417; GO:0007294; GO:0008298; GO:0009949; GO:0009951; GO:0016321; GO:0016787; GO:0030717; GO:0045003; GO:0048477; GO:1990518","double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; female meiosis chromosome segregation [GO:0016321]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; polarity specification of anterior/posterior axis [GO:0009949]; polarity specification of dorsal/ventral axis [GO:0009951]; regulation of translation [GO:0006417]","chromosome [GO:0005694]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; hydrolase activity [GO:0016787]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; female meiosis chromosome segregation [GO:0016321]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; polarity specification of anterior/posterior axis [GO:0009949]; polarity specification of dorsal/ventral axis [GO:0009951]; regulation of translation [GO:0006417]","","","",""
"1217","sp|Q17388|FER1_CAEEL","lcl|NC_088860.1_cds_XP_065924831.1_40666",3.89e-127,446,"Q17388","FER1_CAEEL","Sperm vesicle fusion protein fer-1","fer-1 F43G9.6","Caenorhabditis elegans",2034,"GO:0001778; GO:0005544; GO:0005886; GO:0007009; GO:0007283; GO:0031090; GO:0031260; GO:0031268; GO:0032809; GO:0033292; GO:0061025; GO:0097723","amoeboid sperm motility [GO:0097723]; membrane fusion [GO:0061025]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; pseudopodium organization [GO:0031268]; spermatogenesis [GO:0007283]; T-tubule organization [GO:0033292]","neuronal cell body membrane [GO:0032809]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; pseudopodium membrane [GO:0031260]; calcium-dependent phospholipid binding [GO:0005544]; amoeboid sperm motility [GO:0097723]; membrane fusion [GO:0061025]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; pseudopodium organization [GO:0031268]; spermatogenesis [GO:0007283]; T-tubule organization [GO:0033292]","","","","TISSUE SPECIFICITY: Exclusively expressed in the testis."
"1218","sp|Q61584|FXR1_MOUSE","lcl|NC_088860.1_cds_XP_065924991.1_44659",1.17e-153,462,"Q61584","FXR1_MOUSE","RNA-binding protein FXR1 (FXR1P) (mFxr1p)","Fxr1 Fxr1h","Mus musculus (Mouse)",677,"GO:0002151; GO:0003729; GO:0003730; GO:0005634; GO:0005635; GO:0005737; GO:0005829; GO:0005840; GO:0007286; GO:0007517; GO:0010494; GO:0010608; GO:0017148; GO:0021542; GO:0030424; GO:0030425; GO:0032720; GO:0033592; GO:0035025; GO:0035770; GO:0035925; GO:0036464; GO:0042803; GO:0043021; GO:0043034; GO:0043197; GO:0043232; GO:0045187; GO:0045727; GO:0046982; GO:0048471; GO:0050728; GO:0050767; GO:0051292; GO:0051664; GO:0051966; GO:0060538; GO:0061157; GO:0098794; GO:0098978; GO:0140693; GO:0140694; GO:1900272; GO:1902373; GO:2000637","dentate gyrus development [GO:0021542]; membraneless organelle assembly [GO:0140694]; mRNA destabilization [GO:0061157]; muscle organ development [GO:0007517]; negative regulation of inflammatory response [GO:0050728]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mRNA catabolic process [GO:1902373]; negative regulation of translation [GO:0017148]; negative regulation of tumor necrosis factor production [GO:0032720]; nuclear pore complex assembly [GO:0051292]; nuclear pore localization [GO:0051664]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of translation [GO:0045727]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of neurogenesis [GO:0050767]; regulation of synaptic transmission, glutamatergic [GO:0051966]; skeletal muscle organ development [GO:0060538]; spermatid development [GO:0007286]","axon [GO:0030424]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; intracellular membraneless organelle [GO:0043232]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; ribonucleoprotein granule [GO:0035770]; ribosome [GO:0005840]; G-quadruplex RNA binding [GO:0002151]; molecular condensate scaffold activity [GO:0140693]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ribonucleoprotein complex binding [GO:0043021]; RNA strand annealing activity [GO:0033592]; dentate gyrus development [GO:0021542]; membraneless organelle assembly [GO:0140694]; mRNA destabilization [GO:0061157]; muscle organ development [GO:0007517]; negative regulation of inflammatory response [GO:0050728]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mRNA catabolic process [GO:1902373]; negative regulation of translation [GO:0017148]; negative regulation of tumor necrosis factor production [GO:0032720]; nuclear pore complex assembly [GO:0051292]; nuclear pore localization [GO:0051664]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of translation [GO:0045727]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of neurogenesis [GO:0050767]; regulation of synaptic transmission, glutamatergic [GO:0051966]; skeletal muscle organ development [GO:0060538]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: In early embryogenesis, highest expression in somites and central nervous system (PubMed:10409431, PubMed:16000371). Also expressed in spinal cord, surrounding mesenchymal tissue and undifferentiated gonad (PubMed:10409431). In mid-embryogenesis, most prominent in gonad and muscle tissue (PubMed:10409431). Also expressed in liver, retina, telencephalon and mesencephalon (PubMed:10409431). In late embryogenesis, restricted to skeletal muscle and proliferative active layers of brain (PubMed:10409431). After birth, highly expressed in postmeiotic spermatids (at protein level) (PubMed:10409431, PubMed:35951695). Expressed in neurons of the developing hippocampus (PubMed:22022532). Expressed in new cells generated in the adult dentate gyrus throughout the progression of adult neurogenesis (PubMed:28204491). Intermediate levels are found in heart, liver and kidney with lower levels in brain and skeletal muscle (PubMed:10409431). Isoform(s) containing the 27 amino acid pocket (residues 564-590) are present in adult heart and muscle (PubMed:10409431, PubMed:32328638). {ECO:0000269|PubMed:10409431, ECO:0000269|PubMed:16000371, ECO:0000269|PubMed:22022532, ECO:0000269|PubMed:28204491, ECO:0000269|PubMed:32328638, ECO:0000269|PubMed:35951695}.; TISSUE SPECIFICITY: [Isoform A]: Present in adult heart and muscle. {ECO:0000269|PubMed:10409431, ECO:0000269|PubMed:32328638}.; TISSUE SPECIFICITY: [Isoform B]: Present in adult heart and muscle. {ECO:0000269|PubMed:10409431, ECO:0000269|PubMed:32328638}.; TISSUE SPECIFICITY: [Isoform E]: Present in adult heart and muscle. {ECO:0000269|PubMed:10409431, ECO:0000269|PubMed:32328638}.; TISSUE SPECIFICITY: [Isoform F]: Present in adult heart and muscle. {ECO:0000269|PubMed:10409431, ECO:0000269|PubMed:32328638}.; TISSUE SPECIFICITY: [Isoform G]: Present in adult heart and muscle. {ECO:0000269|PubMed:10409431, ECO:0000269|PubMed:32328638}."
"1219","sp|Q4LBB9|OCTB2_DROME","lcl|NC_088860.1_cds_XP_065925063.1_42769",6.45e-97,300,"Q4LBB9","OCTB2_DROME","Octopamine receptor beta-2R (DmOct-beta-12) (DmOct-beta-2R)","Octbeta2R Octbeta2 CG33976","Drosophila melanogaster (Fruit fly)",536,"GO:0003700; GO:0004989; GO:0005886; GO:0007186; GO:0007189; GO:0008227; GO:0009566; GO:0016020; GO:0030728; GO:0043410; GO:0045887; GO:0071880","adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; fertilization [GO:0009566]; G protein-coupled receptor signaling pathway [GO:0007186]; ovulation [GO:0030728]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]","membrane [GO:0016020]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity [GO:0003700]; G protein-coupled amine receptor activity [GO:0008227]; octopamine receptor activity [GO:0004989]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; fertilization [GO:0009566]; G protein-coupled receptor signaling pathway [GO:0007186]; ovulation [GO:0030728]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]","DEVELOPMENTAL STAGE: Expressed in adult, pupae and third instar larvae. Levels peak at the late embryonic and late larvae stages. Relatively low expression in the pupal stage, with a slight increase in the adult. {ECO:0000269|PubMed:22303848}.","","","TISSUE SPECIFICITY: In the adult, expressed in the superior protocerebrum and the optic lobe medulla of the central nervous system, nurse cells of egg chambers in the ovary at oogenic stages 1-10, and spermatogonia and spermatocytes in the testis (PubMed:22303848). Expressed in the oviduct epithelium (PubMed:25099506). Also expressed in the spermatheca (PubMed:25353988). Expressed in embryonic and larval ventral nerve cord and brain lobe, embryonic and larval salivary glands and larval imaginal disk and midgut (PubMed:22303848). Also expressed in larval synaptic boutons (PubMed:21186359). {ECO:0000269|PubMed:21186359, ECO:0000269|PubMed:22303848, ECO:0000269|PubMed:25099506, ECO:0000269|PubMed:25353988}."
"1220","sp|Q9VEG6|PERC_DROME","lcl|NC_088860.1_cds_XP_065925068.1_40993",7.52e-101,330,"Q9VEG6","PERC_DROME","Chorion peroxidase (EC 1.11.1.7) (Peroxinectin-related protein) (Dpxt)","Pxt CG7660","Drosophila melanogaster (Fruit fly)",809,"GO:0001516; GO:0004601; GO:0005615; GO:0006979; GO:0007304; GO:0007306; GO:0020037; GO:0030707; GO:0042743; GO:0042744; GO:0046872; GO:0140825","chorion-containing eggshell formation [GO:0007304]; egg chorion assembly [GO:0007306]; follicle cell of egg chamber development [GO:0030707]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]","extracellular space [GO:0005615]; heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; chorion-containing eggshell formation [GO:0007304]; egg chorion assembly [GO:0007306]; follicle cell of egg chamber development [GO:0030707]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. {ECO:0000269|PubMed:12459925}.","","","TISSUE SPECIFICITY: Expressed at low levels in the germarium and early follicles. Expression becomes progressively stronger during vitellogenesis, and is highly expressed in germ cells and somatic cells. A subset of follicle cells, termed border cells (BC), exhibit a high level of expression. {ECO:0000269|PubMed:18216169}."
"1221","sp|Q7JQF1|OAMB_DROME","lcl|NC_088860.1_cds_XP_065925091.1_41220",1.63e-31,129,"Q7JQF1","OAMB_DROME","Octopamine receptor Oamb (Octopamine receptor in mushroom bodies)","Oamb oa1 CG3856","Drosophila melanogaster (Fruit fly)",645,"GO:0000122; GO:0004989; GO:0005886; GO:0006874; GO:0006979; GO:0007187; GO:0007200; GO:0007268; GO:0007612; GO:0008049; GO:0010841; GO:0016020; GO:0030425; GO:0030594; GO:0030728; GO:0042594; GO:0045202; GO:0060278; GO:0060279; GO:0090328; GO:1904068; GO:1905050","chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway involved in social behavior [GO:1904068]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; intracellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; male courtship behavior [GO:0008049]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovulation [GO:0030728]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of circadian sleep/wake cycle, wakefulness [GO:0010841]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of ovulation [GO:0060279]; regulation of olfactory learning [GO:0090328]; regulation of ovulation [GO:0060278]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]","dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; neurotransmitter receptor activity [GO:0030594]; octopamine receptor activity [GO:0004989]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway involved in social behavior [GO:1904068]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; intracellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; male courtship behavior [GO:0008049]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovulation [GO:0030728]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of circadian sleep/wake cycle, wakefulness [GO:0010841]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of ovulation [GO:0060279]; regulation of olfactory learning [GO:0090328]; regulation of ovulation [GO:0060278]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]","DEVELOPMENTAL STAGE: Isoform C: Barely detectable in adult body but is expressed in adult head and third instar larva. Isoform B: Detected in adult head, adult body, pupa, third instar larva, 0-4 hour embryo, 0-18 hour embryo and 17-19 hour embryo with lowest expression observed in adult body and 17-19 hour embryo. {ECO:0000269|PubMed:15816867}.","","","TISSUE SPECIFICITY: Highly enriched in mushroom body neuropil and in the ellipsoid body (at protein level) (PubMed:9570796). Expressed in oviduct epithelium (at protein level) (PubMed:19262750). Expressed in the adult and larval brain, thoracic and abdominal ganglia, terminal cells of the larval tracheal system, muscle, mature eggs and reproductive system (PubMed:14623240, PubMed:25743690). {ECO:0000269|PubMed:14623240, ECO:0000269|PubMed:19262750, ECO:0000269|PubMed:25743690, ECO:0000269|PubMed:9570796}."
"1222","sp|O19010|CRIS3_HORSE","lcl|NC_088860.1_cds_XP_065925184.1_44084",1e-34,127,"O19010","CRIS3_HORSE","Cysteine-rich secretory protein 3 (CRISP-3) (Acidic epididymal glycoprotein 2) (AEG2)","CRISP3","Equus caballus (Horse)",245,"GO:0005576; GO:0005615; GO:0007283; GO:0009566; GO:0019953; GO:0042581; GO:0098609","cell-cell adhesion [GO:0098609]; fertilization [GO:0009566]; sexual reproduction [GO:0019953]; spermatogenesis [GO:0007283]","extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule [GO:0042581]; cell-cell adhesion [GO:0098609]; fertilization [GO:0009566]; sexual reproduction [GO:0019953]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in the salivary gland, in the ampulla and the seminal vesicle. {ECO:0000269|PubMed:12459257, ECO:0000269|PubMed:9748582}."
"1223","sp|O94993|SOX30_HUMAN","lcl|NC_088860.1_cds_XP_065925335.1_41542",2.93e-17,88.2,"O94993","SOX30_HUMAN","Transcription factor SOX-30","SOX30","Homo sapiens (Human)",753,"GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0007286; GO:0008013; GO:0010369; GO:0030178; GO:0031960; GO:0043231; GO:0045944; GO:0120211; GO:1990837","negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proacrosomal vesicle fusion [GO:0120211]; regulation of transcription by RNA polymerase II [GO:0006357]; response to corticosteroid [GO:0031960]; spermatid development [GO:0007286]","chromatin [GO:0000785]; chromocenter [GO:0010369]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proacrosomal vesicle fusion [GO:0120211]; regulation of transcription by RNA polymerase II [GO:0006357]; response to corticosteroid [GO:0031960]; spermatid development [GO:0007286]","","","",""
"1224","sp|Q07266|DREB_RAT","lcl|NC_088860.1_cds_XP_065925353.1_41547",7.2e-33,135,"Q07266","DREB_RAT","Drebrin (Developmentally-regulated brain protein)","Dbn1","Rattus norvegicus (Rat)",707,"GO:0001701; GO:0005522; GO:0005737; GO:0005856; GO:0005884; GO:0005886; GO:0005911; GO:0005921; GO:0007015; GO:0007283; GO:0007399; GO:0008092; GO:0009410; GO:0010643; GO:0010644; GO:0010811; GO:0010976; GO:0014069; GO:0014823; GO:0015629; GO:0016020; GO:0030027; GO:0030175; GO:0030425; GO:0030426; GO:0030427; GO:0030833; GO:0030864; GO:0031915; GO:0032232; GO:0032279; GO:0032507; GO:0043025; GO:0043197; GO:0043198; GO:0044295; GO:0044308; GO:0044309; GO:0045211; GO:0045773; GO:0048286; GO:0048471; GO:0048699; GO:0048812; GO:0051015; GO:0051489; GO:0060076; GO:0060134; GO:0061003; GO:0061351; GO:0071356; GO:0071481; GO:0071560; GO:0090327; GO:0098828; GO:0098871; GO:0098974; GO:0098978; GO:0099524; GO:0140311; GO:0140661; GO:1900026; GO:1902685; GO:1902737; GO:1902897; GO:1904113; GO:2000463","actin filament organization [GO:0007015]; cell communication by chemical coupling [GO:0010643]; cell communication by electrical coupling [GO:0010644]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to X-ray [GO:0071481]; generation of neurons [GO:0048699]; in utero embryonic development [GO:0001701]; lung alveolus development [GO:0048286]; maintenance of protein location in cell [GO:0032507]; modulation of inhibitory postsynaptic potential [GO:0098828]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of muscle filament sliding [GO:1904113]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of neuron projection development [GO:0010976]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of synaptic plasticity [GO:0031915]; postsynaptic actin cytoskeleton organization [GO:0098974]; prepulse inhibition [GO:0060134]; regulation of actin filament polymerization [GO:0030833]; regulation of filopodium assembly [GO:0051489]; regulation of postsynaptic density protein 95 clustering [GO:1902897]; response to activity [GO:0014823]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]","actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; asymmetric synapse [GO:0032279]; axonal growth cone [GO:0044295]; axonal spine [GO:0044308]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; dendritic filopodium [GO:1902737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; filopodium [GO:0030175]; gap junction [GO:0005921]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron spine [GO:0044309]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; site of polarized growth [GO:0030427]; actin filament binding [GO:0051015]; cytoskeletal motor inhibitor activity [GO:0140661]; cytoskeletal protein binding [GO:0008092]; profilin binding [GO:0005522]; protein sequestering activity [GO:0140311]; actin filament organization [GO:0007015]; cell communication by chemical coupling [GO:0010643]; cell communication by electrical coupling [GO:0010644]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to X-ray [GO:0071481]; generation of neurons [GO:0048699]; in utero embryonic development [GO:0001701]; lung alveolus development [GO:0048286]; maintenance of protein location in cell [GO:0032507]; modulation of inhibitory postsynaptic potential [GO:0098828]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of muscle filament sliding [GO:1904113]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of neuron projection development [GO:0010976]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of synaptic plasticity [GO:0031915]; postsynaptic actin cytoskeleton organization [GO:0098974]; prepulse inhibition [GO:0060134]; regulation of actin filament polymerization [GO:0030833]; regulation of filopodium assembly [GO:0051489]; regulation of postsynaptic density protein 95 clustering [GO:1902897]; response to activity [GO:0014823]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Brain neurons."
"1225","sp|Q13939|CALI_HUMAN","lcl|NC_088860.1_cds_XP_065925562.1_42818",2.59e-31,130,"Q13939","CALI_HUMAN","Calicin","CCIN","Homo sapiens (Human)",588,"GO:0005634; GO:0005737; GO:0007283; GO:0030154; GO:0031463; GO:0033150; GO:0043161; GO:1990756","cell differentiation [GO:0030154]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; spermatogenesis [GO:0007283]","Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeletal calyx [GO:0033150]; nucleus [GO:0005634]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; cell differentiation [GO:0030154]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in testis, in spermatozoa (at protein level). {ECO:0000269|PubMed:36527329, ECO:0000269|PubMed:36546111}."
"1226","sp|B2RW38|CFA58_MOUSE","lcl|NC_088860.1_cds_XP_065925575.1_43630",0,988,"B2RW38","CFA58_MOUSE","Cilia- and flagella-associated protein 58","Cfap58","Mus musculus (Mouse)",873,"GO:0005737; GO:0005813; GO:0007219; GO:0007288; GO:0030317; GO:0036126; GO:0060271; GO:0097225; GO:0120229; GO:0120316; GO:0120317","cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; Notch signaling pathway [GO:0007219]; protein localization to motile cilium [GO:0120229]; sperm axoneme assembly [GO:0007288]; sperm flagellum assembly [GO:0120316]; sperm mitochondrial sheath assembly [GO:0120317]","centrosome [GO:0005813]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; Notch signaling pathway [GO:0007219]; protein localization to motile cilium [GO:0120229]; sperm axoneme assembly [GO:0007288]; sperm flagellum assembly [GO:0120316]; sperm mitochondrial sheath assembly [GO:0120317]","","","","TISSUE SPECIFICITY: Predominantly expressed in the testis (PubMed:31904090, PubMed:32791035). Also found at lower levels in ciliated cells and tissues such as neural progenitor cells and oviducts (PubMed:31904090). {ECO:0000269|PubMed:31904090, ECO:0000269|PubMed:32791035}."
"1227","sp|Q99542|MMP19_HUMAN","lcl|NC_088860.1_cds_XP_065925949.1_41156",7.77e-83,268,"Q99542","MMP19_HUMAN","Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI) (Matrix metalloproteinase-18) (MMP-18)","MMP19 MMP18 RASI","Homo sapiens (Human)",508,"GO:0001525; GO:0001541; GO:0001542; GO:0001554; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0009725; GO:0022617; GO:0030154; GO:0030198; GO:0030574; GO:0031012; GO:0051591","angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; luteolysis [GO:0001554]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to hormone [GO:0009725]","extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; luteolysis [GO:0001554]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to hormone [GO:0009725]","","","","TISSUE SPECIFICITY: Expressed in mammary gland, placenta, lung, pancreas, ovary, small intestine, spleen, thymus, prostate, testis colon, heart and blood vessel walls. Not detected in brain and peripheral blood leukocytes. Also expressed in the synovial fluid of normal and rheumatoid patients (PubMed:8920941). {ECO:0000269|PubMed:8920941}."
"1228","sp|Q24210|CSKP_DROME","lcl|NC_088860.1_cds_XP_065926005.1_43201",0,1020,"Q24210","CSKP_DROME","Peripheral plasma membrane protein CASK (dCASK) (EC 2.7.11.17) (Calcium/calmodulin-dependent protein kinase) (CAKI) (Camguk)","CASK Caki cmg CG6703","Drosophila melanogaster (Fruit fly)",898,"GO:0004674; GO:0004683; GO:0005102; GO:0005516; GO:0005524; GO:0005886; GO:0005911; GO:0007269; GO:0007274; GO:0007298; GO:0007615; GO:0007616; GO:0007628; GO:0008049; GO:0008104; GO:0008344; GO:0008582; GO:0016080; GO:0016081; GO:0031594; GO:0040011; GO:0040012; GO:0042043; GO:0046928; GO:0048149; GO:0048488; GO:0061174; GO:0072375; GO:0097060; GO:0106310; GO:1900073; GO:1900244; GO:2000331","adult locomotory behavior [GO:0008344]; adult walking behavior [GO:0007628]; anesthesia-resistant memory [GO:0007615]; behavioral response to ethanol [GO:0048149]; border follicle cell migration [GO:0007298]; locomotion [GO:0040011]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; medium-term memory [GO:0072375]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein localization [GO:0008104]; regulation of locomotion [GO:0040012]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; regulation of terminal button organization [GO:2000331]; synaptic vesicle docking [GO:0016081]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]","cell-cell junction [GO:0005911]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060]; type I terminal bouton [GO:0061174]; ATP binding [GO:0005524]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; neurexin family protein binding [GO:0042043]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor binding [GO:0005102]; adult locomotory behavior [GO:0008344]; adult walking behavior [GO:0007628]; anesthesia-resistant memory [GO:0007615]; behavioral response to ethanol [GO:0048149]; border follicle cell migration [GO:0007298]; locomotion [GO:0040011]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; medium-term memory [GO:0072375]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein localization [GO:0008104]; regulation of locomotion [GO:0040012]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; regulation of terminal button organization [GO:2000331]; synaptic vesicle docking [GO:0016081]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]","DEVELOPMENTAL STAGE: Expressed in glutamatergic type I boutons of the larval body wall muscles (at protein level) (PubMed:19379781). In the larval brain, expressed in neuropil of brain and ventral nerve cord (at protein level) (PubMed:19379781). {ECO:0000269|PubMed:19379781}.","","","TISSUE SPECIFICITY: During embryogenesis, larval and pupal life, found almost exclusively in the central nervous system. In the adult head found in the lamina, the neuropil of the medulla, lobula, lobula plate and in the central brain. {ECO:0000269|PubMed:8617233}."
"1229","sp|D3Z4R1|HFM1_MOUSE","lcl|NC_088860.1_cds_XP_065926333.1_41759",0,998,"D3Z4R1","HFM1_MOUSE","Probable ATP-dependent DNA helicase HFM1 (EC 5.6.2.4) (DNA 3'-5' helicase HFM1)","Hfm1","Mus musculus (Mouse)",1434,"GO:0000712; GO:0003676; GO:0004386; GO:0005524; GO:0007283; GO:0016887; GO:0048477","oogenesis [GO:0048477]; resolution of meiotic recombination intermediates [GO:0000712]; spermatogenesis [GO:0007283]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; nucleic acid binding [GO:0003676]; oogenesis [GO:0048477]; resolution of meiotic recombination intermediates [GO:0000712]; spermatogenesis [GO:0007283]","","","",""
"1230","sp|Q8BX90|FND3A_MOUSE","lcl|NC_088860.1_cds_XP_065926392.1_42507",0,723,"Q8BX90","FND3A_MOUSE","Fibronectin type-III domain-containing protein 3A","Fndc3a D14Ertd453e Fndc3 Kiaa0970","Mus musculus (Mouse)",1198,"GO:0000139; GO:0001669; GO:0005829; GO:0007286; GO:0009566; GO:0012506; GO:0031410; GO:0060009; GO:0098609","cell-cell adhesion [GO:0098609]; fertilization [GO:0009566]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286]","acrosomal vesicle [GO:0001669]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; vesicle membrane [GO:0012506]; cell-cell adhesion [GO:0098609]; fertilization [GO:0009566]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Testis. Localizes to the acrosome of spermatids, as well as to Leydig cells. Can be detected on the acrosome beginning at steps 2-3 and continuing until step 12 of spermiogenesis. {ECO:0000269|PubMed:16904100}."
"1231","sp|P34739|TTF2_DROME","lcl|NC_088860.1_cds_XP_065926395.1_42494",1.01e-143,447,"P34739","TTF2_DROME","Transcription termination factor 2 (EC 3.6.4.-) (Protein lodestar) (RNA polymerase II termination factor) (Transcription release factor 2)","lds CG2684","Drosophila melanogaster (Fruit fly)",1061,"GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0006281; GO:0006353; GO:0007143; GO:0007283; GO:0008094; GO:0016887; GO:0034454; GO:0140658","DNA repair [GO:0006281]; DNA-templated transcription termination [GO:0006353]; female meiotic nuclear division [GO:0007143]; microtubule anchoring at centrosome [GO:0034454]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; DNA repair [GO:0006281]; DNA-templated transcription termination [GO:0006353]; female meiotic nuclear division [GO:0007143]; microtubule anchoring at centrosome [GO:0034454]; spermatogenesis [GO:0007283]","","","",""
"1232","sp|Q3TCH7|CUL4A_MOUSE","lcl|NC_088860.1_cds_XP_065926459.1_42540",0,1064,"Q3TCH7","CUL4A_MOUSE","Cullin-4A (CUL-4A)","Cul4a","Mus musculus (Mouse)",759,"GO:0001701; GO:0005634; GO:0005737; GO:0006281; GO:0006511; GO:0006974; GO:0007283; GO:0008283; GO:0008284; GO:0016567; GO:0030097; GO:0030853; GO:0031464; GO:0031625; GO:0034644; GO:0035019; GO:0042110; GO:0042254; GO:0043161; GO:0045732; GO:0048511; GO:0051246; GO:0061630; GO:0080008; GO:0140627; GO:0160072; GO:1900087; GO:2000001; GO:2000819","cell population proliferation [GO:0008283]; cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; negative regulation of granulocyte differentiation [GO:0030853]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; somatic stem cell population maintenance [GO:0035019]; spermatogenesis [GO:0007283]; T cell activation [GO:0042110]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex scaffold activity [GO:0160072]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; cell population proliferation [GO:0008283]; cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; negative regulation of granulocyte differentiation [GO:0030853]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; somatic stem cell population maintenance [GO:0035019]; spermatogenesis [GO:0007283]; T cell activation [GO:0042110]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","DEVELOPMENTAL STAGE: Expressed at high levels in germinal vesicle (GV) stage oocytes and at lower levels in MII-stage oocytes and zygotes. Expression then decreases from 4-cell stage to blastula. {ECO:0000269|PubMed:24357321}.","","","TISSUE SPECIFICITY: Expressed in oocytes (at protein level) (PubMed:24357321). In the ovary, also expressed in cumulus cells. Expressed in testis, spleen and kidney (PubMed:24357321). {ECO:0000269|PubMed:24357321}."
"1233","sp|P25427|NGF_RAT","lcl|NC_088861.1_cds_XP_011412562.3_45388",2.26e-12,66.6,"P25427","NGF_RAT","Beta-nerve growth factor (Beta-NGF)","Ngf Ngfb","Rattus norvegicus (Rat)",241,"GO:0001934; GO:0005163; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0007169; GO:0007283; GO:0007422; GO:0007613; GO:0007623; GO:0008021; GO:0008083; GO:0008191; GO:0008283; GO:0008284; GO:0008289; GO:0008344; GO:0008625; GO:0009410; GO:0009612; GO:0010193; GO:0010628; GO:0010976; GO:0014042; GO:0019233; GO:0021675; GO:0021846; GO:0030182; GO:0030297; GO:0030307; GO:0030424; GO:0030425; GO:0031175; GO:0031398; GO:0031904; GO:0031954; GO:0032092; GO:0032496; GO:0035094; GO:0038180; GO:0043434; GO:0043524; GO:0045664; GO:0045666; GO:0045773; GO:0046579; GO:0046928; GO:0048672; GO:0048675; GO:0048812; GO:0050804; GO:0051091; GO:0051279; GO:0051384; GO:0051388; GO:0051402; GO:0051602; GO:0062036; GO:0070374; GO:0097192; GO:1902236; GO:2000648; GO:2000675","adult locomotory behavior [GO:0008344]; axon extension [GO:0048675]; cell population proliferation [GO:0008283]; cell proliferation in forebrain [GO:0021846]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; circadian rhythm [GO:0007623]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; nerve development [GO:0021675]; nerve growth factor signaling pathway [GO:0038180]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; peripheral nervous system development [GO:0007422]; positive regulation of axon extension [GO:0045773]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of stem cell proliferation [GO:2000648]; regulation of neuron differentiation [GO:0045664]; regulation of neurotransmitter secretion [GO:0046928]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to electrical stimulus [GO:0051602]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to nicotine [GO:0035094]; response to ozone [GO:0010193]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410]; sensory perception of hot stimulus [GO:0062036]; sensory perception of pain [GO:0019233]; spermatogenesis [GO:0007283]","axon [GO:0030424]; dendrite [GO:0030425]; endoplasmic reticulum lumen [GO:0005788]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; synaptic vesicle [GO:0008021]; growth factor activity [GO:0008083]; lipid binding [GO:0008289]; metalloendopeptidase inhibitor activity [GO:0008191]; nerve growth factor receptor binding [GO:0005163]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; adult locomotory behavior [GO:0008344]; axon extension [GO:0048675]; cell population proliferation [GO:0008283]; cell proliferation in forebrain [GO:0021846]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; circadian rhythm [GO:0007623]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; nerve development [GO:0021675]; nerve growth factor signaling pathway [GO:0038180]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; peripheral nervous system development [GO:0007422]; positive regulation of axon extension [GO:0045773]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of stem cell proliferation [GO:2000648]; regulation of neuron differentiation [GO:0045664]; regulation of neurotransmitter secretion [GO:0046928]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to electrical stimulus [GO:0051602]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to nicotine [GO:0035094]; response to ozone [GO:0010193]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410]; sensory perception of hot stimulus [GO:0062036]; sensory perception of pain [GO:0019233]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Detected in the granule and pyramidal cell layer in the hippocampus. {ECO:0000269|PubMed:3184206}."
"1234","sp|Q8CEE0|CEP57_MOUSE","lcl|NC_088861.1_cds_XP_011413928.2_47884",3.44e-70,233,"Q8CEE0","CEP57_MOUSE","Centrosomal protein of 57 kDa (Cep57) (Testis-specific protein 57) (Translokin)","Cep57 Kiaa0092 Tsp57","Mus musculus (Mouse)",500,"GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005874; GO:0007286; GO:0008017; GO:0008543; GO:0017134; GO:0034451; GO:0042803; GO:0043015; GO:0051260","fibroblast growth factor receptor signaling pathway [GO:0008543]; protein homooligomerization [GO:0051260]; spermatid development [GO:0007286]","centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nucleus [GO:0005634]; fibroblast growth factor binding [GO:0017134]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; fibroblast growth factor receptor signaling pathway [GO:0008543]; protein homooligomerization [GO:0051260]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Ubiquitous (at protein level). Expressed in testis, predominantly in round spermatids. Low expression is detected in other tissues. {ECO:0000269|PubMed:12954732, ECO:0000269|PubMed:18294141}."
"1235","sp|B4F7A7|CEP57_RAT","lcl|NC_088861.1_cds_XP_011413931.2_47890",6.06e-68,227,"B4F7A7","CEP57_RAT","Centrosomal protein of 57 kDa (Cep57) (Translokin)","Cep57","Rattus norvegicus (Rat)",499,"GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005874; GO:0007286; GO:0008017; GO:0008543; GO:0017134; GO:0034451; GO:0042803; GO:0043015; GO:0051260","fibroblast growth factor receptor signaling pathway [GO:0008543]; protein homooligomerization [GO:0051260]; spermatid development [GO:0007286]","centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nucleus [GO:0005634]; fibroblast growth factor binding [GO:0017134]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; fibroblast growth factor receptor signaling pathway [GO:0008543]; protein homooligomerization [GO:0051260]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Ubiquitous (at protein level). {ECO:0000269|PubMed:18294141}."
"1236","sp|Q94524|DYLT_DROME","lcl|NC_088861.1_cds_XP_011414315.1_45675",7.92e-57,172,"Q94524","DYLT_DROME","Dynein light chain Tctex-type (TCTEX-1 protein homolog)","Dlc90F Tctex CG12363","Drosophila melanogaster (Fruit fly)",111,"GO:0000278; GO:0005737; GO:0005868; GO:0005874; GO:0007018; GO:0007286; GO:0008090; GO:0008340; GO:0030286; GO:0032991; GO:0042802; GO:0042803; GO:0045505; GO:0051959; GO:0097718; GO:1904115","determination of adult lifespan [GO:0008340]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; retrograde axonal transport [GO:0008090]; spermatid development [GO:0007286]","axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; determination of adult lifespan [GO:0008340]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; retrograde axonal transport [GO:0008090]; spermatid development [GO:0007286]","","","",""
"1237","sp|Q8N4E4|PDCL2_HUMAN","lcl|NC_088861.1_cds_XP_011417846.2_48145",1.25e-57,184,"Q8N4E4","PDCL2_HUMAN","Phosducin-like protein 2","PDCL2","Homo sapiens (Human)",241,"GO:0001675; GO:0005737; GO:0005783; GO:0006457; GO:0007286; GO:0007288","acrosome assembly [GO:0001675]; protein folding [GO:0006457]; sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286]","cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; acrosome assembly [GO:0001675]; protein folding [GO:0006457]; sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Testis-specific. {ECO:0000269|PubMed:36253364, ECO:0000269|PubMed:36278277}."
"1238","sp|Q9Y385|UB2J1_HUMAN","lcl|NC_088861.1_cds_XP_011427280.3_45490",1.44e-93,288,"Q9Y385","UB2J1_HUMAN","Ubiquitin-conjugating enzyme E2 J1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme J1) (Non-canonical ubiquitin-conjugating enzyme 1) (NCUBE-1) (Yeast ubiquitin-conjugating enzyme UBC6 homolog E) (HsUBC6e)","UBE2J1 NCUBE1 CGI-76 HSPC153 HSPC205","Homo sapiens (Human)",318,"GO:0000209; GO:0000836; GO:0005524; GO:0005634; GO:0005789; GO:0007286; GO:0010935; GO:0018279; GO:0031625; GO:0032680; GO:0036503; GO:0061631; GO:1904153","ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein N-linked glycosylation via asparagine [GO:0018279]; protein polyubiquitination [GO:0000209]; regulation of macrophage cytokine production [GO:0010935]; regulation of tumor necrosis factor production [GO:0032680]; spermatid development [GO:0007286]","endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase complex [GO:0000836]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein N-linked glycosylation via asparagine [GO:0018279]; protein polyubiquitination [GO:0000209]; regulation of macrophage cytokine production [GO:0010935]; regulation of tumor necrosis factor production [GO:0032680]; spermatid development [GO:0007286]","","INDUCTION: By Dengue virus infection. {ECO:0000269|PubMed:30157886}.","INDUCTION: By Dengue virus infection. {ECO:0000269|PubMed:30157886}.","TISSUE SPECIFICITY: Expressed in testes. {ECO:0000269|PubMed:35831855}."
"1239","sp|Q86VW1|S22AG_HUMAN","lcl|NC_088861.1_cds_XP_011433834.3_45086",6.88e-82,268,"Q86VW1","S22AG_HUMAN","Solute carrier family 22 member 16 (Carnitine transporter 2) (CT2) (Fly-like putative transporter 2) (FLIPT2) (Flipt 2) (Organic cation transporter OKB1) (Organic cation/carnitine transporter 6)","SLC22A16 OCT6","Homo sapiens (Human)",577,"GO:0005275; GO:0005829; GO:0005886; GO:0006811; GO:0007283; GO:0007338; GO:0015101; GO:0015226; GO:0015606; GO:0015695; GO:0015879; GO:0016020; GO:0030154; GO:0030317; GO:0046717; GO:1902603; GO:1903711","acid secretion [GO:0046717]; carnitine transmembrane transport [GO:1902603]; carnitine transport [GO:0015879]; cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; monoatomic ion transport [GO:0006811]; organic cation transport [GO:0015695]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; spermidine transmembrane transport [GO:1903711]","cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; amine transmembrane transporter activity [GO:0005275]; carnitine transmembrane transporter activity [GO:0015226]; organic cation transmembrane transporter activity [GO:0015101]; spermidine transmembrane transporter activity [GO:0015606]; acid secretion [GO:0046717]; carnitine transmembrane transport [GO:1902603]; carnitine transport [GO:0015879]; cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; monoatomic ion transport [GO:0006811]; organic cation transport [GO:0015695]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; spermidine transmembrane transport [GO:1903711]","","","","TISSUE SPECIFICITY: Expressed in testis and epididymis (at protein level) (PubMed:12089149, PubMed:12384147, PubMed:15963465). Expressed in endometrium (at protein level); highly expressed during the normal secretory phase, but expression is significantly reduced in the proliferative phase (PubMed:17197897). Expressed at lower levels in adult tissues including bone marrow (at protein level) (PubMed:12372408, PubMed:12384147, PubMed:15963465). Expressed in hematopoietic cells, including CD34(+) leukocytes (PubMed:12384147). Expressed in fetal liver (at protein level), brain, lung, kidney, heart, skeletal muscle, spleen and thymus (PubMed:12372408, PubMed:12384147, PubMed:15963465). Expressed in leukemia cells (PubMed:12384147). Abundantly expressed in ovarian cancer clear-cell adenocarcinoma (PubMed:17581421). {ECO:0000269|PubMed:12089149, ECO:0000269|PubMed:12372408, ECO:0000269|PubMed:12384147, ECO:0000269|PubMed:15963465, ECO:0000269|PubMed:17197897, ECO:0000269|PubMed:17581421}."
"1240","sp|Q64612|PTPRV_RAT","lcl|NC_088861.1_cds_XP_011434022.3_46936",3.96e-68,256,"Q64612","PTPRV_RAT","Receptor-type tyrosine-protein phosphatase V (R-PTP-V) (EC 3.1.3.48) (Embryonic stem cell protein-tyrosine phosphatase) (ES cell phosphatase) (Osteotesticular protein-tyrosine phosphatase) (OST-PTP)","Ptprv Esp","Rattus norvegicus (Rat)",1711,"GO:0004725; GO:0007165; GO:0007283; GO:0007411; GO:0016020; GO:0036035; GO:0046849; GO:0071320; GO:0071364; GO:0071374","axon guidance [GO:0007411]; bone remodeling [GO:0046849]; cellular response to cAMP [GO:0071320]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to parathyroid hormone stimulus [GO:0071374]; osteoclast development [GO:0036035]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]","membrane [GO:0016020]; protein tyrosine phosphatase activity [GO:0004725]; axon guidance [GO:0007411]; bone remodeling [GO:0046849]; cellular response to cAMP [GO:0071320]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to parathyroid hormone stimulus [GO:0071374]; osteoclast development [GO:0036035]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Up-regulated in differentiating cultures of primary osteoblasts and down-regulated in late stage mineralizing cultures. In testis, expression is highest between stages I and VII when maturing spermatids remain buried within the Sertoli epithelium. {ECO:0000269|PubMed:7527035}.","INDUCTION: By parathyroid hormone and cAMP analogs. {ECO:0000269|PubMed:7527035}.","INDUCTION: By parathyroid hormone and cAMP analogs. {ECO:0000269|PubMed:7527035}.","TISSUE SPECIFICITY: Bone and testis. In the latter, restricted to the basal portion of the seminiferous tubule. {ECO:0000269|PubMed:7527035}."
"1241","sp|Q8NHR9|PROF4_HUMAN","lcl|NC_088861.1_cds_XP_011435669.1_45324",3.26e-34,117,"Q8NHR9","PROF4_HUMAN","Profilin-4 (Profilin IV)","PFN4","Homo sapiens (Human)",129,"GO:0001675; GO:0003785; GO:0005938; GO:0007283; GO:0008289; GO:0030317; GO:0120316; GO:1905198","acrosome assembly [GO:0001675]; flagellated sperm motility [GO:0030317]; manchette assembly [GO:1905198]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283]","cell cortex [GO:0005938]; actin monomer binding [GO:0003785]; lipid binding [GO:0008289]; acrosome assembly [GO:0001675]; flagellated sperm motility [GO:0030317]; manchette assembly [GO:1905198]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in testis, in germ cells in seminiferous tubules (at protein level) (PubMed:15591451, PubMed:19419568). Prominently expressed in pachytene/diplotene stage spematocytes (PubMed:33438010). {ECO:0000269|PubMed:15591451, ECO:0000269|PubMed:19419568, ECO:0000269|PubMed:33438010}."
"1242","sp|Q9D6I3|PROF4_MOUSE","lcl|NC_088861.1_cds_XP_011435672.1_45329",6.57e-34,115,"Q9D6I3","PROF4_MOUSE","Profilin-4 (Profilin IV)","Pfn4","Mus musculus (Mouse)",129,"GO:0001675; GO:0003779; GO:0005737; GO:0007283; GO:0008289; GO:0030317; GO:0120316; GO:1905198","acrosome assembly [GO:0001675]; flagellated sperm motility [GO:0030317]; manchette assembly [GO:1905198]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; actin binding [GO:0003779]; lipid binding [GO:0008289]; acrosome assembly [GO:0001675]; flagellated sperm motility [GO:0030317]; manchette assembly [GO:1905198]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in testis, in germ cells in seminiferous tubules (at protein level). {ECO:0000269|PubMed:15591451}."
"1243","sp|O08807|PRDX4_MOUSE","lcl|NC_088861.1_cds_XP_011441532.1_46296",1.19e-125,358,"O08807","PRDX4_MOUSE","Peroxiredoxin-4 (EC 1.11.1.24) (Antioxidant enzyme AOE372) (Peroxiredoxin IV) (Prx-IV) (Thioredoxin peroxidase AO372) (Thioredoxin-dependent peroxide reductase A0372) (Thioredoxin-dependent peroxiredoxin 4)","Prdx4","Mus musculus (Mouse)",274,"GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006979; GO:0007283; GO:0008584; GO:0030198; GO:0042802; GO:0045454; GO:0051604; GO:0072593; GO:0140313; GO:0140824; GO:2000255","cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; protein maturation [GO:0051604]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; molecular sequestering activity [GO:0140313]; thioredoxin-dependent peroxiredoxin activity [GO:0140824]; cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; protein maturation [GO:0051604]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]","","","",""
"1244","sp|P56225|PO5F2_RAT","lcl|NC_088861.1_cds_XP_011441819.3_45837",2.84e-33,128,"P56225","PO5F2_RAT","POU domain, class 5, transcription factor 2 (Sperm 1 POU domain transcription factor) (SPRM-1)","Pou5f2 Sprm1","Rattus norvegicus (Rat)",335,"GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007283; GO:0030154; GO:0043565; GO:0051321","cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed transiently immediately prior to meiosis I during spermatogenesis in the male germ cell.","","","TISSUE SPECIFICITY: Highly restricted to adult testis."
"1245","sp|Q8BH60|GOPC_MOUSE","lcl|NC_088861.1_cds_XP_011444051.3_46779",7.02e-157,453,"Q8BH60","GOPC_MOUSE","Golgi-associated PDZ and coiled-coil motif-containing protein (CFTR-associated ligand) (PDZ protein interacting specifically with TC10) (PIST)","Gopc Cal","Mus musculus (Mouse)",463,"GO:0000139; GO:0005109; GO:0005737; GO:0005794; GO:0005886; GO:0006914; GO:0007289; GO:0014069; GO:0015031; GO:0016020; GO:0019905; GO:0030140; GO:0030425; GO:0030695; GO:0032991; GO:0042802; GO:0042803; GO:0044325; GO:0045202","autophagy [GO:0006914]; protein transport [GO:0015031]; spermatid nucleus differentiation [GO:0007289]","cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; trans-Golgi network transport vesicle [GO:0030140]; frizzled binding [GO:0005109]; GTPase regulator activity [GO:0030695]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; syntaxin binding [GO:0019905]; transmembrane transporter binding [GO:0044325]; autophagy [GO:0006914]; protein transport [GO:0015031]; spermatid nucleus differentiation [GO:0007289]","DEVELOPMENTAL STAGE: In the cerebellum, expression increases post-natally, following maturation of this tissue (at protein level). {ECO:0000269|PubMed:12372286}.","","","TISSUE SPECIFICITY: Ubiquitously expressed (at protein level). Expressed in dorsal root glanglion (DRG), spinal cord and brain. Isoform 1 is preferentially expressed in whole brain (at protein level) and cerebellum. Expressed in spermatocytes and spermatides but not in Sertoli cells and spermatogonia. {ECO:0000269|PubMed:11384996, ECO:0000269|PubMed:12149515, ECO:0000269|PubMed:12372286, ECO:0000269|PubMed:15317815}."
"1246","sp|O08725|GHSR_RAT","lcl|NC_088861.1_cds_XP_011444053.3_46783",6.32e-50,176,"O08725","GHSR_RAT","Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor)","Ghsr","Rattus norvegicus (Rat)",364,"GO:0001616; GO:0004930; GO:0005131; GO:0005886; GO:0007186; GO:0007283; GO:0007565; GO:0007611; GO:0008154; GO:0008343; GO:0009725; GO:0009755; GO:0009986; GO:0010700; GO:0016520; GO:0017046; GO:0030252; GO:0032094; GO:0032099; GO:0032100; GO:0032354; GO:0032355; GO:0032691; GO:0032715; GO:0032720; GO:0032869; GO:0036321; GO:0040018; GO:0042562; GO:0043005; GO:0043134; GO:0043568; GO:0045121; GO:0045923; GO:0045927; GO:0046676; GO:0046697; GO:0048009; GO:0050728; GO:0051963; GO:0051969; GO:0060123; GO:0060259; GO:0060416; GO:0071222; GO:0071548; GO:0090327; GO:0097060; GO:0097067; GO:0098685; GO:0098696; GO:0098794; GO:0098978; GO:0099170; GO:0099175; GO:0120058; GO:1902065; GO:1903672; GO:1904000; GO:1904349; GO:1905333; GO:1905564; GO:1990314; GO:2000110","actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to thyroid hormone stimulus [GO:0097067]; decidualization [GO:0046697]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; ghrelin secretion [GO:0036321]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; insulin-like growth factor receptor signaling pathway [GO:0048009]; learning or memory [GO:0007611]; negative regulation of appetite [GO:0032099]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of norepinephrine secretion [GO:0010700]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of appetite [GO:0032100]; positive regulation of eating behavior [GO:1904000]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of growth [GO:0045927]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of small intestinal transit [GO:0120058]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of feeding behavior [GO:0060259]; regulation of gastric motility [GO:1905333]; regulation of growth hormone secretion [GO:0060123]; regulation of hindgut contraction [GO:0043134]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of postsynapse organization [GO:0099175]; regulation of synapse assembly [GO:0051963]; regulation of transmission of nerve impulse [GO:0051969]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to follicle-stimulating hormone [GO:0032354]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to L-glutamate [GO:1902065]; spermatogenesis [GO:0007283]","cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; G protein-coupled receptor activity [GO:0004930]; growth hormone receptor binding [GO:0005131]; growth hormone secretagogue receptor activity [GO:0001616]; growth hormone-releasing hormone receptor activity [GO:0016520]; hormone binding [GO:0042562]; peptide hormone binding [GO:0017046]; actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to thyroid hormone stimulus [GO:0097067]; decidualization [GO:0046697]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; ghrelin secretion [GO:0036321]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; insulin-like growth factor receptor signaling pathway [GO:0048009]; learning or memory [GO:0007611]; negative regulation of appetite [GO:0032099]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of norepinephrine secretion [GO:0010700]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of appetite [GO:0032100]; positive regulation of eating behavior [GO:1904000]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of growth [GO:0045927]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of small intestinal transit [GO:0120058]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of feeding behavior [GO:0060259]; regulation of gastric motility [GO:1905333]; regulation of growth hormone secretion [GO:0060123]; regulation of hindgut contraction [GO:0043134]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of postsynapse organization [GO:0099175]; regulation of synapse assembly [GO:0051963]; regulation of transmission of nerve impulse [GO:0051969]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to follicle-stimulating hormone [GO:0032354]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to L-glutamate [GO:1902065]; spermatogenesis [GO:0007283]","","","",""
"1247","sp|Q99417|MYCBP_HUMAN","lcl|NC_088861.1_cds_XP_011445607.1_46462",1.9e-41,132,"Q99417","MYCBP_HUMAN","c-Myc-binding protein (Associate of Myc 1) (AMY-1)","MYCBP AMY1","Homo sapiens (Human)",103,"GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006355; GO:0007283","regulation of DNA-templated transcription [GO:0006355]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; regulation of DNA-templated transcription [GO:0006355]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Highly expressed in heart, placenta, pancreas, skeletal muscle and kidney. Also present at low levels in lung."
"1248","sp|Q8IYX1|TBC21_HUMAN","lcl|NC_088861.1_cds_XP_011448761.3_46332",1.16e-26,112,"Q8IYX1","TBC21_HUMAN","TBC1 domain family member 21 (Male germ cell Rab GTPase-activating protein)","TBC1D21 MGCRABGAP","Homo sapiens (Human)",336,"GO:0001669; GO:0003779; GO:0005096; GO:0005856; GO:0007283; GO:0007288; GO:0030317; GO:0031267; GO:0031410; GO:0048227; GO:0070062; GO:0097225; GO:0120317","flagellated sperm motility [GO:0030317]; plasma membrane to endosome transport [GO:0048227]; sperm axoneme assembly [GO:0007288]; sperm mitochondrial sheath assembly [GO:0120317]; spermatogenesis [GO:0007283]","acrosomal vesicle [GO:0001669]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; sperm midpiece [GO:0097225]; actin binding [GO:0003779]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; flagellated sperm motility [GO:0030317]; plasma membrane to endosome transport [GO:0048227]; sperm axoneme assembly [GO:0007288]; sperm mitochondrial sheath assembly [GO:0120317]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in round and elongated spermatids (at protein level). Expressed specifically in adult testis and very weakly in fetal brain. {ECO:0000269|PubMed:21128978, ECO:0000269|PubMed:33536340}."
"1249","sp|Q9XZL8|SRA_DROME","lcl|NC_088861.1_cds_XP_011448762.3_46333",2.75e-51,169,"Q9XZL8","SRA_DROME","Protein sarah (Protein nebula)","sra nla CG6072","Drosophila melanogaster (Fruit fly)",292,"GO:0003676; GO:0005634; GO:0005737; GO:0005759; GO:0005829; GO:0007143; GO:0007343; GO:0007616; GO:0008355; GO:0008597; GO:0019722; GO:0030431; GO:0035039; GO:0035794; GO:0045924; GO:0046008; GO:0048477; GO:0051321; GO:0070884; GO:0141109","calcium-mediated signaling [GO:0019722]; egg activation [GO:0007343]; female meiotic nuclear division [GO:0007143]; long-term memory [GO:0007616]; male pronucleus assembly [GO:0035039]; meiotic cell cycle [GO:0051321]; olfactory learning [GO:0008355]; oogenesis [GO:0048477]; positive regulation of mitochondrial membrane permeability [GO:0035794]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of female receptivity [GO:0045924]; regulation of female receptivity, post-mating [GO:0046008]; sleep [GO:0030431]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; nucleic acid binding [GO:0003676]; transporter activator activity [GO:0141109]; calcium-mediated signaling [GO:0019722]; egg activation [GO:0007343]; female meiotic nuclear division [GO:0007143]; long-term memory [GO:0007616]; male pronucleus assembly [GO:0035039]; meiotic cell cycle [GO:0051321]; olfactory learning [GO:0008355]; oogenesis [GO:0048477]; positive regulation of mitochondrial membrane permeability [GO:0035794]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of female receptivity [GO:0045924]; regulation of female receptivity, post-mating [GO:0046008]; sleep [GO:0030431]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. {ECO:0000269|PubMed:15611177}.","","","TISSUE SPECIFICITY: Expressed in central nervous system of the third instar larvae, with a relatively intense signal in the brain and weak signals in the ventral ganglion. Relatively low, but ubiquitous expression level is observed in leg and wing imaginal disks, no signal is detected in the eye-antennal disks. Expressed in all neurons in the adult brain. {ECO:0000269|PubMed:15611177}."
"1250","sp|P41586|PACR_HUMAN","lcl|NC_088861.1_cds_XP_011449164.3_47918",4.33e-69,229,"P41586","PACR_HUMAN","Pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1 receptor) (PAC1R) (PACAP type I receptor) (PACAP-R-1) (PACAP-R1)","ADCYAP1R1","Homo sapiens (Human)",468,"GO:0001634; GO:0004999; GO:0005768; GO:0005886; GO:0005901; GO:0005923; GO:0007166; GO:0007188; GO:0007189; GO:0007283; GO:0008179; GO:0008528; GO:0009410; GO:0009986; GO:0010524; GO:0017046; GO:0030154; GO:0031267; GO:0032355; GO:0033555; GO:0038023; GO:0042923; GO:0043231; GO:0043235; GO:0045471; GO:0046545; GO:0051057; GO:0060732; GO:0141156; GO:0141163; GO:1901032","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP/PKA signal transduction [GO:0141156]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; development of primary female sexual characteristics [GO:0046545]; multicellular organismal response to stress [GO:0033555]; negative regulation of response to reactive oxygen species [GO:1901032]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cAMP/PKA signal transduction [GO:0141163]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]","bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell surface [GO:0009986]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; adenylate cyclase binding [GO:0008179]; G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046]; pituitary adenylate cyclase-activating polypeptide receptor activity [GO:0001634]; signaling receptor activity [GO:0038023]; small GTPase binding [GO:0031267]; vasoactive intestinal polypeptide receptor activity [GO:0004999]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP/PKA signal transduction [GO:0141156]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; development of primary female sexual characteristics [GO:0046545]; multicellular organismal response to stress [GO:0033555]; negative regulation of response to reactive oxygen species [GO:1901032]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cAMP/PKA signal transduction [GO:0141163]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Most abundant in the brain, low expression in the lung, liver, thymus, spleen, pancreas and placenta."
"1251","sp|O75398|DEAF1_HUMAN","lcl|NC_088861.1_cds_XP_011449328.1_47701",1.2e-49,180,"O75398","DEAF1_HUMAN","Deformed epidermal autoregulatory factor 1 homolog (Nuclear DEAF-1-related transcriptional regulator) (NUDR) (Suppressin) (Zinc finger MYND domain-containing protein 5)","DEAF1 SPN ZMYND5","Homo sapiens (Human)",565,"GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0001650; GO:0001662; GO:0001843; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006366; GO:0007281; GO:0008270; GO:0008542; GO:0009653; GO:0033599; GO:0045892; GO:0045893; GO:0048706; GO:0090575","anatomical structure morphogenesis [GO:0009653]; behavioral fear response [GO:0001662]; embryonic skeletal system development [GO:0048706]; germ cell development [GO:0007281]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; visual learning [GO:0008542]","chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; anatomical structure morphogenesis [GO:0009653]; behavioral fear response [GO:0001662]; embryonic skeletal system development [GO:0048706]; germ cell development [GO:0007281]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; visual learning [GO:0008542]","","","","TISSUE SPECIFICITY: Expressed in various tissues and cells such as in peripheral mononuclear cells and hormone-secreting pituitary cells. Expression in pancreatic lymph nodes of patients with type 1 diabetes is 20 times higher than in healthy controls. Highly expressed in fetal and adult brain. {ECO:0000269|PubMed:19668219, ECO:0000269|PubMed:24726472}."
"1252","sp|Q96PU9|CMA1A_HUMAN","lcl|NC_088861.1_cds_XP_011450675.1_46090",1.11e-58,187,"Q96PU9","CMA1A_HUMAN","Ciliary microtubule associated protein 1A (Outer dense fiber of sperm tails protein 3) (Outer dense fiber protein 3) (Sperm tail protein SHIPPO 1) (Transcript induced in spermiogenesis protein 50)","CIMAP1A ODF3 SHIPPO1 TISP50","Homo sapiens (Human)",254,"GO:0001520; GO:0005737; GO:0005856; GO:0007283; GO:0030154; GO:0030317","cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; outer dense fiber [GO:0001520]; cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Testis-specific. {ECO:0000269|PubMed:11870087, ECO:0000269|Ref.2}."
"1253","sp|Q9W0S7|SND1_DROME","lcl|NC_088861.1_cds_XP_011451753.3_46353",0,957,"Q9W0S7","SND1_DROME","Staphylococcal nuclease domain-containing protein 1 (EC 3.1.31.1) (Tudor staphylococcal nuclease)","Tudor-SN p100 SND1 TSN CG7008","Drosophila melanogaster (Fruit fly)",926,"GO:0003723; GO:0004518; GO:0005634; GO:0005737; GO:0005829; GO:0006402; GO:0007283; GO:0016442; GO:0016894; GO:0031047","mRNA catabolic process [GO:0006402]; regulatory ncRNA-mediated gene silencing [GO:0031047]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RISC complex [GO:0016442]; endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters [GO:0016894]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; mRNA catabolic process [GO:0006402]; regulatory ncRNA-mediated gene silencing [GO:0031047]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed in both germline and somatic cells during oogenesis and spermatogenesis (at protein level). {ECO:0000269|PubMed:26808625}.","","","TISSUE SPECIFICITY: Expressed in adult ovaries and testis (at protein level). {ECO:0000269|PubMed:26808625}."
"1254","sp|Q9VW97|LSDA_DROME","lcl|NC_088861.1_cds_XP_011453074.3_46246",0,841,"Q9VW97","LSDA_DROME","Possible lysine-specific histone demethylase 1 (EC 1.-.-.-)","Su(var)3-3 Hdm LSD1 CG17149","Drosophila melanogaster (Fruit fly)",890,"GO:0000785; GO:0003682; GO:0005634; GO:0006325; GO:0006355; GO:0007474; GO:0008284; GO:0017053; GO:0032453; GO:0033696; GO:0040029; GO:0048477; GO:0050660; GO:0070828; GO:0106222; GO:0140682; GO:0141006","chromatin organization [GO:0006325]; epigenetic regulation of gene expression [GO:0040029]; heterochromatin boundary formation [GO:0033696]; heterochromatin organization [GO:0070828]; imaginal disc-derived wing vein specification [GO:0007474]; oogenesis [GO:0048477]; positive regulation of cell population proliferation [GO:0008284]; regulation of DNA-templated transcription [GO:0006355]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006]","chromatin [GO:0000785]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; FAD-dependent H3K4me/H3K4me3 demethylase activity [GO:0140682]; flavin adenine dinucleotide binding [GO:0050660]; histone H3K4 demethylase activity [GO:0032453]; lncRNA binding [GO:0106222]; chromatin organization [GO:0006325]; epigenetic regulation of gene expression [GO:0040029]; heterochromatin boundary formation [GO:0033696]; heterochromatin organization [GO:0070828]; imaginal disc-derived wing vein specification [GO:0007474]; oogenesis [GO:0048477]; positive regulation of cell population proliferation [GO:0008284]; regulation of DNA-templated transcription [GO:0006355]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006]","","","",""
"1255","sp|Q8K3Y3|LN28A_MOUSE","lcl|NC_088861.1_cds_XP_011453075.1_46252",2.49e-35,125,"Q8K3Y3","LN28A_MOUSE","Protein lin-28 homolog A (Lin-28A) (Testis-expressed protein 17)","Lin28a Lin28 Tex17","Mus musculus (Mouse)",209,"GO:0000932; GO:0002151; GO:0003723; GO:0003729; GO:0005634; GO:0005730; GO:0005737; GO:0005791; GO:0005829; GO:0007281; GO:0008270; GO:0010494; GO:0010586; GO:0010587; GO:0017148; GO:0019827; GO:0031054; GO:0031123; GO:0031369; GO:0032008; GO:0035198; GO:0045666; GO:0045686; GO:0045727; GO:0048863; GO:0051897; GO:0060964; GO:0070883; GO:0071333; GO:0140517; GO:1901724; GO:1990825; GO:2000632; GO:2000767","cellular response to glucose stimulus [GO:0071333]; germ cell development [GO:0007281]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; negative regulation of glial cell differentiation [GO:0045686]; negative regulation of pre-miRNA processing [GO:2000632]; negative regulation of translation [GO:0017148]; positive regulation of cell proliferation involved in kidney development [GO:1901724]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of TOR signaling [GO:0032008]; positive regulation of translation [GO:0045727]; pre-miRNA processing [GO:0031054]; regulation of miRNA-mediated gene silencing [GO:0060964]; RNA 3'-end processing [GO:0031123]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]","cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; P-body [GO:0000932]; rough endoplasmic reticulum [GO:0005791]; G-quadruplex RNA binding [GO:0002151]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; pre-miRNA binding [GO:0070883]; protein-RNA adaptor activity [GO:0140517]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]; cellular response to glucose stimulus [GO:0071333]; germ cell development [GO:0007281]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; negative regulation of glial cell differentiation [GO:0045686]; negative regulation of pre-miRNA processing [GO:2000632]; negative regulation of translation [GO:0017148]; positive regulation of cell proliferation involved in kidney development [GO:1901724]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of TOR signaling [GO:0032008]; positive regulation of translation [GO:0045727]; pre-miRNA processing [GO:0031054]; regulation of miRNA-mediated gene silencing [GO:0060964]; RNA 3'-end processing [GO:0031123]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]","DEVELOPMENTAL STAGE: Strongly expressed throughout the whole embryo at 6.5 dpc, including the embryonic and extraembryonic ectoderm and endoderm (at protein level). Subsequently expressed in the ectoderm, endoderm and mesoderm at 7.5 dpc (at protein level). At 9.5 dpc, expressed in epithelia covering the first branchial arch and the coelomic cavity, the myocardium of the developing heart, the neuroepithelium and some extraembryonic tissues such as the visceral yolk sac (at protein level). Expression persists in a variety of epithelial tissues at 10.5 dpc. At 15.5 dpc, expression is lost in bronchial epithelium and becomes weaker in neuroepithelium, while increasing in the myotome of somites, the foregut epithelium, stratified epithelium and some kidney tubules (at protein level). At 17.5 dpc, expression persists in the myocardium and in the epithelium covering the body surface and skeletal muscles (at protein level). Expression is reduced during differentiation of ES cells. In adult primary myoblasts, barely detectable during proliferation, but dramatically up-regulated during terminal differentiation. Induced as early as 24 hours after differentiation signal and remains high as late as 7 days of differentiation. Little expression in resting muscle, but strongly up-regulated during regeneration of skeletal muscle fibers. Expression decreases when regeneration is histologically and functionally complete. {ECO:0000269|PubMed:12798299, ECO:0000269|PubMed:14643679, ECO:0000269|PubMed:15722555, ECO:0000269|PubMed:17473174}.","INDUCTION: Negatively regulated by the microRNA miR-125b in response to retinoic acid. {ECO:0000269|PubMed:15003116, ECO:0000269|PubMed:16227573}.","INDUCTION: Negatively regulated by the microRNA miR-125b in response to retinoic acid. {ECO:0000269|PubMed:15003116, ECO:0000269|PubMed:16227573}.","TISSUE SPECIFICITY: Expressed in embryonic stem cells (ES cells), spermatagonia and testis. Expressed in numerous epithelial tissues including the epithelia of the small intestine, the intralobular duct epithelium of the mammary gland and the epithelia of Henle's loop in the kidney and in the collecting duct (at protein level). Also expressed in the myocardium and skeletal muscle (at protein level). {ECO:0000269|PubMed:11279525, ECO:0000269|PubMed:12798299, ECO:0000269|PubMed:14643679, ECO:0000269|PubMed:15722555}."
"1256","sp|P46150|MOEH_DROME","lcl|NC_088861.1_cds_XP_011453102.2_45271",0,661,"P46150","MOEH_DROME","Moesin/ezrin/radixin homolog 1 (Ezrin-moesin-radixin 1) (Moesin) (dMoesin) (Protein D17)","Moe EMR1 CG10701","Drosophila melanogaster (Fruit fly)",578,"GO:0000791; GO:0002009; GO:0003779; GO:0005546; GO:0005634; GO:0005654; GO:0005703; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0005912; GO:0005938; GO:0006405; GO:0007010; GO:0007314; GO:0007315; GO:0007318; GO:0007368; GO:0008017; GO:0008104; GO:0008284; GO:0008360; GO:0009952; GO:0010669; GO:0016028; GO:0016057; GO:0016324; GO:0016336; GO:0030029; GO:0030036; GO:0030175; GO:0030866; GO:0031234; GO:0031514; GO:0032154; GO:0032956; GO:0034453; GO:0035003; GO:0035088; GO:0035149; GO:0042052; GO:0042462; GO:0043622; GO:0045177; GO:0045197; GO:0045313; GO:0045807; GO:0050839; GO:0060446; GO:0072499; GO:0098592; GO:1902115; GO:1902846; GO:1902966; GO:1990023; GO:1990146; GO:2000643","actin cytoskeleton organization [GO:0030036]; actin filament-based process [GO:0030029]; anterior/posterior pattern specification [GO:0009952]; branching involved in open tracheal system development [GO:0060446]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; cytoskeleton organization [GO:0007010]; determination of left/right symmetry [GO:0007368]; epithelial structure maintenance [GO:0010669]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; eye photoreceptor cell development [GO:0042462]; lumen formation, open tracheal system [GO:0035149]; microtubule anchoring [GO:0034453]; morphogenesis of an epithelium [GO:0002009]; oocyte anterior/posterior axis specification [GO:0007314]; photoreceptor cell axon guidance [GO:0072499]; pole plasm assembly [GO:0007315]; pole plasm protein localization [GO:0007318]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of endocytosis [GO:0045807]; positive regulation of mitotic spindle elongation [GO:1902846]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization [GO:0008104]; protein localization to rhabdomere [GO:1990146]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of membrane potential in photoreceptor cell [GO:0016057]; regulation of organelle assembly [GO:1902115]; rhabdomere development [GO:0042052]; rhabdomere membrane biogenesis [GO:0045313]; RNA export from nucleus [GO:0006405]","adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; euchromatin [GO:0000791]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; filopodium [GO:0030175]; microvillus [GO:0005902]; mitotic spindle midzone [GO:1990023]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polytene chromosome puff [GO:0005703]; rhabdomere [GO:0016028]; subapical complex [GO:0035003]; actin binding [GO:0003779]; cell adhesion molecule binding [GO:0050839]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin cytoskeleton organization [GO:0030036]; actin filament-based process [GO:0030029]; anterior/posterior pattern specification [GO:0009952]; branching involved in open tracheal system development [GO:0060446]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; cytoskeleton organization [GO:0007010]; determination of left/right symmetry [GO:0007368]; epithelial structure maintenance [GO:0010669]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; eye photoreceptor cell development [GO:0042462]; lumen formation, open tracheal system [GO:0035149]; microtubule anchoring [GO:0034453]; morphogenesis of an epithelium [GO:0002009]; oocyte anterior/posterior axis specification [GO:0007314]; photoreceptor cell axon guidance [GO:0072499]; pole plasm assembly [GO:0007315]; pole plasm protein localization [GO:0007318]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of endocytosis [GO:0045807]; positive regulation of mitotic spindle elongation [GO:1902846]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization [GO:0008104]; protein localization to rhabdomere [GO:1990146]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of membrane potential in photoreceptor cell [GO:0016057]; regulation of organelle assembly [GO:1902115]; rhabdomere development [GO:0042052]; rhabdomere membrane biogenesis [GO:0045313]; RNA export from nucleus [GO:0006405]","DEVELOPMENTAL STAGE: Expressed in the salivary glands of third instar larvae (at protein level) (PubMed:28554770). Expressed in follicular epithelium and oocyte in late stage 9/10 of oogenesis (at protein level) (PubMed:24768049). Expressed in elongating spermatid cysts during spermatogenesis (at protein level) (PubMed:20237161). Expressed in apical and basolateral ends of follicular epithelium during oogenesis (PubMed:8666669). In embryonic CNS, expression is seen in the neuropil, developing brain and neuronal cell bodies (PubMed:8666669). In embryonic PNS, expression is seen at the cell membrane (PubMed:8666669). In third instar larvae, eye imaginal disk expression is seen at the membranes of developing photoreceptors posterior to the morphogenetic furrow (PubMed:8666669). In pupal eyes, expression is at the membrane of cone cells, secondary and tertiary pigment cells, bristle precursor cells and rhabdomeres (PubMed:8666669). {ECO:0000269|PubMed:20237161, ECO:0000269|PubMed:24768049, ECO:0000269|PubMed:28554770, ECO:0000269|PubMed:8666669}.","","",""
"1257","sp|Q3URY6|ARMC2_MOUSE","lcl|NC_088861.1_cds_XP_011454790.3_45261",1e-165,504,"Q3URY6","ARMC2_MOUSE","Armadillo repeat-containing protein 2","Armc2","Mus musculus (Mouse)",854,"GO:0000902; GO:0006997; GO:0007283; GO:0007288; GO:0030317; GO:0044782","cell morphogenesis [GO:0000902]; cilium organization [GO:0044782]; flagellated sperm motility [GO:0030317]; nucleus organization [GO:0006997]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]","cell morphogenesis [GO:0000902]; cilium organization [GO:0044782]; flagellated sperm motility [GO:0030317]; nucleus organization [GO:0006997]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]","","","",""
"1258","sp|A1Z8D0|PWP1_DROME","lcl|NC_088861.1_cds_XP_011455032.3_45238",2.85e-78,254,"A1Z8D0","PWP1_DROME","Periodic tryptophan protein 1 homolog (PWP1) (Protein no child left behind)","nclb dpwp1 CG6751","Drosophila melanogaster (Fruit fly)",459,"GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006364; GO:0007281; GO:0008584; GO:0010468; GO:0030707; GO:0030723; GO:0031490; GO:0032869; GO:0036098; GO:0045945; GO:0090070; GO:1901838","cellular response to insulin stimulus [GO:0032869]; follicle cell of egg chamber development [GO:0030707]; germ cell development [GO:0007281]; male germ-line stem cell population maintenance [GO:0036098]; male gonad development [GO:0008584]; ovarian fusome organization [GO:0030723]; positive regulation of ribosome biogenesis [GO:0090070]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; regulation of gene expression [GO:0010468]; rRNA processing [GO:0006364]","chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; cellular response to insulin stimulus [GO:0032869]; follicle cell of egg chamber development [GO:0030707]; germ cell development [GO:0007281]; male germ-line stem cell population maintenance [GO:0036098]; male gonad development [GO:0008584]; ovarian fusome organization [GO:0030723]; positive regulation of ribosome biogenesis [GO:0090070]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; regulation of gene expression [GO:0010468]; rRNA processing [GO:0006364]","DEVELOPMENTAL STAGE: Detected in embryonic cell types, including germ cells (at protein level) (PubMed:21752937). In early third instar larvae, detected in the fat body (at protein level) (PubMed:29065309). Detected in the larval salivary glands and fat body (at protein level) (PubMed:21752937). Expressed in stage 17 embryos in male but not female gonads (PubMed:21752937). {ECO:0000269|PubMed:21752937, ECO:0000269|PubMed:29065309}.","INDUCTION: Increased expression upon activation of the Insulin/TOR/Myc pathway in response to protein diet. {ECO:0000269|PubMed:29065309}.","INDUCTION: Increased expression upon activation of the Insulin/TOR/Myc pathway in response to protein diet. {ECO:0000269|PubMed:29065309}.","TISSUE SPECIFICITY: Detected in the germline of adult testis and ovary (at protein level) (PubMed:21752937). Detected in ovary somatic cells, in zfh1-positive cyst cells in the testis and absent in differentiated cyst cells (at protein level) (PubMed:21752937). {ECO:0000269|PubMed:21752937}."
"1259","sp|Q05831|H1L_MYTTR","lcl|NC_088861.1_cds_XP_019927861.2_45747",1.91e-29,111,"Q05831","H1L_MYTTR","Sperm-specific protein PHI-2B/PHI-3 [Cleaved into: Sperm-specific protein PHI-2B (PL-II*) (Sperm-specific linker histone H1-like protein); Sperm-specific protein PHI-3 (PL-IV) (Protamine-like protein PHI-3)]","","Mytilus trossulus (Blue mussel)",203,"GO:0000786; GO:0003677; GO:0005634; GO:0006334; GO:0007283; GO:0030154; GO:0030261; GO:0030527","cell differentiation [GO:0030154]; chromosome condensation [GO:0030261]; nucleosome assembly [GO:0006334]; spermatogenesis [GO:0007283]","nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; structural constituent of chromatin [GO:0030527]; cell differentiation [GO:0030154]; chromosome condensation [GO:0030261]; nucleosome assembly [GO:0006334]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Sperm. {ECO:0000269|PubMed:8416927}."
"1260","sp|Q7KHG2|JING_DROME","lcl|NC_088861.1_cds_XP_019929063.3_46454",1.23e-39,153,"Q7KHG2","JING_DROME","Zinc finger protein jing (Zinc finger protein rhumba)","jing rhumba CG9397 CG9403","Drosophila melanogaster (Fruit fly)",1486,"GO:0000122; GO:0005634; GO:0006325; GO:0006357; GO:0007298; GO:0007382; GO:0007411; GO:0007417; GO:0007418; GO:0007424; GO:0007474; GO:0007479; GO:0008270; GO:0008347; GO:0035098; GO:0042246; GO:0044877; GO:0045944","axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; central nervous system development [GO:0007417]; chromatin organization [GO:0006325]; glial cell migration [GO:0008347]; imaginal disc-derived wing vein specification [GO:0007474]; leg disc proximal/distal pattern formation [GO:0007479]; negative regulation of transcription by RNA polymerase II [GO:0000122]; open tracheal system development [GO:0007424]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of segmental identity, maxillary segment [GO:0007382]; tissue regeneration [GO:0042246]; ventral midline development [GO:0007418]","ESC/E(Z) complex [GO:0035098]; nucleus [GO:0005634]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; central nervous system development [GO:0007417]; chromatin organization [GO:0006325]; glial cell migration [GO:0008347]; imaginal disc-derived wing vein specification [GO:0007474]; leg disc proximal/distal pattern formation [GO:0007479]; negative regulation of transcription by RNA polymerase II [GO:0000122]; open tracheal system development [GO:0007424]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of segmental identity, maxillary segment [GO:0007382]; tissue regeneration [GO:0042246]; ventral midline development [GO:0007418]","DEVELOPMENTAL STAGE: Expressed from precellular blastoderm stages. Expressed in the CNS midline, neuroectoderm, supraoesophogal ganglion and trachea from embryonic stage 9. Expressed in the tracheal placodes from stage 10. Expressed in a subset of posterior glia in the brain and a subset of anterior neurons at stage 11. Expressed in CNS midline cells and segmental ectodermal stripes during stages 12 and 13 and in dorsally positioned midline glia and ventrally positioned midline neurons from stage 14. Expressed in posterior and anterior glia and neurons at stage 15. {ECO:0000269|PubMed:12015288, ECO:0000269|PubMed:12111212, ECO:0000269|PubMed:16648585}.","INDUCTION: Induced in ventrally positioned cells in pair-rule ectodermal stripes by expression of sim.","INDUCTION: Induced in ventrally positioned cells in pair-rule ectodermal stripes by expression of sim.","TISSUE SPECIFICITY: Expressed in the imaginal disks of the leg and wing. {ECO:0000269|PubMed:16510782}."
"1261","sp|P52295|IMA_DROME","lcl|NC_088861.1_cds_XP_034331900.1_45905",9.04e-167,483,"P52295","IMA_DROME","Importin subunit alpha (Karyopherin subunit alpha) (Pendulin)","Pen CG4799","Drosophila melanogaster (Fruit fly)",522,"GO:0005634; GO:0005737; GO:0006607; GO:0007291; GO:0007301; GO:0008139; GO:0042332; GO:0048542; GO:0061608","female germline ring canal formation [GO:0007301]; gravitaxis [GO:0042332]; lymph gland development [GO:0048542]; NLS-bearing protein import into nucleus [GO:0006607]; sperm individualization [GO:0007291]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; female germline ring canal formation [GO:0007301]; gravitaxis [GO:0042332]; lymph gland development [GO:0048542]; NLS-bearing protein import into nucleus [GO:0006607]; sperm individualization [GO:0007291]","DEVELOPMENTAL STAGE: High levels are detected during the first half of embryogenesis reaching a maximum between 4 and 8 hours of development. Protein expression increases again from the third larval instar onwards. It is expressed in a maternal/early embryonic phase, and again during morphogenesis in late larval and pupal stages.","","","TISSUE SPECIFICITY: Predominantly expressed in the neuroblast stem cells."
"1262","sp|Q8BWY9|CIP2A_MOUSE","lcl|NC_088861.1_cds_XP_034332807.2_45393",2.24e-114,373,"Q8BWY9","CIP2A_MOUSE","Protein CIP2A (Cancerous inhibitor of PP2A) (p90 autoantigen homolog)","Cip2a Kiaa1524","Mus musculus (Mouse)",907,"GO:0002052; GO:0004864; GO:0005694; GO:0005737; GO:0006974; GO:0007283; GO:0007405; GO:0042803; GO:0051276; GO:0061351","chromosome organization [GO:0051276]; DNA damage response [GO:0006974]; neural precursor cell proliferation [GO:0061351]; neuroblast proliferation [GO:0007405]; positive regulation of neuroblast proliferation [GO:0002052]; spermatogenesis [GO:0007283]","chromosome [GO:0005694]; cytoplasm [GO:0005737]; protein homodimerization activity [GO:0042803]; protein phosphatase inhibitor activity [GO:0004864]; chromosome organization [GO:0051276]; DNA damage response [GO:0006974]; neural precursor cell proliferation [GO:0061351]; neuroblast proliferation [GO:0007405]; positive regulation of neuroblast proliferation [GO:0002052]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Highly expressed in 17.5 and 18.5 dpc liver but not expressed in adult liver. Expressed at moderate level in embryonic brain, muscle and epidermal layers. {ECO:0000269|PubMed:12118381}."
"1263","sp|A8WR63|CTU1_CAEBR","lcl|NC_088861.1_cds_XP_034333137.2_47360",3.84e-150,430,"A8WR63","CTU1_CAEBR","Cytoplasmic tRNA 2-thiolation protein 1 (EC 2.7.7.-) (Cytoplasmic tRNA adenylyltransferase 1) (Thiolation of uridine in tRNA protein 1)","tut-1 ctu-1 CBG01646","Caenorhabditis briggsae",372,"GO:0000049; GO:0002098; GO:0002143; GO:0002144; GO:0005829; GO:0006412; GO:0007283; GO:0016779; GO:0016783; GO:0032447; GO:0034227; GO:0040025; GO:0048598; GO:0048599","embryonic morphogenesis [GO:0048598]; oocyte development [GO:0048599]; protein urmylation [GO:0032447]; spermatogenesis [GO:0007283]; translation [GO:0006412]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]; vulval development [GO:0040025]","cytosol [GO:0005829]; cytosolic tRNA wobble base thiouridylase complex [GO:0002144]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]; embryonic morphogenesis [GO:0048598]; oocyte development [GO:0048599]; protein urmylation [GO:0032447]; spermatogenesis [GO:0007283]; translation [GO:0006412]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]; vulval development [GO:0040025]","","","",""
"1264","sp|Q8WWU5|TCP11_HUMAN","lcl|NC_088861.1_cds_XP_034333286.1_46093",3.06e-68,228,"Q8WWU5","TCP11_HUMAN","T-complex protein 11 homolog","TCP11","Homo sapiens (Human)",503,"GO:0001669; GO:0007189; GO:0007281; GO:0007283; GO:0010737; GO:0016020; GO:0036126; GO:0097225; GO:1902490","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; germ cell development [GO:0007281]; protein kinase A signaling [GO:0010737]; regulation of sperm capacitation [GO:1902490]; spermatogenesis [GO:0007283]","acrosomal vesicle [GO:0001669]; membrane [GO:0016020]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; germ cell development [GO:0007281]; protein kinase A signaling [GO:0010737]; regulation of sperm capacitation [GO:1902490]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Isoform 2 and isoform 3 are expressed in sperm. Isoform 1 is not detected in sperm (at protein level) (PubMed:21597245). Testis-specific (PubMed:11756566). Isoform 1, isoform 2 and isoform 3 are expressed in sperm (PubMed:21597245). {ECO:0000269|PubMed:11756566, ECO:0000269|PubMed:21597245}."
"1265","sp|Q9NQV7|PRDM9_HUMAN","lcl|NC_088861.1_cds_XP_034333813.2_47745",0,595,"Q9NQV7","PRDM9_HUMAN","Histone-lysine N-methyltransferase PRDM9 (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361)","PRDM9 PFM6","Homo sapiens (Human)",894,"GO:0000976; GO:0005634; GO:0005654; GO:0005694; GO:0006311; GO:0006355; GO:0007129; GO:0007292; GO:0008270; GO:0010468; GO:0010844; GO:0010845; GO:0032259; GO:0042800; GO:0042803; GO:0043066; GO:0046975; GO:0048232; GO:0140941; GO:0140944; GO:0140949; GO:0140955; GO:0140999; GO:1905516; GO:1990918","double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; methylation [GO:0032259]; negative regulation of apoptotic process [GO:0043066]; positive regulation of fertilization [GO:1905516]; positive regulation of reciprocal meiotic recombination [GO:0010845]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]","chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone H3K36 methyltransferase activity [GO:0046975]; histone H3K36 trimethyltransferase activity [GO:0140955]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 trimethyltransferase activity [GO:0140999]; histone H3K9 trimethyltransferase activity [GO:0140949]; histone H4K20 monomethyltransferase activity [GO:0140944]; histone H4K20me methyltransferase activity [GO:0140941]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; methylation [GO:0032259]; negative regulation of apoptotic process [GO:0043066]; positive regulation of fertilization [GO:1905516]; positive regulation of reciprocal meiotic recombination [GO:0010845]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]","","","",""
"1266","sp|Q4QR85|MEP50_RAT","lcl|NC_088861.1_cds_XP_034334291.2_46335",9.57e-64,207,"Q4QR85","MEP50_RAT","Methylosome protein WDR77 (Methylosome protein 50) (MEP-50) (WD repeat-containing protein 77)","Wdr77 Mep50","Rattus norvegicus (Rat)",342,"GO:0000209; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006357; GO:0006511; GO:0007309; GO:0008284; GO:0008285; GO:0008327; GO:0031465; GO:0034709; GO:0060528; GO:0060767; GO:0060770; GO:1990756","epithelial cell proliferation involved in prostate gland development [GO:0060767]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; oocyte axis specification [GO:0007309]; positive regulation of cell population proliferation [GO:0008284]; protein polyubiquitination [GO:0000209]; regulation of transcription by RNA polymerase II [GO:0006357]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; ubiquitin-dependent protein catabolic process [GO:0006511]","Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; methyl-CpG binding [GO:0008327]; transcription coactivator activity [GO:0003713]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; epithelial cell proliferation involved in prostate gland development [GO:0060767]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; oocyte axis specification [GO:0007309]; positive regulation of cell population proliferation [GO:0008284]; protein polyubiquitination [GO:0000209]; regulation of transcription by RNA polymerase II [GO:0006357]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; ubiquitin-dependent protein catabolic process [GO:0006511]","","","",""
"1267","sp|Q9Y267|S22AE_HUMAN","lcl|NC_088861.1_cds_XP_034334402.2_47800",1.47e-49,181,"Q9Y267","S22AE_HUMAN","Solute carrier family 22 member 14 (Organic cation transporter-like 4) (ORCTL-4)","SLC22A14 OCTL2 ORCTL4","Homo sapiens (Human)",594,"GO:0005743; GO:0005886; GO:0030317; GO:0032217; GO:0048240; GO:0097228","flagellated sperm motility [GO:0030317]; sperm capacitation [GO:0048240]","mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; riboflavin transmembrane transporter activity [GO:0032217]; flagellated sperm motility [GO:0030317]; sperm capacitation [GO:0048240]","","","","TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10072596}."
"1268","sp|P08228|SODC_MOUSE","lcl|NC_088861.1_cds_XP_034334952.2_46720",2.22e-75,223,"P08228","SODC_MOUSE","Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)","Sod1","Mus musculus (Mouse)",154,"GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006915; GO:0006979; GO:0007283; GO:0007566; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0008340; GO:0009408; GO:0009410; GO:0010467; GO:0019226; GO:0019228; GO:0019430; GO:0030346; GO:0031045; GO:0031267; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0032991; GO:0034465; GO:0035234; GO:0035865; GO:0040014; GO:0042542; GO:0042554; GO:0042803; GO:0043025; GO:0043066; GO:0043209; GO:0043410; GO:0043524; GO:0045471; GO:0046688; GO:0046716; GO:0048678; GO:0050665; GO:0050728; GO:0050766; GO:0051087; GO:0051093; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:0099610; GO:1902177; GO:1904115; GO:2000242","action potential initiation [GO:0099610]; anterograde axonal transport [GO:0008089]; apoptotic process [GO:0006915]; auditory receptor cell stereocilium organization [GO:0060088]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; determination of adult lifespan [GO:0008340]; ectopic germ cell programmed cell death [GO:0035234]; embryo implantation [GO:0007566]; gene expression [GO:0010467]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; intracellular iron ion homeostasis [GO:0006879]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reproductive process [GO:2000242]; neurofilament cytoskeleton organization [GO:0060052]; neuronal action potential [GO:0019228]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of cytokine production [GO:0001819]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of phagocytosis [GO:0050766]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; relaxation of vascular associated smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; response to xenobiotic stimulus [GO:0009410]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]","axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dense core granule [GO:0031045]; extracellular space [GO:0005615]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; copper ion binding [GO:0005507]; protein homodimerization activity [GO:0042803]; protein phosphatase 2B binding [GO:0030346]; protein-folding chaperone binding [GO:0051087]; small GTPase binding [GO:0031267]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; action potential initiation [GO:0099610]; anterograde axonal transport [GO:0008089]; apoptotic process [GO:0006915]; auditory receptor cell stereocilium organization [GO:0060088]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; determination of adult lifespan [GO:0008340]; ectopic germ cell programmed cell death [GO:0035234]; embryo implantation [GO:0007566]; gene expression [GO:0010467]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; intracellular iron ion homeostasis [GO:0006879]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reproductive process [GO:2000242]; neurofilament cytoskeleton organization [GO:0060052]; neuronal action potential [GO:0019228]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of cytokine production [GO:0001819]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of phagocytosis [GO:0050766]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; relaxation of vascular associated smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; response to xenobiotic stimulus [GO:0009410]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]","","","",""
"1269","sp|Q6ZTR5|CFA47_HUMAN","lcl|NC_088861.1_cds_XP_034335188.2_45598",0,1799,"Q6ZTR5","CFA47_HUMAN","Cilia- and flagella-associated protein 47","CFAP47 CHDC2 CXorf22 CXorf30 CXorf59","Homo sapiens (Human)",3187,"GO:0005737; GO:0005856; GO:0005929; GO:0007288; GO:0031514; GO:0060271; GO:0120212","cilium assembly [GO:0060271]; sperm axoneme assembly [GO:0007288]","cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; sperm head-tail coupling apparatus [GO:0120212]; cilium assembly [GO:0060271]; sperm axoneme assembly [GO:0007288]","","","","TISSUE SPECIFICITY: Highly expressed in spermatzoa (at protein level). {ECO:0000269|PubMed:33472045}."
"1270","sp|Q01989|MYS9_DROME","lcl|NC_088861.1_cds_XP_034335577.2_47776",0,1317,"Q01989","MYS9_DROME","Myosin heavy chain 95F (95F MHC) (Protein jaguar)","jar Mhc95F CG5695","Drosophila melanogaster (Fruit fly)",1253,"GO:0000146; GO:0003779; GO:0005516; GO:0005524; GO:0005737; GO:0005875; GO:0005886; GO:0005938; GO:0006997; GO:0007015; GO:0007051; GO:0007283; GO:0007291; GO:0007297; GO:0007298; GO:0007300; GO:0007391; GO:0007552; GO:0007560; GO:0008017; GO:0008104; GO:0008363; GO:0015629; GO:0016333; GO:0016461; GO:0030036; GO:0030048; GO:0030139; GO:0030317; GO:0030426; GO:0030589; GO:0031476; GO:0032027; GO:0032880; GO:0032956; GO:0032970; GO:0032991; GO:0040001; GO:0045167; GO:0045172; GO:0045175; GO:0045178; GO:0045217; GO:0045921; GO:0047497; GO:0051015; GO:0051647; GO:0055057; GO:0070856; GO:0070864; GO:0070865","actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; asymmetric protein localization involved in cell fate determination [GO:0045167]; basal protein localization [GO:0045175]; border follicle cell migration [GO:0007298]; cell-cell junction maintenance [GO:0045217]; dorsal closure [GO:0007391]; establishment of mitotic spindle localization [GO:0040001]; flagellated sperm motility [GO:0030317]; follicle cell of egg chamber migration [GO:0007297]; imaginal disc morphogenesis [GO:0007560]; larval chitin-based cuticle development [GO:0008363]; metamorphosis [GO:0007552]; mitochondrion transport along microtubule [GO:0047497]; morphogenesis of follicular epithelium [GO:0016333]; neuroblast division [GO:0055057]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of exocytosis [GO:0045921]; protein localization [GO:0008104]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of protein localization [GO:0032880]; sperm individualization [GO:0007291]; spermatogenesis [GO:0007283]; spindle organization [GO:0007051]","actin cytoskeleton [GO:0015629]; basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; germline ring canal [GO:0045172]; growth cone [GO:0030426]; investment cone [GO:0070865]; microtubule associated complex [GO:0005875]; myosin VI complex [GO:0031476]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sperm individualization complex [GO:0070864]; unconventional myosin complex [GO:0016461]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; microtubule binding [GO:0008017]; myosin light chain binding [GO:0032027]; myosin VI light chain binding [GO:0070856]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; asymmetric protein localization involved in cell fate determination [GO:0045167]; basal protein localization [GO:0045175]; border follicle cell migration [GO:0007298]; cell-cell junction maintenance [GO:0045217]; dorsal closure [GO:0007391]; establishment of mitotic spindle localization [GO:0040001]; flagellated sperm motility [GO:0030317]; follicle cell of egg chamber migration [GO:0007297]; imaginal disc morphogenesis [GO:0007560]; larval chitin-based cuticle development [GO:0008363]; metamorphosis [GO:0007552]; mitochondrion transport along microtubule [GO:0047497]; morphogenesis of follicular epithelium [GO:0016333]; neuroblast division [GO:0055057]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of exocytosis [GO:0045921]; protein localization [GO:0008104]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of protein localization [GO:0032880]; sperm individualization [GO:0007291]; spermatogenesis [GO:0007283]; spindle organization [GO:0007051]","DEVELOPMENTAL STAGE: Isoform B is expressed both maternally and zygotically throughout development with highest level during mid-embryogenesis and adulthood. At these zygotic stages isoform D is also expressed. {ECO:0000269|PubMed:1429838}.","","","TISSUE SPECIFICITY: Isoform B is present at a higher level in the head and gonads than in the thoraxes. Isoform 145 kDa is found only in the head. CLIP-190 and jar are coexpressed at several times in development and in a number of tissues, including embryonic axonal neuron processes and posterior pole. {ECO:0000269|PubMed:1429838, ECO:0000269|PubMed:9472041}."
"1271","sp|Q9D9D3|TBC21_MOUSE","lcl|NC_088861.1_cds_XP_065926593.1_46331",3.9e-26,110,"Q9D9D3","TBC21_MOUSE","TBC1 domain family member 21 (Male germ cell Rab GTPase-activating protein)","Tbc1d21 MgcRabGAP","Mus musculus (Mouse)",336,"GO:0001669; GO:0003779; GO:0005096; GO:0005856; GO:0007283; GO:0007288; GO:0030317; GO:0031267; GO:0097225; GO:0120317","flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]; sperm mitochondrial sheath assembly [GO:0120317]; spermatogenesis [GO:0007283]","acrosomal vesicle [GO:0001669]; cytoskeleton [GO:0005856]; sperm midpiece [GO:0097225]; actin binding [GO:0003779]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]; sperm mitochondrial sheath assembly [GO:0120317]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Detected from postnatal day 35 onward. {ECO:0000269|PubMed:21128978, ECO:0000269|PubMed:30360518}.","","","TISSUE SPECIFICITY: Expressed in testis, specifically in elongating and elongated spermatids (at protein level) (PubMed:21128978, PubMed:30360518, PubMed:33536340). Expressed in the sperm midpiece (at protein level) (PubMed:32976492, PubMed:33536340). {ECO:0000269|PubMed:21128978, ECO:0000269|PubMed:30360518, ECO:0000269|PubMed:32976492, ECO:0000269|PubMed:33536340}."
"1272","sp|Q6EJB6|UT14B_MOUSE","lcl|NC_088861.1_cds_XP_065926610.1_47973",5.26e-56,206,"Q6EJB6","UT14B_MOUSE","U3 small nucleolar RNA-associated protein 14 homolog B (Juvenile spermatogonial depletion protein)","Utp14b Jsd","Mus musculus (Mouse)",756,"GO:0005730; GO:0006364; GO:0007283; GO:0030154; GO:0032040; GO:0051321","cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; rRNA processing [GO:0006364]; spermatogenesis [GO:0007283]","nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; rRNA processing [GO:0006364]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed predominantly in germ cells of the testis; weakly expressed in brain. {ECO:0000269|PubMed:15258580, ECO:0000269|PubMed:15289605}."
"1273","sp|Q62209|SYCP1_MOUSE","lcl|NC_088861.1_cds_XP_065926634.1_46398",4.47e-17,88.2,"Q62209","SYCP1_MOUSE","Synaptonemal complex protein 1 (SCP-1)","Sycp1 Scp1","Mus musculus (Mouse)",993,"GO:0000711; GO:0000775; GO:0000794; GO:0000795; GO:0000800; GO:0000801; GO:0000802; GO:0001673; GO:0003690; GO:0005654; GO:0005694; GO:0007129; GO:0007130; GO:0007131; GO:0007283; GO:0030849; GO:0032880; GO:0035092; GO:0051026; GO:0051289; GO:0051301; GO:0051878","cell division [GO:0051301]; chiasma assembly [GO:0051026]; homologous chromosome pairing at meiosis [GO:0007129]; lateral element assembly [GO:0051878]; meiotic DNA repair synthesis [GO:0000711]; protein homotetramerization [GO:0051289]; reciprocal meiotic recombination [GO:0007131]; regulation of protein localization [GO:0032880]; sperm DNA condensation [GO:0035092]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]","autosome [GO:0030849]; central element [GO:0000801]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed nuclear chromosome [GO:0000794]; lateral element [GO:0000800]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; synaptonemal complex [GO:0000795]; transverse filament [GO:0000802]; double-stranded DNA binding [GO:0003690]; cell division [GO:0051301]; chiasma assembly [GO:0051026]; homologous chromosome pairing at meiosis [GO:0007129]; lateral element assembly [GO:0051878]; meiotic DNA repair synthesis [GO:0000711]; protein homotetramerization [GO:0051289]; reciprocal meiotic recombination [GO:0007131]; regulation of protein localization [GO:0032880]; sperm DNA condensation [GO:0035092]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]","","","","TISSUE SPECIFICITY: Detected in testis (PubMed:15937223). Detected in spermatocytes (at protein level) (PubMed:22761579). {ECO:0000269|PubMed:15937223, ECO:0000269|PubMed:22761579}."
"1274","sp|Q03410|SYCP1_RAT","lcl|NC_088861.1_cds_XP_065926635.1_46399",6.45e-17,87.8,"Q03410","SYCP1_RAT","Synaptonemal complex protein 1 (SCP-1)","Sycp1 Scp1","Rattus norvegicus (Rat)",997,"GO:0000711; GO:0000775; GO:0000794; GO:0000795; GO:0000801; GO:0000802; GO:0001673; GO:0003690; GO:0005694; GO:0007129; GO:0007130; GO:0007131; GO:0007283; GO:0030849; GO:0032880; GO:0035092; GO:0051026; GO:0051289; GO:0051301; GO:0051878","cell division [GO:0051301]; chiasma assembly [GO:0051026]; homologous chromosome pairing at meiosis [GO:0007129]; lateral element assembly [GO:0051878]; meiotic DNA repair synthesis [GO:0000711]; protein homotetramerization [GO:0051289]; reciprocal meiotic recombination [GO:0007131]; regulation of protein localization [GO:0032880]; sperm DNA condensation [GO:0035092]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]","autosome [GO:0030849]; central element [GO:0000801]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed nuclear chromosome [GO:0000794]; male germ cell nucleus [GO:0001673]; synaptonemal complex [GO:0000795]; transverse filament [GO:0000802]; double-stranded DNA binding [GO:0003690]; cell division [GO:0051301]; chiasma assembly [GO:0051026]; homologous chromosome pairing at meiosis [GO:0007129]; lateral element assembly [GO:0051878]; meiotic DNA repair synthesis [GO:0000711]; protein homotetramerization [GO:0051289]; reciprocal meiotic recombination [GO:0007131]; regulation of protein localization [GO:0032880]; sperm DNA condensation [GO:0035092]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]","DEVELOPMENTAL STAGE: Expressed exclusively in meiotic prophase cells. {ECO:0000269|PubMed:1464329}.","","","TISSUE SPECIFICITY: Testis. {ECO:0000269|PubMed:1464329}."
"1275","sp|A0A5F8MPU3|CTSRT_MOUSE","lcl|NC_088861.1_cds_XP_065926683.1_45823",7.08e-20,99.4,"A0A5F8MPU3","CTSRT_MOUSE","Cation channel sperm-associated targeting subunit tau (CatSper-tau) (C2 calcium-dependent domain-containing 6)","C2cd6 Als2cr11 CATSPERT","Mus musculus (Mouse)",2282,"GO:0007283; GO:0007338; GO:0030317; GO:0036126; GO:0036128; GO:0048240; GO:0065003; GO:0070588; GO:0097228; GO:0098876","calcium ion transmembrane transport [GO:0070588]; flagellated sperm motility [GO:0030317]; protein-containing complex assembly [GO:0065003]; single fertilization [GO:0007338]; sperm capacitation [GO:0048240]; spermatogenesis [GO:0007283]; vesicle-mediated transport to the plasma membrane [GO:0098876]","CatSper complex [GO:0036128]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; calcium ion transmembrane transport [GO:0070588]; flagellated sperm motility [GO:0030317]; protein-containing complex assembly [GO:0065003]; single fertilization [GO:0007338]; sperm capacitation [GO:0048240]; spermatogenesis [GO:0007283]; vesicle-mediated transport to the plasma membrane [GO:0098876]","","","","TISSUE SPECIFICITY: [Isoform 1]: Expressed in cauda sperm (at protein level). {ECO:0000269|PubMed:34998468}.; TISSUE SPECIFICITY: [Isoform 2]: Expressed in cauda sperm (at protein level). {ECO:0000269|PubMed:34998468}."
"1276","sp|Q13489|BIRC3_HUMAN","lcl|NC_088861.1_cds_XP_065926708.1_45133",6.04e-50,184,"Q13489","BIRC3_HUMAN","Baculoviral IAP repeat-containing protein 3 (EC 2.3.2.27) (Apoptosis inhibitor 2) (API2) (Cellular inhibitor of apoptosis 2) (C-IAP2) (IAP homolog C) (Inhibitor of apoptosis protein 1) (hIAP-1) (hIAP1) (RING finger protein 49) (RING-type E3 ubiquitin transferase BIRC3) (TNFR2-TRAF-signaling complex protein 1)","BIRC3 API2 MIHC RNF49","Homo sapiens (Human)",604,"GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0007166; GO:0007249; GO:0007283; GO:0008270; GO:0016740; GO:0031398; GO:0032991; GO:0033209; GO:0034121; GO:0038061; GO:0039535; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0044877; GO:0045088; GO:0050727; GO:0051726; GO:0060544; GO:0060546; GO:0061630; GO:0070424","apoptotic process [GO:0006915]; canonical NF-kappaB signal transduction [GO:0007249]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; spermatogenesis [GO:0007283]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; protein-containing complex binding [GO:0044877]; transferase activity [GO:0016740]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; canonical NF-kappaB signal transduction [GO:0007249]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; spermatogenesis [GO:0007283]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","","","","TISSUE SPECIFICITY: Highly expressed in fetal lung, and kidney. In the adult, expression is mainly seen in lymphoid tissues, including spleen, thymus and peripheral blood lymphocytes."
"1277","sp|Q8K214|SCMH1_MOUSE","lcl|NC_088861.1_cds_XP_065926824.1_45841",1.57e-100,322,"Q8K214","SCMH1_MOUSE","Polycomb protein SCMH1 (Sex comb on midleg homolog 1)","Scmh1","Mus musculus (Mouse)",706,"GO:0001673; GO:0006338; GO:0007283; GO:0009952; GO:0010369; GO:0031507; GO:0045892","anterior/posterior pattern specification [GO:0009952]; chromatin remodeling [GO:0006338]; heterochromatin formation [GO:0031507]; negative regulation of DNA-templated transcription [GO:0045892]; spermatogenesis [GO:0007283]","chromocenter [GO:0010369]; male germ cell nucleus [GO:0001673]; anterior/posterior pattern specification [GO:0009952]; chromatin remodeling [GO:0006338]; heterochromatin formation [GO:0031507]; negative regulation of DNA-templated transcription [GO:0045892]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Detected throughout embryogenesis. Expressed ubiquitously in 8.5 dpc embryos. At 10.5 dpc, strongly expressed in nervous system including hindbrain and spinal cord, and in the pharyngeal arches and visceral organs. By 14.5 dpc, strong expression is detected throughout the central nervous system, and in tongue, heart, midgut and urogenital regions. {ECO:0000269|PubMed:10653359}.","INDUCTION: By retinoic acid in F9 and F19 embryonal carcinoma cell lines. {ECO:0000269|PubMed:10653359}.","INDUCTION: By retinoic acid in F9 and F19 embryonal carcinoma cell lines. {ECO:0000269|PubMed:10653359}.","TISSUE SPECIFICITY: Most abundant in testis. Moderate levels detected in heart, brain, lung, liver, skeletal muscle and kidney and lower levels in spleen. {ECO:0000269|PubMed:10653359}."
"1278","sp|Q9VHA0|SCM_DROME","lcl|NC_088861.1_cds_XP_065926829.1_45844",1.16e-75,259,"Q9VHA0","SCM_DROME","Polycomb protein Scm (Sex comb on midleg protein)","Scm CG9495","Drosophila melanogaster (Fruit fly)",877,"GO:0003682; GO:0005634; GO:0005700; GO:0006357; GO:0007409; GO:0007419; GO:0008270; GO:0009948; GO:0022008; GO:0030708; GO:0030713; GO:0031507; GO:0042393; GO:0042802; GO:0043565; GO:0045892; GO:0045926; GO:0048749; GO:0140259","anterior/posterior axis specification [GO:0009948]; axonogenesis [GO:0007409]; compound eye development [GO:0048749]; follicle cell of egg chamber stalk formation [GO:0030713]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; heterochromatin formation [GO:0031507]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of growth [GO:0045926]; neurogenesis [GO:0022008]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]","nucleus [GO:0005634]; polytene chromosome [GO:0005700]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; PRC1 complex binding [GO:0140259]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; anterior/posterior axis specification [GO:0009948]; axonogenesis [GO:0007409]; compound eye development [GO:0048749]; follicle cell of egg chamber stalk formation [GO:0030713]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; heterochromatin formation [GO:0031507]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of growth [GO:0045926]; neurogenesis [GO:0022008]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. Levels are highest in 0-2 hours embryos and at lower levels during later embryonic and larval stages. A modest increase in expression is seen during the pupal stage. Expressed throughout the 9 hours embryo. After 12 hours expression is concentrated in the central nervous system. {ECO:0000269|PubMed:8625848}.","","",""
"1279","sp|Q9XYP7|GCP2_DROME","lcl|NC_088861.1_cds_XP_065926912.1_47723",7.83e-148,460,"Q9XYP7","GCP2_DROME","Gamma-tubulin complex component 2 homolog (Gamma-ring complex protein 84 kDa) (d84p) (dGrip84)","Grip84 CG3917","Drosophila melanogaster (Fruit fly)",852,"GO:0000278; GO:0000922; GO:0000930; GO:0000931; GO:0005813; GO:0005874; GO:0007020; GO:0007098; GO:0007283; GO:0008275; GO:0030953; GO:0031122; GO:0043015; GO:0048471; GO:0051225; GO:0051321; GO:0051726; GO:0090221","astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic spindle-templated microtubule nucleation [GO:0090221]; regulation of cell cycle [GO:0051726]; spermatogenesis [GO:0007283]; spindle assembly [GO:0051225]","centrosome [GO:0005813]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0000931]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic spindle-templated microtubule nucleation [GO:0090221]; regulation of cell cycle [GO:0051726]; spermatogenesis [GO:0007283]; spindle assembly [GO:0051225]","","","",""
"1280","sp|Q60636|PRDM1_MOUSE","lcl|NC_088861.1_cds_XP_065926920.1_46292",2.8e-77,266,"Q60636","PRDM1_MOUSE","PR domain zinc finger protein 1 (EC 2.1.1.-) (B lymphocyte-induced maturation protein 1) (Blimp-1) (Beta-interferon gene positive regulatory domain I-binding factor) (PR domain-containing protein 1)","Prdm1 Blimp1","Mus musculus (Mouse)",856,"GO:0000122; GO:0000976; GO:0000978; GO:0001227; GO:0001701; GO:0001763; GO:0001822; GO:0001892; GO:0001893; GO:0002250; GO:0003170; GO:0003279; GO:0003281; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006357; GO:0007281; GO:0008168; GO:0008270; GO:0009791; GO:0010467; GO:0010628; GO:0010629; GO:0030889; GO:0031665; GO:0032259; GO:0032823; GO:0033082; GO:0035904; GO:0042127; GO:0042462; GO:0042826; GO:0043565; GO:0045087; GO:0045165; GO:0045579; GO:0048844; GO:0051136; GO:0060040; GO:0060576; GO:0060707; GO:0060976; GO:1990226; GO:1990654; GO:1990841","adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cardiac septum development [GO:0003279]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; embryonic placenta development [GO:0001892]; eye photoreceptor cell development [GO:0042462]; gene expression [GO:0010467]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; maternal placenta development [GO:0001893]; methylation [GO:0032259]; morphogenesis of a branching structure [GO:0001763]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of gene expression [GO:0010629]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal bipolar neuron differentiation [GO:0060040]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]","cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; histone methyltransferase binding [GO:1990226]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cardiac septum development [GO:0003279]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; embryonic placenta development [GO:0001892]; eye photoreceptor cell development [GO:0042462]; gene expression [GO:0010467]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; maternal placenta development [GO:0001893]; methylation [GO:0032259]; morphogenesis of a branching structure [GO:0001763]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of gene expression [GO:0010629]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal bipolar neuron differentiation [GO:0060040]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]","","INDUCTION: By lymphokines, specifically IL-2 and IL-5. Up-regulated during dendritic cell maturation.; INDUCTION: (Microbial infection) Up-regulated in response to Herpes simplex virus (HSV) infection in skin and spleen memory CD8(+) T cells. {ECO:0000269|PubMed:27102484}.; INDUCTION: (Microbial infection) Up-regulated in response to Lymphocytic choriomeningitis virus (LCMV) in memory CD8(+) T cells. {ECO:0000269|PubMed:27102484}.","INDUCTION: By lymphokines, specifically IL-2 and IL-5. Up-regulated during dendritic cell maturation.; INDUCTION: (Microbial infection) Up-regulated in response to Herpes simplex virus (HSV) infection in skin and spleen memory CD8(+) T cells. {ECO:0000269|PubMed:27102484}.; INDUCTION: (Microbial infection) Up-regulated in response to Lymphocytic choriomeningitis virus (LCMV) in memory CD8(+) T cells. {ECO:0000269|PubMed:27102484}.","TISSUE SPECIFICITY: Expressed in bone marrow macrophages (at protein level) (PubMed:32741026). Expressed in innate lymphocytes, including tissue-resident conventional natural killer (cNK) cells in liver (PubMed:27102484). Expressed also weakly in tissue-resident natural killer (trNK) and natural killer T (NKT) cells in liver (PubMed:27102484). {ECO:0000269|PubMed:11121475, ECO:0000269|PubMed:19737919, ECO:0000269|PubMed:27102484, ECO:0000269|PubMed:32741026, ECO:0000269|PubMed:8168136}.; TISSUE SPECIFICITY: [Isoform 1]: Expressed in bone marrow, spleen and lymph node but not in brain, heart, kidney, liver, ovary or muscle. Weak expression detected in the lung.; TISSUE SPECIFICITY: [Isoform 3]: Expressed only in the yolk sac. {ECO:0000269|PubMed:19737919}.; TISSUE SPECIFICITY: [Isoform 4]: Expressed in embryo, yolk sac, placenta, splenocytes, and activated T-cells. {ECO:0000269|PubMed:19737919}."
"1281","sp|P0C6R2|ARMC2_BOVIN","lcl|NC_088861.1_cds_XP_065926935.1_45260",7.26e-149,461,"P0C6R2","ARMC2_BOVIN","Armadillo repeat-containing protein 2","ARMC2","Bos taurus (Bovine)",865,"GO:0000902; GO:0006997; GO:0007288; GO:0044782","cell morphogenesis [GO:0000902]; cilium organization [GO:0044782]; nucleus organization [GO:0006997]; sperm axoneme assembly [GO:0007288]","cell morphogenesis [GO:0000902]; cilium organization [GO:0044782]; nucleus organization [GO:0006997]; sperm axoneme assembly [GO:0007288]","","","",""
"1282","sp|Q9SND6|M3K20_ARATH","lcl|NC_088861.1_cds_XP_065927004.1_46874",6.36e-45,166,"Q9SND6","M3K20_ARATH","Mitogen-activated protein kinase kinase kinase 20 (MAPKK kinase 20) (EC 2.7.11.25) (Protein ABA-INSENSITIVE PROTEIN KINASE 1)","MAPKKK20 AIK1 MKKK20 At3g50310 F11C1.150","Arabidopsis thaliana (Mouse-ear cress)",342,"GO:0000302; GO:0004672; GO:0004708; GO:0004709; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0009409; GO:0009414; GO:0009651; GO:0009737; GO:0009738; GO:0010082; GO:0019901; GO:0046777; GO:0048235; GO:0051301; GO:0051510; GO:0090333; GO:0106310","abscisic acid-activated signaling pathway [GO:0009738]; cell division [GO:0051301]; pollen sperm cell differentiation [GO:0048235]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of root meristem growth [GO:0010082]; regulation of stomatal closure [GO:0090333]; regulation of unidimensional cell growth [GO:0051510]; response to abscisic acid [GO:0009737]; response to cold [GO:0009409]; response to reactive oxygen species [GO:0000302]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; abscisic acid-activated signaling pathway [GO:0009738]; cell division [GO:0051301]; pollen sperm cell differentiation [GO:0048235]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of root meristem growth [GO:0010082]; regulation of stomatal closure [GO:0090333]; regulation of unidimensional cell growth [GO:0051510]; response to abscisic acid [GO:0009737]; response to cold [GO:0009409]; response to reactive oxygen species [GO:0000302]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]","DEVELOPMENTAL STAGE: During flower development, strongly expressed in pollen grains with a progressive increase from young buds to later stages of maturation (PubMed:28848569). To a lesser extent, present in the gynoecium, particularly in the style and carpel (PubMed:28848569). Also expressed in nectaries, petals, sepals and pollen tubes (PubMed:28848569). Accumulates progressively during seedlings development (PubMed:21969089). In mature plants, confined to floral clusters (PubMed:21969089). In roots, present in meristematic and elongation zones (PubMed:27913741). {ECO:0000269|PubMed:21969089, ECO:0000269|PubMed:27913741, ECO:0000269|PubMed:28848569}.","INDUCTION: Induced by salt (NaCl), mannitol, methyl viologen (MV), sorbitol and cold (PubMed:21969089). Triggered by abscisic acid (ABA) (PubMed:27913741). {ECO:0000269|PubMed:21969089, ECO:0000269|PubMed:27913741}.","INDUCTION: Induced by salt (NaCl), mannitol, methyl viologen (MV), sorbitol and cold (PubMed:21969089). Triggered by abscisic acid (ABA) (PubMed:27913741). {ECO:0000269|PubMed:21969089, ECO:0000269|PubMed:27913741}.","TISSUE SPECIFICITY: Expressed in roots, seedlings, leaves, flower buds, flowers and siliques. {ECO:0000269|PubMed:21969089, ECO:0000269|PubMed:27913741, ECO:0000269|PubMed:28848569}."
"1283","sp|O01367|HOW_DROME","lcl|NC_088861.1_cds_XP_065927087.1_47427",1.23e-106,318,"O01367","HOW_DROME","Protein held out wings (KH domain protein KH93F) (Protein muscle-specific) (Protein struthio) (Protein wings held out) (Putative RNA-binding protein) (Quaking-related 93F)","how KH93F qkr93F stru who CG10293","Drosophila melanogaster (Fruit fly)",405,"GO:0000381; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0007155; GO:0007284; GO:0007438; GO:0007475; GO:0007498; GO:0007517; GO:0007521; GO:0007525; GO:0008016; GO:0008078; GO:0008347; GO:0008366; GO:0016203; GO:0016477; GO:0030154; GO:0030718; GO:0045214; GO:0045995; GO:0046832; GO:0048024; GO:0048027","apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon ensheathment [GO:0008366]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; germ-line stem cell population maintenance [GO:0030718]; glial cell migration [GO:0008347]; mesoderm development [GO:0007498]; mesodermal cell migration [GO:0008078]; muscle attachment [GO:0016203]; muscle cell fate determination [GO:0007521]; muscle organ development [GO:0007517]; negative regulation of RNA export from nucleus [GO:0046832]; oenocyte development [GO:0007438]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of embryonic development [GO:0045995]; regulation of heart contraction [GO:0008016]; regulation of mRNA splicing, via spliceosome [GO:0048024]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]; spermatogonial cell division [GO:0007284]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon ensheathment [GO:0008366]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; germ-line stem cell population maintenance [GO:0030718]; glial cell migration [GO:0008347]; mesoderm development [GO:0007498]; mesodermal cell migration [GO:0008078]; muscle attachment [GO:0016203]; muscle cell fate determination [GO:0007521]; muscle organ development [GO:0007517]; negative regulation of RNA export from nucleus [GO:0046832]; oenocyte development [GO:0007438]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of embryonic development [GO:0045995]; regulation of heart contraction [GO:0008016]; regulation of mRNA splicing, via spliceosome [GO:0048024]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]; spermatogonial cell division [GO:0007284]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically during embryonic, larval and pupal development. {ECO:0000269|PubMed:9332381, ECO:0000269|PubMed:9344542}.","INDUCTION: By 20-hydroxyecdysone at the onset of metamorphosis. {ECO:0000269|PubMed:9118803}.","INDUCTION: By 20-hydroxyecdysone at the onset of metamorphosis. {ECO:0000269|PubMed:9118803}.","TISSUE SPECIFICITY: During embryogenesis, expression is seen in mesodermal precursors of somatic, visceral and pharyngeal muscle. Later in embryogenesis, expression is restricted to heart and muscle attachment sites of the epidermis. During onset of metamorphosis, expression is seen in muscle and muscle attachment cells. {ECO:0000269|PubMed:9118803, ECO:0000269|PubMed:9332381, ECO:0000269|PubMed:9344542}."
"1284","sp|O43903|GAS2_HUMAN","lcl|NC_088861.1_cds_XP_065927204.1_47317",1.95e-52,176,"O43903","GAS2_HUMAN","Growth arrest-specific protein 2 (GAS-2)","GAS2","Homo sapiens (Human)",313,"GO:0001544; GO:0001547; GO:0001725; GO:0005829; GO:0005884; GO:0006915; GO:0008017; GO:0008360; GO:0008593; GO:0016020; GO:0030728; GO:0051015; GO:0051726; GO:0051764; GO:0071711","actin crosslink formation [GO:0051764]; antral ovarian follicle growth [GO:0001547]; apoptotic process [GO:0006915]; basement membrane organization [GO:0071711]; initiation of primordial ovarian follicle growth [GO:0001544]; ovulation [GO:0030728]; regulation of cell cycle [GO:0051726]; regulation of cell shape [GO:0008360]; regulation of Notch signaling pathway [GO:0008593]","actin filament [GO:0005884]; cytosol [GO:0005829]; membrane [GO:0016020]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; microtubule binding [GO:0008017]; actin crosslink formation [GO:0051764]; antral ovarian follicle growth [GO:0001547]; apoptotic process [GO:0006915]; basement membrane organization [GO:0071711]; initiation of primordial ovarian follicle growth [GO:0001544]; ovulation [GO:0030728]; regulation of cell cycle [GO:0051726]; regulation of cell shape [GO:0008360]; regulation of Notch signaling pathway [GO:0008593]","DEVELOPMENTAL STAGE: Specifically expressed at growth arrest.","","","TISSUE SPECIFICITY: Ubiquitously expressed with highest levels in liver, lung, and kidney. Not found in spleen."
"1285","sp|Q9VRN5|LIN28_DROME","lcl|NC_088861.1_cds_XP_065927389.1_46251",6.39e-49,157,"Q9VRN5","LIN28_DROME","Protein lin-28 homolog","lin-28 CG17334","Drosophila melanogaster (Fruit fly)",195,"GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0010494; GO:0010608; GO:0031054; GO:0046427; GO:0046628; GO:0048477; GO:0048621; GO:0060250; GO:0070935; GO:0098724; GO:2000632; GO:2000648","3'-UTR-mediated mRNA stabilization [GO:0070935]; germ-line stem-cell niche homeostasis [GO:0060250]; negative regulation of pre-miRNA processing [GO:2000632]; oogenesis [GO:0048477]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of stem cell proliferation [GO:2000648]; post-embryonic digestive tract morphogenesis [GO:0048621]; post-transcriptional regulation of gene expression [GO:0010608]; pre-miRNA processing [GO:0031054]; symmetric stem cell division [GO:0098724]","cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; germ-line stem-cell niche homeostasis [GO:0060250]; negative regulation of pre-miRNA processing [GO:2000632]; oogenesis [GO:0048477]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of stem cell proliferation [GO:2000648]; post-embryonic digestive tract morphogenesis [GO:0048621]; post-transcriptional regulation of gene expression [GO:0010608]; pre-miRNA processing [GO:0031054]; symmetric stem cell division [GO:0098724]","DEVELOPMENTAL STAGE: Expressed from embryogenesis to the first instar larval stage, then at the pupal stage. Not expressed at significant levels in the adult. {ECO:0000269|PubMed:12798299}.","","",""
"1286","sp|Q92847|GHSR_HUMAN","lcl|NC_088861.1_cds_XP_065927695.1_46781",2.8e-50,176,"Q92847","GHSR_HUMAN","Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor)","GHSR","Homo sapiens (Human)",366,"GO:0001616; GO:0004930; GO:0005886; GO:0007186; GO:0007283; GO:0007611; GO:0008154; GO:0008343; GO:0009725; GO:0009755; GO:0009986; GO:0010700; GO:0016520; GO:0017046; GO:0030252; GO:0032094; GO:0032099; GO:0032100; GO:0032354; GO:0032355; GO:0032691; GO:0032715; GO:0032720; GO:0032869; GO:0036321; GO:0040018; GO:0042802; GO:0043005; GO:0043134; GO:0043568; GO:0045121; GO:0045923; GO:0046676; GO:0046697; GO:0048009; GO:0050728; GO:0051963; GO:0051969; GO:0060123; GO:0060416; GO:0071222; GO:0071548; GO:0090327; GO:0097060; GO:0097067; GO:0098685; GO:0098696; GO:0098794; GO:0098978; GO:0099170; GO:0099175; GO:0120058; GO:1902065; GO:1903672; GO:1904000; GO:1904349; GO:1905333; GO:1905564; GO:1990314; GO:2000110","actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to thyroid hormone stimulus [GO:0097067]; decidualization [GO:0046697]; G protein-coupled receptor signaling pathway [GO:0007186]; ghrelin secretion [GO:0036321]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; insulin-like growth factor receptor signaling pathway [GO:0048009]; learning or memory [GO:0007611]; negative regulation of appetite [GO:0032099]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of norepinephrine secretion [GO:0010700]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of appetite [GO:0032100]; positive regulation of eating behavior [GO:1904000]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of small intestinal transit [GO:0120058]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of gastric motility [GO:1905333]; regulation of growth hormone secretion [GO:0060123]; regulation of hindgut contraction [GO:0043134]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of postsynapse organization [GO:0099175]; regulation of synapse assembly [GO:0051963]; regulation of transmission of nerve impulse [GO:0051969]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to follicle-stimulating hormone [GO:0032354]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to L-glutamate [GO:1902065]; spermatogenesis [GO:0007283]","cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; G protein-coupled receptor activity [GO:0004930]; growth hormone secretagogue receptor activity [GO:0001616]; growth hormone-releasing hormone receptor activity [GO:0016520]; identical protein binding [GO:0042802]; peptide hormone binding [GO:0017046]; actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to thyroid hormone stimulus [GO:0097067]; decidualization [GO:0046697]; G protein-coupled receptor signaling pathway [GO:0007186]; ghrelin secretion [GO:0036321]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; insulin-like growth factor receptor signaling pathway [GO:0048009]; learning or memory [GO:0007611]; negative regulation of appetite [GO:0032099]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of norepinephrine secretion [GO:0010700]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of appetite [GO:0032100]; positive regulation of eating behavior [GO:1904000]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of small intestinal transit [GO:0120058]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of gastric motility [GO:1905333]; regulation of growth hormone secretion [GO:0060123]; regulation of hindgut contraction [GO:0043134]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of postsynapse organization [GO:0099175]; regulation of synapse assembly [GO:0051963]; regulation of transmission of nerve impulse [GO:0051969]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to follicle-stimulating hormone [GO:0032354]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to L-glutamate [GO:1902065]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Pituitary and hypothalamus."
"1287","sp|Q7Z7L9|ZSCA2_HUMAN","lcl|NC_088861.1_cds_XP_065927699.1_47744",4.2e-142,435,"Q7Z7L9","ZSCA2_HUMAN","Zinc finger and SCAN domain-containing protein 2 (Zinc finger protein 29 homolog) (Zfp-29) (Zinc finger protein 854)","ZSCAN2 ZFP29 ZNF854","Homo sapiens (Human)",614,"GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007283; GO:0008270; GO:0030154; GO:0045944","cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","","","",""
"1288","sp|Q6Q759|SPG17_HUMAN","lcl|NC_088861.1_cds_XP_065928067.1_45198",6.39e-142,495,"Q6Q759","SPG17_HUMAN","Sperm-associated antigen 17 (Projection protein PF6 homolog)","SPAG17","Homo sapiens (Human)",2223,"GO:0001669; GO:0002177; GO:0003351; GO:0005576; GO:0005794; GO:0005874; GO:0007283; GO:0031514; GO:0044458; GO:1904158; GO:1905198; GO:1990716; GO:1990953","axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283]","acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; microtubule [GO:0005874]; motile cilium [GO:0031514]; axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Highly expressed in testis. Expressed in organs that contain cilia-bearing cells including brain, oviduct, lung, and uterus. {ECO:0000269|PubMed:15827353}."
"1289","sp|P11717|MPRI_HUMAN","lcl|NC_088861.1_cds_XP_065928096.1_46792",0,1230,"P11717","MPRI_HUMAN","Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222)","IGF2R MPRI","Homo sapiens (Human)",2491,"GO:0000139; GO:0001889; GO:0001965; GO:0001972; GO:0005010; GO:0005520; GO:0005537; GO:0005641; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005802; GO:0005886; GO:0005925; GO:0006898; GO:0007041; GO:0007165; GO:0007186; GO:0007283; GO:0009791; GO:0009986; GO:0010008; GO:0016020; GO:0019899; GO:0030118; GO:0030133; GO:0030139; GO:0030140; GO:0030667; GO:0030669; GO:0031100; GO:0031995; GO:0032526; GO:0032588; GO:0038023; GO:0042802; GO:0043065; GO:0044794; GO:0048471; GO:0051219; GO:0070062; GO:1904772; GO:1905394","animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation by host of viral process [GO:0044794]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; receptor-mediated endocytosis [GO:0006898]; response to retinoic acid [GO:0032526]; response to tetrachloromethane [GO:1904772]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]","cell surface [GO:0009986]; clathrin coat [GO:0030118]; clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133]; D-mannose binding [GO:0005537]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor receptor activity [GO:0005010]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; retromer complex binding [GO:1905394]; signaling receptor activity [GO:0038023]; animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation by host of viral process [GO:0044794]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; receptor-mediated endocytosis [GO:0006898]; response to retinoic acid [GO:0032526]; response to tetrachloromethane [GO:1904772]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]","","","",""
"1290","sp|Q99MV7|RNF17_MOUSE","lcl|NC_088861.1_cds_XP_065928182.1_46199",2.85e-75,279,"Q99MV7","RNF17_MOUSE","RING finger protein 17 (Mad member-interacting protein 2) (Mmip-2)","Rnf17","Mus musculus (Mouse)",1640,"GO:0005634; GO:0005737; GO:0007286; GO:0008270; GO:0042802","spermatid development [GO:0007286]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Expressed at high levels in adult testis. Expressed in male germ cells (at protein level). Expressed at lower levels in adult thyroid, submaxillary gland, ovary and epididymis. {ECO:0000269|PubMed:10597267, ECO:0000269|PubMed:16093322}."
"1291","sp|Q8VI95|OAS1D_MOUSE","lcl|NC_088861.1_cds_XP_065928362.1_45216",1.49e-18,87.4,"Q8VI95","OAS1D_MOUSE","Inactive 2'-5'-oligoadenylate synthase 1D","Oas1d Oasl8","Mus musculus (Mouse)",361,"GO:0001541; GO:0001542; GO:0003725; GO:0004857; GO:0005737","ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]","cytoplasm [GO:0005737]; double-stranded RNA binding [GO:0003725]; enzyme inhibitor activity [GO:0004857]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]","DEVELOPMENTAL STAGE: Detected in fully grown, germinal vesicle (GV)-intact oocytes and in oocytes at the metaphase II stage, with levels decreasing thereafter (at protein level) (PubMed:15899864). Detected 1 week after birth in developing ovary (PubMed:27663720). Detected at 17.5 dpc, with levels increasing thereafter (PubMed:17567914). {ECO:0000269|PubMed:15899864, ECO:0000269|PubMed:17567914, ECO:0000269|PubMed:27663720}.","INDUCTION: Unlike other OAS1 proteins, not induced by polyinosinic:polycytidylic acid (poly I:C). {ECO:0000269|PubMed:15899864, ECO:0000269|PubMed:27663720}.","INDUCTION: Unlike other OAS1 proteins, not induced by polyinosinic:polycytidylic acid (poly I:C). {ECO:0000269|PubMed:15899864, ECO:0000269|PubMed:27663720}.","TISSUE SPECIFICITY: Expressed specifically in oocytes (at protein level) (PubMed:15899864). Expressed at highest level in ovary with lesser amounts in intestine, brain, thymus lung, kidney, liver and uterus (PubMed:17567914, PubMed:27663720). {ECO:0000269|PubMed:15899864, ECO:0000269|PubMed:17567914, ECO:0000269|PubMed:27663720}."
"1292","sp|A0A1B0GUW6|SPEM3_HUMAN","lcl|NC_088861.1_cds_XP_065928610.1_48307",5.48e-17,88.6,"A0A1B0GUW6","SPEM3_HUMAN","Uncharacterized protein SPEM3","SPEM3","Homo sapiens (Human)",1196,"GO:0005737; GO:0007291; GO:0016020; GO:0030317","flagellated sperm motility [GO:0030317]; sperm individualization [GO:0007291]","cytoplasm [GO:0005737]; membrane [GO:0016020]; flagellated sperm motility [GO:0030317]; sperm individualization [GO:0007291]","","","",""
"1293","sp|P05556|ITB1_HUMAN","lcl|NC_088862.1_cds_NP_001292309.1_50197",0,580,"P05556","ITB1_HUMAN","Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29)","ITGB1 FNRB MDF2 MSK12","Homo sapiens (Human)",798,"GO:0000082; GO:0000132; GO:0000287; GO:0001525; GO:0001618; GO:0001701; GO:0001726; GO:0001968; GO:0002020; GO:0002042; GO:0002052; GO:0003779; GO:0005178; GO:0005509; GO:0005737; GO:0005886; GO:0005925; GO:0006909; GO:0006968; GO:0007155; GO:0007156; GO:0007159; GO:0007160; GO:0007161; GO:0007229; GO:0007405; GO:0007517; GO:0007520; GO:0008305; GO:0008354; GO:0008542; GO:0009897; GO:0009986; GO:0010008; GO:0010710; GO:0010763; GO:0014704; GO:0014850; GO:0015026; GO:0016020; GO:0016477; GO:0019901; GO:0021943; GO:0021953; GO:0023035; GO:0030027; GO:0030030; GO:0030032; GO:0030175; GO:0030183; GO:0030198; GO:0030335; GO:0031589; GO:0031594; GO:0031623; GO:0032154; GO:0032587; GO:0033627; GO:0033631; GO:0034113; GO:0034665; GO:0034666; GO:0034667; GO:0034668; GO:0034674; GO:0034675; GO:0034677; GO:0034678; GO:0034679; GO:0034680; GO:0034681; GO:0034682; GO:0035024; GO:0035313; GO:0035633; GO:0035748; GO:0042383; GO:0042470; GO:0043065; GO:0043197; GO:0043235; GO:0043236; GO:0043547; GO:0044877; GO:0045121; GO:0045202; GO:0045214; GO:0045296; GO:0045445; GO:0045665; GO:0045743; GO:0045766; GO:0045906; GO:0046982; GO:0048333; GO:0048471; GO:0048626; GO:0048675; GO:0048813; GO:0050839; GO:0050901; GO:0051726; GO:0051897; GO:0051951; GO:0055007; GO:0055037; GO:0060379; GO:0060912; GO:0070062; GO:0071404; GO:0071711; GO:0090303; GO:0097060; GO:0097386; GO:0098609; GO:0098639; GO:0098640; GO:0098685; GO:0150003; GO:0150053; GO:0150103; GO:1900748; GO:1903078; GO:1905806; GO:1990782; GO:2000811","angiogenesis [GO:0001525]; axon extension [GO:0048675]; B cell differentiation [GO:0030183]; basement membrane organization [GO:0071711]; calcium-independent cell-matrix adhesion [GO:0007161]; cardiac cell fate specification [GO:0060912]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell myoblast differentiation [GO:0060379]; CD40 signaling pathway [GO:0023035]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cellular defense response [GO:0006968]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; central nervous system neuron differentiation [GO:0021953]; dendrite morphogenesis [GO:0048813]; establishment of mitotic spindle orientation [GO:0000132]; extracellular matrix organization [GO:0030198]; formation of radial glial scaffolds [GO:0021943]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell migration [GO:0008354]; heterotypic cell-cell adhesion [GO:0034113]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte tethering or rolling [GO:0050901]; maintenance of blood-brain barrier [GO:0035633]; mesodermal cell differentiation [GO:0048333]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; myoblast fate specification [GO:0048626]; myoblast fusion [GO:0007520]; negative regulation of anoikis [GO:2000811]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of vasoconstriction [GO:0045906]; neuroblast proliferation [GO:0007405]; phagocytosis [GO:0006909]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of glutamate uptake involved in transmission of nerve impulse [GO:0051951]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; positive regulation of wound healing [GO:0090303]; reactive gliosis [GO:0150103]; receptor internalization [GO:0031623]; regulation of cell cycle [GO:0051726]; regulation of collagen catabolic process [GO:0010710]; regulation of spontaneous synaptic transmission [GO:0150003]; regulation of synapse pruning [GO:1905806]; response to muscle activity [GO:0014850]; sarcomere organization [GO:0045214]; visual learning [GO:0008542]; wound healing, spreading of epidermal cells [GO:0035313]","cell surface [GO:0009986]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; glial cell projection [GO:0097386]; integrin alpha1-beta1 complex [GO:0034665]; integrin alpha10-beta1 complex [GO:0034680]; integrin alpha11-beta1 complex [GO:0034681]; integrin alpha2-beta1 complex [GO:0034666]; integrin alpha3-beta1 complex [GO:0034667]; integrin alpha4-beta1 complex [GO:0034668]; integrin alpha5-beta1 complex [GO:0034674]; integrin alpha6-beta1 complex [GO:0034675]; integrin alpha7-beta1 complex [GO:0034677]; integrin alpha8-beta1 complex [GO:0034678]; integrin alpha9-beta1 complex [GO:0034679]; integrin alphav-beta1 complex [GO:0034682]; integrin complex [GO:0008305]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; recycling endosome [GO:0055037]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; collagen binding involved in cell-matrix adhesion [GO:0098639]; coreceptor activity [GO:0015026]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640]; laminin binding [GO:0043236]; magnesium ion binding [GO:0000287]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein-containing complex binding [GO:0044877]; virus receptor activity [GO:0001618]; angiogenesis [GO:0001525]; axon extension [GO:0048675]; B cell differentiation [GO:0030183]; basement membrane organization [GO:0071711]; calcium-independent cell-matrix adhesion [GO:0007161]; cardiac cell fate specification [GO:0060912]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell myoblast differentiation [GO:0060379]; CD40 signaling pathway [GO:0023035]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cellular defense response [GO:0006968]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; central nervous system neuron differentiation [GO:0021953]; dendrite morphogenesis [GO:0048813]; establishment of mitotic spindle orientation [GO:0000132]; extracellular matrix organization [GO:0030198]; formation of radial glial scaffolds [GO:0021943]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell migration [GO:0008354]; heterotypic cell-cell adhesion [GO:0034113]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte tethering or rolling [GO:0050901]; maintenance of blood-brain barrier [GO:0035633]; mesodermal cell differentiation [GO:0048333]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; myoblast fate specification [GO:0048626]; myoblast fusion [GO:0007520]; negative regulation of anoikis [GO:2000811]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of vasoconstriction [GO:0045906]; neuroblast proliferation [GO:0007405]; phagocytosis [GO:0006909]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of glutamate uptake involved in transmission of nerve impulse [GO:0051951]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; positive regulation of wound healing [GO:0090303]; reactive gliosis [GO:0150103]; receptor internalization [GO:0031623]; regulation of cell cycle [GO:0051726]; regulation of collagen catabolic process [GO:0010710]; regulation of spontaneous synaptic transmission [GO:0150003]; regulation of synapse pruning [GO:1905806]; response to muscle activity [GO:0014850]; sarcomere organization [GO:0045214]; visual learning [GO:0008542]; wound healing, spreading of epidermal cells [GO:0035313]","","INDUCTION: Induced in alveolar epithelial cells during exposure to the fungus R.delemar, a causative agent of mucormycosis. {ECO:0000269|PubMed:32487760}.","INDUCTION: Induced in alveolar epithelial cells during exposure to the fungus R.delemar, a causative agent of mucormycosis. {ECO:0000269|PubMed:32487760}.","TISSUE SPECIFICITY: Expressed in vascular smooth muscle cells (at protein level). {ECO:0000269|PubMed:35802072}.; TISSUE SPECIFICITY: [Isoform 1]: Expressed in placenta (at protein level) (PubMed:33962943). Widely expressed, other isoforms are generally coexpressed with a more restricted distribution (PubMed:1551917, PubMed:7545396, PubMed:7681433). {ECO:0000269|PubMed:1551917, ECO:0000269|PubMed:33962943, ECO:0000269|PubMed:7545396, ECO:0000269|PubMed:7681433}.; TISSUE SPECIFICITY: [Isoform 2]: Expressed in skin, liver, skeletal muscle, cardiac muscle, placenta, umbilical vein endothelial cells, neuroblastoma cells, lymphoma cells, hepatoma cells and astrocytoma cells. {ECO:0000269|PubMed:2249781}.; TISSUE SPECIFICITY: [Isoform 3]: Together with isoform 4, is expressed in muscle, kidney, liver, placenta, cervical epithelium, umbilical vein endothelial cells, fibroblast cells, embryonal kidney cells, platelets and several blood cell lines. Expressed in non-proliferating and differentiated prostate gland epithelial cells and in platelets, on the surface of erythroleukemia cells and in various hematopoietic cell lines. {ECO:0000269|PubMed:1551917, ECO:0000269|PubMed:9494094}.; TISSUE SPECIFICITY: [Isoform 4]: Together with isoform 3, is expressed in muscle, kidney, liver, placenta, cervical epithelium, umbilical vein endothelial cells, fibroblast cells, embryonal kidney cells, platelets and several blood cell lines. Rather than isoform 3, is selectively expressed in peripheral T-cells. {ECO:0000269|PubMed:9494094}.; TISSUE SPECIFICITY: [Isoform 5]: Expressed specifically in striated muscle (skeletal and cardiac muscle). {ECO:0000269|PubMed:7544298, ECO:0000269|PubMed:7545396}."
"1294","sp|Q9PW80|IF2B3_DANRE","lcl|NC_088862.1_cds_XP_011412008.2_49912",4.79e-90,291,"Q9PW80","IF2B3_DANRE","Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2 mRNA-binding protein 3) (IMP-3) (Decapentaplegic and Vg-related 1 RNA-binding protein) (IGF-II mRNA-binding protein 3) (VICKZ family member 3) (Vg1 RNA-binding protein) (Vg1-RBP)","igf2bp3 dvr1rbp vickz3","Danio rerio (Zebrafish) (Brachydanio rerio)",582,"GO:0000932; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006417; GO:0007281; GO:0007399; GO:0007530; GO:0008354; GO:0010494; GO:0045995; GO:0051028; GO:0070934; GO:1990247","CRD-mediated mRNA stabilization [GO:0070934]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; mRNA transport [GO:0051028]; nervous system development [GO:0007399]; regulation of embryonic development [GO:0045995]; regulation of translation [GO:0006417]; sex determination [GO:0007530]","cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; CRD-mediated mRNA stabilization [GO:0070934]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; mRNA transport [GO:0051028]; nervous system development [GO:0007399]; regulation of embryonic development [GO:0045995]; regulation of translation [GO:0006417]; sex determination [GO:0007530]","DEVELOPMENTAL STAGE: Expressed in oocytes from stages I to III. Expressed in 8-cell embryo. Expressed in brain, eye, branchial arches and neural tube at 24 hours post-fertilization (hpf). Detected predominantly in the CNS, putative neural crest, the sensorial layer of the epidermal ectoderm and their derivatives until the tailbud stage. {ECO:0000269|PubMed:10525193, ECO:0000269|PubMed:14522877}.","","",""
"1295","sp|P34021|ECR_DROME","lcl|NC_088862.1_cds_XP_011416718.1_50533",6.11e-84,278,"P34021","ECR_DROME","Ecdysone receptor (20-hydroxy-ecdysone receptor) (20E receptor) (EcRH) (Ecdysteroid receptor) (Nuclear receptor subfamily 1 group H member 1)","EcR NR1H1 CG1765","Drosophila melanogaster (Fruit fly)",878,"GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001046; GO:0001222; GO:0001223; GO:0001228; GO:0001752; GO:0002164; GO:0003677; GO:0004879; GO:0005102; GO:0005496; GO:0005634; GO:0005700; GO:0005737; GO:0006357; GO:0006911; GO:0006914; GO:0007155; GO:0007281; GO:0007291; GO:0007298; GO:0007390; GO:0007422; GO:0007443; GO:0007476; GO:0007488; GO:0007552; GO:0007616; GO:0008230; GO:0008231; GO:0008232; GO:0008258; GO:0008270; GO:0008340; GO:0008362; GO:0008544; GO:0010002; GO:0010629; GO:0016241; GO:0016319; GO:0016322; GO:0018990; GO:0030154; GO:0030425; GO:0030522; GO:0035053; GO:0035073; GO:0035075; GO:0035076; GO:0035100; GO:0035180; GO:0035188; GO:0035193; GO:0035206; GO:0035297; GO:0040003; GO:0040034; GO:0042220; GO:0042632; GO:0042803; GO:0043065; GO:0043457; GO:0045892; GO:0045893; GO:0045938; GO:0045944; GO:0046982; GO:0048102; GO:0048477; GO:0048738; GO:0048813; GO:0050728; GO:0090575; GO:0140297; GO:1904799; GO:1904801","autophagic cell death [GO:0048102]; autophagy [GO:0006914]; border follicle cell migration [GO:0007298]; cardiac muscle tissue development [GO:0048738]; cardioblast differentiation [GO:0010002]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; cholesterol homeostasis [GO:0042632]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; dorsal vessel heart proper cell fate commitment [GO:0035053]; ecdysis, chitin-based cuticle [GO:0018990]; ecdysone receptor signaling pathway [GO:0035076]; epidermis development [GO:0008544]; germ cell development [GO:0007281]; germ-band shortening [GO:0007390]; hatching [GO:0035188]; head involution [GO:0008258]; histoblast morphogenesis [GO:0007488]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular receptor signaling pathway [GO:0030522]; larval central nervous system remodeling [GO:0035193]; larval development [GO:0002164]; larval wandering behavior [GO:0035180]; long-term memory [GO:0007616]; Malpighian tubule morphogenesis [GO:0007443]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron remodeling [GO:0016322]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; phagocytosis, engulfment [GO:0006911]; positive regulation of apoptotic process [GO:0043065]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of neuron remodeling [GO:1904801]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pupariation [GO:0035073]; regulation of cellular respiration [GO:0043457]; regulation of development, heterochronic [GO:0040034]; regulation of hemocyte proliferation [GO:0035206]; regulation of macroautophagy [GO:0016241]; regulation of Malpighian tubule diameter [GO:0035297]; regulation of neuron remodeling [GO:1904799]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cocaine [GO:0042220]; response to ecdysone [GO:0035075]; sperm individualization [GO:0007291]","activator ecdysone receptor complex [GO:0008232]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; ecdysone receptor holocomplex [GO:0008230]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; repressor ecdysone receptor complex [GO:0008231]; RNA polymerase II transcription regulator complex [GO:0090575]; core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor binding [GO:0005102]; steroid binding [GO:0005496]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270]; autophagic cell death [GO:0048102]; autophagy [GO:0006914]; border follicle cell migration [GO:0007298]; cardiac muscle tissue development [GO:0048738]; cardioblast differentiation [GO:0010002]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; cholesterol homeostasis [GO:0042632]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; dorsal vessel heart proper cell fate commitment [GO:0035053]; ecdysis, chitin-based cuticle [GO:0018990]; ecdysone receptor signaling pathway [GO:0035076]; epidermis development [GO:0008544]; germ cell development [GO:0007281]; germ-band shortening [GO:0007390]; hatching [GO:0035188]; head involution [GO:0008258]; histoblast morphogenesis [GO:0007488]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular receptor signaling pathway [GO:0030522]; larval central nervous system remodeling [GO:0035193]; larval development [GO:0002164]; larval wandering behavior [GO:0035180]; long-term memory [GO:0007616]; Malpighian tubule morphogenesis [GO:0007443]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron remodeling [GO:0016322]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; phagocytosis, engulfment [GO:0006911]; positive regulation of apoptotic process [GO:0043065]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of neuron remodeling [GO:1904801]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pupariation [GO:0035073]; regulation of cellular respiration [GO:0043457]; regulation of development, heterochronic [GO:0040034]; regulation of hemocyte proliferation [GO:0035206]; regulation of macroautophagy [GO:0016241]; regulation of Malpighian tubule diameter [GO:0035297]; regulation of neuron remodeling [GO:1904799]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cocaine [GO:0042220]; response to ecdysone [GO:0035075]; sperm individualization [GO:0007291]","DEVELOPMENTAL STAGE: In the salivary glands of mid instar larvae levels increase during puff stage 1 at 86-94 hours of development then remain relatively constant until the premetamorphic pulse of ecdysone in late larvae. Levels diminish dramatically from puff stage 7 onwards. Levels increase in the prepupal period during puff stage 13-14, the level remains stable until stage 21. A decrease in levels at puff stage 7 is also seen in the Malpighian tubules and less dramatically in the fat body and gut. In the wing disk the relatively low level remains unchanged. {ECO:0000269|PubMed:1913820, ECO:0000269|PubMed:8223281}.","","","TISSUE SPECIFICITY: Isoform B1 predominates over isoform A in larval tissues, imaginal histoblast nests and midgut islands. Isoform A predominates over B1 in imaginal disks, and the larval prothoracic gland. {ECO:0000269|PubMed:1913820}."
"1296","sp|P48555|RALA_DROME","lcl|NC_088862.1_cds_XP_011423235.2_50703",8.81e-113,321,"P48555","RALA_DROME","Ras-related protein Ral-a (EC 3.6.5.2)","Rala CG2849","Drosophila melanogaster (Fruit fly)",201,"GO:0003924; GO:0003925; GO:0005525; GO:0005886; GO:0007265; GO:0007298; GO:0007464; GO:0019003; GO:0022604; GO:0030165; GO:0031623; GO:0032154; GO:0045087; GO:0045742; GO:0045824; GO:0046329; GO:0050829; GO:0090543; GO:2000648","border follicle cell migration [GO:0007298]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of JNK cascade [GO:0046329]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of stem cell proliferation [GO:2000648]; R3/R4 cell fate commitment [GO:0007464]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of cell morphogenesis [GO:0022604]","cleavage furrow [GO:0032154]; Flemming body [GO:0090543]; plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; PDZ domain binding [GO:0030165]; border follicle cell migration [GO:0007298]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of JNK cascade [GO:0046329]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of stem cell proliferation [GO:2000648]; R3/R4 cell fate commitment [GO:0007464]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of cell morphogenesis [GO:0022604]","","","",""
"1297","sp|P62828|RAN_RAT","lcl|NC_088862.1_cds_XP_011426860.1_50222",5.78e-135,378,"P62828","RAN_RAT","GTP-binding nuclear protein Ran (EC 3.6.5.-) (GTPase Ran) (Ras-like protein TC4) (Ras-related nuclear protein)","Ran","Rattus norvegicus (Rat)",216,"GO:0000054; GO:0000055; GO:0000056; GO:0000070; GO:0000287; GO:0000785; GO:0001673; GO:0002177; GO:0003924; GO:0003925; GO:0005049; GO:0005525; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005730; GO:0005737; GO:0005814; GO:0005829; GO:0006606; GO:0006611; GO:0006913; GO:0007286; GO:0008104; GO:0016442; GO:0019003; GO:0019904; GO:0021766; GO:0030036; GO:0030496; GO:0031503; GO:0032991; GO:0036126; GO:0042307; GO:0042470; GO:0042565; GO:0044877; GO:0045505; GO:0046039; GO:0046827; GO:0046982; GO:0051301; GO:0055037; GO:0061015; GO:0061676; GO:0070883; GO:0071389; GO:1902570; GO:1905172","actin cytoskeleton organization [GO:0030036]; cell division [GO:0051301]; cellular response to mineralocorticoid stimulus [GO:0071389]; GTP metabolic process [GO:0046039]; hippocampus development [GO:0021766]; mitotic sister chromatid segregation [GO:0000070]; nucleocytoplasmic transport [GO:0006913]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to nucleolus [GO:1902570]; protein-containing complex localization [GO:0031503]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; snRNA import into nucleus [GO:0061015]; spermatid development [GO:0007286]","centriole [GO:0005814]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; manchette [GO:0002177]; melanosome [GO:0042470]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565]; sperm flagellum [GO:0036126]; dynein intermediate chain binding [GO:0045505]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; importin-alpha family protein binding [GO:0061676]; magnesium ion binding [GO:0000287]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; RISC complex binding [GO:1905172]; actin cytoskeleton organization [GO:0030036]; cell division [GO:0051301]; cellular response to mineralocorticoid stimulus [GO:0071389]; GTP metabolic process [GO:0046039]; hippocampus development [GO:0021766]; mitotic sister chromatid segregation [GO:0000070]; nucleocytoplasmic transport [GO:0006913]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to nucleolus [GO:1902570]; protein-containing complex localization [GO:0031503]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; snRNA import into nucleus [GO:0061015]; spermatid development [GO:0007286]","","","",""
"1298","sp|Q9JLI7|SPAG6_MOUSE","lcl|NC_088862.1_cds_XP_011427854.1_49475",0,923,"Q9JLI7","SPAG6_MOUSE","Sperm-associated antigen 6 (Axoneme central apparatus protein) (Protein PF16 homolog)","Spag6 Pf16","Mus musculus (Mouse)",507,"GO:0001669; GO:0002177; GO:0003351; GO:0003356; GO:0005576; GO:0005829; GO:0005874; GO:0005930; GO:0006931; GO:0007283; GO:0007288; GO:0008017; GO:0008104; GO:0010761; GO:0021591; GO:0030317; GO:0031410; GO:0043149; GO:0043583; GO:0044458; GO:0045198; GO:0046847; GO:0051301; GO:0051649; GO:0090175; GO:0090660; GO:0097228; GO:0120197; GO:0120249; GO:1905515; GO:1990138; GO:1990716","cell division [GO:0051301]; cerebrospinal fluid circulation [GO:0090660]; ear development [GO:0043583]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of localization in cell [GO:0051649]; fibroblast migration [GO:0010761]; filopodium assembly [GO:0046847]; flagellated sperm motility [GO:0030317]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; neuron projection extension [GO:1990138]; non-motile cilium assembly [GO:1905515]; protein localization [GO:0008104]; regulation of cilium beat frequency [GO:0003356]; regulation of establishment of planar polarity [GO:0090175]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]; stress fiber assembly [GO:0043149]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; ventricular system development [GO:0021591]","acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; lateral wall of outer hair cell [GO:0120249]; manchette [GO:0002177]; microtubule [GO:0005874]; sperm principal piece [GO:0097228]; microtubule binding [GO:0008017]; cell division [GO:0051301]; cerebrospinal fluid circulation [GO:0090660]; ear development [GO:0043583]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of localization in cell [GO:0051649]; fibroblast migration [GO:0010761]; filopodium assembly [GO:0046847]; flagellated sperm motility [GO:0030317]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; neuron projection extension [GO:1990138]; non-motile cilium assembly [GO:1905515]; protein localization [GO:0008104]; regulation of cilium beat frequency [GO:0003356]; regulation of establishment of planar polarity [GO:0090175]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]; stress fiber assembly [GO:0043149]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; ventricular system development [GO:0021591]","","","","TISSUE SPECIFICITY: Highly expressed in testis. Not detected in prostate, ovary, spleen, thymus, small intestine, colon and peripheral blood leukocytes. {ECO:0000269|PubMed:10684790, ECO:0000269|PubMed:12391165}."
"1299","sp|P61209|ARF1_DROME","lcl|NC_088862.1_cds_XP_011428363.1_49943",7.39e-124,347,"P61209","ARF1_DROME","ADP-ribosylation factor 1 (EC 3.6.5.2)","Arf1 Arf79F CG8385","Drosophila melanogaster (Fruit fly)",182,"GO:0000139; GO:0001745; GO:0002786; GO:0003924; GO:0005525; GO:0005737; GO:0005764; GO:0005768; GO:0005794; GO:0005795; GO:0005829; GO:0005886; GO:0006886; GO:0006892; GO:0006897; GO:0007112; GO:0007269; GO:0007476; GO:0010883; GO:0016192; GO:0032011; GO:0032154; GO:0035331; GO:0043001; GO:0045177; GO:0045807; GO:0048488; GO:0048749; GO:0061484; GO:0098793; GO:1904801; GO:1990386","ARF protein signal transduction [GO:0032011]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; endocytosis [GO:0006897]; Golgi to plasma membrane protein transport [GO:0043001]; hematopoietic stem cell homeostasis [GO:0061484]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular protein transport [GO:0006886]; male meiosis cytokinesis [GO:0007112]; mitotic cleavage furrow ingression [GO:1990386]; negative regulation of hippo signaling [GO:0035331]; neurotransmitter secretion [GO:0007269]; positive regulation of endocytosis [GO:0045807]; positive regulation of neuron remodeling [GO:1904801]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of antibacterial peptide production [GO:0002786]; regulation of lipid storage [GO:0010883]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]","apical part of cell [GO:0045177]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ARF protein signal transduction [GO:0032011]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; endocytosis [GO:0006897]; Golgi to plasma membrane protein transport [GO:0043001]; hematopoietic stem cell homeostasis [GO:0061484]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular protein transport [GO:0006886]; male meiosis cytokinesis [GO:0007112]; mitotic cleavage furrow ingression [GO:1990386]; negative regulation of hippo signaling [GO:0035331]; neurotransmitter secretion [GO:0007269]; positive regulation of endocytosis [GO:0045807]; positive regulation of neuron remodeling [GO:1904801]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of antibacterial peptide production [GO:0002786]; regulation of lipid storage [GO:0010883]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]","","","",""
"1300","sp|O35952|GLO2_RAT","lcl|NC_088862.1_cds_XP_011432635.2_49227",8.5e-106,311,"O35952","GLO2_RAT","Hydroxyacylglutathione hydrolase, mitochondrial (EC 3.1.2.6) (Glyoxalase II) (Glx II) (Round spermatid protein RSP29)","Hagh Rsp29","Rattus norvegicus (Rat)",309,"GO:0004416; GO:0005739; GO:0005759; GO:0006749; GO:0006750; GO:0007283; GO:0019243; GO:0046872","glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]; spermatogenesis [GO:0007283]","mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Strongly expressed in testis, skeletal muscle and heart. Weakly expressed in placenta, pancreas, spleen and peripheral blood leukocytes. {ECO:0000269|PubMed:9434774}."
"1301","sp|Q865K9|MPRB_PIG","lcl|NC_088862.1_cds_XP_011435715.2_48600",3.35e-57,190,"Q865K9","MPRB_PIG","Membrane progestin receptor beta (mPR beta) (Progestin and adipoQ receptor family member VIII)","PAQR8 MPRB","Sus scrofa (Pig)",354,"GO:0003707; GO:0005496; GO:0005886; GO:0048477; GO:0048545","oogenesis [GO:0048477]; response to steroid hormone [GO:0048545]","plasma membrane [GO:0005886]; nuclear steroid receptor activity [GO:0003707]; steroid binding [GO:0005496]; oogenesis [GO:0048477]; response to steroid hormone [GO:0048545]","","","",""
"1302","sp|A4D263|SMIP7_HUMAN","lcl|NC_088862.1_cds_XP_011436266.2_48929",3.64e-40,150,"A4D263","SMIP7_HUMAN","Protein SPMIP7 (Sperm microtubule inner protein 7) (Spermatogenesis-associated protein 48)","SPMIP7 C7orf72 SPATA48","Homo sapiens (Human)",438,"GO:0007283; GO:0030154","cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","","INDUCTION: Down-regulated expression in testicular samples of azoospermic men. {ECO:0000269|PubMed:36896575}.","INDUCTION: Down-regulated expression in testicular samples of azoospermic men. {ECO:0000269|PubMed:36896575}.","TISSUE SPECIFICITY: Testis-specific. {ECO:0000269|PubMed:29700843, ECO:0000269|PubMed:36896575}."
"1303","sp|Q6NUT2|D19L2_HUMAN","lcl|NC_088862.1_cds_XP_011436284.3_48928",0,610,"Q6NUT2","D19L2_HUMAN","Probable C-mannosyltransferase DPY19L2 (EC 2.4.1.-) (Dpy-19-like protein 2) (Protein dpy-19 homolog 2)","DPY19L2 UNQ3127/PRO10284","Homo sapiens (Human)",758,"GO:0000030; GO:0005634; GO:0005637; GO:0007286","spermatid development [GO:0007286]","nuclear inner membrane [GO:0005637]; nucleus [GO:0005634]; mannosyltransferase activity [GO:0000030]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Widely expressed with high expression in testis. Not detectable in ejaculated sperm (at protein level). {ECO:0000269|PubMed:16526957, ECO:0000269|PubMed:21397064}."
"1304","sp|P04657|CYC1_DROME","lcl|NC_088862.1_cds_XP_011450103.1_49885",1.76e-48,151,"P04657","CYC1_DROME","Cytochrome c-1 (Cytochrome c-distal)","Cyt-c-d CytC1 DC3 CG13263","Drosophila melanogaster (Fruit fly)",105,"GO:0005739; GO:0005758; GO:0005829; GO:0006119; GO:0006122; GO:0006123; GO:0007291; GO:0008656; GO:0009055; GO:0020037; GO:0046669; GO:0046872","mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; oxidative phosphorylation [GO:0006119]; regulation of compound eye retinal cell programmed cell death [GO:0046669]; sperm individualization [GO:0007291]","cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; oxidative phosphorylation [GO:0006119]; regulation of compound eye retinal cell programmed cell death [GO:0046669]; sperm individualization [GO:0007291]","DEVELOPMENTAL STAGE: Expressed at constant, but relatively low levels throughout development.","","",""
"1305","sp|Q6JEL2|KLH10_HUMAN","lcl|NC_088862.1_cds_XP_011455266.2_50153",0,686,"Q6JEL2","KLH10_HUMAN","Kelch-like protein 10","KLHL10","Homo sapiens (Human)",608,"GO:0000902; GO:0005737; GO:0007286; GO:0008584; GO:0009566; GO:0016567; GO:0031463; GO:0043161; GO:0048808; GO:0048873; GO:1990756","cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286]","Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286]","","","",""
"1306","sp|Q9VJY9|LOQS_DROME","lcl|NC_088862.1_cds_XP_011456094.2_49612",3.4e-52,180,"Q9VJY9","LOQS_DROME","Protein Loquacious","loqs dRax loq r3d1 TRBP CG6866","Drosophila melanogaster (Fruit fly)",465,"GO:0003725; GO:0005634; GO:0005737; GO:0005829; GO:0007417; GO:0009047; GO:0010586; GO:0016442; GO:0030422; GO:0030718; GO:0031054; GO:0035197; GO:0048132; GO:0070578; GO:0070920; GO:0070922; GO:1905172","central nervous system development [GO:0007417]; dosage compensation by hyperactivation of X chromosome [GO:0009047]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; miRNA metabolic process [GO:0010586]; pre-miRNA processing [GO:0031054]; regulation of regulatory ncRNA processing [GO:0070920]; RISC complex assembly [GO:0070922]; siRNA processing [GO:0030422]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; double-stranded RNA binding [GO:0003725]; RISC complex binding [GO:1905172]; siRNA binding [GO:0035197]; central nervous system development [GO:0007417]; dosage compensation by hyperactivation of X chromosome [GO:0009047]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; miRNA metabolic process [GO:0010586]; pre-miRNA processing [GO:0031054]; regulation of regulatory ncRNA processing [GO:0070920]; RISC complex assembly [GO:0070922]; siRNA processing [GO:0030422]","DEVELOPMENTAL STAGE: [Isoform PA]: Expressed both maternally and zygotically (at protein level). Detected in embryos, larvae and adults (at protein level). {ECO:0000269|PubMed:17320391}.; DEVELOPMENTAL STAGE: [Isoform PB]: Expressed both maternally and zygotically (at protein level). Detected in embryos, larvae and adults (at protein level). {ECO:0000269|PubMed:17320391}.","INDUCTION: [Isoform PD]: Slightly down-regulated in response to a low-dose/dose-rate (LDR) of ionizing radiation. {ECO:0000269|PubMed:36057690}.","INDUCTION: [Isoform PD]: Slightly down-regulated in response to a low-dose/dose-rate (LDR) of ionizing radiation. {ECO:0000269|PubMed:36057690}.","TISSUE SPECIFICITY: [Isoform PA]: Strong expression in males and females (PubMed:15918770). Expression in ovaries is relatively weak (PubMed:15918770). {ECO:0000269|PubMed:15918770}.; TISSUE SPECIFICITY: [Isoform PB]: Strong expression in females and relatively weak expression in males (PubMed:15918770). Strong expression in ovaries (PubMed:15918770). {ECO:0000269|PubMed:15918770}."
"1307","sp|Q9QZH2|BARD1_RAT","lcl|NC_088862.1_cds_XP_034308727.2_49853",2.8e-58,210,"Q9QZH2","BARD1_RAT","BRCA1-associated RING domain protein 1 (BARD-1) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase BARD1)","Bard1","Rattus norvegicus (Rat)",768,"GO:0000152; GO:0003723; GO:0005634; GO:0005737; GO:0006281; GO:0007283; GO:0008270; GO:0016740; GO:0031436; GO:0034599; GO:0042325; GO:0042803; GO:0043065; GO:0043066; GO:0046826; GO:0046982; GO:0070531; GO:0070532; GO:0070533; GO:0071372; GO:0071394; GO:0071479; GO:0085020; GO:1904044","cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxidative stress [GO:0034599]; cellular response to testosterone stimulus [GO:0071394]; DNA repair [GO:0006281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein export from nucleus [GO:0046826]; positive regulation of apoptotic process [GO:0043065]; protein K6-linked ubiquitination [GO:0085020]; regulation of phosphorylation [GO:0042325]; response to aldosterone [GO:1904044]; spermatogenesis [GO:0007283]","BRCA1-A complex [GO:0070531]; BRCA1-B complex [GO:0070532]; BRCA1-BARD1 complex [GO:0031436]; BRCA1-C complex [GO:0070533]; cytoplasm [GO:0005737]; nuclear ubiquitin ligase complex [GO:0000152]; nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxidative stress [GO:0034599]; cellular response to testosterone stimulus [GO:0071394]; DNA repair [GO:0006281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein export from nucleus [GO:0046826]; positive regulation of apoptotic process [GO:0043065]; protein K6-linked ubiquitination [GO:0085020]; regulation of phosphorylation [GO:0042325]; response to aldosterone [GO:1904044]; spermatogenesis [GO:0007283]","","","",""
"1308","sp|G5EEN4|GCK3_CAEEL","lcl|NC_088862.1_cds_XP_034309503.2_50034",3.79e-146,434,"G5EEN4","GCK3_CAEEL","Germinal center kinase 3 (EC 2.7.11.1) (STE20-like serine/threonine kinase)","gck-3 Y59A8B.23","Caenorhabditis elegans",596,"GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006972; GO:0007283; GO:0010628; GO:0019901; GO:0030154; GO:0035556; GO:0050891; GO:0051321; GO:0060562; GO:0071474; GO:0106310","cell differentiation [GO:0030154]; cellular hyperosmotic response [GO:0071474]; epithelial tube morphogenesis [GO:0060562]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; meiotic cell cycle [GO:0051321]; multicellular organismal-level water homeostasis [GO:0050891]; positive regulation of gene expression [GO:0010628]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell differentiation [GO:0030154]; cellular hyperosmotic response [GO:0071474]; epithelial tube morphogenesis [GO:0060562]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; meiotic cell cycle [GO:0051321]; multicellular organismal-level water homeostasis [GO:0050891]; positive regulation of gene expression [GO:0010628]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed at all stages. {ECO:0000269|PubMed:20595048}.","","","TISSUE SPECIFICITY: Ubiquitously expressed with a higher expression in the excretory cell. Expressed in both male and female germ cells; up-regulated in maturing spermatocytes but absent in mature sperm. {ECO:0000269|PubMed:20595048}."
"1309","sp|P56702|DBIL5_RAT","lcl|NC_088862.1_cds_XP_034309625.1_49174",4.92e-20,77.8,"P56702","DBIL5_RAT","Diazepam-binding inhibitor-like 5 (Endozepine-like peptide) (ELP)","Dbil5","Rattus norvegicus (Rat)",87,"GO:0000062; GO:0005737; GO:0006631; GO:0006637; GO:0007283","acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; fatty-acyl-CoA binding [GO:0000062]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Specifically expressed in late haploid male germ cells.","","","TISSUE SPECIFICITY: Testis."
"1310","sp|A1Z9L3|DHX8_DROME","lcl|NC_088862.1_cds_XP_034309636.2_50220",0,1501,"A1Z9L3","DHX8_DROME","ATP-dependent RNA helicase DHX8 (EC 3.6.4.13) (Peanuts)","pea Prp22 CG8241","Drosophila melanogaster (Fruit fly)",1242,"GO:0000381; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0006325; GO:0007419; GO:0016887; GO:0030261; GO:0048477; GO:0071011; GO:0071013","chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; mRNA splicing, via spliceosome [GO:0000398]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; ventral cord development [GO:0007419]","catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; mRNA splicing, via spliceosome [GO:0000398]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; ventral cord development [GO:0007419]","","","",""
"1311","sp|P41183|BCL6_MOUSE","lcl|NC_088862.1_cds_XP_034309932.2_50757",8.68e-42,159,"P41183","BCL6_MOUSE","B-cell lymphoma 6 protein homolog","Bcl6 Bcl-6","Mus musculus (Mouse)",707,"GO:0000122; GO:0000902; GO:0000977; GO:0000978; GO:0001161; GO:0001222; GO:0001227; GO:0001953; GO:0002317; GO:0002467; GO:0002829; GO:0003682; GO:0005634; GO:0005657; GO:0005730; GO:0005794; GO:0006357; GO:0006366; GO:0006954; GO:0006974; GO:0007160; GO:0007266; GO:0007283; GO:0008104; GO:0008270; GO:0008283; GO:0021859; GO:0030036; GO:0030183; GO:0030308; GO:0030890; GO:0031490; GO:0031507; GO:0032764; GO:0032943; GO:0032945; GO:0035024; GO:0042092; GO:0042100; GO:0042129; GO:0042382; GO:0042802; GO:0043065; GO:0043066; GO:0043380; GO:0043565; GO:0045064; GO:0045591; GO:0045629; GO:0045666; GO:0045746; GO:0048289; GO:0048294; GO:0048821; GO:0048870; GO:0050727; GO:0140297; GO:1900099; GO:2000147; GO:2000773","actin cytoskeleton organization [GO:0030036]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cell-matrix adhesion [GO:0007160]; DNA damage response [GO:0006974]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; heterochromatin formation [GO:0031507]; inflammatory response [GO:0006954]; isotype switching to IgE isotypes [GO:0048289]; mononuclear cell proliferation [GO:0032943]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular senescence [GO:2000773]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mononuclear cell proliferation [GO:0032945]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of plasma cell differentiation [GO:1900099]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type 2 immune response [GO:0002829]; plasma cell differentiation [GO:0002317]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell motility [GO:2000147]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein localization [GO:0008104]; pyramidal neuron differentiation [GO:0021859]; regulation of inflammatory response [GO:0050727]; regulation of memory T cell differentiation [GO:0043380]; regulation of T cell proliferation [GO:0042129]; regulation of transcription by RNA polymerase II [GO:0006357]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; T-helper 2 cell differentiation [GO:0045064]; transcription by RNA polymerase II [GO:0006366]; type 2 immune response [GO:0042092]","Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; replication fork [GO:0005657]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270]; actin cytoskeleton organization [GO:0030036]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cell-matrix adhesion [GO:0007160]; DNA damage response [GO:0006974]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; heterochromatin formation [GO:0031507]; inflammatory response [GO:0006954]; isotype switching to IgE isotypes [GO:0048289]; mononuclear cell proliferation [GO:0032943]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular senescence [GO:2000773]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mononuclear cell proliferation [GO:0032945]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of plasma cell differentiation [GO:1900099]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type 2 immune response [GO:0002829]; plasma cell differentiation [GO:0002317]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell motility [GO:2000147]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein localization [GO:0008104]; pyramidal neuron differentiation [GO:0021859]; regulation of inflammatory response [GO:0050727]; regulation of memory T cell differentiation [GO:0043380]; regulation of T cell proliferation [GO:0042129]; regulation of transcription by RNA polymerase II [GO:0006357]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; T-helper 2 cell differentiation [GO:0045064]; transcription by RNA polymerase II [GO:0006366]; type 2 immune response [GO:0042092]","DEVELOPMENTAL STAGE: Detected in the cerebral cortex from 12.5 dpc until birth, with highest levels in the frontal and parietal parts of the neocortex than the occipital parts. {ECO:0000269|PubMed:23160044}.","","","TISSUE SPECIFICITY: Expressed at least in germinal center B-cells of spleen. {ECO:0000269|PubMed:17828269, ECO:0000269|PubMed:23166356}."
"1312","sp|P53563|B2CL1_RAT","lcl|NC_088862.1_cds_XP_034310065.1_48456",8.22e-34,121,"P53563","B2CL1_RAT","Bcl-2-like protein 1 (Bcl2-L-1) (Apoptosis regulator Bcl-X)","Bcl2l1 Bclx Blc2l","Rattus norvegicus (Rat)",233,"GO:0001541; GO:0001666; GO:0001701; GO:0001836; GO:0002931; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005813; GO:0005829; GO:0006897; GO:0006915; GO:0006979; GO:0007005; GO:0007281; GO:0007283; GO:0008021; GO:0008584; GO:0008630; GO:0009314; GO:0009410; GO:0009566; GO:0009615; GO:0010288; GO:0015267; GO:0016020; GO:0019901; GO:0021987; GO:0030276; GO:0030672; GO:0031965; GO:0031966; GO:0032465; GO:0032496; GO:0032946; GO:0034097; GO:0034976; GO:0035234; GO:0036017; GO:0036018; GO:0036466; GO:0040008; GO:0042542; GO:0042802; GO:0042981; GO:0043027; GO:0043065; GO:0043066; GO:0043434; GO:0043524; GO:0044565; GO:0044877; GO:0046898; GO:0046902; GO:0050673; GO:0051020; GO:0051093; GO:0051400; GO:0051402; GO:0051434; GO:0051602; GO:0051881; GO:0071230; GO:0071312; GO:0071320; GO:0071347; GO:0071356; GO:0071456; GO:0071466; GO:0071480; GO:0071549; GO:0071732; GO:0071839; GO:0072347; GO:0090201; GO:0097048; GO:0097136; GO:0097192; GO:0097284; GO:0097371; GO:0098793; GO:1900118; GO:1900242; GO:1900244; GO:1900452; GO:1901029; GO:1902042; GO:1902230; GO:1902236; GO:1903077; GO:1905218; GO:1990646; GO:2000242; GO:2000302; GO:2000669; GO:2000809; GO:2001171; GO:2001243","apoptotic process [GO:0006915]; apoptotic process in bone marrow cell [GO:0071839]; cellular response to alkaloid [GO:0071312]; cellular response to amino acid stimulus [GO:0071230]; cellular response to astaxanthin [GO:1905218]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to erythropoietin [GO:0036018]; cellular response to gamma radiation [GO:0071480]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to nitric oxide [GO:0071732]; cellular response to prolactin [GO:1990646]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; cerebral cortex development [GO:0021987]; dendritic cell apoptotic process [GO:0097048]; dendritic cell proliferation [GO:0044565]; ectopic germ cell programmed cell death [GO:0035234]; endocytosis [GO:0006897]; epithelial cell proliferation [GO:0050673]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fertilization [GO:0009566]; germ cell development [GO:0007281]; hepatocyte apoptotic process [GO:0097284]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; male gonad development [GO:0008584]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of developmental process [GO:0051093]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of reproductive process [GO:2000242]; neuron apoptotic process [GO:0051402]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of mononuclear cell proliferation [GO:0032946]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; regulation of apoptotic process [GO:0042981]; regulation of cytokinesis [GO:0032465]; regulation of growth [GO:0040008]; regulation of long-term synaptic depression [GO:1900452]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of synaptic vesicle endocytosis [GO:1900242]; release of cytochrome c from mitochondria [GO:0001836]; response to anesthetic [GO:0072347]; response to cycloheximide [GO:0046898]; response to cytokine [GO:0034097]; response to electrical stimulus [GO:0051602]; response to endoplasmic reticulum stress [GO:0034976]; response to erythropoietin [GO:0036017]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; response to lead ion [GO:0010288]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; response to peptide hormone [GO:0043434]; response to radiation [GO:0009314]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]; synaptic vesicle recycling via endosome [GO:0036466]","Bcl-2 family protein complex [GO:0097136]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; BH domain binding [GO:0051400]; BH3 domain binding [GO:0051434]; channel activity [GO:0015267]; clathrin binding [GO:0030276]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; apoptotic process [GO:0006915]; apoptotic process in bone marrow cell [GO:0071839]; cellular response to alkaloid [GO:0071312]; cellular response to amino acid stimulus [GO:0071230]; cellular response to astaxanthin [GO:1905218]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to erythropoietin [GO:0036018]; cellular response to gamma radiation [GO:0071480]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to nitric oxide [GO:0071732]; cellular response to prolactin [GO:1990646]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; cerebral cortex development [GO:0021987]; dendritic cell apoptotic process [GO:0097048]; dendritic cell proliferation [GO:0044565]; ectopic germ cell programmed cell death [GO:0035234]; endocytosis [GO:0006897]; epithelial cell proliferation [GO:0050673]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fertilization [GO:0009566]; germ cell development [GO:0007281]; hepatocyte apoptotic process [GO:0097284]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; male gonad development [GO:0008584]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of developmental process [GO:0051093]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of reproductive process [GO:2000242]; neuron apoptotic process [GO:0051402]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of mononuclear cell proliferation [GO:0032946]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; regulation of apoptotic process [GO:0042981]; regulation of cytokinesis [GO:0032465]; regulation of growth [GO:0040008]; regulation of long-term synaptic depression [GO:1900452]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of synaptic vesicle endocytosis [GO:1900242]; release of cytochrome c from mitochondria [GO:0001836]; response to anesthetic [GO:0072347]; response to cycloheximide [GO:0046898]; response to cytokine [GO:0034097]; response to electrical stimulus [GO:0051602]; response to endoplasmic reticulum stress [GO:0034976]; response to erythropoietin [GO:0036017]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; response to lead ion [GO:0010288]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; response to peptide hormone [GO:0043434]; response to radiation [GO:0009314]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]; synaptic vesicle recycling via endosome [GO:0036466]","","","","TISSUE SPECIFICITY: Expressed in most tissues. Bcl-X(beta) is specifically expressed in cerebellum, heart, and thymus. In the ovary, the predominant form is Bcl-X(L), with a small but detectable level of Bcl-X(S)."
"1313","sp|Q9H0H5|RGAP1_HUMAN","lcl|NC_088862.1_cds_XP_034310301.2_50507",3.09e-148,444,"Q9H0H5","RGAP1_HUMAN","Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4)","RACGAP1 KIAA1478 MGCRACGAP","Homo sapiens (Human)",632,"GO:0000281; GO:0000915; GO:0001669; GO:0005096; GO:0005547; GO:0005634; GO:0005654; GO:0005739; GO:0005819; GO:0005829; GO:0005874; GO:0006811; GO:0007266; GO:0007283; GO:0007405; GO:0008017; GO:0008270; GO:0009898; GO:0019901; GO:0030218; GO:0030496; GO:0030674; GO:0032154; GO:0032467; GO:0043014; GO:0043015; GO:0045995; GO:0048487; GO:0051056; GO:0051233; GO:0051256; GO:0051988; GO:0070062; GO:0072686; GO:0090543; GO:0097149; GO:1902358","actomyosin contractile ring assembly [GO:0000915]; erythrocyte differentiation [GO:0030218]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; monoatomic ion transport [GO:0006811]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; sulfate transmembrane transport [GO:1902358]","acrosomal vesicle [GO:0001669]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; zinc ion binding [GO:0008270]; actomyosin contractile ring assembly [GO:0000915]; erythrocyte differentiation [GO:0030218]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; monoatomic ion transport [GO:0006811]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; sulfate transmembrane transport [GO:1902358]","","INDUCTION: Expression is down-regulated during macrophage differention of HL-60 cells. {ECO:0000269|PubMed:10979956}.","INDUCTION: Expression is down-regulated during macrophage differention of HL-60 cells. {ECO:0000269|PubMed:10979956}.","TISSUE SPECIFICITY: Highly expressed in testis, thymus and placenta. Expressed at lower levels in spleen and peripheral blood lymphocytes. In testis, expression is restricted to germ cells with the highest levels of expression found in spermatocytes. Expression is regulated in a cell cycle-dependent manner and peaks during G2/M phase. {ECO:0000269|PubMed:10979956, ECO:0000269|PubMed:11278976, ECO:0000269|PubMed:12590651, ECO:0000269|PubMed:9497316}."
"1314","sp|Q8N9W6|BOLL_HUMAN","lcl|NC_088862.1_cds_XP_034310512.2_49022",1.79e-47,166,"Q8N9W6","BOLL_HUMAN","Protein boule-like","BOLL BOULE","Homo sapiens (Human)",283,"GO:0003730; GO:0005737; GO:0007283; GO:0008494; GO:0030154; GO:0042802; GO:0045948; GO:0051321; GO:0070935","3'-UTR-mediated mRNA stabilization [GO:0070935]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; positive regulation of translational initiation [GO:0045948]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; translation activator activity [GO:0008494]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; positive regulation of translational initiation [GO:0045948]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Testis specific. Not expressed in early embryos, primordial germ cells and spermatogonial cells. First expressed in the cytoplasm of spermatocytes and then persists through meiosis. {ECO:0000269|PubMed:11390979, ECO:0000269|PubMed:17114206}."
"1315","sp|O44386|ITA3_DROME","lcl|NC_088862.1_cds_XP_034310648.2_49409",2.56e-53,205,"O44386","ITA3_DROME","Integrin alpha-PS3 (Position-specific antigen subunit alpha-3) (Protein scab) (Protein volado) [Cleaved into: Integrin alpha-PS3 heavy chain; Integrin alpha-PS3 light chain]","scb alphaPS3 Vol CG8095","Drosophila melanogaster (Fruit fly)",1115,"GO:0001555; GO:0003344; GO:0005178; GO:0005737; GO:0005925; GO:0006909; GO:0007157; GO:0007160; GO:0007229; GO:0007391; GO:0007411; GO:0007431; GO:0007494; GO:0007508; GO:0007613; GO:0007614; GO:0008305; GO:0009897; GO:0009925; GO:0016020; GO:0016324; GO:0016328; GO:0016477; GO:0030336; GO:0033627; GO:0035001; GO:0042060; GO:0043277; GO:0045886; GO:0046982; GO:0048149; GO:0098609","apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; behavioral response to ethanol [GO:0048149]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; memory [GO:0007613]; midgut development [GO:0007494]; negative regulation of cell migration [GO:0030336]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; oocyte growth [GO:0001555]; pericardium morphogenesis [GO:0003344]; phagocytosis [GO:0006909]; salivary gland development [GO:0007431]; short-term memory [GO:0007614]; wound healing [GO:0042060]","apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; behavioral response to ethanol [GO:0048149]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; memory [GO:0007613]; midgut development [GO:0007494]; negative regulation of cell migration [GO:0030336]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; oocyte growth [GO:0001555]; pericardium morphogenesis [GO:0003344]; phagocytosis [GO:0006909]; salivary gland development [GO:0007431]; short-term memory [GO:0007614]; wound healing [GO:0042060]","DEVELOPMENTAL STAGE: Expressed throughout development. Highest expression is observed in pupae (at protein level). During oogenesis, expressed from stage 10B onwards. {ECO:0000269|PubMed:19035354, ECO:0000269|PubMed:23426364}.","","","TISSUE SPECIFICITY: Expressed in embryonic and larval hemocytes (at protein level). Expressed in tissues undergoing invagination, tissue movement and morphogenesis such as salivary gland, trachea, midgut endoderm, dorsal vessel, midline of the ventral nerve cord, amnioserosa and the amnioproctodeal invagination. Expressed in the mushroom body neuropil, brain areas that contain mushroom body processes in synaptic contact with other neurons. In egg chambers, expressed in border cells, in stretch cells and in dorsal appendage primordia. {ECO:0000269|PubMed:15469969, ECO:0000269|PubMed:19035354, ECO:0000269|PubMed:23426364, ECO:0000269|PubMed:9409675, ECO:0000269|PubMed:9461212}."
"1316","sp|P12080|ITA2_DROME","lcl|NC_088862.1_cds_XP_034310649.2_49410",1.31e-139,458,"P12080","ITA2_DROME","Integrin alpha-PS2 (Position-specific antigen subunit alpha-2) (Protein inflated) [Cleaved into: Integrin alpha-PS2 heavy chain; Integrin alpha-PS2 light chain]","if CG9623","Drosophila melanogaster (Fruit fly)",1396,"GO:0005178; GO:0005886; GO:0005925; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007411; GO:0007414; GO:0007419; GO:0007431; GO:0007435; GO:0007475; GO:0007476; GO:0007494; GO:0007608; GO:0008305; GO:0009897; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016477; GO:0021551; GO:0030239; GO:0033627; GO:0034446; GO:0035099; GO:0035160; GO:0042383; GO:0045185; GO:0045214; GO:0046982; GO:0050840; GO:0051492; GO:0098609","apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; border follicle cell migration [GO:0007298]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; central nervous system morphogenesis [GO:0021551]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived wing morphogenesis [GO:0007476]; integrin-mediated signaling pathway [GO:0007229]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; maintenance of protein location [GO:0045185]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; myofibril assembly [GO:0030239]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; ventral cord development [GO:0007419]","apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; border follicle cell migration [GO:0007298]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; central nervous system morphogenesis [GO:0021551]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived wing morphogenesis [GO:0007476]; integrin-mediated signaling pathway [GO:0007229]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; maintenance of protein location [GO:0045185]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; myofibril assembly [GO:0030239]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; ventral cord development [GO:0007419]","DEVELOPMENTAL STAGE: Expressed throughout embryonic and larval development with peaks of expression during mid-embryogenesis and at third larval instar (at protein level). The relative ratio of isoform 1/PS2C and isoform 2/PS2M8 varies widely during development. {ECO:0000269|PubMed:2507168, ECO:0000269|PubMed:2961459, ECO:0000269|PubMed:8240969}.","","","TISSUE SPECIFICITY: In ovaries, highly expressed in follicle cells. At syncytial blastoderm stage, expressed in the embryonic mesodermal precursors but not in the ectoderm. At embryonic stages 7 and 10, expression is restricted to the mesoderm. At stage 12, expressed in the gonadal sheath and the interstitial cells of the gonad. In stage 16 embryos, expressed in the somatic and visceral muscles where localizes to sites of attachment between adjacent muscles. In third larval instar wing imaginal disk, expressed in the ventral compartment and in a subset of adepithelial and peripodial cells (at protein level). {ECO:0000269|PubMed:15469969, ECO:0000269|PubMed:19035354, ECO:0000269|PubMed:2961459, ECO:0000269|PubMed:8240969}."
"1317","sp|Q9V7A4|ITA4_DROME","lcl|NC_088862.1_cds_XP_034310650.2_49408",1.17e-46,184,"Q9V7A4","ITA4_DROME","Integrin alpha-PS4 (Position-specific antigen subunit alpha-4)","ItgaPS4 alphaPS4 ItgalphaPS4 CG16827","Drosophila melanogaster (Fruit fly)",1069,"GO:0001555; GO:0005178; GO:0007157; GO:0007160; GO:0007229; GO:0008305; GO:0009897; GO:0016020; GO:0033627; GO:0046982; GO:0098609","cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; integrin-mediated signaling pathway [GO:0007229]; oocyte growth [GO:0001555]","external side of plasma membrane [GO:0009897]; integrin complex [GO:0008305]; membrane [GO:0016020]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; integrin-mediated signaling pathway [GO:0007229]; oocyte growth [GO:0001555]","DEVELOPMENTAL STAGE: Weakly expressed during late-oogenesis. {ECO:0000269|PubMed:19035354}.","","","TISSUE SPECIFICITY: Expressed in lamellocytes (at protein level). At the anterior end of the oocyte, expressed in the follicle cells that will form the operculum and the micropyle. {ECO:0000269|PubMed:19035354, ECO:0000269|PubMed:20689801, ECO:0000269|PubMed:21124962}."
"1318","sp|P32215|PACR_RAT","lcl|NC_088862.1_cds_XP_034310695.1_49346",6.2e-64,218,"P32215","PACR_RAT","Pituitary adenylate cyclase-activating polypeptide type I receptor (PACAP type I receptor) (PACAP-R-1) (PACAP-R1)","Adcyap1r1","Rattus norvegicus (Rat)",523,"GO:0000139; GO:0001634; GO:0004999; GO:0005768; GO:0005886; GO:0005901; GO:0005923; GO:0007166; GO:0007188; GO:0007189; GO:0007283; GO:0008179; GO:0008528; GO:0009410; GO:0009986; GO:0010524; GO:0017046; GO:0030154; GO:0031267; GO:0032355; GO:0033555; GO:0042923; GO:0043235; GO:0045471; GO:0046545; GO:0051057; GO:0060732; GO:0141156; GO:0141163; GO:1901032","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP/PKA signal transduction [GO:0141156]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; development of primary female sexual characteristics [GO:0046545]; multicellular organismal response to stress [GO:0033555]; negative regulation of response to reactive oxygen species [GO:1901032]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cAMP/PKA signal transduction [GO:0141163]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]","bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell surface [GO:0009986]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; adenylate cyclase binding [GO:0008179]; G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046]; pituitary adenylate cyclase-activating polypeptide receptor activity [GO:0001634]; small GTPase binding [GO:0031267]; vasoactive intestinal polypeptide receptor activity [GO:0004999]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP/PKA signal transduction [GO:0141156]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; development of primary female sexual characteristics [GO:0046545]; multicellular organismal response to stress [GO:0033555]; negative regulation of response to reactive oxygen species [GO:1901032]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cAMP/PKA signal transduction [GO:0141163]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Hypothalamus, anterior pituitary, adrenal medulla, testicular germ cells."
"1319","sp|Q7Z4T8|GLTL5_HUMAN","lcl|NC_088862.1_cds_XP_034317695.2_49546",7.36e-120,363,"Q7Z4T8","GLTL5_HUMAN","Inactive polypeptide N-acetylgalactosaminyltransferase-like protein 5 (Polypeptide GalNAc transferase 15) (GalNAc-T15) (pp-GaNTase 15) (Protein-UDP acetylgalactosaminyltransferase 15) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 15)","GALNTL5 GALNT15","Homo sapiens (Human)",443,"GO:0005794; GO:0007286; GO:0031902; GO:0046872","spermatid development [GO:0007286]","Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; metal ion binding [GO:0046872]; spermatid development [GO:0007286]","","","","TISSUE SPECIFICITY: Mainly expressed in testis. Weakly or not expressed in other tissues. {ECO:0000269|PubMed:24398516}."
"1320","sp|Q8BLA1|DLEC1_MOUSE","lcl|NC_088862.1_cds_XP_034317814.2_49438",8.67e-121,395,"Q8BLA1","DLEC1_MOUSE","Deleted in lung and esophageal cancer protein 1 homolog","Dlec1","Mus musculus (Mouse)",635,"GO:0005737; GO:0007283; GO:0008285; GO:0030154","cell differentiation [GO:0030154]; negative regulation of cell population proliferation [GO:0008285]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; cell differentiation [GO:0030154]; negative regulation of cell population proliferation [GO:0008285]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expression begins at postnatal day 20 (P20) and reaches a mximum at P25 in the testis (at protein level). {ECO:0000269|PubMed:33144677}.","","","TISSUE SPECIFICITY: Expressed in germ cells of the testis (at protein level) (PubMed:33144677). Also expressed in the lung and kidney (PubMed:33144677). {ECO:0000269|PubMed:33144677}."
"1321","sp|Q9Y238|DLEC1_HUMAN","lcl|NC_088862.1_cds_XP_034317816.2_49439",0,981,"Q9Y238","DLEC1_HUMAN","Deleted in lung and esophageal cancer protein 1 (Deleted in lung cancer protein 1) (DLC-1)","DLEC1 DLC1","Homo sapiens (Human)",1755,"GO:0002357; GO:0005737; GO:0005829; GO:0005929; GO:0007283; GO:0008285; GO:0015631; GO:0030154; GO:0043014; GO:0048487","cell differentiation [GO:0030154]; defense response to tumor cell [GO:0002357]; negative regulation of cell population proliferation [GO:0008285]; spermatogenesis [GO:0007283]","cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; tubulin binding [GO:0015631]; cell differentiation [GO:0030154]; defense response to tumor cell [GO:0002357]; negative regulation of cell population proliferation [GO:0008285]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in all tissues examined. Expression is highest in prostate and testis. {ECO:0000269|PubMed:10213508}."
"1322","sp|Q9R157|ADA18_MOUSE","lcl|NC_088862.1_cds_XP_034318336.2_51029",1.68e-66,240,"Q9R157","ADA18_MOUSE","Disintegrin and metalloproteinase domain-containing protein 18 (ADAM 18) (Disintegrin and metalloproteinase domain-containing protein 27) (ADAM 27) (Transmembrane metalloproteinase-like, disintegrin-like, and cysteine-rich protein III) (tMDC III)","Adam18 Adam27 Dtgn3 Tmdc3","Mus musculus (Mouse)",719,"GO:0004222; GO:0005178; GO:0006508; GO:0007283; GO:0016020; GO:0030154","cell differentiation [GO:0030154]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]","membrane [GO:0016020]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; cell differentiation [GO:0030154]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Adult levels are reached by day 16 after birth.","","","TISSUE SPECIFICITY: Expressed specifically in testis."
"1323","sp|P27605|HPRT_RAT","lcl|NC_088862.1_cds_XP_034318342.1_51024",2.35e-105,304,"P27605","HPRT_RAT","Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) (HGPRTase) (EC 2.4.2.8)","Hprt1 Hprt","Rattus norvegicus (Rat)",218,"GO:0000166; GO:0000287; GO:0001913; GO:0001975; GO:0004422; GO:0005737; GO:0005829; GO:0006164; GO:0006166; GO:0006178; GO:0007283; GO:0007625; GO:0007626; GO:0021756; GO:0021895; GO:0021954; GO:0032263; GO:0032264; GO:0032869; GO:0042417; GO:0042802; GO:0043103; GO:0044209; GO:0045964; GO:0046038; GO:0046040; GO:0046083; GO:0046100; GO:0046651; GO:0048813; GO:0051289; GO:0052657; GO:0071542","adenine metabolic process [GO:0046083]; AMP salvage [GO:0044209]; cellular response to insulin stimulus [GO:0032869]; central nervous system neuron development [GO:0021954]; cerebral cortex neuron differentiation [GO:0021895]; dendrite morphogenesis [GO:0048813]; dopamine metabolic process [GO:0042417]; dopaminergic neuron differentiation [GO:0071542]; GMP catabolic process [GO:0046038]; GMP salvage [GO:0032263]; grooming behavior [GO:0007625]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; locomotory behavior [GO:0007626]; lymphocyte proliferation [GO:0046651]; positive regulation of dopamine metabolic process [GO:0045964]; protein homotetramerization [GO:0051289]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166]; response to amphetamine [GO:0001975]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; T cell mediated cytotoxicity [GO:0001913]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; adenine metabolic process [GO:0046083]; AMP salvage [GO:0044209]; cellular response to insulin stimulus [GO:0032869]; central nervous system neuron development [GO:0021954]; cerebral cortex neuron differentiation [GO:0021895]; dendrite morphogenesis [GO:0048813]; dopamine metabolic process [GO:0042417]; dopaminergic neuron differentiation [GO:0071542]; GMP catabolic process [GO:0046038]; GMP salvage [GO:0032263]; grooming behavior [GO:0007625]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; locomotory behavior [GO:0007626]; lymphocyte proliferation [GO:0046651]; positive regulation of dopamine metabolic process [GO:0045964]; protein homotetramerization [GO:0051289]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166]; response to amphetamine [GO:0001975]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; T cell mediated cytotoxicity [GO:0001913]","","","",""
"1324","sp|Q4G0U5|PCDP1_HUMAN","lcl|NC_088862.1_cds_XP_034318430.2_48599",0,562,"Q4G0U5","PCDP1_HUMAN","Cilia- and flagella-associated protein 221 (Primary ciliary dyskinesia protein 1)","CFAP221 PCDP1","Homo sapiens (Human)",840,"GO:0002177; GO:0005516; GO:0005576; GO:0005737; GO:0005929; GO:0005930; GO:0036126; GO:0044458; GO:0051649; GO:0060271; GO:0090660; GO:0097386; GO:0097729; GO:0120197; GO:0120316","cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; establishment of localization in cell [GO:0051649]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; sperm flagellum assembly [GO:0120316]","9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; manchette [GO:0002177]; sperm flagellum [GO:0036126]; calmodulin binding [GO:0005516]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; establishment of localization in cell [GO:0051649]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; sperm flagellum assembly [GO:0120316]","","","","TISSUE SPECIFICITY: Expressed in ciliated respiratory epithelial cells and brain ependymal cells (at protein level). {ECO:0000269|PubMed:18039845}."
"1325","sp|P11584|ITBX_DROME","lcl|NC_088862.1_cds_XP_065928671.1_50200",0,625,"P11584","ITBX_DROME","Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)","mys l(1)mys olfC CG1560","Drosophila melanogaster (Fruit fly)",846,"GO:0003344; GO:0005178; GO:0005886; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007419; GO:0007431; GO:0007476; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0009986; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016477; GO:0021551; GO:0030336; GO:0030425; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0042734; GO:0043034; GO:0045211; GO:0045214; GO:0046982; GO:0048803; GO:0051492; GO:0090129; GO:0098609","actin filament organization [GO:0007015]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing morphogenesis [GO:0007476]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]","apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; actin filament organization [GO:0007015]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing morphogenesis [GO:0007476]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]","DEVELOPMENTAL STAGE: During stage 9-10 of oogenesis expressed in migrating border cell clusters. {ECO:0000269|PubMed:38283991}.","","","TISSUE SPECIFICITY: In ovaries, strongly expressed in follicle cells (PubMed:19035354). In oocytes, expressed in the forming dorsal appendages (at protein level) (PubMed:19035354). Expressed in the embryonic dorsal cuticle, the larval eye and the wing imaginal disk (PubMed:8119134). In testes, detected at the interface between somatic hub cells and cyst stem cells (PubMed:27191715). {ECO:0000269|PubMed:19035354, ECO:0000269|PubMed:27191715, ECO:0000269|PubMed:8119134}."
"1326","sp|O55047|TLK2_MOUSE","lcl|NC_088862.1_cds_XP_065928773.1_50734",0,691,"O55047","TLK2_MOUSE","Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (PKU-alpha) (Tousled-like kinase 2)","Tlk2 Tlk","Mus musculus (Mouse)",718,"GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005882; GO:0006325; GO:0006468; GO:0006974; GO:0007059; GO:0007283; GO:0018105; GO:0030154; GO:0032435; GO:0035556; GO:0044325; GO:0048471; GO:0106310; GO:1902275","cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; intracellular signal transduction [GO:0035556]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of chromatin organization [GO:1902275]; spermatogenesis [GO:0007283]","intermediate filament [GO:0005882]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transmembrane transporter binding [GO:0044325]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; intracellular signal transduction [GO:0035556]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of chromatin organization [GO:1902275]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Ubiquitously expressed in all tissues examined, with high levels in heart and testis, in particular the pachytene spermatocytes and in round spermatids. Some evidence for the existence of a testis-specific isoform suggesting a role in spermatogenesis. {ECO:0000269|PubMed:10092119, ECO:0000269|PubMed:10455159, ECO:0000269|PubMed:10523312, ECO:0000303|PubMed:10092119}."
"1327","sp|Q17390|CUL2_CAEEL","lcl|NC_088862.1_cds_XP_065928794.1_49558",0,588,"Q17390","CUL2_CAEEL","Cullin-2 (CUL-2)","cul-2 ccd-3 div-3 ZK520.4","Caenorhabditis elegans",791,"GO:0005634; GO:0005737; GO:0008104; GO:0008595; GO:0016567; GO:0019005; GO:0019100; GO:0019102; GO:0030238; GO:0030261; GO:0030674; GO:0031145; GO:0031146; GO:0031462; GO:0031625; GO:0042078; GO:0043161; GO:0051232; GO:0051759; GO:1902104","anaphase-promoting complex-dependent catabolic process [GO:0031145]; anterior/posterior axis specification, embryo [GO:0008595]; chromosome condensation [GO:0030261]; germ-line stem cell division [GO:0042078]; male germ-line sex determination [GO:0019100]; male sex determination [GO:0030238]; male somatic sex determination [GO:0019102]; meiotic spindle elongation [GO:0051232]; positive regulation of metaphase/anaphase transition of meiotic cell cycle [GO:1902104]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromosome movement towards spindle pole involved in meiotic sister chromatid segregation [GO:0051759]","Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; anterior/posterior axis specification, embryo [GO:0008595]; chromosome condensation [GO:0030261]; germ-line stem cell division [GO:0042078]; male germ-line sex determination [GO:0019100]; male sex determination [GO:0030238]; male somatic sex determination [GO:0019102]; meiotic spindle elongation [GO:0051232]; positive regulation of metaphase/anaphase transition of meiotic cell cycle [GO:1902104]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromosome movement towards spindle pole involved in meiotic sister chromatid segregation [GO:0051759]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. Highest levels in embryos and lower levels in larvae and adults. {ECO:0000269|PubMed:10587644}.","","","TISSUE SPECIFICITY: In adults, highly expressed in meiotic cells and oocytes. In larvae, expressed in many proliferating cell types: P cells during the L1 stage; seam cells when they divide at every molt; vulval and somatic gonad cells in late L3 and L4 stages; and intestinal cells throughout larval development. {ECO:0000269|PubMed:10587644}."
"1328","sp|P40692|MLH1_HUMAN","lcl|NC_088862.1_cds_XP_065928956.1_48591",0,913,"P40692","MLH1_HUMAN","DNA mismatch repair protein Mlh1 (MutL protein homolog 1)","MLH1 COCA2","Homo sapiens (Human)",756,"GO:0000289; GO:0000712; GO:0000795; GO:0001673; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005712; GO:0005715; GO:0006298; GO:0006303; GO:0007060; GO:0007129; GO:0007283; GO:0008047; GO:0008630; GO:0009617; GO:0016020; GO:0016321; GO:0016446; GO:0016887; GO:0019899; GO:0032137; GO:0032389; GO:0043060; GO:0045141; GO:0045190; GO:0045950; GO:0048298; GO:0048304; GO:0048477; GO:0051257; GO:0140664","double-strand break repair via nonhomologous end joining [GO:0006303]; female meiosis chromosome segregation [GO:0016321]; homologous chromosome pairing at meiosis [GO:0007129]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; male meiosis chromosome segregation [GO:0007060]; meiotic metaphase I homologous chromosome alignment [GO:0043060]; meiotic spindle midzone assembly [GO:0051257]; meiotic telomere clustering [GO:0045141]; mismatch repair [GO:0006298]; negative regulation of mitotic recombination [GO:0045950]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oogenesis [GO:0048477]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; resolution of meiotic recombination intermediates [GO:0000712]; response to bacterium [GO:0009617]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spermatogenesis [GO:0007283]","chiasma [GO:0005712]; chromosome [GO:0005694]; late recombination nodule [GO:0005715]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; chromatin binding [GO:0003682]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; double-strand break repair via nonhomologous end joining [GO:0006303]; female meiosis chromosome segregation [GO:0016321]; homologous chromosome pairing at meiosis [GO:0007129]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; male meiosis chromosome segregation [GO:0007060]; meiotic metaphase I homologous chromosome alignment [GO:0043060]; meiotic spindle midzone assembly [GO:0051257]; meiotic telomere clustering [GO:0045141]; mismatch repair [GO:0006298]; negative regulation of mitotic recombination [GO:0045950]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oogenesis [GO:0048477]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; resolution of meiotic recombination intermediates [GO:0000712]; response to bacterium [GO:0009617]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Colon, lymphocytes, breast, lung, spleen, testis, prostate, thyroid, gall bladder and heart."
"1329","sp|Q70FJ1|AKAP9_MOUSE","lcl|NC_088862.1_cds_XP_065929011.1_50999",7.75e-40,166,"Q70FJ1","AKAP9_MOUSE","A-kinase anchor protein 9 (AKAP-9) (Protein kinase A-anchoring protein 9) (PRKA9)","Akap9 Kiaa0803","Mus musculus (Mouse)",3797,"GO:0000242; GO:0005737; GO:0005794; GO:0005795; GO:0005813; GO:0007020; GO:0007165; GO:0007283; GO:0031503; GO:0034237; GO:0034705; GO:0036064; GO:0051661; GO:0060009; GO:0060090; GO:0097386; GO:0097729; GO:0120219; GO:1903358","maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; protein-containing complex localization [GO:0031503]; regulation of Golgi organization [GO:1903358]; Sertoli cell development [GO:0060009]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]","9+2 motile cilium [GO:0097729]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; glial cell projection [GO:0097386]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; pericentriolar material [GO:0000242]; potassium channel complex [GO:0034705]; subapical part of cell [GO:0120219]; molecular adaptor activity [GO:0060090]; protein kinase A regulatory subunit binding [GO:0034237]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; protein-containing complex localization [GO:0031503]; regulation of Golgi organization [GO:1903358]; Sertoli cell development [GO:0060009]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]","","","",""
"1330","sp|Q00449|MDR49_DROME","lcl|NC_088862.1_cds_XP_065929064.1_50174",0,959,"Q00449","MDR49_DROME","Multidrug resistance protein homolog 49 (EC 7.6.2.2) (P-glycoprotein 49)","Mdr49 CG3879","Drosophila melanogaster (Fruit fly)",1302,"GO:0001666; GO:0005524; GO:0005886; GO:0006855; GO:0008354; GO:0008559; GO:0009636; GO:0015562; GO:0016020; GO:0016887; GO:0017085; GO:0042626; GO:0042908; GO:0042910; GO:0043190; GO:0055085; GO:0097254","germ cell migration [GO:0008354]; renal tubular secretion [GO:0097254]; response to hypoxia [GO:0001666]; response to insecticide [GO:0017085]; response to toxic substance [GO:0009636]; transmembrane transport [GO:0055085]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908]","ATP-binding cassette (ABC) transporter complex [GO:0043190]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; xenobiotic transmembrane transporter activity [GO:0042910]; germ cell migration [GO:0008354]; renal tubular secretion [GO:0097254]; response to hypoxia [GO:0001666]; response to insecticide [GO:0017085]; response to toxic substance [GO:0009636]; transmembrane transport [GO:0055085]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908]","","","",""
"1331","sp|B0CM26|CFA69_PAPAN","lcl|NC_088862.1_cds_XP_065929080.1_49991",0,835,"B0CM26","CFA69_PAPAN","Cilia- and flagella-associated protein 69","CFAP69","Papio anubis (Olive baboon)",941,"GO:0005737; GO:0007283; GO:0007608; GO:0030154; GO:0042048; GO:0097225; GO:0097730; GO:1902093; GO:1905516; GO:1990834","cell differentiation [GO:0030154]; olfactory behavior [GO:0042048]; positive regulation of fertilization [GO:1905516]; positive regulation of flagellated sperm motility [GO:1902093]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; sperm midpiece [GO:0097225]; cell differentiation [GO:0030154]; olfactory behavior [GO:0042048]; positive regulation of fertilization [GO:1905516]; positive regulation of flagellated sperm motility [GO:1902093]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; spermatogenesis [GO:0007283]","","","",""
"1332","sp|Q924M5|BOLL_MOUSE","lcl|NC_088862.1_cds_XP_065929081.1_49024",1.12e-43,156,"Q924M5","BOLL_MOUSE","Protein boule-like","Boll Boule","Mus musculus (Mouse)",293,"GO:0003723; GO:0005737; GO:0007283; GO:0008494; GO:0030154; GO:0042802; GO:0045948; GO:0051321","cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; positive regulation of translational initiation [GO:0045948]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; positive regulation of translational initiation [GO:0045948]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: First expressed in stage III spermatocytes and peaks in late pachytene or diplotene stage spermatocytes. Expressed in secondary spermatocytes and early spermatids, then decreases until it is undetectable in spermatids. {ECO:0000269|PubMed:11390979}.","","","TISSUE SPECIFICITY: Testis specific. Not expressed in early embryos, primoridal germ cells and spermatogonial cells. First expressed in the cytoplasm of spermatocytes and then persists through meiosis. {ECO:0000269|PubMed:11390979}."
"1333","sp|Q24207|BOULE_DROME","lcl|NC_088862.1_cds_XP_065929082.1_49025",7.93e-33,124,"Q24207","BOULE_DROME","Protein boule","bol CG4760","Drosophila melanogaster (Fruit fly)",228,"GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0006417; GO:0008315; GO:0008494; GO:0030154; GO:0043204; GO:0045924; GO:0045948; GO:0048137; GO:0070935","3'-UTR-mediated mRNA stabilization [GO:0070935]; cell differentiation [GO:0030154]; G2/MI transition of meiotic cell cycle [GO:0008315]; positive regulation of translational initiation [GO:0045948]; regulation of female receptivity [GO:0045924]; regulation of translation [GO:0006417]; spermatocyte division [GO:0048137]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; perikaryon [GO:0043204]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cell differentiation [GO:0030154]; G2/MI transition of meiotic cell cycle [GO:0008315]; positive regulation of translational initiation [GO:0045948]; regulation of female receptivity [GO:0045924]; regulation of translation [GO:0006417]; spermatocyte division [GO:0048137]","DEVELOPMENTAL STAGE: Not expressed in embryos. Expressed in larvae, pupae and adult males. Expressed during spermatogenesis. {ECO:0000269|PubMed:8657280}.","","","TISSUE SPECIFICITY: Testis specific. {ECO:0000269|PubMed:8657280}."
"1334","sp|P40809|RG84C_DROME","lcl|NC_088862.1_cds_XP_065929298.1_50511",5.88e-50,178,"P40809","RG84C_DROME","GTPase-activating protein RacGAP84C (Protein rotund RacGAP)","RacGAP84C rnRacGAP CG2595","Drosophila melanogaster (Fruit fly)",384,"GO:0000281; GO:0001745; GO:0005085; GO:0005096; GO:0005634; GO:0007266; GO:0007283; GO:0008270; GO:0030154; GO:0030496; GO:0031267; GO:0032154; GO:0051233; GO:0051256; GO:0097149","cell differentiation [GO:0030154]; compound eye morphogenesis [GO:0001745]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]","centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; compound eye morphogenesis [GO:0001745]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expressed during spermatogenesis, in primary spermatocytes and imaginal disk morphogenesis. {ECO:0000269|PubMed:1406685}.","","","TISSUE SPECIFICITY: In pupae, expressed in imaginal disks and only in the male gonad. In adults; isoform 1 is the predominant form in the testes and is expressed at a low level in the ovary and somatic tissues, and isoform 2 is very weakly expressed and is detectable solely in the testes. {ECO:0000269|PubMed:1406685, ECO:0000269|PubMed:8654933}."
"1335","sp|P70419|GALT3_MOUSE","lcl|NC_088862.1_cds_XP_065929358.1_50140",7.74e-156,464,"P70419","GALT3_MOUSE","Polypeptide N-acetylgalactosaminyltransferase 3 (EC 2.4.1.41) (Polypeptide GalNAc transferase 3) (GalNAc-T3) (pp-GaNTase 3) (Protein-UDP acetylgalactosaminyltransferase 3) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3)","Galnt3","Mus musculus (Mouse)",633,"GO:0001958; GO:0002063; GO:0004653; GO:0005509; GO:0005976; GO:0006493; GO:0006915; GO:0007283; GO:0010467; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0032580; GO:0035264; GO:0048469; GO:0048471; GO:0050650; GO:0060173","apoptotic process [GO:0006915]; cell maturation [GO:0048469]; chondrocyte development [GO:0002063]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; endochondral ossification [GO:0001958]; gene expression [GO:0010467]; limb development [GO:0060173]; multicellular organism growth [GO:0035264]; polysaccharide metabolic process [GO:0005976]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]; spermatogenesis [GO:0007283]","Golgi cisterna membrane [GO:0032580]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; apoptotic process [GO:0006915]; cell maturation [GO:0048469]; chondrocyte development [GO:0002063]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; endochondral ossification [GO:0001958]; gene expression [GO:0010467]; limb development [GO:0060173]; multicellular organism growth [GO:0035264]; polysaccharide metabolic process [GO:0005976]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Highly expressed in the reproductive tract, principally in the testis and uterus, and to a lesser degree in the cervix with only trace levels in the ovary. Also expressed at high level in sublingual gland, stomach and colon, with more moderate amounts present in the submandibular and parotid gland as well as the kidney. {ECO:0000269|PubMed:8912633}."
"1336","sp|Q9D5U8|CNBD2_MOUSE","lcl|NC_088862.1_cds_XP_065929418.1_49358",4.41e-23,105,"Q9D5U8","CNBD2_MOUSE","Cyclic nucleotide-binding domain-containing protein 2 (Cyclic nucleotide receptor involved in sperm function)","Cnbd2 Cris","Mus musculus (Mouse)",673,"GO:0005829; GO:0007283; GO:0030552","spermatogenesis [GO:0007283]","cytosol [GO:0005829]; cAMP binding [GO:0030552]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Testis-specific. Exclusively expressed in testicular germ cells while it is not present in mature sperm (at protein level). {ECO:0000269|PubMed:24339785}."
"1337","sp|P54619|AAKG1_HUMAN","lcl|NC_088862.1_cds_XP_065929569.1_48734",4.65e-138,404,"P54619","AAKG1_HUMAN","5'-AMP-activated protein kinase subunit gamma-1 (AMPK gamma1) (AMPK subunit gamma-1) (AMPKg)","PRKAG1","Homo sapiens (Human)",331,"GO:0004679; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006110; GO:0006468; GO:0006633; GO:0007165; GO:0007283; GO:0008603; GO:0016020; GO:0016208; GO:0019887; GO:0019901; GO:0031588; GO:0031669; GO:0042149; GO:0043531; GO:0043609; GO:0044877; GO:0045722; GO:0045860; GO:0051170; GO:0051726","cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; import into nucleus [GO:0051170]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468]; regulation of carbon utilization [GO:0043609]; regulation of cell cycle [GO:0051726]; regulation of glycolytic process [GO:0006110]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cAMP-dependent protein kinase regulator activity [GO:0008603]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877]; cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; import into nucleus [GO:0051170]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468]; regulation of carbon utilization [GO:0043609]; regulation of cell cycle [GO:0051726]; regulation of glycolytic process [GO:0006110]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]","","","",""
"1338","sp|Q20402|EGG3_CAEEL","lcl|NC_088862.1_cds_XP_065929594.1_48613",1.16e-15,82,"Q20402","EGG3_CAEEL","Protein tyrosine phosphatase-like protein egg-3 (Egg sterile protein 3)","egg-3 F44F4.2","Caenorhabditis elegans",555,"GO:0001556; GO:0004725; GO:0005938; GO:0019901; GO:0030703; GO:0030866; GO:0040038; GO:1904778","cortical actin cytoskeleton organization [GO:0030866]; eggshell formation [GO:0030703]; oocyte maturation [GO:0001556]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of protein localization to cell cortex [GO:1904778]","cell cortex [GO:0005938]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cortical actin cytoskeleton organization [GO:0030866]; eggshell formation [GO:0030703]; oocyte maturation [GO:0001556]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of protein localization to cell cortex [GO:1904778]","DEVELOPMENTAL STAGE: Expressed in oocytes during meiosis I and II followed by proteasomal degradation at the 1-cell and 2-cell embryonic stages (at protein level). {ECO:0000269|PubMed:17869113, ECO:0000269|PubMed:19879842}.","","",""
"1339","sp|Q7T3H1|DCTN2_DANRE","lcl|NC_088862.1_cds_XP_065929703.1_49616",2.94e-109,328,"Q7T3H1","DCTN2_DANRE","Dynactin subunit 2","dctn2","Danio rerio (Zebrafish) (Brachydanio rerio)",405,"GO:0001754; GO:0005737; GO:0005813; GO:0005869; GO:0005874; GO:0007052; GO:0007097; GO:0010001; GO:0016020; GO:0030286; GO:0030719; GO:0031982; GO:0035088; GO:0045494; GO:0060117","auditory receptor cell development [GO:0060117]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; eye photoreceptor cell differentiation [GO:0001754]; glial cell differentiation [GO:0010001]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P granule organization [GO:0030719]; photoreceptor cell maintenance [GO:0045494]","centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; membrane [GO:0016020]; microtubule [GO:0005874]; vesicle [GO:0031982]; auditory receptor cell development [GO:0060117]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; eye photoreceptor cell differentiation [GO:0001754]; glial cell differentiation [GO:0010001]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P granule organization [GO:0030719]; photoreceptor cell maintenance [GO:0045494]","","","",""
"1340","sp|Q03060|CREM_HUMAN","lcl|NC_088862.1_cds_XP_065929925.1_48582",1.31e-59,194,"Q03060","CREM_HUMAN","cAMP-responsive element modulator (Inducible cAMP early repressor) (ICER)","CREM","Homo sapiens (Human)",345,"GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0006687; GO:0007165; GO:0007283; GO:0008140; GO:0016020; GO:0030154; GO:0045944; GO:0048511; GO:1990589; GO:1990837","cell differentiation [GO:0030154]; glycosphingolipid metabolic process [GO:0006687]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]","ATF4-CREB1 transcription factor complex [GO:1990589]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; cAMP response element binding protein binding [GO:0008140]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; glycosphingolipid metabolic process [GO:0006687]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]","","","","TISSUE SPECIFICITY: Expressed in testes (round spermatids) (at protein level). Isoform 14 is the major activator form in testes. {ECO:0000269|PubMed:11044457, ECO:0000269|PubMed:14511788, ECO:0000269|PubMed:16143638}."
"1341","sp|P42271|TBG2_DROME","lcl|NC_088862.1_cds_XP_065929931.1_50680",0,729,"P42271","TBG2_DROME","Tubulin gamma-2 chain (Gamma-2-tubulin)","gammaTub37C Tub37CD TubG2 TubG37C CG17566","Drosophila melanogaster (Fruit fly)",457,"GO:0000070; GO:0000212; GO:0000278; GO:0000931; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007020; GO:0007052; GO:0007057; GO:0007312; GO:0031122; GO:0051301; GO:0051316; GO:0072687; GO:0090221; GO:0140490","attachment of meiotic spindle microtubules to kinetochore [GO:0051316]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; meiotic spindle organization [GO:0000212]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; mitotic spindle-templated microtubule nucleation [GO:0090221]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; spindle assembly involved in female meiosis I [GO:0007057]","centrosome [GO:0005813]; cytoplasm [GO:0005737]; gamma-tubulin ring complex [GO:0000931]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; GTP binding [GO:0005525]; microtubule nucleator activity [GO:0140490]; attachment of meiotic spindle microtubules to kinetochore [GO:0051316]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; meiotic spindle organization [GO:0000212]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; mitotic spindle-templated microtubule nucleation [GO:0090221]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; spindle assembly involved in female meiosis I [GO:0007057]","DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. Zygotic expression is restricted to adult females. {ECO:0000269|PubMed:9133431, ECO:0000269|PubMed:9155007}.","","","TISSUE SPECIFICITY: Expressed in nurse cells and oocytes of developing egg chambers. {ECO:0000269|PubMed:9133431, ECO:0000269|PubMed:9698447}."
"1342","sp|Q9VQ89|MIO_DROME","lcl|NC_088862.1_cds_XP_065930114.1_50911",3.52e-110,359,"Q9VQ89","MIO_DROME","GATOR2 complex protein Mio (Protein missing oocyte)","mio CG7074","Drosophila melanogaster (Fruit fly)",867,"GO:0001674; GO:0005634; GO:0005737; GO:0005764; GO:0006302; GO:0007293; GO:0008270; GO:0009994; GO:0010507; GO:0010508; GO:0030716; GO:0032008; GO:0032991; GO:0034198; GO:0035859; GO:0040020; GO:0044754; GO:0045793; GO:0051301; GO:0051321; GO:0061700; GO:1904263","cell division [GO:0051301]; cellular response to amino acid starvation [GO:0034198]; double-strand break repair [GO:0006302]; germarium-derived egg chamber formation [GO:0007293]; meiotic cell cycle [GO:0051321]; negative regulation of autophagy [GO:0010507]; oocyte differentiation [GO:0009994]; oocyte fate determination [GO:0030716]; positive regulation of autophagy [GO:0010508]; positive regulation of cell size [GO:0045793]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of meiotic nuclear division [GO:0040020]","autolysosome [GO:0044754]; cytoplasm [GO:0005737]; female germ cell nucleus [GO:0001674]; GATOR2 complex [GO:0061700]; lysosome [GO:0005764]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Seh1-associated complex [GO:0035859]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to amino acid starvation [GO:0034198]; double-strand break repair [GO:0006302]; germarium-derived egg chamber formation [GO:0007293]; meiotic cell cycle [GO:0051321]; negative regulation of autophagy [GO:0010507]; oocyte differentiation [GO:0009994]; oocyte fate determination [GO:0030716]; positive regulation of autophagy [GO:0010508]; positive regulation of cell size [GO:0045793]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of meiotic nuclear division [GO:0040020]","","","","TISSUE SPECIFICITY: Present in the oocyte. {ECO:0000269|PubMed:14973288}."
"1343","sp|Q22531|AMP2_CAEEL","lcl|NC_088862.1_cds_XP_065930131.1_48493",1.26e-144,501,"Q22531","AMP2_CAEEL","Putative aminopeptidase-2 (EC 3.4.11.-)","T16G12.1","Caenorhabditis elegans",1890,"GO:0005615; GO:0005737; GO:0006508; GO:0008270; GO:0009792; GO:0016020; GO:0042277; GO:0043171; GO:0046662; GO:0048477; GO:0070006; GO:1903538","embryo development ending in birth or egg hatching [GO:0009792]; oogenesis [GO:0048477]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of egg-laying behavior [GO:0046662]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]","cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; embryo development ending in birth or egg hatching [GO:0009792]; oogenesis [GO:0048477]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of egg-laying behavior [GO:0046662]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]","","","",""
"1344","sp|Q9VMN5|CH60C_DROME","lcl|NC_088862.1_cds_XP_065930249.1_49264",0,811,"Q9VMN5","CH60C_DROME","60 kDa heat shock protein homolog 2, mitochondrial (60 kDa chaperonin) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60)","Hsp60C CG7235","Drosophila melanogaster (Fruit fly)",576,"GO:0005524; GO:0005743; GO:0005759; GO:0006457; GO:0007283; GO:0007301; GO:0007424; GO:0008637; GO:0016887; GO:0030707; GO:0034514; GO:0042026; GO:0045041; GO:0048477; GO:0051087; GO:0140662","apoptotic mitochondrial changes [GO:0008637]; female germline ring canal formation [GO:0007301]; follicle cell of egg chamber development [GO:0030707]; mitochondrial unfolded protein response [GO:0034514]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; protein folding [GO:0006457]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]; spermatogenesis [GO:0007283]","mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein-folding chaperone binding [GO:0051087]; apoptotic mitochondrial changes [GO:0008637]; female germline ring canal formation [GO:0007301]; follicle cell of egg chamber development [GO:0030707]; mitochondrial unfolded protein response [GO:0034514]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; protein folding [GO:0006457]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]; spermatogenesis [GO:0007283]","DEVELOPMENTAL STAGE: Expression first seen in late embryonic stages and continues in larval and adult stages. {ECO:0000269|PubMed:16385159}.","","","TISSUE SPECIFICITY: First detectable expression is seen in the posterior part of the dorsal tracheal trunk at stage 14-15, which marks the beginning of terminal tracheation. In the larval gut, expression in proventriculus is stronger than in midgut and hindgut. Malpighian tubules shows low expression and late third instar larval imaginal disks and brain showed moderate expression. In larval ovary and testis, expression is strong in the posterior region. {ECO:0000269|PubMed:16385159}."
"1345","sp|D3Z2X2|DNHD1_MOUSE","lcl|NC_088862.1_cds_XP_065930278.1_49027",6.87e-82,306,"D3Z2X2","DNHD1_MOUSE","Dynein heavy chain domain-containing protein 1 (Coiled-coil domain-containing protein 35) (Dynein heavy chain domain 1-like protein)","Dnhd1 Ccdc35","Mus musculus (Mouse)",4749,"GO:0005524; GO:0008569; GO:0030286; GO:0030317; GO:0036126; GO:0045505; GO:0051959; GO:0120316","flagellated sperm motility [GO:0030317]; sperm flagellum assembly [GO:0120316]","dynein complex [GO:0030286]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; flagellated sperm motility [GO:0030317]; sperm flagellum assembly [GO:0120316]","","","","TISSUE SPECIFICITY: Expressed in spermatozoa (at protein level). {ECO:0000269|PubMed:34932939}."
